<SEC-DOCUMENT>0001062993-20-005949.txt : 20201130
<SEC-HEADER>0001062993-20-005949.hdr.sgml : 20201130
<ACCEPTANCE-DATETIME>20201130130411
ACCESSION NUMBER:		0001062993-20-005949
CONFORMED SUBMISSION TYPE:	40-F
PUBLIC DOCUMENT COUNT:		145
CONFORMED PERIOD OF REPORT:	20200831
FILED AS OF DATE:		20201130
DATE AS OF CHANGE:		20201130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANIGRAM HOLDINGS INC.
		CENTRAL INDEX KEY:			0001620737
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		40-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38885
		FILM NUMBER:		201357423

	BUSINESS ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3
		BUSINESS PHONE:		506-384-1571

	MAIL ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORGANIGRAM HOLDINGS INC
		DATE OF NAME CHANGE:	20140926
</SEC-HEADER>
<DOCUMENT>
<TYPE>40-F
<SEQUENCE>1
<FILENAME>form40f.htm
<DESCRIPTION>FORM 40-F
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Form 40-F - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><font style="font-size: 18pt;"><b>UNITED STATES </b></font><br><font style="font-size: 18pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></font><br><b>WASHINGTON, D.C.&#160; 20549</b></p>
    <p style="text-align: center;"><font style="font-size: 18pt;"><b>FORM 40-F</b></font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 2%; padding: 5.75pt; vertical-align: top;">
                <p style="text-align: center;">&#9744;</p>
            </td>
            <td style="width: 93%; padding: 5.75pt; vertical-align: top;">
                <p><b>REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 2%; padding: 5.75pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 93%; padding: 5.75pt; vertical-align: top;">
                <p style="text-align: center;">OR</p>
            </td>
        </tr>
        <tr>
            <td style="width: 2%; padding: 5.75pt; vertical-align: top;">
                <p style="text-align: center;">&#9746;</p>
            </td>
            <td style="width: 93%; padding: 5.75pt; vertical-align: top;">
                <p><b>ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
            </td>
        </tr>
    </table>
    <br>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">For the fiscal year ended <u><b>August 31, 2020</b></u><b> </b></p>
            </td>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">Commission File Number: <u><b>001-38885</b></u></p>
            </td>
        </tr>
    </table>
    <p style="text-align: center;"><b><font size="5"><u><font style="font-variant: small-caps;">Organigram Holdings Inc</font>.<br></u></font></b><i>(Exact name of Registrant as specified in its charter)</i></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 29%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;" colspan="2">
                <p style="text-align: center;"><u><b>Canada</b></u></p>
            </td>
            <td style="width: 1%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;">
                <p style="text-align: center;"><b>&#160;</b></p>
            </td>
            <td style="width: 29%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;">
                <p style="text-align: center;"><u><b>2833</b></u></p>
            </td>
            <td style="width: 1%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;">
                <p style="text-align: center;"><b>&#160;</b></p>
            </td>
            <td style="width: 29%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;" colspan="2">
                <p style="text-align: center;"><u><b>N/A</b></u></p>
            </td>
        </tr>
        <tr>
            <td style="width: 29%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;" colspan="2">
                <p style="text-align: center;"><i>(Province or Other Jurisdiction of Incorporation or Organization)</i></p>
            </td>
            <td style="width: 1%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 29%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;">
                <p style="text-align: center;"><i>(Primary Standard Industrial <br>Classification Code)</i></p>
            </td>
            <td style="width: 1%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 29%; padding-right: 5.75pt; padding-left: 5.75pt; vertical-align: top;" colspan="2">
                <p style="text-align: center;"><i>(I.R.S. Employer </i><br><i>Identification No.)</i></p>
            </td>
        </tr>
    </table>
    <p style="text-align: center;"><b>35 English Dr.</b><br><b>Moncton, New Brunswick</b><br><b>Canada E1E 3X3</b><br><u><b>Tel: 1-855-961-9420<br></b></u><i>(Address and telephone number of Registrant's principal executive offices)</i></p>
    <p style="text-align: center;"><b>CORPORATION SERVICE COMPANY </b><br><b>251 Little Falls Drive</b><br><b>County of New Castle</b><br><b>Wilmington, Delaware 19808</b><br><u><b>Tel: 1-800-927-9800<br></b></u><i>(Name, address (including zip code) and telephone number (including </i><br><i>area code) of agent for service in the United States)</i></p>
    <p style="text-align: justify;">Securities registered or to be registered pursuant to Section 12(b) of the Act.</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 31%; padding: 5.75pt; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;">Title of each class</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 28%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding: 5.75pt;">
                <p style="text-align: center;">Trading Symbol</p>
            </td>
            <td style="width: 39%; padding: 5.75pt; vertical-align: top; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;">Name of each exchange on which registered</p>
            </td>
        </tr>
        <tr>
            <td style="width: 31%; padding: 5.75pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Common Shares</b></p>
            </td>
            <td style="width: 28%; vertical-align: top; border-left: 0.75pt solid #000000; padding: 5.75pt; border-right: 0.75pt solid #000000; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>OGI</b></p>
            </td>
            <td style="width: 39%; padding: 5.75pt; vertical-align: top; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>NASDAQ Global Select Market</b></p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">Securities registered or to be registered pursuant to Section 12(g) of the Act: <u><b>None</b></u></p>
    <p style="text-align: justify;">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:&#160; <u><b>None</b></u></p>
    <p style="text-align: justify;">For annual reports, indicate by check mark the information filed with this Form:</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#9746; Annual Information Form</p>
            </td>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#9746; Audited Annual Financial Statements</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">Indicate the number of outstanding shares of each of the Registrant's classes of capital or common stock as of the close of the period covered by the annual report: 156,196,347</p>
    <p style="text-align: justify;">Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</p>
    <table style="margin-right: auto; margin-left: auto; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">Yes</p>
            </td>
            <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p>&#9746;</p>
            </td>
            <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">No</p>
            </td>
            <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p>&#9744;</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).</p>
    <table style="margin-right: auto; margin-left: auto; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">Yes</p>
            </td>
            <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p>&#9746;</p>
            </td>
            <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">No</p>
            </td>
            <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p>&#9744;</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.</p>
    <p style="text-align: right;">Emerging growth company &#9746;</p>
    <p style="text-align: justify;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act.&#160; &#160; &#160; &#160; &#160; &#160; &#9744;</p>
    <p style="text-align: justify;">&#8224; The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</p>
    <p style="text-align: justify;">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160; &#160; &#160; &#160; &#160; &#160; &#9744;</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><b>INTRODUCTORY INFORMATION</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Organigram Holdings Inc. (the "<b>Company</b>" or "<b>Organigram</b>") is a "foreign private issuer" as defined in Rule 3b-4 under Securities Exchange Act of 1934, as amended (the "<b>Exchange Act</b>"), and is a Canadian issuer eligible to file its annual report ("<b>Annual Report</b>") pursuant to Section 13 of the Exchange Act on Form 40-F pursuant to the multi-jurisdictional disclosure system (the "<b>MJDS</b>") adopted by the United States Securities and Exchange Commission (the "<b>SEC</b>"). The Company's common shares are listed on the Toronto Stock Exchange and the Nasdaq Global Select Market ("<b>Nasdaq</b>") under the trading symbol "OGI".&#160;</p>
    <p style="text-indent: 36pt; text-align: justify;">In this annual report, references to "we", "our", "us", the "Company" or "Organigram", mean Organigram Holdings Inc. and our wholly-owned subsidiaries, unless the context suggests otherwise.</p>
    <p style="text-indent: 36pt; text-align: justify;">Unless otherwise indicated, all amounts in this annual report are in Canadian dollars and all references to "$" mean Canadian dollar and references to "U.S. dollars" or "US$" are to United States dollars.</p>
    <p style="text-align: center;"><b>PRINCIPAL DOCUMENTS </b></p>
    <p style="text-indent: 36pt; text-align: justify;">The following principal documents are filed as exhibits to, and incorporated by reference into this Annual Report:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 80%; vertical-align: bottom; background-color: #d5dce4; padding-right: 5.03pt; padding-left: 5.03pt; border: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Document</b></p>
            </td>
            <td style="width: 14%; vertical-align: bottom; background-color: #d5dce4; padding-right: 5.03pt; padding-left: 5.03pt; border: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Exhibit No.</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 80%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: bottom; border: 0.75pt solid #000000;">
                <p>Audited consolidated financial statements of the Company and notes thereto as at and for the year ended August 31, 2020, together with the report thereon of the independent registered public accounting firm</p>
            </td>
            <td style="width: 14%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">99.4</p>
            </td>
        </tr>
        <tr>
            <td style="width: 80%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: bottom; border: 0.75pt solid #000000;">
                <p>Management's Discussion and Analysis of the Company for the year ended August 31, 2020 (the "<b>MD&amp;A</b>")</p>
            </td>
            <td style="width: 14%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">99.5</p>
            </td>
        </tr>
        <tr>
            <td style="width: 80%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: bottom; border: 0.75pt solid #000000;">
                <p>Annual Information Form of the Company for the year ended August 31, 2020 (the "<b>AIF</b>")</p>
            </td>
            <td style="width: 14%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">99.6</p>
            </td>
        </tr>
    </table>
    <p style="text-align: center;"><b>FORWARD-LOOKING STATEMENTS</b></p>
    <p style="text-indent: 36pt; text-align: justify;">This Annual Report (including the documents incorporated by reference herein) includes or incorporates by reference certain statements that constitute "forward-looking statements" within the meaning of the United States <i>Private Securities Litigation Reform Act of 1995</i>. These statements appear in a number of places in this Annual Report and include statements regarding our intent, belief or current expectation and that of our officers and directors.&#160; Such statements can be identified by the use of forward-looking terminology such as "outlook", "objective", "may," "will," "could", "would", "might", "expect", "intend", "estimate", "anticipate", "believe", "plan", "continue", "budget", "schedule" or "forecast" or similar expressions suggesting future outcomes or events.&#160; They include, but are not limited to, statements with respect to expectations, forecasts or other characterizations of future events or circumstances, and the Company's objectives, goals, strategies, beliefs, intentions, plans, estimates, projections and outlook, including statements relating to the Company's plans and objectives, or estimates or predictions of actions of customers, suppliers, partners, distributors, competitors or regulatory authorities; and, statements regarding the Company's future economic performance. These statements are not historical facts but instead represent management beliefs regarding future events, many of which, by their nature are inherently uncertain and beyond management control. Forward-looking information has been based on the Company's current expectations about future events.</p>
    <p style="text-indent: 36pt; text-align: justify;">Forward-looking statements in this Annual Report include, but are not limited to, statements with respect to:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Moncton Campus (as defined in the AIF) licensing and target capacity and timing thereof;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Expectations regarding production capacity, facility size, THC content, costs and yields;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The impact of the current global health crisis caused by COVID-19 (as defined in the AIF);</p>
        </li>
    </ul>
    <p>&#160;</p>
    <div id="footer_page_3">
        <p style="text-align: center;">1</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Expectations around demand for cannabis and related products, future opportunities and sales including the relative mix of medical versus adult-use recreational products, the relative mix of products within the adult-use recreational category including wholesale, the Company's financial position, future liquidity and other financial results;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Legislation of additional cannabis types and forms for adult-use in Canada including regulations relating thereto and the implementation thereof and our future product forms;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Expectations around branded products and derivative-based products with respect to timing, launch, product attributes, composition and consumer demand;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Strategic investments and capital expenditures, and expected related benefits;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Expectations regarding the resolution of litigation and other legal proceedings;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The general continuance of current, or where applicable, assumed industry conditions;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Changes in laws, regulations and guidelines, including the recreational and medical cannabis market;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Price of cannabis and derivative cannabis products;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Impact of the Company's cash flow and financial performance on third parties, including its supply partners;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Fluctuations in the price of the Company's common shares and the market for the Company's common shares;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Treatment of the Company's business under governmental regulatory regimes and tax laws, including the Excise Act (as defined in the AIF) and the renewal of the Company's license thereunder and the Company's ability to obtain export licenses from time to time;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The Company's growth strategy, targets for future growth and forecasts of the results of such growth;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Expectations concerning access to capital and liquidity and the Company's ability to access the public markets to fund operational activities and growth;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The Company's ability to remain listed on the TSX and Nasdaq and the impact of any actions it may be required to take to remain listed;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The ability of the Company to generate cash flow from operations and from financing activities;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The competitive conditions of the industry, including the Company's ability to maintain or grow its market share;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Expectations with respect to the success of the Company's research and development initiatives;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The scope of protection the Company is able to establish and maintain, if any, for its intellectual property rights;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The Company's ability to enter into and maintain strategic arrangements with distributors and retailers and the potential costs and benefits of such arrangements;</p>
        </li>
    </ul>
    <div id="footer_page_4">
        <p style="text-align: center;">2</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The Company's anticipated investments in community relations, cannabis health and safety education programming in the locations where the Company operates and the further development of its social responsibility programs;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The targeting of international opportunities as the laws and regulations governing cannabis evolve internationally;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The legalization of industrial hemp or cannabis for medical use or adult recreational use in jurisdictions outside of Canada and the Company's ability to participate in any such markets, if and when such use is legalized;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The Company's ability to import and export cannabis, hemp, and cannabis and hemp extracts to/from foreign jurisdictions it may identify from time to time;</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>Whether key personnel will continue their employment with the Company; and</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>The Company's plan with respect to the payment of dividends.</p>
        </li>
    </ul>
    <p style="text-indent: 36pt; text-align: justify;">Forward-looking statements are provided for the purposes of assisting the reader in understanding the Company and its business, operations, risks, financial performance, financial position and cash flows as at and for the periods ended on certain dates and to present information about management's current expectations and plans relating to the future and the reader is cautioned that such statements may not be appropriate for other purposes. Forward-looking statements do not guarantee future performance and involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in the forward-looking statements. In addition, this Annual Report may contain forward-looking statements attributed to third party industry sources. Undue reliance should not be placed on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the expectations, predictions, forecasts, projections and, conclusions will not occur or prove accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.</p>
    <p style="text-indent: 36pt; text-align: justify;">Factors that could cause actual results to differ materially from those set forth in forward-looking statements include, but are not limited to: financial risks; dependence on senior management, the board of directors of the Company (the &#8220;<b>Board of Directors</b>&#8221;), consultants and advisors; availability and sufficiency of insurance including continued availability and sufficiency of director and officer and other forms of insurance; the Company and its subsidiaries being able to, where applicable, cultivate cannabis pursuant to applicable law and on the currently anticipated timelines; industry competition; general economic conditions and global events including COVID-19 retail store closures or reduced sales at retail stores or otherwise due to COVID-19; heightened uncertainty as a result of COVID-19 including economic and industry uncertainty and governmental action in respect thereto including with respect to&#160; impacts on production, operations, product development, new product launches, disclosure controls and procedures or internal control over financial reporting, including as they may be impacted by delays in remediation due to work from home policies and other COVID 19&#160; impacts, demand for products and services,&#160; third-party suppliers or service providers, and any existing or new international business partnerships; production facilities running at less than full capacity due to reduced workforce for reasons related to COVID-19 (as described herein) and market demand; potential supply chain and distribution disruptions; product development, facility and technological risks; changes to government laws, regulations or policy, including environmental or tax, or the enforcement thereof; agricultural risks; ability to maintain any required licenses or certifications; supply risks; product risks; construction delays or postponements; packaging and shipping logistics; expected number of medical and adult-use recreational cannabis users in Canada and internationally; potential time frame for the implementation of legislation to legalize cannabis internationally; the Company&#8217;s, its subsidiaries and its investments&#8217; ability to, where applicable, obtain and/or maintain their status as Licensed Producers (as defined in the AIF) or other applicable licenses; risk factors affecting its investments; availability of any required financing on commercially attractive terms or at all; non-compliance with debt covenants; the potential size of the regulated adult-use recreational cannabis market in Canada; demand for and changes in the Company&#8217;s cannabis and related products, including the Company&#8217;s Rec 2.0 products (as defined in the MD&amp;A), and the sufficiency of the retail networks to supply such demand; ability to enter and participate in international market opportunities; general economic, financial market, regulatory, industry and political conditions affecting the Company; the ability of the Company to compete in the cannabis industry and changes in the competitive landscape; a material decline in cannabis prices; the Company&#8217;s ability to manage anticipated and unanticipated costs; the Company&#8217;s ability to implement and maintain effective internal controls over financial reporting and disclosure controls and procedures; and, other risks and factors described from time to time in the documents filed by the Company with securities regulators. Material factors and assumptions used in establishing forward-looking information include that construction and production activities will proceed as planned and demand for cannabis and related products will change in the manner expected by management, in each case after taking into account any impacts related to COVID-19 that are currently known or predicted by management based on the limited information available and the fluidity and uncertainty of the crisis.&#160;</p>
    <div id="footer_page_5">
        <p style="text-align: center;">3</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <p style="text-indent: 36pt; text-align: justify;">All forward-looking information is provided as of the date of this Annual Report. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as and to the extent required by applicable law, including applicable United States federal securities laws.</p>
    <p style="text-indent: 36pt; text-align: justify;">See also "Risk Factors" in the MD&amp;A and the AIF.&#160;</p>
    <p style="text-align: center;"><b>NOTE TO UNITED STATES READERS REGARDING DIFFERENCES </b><br><b>BETWEEN UNITED STATES AND CANADIAN REPORTING PRACTICES </b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Company is permitted to prepare this Annual Report in accordance with Canadian disclosure requirements, which are different from those of the United States. The Company prepares its consolidated financial statements in accordance with International Financial Reporting Standards ("<b>IFRS</b>"), as issued by the International Accounting Standards Board (the "<b>IASB</b>"), which differ in certain respects from United States generally accepted accounting principles ("<b>US GAAP</b>") and from practices prescribed by the SEC. Therefore, the Company's financial statements incorporated by reference in this Annual Report may not be comparable to financial statements prepared in accordance with U.S. GAAP.&#160;</p>
    <p style="text-align: center;"><b>CURRENCY</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Unless otherwise indicated, all dollar amounts in this Annual Report are in Canadian dollars.&#160; The exchange rate of Canadian dollars into United States dollars, on August 31, 2020 based upon the daily exchange rate as quoted by the Bank of Canada was U.S.$1.00 = Cdn.$1.30.</p>
    <p style="text-align: center;"><b>TAX MATTERS</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Purchasing, holding, or disposing of the Company's securities may have tax consequences under the laws of the United States and Canada that are not described in this Annual Report.</p>
    <p style="text-align: center;"><b>DISCLOSURE CONTROLS AND PROCEDURES</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Disclosure controls and procedures are defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act to mean controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms and includes, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</p>
    <p style="text-indent: 36pt; text-align: justify;">As of the end of the period covered by this report, our management carried out an evaluation, with the participation of our Chief Executive Officer ("<b>CEO</b>") and Chief Financial Officer ("<b>CFO</b>"), of the effectiveness of our disclosure controls and procedures. Based upon that evaluation, our CEO and CFO concluded that, as of the end of the period covered by this report, our disclosure controls and procedures, as defined in Rule 13a-15(e), were not effective because of the material weaknesses in our internal control over financial reporting described below.</p>
    <div id="footer_page_6">
        <p style="text-align: center;">4</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <p style="text-indent: 36pt; text-align: justify;">Regardless of how well the disclosure controls and procedures and internal control over financial reporting are designed, internal controls have inherent limitations and can only provide reasonable assurance that the controls are meeting the Company's objectives in providing reliable financial reporting information in accordance with IFRS as issued by the IASB. These inherent limitations include, but are not limited to, human error and circumvention of controls and as such, there can be no assurance that the controls will prevent or detect all misstatements due to errors or fraud, if any.</p>
    <p style="text-align: center;"><b>INTERNAL CONTROL OVER FINANCIAL REPORTING</b></p>
    <p style="text-align: justify;"><b>Internal Control over Financial Reporting</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Internal control over financial reporting, as defined by Rule 13a-15(f) and 15d-15(f) of the Exchange Act, is a process designed by, or under the supervision of the Company's principal executive and principal financial officers or persons performing similar functions and effected by the Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS as issued by the IASB.&#160; Internal control over financial reporting includes policies and procedures that:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 27.45pt; text-align: justify; padding-left: 8.25pt;">
            <p>pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;</p>
        </li>
        <li style="margin-left: 27.45pt; text-align: justify; padding-left: 8.25pt;">
            <p>provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the company; and</p>
        </li>
        <li style="margin-left: 27.45pt; text-align: justify; padding-left: 8.25pt;">
            <p>provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.</p>
        </li>
    </ul>
    <p style="text-indent: 36pt; text-align: justify;">In connection with the Company's reporting obligations in Canada and its obligations under Rule 13a-15(c) under the Exchange Act, management, under the supervision and with the participation of its CEO and CFO, conducted an evaluation of the effectiveness of the Company's internal control over financial reporting as of August 31, 2020, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013). Based on this evaluation management concluded that certain material weaknesses existed as of August 31, 2020, as described at page 39 of the MD&amp;A, filed as Exhibit 99.5 to this Annual Report.</p>
    <p style="text-align: justify;"><b>No Auditor's Attestation Report</b></p>
    <p style="text-indent: 36pt; text-align: justify;">As an "emerging growth company" (as such term is defined in Rule 12b-2 under the Exchange Act), the Company is not required to include in this Annual Report an attestation report of the Company's independent registered public accounting firm relating to the Company's internal control over financial reporting. The Company will be required to provide an attestation report when it no longer qualifies as an emerging growth company.</p>
    <p style="text-align: justify;"><b>No Changes in Internal Control over Financial Reporting</b></p>
    <p style="text-indent: 36pt; text-align: justify;">There have been no changes to the Company's internal control over financial reporting during the year ended August 31, 2020 that have materially affected, or are likely to materially affect, the Company's internal control over financial reporting.&#160;</p>
    <p style="text-align: center;"><b>CORPORATE GOVERNANCE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Board of Directors is responsible for the Company&#8217;s corporate governance and has the following separately designated standing committees: the Governance and Nominating Committee, the Compensation Committee, the Investment Committee, and the Audit Committee.&#160; The respective charters of the Governance and Nominating Committee, the Compensation Committee, the Investment Committee, and the Audit Committee can be viewed on the Company&#8217;s corporate website at <font style="color: #0000ff;"><u>www.organigram.ca</u></font>.&#160; In addition, the Company&#8217;s Audit Committee Charter is attached as Appendix &#8220;A&#8221; to the AIF, which is filed as Exhibit 99.6 to this Annual Report.</p>
    <div id="footer_page_7">
        <p style="text-align: center;">5</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <p style="text-align: justify;"><i><b>Governance and Nominating and Compensation Committees </b></i></p>
    <p style="text-indent: 36pt; text-align: justify;">The Governance and Nominating and Compensation Committees are responsible for reviewing, overseeing and evaluating the governance, nominating and compensation policies of the Company. The Committee mandates include: (a) assessing the effectiveness of the Board of Directors, each of its committees and individual directors; (b) overseeing the recruitment and selection of candidates to be nominated for election as directors; (c) organizing an orientation and education program for new directors; (d) considering and approving proposals by the directors to engage outside advisors on behalf of the Board of Directors as a whole or on behalf of the independent directors; (e) reviewing and making recommendations to the Board of Directors concerning the size, composition and structure of the Board of Directors and its committees; (f) overseeing management succession; (g) administering any securities-based compensation plans of the Company; (h) assessing the performance of the Company's management; (i) reviewing and approving the compensation paid by the Company, if any, to the Company's officers; and (j) reviewing and making recommendations to the Board of Directors concerning the level and nature of the compensation payable to Company's directors and officers.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Compensation Committee reviews and makes recommendations to the Board of Directors at least annually with respect to the compensation of the Chief Executive Officer and other senior executive officers of the Company, including incentive compensation plans, equity-based plans, the terms of any employment agreements, severance arrangements, and change of control arrangements or provisions, and any special or supplemental benefits. In considering compensation matters, the Committee is required under its Charter to be guided by the following principles: (a) offering competitive compensation to attract, retain and motivate the very best qualified individuals in order for the Company to meet its goals; and (b) acting in the interests of the Company by being fiscally responsible.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Company's Governance and Nominating and Compensation Committees are required under their Charter to meet at least semi-annually and more frequently as circumstances require. The Governance and Nominating Committee is comprised of Geoffrey Machum (Chair), Sherry Porter and Dexter John.&#160; The Compensation Committee is comprised of Sherry Porter (Chair), Geoffrey Machum and Ken Manget. The Board of Directors has determined that all three members of each of the Governance and Nominating and the Compensation Committees are independent, based on the criteria for independence prescribed by Rule 5605(a)(2) of the Nasdaq Marketplace Rules.</p>
    <p style="text-align: justify;"><i>Investment Committee</i></p>
    <p style="text-indent: 36pt; text-align: justify;">The Investment Committee's mandate is to assist the Board of Directors in discharging the Board of Directors' oversight responsibilities relating to proposed acquisitions, dispositions, major capital investments and financing arrangements.&#160; The Investment Committee is responsible for: (a) reviewing at least quarterly with management the Company's strategic business objectives, including potential acquisitions, dispositions, transaction opportunities and financing arrangements; (b) convening with management as needed to discuss and assess such opportunities, and reviewing and evaluating such opportunities with management on a regular basis; (c) monitoring the performance of the Company's completed transactions and investments by conducting periodic reviews for the purposes of evaluating the degree of success achieved, assessing the accuracy of projections and other assumptions relied upon in approving transactions, identifying the factors that differentiate more successful transactions from less successful ones, and evaluating the strategic contributions resulting from transactions; (d) considering, in conjunction with the Audit Committee as appropriate, the accounting treatment and impact of proposed investments; (e) when appropriate, making recommendations to the Board of Directors in respect of a proposed acquisition, disposition, financing or other arrangement (provided, however, that management may approve, without the requirement for further Committee or Board of Directors action, corporate development, business development, acquisitions and divestiture transactions in the normal course of business involving consideration up to CAD$5,000,000); and (f) considering conformance with applicable law and compliance elements of proposed investments.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Investment Committee is comprised of Dexter John (Chair), Stephen Smith and Ken Manget. The Board of Directors has determined that all three members of the Investment Committee are independent, based on the criteria for independence prescribed by Rule 5605(a)(2) of the Nasdaq Marketplace Rules.</p>
    <div id="footer_page_8">
        <p style="text-align: center;">6</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <p style="text-align: center;"><b>AUDIT COMMITTEE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Our Board of Directors has established the Audit Committee in accordance with section 3(a)(58)(A) of the Exchange Act and Rule 5605(c) of the Nasdaq Marketplace Rules for the purpose of overseeing our accounting and financial reporting processes and the audits of our annual financial statements.&#160;</p>
    <p style="text-indent: 36pt; text-align: justify;">The Audit Committee is comprised of Stephen Smith (Chair), Ken Manget and Dexter John.&#160; Our Board of Directors has determined that the Audit Committee meets the composition requirements set forth by Section 5605(c)(2) of the Nasdaq Marketplace Rules, and that each of the members of the Audit Committee is independent as determined under Rule 10A-3 of the Exchange Act and Rule 5605(a)(2) of the Nasdaq Marketplace Rules. All three members of the Audit Committee are financially literate, meaning they are able to read and understand the Company's financial statements and to understand the breadth and level of complexity of the issues that can reasonably be expected to be raised by the Company's financial statements.&#160;</p>
    <p style="text-indent: 36pt; text-align: justify;">Our Board of Directors has determined that Stephen Smith:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>qualifies as an "audit committee financial expert" (as defined in paragraph (8)(b) of General Instruction B to Form 40-F),</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>has past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in his financial sophistication (pursuant to Rule 5605(c)(2)(A) of the Nasdaq Marketplace Rules), and</p>
        </li>
        <li style="margin-left: 63.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>is independent (as determined under Exchange Act Rule 10A-3 and Rule 5605(a)(2) of the Nasdaq Marketplace Rules).</p>
        </li>
    </ul>
    <p style="text-align: center;"><b>PRE-APPROVAL OF AUDIT AND NON-AUDIT SERVICES PROVIDED BY</b><br><b>INDEPENDENT AUDITOR</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Audit Committee Charter sets out responsibilities regarding the provision of non-audit services by the Company's external auditors and requires the Audit Committee to pre-approve all permitted non-audit services to be provided by the Company's external auditors, in accordance with applicable law.</p>
    <p style="text-align: center;"><b>PRINCIPAL ACCOUNTING FEES AND SERVICES</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Tabular disclosure of the amounts billed to us by our independent auditor for each of our last two fiscal years ended August 31, as Audit Fees, Audit-Related Fees, Tax Fees and All Other Fees, is made on page 62 of the AIF, filed as Exhibit 99.6 to this Annual Report.</p>
    <p style="text-align: justify;"><b>Audit Fees</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Audit Fees include fees necessary to perform the annual audit and quarterly reviews of the Company&#8217;s financial statements. Audit Fees include fees for review of tax provisions and for accounting consultations on matters reflected in the financial statements. Audit Fees also include audit or other attest services required by legislation or regulation, such as comfort letters, consents, reviews of securities filings and statutory audits.&#160; For the year ended August 31, 2020, Audit Fees were comprised of quarterly reviews and the annual audit, and <b></b>fees with respect to a base shelf prospectus and two prospectus supplements documents filed by the Company.</p>
    <p style="text-align: justify;"><b>Audit-Related Fees</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Audit&#8211;Related Fees include fees for assurance and related services that are related to the performance of the review of the financial statements, including fees for review of the Company&#8217;s Annual Information Form.&#160; For the year ended August 31, 2020, Audit-Related Fees were comprised of fees for Canadian Public Accountability Board (&#8220;<b>CPAB</b>&#8221;) participation, and, for the year ended August 31, 2019, Audit-Related Fees were comprised of CPAB participation fees.</p>
    <div id="footer_page_9">
        <p style="text-align: center;">7</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <p style="text-align: justify;"><b>Tax Fees</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Tax Fees include fees for all tax services other than those included in "Audit Fees" and "Audit-Related Fees". This category includes fees for tax compliance, tax planning and tax advice. Tax planning and tax advice includes assistance with tax audits and appeals, tax advice related to mergers and acquisitions, and requests for rulings or technical advice from tax authorities.&#160;</p>
    <p style="text-align: justify;"><b>All Other Fees</b></p>
    <p style="text-indent: 36pt; text-align: justify;">All other fees relate to services other than the Audit Fees, Audit-Related Fees and Tax Fees, and includes fees on consultations on acquisition related matters.</p>
    <p style="text-align: justify;"><b>Audit Committee Pre-Approval Policies</b></p>
    <p style="text-indent: 36pt; text-align: justify;">From time to time, management of the Company recommends to and requests approval from the Audit Committee for audit and non-audit services to be provided by the Company's auditor.&#160;</p>
    <p style="text-indent: 36pt; text-align: justify;">The Audit Committee may delegate to one or more of its members the authority to pre-approve non-audit services to be provided to the Company or its subsidiaries by the Company's external auditor. The pre-approval of non-audit services must be presented to the Audit Committee at its first scheduled meeting following such pre-approval.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Audit Committee may satisfy its duty to pre-approve non-audit services by adopting specific policies and procedures for the engagement of the non-audit services, provided the policies and procedures are detailed as to the particular service, the Audit Committee is informed of each non-audit service and the procedures do not include delegation of the Audit Committee's responsibilities to management.</p>
    <p style="text-align: center;"><b>OFF-BALANCE SHEET ARRANGEMENTS </b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Company has not entered into any "off-balance sheet arrangements", as defined in General Instruction B(11) to Form 40-F, that have or are reasonably likely to have a current or future effect on the Company's financial condition, changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.</p>
    <p style="text-align: center;"><b>CONTRACTUAL OBLIGATIONS</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Tabular disclosure of the Company's contractual obligations as at August 31, 2020 is made on page 41 of the MD&amp;A, filed as Exhibit 99.5 to this Annual Report.</p>
    <p style="text-align: center;"><b>CODE OF ETHICS</b></p>
    <p style="text-indent: 36pt; text-align: justify;">We have adopted a Code of Business Conduct and Ethics (the "<b>Code</b>") that applies to our officers (including without limitation, the CEO, CFO), employees and directors of the Company and its subsidiaries and promotes, among other things, honest and ethical conduct.&#160; The Code meets the requirements for a "code of ethics" within the meaning of that term in Form 40-F.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Code was reviewed and approved by the Board of Directors on August 26, 2020.&#160; The Code is available on the Company's corporate website at <font style="color: #0000ff;"><u>www.organigram.ca</u></font> and under the Company's SEDAR profile on <font style="color: #0000ff;"><u>www.SEDAR.com</u></font> and is filed as Exhibit 99.7 to this Annual Report.</p>
    <div id="footer_page_10">
        <p style="text-align: center;">8</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_11"></a>
    <p style="text-indent: 36pt; text-align: justify;">No waivers of the Code were granted to any principal officer of the Company or any person performing similar functions during the fiscal year ended August 31, 2020.</p>
    <p style="text-align: center;"><b>NOTICES PURSUANT TO REGULATION BTR</b></p>
    <p style="text-indent: 36pt; text-align: justify;">There were no notices required by Rule 104 of Regulation BTR that the Company sent during the year ended August 31, 2020 concerning any equity security subject to a blackout period under Rule 101 of Regulation BTR.</p>
    <p style="text-align: center;"><b>NASDAQ CORPORATE GOVERNANCE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Company complies with corporate governance requirements of both the TSX and Nasdaq. As a foreign private issuer the Company is not required to comply with all of the corporate governance requirements of Nasdaq; however, the Company adopts best practices consistent with domestic Nasdaq listed companies when appropriate to its circumstances.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Company has reviewed the Nasdaq corporate governance requirements and confirms that except as described below, the Company is in compliance with the Nasdaq corporate governance standards in all significant respects:</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Executive Sessions:</i> Under Rule 5605(b)(2) of the Nasdaq Marketplace Rules, a listed company must have regularly scheduled meetings at which only independent directors are present ("<b>executive sessions</b>").&#160; The rule contemplates that executive sessions will occur at least twice a year, and perhaps more frequently, in conjunction with regularly scheduled board meetings.&#160; Under applicable Canadian rules, customs and practice, the Company's independent directors are not required to hold executive sessions.&#160; However, the Company is subject to certain disclosure requirements prescribed in Canadian Form 58-101F1 - <i>Corporate Governance Disclosure</i>.&#160; In particular, the Company must disclose whether the independent directors hold executive sessions and, if such executive sessions are held, how many of these meetings have been held since the beginning of the Company's most recently completed financial year. If the Company does not hold executive sessions, the Company must describe what the Board of Directors does to facilitate open and candid discussion among its independent directors.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Contents of Audit Committee Charter:</i>&#160; Under Rule 5605(c)(1) of the Nasdaq Marketplace Rules, a listed company must adopt a formal written charter that specifies the scope of its responsibilities and the means by which it carries out those responsibilities; the outside auditor's accountability to the audit committee; and the audit committee's responsibility to ensure the independence of the outside auditor.&#160; In accordance with section 2.3(1) of Canadian National Instrument 52-110 - <i>Audit Committees</i>, the Company has adopted an Audit Committee Charter that sets out its mandate and responsibilities, and substantially complies with Rule 5605(c)(1) of the Nasdaq Marketplace Rules. However, the Audit Committee Charter does not strictly comply with the requirement under Rule 5605(c)(1)(B) that an audit committee charter must specify the committee's responsibility for ensuring its receipt from the outside auditors of a formal written statement delineating all relationships between the auditor and the company, with the view to confirming the objectivity and independence of the auditor. Instead, consistent with the laws, customs and practices in Canada, the Company's Audit Committee Charter provides that: (a) the Committee shall satisfy itself, on behalf of the Board of Directors, that the external auditor is independent of management; and (b) in assessing such independence, the Committee shall discuss with the external auditor, and may require a letter from the external auditor outlining, any relationships between the external auditor and the Company or its affiliates.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Composition of Compensation Committee:</i>&#160; Under Rule 5605(d)(1) of the Nasdaq Marketplace Rules, a listed company must adopt a formal written compensation committee charter that specifies the scope of its responsibilities and the means by which it carries out those responsibilities, including structure, processes and membership requirements.&#160; Rule 5605(d)(2)(A) requires that, subject to a limited exception, the compensation committee must be composed of at least two members, each of whom must be an independent director as defined in Rule 5605(a)(2).</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Independent Director Oversight of Director Nominations:</i>&#160; Rule 5605(e)(1) of the Nasdaq Marketplace Rules prescribes that, subject to a limited exception, director nominees must either be selected, or recommended for the Board of Directors' selection, either by: (a) independent directors (as defined in Rule 5605(a)(2)) constituting a majority of the Board of Directors' independent directors in a vote in which only independent directors participate, or (b) a nominations committee comprised solely of independent directors.&#160; Rule 5605(e)(2) requires a listed company to adopt a formal written charter or board resolution, as applicable, addressing the nominations process and such related matters as may be required under United States federal securities laws.</p>
    <div id="footer_page_11">
        <p style="text-align: center;">9</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_12"></a>
    <p style="text-indent: 36pt; text-align: justify;"><i>The Company's Governance and Nominating Committee and Compensation Committee</i>: The Company has adopted a Governance and Nominating Committee Charter and a Compensation Committee Charter that substantially comply with Rules 5605(d)(1) and Rule 5605(e)(2) of the Nasdaq Marketplace Rules.&#160; However, in contrast to the requirements of Rules 5605(d)(2)(A) and 5605(e)(1), the Charters prescribe that only a majority of the Committee (which should be comprised of a minimum of three directors) must be independent as defined in Canadian National Instrument 58 101 - <i>Disclosure of Corporate Governance Practices</i>, and free from any relationship that, in the view of the Board of Directors, could be reasonably expected to interfere with the exercise of his or her independent judgment as a member of the Committee.&#160; This is consistent with the laws, customs and practices in Canada.&#160; As disclosed elsewhere in this Annual Report, the Company's Governance and Nominating Committee is currently comprised of Geoff Machum (Chair), Sherry Porter and Dexter John and the Compensation Committee is currently comprised of Sherry Porter (Chair), Geoff Machum and Ken Manget, each of whom has been determined by the Board of Directors to be independent based on the criteria for independence prescribed by Rule 5605(a)(2) of the Nasdaq Marketplace Rules.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Shareholder Meeting Quorum Requirement</i>: Under Rule 5620(c) of the Nasdaq Marketplace Rules, a listed company that is not a limited partnership must provide in its by-laws for a quorum of not less than 33 <sup>1</sup>/<sub>3</sub>% of the outstanding shares of the company's common voting stock in respect of all meetings of the holders of its common stock. The Company's Bylaws provide that a quorum for a meeting of shareholders of the Company is present if two persons who are, or who represent by proxy, one or more shareholders who, in the aggregate, hold at least five percent of the issued shares. This quorum requirement is consistent with the laws, customs and practices in Canada.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Proxy Delivery Requirement</i>: Under Rule 5620(b) of the Nasdaq Marketplace Rules, a listed company that is not a limited partnership must solicit proxies and provide proxy statements for all meetings of shareholders, and also provide copies of such proxy solicitation materials to Nasdaq.&#160; The Company is a "foreign private issuer" as defined in Rule 3b-4 under the Exchange Act, and the equity securities of the Company are accordingly exempt from the proxy rules set forth in Sections 14(a), 14(b), 14(c) and 14(f) of the Exchange Act. The Company solicits proxies in accordance with applicable rules and regulations in Canada.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Distribution of Annual Reports:</i>&#160; NASDAQ Marketplace Rule 5250(d) requires a NASDAQ-listed company to make available to shareholders an annual report containing audited financial statements of the company and its subsidiaries (which, for example, may be on 40-F under the Exchange Act) within a reasonable period of time following the filing of the annual report with the SEC. The Company may comply with this requirement either:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 27.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>by mailing the report to shareholders (as opposed to electronic or notice-and-access delivery);</p>
        </li>
        <li style="margin-left: 27.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>by satisfying the requirements for furnishing an annual report contained in Rule 14a-16 under the Exchange Act; or</p>
        </li>
        <li style="margin-left: 27.6pt; text-align: justify; padding-left: 8.4pt;">
            <p>by posting the annual report to shareholders on or through the company's website, along with a prominent undertaking in the English language to provide shareholders, upon request, a hard copy of the annual report free of charge. A company that chooses to satisfy this requirement pursuant in this manner must, simultaneous with this posting, issue a press release stating that its annual report has been filed with the Commission. The press release must also state that: (a) the annual report is available on the company's website and include the website address, and (b) shareholders may receive a hard copy free of charge upon request.&#160;</p>
        </li>
    </ul>
    <div id="footer_page_12">
        <p style="text-align: center;">10</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_13"></a>
    <p style="text-align: justify;">As indicated above, the Company is exempt from the proxy rules set forth in Sections 14(a), 14(b), 14(c) and 14(f) of the Exchange Act (as well as Rule 14a-16 promulgated under the Exchange Act), and solicits proxies in accordance with applicable rules and regulations in Canada.</p>
    <p style="text-align: justify;">Section 437 of the TSX Company Manual requires that: (a) every TSX-listed company must forward annually to each shareholder who has requested them its annual financial statements and its related management's discussion and analysis in accordance with Canadian National Instrument 51-102 - <i>Continuous Disclosure Obligations</i> ("<b>NI 51-102</b>"); and (b) if a listed company produces an annual report, it must be filed publicly through SEDAR, available at <font style="color: #0000ff;"><u>www.sedar.com</u></font>.</p>
    <p style="text-align: justify;">Pursuant to NI 51-102, the Company is required to send annually a request form to the registered holders and beneficial owners of its securities, other than debt instruments, that registered holders and beneficial owners may use to request a copy of the Company's annual financial statements and related management's discussion and analysis, the interim financial statements and related management's discussion and analysis, or both. If a registered holder or beneficial owner of securities, other than debt instruments, of the Company requests the Company's annual or interim financial statements, the Company must send a copy of the requested financial statements to the person or company that made the request, without charge, by the later of: (a) 10 days after the filing deadline for the financial statements, or (b) 10 calendar days after the Company receives the request.&#160; If the Company sends financial statements it must also send, at the same time, the annual or interim management's discussion and analysis relating to the financial statements.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Shareholder Approval Requirements:<b> </b></i> Section 5635 of the Nasdaq Marketplace Rules requires shareholder approval for issuances of common shares, or any securities convertible or exercisable into common shares:</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(a)<font style="width: 24.9pt; text-indent: 0pt; display: inline-block;">&#160;</font>in connection with the acquisition of the stock or assets of another company</p>
    <p style="margin-left: 108pt; text-indent: -36pt; text-align: justify;">(i)<font style="width: 26.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>where, due to the present or potential issuance of common shares (including shares issued pursuant to an earn-out or similar type of provision, or securities convertible into or exercisable for common shares) other than a public offering for cash:</p>
    <p style="margin-left: 126pt; text-indent: -18pt; text-align: justify;">(A)<font style="width: 4.12pt; text-indent: 0pt; display: inline-block;">&#160;</font>the common shares constitute or will upon issuance constitute at least 20% of the voting power outstanding before the issuance of the common shares (or, if applicable before the issuance of the securities convertible into or exercisable for common shares); or</p>
    <p style="margin-left: 126pt; text-indent: -18pt; text-align: justify;">(B)<font style="width: 4.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>the common shares constitute or will upon issuance constitute at least 20% of the number of common shares outstanding before the issuance; or</p>
    <p style="margin-left: 108pt; text-indent: -36pt; text-align: justify;">(ii)<font style="width: 23.78pt; text-indent: 0pt; display: inline-block;">&#160;</font>if any director, officer or Substantial Shareholder (as defined by Rule 5635(e)(3) of the Nasdaq Marketplace Rules) of the listed company has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target company or assets to be acquired, or in the consideration to be paid in the transaction or series of related transactions, and the present or potential issuance of common shares, or securities convertible into or exercisable for common shares, could result in an increase of 5% or more in the outstanding common shares or voting power of the listed company;</p>
    <p style="margin-left: 36pt; text-align: justify;">(b)<font style="width: 24.34pt; display: inline-block;">&#160;</font>where the common shares sold (or the number of common shares into which the securities sold are convertible or exercisable), either alone or together with sales by officers, directors or Substantial Shareholders of the listed company, constitute at least</p>
    <p style="margin-left: 72pt; text-align: justify;">(i)<font style="width: 26.56pt; display: inline-block;">&#160;</font>20% of the outstanding common shares before the issuance, or</p>
    <p style="margin-left: 72pt; text-align: justify;">(ii)<font style="width: 23.78pt; display: inline-block;">&#160;</font>20% of the voting power of the outstanding common shares before the issuance,</p>
    <div id="footer_page_13">
        <p style="text-align: center;">11</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_14"></a>
    <p style="margin-left: 36pt; text-align: justify;">in either case except for (A) public offerings of common shares for cash, and (B) transactions involving the sale, issuance or potential issuance of common shares at a price, or securities convertible or exercisable into common shares with a conversion or exercise price, that is greater than or equal to the lesser of (1) the last closing price immediately preceding the signing of a binding agreement, and (2) the average closing price of the common shares on Nasdaq for the five trading days immediately preceding the signing of the binding agreement; and</p>
    <p style="text-indent: 36pt; text-align: justify;">(c)<font style="width: 24.9pt; text-indent: 0pt; display: inline-block;">&#160;</font>where the issuance would result in a change of control of the listed company.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Company intends to follow TSX rules for shareholder approval of new issuances of its common shares. Following TSX rules, shareholder approval is required for certain issuances of shares that: (i) materially affect control of the listed issuer; or (ii) provide consideration to insiders in aggregate of 10% or greater of the market capitalization of the listed issuer, during any six-month period, and has not been negotiated at arm's length. Shareholder approval is also required, pursuant to TSX rules, in the case of private placements: (a) for an aggregate number of listed securities issuable greater than 25% of the number of securities of the listed issuer which are outstanding, on a non-diluted basis, prior to the date of closing of the transaction if the price per security is less than the market price; or (b) that during any six month period are to insiders for listed securities or options, rights or other entitlements to listed securities greater than 10% of the number of securities of the listed issuer which are outstanding, on a non-diluted basis, prior to the date of the closing of the first private placement to an insider during the six month period. The rules of the TSX also require shareholder approval in connection with an acquisition by a listed issuer where the number of securities issued or issuable in payment of the purchase price for the acquisition exceeds 25% of the number of securities of the listed issuer that are outstanding, on a non-diluted basis.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Equity Compensation Plans:<b> </b></i>Section 5635(c) of the Nasdaq Marketplace Rules also requires shareholder approval of all stock option or purchase plans or other arrangements that provide for equity securities as compensation to officers, directors, employees or consultants, and any material amendments to such plans or arrangements, except for certain plans and arrangements, including:</p>
    <p style="margin-left: 36pt; text-align: justify;">(a)<font style="width: 24.9pt; display: inline-block;">&#160;</font>stock purchase plans available on equal terms to all security holders of the listed company (such as a typical dividend reinvestment plan);</p>
    <p style="margin-left: 36pt; text-align: justify;">(b)<font style="width: 24.34pt; display: inline-block;">&#160;</font>tax qualified, non-discriminatory employee benefit plans (e.g., plans that meet the requirements of section 401(a) or 423 of the Internal Revenue Code) or parallel nonqualified plans, provided that such plans are approved by the listed company's independent compensation committee or a majority of the company's independent directors;</p>
    <p style="margin-left: 36pt; text-align: justify;">(c)<font style="width: 24.9pt; display: inline-block;">&#160;</font>those plans or arrangements allowing employees, directors or service providers to buy such securities on the open market or from the listed company for current fair market value;</p>
    <p style="margin-left: 36pt; text-align: justify;">(d)<font style="width: 24.34pt; display: inline-block;">&#160;</font>grants of options or other equity-based compensation as a material inducement to the grantee's entering into employment with the listed company, provided that such grants are approved by the listed company's independent compensation committee or a majority of the company's independent directors; and</p>
    <p style="margin-left: 36pt; text-align: justify;">(e)<font style="width: 24.9pt; display: inline-block;">&#160;</font>conversions, replacements or adjustments of outstanding options or other equity compensation awards to reflect a merger or acquisition.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Company intends to follow TSX rules in respect of its security based compensation arrangements.&#160; The TSX requires shareholder approval of all security based compensation arrangements, and any material amendments to such arrangements, except for arrangements used as an inducement to persons or companies not previously employed by and not previously an insider of the listed issuer, provided that: (i) such persons or companies enter into a contract of full time employment as an officer of the listed issuer; and (ii) the number of securities made issuable to such persons or companies during any twelve month period does not exceed in aggregate 2% of the number of securities of the listed issuer which are outstanding, on a non-diluted basis, prior to the date the exemption is first used during such twelve month period. Such shareholder approval is required when the security based arrangement is instituted and every three years thereafter if the arrangement does not have a fixed maximum aggregate of securities issuable. The TSX considers a security based compensation arrangement to be any compensation or incentive mechanism involving the issuance from treasury or potential issuance from treasury of securities of a listed issuer.</p>
    <div id="footer_page_14">
        <p style="text-align: center;">12</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_15"></a>
    <p style="text-indent: 36pt; text-align: justify;">Insiders of a listed issuer that are entitled to receive a benefit under a security based compensation arrangement are not eligible to vote their securities in respect of the shareholder approval required by the TSX unless such security based compensation arrangement contains an "insider participation limit". An "insider participation limit" is a provision typically found in security based compensation arrangements which limits the number of a listed issuer's securities: (i) issued to insiders of the listed issuer, within any one year period; and (ii) issuable to insiders of the listed issuer at any time, to 10% of the listed issuer's total issued and outstanding securities. For the purposes of security based compensation arrangements, the definition of "insider" would include the CEO, CFO, all directors of the listed issuer and its major subsidiaries, any person responsible for a principal business unit, division or function, and any shareholder that has beneficial ownership or control or direction over, more than 10% of the issued and outstanding common shares of the listed issuer. The Company obtains shareholder approval of its equity compensation plans in accordance with applicable rules and regulations of the TSX.</p>
    <p style="text-indent: 36pt; text-align: justify;">The foregoing are consistent with the laws, customs and practices in Canada.</p>
    <p style="text-align: center;"><b>MINE SAFETY DISCLOSURE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Not applicable.</p>
    <p style="text-align: center;"><b>UNDERTAKING AND CONSENT TO SERVICE OF PROCESS</b></p>
    <p style="text-align: justify;"><b>Undertaking</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Company undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the securities registered pursuant to Form 40-F; the securities in relation to which the obligation to file an annual report on Form 40-F arises; or transactions in said securities.</p>
    <p style="text-align: justify;"><b>Consent to Service of Process</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Company has previously filed with the SEC a written consent to service of process on Form F-X. Any change to the name or address of the Company's agent for service shall be communicated promptly to the SEC by amendment to the Form F-X referencing the file number of the Company.</p>
    <div id="footer_page_15">
        <p style="text-align: center;">13</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_16"></a>
    <p style="text-align: center;"><b>SIGNATURES</b></p>
    <p style="text-align: justify;">Pursuant to the requirements of the Exchange Act, the Company certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this annual report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 47%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p>Date:&#160; November 30, 2020</p>
            </td>
            <td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p><font style="font-variant: small-caps;"><b>Organigram Holdings Inc.</b></font></p>
                <p style="margin-left: 21.6pt; text-indent: -21.6pt;">By:<font style="display: inline-block; width: 8pt;">&#160;</font>/s/ Gregory Engel&#160; <br>______________________________<br><b>Gregory Engel</b><br><b>Chief Executive Officer</b></p>
            </td>
        </tr>
    </table>
    <br>
    <div id="footer_page_16">
        <p style="text-align: center;">14</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_17"></a>
    <p style="text-align: center;"><b>EXHIBIT INDEX</b></p>
    <table style="font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: top;"><b>Exhibit <br>Number</b></td>
            <td style="width: 85%; vertical-align: top;"><b>Exhibit Description</b></td>
        </tr>
        <tr>
            <td style="vertical-align: top;">&#160;</td>
            <td style="width: 85%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #eeeeee;"><a href="exhibit99-1.htm">99.1</a></td>
            <td style="width: 85%; vertical-align: top; background-color: #eeeeee;"><a href="exhibit99-1.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top;"><a href="exhibit99-2.htm">99.2</a></td>
            <td style="width: 85%; vertical-align: top;"><a href="exhibit99-2.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #eeeeee;"><a href="exhibit99-3.htm">99.3</a></td>
            <td style="width: 85%; vertical-align: top; background-color: #eeeeee;"><a href="exhibit99-3.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002&#160;</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top;"><a href="exhibit99-4.htm">99.4</a></td>
            <td style="width: 85%; vertical-align: top;"><a href="exhibit99-4.htm">Audited consolidated financial statements of the Company and notes thereto as at and for the years ended August 31, 2020, together with the report of the Independent Registered Public Accounting Firm thereon</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #eeeeee;"><a href="exhibit99-5.htm">99.5</a></td>
            <td style="width: 85%; vertical-align: top; background-color: #eeeeee;"><a href="exhibit99-5.htm">Management's Discussion and Analysis for the year ended August 31, 2020</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top;"><a href="exhibit99-6.htm">99.6</a></td>
            <td style="width: 85%; vertical-align: top;"><a href="exhibit99-6.htm">Annual Information Form of the Company for the year ended August 31, 2020</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #eeeeee;"><a href="exhibit99-7.htm">99.7</a></td>
            <td style="width: 85%; vertical-align: top; background-color: #eeeeee;"><a href="exhibit99-7.htm">The Company's Code of Business Conduct and Ethics as approved on August 26, 2020</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top;"><a href="exhibit99-8.htm">99.8</a></td>
            <td style="width: 85%; vertical-align: top;"><a href="exhibit99-8.htm">Consent of Deloitte LLP, Independent Registered Public Accounting Firm</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #eeeeee;"><a href="ogi-20200831.xml">101.INS</a></td>
            <td style="width: 85%; vertical-align: top; background-color: #eeeeee;"><a href="ogi-20200831.xml">XBRL Instance</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top;"><a href="ogi-20200831.xsd">101.SCH</a></td>
            <td style="width: 85%; vertical-align: top;"><a href="ogi-20200831.xsd">XBRL Taxonomy Extension Schema</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #eeeeee;"><a href="ogi-20200831_cal.xml">101.CAL</a></td>
            <td style="width: 85%; vertical-align: top; background-color: #eeeeee;"><a href="ogi-20200831_cal.xml">XBRL Taxonomy Extension Calculation Linkbase</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top;"><a href="ogi-20200831_def.xml">101.DEF</a></td>
            <td style="width: 85%; vertical-align: top;"><a href="ogi-20200831_def.xml">XBRL Taxonomy Extension Definition Linkbase</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #eeeeee;"><a href="ogi-20200831_lab.xml">101.LAB</a></td>
            <td style="width: 85%; vertical-align: top; background-color: #eeeeee;"><a href="ogi-20200831_lab.xml">XBRL Taxonomy Extension Label Linkbase</a></td>
        </tr>
        <tr>
            <td style="vertical-align: top;"><a href="ogi-20200831_pre.xml">101.PRE</a></td>
            <td style="width: 85%; vertical-align: top;"><a href="ogi-20200831_pre.xml">XBRL Taxonomy Extension Presentation Linkbase</a></td>
        </tr>
    </table>
    <br>
    <div>
        <div><br></div>
    </div>
    <div id="footer_page_17">
        <p style="text-align: center;">15</p>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><b>CERTIFICATION</b></p>
    <p style="text-align: justify;">I, Greg Engel, certify that:</p>
    <p style="text-align: justify;">1. <font style="width: 26pt; display: inline-block;">&#160;</font>I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.;</p>
    <p style="text-align: justify;">2. <font style="width: 26pt; display: inline-block;">&#160;</font>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
    <p style="text-align: justify;">3. <font style="width: 26pt; display: inline-block;">&#160;</font>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;</p>
    <p style="text-align: justify;">4. <font style="width: 26pt; display: inline-block;">&#160;</font>The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:</p>
    <p style="margin-left: 36pt; text-align: justify;">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
    <p style="margin-left: 36pt; text-align: justify;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
    <p style="margin-left: 36pt; text-align: justify;">(c) Evaluated the effectiveness of the issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
    <p style="margin-left: 36pt; text-align: justify;">(d) Disclosed in this report any change in the issuer's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer's internal control over financial reporting; and</p>
    <p style="text-align: justify;">5. <font style="width: 26pt; display: inline-block;">&#160;</font>The issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer's auditors and the audit committee of the issuer's board of directors (or persons performing the equivalent functions):</p>
    <p style="margin-left: 36pt; text-align: justify;">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer's ability to record, process, summarize and report financial information; and</p>
    <p style="margin-left: 36pt; text-align: justify;">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer's internal control over financial reporting.</p>
    <p style="text-align: justify;">Date:<font style="width: 14.34pt; display: inline-block;">&#160;</font>November 30, 2020</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">&#160;</td>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">By:</p>
            </td>
            <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: justify;">/s/ Greg Engel</p>
            </td>
        </tr>
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">&#160;</td>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000;">
                <p style="margin-bottom: 0pt; text-align: justify;">Greg Engel</p>
                <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Chief Executive Officer</p>
                <p style="margin-top: 0pt; text-align: justify;">(Principal Executive Officer)</p>
            </td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibit 99.2 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><b>CERTIFICATION</b></p>
    <p style="text-align: justify;">I, Derrick West, certify that:</p>
    <p style="text-align: justify;">1. <font style="width: 26pt; display: inline-block;">&#160;</font>I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.;</p>
    <p style="text-align: justify;">2. <font style="width: 26pt; display: inline-block;">&#160;</font>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
    <p style="text-align: justify;">3. <font style="width: 26pt; display: inline-block;">&#160;</font>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;</p>
    <p style="text-align: justify;">4. <font style="width: 26pt; display: inline-block;">&#160;</font>The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:</p>
    <p style="margin-left: 36pt; text-align: justify;">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
    <p style="margin-left: 36pt; text-align: justify;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
    <p style="margin-left: 36pt; text-align: justify;">(c) Evaluated the effectiveness of the issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
    <p style="margin-left: 36pt; text-align: justify;">(d) Disclosed in this report any change in the issuer's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer's internal control over financial reporting; and</p>
    <p style="text-align: justify;">5. <font style="width: 26pt; display: inline-block;">&#160;</font>The issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer's auditors and the audit committee of the issuer's board of directors (or persons performing the equivalent functions):</p>
    <p style="margin-left: 36pt; text-align: justify;">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer's ability to record, process, summarize and report financial information; and</p>
    <p style="margin-left: 36pt; text-align: justify;">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer's internal control over financial reporting.</p>
    <p style="text-align: justify;">Date:<font style="width: 14.34pt; display: inline-block;">&#160;</font>November 30, 2020</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">&#160;</td>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">By:</p>
            </td>
            <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: justify;">/s/ Derrick West</p>
            </td>
        </tr>
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">&#160;</td>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000;">
                <p style="margin-bottom: 0pt; text-align: justify;">Derrick West</p>
                <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Chief Financial Officer</p>
                <p style="margin-top: 0pt; text-align: justify;">(Principal Financial Officer)</p>
            </td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibit 99.3 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: center;">CERTIFICATION PURSUANT TO</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">18 U.S.C. &#167;1350,</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">AS ADOPTED PURSUANT TO</p>
    <p style="margin-top: 0pt; text-align: center;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
    <p style="text-align: justify;">In connection with the Annual Report of Organigram Holdings Inc. (the "Company") on Form 40-F for the period ended August 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Greg Engel, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</p>
    <p style="text-align: justify;">(1) <font style="width: 19.34pt; display: inline-block;">&#160;</font>The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p>
    <p style="text-align: justify;">(2) <font style="width: 21.84pt; display: inline-block;">&#160;</font>The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
    <p style="text-align: justify;">November 30, 2020</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">&#160;</td>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">By:</p>
            </td>
            <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: justify;">/s/ Greg Engel</p>
            </td>
        </tr>
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">&#160;</td>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000;">
                <p style="margin-bottom: 0pt; text-align: justify;">Greg Engel</p>
                <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Chief Executive Officer</p>
                <p style="margin-top: 0pt; text-align: justify;">(Principal Executive Officer)</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">A signed original of this written statement required by Section 906 has been provided to Organigram Holdings Inc. and will be retained by Organigram Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="margin-bottom: 0pt; text-align: center;">CERTIFICATION PURSUANT TO</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">18 U.S.C. &#167;1350,</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">AS ADOPTED PURSUANT TO</p>
    <p style="margin-top: 0pt; text-align: center;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
    <p style="text-align: justify;">In connection with the Annual Report of Organigram Holdings Inc. (the "Company") on Form 40-F for the period ended August 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Derrick West, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</p>
    <p style="text-align: justify;">(1) <font style="width: 21.84pt; display: inline-block;">&#160;</font>The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p>
    <p style="text-align: justify;">(2) <font style="width: 21.84pt; display: inline-block;">&#160;</font>The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
    <p style="text-align: justify;">November 30, 2020</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">&#160;</td>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">By:</p>
            </td>
            <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: justify;">/s/ Derrick West</p>
            </td>
        </tr>
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">&#160;</td>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000;">
                <p style="margin-bottom: 0pt; text-align: justify;">Derrick West</p>
                <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Chief Financial Officer</p>
                <p style="margin-top: 0pt; text-align: justify;">(Principal Financial Officer)</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">A signed original of this written statement required by Section 906 has been provided to Organigram Holdings Inc. and will be retained by Organigram Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>exhibit99-4.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibit 99.4 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>&#160; <br>
    <p style="text-align: center;"><img src="exhibit99-4xu001.jpg"><br><font style="width: 623pt; display: block;"><br></font></p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify;"><font style="vertical-align: 2pt; color: #85b8d8;">&#160;</font></p>
    <p style="margin-left: 70pt; text-align: justify;"><font style="color: #86b4cd;">TABLE OF CONTENTS</font></p>
    <div style="margin-left: 70pt;">
        <table style="font-size: 10pt; width: 90%; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="text-align: left; background-color: #eeeeee;"><a href="#page_3">Management's Responsibility for the Financial Statements</a></td>
                <td style="width: 5%; text-align: right; background-color: #eeeeee;"><a href="#page_3">1</a></td>
            </tr>
            <tr>
                <td style="text-align: left;">&#160;</td>
                <td style="width: 5%; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="text-align: left; background-color: #eeeeee;"><a href="#page_4">Independent Auditor's Report</a></td>
                <td style="width: 5%; text-align: right; background-color: #eeeeee;"><a href="#page_4">2</a></td>
            </tr>
            <tr>
                <td style="text-align: left;">&#160;</td>
                <td style="width: 5%; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="text-align: left; background-color: #eeeeee;"><a href="#page_5">Consolidated Statements of Financial Position</a></td>
                <td style="width: 5%; text-align: right; background-color: #eeeeee;"><a href="#page_5">3</a></td>
            </tr>
            <tr>
                <td style="text-align: left;">&#160;</td>
                <td style="width: 5%; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="text-align: left; background-color: #eeeeee;"><a href="#page_6">Consolidated Statements of (Loss) Income and Comprehensive (Loss) Income</a></td>
                <td style="width: 5%; text-align: right; background-color: #eeeeee;"><a href="#page_6">4</a></td>
            </tr>
            <tr>
                <td style="text-align: left;">&#160;</td>
                <td style="width: 5%; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="text-align: left; background-color: #eeeeee;"><a href="#page_7">Consolidated Statements of Changes in Equity</a></td>
                <td style="width: 5%; text-align: right; background-color: #eeeeee;"><a href="#page_7">5</a></td>
            </tr>
            <tr>
                <td style="text-align: left;">&#160;</td>
                <td style="width: 5%; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="text-align: left; background-color: #eeeeee;"><a href="#page_8">Consolidated Statements of Cash Flows</a></td>
                <td style="width: 5%; text-align: right; background-color: #eeeeee;"><a href="#page_8">6</a></td>
            </tr>
            <tr>
                <td style="text-align: left;">&#160;</td>
                <td style="width: 5%; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="text-align: left; background-color: #eeeeee;"><a href="#page_9">Notes to the Consolidated Financial Statements</a></td>
                <td style="width: 5%; text-align: right; background-color: #eeeeee;"><a href="#page_41">7 - 39</a></td>
            </tr>
        </table>
    </div>
    <p style="text-align: center;"><img src="exhibit99-4xu004.jpg"></p>
    <p>&#160;</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: justify;"><img src="exhibit99-4xz001.jpg" style="width: 112px;" height="100"></p>
    <p style="text-align: justify;">&#160;</p>
    <p style="text-align: justify;">&#160;</p>
    <p style="text-align: justify;"><font style="color: #000000;">November 29, 2020</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Management's Responsibility for the Financial Statements</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The accompanying consolidated financial statements of Organigram Holdings Inc. (the "Company") have been prepared by the Company's management in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board and contain estimates based on management's judgment. Internal control systems are maintained by management to provide reasonable assurance that assets are safe-guarded and financial information is reliable.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Board of Directors of the Company is responsible for ensuring that management fulfills its responsibilities for financial reporting and is ultimately responsible for reviewing and approving the financial statements and the accompanying management discussion and analysis. The Board of Directors carries out this responsibility principally through its Audit Committee.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;"> The Audit Committee is appointed by the Board of Directors. It meets with the Company&#8217;s management and auditors, and reviews internal controls and financial reporting matters to ensure that management is properly discharging its responsibilities before submitting the financial statements to the Board of Directors for approval.</font></p>
    <p style="text-align: justify;">&#160;</p>
    <p style="text-align: justify;">&#160;</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%;">
                <p><b>/s/ Greg Engel</b></p>
            </td>
            <td style="width: 50%;">
                <p><b>/s/ Derrick West</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 50%;">
                <p><b>Chief Executive Officer</b></p>
            </td>
            <td style="width: 50%;">
                <p><b>Chief Financial Officer</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 50%;">
                <p><b>Moncton, New Brunswick</b></p>
            </td>
            <td style="width: 50%;">
                <p><b>Moncton, New Brunswick</b></p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">&#160;</font></p>
    <div id="footer_page_3">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">1</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <p style="text-align: justify;"><img src="exhibit99-4xu006.jpg"></p>
    <p style="text-align: justify;"><font style="font-size: 12pt;"><b>Report of Independent Registered Public Accounting Firm</b></font></p>
    <p style="text-align: justify;">&#160;</p>
    <p style="text-align: justify;">To the Shareholders and the Board of Directors of<br>Organigram Holdings Inc.</p>
    <p style="text-align: justify;"><b>Opinion on the Financial Statements</b><br>We have audited the accompanying consolidated statements of financial position of Organigram Holdings Inc. and subsidiaries (the &#8220;Company&#8221;) as of August 31, 2020 and 2019, the related consolidated statements of loss and comprehensive loss, consolidated statements of changes in equity, and consolidated statements of cash flows, for each of the two years in the period ended August 31, 2020, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of August 31, 2020 and 2019, and its financial performance and its cash flows for each of the two years in the period ended August 31, 2020, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.</p>
    <p style="text-align: justify;"><b>Change in Accounting Principle<br></b>As discussed in Note 3 to the financial statements, effective September 1, 2019, the Company adopted IFRS 16, <i>Leases, </i>using the modified retrospective approach.</p>
    <p style="text-align: justify;"><b>Basis for Opinion</b><br>These financial statements are the responsibility of the Company&#8217;s management. Our&#160;responsibility is express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
    <p style="text-align: justify;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p>
    <p style="text-align: justify;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>
    <p style="text-align: justify;">&#160;</p>
    <p style="text-align: justify;">/s/ Deloitte LLP</p>
    <p style="text-align: justify;">Chartered Professional Accountants<br>Moncton, Canada<br>November 29, 2020</p>
    <p style="text-align: justify;">We have served as the Company's auditor since 2015. &#160;</p>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_4">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">2</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">ORGANIGRAM HOLDINGS INC.</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i>As at August 31, 2020 and 2019</i></font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #86b4cd;">(Expressed in CDN $000's except share amounts)</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="vertical-align: bottom; text-align: center; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;"><font style="color: #86b4cd;">&#160;ASSETS&#160;</font></td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Current assets&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Cash&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">24,600</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">47,555</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Short-term investments (Note 4)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">50,128</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">380</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Accounts receivable (Note 5)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">14,747</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">16,541</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Current portion of loan receivable (Note 6)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,229</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">909</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Biological assets (Note 7)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">5,394</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">20,652</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Inventories (Note 8)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">66,365</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">93,144</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Prepaid expenses and deposits (Note 12 and Note 24)&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">6,741</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">17,100</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">170,204</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">196,281</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Restricted investment (Note 11)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">8,032</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Loan receivable (Note 6)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Property, plant and equipment (Note 9)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">247,420</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">218,470</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Intangible assets (Note 10)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,772</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">2,074</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Deferred charges (Note 12 and Note 24)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">698</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">592</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Investments in associates (Note 14)&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">7,001</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">11,108</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">435,127</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">428,525</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;<font style="color: #86b4cd;">LIABILITIES&#160;</font></td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Current liabilities&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Accounts payable and accrued liabilities&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">17,486</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">40,355</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160; Current portion of long term debt (Note 11)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,595</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">3,509</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">29,081</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">43,864</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Long-term debt (Note 11)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">103,671</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">46,067</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Other liabilities (Note 13)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,848</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,117</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Deferred tax liability (Note 23)&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">10,471</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">135,600</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">101,519</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;<font style="color: #86b4cd;">SHAREHOLDERS' EQUITY&#160;</font></td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Share capital (Note 12)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">420,673</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">318,125</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Equity reserves (Note 12)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">23,744</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">17,707</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Accumulated other comprehensive income (loss)&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">50</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;Accumulated deficit&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(144,940</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(8,783</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">299,527</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">327,006</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">435,127</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">428,525</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;">On Behalf of the Board:</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">s/Greg Engel, Director</p>
    <p style="margin-top: 0pt; text-align: justify;">s/Peter Amirault, Director</p>
    <p style="text-align: justify;"><font style="color: #000000;">The accompanying notes are an integral part of these Consolidated Financial Statements.</font></p>
    <div id="footer_page_5">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">3</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <p style="margin-bottom: 0pt; text-align: justify;">ORGANIGRAM HOLDINGS INC.</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS </font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i>For the years ended August 31, 2020 and 2019</i></font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #86b4cd;">(Expressed in CDN $000's except share amounts)</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;"><font style="color: #86b4cd;">REVENUES</font></td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Gross revenue (Note 18)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">103,387</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">97,547</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Excise taxes</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(16,592</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(17,134</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Net revenue</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">86,795</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">80,413</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Cost of sales (Note 19)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">105,004</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">42,521</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Gross margin before fair value adjustments</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(18,209</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">37,892</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Fair value changes to biological assets and changes <br>&#160;&#160; in inventory sold (Note 7)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(38,281</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">10,577</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Gross margin</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(56,490</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">48,469</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;"><font style="color: #86b4cd;">OPERATING EXPENSES</font></td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;General and administrative (Note 22)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">27,996</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">18,593</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Sales and marketing</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">16,528</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">14,625</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Share-based compensation (Note 12)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">4,725</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">9,151</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Impairment of property, plant and equipment (Note 9)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">39,771</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">613</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Total operating expenses</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">89,020</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">42,982</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;"><font style="color: #86b4cd;">(LOSS) INCOME FROM OPERATIONS</font></td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(145,510</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">5,487</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Financing costs</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">6,008</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">9,668</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Investment income</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(308</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(662</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Government subsidies (Note 25)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(7,883</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Share of loss from investments in associates (Note 14)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,187</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,261</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Impairment of investments in associates (Note 14)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">3,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">950</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Unrealized (gain) on changes in fair value of contingent <br>&#160;&#160;&#160; consideration (Note 13(i))</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(886</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">145</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Loss from continuing operations before tax</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(146,628</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(5,875</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Income tax (recovery) expense (Note 23)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Deferred, net</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(10,471</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">3,629</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net loss from continuing operations</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(136,157</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(9,504</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Loss from discontinued operations (Note 26)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(38</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;"><font style="color: #86b4cd;">NET LOSS</font></td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(136,157</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(9,542</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Other comprehensive gain (loss)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Foreign currency translation gain (loss), net of tax</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">94</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(43</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;"><font style="color: #86b4cd;">COMPREHENSIVE LOSS</font></td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(136,063</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(9,585</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net loss from continuing operations per common share, <br>&#160;&#160; basic (Note 12 (vi))</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(0.789</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(0.067</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net loss from continuing operations per common share, <br>&#160;&#160; diluted (Note 12 (vi))</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(0.789</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(0.067</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net loss from discontinued operations per common share, <br>&#160;&#160; basic (Note 12 (vi))</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net loss from discontinued operations per common share, <br>&#160;&#160; diluted (Note 12 (vi))</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net loss per common share, basic (Note 12 (vi))</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(0.789</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(0.068</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net loss per common share, diluted (Note 12 (vi))</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(0.789</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(0.068</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;">&#160;</p>
    <p style="text-align: justify;"><font style="color: #000000;">The accompanying notes are an integral part of these Consolidated Financial Statements.</font></p>
    <div id="footer_page_6">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">4</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <p style="margin-bottom: 0pt; text-align: justify;">ORGANIGRAM HOLDINGS INC.</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i>For the years ended August 31, 2020 and 2019</i></font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #86b4cd;">(Expressed in CDN $000's except share amounts)</font><br><font style="color: #86b4cd;">&#160;</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 8pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">NUMBER OF <br>SHARES</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">SHARE <br>CAPITAL</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">EQUITY <br>RESERVES</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">ACCUMULATED &#160;<br>OTHER <br>COMPREHENSIVE <br>LOSS</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">RETAINED <br>EARNINGS/<br>(ACCUMULATED<br>DEFICIT)</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">SHAREHOLDERS'<br>EQUITY</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;"><font style="color: #86b4cd;">Balance - September 1, 2018</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">125,207,938</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">157,790</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">26,045</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">759</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">184,594</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; white-space: nowrap;">Share-based compensation&#160;<br>&#160;&#160; (Note 12 (v))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">41,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">180</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">14,608</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">14,788</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee; white-space: nowrap;">Exercise of stock options (Note 12 (iii))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,167,864</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">6,588</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(2,418</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">4,170</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; white-space: nowrap;">Exercise of warrants (Note 12 (iv))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">7,751,700</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">39,257</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(8,281</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">30,976</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee; white-space: nowrap;">Exercise of restricted share units <br>&#160;&#160; (Note 12 (v))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">182,473</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">837</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(837</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; white-space: nowrap;">Conversion of debentures <br>&#160;&#160; (Note 12 (iii))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">20,845,372</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">112,166</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(11,247</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">100,919</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Tax impact of equity issue costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">1,307</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(163</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">1,144</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Foreign currency translation <br>&#160; gain, net of tax</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Net income</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(9,542</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(9,542</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #86b4cd;">Balance - August 31, 2019</font></td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right;">156,196,347</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right;">318,125</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right;">17,707</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right;">(43</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right;">(8,783</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right;">327,006</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;"><font style="color: #86b4cd;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #86b4cd;">Balance - September 1, 2019</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">156,196,347</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">318,125</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">17,707</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(8,783</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">327,006</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">At-the-market equity financing, net of<br>&#160;&#160; issue costs of $3,754 (Note 12 (iii))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">37,281,412</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">99,997</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">99,997</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share-based compensation&#160;<br>&#160;&#160; (Note 12 (v))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">7,519</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">7,519</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Exercise of stock options (Note 12 (iii))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">879,240</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">1,786</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(717</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">1,069</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Exercise of restricted share units <br>&#160;&#160;&#160; (Note 12 (v))</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">154,062</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">765</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(765</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Foreign currency translation <br>&#160; loss, net of tax</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">93</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">93</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net loss</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(136,157</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(136,157</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;"><font style="color: #86b4cd;">Balance - August 31, 2020</font></td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">194,511,061</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">420,673</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">23,744</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">50</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(144,940</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">299,527</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;">&#160;</p>
    <p style="text-align: justify;"><font style="color: #000000;">The accompanying notes are an integral part of these Consolidated Financial Statements.</font></p>
    <div id="footer_page_7">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">5</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <p style="margin-bottom: 0pt; text-align: justify;">ORGANIGRAM HOLDINGS INC.</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i>For the years ended August 31, 2020 and 2019</i></font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #86b4cd;">(Expressed in CDN $000's except share amounts)</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: center; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: center; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: center; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: center; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">CASH PROVIDED (USED)</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">OPERATING ACTIVITIES</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net loss from continuing operations</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(136,157</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(9,504</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Items not affecting cash:</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Share-based compensation (Note 12)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">7,796</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">14,894</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Depreciation and amortization (Note 9 and Note 10)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">17,958</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">8,902</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Loss on disposal of property, plant and equipment (Note 9)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">778</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">133</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Impairment losses (Note 9, Note 10 and Note 14)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">42,771</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,563</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Fair value adjustment to biological assets</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(2,853</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(8,060</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Financing costs</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">6,008</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">9,668</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Investment income</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(308</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(662</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Share of loss from investments in associates (Note 14)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,201</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,261</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Unrealized gain on changes in fair value of contingent consideration (Note 13(i))</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(886</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">145</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Deferred tax expense</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(10,471</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">3,635</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Changes in non-cash working capital:</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Net change in accounts receivable</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,794</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(13,134</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Net change in biological assets</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">18,111</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">7,266</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Net change in inventories</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">27,530</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(48,175</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Net change in accounts payable and accrued liabilities</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(27,995</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">10,562</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Net change in prepaid expenses and deferred charges</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">9,598</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(13,540</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net cash used in continuing operations</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(45,125</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(35,046</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net cash used in discontinued operations (Note 26)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(35</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net cash used in operating activities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(45,125</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(35,081</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">FINANCING ACTIVITIES</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Proceeds from equity financing, net of issue costs of $3,754 (Note 12 (iii))</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">99,997</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Payment of lease liabilities (Note 13(ii))</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(897</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Payment of long-term debt (Note 11)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(55</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(12,674</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Proceeds from long-term debt, net of fees of $705 (2019 - $1,250) (Note 11)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">64,295</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">58,851</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Stock options, warrants and units exercised (Note 12)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,069</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">35,146</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Interest paid</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(4,043</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(6,995</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net cash provided by financing activities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">160,366</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">74,328</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">INVESTING ACTIVITES</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Purchase of short-term investments (Note 4)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(50,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Proceeds from short-term investments&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">135</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">75,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Investment income</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">393</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,637</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Investments in associates (Note 14)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(12,758</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Investment in GIC - restricted investment (Note 11)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(8,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Distributions received from investments in associates</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">374</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Loan advance (Note 6)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(2,071</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(909</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Proceeds on sale of property, plant and equipment (Note 9)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">168</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Purchase of property, plant and equipment (Note 9)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(77,223</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(108,764</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Purchase of intangible assets (Note 10)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(1,430</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(1,530</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net cash used in investing activities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(138,196</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(46,782</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Effects of foreign exchange on cash</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">26</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">DECREASE IN CASH</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(22,955</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(7,509</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">CASH POSITION&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;Beginning of period&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">47,555</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">55,064</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160; &#160;End of period&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">24,600</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">47,555</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;">&#160;</p>
    <p style="text-align: justify;"><font style="color: #000000;">The accompanying notes are an integral part of these Consolidated Financial Statements. </font></p>
    <div id="footer_page_8">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">6</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <p style="margin-bottom: 0pt; text-align: justify;">ORGANIGRAM HOLDINGS INC.</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i>For the years ended August 31, 2020 and 2019</i></font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #86b4cd;">(Expressed in CDN $000's except share amounts)</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">1.</font><font style="width: 6.89pt; display: inline-block;">&#160;</font><font style="color: #86b4cd;">NATURE OF OPERATIONS</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Organigram Holdings Inc. (the "Company") is a publicly traded corporation with its common shares trading on the Toronto Stock Exchange ("TSX") and on the Nasdaq Global Select Market ("NASDAQ") under the symbol "OGI". The head and the registered address of the Company is 35 English Drive, Moncton, New Brunswick, Canada, E1E 3X3.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Company's major wholly-owned subsidiaries are: (i) Organigram Inc., a licensed producer ("LP" or "Licensed Producer") of cannabis and cannabis-derived products in Canada regulated by Health Canada under the <i>Cannabis Act</i> and the <i>Cannabis Regulations </i>(Canada), and (ii) 10870277 Canada Inc., a special purpose holding company for the Company.&#160; Organigram Inc. was incorporated under the <i>Business Corporation Act </i>(New Brunswick), on March 1, 2013. Organigram Holdings Inc, was incorporated under the <i>Canada Business Corporations Act</i> ("CBCA") on April 6, 2016. 10870277 Canada Inc. was incorporated under the CBCA on July 4, 2018.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">2.</font><font style="width: 6.89pt; display: inline-block;">&#160;</font><font style="color: #86b4cd;">BASIS OF PREPARATION</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">i) Statement of compliance</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">These consolidated financial statements have been prepared in accordance with the International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB") and interpretations of the IFRS Interpretations Committee ("IFRIC").</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">These consolidated financial statements were approved and authorized for issue by the Board of Directors of the Company on November 29, 2020.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">ii) Basis of measurement </font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">These consolidated financial statements have been prepared on a historical cost basis except for biological assets, short-term investments, share-based compensation, and contingent share consideration, which are measured at fair value.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Historical cost is the fair value of the consideration given in exchange for goods and services, which is generally based upon the fair value of the consideration given in exchange for assets at the time of the transaction.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">iii) Basis of consolidation</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">These consolidated financial statements include the accounts of the Company and its subsidiaries on a consolidated basis after elimination of intercompany transactions and balances. Subsidiaries are entities that the Company controls when it is exposed, or has rights, to variable returns from its involvement and has the ability to affect those returns through its power to direct the relevant activities of the entity.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">iv) COVID-19 estimation uncertainty</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">In March 2020, the World Health Organization declared the outbreak of a novel strain of coronavirus ("COVID-19"), a global pandemic.&#160; Government measures to limit the spread of COVID-19, including the closure of non-essential businesses, disrupted the Company's operations during the year ended August 31, 2020.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The production and sale of cannabis have been recognized as essential services across Canada, however COVID-19-related challenges have persisted, including, but not limited to, reduced staffing levels, production inefficiencies resulting from increased health and safety measures, and limited supply chain issues.&#160; For the year ended August 31, 2020, the Company recorded impairments against its assets (inventories and property, plant and equipment) due in part to the COVID-19 pandemic.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Due to the ongoing developments and uncertainty surrounding COVID-19, it is not possible to predict the continuing impact that COVID-19 will have on the Company, its financial position, and/or its operating results in the future.&#160; In addition, it is possible that estimates in the Company's financial statements will change in the near-term as a result of COVID-19, and the effect of any such changes could be material, which could result in, among other things, further impairment of inventories and long-lived assets including intangible assets. The Company is closely monitoring the impact of the COVID-19 on all aspects of its business.</font></p>
    <div id="footer_page_9">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">7</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">vi) Foreign currency translation</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Functional and presentation currency</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">These consolidated financial statements are presented in Canadian dollars, which is the Company's and its subsidiaries' functional currency, except for the Company's investment in its associate, alpha-cannabis Pharma GmbH ("ACG"), for which the functional currency has been determined to be Euros.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Transactions and balances</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Foreign currency transactions are translated into the functional currency using the exchange rate in effect on the date of the applicable transaction. Foreign exchange gains and losses resulting from the settlement of foreign currency transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in currencies other than an operation's functional currency are recognized in the consolidated statements of (loss) income and comprehensive (loss) income.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Foreign operations</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on acquisition, are translated to Canadian dollars at the exchange rate in effect on the reporting date. The income and expenses of foreign operations are translated to Canadian dollars using average exchange rates for the month during which the transactions occurred. Foreign currency differences are recognized in other comprehensive income (loss) in the accumulated other comprehensive loss account.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">When the Company disposes of its entire interest in a foreign operation, or loses control over a foreign operation, the foreign currency gains or losses accumulated in other comprehensive income (loss) related to the foreign operation are recognized in profit or loss. If the Company disposes of part of an interest in a foreign operation that remains a subsidiary, a proportionate amount of foreign currency gains or losses accumulated in other comprehensive income (loss) related to the subsidiary is reallocated between controlling and non-controlling interests.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">3.</font><font style="width: 6.89pt; display: inline-block;">&#160;</font><font style="color: #86b4cd;">SIGNIFICANT ACCOUNTING POLICIES</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">i) Cash</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Cash is a financial asset that is measured at amortized cost, which approximates fair value and includes cash-on-hand and deposits held with financing institutions.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">ii) Short-term investments</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company considers short-term investments in the form of guaranteed investment certificates to be an investing activity. These investments are measured at amortized cost. The Company also has equity securities that are carried at fair value through profit or loss.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">iii) Biological assets</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">While the Company's biological assets are within the scope of IAS 41 Agriculture, the direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2 Inventories. This includes the direct cost of seeds and growing materials as well as other indirect costs such as utilities and supplies used in the growing process. Indirect labour cost for individuals involved in the growing and quality control process is also included, as well as depreciation of manufacturing assets. All direct and indirect costs of biological assets are capitalized as they are incurred. Unrealized fair value gains/losses on growth of biological assets are recorded on the consolidated statements of (loss) income and comprehensive (loss) income. Biological assets are measured at their fair value less costs to sell on the consolidated statement of financial position.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">iv) Inventories</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Inventories for finished goods and packaging and supplies are initially valued at cost, and subsequently at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less the estimated costs to sell. The Company reviews inventories for obsolete, redundant and slow-moving goods and any such inventories identified are written down to net realizable value. The direct and indirect costs of finished goods inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labour and depreciation expense on equipment involved in packaging, labeling and inspection. All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of sales on the consolidated statements of (loss) income and comprehensive (loss) income at the time the cannabis is sold. Inventory is measured at lower of cost or net realizable value on the statement of financial position.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">v) Property, plant and equipment</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Property, plant and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company's management. Property, plant and equipment are subsequently measured at cost, less accumulated depreciation and impairment losses.</font></p>
    <div id="footer_page_10">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">8</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_11"></a>
    <p style="text-align: justify;"><font style="color: #000000;">Depreciation is recognized on a straight-line basis to reduce the cost, less estimated residual value, of depreciable fixed assets. The following useful lives are applied:</font></p>
    <table style="font-size: 10pt; width: 100%; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 12.5%; white-space: nowrap;">&#160;</td>
            <td style="width: 35%; white-space: nowrap;">Building</td>
            <td style="text-align: left; width: 69.0122%;">25 years</td>
        </tr>
        <tr>
            <td style="width: 12.5%; white-space: nowrap;">&#160;</td>
            <td style="width: 35%; white-space: nowrap;">Growing equipment</td>
            <td style="text-align: left; width: 69.0122%;">10 years</td>
        </tr>
        <tr>
            <td style="width: 12.5%; white-space: nowrap;">&#160;</td>
            <td style="width: 35%; white-space: nowrap;">Computer equipment</td>
            <td style="text-align: left; width: 69.0122%;">5 years</td>
        </tr>
        <tr>
            <td style="width: 12.5%; white-space: nowrap;">&#160;</td>
            <td style="width: 35%; white-space: nowrap;">Vehicles</td>
            <td style="text-align: left; width: 69.0122%;">5 years</td>
        </tr>
        <tr>
            <td style="width: 12.5%; white-space: nowrap;">&#160;</td>
            <td style="width: 35%; white-space: nowrap;">Furniture and fixtures</td>
            <td style="text-align: left; width: 69.0122%;">10 years</td>
        </tr>
        <tr>
            <td style="width: 12.5%; white-space: nowrap;">&#160;</td>
            <td style="width: 35%; white-space: nowrap;">Leasehold improvements</td>
            <td style="text-align: left; width: 69.0122%;">5 years</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets, and are recognized as profit or loss within other income or other expenses.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Assets in process are transferred to the appropriate asset class when available for use and depreciation of these assets commences at that point.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">An asset's residual value, useful life and depreciation method are reviewed during each financial year and adjusted if appropriate. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) and depreciated accordingly.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">vi) Goodwill</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Goodwill represents the future economic benefits arising from a business combination that are not individually identified and separately recognized. Goodwill is carried at cost less accumulated impairment losses. Refer to Note 3(viii) for a description of impairment testing procedures.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">vii) Assets held for sale</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Assets and liabilities held for sale are no longer depreciated and are presented separately in the statement of financial position at the lower of their carrying amount and fair value less costs to sell. An asset is regarded as held for sale if its carrying amount will be recovered principally through a sale transaction, rather than through continuing use. For this to be the case, the asset must be available for immediate sale and its sale must be highly probable.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">viii) Impairment of long-lived and intangible assets</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Long-lived assets, including property, plant and equipment are reviewed each reporting period for indicators of impairment. Goodwill is assessed for indicators of impairment at each reporting date and is tested annually or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs of disposal, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Except for goodwill, where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">ix) Share-based payments</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense in profit or loss over the vesting period based on the Company's estimate of equity instruments that will eventually vest.&#160; Fair value for options is determined using the Black-Scholes pricing model and fair value for Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") is determined using the Company's share price at the grant date.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Expected forfeitures are estimated at the date of the grant and subsequently adjusted if further information indicates actual forfeitures may vary from the original estimate.&#160; The impact of the revision of the original estimate is recognized in profit or loss such that the cumulative expenses reflect the revised estimate. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">For stock options granted to non-employees, the expense is measured at the fair value of the goods and services received except when the fair value cannot be estimated in which case it is measured at the fair value of the equity instrument granted.&#160; </font></p>
    <div id="footer_page_11">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">9</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_12"></a>
    <p style="text-align: justify;"><font style="color: #000000;">Consideration paid by employees or non-employees on the exercise of options is recorded as an increase to share capital and the related share-based expense is transferred from equity reserves to share capital.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">x) Investments in associates</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Associates are companies over which the Company has significant influence and are accounted for under the equity method. Significant influence is presumed when the Company has an ownership interest greater than 20%, unless certain qualitative factors overcome this assumption. Conversely, where the Company has an ownership interest less than 20%, it is presumed that the Company does not have significant influence, unless certain qualitative factors overcome this assumption. In assessing significant influence and the ownership interest, potential voting rights that are currently exercisable are taken into consideration.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Investments in associates are accounted for using the equity method and are initially recognized at cost, inclusive of transaction costs. The consolidated financial statements include the Company's share of the income or loss and equity movement of equity accounted associates. In accordance with IFRS, the associate's most recent available financial statements are used in the application of the equity method. Where the associate's reporting period differs from the Company's, the associate prepares financial information as of the same period end as the Company, unless it is impracticable to do so. Otherwise, the Company will adjust for its share of income and expenses and equity movement based on the associate's most recently completed financial statements, adjusted for the effects of significant transactions. The Company does not recognize losses exceeding the carrying value of its interest in the associate.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">xi) Intangible assets</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any, except for off-market supply agreements, where amortization is provided based on the actual output received versus the estimated output forecast to be received over the life of the agreement.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively. Intangible assets with an indefinite life or not yet available for use are not subject to amortization.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Research costs are expensed as incurred. Development expenditures are capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development to use or sell the asset. Research costs and other development expenditures are recognized as general and administrative expenses on the consolidated statement of income (loss) and comprehensive income (loss) as incurred.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">xii) Earnings (loss) per share</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Basic earnings (loss) per share is calculated by dividing net income (loss) attributable to common shareholders by the weighted-average number of shares outstanding during the period.&#160; Diluted earnings (loss) per share is calculated in a similar manner, but with adjustments to give effect to all dilutive potential common shares outstanding during the period. The dilutive effect of warrants, options, RSUs and PSUs is calculated using the treasury stock method. The if-converted method, which assumes that all convertible debt has been converted if the debt is in-the-money, is used to calculate the dilutive effect of convertible debt.&#160; Anti-dilutive effects of potential conversions of securities are ignored for this calculation.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">xiii) Revenue recognition</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Revenue from the direct sale of cannabis and cannabis oil for a fixed price is recognized when the Company transfers control of the good to the customer, which is at point of delivery for medical cannabis and recreational cannabis. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Revenue includes excise taxes, which the Company pays as principal, but excludes duties and taxes collected on behalf of third parties. Revenue also includes the net consideration to which the Company expects to be entitled. Revenue is recognized to the extent that it is highly probable that a significant reversal will not occur. Therefore, revenue is stated net of expected price discounts, allowances for customer returns and certain promotional activities and similar items. Generally, payment of the transaction price is due within credit terms that are consistent with industry practices, with no element of financing. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Net revenue is revenue less excise taxes. Excise taxes are effectively a production tax which becomes payable when the product is removed from the Company's premises and may or may not be directly related to the value of revenue depending on the province of sale. It is generally not included as a separate item on external invoices; increases in excise tax are not always passed on to the customer and where a customer fails to pay for product received the Company cannot reclaim the excise tax. The Company therefore recognizes excise tax, unless it regards itself as an agent of the regulatory authorities, as a cost and reduction to revenue for the Company.</font></p>
    <div id="footer_page_12">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">10</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_13"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">xiv) Income taxes</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The measurement of income taxes payable and deferred income tax assets and liabilities requires management to make judgments in the interpretation and application of the relevant tax laws. The actual amount of income taxes only becomes final upon filing and acceptance of the tax return by the relevant authorities, which occurs subsequent to the issuance of the consolidated financial statements.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Income tax expense (recovery) in the statements of income (loss) and comprehensive income (loss) is the sum of current and deferred tax as explained below.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Current tax is the expected income tax payable (recoverable) on the taxable income (loss) for the period, using tax rates enacted, or substantively enacted, as at the end of the reporting period.&#160; Current tax expense (recovery) included in the statements of income (loss) and comprehensive income (loss) reflects the current tax for the reporting period, plus adjustments to the current tax of prior periods, less current tax recorded directly in other comprehensive income (loss) or equity.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Deferred taxes are accounted for under the liability method and are the taxes expected to be payable or recoverable on the temporary differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable income.&#160; Deferred tax liabilities are generally recognized for all taxable temporary differences and deferred tax assets are recognized to the extent that it is probable that taxable income will be available against which deductible temporary differences and unused tax losses and tax credits can be utilized.&#160; Deferred tax is calculated on a non-discounted basis, using enacted or substantively enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&#160; The carrying amounts of individual deferred tax assets are reviewed at the end of each reporting period, but are only recognized for the proportion on which it is probable that sufficient taxable profits will be available for such assets to be recovered.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Deferred tax is not recognized for: i) temporary differences related to the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss; ii) differences relating to investments in subsidiaries to the extent that it is probable that they will not reverse in the foreseeable future; and, iii) differences arising on the initial recognition of goodwill.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">xv) Borrowing costs</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time that the assets are substantially ready for their intended use or sale. Other borrowing costs are expensed in the period in which they are incurred and reported in finance costs. No borrowing costs were capitalized during the periods presented.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">xvi) Discontinued operations</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">A disposal group is presented as a discontinued operation if all of the following conditions are met: i) it is a component of the Company for which operations and cash flows can be clearly distinguished operationally and financially from the rest of the Company, ii) it represents a separate major line of business or operations that either has been disposed of or is classified as held for sale; and iii) it is part of a single coordinated plan to dispose of a separate major line of business of operations.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Assets in a disposal group classified as held for sale are presented separately in the consolidated statements of financial position. Discontinued operations are presented separately from continuing operations in the consolidated statements of income (loss) and comprehensive income (loss) and consolidated statements of cash flows.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">xvii) Government subsidies</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Government subsidies are recognized when there is reasonable assurance that the subsidy will be received, and all the attached conditions will be complied with. Subsidies are recognized as income in the statement of income (loss) and comprehensive income (loss) on a systematic basis over the periods in which the expenses are recognized for the related costs for which the subsidies are intended to compensate, which in the case of subsidies related to assets requires setting it up as deferred income or deducting it from the carrying amount of the asset.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">xviii) Critical accounting estimates and judgments</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimates are revised and in any future years affected.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The following are the estimates and judgments made by management in applying the accounting policies of the Company that have the most significant effect on the financial statements.</font></p>
    <div id="footer_page_13">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">11</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_14"></a>
    <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i><b>1) Biological assets and inventories</b></i></font></p>
    <p style="margin-top: 0pt; margin-left: 18pt; text-align: justify;"><font style="color: #000000;">Determination of the fair value of biological assets requires management&#160; to make a number of estimates, including estimating harvesting costs, selling costs, sales prices, wastage, oil conversion factor, expected yields, and post-harvest costs of the cannabis plant.&#160; The Company records&#160; obsolete and unsaleable inventories at the lower of cost and net realizable value.&#160; Adjustments to the carrying value of inventories are based on obsolescence trends, historical experience, and forecast demand and pricing for obsolete and unsaleable inventories. Refer to Notes 7 and 8 for further information.&#160; </font></p>
    <p style="margin-left: 18pt; text-align: justify;"><font style="color: #000000;"><i><b>(2) Estimated useful lives and impairment of property, plant and equipment<br></b></i></font><font style="color: #000000;">Amortization of property, plant and equipment requires estimates of useful lives, which are determined through the exercise of judgment.&#160; The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts, taking into consideration factors such as economic and market conditions and the useful lives of assets.</font></p>
    <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i><b>(3) Share-based payments</b></i></font></p>
    <p style="margin-top: 0pt; margin-left: 18pt; text-align: justify;"><font style="color: #000000;">In determining the fair value of options and related expenses, management estimates the expected life of the option, the volatility of the Company's share price, the risk-free interest rate, and the rate of forfeitures.&#160; Refer to Note 12 for further information.&#160; </font></p>
    <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i><b>(4) Warrants</b></i></font></p>
    <p style="margin-top: 0pt; margin-left: 18pt; text-align: justify;"><font style="color: #000000;">In determining the value of warrants, management estimates the expected life of the warrant, the volatility of the Company's share price, and the risk-free interest rate.&#160; </font></p>
    <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i><b>(5) Adult-use recreational cannabis revenue - provision for returns and price adjustments </b></i></font></p>
    <p style="margin-top: 0pt; margin-left: 18pt; text-align: justify;"><font style="color: #000000;">Government customers typically have the right to return products, and in some cases, the right to pricing adjustments for products that are subsequently discounted or sold for a lower price in another jurisdiction.&#160; The estimation of potential future returns and pricing adjustments includes the use of management estimates and assumptions that may not be certain given the evolving nature of the industry.</font></p>
    <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i><b>(6) Investments in associates</b></i></font></p>
    <p style="margin-top: 0pt; margin-left: 17.85pt; text-align: justify;"><font style="color: #000000;">Management has applied significant judgment in the determination of whether the Company exerts significant influence with respect to its investments, which then allows the Company to account for its investments under the equity accounting method.&#160; Further, management has applied significant judgment and made use of management estimates and assumptions in determining and quantifying any impairment losses that may need to be recorded against its investments in associates.</font></p>
    <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;"><i><b>(7) Impairment of long-lived and intangible assets</b></i></font></p>
    <p style="margin-top: 0pt; margin-left: 17.85pt; text-align: justify;"><font style="color: #000000;">In determining the recoverable amount of the Company's Moncton campus (the "Moncton Campus") CGU, management has applied significant judgment in the aggregation of the CGU and has made various estimates with respect to the forecast cash flows, terminal growth rate, post-tax discount rate, and income taxes utilized in the discounted cash flow model to estimate fair value less costs of disposal.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">NEW STANDARDS AND INTERPRETATIONS ADOPTED</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">New or amended standards effective September 1, 2019</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company has adopted the following new or amended IFRS standard for the annual period beginning on September 1, 2019:</font></p>
    <p style="text-align: justify;"><font style="color: #000000;"><b>IFRS 16 - Leases</b></font></p>
    <p style="text-align: justify;"><font style="color: #000000;">In January 2016, the IASB issued IFRS 16 Leases, which replaced IAS 17 Leases. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than twelve months, unless the underlying asset is of low value. A lessee is required to recognize a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. The standard was effective for annual periods beginning on or after January 1, 2019 and has been adopted by the Company effective September 1, 2019 using the modified retrospective approach where comparative figures were not restated.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">As a result of adopting IFRS 16, the Company recognized right-of use ("ROU") assets of $4,464 recorded under property, plant and equipment (Note 9), lease liabilities of $4,439 recorded under other liabilities (Note 13), and a reduction to prepaid expenses of $25 as a result of the leasing arrangements in place at September 1, 2019 and entered during the year ended August 31, 2020 by the Company.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The ROU asset was measured as the amount of the lease liability, using the Company's incremental borrowing rate on September 1, 2019 that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. The weighted average interest rate as of September 1, 2019 to measure the lease liabilities was 5.70%.</font></p>
    <div id="footer_page_14">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">12</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_15"></a>
    <p style="text-align: justify;"><font style="color: #000000;">The Company elected to use the following practical expedients on adoption of IFRS 16 on all of its leases:</font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(a)<font style="display: inline-block; width: 7.5pt;">&#160;</font></font><font style="color: #000000;">In accordance with IFRS 16.C3, an election is being taken to not reassess whether a contract is or contains a lease at the date of initial application, and instead to only apply IFRS 16 to contracts that were in the scope of IAS 17;</font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(b)<font style="display: inline-block; width: 6.5pt;">&#160;</font></font><font style="color: #000000;">In accordance with IFRS 16.C8(b)(ii), an election is being taken to measure the ROU asset on September 1, 2019 as an amount equal to the lease liability, adjusted for prepaid or accrued lease payments;</font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(c)<font style="display: inline-block; width: 6.5pt;">&#160;</font></font><font style="color: #000000;">In accordance with IFRS 16.C10(a), an election is being taken to apply a single discount rate to a portfolio of leases with reasonably similar characteristics;</font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(d)</font><font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">In accordance with IFRS 16.C10(b), an election is being taken to rely on the IAS 37 assessment of whether leases are onerous instead of performing an impairment review; </font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(e)</font><font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">In accordance with IFRS 16.C10(c), an election is being taken to exclude leases for which the term ends within 12 months from September 1, 2019; </font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(f)</font><font style="width: 7.5pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">In accordance with IFRS 16.C10(d), an election is being taken to exclude initial direct costs from the measurement of the ROU asset on September 1, 2019;</font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(g)</font><font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">In accordance with IFRS 16.15, an election is being taken, by class of underlying asset, not to separate non-lease components from lease components, and instead account for each lease component and any associated non-lease components as a single lease component where the non-lease components are not significant compared to the lease components; </font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(h)</font><font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">In accordance with IFRS 16.5(a), an election is being taken to not recognize a ROU asset and lease liability for leases for which the lease has a term less than 12 months; and </font></p>
    <p style="margin-left: 26pt; text-indent: -18pt; text-align: justify;"><font style="color: #000000;">(i)</font><font style="width: 8pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">In accordance with IFRS 16.5(b), an election is being taken to not recognize a ROU asset and lease liability for leases for which the underlying asset is of low value, which is defined to mean less than $5,000 USD when new.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The following is a reconciliation between the Company's operating lease commitments disclosed applying IAS 17 as at August 31, 2019 and the lease liabilities as at September 1, 2019 after adopting IFRS 16:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">Operating lease obligations as at August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">3,049</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Minimum future payments not related to lease payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(411</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Lease payments for renewal options reasonably expected to be exercised but not contractually obligated</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">655</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Relief option for short-term leases</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(538</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Relief option for leases of low-value&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(76</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Gross lease liabilities at September 1, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,679</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Discounting</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(459</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Present value of lease liabilities at September 1, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,220</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">New Accounting Pronouncements</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The following IFRS standards have been recently issued by the IASB. Pronouncements that are irrelevant or not expected to have a significant impact have been excluded. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;"><b>Amendments to IFRS 3: Definition of a Business</b> </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">In October 2018, the IASB issued "Definition of a Business (Amendments to IFRS 3)". The amendments clarify the definition of a business, with the objective of assisting entities to determine whether a transaction should be accounted for as a business combination or as an asset acquisition. The amendment provides an assessment framework to determine when a series of integrated activities is not a business. The amendments are effective for business combinations occurring on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements resulting from any future transactions. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;"><b>Amendments to IAS 1: Classification of Liabilities as Current or Non-Current</b> </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The amendments to IAS 1 clarify the requirements relating to determining whether a liability should be presented as current or non-current in the statement of financial position. Under the new requirements, the assessment of whether a liability is presented as current or non-current is based on the contractual arrangements in place as at the reporting date and does not impact the amount or timing of recognition. The amendment applies retrospectively for annual reporting periods beginning on or after January 1, 2023. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements.</font></p>
    <div id="footer_page_15">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">13</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_16"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">4.</font><font style="width: 6.89pt; display: inline-block;">&#160;</font><font style="color: #86b4cd;">SHORT TERM INVESTMENTS</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company's short-term investments included the following on August 31, 2020 and August 31, 2019:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 45.1628%;">DESCRIPTION</td>
            <td style="text-align: center; vertical-align: bottom; width: 18.8837%;">INTEREST %</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="vertical-align: bottom; text-align: center; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 45.1628%;">GIC - maturing September 16, 2020</td>
            <td style="text-align: center; vertical-align: bottom; width: 18.8837%;">0.95%</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">10,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 45.1628%;">GIC - maturing September 24, 2020</td>
            <td style="text-align: center; vertical-align: bottom; width: 18.8837%;">0.95%</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">10,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 45.1628%;">GIC - maturing December 15, 2020</td>
            <td style="text-align: center; vertical-align: bottom; width: 18.8837%;">1.16%</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">10,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 45.1628%;">GIC - maturing December 23, 2020</td>
            <td style="text-align: center; vertical-align: bottom; width: 18.8837%;">1.16%</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">10,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 45.1628%;">GIC - maturing June 17, 2021</td>
            <td style="text-align: center; vertical-align: bottom; width: 18.8837%;">0.93%</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">10,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 45.1628%;">Equity securities in VIVO Cannabis Inc.</td>
            <td style="text-align: center; vertical-align: bottom; width: 18.8837%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">128</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">380</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 45.1628%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 18.8837%;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">50,128</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">380</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">On October 16, 2018, the Company sold its wholly-owned subsidiary, Trauma Healing Centers, Incorporated ("THCI"), in exchange for consideration consisting of common shares in the purchaser (an unaffiliated publicly-traded company), VIVO Cannabis Inc. ("VIVO") (the "VIVO Shares").&#160; The VIVO Shares are carried at fair value through profit or loss. Subsequent to August 31, 2020, all of the VIVO Shares were sold.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">5.</font><font style="width: 6.89pt; display: inline-block;">&#160;</font><font style="color: #86b4cd;">ACCOUNTS RECEIVABLE</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company's accounts receivable included the following balances as of August 31, 2020 and August 31, 2019:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Trade receivables</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,096</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">11,900</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Harmonized sales taxes receivable</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">728</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">4,741</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Government programs</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,936</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">168</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Less: Provision for doubtful accounts</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(13</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(268</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">14,747</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">16,541</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">On April 1, 2020, Department of Finance Canada announced the Canada Emergency Wage Subsidy ("CEWS"), which would subsidize 75% of employee wages, retroactive to March 15, 2020, to Canadian employers whose businesses had been affected by COVID-19 in order to enable them to re-hire workers previously laid off as a result of pandemic, help prevent further job losses, and to better position companies to resume normal operations following the crisis.&#160; At August 31, 2020, under this program, the Company applied for a wage subsidy of $2,936 for the period July 5, 2020 to August 29, 2020, which is included under government programs above.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">6.</font><font style="width: 6.89pt; display: inline-block;">&#160;</font><font style="color: #86b4cd;">LOAN RECEIVABLE </font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On July 26, 2019, the Company entered into an advance payment and support agreement ("Payment Agreement") with 703454 N.B. Inc. (carrying on business as 1812 Hemp) ("1812 Hemp"). Under the terms of the Payment Agreement, the Company advanced $3,000 to 1812 Hemp in the form of a secured loan. This amount may be applied against future purchases of hemp under the Supply Agreement described in Note 10. The aggregate amount of advances outstanding as of January 1, 2020 accrue interest of 9.0% per annum, calculated monthly, until the entire balance of advances is paid.&#160; At August 31, 2020, $2,229 in principal was outstanding under the Payment Agreement.&#160; Subsequent to August 31, 2020, the Company demanded repayment of the entire amount owing by 1812 Hemp to the Company under the Payment Agreement.<i> </i></font></p>
    <div id="footer_page_16">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">14</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_17"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">7.</font><font style="width: 6.89pt; display: inline-block;">&#160;</font><font style="color: #86b4cd;">BIOLOGICAL ASSETS </font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company measures biological assets, which consist of cannabis plants, at fair value less costs to sell up to the point of harvest, which then becomes the basis for the cost of finished goods inventories after harvest. Subsequent expenditures incurred on these finished goods inventories after harvest are capitalized based on IAS 2 <i>Inventories.</i></font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The changes in the carrying value of biological assets as of August 31, 2020 are as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">OTHER<br>BIOLOGICAL ASSETS</td>
            <td style="text-align: right; border-bottom: 2px solid transparent; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">CANNABIS ON PLANTS</td>
            <td style="text-align: right; border-bottom: 2px solid transparent; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">TOTAL</td>
            <td style="text-align: right; border-bottom: 2px solid transparent; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Carrying amount, August 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">599</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">19,259</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">19,858</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Add net production costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(596</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">37,534</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">36,938</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net change in fair value less costs to sell<br>&#160;&#160; due to biological transformation</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(8,060</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(8,060</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Transferred to inventory upon harvest</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(28,084</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(28,084</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Carrying amount, August 31, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">3</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">20,649</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">20,652</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Add net production costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">13</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">41,039</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">41,052</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net change in fair value less costs to sell<br>&#160;&#160; due to biological transformation</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(2,853</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(2,853</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Deduct net abnormal plant destruction costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(5,048</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(5,048</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Transferred to inventory upon harvest</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(48,409</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(48,409</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Carrying amount, August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">16</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">5,378</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">5,394</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, the Company had to cull plants with a carrying value of $5,048 (August 31, 2019 - $nil) due to lack of sufficient staffing as a result of COVID-19. These costs were expensed to cost of sales.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The fair value less costs to sell of biological assets is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred, such as post-harvest costs. The following unobservable inputs, all of which are classified as Level 3 on the fair value hierarchy (see Note 16), are used in determining the fair value of biological assets:</font></p>
    <p style="margin-left: 21.6pt; text-indent: -12.95pt; text-align: justify;"><font style="color: #85b8d8;">i.</font><font style="text-indent: 0pt; display: inline-block; width: 7.61pt;">&#160;</font><font style="color: #000000;">Average selling price per gram - calculated as the weighted average current selling price of cannabis sold by the Company, adjusted for expectations about future pricing;</font></p>
    <p style="margin-left: 21.6pt; text-indent: -12.95pt; text-align: justify;"><font style="color: #85b8d8;">ii.</font><font style="width: 5.05pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">Yield by plant - represents the number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant;</font></p>
    <p style="margin-left: 21.6pt; text-indent: -12.95pt; text-align: justify;"><font style="color: #85b8d8;">iii.</font><font style="width: 2.48pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">Wastage of plants based on their various stages of growth - represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested; and</font></p>
    <p style="margin-left: 21.85pt; text-indent: -13.05pt; text-align: justify;"><font style="color: #85b8d8;">iv.</font><font style="width: 3.4pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">Post-harvest costs - calculated as the cost per gram of harvested cannabis to complete the sale of cannabis plants post-harvest, consisting of the cost of direct and indirect materials and labour related to drying, labelling and packaging.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Company estimates the harvest yields for the cannabis on plants at various stages of growth. As of August 31, 2020, it is expected that the Company's biological assets will yield 5,096 kg (August 31, 2019 - 16,595 kg) of cannabis when eventually harvested. The Company's estimates are, by their nature, subject to change, and differences from the anticipated yield will be reflected in the fair value adjustment to biological assets in future periods. The Company accretes fair value on a straight-line basis according to stage of growth. As a result, a cannabis plant that is 50% through its 19-week growing cycle would be ascribed approximately 50% of its harvest date expected fair value less costs to sell (subject to wastage adjustments).</font></p>
    <div id="footer_page_17">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">15</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_18"></a>
    <p style="text-align: justify;"><font style="color: #000000;">Management believes the most significant unobservable inputs and their impact on fair value are as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #86b4cd;">SIGNIFICANT INPUTS &amp;</font></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; white-space: nowrap;" colspan="4">WEIGHTED AVERAGE INPUT</td>
            <td style="text-align: center; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; white-space: nowrap;" colspan="4">EFFECT ON FAIR VALUE</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #86b4cd;">ASSUMPTIONS</font></td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">AUG. 31, 2020</td>
            <td style="text-align: center; border-bottom: 2px solid transparent; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">AUG. 31, 2019</td>
            <td style="text-align: center; border-bottom: 2px solid transparent; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">SENSITIVITY</td>
            <td style="text-align: center; border-bottom: 2px solid transparent; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">AUG. 31, 2020</td>
            <td style="text-align: center; border-bottom: 2px solid transparent; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">AUG. 31, 2019</td>
            <td style="text-align: center; border-bottom: 2px solid transparent; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Average net selling price per gram</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">3.36</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">5.65</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; white-space: nowrap;">Increase or decrease<br>by $1.00 per gram</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">1,602</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">3,657</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Average yield per plant</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">101 grams</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">151 grams</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">Increase or decrease<br>by 10 grams</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">532</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">1,367</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">During the three months ended May 31, 2020, management ceased the harvesting of trim from the cannabis plants and therefore the average yield per plant at August 31, 2020 primarily reflects the average yield of the flower component of the plant.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The fair value adjustment to biological assets and inventory sold consists of the following:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;">AUGUST 31, 2020</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;">AUGUST 31, 2019</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Realized fair value amounts included in inventory sold</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(39,455</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(50,477</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Increase (decrease) in fair value on growth of biological assets</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">73,975</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">75,338</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Adjustment to net realizable value</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(72,801</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(14,284</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Fair value adjustment to biological assets</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(38,281</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">10,577</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">The adjustment to net realizable value is related to the write-down of the fair value component of dry cannabis available for packaging, flower and trim available for extraction, concentrated extract, and packaged inventories due to excess or obsolete quantities as well as the decrease in the estimated net realizable value of these inventories based on the evolving nature of the adult-use market.</font></p>
    <div id="footer_page_18">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">16</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_19"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">8. INVENTORIES</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company's inventories are comprised of the following balances as of August 31, 2020 and August 31, 2019:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;" colspan="7"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;"><font style="color: #ffffff;">CAPITALIZED </font><br><font style="color: #ffffff;">COST</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;"><font style="color: #ffffff;">FAIR VALUE </font><br><font style="color: #ffffff;">ADJUSTMENT</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;"><font style="color: #ffffff;">CARRYING </font><br><font style="color: #ffffff;">VALUE</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #a7c7d2;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Plants in drying stage</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,036</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,841</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">3,877</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Dry cannabis</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Available for packaging</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">13,124</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">7,808</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">20,932</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Packaged inventory</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">3,707</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,956</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">5,663</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Flower and trim available for extraction</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">849</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,062</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,911</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Concentrated extract</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">13,252</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">6,130</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">19,382</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Formulated extracts</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Available for packaging</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,097</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">384</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,481</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Packaged inventory</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,045</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">226</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,271</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Packaging and supplies</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,848</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,848</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">46,958</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">19,407</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">66,365</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">&#160;</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #7f7f7f;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #7f7f7f;" colspan="7"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #7f7f7f;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;"><font style="color: #ffffff;">CAPITALIZED </font><br><font style="color: #ffffff;">COST</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;"><font style="color: #ffffff;">FAIR VALUE </font><br><font style="color: #ffffff;">ADJUSTMENT</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;"><font style="color: #ffffff;">CARRYING </font><br><font style="color: #ffffff;">VALUE</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #dadada;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Plants in drying stage</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,945</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">4,256</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">6,201</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Dry cannabis</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Available for packaging</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">5,261</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">12,718</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">17,979</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Packaged inventory</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">4,205</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">2,549</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">6,754</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Flower and trim available for extraction</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">4,433</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">12,193</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">16,626</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Concentrated extract</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">15,393</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">21,573</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">36,966</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Formulated extracts</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Available for packaging</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">754</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,121</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,875</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Packaged inventory</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">728</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">425</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,153</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Packaging and supplies</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee; border-bottom: 1px solid #000000;">5,590</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid transparent;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee; border-bottom: 1px solid #000000;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid transparent;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee; border-bottom: 1px solid #000000;">5,590</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee; border-bottom: 3px double #000000;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee; border-bottom: 3px double #000000;">38,309</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 3px double transparent;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee; border-bottom: 3px double #000000;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee; border-bottom: 3px double #000000;">54,835</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 3px double transparent;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee; border-bottom: 3px double #000000;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee; border-bottom: 3px double #000000;">93,144</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee; border-bottom: 3px double #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Flower and trim available for extraction </font><font style="color: #000000;">are converted into concentrated extract, which can then be used for oil formulation (combining with a carrier oil) or other products such as edibles, and beverage and vaporizable products.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The amount of inventory expensed in cost of sales for the year ended August 31, 2020 was $42,872 (August 31, 2019 - $35,224). The amount of inventory write-down, provision, and plant waste included in cost of sales for the year ended August 31, 2020 was $45,270 (August 31, 2019 - $4,733), which relates to the production or purchase costs of these inventories and biological assets (refer to Note 7 for the write-down and provisions against the fair value component of these inventories).</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Inventory write-down and provision relating to excess and unsaleable inventories for the year ended August 31, 2020 was $32,831 (August 31, 2019 - $744), of which $20,251 (August 31, 2019 - $nil) related to concentrated extract and flower and trim available for extraction.&#160; Inventory write-down related to adjustments to net realizable value during the year ended August 31, 2020 was $2,753 (August 31, 2019 - $nil).&#160; Inventory write-offs for the year ended August 31, 2020 related to abnormal plant waste due to lack of sufficient staffing as a result of COVID-19 was $5,048 (August 31, 2019 - $nil).</font></p>
    <div id="footer_page_19">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">17</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_20"></a>
    <p style="text-align: justify;"><font style="color: #86b4cd;">9.</font><font style="width: 6.89pt; display: inline-block;">&#160;</font><font style="color: #86b4cd;">PROPERTY, PLANT AND EQUIPMENT</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 8pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">LAND</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">BUILDINGS</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">CONSTRUCTION<br>IN PROCESS</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">GROWING &amp; PROCESSING<br>EQUIPMENT</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">OTHER<br>(NOTE A)</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">RIGHT-OF-USE LEASE ASSETS<br>(NOTE B)</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">TOTAL</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Cost</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Balance, August 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,205</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">47,101</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">11,993</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">40,493</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,922</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">104,714</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Additions</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">6</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">15,753</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">105,512</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">5,554</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">3,366</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">130,191</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee; white-space: nowrap;">&#160; &#160;Construction completed</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">8,042</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(51,990</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">42,698</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">1,250</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Disposals</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(122</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(201</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(323</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Impairment loss</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(613</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(613</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee; white-space: nowrap;">&#160; &#160;Reclassification of <br>&#160; &#160; computer software <br>&#160; &#160; (NOTE A)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(841</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(841</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Balance, August 31, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,211</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">70,774</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">65,515</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">87,931</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">6,697</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">233,128</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Accumulated depreciation</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee; white-space: nowrap;">Balance, August 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(1,997</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(2,956</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(1,122</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(6,075</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Depreciation</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(2,245</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(5,679</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(946</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(8,870</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Disposals</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">5</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">17</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">22</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Reclassification of <br>&#160; &#160; computer software <br>&#160; &#160; (NOTE A)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">265</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">265</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Balance, August 31, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(4,237</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(8,618</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(1,803</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(14,658</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Cost</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Balance, August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,211</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">70,774</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">65,515</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">87,931</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">6,697</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">233,128</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Transition to IFRS 16</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,244</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,244</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Additions (Note C)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">1,864</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">22,316</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">46,847</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">7,597</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">1,335</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,220</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">82,179</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Construction completed</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">71,663</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(110,234</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">37,851</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">720</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Disposals</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(517</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(436</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(75</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(1,028</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee; white-space: nowrap;">&#160; &#160;Impairment loss (Note D)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(37,214</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">48</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(37,166</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Balance, August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">4,075</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">127,022</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,128</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">132,991</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">8,677</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">4,464</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">279,357</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Accumulated depreciation</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Balance, August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(4,237</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(8,618</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(1,803</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(14,658</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Depreciation</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(4,074</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(11,568</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(1,362</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(557</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(17,561</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">&#160; &#160;Disposals</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">108</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">145</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">29</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">282</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Balance, August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(8,203</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(20,041</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(3,136</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(557</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">(31,937</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">Net book value</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">August 31, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,211</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">66,537</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">65,515</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">79,313</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">4,894</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">218,470</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #eeeeee;">August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">4,075</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">118,819</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">2,128</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">112,950</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">5,541</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">3,907</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #eeeeee;">247,420</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Most of the additions during the year ended August 31, 2020 were related to the expansion of the Company's facility located in Moncton (the "Moncton Campus").</font></p>
    <div id="footer_page_20">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">18</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_21"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">A) Other - Computer Software</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">During the three months ended November 30, 2019, the Company determined that due to the increasing value of its computer software, it should be reclassified from property, plant and equipment to intangible assets.&#160; Computer software has historically been included in the "other" category within property, plant and equipment due to its relatively insignificant value. The August 31, 2019 cost of $841 and accumulated amortization of $265 relating to computer software have been reclassified from property, plant and equipment to intangible assets (Note 10) as a result.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">B) Right-of-Use Assets and Transition to IFRS 16</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">As described in Note 4, the Company adopted IFRS 16 effective September 1, 2019. As a result, certain lease obligations were capitalized as ROU assets on the transition date and depreciated for the year ended August 31, 2020.&#160; ROU assets mostly comprise of office and warehouse space.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">C) Reconciliation of property, plant and equipment additions to the statements of cash flows</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The following table reconciles additions of property, plant and equipment per the above table to the purchases of property, plant and equipment per the statements of cash flows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Additions</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">82,179</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">130,191</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Additions related to IFRS 16 Leases</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(2,220</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net change in accounts payable and accrued liabilities related to purchases of <br>&#160;&#160; property, plant and equipment</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(2,736</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(21,427</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Purchase of property, plant and equipment</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">77,223</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">108,764</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">&#160;</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">D) Impairment</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company reviews the carrying value of its property, plant and equipment at each reporting period for indicators of impairment. During the year ended August 31, 2020, management noted indicators of impairment and recorded impairments at an asset specific level.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;"><b>Moncton Campus - Phase 4C (asset specific)</b></font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The construction of Phase 4C of the Moncton Campus, which was intended to house grow rooms with a previously estimated cultivation capacity of 24,000 kg per annum, was indefinitely deferred during the three months ended May 31, 2020 based on available capacity and forecast market demand.&#160; Phase 4C of the Moncton Campus has effectively been left partially completed and, due to the specialized and integrated nature of Phase 4C, without any foreseeable near-term use.&#160; Management estimated the fair value less cost to dispose ("FVLCD") of Phase 4C to approximate the purchase cost of the land and movable equipment, which is $1,328.&#160; As a result, the Company recognized an impairment loss of $37,749 in relation to this asset for the year ended August 31, 2020.&#160; The entire amount of the impairment loss was recorded against the building infrastructure of Phase 4C. In addition, subsequently incurred and contractually committed future costs totaling $1,050 with respect to Phase 4C at August 31, 2020 were included in the impairment loss for the year ended August 31, 2020.</font></p>
    <div id="footer_page_21">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">19</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_22"></a>
    <p style="text-align: justify;"><font style="color: #86b4cd;">10. INTANGIBLE ASSETS</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">SUPPLY <br>AGREEMENT</td>
            <td style="text-align: right; border-bottom: 2px solid transparent; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">LICENSE <br>AGREEMENT</td>
            <td style="text-align: right; border-bottom: 2px solid transparent; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">COMPUTER <br>SOFTWARE</td>
            <td style="text-align: right; border-bottom: 2px solid transparent; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">TOTAL</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Cost</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Additions</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,530</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,530</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Reclassification of computer software (NOTE A)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">841</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">841</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">1,530</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">841</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">2,371</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Accumulated amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(32</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(32</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Reclassification of computer software (NOTE A)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(265</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(265</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">(32</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">(265</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">(297</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Cost</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,530</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">841</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">2,371</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Additions</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">198</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,232</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,430</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Impairment (NOTE B)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(1,303</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(1,303</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Disposal</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(32</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(32</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">227</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">198</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">2,041</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">2,466</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Accumulated amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(32</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(265</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(297</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Amortization</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(195</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(202</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(397</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">(227</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">(467</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">(694</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net book value</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">August 31, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">1,498</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">576</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">2,074</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">198</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">1,574</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">1,772</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">A) Other - Computer Software</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">During the three months ended November 30, 2019, the Company determined that due to the increasing value of its computer software, it should be reclassified from property, plant and equipment to intangible assets.&#160; Computer software has historically been included in the "other" category within property, plant and equipment due to its relatively insignificant value.&#160; The August 31, 2019 cost of $841 and accumulated amortization of $265 relating to computer software have been reclassified from property, plant and equipment to intangible assets as a result.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">B) Impairment</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On January 18, 2019, the Company entered into an agreement with 1812 Hemp to secure supply of hemp (the "Supply&#160; Agreement"). Pursuant to the Supply Agreement, the Company is to receive a 25% discount on the price per kilogram of dried hemp flower harvested that is purchased from 1812 Hemp. The term of the Supply Agreement is from December 17, 2018 to December 16, 2023 and the Company has the option to renew it for an additional five-year period upon six months' notice. In addition, the Company has a right-of-first refusal on the future procurement of high cannabidiol (CBD) hemp from 1812. The Company paid $1,500 to 1812 Hemp plus transaction costs of $30 in connection with this transaction, which it has recorded as an intangible asset with a finite useful life that will be amortized based on the actual volume of dried hemp flower purchased as a proportion of its forecast purchase volumes. During the three months ended August 31, 2020, management became aware that 1812 Hemp was facing financial hardship due to a lack of customer demand and a change in market conditions and as a result, 1812 Hemp had significantly scaled back operations.&#160; Separately, the Company's forecast hemp purchases have decreased significantly as a result of slower than expected progression in Canadian hemp and CBD regulations. Thus, as a result of the aforementioned challenges, management impaired the Supply Agreement intangible asset to its recoverable amount, which was estimated to be $nil, by recording an impairment charge of $1,303 at August 31, 2020.</font></p>
    <div id="footer_page_22">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">20</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_23"></a>
    <p style="text-align: justify;"><font style="color: #86b4cd;">11. LONG-TERM DEBT</font></p>
    <table style="border-color: #000000; width: 100%; font-size: 10pt; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="width: 12%; text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="width: 2%; text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="width: 2%; text-align: center; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="width: 1.02%; text-align: center; vertical-align: bottom; background-color: #a6a4a4; white-space: nowrap;">&#160;</td>
            <td style="width: 12%; text-align: center; vertical-align: bottom; background-color: #a6a4a4; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="width: 2%; text-align: center; vertical-align: bottom; background-color: #a6a4a4;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 2%; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom; white-space: nowrap;">Bank of Montreal ("BMO") senior secured term loan ("Term Loan")<br>&#160; maturing May 31, 2022 with principal repayments starting November 30, 2020 <br>&#160; based on a 10 year amortization</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">$</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">115,000</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">$</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">50,000</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">Atlantic Canada Opportunities Agency ("ACOA") <br>&#160; Business Development Program loan maturing September 1, 2024 with a 7 year<br>&#160; amortization, bearing interest at an interest rate of 0%</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">311</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">346</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">Vehicle loans - five year term maturing June 17, 2024</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">78</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">98</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">Deferred financing costs, net of loan modification loss on BMO Term Loan</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">(123</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">)</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom-color: transparent; border-bottom-width: 1px; border-bottom-style: solid;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #eeeeee;">(868</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">115,266</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">49,576</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">Less: current portion of long term debt</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">(11,595</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">)</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom-color: transparent; border-bottom-width: 1px; border-bottom-style: solid;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #eeeeee;">(3,509</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 65.04%; vertical-align: bottom;">Long-term portion</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #cee5ea;">$</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #cee5ea;">103,671</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #cee5ea;">&#160;</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom-color: transparent; border-bottom-width: 3px; border-bottom-style: double;">&#160;</td>
            <td style="width: 1.02%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #eeeeee;">$</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #eeeeee;">46,067</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">BMO CREDIT FACILITY</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On May 31, 2019, the Company entered into a credit facility with Bank of Montreal ("BMO") as lead arranger and agent and a syndicate including three other lenders. The facility consists of a $115,000 term loan ("Term Loan") and a $25,000 revolving credit facility ("Revolver", and together with the Term Loan, as amended, the "Facilities"), both of which mature on May 31, 2022. Included in the facility was an uncommitted option to increase the Facilities by an incremental $35,000 to a total of $175,000, subject to agreement by BMO and the syndicate lenders and satisfaction of certain legal and business conditions.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Facilities are secured by assets of the Company and its subsidiaries. The proceeds of the Term Loan have been used to fund the Phase 4 and 5 expansions of the Moncton Campus and were also used to refinance the Company's long-term debt with Farm Credit Canada. The Revolver may be used for general corporate and working capital purposes.&#160; Availability under the Revolver is based on a percentage of the Company's trade receivables at the end of each month and remains undrawn at August 31, 2020.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">First Amendment</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On November 15, 2019, the Company amended its Facilities with BMO to: i) extend the final draw deadline of the Term Loan ("Amended Term Loan") from November 30, 2019 to March 31, 2020; ii) postpone the commencement of scheduled principal repayments on the Term Loan from February 28, 2020 to May 31, 2020; and iii) realign the financial covenants structure, effective November 30, 2019, to be more consistent with industry norms up to and including May 31, 2020.&#160; Prior to the Second Amendment, as described below, the financial covenants were to revert to the original structure on August 31, 2020.&#160; The Company incurred an amendment fee of $140 plus customary legal expenses in connection with the first amendment.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The amended Facilities were further amended on February 28, 2020 to extend the final draw deadline of the Amended Term Loan from March 31, 2020 to May 31, 2020. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">In accordance with IFRS 9, such modification to the Facilities as outlined above is not an extinguishment of debt either qualitatively or quantitatively, rather it is a non-substantial modification. Therefore, as per the provisions of IFRS 9 the Company recorded a loss on debt restructuring based on the difference in the present value of the restructured net cash flows discounted at the original effective interest rate ("EIR") versus the present value of the original net cash flows discounted at the original EIR.&#160; This loss of $831 has been recorded under financing costs in the statement of (loss) income and comprehensive (loss) income for the year ended August 31, 2020.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">Second Amendment</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On May 28, 2020, the Company further amended its Facilities ("Second Amendment") with BMO to: (i) extend the final draw deadline of the Term Loan to July 31, 2020; (ii) postpone the commencement of principal repayments on the Amended Term Loan to November 30, 2020; (iii) adjust certain financial ratios to be maintained by the Company both before and after November 30, 2021 (the "Conversion Date"); (iv) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (v) remove the uncommitted option to increase the Amended Facilities by an incremental $35 million.&#160; The financial covenants will revert to the original structure, albeit at different ratios, on November 30, 2021.&#160; The interest rate margin will be fixed during this period.&#160; The Company incurred an amendment fee of $490 plus customary legal expenses in connection with the second amendment.</font></p>
    <div id="footer_page_23">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">21</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_24"></a>
    <p style="text-align: justify;"><font style="color: #000000;">As a result of the Second Amendment, the Company recorded a loan modification loss of $813 under financing costs in the statement of (loss) income and comprehensive (loss) income for the three months ended May 31, 2020.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">As part of the Second Amendment, the Company is also required to establish and maintain with BMO a cash collateral of $8,000 at all times.&#160; As a result, the Company purchased a two-year GIC not redeemable before maturity, which is to be held by BMO as a pledged deposit.&#160; Since the GIC is restricted from being exchanged or used for any other purpose for greater than one year, the Company has classified it as a restricted investment on the statement of financial position under non-current assets.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Pursuant to the agreed upon conditions of the Second Amendment, the Company drew down additional funds up to the $115,000 Term Loan commitment during June 2020.&#160; Principal repayments on the Amended Term Loan will commence on November 30, 2020 at a rate of 2.5% per quarter of the total Amended Term Loan balance.&#160; The Company may, at its discretion, repay the balance of the Amended Facilities without penalty, at any time.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">Amendment and Restatement</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Subsequent to the year-end, on November 27, 2020, the Company further amended its Facilities pursuant to an amended and restated credit agreement ("Amendment and Restatement") with BMO to: (i) reduce the Term Loan amount from $115,000 to $60,000 based on a repayment of $55,000 to be made on December 1, 2020 of the outstanding Term Loan balance of $115,000; (ii) have repayments on the balance of the Term Loan commence on February 28, 2021 in an amount equal to $1,500 per quarter; (iii) reduce the Revolver commitment to $2,000 from up to $25,000; (iv) adjust the minimum quarterly EBITDA covenants to be maintained by the Company commencing on February 28, 2021 and continuing through to maturity, thereby removing this covenant for the fiscal period ended November 30, 2020 and eliminating the reversion of the financial covenants to that of the original structure on November 30, 2021; (v) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (vi) reduce the minimum unrestricted cash balance requirement to $20,000, which is already inclusive of the $8,000 restricted investment currently outstanding.&#160; The interest rate margin will be fixed from November 27, 2020 through to maturity on May 31, 2021.&#160; The Company incurred an amendment fee of $217 plus customary legal expenses in connection with the amendment and restatement.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">Other Terms and Conditions</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Under the terms of the Facilities, the Company can elect, at its sole discretion, to receive advances under the Amended Term Loan through certain availment options, which includes prime rate loans and bankers' acceptances with maturity dates between 28 and 182 days. The Company, therefore, has the choice to continuously roll over the bankers' acceptances upon their maturities or to convert the then outstanding principal and interest into prime rate loans at any time before May 31, 2022.&#160; The interest rate of the Amended Facilities is a set margin over the above-noted availment options, which shall remain fixed until November 30, 2021, at which point it may subsequently increase or decrease based on a pricing grid linked to the Company's debt to EBITDA coverage at each quarter-end.&#160; </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2019, the Company converted its $50,000 outstanding principal amount under the Term Loan to bankers' acceptances, which reduced the cash interest rate from 5.70% (EIR of 6.39%) as at May 31, 2019 to 4.46% (EIR of 5.18%) as at August 31, 2019.&#160; In accordance with IFRS 9, the loan conversion was determined to not be a modification of the loan terms.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, the Company drew an additional $65,000 under the Term Loan, in three tranches, and similar to the initial draw noted above, converted the balances from prime rate loans to bankers' acceptances.&#160; During the year ended August 31, 2020, the Company rolled over $115,000 of the Term Loan balance on a monthly basis through bankers' acceptances with an average cash interest rate of approximately 4.25%.&#160; Based on the current availment option of bankers acceptances' the applicable margin rate is 3.75% above the applicable bankers acceptances' rate.&#160; </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Transaction costs incurred with respect to the Amended Facilities have totaled $2,085 to date, which have been allocated against the Term Loan ($1,899) and Revolver ($186 split between prepaid assets and deferred charges).&#160; The weighted-average effective interest rate for the Term Loan based on these capitalized transaction costs, the loan modification loss, and the current cash interest rate was approximately 4.3% at August 31, 2020.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Facilities contain customary financial and restrictive covenants. At August 31, 2020, the Company was in compliance with these covenants.</font></p>
    <div id="footer_page_24">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">22</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_25"></a>
    <p style="text-align: justify;"><font style="color: #000000;">Principal repayments required on the long-term debt for the next five years as at August 31, 2020 are as follows:</font></p>
    <table style="width: 50%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">Less than 1 year</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">11,605</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">1 to 2 years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">103,580</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">2 to 3 years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">80</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">3 to 4 years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">78</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">4 to 5 years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">46</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Thereafter</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Total</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">115,389</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">12. SHARE CAPITAL</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(i) Authorized share capital</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The authorized share capital of the Company is an unlimited number of common shares without par value and an unlimited number of preferred shares without par value. All issued shares, consisting only of common shares, are fully paid and non-assessable.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(ii) Issued share capital</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">As at August 31, 2020, the Company's issued and outstanding share capital consisted of 194,511,061 (August 31, 2019 - 156,196,347) common shares with a stated value of $420,673 (August 31, 2019 - $318,125).</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(iii) Issuances of share capital</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">At-the-market ("ATM") equity financing - December 2019 Offering</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On December 4, 2019, the Company established an at-the-market equity program (the "December 2019 ATM Program") that allowed the Company to issue up to $55,000 (or its U.S. dollar equivalent) of common shares from treasury to the public. Common shares sold in the December 2019 ATM Program were sold through the TSX or the NASDAQ at the prevailing market price at the time of sale.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Subject to securities laws and stock exchange requirements, the volume and timing of distributions under the December 2019 ATM Program were determined in the Company's sole discretion. All of the common shares issuable pursuant to the December 2019 ATM Program, were issued as of February 13, 2020. The Company has used, and intends to continue to use, the net proceeds of the December 2019 ATM Program to fund capital projects, for general corporate purposes and to repay indebtedness.&#160; As common shares distributed in the December 2019 ATM Program were issued and sold at the prevailing market price at the time of the sale, prices varied among purchasers during the period of the distribution.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Distributions of the common shares through the December 2019 ATM Program were made pursuant to the terms of an equity distribution agreement dated December 4, 2019 among the Company, BMO Nesbitt Burns Inc., as Canadian agent, and BMO Capital Markets Corp., as U.S. agent (collectively, the "agents").</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Company issued 16,201,183 common shares during the three months ended February 29, 2020 for gross proceeds of $54,966 at a weighted average price of $3.39 per common share. Net proceeds realized were $52,885 after agents' commissions of $1,100, regulatory fees of $12, and legal and professional fees of $969. Proceeds were raised in both USD (for shares sold through the NASDAQ) and CAD (for shares sold through the TSX) and the weighted average share price was calculated using the spot rate on the day of settlement.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">ATM equity financing - April 2020 Offering</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On April 22, 2020, the Company established an at-the-market equity program (the "April 2020 ATM Program") that allowed the Company to issue up to $49,000 (or its U.S. dollar equivalent) of common shares from treasury to the public. Common shares sold in the April 2020 ATM Program were sold through the TSX or the NASDAQ at the prevailing market price at the time of sale.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Subject to securities laws and stock exchange requirements, the volume and timing of distributions under the April 2020 ATM Program were determined in the Company's sole discretion. All of the common shares issuable pursuant to the April 2020 ATM Program, were issued as of June 8, 2020. The Company has used, and intends to continue to use, the net proceeds of the April 2020 ATM Program to fund capital projects, for general corporate purposes and to repay indebtedness.&#160; As common shares distributed in the April 2020 ATM Program were issued and sold at the prevailing market price at the time of the sale, prices varied among purchasers during the period of the distribution.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Distributions of the common shares through the April 2020 ATM Program were made pursuant to the terms of an equity distribution agreement dated April 22, 2020 among the Company and the agents.</font></p>
    <div id="footer_page_25">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">23</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_26"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">The Company issued 14,035,278 common shares during the three months ended May 31, 2020 for gross proceeds of $31,069 at a weighted average price of $2.21 per common share. The Company subsequently completed its April 2020 ATM Program on June 8, 2020, by issuing the remaining shares under the ATM, which comprised of 7,044,951 common shares for gross proceeds of $17,915 at a weighted average price of $2.54 per common share.&#160; In aggregate, the Company issued 21,080,229 common shares under the April 2020 ATM Program during the year ended August 31, 2020 for gross proceeds of $48,785 at a weighted average price of $2.31 per common share. Net proceeds realized were $47,112 after agents' commissions of $975, regulatory fees of $1, and legal and professional fees of $697. Proceeds were raised in both USD (for shares sold through the NASDAQ) and CAD (for shares sold through the TSX) and the weighted average share price was calculated using the spot rate on the day of settlement.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Equity financing</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On December 18, 2017, the Company issued 16,428,572 units by way of a bought deal at $3.50 per unit share for total gross consideration of $48,711 recorded to share capital and an increase of $8,789 to the reserve for options and warrants. Each unit consisted of one common share and one-half common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant entitled the holder thereof to acquire one common share of the Company at a price of $4.00 until June 18, 2019. Total issue costs were $3,678, with $3,116 charged to share capital and the remaining $562 charged to the reserve for options and warrants. These Warrants are measured at fair value at the date of grant. In determining the amount of reserve for the Warrants, the Company used the Black-Scholes option pricing model to establish the fair value of Warrants granted using the following assumptions:&#160; </font></p>
    <table style="font-size: 10pt; width: 100%; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 10%;">&#160;</td>
            <td style="width: 35%;">Risk free interest rate %</td>
            <td style="text-align: left; width: 50%;">1.6%</td>
        </tr>
        <tr>
            <td style="text-align: left; width: 10%;">&#160;</td>
            <td style="text-align: left; width: 35%;">Expected life of Warrants (years)</td>
            <td style="text-align: left; width: 50%;">1.5</td>
        </tr>
        <tr>
            <td style="width: 10%;">&#160;</td>
            <td style="width: 35%;">Expected annualized volatility %</td>
            <td style="text-align: left; width: 50%;">64.6%</td>
        </tr>
        <tr>
            <td style="width: 10%;">&#160;</td>
            <td style="width: 35%;">Expected dividend yield %</td>
            <td style="text-align: left; width: 50%;">-</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Volatility was estimated by using the weighted average historical volatility of the Company and other companies that the Company considers comparable. The expected life in years represents the period of time that the Warrants granted are expected to be outstanding. The risk-free rate is based on government of Canada bonds with a remaining term equal to the expected life of the Warrants. A forfeiture rate of zero percent was used as the Company anticipated all Warrants will be exercised.&#160; </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the prior fiscal year, all except for 347,432 Warrants were exercised prior to expiry on June 18, 2019 on a one-for-one basis.&#160; The 347,432 Warrants that remained unexercised at the expiry time expired as a result. The Warrants were delisted from the TSX Venture Exchange on June 18, 2019.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Convertible debenture financing</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On January 31, 2018, 115,000 convertible debentures were sold at a price of $1,000 per convertible debenture, for aggregate gross proceeds of $115,000 resulting in an increase to the reserve for options and warrants of $12,003, net of deferred tax of $4,902, related to the embedded conversion feature in the convertible debenture. Total issue cost was $7,155 with $6,094 charged to the debenture liability and the remaining $756, net of deferred tax of $305, charged to the reserve for options and warrants.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Conversion of debentures</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">For the year ended August 31, 2019, the Company issued 20,845,372 common shares at a price per share of $5.42 on the conversion of convertible debentures for an increase of $112,166 to share capital and a decrease of $11,247 to the reserve for options and warrants, respectively. This non-cash financing activity has been excluded from the Company's statement of cash flows as it did not provide or use any cash.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On February 27, 2019, the Company elected to exercise its right under the indenture governing the convertible unsecured debentures to convert all of the principal amount outstanding of the remaining debentures on April 1, 2019 into common shares of the Company on the basis of the daily volume-weighted average price ("VWAP") of the common shares exceeding $7.05 for any 10 consecutive trading days.&#160; As of April 1, 2019, all of the convertible unsecured debentures issued were converted to common shares of the Company and no further liability or obligation exists with respect to the convertible unsecured debentures.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Share-based payments</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On July 14, 2017, the Company entered into an advisory services agreement with a cannabis consultant that resulted in the grant of 125,000 common shares that vested over various service periods up to and including October 14, 2018. The fair value of the grant was measured based on the average monthly share price of the Company over the various tranches and vesting periods resulting in a cumulative expense of $539.&#160; On October 23, 2017, the Company issued 50,000 common shares, of which 20,000 related to the advisory services agreement, as share consideration to the consultant and recognized $144 to share capital. During the year ended August 31, 2019, the Company settled the remaining balance of 105,000 common shares due to the consultant in the form of 41,000 common shares of the Company and 84,000 restricted stock units, which vest immediately, to purchase 84,000 common shares of the Company, which fully settled the Company's obligations relating to this agreement.</font></p>
    <div id="footer_page_26">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">24</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_27"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Exercise of stock options</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, 879,240 (August 31, 2019 - 2,167,864) share options were exercised at an average exercise price of $1.21 (August 31, 2019 - $1.92) for an increase of $1,786 (August 31, 2019 - $6,588) to share capital and a decrease to the reserve for options and warrants of $717 (August 31, 2019 - $2,418).</font><font style="color: #000000;">&#160;</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(iv) Warrants</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2019, 7,739,205 Warrants were exercised at an average price of $4.00 for a value of $39,257 to share capital and a decrease to the reserve for options and warrants of $8,281. All the outstanding Warrants at June 18, 2019 that were not exercised into common shares prior to expiry on June 18, 2019 lapsed and therefore no further Warrants remain outstanding.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(v) Share-based compensation </font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On February 25, 2020 (the "Approval Date"), the Company's shareholders approved a new omnibus equity incentive plan (the "New Equity Incentive Plan") that governs grants made on or after the Approval Date.&#160; Grants made prior to the Approval Date will continue to be governed under the terms of the plan under which they were granted including the Company's 2011 stock option plan and its 2017 equity incentive plan (the "2017 Equity Incentive Plan"), however, no new grants may be made under such plans.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Stock options</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The following table summarizes changes in the Company's outstanding stock options for the years ended August 31, 2020 and 2019:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; width: 16.9302%; white-space: nowrap;">NUMBER</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid transparent; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 16.9302%; white-space: nowrap;">WEIGHTED AVERAGE<br>EXERCISE PRICE</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Balance&#160; -&#160; August 31, 2018</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">7,709,746</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">2.10</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Granted</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">3,589,500</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">7.59</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Exercised</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">(2,167,864</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">1.92</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Cancelled / Forfeited</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 16.9302%; text-align: right;">(298,188</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 16.9302%; text-align: right;">6.41</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Balance&#160; -&#160; August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">8,833,194</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">4.23</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Granted</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">2,125,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">3.21</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Exercised</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">(879,240</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 16.9302%; text-align: right;">1.21</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Cancelled / Forfeited</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 16.9302%; text-align: right;">(1,050,050</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 16.9302%; text-align: right;">6.20</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 55.093%;">Balance&#160; -&#160; August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 16.9302%; text-align: right;">9,028,904</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 16.9302%; text-align: right;">4.06</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">&#160;</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The following is a summary of the outstanding stock options as </font><font style="color: #000000;">at August 31, 2020</font><font style="color: #000000;">:</font></p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="text-align: right; border-bottom: 1px solid #000000;" colspan="2">
                <p style="text-align: center;">OPTIONS OUTSTANDING</p>
            </td>
            <td style="width: 4%; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000;" colspan="2">
                <p style="text-align: center;">OPTIONS EXERCISABLE</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">Range of Exercise</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">&#160;</p>
            </td>
            <td style="width: 4%; text-align: right;">&#160;</td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">Weighted Average Remaining</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; text-align: right; border-bottom: 2px solid #000000;">
                <p style="text-align: right;">Prices</p>
            </td>
            <td style="width: 24%; text-align: right; border-bottom: 2px solid #000000;">
                <p style="text-align: right;">Quantity Outstanding</p>
            </td>
            <td style="width: 4%; text-align: right; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="width: 24%; text-align: right; border-bottom: 2px solid #000000;">
                <p style="text-align: right;">Contractual Life (years)</p>
            </td>
            <td style="width: 24%; text-align: right; border-bottom: 2px solid #000000;">
                <p style="text-align: right;">Quantity Exercisable</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%;">
                <p>&#160;</p>
            </td>
            <td style="width: 24%;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%;">&#160;</td>
            <td style="width: 24%;">
                <p>&#160;</p>
            </td>
            <td style="width: 24%;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">$0.30 - $1.48</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">1,440,599</p>
            </td>
            <td style="width: 4%; text-align: right;">&#160;</td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">4.7</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">1,376,683</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">$1.49 - $2.38</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">2,204,333</p>
            </td>
            <td style="width: 4%; text-align: right;">&#160;</td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">7.5</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">1,652,833</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">$2.39 - $4.65</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">2,069,854</p>
            </td>
            <td style="width: 4%; text-align: right;">&#160;</td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">7.9</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">1,217,504</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">$4.66 - $7.67</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">1,886,518</p>
            </td>
            <td style="width: 4%; text-align: right;">&#160;</td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">8.2</p>
            </td>
            <td style="width: 24%; text-align: right;">
                <p style="text-align: right;">1,276,194</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; text-align: right; border-bottom: 1px solid #000000;">
                <p style="text-align: right;">$7.68 - $11.27</p>
            </td>
            <td style="width: 24%; text-align: right; border-bottom: 1px solid #000000;">
                <p style="text-align: right;">1,427,600</p>
            </td>
            <td style="width: 4%; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="width: 24%; text-align: right; border-bottom: 1px solid #000000;">
                <p style="text-align: right;">8.7</p>
            </td>
            <td style="width: 24%; text-align: right; border-bottom: 1px solid #000000;">
                <p style="text-align: right;">949,900</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; border-bottom: 2px solid #000000;">
                <p>&#160;</p>
            </td>
            <td style="width: 24%; text-align: right; border-bottom: 2px solid #000000;">
                <p style="text-align: right;">9,028,904</p>
            </td>
            <td style="width: 4%; text-align: right; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="width: 24%; text-align: right; border-bottom: 2px solid #000000;">
                <p style="text-align: right;">7.5</p>
            </td>
            <td style="width: 24%; text-align: right; border-bottom: 2px solid #000000;">
                <p style="text-align: right;">6,473,114</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Options outstanding have exercise prices that range from $0.30 to $11.27 with a weighted average remaining life of 7.5 years. Total share-based compensation charges, including related to production employees that are charged to biological assets and inventory, for the year ended August 31, 2020 was $7,796 (August 31, 2019 - $14,894) of which $6,127 (August 31, 2019 - $10,036) related to the Company's stock option plan. The fair value of options granted during the year ended August 31, 2020 was $3,743 (August 31, 2019 - $13,848). These options are measured at fair value at the date of grant and are expensed over the option's vesting period, which typically range from two to three-year terms with options vesting in annual tranches evenly over this time period. In determining the amount of share-based compensation related to the options, the Company used the Black-Scholes option pricing model to establish the fair value of options granted.</font><font style="color: #000000;">&#160;</font></p>
    <div id="footer_page_27">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">25</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_28"></a>
    <p style="text-align: justify;"><font style="color: #000000;">The following is the range of assumptions for the years ended August 31, 2020 and 2019:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0">
        <tr>
            <td style="width: 391px;">&#160;</td>
            <td style="width: 147px; text-align: center; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="width: 13px; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="width: 147px; text-align: center; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
        </tr>
        <tr>
            <td style="width: 391px;">Risk free interest rate</td>
            <td style="text-align: center; background-color: #cee5ea;">&#160;0.45% - 1.65%&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 147px; text-align: center; background-color: #eeeeee;">&#160;1.20% - 2.42%&#160;</td>
        </tr>
        <tr>
            <td style="width: 391px;">Expected life of options</td>
            <td style="text-align: center; background-color: #cee5ea;">&#160;5.0 - 6.0 years&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 147px; text-align: center; background-color: #eeeeee;">&#160;5.0 -6.5 years&#160;</td>
        </tr>
        <tr>
            <td style="width: 391px;">Expected annualized volatility</td>
            <td style="text-align: center; background-color: #cee5ea;">&#160;72% - 85%&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 147px; text-align: center; background-color: #eeeeee;">&#160;64% -71%&#160;</td>
        </tr>
        <tr>
            <td style="width: 391px;">Expected dividend yield</td>
            <td style="text-align: center; background-color: #cee5ea;">&#160;-&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 147px; text-align: center; background-color: #eeeeee;">&#160;-&#160;</td>
        </tr>
        <tr>
            <td style="width: 391px;">Forfeiture Rate</td>
            <td style="text-align: center; background-color: #cee5ea;">&#160;8.0% - 8.7%&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 147px; text-align: center; background-color: #eeeeee;">&#160;7.3% - 8.0%&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Volatility was estimated by using the weighted average historical volatility of the Company and other companies that the Company considers comparable. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate is based on government of Canada bonds with a remaining term equal to the expected life of the options. The forfeiture rate is calculated based on historical experience.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #000000;">Equity incentive plan</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">As of August 31, 2020, the Company has granted both restricted share units ("RSUs") and performance share units ("PSUs") under the 2017 Equity Incentive Plan and RSUs under the New Equity Incentive Plan. The grant price of any RSU or PSU was determined based on market price calculated in accordance with TSX rules at the time of grant and with respect to PSUs, adjusted for any non-market and market performance vesting conditions in accordance with IFRS 2.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The following table summarizes the movements in the Company's outstanding RSUs:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">NUMBER</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance - August 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">145,200</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">879,635</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Exercised</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(182,473</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance - August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">842,362</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">265,258</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(154,062</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Cancelled/Forfeited</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(60,387</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance - August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">893,171</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">The estimated fair value of the equity settled RSUs granted during the year ended August 31, 2020 was $1,037 (August 31, 2019 - $4,543), which was based on the Company's share price at the grant date and will be recognized as an expense over the vesting period of the RSUs, which is over a period of one year for most grants. For the year ended August 31, 2020, $1,576 (August 31, 2019 - $3,475) has been recognized as share-based compensation expense.</font></p>
    <div id="footer_page_28">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">26</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_29"></a>
    <p style="text-align: justify;"><font style="color: #000000;">The following table summarizes the movements in the Company's outstanding PSUs:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">NUMBER</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance&#160; -&#160; August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">142,187</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Exercised</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(15,502</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance&#160; -&#160; August 31, 2020</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right;">126,685</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">The estimated fair value of the equity settled PSUs granted during the year ended August 31, 2020 was $305 (August 31, 2019 - $nil), which was based on the Company's share price at the grant date, adjusted for an estimate of likelihood of achievement, and will be recognized as an expense over the vesting period of the PSUs, which is during the fiscal year-ended August 31, 2020. For the year ended August 31, 2020, $272 (August 31, 2019 - $nil) has been recognized as share-based compensation expense.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(vi) Earnings (Loss) per share</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Earnings (loss) per share represents net income (loss) attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Diluted (loss) income per share is calculated by dividing the applicable net (loss) income by the sum of the weighted average number of common shares outstanding and all additional common shares that would have been outstanding if potentially dilutive common shares had been issued during the year.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The reconciliation of the weighted average number of shares, for the purposes of diluted earnings per share, to the weighted average number of ordinary shares, used in the calculation of basic earnings per share, is as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Weighted average number of shares used in basic earnings per share</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">172,668,816</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">140,923,324</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Options</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">4,540,182</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">5,194,827</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Warrants</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">4,738,388</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Restricted share units</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">727,275</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">684,534</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Performance share units</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">126,685</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Weighted average number of shares used in diluted <br>&#160;&#160; earnings per share</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">178,062,958</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">151,541,073</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">The outstanding number and type of securities that could potentially dilute basic net (loss) income per share in the future but that were not included in the computation of diluted net income (loss) per share because to do so would have increased (decreased) the net (loss) income per share (anti-dilutive) are as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Stock options</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">4,382,918</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,847,500</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">4,382,918</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,847,500</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">13. OTHER LIABILITIES</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The carrying value of other liabilities consists of:</font><font style="color: #000000;">&#160;</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Contingent share consideration</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">231</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,117</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">Lease liabilities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,617</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 70.0465%;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,848</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,117</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(i) Contingent share consideration</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">In connection with the Company's investment in alpha-cannabis&#174; Pharma GmbH as described in Note 14, the Company has a commitment to deliver additional consideration of up to &#8364;875 in the form of the Company's common shares contingent on the achievement of certain gross margin-based milestones. At August 31, 2020, the Company revalued the contingent liability and recorded a corresponding gain in the statement of operations of $886 for the year ended August 31, 2020 (August 31, 2019 - loss of $145).</font></p>
    <div id="footer_page_29">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">27</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_30"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(ii) Lease liabilities</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">In connection with the Company's adoption of IFRS 16 effective September 1, 2019, lease liabilities were recorded as described in Note 3.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On March 13, 2020, the Company entered into a lease amending agreement for its Toronto corporate office: i) extending the lease of its existing 5,007 square feet of office space (the "Existing Premises") originally expiring on August 31, 2020; and ii) leasing an additional 6,572 square feet of office space adjacent to the Existing Premises (the "Additional Premises"). The term of the lease for Existing Premises will be extended for a period of five years and two months commencing on September 1, 2020 and expiring on October 31, 2025.&#160; As this amending lease agreement for the Existing Premises is effectively a modification to the original lease agreement, the Company has recognized the ROU asset and corresponding lease liability pertaining to the Existing Premises as of the effective date of the lease amending agreement, which was March 13, 2020. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On April 21, 2020, the Company, as sub-landlord, entered into a sublease agreement with a subtenant pursuant to which the Company agreed to sublease 3,099 square feet of its Additional Premises noted above for a period of five years and two months commencing on September 1, 2020 and expiring on October 30, 2025 for a total of $251 per annum for an aggregate rental income of $1,296 over the term of the sublease. Under the currently contemplated terms, both parties have the mutual right to terminate the sublease upon six months' written notice to either party, which shall not occur prior to August 31, 2023. This sublease agreement has no impact on the amount of lease liabilities as it is a net investment in the sublease by the Company.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On July 16, 2020, the Company, as sublandlord, entered into a sublease agreement with a subtenant, pursuant to which the Company agreed to sublease 3,473 square feet of its rented premises for a period of five years and two months commencing on September 1, 2020 and expiring on October 30, 2025 for a total of $282 per annum for an aggregate rental income of $1,431 over the term of the sublease. Under the terms, the sub-landlord has a right to terminate the sublease upon six months' written notice to the subtenant, which shall not occur prior to April 30, 2021, whereas the subtenant have a right to terminate the sublease upon eight months' written notice to the sublandlord, which shall not occur prior to February 28, 2022.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The following is a continuity schedule of lease liabilities for the year ended August 31, 2020:</font></p>
    <table style="width: 60%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">IFRS 16 transition</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">2,219</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Lease additions</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">2,220</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Lease payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">(897</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Interest expense on lease liabilities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">163</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, August 31, 2020</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">3,705</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Current portion included in accounts payable and accrued liabilities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">(1,088</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom;">Long-term portion</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 22%; text-align: right;">2,617</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p><font style="color: #000000;">The undiscounted contractual payments relating to the current and future lease liabilities at August 31, 2020 is:</font></p>
    <table style="width: 60%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">Less than 1&#160; year</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">1,553</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">1 to 2 years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">1,049</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">2 to 3 years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">1,045</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">3 to 4 years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">998</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">4 to 5 years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">768</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Thereafter</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">606</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Total</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">6,019</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Included in the undiscounted contractual payments relating to current and future lease liabilities above is the Additional Premises as noted above, the term of which will commences on September 1, 2020.</font></p>
    <div id="footer_page_30">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">28</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_31"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">14. INVESTMENTS IN ASSOCIATES</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The carrying value of investments in associates consist of:</font></p>
    <div>
        <div>
            <table style="border-color: #000000; width: 100%; font-size: 10pt; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0">
                <tr>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 11.9891%;">ALPHA-CANNABIS</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 11.9891%;">EVIANA HEALTH</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 11.9891%;">HYASYNTH</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="width: 11.9891%;">&#160;</td>
                    <td style="width: 1.99818%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; width: 39.9637%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 11.9891%;">PHARMA GMBH</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 11.9891%;">CORPORATION</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 11.9891%;">BIOLOGICALS INC.</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; white-space: nowrap; width: 11.9891%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; width: 1.99818%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; width: 39.9637%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap; width: 11.9891%;">(A)</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid transparent; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap; width: 11.9891%;">(B)</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid transparent; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap; width: 11.9891%;">(C)</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid transparent; white-space: nowrap; width: 1.99818%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap; width: 0.999092%;">&#160;</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap; width: 11.9891%;">TOTAL</td>
                    <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid transparent; width: 1.99818%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">Participating share&#160;<sup>(1)</sup></td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">25.0%</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">19.9%</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">43.4%</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">Balance, August 31, 2018</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Additions</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">3,408</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">5,000</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">5,000</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">322</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Transaction costs</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">160</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">73</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">89</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">&#160;</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Distributions</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(374</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(374</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Share of net loss</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(50</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(734</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(477</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(1,261</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Impairment loss</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(950</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(950</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Foreign currency translation gain (loss)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">(22</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">(15</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">(37</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">Balance, August 31, 2019</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">3,496</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">3,000</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">4,612</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">11,108</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Share of net loss</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(75</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(1,112</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(1,187</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Impairment loss</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(3,000</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(3,000</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Elimination of proportionate share of<br>&#160;&#160;&#160;&#160; transactions with associates</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(14</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom;">(14</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; white-space: nowrap; width: 39.9637%;">&#160; &#160;Foreign currency translation gain (loss)</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">94</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">94</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 1px solid transparent;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; width: 39.9637%;">Balance, August 31, 2020&#160;<sup>(2)</sup></td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 3px double #000000;">3,501</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 3px double transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 3px double #000000;">-</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 3px double transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 3px double #000000;">3,500</td>
                    <td style="width: 1.99818%; text-align: left; vertical-align: bottom; border-bottom: 3px double transparent;">&#160;</td>
                    <td style="width: 0.999092%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000;">$</td>
                    <td style="width: 11.9891%; text-align: right; vertical-align: bottom; border-bottom: 3px double #000000;">7,001</td>
                    <td style="width: 1.99818%;">&#160;</td>
                </tr>
            </table>
        </div>
    </div>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">&#160;</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Note 1: % Interest includes the potential ownership interest that could result from the conversion of debentures and exercise of warrants</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Note 2: The Company utilizes the most recently issued quarterly financial statements of its associates in its results with a two month lag since the Company does not have the same reporting date as its associates (for the year ended August 31, 2020, the Company utilized its associates' June 30, 2020 results)</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">a) alpha-cannabis Pharma GmbH</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On October 10, 2018, the Company executed an investment agreement with alpha-cannabis&#174; Pharma GmbH ("ACG") pursuant to which the Company acquired 8,333 common shares of ACG, representing a 25% stake in the capital of ACG, for aggregate proceeds of &#8364;1,625 ($2,436). Established in 2016, ACG is a privately held company that is strategically positioned to serve the German medical cannabis market.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Company has a commitment to deliver additional consideration of up to &#8364;875 in the form of the Company's common shares contingent on the achievement of certain gross margin-based milestones. The Company has estimated the fair value of these contingent shares as &#8364;649 ($972) as of the investment date and has included a corresponding long-term liability under other liabilities in the statement of financial position. Refer to Note 12 for further information.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Concurrent with the Company's investment in ACG, the parties entered into a CBD supply agreement, whereby ACG may supply the Company with synthetic CBD, as well as a cannabis supply agreement, whereby the Company may supply ACG with dried cannabis flowers. </font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">b) Eviana Health Corporation</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On October 2, 2018, the Company participated in the debenture offering of Eviana Health Corporation ("Eviana") by way of private placement. Eviana is a Canadian Securities Exchange ("CSE") listed company that was established with the aim of delivering customized consumer health care products using natural hemp strains of cannabis sativa for cannabinoid-based topical creams and products. The Company's investment is in the form of convertible debentures and share purchase warrants, which together provide a potential ownership interest of up to 21.4%, which is capped at 19.9% based on certain contractual obligations. In addition to this ownership interest, the Company also considered various qualitative factors in arriving at the determination that significant influence exists, including representation rights on Eviana's board of directors, and thereby concluding that the equity method of accounting is appropriate.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The convertible debentures have a face value of $5,000, bear interest at 10% per annum, are non-redeemable, and mature on October 2, 2020. The convertible debentures are convertible at the option of the holder at any time at a price of $1.15 per share, or into 4,347,826 common shares of Eviana. Conversion of the debentures may be forced by Eviana in the event that the volume weighted average price of the common shares of Eviana for ten consecutive days is greater than $2.15, subject to a minimum volume of 100,000 shares in each of those 10 days.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The share purchase warrants were acquired for no additional consideration, concurrent with the debenture offering, are transferrable, and are exercisable until October 2, 2020. 2,500 share purchase warrant units were acquired, each of which is convertible into 870 common shares per unit, or 2,175,000 common shares in aggregate, at an exercise price of $1.30 per share.</font></p>
    <div id="footer_page_31">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">29</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_32"></a>
    <p style="text-align: justify;"><font style="color: #000000;">Concurrent with the Company's investment in Eviana, the parties entered into a CBD oil supply agreement, whereby the Company has the right, but not obligation, to purchase up to 25% of Eviana's annual CBD oil at 95% of the agreed raw CBD oil wholesale market price for a period of 5 years from the date on which the CBD oil is first made commercially available by Eviana for wholesale.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On October 28, 2019, Eviana provided a default announcement in accordance with National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). Eviana made an application to the British Columbia Securities Commission, as its principal regulator, for a management cease trade order ("MCTO") under NP 12-203 in respect of an anticipated default regarding its annual filings. On November 1, 2019, a cease trade order ("CTO") was issued by the British Columbia Securities Commission and the Ontario Securities Commission.&#160; On November 5, 2019, Eviana was suspended from the CSE in accordance with CSE Policy 3 which is considered a regulatory halt as defined in National Instrument 23-101 - Trading Rules.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">At May 31, 2020, the Company identified indicators of impairment with respect to its investment in Eviana. The Company determined the recoverable amount of Eviana to approximate $nil based on the higher of fair value less costs to sell ("FVLCS") and value-in-use ("VIU").&#160; An impairment loss of $3,000 has been included in the statement of (loss) income and comprehensive (loss) income for the year ended August 31, 2020. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On June 18, 2020, the Company served Eviana with a notice of default and demand letter with respect to the non-payment of interest relating to its convertible debentures as well as other applicable events of default under the debenture agreement.&#160; As of the date these financial statements were approved, the Company has not yet received its December 31, 2019 or June 30, 2020 interest payment on the Eviana convertible debenture.&#160; </font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">c) Hyasynth Biologicals Inc.</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On September 12, 2018, the Company invested in Hyasynth Biologicals Inc. ("Hyasynth") by way of convertible secured debentures, to be purchased in three tranches and valued in the aggregate at $10,000. Tranche 1 was issued on that date, Tranche 2 was issued on October 23, 2020 (as described below), and one additional tranche that may be issued based on the achievement of a specific milestone. Hyasynth is a privately held biotechnology company based in Montreal, Quebec and is a leader in the field of cannabinoid science and biosynthesis. The Company's investment is in the form of convertible debentures, which provide a potential ownership interest of up to 43.4% based on Tranche 1. In addition to the ownership interest, the Company also considered various qualitative factors in arriving at the determination that significant influence exists, including representation on Hyasynth's board of directors, and thereby concluded that the equity method of accounting is appropriate.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Tranche 1 of the convertible debentures has a face value of $5,000, bears interest at 8.0% per annum, are secured, and mature on the earlier of August 31, 2023 or the closing date of a qualified sale transaction, unless an automatic or optional conversion has occurred. Tranche 1 of the convertible debentures are convertible at the option of the holder at any time at a price of $40 per share, or into 125,000 common shares. Conversion of the debentures may be automatically triggered based on the completion of a qualified transaction or Hyasynth's facility reaching a pre-defined production capacity. Tranche 2 and 3 of the convertible debentures, each of which commits $2.5 million for an aggregate of $5 million, have certain production-related milestones that must be achieved within a 24- and 36-month period, respectively, for issuance to occur.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Concurrent with the Company's investment in Hyasynth, the parties entered into a CBD supply agreement, whereby the Company has the ability to purchase up to 100% of Hyasynth's annual cannabinoid or cannabinoid-related production at a 10% discount to the agreed upon wholesale market price for a period of 10 years from the date Hyasynth commences commercial production of the products.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Subsequent to the year end, on October 23, 2020, the Company advanced an additional $2,500 to Hyasynth by way of convertible debentures as a result of Hyasynth&#8217;s achievement of the contractual production-related milestone for Tranche 2 of the convertible debentures.&#160; This brings the Company&#8217;s total face value of convertible debentures investment in Hyasynth to $7,500, which provides the Company with a potential ownership interest of up to 46.5% on a fully diluted basis.</font></p>
    <div id="footer_page_32">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">30</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_33"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">15. RELATED PARTY TRANSACTIONS</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly. The key management personnel of the Company are the members of the Company's executive management team and Board of Directors. The transactions are conducted at arm's length and in the normal course of operations. </font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(i) Management and Board compensation</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">For the years ended August 31, 2020 and 2019, the Company's expenses included the following management and board compensation:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Salaries and consulting fees</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,953</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">2,521</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Share-based compensation</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,750</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">5,155</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Total key management compensation</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">5,703</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">7,676</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">&#160;</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, 790,000 stock options (August 31, 2019 - 685,000) were granted to key management personnel at an average exercise price of $2.48 (August 31, 2019 - $4.75) and aggregate fair value of $1,794 (August 31, 2019 - $1,736).&#160; In addition, during the year ended August 31, 2020, 211,981 RSUs (August 31, 2019 - 631,949), were granted to key management personnel with an aggregate fair value of $902 (August 31, 2019 - $3,002).&#160; For the year ended August 31, 2020, 88,910 PSUs (August 31, 2019 - nil) were issued to key management personnel with an aggregate fair value of $191 (August 31, 2019 - $nil).</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">(ii) Significant transactions with associates</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">For the year ended August 31, 2020, the Company received no interest income (August 31, 2019 - $374) on its convertible debenture investment in Eviana as disclosed in Note 14, which is being recorded as distributions under the equity accounting method.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">For the year ended August 31, 2020, the Company earned revenues of $52 (August 31, 2019 - $nil) on product sold to ACG, which has been proportionately eliminated from the consolidated financial statements based on the Company's proportionate share of investment in ACG.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">16. CAPITAL MANAGEMENT</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company considers its capital to consist of share capital, equity reserves, long-term debt, accumulated other comprehensive income, and retained earnings, which is disclosed in the August 31, 2020 consolidated statement of financial position as $414,793 (August 31, 2019 - $376,582).&#160; Equity reserves is comprised of any amounts recorded with respect to the recognition of share-based compensation expense (options, RSUs, or PSUs) or the fair value of warrants issued.&#160; Accumulated other comprehensive income is entirely comprised of foreign currency translation gains and losses recorded on the Company's investment in ACG.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Company manages its capital structure and adjusts it based on funds available to the Company, in order to fund its expansion and construction of its facility. The Board of Directors does not establish quantitative return on capital criteria for management, but rather relies on the expertise of the Company's management to sustain future development of the business.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative stage of the Company, is reasonable. There has been no chan</font><font style="color: #000000;">ge in how the Company defines or manages capital during the period.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">17. FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS</font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">i) Fair value of financial instruments</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly fashion between market participants. The Company records certain financial instruments at fair value. The Company's financial instruments include cash, short-term investments (including marketable securities), accounts receivable, loan receivable, accounts payable and accrued liabilities, long-term debt, and contingent share consideration. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Fair value measurements are categorized into Level 1, 2 or 3 based on the degree to which the inputs to the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are described as follows:</font></p>
    <p style="margin-left: 21.6pt; text-indent: -12.95pt; text-align: justify;"><font style="color: #87b5cf;">&#8226;</font><font style="text-indent: 0pt; display: inline-block; width: 8.47pt;">&#160;</font><font style="color: #000000;">Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date;</font></p>
    <p style="margin-left: 21.6pt; text-indent: -12.95pt; text-align: justify;"><font style="color: #87b5cf;">&#8226;</font><font style="text-indent: 0pt; display: inline-block; width: 8.47pt;">&#160;</font><font style="color: #000000;">Level 2 inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly or indirectly; and </font></p>
    <div id="footer_page_33">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">31</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_34"></a>
    <p style="margin-left: 26.45pt; text-indent: -17.45pt; text-align: justify;"><font style="color: #87b5cf;">&#8226; </font><font style="width: 6.08pt; text-indent: 0pt; display: inline-block;">&#160;</font><font style="color: #000000;">Level 3 inputs are unobservable inputs for the asset or liability.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The fair value of cash, short-term investments, accounts receivable, loan receivable, accounts payable and accrued liabilities approximate their carrying amounts due to their short-term nature. The fair value of marketable securities is based on quoted prices in active markets and is reflected in the carrying value of these financial assets. The fair value of long-term debt approximates $115,389 based on the face value of debt outstanding, which carries a floating interest rate.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The fair value of the contingent share consideration is primarily based on Level 3 unobservable inputs. The determination of the fair value of this liability is primarily driven by the Company's expectations of the investment in associate achieving certain milestones. The expected milestones were assigned probabilities and the expected related cash flows were discounted to derive the fair value of the contingent consideration. At August 31, 2020, the probability of achieving the milestones was estimated to be 68% and the discount rate was estimated to be 20%.&#160; If the probabilities of achieving the milestones increased or decreased by 10%, the estimated fair value of the contingent share consideration would increase or decrease by approximately $33.&#160; If the discount rates increased or decreased by 5%, the estimated fair value of contingent consideration would decrease or increase, respectively, by approximately $12.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the period, there were no transfers of amounts between Levels 1, 2 and 3.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">ii) Financial risk factors</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company is exposed to various risks through its financial instruments, as follows: </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">(i) <b>Credit risk</b> arises from deposits with banks, short-term investments (excluding investments in equity securities), outstanding trade and loan receivables, and restricted investments.&#160; For trade receivables, the Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance.&#160; For other receivables, out of the normal course of business such as the loan receivable, management generally obtains guarantees and general security agreements. The maximum exposure to credit risk of cash, short-term investments, accounts receivable, loans receivable, and restricted investment on the statement of financial position at August 31, 2020 approximates $99,736 (August 31, 2019 - $65,385).</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">As of August 31, 2020, the Company's aging of trade receivables was as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">0-60 days</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,023</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">11,748</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">61-120 days</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">73</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">152</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Gross trade receivables</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,096</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">11,900</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Less: Provision for doubtful accounts</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(13</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(268</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,083</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">11,632</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">(ii)<b> Liquidity risk - </b></font><font style="color: #000000;">The Company's liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company manages its liquidity risk by reviewing on an ongoing basis its capital requirements. At August 31, 2020, the Company had $24,600 (August 31, 2019 - $47,555) of cash and working capital of $141,123 (August 31, 2019 - $152,417).&#160; Further, the Company may further consider accessing equity capital through the capital markets.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Company is obligated to the following contractual maturities relating to their undiscounted cash flows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;"><font style="color: #ffffff;">Carrying </font><br><font style="color: #ffffff;">Amount</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;"><font style="color: #ffffff;">Contractual </font><br><font style="color: #ffffff;">Cash Flows</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;"><font style="color: #ffffff;">Less than </font><br><font style="color: #ffffff;">1 year</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;"><font style="color: #ffffff;">1 to 3 years</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;"><font style="color: #ffffff;">3 to 5 years</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;"><font style="color: #ffffff;">More than </font><br><font style="color: #ffffff;">5 years</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Accounts payable and accrued liabilities</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">17,486</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">17,486</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">17,486</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Long-term debt</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">115,266</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">115,388</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">11,605</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">103,660</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">123</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Interest payments</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">7,729</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">4,682</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">3,047</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">132,752</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">140,603</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">33,773</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">106,707</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">123</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">The contractual maturities noted above are based on contractual due dates of the respective financial liabilities.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">In connection with the Company's Moncton Campus expansion plans, the Company is contractually committed to approximately $1,600 of capital expenditures.</font></p>
    <div id="footer_page_34">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">32</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_35"></a>
    <p style="text-align: justify;"><font style="color: #000000;">(iii) </font><font style="color: #000000;"><b>Market risk</b> is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.&#160; Market risk for the Company comprises of:</font></p>
    <p style="margin-left: 36pt; text-align: justify;"><font style="color: #000000;"><b>Interest rate risk</b> is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.&#160; The Company is exposed to interest rate risk at August 31, 2020 pursuant to the variable rate loans described in Note 11. A 1% change in benchmark interest rates will increase or decrease the Company&#8217;s interest expense by $1,150 (August 31, 2019 - $500) per year.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">18. REVENUE</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Net revenue for the Company is defined as gross revenue, which is net of any customer discounts, rebates, and sales returns and recoveries, less excise taxes.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Revenues for the years ended August 31, 2020 and 2019 are disaggregated as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="vertical-align: bottom; text-align: center; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="vertical-align: bottom; width: 1.95349%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Adult-use recreational wholesale revenue (Canadian)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">73,938</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">85,018</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Wholesale to Licensed Producers revenue (Canadian)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">15,184</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">709</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Direct to patient medical revenue (Canadian)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">10,748</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">11,192</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">International (business to business)</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">3,272</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">98</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Other revenue</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">245</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">530</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Gross revenue</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">103,387</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">97,547</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Excise taxes</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(16,592</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(17,134</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Net revenue</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">86,795</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">80,413</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.95349%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Recreational revenue is primarily comprised of provincial government bodies and large retailers that sell cannabis through their respective distribution models, whereas wholesale revenue is comprised of wholesale shipments to other cannabis companies, including licensed producers, for further processing and sales onto their end customers.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, the Company had three customers (August 31, 2019 - two customers) that individually represented more than 10% of the Company's net revenue.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">19. COST OF SALES</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">Cost of sales is comprised of the cost of inventories sold during the period, shipping expenses, the production cost of late-stage biological assets that are disposed of, provisions and write-downs for inventory that does not pass the Company's quality assurance standards and obsolete products and packaging, and other production overhead. For the three months ended November 30, 2019, the Company determined that the classification of indirect production is more accurately reflected as and most comparable to industry peers as a component of cost of sales rather than a separate line in the statement of operations.&#160; As a result, indirect production of $4,733 has been reclassified from indirect production to cost of sales for the year ended August 31, 2019 to conform to the current period presentation. This change in presentation has no impact on gross margin before fair value adjustments.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, the Company recorded write-downs and provisions in relation to excess and obsolete inventories and biological assets as well as adjustments to net realizable value totaling $35,584 (August 31, 2019 - $4,733), which are detailed in Note 8.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, the Company recorded charges of $6,095 (August 31, 2019 - $nil) related to a reduced workforce due to COVID-19, which was comprised of $5,048 in plant culling, $1,047 mostly related to lump-sum payments paid to temporarily laid-off workers.&#160; The Company also recorded $5,434 (August 31, 2019 - $nil) in charges for unabsorbed fixed overhead related to reduced production volumes.</font><font style="color: #86b4cd;">&#160; </font><font style="color: #000000;">These charges were expensed to cost of sales.</font></p>
    <div id="footer_page_35">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">33</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_36"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">20. CONTINGENCIES</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company recognizes loss contingency provisions for probable losses when management can reasonably estimate the loss. When the estimated loss lies within a range, the Company records a loss contingency provision based on its best estimate of the probable loss. If no particular amount within that range is a better estimate than any other amount, the mid-point of the range is used. As information becomes known a loss contingency provision is recorded when a reasonable estimate can be made. The estimates are reviewed at each reporting date and the estimates are changed when expectations are revised. An outcome that deviates from the Company's estimate may result in an additional expense or release in a future accounting period.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During 2015, the Company was named as a defendant in a lawsuit in New Brunswick for breach of confidence, conversion, breach of contract, conspiracy and breach of trust, breach of fiduciary duty, and negligent misrepresentation. The Company believes the lawsuit to be without merit though it will rigorously defend the action. No amount has been accrued in relation to the consolidated financial statements for the claim. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On March 3, 2017, a claim in connection with a proposed class-action lawsuit (the "Claim") was filed with the Supreme Court of Nova Scotia (the "Court") seeking to represent a class who purchased medical marijuana that was the subject of the Company's product recalls in December 2016 and January 2017 as it may have contained trace elements of the pesticides myclobutanil and bifenazate which are not approved for use by licensed producers. The Claim identifies several causes of action including, among others: (i) negligent design, development and testing, (ii) negligent manufacturing, (iii) negligent distribution, marketing and sale, (iv) breach of contract, and (v) breach of the Competition Act, the Consumer Protection Act, and the Sale of Goods Act, and is seeking remedy in the form of, among other things, the disgorgement of profits accrued to the Company for the sale of contaminated products, exemplary or punitive damages and certain costs. </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Claim was amended on November 16, 2017, to include a claim for alleged adverse health consequences caused as a result of using the recalled product. As at the date hereof, the Company has not received any medical information demonstrating adverse health effects caused as a result of using the recalled product.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The amended Claim also contained a request for an order certifying the proceeding as a class proceeding.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During late June 2018, certification hearings were heard before the Court. On January 18, 2019, the Court issued its decision granting certification. On March 4, 2019, the Company filed a notice for leave to appeal the certification of the class action brought against it. Leave to appeal was granted and the appeal was heard on October 15, 2019 and the decision was reserved.&#160; On April 30, 2020, the Nova Scotia Court of Appeal ruled that the plaintiff failed to present any evidence that the cannabis purchased by medical customers in 2016 could cause any particular adverse health effects.&#160; As a result, class members would not be able to bring claims for damages for adverse health effects in the class proceeding.&#160; On June 26, 2020, the plaintiff filed an application for leave to appeal the Nova Scotia Court of Appeal's decision with the Supreme Court of Canada.&#160; On November 5, 2020, the application for leave to appeal was dismissed by the Supreme Court of Canada.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The Company is contesting what remains of the litigation. The Company reported the Claim to its insurance provider which appointed counsel to defend the Claim. Insurance may be available to cover all or a portion of the fees or damages which may be associated with the Claim although the Company&#8217;s coverage may be subject to varying limits and exclusions. The litigation process will continue into the foreseeable future unless settled out of court. No amount has been recorded in the consolidated financial statements as the Company has not yet determined a reasonable estimate of the cost to resolve this class action.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On June 16, 2020, a claim in connection with a proposed national consumer protection class-action lawsuit was filed with the Court of Queen's Bench in Alberta (the "Alberta Claim") seeking damages against several Canadian cannabis companies including the Company.&#160; The Alberta Claim does not particularize all of the claims against the companies however it makes allegations with respect to the content of THC and CBD in the companies' products. The proposed action is not certified.&#160; The Company has reported the Alberta Claim to its insurers.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">21. OPERATING SEGMENTS</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">The Company previously operated in two operating segments - production and sale of cannabis and patient counselling, operating as Trauma Healing Centers, Incorporated ("THCI"). THCI was disposed of on October 16, 2018 (see Note 24). As a result, the Company currently operates in only one operating segment, the production and sale of cannabis. All assets for the production and sale of cannabis segment are domiciled within Canada and effectively all revenues are generated in Canada, except those revenues disclosed in Note 18.</font></p>
    <div id="footer_page_36">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">34</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_37"></a>
    <p style="text-align: justify;"><font style="color: #86b4cd;">22. GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Office and general</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,819</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">7,942</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Wages and benefits</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">7,611</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">4,443</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Professional fees</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">5,367</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">4,636</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Depreciation and amortization</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,510</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">664</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Research and development</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,269</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">409</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Travel and accommodation</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">383</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">456</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Utilities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">37</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">43</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Total general and administrative expenses</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">27,996</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">18,593</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">23. INCOME TAXES</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">There are no current income taxes payable or recoverable for the years ended August 31, 2020 and 2019.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Components of deferred income tax expense are as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Origination and reversal of temporary differences</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(37,875</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,987</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Change in tax rate and rate differences</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">421</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">281</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Change in unrecognized temporary differences</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">27,245</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,349</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Prior period adjustments</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(262</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">12</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 65.0465%;">Total income tax (recovery) expense</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(10,471</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">3,629</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">A reconciliation of income tax expense at the statutory rate to amounts recorded in the consolidated financial statements is provided below.</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Income (loss) from continuing operations before income taxes</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(146,628</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(5,875</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Statutory income tax rate</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">29.0%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">29.0%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Tax calculated at statutory rate</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(42,522</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(1,704</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Non-deductible (non-taxable) items</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,643</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">3,742</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Difference between current and future tax rates</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">421</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">281</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Benefit of deductible temporary differences not recognized</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">27,245</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,349</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Effect of tax rates in other jurisdictions</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">2,016</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Other</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(274</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(39</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Income tax (recovery) expense per financial statements</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(10,471</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">3,629</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <br>
    <div id="footer_page_37">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">35</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_38"></a>
    <p style="text-align: justify;"><font style="color: #000000;">Recognized deferred tax assets and liabilities consist of the following:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Deferred tax assets are attributable to the following:</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Non-capital losses</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">6,670</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">10,708</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Lease liabilities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,038</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Deferred tax assets</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">7,708</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">10,708</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Set-off of tax</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(7,708</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(10,708</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net deferred tax asset</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Deferred tax liabilities are attributable to the following:</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Long-term assets</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(961</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(4,983</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Biological assets</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(170</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(961</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Inventories</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(5,367</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(15,200</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Right-of-use lease assets</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(1,096</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Other</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(114</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(35</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Deferred tax liabilities</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(7,708</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(21,179</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Set-off of tax</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">7,708</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">10,708</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net deferred tax liability</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(10,471</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">The changes in temporary differences during the years ended August 31, 2020 and 2019 were as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">NET BALANCE AT </font><br><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">RECOGNIZED IN </font><br><font style="color: #ffffff;">PROFIT OR LOSS</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">RECOGNIZED </font><br><font style="color: #ffffff;">DIRECTLY IN </font><br><font style="color: #ffffff;">EQUITY &amp; OCI</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">NET BALANCE AT </font><br><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Non-capital losses</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">10,708</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(4,039</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">6,669</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share issuance costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">PP&amp;E</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(4,983</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">4,022</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(961</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Biological assets</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(961</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">791</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(170</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Inventories</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(15,200</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">9,833</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(5,367</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Lease liabilities</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,038</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,038</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Right-of-use lease assets</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(1,096</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(1,096</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Other</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(35</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(78</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(113</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net tax assets (liabilities)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(10,471</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">10,471</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #7f7f7f;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #7f7f7f;"><font style="color: #ffffff;">NET BALANCE AT </font><br><font style="color: #ffffff;">AUGUST 31, 2018</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #7f7f7f;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #7f7f7f;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #7f7f7f;"><font style="color: #ffffff;">RECOGNIZED IN </font><br><font style="color: #ffffff;">PROFIT OR LOSS</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #7f7f7f;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #7f7f7f;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #7f7f7f;"><font style="color: #ffffff;">RECOGNIZED </font><br><font style="color: #ffffff;">DIRECTLY IN </font><br><font style="color: #ffffff;">EQUITY &amp; OCI</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #7f7f7f;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #7f7f7f;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #7f7f7f;"><font style="color: #ffffff;">NET BALANCE AT </font><br><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Non-capital losses</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">8,604</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">2,723</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(619</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">10,708</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share issuance costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,657</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(1,657</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">PP&amp;E</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(1,275</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(3,708</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(4,983</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Biological assets</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(3,307</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">2,346</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(961</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Inventories</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(10,385</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(4,815</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(15,200</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Unsecured convertible debentures</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(3,306</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(108</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">3,414</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Other</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">32</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(67</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(35</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net tax assets (liabilities)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(7,980</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(3,629</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">1,138</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">(10,471</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">)</td>
        </tr>
    </table>
    <br>
    <div id="footer_page_38">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">36</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_39"></a>
    <p style="text-align: justify;"><font style="color: #000000;">At August 31, 2020, the Compansy has non-capital loss carryforwards available to offset future taxable income in Canada, which expire as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">August 31, 2035</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">1,070</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">August 31, 2037</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">11,727</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">August 31, 2038</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">14,296</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">August 31, 2039</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">16,746</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">August 31, 2040</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; border-bottom: 1px solid #000000; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #cee5ea;">81,205</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; border-bottom: 3px double #000000; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 3px double #000000; background-color: #cee5ea;">125,044</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 3px double #000000; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.95349%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">The Company recognizes tax benefits on losses or other deductible amounts where the probable criteria for the recognition of deferred tax assets has been met.&#160; The Company's unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #86b4cd; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
            <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Deductible temporary differences</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">17,348</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">12,010</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Tax losses</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">102,183</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">3,809</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">119,531</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 3px double transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">15,819</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">24. LICENSING AGREEMENT</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On October 4, 2016, the Company entered into a licensing agreement with Swear Net Inc. (the Trailer Park Boys Inc. "TPB") for an exclusive product and branding partnership superseded by a licensing agreement with TPB dated April 15, 2020 and terminated on September 14, 2020 subject to transitionary licensing provisions until April 30, 2021. In exchange for services, the Company paid $100 in cash and issued 150,000 options at a strike price of $1.52 per share. The fee is being recognized over the life of the agreement of five years as services are delivered. For the year ended August 31, 2020, $22 (August 31, 2019 - $99) has been amortized to share-based compensation and $32 (August 31, 2019 - $32) has been amortized to selling and marketing expenses. At August 31, 2020, the Company has recorded the current portion of the cash payment and stock options fee of $57 (August 31, 2019 - $89) as a prepaid expense and the long-term portion of the fee of $2 (August 31, 2019 - $24) in deferred charges on the consolidated statements of financial position.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Under the agreement, the Company issued an additional 350,000 in options at a price of $1.52 which vest in accordance with certain conditions being met. As of August 31, 2020, these conditions have been met. For the year ended August 31, 2020, $51 has been expensed (August 31, 2019 - $51) to share-based compensation. At August 31, 2020, the Company has recorded the current portion of the stock options fee of $51 (August 31, 2019 - $51) as a prepaid expense and the long-term portion of the fee of $4 (August 31, 2019 - $55) in deferred charges on the consolidated statements of financial position.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">25. GOVERNMENT SUBSIDIES</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On April 1, 2020, Department of Finance Canada announced the CEWS, which would subsidize 75% of employee wages, retroactive to March 15, 2020, to Canadian employers whose business had been affected by COVID-19 to enable them to re-hire workers previously laid off as a result of pandemic, help prevent further job losses, and to better position companies to resume normal operations following the crisis. Under this program, the Company applied for a wage subsidy of $7,883 for the period March 15, 2020 to August 29, 2020, which has been included as government subsidies in the statements of (loss) income and comprehensive (loss) income.</font></p>
    <div id="footer_page_39">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">37</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_40"></a>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">26. OPERATIONS OF TRAUMA HEALING CENTERS</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">THCI previously offered a multi-disciplinary approach to post traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.&#160; On October 16, 2018, the Company sold THCI to Harvest Medicine ("HMED"). HMED is a wholly owned subsidiary of VIVO Cannabis Inc. ("VIVO"). The transaction resulted in HMED acquiring 100% of the issued and outstanding shares of THCI from the Company. The total purchase price for the shares was $1,141 which was satisfied by the issuance of 864,678 common shares in the capital of VIVO at a share price of $1.32. This non-cash investing activity has been excluded from the statement of cash flows as it did not use or provide any cash. The derecognized assets and liabilities on October 16, 2018 were as follows:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">Derecognized assets and liabilities</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Cash</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">96</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Accounts receivable</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">140</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Other current assets</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">9</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Property, plant and equipment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">86</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Goodwill</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">880</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Trade and other payables</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(70</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Net assets disposed</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,141</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Fair value of consideration received</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">1,141</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Gain/(loss) on disposal</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">&#160;</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">During the fourth quarter of fiscal year 2018, management decided to divest the operations of THCI. Consequently, assets and liabilities allocable to THCI were classified as a disposal group. Revenue and expenses, gains and losses relating to the discontinuation of THCI have been eliminated from profit or loss from the Company's continuing operations and are shown as a single line item in the statements of income (loss) and comprehensive income (loss). </font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Operating income (loss) of THCI and the loss from re-measurement of assets and liabilities classified as discontinued operations are summarized as follows up to the date of disposal (see below):</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; white-space: nowrap;"><font style="color: #ffffff;">FOR THE PERIOD </font><br><font style="color: #ffffff;">SEPTEMBER 1, 2018&#160; </font><br><font style="color: #ffffff;">TO OCTOBER 16, 2018&#160;</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Revenue&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;&#160;&#160;&#160; Sales</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">138</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;&#160;&#160;&#160; Cost of sales</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">54</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;&#160;&#160;&#160; Gross margin from discontinued operations</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">84</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Expenses&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;&#160;&#160;&#160; General and administrative</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">75</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Total expenses&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">75</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;&#160;&#160;&#160; Investment income (expense)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">-</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Income (loss) from operations</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">9</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Loss on remeasurement to fair value less costs to sell</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(47</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Loss on discontinued operations</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #cee5ea;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #cee5ea;">(38</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #cee5ea;">)</td>
        </tr>
    </table>
    <br>
    <div id="footer_page_40">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">38</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_41"></a>
    <p style="text-align: justify;"><font style="color: #000000; font-size: 10pt;">Cash flows generated by THCI for the reporting periods are summarized as follows:</font></p>
    <table style="border-color: #000000; width: 100%; font-size: 10pt; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd; width: 12%; white-space: nowrap;"><font style="color: #ffffff;">FOR THE PERIOD</font><br><font style="color: #ffffff;">SEPTEMBER 1, 2018</font><br><font style="color: #ffffff;">TO OCTOBER 16,2018</font></td>
            <td style="text-align: center; vertical-align: bottom; background-color: #86b4cd;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Operating activities</td>
            <td style="width: 1%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">$</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; background-color: #cee5ea;">(35</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; background-color: #cee5ea;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Investing activities</td>
            <td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">&#160;</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">-</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #cee5ea;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Cash used by discounted operations</td>
            <td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #cee5ea;">$</td>
            <td style="width: 12%; text-align: right; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #cee5ea;">(35</td>
            <td style="width: 2%; text-align: left; vertical-align: bottom; border-bottom: 3px double #000000; background-color: #cee5ea;">)</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #86b4cd;">27. SUBSEQUENT EVENTS<br></font><font style="color: #86b4cd;">i) Hyasynth Tranche 2 convertible debentures issuance<br></font><font style="color: #000000;">On October 23, 2020, the Company advanced an additional $2,500 to Hyasynth by way of convertible debentures as a result of Hyasynth&#8217;s achievement of the contractual production-related milestone for Tranche 2 of the convertible debentures.&#160; This brings the Company&#8217;s total face value of convertible debentures investment in Hyasynth to $7,500, which provides the Company with a potential ownership interest of up to 46.5% on a fully diluted basis as of October 23, 2020.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">ii) Unit offering</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On November 12, 2020, the Company closed an underwritten public offering of 37,375,000 units of the Company at a price of $1.85 per unit, including a full exercise of the over-allotment option, underwritten by a syndicate of underwriters led by Canaccord Genuity Corp., for total gross proceeds of $69,144.&#160; Each unit is comprised of one Common Share of the Company and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a "Warrant").&#160; Each Warrant will be exercisable to acquire one common share of the Company (a "Warrant Share") for a period of three years following the closing date of the Offering at an exercise price of $2.50 per Warrant Share, subject to adjustment in certain events.&#160; The Company expects to use the net proceeds from the Offering to repay indebtedness and for working capital and other general corporate purposes.</font></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="color: #86b4cd;">iii) Credit facility amendment and restatement</font></p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #000000;">On November 27, 2020, the Company further amended its Facilities pursuant to an amended and restated credit agreement ("Amendment and Restatement") with BMO to: (i) reduce the Term Loan amount from $115,000 to $60,000 based on a repayment of $55,000 to be made on December 1, 2020 of the outstanding Term Loan balance of $115,000; (ii) have repayments on the balance of the Term Loan commence on February 28, 2021 in an amount equal to $1,500 per quarter; (iii) reduce the Revolver commitment to $2,000 from up to $25,000; (iv) adjust the minimum quarterly EBITDA covenants to be maintained by the Company commencing on February 28, 2021 and continuing through to maturity, thereby removing this covenant for the fiscal period ended November 30, 2020 and eliminating the reversion of the financial covenants to that of the original structure on November 30, 2021; (v) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (vi) reduce the minimum unrestricted cash balance requirement to $20,000, which is already inclusive of the $8,000 restricted investment currently outstanding.&#160; The interest rate margin will be fixed from November 27, 2020 through to maturity on May 31, 2021.&#160; The Company incurred an amendment fee of $217 plus customary legal expenses in connection with the amendment and restatement.</font></p>
    <div id="footer_page_41">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%;"><font style="color: #86b4cd; font-size: 8pt;">CONSOLIDATED FINANCIAL STATEMENTS&#160; |&#160; FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019 </font></td>
                <td style="width: 5%; text-align: right;"><font style="color: #86b4cd; font-size: 8pt;">39</font></td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_42"></a>
    <p style="text-align: center;"><font style="color: #000000;">&#160;<img src="exhibit99-4xu007.jpg"></font></p>
    <div><br></div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>6
<FILENAME>exhibit99-5.htm
<DESCRIPTION>EXHIBIT 99.5
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibit 99.5 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a> <br>
    <div style="text-align: center;"><br><img src="exhibit99-5xu001.jpg"><br></div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">INTRODUCTION</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">This Management&#8217;s Discussion and Analysis dated November 29, 2020 (this &#8220;MD&amp;A&#8221;), should be read in conjunction with the audited annual consolidated financial statements (the &#8220;Financial Statements&#8221;) of Organigram Holdings Inc. (the &#8220;Company&#8221; or &#8220;Organigram&#8221;) for the year ended August 31, 2020 (&#8220;Fiscal 2020&#8221; or &#8220;Q4 Fiscal 2020&#8221; when referring to the three months ended August 31, 2020), including the accompanying notes thereto.</font></p>
    </div>
    F<font style="color: #000000;">inancial data in this MD&amp;A is based on the consolidated Financial Statements of the Company for the year ended August 31, 2020 and has been prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board (&#8220;IASB&#8221;), unless otherwise stated. All financial information in this MD&amp;A is expressed in thousands of Canadian dollars (&#8220;$&#8221;), except for share and per share calculations, references to $ millions, per gram (&#8220;g&#8221;) or kilogram (&#8220;kg&#8221;) of dried flower and per milliliter (&#8220;mL&#8221;) or liter (&#8220;L&#8221;) of cannabis oil calculations.</font>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">Financial figures relating to prior periods in the eight&#8208;quarter comparative table captioned &#8220;Summary of Quarterly Results&#8221; have been restated due to the reclassification of discontinued operations (see note 26 of the Financial Statements) and the reclassification of indirect production to cost of sales (see note 19 of the Financial Statements).</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The financial information in this MD&amp;A contains certain financial and operational performance measures that are not defined by and do not have any standardized meaning under IFRS but are used by management to assess the financial and operational performance of the Company. These include, but are not limited to, the following:</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">&#8226;<font style="width: 9pt; display: inline-block;">&#160;</font>Yield per plant (in grams);</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">&#8226;<font style="width: 9pt; display: inline-block;">&#160;</font>Plants per room;</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">&#8226;<font style="width: 9pt; display: inline-block;">&#160;</font>Target production capacity;</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">&#8226;<font style="width: 9pt; display: inline-block;">&#160;</font>Adjusted Gross Margin; and</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">&#8226;<font style="width: 9pt; display: inline-block;">&#160;</font>Adjusted EBITDA.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company believes that these non&#8208;IFRS financial measures and operational performance measures, in addition to conventional measures prepared in accordance with IFRS, enable investors to evaluate the Company&#8217;s operating results, underlying performance and prospects in a similar manner to the Company&#8217;s management. The non&#8208;IFRS financial performance measures are defined in the sections in which they appear. Adjusted Gross Margin and Adjusted EBITDA are reconciled to IFRS in the &#8220;Financial Review and Discussion of Operations&#8221; section of this MD&amp;A.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">As there are no standardized methods of calculating these non&#8208;IFRS measures, the Company&#8217;s approaches may differ from those used by others, and accordingly, the use of these measures may not be directly comparable. Accordingly, these non&#8208;IFRS measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company has determined to discontinue reporting cost&#8208;of&#8208;cultivation as a non&#8208;IFRS financial measure, on the basis that due to the absence of standardized methods for calculating non&#8208;IFRS financial measures, and widely varying inputs and methodologies used in the industry for metrics of this nature, the information is difficult to compare and potentially confusing.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company&#8217;s wholly&#8208;owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis derived products (a &#8220;Licensed Producer&#8221; or &#8220;LP&#8221;) under the </font><font style="color: #000000;"><font style="color: #000000;"><i>Cannabis Act </i></font></font><font style="color: #000000;">(Canada) and the </font><font style="color: #000000;"><font style="color: #000000;"><i>Cannabis Regulations </i></font></font><font style="color: #000000;">(Canada) (together, the &#8220;Cannabis Act&#8221;) and regulated by Health Canada.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company&#8217;s head and registered office is located at 35 English Drive, Moncton, New Brunswick, E1E 3X3. The Company&#8217;s common shares (&#8220;Common Shares&#8221;) are listed under the ticker symbol &#8220;OGI&#8221; on both the Nasdaq Global Select Market (&#8220;NASDAQ&#8221;) and on the Toronto Stock Exchange (&#8220;TSX&#8221;). Any inquiries regarding the Company may be directed to its Vice President, Investor Relations, Amy Schwalm, at (416) 704&#8208; 9057 or by email to </font><font style="color: #205d9e;"><font style="color: #000000;"><u>investorrelations@organigram.ca</u></font></font><font style="color: #000000;">.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Additional information relating to the Company, including the Company&#8217;s most recent Annual Information Form (the &#8220;AIF&#8221;) is available under the Company&#8217;s issuer profile on the Canadian Securities Administrators&#8217; System for Electronic Document Analysis and Retrieval (&#8220;SEDAR&#8221;) at </font><font style="color: #205d9e;"><font style="color: #000000;"><u>www.sedar.com</u></font></font><font style="color: #000000;">. The Company&#8217;s reports and other information filed with or furnished to the United States Securities and Exchange Commission (&#8220;SEC&#8221;) are available on the SEC&#8217;s Electronic Document Gathering and Retrieval System (&#8220;EDGAR&#8221;) at </font><font style="color: #205d9e;"><font style="color: #000000;"><u>www.sec.gov</u></font></font><font style="color: #000000;">.</font></p>
    </div>
    <div id="footer_page_2">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">1</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <div>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #87b5cf;">CAUTIONARY STATEMENT REGARDING FORWARD&#8208;LOOKING INFORMATION</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Certain information herein contains or incorporates comments that constitute forward&#8208;looking information within the meaning of applicable securities legislation (&#8220;forward&#8208;looking information&#8221;). Forward&#8208;looking information, in general, can be identified by the use of forward&#8208;looking terminology such as &#8220;outlook&#8221;, &#8220;objective&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;could&#8221;, &#8220;would&#8221;, &#8220;might&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;plan&#8221;, &#8220;continue&#8221;, &#8220;budget&#8221;, &#8220;schedule&#8221; or &#8220;forecast&#8221; or similar expressions suggesting future outcomes or events. They include, but are not limited to, statements with respect to expectations, forecasts or other characterizations of future events or circumstances, and the Company&#8217;s objectives, goals, strategies, beliefs, intentions, plans, estimates, projections and outlook, including statements relating to the Company&#8217;s plans and objectives, or estimates or predictions of actions of customers, suppliers, partners, distributors, competitors or regulatory authorities; and, statements regarding the Company&#8217;s future economic performance. These statements are not historical facts but instead represent management beliefs regarding future events, many of which, by their nature are inherently uncertain and beyond management control. Forward&#8208;looking information has been based on the Company&#8217;s current expectations about future events.</font></p>
    </div>
    C<font style="color: #000000;">ertain forward&#8208;looking information in this MD&amp;A includes, but is not limited to the following:</font>
    <div>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Moncton Campus (as defined herein) licensing and target production capacity and timing thereof;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Expectations regarding production capacity, facility size, THC (as defined herein) content, costs and yields;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The impact of the current global health crisis caused by COVID&#8208;19 (as defined below);</font></font></p>
        <p style="margin-left: 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Expectations around demand for cannabis and related products, future opportunities and sales including the relative mix of medical versus adult&#8208;use recreational products, the relative mix of products within the adult&#8208;use recreational category including wholesale, the Company&#8217;s financial position, future liquidity and other financial results;</font></font></p>
        <p style="margin-left: 18pt; text-align: justify; text-indent: -18pt; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Legislation of additional cannabis types and forms for adult&#8208;use in Canada including regulations relating thereto and the implementation thereof and our future product forms;</font></font></p>
        <p style="margin-left: 18pt; text-align: justify; text-indent: -18pt; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Expectations around branded products and derivative&#8208;based products with respect to timing, launch, product attributes, composition and consumer demand;</font></font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Strategic investments and capital expenditures, and expected related benefits;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Expectations regarding the resolution of litigation and other legal proceedings;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The general continuance of current, or where applicable, assumed industry conditions;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Changes in laws, regulations and guidelines, including the recreational and medical cannabis market;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Price of cannabis and derivative cannabis products;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Impact of the Company&#8217;s cash flow and financial performance on third parties, including its supply partners;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Fluctuations in the price of Common Shares and the market for the Common Shares;</font></font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Treatment of the Company&#8217;s business under governmental regulatory regimes and tax laws, including the Excise Act</font></font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 18pt;"><font style="color: #000000;">(as defined herein) and the renewal of the Company&#8217;s license thereunder and the Company&#8217;s ability to obtain export licenses from time to time;</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The Company&#8217;s growth strategy, targets for future growth and forecasts of the results of such growth;</font></font></p>
        <p style="margin-left: 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Expectations concerning access to capital and liquidity and the Company&#8217;s ability to access the public markets to fund operational activities and growth;</font></font></p>
        <p style="margin-left: 18pt; text-align: justify; text-indent: -18pt; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The Company&#8217;s ability to remain listed on the TSX and NASDAQ and the impact of any actions it may be required to take to remain listed;</font></font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The ability of the Company to generate cash flow from operations and from financing activities; and</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The competitive conditions of the industry, including the Company&#8217;s ability to maintain or grow its market share.</font></font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Forward-looking information is provided for the purposes of assisting the reader in understanding the Company and its business, operations, risks, financial performance, financial position and cash flows as at and for the periods ended on certain dates and to present information about management&#8217;s current expectations and plans relating to the future and the reader is cautioned that such statements may not be appropriate for other purposes. Forward-looking information does not guarantee future performance and involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in the forward-looking information. In addition, this MD&amp;A may contain forward-looking information attributed to third party industry sources. Undue reliance should not be placed on forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By its nature, forward-looking information involves numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the expectations, predictions, forecasts, projections and, conclusions will not occur or prove accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. </font></p>
    </div>
    <div id="footer_page_3">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">2</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">Factors that could cause actual results to differ materially from those set forth in forward&#8208;looking information include, but are not limited to: financial risks; dependence on senior management, the board of directors of the Company (the &#8220;Board of Directors&#8221;), consultants and advisors; availability and sufficiency of insurance including continued availability and sufficiency of director and officer and other forms of insurance; the Company and its subsidiaries being able to, where applicable, cultivate cannabis pursuant to applicable law and on the currently anticipated timelines; industry competition; general economic conditions and global events including COVID&#8208;19 retail store closures or reduced sales at retail stores or otherwise due to COVID&#8208;19; heightened uncertainty as a result of COVID&#8208;19 including economic and industry uncertainty and governmental action in respect thereto including with respect to impacts on production, operations, product development, new product launches, disclosure controls and procedures or internal control over financial reporting, including as they may be impacted by delays in remediation due to work from home policies and other COVID 19 impacts, demand for products and services, third&#8208;party suppliers or service providers, and any existing or new international business partnerships; production facilities running at less than full capacity due to reduced workforce for reasons related to COVID&#8208;19 (as described herein) and market demand; potential supply chain and distribution disruptions; product development, facility and technological risks; changes to government laws, regulations or policy, including environmental or tax, or the enforcement thereof; agricultural </font><font style="color: #000000;">risks; ability to maintain any required licenses or certifications; supply risks; product risks; construction delays or postponements; packaging and shipping logistics; expected number of medical and adult&#8208;use recreational cannabis users in Canada and internationally; potential time frame for the implementation of legislation to legalize cannabis internationally; the Company&#8217;s, its subsidiaries and its investees&#8217; ability to, where applicable, obtain and/or maintain their status as Licensed Producers (as defined herein) or other applicable licenses; risk factors affecting its investees; availability of any required financing on commercially attractive terms or at all; non&#8208;compliance with debt covenants; the potential size of the regulated adult&#8208;use recreational cannabis market in Canada; demand for and changes in the Company&#8217;s cannabis and related products, including the Company&#8217;s Rec 2.0 products (as defined herein), and the sufficiency of the retail networks to supply such demand; ability to enter and participate in international market opportunities; general economic, financial market, regulatory, industry and political conditions affecting the Company; the ability of the Company to compete in the cannabis industry and changes in the competitive landscape; a material decline in cannabis prices; the Company&#8217;s ability to manage anticipated and unanticipated costs; the Company&#8217;s ability to implement and maintain effective internal controls over financial reporting and disclosure controls and procedures; and, other risks and factors described from time to time in the documents filed by the Company with securities regulators. Material factors and assumptions used in establishing forward&#8208;looking information include that construction and production activities will proceed as planned and demand for cannabis and related products will change in the manner expected by management, in each case after taking into account any impacts related to COVID&#8208;19 that are currently known or predicted by management based on the limited information available and the fluidity and uncertainty of the crisis. All forward&#8208;looking information is provided as of the date of this MD&amp;A. </font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company does not undertake to update any such forward&#8208;looking information whether as a result of new information, future events or otherwise, except as required by law.</font></p>
    </div>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">ADDITIONAL INFORMATION ABOUT THE ASSUMPTIONS, RISKS AND UNCERTAINTIES OF THE COMPANY&#8217;S BUSINESS AND MATERIAL FACTORS OR ASSUMPTIONS ON WHICH INFORMATION CONTAINED IN FORWARD&#8208;LOOKING INFORMATION IS BASED IS PROVIDED IN THE COMPANY&#8217;S DISCLOSURE MATERIALS, INCLUDING IN THIS MD&amp;A UNDER &#8220;RISK FACTORS&#8221; AND THE COMPANY&#8217;S CURRENT AIF UNDER &#8220;RISK FACTORS&#8221;, FILED WITH THE SECURITIES REGULATORY AUTHORITIES IN CANADA AND AVAILABLE UNDER THE COMPANY&#8217;S ISSUER PROFILE ON SEDAR AT </font><font style="color: #205d9e;"><font style="color: #000000;"><u>WWW.SEDAR.COM</u></font></font><font style="color: #000000;"> AND FILED WITH OR FURNISHED TO THE SEC AND AVAILABLE ON EDGAR AT </font><font style="color: #205d9e;"><font style="color: #000000;"><u>WWW.SEC.GOV</u></font></font><font style="color: #000000;">. </font><font style="color: #000000;"><font style="color: #000000;">ALL FORWARD&#8208;LOOKING INFORMATION IN THIS MD&amp;A IS QUALIFIED BY THESE CAUTIONARY STATEMENTS.</font></font></p>
    </div>
    <div id="footer_page_4">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">3</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <div>
        <div>
            <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">BUSINESS OVERVIEW</font></p>
            <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #87b5cf;">NATURE AND HISTORY OF THE COMPANY&#8217;S BUSINESS</font></p>
            <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company&#8217;s wholly&#8208;owned subsidiary Organigram Inc. is a Licensed Producer of cannabis under the Cannabis Act.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">The Company conducts its operations at its facility located in Moncton, New Brunswick. The Company has expanded its main facility over time to create additional production capabilities by strategically acquiring land and buildings adjacent to the main facility (together, the &#8220;Moncton Campus&#8221;). The Moncton Campus has been designed for differentiated cultivation and production with three&#8208;tiered growing. While the Company has essentially completed its expansion at the Moncton Campus with respect to cannabis production capacity, it is still completing its refurbishment with respect to derivative products allowed for legal sale by Licensed Producers such as the Company under amendments to the Cannabis Act (&#8220;Rec 2.0&#8221;).</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">Patients order medical cannabis and cannabis derivative based products from the Company primarily through the Company&#8217;s online store or by phone. Medical cannabis dried flower and cannabis derivative based products are and will continue to be delivered by secured courier or other methods permitted by the Cannabis Act. The Company&#8217;s prices vary based on grow time, strain yield and market conditions.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">The Company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre&#8208;rolls and cannabis derivative based products to approved retailers and wholesalers for adult&#8208;use recreational cannabis under the individual provincial and territorial regulations as per the Cannabis Act.</font></p>
        </div>
        <div>
            <div>
                <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">BUSINESS ENVIRONMENT</font></p>
                <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company&#8217;s business and activities are heavily regulated. framework of the Company&#8217;s business as of the date of the AIF. have the potential to impact the Company&#8217;s performance.</font></p>
            </div>
            <div>
                <p style="margin-left: 0.75pt; text-align: justify; text-indent: -0.75pt;"><font style="color: #000000;">The Company&#8217;s AIF contains a more detailed description of the regulatory The following provides a description of recent regulatory developments that</font></p>
            </div>
        </div>
        <div>
            <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Current Regulatory Landscape</font></p>
            <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Medical cannabis has been legal in Canada since 2001 under various regulatory regimes. On June 20, 2018, the Government of Canada passed the Cannabis Act to allow regulated and restricted access to cannabis for adult&#8208;recreational users. The Cannabis Act came into force on October 17, 2018.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">The Cannabis Act creates a strict legal framework for controlling the production, distribution, sale and possession of cannabis in Canada. The Cannabis Act allows adults to legally possess and use cannabis and therefore the possession of small amounts of cannabis is no longer a criminal offence. It also made it a specific criminal offence to sell cannabis to a minor and created significant penalties for those who engage young Canadians in cannabis&#8208;related offences.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">On November 9, 2018, Health Canada issued a license to the Company under the Cannabis Act for standard cultivation, standard processing and sale for medical purposes (the &#8220;License&#8221;). On October 21, 2019, Health Canada amended the License to expand the classes of cannabis products that may be sold to adult recreational use sales channels or sold for medical purposes, to include cannabis topicals, cannabis extracts and edible cannabis. The License has also been amended to add additional growing, processing, drying and storage rooms. The Company received Health Canada&#8217;s approval for the renewal of the License effective March 20, 2020. The License is valid until March 20, 2023 and is subject to customary terms and conditions.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">The Company also holds a cannabis license under the Excise Act, 2001 (the &#8220;Excise Act&#8221;) which was renewed on October 17, 2020 and expires on October 16, 2022. All Licensed Producers who are authorized to cultivate, produce and package cannabis products are also required to hold a cannabis license under the Excise Act from the Canada Revenue Agency. The Company intends to renew its licenses prior to expiry.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">The Company received its research and development license (the &#8220;Research License&#8221;) from Health Canada on October 23, 2019 to conduct further in&#8208;house research. The activities authorized under the Research License have and will continue to support the Company&#8217;s plans to commercialize cannabis products for Rec 2.0.</font></p>
        </div>
    </div>
    <div id="footer_page_5">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">4</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Edibles and Derivative Products Regulation</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Cannabis Act was amended on October 17, 2019 to include provisions that came into force on that day relating to the legal sale by Licensed Producers, such as the Company, of a range of new cannabis product forms such as: &#8220;edible cannabis&#8221;, &#8220;cannabis extracts&#8221; and &#8220;cannabis topicals&#8221;.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Certain provinces have announced restrictions on the launch and sale of edible and vaporizable products in their markets, including Quebec and Newfoundland and Labrador. Alberta lifted its previously announced ban on vaporizable cannabis products on February 14, 2020. As the market and regulations are rapidly developing the impact of these announcements is not readily determinable at this time.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">A limited selection of Rec 2.0 products began to appear gradually in physical or online stores in the latter half of December 2019. Licensed Producers are required to provide 60&#8208;days prior notice to Health Canada of their intent to sell any new products and such notices could not be given until the new product forms were legalized on October 17, 2019. The Company provided notice for its vaporizer pen portfolio and cannabis&#8208;infused chocolates in 2019 and continues to provide notices to Health Canada for new products from time to time.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">See &#8220;Canadian Adult&#8208;Use Recreational Market 2.0&#8221; in this MD&amp;A.</font></p>
    </div>
    <div id="footer_page_6">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">5</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #87b5cf;">KEY QUARTERLY FINANCIAL AND OPERATING RESULTS</font></p>
        <table style="width: 100%; color: #5f6369; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">Q4-2020</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">Q4-2019</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">CHANGE</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">% CHANGE</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000; font-size: 12pt;">Financial Results</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Gross revenue</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">25,389</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">19,235</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">6,154</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">32%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Net revenue</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">20,400</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">16,290</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">4,110</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">25%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Cost of sales</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">29,007</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">15,543</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">13,464</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">87%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Gross margin before fair value adjustments</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(8,607</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">747</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(9,354</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(1,252)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 9pt;"><font style="color: #000000;">Gross margin % before fair value adj. (1)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">-42%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">5%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">-47%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">(940)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Operating expenses</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">13,573</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">16,645</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(3,072</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(18)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Adjusted EBITDA (2)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">(2,663</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">(7,163</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">4,500</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">(63)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Net loss</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(38,590</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(22,456</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(16,134</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">72%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Net cash used in operating activities (3)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(10,128</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(15,722</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">5,594</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(36)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Adjusted Gross Margin (4)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">6,156</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">1,491</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">4,665</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">313%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 9pt;"><font style="color: #000000;">Adjusted Gross Margin % (4)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">30%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">9%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">21%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">233%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #eeeeee;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000; font-size: 12pt;">Financial Position</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Working capital</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">141,123</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">152,417</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(11,294</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(7)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Inventories and biological assets</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">71,759</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">113,796</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">(42,037</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">(37)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Total assets</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">435,127</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">428,525</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">6,602</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">2%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000; font-size: 12pt;">Operating Results</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Kilograms harvested</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">11,137</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">7,434</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">3,703</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">50%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">Kilograms sold - dried flower</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">4,859</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">2,425</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">2,434</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">100%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
        </table>
        <p style="margin-left: 40pt; text-align: justify; text-indent: -40pt; margin-bottom: 0pt;"><font style="color: #000000;">Note<font style="display: inline-block; width: 2pt;">&#160;</font>1:<font style="display: inline-block; width: 11pt;">&#160;</font>Equals gross margin before fair value adjustments (as reflected in the Financial Statements) and gross margin before fair value adjustments divided by net revenue, respectively.</font></p>
        <p style="margin-left: 40pt; text-align: justify; margin-bottom: 0pt; text-indent: -40pt; margin-top: 0pt;"><font style="color: #000000;">Note<font style="display: inline-block; width: 3pt;">&#160;</font>2:<font style="display: inline-block; width: 10pt;">&#160;</font>Adjusted EBITDA is a non&#8208;IFRS measure that the Company defines as net income (earnings) from continuing operations before: interest expense, net of investment income; income tax; depreciation, amortization, impairment, and gain (loss) on disposal of PP&amp;E (per the statement of cash flows); share&#8208;based compensation (per the statement of cash flows); share of loss and impairment loss from investments in associates; unrealized loss (gain) on changes in fair value of contingent consideration; expenditures incurred in connection with the NASDAQ cross&#8208;listing; the fair value adjustment to biological assets and inventory; write&#8208;offs and impairment of inventories and biological assets; write&#8208;downs of inventory to net realizable value; and COVID&#8208;19 related charges, net of any government subsidies. See the cautionary statement regarding non&#8208;IFRS financial measures in the &#8220;Introduction&#8221; section at the beginning of this MD&amp;A and the reconciliation to IFRS measures in the Financial Results and Review of Operations section of this MD&amp;A.</font></p>
        <p style="margin-left: 40pt; text-align: justify; margin-bottom: 0pt; text-indent: -40pt; margin-top: 0pt;"><font style="color: #000000;">Note<font style="display: inline-block; width: 3pt;">&#160;</font>3:<font style="display: inline-block; width: 10pt;">&#160;</font>Q4 Fiscal 2020 net cash used in operating activities has been calculated based on a correction of a presentation error of Q1 to Q3 Fiscal 2020 net cash used in operating activities. Fiscal 2020 year&#8208;to&#8208;date net cash used in operating activities is correctly stated as per the Financial Statements.</font></p>
        <p style="margin-left: 40pt; text-align: justify; text-indent: -40pt; margin-top: 0pt;"><font style="color: #000000;">Note<font style="display: inline-block; width: 3pt;">&#160;</font>4:<font style="display: inline-block; width: 10pt;">&#160;</font>Adjusted Gross Margin is a non&#8208;IFRS measure that the Company defines as net revenue less: (i) cost of sales, before the effects fair value changes to biological assets and changes in inventory sold; excluding (ii) write&#8208;offs and impairment of inventories and biological assets; (iii) write&#8208;downs to net realizable value; (iv) COVID&#8208;19 related charges; and (v) unabsorbed overhead relating to underutilization of the production facility, most of which is related to non&#8208;cash depreciation expense. See the cautionary statement regarding non&#8208;IFRS financial measures in the &#8220;Introduction&#8221; section at the beginning of this MD&amp;A and the reconciliation to IFRS measures in the Financial Results and Review of Operations section of this MD&amp;A.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">REVENUE</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">For the three months ended August 31, 2020, the Company reported $20,400 in net revenue. Of this amount $15,063 (73%) was sold to the adult&#8208;use recreational market, $2,275 (11%) to the medical market, $2,593 (13%) to the international market, and $405 (2%) to the wholesale market with the balance to other revenues. Q4 Fiscal 2020 net revenue increased 25% from Q4 Fiscal 2019 net revenue of $16,290, primarily due to higher flower sales volumes, which was offset by a lower average net selling price (&#8220;ASP&#8221;) compared to Q4 Fiscal 2019, as the dried flower value segment of the recreational market, particularly in large format, grew in Q4 2020 and as the Company now has a number of value products in the market. Additionally, the sale of Rec 2.0 products (vape products and cannabis&#8208;infused chocolates), which had not yet been legalized in Q4 Fiscal 2019, as well as significantly higher international revenues, contributed to the increase over Q4 Fiscal 2019. Q4 Fiscal 2019 net revenue was also lower than Q4 Fiscal 2020 due to a higher sales provision for returns and price adjustments. These contributors to higher net revenue in Q4 Fiscal 2020 were partly offset by a decline in recreational oil sales on lower demand for THC oil in the second year of adult&#8208;use legalization.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Q4 Fiscal 2020 gross revenue increased 32% to $25,389 from $19,235 in the prior year period and was similarly impacted by the factors described above. The percentage increase in gross revenue highlights the increase in shipments and was substantially higher than the net revenue increase as excise taxes represented a greater proportion of gross revenue in Q4 Fiscal 2020 as ASP declined.</font></p>
    </div>
    <div id="footer_page_7">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">6</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <p style="text-align: justify;"><font style="color: #000000;">Net revenue for Q4 Fiscal 2020 of $20,400 was net of a provision for product returns and pricing adjustments of $1,986 (each net of excise taxes) related to slow-moving products compared to net revenue for Q4 Fiscal 2019 of $16,290, which was net of a provision of $3,698. &#160;The Company is cognizant that in this new and emerging market, the size of the customer base, its demands, and preferences cannot yet be ascertained with any level of certainty or reliability, and future demand for existing and new products remains to be determined as the market further develops and matures.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Dried flower comprised 85% of net revenue in the quarter. The ASP of dried flower decreased to $3.58 per gram on a quarter&#8208;over&#8208;quarter basis compared to $5.18 per gram for Q4 Fiscal 2019 as both the Company and the Canadian cannabis industry experienced general price compression in the adult&#8208;recreational and medical markets as these markets matured and the customer and product mix evolved to focus more on value offerings. Further, the lower ASP was in part attributable to international bulk dried flower revenues, which was sold at a lower ASP as compared to Canadian domestic revenues. Selling prices are prone to fluctuation and there may be further price compression if the market remains oversupplied. The Company is committed to refining its product mix as customer preferences evolve.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Sales volumes of dried flower in grams increased 100% to 4,859 kg in Q4 Fiscal 2020 compared to the prior year comparative quarter, primarily as a result of a shift towards large format products as well as the contribution of wholesale and international dried flower sales.</font></p>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">COST OF SALES</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Cost of sales for the three months ended August 31, 2020 increased to $29,007 compared to $15,543 in the prior year comparative period, primarily as a result of increased sales volumes. Included in Fiscal Q4 2020 cost of sales the Company wrote&#8208;off excess and unsaleable inventories of $11,099, of which $8,325 related to trim and concentrated extract and $2,774 related to inventory write&#8208;downs on account of provisions for unsaleable inventories and to reflect an estimated decline in selling prices. Additionally, $3,470 was incurred with respect to unabsorbed fixed overhead costs as a result of lower production volumes related to COVID&#8208;19 and market demand. None of these write&#8208;offs and charges were incurred in the prior year comparative period.</font></p>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">GROSS MARGIN BEFORE FAIR VALUE ADJUSTMENTS AND ADJUSTED GROSS MARGIN</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company realized gross margin before fair value adjustments for the three months ended August 31, 2020 of ($8,607), or (42%) as a percentage of net revenue, compared to $747, or 5%, in the prior year comparative period. The decrease in gross margin before fair value adjustments as a percentage of net revenue is largely due to: (i) inventory provisions and write&#8208;off of excess and obsolete inventories; (ii) inventory write&#8208;downs to net realizable value; (iii) unabsorbed overhead as a result of lower production volumes; (iv) higher cost of sales on higher post&#8208;harvest costs; and (v) a lower ASP from increased competition and the ongoing evolution of the customer and product mix as well as provisions for product returns and pricing adjustments.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Adjusted gross margin</font><font style="color: #000000;"><sup><font style="color: #000000;">1 </font></sup></font><font style="color: #000000;">for the three months ended August 31, 2020 was $6,156, or 30%, compared to $1,491, or 9%, in the prior year quarter largely due to a higher provision for sales returns and pricing adjustments .in Q4 Fiscal 2019.</font></p>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">OPERATING EXPENSES</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Selling, general and administrative expenses and share-based compensation were collectively $11,542 for Q4 Fiscal 2020, a decrease from $16,032 in Q4 Fiscal 2019, due to the Company&#8217;s efforts to right-size operations particularly as a result of COVID-19, higher than normal licensing and professional fees in the prior year of $1,976, and a reduction in share-based compensation expense of $1,437 (for SG&amp;A employees as defined and discussed below) in part as a result of the Company&#8217;s shift in equity compensation schemes.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Included in operating expenses are impairment losses on property, plant and equipment and intangible assets of $2,031, which is comprised of impairment charges of $1,303 against the 1812 Hemp supply agreement intangible asset with the balance mostly related to miscellaneous impairment of property, plant and equipment and an onerous&#160; provision related to the future contractual construction costs relating to Phase 4C (the final stage of the Company's Phase 4 expansion, discussed below). &#160;The Company reviews the carrying value of its property, plant and equipment at each reporting period for indicators of impairment.</font></p>
    <p style="text-align: justify;"><sup><font style="color: #000000;"><font style="color: #000000;">__________________________________________</font></font></sup></p>
    <p style="text-align: justify; text-indent: -8pt; margin-left: 8pt;"><sup><font style="color: #000000;"><font style="color: #000000;">1</font></font></sup><font style="width: 3.75pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Adjusted gross margin is a non&#8208;IFRS financial measure. See the cautionary statement regarding non&#8208;IFRS financial measures in the &#8220;Introduction&#8221; section of this MD&amp;A.</font></font></p>
    <div id="footer_page_8">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">7</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">ADJUSTED EBITDA</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Negative adjusted EBITDA</font><font style="color: #000000;"><sup><font style="color: #000000;">2 </font></sup></font><font style="color: #000000;">was $2,663 in Q4 Fiscal 2020 compared to negative adjusted EBITDA of $7,163 in Q4 Fiscal 2019. The improvement in adjusted EBITDA is primarily attributed to higher adjusted gross margin in Q4 Fiscal 2020 as discussed above. Please refer to the Financial Review and Discussion of Operations section of this MD&amp;A for a reconciliation of net (loss) income to Adjusted EBITDA.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">NET LOSS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The net loss was $38,590 in Q4 Fiscal 2020 compared to a net loss of $22,456 in Q4 Fiscal 2019. The increase in net loss was primarily attributed to higher cost of sales resulting from inventory write&#8208;downs and provisions, which was partially offset by higher revenues as described above.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">FINANCIAL POSITION</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Working capital as at August 31, 2020 declined to $141,123 from $152,417 as at August 31, 2019 as the Company adjusted its fair value inputs and wrote&#8208;down its biological assets and inventories, respectively. This was offset by a net increase in the Company&#8217;s cash and short&#8208;term investments of $26,793 resulting from the two at&#8208;the&#8208;market equity raises and debt draws under the Company&#8217;s credit facility during Fiscal 2020.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">KEY DEVELOPMENTS DURING THE QUARTER AND SUBSEQUENT TO AUGUST 31, 2020</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #87b5cf;">COVID&#8208;19 CORPORATE ACTION PLAN</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">In March 2020, the World Health Organization declared the outbreak of a novel strain of coronavirus (&#8220;COVID&#8208;19&#8221;) a global pandemic. Government measures to limit the spread of COVID&#8208;19, including the closure of non&#8208;essential businesses for periods of time, disrupted the Company&#8217;s operations during the year ended August 31, 2020 which disruption is ongoing.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The production and sale of cannabis have been recognized as essential services across Canada and non&#8208;essential businesses have had periods of reopening, however COVID&#8208;19 pandemic related challenges persist. Due to the ongoing developments and uncertainty, it is not possible to predict the continuing impact that COVID&#8208;19 will have on the Company, its financial position, its operating results and/or its cash flows. In addition, it is possible that estimates in the Company&#8217;s financial statements will change in the near&#8208;term as a result of COVID&#8208;19 and the effect of any such changes could be material, which could result in, among other things, further impairment of long&#8208;lived assets including intangible assets. The Company continues to closely monitor the impact of COVID&#8208;19 on all aspects of its business.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On April 6, 2020, Organigram announced the temporary layoff of approximately 45% of its workforce primarily in an effort to help contain COVID&#8208;19. The Company offered voluntary layoffs to certain staff and those that accepted made up the majority of the layoffs. In some cases, due to the impacts of COVID&#8208;19, some administrative, support and other functions were deemed non&#8208;essential to the short&#8208;term needs of the business and were temporarily laid off. The temporary layoffs were initiated on March 24, 2020. Lump&#8208;sum payments (equating to approximately two weeks of work) were paid to the affected employees to help bridge the gap to available government programs. In addition, the Company absorbed the employee paid portion of health, dental and short&#8208;term disability premiums for all employees during this difficult time. The impact of these temporary layoffs resulted in a charge of approximately $0.7 million during the month of April 2020, which is primarily associated with the lump sum payments provided to these employees. The Company also put in place a number of health and safety measures during Q3 and Q4 2020 including, but not limited to, the following:</font></p>
        <p style="margin-left: 18pt; text-align: justify; margin-bottom: 0pt; text-indent: -18pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">An Emergency Response Team was established to monitor pandemic updates, review safety protocols, assess public health risk and develop action plans;</font></font></p>
        <p style="text-align: justify;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Moved to a work from home environment for any functions not required onsite;</font></font></p>
        <p style="margin-left: 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Implemented travel restrictions for work related travel, restricted visitor access to the Company&#8217;s facilities and imposed self-isolation for any employees who may have had symptoms of sickness and/or returned from international travel as of March 13</font></font><font style="color: #000000;"><sup><font style="color: #000000;">th</font></sup></font><font style="color: #000000;">;</font></p>
        <p style="margin-left: 18pt; text-align: justify; text-indent: -18pt; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Increased focus on sanitation and social distancing, with additional hand sanitizing stations throughout the Moncton Campus, cleaning and sanitizing of high touch surfaces, and additional cleaning in common areas;</font></font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Imposed restrictions on large meetings and gatherings, opting for web&#8208;based meetings and teleconferencing;</font></font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;"><sup>__________________________________________</sup></font></font></p>
        <p style="text-align: justify; margin-top: 0pt; text-indent: -8pt; margin-left: 8pt;"><font style="color: #000000;"><font style="color: #000000;"><sup>2</sup><font style="width: 3.75pt; display: inline-block;">&#160;</font>Adjusted EBITDA is a non&#8208;IFRS financial measure. See the cautionary statement regarding non&#8208;IFRS financial measures in the &#8220;Introduction&#8221; section of this MD&amp;A.</font></font></p>
    </div>
    <div id="footer_page_9">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">8</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <div>
        <p style="margin-left: 18pt; text-align: justify; margin-bottom: 0pt; text-indent: -18pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Mandatory reporting of any hourly employee absence to an attendance phone line including specific reporting of any COVID&#8208;19 symptoms; and</font></font></p>
        <p style="text-align: justify; text-indent: -18pt; margin-left: 18pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Reminders of measures to reduce risk of infection and prevent spread including washing hands and avoiding contact with faces. </font></font></p>
        <p style="text-align: justify; text-indent: -18pt; margin-left: 18pt;"><font style="color: #000000;"><font style="color: #000000;">Effective May 13, 2020, the Company began to implement a staggered return&#8208;to&#8208;work plan.</font></font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On July 3, 2020, in response to the continued impact of COVID-19 on the Company&#8217;s business and the continuing evolution of the Canadian cannabis industry the Company announced that in order to better align its production capacity to prevailing market conditions it had reduced its workforce by 25% by permanently laying off 220 employees. &#160;As of the date of this MD&amp;A, the Company has 431 active employees operating out of its Moncton Campus facility and another 86 outside the facility for 517 total active employees.</font></p>
    </div>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">LEADERSHIP CHANGES<br></font><font style="color: #000000;"><font style="color: #000000;"><b>On July 20, 2020, </b></font></font><font style="color: #000000;">the Company announced the departure of Ray Gracewood, Senior Vice President of Marketing and Communications who left the Company to pursue other interests.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;"><b>On October 23, 2020, </b></font></font><font style="color: #000000;">the Company announced the departure of Julie Chamberlain, Vice President, Marketing who left the Company effective November 6, 2020 for a General Manager role in a non&#8208;competing industry. Further, Cameron Bishop, Vice President, Public Affairs and Stakeholder Relations has also left Organigram to pursue other interests as a consultant.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">OTHER KEY DEVELOPMENTS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;"><b>On June 9, 2020, </b></font></font><font style="color: #000000;">the Company announced its largest international supply deal to date in the form of a multi&#8208;year agreement with one of Israel&#8217;s largest and most established medical cannabis producers, Canndoc Ltd., a subsidiary of InterCure Ltd. for supply of up to 6,000 kg of dried flower. Canndoc has been a pioneer in pharmaceutical&#8208;grade cannabis for more than 12 years and holds international cultivation and distribution agreements in the European Union and Canada.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;"><b>On August 14, 2020, </b></font></font><font style="color: #000000;">the Company announced its first shipment of bulk dried flower to Canndoc Ltd. as part of the Company&#8217;s multi&#8208;year deal with Canndoc Ltd.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;"><b>On October 23, 2020, </b></font></font><font style="color: #000000;">the Company announced the funding of an additional $2.5 million investment in Hyasynth Biologicals Inc. (&#8220;Hyasynth&#8221;), a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;"><b>On November 12, 2020, </b></font></font><font style="color: #000000;">the Company closed an underwritten public offering (the &#8220;Offering&#8221;) of 37,375,000 units (the &#8220;Units&#8221;) at a price of $1.85 per Unit, including the full exercise of the over&#8208;allotment option, underwritten by a syndicate of underwriters led by Canaccord Genuity Corp.. Each Unit is comprised of one common share of the Company and one&#8208;half of one common share purchase warrant of the Company (each full common share purchase warrant, a &#8220;Warrant&#8221;). Each Warrant will be exercisable to acquire one common share of the Company (a &#8220;Warrant Share&#8221;) for a period of three years following the closing date of the Offering at an exercise price of $2.50 per Warrant Share, subject to adjustment for certain events.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">OPERATIONS AND PRODUCTION</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #87b5cf;">CULTIVATION</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">While the vast majority of incremental production capacity between 2017 to 2019 by the Company&#8217;s competitors was generated from greenhouse (not indoor) production, Organigram focused on a core competency of controlling conditions in precisely built indoor environments with a commitment to continuous improvement and investment in information technology.</font></font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company&#8217;s cultivation plans focus on bringing new cultivars to the market and increasing the tetrahydrocannabinol (&#8220;THC&#8221;) and terpene profile of its dried flower to meet emerging consumer demand.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company is able to control all critical facets of the lighting and environmental elements in its facilities to drive maximum quality and yield in the plants it produces. The Company has also developed its own in&#8208;house proprietary information technology system called </font><font style="color: #000000;"><font style="color: #000000;"><i>OrganiGrow</i></font></font><font style="color: #000000;">, a database which tracks all grow cycles by harvest period, strain, room, environmental conditions and other factors, which in turn allows the Company to understand and refine the optimal methods to grow cannabis plants.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">As a function of its reduced workforce in Q4 Fiscal 2020 due to its layoff of 25% of its workforce, the Company experienced reductions in production and cultivation, as well as processing and packaging capacity. In early Q4 Fiscal 2020, the Company resumed pre&#8208;roll production after it was paused in early Q3 Fiscal 2020 due to a significantly reduced workforce as a result of COVID&#8208;19.</font></p>
    </div>
    <div id="footer_page_10">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">9</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_11"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">The Company harvested 11,138 kg of cannabis during Q4 Fiscal 2020 compared to 7,434 kg in Q4 Fiscal 2019.&#160; The increase from the comparative period, notwithstanding the reduced workforce, was due to greater capacity from the build out of the Moncton Campus.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">PHASE 4 EXPANSION</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">As previously disclosed in Q2 Fiscal 2020, the Company has completed construction of Phases 4A and 4B of the Moncton Campus and received licensing approval from Health Canada for total licensed cultivation capacity of 89,000 kg per year. As the Company adjusts its production methods to achieve higher THC levels in its cannabis plants, the yield per plant has been reduced by approximately 20%, thereby resulting in a licensed capacity of approximately 70,000 kg per year. The total capacity will fluctuate as we refine growing methods and the actual utilization will be dependent on the combination of inventory levels and forecasted sales demand.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">As first disclosed with the release of Organigram&#8217;s 2019 annual financial results on November 25, 2019, the Company&#8217;s management made a strategic decision to delay completion of Phase 4C (the final stage of the Phase 4 expansion), largely due to lower than anticipated consumer demand (which the Company believes is largely due to the lack of an adequate retail store network) and to more effectively manage and prioritize cash flow as well as potentially use the space in Phase 4C for other opportunities (if strategic and/or market factors dictate). During Q3 2020, the Company&#8217;s management decided to indefinitely defer completion of Phase 4C, as originally designed for additional cultivation capacity, based on forecast market demand.&#160; Phase 4C of the Moncton Campus has effectively been partially completed and without any foreseeable near-term use for this Phase, the Company recognized an impairment loss of $37.7 million in relation to this asset in Q3 Fiscal 2020.&#160; Refer to the Financial Review and Discussion of Operations section of this MD&amp;A for further information.</font></p>
        <font style="color: #000000;">As previously estimated and disclosed, the complete Phase 4 expansion of the Moncton Campus facility represented a total of 77,000 kg per year of additional annual target production capacity and&#160;was divided into a series of stages&#160;(4A: 25,000 kg; 4B: 28,000 kg;&#160;and 4C: 24,000 kg).&#160; As a consequence of the aforementioned yield reduction and indefinite deferral of the completion of Phase 4C, the revised annual target production capacity for Phase 4 is now estimated at 42,000 kg (4A: 20,000 kg; 4B: 22,000 kg). &#160;During Q4 Fiscal 2020, Phase 4C was completed such that it could be occupied.</font>
    </div>
    <div>
        <div>
            <p style="text-align: justify;"><font style="color: #000000;">For the foreseeable future, the Company plans to continue to cultivate less than its cultivation capacity in response to less than anticipated consumer demand as noted above. As discussed herein, the Company has adjusted its workforce to align with expected demand trends. The Company continues to closely monitor market conditions and the evolving COVID&#8208;19 situation.</font></p>
            <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">PHASE 5 REFURBISHMENT</font></p>
            <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Phase 5 plans include refurbishing 56,000 square feet of interior space within the Company&#8217;s existing facility for design under European Union GMP (&#8220;EU GMP&#8221;) standards for additional extraction capacity, a derivatives and edibles facility and additional office space. EU GMP describes the minimum standard that a manufacturer must meet in its production processes. EU GMP certification is subject to inspections coordinated by the European Medicines Agency. The Company has no plans to seek certification in the near future. Phase 5 houses the high speed, high capacity, fully automated chocolate production line which includes an advanced chocolate molding line and a fully integrated packaging line that includes advanced engineering, robotics, high speed labeling and automated carton packing. Phase 5 plans also include expanded vaporizer pen filling and automated packaging, additional extraction by both CO2 and hydrocarbons as well as expanded areas for formulation including short path distillation for edibles and vaporizer pen formulas. During Q3 Fiscal 2020, Phase 5 received licensing from Health Canada and includes the approval of a two&#8208;floor production facility designed to support all processing activity as well as dedicated spaces for packaging of flower, pre&#8208;rolls, vape pens and powdered beverages. The amendment to the License also allows for new purpose&#8208;built harvest and drying rooms and support areas for quality assurance, maintenance and sanitation.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">The estimated total capital cost of Phase 5 is expected to be approximately $65 million. Phase 5 began generating revenue in the Fiscal Year ended 2020 and was substantially complete at year end.&#160; The Company is continuing to work on the installation and commissioning of certain equipment in its edibles and extraction area including its hydrocarbon extraction equipment.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">In addition to the Phase 4 and Phase 5 expansions, the Company also owns approximately 12.1 acres located across the road from its current production facility, which is available for any future expansion if needed.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">The estimates of additional production capacity and costs related thereto in Phase 4 and Phase 5 represent forward&#8208;looking information and are based on a number of material factors and assumptions, including the following:</font></p>
        </div>
    </div>
    <div id="footer_page_11">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">10</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_12"></a>
    <div>
        <div>
            <div>
                <p style="text-align: justify; text-indent: -18pt; margin-left: 18pt;"><font style="color: #87b5cf;">&#8226;<font style="display: inline-block; width: 15pt;">&#160;</font><font style="color: #000000;">The facility size of the Moncton Campus will be as estimated with the same amount of cultivation space being used per grow room for cultivation as in Phase 2 and Phase 3;</font></font></p>
                <p style="text-align: justify; text-indent: -18pt; margin-left: 18pt;"><font style="color: #87b5cf;">&#8226;<font style="display: inline-block; width: 15pt;">&#160;</font><font style="color: #000000;">The ratio of dried flower cultivated per canopy square foot of grow room will be consistent with historical output in the Company&#8217;s existing facilities; and</font></font></p>
                <p style="text-align: justify; text-indent: -18pt; margin-left: 18pt;"><font style="color: #87b5cf;">&#8226;<font style="display: inline-block; width: 15pt;">&#160;</font><font style="color: #000000;">All grow rooms designated as production rooms will be utilized for their intended purposes (from time to time rooms may be used for other permitted purposes, such as for storage).</font></font></p>
            </div>
            <div>
                <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000; font-size: 10pt;">Several factors can cause actual costs and capacity to differ from estimates including, but not limited to, timing for receipt of regulatory approvals from Health Canada, construction delays or postponements and unforeseen obstacles. See &#8220;Risk Factors&#8221; in this MD&amp;A and in the Company&#8217;s current AIF. Capital expenditures incurred encompass cost of work performed (including any retention/holdback amounts) and are added to property, plant and equipment during the period.</font></p>
            </div>
        </div>
    </div>
    <div>
        <div>
            <div>
                <table style="width: 100%; border-collapse: collapse; font-size: 8pt;" border="0">
                    <tr>
                        <td style="width: 48px; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 140px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 5px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 107px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 5px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 12%; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 5px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 12%; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 5px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="text-align: center; border-bottom: 2px solid #000000; white-space: nowrap;" colspan="3">EXPENDITURES ($M)</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 140px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 5px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 107px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 5px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 12%; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 5px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 12%; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="width: 5px; text-align: center; white-space: nowrap;">&#160;</td>
                        <td style="text-align: center; white-space: nowrap;" colspan="3">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; text-align: center; border-bottom: 2px solid #000000;">PHASE</td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 140px; text-align: center; border-bottom: 2px solid #000000; white-space: nowrap;">PURPOSE</td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
                        <td style="width: 107px; text-align: center; border-bottom: 2px solid #000000; white-space: nowrap;">STATUS AS OF DATE<br>OF MD&amp;A</td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 2px solid #000000; white-space: nowrap;">KG/YR OF <br>TARGET<br>PRODUCTION<sup>(1)</sup></td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 2px solid #000000; white-space: nowrap;">KG/YR OF <br>CURRENT <br>FLOWER<br>CAPACITY<sup>(2)</sup></td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 2px solid #000000; white-space: nowrap;">SPENT IN <br>Q4-2020</td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent; white-space: nowrap;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 2px solid #000000; white-space: nowrap;">SPENT IN <br>FISCAL 2020</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 140px; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 107px; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; border-bottom: 1px solid #000000;">1/2/3</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 140px; border-bottom: 1px solid #000000;">Propagation, PreVeg, Organic, Flower, Post Harvest, Temporary Vapes Processing Area</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 107px; border-bottom: 1px solid #000000;">Licensed and in Production</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; border-bottom: 1px solid #000000; text-align: center;">28,000</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent; text-align: center;">&#160;</td>
                        <td style="width: 12%; border-bottom: 1px solid #000000; text-align: center;">20,000</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent; text-align: center;">&#160;</td>
                        <td style="width: 12%; border-bottom: 1px solid #000000; text-align: center;">_</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent; text-align: center;">&#160;</td>
                        <td style="width: 12%; border-bottom: 1px solid #000000; text-align: center;">_</td>
                    </tr>
                    <tr>
                        <td style="width: 48px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 140px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 107px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; border-bottom: 1px solid #000000;">4A</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 140px; border-bottom: 1px solid #000000;">Flower Rooms</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 107px; border-bottom: 1px solid #000000;">Licensed and in Production</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">20,000</td>
                        <td style="width: 5px; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">14,000</td>
                        <td style="width: 5px; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">_</td>
                        <td style="width: 5px; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">_</td>
                    </tr>
                    <tr>
                        <td style="width: 48px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 140px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 107px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; border-bottom: 1px solid #000000;">4B <sup>(3)</sup></td>
                        <td style="width: 5px; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 140px; border-bottom: 1px solid #000000;">Flower Rooms</td>
                        <td style="width: 5px; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 107px; border-bottom: 1px solid #000000;">Licensed and in Production</td>
                        <td style="width: 5px; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">22,000</td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">16,000</td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">1</td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">4</td>
                    </tr>
                    <tr>
                        <td style="width: 48px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 140px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 107px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; border-bottom: 1px solid #000000;">4C</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 140px; border-bottom: 1px solid #000000;">Flower Rooms</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 107px; border-bottom: 1px solid #000000;">Completion Halted in Response to Market Conditions</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">N/A</td>
                        <td style="width: 5px; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">N/A</td>
                        <td style="width: 5px; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">1</td>
                        <td style="width: 5px; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">18</td>
                    </tr>
                    <tr>
                        <td style="width: 48px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 140px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 107px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px;">5 (i) <sup>(4)</sup></td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 140px;">Post Harvest Rooms, Edibles, Vapes</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 107px;">Licensed and in Production</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 12%; text-align: center;">N/A</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">N/A</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 2px solid #000000;" rowspan="3">2</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 2px solid #000000;" rowspan="3">39</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; border-bottom: 1px solid #000000;">&#160;</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 140px; border-bottom: 1px solid #000000;">&#160;</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 107px; border-bottom: 1px solid #000000;">&#160;</td>
                        <td style="width: 5px; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                        <td style="width: 5px; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                        <td style="width: 5px; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px; border-bottom: 2px solid #000000;">5 (ii) <sup>(4)</sup></td>
                        <td style="width: 5px; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 140px; border-bottom: 2px solid #000000;">Harvest Rooms, Drying Rooms, Filling and Packaging Rooms for Various Products, Larger Extraction Facilities</td>
                        <td style="width: 5px; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 107px; border-bottom: 2px solid #000000;">Licensed</td>
                        <td style="width: 5px; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 2px solid #000000;">N/A</td>
                        <td style="width: 5px; text-align: center; border-bottom: 2px solid transparent;">&#160;</td>
                        <td style="width: 12%; text-align: center; border-bottom: 2px solid #000000;">N/A</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 140px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 107px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="width: 48px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 140px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 107px;">&#160;</td>
                        <td style="width: 5px;">&#160;</td>
                        <td style="width: 12%; text-align: center;">70,000</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="width: 12%; text-align: center;">50,000</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="text-align: center; width: 12%;">4</td>
                        <td style="width: 5px; text-align: center;">&#160;</td>
                        <td style="text-align: center; width: 12%;">61</td>
                    </tr>
                </table>
            </div>
        </div>
        <div>
            <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;">(1)</font></font><font style="width: 3.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Based on current capacity and optimal operating condition for the whole cannabis plant.</font></font></p>
            <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;">(2)</font></font><font style="width: 3pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Based on current capacity and optimal operating condition for only the flower component of the cannabis plant. The overall Flower capacity can fluctuate significantly as management adjusts the number of plants it grows in each room.</font></font></p>
            <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;">(3)</font></font><font style="width: 3.5pt; display: inline-block;">&#160;</font>Due to less than anticipated consumer demand largely discussed herein, the Company&#8217;s management is currently utilizing less than the current operating capacity.</p>
            <p>(4)<font style="display: inline-block; width: 3pt;">&#160;</font>The Company is continuing with commissioning work and expects there to be modest ongoing spend related to that as well as ongoing sustaining capex.</p>
            <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">CANADIAN ADULT&#8208;USE RECREATIONAL MARKET</font></p>
            <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Organigram conducts ongoing consumer research and leverages detailed analyses of consumer purchasing behaviors across Canada to help ensure the Company&#8217;s offerings are aligned with anticipated consumer preferences. The Company has been revitalizing its product portfolio with the launch of 40 new stock keeping units (&#8220;SKUs&#8221;) since July 2020 and expects to launch up to 18 more new SKUs by the end of Q2 Fiscal 2021.</font></p>
            <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">REC 1.0</font></p>
            <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Dried flower remains the largest category in the Canadian adult&#8208;use recreational market of all product form factors and the Company believes this category will continue to dominate based on the sales history in mature legal markets in certain US states.</font></p>
            <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Value segment offerings</font></p>
            <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company has noted the significant growth in the dried flower value segment of the market with intensifying competition including recent entries of lower priced offerings which have caused significant market share shifts within the value segment.&#160; Particularly since the onset of the COVID-19 pandemic, value in large format sizes have become an increasing focus of consumers. In Q3 Fiscal 2020, the Company responded with the introduction of Trailer Park Buds (&#8220;TPB&#8221;), its first value offering of dried flower in a large size format of 28g which the Company believes is a differentiated product that does not compete on price alone because it is indoor-grown, whole dried flower and strain specific.&#160; In early Q4 Fiscal 2020, the Company announced that it was proactively making some changes to the TPB brand and logo after reviewing perception around the brand with Health Canada.&#160; In the intermediate term, Organigram moved to a modified version of the brand and logo, &#8220;Buds&#8221;. Longer term, the Company has identified options for a permanent revised brand and logo combination for its large format value brand. </font></p>
        </div>
    </div>
    <div id="footer_page_12">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">11</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_13"></a>
    <div>
        <div>
            <p style="text-align: justify;"><font style="color: #000000;">The Company&#8217;s value segment strategy also includes dried flower offerings that were launched in larger format sizes of 7g and 15g under the Trailblazer brand in July 2020. The Trailblazer value brand continues to offer increasingly higher THC levels versus what was offered when originally launched (near the start of adult&#8208;use cannabis legalization), at a competitive price point, such that the Company believes that it can compete in the growing large format value segment of the market.</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">Subsequent to Q4 Fiscal 2020, Organigram continued to launch new products and in mid&#8208;September 2020, expanded its strong value portfolio with the launch of SHRED, a high quality, high potency and affordable dried flower that is pre&#8208;shredded for consumer convenience. SHRED offers three pre&#8208;milled varieties, all with THC of 18% or more. It is made from whole flower, does not contain any shake or trim and is milled </font><font style="color: #000000;">to the same specifications as the Company&#8217;s existing pre&#8208;roll products. SHRED is currently Organigram&#8217;s most affordable option (on a per gram basis).</font></p>
        </div>
    </div>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">In November 2020, the Company announced the launch of limited edition seasonal offerings, including Trailblazer Kushmas Stix, an affordable 0.5g pre&#8208;roll available in time for gift giving or for adult stocking stuffers</font><font style="color: #000000;"><font style="color: #000000;"><i>.</i></font></font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">High THC strains</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Cannabis consumers continue to want both high THC dried flower products and cultivar diversity as supported by available sales data. As such, in early August 2020, the Company announced the launch of three new strains of Edison Cannabis Co. (&#8220;Edison&#8221;) dried flower products, with higher THC: The General (Grapefruit GG4), Chemdog and limited time offering, Samurai Spy (Ninja Fruit). Going forward, the Company has decided to change naming conventions to the street genetic names for dried flower products as it believes these names will better resonate with consumers.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Organigram also began rolling out further line extensions in June 2020, including new size formats and three pack pre&#8208;rolls of its most popular strains such as Limelight and Blue Velvet, for example.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">REC 2.0</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #86b4cd;">Cannabis&#8208;Infused Chocolates</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">At the end of July 2020, the Company announced the launch of Trailblazer Snax, a value&#8208;priced, cannabis&#8208;infused chocolate bar which is made with premium quality ingredients including cocoa butter, all&#8208;natural flavors and pure distillate, while remaining an affordable cannabis&#8208;infused option. It is available in both mint and mocha flavours at 42g with 10mg of THC. Organigram&#8217;s investment in state&#8208;of&#8208;the art chocolate equipment and manufacturing processes means that each of the five sections of the Trailblazer Snax bar are filled separately, allowing for higher accuracy of infusion.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company&#8217;s chocolate portfolio also consists of Edison Bytes truffles which are available in both milk and dark chocolate formulations. These products are available as single chocolates containing 10 mg of THC each or sets of two truffles containing 5 mg each.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">In addition to Trailblazer Kushmas Stix, the Company is also offering Canadian cannabis consumers delicately spicy gingerbread flavours mingled with Edison Bytes&#8217; signature rich milk chocolate. These limited time offerings are available in a two&#8208;per&#8208;pack format, with each truffle containing 5 mg THC for a total of 10 mg total in the box.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Vape Portfolio</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company expects to launch Trailblazer Spark, Flicker and Glow 510&#8208;thread Torch vape cartridges in a new 1g format before the end of Q2 Fiscal 2021 which will extend Organigram&#8217;s line up to a suite of trial&#8208;size 0.5 g and full&#8208;size 1 g cartridges for the 510 vaporizer. Trailblazer Torch offers customers 510 cartridges, high&#8208;quality CO2 extract and three unique terpene&#8208;infused flavours.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">In addition to the Trailblazer Torch value&#8208;segment offerings, the Company&#8217;s vape portfolio also includes products for the mainstream and the premium segments: Edison + Feather ready&#8208;to&#8208;go distillate pens and Edison + PAX ERA&#174; distillate cartridges.</font></p>
    </div>
    <div id="footer_page_13">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">12</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_14"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Powdered Beverage Launch</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">In November 2020, Organigram launched Edison RE:MIX dissolvable cannabis powder. The pre&#8208;packaged powder format makes it easy to mix Edison RE:MIX into beverages quickly and discreetly, so the product can be enjoyed, based on the consumer&#8217;s own preference, in a wide variety of settings and on occasions of their choosing.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The results of a recent Organigram survey suggest a significant majority of current cannabis consumers (74%) would prefer to add cannabis to their beverages by themselves (vs. a pre&#8208;mixed beverage). The discreet nature of the product also addresses consumer concerns related to open cannabis consumption.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">According to recent third party sales data in Colorado, cannabinoid-infused powders have rapidly risen to the top of the beverage category in popularity, representing 55% of the state&#8217;s beverage market sales. In fact, 46% of cannabis consumers reported enjoying cannabinoid-infused beverages multiple times a day (Headset &#8211; Colorado Market Insights &#8211; July 2020). In Canada, estimates suggest the recreational cannabis beverage market represents a $467M category opportunity and it is expected to increase by 15x its current market size over the next five years (Brightfield Group &#8211; Canadian Market Size Insights &#8211; July 2020).</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">As previously announced, Organigram&#8217;s researchers have developed a proprietary nano&#8208;emulsification technology that generates nano&#8208; droplets which are very small and uniform; this provides improved absorption compared to traditional solid edibles and beverages, potentially allowing for a more reliable and controlled experience.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">With traditional edibles, beverages, and ingestible oil&#8208;based extracts, the body spends significant time breaking down fat soluble cannabinoid particles which are then absorbed and metabolized in the body before the effects are felt. This lengthy process can result in accidental overconsumption and undesirable experiences.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The nanoemulsion technology is also anticipated to have increased stability to temperature variations, mechanical disturbance, salinity, pH, and sweeteners. The powdered formulation holds the potential to offer consumers a measured dose of cannabinoids which they can then add to liquid, such as a beverage of their choice, while also offering the discretion, portability and shelf life expected of a dried powder formulation.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Edison RE:MIX is available in three formats: two sachets with 5 mg THC per sachet; two sachets with 5:5 mg THC:CBD per sachet; and five sachets with 10 mg CBD per sachet.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">OUTLOOK</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Organigram remains positive on the cannabis market both in Canada and abroad. The most recent data available from Statistics Canada shows that total Canadian adult use market sales (which represent the majority of legal cannabis sales in the country) tallied $256 million for just the month of September 2020</font><font style="color: #000000;"><sup><font style="color: #000000;">3</font></sup></font><font style="color: #000000;">. This represents an annualized run rate of approximately $3.1 billion, which is a record since adult recreational use was legalized in October 2018. Month&#8208;over&#8208;month sequential growth rate was 5.2% and year&#8208;over&#8208;year growth for September was 108.5%.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company believes there are a few factors that are creating tailwinds to further industry growth. First the legalization in October of 2019 of Rec 2.0 products has attracted consumers who were not interested in smoking or vaping. New categories such as vape pens, edibles (soft chews, chocolates), beverages to name a few have significantly expanded the addressable market. Second, the number of brick and mortar retail stores has increased significantly particularly in the back half of calendar 2020. Third, the industry as a whole has made a concerted effort to match or beat illicit market pricing which has helped accelerate the conversion of consumers from illicit to legal consumption.</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Notwithstanding the above, the cannabis industry in Canada remains highly competitive and generally oversupplied versus the current market demand considering both regulated licensed producers and the still largely unfettered illicit market.&#160; In early July 2020, the Company announced it had reduced its workforce by 25% in an effort to better align its production capacity to prevailing market conditions. After two years of adult-use recreational legalization in Canada, consumer trends and preferences continued to solidify, including significant growth in the large format value segment, a desire for higher THC potency particularly in dried flower as well as a penchant for newness including new genetic strains and novel products.&#160; Organigram began a product portfolio revitalization earlier this year in an effort to address what it believes to be some of the biggest trends in order to grow sales and capture market share.</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;"><sup>__________________________________________</sup></font></p>
        <p style="text-align: justify; margin-top: 0pt; text-indent: -8pt; margin-left: 8pt;"><font style="color: #000000;"><sup>3</sup><font style="width: 3.5pt; display: inline-block;">&#160;</font>Statistics Canada, <i>Cannabis Stats Hub</i>, Accessed: November 26, 2020, (https://www150.statcan.gc.ca/n1/pub/13&#8208;610&#8208;x/cannabis&#8208;eng.htm)</font></p>
    </div>
    <div id="footer_page_14">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">13</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_15"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">At the same time, the number of retail stores in Canada began to grow meaningfully for the first time since legalization and in September 2020, Ontario&#8217;s cannabis retail&#160; regulator began doubling the number of licenses being granted from 10 to 20 per month and is now on pace to add up to 40 stores per month, resulting in accelerated growth for Canada&#8217;s largest adult-use cannabis market.&#160; Since July 2020, the number of retail stores in Canada&#8217;s 10 provinces grew one-third and increased approximately 140% in Ontario alone.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">With a leaner workforce, the Company experienced some reductions in production, cultivation, processing and packaging capacity.&#160; At certain times, this contributed to delays in the product launches for its portfolio revamp and hindered consistent order fulfillment, particularly for high velocity or fast moving items. The Company believes this resulted in some meaningful missed revenue opportunities in Q4 Fiscal 2020 and in Q1 Fiscal 2021.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">With substantial retail store growth in play, the Company is evaluating its processes and supply chain, including the benefit of gradually scaling up staffing, to help ensure improved order fulfillment rates and in turn, potentially realize greater sales opportunities. Further, as many of the Company&#8217;s product launches are recent and some are still to come, the Company believes it will still take time for the new products to reach their full potential and gain market share to drive meaningful sales growth.</font></p>
    </div>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">Organigram also continues to make investments in new genetics and improved cultivation processes to increase THC potency and introduce new strains into the highly important dried flower and pre&#8208;roll categories. As discussed in the &#8220;Phase 4 Expansion&#8221; section of this MD&amp;A, the Company intends to cultivate at less than its full cultivation capacity for the foreseeable future partly to help increase THC potency in its plants, which is anticipated to result in a negative non&#8208;cash adjustment to cost of sales for unabsorbed fixed overhead costs.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">In addition to Rec 1.0, the Company plans to continue to expand on Rec 2.0, which it believes will increasingly become a larger relative category more in line with mature U.S. legal markets. As indicated in previous quarters, the Company expects some production inefficiencies to persist in the near term and impact gross margin while it continues to launch new Rec 2.0 products and optimize production.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Outside of Canada, the Company continues to serve international markets (Israel and Australia) from Canada via export permits and looks to augment sales channels internationally over time. International sales increased significantly in Q4 Fiscal 2020 from the prior year period as Organigram shipped its first product to Canndoc Ltd in August 2020 under its supply agreement with the Israeli cannabis medical producer. In early Q1 Fiscal 2021, the Israeli Ministry of Health Israel amended its quality standards for imported medical cannabis. The Company has identified a pathway for demonstrating compliance with these updated standards and has initiated a process which, if completed successfully, will allow it to continue to supply product into the Israeli market.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Recent political changes and cannabis election ballot initiatives for both medical and recreational use in the United States suggest that the potential movements to U.S. federal legalization of cannabis (THC) has increased momentum but the timing and outcome remains difficult to predict.&#160; As the Company continues to monitor and develop a potential &#160;U.S. THC strategy, it continues to evaluate CBD entry opportunities in the United States.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">MEDICAL MARKET</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Organigram&#8217;s sales in the medical market in Q4 Fiscal 2020 decreased slightly from Q4 Fiscal 2019 due to a lower ASP on medical oil, which was offset by higher volumes, as well as higher revenues on medical flower and the launch of medical vapes and chocolates, which were not available in the prior year. The Company continues to be focused on ensuring there is no disruption in product availability for its patients.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On August 18, 2020, the Company announced its partnership with Medical Cannabis by Shoppers Inc. and TruTrace Technologies Inc. in an effort to track source and genetics of cannabis used by medical patients in order to provide real&#8208;time information about the composition of each cannabis product used by Medical Cannabis by Shoppers customers.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">REGISTERED PATIENTS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company quantifies the number of patients as those with an active prescription registration. The Company&#8217;s active patient count was 18,934 at the end of Q4 Fiscal 2020 compared to 17,200 at the end of Q4 Fiscal 2019. One of the contributors to the growth in patient count was Health Canada&#8217;s response to COVID&#8208;19 whereby medical documents expiring between March 13, 2020 and September 30, 2020 were provided an extension for six months beginning on the day after their expiry. As a result of the shifting dynamics (launch of adult&#8208;use recreational market) it will take the Company a number of quarters to be able to better anticipate the longer&#8208;term trend of the medical patient count and medical cannabis business in Canada.</font></p>
    </div>
    <div id="footer_page_15">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">14</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_16"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">INTERNATIONAL CANNABIS &amp; CBD MARKETS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company continued to monitor its investments during Q4 Fiscal 2020.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">ALPHA&#8208;CANNABIS GERMANY</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On October 10, 2018, the Company, through a wholly&#8208;owned subsidiary, executed an investment agreement with alpha&#8208;cannabis&#174; Pharma GmbH (&#8220;Alpha&#8208;Cannabis Germany&#8221; or &#8220;ACG&#8221;), located in Stadthagen, Germany, pursuant to which the Company acquired 8,333 common shares of ACG, representing a 25% interest in the aggregate issued and outstanding capital of ACG, on a fully diluted basis, for an aggregate investment of &#8364;1,625,000 (approximately $2.44 million) plus an additional amount of up to &#8364;875,000 (approximately $1.35 million) payable to ACG by way of issuance of Common Shares of the Company upon achievement of certain milestones.</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Established in 2016, ACG is a privately held company that is strategically positioned to serve the German medical cannabis market. With a team of highly experienced and reputable specialists from the pharmaceutical industry with scientific and business backgrounds, ACG is focused on the development, production and marketing of cannabis&#8208;based active pharmaceutical ingredients and pharmaceuticals.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company intends to provide ACG with dried cannabis flower as well as sweet leaf for conversion into extracts for the burgeoning German medical cannabis market. Further, the parties also entered into an agreement whereby the Company has an option to purchase pure synthetic CBD isolate from Alpha&#8208;Cannabis Germany.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Organigram and ACG jointly submitted a tender for domestic cultivation in Germany in Q1 Fiscal 2019. In April 2019, the Company and ACG learned they were not awarded any lots for domestic cannabis production by Germany&#8217;s Federal Institute for Drugs and Medical Devices. The Company believes another tender process is likely in the future. With further improvements to ACG facilities underway as well as additional licensing expected, Organigram believes ACG and itself will be better positioned in the next tender process for domestic cultivation.</font></p>
    </div>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">During Q3 Fiscal 2020, the Company delivered its first shipment of dried flower to ACG for testing purposes as ACG is seeking to obtain certification for EU-GMP certified cannabis oil extracted from the Company&#8217;s non-certified dried flower.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">EVIANA</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On October 2, 2018, the Company participated in the debenture offering of Eviana Health Corporation (&#8220;Eviana&#8221;) by way of private placement. Eviana is a Canadian Securities Exchange (&#8220;CSE&#8221;) listed company that was established with the aim of delivering customized consumer health care products using natural hemp strains of cannabis sativa for cannabinoid&#8208;based topical creams and products. The Company&#8217;s investment is in the form of convertible debentures and share purchase warrants, which together provide a potential ownership interest of up to 21.4%, which is capped at 19.9% based on certain contractual obligations. In addition to this ownership interest, the Company also considered various qualitative factors in arriving at the determination that significant influence exists, including representation rights on Eviana&#8217;s board of directors, and thereby concluding that the equity method of accounting is appropriate.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The convertible debentures have a face value of $5,000, bear interest at 10% per annum, are non&#8208;redeemable, and mature on October 2, 2020. The convertible debentures are convertible at the Company&#8217;s option at any time at a price of $1.15 per share, or into 4,347,826 common shares. Conversion of the debentures may be forced by Eviana in the event that the volume weighted average price of the common shares of Eviana for ten consecutive days is greater than $2.15, subject to a minimum volume of 100,000 shares in each of those 10 days.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The share purchase warrants were acquired for no additional consideration, concurrent with the debenture offering, are transferrable, and are exercisable until October 2, 2020. 2,500 share purchase warrant units were acquired, each of which is convertible into 870 common shares per unit, or 2,175,000 common shares in aggregate, at an exercise price of $1.30 per share. These share purchase warrants were not exercised and have expired as of the date of this MD&amp;A.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Concurrent with the Company&#8217;s investment in Eviana, the parties entered into a CBD oil supply agreement, whereby the Company has the right, but not obligation, to purchase up to 25% of Eviana&#8217;s annual CBD oil at 95% of the agreed raw CBD oil wholesale market price for a period of five years from the date on which the CBD oil is first made commercially available by Eviana for wholesale.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On October 28, 2019, Eviana provided a default announcement in accordance with National Policy - 12-203 <i>Management Cease Trade Orders </i>(&#8220;NP 12-203&#8221;). Eviana made an application to the British Columbia Securities Commission, as its principal regulator, for a management cease trade order under NP 12-203 in respect of an anticipated default regarding its annual filings. On November 1, 2019, a cease trade order (CTO) was issued by the British Columbia Securities Commission and the Ontario Securities Commission.&#160; On November 5, 2019, Eviana was suspended from the CSE in accordance with CSE Policy 3 which is considered a regulatory halt as defined in National Instrument 23-101 &#8211; <i>Trading Rules</i>.</font></p>
    </div>
    <div id="footer_page_16">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">15</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_17"></a>
    <p style="text-align: justify;"><font style="color: #000000;">At May 31, 2020, the Company identified indicators of impairment with respect to its investment in Eviana. The Company determined the recoverable amount of Eviana to approximate $nil based on the higher of fair value less costs to dispose (&#8220;FVLCD&#8221;) and value&#8208;in&#8208;use (&#8220;VIU&#8221;). An impairment loss of $1,400 and $3,000 has been included in the statement of (loss) income and comprehensive (loss) income for the three and nine months ended May 31, 2020, respectively.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">On June 18, 2020, the Company served Eviana with a notice of default and demand letter with respect to the non&#8208;payment of interest relating to its convertible debentures as well as other applicable events of default under the debenture instrument. As of the date of this MD&amp;A, the Company has not yet received its December 31, 2019 or June 30, 2020 interest payment on the Eviana convertible debenture.</font></p>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">OTHER STRATEGIC INVESTMENTS AND DEVELOPMENTS</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company remains committed to the development and acquisition of cannabis or hemp related businesses and production assets in Canada or abroad (subject to compliance with applicable law), intellectual properties, technologies or other assets that are synergistic to the Company&#8217;s Canadian and international strategies.</font></p>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">HYASYNTH</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On September 12, 2018, the Company entered into a strategic investment to purchase an aggregate of $10,000 convertible secured debentures (the &#8220;Hyasynth Debentures&#8221;) of Hyasynth Biologicals Inc. (&#8220;Hyasynth&#8221;), a biotechnology company based in Montreal and leader in the field of cannabinoid science and biosynthesis, in three separate tranches. Organigram has purchased $5,000 in secured convertible 8% Hyasynth Debentures and has further agreed to purchase up to an additional $5,000 of Hyasynth Debentures in a series of two other tranches of $2,500 each based on Hyasynth attaining certain production milestones and the satisfaction of certain other customary closing conditions.</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Hyasynth has patent&#8208;pending enzymes, yeast cells and processes that make it possible to produce phytocannabinoids and phytocannabinoid analogues in genetically modified strains of yeast. These proprietary enzymes and yeast strains have allowed Hyasynth to produce CBG, CBD and THC for novel and specialized products such as vaporizable cannabis products and cannabis infused beverages for a fraction of the cost of traditional plant&#8208;based production. The Company anticipates that its investment in Hyasynth has the potential to provide the Company with access to what it expects to be the future of cannabinoid production. The Company expects that cost&#8208;effectiveness and scalability will be necessary to meet the needs of both the Canadian and global cannabis markets.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">In addition to the investment, Organigram has the right to purchase potentially all of Hyasynth&#8217;s cannabinoid or cannabinoid&#8208;related production at a 10% discount to the wholesale market price for a period of ten years. In addition to the major cannabinoids such as CBD and THC, Hyasynth </font><font style="color: #000000;">is also pursuing the production and scale&#8208;up of minor cannabinoids found only in limited quantities in the cannabis plant. One subset of these minor cannabinoids includes propyl&#8208;cannabinoids such as cannabigerivarin (CBGV) and tetrahydrocannabivarin (THCV). While the Company expects that there will always be a need for premium indoor grown cannabis flowers, working with Hyasynth offers the potential to more quickly respond to market demand for cannabinoid&#8208;based recreational and medical cannabis products.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Subsequent to year end, on October 23, 2020, the Company advanced an additional $2,500 to Hyasynth by way of convertible debentures as a result of Hyasynth&#8217;s achievement of the contractual production-related milestone for Tranche 2 of the convertible debentures.&#160; This brings the Company&#8217;s total face value of convertible debentures investment in Hyasynth to $7,500, which provides the Company with a potential ownership interest of up to 46.5% on a fully diluted basis as of October 23, 2020.</font></p>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">SUPPLY AGREEMENT FOR HEMP FOR CBD EXTRACTION</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On January 18, 2019, the Company entered into an agreement (the &#8220;Supply Agreement&#8221;) with 703454 N.B. Inc. (carrying on business as 1812 Hemp) (&#8220;1812 Hemp&#8221;), a New Brunswick based industrial hemp research company to secure supply of hemp.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Pursuant to the Supply Agreement, the Company receives a 25% discount on all dried product purchased from 1812 Hemp and has continued access to future 1812 harvests until December 16, 2023, with the option to extend for an additional five&#8208;year period. The Company made a payment of $1,500 to 1812 Hemp in connection with the Supply Agreement. Organigram acquired access to approximately 6,000 kg of dried hemp flower harvested in the fall of 2018, which it mostly acquired in Q3 Fiscal 2019.</font></p>
    <div id="footer_page_17">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">16</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_18"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">In addition, pursuant to the Supply Agreement, Organigram has a right&#8208;of&#8208;first refusal on future procurement of hemp from 1812 Hemp.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On July 26, 2019, the Company entered into an advance payment and support agreement (&#8220;Payment Agreement&#8221;) with 1812 Hemp. Under the terms of the Payment Agreement, the Company advanced $3.0 million to 1812 Hemp in the form of a secured loan. These amounts may be applied against future purchases of hemp under the Supply Agreement. The aggregate amount of advances outstanding under the Payment Agreement as of January 1, 2020 will accrue interest of 9.0% per annum, calculated monthly, until the entire balance of advances is paid. At August 31, 2020, $2,229 in principal was outstanding under the Payment Agreement. Subsequent to August 31, 2020, the Company demanded repayment of the entire amount owing by 1812 Hemp to the Company under the Payment Agreement.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">During the three months ended August 31, 2020, management became aware that 1812 Hemp was facing financial hardship due to a lack of customer demand and a change in market conditions, and as a result had significantly scaled back operations.&#160; Separately, the Company&#8217;s forecasted hemp purchases have decreased significantly as a result of slower than expected progression in Canadian hemp and CBD regulations. Thus, as a result of the aforementioned challenges, management impaired the Supply Agreement intangible asset to its recoverable amount, which was estimated to be $nil, by recording an impairment charge of $1,303 at August 31, 2020.</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #87b5cf;">USE OF PROCEEDS OF PRIOR FINANCINGS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The following table sets out the Company&#8217;s previously disclosed expected uses of prior financings as set out in the prospectus filings of prior financings, which include: i) the proceeds of the offering of the December 2017 units; and ii) the proceeds of the offering of the January 2018 Debentures.</font></p>
        <table style="width: 100%; color: #4d4d4c; font-size: 8pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">
                    <p style="text-align: right;"><font style="color: #000000;">ESTIMATED FUNDS</font><br><font style="color: #000000;">REQUIRED FOR</font><br><font style="color: #000000;">COMPLETION AS AT THE</font><br><font style="color: #000000;">DATE OF THE <br>RELATED</font><br><font style="color: #000000;">PROSPECTUS</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; white-space: nowrap;"><font style="color: #000000;">&#160;&#160;&#160;&#160;&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">
                    <p style="text-align: right;"><font style="color: #000000;">FUNDS THE <br>COMPANY</font><br><font style="color: #000000;">EXPECTS TO <br>REQUIRE </font><font style="color: #000000;">FOR <br>COMPLETION AS</font><br><font style="color: #000000;">AT AUG 31, 2020</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; white-space: nowrap;"><font style="color: #000000;">&#160;&#160;&#160;&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">
                    <p style="text-align: right;"><font style="color: #000000;">ACTUAL FUNDS<br>SPENT </font><font style="color: #000000;">AS OF</font><br><font style="color: #000000;">AUG 31, 2020</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; white-space: nowrap;"><font style="color: #000000;">&#160;&#160;&#160;&#160;&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">
                    <p style="text-align: right;"><font style="color: #000000;">EXPECTED <br>TIMEFRAME </font><font style="color: #000000;">FOR <br>COMPLETION AS </font><font style="color: #000000;">AT <br>THE DATE OF THE</font><br><font style="color: #000000;">RELATED <br>PROSPECTUS</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; white-space: nowrap;"><font style="color: #000000;">&#160;&#160;&#160;&#160;&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">
                    <p style="text-align: right;"><font style="color: #000000;">EXPECTED</font><br><font style="color: #000000;">TIMEFRAME FOR</font><br><font style="color: #000000;">COMPLETION AS <br>AT </font><font style="color: #000000;">THE DATE <br>HEREOF</font></p>
                </td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="width: 2%; vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="width: 2%; vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 2%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 15%;"><font style="color: #000000;"><br></font></td>
                <td style="width: 2%; vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; white-space: nowrap;">
                    <p style="text-align: left;"><font style="color: #000000;">Moncton Campus</font><br><font style="color: #000000;">&#160; &#160;expansion (Phase 4)</font></p>
                </td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">$95.0 million</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">$nil</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">$123.8 million</font></p>
                </td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent; width: 2%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000; width: 15%;"><font style="color: #000000;">December 2019</font></td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">December 2019<sup>3</sup></font></p>
                </td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; white-space: nowrap;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 15%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;"><font style="color: #000000;">&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;"><font style="color: #000000;">&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;"><font style="color: #000000;">&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;"><font style="color: #000000;">&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; white-space: nowrap;">
                    <p style="text-align: left;"><font style="color: #000000;">Strategic international</font><br><font style="color: #000000;">&#160; &#160;opportunities</font></p>
                </td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">$5.4 million</font><br><font style="color: #000000;">to $21.6 million<sup>1</sup></font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">$5.4 million</font><br><font style="color: #000000;">to $21.6 million1</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">$7.6 million<sup>2</sup></font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Ongoing</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Ongoing</font></p>
                </td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; white-space: nowrap;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
                <td style="width: 2%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
                <td style="width: 2%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
                <td style="width: 2%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
                <td style="width: 2%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;"><font style="color: #000000;"><br></font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; white-space: nowrap;">
                    <p style="text-align: left;"><font style="color: #000000;">Strategic domestic</font><br><font style="color: #000000;">&#160; &#160;expansion</font></p>
                </td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Up to $43.1 million</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Up to $38.0 million</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">$5.1 million</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Ongoing</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Ongoing</font></p>
                </td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; white-space: nowrap;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;">
                    <p style="text-align: right;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;">
                    <p style="text-align: right;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;">
                    <p style="text-align: right;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;">
                    <p style="text-align: right;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right;">
                    <p style="text-align: right;"><font style="color: #000000;">&#160;</font></p>
                </td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; white-space: nowrap;">
                    <p style="text-align: left;"><font style="color: #000000;">Hemp market presence</font></p>
                </td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Up to $10.8 million</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Up to $8.4 million</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">$4.5 million</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Ongoing</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: right; border-bottom: 1px solid transparent;"><font style="color: #000000;"><br></font></td>
                <td style="width: 15%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">
                    <p style="text-align: right;"><font style="color: #000000;">Ongoing</font></p>
                </td>
            </tr>
        </table>
        <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;">(1)</font></font><font style="width: 2.25pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Comprised of December 2017 and January 2018 financings</font></font></p>
        <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;">(2)</font></font><font style="width: 1.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Excludes contingent consideration that is to be settled in Common Shares of the Company</font></font></p>
        <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;">(3)</font></font><font style="width: 2.25pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">As disclosed in the &#8220;Moncton Campus Expansion&#8221; section of the MD&amp;A, the Company has decided to indefinitely cease construction completion of Phase 4C, originally scheduled for completion by the end of calendar 2019. The Company completed Phase 4A and 4B prior to December 2019.</font></font></p>
        <p style="text-align: justify;"><font style="color: #000000;">As set out in the table above, the majority of the funds raised were allocated for specific purposes, particularly related to the expansion of the Moncton Campus and strategic opportunities (refer to the &#8220;Moncton Campus Expansion&#8221; and &#8220;International Cannabis &amp; CBD Markets&#8221; sections in this MD&amp;A). At this stage, potential strategic acquisitions are at various stages of progression and the allocation of funds may change depending on the strategic priorities of the Company and management&#8217;s assessment of the competitive landscape.</font></p>
    </div>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, the Company raised net proceeds of approximately $52.9 million and $47.1 million under its December 2019 and April 2020 at&#8208;the&#8208;market equity offerings (&#8220;ATM Programs&#8221;), respectively. The Company has used, and intends to continue to use, the net proceeds from the ATM Programs to fund capital projects, for general corporate purposes, and to repay indebtedness.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On November 12, 2020, the Company closed an underwritten public offering of units for total gross proceeds of $69,144.&#160; Please refer to the &#8220;Balance Sheet, Liquidity, and Capital Resources&#8221; section of the MD&amp;A for further information.</font></p>
    </div>
    <div id="footer_page_18">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">17</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_19"></a>
    <div>
        <div><br></div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">FINANCIAL REVIEW AND DISCUSSION OF OPERATIONS</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #87b5cf;">CAUTIONARY NOTE REGARDING NON&#8208;IFRS FINANCIAL MEASURES</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company uses certain non&#8208;IFRS performance measures such as Adjusted EBITDA (excluding fair value adjustment to inventory and biological assets) and Adjusted Gross Margin in its MD&amp;A or other public documents, which are not measures calculated in accordance with IFRS and have limitations as analytical tools. These performance measures have no prescribed meaning under IFRS and therefore amounts presented may not be comparable to similar data presented by other companies. The data is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance such as net income or other data prepared in accordance with IFRS. See the cautionary statement in the &#8220;Introduction&#8221; section at the beginning of this MD&amp;A.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">FINANCIAL HIGHLIGHTS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Below is an analysis of the changes from Fiscal 2018 to Fiscal 2019 and Fiscal 2019 to Fiscal 2020. In depth commentary is provided in the pages that follow in relation to the latter. Fiscal 2019 net revenue and gross margin increased over Fiscal 2018 as a result of the launch of the adult&#8208;use recreational market in October 2018, which also resulted in a corresponding increase in operating expenses and other expenses as a result of this new market development, whereas during Fiscal 2018 the Company only generated revenues from medical patients.</font></p>
        <table style="width: 100%; color: #5f6369; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">FISCAL 2020</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">FISCAL 2019</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">$ CHANGE</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">% CHANGE</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: center; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">FISCAL 2018</font></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid transparent; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Financial Results</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Gross revenue</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">103,387</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">97,547</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">5,840</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">6%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">12,429</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Net revenue</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">86,795</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">80,413</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">6,382</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">8%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">12,429</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Cost of sales</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">105,004</font></td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">42,521</font></td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">62,483</font></td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">147%</font></td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">6,814</font></td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Gross margin before fair value adjustments</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(18,209</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">37,892</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(56,101</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(148)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">5,615</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 11.25pt;"><font style="color: #000000;">Gross margin % before fair value adj.</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(21)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">47%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(68)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(145)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">45%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Fair value adjustments to biological assets and</font><br><font style="color: #000000;">&#160; &#160; changes in inventory sold</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(38,281</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">10,577</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(48,858</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(462)%</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">46,018</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Gross margin</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(56,490</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">48,469</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(104,959</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(217)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">51,633</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Operating expenses</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">89,020</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">42,982</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">46,038</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">107%</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">15,217</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Income (loss) from operations</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(145,510</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">5,487</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(150,997</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(2,752)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">36,416</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Other expense (income)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(9,353</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">14,991</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(24,344</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(162)%</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">14,292</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Net income (loss) from continuing operations</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(136,157</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(9,504</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">(126,653</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">1,333%</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;"><font style="color: #000000;">22,124</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Net income (loss) from continuing operations</font><br><font style="color: #000000;">&#160; &#160;per common share, basic</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(0.789</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(0.067</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(0.722</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">1,078%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">0.184</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Net income (loss) from continuing operations</font><br><font style="color: #000000;">&#160; &#160;per common share, diluted</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(0.789</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(0.067</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(0.722</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">1,078%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">0.174</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Net cash used in operating activities</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(45,125</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(35,081</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(10,044</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">29%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(12,704</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Adjusted Gross M argin1</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">28,904</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">38,633</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(9,729</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(25)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">5,615</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 11.25pt;"><font style="color: #000000;">Adjusted Gross Margin % 1</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">33%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">48%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(15)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(31)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">45%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Adjusted EBITDA 1</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">852</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">20,644</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(19,792</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(96)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(1,003</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 10%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Financial Position</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Working capital</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">141,123</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">152,417</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(11,294</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(7)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">191,964</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Inventory and biological assets</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">71,759</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">113,796</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(42,037</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">(37)%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">64,827</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Total assets</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">435,127</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">428,525</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">6,602</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">2%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">302,567</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 2.25pt;"><font style="color: #000000;">Non-current financial liabilities</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">106,289</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">46,067</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">60,222</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">131%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="color: #000000;">98,743</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
        </table>
        <p style="text-align: justify;"><font style="color: #000000;">Note 1: Non&#8208;IFRS measures that have been defined and reconciled within their respective section sof the MD&amp;A</font></p>
    </div>
    <div id="footer_page_19">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">18</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_20"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">NET REVENUE FROM CONTINUING OPERATIONS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Net revenue for the Company is defined as gross revenue net of any customer discounts, rebates, and sales returns and recoveries, less excise taxes. Revenue consists primarily of dried flower and cannabis oil sold to the adult&#8208;use recreational, medical, wholesale, and international marketplaces. During Q2 Fiscal 2020, the Company also launched its vape and chocolate products to the adult&#8208;use recreational market.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">For the three months ended August 31, 2020, net revenues increased by 25% to $20,400 from $16,290 for the three months ended August 31, 2019 primarily due to higher flower sales volumes, which was offset by a lower average net selling price (&#8220;ASP&#8221;) compared to Q4 Fiscal 2019, as the dried flower value segment of the recreational market, particularly in large format, grew in Q4 2020. Additionally, the sales of Rec 2.0 products (vape products and cannabis&#8208;infused chocolates), which had not yet been legalized in Q4 Fiscal 2019, as well as significantly higher international revenues, contributed to the increase over Q4 Fiscal 2019. These contributors to revenue were offset by a decline in recreational oil sales as demand for THC oil decreased relative to Fiscal 2019 and the Company received returns primarily related to Fiscal 2019 sales.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Net revenue for Q4 Fiscal 2020 of $20,400 was net of a provision for product returns and pricing adjustments of $1,986 (each net of excise) compared to net revenue for Q4 Fiscal 2019 of $16,290 and a provision for product returns and pricing adjustments of $3,698. The majority of the current period product returns and price adjustments were due to vapes and an isolated wholesale return as well as slow moving recreational flower products. The lack of a sufficient retail network and slower than expected store openings in Ontario also continued to impact sales in Q4 Fiscal 2020, which was further exacerbated by increased industry supply. The Company is cognizant that in this new and emerging market, the size of the customer base, its demands, and preferences cannot yet be ascertained with any level of certainty or reliability and future demand for existing and new products remains to be determined as the market develops and matures.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Dried flower comprised 85% of net revenue in the quarter. The ASP of dried flower decreased to $3.58 per gram on a quarter&#8208;over&#8208;quarter basis compared to $5.18 per gram for Q4 Fiscal 2019 as both the Company and Canadian industry experienced general price compression in the adult&#8208;recreational and medical markets as these markets matured and the customer and product mix evolved to more value offerings. Further, the lower ASP was a result of international bulk dried flower revenues, which was sold at a lower ASP compared to Canadian domestic revenues. Selling prices are prone to fluctuation and there may be further price compression if the market remains oversupplied. The Company is committed to refining its product mix as customer preferences evolve.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Sales volumes of dried flower in grams increased by 100% to 4,859 kg in Q4 Fiscal 2020 compared to the prior year comparative quarter, primarily as a result a shift towards large format products as well as the contribution of wholesale and international dried flower sales.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">For the year ended August 31, 2020, the Company recorded an increase of 8% in net revenues to $86,795 from $80,413 for the year ended August 31, 2019. Net revenue increased on a year&#8208;to&#8208;date basis primarily due to the launch of Rec 2.0 products (vapes and chocolates) during Q2 Fiscal 2020 and wholesale and international revenues, which had not occurred in the prior comparative period. This was offset by a decrease in recreational flower and oil sales volumes as a result of large pipeline fill orders shipped during the initial launch of the adult&#8208;use recreational market in the prior year, increased competition, and changing consumer preferences, particularly with respect to oil.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">Net revenue for Fiscal 2020 of $86,795 was net of a provision for product returns and pricing adjustments of $8,282 (each net of excise) compared to net revenue for Fiscal 2019 of $80,413 and a provision for product returns and pricing adjustments of $3,698. The majority of Fiscal 2020 product returns and price adjustments were due to slow moving recreational oil and flower products, most of which related to revenues generated in Fiscal 2019.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">For the year ended August 31, 2020, the ASP of dried flower decreased to $4.12 per gram compared to $5.00 per gram for the year ended August 31, 2019 due to $15,184 (or 17% as a percentage total net revenue) in opportunistic wholesale revenues, which garner a lower ASP at a higher gross margin, compared to $709 in the prior year, as well as a shift towards value&#8208;oriented large format products and sales returns provisions related primarily to prior year sales. Offsetting this decline in ASP was a 41% increase in sales volumes to 17,269 kg over the prior year comparative period due to legalization of adult&#8208;recreational use cannabis coming into effect partway through Q1 Fiscal 2019 as well as the general growth in this market.</font></p>
    </div>
    <div id="footer_page_20">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">19</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_21"></a>
    <div>
        <div><br></div>
        <div>
            <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">REVENUE COMPOSITION</font></p>
            <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company&#8217;s management reviews revenue composition by product category as follows for years ended August 31, 2020 and 2019:</font></p>
        </div>
        <div>
            <div>
                <p style="margin-left: 12pt; text-align: center; text-indent: -12pt;"><img src="exhibit99-5xz004.jpg"></p>
            </div>
        </div>
        <div>
            <p style="text-align: justify;"><font style="color: #000000;">(1) Comprised primarily of sales returns and price allowance provisions for recreational oil.</font></p>
            <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">COST OF SALES AND GROSS MARGIN</font></p>
            <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The gross margin from continuing operations for the three months ended August 31, 2020 was ($28,756) compared to ($11,059) for the prior year comparative period. The decrease in gross margin quarter&#8208;over&#8208;quarter was primarily driven by primarily as a result of: (i) higher cost of sales on higher post&#8208;harvest costs; (ii) inventory provisions and write&#8208;off of excess and unsaleable inventories as well as inventory write&#8208;downs to net realizable value ($11,099); (iii) unabsorbed overhead ($3,470) as a result of lower production volumes; (iv) a lower ASP from increased competition and the ongoing evolution of the customer and product mix; and (v) write&#8208;downs to net realizable value relating to the fair value component of inventories (fair value loss of $16,261).</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">The gross margin from continuing operations for the year ended August 31, 2020 was ($56,490) compared to $48,469 for the prior year comparative period. The decrease in gross margin year&#8208;over&#8208;year was primarily driven by the same factors as described above: (i) higher cost of sales on higher post&#8208;harvest costs; (ii) inventory provisions and write&#8208;off of excess and unsaleable inventories as well as inventory write&#8208; downs to net realizable value ($35,584 compared to $744 in the prior year); (iii) unabsorbed overhead ($5,434 compared to $nil) as a result of lower production volumes; (iv) a lower ASP from increased competition and the ongoing evolution of the customer and product mix; and (v) write&#8208;downs to net realizable value relating to the fair value component of inventories (fair value loss of $72,801 compared to $14,284).</font></p>
            <p style="text-align: justify;"><font style="color: #000000;">Included in gross margin are the changes in the fair value of biological assets related to IFRS standard IAS 41 &#8211; Agriculture. The net decrease in fair value adjustments on a fiscal quarter&#8208;to&#8208;date and year&#8208;to&#8208;date basis compared to the prior year is due to an increase in harvested plants resulting in an increase in fair value on the growth of biological assets of $4,778 and $73,975 (August 31, 2019 &#8208; $13,334 and $75,338), respectively, which was offset by the realization of the fair value increment for inventory sold of ($8,666) and ($39,455) (August 31, 2019 &#8211; ($11,712) and ($50,477)) and adjustments to the net realizable value of inventory of ($16,261) and ($72,801) (August 31, 2019 &#8211; ($13,428) and ($14,284)). The significant increase in adjustment to the net realizable value of inventory relates primarily to a write&#8208;down of the Company&#8217;s inventory of flower, trim available for extraction, and concentrated extract for which the Company has excess quantities based on current market dynamics and forecast demand, also taking into consideration requirements with respect to the dating and specifications of products available for sale.</font></p>
        </div>
    </div>
    <div id="footer_page_21">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">20</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_22"></a>
    <div>
        <div>
            <p style="text-align: justify;"><font style="color: #000000;">Cost of sales primarily consists of the following:</font></p>
        </div>
    </div>
    <div>
        <p style="margin-left: 21pt; text-align: justify; margin-bottom: 0pt; text-indent: -18pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Costs of sales of cannabis (dried flower, pre&#8208;rolls, and wholesale/international bulk flower), cannabis oil, vapes, chocolates, and other wholesale formats such as extract include the direct costs of materials and packaging, labour including any associated share&#8208;based compensation, and depreciation of manufacturing related items such as building and equipment related to the production of cannabis and derivatives sold. This includes growing, cultivation and harvesting costs, extraction, vape filling, quality assurance and quality control, as well as packaging and labelling;</font></font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 3pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Costs related to other products such as vaporizers and other accessories;</font></font></p>
        <p style="text-align: justify; margin-left: 3pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Shipping expenses to deliver product to the customer;</font></font></p>
        <p style="margin-left: 21pt; text-align: justify; margin-bottom: 0pt; text-indent: -18pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The production cost of late&#8208;stage biological assets that are disposed of, provisions and write&#8208;downs for inventory that does not pass the Company&#8217;s quality assurance standards and obsolete products and packaging, write&#8208;downs to net realizable value that reduce the value of inventory below the original production or purchase cost, and other production overhead; and</font></font></p>
        <p style="margin-left: 21pt; text-align: justify; text-indent: -18pt; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 13.5pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Unabsorbed fixed overhead charges, primarily comprised of depreciation, resulting from the underutilization of cultivation and production capacity.</font></font></p>
        <p style="text-align: center;"><font style="color: #000000;">Illustrative Overview of Composition and Flow of Biological Assets, Inventories, and Cost of Sales</font></p>
        <p style="text-align: center; margin-left: 9.75pt;"><font style="color: #000000;"><img src="exhibit99-5xz001.jpg" style="font-size: 10pt; width: 625px; height: 306px;"></font></p>
        <p style="text-align: left;"><font style="color: #000000;">N<font style="font-size: 10pt;">otes:</font></font></p>
        <p style="margin-left: 9.75pt; text-align: justify; text-indent: -11pt;"><font style="color: #000000;"><font style="color: #000000;">1.</font></font><font style="width: 3pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The above illustration is for informational purposes only and should not be viewed as an exact representation of the actual flow of inputs and outputs. Certain items referenced above may not have a standard meaning under IFRS and therefore should be considered non&#8208;IFRS measures. Readers should refer to the notes of the August 31, 2020 year&#8208;end financial statements for the official accounting policies.</font></font></p>
        <p style="margin-left: 9.75pt; text-align: justify; text-indent: -11pt;"><font style="color: #000000;"><font style="color: #000000;">2.</font></font><font style="width: 3pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The majority of stock options expense related to the manufacturing and operations groups and most of the Moncton Campus depreciation is captured as part of cultivation costs, however a certain amount of these costs are also added during the post&#8208;harvest and extraction phases.</font></font></p>
        <p style="margin-left: 9.75pt; text-align: justify; text-indent: -11pt;"><font style="color: #000000;"><font style="color: #000000;">3.</font></font><font style="width: 3pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Fair value adjustments are made to the cost basis of biological assets which collectively become the cost basis of inventories. Inventories are then carried at the lower of cost and net realizable value. When sold a portion of inventory is charged to cost of sales (actual costs) with the remainder (FV adjustments) to &#8220;Fair value adjustments to biological assets&#8221; on statements of income.</font></font></p>
        <p style="margin-left: 9.75pt; text-align: justify; text-indent: -11pt;"><font style="color: #000000;"><font style="color: #000000;">4.</font></font><font style="width: 3pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Excise taxes are excluded from this diagram and are reflected as a netting adjustment against gross revenue to arrive at net revenue for presentation purposes in the consolidated financial statements.</font></font></p>
    </div>
    <div id="footer_page_22">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">21</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_23"></a>
    <div>
        <div><br></div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">GROSS MARGIN BEFORE FAIR VALUE CHANGES TO BIOLOGICAL ASSETS AND INVENTORIES SOLD AND ADJUSTED GROSS MARGIN</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The fair value adjustment to biological assets and inventories sold is comprised of the non&#8208;cash fair value gains (losses) for inventories sold, growth of biological assets, and adjustments to net realizable value. Prior quarters have been adjusted to reflect results only from continuing operations and the reclassification of shipping expenses.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The increase in gross margin before fair value changes to biological assets and inventories sold up to Q1 Fiscal 2019 is consistent with the Company&#8217;s low cost of production and ability to sell most of its products at the medium to high end of the product categories. The decline in gross margin before fair value changes to biological assets and inventories sold in Q4 Fiscal 2019 is believed to be an anomaly resulting from an increase in production costs, a temporary decline in production yields during Q3 Fiscal 2019 that resulted in higher cost product being sold through in Q4 Fiscal 2019, year&#8208;end inventory adjustments, and write&#8208;downs of legacy packaging materials that have been replaced with new, more consumer&#8208;friendly packaging. During Q1 Fiscal 2020, the Company&#8217;s gross margin before fair value changes to biological assets and inventories sold increased to $9,342 , which then decreased in Q2 and Q3 Fiscal 2020 due to lower sales volumes and costs associated with the launch the new Rec 2.0 products, higher post&#8208;harvest costs, and inventory write&#8208;downs and provisions. The negative gross margin before value changes to biological assets and inventories sold in Q4 2020 of ($6,192) is primarily due to inventory provisions and write&#8208;off of excess and unsaleable inventories, inventory write&#8208;downs to net realizable value, and unabsorbed overhead as a result of lower production volumes.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Adjusted Gross Margin is a non-IFRS measure that the Company defines as net revenue less: (i) cost of sales, before the effects fair value changes to biological assets and changes in inventory sold; excluding (ii) write-offs and impairment of inventories and biological assets; (iii) write-downs to net realizable value; (iv) COVID-19 related charges; and (v) unabsorbed overhead relating to underutilization of the production facility, most of which is related to non-cash depreciation expense. Management believes this measure is useful and relevant as it more fairly represents the gross margin for the revenues generated in the period as it is based on the direct and indirect costs of production related to these revenues and excludes impairments and write-offs related to other inventories resulting from internal or external influences. See the cautionary statement regarding non-IFRS financial measures in the &#8220;Introduction&#8221; section at the beginning of this MD&amp;A and the reconciliation to IFRS measures in the Financial Results and Review of Operations section of this MD&amp;A.&#160; The most directly comparable measure to Adjusted Gross Margin calculated in accordance with IFRS is gross margin before fair value changes to biological assets and inventories sold.</font></p>
        <p style="text-align: justify; margin-left: 2.25pt;"><font style="color: #85b8d8;">Gross margin before fair value changes to biological assets and inventories sold and Adjusted Gross Margin</font></p>
        <table style="width: 100%; color: #5f6369; font-size: 8pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">Q1-F19</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">Q2-F19</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">Q3-F19</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">Q4-F19</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">Q1-F20</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">Q2-F20</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">Q3-F20</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; background: #c0d7e3 none repeat scroll 0% 0%; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; background: #c0d7e3 none repeat scroll 0% 0%; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><font style="color: #000000;">Q4-F20</font></td>
                <td style="vertical-align: bottom; background: #c0d7e3; border-bottom: 1px solid #000000; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Net revenue</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">12,439</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">26,934</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">24,750</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">16,290</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">25,153</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">23,221</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">18,021</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">20,400</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Cost of sales before adjustments</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">3,618</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">10,890</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">12,473</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">14,799</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">14,966</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">14,772</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">13,909</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">14,244</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Adjusted Gross Margin</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">8,821</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">16,044</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">12,277</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">1,491</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">10,187</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">8,449</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">4,112</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">6,156</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Adjusted Gross Margin %</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">71%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">60%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">50%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">9%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">41%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">36%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">23%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">30%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Less:</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 9pt;"><font style="color: #000000;">Write-offs and impairment of inventories and</font> <font style="color: #000000;">biological assets</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">744</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">845</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">1,027</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">19,940</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">11,019</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 9pt;"><font style="color: #000000;">Write-downs to net realizable value</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">12</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">2,661</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">80</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 9pt;"><font style="color: #000000;">COVID-19 related charges</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">5,901</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">194</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 9pt;"><font style="color: #000000;">Unabsorbed overhead</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">1,964</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">3,470</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Gross margin before fair value changes to </font><font style="color: #000000;">biological assets and inventories sold</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">8,821</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">16,044</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">12,277</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">747</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">9,342</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">7,410</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">(26,354</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">(8,607</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Gross margin % (before fair value changes to bio </font><font style="color: #000000;">assets and inventories sold</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">71%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">60%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">50%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">5%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">37%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">32%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-146%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">-42%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Add/(Deduct): Fair value changes to biological </font><font style="color: #000000;">assets and changes in inventory sold</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">42,925</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">(8,086</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">(12,456</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">(11,806</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">1,852</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">3,878</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%;"><font style="color: #000000;">(23,862</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">(20,149</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Gross margin (1)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">51,746</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">7,958</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">(179</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">(11,059</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">11,194</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">11,288</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">(50,216</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">(28,756</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; width: 7%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Gross margin % (1)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">416%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">30%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-1%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-68%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">45%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">49%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%;"><font style="color: #000000;">-279%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 7%; background-color: #c0d7e3;"><font style="color: #000000;">-141%</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
            </tr>
        </table>
        <p style="text-align: justify;"><font style="color: #000000;">Note 1: Gross margin reflects the IFRS measure per the Company&#8217;s Financial Statements.</font></p>
    </div>
    <div id="footer_page_23">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">22</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_24"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">GENERAL AND ADMINISTRATIVE</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">For the three months ended August 31, 2020, general and administrative expenses from continuing operations decreased to $7,612 compared to $9,171 in the prior year comparative period. The decrease is mainly due to adjustments of approximately $1,976 for licensing and professional fees during Q4 Fiscal 2020 that were not expected to recur at the same level as well as a general reduction of staffing, travel, and other administrative expenses stemming from the impact of COVID&#8208;19.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">For the year ended August 31, 2020, the Company incurred general and administrative expenses from continuing operations of $27,996 compared to $18,593 (excluding general and administrative expenses attributable to Trauma Healing Centers (&#8220;Trauma Healing&#8221;) of $75) in the prior year comparative period. The increase from the prior year comparative period is related to an increase in internal resources, office and general expenses, office building depreciation, professional fees, research and development efforts, and public company&#8208;related costs as the Company continued to scale up its operations in connection with the development of the adult&#8208;use recreational market and the cannabis derivatives market that launched in December 2019.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">SALES AND MARKETING</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">For the three months ended August 31, 2020, the Company incurred sales and marketing expenses from continuing operations of $3,218 compared to $4,712 for the three months ended August 31, 2019. The decrease in expenses in the current quarter was due to the decision to scale back on certain sales and marketing efforts, including a workforce reduction in certain areas, as a result of the COVID&#8208;19 pandemic. These expenses include advertising and promotion, client service and sales staff, educational materials, as well as trade investment.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">For the year ended August 31, 2020, the Company incurred sales and marketing expenses from continuing operations of $16,528 compared to $14,625 for the prior year comparative period. The increase year&#8208;over&#8208;year is related to the continued development of the adult&#8208;use recreational market and the Company&#8217;s investment in its brand portfolio as well as the preparation for the Rec 2.0 launch.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Sales and marketing and general and administrative expenses, excluding non&#8208;cash share&#8208;based compensation (&#8220;SG&amp;A&#8221;), were $10,830 for Q4 Fiscal 2020, a decrease from $13,883 in Q4 Fiscal 2019. As a percentage of net revenue, SG&amp;A expenses decreased to 52% in Q4 Fiscal 2020 from 85% in Q4 Fiscal 2019 as the Company scaled back on certain sales and marketing efforts, including a workforce reduction in certain areas, as a result of the COVID&#8208;19 pandemic.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">SG&amp;A expenses for Fiscal 2020 were $44,524 compared to $33,218 in Fiscal 2019. As a percentage of net revenue, SG&amp;A expenses increased to 51% in Fiscal 2020 from 41% in Fiscal 2019.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">IMPAIRMENT OF PROPERTY, PLANT AND EQUIPMENT</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company reviews the carrying value of its property, plant and equipment at each reporting period for indicators of impairment. During the year ended August 31, 2020, management noted indicators of impairment and recorded impairments at an asset specific level as described below.</font></p>
        <p style="text-align: justify;"><b><font style="color: #000000;">Moncton Campus &#8211; Phase 4C (asset specific)</font></b></p>
        <p style="text-align: justify;"><font style="color: #000000;">The construction of Phase 4C of the Moncton Campus, which was intended to house grow rooms with an previously estimated cultivation capacity of 24,000 kg per annum, was indefinitely deferred during the three months ended May 31, 2020 based on available capacity and forecast market demand.&#160; Phase 4C of the Moncton Campus has effectively been left partially completed and, due to the specialized and integrated nature of Phase 4C, without any foreseeable near-term use.&#160; Management estimated the FVLCD of Phase 4C to approximate the purchase cost of the land and movable equipment, which is $1,328.&#160; As a result, the Company recognized an impairment loss of $37,749 in relation to this asset for the year ended August 31, 2020.&#160; The entire amount of the impairment loss was recorded against the building infrastructure of Phase 4C. In addition, subsequently incurred and contractually committed future costs totaling $1,050 with respect to Phase 4C at August 31, 2020 were included in the impairment loss for the year ended August 31, 2020.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">SHARE&#8208;BASED COMPENSATION</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company recognized $712 and $4,725 in share&#8208;based compensation in relation to selling, general and administrative employees for the three months and year ended August 31, 2020, respectively, compared to $2,149 and $9,151 for the prior year comparative periods. For the three months ended August 31, 2020, 60,000 options were granted to employees of the Company, valued at $106, compared to 965,000 options granted in the prior year comparative period, valued at $4,300. There were no options granted to key management personnel during the three months ended August 31, 2020 and 2019. The decrease in share&#8208;based compensation expense year&#8208;over&#8208;year is primarily a result of fewer options having been granted during the current period.</font></p>
    </div>
    <div id="footer_page_24">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">23</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_25"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">For the year ended August 31, 2020, 2,125,000 options were granted, valued at $3,743, compared to 3,589,500 options granted in the prior year comparative period, valued at $13,848. Included in the year ended August 31, 2020 were 790,000 options granted to key management personnel compared to 685,000 options granted for the year ended August 31, 2019.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Included in the three months and year ended August 31, 2020 were nil and 265,258 (August 31, 2019 &#8211; nil and 631,949), restricted share units (&#8220;RSUs&#8221;) granted to employees, of which nil and 211,981 RSUs were issued to key management personnel and members of the Board of Directors compared to nil and 631,949 RSUs issued for the three months and year ended August 31, 2019.</font></p>
    </div>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">During the three months and year ended August 31, 2020, nil and 142,187 performance share units (&#8220;PSUs&#8221;) were granted to employees (August 31, 2019 &#8211; nil and nil), of which nil and 88,910 PSUs were issued to key management personnel and members of the Board of Directors compared to nil and nil issued for the prior year comparative periods.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Share&#8208;based compensation represent a non&#8208;cash expense, and was valued using the Black&#8208;Scholes valuation model for stock options and using the fair value of the shares on the date of the grant for RSUs. The fair value of PSUs was based on the Company&#8217;s share price at the grant date, adjusted for an estimate of likelihood of achievement of the defined performance criteria.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">FINANCING COSTS AND INVESTMENT INCOME</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Financing costs are comprised of cash interest expense, the amortization of transaction costs, the discount of the long&#8208;term debt outstanding during the period, loan modification losses as described below, and for the prior year comparative period, the discount of the convertible debentures that were previously outstanding. The increase in financing costs for the three months ended August 31, 2020 to $955 from $786 in the prior year comparative period is mainly attributable to the higher term loan balance outstanding during Q4 Fiscal 2020 ($115,000 at August 31, 2020), whereas only the initial draw of the term loan was outstanding during Q4 Fiscal 2020 ($50,000 at August 31, 2019). However, the decrease for the year ended August 31, 2020 to $6,008 from $9,668 in the prior year comparative period is primarily attributable to the convertible debentures previously outstanding, which were completely converted in April 2019, and the resulting lower effective interest rate as well as a lower average outstanding debt balance. This decrease is offset by the loan modification losses of $1,644 incurred with respect to the first and second amendments to the Company&#8217;s credit facility as outlined below.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On May 31, 2019, the Company entered into a credit facility with Bank of Montreal (&#8220;BMO&#8221;) and a syndicate including three other lenders. The facility consists of a $115 million term loan (&#8220;Term Loan&#8221;) and a $25 million revolving credit facility (&#8220;Revolver&#8221;, or together with the Term loan, as amended, the &#8220;Facilities&#8221;), both of which mature on May 31, 2022. Included in the facility is an uncommitted option to increase the Facilities by an incremental $35 million to a total of $175 million, subject to agreement by BMO and the syndicate of lenders and satisfaction of certain legal and business conditions.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On November 15, 2019, the Company amended its Facilities with BMO to: i) extend the final draw deadline of the Term Loan (&#8220;Amended Term Loan&#8221;) from November 30, 2019 to March 31, 2020; ii) postpone the commencement of scheduled principal repayments on the Term Loan from February 28, 2020 to May 31, 2020; and iii) realign the financial covenants structure, effective November 30, 2019, to be more consistent with industry norms up to and including May 31, 2020. Prior to the Second Amendment, as described below, the financial covenants were to revert to the original structure on August 31, 2020. The Company incurred an amendment fee of $140 plus customary legal expenses in connection with the first amendment.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Facilities were further amended on February 28, 2020 to extend the final draw deadline of the Term Loan from March 31, 2020 to May 31, 2020.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">In accordance with IFRS 9, such modification to the credit facility as outlined above is not an extinguishment of debt either qualitatively or quantitatively, rather it is a non&#8208;substantial modification. Therefore, as per the provisions of IFRS 9 the Company recorded a loss on debt restructuring based on the difference in the present value of the restructured net cash flows discounted at the original effective interest rate (&#8220;EIR&#8221;) versus the present value of the original net cash flows discounted at the original EIR. This loss of $831 has been recorded under financing costs in the statement of (loss) income and comprehensive (loss) income for the year ended May 31, 2020.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On May 28, 2020, the Company further amended its Facilities (&#8220;Second Amendment&#8221;) with BMO and the syndicate of lenders to: (i) extend the final draw deadline of the Term Loan to July 31, 2020; (ii) postpone the commencement of principal repayments on the Term Loan to November 30, 2020; (iii) adjust certain financial ratios to be maintained by the Company both before and after November 30, 2021 (the &#8220;Conversion Date&#8221;); (iv) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (v) remove the uncommitted option to increase the Facilities by an incremental $35 million. The financial covenants will revert to the original structure, albeit at different ratios, on November 30, 2021. The interest rate margin will be fixed during this period. The Company incurred an amendment fee of $490 plus customary legal expenses in connection with the second amendment.</font></p>
    </div>
    <div id="footer_page_25">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">24</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_26"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">As a result of the Second Amendment, the Company recorded a loan modification loss of $813 under financing costs in the statement of (loss) income and comprehensive (loss) income for the three months ended May 31, 2020.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">During the three months and year ended August 31, 2020, the Company drew an additional $30,000 and $65,000 under the Term Loan, in two tranches, and similar to the initial draw noted above, converted the balances from prime rate loans to bankers&#8217; acceptances. During the year ended August 31, 2020, the Company rolled over $115,000 of the Term Loan balance on a monthly basis through bankers&#8217; acceptances with an average cash interest rate of approximately 4.25%. Based on the current availment option of bankers acceptances&#8217; the applicable margin rate is 3.75% above the applicable bankers acceptances&#8217; rate.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Investment income of $171 and $308 was earned for the three months and year ended August 31, 2020, respectively, compared to investment income of $170 and $662 for the prior year comparative periods. The year&#8208;over&#8208;year decrease in investment income, primarily comprised of interest income, was related to the maturing of short&#8208;term investments in August 2019 ($nil outstanding during the current period). Income was offset for the periods by realized and unrealized fair value losses on the mark&#8208;to&#8208;market revaluation of marketable securities.</font></p>
    </div>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">GOVERNMENT SUBSIDIES</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On April 1, 2020, Department of Finance Canada announced the Canada Emergency Wage Subsidy (&#8220;CEWS&#8221;), which would subsidize 75% of employee wages, retroactive to March 15, 2020 to Canadian employers whose business had been affected by COVID-19 to enable them to re-hire workers previously laid off as a result of pandemic, help prevent further job losses, and to better position companies to resume normal operations following the crisis. Under this program, the Company recorded a wage subsidy of $4,646 and $7,883 for the three months and year ended August 31, 2020, which has been included as government subsidies in the statements of (loss) income and comprehensive (loss) income.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">INVESTMENTS IN ASSOCIATES AND CONTINGENT CONSIDERATION</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">During Q1 Fiscal 2019, the Company made three strategic and international investments as described previously in this MD&amp;A, which are being accounted for as investments in associates in the Company&#8217;s financial statements. During the three months and year ended August 31, 2020, the Company&#8217;s share of loss from these investments in associates was $209 and $1,187, respectively, compared to $339 and $1,261 in the prior year comparative periods. Since all three of these investments are effectively in the start&#8208;up or early phases of their operations, these losses are generally to be expected.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">At May 31, 2020, the Company identified indicators of impairment with respect to its investment in Eviana. The Company determined the recoverable amount of Eviana to approximate $nil based on the higher of 1) FVLCS; and 2) VIU. An impairment loss of $3,000 has been included in the statement of (loss) income and comprehensive (loss) income for the year ended August 31, 2020.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">In connection with the Alpha&#8208;Cannabis Germany investment, the Company had committed to contingent consideration to be paid in the form of Common Shares of the Company upon the achievement of certain milestones by Alpha&#8208;Cannabis Germany. This contingent consideration liability is carried at fair value in the Company&#8217;s statement of financial position. For the three months and year ended August 31, 2020, the Company recorded an unrealized gain of $86 and $886, respectively, on the revaluation of this liability compared to an unrealized gain of $864 and unrealized loss of $145 in the prior year comparative periods. The gain is primarily attributable to the decrease in the market price of the Company&#8217;s Common Shares.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">NET INCOME (LOSS) FROM CONTINUING OPERATIONS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Net loss from continuing operations for the three months ended August 31, 2020 was ($38,590) or ($0.199) per Common Share (basic and diluted), compared to ($22,456) or ($0.144) per Common Share (basic and diluted) for the prior year comparative period. The change to net loss for the current quarter was a result of lower gross margin due to higher cost of sales, inventory write&#8208;offs and provisions, including adjustments to net realizable value, and COVID&#8208;19 related production inefficiencies; and negative fair value changes to biological assets and inventories written&#8208;down to net realizable value.</font></p>
    </div>
    <div id="footer_page_26">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">25</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_27"></a>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">Net loss from continuing operations for the year ended August 31, 2020 was ($136,157) or ($0.789) per Common Share (basic and diluted), compared to ($9,504) or ($0.067) per Common Share (basic and diluted) for the prior year comparative period. The increase in net loss over the prior year comparative period is largely a result of the same factors identified above for the quarter&#8208;to&#8208;date period.</font></p>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">DISCONTINUED OPERATIONS</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">During the fourth quarter of Fiscal 2018, management decided to discontinue operations of Trauma Healing. On October 16, 2018, the Company sold Trauma Healing to VIVO Cannabis Inc. Revenue and expenses, gains and losses relating to the discontinuation of Trauma Healing have been eliminated from profit or loss from the Company&#8217;s continuing operations and are shown as a single line item in the statements of income and comprehensive income. The Company made the decision to divest its interest in Trauma Healing in order to focus its efforts on the emerging adult&#8208;use recreational cannabis market. The Company did not view Trauma Healing as a part of its core business and does not anticipate that the disposal of its interest in Trauma Healing to have any material impact on the expected financial performance on Organigram going forward.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The net loss from discontinued operations during the three months and year ended August 31, 2019 was $nil and $38, or $nil and $nil per Common Share (basic and diluted).</font></p>
    <p style="text-align: justify;"><font style="color: #87b5cf;">SUMMARY OF QUARTERLY RESULTS</font></p>
    <table style="width: 100%; color: #5f6369; font-size: 8pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">Q1-F19</font></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">Q2-F19</font></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">Q3-F19</font></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">Q4-F19</font></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">Q1-F20</font></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">Q2-F20</font></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">Q3-F20</font></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: center;"><font style="color: #000000;">Q4-F20</font></td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background: #c0d7e3 none repeat scroll 0% 0%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background: #c0d7e3 none repeat scroll 0% 0%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #c0d7e3; vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #85b8d8;">Financial Results</font></td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Adult-use recreational revenue (net of excise)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">9,236</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">24,460</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">21,802</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">13,361</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">12,867</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">15,009</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">15,349</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">15,063</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><font style="color: #000000;">Direct to patient medical revenue (net of excise)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,793</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,357</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,793</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,376</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,667</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,384</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,482</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">2,274</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; white-space: nowrap;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><font style="color: #000000;">International, wholesale and other revenue</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">410</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">117</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">155</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">553</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">9,619</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">5,828</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">190</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">3,063</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; white-space: nowrap;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><font style="color: #000000;">Net revenue from continuing operations</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">12,439</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">26,934</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">24,750</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">16,290</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">25,153</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">23,221</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">18,021</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">20,400</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; white-space: nowrap;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><font style="color: #000000;">Net income (loss) from continuing operations</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">29,517</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(6,386</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(10,180</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(22,456</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(863</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(6,833</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(89,871</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">(38,590</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; white-space: nowrap;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><font style="color: #000000;">Net income (loss) from continuing operations</font><br><font style="color: #000000;">&#160; &#160;per common share, basic</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">0.231</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.049</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.068</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.144</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.006</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.041</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.512</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">(0.199</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; white-space: nowrap;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><font style="color: #000000;">Net income (loss) from continuing operations</font><br><font style="color: #000000;">&#160; &#160;per common share, diluted</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">0.195</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.049</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.068</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.144</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.006</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.041</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">(0.512</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">(0.199</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #85b8d8;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #85b8d8;">Operational Results</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Dried yield per plant (grams) (1)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">153</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">164</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">110</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">148</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">152</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">155</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">132</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">104</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Harvest (kg)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">8,042</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">8,315</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">6,052</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">7,434</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">12,759</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">13,710</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">6,830</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">11,137</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Registered medical patients (#)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">13,505</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">14,875</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">17,000</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">17,200</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">18,125</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">16,781</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">14,312</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">18,934</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Employee headcount (#)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">479</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">615</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">622</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">707</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">766</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">816</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">474</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">552</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 14.25pt; text-align: justify; text-indent: -14.25pt;"><font style="color: #000000;"><font style="color: #000000;">(1)</font></font><font style="width: 3pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">The Company ceased the harvesting of trim from the cannabis plant during Q3 Fiscal 2020 and therefore the dried flower yield per plant for Q3 and Q4 Fiscal 2020 relates primarily to the flower component of the plant.</font></font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The legalization of adult&#8208;use cannabis for recreational purposes in October 2018 resulted in a significant increase in revenue in Q1 Fiscal 2019, which continued through Q3 Fiscal 2019 as the recreational market matured. Prior to this period, the Company was incrementally growing its medical cannabis business, while also preparing for the launch of adult&#8208;use cannabis market for recreational purposes. The decrease in revenue in Q4 Fiscal 2019 was largely due to the lack of a sufficient retail network and slower than expected store openings in Ontario, which was further exacerbated by increased industry supply and a changing market dynamic that resulted in the recognition of a provision for product returns and price adjustments as described previously.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Net income for Q1 Fiscal 2019 increased primarily as a result of the Company&#8217;s fair value adjustment to biological assets as the Company built&#8208; up inventories in advance of the recreational market launch. This was offset by increasing SG&amp;A expenditures during the same timeframe as the Company increased its headcount substantially and invested in sales and marketing, recruitment and retention, and various other administrative expenditures. Net income for Q2 Fiscal 2019 through Q4 Fiscal 2020 declined as the Company recorded net negative changes to Company&#8217;s fair value adjustments to biological assets and inventories sold and as investment in SG&amp;A increased and cost of goods sold increased. Besides these factors, the increased net loss during Q4 Fiscal 2020 is primarily driven by the write&#8208;off of excess and unsaleable inventories. Excluding the aforementioned trends, no seasonality has been historically noted.</font></p>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Adjusted EBITDA</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">This is a non&#8208;IFRS measure and the Company calculates adjusted EBITDA from continuing operations as net income (earnings) before interest expense, net of investment income; income tax; depreciation, amortization, impairment, and gain (loss) on disposal of PP&amp;E (per the statement of cash flows); share&#8208;based compensation (per the statement of cash flows); share of loss and impairment loss from investments in associates; unrealized loss (gain) on changes in fair value of contingent consideration; expenditures incurred in connection with the NASDAQ cross&#8208;listing; the fair value adjustment to biological assets and inventory; write&#8208;offs and impairment of inventories and biological assets; write&#8208;downs of inventory to net realizable value; and COVID&#8208;19 related charges, net of any government subsidies. Management believes the exclusion of the fair value adjustment is an alternative representation of performance. The fair value adjustment is a non&#8208;cash gain (loss) and is based on the valuation of biological assets and inventory using a fair value less cost to sell model. The most directly comparable measure to adjusted EBITDA (excluding fair value adjustment to biological assets and inventory) calculated in accordance with IFRS is net income (loss) from continuing operations.</font></p>
    <div id="footer_page_27">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">26</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_28"></a>
    <p style="text-align: justify;"><font style="color: #000000;">Management changed the calculation of adjusted EBITDA during Q2 Fiscal 2019 and has conformed prior quarters accordingly to include an add&#8208;back for share&#8208;based compensation, share of loss from investments in </font><font style="color: #000000;"><font style="color: #000000;">associates, </font></font><font style="color: #000000;">expenditures incurred in connection with the NASDAQ cross&#8208;listing, </font><font style="color: #000000;"><font style="color: #000000;">and unrealized loss on changes in fair value of contingent consideration. During Q4 2020 management further amended the calculation of adjusted EBITDA, and has conformed prior quarters accordingly to include an add&#8208;back for write&#8208;offs and impairment of inventories and biological assets and write&#8208;downs to net realizable value.</font></font></p>
    <p style="text-align: justify;"><font style="color: #000000;">Adjusted EBITDA&#160;increased from Q1 Fiscal 2019 through to Q2 Fiscal 2019 as the adult-use recreational market was legalized in October 2018 but experienced a decrease during Q3 and Q4 Fiscal 2019 due to lower gross margins on increased production costs, inventory write-downs, and sales provisions as well as higher SG&amp;A expenditures. In Q1 and Q2 Fiscal 2020, increased due to increased gross margin and lower operating expenses compared to Q4 of Fiscal 2019. The significant decrease in adjusted EBITDA during Q3 was due to higher cost of sales mainly attributed to lower revenues. The Q4 2020 adjusted EBITDA was similar to the Q3 as slightly higher net revenues were offset by higher cost of sales. Included in COVID-19 related charges (net) for Q3 and Q4 Fiscal 2020 are $5,048 and $nil, respectively, of plant waste due to insufficient staff to harvest plants as a result of COVID-19, lump sum payments paid to temporarily laid off employees, a temporary pay premium paid to Moncton employees, and the employee portion of health and dental benefits paid for by the Company, less government subsidies income of $3,237 and $4,646, respectively.</font></p>
    <table style="width: 100%; color: #5f6369; font-size: 8pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #5f636d;">Adjusted EBITDA (Non-IFRS Measure)</font></td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #5f636d;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #85b8d8;">Adjusted EBITDA Reconciliation</font></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Q1-F19</font><br><font style="color: #000000;">(Note 1)</font></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Q2-F19</font></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Q3-F19</font></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Q4-F19</font></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Q1-F20</font></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Q2-F20</font></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Q3-F20</font></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid transparent; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3 none repeat scroll 0% 0%; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3 none repeat scroll 0% 0%; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Q4-F20</font></td>
            <td style="vertical-align: bottom; background: #c0d7e3 none repeat scroll 0% 0%; text-align: center; border-bottom: 1px solid transparent;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #85b8d8;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #85b8d8;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; background: #c0d7e3;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; background: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Net income (loss) from continuing operations</font> <font style="color: #000000;">as reported</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">29,517</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(6,386</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(10,180</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(22,456</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(863</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(6,833</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(89,871</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;"><font style="color: #000000;">$</font></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">(38,590</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Add/(Deduct):</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Interest expense (investment income)</font> <font style="color: #000000;">from continuing operations</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">3,944</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">4,085</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">362</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">616</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">937</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">1,804</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,175</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">784</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Income tax expense (recovery)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">12,785</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(620</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(2,248</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(6,289</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">202</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(698</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(9,975</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Depreciation, amortization, impairment, and gain (loss)</font> <font style="color: #000000;">on disposal of PP&amp;E from continuing operations</font> <font style="color: #000000;">(per statement of cash flows)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">1,671</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">1,802</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,220</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">3,955</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">3,760</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">4,406</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">5,033</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">5,537</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Impairment of property, plant and equipment</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">37,740</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">2,031</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Fair value adjustment to biological</font> <font style="color: #000000;">assets and net realizable value adjustment</font> <font style="color: #000000;">to inventory</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(42,925</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">8,086</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">12,456</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">11,806</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(1,852</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(3,878</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">23,862</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">20,149</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Share-based compensation</font> <font style="color: #000000;">(per statement of cash flows)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">1,847</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">5,136</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">3,875</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">4,036</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,805</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,400</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">1,937</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">654</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Share of loss and impairment loss from</font> <font style="color: #000000;">investments in associates</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">507</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">415</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">1,289</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">256</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">1,894</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">1,828</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">210</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Unrealized loss on changes in fair value</font> <font style="color: #000000;">of contingent consideration</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">646</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">363</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(864</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(378</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(193</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">(229</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">(85</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">COVID-19 related charges (net)</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><font style="color: #000000;">2,761</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">(4,452</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;"><font style="color: #000000;">)</font></td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Nasdaq cross-listing expenditures</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">449</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b><font style="color: #000000;">Adjusted EBITDA as Previously Reported</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><b><font style="color: #000000;">6,839</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><b><font style="color: #000000;">13,256</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><b><font style="color: #000000;">7,712</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><b><font style="color: #000000;">(7,907</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><b><font style="color: #000000;">)</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><b><font style="color: #000000;">4,867</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><b><font style="color: #000000;">(1,098</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><b><font style="color: #000000;">)</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;"><b><font style="color: #000000;">(24,739</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;"><b><font style="color: #000000;">)</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;"><b><font style="color: #000000;">(13,762</font></b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;"><b><font style="color: #000000;">)</font></b></td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Add/(Deduct):</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 6%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Write-offs and impairment of inventories and biological</font> <font style="color: #000000;">assets and write-downs to net realizable value</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">-</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">744</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">845</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">1,039</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><font style="color: #000000;">22,601</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%; background-color: #c0d7e3;"><font style="color: #000000;">11,099</font></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><font style="color: #000000;"><br></font></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #c0d7e3;">&#160;</td>
            <td style="vertical-align: bottom; width: 6%; text-align: right; background-color: #c0d7e3;"><font style="color: #000000;">&#160;</font></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #c0d7e3;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b><font style="color: #000000;">Adjusted EBITDA Revised</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><b><font style="color: #000000;">6,839</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><b><font style="color: #000000;">13,256</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><b><font style="color: #000000;">7,712</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><b><font style="color: #000000;">(7,163</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><b><font style="color: #000000;">)</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><b><font style="color: #000000;">5,712</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><b><font style="color: #000000;">(59</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><b><font style="color: #000000;">)</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%;"><b><font style="color: #000000;">(2,138</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><b><font style="color: #000000;">)</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #c0d7e3;"><b><font style="color: #000000;">$</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 6%; background-color: #c0d7e3;"><b><font style="color: #000000;">(2,663</font></b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%; background-color: #c0d7e3;"><b><font style="color: #000000;">)</font></b></td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Note 1: Q1 Fiscal 2019 Adjusted EBITDA was originally reported as $4,992, which was subsequently amended to include share&#8208;based compensation in Q2 Fiscal 2019.</font></p>
    <div id="footer_page_28">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">27</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_29"></a>
    <div>
        <div><br></div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">BALANCE SHEET, LIQUIDITY AND CAPITAL RESOURCES</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The following represents selected balance sheet highlights of the Company at the end Fiscal 2020 and Fiscal 2019:</font></p>
        <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 36%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;" colspan="2">
                    <p style="text-align: center;"><font style="color: #ffffff;">AUGUST 31, 2020</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: center; white-space: nowrap;" colspan="2">
                    <p style="text-align: center;"><font style="color: #ffffff;">AUGUST 31, 2019</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">
                    <p style="text-align: center;"><font style="color: #ffffff;">% CHANGE</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 36%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">Cash &amp; short-term investments</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">74,728</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">47,935</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">56%</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 36%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">Inventories</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">66,365</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">93,144</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">(29)%</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 36%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">Working capital</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">141,123</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">152,417</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">(7)%</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 36%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">Total assets</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">435,127</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">428,525</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">2%</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 36%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">Total current and long-term debt</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">115,266</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">49,576</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">133%</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 36%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">Total shareholders' equity</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #000000;">299,527</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">327,006</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #000000;">(8)%</font></p>
                </td>
            </tr>
        </table>
        <p style="text-align: justify;"><font style="color: #000000;">On August 31, 2020, the Company had a cash and short&#8208;term investments balance of $74,728 compared to $47,935 at August 31, 2019, an increase of $26,793 which is a result of the two ATM Programs and draws against the Company&#8217;s Term Loan, as described below, offset by investments in working capital and property, plant and equipment.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Write&#8208;downs and provisions for excess and unsaleable inventories recorded during Q3 and Q4 Fiscal 2020, resulted in a decrease in the value of inventories at the end of Fiscal 2020 as compared to Fiscal 2019.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Management believes working capital is generally healthy and that as the Company&#8217;s original Moncton Campus capital expenditure plan comes to a close, there is sufficient liquidity available for the near to medium term. In the event that the Company is unable to finance any new expansionary capital expenditures or acquisitions from cash on hand or operating cash flows, it could, if necessary and subject to prevailing market conditions, obtain liquidity through the capital markets as the Common Shares are actively traded on two senior exchanges and there is good analyst coverage amongst sell&#8208;side brokerages.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On November 22, 2019, the Company filed a base shelf prospectus (the &#8220;Shelf Prospectus&#8221;) with the securities regulators in each of the provinces and territories of Canada, and, on November 26, 2019, filed with the U.S. Securities and Exchange (the &#8220;SEC&#8221;) a corresponding amended shelf registration statement (the &#8220;Registration Statement&#8221;) on Form F-10 (SEC File No. 333-234564) under the United States Securities Act of 1933, as amended. The Canadian Shelf Prospectus was receipted by the applicable Canadian securities regulatory authorities on November 22, 2019, and the Registration Statement, as amended, was declared effective by the SEC on November 27, 2019. The Shelf Prospectus and Registration Statement allowed the Company to make offerings of up to $175,000 during the 25-month period that the shelf prospectus remains valid through the issuance of Common Shares, preferred shares, debt securities, subscription receipts, warrants or units or a combination thereof.&#160; The Company was able, subject to prevailing market conditions, to raise funds from time to time by filing one or more prospectus supplements under the Shelf Prospectus.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On each of December 4, 2019 and April 22, 2020, the Company filed a prospectus supplement to raise up to $55 million and $49 million, respectively, under ATM Programs as described herein to shorten the timeline to raise funds for growth opportunities, working capital, to repay indebtedness, and general corporate purposes. During the year ended August 31, 2020, the Company raised net proceeds of $52,885 and $47,112, respectively, by issuing 16,201,183 and 21,080,229 Common Shares under these programs, bringing both of these ATM Programs to a close within Fiscal 2020.</font></p>
    </div>
    <div id="footer_page_29">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">28</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_30"></a>
    <div>
        <div><br></div>
        <p style="text-align: justify;"><font style="color: #000000;">The following highlights the Company&#8217;s cash flows during the three months and year ended August 31, 2020 and 2019:</font></p>
        <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: center;" colspan="5"><font style="color: #ffffff;">THREE MONTHS ENDED</font></td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: center;" colspan="5"><font style="color: #ffffff;">YEAR ENDED</font></td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: right; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: center;" colspan="5"><font style="color: #ffffff;">AUGUST 31,</font></td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: right; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: center;" colspan="5"><font style="color: #ffffff;">AUGUST 31,</font></td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: right; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; width: 12%; text-align: center;"><font style="color: #ffffff;">2020</font></td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: right; width: 0.976745%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: right; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: left; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: left; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: left; width: 0.976745%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: left; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; width: 12%; text-align: center;"><font style="color: #ffffff;">(Note 1)</font></td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: left; width: 0.976745%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: right; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #87b5cf; width: 12%; text-align: center;"><font style="color: #ffffff;">2019</font></td>
                <td style="vertical-align: bottom; background: #87b5cf; text-align: right; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: right; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; width: 12%; text-align: center;"><font style="color: #ffffff;">2020</font></td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: right; width: 0.976745%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: right; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; text-align: right; width: 1.02326%;">&#160;</td>
                <td style="vertical-align: bottom; background: #aeaaaa; width: 12%; text-align: center;"><font style="color: #ffffff;">2019</font></td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: right; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #4d4d4c;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 0.976745%; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
                <td style="vertical-align: bottom; width: 0.976745%; background-color: #eeeeee;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;"><font style="color: #000000;">Cash (used) provided by:</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;"><font style="color: #000000;">Operating activities</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">(10,128</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">(15,722</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(45,125</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(35,081</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;"><font style="color: #000000;">Financing activities</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">46,075</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">8,572</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">160,366</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">74,328</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;">Investing activities</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">(55,988</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; width: 2%; text-align: left;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">7,515</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">(138,196</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; width: 2%; text-align: left;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">(46,782</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;"><font style="color: #000000;">Cash (used) provided</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">(20,041</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">$365</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(22,955</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">(7,535</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;"><font style="color: #000000;">Effects of foreign exchange on cash</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">26</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">26</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;"><font style="color: #000000;">Cash position</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;">&#160; &#160; Beginning of period</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">44,641</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">47,190</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 9pt; width: 35.093%;"><font style="color: #000000;">End of period</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">24,600</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">47,555</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">24,600</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">47,555</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 9pt; width: 35.093%;"><font style="color: #000000;">Short-term investments</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">50,128</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">380</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">50,128</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">380</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 35.093%;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 0.976745%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 35.093%;"><font style="color: #000000;">Cash and short-term investments</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">74,728</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 0.976745%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #000000;">47,935</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">74,728</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 0.976745%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #000000;">47,935</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #000000;">&#160;</font></td>
            </tr>
        </table>
        <p style="text-align: justify; margin-bottom: 0pt; text-indent: -36pt; margin-left: 36pt;"><font style="color: #000000;">Note<font style="display: inline-block; width: 4pt;">&#160;</font>1:<font style="display: inline-block; width: 4.5pt;">&#160;</font>Net cash used in operating activities for the three months ended August 31, 2020 has been calculated based on a correction of a reclassification error to the presentation of </font><font style="color: #000000;">prior quarter net cash used in operating activities. Fiscal 2020 year&#8208;to&#8208;date net cash used in operating activities is correctly stated as per the Financial Statements.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Cash used in operating activities was $10,128 for the three months ended August 31, 2020, which was primarily driven by the net loss and reduction in accounts payables and accrued liabilities. This compares to cash used in operating activities of $15,722 for the prior year comparative period. Cash used in operating activities for the year ended August 31, 2020 was $45,125, which primarily relates to the continued scaling up of operations and investment in working capital to meet the demands of the adult&#8208;use recreational market whereas cash used in operating activities in the prior year comparative period of $35,081 relates mostly to the building of inventories.</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Cash provided by financing activities for the three months and year ended August 31, 2020 was $46,075 and $160,366, respectively, mainly driven by net proceeds from the December 2019 ATM Program (as defined below) and the April 2020 ATM Program (as defined below) of $17,282 and $99,997 in addition to proceeds from long&#8208;term debt issued of $30,000 and $65,000 (excluding fees), respectively. This was offset by cash interest paid for the three months and year ended August 31, 2020 of $1,007 and $4,043, respectively and payments towards lease liabilities of $350 and $897, respectively. In comparison, for the three months and year ended August 31, 2019, cash provided by financing activities was $8,572 and $74,328, respectively, which was primarily driven by long&#8208;term debt issued for net proceeds of $44 and $58,851, respectively, plus stock options and warrants exercised of $9,245 and $35,146, respectively. This was offset by payment of long&#8208;term debt of $3 and $12,674 and cash interest paid of $714 and $6,995, respectively.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">During the year ended August 31, 2020, the Company drew an additional $65,000 under the Term Loan, in three tranches, bringing the total outstanding balance of the Term Loan to $115,000, which incurred an average cash interest rate of approximately 4.25% during the period. Based on the current availment option of bankers acceptances&#8217; the applicable margin rate is 3.75% above the applicable bankers acceptances&#8217; rate.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Pursuant to the previously noted Shelf Prospectus, on December 4, 2019, the Company established an ATM Program (the &#8220;December 2019 ATM Program&#8221;) that allowed the Company to issue up to $55,000 (or its U.S. dollar equivalent) of Common Shares from treasury to the public. Any Common Shares sold in the December 2019 ATM Program were sold through the TSX or the NASDAQ at the prevailing market price at the time of sale.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company issued 16,201,183 Common Shares pursuant to the December 2019 ATM Program during the three months ended February 29, 2020 for gross proceeds of $54,966 at a weighted average price of $3.39 per Common Share. Net proceeds realized were $52,885 after agents&#8217; commissions of $1,099, regulatory fees of $12, and legal and professional fees of $968. Proceeds were raised in both USD (for shares sold through the NASDAQ) and CAD (for shares sold through the TSX) and the weighted average share price was calculated using the spot rate on the day of settlement.</font></p>
    </div>
    <div id="footer_page_30">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">29</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_31"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">On April 22, 2020, the Company established an ATM Program (the &#8220;April 2020 ATM Program&#8221;) that allowed the Company to issue up to $49,000 (or its U.S. dollar equivalent) of Common Shares from treasury to the public. Common Shares sold in the April 2020 ATM Program were sold through the TSX or the NASDAQ at the prevailing market price at the time of sale.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company issued 21,080,229 Common Shares pursuant to the April 2020 ATM Program during the year ended August 31, 2020 for gross proceeds of $48,785 at a weighted average price of $2.31 per common share. Net proceeds realized were $47,112 after agents&#8217; commissions </font><font style="color: #000000;">of $975, regulatory fees of $1, and legal and professional fees of $697. Proceeds were raised in both USD (for shares sold through the NASDAQ) and CAD (for shares sold through the TSX) and the weighted average share price was calculated using the spot rate on the day of settlement.</font></p>
    </div>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">Cash used by investing activities for the three months and year ended August 31, 2020 was $37,462 and $138,196, respectively, primarily driven by the purchase of short&#8208;term investments of $50,000 and $50,000, and by purchase of property, plant and equipment of $nil and $77,223 for the Company&#8217;s Moncton Campus, which is effectively completed, as well as the purchase of GICs for restricted cash of $50,000 and $8,000. This compares to cash provided by investing activities of $7,515 and used in investing activities of $46,782 for the prior year comparative periods, which was primarily due to the purchase of property, plant and equipment for $32,740 and $108,764 and investment in associates for $10 and $12,758, which was offset by proceeds from short&#8208;term investments of $40,000 and $75,000.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On November 12, 2020, the Company closed an underwritten public offering of 37,375,000 units of the Company at a price of $1.85 per unit, including a full exercise of the over&#8208;allotment option, underwritten by a syndicate of underwriters led by Canaccord Genuity Corp., for total gross proceeds of $69,144. Each unit is comprised of one Common Share of the Company and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a &#8220;Warrant&#8221;). Each Warrant will be exercisable to acquire one common share of the Company (a &#8220;Warrant Share&#8221;) for a period of three years following the closing date of the Offering at an exercise price of $2.50 per Warrant Share, subject to adjustment in certain events. The Company expects to use the net proceeds from the Offering to repay indebtedness and for working capital and other general corporate purposes.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Following completion of the unit offering in November 2020, the Company has exhausted its current Shelf Prospectus. The Company believes it can access the public markets from time to time to raise funds subject to prevailing market conditions.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">Subsequent to the year-end, on November 27, 2020, the Company executed the third amendment to its loan Facilities with BMO (as described in the Subsequent Events section of this MD&amp;A).&#160; In connection with this amendment and restatement, the Company will use $55 million of the proceeds from the November 12, 2020 offering to pay down its Term Loan balance to $60 million on December 1, 2020, thereby significantly deleveraging the Company and providing management with the financial flexibility required to execute upon the Company&#8217;s strategy.&#160; The loan facilities contain covenants that require the Company to maintain certain minimum financial ratios and targets, which, given the early stages of the industry and market and the developing consumer trends, among other factors, may be difficult to maintain period-over-period.&#160; If the Company does not maintain such ratios and targets, it could have consequences for the availability of credit under the loan facilities or result in repayment requirements that the Company may not be able to satisfy if the Company is unable to renegotiate the terms of the loan facilities, as it has been able to do historically when faced with possible financial covenant breaches.&#160; In addition, restrictions and covenants from those facilities may limit the Company&#8217;s ability to execute its plans.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">As at November 29, 2020, excluding the $8.0 million of restricted investment (GIC), the Company had $135 million in cash and short-term investments.&#160; After completing the $55 million term loan repayment on December 1, 2020, on a pro forma basis the Company would have $80 million in cash and short-term investments and $60 million in long-term debt.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">OFF BALANCE SHEET ARRANGEMENTS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">There were no off&#8208;balance sheet arrangements during the three months and year ended August 31, 2020.</font></p>
    </div>
    <div id="footer_page_31">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">30</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_32"></a>
    <div>
        <div><br></div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">RELATED PARTY TRANSACTIONS</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #87b5cf;">MANAGEMENT AND BOARD COMPENSATION</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the Company, directly or indirectly. The key management personnel of the Company are the members of the Company&#8217;s executive management team and the Board of Directors.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">For the three months and year ended August 31, 2020 and 2019, the Company&#8217;s expenses included the following management and board compensation:</font></p>
        <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 33%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #87b5cf;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; white-space: nowrap;" colspan="4">
                    <p style="text-align: center;"><font style="color: #ffffff;">THREE MONTHS ENDED</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; white-space: nowrap;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: center; white-space: nowrap;" colspan="4">
                    <p style="text-align: center;"><font style="color: #ffffff;">YEAR ENDED</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 33%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;" colspan="2">
                    <p style="margin-left: 4.5pt; text-align: center;"><font style="color: #ffffff;">AUGUST 31, 2020</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">
                    <p style="text-align: center;">&#160;</p>
                </td>
                <td style="vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;" colspan="2">
                    <p style="margin-left: 4.5pt; text-align: center;"><font style="color: #ffffff;">AUGUST 31, 2019</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; white-space: nowrap;" colspan="2">
                    <p style="margin-left: 4.5pt; text-align: center;"><font style="color: #ffffff;">AUGUST 31, 2020</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; white-space: nowrap;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; white-space: nowrap;" colspan="2">
                    <p style="margin-left: 4.5pt; text-align: center;"><font style="color: #ffffff;">AUGUST 31, 2019</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 33%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #87b5cf;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #87b5cf;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #87b5cf;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #87b5cf;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #87b5cf;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #aeaaaa;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #aeaaaa;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 2%; vertical-align: bottom; background: #aeaaaa;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #aeaaaa;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #aeaaaa;">
                    <p style="text-align: left;">&#160;</p>
                </td>
            </tr>
            <tr>
                <td style="width: 33%; vertical-align: bottom;">
                    <p style="margin-left: 1.5pt; text-align: left;"><font style="color: #4d4d4c;">Salaries and consulting fees</font></p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">995</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #e1eaed;">
                    <p style="margin-left: 3.75pt; text-align: left;"><font style="color: #4d4d4c;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #e1eaed;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">1,091</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="margin-left: 3.75pt; text-align: left;"><font style="color: #4d4d4c;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">2,953</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="width: 1%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="margin-left: 3.75pt; text-align: left;"><font style="color: #4d4d4c;">$</font></p>
                </td>
                <td style="width: 12%; vertical-align: bottom; background: #d6d6d6;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">2,521</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 33%; vertical-align: bottom;">
                    <p style="margin-left: 1.5pt; text-align: left;"><font style="color: #4d4d4c;">Non-cash share-based compensation</font></p>
                </td>
                <td style="border-bottom: 1px solid #000000; width: 1%; vertical-align: bottom; background: #e1eaed none repeat scroll 0% 0%;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-bottom: 1px solid #000000; width: 12%; vertical-align: bottom; background: #e1eaed none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">537</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-bottom: 1px solid #000000; width: 1%; vertical-align: bottom; background: #e1eaed none repeat scroll 0% 0%;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-bottom: 1px solid #000000; width: 12%; vertical-align: bottom; background: #e1eaed none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">787</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-bottom: 1px solid #000000; width: 1%; vertical-align: bottom; background: #d6d6d6 none repeat scroll 0% 0%;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-bottom: 1px solid #000000; width: 12%; vertical-align: bottom; background: #d6d6d6 none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">2,750</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-bottom: 1px solid #000000; width: 1%; vertical-align: bottom; background: #d6d6d6 none repeat scroll 0% 0%;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-bottom: 1px solid #000000; width: 12%; vertical-align: bottom; background: #d6d6d6 none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">5,155</font></p>
                </td>
            </tr>
            <tr>
                <td style="width: 33%; vertical-align: bottom;">
                    <p style="margin-left: 1.5pt; text-align: left;"><font style="color: #4d4d4c;">Total key management compensation</font></p>
                </td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; width: 1%; vertical-align: bottom; background: #e1eaed none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">$</font></p>
                </td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; width: 12%; vertical-align: bottom; background: #e1eaed none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">1,532</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; width: 1%; vertical-align: bottom; background: #e1eaed none repeat scroll 0% 0%;">
                    <p style="margin-left: 4.5pt; text-align: left;"><font style="color: #4d4d4c;">$</font></p>
                </td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; width: 12%; vertical-align: bottom; background: #e1eaed none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">1,878</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-top: 1px solid #a6a6a6; border-bottom: 3px double #000000; width: 1%; vertical-align: bottom; background: #d6d6d6 none repeat scroll 0% 0%;">
                    <p style="margin-left: 3.75pt; text-align: left;"><font style="color: #4d4d4c;">$</font></p>
                </td>
                <td style="border-top: 1px solid #a6a6a6; border-bottom: 3px double #000000; width: 12%; vertical-align: bottom; background: #d6d6d6 none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">5,703</font></p>
                </td>
                <td style="width: 2%; vertical-align: bottom; border-bottom: 1px solid transparent;">
                    <p style="text-align: left;">&#160;</p>
                </td>
                <td style="border-top: 1px solid #a6a6a6; border-bottom: 3px double #000000; width: 1%; vertical-align: bottom; background: #d6d6d6 none repeat scroll 0% 0%;">
                    <p style="margin-left: 3.75pt; text-align: left;"><font style="color: #4d4d4c;">$</font></p>
                </td>
                <td style="border-top: 1px solid #a6a6a6; border-bottom: 3px double #000000; width: 12%; vertical-align: bottom; background: #d6d6d6 none repeat scroll 0% 0%;">
                    <p style="text-align: right;"><font style="color: #4d4d4c;">7,676</font></p>
                </td>
            </tr>
        </table>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">During the three months and year ended August 31, 2020, nil and 790,000 stock options (August 31, 2019 &#8211; nil and 685,000), respectively, were granted to key management personnel at an average exercise price of $nil and $2.48 (August 31, 2019 &#8208; $nil and $4.75) and aggregate fair value of $nil and $1,794 (August 31, 2019 &#8208; $nil and $1,736). In addition, during the three months and year ended August 31, 2020, nil and 211,981 RSUs (August 31, 2019 &#8211; nil and 631,949), were granted to key management personnel with an aggregate fair value of $nil and $902 (August 31, 2019 &#8211; $nil and $3,002), respectively. For the three months and year ended August 31, 2020, nil and 88,910 PSUs (August 31, 2019&#160;</font><font style="color: #000000;"><font style="color: #000000;">&#8211; </font></font><font style="color: #000000;"><font style="color: #000000;">nil and nil) were issued to key management personnel with an aggregate fair value of $nil and $190,712 (August 31, 2019 &#8211; $nil and $nil), respectively.</font></font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">SIGNIFICANT TRANSACTIONS WITH ASSOCIATES</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">For the year ended August 31, 2020, the Company received no interest income (August 31, 2019 &#8208; $374) on its convertible debenture investment in Eviana, which is being recorded as distributions under the equity accounting method.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">For the year ended August 31, 2020, the Company earned revenues of $52 (August 31, 2019 &#8208; $nil) on product sold to ACG, which has been proportionately eliminated from the Financial Statements based on the Company&#8217;s proportionate share of investment in ACG.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">SUBSEQUENT EVENTS</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #86b4cd;">i) Hyasynth Tranche 2 Convertible Debentures Issuance</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On October 23, 2020, the Company advanced an additional $2,500 to Hyasynth by way of convertible debentures as a result of Hyasynth&#8217;s achievement of the contractual production&#8208;related milestone for Tranche 2 of the convertible debentures. This brings the Company&#8217;s total face value of convertible debentures investment in Hyasynth to $7,500.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">ii) Unit Offering</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On November 12, 2020, the Company closed an underwritten public offering of 37,375,000 units of the Company at a price of $1.85 per unit, including a full exercise of the over&#8208;allotment option, underwritten by a syndicate of underwriters led by Canaccord Genuity Corp., for total gross proceeds of $69,144. Each unit is comprised of one Common Share of the Company and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a &#8220;Warrant&#8221;). Each Warrant will be exercisable to acquire one common share of the Company (a &#8220;Warrant Share&#8221;) for a period of three years following the closing date of the Offering at an exercise price of $2.50 per Warrant Share, subject to adjustment in certain events. The Company expects to use the net proceeds from the Offering to repay indebtedness and for working capital and other general corporate purposes.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">iii) Credit facility amendment and restatement</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On November 27, 2020, the Company further amended its Facilities pursuant to an amended and restated credit agreement (&#8220;Amendment and Restatement&#8221;) with BMO to: (i) reduce the Term Loan amount from $115,000 to $60,000 based on a repayment of $55,000 to be made on December 1, 2020 of the outstanding Term Loan balance of $115,000; (ii) have repayments on the balance of the Term Loan commence on February 28, 2021 in an amount equal to $1,500 per quarter; (iii) reduce the Revolver commitment to $2,000 from up to $25,000; (iv) adjust the minimum quarterly EBITDA covenants to be maintained by the Company commencing on February 28, 2021 and continuing through to maturity, thereby removing this covenant for the fiscal period ended November 30, 2020 and eliminating the reversion of the financial covenants to that of the original structure on November 30, 2021; (v) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (vi) reduce the minimum unrestricted cash balance requirement to $20,000, which is already inclusive of the $8,000 restricted investment currently outstanding. The interest rate margin will be fixed from November 27, 2020 through to maturity on May 31, 2021. The Company incurred an amendment fee of $217 plus customary legal expenses in connection with the amendment and restatement.</font></p>
    </div>
    <div id="footer_page_32">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">31</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_33"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">FAIR VALUE MEASUREMENTS</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #86b4cd;">(i) Financial Instruments</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly fashion between market participants. The Company records certain financial instruments at fair value. The Company&#8217;s financial instruments include cash, short&#8208;term investments (including marketable securities), accounts receivable, loan receivable, accounts payable and accrued liabilities, long&#8208;term debt, and contingent share consideration.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Fair value measurements are categorized into Level 1, 2 or 3 based on the degree to which the inputs to the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are described as follows:</font></p>
        <p style="text-align: justify; margin-left: 8.25pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date;</font></font></p>
        <p style="margin-left: 21.75pt; text-align: justify; text-indent: -13.5pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Level 2 inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly or indirectly; and</font></font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 9pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 8.25pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Level 3 inputs are unobservable inputs for the asset or liability.</font></font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The fair value of cash, short&#8208;term investments, accounts receivable, loan receivable, accounts payable and accrued liabilities approximate their carrying amounts due to their short&#8208;term nature. The fair value of marketable securities is based on quoted prices in active markets and is reflected in the carrying value of these financial assets. The fair value of long&#8208;term debt approximates $115,389 based on the face value of debt outstanding, which carries a floating interest rate.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The fair value of the contingent share consideration is primarily based on Level 3 unobservable inputs. The determination of the fair value of this liability is primarily driven by the Company&#8217;s expectations of the investment in associate achieving certain milestones. The expected milestones were assigned probabilities and the expected related cash flows were discounted to derive the fair value of the contingent consideration. At August 31, 2020, the probability of achieving the milestones was estimated to be 68% and the discount rate was estimated to be 20%. If the probabilities of achieving the milestones increased or decreased by 10%, the estimated fair value of the contingent share consideration would increase or decrease by approximately $33. If the discount rates increased or decreased by 5%, the estimated fair value of contingent consideration would decrease or increase, respectively, by approximately $12.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">During the period, there were no transfers of amounts between Levels 1, 2 and 3.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">(ii) Biological Assets</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company measures biological assets consisting of cannabis plants at fair value less costs to sell up to the point of harvest, which becomes the basis for the cost of finished goods inventories after harvest. The fair value less costs to sell of biological assets is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred, such as post&#8208;harvest costs. The following unobservable inputs, all of which are classified as Level 3 on the fair value hierarchy (see above), are used in determining the fair value of biological assets:</font></p>
        <p style="margin-left: 12.75pt; text-align: justify; text-indent: -12.75pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Average selling price per gram &#8211; calculated as the weighted average current selling price of cannabis sold by the Company, adjusted for expectations about future pricing;</font></font></p>
        <p style="margin-left: 12.75pt; text-align: justify; text-indent: -12.75pt; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Yield by plant &#8211; represents the number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant;</font></font></p>
        <p style="margin-left: 12.75pt; text-align: justify; text-indent: -12.75pt; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Wastage of plants based on their various stages of growth &#8211; represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested;</font></font></p>
        <p style="margin-left: 12.75pt; text-align: justify; text-indent: -12.75pt; margin-top: 0pt;"><font style="color: #87b5cf;"><font style="color: #000000;">&#8226;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Post&#8208;harvest costs &#8211; calculated as the cost per gram of harvested cannabis to complete the sale of cannabis plants post&#8208;harvest, consisting of the cost of direct and indirect materials and labour related to drying, labelling and packing.</font></font></p>
    </div>
    <div id="footer_page_33">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">32</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_34"></a>
    <div>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company estimates the harvest yields for the cannabis on plants at various stages of growth. As of August 31, 2020, it is expected that the Company&#8217;s biological assets will yield 5,096 kg (August 31, 2019 &#8211; 16,595 kg) of cannabis when eventually harvested. The Company&#8217;s estimates are, by their nature, subject to change and differences from the anticipated yield will be reflected in the fair value adjustment to biological assets in future periods. The Company accretes fair value on a straight&#8208;line basis according to stage of growth. As a result, a cannabis plant that is 50% through its 19&#8208;week growing cycle would be ascribed approximately 50% of its harvest date expected fair value less costs to sell (subject to wastage adjustments).</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">Management believes the most significant unobservable inputs and their impact on fair value are as follows:</font></p>
    </div>
    <div>
        <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #85b8d8;">SIGNIFICANT INPUTS &amp;</font></td>
                <td style="vertical-align: bottom; text-align: center;" colspan="1"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;" colspan="4"><font style="color: #000000;">WEIGHTED AVERAGE INPUT</font></td>
                <td style="vertical-align: bottom; text-align: center;" colspan="1"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">EFFECT ON FAIR VALUE</font></td>
                <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #85b8d8;">ASSUMPTIONS</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">AUG. 31, 2020</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">AUG. 31, 2019</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">SENSITIVITY</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">AUG. 31, 2020</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid #000000;"><font style="color: #000000;">AUG. 31, 2019</font></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 2px solid transparent;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; border-bottom: 1px solid transparent;"><font style="color: #000000;">Average net selling price per gram</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000;"><font style="color: #000000;">3.36</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000;"><font style="color: #000000;">5.65</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Increase or decrease</font><br><font style="color: #000000;">by $1.00 per gram</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000;"><font style="color: #000000;">1,602</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000;"><font style="color: #000000;">3,657</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; border-bottom: 1px solid transparent;"><font style="color: #000000;">Average yield per plant</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000;"><font style="color: #000000;">101 grams</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000;"><font style="color: #000000;">151 grams</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000; white-space: nowrap;"><font style="color: #000000;">Increase or decrease</font><br><font style="color: #000000;">by 10 grams</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000;"><font style="color: #000000;">532</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 1px solid #000000;"><font style="color: #000000;">1,367</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; border-bottom: 1px solid transparent;">&#160;</td>
            </tr>
        </table>
        <p style="text-align: justify;"><font style="color: #000000;">During the three months ended May 31, 2020, management ceased the harvesting of trim from the cannabis plants and therefore the average yield per plant at August 31, 2020 only reflects the average yield of the flower component of the plant.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">OUTSTANDING SHARE DATA</font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #86b4cd;">(i) Outstanding Shares, Warrants and Options and Other Securities</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The following table sets out the number of Common Shares, options, and restricted share units outstanding of the Company as at August 31,&#160;</font><font style="color: #000000;">2020 and November 29</font><font style="color: #767070;"><font style="color: #000000;">,</font></font><font style="color: #000000;"> 2020:</font></p>
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
            <tr>
                <td style="vertical-align: bottom; width: 65.0465%;">&#160;</td>
                <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #c0d7e3;">&#160;</td>
                <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #c0d7e3; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
                <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #c0d7e3; white-space: nowrap;">&#160;</td>
                <td style="text-align: center; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
                <td style="text-align: center; vertical-align: bottom; width: 1.02326%; background-color: #7f7f7f; white-space: nowrap;">&#160;</td>
                <td style="text-align: center; vertical-align: bottom; width: 12%; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">NOVEMBER 28, 2020</font></td>
                <td style="text-align: center; vertical-align: bottom; width: 2%; background-color: #7f7f7f;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 65.0465%;">Common shares issued and outstanding</td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">194,511,061</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">232,088,219</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 65.0465%;">Options</td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">9,028,904</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">8,144,104</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 65.0465%;">Restricted share units</td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">893,171</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">870,816</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 65.0465%;">Performance share units</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">126,685</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">124,988</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; width: 65.0465%;">Total fully diluted shares</td>
                <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">204,559,821</td>
                <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
                <td style="border-bottom: 2px solid transparent; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1.02326%; text-align: left; background-color: #eeeeee;">&#160;</td>
                <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #eeeeee;">241,228,127</td>
                <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #eeeeee;">&#160;</td>
            </tr>
        </table>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">(ii) Share&#8208;based Compensation</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">On February 25, 2020 (the &#8220;Approval Date&#8221;), the Company&#8217;s shareholders approved a new omnibus equity incentive plan that governs grants made on or after the Approval Date. Grants made prior to the Approval Date will continue to be governed under the terms of the plan under which they were granted, including the Company&#8217;s 2011 stock option plan and 2017 equity incentive plan, however, no new grants may be made under such plans.</font></p>
    </div>
    <div id="footer_page_34">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">33</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_35"></a>
    <p style="text-align: justify;"><font style="color: #000000;">The following table summarizes changes in the Company&#8217;s outstanding stock options for the years ended August 31, 2020 and 2019:</font></p>
    <div style="margin-left: 2.25pt;">
        <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><font style="color: #000000;">WEIGHTED AVERAGE</font></td>
                <td style="vertical-align: bottom; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;"><font style="color: #000000;">NUMBER</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: right; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;"><font style="color: #000000;">EXERCISE PRICE</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: right;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Balance - August 31, 2018</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">7,709,746</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">2.10</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Granted</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">3,589,500</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">7.59</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Exercised</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">(2,167,864</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">1.92</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Cancelled / Forfeited</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 15%;"><font style="color: #000000;">(298,188</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 15%;"><font style="color: #000000;">6.41</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Balance - August 31, 2019</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">8,833,194</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">4.23</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Granted</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">2,125,000</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">3.21</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Exercised</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">(879,240</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 15%;"><font style="color: #000000;">1.21</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Cancelled / Forfeited</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 15%;"><font style="color: #000000;">(1,050,050</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 15%;"><font style="color: #000000;">6.20</font></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Balance - August 31, 2020</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: right; width: 15%;"><font style="color: #000000;">9,028,904</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 1%;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: right; width: 15%;"><font style="color: #000000;">4.06</font></td>
                <td style="vertical-align: bottom; border-bottom: 3px double transparent; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><font style="color: #000000;">The following is a summary of the outstanding stock options as at August 31, 2020:</font></p>
    <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="border-bottom: 1px solid #87b5cf; width: 25%; vertical-align: bottom;">
                <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
            </td>
            <td style="border-bottom: 1px solid #87b5cf; width: 25%; vertical-align: bottom;">
                <p style="text-align: center;"><font style="color: #000000;">OPTIONS OUTSTANDING</font></p>
            </td>
            <td style="border-bottom: 1px solid #87b5cf; width: 25%; vertical-align: bottom;">
                <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
            </td>
            <td style="border-bottom: 1px solid #87b5cf; width: 25%; vertical-align: bottom;">
                <p style="text-align: center;"><font style="color: #000000;">OPTIONS EXERCISABLE</font></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">Range of Exercise</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">Weighted Average Remaining</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">Prices</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">Quantity Outstanding</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">Contractual Life (years)</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">Quantity Exercisable</font></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">$0.30 - $1.48</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">1,440,599</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">4.7</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">1,376,683</font></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">$1.49 - $2.38</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">2,204,333</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">7.5</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">1,652,833</font></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">$2.39 - $4.65</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">2,069,854</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">7.9</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">1,217,504</font></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">$4.66 - $7.67</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">1,886,518</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">8.2</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: right;"><font style="color: #000000;">1,276,194</font></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">$7.68 - $11.27</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">1,427,600</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">8.7</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">949,900</font></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: left;"><font style="color: #000000;">&#160;</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">9,028,904</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">7.5</font></p>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><font style="color: #000000;">6,473,114</font></p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Options outstanding have exercise prices ranging from $0.30 to $11.27 with a weighted average remaining life of seven&#8208;and&#8208;a&#8208;half years. Total share&#8208;based compensation charges, including related to production employees that are charged to biological assets and inventory, for the year ended August 31, 2020 was $7,796 (August 31, 2019 &#8211; $14,894) of which $6,127 (August 31, 2019 &#8208; $10,036) related to the Company&#8217;s stock option plan. The fair value of options granted during the year ended August 31, 2020 was $3,743 (August 31, 2019 &#8208; $13,848). These options are measured at fair value at the date of grant and are expensed over the option&#8217;s vesting period, which typically range from two to three&#8208;year terms with options vesting in annual tranches evenly over this time period. In determining the amount of share&#8208;based compensation related to the options, the Company used the Black&#8208;Scholes option pricing model to establish the fair value of options granted.</font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The following is the range of assumptions for the years ended August 31, 2020 and 2019:</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0">
        <tr>
            <td style="width: 371px;">&#160;</td>
            <td style="width: 136px; text-align: center; background-color: #c0d7e3; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
            <td style="width: 13px; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="width: 133px; text-align: center; background-color: #7f7f7f; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
        </tr>
        <tr>
            <td style="width: 371px;">Risk free interest rate</td>
            <td style="text-align: center; background-color: #e1eaed;">&#160;0.45% - 1.65%&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 133px; text-align: center; background-color: #eeeeee;">&#160;1.20% - 2.42%&#160;</td>
        </tr>
        <tr>
            <td style="width: 371px;">Expected life of options</td>
            <td style="text-align: center; background-color: #e1eaed;">&#160;5.0 - 6.0 years&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 133px; text-align: center; background-color: #eeeeee;">&#160;5.0 -6.5 years&#160;</td>
        </tr>
        <tr>
            <td style="width: 371px;">Expected annualized volatility</td>
            <td style="text-align: center; background-color: #e1eaed;">&#160;72% - 85%&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 133px; text-align: center; background-color: #eeeeee;">&#160;64% -71%&#160;</td>
        </tr>
        <tr>
            <td style="width: 371px;">Expected dividend yield</td>
            <td style="text-align: center; background-color: #e1eaed;">&#160;-&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 133px; text-align: center; background-color: #eeeeee;">&#160;-&#160;</td>
        </tr>
        <tr>
            <td style="width: 371px;">Forfeiture Rate</td>
            <td style="text-align: center; background-color: #e1eaed;">&#160;8.0% - 8.7%&#160;</td>
            <td style="width: 13px; text-align: center;">&#160;</td>
            <td style="width: 133px; text-align: center; background-color: #eeeeee;">&#160;7.3% - 8.0%&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="color: #000000;">Volatility was estimated by using the weighted average historical volatility of the Company and other companies that the Company considers comparable. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk&#8208;free rate is based on government of Canada bonds with a remaining term equal to the expected life of the options. The forfeiture rate is calculated based on historical experience.</font></p>
    <div id="footer_page_35">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">34</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_36"></a>
    <div>
        <div>
            <p style="text-align: justify;"><font style="color: #000000;">The following table summarizes the changes in the Company&#8217;s outstanding RSUs:</font></p>
        </div>
    </div>
    <div>
        <div style="margin-left: 2.25pt;">
            <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">NUMBER</font></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Balance - August 31, 2018</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">145,200</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Granted</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">879,635</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Exercised</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><font style="color: #000000;">(182,473</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><font style="color: #000000;">Balance - August 31, 2019</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">842,362</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Granted</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">265,258</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Exercised</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">(154,062</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Cancelled/Forfeited</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><font style="color: #000000;">(60,387</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Balance - August 31, 2020</font></td>
                    <td style="vertical-align: bottom; border-bottom: 3px double #000000; width: 1%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 3px double #000000; width: 12%; text-align: right;"><font style="color: #000000;">893,171</font></td>
                    <td style="vertical-align: bottom; border-bottom: 3px double #000000; width: 2%; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                </tr>
            </table>
        </div>
        <p style="text-align: justify;"><font style="color: #000000;">The estimated fair value of the equity settled RSUs granted during the year ended August 31, 2020 was $1,037 (August 31, 2019 &#8208; $4,543), which was based on the Company&#8217;s share price at the grant date and will be recognized as an expense over the vesting period of the RSUs, which is one&#8208;third each year recognized over three years. For the year ended August 31, 2020, $1,576 (August 31, 2019 &#8211; $3,475) has been recognized as share&#8208;based compensation expense.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The following table summarizes the movements in the Company&#8217;s outstanding PSUs:</font></p>
        <div style="margin-left: 2.25pt;">
            <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">NUMBER</font></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;"><font style="color: #000000;">&#160;</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Balance - August 31, 2019</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">-</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Granted</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><font style="color: #000000;">142,187</font></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Exercised</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><font style="color: #000000;">(15,502</font></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;"><font style="color: #000000;">)</font></td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><font style="color: #000000;">Balance - August 31, 2020</font></td>
                    <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 1%;"><font style="color: #000000;">&#160;</font></td>
                    <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: right; width: 12%;"><font style="color: #000000;">126,685</font></td>
                    <td style="vertical-align: bottom; border-bottom: 3px double #000000; text-align: left; width: 2%;"><font style="color: #000000;">&#160;</font></td>
                </tr>
            </table>
        </div>
        <p style="text-align: justify;"><font style="color: #000000;">The estimated fair value of the equity settled PSUs granted during the year ended August 31, 2020 was $305 (August 31, 2019 &#8208; $nil), which was based on the Company&#8217;s share price at the grant date, adjusted for an estimate of likelihood of achievement, and will be recognized as an expense over the vesting period of the PSUs, which is during the fiscal year&#8208;ended August 31, 2020. For the year ended August 31, 2020, $272 (August 31, 2019 &#8208; $nil) has been recognized as share&#8208;based compensation expense.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The preparation of the Financial Statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimates are revised and in any future years affected.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The following are the estimates and judgments made by management in applying the accounting policies of the Company that have the most significant effect on the financial statements.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt; margin-left: 18pt;"><b><i><font style="color: #000000;">1) Biological assets and inventories</font></i></b></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 18pt;"><font style="color: #000000;">Determination of the fair value of biological assets requires management to make a number of estimates, including estimating harvesting costs, selling costs, sales prices, wastage, oil conversion factor, expected yields, and post&#8208;harvest costs of the cannabis plant. The Company records obsolete and unsaleable inventories at the lower of cost and net realizable value. Adjustments to the carrying value of inventories are based on obsolescence trends, historical experience, and forecast demand and pricing for obsolete and unsaleable inventories. Refer to Notes 7 and 8 for further information.</font></p>
    </div>
    <div id="footer_page_36">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">35</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_37"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt; margin-left: 18pt;"><b><i><font style="color: #000000;">(2) Estimated useful lives and impairment of property, plant and equipment</font></i></b></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 18pt;"><font style="color: #000000;">Amortization of property, plant and equipment requires estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts, taking into consideration factors such as economic and market conditions and the useful lives of assets.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt; margin-left: 18pt;"><b><i><font style="color: #000000;">(3) Share&#8208;based payments</font></i></b></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 18pt;"><font style="color: #000000;">In determining the fair value of options and related expenses, management estimates the expected life of the option, the volatility of the Company&#8217;s share price, the risk&#8208;free interest rate, and the rate of forfeitures. Refer to Note 12 for further information.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt; margin-left: 18pt;"><b><i><font style="color: #000000;">(4) Warrants</font></i></b></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 18pt;"><font style="color: #000000;">In determining the value of warrants, management estimates the expected life of the warrant, the volatility of the Company&#8217;s share price, and the risk&#8208;free interest rate.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt; margin-left: 18pt;"><b><i><font style="color: #000000;">(5) Adult&#8208;use recreational cannabis revenue &#8211; provision for returns and price adjustments</font></i></b></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 18pt;"><font style="color: #000000;">Government customers typically have the right to return products, and in some cases, the right to pricing adjustments for products that are subsequently discounted or sold for a lower price in another jurisdiction. The estimation of potential future returns and pricing adjustments includes the use of management estimates and assumptions that may not be certain given the evolving nature of the industry.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt; margin-left: 18pt;"><b><i><font style="color: #000000;">(6) Investments in associates</font></i></b></p>
        <p style="text-align: justify; margin-left: 18pt;"><font style="color: #000000;">Management has applied significant judgment in the determination of whether the Company exerts significant influence with respect to its investments, which then allows the Company to account for its investments under the equity accounting method. Further, management has applied significant judgment and made use of management estimates and assumptions in determination and quantification of any impairment losses that may need to be recorded against its investments in associates.</font></p>
        <p style="text-align: justify; margin-left: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><b><i><font style="color: #000000;">(7) Impairment of long&#8208;lived and intangible assets</font></i></b></p>
        <p style="text-align: justify; margin-left: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><font style="color: #000000;">In determining the recoverable amount of the Moncton Campus CGU, management has applied significant judgment in the aggregation of the CGU and has made various estimates with respect to the forecast cash flows, terminal growth rate, post&#8208;tax discount rate, and income taxes utilized in the discounted cash flow model to estimate fair value less costs of disposal.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">NEW STANDARDS AND INTERPRETATIONS ADOPTED </font><font style="color: #86b4cd;"><font style="color: #000000;">New or amended standards effective September 1, 2019</font></font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company has adopted the following new or amended IFRS standard for the annual period beginning on September 1, 2019:</font></p>
        <p style="text-align: justify;"><b><font style="color: #000000;">IFRS 16 &#8211; Leases</font></b></p>
        <p style="text-align: justify;"><font style="color: #000000;">In January 2016, the IASB issued IFRS 16 Leases, which replaced IAS 17 Leases. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than twelve months, unless the underlying asset is of low value. A lessee is required to recognize a right&#8208;of&#8208;use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. The standard was effective for annual periods beginning on or after January 1, 2019 and has been adopted by the Company effective September 1, 2019 using the modified retrospective approach where comparative figures were not restated.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">As a result of adopting IFRS 16, the Company recognized right&#8208;of use (&#8220;ROU&#8221;) assets of $4,464 recorded under property, plant and equipment (Note 9 of the Financial Statements), lease liabilities of $4,439 recorded under other liabilities (Note 13 of the Financial Statements), and a reduction to prepaid expenses of $25 as a result of the leasing arrangements in place at September 1, 2019 and entered during the year ended August 31, 2020 by the Company.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The ROU asset was measured as the amount of the lease liability, using the Company&#8217;s incremental borrowing rate on September 1, 2019 that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. The weighted average interest rate as of September 1, 2019 to measure the lease liabilities was 5.70%.</font></p>
    </div>
    <div id="footer_page_37">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">36</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_38"></a>
    <p style="text-align: justify;"><font style="color: #000000;">The Company elected to use the following practical expedients on adoption of IFRS 16 on all of its leases:</font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt;"><font style="color: #000000;"><font style="color: #000000;">(a)</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.C3, an election is being taken to not reassess whether a contract is or contains a lease at the date of initial application, and instead to only apply IFRS 16 to contracts that were in the scope of IAS 17;</font></font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">(b)</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.C8(b)(ii), an election is being taken to measure the ROU asset on September 1, 2019 as an amount equal to the lease liability, adjusted for prepaid or accrued lease payments;</font></font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">(c)</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.C10(a), an election is being taken to apply a single discount rate to a portfolio of leases with reasonably similar characteristics;</font></font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">(d)</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.C10(b), an election is being taken to rely on the IAS 37 assessment of whether leases are onerous instead of performing an impairment review;</font></font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">(e)</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.C10(c), an election is being taken to exclude leases for which the term ends within 12 months from September 1, 2019;</font></font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">(f)</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.C10(d), an election is being taken to exclude initial direct costs from the measurement of the ROU asset on September 1, 2019;</font></font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">(g)</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.15, an election is being taken, by class of underlying asset, not to separate non&#8208;lease components from lease components, and instead account for each lease component and any associated non&#8208;lease components as a single lease component where the non&#8208;lease components are not significant compared to the lease components;</font></font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">(h)</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.5(a), an election is being taken to not recognize a ROU asset and lease liability for leases for which the lease has a term less than 12 months; and</font></font></p>
    <p style="margin-left: 27pt; text-align: justify; margin-bottom: 0pt; text-indent: -20pt; margin-top: 0pt;"><font style="color: #000000;"><font style="color: #000000;">(i)</font></font><font style="width: 10pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">In accordance with IFRS 16.5(b), an election is being taken to not recognize a ROU asset and lease liability for leases for which the underlying asset is of low value, which is defined to mean less than $5,000 USD when new.</font></font></p>
    <p style="text-align: justify;"><font style="color: #000000;">The following is a reconciliation between the Company&#8217;s operating lease commitments disclosed applying IAS 17 as at August 31, 2019 and the lease liabilities as at September 1, 2019 after adopting IFRS 16:</font><font style="color: #000000;">&#160;</font></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">Reconciliation - IAS 17 to IFRS 16</td>
            <td style="vertical-align: bottom; background-color: #e1eaed;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e1eaed;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e1eaed;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Operating lease obligations as at August 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e1eaed;">$</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">3,049</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Minimum Future payments not related to lease payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e1eaed;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">(411</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Lease payments for renewal options reasonably expected to be exercised but not contractually obligated</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e1eaed;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">655</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Relief option for short-term leases</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e1eaed;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">(538</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Relief option for leases of low-value assets</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e1eaed;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">(76</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Gross lease liabilities at September 1, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e1eaed;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">2,679</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Discounting</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e1eaed;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">(459</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Present value of lease liabilities at September 1, 2019</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e1eaed;">$</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e1eaed;">2,220</td>
            <td style="border-bottom: 3px double #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e1eaed;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">New Accounting Pronouncements</font></p>
    <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The following IFRS standards have been recently issued by the IASB. Pronouncements that are irrelevant or not expected to have a significant impact have been excluded.</font></p>
    <p style="text-align: justify;"><b><font style="color: #000000;">Amendments to IFRS 3: Definition of a Business</font></b></p>
    <p style="text-align: justify;"><font style="color: #000000;">In October 2018, the IASB issued &#8220;Definition of a Business (Amendments to IFRS 3)&#8221;. The amendments clarify the definition of a business, with the objective of assisting entities to determine whether a transaction should be accounted for as a business combination or as an asset acquisition. The amendment provides an assessment framework to determine when a series of integrated activities is not a business. The amendments are effective for business combinations occurring on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The Company is currently evaluating the potential impact of these amendments on the Company&#8217;s consolidated financial statements resulting from any future transactions.</font></p>
    <div id="footer_page_38">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">37</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_39"></a>
    <div>
        <p style="text-align: justify;"><b><font style="color: #000000;">Amendments to IAS 1: Classification of Liabilities as Current or Non&#8208;Current</font></b></p>
        <p style="text-align: justify;"><font style="color: #000000;">The amendments to IAS 1 clarify the requirements relating to determining if a liability should be presented as current or non&#8208;current in the statement of financial position. Under the new requirements, the assessment of whether a liability is presented as current or non&#8208;current is based on the contractual arrangements in place as at the reporting date and does not impact the amount or timing of recognition. The amendment applies retrospectively for annual reporting periods beginning on or after January 1, 2023. The Company is currently evaluating the potential impact of these amendments on the Company&#8217;s consolidated financial statements.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">CONTINGENT LIABILITIES</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company recognizes loss contingency provisions for probable losses when management can reasonably estimate the loss. When the estimated loss lies within a range, the Company records a loss contingency provision based on its best estimate of the probable loss. If no particular amount within that range is a better estimate than any other amount, the mid&#8208;point of the range is used. As information becomes known a loss contingency provision is recorded when a reasonable estimate can be made. The estimates are reviewed at each reporting date and the estimates are changed when expectations are revised. An outcome that deviates from the Company&#8217;s estimate may result in an additional expense or release in a future accounting period.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">During 2015, the Company was named as a defendant in a lawsuit in New Brunswick for breach of confidence, conversion, breach of contract, conspiracy and breach of trust, breach of fiduciary duty, and negligent misrepresentation. The Company believes the lawsuit to be without merit though it will rigorously defend the action. No amount has been accrued in relation to the condensed consolidated interim financial statements for the claim.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On March 3, 2017, a claim in connection with a proposed class&#8208;action lawsuit (the &#8220;Claim&#8221;) was filed with the Supreme Court of Nova Scotia (the &#8220;Court&#8221;) seeking to represent a class who purchased medical marijuana that was the subject of the Company&#8217;s product recalls in December 2016 and January 2017 as it may have contained trace elements of the pesticides myclobutanil and bifenazate which are not approved for use by licensed producers. The Claim identifies several causes of action including, among others: (i) negligent design, development and testing, (ii) negligent manufacturing, (iii) negligent distribution, marketing and sale, (iv) breach of contract, and (v) breach of the Competition Act, the Consumer Protection Act, and the Sale of Goods Act, and is seeking remedy in the form of, among other things, the disgorgement of profits accrued to the Company for the sale of contaminated products, exemplary or punitive damages and certain costs.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Claim was amended on November 16, 2017, to include a claim for alleged adverse health consequences caused as a result of using the recalled product. As at the date hereof, the Company has not received any medical information demonstrating adverse health effects caused as a result of using the recalled product.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The amended Claim also contained a request for an order certifying the proceeding as a class proceeding.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">During late June 2018, certification hearings were heard before the Court. On January 18, 2019, the Court issued its decision granting certification. On March 4, 2019, the Company filed a notice for leave to appeal the certification of the class action brought against it. Leave to appeal was granted and the appeal was heard on October 15, 2019 and the decision was reserved. On April 30, 2020, the Nova Scotia Court of Appeal ruled that the plaintiff failed to present any evidence that the cannabis purchased by medical customers in 2016 could cause any particular adverse health effects. As a result, class members would not be able to bring claims for damages for adverse health effects in the class proceeding. On June 26, 2020, the plaintiff filed an application for leave to appeal the Nova Scotia Court of Appeal&#8217;s decision with the Supreme Court of Canada. On November 5, 2020, the application for leave to appeal was dismissed by the Supreme Court of Canada.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #000000;">The Company is contesting what remains of the litigation. The Company reported the Claim to its insurance provider which appointed counsel to defend the Claim. Insurance may be available to cover all or a portion of the fees or damages which may be associated with the Claim although the Company&#8217;s coverage may be subject to varying limits and exclusions. The litigation process will continue into the foreseeable future unless settled out of court. No amount has been recorded in the condensed consolidated interim financial statements as the Company has not yet determined a reasonable estimate of the cost to resolve this class action.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">On June 16, 2020, a claim in connection with a proposed national consumer protection class&#8208;action lawsuit was filed with the Court of Queen&#8217;s Bench in Alberta (the &#8220;Alberta Claim&#8221;) seeking damages against several Canadian cannabis companies including the Company. The Alberta Claim does not particularize all of the claims against the companies however it makes allegations with respect to the content of THC and CBD in the companies&#8217; products. The proposed action is not certified. The Company has reported the Alberta Claim to its insurers.</font></p>
    </div>
    <div id="footer_page_39">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">38</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_40"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">DISCLOSURE CONTROLS AND PROCEDURES AND INTERNAL CONTROL OVER FINANCIAL REPORTING</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">In accordance with National Instrument 52-109 - Certification of Disclosure in Issuers&#8217; Annual and Interim Filings (&#8220;NI 52-109&#8221;) and Rule 13a-15 under the United States Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), the establishment and maintenance of Disclosure Controls and Procedures (&#8220;DCP&#8221;) and Internal Control Over Financial Reporting (&#8220;ICFR&#8221;) is the responsibility of management.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">DISCLOSURE CONTROLS AND PROCEDURES</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company maintains a set of DCP designed to provide reasonable assurance that information required to be publicly disclosed is recorded, processed, summarized and reported on a timely basis.&#160; As required by NI 52-109 and Exchange Act Rule 13a-15(b), an evaluation of the design of our disclosure controls was done under the supervision and with the participation of management, including our Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;) using the criteria set forth in Internal Control - Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (the &#8220;COSO 2013 Framework&#8221;). Based upon this evaluation, our CEO and CFO concluded that because of the material weaknesses in our internal control over financial reporting (&#8220;ICFR&#8221;) described below, our disclosure controls were not effective as at August 31, 2020.</font></p>
    </div>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">INTERNAL CONTROL OVER FINANCIAL REPORTING</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">NI 52-109 requires the CEO and CFO to certify that they are responsible for establishing and maintaining ICFR for the Company and that those internal controls have been designed and are effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with IFRS. Similarly, Exchange Act Rule 13a-15(c) requires the Company&#8217;s management, with the participation of the CEO and CFO, to evaluate ICFR as of the end of the fiscal year. The CEO and CFO are also responsible for disclosing any changes to the Company&#8217;s internal controls during the most recent period that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company&#8217;s management, under the supervision and with the participation of its CEO and CFO, conducted an evaluation of the effectiveness of the Company&#8217;s ICFR as of August 31, 2020, using the criteria set forth by the COSO 2013 Framework. Based on this evaluation, management concluded that material weaknesses existed as of August 31, 2020, as described below.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">MATERIAL CHANGES TO THE CONTROL ENVIRONMENT</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">There have been no changes to the Company ICFR during the three months ended August 31, 2020 that have materially affected, or are likely to materially affect, the Company&#8217;s ICFR.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">COMPLEX SPREADSHEET CONTROLS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Management concluded that the Company did not implement and maintain effective controls surrounding complex spreadsheets related to the Company&#8217;s valuation of Inventories and Property, Plant and Equipment. Spreadsheets are inherently prone to error due to the manual nature and increased risk of human error. The Company&#8217;s controls related to complex spreadsheets did not address all identified material risks associated with manual data entry, updating of assumptions and evidence of sufficient levels of review of completed spreadsheets.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Remediation Plan and Activities</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Management has taken steps since this material weakness was first identified for the fiscal year ended August 31, 2018, to improve its process including establishing checklists to be completed quarterly with multiple levels of review. Additional process improvements and further refinements continued to be developed during the quarter. Senior management has discussed this material weakness with the Audit Committee and the Board of Directors continues to review progress on these remediation activities on a regular and ongoing basis. The Company had engaged a third party to aid in the identification, assessment and remediation over the design and implementation effectiveness of internal controls over financial reporting. The Company changed service providers during Q2 2020 and a new third party has been working on identification and assessment of internal controls over financial reporting with the remediation activities being handled by the Company. The Company continued during the quarter to perform some scoping exercises and planning for an enterprise resource planning (&#8220;ERP&#8221;) implementation. The timing for the ERP implementation is under review and is expected to be a longer&#8208;term exercise as the Company allocates its personnel to various initiatives and continues to responds to COVID&#8208;19. The ERP possesses specific functionality to remove the manual nature and usage of complex spreadsheets in future periods once fully scoped and operational.</font></p>
    </div>
    <div id="footer_page_40">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">39</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_41"></a>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">GENERAL INFORMATION TECHNOLOGY CONTROLS (GITC)</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company did not have effective information technology (IT) general controls over all operating systems, databases, and IT applications supporting financial reports. Accordingly, process&#8208;level automated controls and manual controls that were dependent upon the information derived from IT systems were also determined to be ineffective.</font></p>
    </div>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Remediation Plan</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company has engaged a third party to aid in the identification and assessment of the design and implementation effectiveness of IT related ICFR. The Company is implementing the remediation internally. The Company continued to advance a logical access review to enhance segregation of duties on certain in&#8208;scope applications during Q4 2020. The majority of this work is expected to take place in Fiscal 2021. The Company also continued during the quarter to perform some scoping exercises and planning for an ERP implementation as described above. The timing for the ERP implementation is under review and is expected to be a longer&#8208;term exercise as the Company allocates its personnel to various initiatives and continues to responds to COVID&#8208;19.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #87b5cf;">PROPERTY, PLANT AND EQUIPMENT</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company did not maintain effective controls over the acquisition and disposal of capital assets, including the review of source documentation, authorization for disposal and processing of the related financial transaction(s).</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">Remediation Plan</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">To further strengthen controls surrounding property, plant and equipment, management has initiated or intends to initiate during Fiscal 2021 the following procedures:</font></p>
        <p style="margin-left: 28.5pt; text-align: justify; margin-bottom: 0pt; text-indent: -11.25pt;"><font style="color: #000000;"><font style="color: #000000;">&#8729;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Implement a formalized capitalization policy and provide additional training and guidance to internal teams regarding the communicated processes;</font></font></p>
        <p style="text-align: justify; margin-top: 0pt; margin-left: 17.25pt;"><font style="color: #000000;"><font style="color: #000000;">&#8729;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Enhancements to the quarterly capital budget analysis prepared on major projects; and</font></font></p>
        <p style="text-align: justify; margin-left: 17.25pt;"><font style="color: #000000;"><font style="color: #000000;">&#8729;</font></font><font style="width: 9pt; display: inline-block;">&#160;</font><font style="color: #000000;"><font style="color: #000000;">Review the asset register and perform a physical inventory count of all the Company&#8217;s assets.</font></font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company made advancements during Fiscal 2020 on formalizing the capitalization policy and providing additional training and guidance on processes, further enhancing the capital budget analysis and reviewing the asset register and performing a physical inventory count of the Company&#8217;s assets. There remains further work to be done which the Company currently expects will be completed in Fiscal 2021.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">RISK FACTORS</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company&#8217;s business is subject to risks inherent in a high growth, heavily regulated enterprise, and the Company has identified certain risks pertinent to its business that may have affected or may affect its business, financial conditions, results of operations and cash flows, as further described throughout this MD&amp;A and under &#8220;Risk Factors&#8221; in the AIF. For additional risk factors, readers are directed to the Company&#8217;s most recent AIF available under the Company&#8217;s issuer profile on SEDAR at </font><font style="color: #205d9e;"><font style="color: #000000;"><u>www.sedar.com</u></font></font><font style="color: #000000;"> and on EDGAR at </font><font style="color: #205d9e;"><font style="color: #000000;"><u>www.sec.gov</u></font></font><font style="color: #000000;">. As a general matter, management of the Company attempts to assess and mitigate any risks and uncertainties by retaining experienced professional staff and assuring that the Board of Directors and senior management of the Company are monitoring the risks impacting or likely to impact the business on a continuous basis.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">(i) Credit Risk</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Credit risk arises from deposits with banks, short&#8208;term investments (excluding investments in equity securities), outstanding trade and loan receivables, and restricted investments. For trade receivables, the Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non&#8208;performance. For other receivables, out of the normal course of business such as the loan receivable, management generally obtains guarantees and general security agreements. The maximum exposure to credit risk of cash, short&#8208;term investments, accounts receivable, loans receivable, and restricted investment on the statement of financial position at August 31, 2020 approximates $99,736 (August 31, 2019 &#8208; $65,385).</font></p>
    </div>
    <div id="footer_page_41">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">40</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_42"></a>
    <div>
        <p style="text-align: justify;"><font style="color: #000000;">As of August 31, 2020, the Company&#8217;s aging of trade receivables was as follows:</font></p>
        <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 65.0465%;">&#160;</td>
                <td style="border-bottom: 1px solid #87b5cf; vertical-align: bottom; background: #87b5cf; text-align: left; width: 1.02326%;">&#160;</td>
                <td style="border-bottom: 1px solid #87b5cf; vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: center; width: 12%; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2020</font></td>
                <td style="border-bottom: 1px solid #87b5cf; vertical-align: bottom; background: #87b5cf none repeat scroll 0% 0%; text-align: center; width: 2%; white-space: nowrap;">&#160;</td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: center; width: 2%; white-space: nowrap;">&#160;</td>
                <td style="border-bottom: 1px solid #aeaaaa; vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: center; width: 1.02326%; white-space: nowrap;">&#160;</td>
                <td style="border-bottom: 1px solid #aeaaaa; vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: center; width: 12%; white-space: nowrap;"><font style="color: #ffffff;">AUGUST 31, 2019</font></td>
                <td style="border-bottom: 1px solid #aeaaaa; vertical-align: bottom; background: #aeaaaa none repeat scroll 0% 0%; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 1.5pt; width: 65.0465%;"><font style="color: #000000;">0-60 days</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #4d4d4c;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #4d4d4c;">11,023</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #4d4d4c;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #4d4d4c;">11,748</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 1.5pt; width: 65.0465%;"><font style="color: #000000;">61-120 days</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #4d4d4c;">73</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;">&#160;</td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #4d4d4c;">152</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 1.5pt; width: 65.0465%;"><font style="color: #000000;">Gross trade receivables</font></td>
                <td style="border-top: 1px solid #87b5cf; vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #4d4d4c;">$</font></td>
                <td style="border-top: 1px solid #87b5cf; vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #4d4d4c;">11,096</font></td>
                <td style="border-top: 1px solid #87b5cf; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;">&#160;</td>
                <td style="border-top: 1px solid transparent; vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="border-top: 1px solid #a6a6a6; vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #4d4d4c;">$</font></td>
                <td style="border-top: 1px solid #a6a6a6; vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #4d4d4c;">11,900</font></td>
                <td style="border-top: 1px solid #a6a6a6; vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 1.5pt; width: 65.0465%;"><font style="color: #000000;">Less: Provision for doubtful accounts</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #4d4d4c;">(13</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #4d4d4c;">)</font></td>
                <td style="border-bottom: 1px solid transparent; vertical-align: bottom; text-align: left; width: 2%;"><font style="color: #4d4d4c;"><br></font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #4d4d4c;">(268</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;"><font style="color: #4d4d4c;">)</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; width: 65.0465%;">&#160;</td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #e1eaed;"><font style="color: #4d4d4c;">$</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: right; width: 12%; background-color: #e1eaed;"><font style="color: #4d4d4c;">11,083</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;">&#160;</td>
                <td style="border-top: 1px solid transparent; border-bottom: 3px double transparent; vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="border-top: 1px solid #a6a6a6; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 1.02326%; background-color: #eeeeee;"><font style="color: #4d4d4c;">$</font></td>
                <td style="border-top: 1px solid #a6a6a6; border-bottom: 3px double #000000; vertical-align: bottom; text-align: right; width: 12%; background-color: #eeeeee;"><font style="color: #4d4d4c;">11,632</font></td>
                <td style="border-top: 1px solid #a6a6a6; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #eeeeee;">&#160;</td>
            </tr>
        </table>
    </div>
    <div>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">(ii) Liquidity Risk</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company&#8217;s liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company manages its liquidity risk by reviewing on an ongoing basis its capital requirements. At August 31, 2020, the Company had $24,600 (August 31, 2019 &#8211; $47,555) of cash and working capital of $141,123 (August 31, 2019 &#8208; $152,417). Further, the Company may further consider accessing equity capital through the capital markets.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">The Company is obligated to the following contractual maturities relating to their undiscounted cash flows:</font></p>
        <table style="width: 100%; color: #4d4d4c; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: middle; text-align: center;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf; text-align: center;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;"><font style="color: #ffffff;">Contractual</font><br><font style="color: #ffffff;">Cash Flows</font></td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;"><font style="color: #ffffff;">Less than</font><br><font style="color: #ffffff;">1 year</font></td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;"><font style="color: #ffffff;">1 to 3 years</font></td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;"><font style="color: #ffffff;">3 to 5 years</font></td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: middle; background: #87b5cf none repeat scroll 0% 0%; text-align: center; white-space: nowrap;"><font style="color: #ffffff;">More than</font><br><font style="color: #ffffff;">5 years</font></td>
                <td style="vertical-align: middle; background: #87b5cf; text-align: center;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 1.5pt;"><font style="color: #000000;">Long-term debt obligations</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">123,117</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">16,287</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">106,707</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">123</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 1.5pt;"><font style="color: #000000;">Operating lease obligations</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">6,019</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">1,553</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">2,094</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">1,766</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">606</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;"><br></font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">Purchase obligations</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">1,600</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">1,600</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">-</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 1.5pt;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 1.5pt;"><font style="color: #000000;">Accounts payable and accrued liabilities</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">17,486</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">17,486</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">-</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">-</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">-</font></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;"><br></font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 1px solid #e1eaed; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">148,222</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">36,926</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">108,801</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">1,889</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e1eaed;"><font style="color: #000000;">$</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: right; width: 11%; background-color: #e1eaed;"><font style="color: #000000;">606</font></td>
                <td style="border-top: 1px solid #87b5cf; border-bottom: 3px double #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e1eaed;"><font style="color: #000000;">&#160;</font></td>
            </tr>
        </table>
        <p style="text-align: justify;"><font style="color: #000000;">The contractual maturities noted above are based on contractual due dates of the respective financial liabilities.</font></p>
        <p style="text-align: justify;"><font style="color: #000000;">In connection with the Company&#8217;s Moncton Campus expansion plans, the Company is contractually committed to approximately $1,600 of capital expenditures.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">(iii) Market Risk</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk for the Company comprises of:</font></p>
        <p style="text-align: justify;"><font style="color: #000000;"><font style="color: #000000;"><b>Interest rate risk </b></font></font><font style="color: #000000;">is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk at August 31, 2020 pursuant to the variable rate loans described in Note 10. A 1% change in benchmark interest rates will increase or decrease the Company&#8217;s interest expense by $1,150 (August 31, 2019 &#8208; $500) per year.</font></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><font style="color: #86b4cd;">(iv) Concentration risk</font></p>
        <p style="text-align: justify; margin-top: 0pt;"><font style="color: #000000;">The Company&#8217;s accounts receivable are primarily due from provincial government agencies (two of which, individually, represented more than 10% of the Company&#8217;s revenues during the year ended August 31, 2020), corporations (one of which represented more than 10% of the Company&#8217;s revenues during the period), and legal trusts and, thus, the Company believes that the accounts receivable balance is collectible.</font></p>
    </div>
    <div id="footer_page_42">
        <table style="width: 100%; color: #87b5ce; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 76%; vertical-align: bottom;">
                    <p style="text-align: left;"><font style="color: #87b5ce; font-size: 8pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS | FOR THE YEARS ENDED AUGUST 31, 2020 AND 2019</font></p>
                </td>
                <td style="width: 23%; vertical-align: bottom;">
                    <p style="text-align: right;"><font style="color: #87b5ce; font-size: 8pt;">41</font></p>
                </td>
            </tr>
        </table>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_43"></a>
    <div>
        <div style="text-align: center;"><img src="exhibit99-5xu006.jpg"></div>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>7
<FILENAME>exhibit99-6.htm
<DESCRIPTION>EXHIBIT 99.6
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibit 99.6 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><img src="exhibit99-6xz001.jpg" style="width: 409px;" height="42"></p>
    <p style="text-align: center;"><b>2020 ANNUAL INFORMATION FORM OF </b><br><b>ORGANIGRAM HOLDINGS INC.</b></p>
    <p style="text-align: center;">&#160;</p>
    <p style="text-align: center;"><b>For the Financial Year Ended August 31, 2020</b></p>
    <p style="text-align: center;">&#160;</p>
    <p style="text-align: center;"><b>Dated November 29, 2020<br></b></p>
    <p style="text-align: center;">&#160;</p>
    <p style="text-align: center;">&#160;</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: center;"><b>TABLE OF CONTENTS</b></p>
    <table style="font-size: 10pt; width: 100%; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_3">ANNUAL INFORMATION FORM</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_3">1</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_3">FORWARD-LOOKING STATEMENTS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_3">1</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_5">CORPORATE STRUCTURE</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_5">3</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_6">GENERAL DEVELOPMENT OF THE BUSINESS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_6">4</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_18">DESCRIPTION OF THE BUSINESS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_18">16</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_27">RISK FACTORS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_27">25</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_49">DIVIDENDS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_49">47</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_49">CAPITAL STRUCTURE</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_49">47</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_52">MARKET FOR SECURITIES</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_52">50</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_54">PRIOR SALES</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_54">52</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_54">DIRECTORS AND EXECUTIVE OFFICERS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_54">52</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_57">DIRECTOR &amp; EXECUTIVE OFFICER BIOGRAPHIES</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_57">55</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_60">CEASE TRADE ORDERS, BANKRUPTCIES, PENALTIES OR SANCTIONS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_60">58</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_61">CONFLICTS OF INTEREST</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_61">59</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_61">LEGAL PROCEEDINGS AND REGULATORY ACTIONS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_61">59</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_62">INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_62">60</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_62">TRANSFER AGENT AND REGISTRAR</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_62">60</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_62">MATERIAL CONTRACTS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_62">60</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_63">INTERESTS OF EXPERTS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_63">61</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_63">AUDIT COMMITTEE INFORMATION</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_63">61</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_64">ADDITIONAL INFORMATION</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_64">62</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_65">APPENDIX "A" - AUDIT COMMITTEE CHARTER</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_65">63</a></td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><b>ANNUAL INFORMATION FORM</b></p>
    <p style="text-align: justify;">In this annual information form ("<b>Annual Information Form</b>"), unless otherwise noted or the context indicates otherwise, the "<b>Company</b>", "<b>Organigram</b>", "<b>we</b>", "<b>us</b>" and "<b>our</b>" refer to Organigram Holdings Inc. and its wholly-owned subsidiaries, including Organigram Inc. and the term "<b>marijuana</b>" has the meaning given to the term "<b>cannabis</b>" in the <i>Cannabis Act</i> (Canada) (the "<i><b>Cannabis Act</b></i>"). All financial information in this Annual Information Form is prepared in Canadian dollars and using International Financial Reporting Standards as issued by the International Accounting Standards Board. The information contained herein is dated as of August 31, 2020 unless otherwise stated.</p>
    <p style="text-align: center;"><b>FORWARD-LOOKING STATEMENTS</b></p>
    <p style="text-align: justify;">This Annual Information Form contains certain information that may constitute &#8220;forward-looking information&#8221; and &#8220;forward-looking statements&#8221; (collectively, &#8220;<b>forward-looking statements</b>&#8221;) which are based upon the Company&#8217;s current internal expectations, estimates, forecasts, assumptions and beliefs. Such statements can be identified by the use of forward-looking terminology such as &#8220;expect&#8221;, &#8220;likely&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;intend&#8221;, &#8220;anticipate&#8221;, &#8220;potential&#8221;, &#8220;proposed&#8221;, &#8220;estimate&#8221; and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions &#8220;may&#8221;, &#8220;will&#8221; or &#8220;could&#8221; happen, or by discussions of strategy. Forward-looking statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. The forward-looking statements included in this Annual Information Form are made only as of the date of this Annual Information Form. Forward-looking statements in this Annual Information Form include, but are not limited to, statements with respect to:</p>
    <p style="margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the expected performance of the Company's business and operations;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the intention to grow the business, operations and potential activities of the Company;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the operation of the Moncton Campus (as defined below), and receipt and continued maintenance of any required approvals from Health Canada with respect thereto;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the expected growth in the number of customers and patients using the Company's cannabis and extract based products;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the expected growth in the Company's growing and cannabis extraction capacity;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the quantity of cannabis and cannabis related products expected to be used by each customer or patient;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the methods expected to be used by the Company to deliver cannabis extract related products;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the competitive conditions of the industry;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the effect of government regulations (or changes thereto) with respect to the restrictions on production, sale, consumption, export controls, income taxes, expropriation of property, repatriation of profits, environmental legislation, land use, water use and receipt of necessary permits and approvals;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Company's competitive and business strategies;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the grant and impact of any license or supplemental license to conduct activities with hemp, cannabis and/or cannabis or hemp extracts or any amendments thereof;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the anticipated future gross revenues and profit margins of the Company's operations;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Company's ability to raise additional funds including through the sale of equity or debt securities;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>future liquidity and financial capacity;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>expectations regarding revenues and expenses;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>expectations with respect to the success of the Company's research and development initiatives;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the scope of protection the Company is able to establish and maintain, if any, for its intellectual property rights;</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <div id="header_page_4">
        <p style="text-align: center;">- 2 -</p>
    </div>
    <p style="margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Company's ability to enter into and maintain strategic arrangements with distributors and retailers and the potential costs and benefits of such arrangements;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Company's anticipated investments in community relations, cannabis health and safety education programming in the locations where the Company operates and the further development of its social responsibility programs;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the targeting of international opportunities as the laws and regulations governing cannabis evolve internationally;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the legalization of industrial hemp or cannabis for medical use or adult recreational use in jurisdictions outside of Canada and the Company's ability to participate in any such markets, if and when such use is legalized;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Company's ability to import and export cannabis, hemp, and cannabis and hemp extracts to/from foreign jurisdictions it may identify from time to time;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>whether key personnel will continue their employment with the Company;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Company's plan with respect to the payment of dividends;</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Company's possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or proceedings involving the Company, including but not limited to the class action proceedings described herein; and</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the general economic conditions and global events including COVID-19 (as defined herein) retail store closures or reduced sales at retail stores or other impacts of COVID-19.</p>
    <p style="text-align: justify;">Certain of the forward-looking statements and forward-looking information and other information contained herein are based on estimates prepared by the Company using data from publicly available governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of the medical cannabis industry, industrial hemp industry, and the adult- use recreational cannabis industry which the Company believes to be reasonable. However, although generally indicative of relative market positions, market shares and performance characteristics, such data is inherently imprecise. While the Company is not aware of any misstatement regarding any industry or government data presented herein, the medical cannabis industry, industrial hemp industry, and the adult- use recreational cannabis industry involve risks and uncertainties that are subject to change based on various factors.</p>
    <p style="text-align: justify;">Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. The Company's forward-looking statements are expressly qualified in their entirety by this cautionary statement. A number of factors could cause actual events, performance or results to differ materially from what is projected in the forward-looking statements. These factors include risks related to license renewal, changes in laws, regulations and guidelines, governmental regulation, financing, product development and marketing, recalls, litigation, product liability, reliance on key personnel, competition from the legal and illicit markets, management of growth, difficulties with forecasts, limited operating history and history of losses, availability and sufficiency of insurance, uninsured and uninsurable events, reliance on a single facility, reliance on third-party transportation, ability to meet target production capacity, TSX and Nasdaq requirements, non-guaranteed contracts or other arrangements with provincial governments, internal controls, differing shareholder protections across jurisdictions, volatility in the wholesale and retail prices of cannabis, status as an "emerging growth company", volatility in the market for the Company's securities, increased volatility for dual-listed shares, risks inherent in agricultural business, foreign private issuer status in the United States, credit risk, liquidity risk, market risk, concentration risk, negative cash flows from operations, dividends, public perception, cyber security and privacy, product security, health and safety regulations, reliance on key inputs, regulatory proceedings, investigations and audits, fraudulent or illegal activity by employees, contractors or consultants, risk inherent in investments, corruption and fraud in emerging markets, restrictions on foreign investors, expansion, reliance on international advisers and consultants, anti-corruption and anti-bribery laws, global economic risks, future acquisitions, general business risks, dilution, dependence on senior management, constraints on marketing products, provincial legislative controls, suppliers and skilled labour, operations at the Moncton Campus, conflicts of interest and holding company status. Material factors and assumptions used in establishing forward-looking information include that construction and production activities will proceed as planned and regulatory conditions will advance in the manner expected by management. The purpose of forward-looking statements is to provide the reader with a description of management's expectations, and such forward-looking statements may not be appropriate for any other purpose. You should not place undue reliance on forward-looking statements contained in this Annual Information Form. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <div id="header_page_5">
        <p style="text-align: center;">- 3 -</p>
    </div>
    <p style="text-align: center;"><b>CORPORATE STRUCTURE</b></p>
    <p style="text-align: justify;">Organigram Holdings Inc. was incorporated under the <i>Business Corporations Act</i> (British Columbia) on July 5, 2010 as "Inform Resources Corp.". The Company changed its name to "0885160 B.C. Ltd." on September 13, 2010, and subsequently to "Inform Exploration Corp." ("<b>Inform</b>") on February 16, 2011. On November 21, 2011, Inform completed its initial public offering and its common shares commenced trading on the TSX Venture Exchange (the "<b>TSX-V</b>") on November 24, 2011.</p>
    <p style="text-align: justify;">On August 22, 2014, Inform and Organigram Inc. entered into an acquisition agreement (the "<b>Acquisition Agreement</b>") pursuant to which Inform agreed, among other things, to change its name to "Organigram Holdings Inc." and to effect a consolidation of the outstanding Inform common shares on a 0.883604747 to 1 basis. Under the Acquisition Agreement, Inform acquired all of the outstanding common shares of Organigram Inc. (the "<b>RTO Transaction</b>"). On April 6, 2016, the Company was continued under the <i>Canada Business Corporations Act</i>.</p>
    <p style="text-align: justify;">The Company graduated from the TSX-V to the Toronto Stock Exchange (the "<b>TSX</b>") in August 2019. As a result of the graduation, the common shares of the Company (the "<b>Common Shares</b>") commenced trading on the TSX under the symbol "OGI" effective August 22, 2019. The Common Shares have also been listed for trading on Nasdaq Global Select Market (the "<b>Nasdaq</b>") under the symbol "OGI" effective May 21, 2019 and were delisted from the OTCQX&#174; Best Market after market close on May 20, 2019.</p>
    <p style="text-align: justify;">The Company's operations are based in Moncton, New Brunswick. The Company's head office and registered office is located at 35 English Drive, Moncton, New Brunswick, E1E 3X3. The Company's telephone number is 1 (844) 644-4726 and its corporate website is <u>www.organigram.ca</u>.</p>
    <p style="text-align: justify;"><i><b>Subsidiaries</b></i></p>
    <p style="text-align: justify;">Organigram Inc., a wholly-owned subsidiary of Organigram Holdings Inc., was incorporated under the <i>Business Corporations Act</i> (New Brunswick) on March 1, 2013.</p>
    <p style="text-align: justify;">10870277 Canada Inc., incorporated under the <i>Canada Business Corporations Act</i> on July 4, 2018, is a wholly owned subsidiary of Organigram Holdings Inc., and is used as a special purpose holding company for the Company for its investment in alpha-cannabis Pharma GmbH as further described herein.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <div id="header_page_6">
        <p style="text-align: center;">- 4 -</p>
    </div>
    <p style="text-align: justify;">The following chart illustrates, as of August 31, 2020, the Company's corporate structure:</p>
    <p style="text-align: center;"><img src="exhibit99-6xz002.jpg" style="width: 541px;" height="253"></p>
    <p style="text-align: justify;">The Company has other non-material subsidiaries not shown above.</p>
    <p style="text-align: center;"><b>GENERAL DEVELOPMENT OF THE BUSINESS</b></p>
    <p style="text-align: justify;"><i><b>Licenses</b></i></p>
    <p style="text-align: justify;">On March 26, 2014, Organigram Inc. was issued a producer's license under the <i>Marihuana for Medical Purposes Regulations</i> ("<b>MMPR</b>") promulgated under the <i>Controlled Drugs and Substances Act</i> (Canada) (the "<b>CDSA</b>"). Pursuant to this license, Organigram Inc. was permitted to produce, sell, possess and ship medical marijuana, in conformity with applicable regulations, and made its first shipment of medical marijuana to registered patients in September 2014.</p>
    <p style="text-align: justify;">On August 24, 2016, the MMPR was replaced by the <i>Access to Cannabis for Medical Purposes Regulations</i> ("<b>ACMPR</b>") promulgated under the CDSA. Under the transitional provisions of the ACMPR, a producer's license issued under the MMPR was continued under the ACMPR and remained valid until that license expired or was revoked. Health Canada issued a license (the "<b>License</b>") to Organigram Inc. under Section 35 of the ACMPR with an effective date of August 10, 2017. The License permitted Organigram Inc. to produce, sell, possess and ship medical marijuana, in conformity with the ACMPR.</p>
    <p style="text-align: justify;">On March 27, 2016, the Company received a license from Health Canada to produce cannabis oil extracts (the "<b>Extracts License</b>") under the class exemption available under Section 56 of the CDSA (the "<b>Section 56 Exemption</b>"). Since June 2016, the Extracts License issued by Health Canada includes both production and sale of cannabis oil extracts.</p>
    <p style="text-align: justify;">On May 15, 2018, the Company received a dealer's license under the CDSA from Health Canada (the "<b>Dealer's License</b>"). The Dealer's License, authorized the Company to develop, test and export and import for the purposes of reformulation an extensive range of products including, but not limited to, a range of cannabis oils as well as an extensive range of derivative based formulations. On June 27, 2018, the Dealer's License was amended under the CDSA.</p>
    <p style="text-align: justify;">Effective October 17, 2018, cannabis is no longer regulated under the CDSA and is now regulated under the <i>Cannabis Act</i> as further described herein under "<i>Canadian Regulatory Landscape</i>". As a result of the <i>Cannabis Act</i> coming into effect, every license issued under the ACMPR that was in force immediately before the day on which the <i>Cannabis Act </i>came into force was deemed to be a license under the <i>Cannabis Act</i>. Additionally, under the Cannabis Act export permits are applied for and received on a case by case basis.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <div id="header_page_7">
        <p style="text-align: center;">- 5 -</p>
    </div>
    <p style="text-align: justify;">On November 9, 2018, Health Canada reissued the License to the Company under the <i>Cannabis Act</i> as a license for standard cultivation, standard processing and sale for medical purposes.</p>
    <p style="text-align: justify;">On October 21, 2019, after the amendment to the Cannabis Regulations, Health Canada amended the License to expand the classes of cannabis products that may be sold to adult recreational use sales channels or sold for medical purposes, to include cannabis topicals, cannabis extracts and edible cannabis. Health Canada renewed the License effective as of March 20, 2020. The License has an expiry date of March 20, 2023. The Company intends to renew the License and it is anticipated that Health Canada will extend or renew the License at the end of its term. See Risk Factors "<i>Reliance on License Renewal</i>".</p>
    <p style="text-align: justify;">The Company also holds a cannabis license under the <i>Excise Act</i>, 2001 (the "<i><b>Excise Act</b></i>") effective October 17, 2018 and expiring October 16, 2022. All holders of a license under the <i>Cannabis Act </i>who are authorized to cultivate, produce and package cannabis products are required to hold a cannabis license under the <i>Excise Act</i>. The Company intends to renew this license prior to expiry.</p>
    <p style="text-align: justify;">On October 23, 2019, Health Canada issued a license to the Company under the <i>Cannabis Act</i> for research (the "<b>Research License</b>"). The Research License allows the Company to test inhalable cannabis in the cannabis extracts class of cannabis, and ingestible cannabis in the cannabis extracts and edible cannabis classes of cannabis, to human research subjects for assessments of taste, sight, smell or touch. The activities authorized under the Research License support the Company's commercialization of cannabis products in the cannabis extracts and edible cannabis classes of cannabis. The Research License has an expiry date of October 23, 2024. The Company intends to renew the Research License at the end of its term.</p>
    <p style="text-align: justify;"><i><b>Expansion</b></i></p>
    <p style="text-align: justify;">The Company acquired its Moncton campus (the "<b>Moncton Campus</b>") located in Moncton, New Brunswick in March 2014. Following its acquisition, and as detailed in the below chart, the Company undertook a series of expansions, which were completed on a phased basis, which each phase assigned a numerical reference.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <div id="header_page_8">
        <p style="text-align: center;">- 6 -</p>
    </div>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">&#160;</td>
            <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">&#160;</td>
            <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">&#160;</td>
            <td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">&#160;</td>
            <td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">&#160;</td>
            <td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center;" colspan="2">
                <p style="text-align: center; border-bottom: 4.5pt solid #82bbea;"><b>&#160;EXPENDITURES ($M)</b></p>
            </td>
        </tr>
        <tr>
            <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center; border-bottom: 4.5pt solid #82bbea;"><b>PHASE</b></p>
            </td>
            <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center; border-bottom: 4.5pt solid #82bbea;"><b>PURPOSE</b></p>
            </td>
            <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center; border-bottom: 4.5pt solid #82bbea;"><b>STATUS AS OF DATE <br>OF MD&amp;A</b></p>
            </td>
            <td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center; border-bottom: 4.5pt solid #82bbea;"><b>KG/YR OF <br>TARGET <br>PRODUCTION</b><sup><b>(1)</b></sup></p>
            </td>
            <td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center; border-bottom: 4.5pt solid #82bbea;"><b>KG/YR OF <br>CURRENT <br>FLOWER <br>CAPACITY</b><sup><b>(2)</b></sup></p>
            </td>
            <td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center; border-bottom: 4.5pt solid #82bbea;"><b>SPENT IN </b><br><b>Q4 2020</b></p>
            </td>
            <td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center; border-bottom: 4.5pt solid #82bbea;"><b>SPENT IN</b><br><b>FISCAL 2020</b></p>
            </td>
        </tr>
        <tr>
            <td style="border-bottom: 2.25pt solid #82bbea; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">1/2/3</p>
            </td>
            <td style="width: 20%; border-bottom: 2.25pt solid #82bbea; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Propagation, PreVeg, Organic, Flower, Post Harvest, Temporary Vapes Processing Area</p>
            </td>
            <td style="width: 20%; border-bottom: 2.25pt solid #82bbea; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Licensed and in Production</p>
            </td>
            <td style="width: 12%; border-bottom: 2.25pt solid #82bbea; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">28,000</p>
            </td>
            <td style="width: 12%; border-bottom: 2.25pt solid #82bbea; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">20,000</p>
            </td>
            <td style="width: 12%; border-bottom: 2.25pt solid #82bbea; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">&#8211;</td>
            <td style="width: 12%; border-bottom: 2.25pt solid #82bbea; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">&#8211;</td>
        </tr>
        <tr>
            <td style="border-top: 2.25pt solid #82bbea; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">4A</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #82bbea; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Flower Rooms</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #82bbea; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Licensed and in Production</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #82bbea; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">20,000</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #82bbea; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">14,000</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #82bbea; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">&#8211;</td>
            <td style="width: 12%; border-top: 2.25pt solid #82bbea; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">&#8211;</td>
        </tr>
        <tr>
            <td style="border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">4B <sup>(3)</sup></p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Flower Rooms</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Licensed and in Production</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">22,000</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">16,000</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">1</td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">4</td>
        </tr>
        <tr>
            <td style="border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">4C</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Flower Rooms</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Completion Halted in Response to Market Conditions</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">N/A</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">N/A</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">1</td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">18</td>
        </tr>
        <tr>
            <td style="border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">5 (i) <sup>(4)</sup></p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Post Harvest Rooms, Edibles, Vapes</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Licensed and in Production</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">N/A</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">N/A</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;" rowspan="2">2</td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;" rowspan="2">39</td>
        </tr>
        <tr>
            <td style="border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">5 (ii) <sup>(4)</sup></p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Harvest Rooms, Drying Rooms, Filling and Packaging Rooms for Various Products, Larger Extraction Facilities</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>Licensed</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">N/A</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">N/A</p>
            </td>
        </tr>
        <tr>
            <td style="border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 20%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">70,000</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;">
                <p style="text-align: center;">50,000</p>
            </td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">4</td>
            <td style="width: 12%; border-top: 2.25pt solid #8db3e2; border-bottom: 2.25pt solid #8db3e2; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: center;">61</td>
        </tr>
    </table>
    <p style="text-align: justify;">(1)<font style="width: 11.17pt; display: inline-block;">&#160;</font>Based on current capacity and optimal operating condition for the whole cannabis plant.</p>
    <p style="text-align: justify; text-indent: -22.5pt; margin-left: 22.5pt;">(2)<font style="width: 11.17pt; display: inline-block;">&#160;</font>Based on current capacity and optimal operating condition for only the flower component of the cannabis plant.&#160; The overall Flower capacity can fluctuate significantly as management adjusts the number of plants it grows in each room.</p>
    <p style="margin-left: 22.5pt; text-indent: -22.5pt; text-align: justify;">(3)<font style="width: 11.17pt; text-indent: 0pt; display: inline-block;">&#160;</font>Due to less than anticipated consumer demand largely discussed herein, the Company&#8217;s management is currently utilizing less than the current operating capacity.</p>
    <p style="margin-left: 22.5pt; text-indent: -22.5pt; text-align: justify;">(4)<font style="width: 11.17pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company is continuing with commissioning work and expects there to be modest ongoing spend related to that as well as ongoing sustaining capex.</p>
    <p style="text-align: justify;">As of the date hereof, the Company's licensed annual maximum production capacity of dried flower and harvested sweet leaf is approximately 89,000 kg of cannabis. This includes new cultivation rooms representing approximately 13,000 kg of increased annual target cultivation capacity, which were approved by Health Canada on December 12, 2019. As the Company adjusts its production methods to achieve higher THC levels in its cannabis plants, the yield per plant has been reduced by approximately 20%, thereby resulting in a licensed capacity of approximately 70,000 kg per year. In addition, Health Canada also approved additional drying and storage areas at the Moncton Campus.</p>
    <p style="text-align: justify;">The Company has made a determination to indefinitely defer completion of Phase 4C, for which Health Canada approved an expanded site perimeter on December 12, 2019, representing the final stage of the Company's Phase 4 expansion of the Moncton Campus. This decision was informed by uncertainty on industry factors including supply and demand trends in an emerging industry and will allow the optionality to use Phase 4C for other purposes as market conditions may dictate. This also provides the ability to prioritize expenditures as the Company focuses on the launch of derivative products.</p>
    <p style="text-align: justify;">Phase 5 includes 56,000 square feet of interior space which was designed and built under European Union GMP standards ("<b>EU GMP</b>") for additional extraction capacity, a derivatives and edibles facility and additional office space. At this point due to a number of factors including reduced staffing, the Company is not actively pursuing EU GMP certification. On March 23, 2020, Health Canada approved the licensing of the remainder of the Phase 5 expansion. Phase 5 includes a new extraction facility with increased capacity for CO2 and hydrocarbon extraction, winterization and capabilities designed for future product development. Phase 5 does not have cannabis cultivation capacity associated with it. Phase 5 also houses the high speed, high capacity, fully automated chocolate production line which includes an advanced chocolate molding line and a fully integrated packaging line.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <div id="header_page_9">
        <p style="text-align: center;">- 7 -</p>
    </div>
    <p style="text-align: justify;">The forward-looking estimate of production capacity and budget amounts noted above are based on a number of material factors and assumptions including that: (a) the facility size will be as estimated with the same amount of cultivation space being used per grow room for cultivation as used to date; (b) the ratio of dried flower cultivated per canopy square foot of grow room will be consistent with historical output in the Company's existing facilities; (c) all grow rooms designated as production rooms will be utilized for their intended purposes (from time to time rooms may be used for other purposes, such as for storage); and (d) a number of factors can cause actual costs to differ from estimates. See "Risk Factors".</p>
    <p style="text-align: justify;"><i><b>Three-Year History</b></i></p>
    <p style="text-align: justify;"><i>Developments During the Financial Year Ended August 31, 2018</i></p>
    <p style="text-align: justify;">On September 15, 2017, the Company entered into a memorandum of understanding with Cannabis NB, the Crown corporation responsible for the supply of cannabis for customers of the adult-use recreational cannabis market in the Province of New Brunswick. The memorandum of understanding was superseded by a supply agreement.</p>
    <p style="text-align: justify;">On October 31, 2017, the Company acquired a land parcel of approximately 1.65 acres with an existing building located at 55 English Drive in Moncton, New Brunswick, which abuts the Moncton Campus.</p>
    <p style="text-align: justify;">On December 18, 2017, the Company closed a short form prospectus offering of 16,428,572 units of the Company at a price of $3.50 per unit, on a bought deal basis, including the full exercise of the over-allotment option, for aggregate gross proceeds of $57,500,002. Each unit consisted of one Common Share and one-half of one Common Share purchase warrant. Each whole warrant entitled the holder thereof to acquire one Common Share at a price of $4.00 until June 18, 2019, at which time any warrants remaining unexercised expired in accordance with their terms.</p>
    <p style="text-align: justify;">On December 19, 2017, the Company appointed Paolo De Luca, CPA, CA, CFA as the Company's Chief Financial Officer. On March 4, 2020, Mr. De Luca was appointed Chief Strategy Officer of the Company. Mr. De Luca has more than 20 years of diversified financial business experience and has held senior financial, investor relations, and accounting leadership roles at companies, including West Face Capital, one of Canada's leading alternative asset management firms; Meridian LNG; Potash Ridge; C.A. Bancorp; and TD Securities.</p>
    <p style="text-align: justify;">On January 16, 2018, the Company announced the entering into of a memorandum of understanding with the Prince Edward Island Liquor Control Commission for the distribution of cannabis to the province's adult-use recreational market in Prince Edward Island.</p>
    <p style="text-align: justify;">On January 31, 2018, the Company closed a short form prospectus offering of 6.00% convertible unsecured debentures, on a bought deal basis, including the full exercise of the over-allotment option, for aggregate gross proceeds of $115,000,000 upon the issuance of 115,000 convertible debentures of the Company at a price of $1,000 per debenture. On February 27, 2019, the Company announced that it had elected its right to force the conversion of the principal amount outstanding into Common Shares, which occurred on April 1, 2019. See "<i>Capital Structure</i>".</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <div id="header_page_10">
        <p style="text-align: center;">- 8 -</p>
    </div>
    <p style="text-align: justify;">On February 12, 2018, Health Canada issued an amendment to the Company's cultivation license that enabled the Company to expand by utilizing new cultivation rooms. This amendment improves the functional design of the Company's facility and facilitates greater production at the Moncton Campus.</p>
    <p style="text-align: justify;">On May 15, 2018, Health Canada issued the Company a license for controlled drugs and substances, making the Company a "licensed dealer" under the Narcotic Control Regulations, promulgated under the CDSA. The license enables the Company to expand its medical product offerings to Germany and other European and key global markets.</p>
    <p style="text-align: justify;">On May 17, 2018, the Company received a "Permit to Export Cannabis" from Health Canada that allowed the Company to export cannabis internationally. The Company was permitted to ship dried cannabis products to Cannatrek Medical PTY Ltd., a licensed Australian medical cannabis enterprise with operations in Melbourne, Victoria through its broker Canada Management Group Global Inc. On July 6, 2018, the Company fulfilled its first shipment to the Australian purchaser.</p>
    <p style="text-align: justify;"><i>Developments During the Financial Year Ended August 31, 2019</i></p>
    <p style="text-align: justify;">On September 6, 2018, the Company began trading on the OTCQX&#174; Best Market under the ticker symbol "OGRMF".</p>
    <p style="text-align: justify;">On September 12, 2018, the Company entered into a debenture purchase agreement with Hyasynth Biologicals Inc. ("<b>Hyasynth</b>") and certain other investors (the "<b>Hyasynth Agreement</b>"). Hyasynth is a biotechnology company that engineers strains of yeast to produce cannabinoids, and holds a licence to produce and possess cannabis for the purpose of research. Under the Hyasynth Agreement, the Company committed to purchase up to $10,000,000 of convertible secured debentures of Hyasynth, subject to the terms and conditions set out in the Hyasynth Agreement. As of the date hereof, the Company has purchased $7,500,000 in convertible secured debentures of Hyasynth in two tranches, and the Hyasynth Agreement provides that the Company will purchase an additional $2,500,000, pending Hyasynth meeting certain milestones and funding conditions. The debentures are automatically convertible into common shares of Hyasynth upon the occurrence of certain events. The debentures are also convertible at the option of the Company at the conversion price applicable to each tranche of debentures specified in the Hyasynth Agreement. The debentures mature on August 31, 2023, unless such maturity is accelerated in accordance with the Hyasynth Agreement. In connection with the Hyasynth Agreement, the Company was granted two seats on Hyasynth's board of directors during the period the debentures granted to the Company remain outstanding and customary veto rights over certain "major decisions" to be taken by Hyasynth until such time as Hyasynth's annualized sales reach $10 million. In addition, Hyasynth and the Company entered into an offtake agreement providing for the purchase by the Company of certain cannabinoids, at a discount to the prevailing market price, as they are brought into commercial production by Hyasynth.</p>
    <p style="text-align: justify;">On September 14, 2018, the Company announced that it had entered into a supply agreement with the Newfoundland and Labrador Liquor Corporation (the "<b>NLC</b>"). On September 20, 2018, the Company entered into a one- year supply and distribution agreement with the NLC which is under renewal as at the date hereof. The Company has also become a key supplier of branded, finished cannabis products to Canopy Growth Corporation's Tweed-branded retail operations in Newfoundland and Labrador and Canopy serves as the exclusive agent of the Company's products under a Distribution and Retail Agreement distributing into retail outlets in that province providing the Company with flexibility on sales staffing in that province.</p>
    <p style="text-align: justify;">On October 2, 2018, the Company closed a private placement investment in Eviana Health Corporation ("<b>Eviana</b>"). Eviana issued 5,000 debenture units of Eviana (the "<b>Debenture Units</b>") to each of the Company and another institutional strategic investor, bearing an annual interest rate of 10%, maturing 24 months from the closing date, being October 2, 2020, each Debenture Unit consisting of (i) $1,000 principal amount of senior unsecured convertible debentures of Eviana (the "<b>Eviana Debentures</b>"); and (ii) one-half of one common share purchase warrant of Eviana (each whole common share purchase warrant, an "<b>Eviana Warrant</b>"). On November 1, 2019, a cease trade order was issued against Eviana by the British Columbia Securities Commission and the Ontario Securities Commission. The Company has identified indicators of impairment with respect to its investment in Eviana and determined the recoverable amount of Eviana to approximate $nil. The Company served Eviana with a notice of default and demand letter with respect to the non-payment of interest relating to the Eviana Debentures. As of the date hereof, the Company has not yet received any principal or interest payments on the Eviana Debentures.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_11"></a>
    <div id="header_page_11">
        <p style="text-align: center;">- 9 -</p>
    </div>
    <p style="text-align: justify;">On October 10, 2018, the Company entered into a definitive agreement with alpha-cannabis Pharma GmbH (&#8220;<b>ACG</b>&#8221;) pursuant to which the Company, through a newly created wholly-owned subsidiary, 10870277 Canada Inc., acquired 8,333 common shares of ACG, representing a 25% stake in the capital of ACG, for aggregate proceeds of &#8364;1,625,000 (approximately $2,440,000 at prevailing exchange rates). An additional &#8364;875,000 (approximately $1,350,000 at prevailing exchange rates) of Common Shares of the Company are payable based on the achievement of certain milestones. As part of the investment, Organigram Inc. entered into two supply agreements with ACG, one for the supply of cannabidiol isolate from ACG to Organigram Inc., and the other for the supply of dried cannabis flower from Organigram Inc. to ACG. In addition, ACG and Organigram Inc. entered into an agreement pursuant to which the parties will jointly evaluate and, if deemed appropriate, bid on certain licenses to supply medical cannabis to the German market. Under the agreement with ACG, the import and export obligations of the Company are subject to receipt by the Company of all necessary licensing and regulatory approvals, including the required Good Manufacturing Practices certification. See update in <i>&#8220;German Regulatory Framework&#8221;</i>.</p>
    <p style="text-align: justify;">On October 16, 2018, the Company completed the sale of THCI. Harvest Medicine Inc., a wholly-owned subsidiary of VIVO Cannabis Inc. ("<b>Vivo</b>"), acquired 100% of the issued and outstanding shares of THCI in exchange for $1,200,000 satisfied by the issuance of common shares in the capital of Vivo at a price per share equal to the ten-day trading volume weighted average price immediately prior to the closing of the transaction. The Company divested of THCI as it was not a part of the Company's core business. The Company's focus is on the emerging adult-use recreational market.</p>
    <p style="text-align: justify;">On October 26, 2018, the Company signed a supply agreement with the Province of British Columbia. The Company signed an agreement with the BC Liquor Distribution Branch, the sole wholesale distributor of non-medical cannabis for the province that operates standalone, public retail stores and provides online sales.</p>
    <p style="text-align: justify;">On December 7, 2018, the Company secured a loan from Farm Credit Canada in the amount of $10,000,000 which was to be used to finance the continued expansion of the Moncton Campus. The debt was for a term of five years at a variable rate of interest, initially at 6.70%. The debt was secured against certain assets of the Company. The loan was repaid in May 2019 coinciding with when the Company entered into the Credit Agreement (as defined below).</p>
    <p style="text-align: justify;">On January 18, 2019, the Nova Scotia Supreme Court certified the class action filed in respect of medical cannabis that was subject to the Company's voluntary product recalls in December 2016 and January 2017. Certification is not a decision on the merits of the lawsuit, but is a determination of whether the case is appropriate to be dealt with as a class proceeding. Certification allows the case to continue to the next stage of litigation. The Company filed an appeal of the certification of the claims alleging adverse health effects with the Nova Scotia Court of Appeal. The Appeal was heard on October 15, 2019 and the decision was taken under reserve. As announced on April 30, 2020, the Nova Scotia Court of Appeal partially overturned the certification of the class action, significantly reducing the scope of the claim against the Company. On November 5, 2020, the Supreme Court of Canada denied the leave to appeal of the decision of the Nova Scotia Court of Appeal. See update in Risk Factors "<i>Product Safety, Product Liability and Illegal Activity</i>" and "<i>Legal Proceedings and Regulatory Actions</i>".</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_12"></a>
    <div id="header_page_12">
        <p style="text-align: center;">- 10 -</p>
    </div>
    <p style="text-align: justify;">On January 18, 2019, the Company entered into an agreement with 1812 Hemp (the &#8220;<b>January Agreement</b>&#8221;), a New Brunswick based industrial hemp research company to secure supply and support research and development on the genetic improvement of hemp through traditional plant breeding methods. 1812 Hemp is focused on further developing a line of Canadian cultivars (specific varieties of plants cultivated to enhance desirable qualities) of high cannabidiol (&#8220;<b>CBD</b>&#8221;) yielding hemp for the Canadian climate. Under the terms of the agreement, the Company is to receive a 25% discount on all dried product purchased from 1812 Hemp and continued access to future 1812 harvests from December 17, 2018 to December 16, 2023, with the option to extend for an additional five-year period. The January Agreement also gave the Company access to approximately 6,000 kg of dried hemp flower the majority of which the Company purchased and sent for extraction. In addition, the January Agreement provides the Company with a right-of-first-refusal on future procurement of hemp from 1812 Hemp. In connection with the parties entering into the January Agreement, the Company paid to 1812 Hemp a bonus in the amount of $1.5 million. The price payable by the Company for the hemp flower is determined in accordance with a formula set out in the agreement. On July 26, 2019, the Company and 1812 Hemp entered into an advance payment and support agreement (the &#8220;<b>Payment Agreement</b>&#8221;). Pursuant to the Payment Agreement, the Company advanced $3.0 million to 1812 Hemp in the form of a secured loan. These amounts may be applied against future purchases of hemp under the January Agreement. The aggregate amount of advances outstanding under the Payment Agreement accrue interest of 9.0% per annum, calculated monthly, until the entire balance of advances is paid. Purchases of hemp from time to time will reduce the outstanding balance of the advances. On November 3, 2020, after having been informed by 1812 that it had effectively ceased to carry on business, the Company provided 1812 with a notice of default under the Payment Agreement and the related security agreement together with a notice of its intention to enforce its security.</p>
    <p style="text-align: justify;">On January 28, 2019, the Company entered into a multi-year extraction agreement with Valens GroWorks Corp., a provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing. Under the terms of the agreement, Valens will extract cannabis flowers and trim from Organigram's Moncton operation as well as hemp to produce extract concentrate. In turn, the concentrate will be used by Organigram to produce oils and, eventually, derivative edible and vaporizable cannabis products.</p>
    <p style="text-align: justify;">On February 26, 2019, the Company signed a letter of intent with the Soci&#233;t&#233; Qu&#233;b&#233;coise du cannabis and has subsequently been registered with the Autorit&#233; des March&#233;s Publics. As a result, the Company now has distribution arrangements in place for all Canadian provinces.</p>
    <p style="text-align: justify;">On February 27, 2019, the Company announced that it had elected to exercise its right under the indenture (the &#8220;<b>Debenture Indenture</b>&#8221;) governing its 6.00% convertible unsecured debentures due January 31, 2020 (the &#8220;<b>Debentures</b>&#8221;) to convert all of the principal amount outstanding of the remaining Debentures on April 1, 2019 (the &#8220;<b>Conversion Date</b>&#8221;) into Common Shares. Pursuant to the terms of the Debenture Indenture, the Company was permitted to force the conversion of the Debentures at the conversion price of $5.42 per Common Share when the volume weighted average trading price of the Common Shares on the TSX-V for 10 consecutive days exceeded $7.05. On April 1, 2019, the outstanding Debentures were converted into Common Shares and accrued interest was paid to the holders.</p>
    <p style="text-align: justify;">On March 4, 2019, the Company announced the appointment of Helen Martin as Corporate Secretary. Ms. Martin was promoted to Senior Vice President, Strategic &amp; Legal Affairs on April 7, 2019.</p>
    <p style="text-align: justify;">On April 30, 2019, the Company announced that it had received a license for expanded cultivation from Health Canada. This expansion enables the Company to use an additional 163,000 square ft. of space accommodating 63 cultivation rooms.</p>
    <p style="text-align: justify;">On May 20, 2019, the Company announced a $15 million investment commitment in a high-speed, high- capacity and fully-automated production line to allow the Company to make its foray into producing chocolate cannabis infused edibles upon legalization of edible cannabis products. On December 13, 2019, the Company announced that it had taken delivery of the chocolate production line.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_13"></a>
    <div id="header_page_13">
        <p style="text-align: center;">- 11 -</p>
    </div>
    <p style="text-align: justify;">On May 21, 2019 the Common Shares began trading on the Nasdaq, under the ticker symbol "OGI".</p>
    <p style="text-align: justify;">On May 31, 2019, Organigram announced that its recreational cannabis plants and growing processes had been certified organic by Pro-Cert Organic Systems Ltd ("<b>Pro-Cert</b>"). Pro-Cert is one of North America's foremost certification bodies and is accredited by IONS to provide third party certification to the Canadian Organic Standards. As a result of the Pro-Cert certification, the Company was able to formalize its plans for launching ANKR Organics, its line of organic flower and organic edible extract oils, which ultimately launched in Q3 2020.</p>
    <p style="text-align: justify;">On May 31, 2019, the Company announced the closing of a credit facility between the Bank of Montreal (&#8220;<b>BMO</b>&#8221;) and a syndicate including three other lenders (&#8220;<b>Credit Agreement</b>&#8221;). The Credit Agreement &#160;was amended in November 2019 and in May 2019 pursuant to Credit Agreement Amendments (as defined below). The credit facilities mature in May 2022, and consist of a $115 million term loan, $50 million of which was drawn on entering into the Credit Agreement, and a $25 million revolving credit facility. The proceeds of the term loan have been used to fund the Phase 4 and 5 expansions of the Moncton Campus and to refinance the Company&#8217;s existing long-term debt with Farm Credit Canada. The revolving facility may be used for general corporate and working capital purposes. The Company may choose to repay the balance of the credit facilities at any time. Principal repayments on the term loan are scheduled to commence on per quarter.</p>
    <p style="text-align: justify;">On June 7, 2019, the Company announced it had been selected as one of the Canadian launch partners of PAX Era, a premium oil vaporizer created by PAX Labs Inc. Under this arrangement, the Company produces and fills its Edison Cannabis Co. branded pods specifically for the PAX Era platform, which are currently offered where permitted by provincial regulations.</p>
    <p style="text-align: justify;">On June 18, 2019, the Company entered into an exclusive agreement with Feather Company Ltd. ("<b>Feather</b>"). Feather is a lifestyle brand committed to producing premium-quality products that enhance the cannabis experience for customers. The agreement allows the Company, through its Edison Cannabis Co. brand, to have the exclusive license to Feather's proprietary vaporizer pen technology and form factor. On February 20, 2020, the Company announced that it made its first shipments of the Edison vape pens powered by Feather.</p>
    <p style="text-align: justify;">On June 20, 2019, the Company registered with Autorit&#233; des March&#233;s Publics in Quebec and its first shipment of cannabis products to the province of Quebec.</p>
    <p style="text-align: justify;">On June 24, 2019, the Company received approval from Health Canada for the licensing of 17 additional cultivation rooms. This license enabled 14,000 kg per year of increased target production of the total licensed production capacity of 61,000 kg per year as at such date.</p>
    <p style="text-align: justify;">On July 8, 2019, the Company announced it had developed a proprietary nano-emulsification technology for the production of both liquid and powdered cannabinoid products. The emulsion process developed in this technology generates micro-droplets that are small and uniform which potentially will help customers' experience in terms of absorption and onset of effect.</p>
    <p style="text-align: justify;">On August 8, 2019, the Company announced it had received conditional approval to graduate from the TSX-V to the TSX. The Company's Common Shares commenced trading on the TSX on August 22, 2019 under the symbol "OGI".</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_14"></a>
    <div id="header_page_14">
        <p style="text-align: center;">- 12 -</p>
    </div>
    <p style="text-align: justify;"><i>Developments during the financial year ended August 31, 2020</i></p>
    <p style="text-align: justify;">Effective September 6, 2019, the Company received Health Canada's approval for the licensing of 17 additional cultivation rooms. In October, the Company submitted a license amendment for the remaining 16 cultivation rooms of Phase 4B and made a licensing submission for the perimeter of Phase 5 of the Company's expansion, to include an edibles and derivative product facility and also extraction capacity.</p>
    <p style="text-align: justify;">On November 15, 2019, the Company amended the Credit Agreement to: (i) extend the final draw deadline of the term loan from November 30, 2019 to March 31, 2020; (ii) postpone the commencement of principal repayments on the term loan to May 31, 2020; and (iii) realign the financial covenants structure, effective November 30, 2019, to be more consistent with industry norms up to and including May 31, 2020, which also provided the Company will greater flexibility around the timing and quantum of any incremental draws. Prior to the further amendment of the Credit Agreement in May 2020, which is described below, the financial covenants were to revert back to the original structure on August 31, 2020.&#160;</p>
    <p style="text-align: justify;">On December 4, 2019, the Company launched an at-the-market equity program (the "<b>December ATM Program</b>") that allowed the Company to issue and sell up to $55,000,000 (or its U.S. dollar equivalent) of Common Shares from treasury to the public, from time to time, at the Company's discretion. All Common Shares sold through the December ATM Program were sold through the TSX, Nasdaq or another marketplace (as defined in National Instrument 21-101 - Marketplace Operations) upon which the Common Shares were then listed, quoted or otherwise traded, at the prevailing market price at the time of sale. Distributions of the Common Shares through the December ATM Program were made pursuant to an equity distribution agreement dated December 4, 2019 among the Company, BMO Nesbitt Burns Inc., as Canadian agent, and BMO Capital Markets Corp., as U.S. agent, and the volume and timing of distributions under the December ATM Program were determined in the Company's sole discretion.</p>
    <p style="text-align: justify;">Effective December 12, 2019, the Company received Health Canada's approval for the licensing of 16 additional cultivation rooms and additional drying and storage areas. The Company also received Health Canada's approval for the expansion of the site perimeter for Phase 4C, which has been indefinitely deferred, and Phase 5 and approval for the operations area that houses the Company's state-of-the-art chocolate line.</p>
    <p style="text-align: justify;">On December 23, 2019, the Company announced that the first of its 'Cannabis 2.0' products had been released, which included Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges. Shipments of the custom-designed cartridges were sent to Manitoba, Saskatchewan, Ontario, New Brunswick and Nova Scotia. The Company also announced that it planned to release its edible products through calendar Q1 and Q2 of 2020.</p>
    <p style="text-align: justify;">On January 16, 2020, the Company announced that it secured a supply agreement with Medical Cannabis by Shoppers (the "<b>Shoppers Agreement</b>"), the online medical cannabis platform by Shoppers Drug Mart Inc. (the "<b>Shoppers</b>"). Under the terms of the Shoppers Agreement, the Company will provide Shoppers with a wide range of products including dried flower, oils and other future derivative products as they become available. The Shoppers Agreement is for a three-year term subject to renewal for an additional two years.</p>
    <p style="text-align: justify;">On February 20, 2020, the Company announced the continued roll out of its innovative portfolio of recreational adult use cannabis products including vape pens and cannabis-infused chocolate. The Company made its first shipments of the Edison vape pens powered by Feather technology to jurisdictions across Canada. The Company also announced the first shipment of cannabis-infused chocolate following its investment in a high-speed, high-capacity, fully automated production line. Edison Bytes, the Company's premium cannabis-infused chocolate truffles are available in both milk and dark chocolate formulations and were the first of Organigram's chocolate products to be available to Canadian adult consumers.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_15"></a>
    <div id="header_page_15">
        <p style="text-align: center;">- 13 -</p>
    </div>
    <p style="text-align: justify;">On March 4, 2020, Derrick West, then a member of the board of directors of the Company, was appointed as Chief Financial Officer.</p>
    <p style="text-align: justify;">On March 23, 2020, the Company announced that Health Canada approved the licensing of the remainder of the Company's Phase 5 expansion together with the renewal of its licenses for standard cultivation, standard processing and sale for medical purposes under the <i>Cannabis Regulations</i>. The terms of the licenses include approval of a two-floor production facility designed to support all processing activity as well as dedicated spaces for packaging of flower, pre-rolls, vape pens and powdered beverages. The Phase 5 expansion also includes a new extraction facility with increased capacity for CO2 extraction, and winterization as well as new capabilities designed for future product development. The amendments also allow for new purpose-built harvest and drying rooms and support areas for quality assurance, maintenance and sanitation. The licenses are valid for a three-year period until March 20, 2023 and are subject to customary terms and conditions.</p>
    <p style="text-align: justify;">On March 23, 2020, the Company announced that it was carefully monitoring and actively planning for the evolving situation related to COVID-19 and the potential impacts on the Company's business and operations. The Company stated that it expected to materially reduce its workforce as a result of voluntary and company-imposed temporary lay-offs, which would result in corresponding production and packaging reductions.</p>
    <p style="text-align: justify;">On April 6, 2020, the Company provided a comprehensive update on the corporate action plan in response to the COVID-19 pandemic. The Company initially announced a temporary layoff of approximately 45 per cent of its workforce primarily to boost COVID-19 containment efforts representing approximately 400 employees. On July 3, 2020, in response to the continued impact of COVID-19 on the Company&#8217;s business and the continuing evolution of the Canadian cannabis industry, the Company reduced its workforce by 25% by permanently laying off 220 employees. As of November 20, 2020, the Company has 431 active employees operating out of its Moncton Campus facility and another 86 outside the facility for 517 total active employees.</p>
    <p style="text-align: justify;">On April 22, 2020, the Company launched an at-the-market equity program (the "<b>April 2020 ATM Program</b>") that allowed the Company to issue and sell up to $49,000,000 (or its U.S. dollar equivalent) of Common Shares from treasury to the public, from time to time, at the Company's discretion. All Common Shares sold through the April 2020 ATM Program are sold through the TSX, Nasdaq or another marketplace (as defined in National Instrument 21-101 - Marketplace Operations) upon which the Common Shares were then listed, quoted or otherwise traded, at the prevailing market price at the time of sale. Distributions of the Common Shares through the April 2020 ATM Program are made pursuant to an equity distribution agreement dated April 22, 2020 among the Company, BMO Nesbitt Burns Inc., as Canadian agent, and BMO Capital Markets Corp., as U.S. agent, and the volume and timing of distributions under the December ATM Program were determined in the Company's sole discretion.</p>
    <p style="text-align: justify;">On April 23, 2020, the Company provided an update related to the Company's release of new adult use recreational cannabis products. Through a new licensing agreement with Trailer Park Boys Incorporated, Organigram introduced Trailer Park Buds ("<b>TPB</b>"), a quality adult recreational use consumer brand intended to compete in the fast-growing high volume, value-focused segment. TPB is initially available as 28g of dried flower and includes two cultivars: Itodaso Indica and Two Birds Sativa. The Company announced that they obtained listings for TPB in a number of provinces. As announced on June 23, 2020, the Company made changes to the TPB brand and logo after reviewing perception around the brand with Health Canada. The Company moved to a modified version of the brand and logo, "Buds". In September 2020, the Company entered into a termination agreement for its agreement with TPB allowing for a transition licensing arrangement for the Company's Buds brand and logo.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_16"></a>
    <div id="header_page_16">
        <p style="text-align: center;">- 14 -</p>
    </div>
    <p style="text-align: justify;">On April 30, 2020, the Company announced that the Nova Scotia Court of Appeal partially overturned the certification of a class action against the Company, thereby significantly reducing the scope of the claim against the Company. On March 3, 2017, an individual filed a class action in the Supreme Court of Nova Scotia on behalf of class members who purchased medical cannabis that the Company voluntarily recalled in December 2016 and January 2017. The Nova Scotia Court of Appeal ruled that the plaintiff failed to present any evidence that the cannabis purchased by medical customers in 2016 could cause any particular adverse health effects. As a result, class members cannot bring claims for damages for adverse health effects in the class proceedings. The class action will continue on the limited grounds of the claimed reimbursement of funds paid for the cannabis purchased by customers in 2016. On June 26, 2020, the plaintiff filed an application for leave to appeal the Nova Scotia Court of Appeal's decision to the Supreme Court of Canada.&#160; The Supreme Court of Canada has dismissed the leave to appeal. The Company will continue to defend what remains of the class action as it has already voluntarily reimbursed many of its customers for this recall via a comprehensive credit and refund program. The Company announced that it previously reported the class action to its insurance provider which appointed counsel to defend the class action. Insurance may be available to cover all or a portion of the fees or damages which may be associated with the class action although the Company's coverage may be subject to varying limits or exclusions. The Company stated that while the ultimate outcome is difficult to ascertain, management of the Company does not anticipate that what remains of the class action will affect its business or operations in any material way. See update in "Risk Factors".</p>
    <p style="text-align: justify;">On May 28, 2020, the Company announced that as of May 19, 2020, the ready-to-use Edison Cannabis Company vape pens powered by Feather, Edison-branded pods specifically for PAX Era vaporizers, and Edison Bytes chocolates in dark and milk chocolate, are now available to medical cannabis consumers. The Company also announced that certain cannabis 2.0 products are expected to be available in the near future through the Shoppers Agreement.</p>
    <p style="text-align: justify;">On May 28, 2020, the Company amended the Credit Agreement to: (i) extend the final draw deadline of the term loan to July 31, 2020; (ii) postpone the commencement of principal payments on the term loan to November 30, 2020; (iii) adjust certain financial ratios to be maintained by the Company both before and after November 30, 2021; (ii) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (v) remove the uncommitted option to increase the facilities by an incremental $35 million. The financial covenants will revert to the original structure, albeit at different ratios, on November 31, 2021. Subject to certain exceptions, funds raised by the Company after December 31, 2020 are required to be used to repay the credit facilities.</p>
    <p style="text-align: justify;">On June 9, 2020, the Company announced that it entered into a multi-year agreement for the supply of dried flower to one of Israel's largest and most established medical cannabis producers, Canndoc Ltd. ("<b>Canndoc</b>"), a subsidiary of InterCure Ltd. (TASE: INCR/INCR.TA) (the "<b>Canndoc Agreement</b>"). Canndoc has GMP-approved medical cannabis products which are sold in pharmacies in Israel. Canndoc holds international cultivation and distribution agreements in the European Union and Canada. Under the terms of the Canndoc Agreement, the Company will provide a guaranteed 3,000 kg of high quality, indoor-grown dried flower product to Canndoc by December 31, 2021 for processing and distribution into the Israeli medical market, and may provide an additional 3,000 kg during the same time period at Canndoc's option, subject to certain conditions. The Canndoc Agreement provides for a tiered pricing scheme and the exact value will vary depending on factors such as potency and product mix. The Canndoc Agreement also contemplates, among other things, an opportunity for the Company to launch branded medical products with Canndoc in Israeli and EU markets, and grants exclusivity and related rights to Canndoc within the Israel market for a period of approximately 7.5 years. Activities under the Canndoc Agreement are subject to compliance with all applicable laws, including receipt of all requisite approvals from Health Canada, the Israeli Ministry of Health, and any other applicable regulatory authorities. As announced on August 14, 2020, the Company made its first shipment of bulk dried flower to Canndoc estimated to be worth approximately $2.4 million. See update in <i>"Israeli Regulatory Framework</i>".</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_17"></a>
    <div id="header_page_17">
        <p style="text-align: center;">- 15 -</p>
    </div>
    <p style="text-align: justify;">On June 23, 2020, the Company announced a number of corporate updates including (i) the completion of its April 2020 ATM Program, issuing an aggregate of 21,080,229 Common Shares for gross proceeds of approximately $49 million; (ii) the commencement of legal action in the Court of Queen's Bench in Alberta, which action seeks damages against many of the largest Canadian cannabis companies, including the Company; and (iii) the rebranding of the Trailer Park Buds brand, which has been previously disclosed as described above.</p>
    <p style="text-align: justify;">On July 20, 2020, the Company announced that Ray Gracewood, Senior Vice President of Marketing and Communications left the Company to pursue other interests. Julie Chamberlain was promoted to Vice President of Marketing.</p>
    <p style="text-align: justify;">On July 28, 2020, the Company announced the launch of its most recent cannabis 2.0 product Trailblazer Snax, a premium-quality, value-priced, cannabis infused chocolate bar. The Trailblazer Snax is a 42g bar with 10mg of THC and comes in both mint and mocha flavours.</p>
    <p style="text-align: justify;">On August 4, 2020, the Company announced the launch of three new strains of Edison Cannabis Co. dried flower products: (i) The General (Grapefruit GG4); (ii) Chemdog; and (iii) Samurai Spy (Ninja Fruit). The Company also announced that it is working with Segra International Corp. to optimize the potential of the Company's cultivars and bring novel cultivars to the market.</p>
    <p style="text-align: justify;">On August 14, 2020, the Company announced that it sent its first shipment of bulk dried flower to Canndoc. The shipment was part of the Canndoc Agreement and is estimated to be worth approximately $2.4 million.</p>
    <p style="text-align: justify;">On August 18, 2020, the Company announced it partnered with Medical Cannabis by Shoppers Inc. and TruTrace in effort to track source and genetics of cannabis used by medical patients. The program is designed to genetically finger-print all participating cannabis products, tracking them throughout the supply chain, from genome to patient, in order to provide real-time information about the composition of each cannabis product used by Medical Cannabis by Shoppers customers. The Company will provide cannabis products to Shoppers for use in the tracking program.</p>
    <p style="text-align: justify;"><i>Developments after the financial year ended August 31, 2020</i></p>
    <p style="text-align: justify;">On September 17, 2020, the Company announced the launch of SHRED, a high quality, high potency, affordable dried flower product pre-shredded for additional consumer convenience. SHRED offers three pre-milled varieties, all featuring THC of 18% or more and each contained in a two-way humidity system to preserve their unique flavour profiles. SHRED features three curated blends, including (i) Tropic Thunder, a combination of strains with citrus and tropical aromas; (ii) Gnarberry, a combining berry and fruity aromas for a refreshing profile; and (iii) Flower Power, a specially curated sweet and floral blend.</p>
    <p style="text-align: justify;">On October 23, 2020, the Company announced the funding of an additional $2.5 million investment in Hyasynth, in accordance with the terms of the debenture purchase agreement dated September 12, 2020, between the Company and Hyasynth.</p>
    <p style="text-align: justify;">On November 10, 2020, the Company announced an underwritten public offering of 37,375,000 units of the Company (the "<b>Units</b>") at a price of $1.85 per Unit, including the full exercise of the over-allotment option, underwritten by a syndicate of underwriters led by Canaccord Genuity Corp. Each Unit is comprised of one common share of the Company and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a "<b>Warrant</b>"). Each Warrant will be exercisable to acquire one common share of the Company (a "<b>Warrant Share</b>") for a period of 3 years following the closing date of the Offering at an exercise price of $2.50 per Warrant Share, subject to adjustment in certain events. The Offering closed on November 12, 2020.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_18"></a>
    <div id="header_page_18">
        <p style="text-align: center;">- 16 -</p>
    </div>
    <p style="text-align: justify;">On November 27, 2020, the Company further amended its Facilities pursuant to an amended and restated credit agreement (the &#8220;<b>Amended and Restated Credit Agreement</b>&#8221;) with BMO to: (i) reduce the Term Loan amount from $115,000 to $60,000 based on a repayment of $55,000 to be made on December 1, 2020 of the outstanding Term Loan balance of $115,000; (ii) have repayments on the balance of the Term Loan commence on February 28, 2021 in an amount equal to $1,500 per quarter; (iii) reduce the Revolver commitment to $2,000 from up to $25,000; (iv) adjust the minimum quarterly EBITDA covenants to be maintained by the Company commencing on February 28, 2021 and continuing through to maturity, thereby removing this covenant for the fiscal period ended November 30, 2020 and eliminating the reversion of the financial covenants to that of the original structure on November 30, 2021; (v) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (vi) reduce the minimum unrestricted cash balance requirement to $20,000, which is already inclusive of the $8,000 restricted investment currently outstanding.&#160; The interest rate margin will be fixed from November 27, 2020 through to maturity on May 31, 2021.&#160; The Company incurred an amendment fee of $217 plus customary legal expenses in connection with the amendment and restatement.</p>
    <p style="text-align: center;"><b>DESCRIPTION OF THE BUSINESS</b></p>
    <p style="text-align: justify;"><i><b>Company Overview</b></i></p>
    <p style="text-align: justify;">The Company is a leading Canadian licensed producer of high quality cannabis and cannabis-derived products in Canada under the <i>Cannabis Act</i>. The Company is focused on producing high-quality, indoor- grown cannabis primarily for adult recreational consumers in Canada and the medical market, as well as developing international business partnerships to extend the Company's global footprint.</p>
    <p style="text-align: justify;">A description of the regulatory framework is included below under the heading "Canadian Regulatory Framework". For a summary of the <i>Cannabis Act</i> and <i>Cannabis Regulations</i> as well as the Company's license issued under the <i>Cannabis Act</i>, see "<i>Canadian Regulatory Framework - Licenses, Permits and Authorizations</i>".</p>
    <p style="text-align: justify;"><i><b>Principal Products and Brands</b></i></p>
    <p style="text-align: justify;">The Company has been working on establishing strong brands for use in the adult-use recreational market place and is seeking to create a portfolio of diverse brands and products. The Company's adult-use recreational brands strategy reflects the Company's views about current and potential consumers, the industry, future product development and opportunities for growth.</p>
    <p style="text-align: justify;"><u>Adult Use Recreational Cannabis</u></p>
    <p style="text-align: justify;">The Company developed its initial portfolio of adult-use recreational brands to specifically meet the evolving needs of Canada&#8217;s recreational use market. The suite of brands created by the Company for Canada&#8217;s adult-use market include Edison Cannabis Co., Trail Blazer and SHRED. Each brand is unique to a specific customer demographic with a product offering designed to meet the needs of its target audience, as described below, including as to strength and price point.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_19"></a>
    <div id="header_page_19">
        <p style="text-align: center;">- 17 -</p>
    </div>
    <p style="text-align: center;"><img src="exhibit99-6xu002.jpg"></p>
    <p style="text-align: justify;"><u>Medical Cannabis</u></p>
    <p style="text-align: justify;">The Company received its Pro-Cert certification on May 31, 2019, and began offering its organically grown medical cannabis under that certification body. The Company offers a broad offering of medical cannabis products, including cannabis flowers, cannabis oils and vaporizers to suit a variety of preferences.</p>
    <p style="text-align: justify;"><u>New Product Development</u></p>
    <p style="text-align: justify;">The Company intends to, subject to applicable regulatory approvals and provincial listings, bring a variety of other cannabis-based products to market. Such products are at various stages of development, including edible products and specifically vape pens, chocolate and dissolvable powdered beverages. These products require 60 day advance new product notifications to be submitted to Health Canada before they can be offered. No assurance can be given that the Company will be successful in bringing these products to the market. See Risk Factors "<i>The Company May Not be Able to Successfully Develop New Products or Find a Market for Their Sale</i>".</p>
    <p style="text-align: justify;"><i><b>Distribution and Sales</b></i></p>
    <p style="text-align: justify;"><u>Adult-Use Recreational Cannabis</u></p>
    <p style="text-align: justify;">The <i>Cannabis Act</i> provides provincial, territorial and municipal governments with the authority to prescribe regulations regarding retail and distribution of recreational cannabis. As such the distribution model for recreational cannabis is prescribed by provincial regulations and differs from province to province. Some provinces have government-run retailers, while others have government-licensed private retailers, and some have a combination of the two. The Company is authorized by its License for wholesale distribution of adult-use recreational cannabis and certain derivative products in all provinces of Canada and has supply arrangements in different forms with the responsible government agency or equivalent in each province.</p>
    <p style="text-align: justify;">The <i>Cannabis Act</i> introduced restrictions on the promotion of cannabis products, cannabis accessories and services related to cannabis. These include restrictions on the content of promotions as well as locations where promotions may take place. With this in mind, the Company has created a portfolio of brands that address unique customer needs, including strength yield, occasions, price points, volume discounts or promotional pricing. See "<i>Description of the Business - Canadian Regulatory Framework</i>" for additional information on current distribution channels under the <i>Cannabis Act</i>.</p>
    <p style="text-align: justify;"><u>Medical Cannabis</u></p>
    <p style="text-align: justify;">The Company distributes medical cannabis through the Company's online store, by telephone and through Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc. Medical cannabis and derivative products are and will continue to be delivered by secured courier or other methods permitted under the <i>Cannabis Act</i>. The Company's prices for cannabis and derivative products vary based on growth time, strain yield and market prices. The Company may from time to time offer volume discount or promotional pricing. The Company is also authorized for wholesale shipping of medical cannabis plant cuttings and dried flower to other licensed producers. See "<i>Description of the Business - Canadian Regulatory Framework</i>" for additional information on current distribution channels under the <i>Cannabis Act</i>.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_20"></a>
    <div id="header_page_20">
        <p style="text-align: center;">- 18 -</p>
    </div>
    <p style="text-align: justify;"><u>Cannabis Edibles</u></p>
    <p style="text-align: justify;">Effective October 17, 2019, the <i>Cannabis Regulations</i> permit the sale to the public of edible cannabis products and concentrates through medical and adult-use consumer channels. Following the investment in a high-speed, high-capacity, fully automated production line, the Company began shipping their cannabis-infused chocolates to retailers across Canada in February 2020.</p>
    <p style="text-align: justify;"><i><b>Operations</b></i></p>
    <p style="text-align: justify;">The Company has assembled a capable management team with significant experience in the management and growth of successful enterprises. Coupled with operational experience, the Company believes that it is a cost-competitive producer of cannabis, owing to various cost-saving attributes of its operations, such as: (i) competitive power costs; (ii) competitive labour costs; (iii) a facility that maximizes real property square footage (e.g. through the use of tiered grow rooms); (iv) competitive real property costs; (v) the adoption of various efficiencies; and (vi) access to various government assistance programs based on the geographical location of the Moncton Campus.</p>
    <p style="text-align: justify;">Substantially all of the Company's revenue is derived from the sale of cannabis, cannabis product and cannabis plant material produced, cultivated and/or processed by the Company at its Moncton Campus. The Company grows cannabis at its Moncton Campus for the purposes of sale and distribution of finished products in accordance with the <i>Cannabis Act</i>.</p>
    <p style="text-align: justify;"><i><b>Storage and Security</b></i></p>
    <p style="text-align: justify;">The <i>Cannabis Act</i> prescribes physical security requirements that are necessary to secure sites where licensed producers conduct activities with cannabis. All facilities currently in production operate in accordance with the <i>Cannabis Act</i> requirements, including in relation to the security requirements. Health Canada conducts <i>ad hoc</i>, unscheduled site inspections of licensed producers under the <i>Cannabis Act</i>. The Company has been subject to these inspections numerous times. The Company has responded to and complied with all requests from Health Canada within the time frames indicated in such requests. As of the date hereof, there are no outstanding inspection issues with Health Canada beyond day-to-day adjustments that may occur in order to ensure ongoing compliance. For a summary of the requirements. See "Risk Factors".</p>
    <p style="text-align: justify;"><i><b>Specialized Skill and Knowledge</b></i></p>
    <p style="text-align: justify;">The nature of growing cannabis is not substantially different from the nature of growing other agricultural products. Variables such as temperature, humidity, lighting, air flow, watering and feeding cycles are meticulously defined and controlled to produce consistent product and to avoid contamination. The product is cut, sorted and dried under defined conditions that are established to protect the activity and purity of the product. Once processing is complete, each and every processed batch is subjected to full testing against stringent quality specifications set for activity and purity. The Company has recruited a production team with specialized skill sets unique to indoor agricultural cultivation and processing of cannabis plants and products at industrial scale.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_21"></a>
    <div id="header_page_21">
        <p style="text-align: center;">- 19 -</p>
    </div>
    <p style="text-align: justify;">The Company also requires client care personnel for its medical sales. The Company believes that it has recruited the necessary customer care staff.</p>
    <p style="text-align: justify;">In addition, in order to ensure compliance with the <i>Cannabis Act</i> and any directives issued by Health Canada, which includes strict security measures, equipment required to manage production, HVAC systems, odour control systems and laboratory equipment to monitor and test product quality, the Company must employ a number of regulatory personnel to assist the Company to remain compliant with the complex and rapidly evolving regulations applicable to the industry. The Company has successfully recruited the necessary personnel with this skill set.</p>
    <p style="text-align: justify;">The Company's management includes individuals who have extensive expertise in the cannabis industry. In addition, the Company's Board of Directors is constituted by experienced professionals from various relevant industries. See "Directors and Executive Officers" for additional information.</p>
    <p style="text-align: justify;"><i><b>Competitive Conditions</b></i></p>
    <p style="text-align: justify;">As of the date hereof, Health Canada has issued cultivation, processing or cannabis sales licences to a total of 550 licence holders. There are also a number of unlicensed growers of cannabis which compete with the legal market. The <i>Cannabis Act </i>allows for adults to legally grow up to four cannabis plants for personal use, however, the Company believes that competition from homegrown cannabis will be minimal and that it will not have a significant impact on market demand for high quality cannabis flower.</p>
    <p style="text-align: justify;">On May 8, 2019, Health Canada introduced changes to the cannabis licensing process. Under the new system, new applicants for licenses will be required by Health Canada to have a fully built site that meets all the requirements under the <i>Cannabis Regulations</i> at the time of their application. The Company believes that this requirement in addition to the extensive regulatory restrictions and large amounts of financing required for operations, will result in a relatively small number of large-scale licensed producers that can compete nationally and internationally, at least in in the short term.</p>
    <p style="text-align: justify;">However, as the demand for cannabis and cannabis products increases both nationally and internationally, the Company believes new competitors will enter the market. The principal aspects of competition between the Company and its competitors will be the price and quality of the products offered and client service provided to patients, government entities and private retailers.</p>
    <p style="text-align: justify;">As edible cannabis products have now been legalized in Canada, we expect that they will become a large market for licensed producers. Edibles are an attractive alternative and will likely appeal to a broader audience, particularly to those who are not interested in smoking. The Company is investing in new product development through research and development, the acquisition of new technologies and investing in new edible production facilities at the Moncton Campus. The Company deployed a strategy aimed at product depth as opposed to breadth to maintain its strong track record of delivering on supply commitments, which is critical to building brand equity. The Company has launched vaporizer pen products, cannabis- infused chocolates and dried powder beverage products.</p>
    <p style="text-align: justify;">In respect of hemp and hemp-derived CBD, with the increased interest in CBD internationally, the Company believes that the industrial hemp market will likely continue to expand. Market entrants in Canada face regulatory hurdles which may impede or delay access to the market.</p>
    <p style="text-align: justify;">There is potential that the Company will face intense competition from other cannabis producers, some of which can be expected to have longer operating histories and more financial resources and manufacturing and marketing experience than the Company. Increased competition by larger and better financed competitors could materially and adversely affect the business, financial condition and results of operations of the Company.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_22"></a>
    <div id="header_page_22">
        <p style="text-align: center;">- 20 -</p>
    </div>
    <p style="text-align: justify;"><i><b>Employees</b></i></p>
    <p style="text-align: justify;">As of August 31, 2020 the Company employees 552 employees, and as of November 20, 2020, the Company employed 517 employees.</p>
    <p style="text-align: justify;"><i><b>Canadian Regulatory Framework</b></i></p>
    <p style="text-align: justify;">On October 17, 2018, the <i>Cannabis Act</i> and the <i>Cannabis Regulations</i> (the "Cannabis Regulations") came into force, legalizing the sale of cannabis for adult recreational use in Canada. Prior to the <i>Cannabis Act</i> and the <i>Cannabis Regulations</i> coming into force, only the sale of medical cannabis was legal. Such sales of medical cannabis were regulated under the ACMPR.</p>
    <p style="text-align: justify;">The <i>Cannabis Act</i> and <i>Cannabis Regulations</i> establish a licensing and permitting scheme for the production, importation, exportation, testing, packaging, labelling, sending, delivery, transportation, sale, possession and disposal of cannabis both for medicinal and non-medicinal use (<i>i.e.</i> adult recreational use).</p>
    <p style="text-align: justify;">The <i>Cannabis Act</i> and the <i>Cannabis Regulations</i> replaced the CDSA and the ACMPR regarding rules for the production, sale and distribution of medical cannabis and related oil extract. The <i>Cannabis Act</i> maintains separate access to cannabis for medical purposes, including providing that import and export licenses and permits will be issued only in respect of cannabis for medical or scientific purposes or in respect of industrial hemp.</p>
    <p style="text-align: justify;">Transitional provisions of the <i>Cannabis Act</i> provided that every license and permit issued under the ACMPR that was in force immediately before the day on which the <i>Cannabis Act</i> came into force (being October 17, 2018) is deemed to be a license or permit issued under the <i>Cannabis Act</i> and that such license or permit will continue in force until it is revoked or expires.</p>
    <p style="text-align: justify;">On May 8, 2019, Health Canada changed its licensing criteria for new applicants for licenses to cultivate, process and sell cannabis for medical purposes. These categories of license applicants are now required to have a fully built site that meets all the requirements of the Cannabis Regulations at the time of their application, as well as satisfying any other applicable application criteria.</p>
    <p style="text-align: justify;">On October 17, 2019, the <i>Regulations Amending the Cannabis Regulations</i> (the "<b>Amended Cannabis Regulations</b>") came into force. The Amended Cannabis Regulations amend the Cannabis Act and Cannabis Regulations to, among other things, allow for the production, distribution and sale of cannabis extracts, cannabis topicals and cannabis edibles in addition to the other previously permitted product categories. The Amended Cannabis Regulations set out certain requirements for the sale of cannabis products, including limiting the THC content and serving size of certain product forms.</p>
    <p style="text-align: justify;">Given that the <i>Cannabis Act </i>and the <i>Cannabis Regulations </i>only recently came into force, the full impact of such regulatory changes on the Company's business is unknown. See Risk Factors "<i>Changes in Laws, Regulations and Guidelines</i>".</p>
    <p style="text-align: justify;"><i>Licenses, Permits and Authorizations</i></p>
    <p style="text-align: justify;">The <i>Cannabis Regulations</i> establish six classes of licenses under the <i>Cannabis Act</i>: cultivation licenses; processing licenses; analytical testing licenses; licenses for sale; research licenses; and cannabis drug licenses. The <i>Cannabis Regulations</i> also create subclasses for cultivation licenses (standard cultivation, micro-cultivation and nursery) and processing licenses (standard processing and micro-processing). Different licenses and each subclass therein carry differing rules and requirements that are intended to be proportional to the public health and safety risks posed by each license category and subclass. The <i>Cannabis Regulations</i> provide that all licenses issued under the <i>Cannabis Act</i> must include both the effective date and expiry date of the license, and may be renewed on or before the expiry date.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_23"></a>
    <div id="header_page_23">
        <p style="text-align: center;">- 21 -</p>
    </div>
    <p style="text-align: justify;">The <i>Cannabis Regulations</i> permit license holders to conduct activities only at the site and building set out in the license (except for destruction, antimicrobial treatment and distribution) and no licensed activities can take place in a "dwelling-house". The holder of a license must not produce, test, store, package or label cannabis outdoors, except for obtaining cannabis by cultivating, propagating or harvesting it.</p>
    <p style="text-align: justify;">The <i>Industrial Hemp Regulations</i> ("<b>IHR</b>") promulgated under the <i>Cannabis Act</i> came into force on October 17, 2018. The regulatory scheme for industrial hemp remained largely the same; however, the IHR permit the sale of hemp plants to licensed cannabis producers, the use of additional parts of the hemp plant and licensing requirements have been eased in accordance with the low risk posed by industrial hemp. The IHR defines "industrial hemp" as cannabis plants whose leaves and flowering heads do not contain more than 0.3% THC.</p>
    <p style="text-align: justify;"><i>Security Clearances</i></p>
    <p style="text-align: justify;">Certain people associated with cannabis licensees, including individuals occupying a "key position" such as directors, officers, significant shareholders and individuals identified by Canada's Minister of Health (the "<b>Minister</b>"), must hold a valid security clearance issued by the Minister. Under the <i>Cannabis Regulations</i>, the Minister may refuse to grant security clearances to individuals with associations to organized crime or with past convictions for, or in association with, drug trafficking, corruption or violent offences. This is largely the approach that has been in place under the ACMPR and other related regulations governing the licensed production of cannabis for medical purposes. Individuals who have histories of nonviolent, lower-risk criminal activity (<i>e.g.</i> simple possession of cannabis, or small-scale cultivation of cannabis plants) are not precluded by legislation from participating in the legal cannabis industry, and the grant of security clearance to such individuals is at the discretion of the Minister and such applications are reviewed on a case-by-case basis. Security clearances issued under the ACMPR are considered to be security clearances for the purposes of the <i>Cannabis Act</i> and the <i>Cannabis Regulations</i>.</p>
    <p style="text-align: justify;"><i>Cannabis Tracking and Licensing System</i></p>
    <p style="text-align: justify;">Under the <i>Cannabis Act</i>, the Minister is authorized to establish and maintain a national cannabis tracking system. The <i>Cannabis Regulations</i> set out a national cannabis tracking system to track cannabis throughout the supply chain to help prevent diversion of cannabis into, and out of, the legal market. The <i>Cannabis Act </i>also provides the Minister with the authority to make a ministerial order requiring certain persons named in such order to report specific information about their authorized activities with cannabis, in the form and manner specified by the Minister. Accordingly, the Minister has introduced the Cannabis Tracking and Licensing System, and license holders are required to use this system to submit monthly reports to the Minister, among other things, pursuant to the <i>Cannabis Tracking System Order</i>.</p>
    <p style="text-align: justify;"><i>Cannabis Products</i></p>
    <p style="text-align: justify;">As of October 17, 2018, the <i>Cannabis Act </i>and <i>Cannabis Regulations </i>permitted the sale to the public of dried cannabis, cannabis oil, fresh cannabis, cannabis plants, and cannabis seeds by authorized license holders. On October 17, 2019, the Amended Cannabis Regulations came into force adding edibles containing cannabis, cannabis extracts and cannabis topicals as new classes of cannabis permitted to be sold through medical and adult-use consumer channels. The THC content and serving size of cannabis products is limited by the <i>Cannabis Regulations</i>. Effective October 17, 2020 cannabis oil was deleted from the <i>Cannabis Act </i>and products must be sold as cannabis extracts, subject to compliance with other prohibitions and requirements of the <i>Cannabis Regulations</i>.<i> </i>See "<i>Developments During the Financial Year Ended August 31, 2019</i>" and "<i>Changes in Laws, Regulations and Guidelines</i>".</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_24"></a>
    <div id="header_page_24">
        <p style="text-align: center;">- 22 -</p>
    </div>
    <p style="text-align: justify;"><i>Packaging and Labelling</i></p>
    <p style="text-align: justify;">The <i>Cannabis Regulations</i> set out requirements pertaining to the packaging and labelling of cannabis products, which requirements are intended to promote informed consumer choice and allow for the safe handling and transportation of cannabis, while also reducing the appeal of cannabis to youth and promoting safe consumption. These requirements include plain packaging for cannabis products, strict requirements for logos, colours and branding as well as packaging that is tamper-proof and child-resistant. The <i>Cannabis Regulations</i> further require mandatory health warnings, product source information, including the class of cannabis and the name, phone number and email of the processor, the standardized cannabis symbol and specific product information including the THC and CBD content.</p>
    <p style="text-align: justify;"><i>Advertising</i></p>
    <p style="text-align: justify;">The <i>Cannabis Act</i> introduces strict restrictions on the promotion of cannabis products to, among other things, prevent promotion that could be appealing to young persons or evoke a positive or negative emotion about or image of, a way of life. Specifically, the Cannabis Act prohibits the promotion of cannabis, cannabis accessories or any services related to cannabis, unless such promotion is authorized under the <i>Cannabis Act</i>. Therefore, the Company may only advertise or promote its products in compliance with the provisions of the <i>Cannabis Act</i>.</p>
    <p style="text-align: justify;"><i>Cannabis for Medical Purposes</i></p>
    <p style="text-align: justify;">The <i>Cannabis Regulations</i> set out the regime governing access to medical cannabis which largely reflects the rules under the ACMPR. Patients who have the authorization of their healthcare provider continue to have access to medical cannabis, either purchased directly from a federally licensed producer, or by registering to produce a limited amount of cannabis for their own medical purposes, or designating someone to produce cannabis for them.</p>
    <p style="text-align: justify;"><i>Provincial Regulatory Framework</i></p>
    <p style="text-align: justify;">While the <i>Cannabis Act</i> provides for the regulation of the commercial production of cannabis for adult-use recreational purposes and related matters by the Government of Canada, the <i>Cannabis Act</i> enables the provinces and territories of Canada to regulate other aspects of adult-use recreational cannabis (similar to what is currently the case for liquor and tobacco products), such as sale and distribution, minimum age requirements, places where cannabis can be consumed, and a range of other matters.</p>
    <p style="text-align: justify;">As at the date hereof, the Company has entered into arrangements with distributors in all the provinces of Canada. The nature of these arrangements vary by jurisdiction.</p>
    <p style="text-align: justify;">The governments of every Canadian province and territory have, to varying degrees, enacted regulatory regimes for the distribution and sale of cannabis for recreational purposes within those jurisdictions. Most of these Canadian jurisdictions have a minimum age of 19 years old, except for Qu&#233;bec and Alberta, where the minimum age is 21 and 18, respectively.</p>
    <p style="text-align: justify;">There are three general frameworks enabled by provincial and territorial governments: (i) private cannabis retailers licensed by the provincial government; (ii) government run retail stores; and (iii) a combination of both frameworks. Regardless of the framework, the recreational cannabis market is ultimately supplied by federally licensed cultivators and processors. In most instances, provinces and territories have a government run wholesaler that is the exclusive source of cannabis products for retailers. The wholesalers, in turn, acquire cannabis products from the federally licensed cultivators and processors. The following chart outlines the current basic regime for recreational cannabis sales in each province and territory of Canada.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_25"></a>
    <div id="header_page_25">
        <p style="text-align: center;">- 23 -</p>
    </div>
    <table style="border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="background-color: #e6e6e6; width: 33%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p><b>Activity</b></p>
            </td>
            <td style="border-bottom: 0.75pt solid #000000; width: 33%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-left: 0.75pt solid #000000;">
                <p><b>Privately Operated</b></p>
            </td>
            <td style="background-color: #e6e6e6; width: 33%; vertical-align: top; border-left: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p><b>Publicly Operated</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 33%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Storefront Adult Use Sale</p>
            </td>
            <td style="width: 33%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>British Columbia <br>Alberta <br>Saskatchewan <br>Manitoba <br>Ontario <br>Newfoundland and Labrador<br>Nunavut<br>Northwest Territories<br>Yukon</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 33%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>British Columbia <br>Quebec <br>New Brunswick <br>Nova Scotia <br>Prince Edward Island<br>Yukon<br>Northwest Territories</p>
            </td>
        </tr>
        <tr>
            <td style="width: 33%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p>Online Adult Use Sale</p>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Saskatchewan <br>Manitoba<br>Nunavut</p>
            </td>
            <td style="width: 33%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p>British Columbia <br>Alberta<br>Ontario<br>Quebec<br>New Brunswick <br>Nova Scotia<br>Prince Edward Island <br>Newfoundland and Labrador<br>Northwest Territories<br>Yukon<br>Nunavut</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><i><b>Israeli Regulatory Framework</b></i></p>
    <p style="text-align: justify;">Cannabis, including all parts of the plant and the roots (but excluding oil extracted from its seeds) is defined, under the Israeli Dangerous Drugs Ordinance <b></b>(New Version<b></b>), 5737-1973, as a &#8220;dangerous drug&#8221; such that the sale and use of cannabis are prohibited unless a permit has been granted by the Israeli Ministry of Health (the &#8220;<b>MOH</b>&#8221;).&#160;</p>
    <p style="text-align: justify;">In recent years, the MOH has made a significant progress in regulating cannabis for medical use - with the end goal of treating medical cannabis as any other pharmaceutical drug. As part of such "medicalization" of cannabis progress, the Israeli Medical Cannabis Agency (the "<b>IMCA</b>"), was established (acting as a "Government Agency" pursuant to the United Nations Single Convention on Narcotic Drugs of 1961), and has been granted the authority to issue licenses for the use of cannabis for medical purposes and for the following aspects related to medical cannabis supply chain: cultivation, manufacturing, storage, sale and for medical cannabis related research. Under such medicalization reform, the IMCA has issued several directives, which set clearer and detailed standards and requirements for obtaining licenses for all such aspects of the medical cannabis.</p>
    <p style="text-align: justify;">The MOH issued, in December 2016 (last updated on October 2020) a procedure titled "Guidelines for Approval of Applications for Importation of Dangerous Drug of Cannabis Type for Medical Use and for Research" ("Procedure 109"). Procedure 109 provides guidelines for import applications and respective approval process, for research and medical use of cannabis. According to Procedure 109, the following permits and licenses are required to be obtained in order to be granted cannabis import license (for medical and research uses): (i) IMCA granted license to possess and operate in the medical cannabis field; (ii) a license to import plant material (to the extent that the imported cannabis is in a form of a plant, such as seeds, tissue culture), granted by the applicable department within the Israeli Ministry of Agriculture; (iii) a permit to import narcotic drugs, pursuant to the Dangerous Drugs Ordinance; and (iv) a license to import a dangerous drug, granted by the Department of Pharmaceutical import and Narcotics within the MOH. The IMCA has the discretion to grant or refuse to grant an import license, as well as to revoke a license previously granted.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_26"></a>
    <div id="header_page_26">
        <p style="text-align: center;">- 24 -</p>
    </div>
    <p style="text-align: justify;"><i><b>German Regulatory Framework</b></i></p>
    <p style="text-align: justify;">The Company, through its wholly-owned subsidiary 10870277 Canada Inc., acquired a 25% interest in the capital of alpha-cannabis Pharma GmbH (<b>"ACG</b>"). In addition, the Company entered into two supply agreements with ACG: one for the supply of CBD isolate from ACG, and the other for the supply of dried cannabis flower from Organigram Inc. to ACG.</p>
    <p style="text-align: justify;">On March 10, 2017, significant changes to the German Federal Law on Narcotic Drugs (<i>Bet&#228;ubungsmittelgesetz</i>, &#8220;<b>BtMG</b>&#8221;) as well as changes of other related legal rules entered into force. The new standards now allow the prescription of medical cannabis in Germany. This changes the overall legal framework for importing, trading and cultivating cannabis as well as the import and trade of cannabinoids such as CBD into and within Germany.</p>
    <p style="text-align: justify;">Cannabis itself is subject to German drug and narcotics law. The question of whether CBD is also subject to German drug law depends on the intended use and the corresponding dosage of the CBD. In any case, the narcotics law is not applicable to CBD. For the import of cannabis into the EU, various permits under German drug and narcotics law are required. For the trade and export of CBD, if classified as a drug or active pharmaceutical ingredient, permits under German drug law or at least notifications to authorities are required.</p>
    <p style="text-align: justify;">Furthermore, based on the United Nations Single Convention on Narcotic Drugs (1961) and Sec. 19 Para. 2aBtMG, the <i>Bundesinstitut fur Arzneimittel und Medizinprodukte</i> ("<b>BfArM</b>") established a so-called "Cannabis Agency" (Cannabisagentur) as soon as the latest changes of the law on narcotic drugs entered into force. The purpose of this agency is solely to control the future cultivation of medicinal cannabis in Germany. This includes the Cannabis Agency's competence for the actual cultivation as well as for harvesting, processing, quality control, storage, packaging and distribution of cannabis to pharmaceutical wholesalers.</p>
    <p style="text-align: justify;">The Cannabis Agency will only distribute cannabis that is grown in accordance with the "Good Agricultural and Collection Practice" for drugs and other relevant guidelines. The cultivation of cannabis will not technically be executed by the Cannabis Agency. The agency therefore enters into "supply contracts" with agricultural businesses. Those contracts are limited in respect of their duration and the quantity of cannabis the business is allowed to grow. Cultivation of medicinal cannabis is therefore not allowed by granting general licenses. To enter into a "supply contract", businesses must first be selected in a public call for tender procedure. Such tender procedures shall be open to be entered by suppliers in the whole European Union. The necessity of a tender process is based on the fact that medicinal cannabis must be bought as part of a public procurement procedure. The first allowances for the growing of medical cannabis in Germany based on a tender procedure were issued on April 17, 2019. Organigram and ACG jointly submitted a tender for domestic cultivation in that process, but were unsuccessful.</p>
    <p style="text-align: justify;"><i>Related Corporate Activities</i></p>
    <p style="text-align: justify;">The activities contemplated to be undertaken by the Company and ACG will require numerous permits from the German government, including the following, which have not yet been obtained: a building permit for operating a laboratory, a wholesale license for pharmaceuticals, an import license for narcotic drugs, a narcotic drugs license, and a manufacturing license for repackaging pharmaceuticals and narcotics drugs.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_27"></a>
    <div id="header_page_27">
        <p style="text-align: center;">- 25 -</p>
    </div>
    <p style="text-align: justify;">Upon obtaining the aforementioned permits, the following activities will be legally authorized in Germany:</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(a)<font style="width: 23.79pt; text-indent: 0pt; display: inline-block;">&#160;</font>the trade in CBD as an active pharmaceutical ingredient by purchasing the same from a German company and selling it to a German wholesaler;</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(b)<font style="width: 23.17pt; text-indent: 0pt; display: inline-block;">&#160;</font>the contemplated export of CBD isolate to the Company;</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(c)<font style="width: 23.79pt; text-indent: 0pt; display: inline-block;">&#160;</font>the import of cannabis flowers into the European Union and the trade in the same within the European Union; and</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(d)<font style="width: 23.17pt; text-indent: 0pt; display: inline-block;">&#160;</font>the production of small-scale cannabis extract products for distribution into German pharmacies.</p>
    <p style="text-align: justify;">The participation in tendering procedures of BfArM for the cultivation and harvesting of cannabis for medical purposes in Germany, however, is not subject to any permits.</p>
    <p style="text-align: justify;">During Q3 Fiscal 2020, the Company delivered its first shipment of dried flower to ACG for testing purposes as ACG is seeking to obtain certification for EU GMP certified cannabis oil extracted from the Company's non-certified dried flower.</p>
    <p style="text-align: center;"><b>RISK FACTORS</b></p>
    <p style="text-align: justify;">There are a number of risk factors that could cause future results to differ materially from those described herein. The risks and uncertainties described herein are not the only ones the Company faces. Additional risks and uncertainties, including those that the Company does not know about now or that it currently deems immaterial, may also adversely affect the Company's business.</p>
    <p style="text-align: justify;">If any of the following risks actually occur, the Company's business may be harmed and its financial condition and results of operations may suffer significantly.</p>
    <p style="text-align: justify;"><i>Competition from the Illicit Market</i></p>
    <p style="text-align: justify;">The Company also faces competition from unlicensed and unregulated market participants, including individuals or groups that process cannabis without a license under the <i>Cannabis Act</i>, including illicit medical dispensaries and other illicit participants selling cannabis in Canada. These competitors may be able to offer products with higher concentrations of active ingredients than the Company would be authorized to produce and sell. The competition presented by these participants, and any unwillingness by consumers currently using these illicit distribution channels to begin purchasing from the regulated market for any reason, or any inability of law enforcement authorities to enforce existing laws prohibiting the unlicensed cultivation, production and sale of cannabis, could adversely affect our market share, result in increased competition through the illicit market for cannabis or have an adverse impact on the public perception of cannabis use, and of Canadian federal license holders.</p>
    <p style="text-align: justify;"><i>Management of Growth</i></p>
    <p style="text-align: justify;">The Company may be subject to growth-related risks, including capacity constraints and pressure on its internal systems and controls. The ability of the Company to manage growth effectively will require it to continue to implement and improve its operational and financial systems and to expand, train and manage its employee base. If the Company is unable to deal with this growth, it may have a material adverse effect on the Company&#8217;s business, financial condition, results of operations and prospects.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_28"></a>
    <div id="header_page_28">
        <p style="text-align: center;">- 26 -</p>
    </div>
    <p style="text-align: justify;"><i>Governmental Regulation</i></p>
    <p style="text-align: justify;">The business and activities of the Company are heavily regulated in all jurisdictions where the Company carries on business. The Company&#8217;s operations are subject to various laws, regulations and guidelines by governmental authorities, particularly Health Canada, relating to the manufacture, marketing, management, transportation, storage, sale, pricing and disposal of cannabis, cannabis oil, and cannabis derivatives. The Company is also subject to laws and regulations relating to health and safety, insurance coverage, the conduct of operations and the protection of the environment. Laws and regulations, applied generally, grant government agencies and self-regulatory bodies broad administrative discretion over the activities of the Company, including the power to limit or restrict business activities as well as impose additional disclosure requirements on the Company regarding its products and services.</p>
    <p style="text-align: justify;">Achievement of the Company&#8217;s business objectives are contingent, in part, upon compliance with regulatory requirements enacted by governmental authorities and obtaining all regulatory approvals, where necessary, for the production and sale of its products. The Company cannot predict the time required to secure all appropriate regulatory approvals for its products, or the extent of testing and documentation that may be required by governmental authorities. Any delays in obtaining, or failure to obtain regulatory approvals would significantly delay the development of markets and products and could have a material adverse effect on the business, results of operations and financial condition of the Company.</p>
    <p style="text-align: justify;">Failure to comply with the laws and regulations applicable to the Company&#8217;s operations may lead to possible sanctions including the revocation or imposition of additional conditions on licenses to operate the Company&#8217;s business; the suspension or expulsion from a particular market or jurisdiction or of its key personnel; the imposition of additional or more stringent inspection, testing and reporting requirements; and, the imposition of fines and censures. To the extent that there are changes to the existing laws and regulations or the enactment of future laws and regulations that affect the sale or offering of the Company&#8217;s products or services in any way, the Company&#8217;s revenues may be adversely affected.</p>
    <p style="text-align: justify;">In light of the illegality of cannabis under U.S. federal law (other than measures to legalize hemp) any engagement in cannabis-related activities, both in Canada as well as in foreign jurisdictions, may lead to heightened scrutiny by regulatory bodies and other authorities that could negatively impact the Company and/or its personnel. The Company does not have U.S. cannabis-related activities. Specifically, the Company has no investment or ownership in any U.S. entity nor does it provide any products or services to U.S. entities.</p>
    <p><i>Changes in Laws, Regulations and Guidelines</i></p>
    <p style="text-align: justify;">The Company&#8217;s business is subject to a variety of laws, regulations and guidelines relating to marketing, acquisition, manufacture, management, transportation, storage, sale and disposal of cannabis but also laws and regulations relating to health and safety, the conduct of operations and the protection of the environment. Changes to such laws, regulations and guidelines may cause adverse effects to the Company&#8217;s operations.</p>
    <p style="text-align: justify;">The legislative framework pertaining to the Canadian recreational cannabis market is subject to significant provincial and territorial regulation, which varies across provinces and territories and results in an asymmetric regulatory and market environment, different competitive pressures and significant additional compliance and other costs and/or limitations on the Company&#8217;s ability to participate in such markets.</p>
    <p style="text-align: justify;">The laws, regulations and guidelines applicable to the cannabis industry domestically and internationally, including in Germany and Israel, may change in ways currently unforeseen by the Company. The <i>Cannabis Act</i> became effective on October 17, 2018. However, uncertainty exists with respect to the implementation of the <i>Cannabis Act</i>, federal regulations thereunder as well as the various provincial and territorial regimes governing the distribution and sale of cannabis for adult-use recreational purposes.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_29"></a>
    <div id="header_page_29">
        <p style="text-align: center;">- 27 -</p>
    </div>
    <p style="text-align: justify;">The laws and regulations may change both federally and provincially, with new rules and regulations arising regularly. The <i>Cannabis Regulations</i> were amended effective October 17, 2019, to allow for cannabis edibles to be introduced into the market and expand the use of cannabis derivatives commercially. However, the amendments are highly restrictive, and include restrictions on adding caffeine, nicotine, or alcohol to cannabis edibles.</p>
    <p style="text-align: justify;">Additional restrictions on edible and other cannabis derivative based products may also be introduced by the Provincial governments. Effective January 1, 2020, the legal age to buy recreational cannabis increased to 21 in Quebec and the Quebec government banned the sale of certain edible cannabis products in the form of chocolate, candy and other desserts. Staying on side of regularly changing rules and regulations will require ongoing time and attention from Company management. In addition, the Company&#8217;s derivative product strategy includes vaporizable products which may be subject to negative consumer perception and may be subject to additional regulation and restriction over and above the current regulatory requirements in place under the <i>Cannabis Act</i>. This may include governmental restriction of the sale of such products and/or imposition of additional costs.</p>
    <p style="text-align: justify;">While the Company does not currently have a license issued under Section 9 of the <i>Industrial Hemp Regulations</i>, it may purchase industrial hemp from such licensees. Any change to the <i>Cannabis Act</i> or the <i>Industrial Hemp Regulations</i> promulgated thereunder that impacts suppliers&#8217; ability to cultivate, produce, or sell industrial hemp to the Company could adversely impact the Company&#8217;s ability to deliver its products or services, should the Company depend on such supply to meet its product production goals or obligations.</p>
    <p><i>Reliance on License Renewal</i></p>
    <p style="text-align: justify;">The Company&#8217;s ability to produce, store and sell cannabis, cannabis oil extracts and derivative products in Canada is dependent on its License from Health Canada. Failure to comply with the requirements of the License or any failure to maintain this License would have a material adverse impact on the business, financial condition and operating results of the Company. The Company&#8217;s License has a current expiry date of March 20, 2023.</p>
    <p style="text-align: justify;">Although management believes it will meet the requirements of the <i>Cannabis Act</i> for extension of the License, there can be no guarantee that Health Canada will extend or renew the License or, if it is extended or renewed, that it will be extended or renewed on the same or similar terms. Should Health Canada not extend or renew the License, or should it renew the License on different terms or not provide the amendments as requested for anticipated capacity increases, the business, financial condition and results of the operations of the Company will be materially adversely affected. The Company has also been issued a Cannabis license under the Excise Act which is required to package and distribute cannabis and a research license as described herein.</p>
    <p><i>Negative Cash Flow from Operations</i></p>
    <p style="text-align: justify;">During the year ended August 31, 2020, the Company had negative cash flow from operating activities. The Company&#8217;s cash and short-term investments as at August 31, 2020, was approximately $74,728,000.</p>
    <p style="text-align: justify;">Although the Company anticipates it will have positive cash flow from operating activities in future periods, the Company cannot guarantee it will have a cash flow positive status in the future due to its desire to increase the number of employees and its level of participation in the adult-use recreational market in Canada. To the extent that the Company has negative cash flow in any future period, certain of the proceeds from its offerings may be used to fund such negative cash flow from operating activities.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_30"></a>
    <div id="header_page_30">
        <p style="text-align: center;">- 28 -</p>
    </div>
    <p><i>Wholesale Price of Cannabis Volatility</i></p>
    <p style="text-align: justify;">The Company&#8217;s revenues are in a large part derived from the production, sale, and distribution of cannabis. The cost of production, sale, and distribution of cannabis is dependent on a number of key inputs and their related costs, including equipment and supplies, labour and raw materials related to our growing operations, as well other overhead costs such as electricity, water, and utilities. Any significant interruption or negative change in the availability or economics of the supply chain for key inputs could materially impact our financial condition and operating results. Any inability to secure required supplies and services or to do so on appropriate terms could have a materially adverse impact on our business, financial condition, results of operations and prospects. This includes any change in the selling price of products set by the applicable province or territory. There is currently no established market price for cannabis and the price of cannabis is affected by numerous factors beyond our control. Any price decline may have a material adverse effect on our business, financial condition and operations.</p>
    <p><i>Reliance on a Single Facility</i></p>
    <p style="text-align: justify;">To date, the Company&#8217;s activities and resources have been primarily focused on the Moncton Campus in Moncton, New Brunswick and the Company will continue to rely on it for the foreseeable future. Adverse changes or developments affecting the Moncton Campus could have a material and adverse effect on the Company&#8217;s business, financial condition and prospects, including impacting the quantity of product produced by the Company.</p>
    <p><i>Competition</i></p>
    <p style="text-align: justify;">There is potential that the Company will face intense competition from other companies, some of which can be expected to have longer operating histories and more financial resources and production and marketing experience than the Company.</p>
    <p style="text-align: justify;">Because of the early stage of the industry in which the Company operates, the Company expects to face additional competition from new entrants. If the number of users of cannabis in Canada increases, the demand for products will increase and the Company expects that competition will become more intense, as current and future competitors begin to offer an increasing number of diversified products and pricing strategies. To remain competitive, the Company will require a continued high level of investment in research and development, marketing, sales and client support. The Company may not have sufficient resources to maintain research and development, marketing, sales and client support efforts on a competitive basis which could materially and adversely affect the business, financial condition and results of operations of the Company.</p>
    <p style="text-align: justify;">In addition, not all of the Company&#8217;s supply arrangements with the various Canadian provinces contain purchase commitments or otherwise obligate the provincial wholesaler to buy a minimum or fixed volume of cannabis products from the Company. The amount of cannabis that the provincial wholesalers may purchase under any supply arrangements may therefore vary from what the Company expects or has planned for. As a result, the Company&#8217;s revenues could fluctuate materially in the future and could be materially and disproportionately impacted by the purchasing and return decisions of the provincial or territorial wholesalers. If any of the provincial wholesalers decide to purchase lower volumes of products from the Company than the Company expects, alters its purchasing patterns at any time with limited notice, returns product or decides not to continue to purchase the Company&#8217;s cannabis products at all, the Company&#8217;s revenues could be materially adversely affected, which could have a material adverse effect on the Company&#8217;s business, financial condition, results of operations and prospects.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_31"></a>
    <div id="header_page_31">
        <p style="text-align: center;">- 29 -</p>
    </div>
    <p><i>Dependence on Senior Management</i></p>
    <p style="text-align: justify;">The success of the Company and its strategic focus is dependent to a significant degree upon the contributions of senior management. The loss of any of these individuals, or an inability to attract, retain and motivate sufficient numbers of qualified senior management personnel could adversely affect the Company&#8217;s business. As well, the implementation of employee compensation packages, composed of monetary short-term compensation and long-term equity-based compensation, has been designed for the retention of key employees.</p>
    <p style="text-align: justify;"><i>Breach of Financial Covenants</i><i>&#160;</i></p>
    <p style="text-align: justify;">The credit facility contains covenants that require the Company to maintain certain&#160;minimum&#160;financial ratios&#160;and targets, which, given the early stages of the industry and market and the developing consumer trends, among other factors, may be difficult to maintain period-over-period. If the Company does not maintain such ratios&#160;and targets, it could have consequences for the availability of credit under the credit facility or result in repayment requirements that the Company may not be able to satisfy if the Company is unable to renegotiate the terms of the credit facility, as it has been able to do historically when faced with possible financial&#160; covenant breaches. In addition, restrictions and covenants from those facilities may limit the Company's ability to execute its plans.</p>
    <p style="text-align: justify;"><i>COVID-19</i></p>
    <p style="text-align: justify;">On March 11, 2020, the World Health Organization declared the outbreak of a novel strain of coronavirus ("<b>COVID-19</b>") a global pandemic. The Company's business, including its operations, supply chains and interactions with counterparties, and its financial condition may be adversely impacted by the effects of COVID-19 and other infectious diseases.</p>
    <p style="text-align: justify;">The extent to which COVID-19 and other infectious diseases may impact the Company's business, including its operations and the market for its securities and its financial condition, will depend on future developments, which are highly uncertain and cannot be predicted at this time. These include the duration, severity and scope of the outbreak and the actions taken by applicable governmental entities to address and mitigate COVID-19 or any other infectious diseases. In particular, the continued spread of COVID-19 globally could materially and adversely impact the Company's business including, without limitation, employee health, workforce productivity, increased insurance premiums, limitations on travel, disruption to supply chains and the ability to deliver the Company's products to end customers. In addition, government efforts to curtail the spread of COVID-19 may result in temporary or long-term suspensions or shut-downs of our operations, impact our customers and affect our supply chain. Such suspensions and disruptions may have a material and adverse effect on the Company's business, financial condition and results of operations.</p>
    <p style="text-align: justify;">In connection with COVID-19, we are taking additional safety measures at our facility. However, such measures and related government mandates may not be effective, and one or more of our employees may get sick and may come to work infected, necessitating a short or long-term closure of the facility, disrupting production. Such measures and mandates may also increase our expenses and otherwise impair our production levels or cause us to close or severely limit production at our facility. Further, legal cannabis dispensaries in certain Canadian markets may close voluntarily or be forced to close by the provincial governments, reducing our ability to distribute cannabis. For example, the Ontario government required retail dispensaries in the province to close for a short period, after which they were allowed to reopen, subject to certain limitations. In addition, consumer demand for cannabis and our other products may be reduced as a result of reductions in consumers' disposable income associated with layoffs and work or pay limitations due to mandatory social distancing and lockdown measures implemented by governments in the geographies where we operate. Production limitations or stoppages, social distancing measures and other impediments affecting our suppliers, partners or our facility, should they materialize, may make it difficult, more costly, or impossible for us to conduct portions of our business. Limitations on the function of Health Canada and other regulators as a result of remote work of its employees or redeployment of its resources to addressing the pandemic may delay our communications with the regulatory authorities and delay renewal of our existing licences or the receipt of additional licences required for our operations, should such licences be sought. If macroeconomic conditions continue to worsen in Canada and around the world, demand for cannabis and our other products may significantly decline and industry participants, including our customers and suppliers, may face financial hardship. In addition, the increased market volatility resulting from global business and economic disruption related to the pandemic and measures to contain it has made it more difficult for companies to access capital markets. The duration and severity of the COVID-19 pandemic is currently unknown, and the pandemic may continue for a significant period of time. Any of the foregoing may adversely affect our business, financial position and results of operations.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_32"></a>
    <div id="header_page_32">
        <p style="text-align: center;">- 30 -</p>
    </div>
    <p><i>Volatile Market Price of the Company&#8217;s Securities</i></p>
    <p style="text-align: justify;">The market price of the Company&#8217;s securities may be volatile and subject to wide fluctuations in response to numerous factors, many of which are beyond the Company&#8217;s control. This volatility may affect the ability of holders of Company&#8217;s securities to sell their securities at an advantageous price. Market price fluctuations in the Company&#8217;s securities may be due to the Company&#8217;s operating results, failing to meet expectations of securities analysts or investors in any period, downward revision in securities analysts&#8217; estimates, adverse changes in general market conditions, economic trends, acquisitions, dispositions, or material public announcements by government and regulatory authorities, the Company or its competitors, along with a variety of additional factors. These broad market fluctuations may adversely affect the market price of the Company&#8217;s securities.</p>
    <p style="text-align: justify;">Financial markets have at times historically experienced significant price and volume fluctuations that have particularly affected the market prices of equity securities of companies and that have often been unrelated to the operating performance, underlying asset values or prospects of such companies. Accordingly, the market price of the Company&#8217;s securities may decline even if the Company&#8217;s operating results, underlying asset values or prospects have not changed. Additionally, these factors, as well as other related factors, may cause decreases in asset values that are deemed to be other than temporary, which may result in impairment losses. There can be no assurance that continuing fluctuations in price and volume will not occur. If such increased levels of volatility and market turmoil continue, the Company&#8217;s operations could be adversely impacted and the trading price of the Company&#8217;s securities may be materially adversely affected.</p>
    <p><i>Limited Operating History and History of Losses</i></p>
    <p style="text-align: justify;">The Company began its business in 2013 and generated minimal revenue until fiscal 2017 and incurred losses since inception. The Company&#8217;s adult recreational business has only been operative since legalization in October 2018 and the sale of its edible and derivative products is in its infancy. The Company is therefore subject to many of the risks common to early-stage enterprises, including limitations with respect to personnel and other resources and lack of revenues. There is no assurance that the Company will be successful in achieving a return on shareholders&#8217; investments and the likelihood of success must be considered in light of the early stage of operations.</p>
    <p><i>Product Liability</i></p>
    <p style="text-align: justify;">As a manufacturer and distributor of products designed to be ingested or vaporized by humans, the Company faces an inherent risk of exposure to product liability claims, regulatory action and litigation if its products are alleged to have caused significant loss or injury. In addition, the manufacture and sale of the Company&#8217;s products involve the risk of injury to consumers due to tampering by unauthorized third parties or product contamination. Previously unknown adverse reactions resulting from human consumption of the Company&#8217;s products alone or in combination with other medications or substances could occur. The Company may be subject to various product liability claims, including, among others, that the Company&#8217;s products caused injury or illness, include inadequate instructions for use or include inadequate warnings concerning possible side effects or interactions with other substances. A product liability claim or regulatory action against the Company could result in increased costs, could adversely affect the Company&#8217;s reputation with its clients and consumers generally, and could have a material adverse effect on our results of operations and financial condition of the Company.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_33"></a>
    <div id="header_page_33">
        <p style="text-align: center;">- 31 -</p>
    </div>
    <p style="text-align: justify;">There can be no assurances that the Company will be able to obtain or maintain product liability insurance on acceptable terms or with adequate coverage against potential liabilities. Such insurance is expensive and may not be available in the future on acceptable terms, or at all. The inability to obtain sufficient insurance coverage on reasonable terms or to otherwise protect against potential product liability claims could prevent or inhibit the commercialization of the Company&#8217;s potential products. As of the current date, the Company has a small amount of insurance coverage for product liabilities.</p>
    <p><i>Sufficiency of Insurance</i></p>
    <p style="text-align: justify;">The Company maintains various types of insurance which may include financial institution bonds; errors and omissions insurance; directors&#8217; and officers&#8217; insurance; property coverage; product liability recall insurance; and, general commercial and liability insurance. There is no assurance that claims will not exceed the limits of available coverage, if any, that any insurer will remain solvent or willing to continue providing insurance coverage with sufficient limits or at a reasonable cost, or that any insurer will not dispute coverage of certain claims. There is also no assurance that coverage will be available to cover any or all claims. A judgment against the Company or any member of the Company in excess of available coverage could have a material adverse effect on the Company in terms of damages awarded and the impact on the reputation of the Company. There can also be no assurance that the Company will be able to secure insurance coverage on commercially reasonable terms, or at all, as it may require to implement its business objectives, including with respect to derivative products.</p>
    <p><i>TSX and Nasdaq Requirements</i></p>
    <p style="text-align: justify;">The Common Shares commenced trading on the TSX on August 22, 2019 following the Company&#8217;s graduation from the TSX-V. The Company&#8217;s Common Shares also began trading on Nasdaq for the first time on May 21, 2019.</p>
    <p style="text-align: justify;">Listing on the TSX and Nasdaq creates different restrictions and requirements, and creates more exposure than did the TSX-V. The Company needs to comply with TSX and Nasdaq rules, policies and guidelines, especially when pursuing business internationally. As a public company, the business is subject to corporate governance and public disclosure requirements that may at times increase the Company&#8217;s compliance costs and risk of non-compliance. These regulations, rules, policies and guidelines may change over time, and failure to continue to meet them could result in significant material adverse consequences.</p>
    <p style="text-align: justify;">The TSX has issued guidance directed at cannabis companies, and specifically with respect to any company operating in the United States. In addition, in connection with its listing on Nasdaq, the Company certified that neither it nor any of its subsidiaries will conduct any business activities in the U.S., or utilize any employees, facilities or operations in the U.S. Presently, the Company has no business in the U.S., but this could present additional barriers in the future should the Company seek to do business in any form in the U.S. Any violation of U.S. federal law regarding cannabis could result in delisting of the Company from TSX and Nasdaq.</p>
    <p style="text-align: justify;">As a public company in the U.S., the Company is subject to additional legal, insurance, accounting, administrative and other costs and expenses which, in the aggregate, can be substantial.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_34"></a>
    <div id="header_page_34">
        <p style="text-align: center;">- 32 -</p>
    </div>
    <p style="text-align: justify;"><i>Financing</i></p>
    <p style="text-align: justify;">There is no guarantee that the Company will be able to achieve its business objectives. The continued development of the Company may require additional financing. The failure to raise such capital could result in the delay or indefinite postponement of current business objectives or the Company ceasing to carry on business. There can be no assurance that additional capital or other types of financing will be available if needed or that, if available, the terms of such financing will be favorable to the Company. In addition, from time to time, the Company may enter into transactions to acquire assets or the shares of other corporations. These transactions may be financed wholly or partially with debt, which may increase the Company's debt levels above industry standards.</p>
    <p style="text-align: justify;">The Credit Agreement includes, and any future debt finance could include, restrictive covenants relating to capital raising activities and other financial and operational matters, which do and may make it more difficult for the Company to obtain additional capital and to pursue business opportunities, including potential acquisitions. The Credit Agreement contains, and any future debt financings may also contain, provisions which, if breached, may entitle lenders or their agents to accelerate repayment of loans and/or realize upon security over the assets of the Company, and there is no assurance that the Company would be able to repay such loans in such an event or prevent the enforcement of security granted pursuant to such debt financing.</p>
    <p style="text-align: justify;"><i>Reliance on Key Personnel</i></p>
    <p style="text-align: justify;">The success of the Company is dependent upon the ability, expertise, judgment, discretion and good faith of its executive management. The Company&#8217;s future success depends on its continuing ability to attract, develop, motivate and retain highly qualified and skilled employees. Qualified individuals are in high demand, and the Company may incur significant costs to attract and retain them. The loss of the services of member of the Company&#8217;s executive management, or an inability to attract other suitably qualified persons when needed, could have a material adverse effect on the Company&#8217;s ability to execute on its business plan and strategy, and the Company may be unable to find adequate replacements on a timely basis, or at all. Further, as designated individuals of a licensee under the <i>Cannabis Act</i>, key personnel of the Company are subject to a security clearance by Health Canada. There is no assurance that any of the Company&#8217;s key personnel who presently or may in the future require a security clearance will be able to obtain or renew such clearances or that new personnel who require a security clearance will be able to obtain one. A failure by any of those individuals to maintain or renew his or her security clearance, could result in a material adverse effect on the Company&#8217;s business, financial condition and results of operations. In addition, if any such individual leaves the Company, and the Company is unable to find a suitable replacement that has a security clearance required by the Cannabis Act in a timely manner, or at all, there could occur a material adverse effect on the Company&#8217;s business, financial condition and results of operations.</p>
    <p style="text-align: justify;"><i>The Company May Not be Able to Successfully Develop New Products or Find a Market for Their Sale</i></p>
    <p style="text-align: justify;">The medical and recreational cannabis industries are in the early stages of development and it is likely that the Company, and its competitors, will seek to introduce new products in the future, including edible cannabis products and cannabis derivatives. In attempting to keep pace with any new market developments, the Company may need to expend significant amounts of capital in order to successfully develop and generate revenues from new products introduced by the Company. As well, the Company may be required to obtain and maintain additional regulatory approvals from Health Canada and any other applicable regulatory authority, which may take significant amounts of time. The Company may not be successful in developing effective and safe new products, bringing such products to market in time to be effectively commercialized, or obtaining any required regulatory approvals, which, together with any capital expenditures made in the course of such product development and regulatory approval processes, may have a material adverse effect on the Company's business, financial condition and results of operations.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_35"></a>
    <div id="header_page_35">
        <p style="text-align: center;">- 33 -</p>
    </div>
    <p style="text-align: justify;"><i>Product Recalls</i></p>
    <p style="text-align: justify;">On January 9, 2017, the Company expanded its voluntary recall to a further 69 lots of product in addition to the recall of five lots of product initiated on December 28, 2016. The recalled products included dried cannabis and cannabis oil supplied between February and December 2016, after testing revealed the presence of low levels of myclobutanil and/or bifenazate in some of the lots, which are unapproved pesticides not registered for use in cannabis production under the <i>Pest Control Products Act</i>. While the initial recall had classified the recall as a Type III recall (not likely to cause harm), the second recall elevated this classification to a Type II recall (product exposure may cause temporary adverse health consequences). As of the date hereof, Health Canada has received nine adverse reaction reports related to the Company's products. There can be no assurance that additional adverse reaction reports will not be filed with Health Canada. To the extent any additional adverse reaction reports are filed, such an occurrence could have an adverse impact on the business, results of operations and financial condition of the Company. A class action lawsuit has also been filed and is now certified, as more particularly described in Risk Factors "<i>Product Liability</i>", "<i>Litigation</i>" and "<i>Legal Proceedings and Regulatory Actions</i>". The decision to certify elements of the class action was appealed and partially overturned by the Nova Scotia Court of Appeal.</p>
    <p style="text-align: justify;">Manufacturers and distributors of products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, such as contamination, unintended harmful side effects or interactions with other substances, packaging safety and inadequate or inaccurate labeling disclosure. Undiscovered product liability claims are always a potential risk. However moving forward, if any of the Company's products are recalled in the future due to an alleged product defect or for any other reason, the Company would be required to incur the unexpected expense of the recall and any legal proceedings that might arise in connection with the recall. The Company may lose a significant amount of sales and may not be able to replace those sales at an acceptable margin or at all. In addition, a product recall may require significant management attention thereby reducing the amount of time members of management would otherwise have focused towards managing the Company. Although the Company has detailed procedures in place for testing finished products, there can be no assurance that any quality, potency or contamination problems will be detected in time to avoid unforeseen product recalls, regulatory action or lawsuits. Additionally, if one of the Company's significant brands were subject to recall, the image of that brand and the Company could be harmed. A recall for any of the foregoing reasons could lead to decreased demand for the Company's products and could have a material adverse effect on the results of operations and financial condition of the Company. Additionally, product recalls may lead to increased scrutiny of the Company's operations by Health Canada or other regulatory agencies, requiring further management attention and potential legal fees and other expenses.</p>
    <p style="text-align: justify;"><i>Litigation</i></p>
    <p style="text-align: justify;">On January 18, 2019, the Nova Scotia Supreme Court certified a class action lawsuit by a class of persons and entities who purchased medical cannabis that was the subject of the Company's product recalls in December 2016 and January 2017, as such products may have contained trace elements of the pesticides myclobutanil and bifenazate, which are not approved for use in cannabis production. On April 30, 2020, the Nova Scotia Court of Appeal partially overturned the certification of the class action, significantly reducing the scope of the claim against the Company. See "<i>Legal Proceedings and Regulatory Actions</i>".</p>
    <p style="text-align: justify;">A legal action has been commenced in the Court of Queen's Bench in Alberta, which action seeks damages against many of the largest Canadian cannabis companies (including the Company). The action is not certified, and does not particularize the claims against the Company or the other companies.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_36"></a>
    <div id="header_page_36">
        <p style="text-align: center;">- 34 -</p>
    </div>
    <p style="text-align: justify;">In addition to ongoing litigation, the Company may become party to litigation from time to time in the ordinary course of business which could adversely affect its business. Should any litigation in which the Company becomes involved be determined against the Company, such a decision could adversely affect the Company's ability to continue operating and the market price for the Common Shares, and could require the use of significant resources. Even if the Company is involved in litigation and wins, litigation can redirect significant Company resources.</p>
    <p style="text-align: justify;"><i>Securities Class Action</i></p>
    <p style="text-align: justify;">Securities class action litigation is often brought against companies following a period of volatility in the market price of their securities. Litigation can result in significant costs and damages and divert management attention and resources.</p>
    <p style="text-align: justify;"><i>Difficulties with Forecasts</i></p>
    <p style="text-align: justify;">The Company must rely largely on its own market research to forecast sales as detailed forecasts are not generally obtainable from other sources at this early stage of the cannabis industry. A failure in the demand for its products to materialize as a result of competition, technological change or other factors could have a material adverse effect on the business, results of operations and financial condition of the Company.</p>
    <p style="text-align: justify;"><i>Uninsured or Uninsurable Risks</i></p>
    <p style="text-align: justify;">While we may have insurance to protect our assets, operations, and employees, such insurance is subject to coverage limits and exclusions and may not be available for the risks and hazards to which we are exposed. No assurance can be given that such insurance will be adequate to cover our liabilities or that it will be available in the future or at all, and that it will be commercially justifiable. We may be subject to liability for risks against which we cannot insure or against which we may elect not to insure due to the high cost of insurance premiums or other factors. The payment of any such liabilities would reduce the funds available for our normal business activities. Payment of liabilities for which we do not carry insurance may have a material adverse effect on our financial position and operations.</p>
    <p style="text-align: justify;"><i>Unknown Health Impact of Use of Cannabis and Derivatives</i></p>
    <p style="text-align: justify;">There is little in the way of longitudinal studies on the short-term and long-term effects of cannabis use on human health, whether used for recreational or medicinal purposes. As such, there are inherent risks associated with using the Company's cannabis and derivative products. Previously unknown or unforeseeable adverse reactions arising from human consumption of cannabis products may occur which could adverse affect social acceptance of cannabis and the demand for the Company's products.</p>
    <p style="text-align: justify;"><i>Third Party Transportation</i></p>
    <p style="text-align: justify;">In order for customers of the Company to receive their product, the Company must rely on third-party transportation services. This can cause logistical problems with and delays in patients, government entities and private retailers obtaining their orders and cannot be directly controlled by the Company. Any delay by third party transportation services may adversely affect the Company's financial performance.</p>
    <p style="text-align: justify;">Moreover, security of the product during transportation to and from the Moncton Campus is critical due to the nature of the product. A breach of security during transport could have material adverse effects on the Company's business, financials and prospects. Any such breach could impact the Company's ability to continue operating under its licenses or the prospect of renewing its licenses.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_37"></a>
    <div id="header_page_37">
        <p style="text-align: center;">- 35 -</p>
    </div>
    <p style="text-align: justify;"><i>Ability to Meet Production Targets </i></p>
    <p style="text-align: justify;">The Company sets production targets on dried flower, extracted oil and formulated oil. Actual production amounts may not achieve targeted production figures as a result of many factors including but not limited to: genetic drift in the strains of cannabis plants grown, shift in strains grown as a result of competitive pressure, natural variations in plant development, inability to precisely influence growth measures as a result of numerous variables that may influence the plant growth that are varied from one growth cycle to another, product that does not meet quality assurance specifications including, but not limited to, pesticide or heavy metals testing, tetrahydrocannabinol and cannabidiol specifications, terpene profile or visual appearance, operational inefficiencies from extraction processes or in production of formulated oil for sale.</p>
    <p style="text-align: justify;"><i>Continuance of Contractual or Other Relations with Provincial Governments Cannot be Guaranteed</i></p>
    <p style="text-align: justify;">The Company expects to derive a significant portion of its future revenues from its supply arrangements with the various Canadian provinces. There are many factors which could impact the Company's contractual arrangements with the provinces, including but not limited to availability of supply, product selection and the popularity of the Company's products with retail customers. If the Company's supply arrangements with certain Canadian provinces are amended, terminated or otherwise altered, the Company's sales and results of operations could be adversely affected, which could have a material adverse effect on the Company's business, financial condition and results of operations. Some provinces have letters of intent or have moved to purchase orders or other listing agreements to form the basis of their distribution arrangements.</p>
    <p style="text-align: justify;">In addition, not all of the Company's supply arrangements with the various Canadian provinces contain purchase commitments or otherwise obligate the provincial wholesaler to buy a minimum or fixed volume of cannabis products from the Company. The amount of cannabis that the provincial wholesalers may purchase under the supply arrangements may therefore vary from what the Company expects or has planned for. As a result, the Company's revenues could fluctuate materially in the future and could be materially and disproportionately impacted by the purchasing decisions of the provincial wholesalers. If any of the provincial wholesalers decide to purchase lower volumes of products from the Company than the Company expects, alters its purchasing patterns at any time with limited notice, decides to return product or decides not to continue to purchase the Company's cannabis products at all, the Company's revenues could be materially adversely affected, which could have a material adverse effect on the Company's business, financial condition, results of operations and prospects.</p>
    <p style="text-align: justify;"><i>No Assurance That Listing Standards of TSX &amp; Nasdaq Will Continue to be Met</i></p>
    <p style="text-align: justify;">The Company must meet continuing listing standards to maintain the listing of the Common Shares on the TSX and Nasdaq, including minimum price of such Common Shares. If the Company fails to comply with listing standards and the TSX or Nasdaq delists the Common Shares, the Company and its shareholders could face significant material adverse consequences, including: (i) a limited availability of market quotations for the Common Shares; (ii) reduced liquidity for the Common Shares; (iii) a determination that the Common Shares are "penny stock," which would require brokers trading in the Common Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for the Common Shares; (iv) a limited amount of news about the Company and analyst coverage; and (v) a decreased ability for the Company to issue additional equity securities or obtain additional equity or debt financing in the future.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_38"></a>
    <div id="header_page_38">
        <p style="text-align: center;">- 36 -</p>
    </div>
    <p style="text-align: justify;"><i>Failure to Develop and Maintain Effective Internal Controls for Reliable Financial Results and to Prevent Fraud (SOX)</i></p>
    <p style="text-align: justify;">Under Section 404 of the Sarbanes-Oxley Act (&#8220;<b>SOX</b>&#8221;) and SEC rules promulgated thereunder, the Company is required to design, document and test the effectiveness of our internal controls over financial reporting (&#8220;<b>ICFR</b>&#8221;) during future periods. There is no assurance that our efforts to develop and maintain our internal controls will be successful or sufficient to meet our obligations under SOX. Effective internal controls are required for the Company to accurately and reliably report our financial results and other financial information. Any failure to design, develop or maintain effective controls; or difficulties encountered in implementing, improving or remediating lapses in internal controls may affect the Company&#8217;s ability to prevent fraud, detect material misstatements, and fulfill its reporting obligations. The Company&#8217;s management, under the supervision and with the participation of its CEO and CFO, has determined for the fiscal years ended August 31, 2019 and 2020, that its ICFR was not effective due to certain material weaknesses. In addition, due to the same material weaknesses, management has determined that the Company&#8217;s disclosure controls and procedures were not effective as of August 31, 2020. If the Company is not able to remediate these deficiencies and maintain effective internal control over financial reporting and disclosure controls and procedures, investors may lose confidence in the Company&#8217;s ability to report timely, accurate and reliable financial and other information, which may expose the Company to certain legal or regulatory actions, thus negatively impacting its business, the trading price of Common Shares and market value of any other securities.</p>
    <p style="text-align: justify;"><i>Canadian Company and Shareholder Protection may Differ from Shareholder Protection in US or Elsewhere</i></p>
    <p style="text-align: justify;">We are organized and exist under the laws of Canada and, accordingly, are governed by the <i>Canada Business Corporations Act</i> (the "<b>CBCA</b>"). The CBCA differs in certain material respects from laws generally applicable to United States corporations and shareholders, including the provisions and proceedings relating to interested directors, mergers, amalgamations, restructuring, takeovers, shareholders' suits, indemnification of directors, and inspection of corporation records.</p>
    <p style="text-align: justify;"><i>Emerging Growth Company</i></p>
    <p style="text-align: justify;">The Company is an "emerging growth company," as defined in the US Jumpstart Our Business Start-ups Act, and it uses the exemption provided to emerging growth companies from the auditor attestation requirements of Section 404(b) of SOX. Therefore, the Company's ICFR will not receive the level of review provided by the process relating to the auditor attestation included in annual reports of issuers that are not using an exemption. The Company may fail to maintain the adequacy of the Company's ICFR as such standards are modified, supplemented or amended from time to time, and may not be able to ensure that the Company can conclude, on an ongoing basis, that the Company has effective ICFR in accordance with Section 404 of SOX or equivalent Canadian legislation. Failure to satisfy the requirements of Section 404 of SOX and equivalent Canadian legislation on an ongoing, timely basis could result in the loss of investor confidence in the reliability of the Company's financial statements, which in turn could harm the Company's business and negatively impact the trading price of the Common Shares or the market value of the Company's other securities. In addition, any failure to implement required new or improved controls, or difficulties encountered in their implementation, could harm the Company's results of operations or cause it to fail to meet reporting obligations. Future acquisitions of companies, if any, may provide the Company with challenges in implementing the required processes, procedures and controls in the Company's acquired operations. No evaluation can provide complete assurance that the Company's ICFR will detect or uncover all failures of persons to disclose material information otherwise required to be reported. The effectiveness of the Company's processes, procedures and controls could also be limited by simple errors or faulty judgments. In addition, as the Company expands, the challenges involved in implementing appropriate ICFR will increase and will require that the Company continues to improve its ICFR. In addition, the Company cannot predict if investors will find the Common Shares less attractive because it relies on the aforementioned exemption. If some investors find the Common Shares less attractive as a result, there may be a less active trading market for the Common Shares and trading price for the Common Shares may be negatively affected.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_39"></a>
    <div id="header_page_39">
        <p style="text-align: center;">- 37 -</p>
    </div>
    <p style="text-align: justify;"><i>Increased Volatility for Dual Listed Shares</i></p>
    <p style="text-align: justify;">The Company's listing on both the TSX and Nasdaq may increase volatility due to the ability to buy and sell Common Shares in two places, different market conditions in different capital markets, and different trading volumes. This may result in less liquidity on both exchanges, different liquidity levels, and different prevailing trading prices.</p>
    <p style="text-align: justify;"><i>Limited Market for Securities</i></p>
    <p style="text-align: justify;">The Common Shares are listed on the TSX and on Nasdaq, however, there can be no assurance that an active and liquid market for the Common Shares will be maintained and an investor may find it difficult to resell any securities of the Company. The market price for Common Shares may be volatile and subject to wide fluctuations in response to numerous factors, many of which are outside of the Company's control.</p>
    <p style="text-align: justify;"><i>Risks Inherent in an Agricultural Business</i></p>
    <p style="text-align: justify;">The Company's business involves the growing of cannabis, an agricultural product. As such, the business is subject to the risks inherent in the agricultural business, such as insects, plant diseases and similar agricultural risks that may create crop failures and supply interruptions for the Company's customers. Although the Company grows its products indoors under climate-controlled conditions and carefully monitors the growing conditions with trained personnel, there can be no assurance that natural elements will not have a material adverse effect on the production of its products.</p>
    <p style="text-align: justify;"><i>The Company is a Foreign Private Issuer Within the Meaning of the U.S. Securities Exchange Act of 1934</i></p>
    <p style="text-align: justify;">The Company is a foreign private issuer under the United States <i>Securities Exchange Act of 1934</i>, as amended (the "<i><b>Exchange Act</b></i>"), and exempt from certain securities rules applicable to U.S. domestic issuers. Some of these rules require reduced reporting and disclosure requirements. As a result, the shareholder may not receive as much information or information as frequently from the Company as would otherwise be made available by a U.S. domestic issuer. The Company's status as a foreign private issuer under the Exchange Act would be lost if a majority of our Common Shares were held by persons in the United States and the Company failed to meet any of the additional requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer would be greater than the cost incurred as a Canadian foreign private issuer.</p>
    <p style="text-align: justify;"><i>Expansion into New Markets</i></p>
    <p style="text-align: justify;">The Company's expansion into jurisdictions outside of Canada is subject to risks. In jurisdictions outside of Canada, there can be no assurance that any market for the Company's products will develop. The Company may face new or unexpected risks or significantly increase its exposure to one or more existing risk factors, including economic instability, changes in laws and regulations, and the effects of competition. These factors may limit the Company's ability to successfully expand its operations into such jurisdictions and may have a material adverse effect on the Company's business, financial condition and results of operations. The Company has no investment or ownership in any U.S. entity nor does it provide any products or services to U.S. entities.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_40"></a>
    <div id="header_page_40">
        <p style="text-align: center;">- 38 -</p>
    </div>
    <p style="text-align: justify;"><i>Foreign Investment</i></p>
    <p style="text-align: justify;">In relation to investments in international operations, in addition to the foregoing, there is also the risk of increased disclosure requirements; currency fluctuations; restrictions on the ability of local operating companies to hold Canadian dollars or other foreign currencies in offshore bank accounts; import and export regulations; increased regulatory requirements and restrictions; limitations on the repatriation of earnings; and increased financing costs.</p>
    <p style="text-align: justify;">These risks may limit or disrupt the Company's strategic alliances or investments, restrict the movement of funds, cause the Company to have to expend more funds than previously expected or required, or result in the deprivation of contract rights or the taking of property by nationalization or expropriation without fair compensation, and may materially adversely affect the Company's financial position and/or results of operations. In addition, the enforcement by the Company of its legal rights in foreign countries, including rights to exploit properties or utilize permits and licenses and contractual rights may not be recognized by the court systems in such foreign countries or enforced in accordance with the rule of law.</p>
    <p style="text-align: justify;"><i>The Company's Operations in Emerging Markets are Subject to Political and Other Risks Associated with Operating in a Foreign Jurisdiction</i></p>
    <p style="text-align: justify;">The Company's investments have operations in various emerging and foreign markets and the Company will be seeking to grow its operations through prudent synergistic acquisitions or development of international operations.</p>
    <p style="text-align: justify;">Such operations expose the Company to the socioeconomic conditions as well as the laws governing the cannabis industry in such countries. Inherent risks with conducting foreign operations include, but are not limited to: high rates of inflation; extreme fluctuations in currency exchange rates, military repression; war or civil war; social and labour unrest; organized crime; hostage taking; terrorism; violent crime; expropriation and nationalization; renegotiation or nullification of existing licenses, approvals, permits and contracts; changes in taxation policies; restrictions on foreign exchange and repatriation; and changing political norms, banking and currency controls and governmental regulations that favour or require the Company to award contracts in, employ citizens of, or purchase supplies from, the jurisdiction.</p>
    <p style="text-align: justify;">Governments in certain foreign jurisdictions intervene in their economies, sometimes frequently, and occasionally make significant changes in policies and regulations. Changes, if any, in cannabis industry or investment policies or shifts in political attitude in the countries in which the Company operates may adversely affect the Company's operations or profitability. Operations may be affected in varying degrees by government regulations with respect to, but not limited to, restrictions on production, price controls, export controls, currency remittance, importation of product and supplies, income and other taxes, royalties, the repatriation of profits, expropriation of property, foreign investment, maintenance of concessions, licenses, approvals and permits, environmental matters, land use, land claims of local people, water use and workplace safety. Failure to comply strictly with applicable laws, regulations and local practices could result in loss, reduction or expropriation of licenses, or the imposition of additional local or foreign parties as joint venture partners with carried or other interests.</p>
    <p style="text-align: justify;">The Company continues to monitor developments and policies in the emerging and foreign markets in which it operates or invests and assess the impact thereof to its operations; however such developments cannot be accurately predicted and could have an adverse effect on the Company's operations or profitability.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_41"></a>
    <div id="header_page_41">
        <p style="text-align: center;">- 39 -</p>
    </div>
    <p style="text-align: justify;"><i>Intellectual Property</i></p>
    <p style="text-align: justify;">The ownership and protection of trademarks, patents, if any, trade secrets and intellectual property rights, if any, are significant aspects of the Company's future success. Unauthorized parties may attempt to replicate or otherwise obtain and use the Company's products and technology or the Company may not be able to secure required protection. Policing the unauthorized use of the Company's current or future trademarks, patents, trade secrets or intellectual property rights could be difficult, expensive, time- consuming and unpredictable, as may be enforcing these rights against unauthorized use by others.</p>
    <p style="text-align: justify;">In addition, other parties may claim that the Company's products infringe on their proprietary or patent protected rights. Such claims, whether or not meritorious, may result in the expenditure of significant financial and managerial resources, legal fees, injunctions, temporary restraining orders and/or require the payment of damages. As well, the Company may need to obtain licenses from third parties who allege that the Company has infringed on their lawful rights. Such licenses, however, may not be available on terms acceptable to the Company or at all. In addition, the Company may not be able to obtain or utilize on terms that are favorable to it, or at all, licenses or other rights with respect to intellectual property that it does not own.</p>
    <p style="text-align: justify;"><i>Credit Risk</i></p>
    <p style="text-align: justify;">Credit risk arises from deposits with banks, short term investments and outstanding receivables. For trade receivables, the Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance. For other receivables, out of the normal course of business, management may obtain guarantees and general security agreements.</p>
    <p style="text-align: justify;"><i>Liquidity Risk</i></p>
    <p style="text-align: justify;">The Company's liquidity risk is the risk the Company will not be able to meet its financial obligations as they become due. The Company manages its liquidity risk by reviewing on an ongoing basis its capital requirements.</p>
    <p style="text-align: justify;"><i>Market Risk</i></p>
    <p style="text-align: justify;">Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises two types of risk: currency rate risk and interest rate risk.</p>
    <p style="text-align: justify;">Currency risk is the risk to the Company's earnings that arise from fluctuations of foreign exchange rates. The Company is not exposed to foreign currency exchange risk as the number of financial instruments denominated in a foreign currency held by the Company is non-material.</p>
    <p style="text-align: justify;">Interest risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk pursuant to long-term debt. A 1% change in benchmark interest rates will increase or decrease the Company's annual interest expense by $1,150,000.</p>
    <p style="text-align: justify;"><i>Concentration Risk</i></p>
    <p style="text-align: justify;">The Company's accounts receivable are primarily due from the Government of Canada, provincial government agencies, legal trusts and patients covered under group insurance, and, thus, the Company believes that the accounts receivable balance is collectible.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_42"></a>
    <div id="header_page_42">
        <p style="text-align: center;">- 40 -</p>
    </div>
    <p style="text-align: justify;"><i>Dividends</i></p>
    <p style="text-align: justify;">The Company has no dividend record and may not pay any dividends on the Common Shares in the foreseeable future. Dividends paid by the Company could be subject to tax and, potentially, withholdings.</p>
    <p style="text-align: justify;"><i>Publicity or Consumer Perception</i></p>
    <p style="text-align: justify;">The Company believes the cannabis industry is highly dependent upon consumer perception regarding the safety, efficacy and quality of the cannabis and other products produced by the Company from time to time. Consumer perception of the Company's products can be significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention and other publicity regarding the consumption of cannabis products. There can be no assurance that future scientific research, findings, regulatory proceedings, litigation, media attention or other research findings or publicity will be favourable to the cannabis market or any particular product, or consistent with earlier publicity. Future research reports, findings, regulatory proceedings, litigation, media attention or other publicity that are perceived as less favourable than, or that question, earlier research reports, findings or publicity could have a material adverse effect on the demand for the Company's products and the business, results of operations, financial condition and the Company's cash flows. The Company's dependence upon consumer perceptions means that adverse scientific research reports, findings, regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, could have a material adverse effect on the Company, the demand for the Company's products, and the business, results of operations, financial condition and cash flows of the Company.</p>
    <p style="text-align: justify;">Any product recall affecting the cannabis industry more broadly could lead consumers to lose confidence in the safety and security of the products sold by licensed producers generally, which could have a material adverse effect on the Company's business, financial condition and results of operations. Adverse publicity reports or other media attention regarding the safety, efficacy and quality of cannabis and derivative products in general, or the Company's products specifically, or associating the consumption of cannabis or use of derivative products with illness or other negative effects or events, could have such a material adverse effect. Such adverse publicity reports or other media attention could arise even if the adverse effects associated with such products resulted from consumers' failure to consume such products appropriately or as directed.</p>
    <p style="text-align: justify;">Research in Canada, the U.S. and internationally regarding the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis or isolated cannabinoids (such as CBD and THC) remains in early stages. There have been relatively few clinical trials on the benefits of cannabis or isolated cannabinoids (such as CBD and THC). Although the Company believes that the articles, reports and studies support its beliefs regarding the medical benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, future research and clinical trials may prove such statements to be incorrect, or could raise concerns regarding, and perceptions relating to, cannabis. Given these risks, uncertainties and assumptions, prospective purchasers of securities should not place undue reliance on such articles and reports. Future research studies and clinical trials may draw opposing conclusions to those stated in this Annual Information Form or reach negative conclusions regarding the medical benefits, viability, safety, efficacy, dosing, social acceptance or other facts and perceptions related to medical cannabis, which could have a material adverse effect on the demand for the Company's products with the potential to lead to a material adverse effect on the Company's business, financial condition and results of operations.</p>
    <p style="text-align: justify;"><i>Cyber Security and Privacy</i></p>
    <p style="text-align: justify;">The Company has entered into agreements with third parties for hardware, software, telecommunications and other information technology services in connection with its operations. The Company's operations depend, in part, on how well it and its suppliers protect networks, equipment, information technology systems and software against damage from a number of threats, including, but not limited to, cable cuts, damage to physical plants, natural disasters, intentional damage and destruction, fire, power loss, hacking, computer viruses, vandalism and theft. The Company's operations also depend on the timely maintenance, upgrade and replacement of networks, equipment, information technology systems and software, as well as pre-emptive expenses to mitigate the risks of failures. Any of these and other events could result in information system failures, delays, and/or increase in capital expenses. The failure of information systems or a component of information systems could, depending on the nature of any such failure, adversely impact the Company's reputation and results of operations.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_43"></a>
    <div id="header_page_43">
        <p style="text-align: center;">- 41 -</p>
    </div>
    <p style="text-align: justify;">The Company has not experienced any material losses to date relating to cyber-attacks or other information security breaches, but there can be no assurance that the Company will not incur such losses in the future. The Company's risk and exposure to these matters cannot be fully mitigated because of, among other things, the evolving nature of these threats. As a result, cyber security and the continued development and enhancement of controls, processes and practices designed to protect systems, computers, software, data and networks from attack, damage or unauthorized access is a priority. As cyber threats continue to evolve, the Company may be required to expend additional resources to continue to modify or enhance protective measures or to investigate and remediate any security vulnerabilities.</p>
    <p style="text-align: justify;"><i>Product Security</i></p>
    <p style="text-align: justify;">Given the nature of the Company's products and the lack of legal availability of such products outside of channels approved by the Government of Canada, as well as the concentration of inventory at the Moncton Campus, despite meeting or exceeding legislated security requirements, there remains a risk of shrinkage as well as theft. A security breach at the Moncton Campus could expose the Company to additional liability and to potentially costly litigation, increased expenses relating to the resolution and future prevention of these breaches and may deter potential patients or recreational users from choosing the Company's products.</p>
    <p style="text-align: justify;"><i>Privacy</i></p>
    <p style="text-align: justify;">In addition, the Company collects and stores personal information about its patients and customers, and is responsible for protecting that information from privacy breaches. A privacy breach may occur through procedural or process failure, information technology malfunction, or deliberate unauthorized intrusions. Theft of data for competitive purposes is an ongoing risk whether perpetrated via employee collusion or negligence or through deliberate cyber-attack. Any such theft or privacy breach would have a material adverse effect on the Company's business, financial condition and results of operations.</p>
    <p style="text-align: justify;">In addition, there are a number of federal and provincial laws protecting the privacy and confidentiality of certain patient health information, including patient records, and restricting the collection, use and disclosure of that protected information. In particular, the privacy rules under the <i>Personal Information Protection and Electronics Documents Act</i> (Canada) ("<b>PIPEDA</b>") and provincial statutes regulating the collection, use and disclosure of personal information, protect medical records and other personal health information by limiting their use and disclosure of health information to the minimum level reasonably necessary to accomplish the intended purpose. If the Company was found to be in violation of the privacy or security rules under PIPEDA or other laws protecting the privacy and confidentiality of patient health information, it could be subject to sanctions and civil or criminal penalties, which could increase its liabilities, harm its reputation and have a material adverse effect on the business, results of operations and financial condition of the Company.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_44"></a>
    <div id="header_page_44">
        <p style="text-align: center;">- 42 -</p>
    </div>
    <p style="text-align: justify;"><i>Environmental and Employee Health and Safety Regulations</i></p>
    <p style="text-align: justify;">The Company's operations are subject to environmental and safety laws and regulations concerning, among other things, emissions and discharges to water, air and land, the handling and disposal of hazardous and non-hazardous materials and wastes, and employee health and safety. The Company will incur ongoing costs and obligations related to compliance with environmental and employee health and safety matters. Failure to comply with environmental and safety laws and regulations may result in additional costs for corrective measures, penalties or in restrictions on the Company's manufacturing operations. In addition, changes in environmental, employee health and safety or other laws, more vigorous enforcement thereof or other unanticipated events could require extensive changes to the Company's operations or give rise to material liabilities, which could have a material adverse effect on the business, results of operations and financial condition of the Company.</p>
    <p style="text-align: justify;">Government approvals and permits are currently and may in the future be required in connection with, the Company's operations. To the extent such approvals are required and not obtained, the Company may be curtailed or prohibited from its proposed production of medical and/or recreational cannabis or from proceeding with the development of its operations as currently proposed.</p>
    <p style="text-align: justify;"><i>Reliance on Key Inputs</i></p>
    <p style="text-align: justify;">The Company's business is dependent on a number of key inputs and their related costs including raw materials and supplies related to its growing operations, as well as electricity, water and other local utilities. Any significant interruption or negative change in the availability or economics of the supply chain for key inputs could materially impact the business, financial condition and operating results of the Company. Some of these inputs may only be available from a single supplier or a limited group of suppliers. If a sole source supplier was to go out of business, the Company might be unable to find a replacement for such source in a timely manner or at all. If a sole source supplier were to be acquired by a competitor, that competitor may elect not to sell to the Company in the future. Any inability to secure required supplies and services or to do so on appropriate terms could have a materially adverse impact on the business, financial condition and operating results of the Company.</p>
    <p style="text-align: justify;"><i>Regulatory Proceedings, Investigations, and Audits</i></p>
    <p style="text-align: justify;">The Company's business requires compliance with many laws and regulations. Failure to comply with these laws and regulations could subject the Company to regulatory proceedings or investigations and could also lead to damage awards, fines and penalties. The Company may become involved in a number of government proceedings, investigations and audits. The outcome of any regulatory or agency proceedings, investigations, audits, and other contingencies could harm the Company's reputation, require the Company to take, or refrain from taking, actions that could harm its operations or require the Company to pay substantial amounts of money, harming its financial condition. There can be no assurance that any pending or future regulatory proceedings, investigations and audits will not result in substantial costs or a diversion of management's attention and resources or have a material adverse impact on the Company's business, financial condition and results of operation.</p>
    <p style="text-align: justify;"><i>Fraudulent or Illegal Activity by the Company's Employees, Contractors and Consultants</i></p>
    <p style="text-align: justify;">The Company is exposed to the risk that its employees, independent contractors and consultants may engage in fraudulent or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct that violates: (i) government regulations; (ii) manufacturing standards; (iii) federal and provincial healthcare fraud and abuse laws and regulations; or (iv) laws that require the true, complete and accurate reporting of financial information or data. It is not always possible for the Company to identify and deter misconduct by its employees and other third parties, and the precautions taken by the Company to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting the Company from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations. If any such actions are instituted against the Company, and it is not successful in defending itself or asserting its rights, those actions could have a significant impact on the Company's business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of the Company's operations, any of which could have a material adverse effect on the Company's business, financial condition and results of operations.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_45"></a>
    <div id="header_page_45">
        <p style="text-align: center;">- 43 -</p>
    </div>
    <p style="text-align: justify;"><i>Risks Inherent in Investments</i></p>
    <p style="text-align: justify;">The Company is not directly involved in the ownership or operation of and may have limited contractual rights relating to the operations of its current and future investee entities. An investee generally has the power to determine the manner in which its business is developed, expanded and operated, and the Company's interest in an investee is subject to the risks applicable to the business carried on by the investee, and the Company may fail to realize all of the potential benefits from its investments. The interests of the Company and its investees may not always be aligned. As a result, any cash flows of the Company from investees will be dependent upon the activities of the investees, which creates the risk that at any time those investees may: (i) have business interests or targets that are inconsistent with those of the Company; (ii) take action contrary to the Company's policies or objectives; (iii) be unable or unwilling to fulfill their obligations under their agreements with the Company; (iv) experience financial, operational or other difficulties, including insolvency, which could limit or suspend an investee's ability to perform its obligations under agreements with the Company or (v) fail to comply with applicable laws or best practices. For example, the Company believes that Eviana may be in breach of its covenants under the Eviana Debenture, Eviana is subject to a cease-trade order for failing to timely file its annual continuous disclosure materials and the Company has recently recorded an impairment loss in connection with its investment in Eviana.</p>
    <p style="text-align: justify;"><i>Corruption and Fraud in Certain Emerging Markets Relating to Ownership of Real Property May Adversely Affect the Company's Business</i></p>
    <p style="text-align: justify;">There are uncertainties, corruption and fraud relating to title ownership of real property in certain emerging markets in which the Company may invest. Property disputes over title ownership are frequent in emerging markets, and, as a result, there is a risk that errors, fraud or challenges could adversely affect the Company's ability to successfully invest in such jurisdictions.</p>
    <p style="text-align: justify;"><i>The Company's Operations may be Impaired as a Result of Restrictions on the Acquisition or Use of Properties by Foreign Investors or Local Companies under Foreign Control</i></p>
    <p style="text-align: justify;">Non-resident individuals and non-domiciled foreign legal entities may be subject to restrictions on the acquisition or lease of properties in certain emerging markets. Limitations also apply to legal entities domiciled in such countries which are controlled by foreign investors, such as the entities through which the Company may make investments. Accordingly, the Company's current and future operations may be impaired as a result of such restrictions on the acquisition or use of property, and the Company's ownership or access rights in respect of any property it owns or leases in such jurisdictions may be subject to legal challenges, all of which could result in a material adverse effect on the Company's business, results of operations, financial condition and cash flows.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_46"></a>
    <div id="header_page_46">
        <p style="text-align: center;">- 44 -</p>
    </div>
    <p style="text-align: justify;"><i>The Company May Expand into Other Geographic Areas, which could Increase the Company's Operational, Regulatory and Other Risks</i></p>
    <p style="text-align: justify;">In addition to the jurisdictions described elsewhere in this Annual Information Form, the Company may in the future expand into other geographic areas, which could increase the Company's operational, regulatory, compliance, reputational and foreign exchange rate risks. The failure of the Company's operating infrastructure to support such expansion could result in operational failures and regulatory fines or sanctions. Future international expansion could require the Company to incur a number of up-front expenses, including those associated with obtaining regulatory approvals, as well as additional ongoing expenses, including those associated with infrastructure, staff and regulatory compliance. The Company may not be able to successfully identify suitable acquisition and expansion opportunities or integrate such operations successfully with the Company's existing operations.</p>
    <p style="text-align: justify;"><i>The Company Relies on International Advisors and Consultants in Order to Keep Abreast of Material Legal, Regulatory and Government Developments that Impact the Company's Business and Operations in the Jurisdictions in Which it Operates</i></p>
    <p style="text-align: justify;">The legal and regulatory requirements in the foreign countries in which the Company may invest or operate with respect to the cultivation and sale of cannabis, banking systems and controls, as well as local business culture and practices are different from those in Canada. The Company's officers and directors must rely, to a great extent, on local legal counsel and consultants in order to keep abreast of material legal, regulatory and governmental developments as they pertain to and affect the Company's business operations, and to assist with governmental relations. The Company must rely, to some extent, on those members of management and the board of directors who have previous experience working and conducting business in these countries, if any, in order to enhance our understanding of and appreciation for the local business culture and practices. The Company also relies on the advice of local experts and professionals in connection with current and new regulations that develop in respect of the cultivation and sale of cannabis as well as in respect of banking, financing, labor, litigation and tax matters in these jurisdictions. Any developments or changes in such legal, regulatory or governmental requirements or in local business practices are beyond the Company's control. The impact of any such changes may adversely affect the Company's business.</p>
    <p style="text-align: justify;"><i>The Company may be held Responsible for Corruption and Anti-bribery Law Violations</i></p>
    <p style="text-align: justify;">The Company's business is subject to Canadian laws, which generally prohibit companies and employees from engaging in bribery or other prohibited payments to foreign officials for the purpose of obtaining or retaining business. In addition, the Company is subject to the anti-bribery laws of any other countries in which it conducts business now or in the future. The Company's employees or other agents may, without its knowledge and despite its efforts, engage in prohibited conduct under the Company's policies and procedures and anti-bribery laws for which the Company may be held responsible. The Company's policies mandate compliance with these anti-corruption and anti-bribery laws. However, there can be no assurance that the Company's internal control policies and procedures will always protect it from recklessness, fraudulent behaviour, dishonesty or other inappropriate acts committed by its affiliates, employees, contractors or agents. If the Company's employees or other agents are found to have engaged in such practices, the Company could suffer severe penalties and other consequences that may have a material adverse effect on its business, financial condition and results of operations.</p>
    <p style="text-align: justify;"><i>Global Economy Risk</i></p>
    <p style="text-align: justify;">An economic downturn of global capital markets has been shown to make the raising of capital by equity or debt financing more difficult. The Company will be dependent upon the capital markets to raise additional financing in the future, while it establishes a user base for its products. As such, the Company is subject to liquidity risks in meeting its development and future operating cost requirements in instances where cash positions are unable to be maintained or appropriate financing is unavailable. These factors may impact the Company's ability to raise equity or obtain loans and other credit facilities in the future and on terms favorable to the Company and its management. If uncertain market conditions persist, the Company's ability to raise capital could be jeopardized, which could have an adverse impact on the Company's operations and the trading price of the Company's shares on the TSX and Nasdaq.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_47"></a>
    <div id="header_page_47">
        <p style="text-align: center;">- 45 -</p>
    </div>
    <p style="text-align: justify;"><i>Future Acquisitions or Dispositions and Management of the Impact of Such Transactions on the Company's Operations</i></p>
    <p style="text-align: justify;">In the event that the Company proceeds with a material acquisition, disposition or other strategic transaction, such transaction would be subject to a number of risks, including: (i) potential disruption of the Company's ongoing business; (ii) distraction of management; (iii) the Company may become more financially leveraged; (iv) the anticipated benefits and cost savings of those transactions may not be realized fully or at all or may take longer to realize than expected; (v) increasing the scope and complexity of the Company's operations, and (vi) loss or reduction of control over certain of the Company's assets.</p>
    <p style="text-align: justify;">The presence of one or more material liabilities of an acquired company that are unknown to the Company at the time of acquisition could have a material adverse effect on the results of operations, business prospects and financial condition of the Company. A strategic transaction may result in a significant change in the nature of the Company's business, operations and strategy. In addition, the Company may encounter unforeseen obstacles or costs in implementing a strategic transaction or integrating any acquired business into the Company's operations.</p>
    <p style="text-align: justify;"><i>General Business Risk and Liability</i></p>
    <p style="text-align: justify;">Given the nature of the Company's business, it may from time to time be subject to claims or complaints from investors or others in the normal course of business. The legal risks facing the Company, its directors, officers, employees or agents in this respect include potential liability for violations of securities laws, breach of fiduciary duty and misuse of investors' funds. Some violations of securities laws and breach of fiduciary duty could result in civil liability, fines, sanctions, or the suspension or revocation of the Company's right to carry on its existing business. The Company may incur significant costs in connection with such potential liabilities.</p>
    <p style="text-align: justify;"><i>Risk Factors Related to Dilution</i></p>
    <p style="text-align: justify;">The Company may issue additional securities in the future, which may dilute a shareholder's holdings, or a holder of a convertible security's underlying relative interest, in the Company. The Company's articles permit the issuance of an unlimited number of Common Shares and preferred shares, and shareholders will have no pre-emptive rights in connection with any such further issuance. The directors of the Company have discretion to determine the price and the terms of further issuances. Moreover, additional Common Shares will be issued by the Company on the exercise of options under its stock option plan and pursuant to the Company's Equity Incentive Plan pursuant to which the Company has issued Restricted Share Units and Performance Share Units.</p>
    <p style="text-align: justify;"><i>Constraints on Marketing Products</i></p>
    <p style="text-align: justify;">In view of the restrictions on marketing, advertising and promotional activities set forth in the Cannabis Act and related regulations, the Company's business and operating results may be hindered by applicable restrictions on sales, branding and marketing activities. If the Company is unable to effectively brand and market its products and compete for market share, or if the costs of compliance with government legislation and regulation cannot be absorbed through increased selling prices for its products, the Company's sales and operating results could be adversely affected.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_48"></a>
    <div id="header_page_48">
        <p style="text-align: center;">- 46 -</p>
    </div>
    <p style="text-align: justify;"><i>Marketing Risks Arising from Provincial Legislative Controls</i></p>
    <p style="text-align: justify;">The provincial recreational markets are end consumer driven. It is not possible to predict the quantities of product that will be purchased and made available to the end consumer in the provincial recreational markets. Further, regulations like those currently proposed in Quebec may limit the marketability of some of the Company's products and the Company's number of end consumers. These factors may have an adverse effect on the Company's business.</p>
    <p style="text-align: justify;"><i>Suppliers and Skilled Labour</i></p>
    <p style="text-align: justify;">The Company's ability to compete and grow will be dependent on having access, at a reasonable cost and in a timely manner, to skilled labor, equipment, parts and components. No assurances can be given that the Company will be successful in maintaining its required supply of skilled labor, equipment, parts and components. It is also possible that the final costs of the major equipment contemplated by the Company's capital expenditure program may be significantly greater than anticipated by management, and may be greater than funds available to the Company, in which circumstance the Company may curtail, or extend the timeframes for completing, capital expenditure plans. This could have an adverse effect on the Company's financial results.</p>
    <p style="text-align: justify;">The Company's success will depend on its directors' and officers' ability to develop and execute on the Company's business strategies and manage its ongoing operations, and on the Company's ability to attract and retain key quality assurance, scientific, sales, public relations and marketing staff or consultants now that production and selling operations have begun. The loss of any key personnel or the inability to find and retain new key persons could have a material adverse effect on the Company's business. Competition for qualified technical, sales and marketing staff, as well as officers and directors can be intense and no assurance can be provided that the Company will be able to attract or retain key personnel in the future, which may adversely impact the Company's operations.</p>
    <p style="text-align: justify;"><i>Conflicts of Interest</i></p>
    <p style="text-align: justify;">The Company may be subject to various potential conflicts of interest because of the fact that some of its officers and directors may be engaged in a range of business activities. In some cases, the executive officers and directors may have fiduciary obligations associated with these business interests that interfere with their ability to devote time to the Company and its affairs, and that could adversely affect Company operations. These business interests could require significant time and attention of the Company's executive officers and directors. In addition, the Company may also become involved in other transactions which conflict with the interests of the Company's directors and officers who may from time to time deal with persons, firms, institutions or corporations with which the Company may be dealing, or which may be seeking investments similar to those the Company desires. The interests of these persons could conflict with the Company's interests. In addition, from time to time, these persons may be competing with the Company for available investment opportunities. Conflicts of interest, if any, will be subject to the procedures and remedies provided under applicable laws. In particular, in the event that such a conflict of interest arises at a meeting of directors, a director who has such a conflict will abstain from voting for or against the approval of such participation or such terms. In accordance with applicable laws, directors are required to act honestly, in good faith and in the Company's best interests.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_49"></a>
    <div id="header_page_49">
        <p style="text-align: center;">- 47 -</p>
    </div>
    <p style="text-align: justify;"><i>Holding Company Status</i></p>
    <p style="text-align: justify;">The Company is a holding company and essentially all of its operating assets are the capital stock of its primary subsidiary, Organigram Inc. As a result, investors in the Company are subject to the risks attributable to its subsidiary. As a holding company, the Company conducts substantially all of its business through its subsidiary, which generates substantially all of its revenues. Consequently, the Company's cash flows and ability to complete current or desirable future enhancement opportunities are dependent on the earnings of the subsidiary and the distribution of those earnings to the Company.</p>
    <p style="text-align: center;"><b>DIVIDENDS</b></p>
    <p style="text-align: justify;">As of the date of this Annual Information Form, the Company has no current intention to declare dividends on its Common Shares in the foreseeable future. Any decision to pay dividends on its Common Shares in the future will be at the discretion of the Company's board of directors and will depend on, among other things, the Company's results of operations, current and anticipated cash requirements and surplus, financial condition, any contractual restrictions and financing agreement covenants, including those in the Credit Agreement, solvency tests imposed by corporate law, and other factors that the Company's board of directors may deem relevant.</p>
    <p style="text-align: center;"><b>CAPITAL STRUCTURE</b></p>
    <p style="text-align: justify;"><i><b>Common Shares</b></i></p>
    <p style="text-align: justify;">The Company is authorized to issue an unlimited number of Common Shares and an unlimited number of Preferred Shares. As of August 31, 2020, there were 194,511,061 Common Shares issued and outstanding and as of November 20, 2020, there are 232,088,219 Common Shares issued and outstanding. There are no Preferred Shares issued and outstanding. The holders of the Common Shares are entitled to one vote per share at all meetings of the shareholders of the Company. The holders of Common Shares are also entitled to dividends, if and when declared by the Company's board of directors, and to the distribution of the residual assets of the Company in the event of a liquidation, dissolution or winding up of the Company. Should the Company issue preferred shares, the holders would be entitled to receive, before any distribution is made to holders of Common Shares, the amount required to be paid in accordance with the special rights and restrictions attached to the series of shares held by them, including any fixed premium and any accrued and unpaid preferential dividends. Following any such payment, preferred shareholders would not, as such, be entitled to share in any further distribution of the property or assets of the Company except as may be specifically provided in the special rights and restrictions attached to any particular series. Preferred shareholders would only be entitled to receive notice of and/or attend and/or vote at any general meeting of shareholders as provided in any special rights and restrictions that may attach to any particular series if and when issued.</p>
    <p style="text-align: justify;">The Company has three equity compensation plans in place: (a) the 2011 stock option plan (the "<b>SOP</b>"), (b) the 2017 equity incentive plan (the "<b>2017 Plan</b>"), and (c) a long term-omnibus equity incentive plan adopted on February 25, 2020 (the "<b>2020 Equity Incentive Plan</b>"). The 2020 Equity Incentive Plan permits the Company to grant equity-based incentive awards in the form of options, restricted share units, preferred share units and deferred share units. Following the adoption of the 2020 Equity Incentive Plan, all future grants of equity-based awards will be made pursuant to, or as otherwise permitted by, the 2020 Equity Incentive Plan and no further equity-based awards will be made pursuant to the SOP or the 2017 Plan. The maximum number of Common Shares that may be issued upon exercise of awards granted under the 2020 Equity Incentive Plan shall not exceed 10% of the Company's issued and outstanding Common Shares from time to time, combined with any equity securities granted under all other compensation plans previously adopted by the Company, including the SOP and 2017 Plan.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_50"></a>
    <div id="header_page_50">
        <p style="text-align: center;">- 48 -</p>
    </div>
    <p style="text-align: justify;">As of August 31, 2020, there were 9,028,904 options issued and outstanding. As of November 20, 2020, there are 8,150,704 options issued and outstanding. As of August 31, 2020, there were 893,171 restricted share units issued and outstanding. As of November 20, 2020, there are 870,816 restricted share units issued and outstanding. As of August 31, 2020, there were 126,685 preferred share units issued and outstanding. As of November 20, 2020, there are 124,988 preferred share units issued and outstanding. As of August 31, 2020, there were nil deferred share units issued and outstanding. As of November 20, 2020, there are nil deferred share units issued and outstanding.</p>
    <p style="text-align: justify;"><i><b>Warrants</b></i></p>
    <p style="text-align: justify;">As of August 31, 2020, the Company had nil Warrants outstanding. As of November 20, 2020, the Company has 18,687,500 Warrants outstanding, exercisable to purchase up to 18,687,500 Warrant Shares (as defined herein) at an exercise price of $2.50 per Warrant Share.</p>
    <p style="text-align: justify;">The following is a summary of certain of the rights, privileges, restrictions and conditions attaching to the Warrants. For a complete description of the Warrants, please refer to the Warrant Indenture (as defined herein), which has been filed on the Canadian Securities Administrators&#8217; SEDAR website at <font style="color: #0000ff;"><u>www.sedar.com</u></font> and on the United States Securities and Exchange Commission&#8217;s EDGAR website at <font style="color: #0000ff;"><u>www.sec.gov</u></font>.</p>
    <p style="text-align: justify;">The outstanding Warrants were issued under and are governed by a warrant indenture (the "<b>Warrant Indenture</b>") entered into on November 12, 2020 between the Company and TSX Trust Company, as warrant agent. The Company has appointed the principal transfer office of the TSX Trust Company in Toronto, Ontario as the location at which the Warrants may be surrendered for exercise, transfer or exchange. A register of holders is maintained at the primary offices of the warrant agent in Toronto, Ontario.</p>
    <p style="text-align: justify;">Each Warrant is transferrable, and entitles the holder thereof to acquire one Warrant Share at an exercise price of $2.50 per Warrant Share, until 5:00 p.m. (Eastern Time) on November 12, 2023, subject to adjustment in certain customary events, after which time the Warrants will expire and become null and void. Pursuant to the Warrant Indenture, and subject to applicable securities legislation and approval of applicable regulatory authorities, the Company is entitled to purchase in the market, by private contract or otherwise, any of the Warrants then outstanding and any Warrants so purchased will be cancelled.</p>
    <p style="text-align: justify;">The Warrant Indenture provides for adjustment in the number of Warrant Shares issuable upon the exercise of the Warrants and/or the exercise price per Warrant Share upon the occurrence of certain events, including:</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">(a)<font style="width: 6.29pt; text-indent: 0pt; display: inline-block;">&#160;</font>the issuance of Common Shares or securities exchangeable for or convertible into Common Shares to all or substantially all of the holders of the Common Shares by way of a stock dividend or other distribution (other than a distribution of Warrant Shares upon the exercise of any Warrants);</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">(b)<font style="width: 5.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>the subdivision, redivision or change of the Common Shares into a greater number of Common Shares;</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify; margin-bottom: 0pt; margin-top: 0pt;">(c)<font style="width: 6.29pt; text-indent: 0pt; display: inline-block;">&#160;</font>the consolidation, reduction or combination of the Common Shares into a lesser number of Common Shares;</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify; margin-bottom: 0pt; margin-top: 0pt;">(d)<font style="width: 5.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>the issuance to all or substantially all of the holders of the Common Shares of rights, options or warrants under which such holders are entitled, during a period expiring not more than 45 days after the record date for such issuance, to subscribe for or purchase Common Shares, or securities exchangeable for or convertible into Common Shares; and</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify; margin-bottom: 0pt; margin-top: 0pt;">(e)<font style="width: 5.79pt; text-indent: 0pt; display: inline-block;">&#160;</font>the issuance or distribution to all or substantially all of the holders of the Common Shares of (i) securities of any class, whether of the Company or any other trust (other than Common Shares), (ii) rights, options or warrants to subscribe for or purchase Common Shares (or other securities convertible into or exchangeable for Common Shares), other than pursuant to a "Rights Offering" (as defined in the Warrant Indenture); (iii) evidences of its indebtedness or (iv) any property or other assets.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_51"></a>
    <div id="header_page_51">
        <p style="text-align: center;">- 49 -</p>
    </div>
    <p style="text-align: justify;">The Warrant Indenture also provides for adjustment in the class and/or number of securities issuable upon the exercise of the Warrants and/or exercise price per security in the event of the following additional events:</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">(a)<font style="width: 6.29pt; text-indent: 0pt; display: inline-block;">&#160;</font>reclassifications of the Common Shares or a capital reorganization of the Company;</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">(b)<font style="width: 5.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>consolidations, amalgamations, arrangements or mergers of the Company with or into any other corporation or other entity; or</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">(c)<font style="width: 6.29pt; text-indent: 0pt; display: inline-block;">&#160;</font>the transfer of the undertaking or assets of the Company as an entirety or substantially as an entirety to another corporation or other entity.</p>
    <p style="text-align: justify;">No adjustment in the exercise price or the number of Warrant Shares issuable upon the exercise of the Warrants will be required to be made unless the cumulative effect of such adjustment or adjustments would result in a change of at least 1% in the exercise price or a change in the number of Warrant Shares issuable upon exercise by at least one one-hundredth of a Warrant Share, as the case may be. Furthermore, no adjustment will be made in the right to acquire Warrant Shares if an issue of Common Shares of the Company is being made in connection with a share incentive plan, restricted share plan or share purchase plan for the benefit of directors, officers, employees, consultants or other service providers, or the satisfaction of existing instruments issued as of the date of the Warrant Indenture.</p>
    <p style="text-align: justify;">Pursuant to the Warrant Indenture, the Company has covenanted that, during the period in which the Warrants are exercisable, it will give notice to TSX Trust Company and to the holders of the Warrants of certain stated events, including events that would result in an adjustment to the exercise price for the Warrants or the number of Warrant Shares issuable upon exercise of the Warrants, at least 14 days prior to the record date of such event, if any.</p>
    <p style="text-align: justify;">No fractional Warrant Shares will be issuable upon the exercise of any Warrants and no cash or other consideration will be paid in lieu of fractional Warrant Shares. Holders of Warrants will not have any voting or pre-emptive rights or any other rights which a holder of Common Shares would have.</p>
    <p style="text-align: justify;">The Company may provide certain buy-in rights to a holder if it fails to cause the warrant agent to deliver the Warrant Shares by three trading days after the delivery to the Company of the notice of exercise and the aggregate exercise price (or notice of cashless exercise). The buy-in rights apply if after the trading day after the date of such delivery by the holder, the holder purchases (in an open market transaction or otherwise) Common Shares to deliver in satisfaction of a sale by the holder of the Warrant Shares that the holder anticipated receiving from the Company upon exercise of the Warrant. In this event, the Company will: (i) pay in cash to the holder the amount equal to the excess (if any) of the buy-in price over the product of (A) such number of Warrant Shares, times (B) the price at which the sell order giving rise to holder's purchase obligation was executed; and (ii) at the election of the holder, either (A) reinstate the portion of the Warrant as to such number of Warrant Shares, or (B) deliver to the holder a certificate or certificates representing such number of Warrant Shares that would have been issued to the holder had the Company complied with its delivery obligations under the Warrant Indenture.</p>
    <p style="text-align: justify;">The Warrant Indenture includes certain beneficial ownership limitations under which Warrants are not exercisable to the extent that, after giving effect to the issuance of the Warrant Shares issuable upon such exercise of the Warrants, the holder, together with its affiliates and other persons acting as a group with the holder or any of its affiliates, would beneficially own in excess of 4.99% of the number of Common Shares outstanding immediately after giving effect to such issuance. Such beneficial ownership limitation may be increased or decreased by the holder upon notice to the Company, to a maximum of 9.99%. Except as provided in the Warrant Indenture, beneficial ownership will be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent the beneficial ownership limitations apply, the determination of whether a Warrant is exercisable and of which portion of a Warrant is exercisable shall be in the sole discretion and at the sole responsibility of the holder, and the submission of an exercise notice in respect of any Warrants shall be deemed to be the holder's determination of whether the Warrants are exercisable, and neither the warrant agent nor the Company will have any obligation to verify or confirm the accuracy of such determination.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_52"></a>
    <div id="header_page_52">
        <p style="text-align: center;">- 50 -</p>
    </div>
    <p style="text-align: justify;">The Warrant Indenture provides that the Company will use its reasonable best efforts to maintain the terms of the registration statement on Form F-10 (File No. 333-234564) or another registration statement relating to the Warrant Shares effective until the earlier of the expiration date of the Warrants and the date on which no Warrants remain outstanding (provided, however, that nothing shall prevent the Company&#8217;s amalgamation, arrangement, merger or sale, including any take-over bid, and any associated delisting or deregistration or ceasing to be a reporting issuer, provided that, so long as the Warrants are still outstanding and represent a right to acquire securities of the acquiring corporation, the acquiring corporation shall assume the Company&#8217;s obligations under the Warrant Indenture). If no such registration statement is effective, no person holding Warrants will be permitted to exercise Warrants, unless an exemption or a safe harbor from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws is available. During any such period, any person holding Warrants may give notice of their desire to exercise the Warrants, at which time the Company will permit the cashless exercise of the Warrants and issue such number of Warrant Shares calculated pursuant to the provisions of the Warrant Indenture, provided that such Warrant Shares shall not be subject to any transfer restrictions in the United States or Canada. If no such registration statement is effective, the Company will notify the holders of the Warrants in accordance with the provisions of the Warrant Indenture</p>
    <p style="text-align: justify;">The Warrant Indenture provides that, from time to time, the Company may amend or supplement the Warrant Indenture for certain purposes, without the consent of the holders of the Warrants, including curing defects or inconsistencies or making any change that does not prejudice the rights of any holder. Any amendment or supplement to the Warrant Indenture that would prejudice the interests of the holders of Warrants may only be made by "extraordinary resolution", which will be defined in the Warrant Indenture as a resolution either: (i) passed at a meeting of the holders of Warrants at which there are holders of Warrants present in person or represented by proxy representing at least 20% of the aggregate number of the then outstanding Warrants by the affirmative vote of the holders of Warrants representing not less than 662/3% of the aggregate number of Warrants represented at the meeting and voted on the poll upon such resolution; or (ii) adopted by an instrument in writing signed by the holders of Warrants representing not less than 66 2/3% of the aggregate number of all the then outstanding Warrants.</p>
    <p style="text-align: center;"><b>MARKET FOR SECURITIES</b></p>
    <p style="text-align: justify;"><i><b>Common Shares</b></i></p>
    <p style="text-align: justify;">Common Shares are listed and traded on the TSX under the trading symbol "OGI". The following table sets forth the price range per share and trading volume for the Common Shares on the TSX for the periods indicated.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_53"></a>
    <div id="header_page_53">
        <p style="text-align: center;">- 51 -</p>
    </div>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;" border="1" cellspacing="0" cellpadding="3">
        <tr>
            <td style="width: 24%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Period</b></p>
            </td>
            <td style="width: 24%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>High Trading Price ($)</b></p>
            </td>
            <td style="width: 25%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Low Trading ($)</b></p>
            </td>
            <td style="width: 25%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Volume (#)</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">August 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.02</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.61</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">11,749,215</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">July 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.23</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.62</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">19,834,461</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">June 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.17</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.12</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">33,232,500</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">May 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.73</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.54</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">29,636,369</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">April 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.77</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.10</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">27,598,002</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">March 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.11</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.95</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">37,269,257</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">February 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.78</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.67</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">24,275,216</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">January 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">4.74</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.47</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">46,925,995</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">December 2019</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.82</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.88</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">20,132,959</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">November 2019</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">4.99</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.64</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">53,979,299</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">October 2019</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">5.23</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.60</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">26,437,503</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">September 2019</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">6.81</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">4.52</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">17,222,116</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">Common Shares are listed and traded on the Nasdaq under the trading symbol "OGI". The following table sets forth the price range per share and trading volume for the Common Shares on the Nasdaq for the periods indicated.</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;" border="1" cellspacing="0" cellpadding="3">
        <tr>
            <td style="width: 24%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Period</b></p>
            </td>
            <td style="width: 24%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>High Trading Price (USD)</b></p>
            </td>
            <td style="width: 25%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Low Trading (USD)</b></p>
            </td>
            <td style="width: 25%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Volume (#)</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">August 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.53</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.20</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">54,717,293</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">July 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.67</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.21</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">83,357,101</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">June 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.36</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.56</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">161,985,204</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">May 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.98</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.09</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">130,347,900</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">April 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.95</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.49</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">76,692,110</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">March 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.32</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.41</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">92,502,139</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">February 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.85</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.00</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">71,187,873</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">January 2020</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.64</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.89</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">110,738,094</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">December 2019</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.87</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.20</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: right;">56,445,647</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: right;">November 2019</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: center;">3.77</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: center;">2.00</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: right;">75,000,652</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: right;">October 2019</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: center;">4.01</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: center;">2.71</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: right;">44,740,493</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: right;">September 2019</p>
            </td>
            <td style="width: 24%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: center;">5.18</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: center;">3.41</p>
            </td>
            <td style="width: 25%; padding-right: 4.9pt; padding-left: 5.4pt; vertical-align: top; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;">
                <p style="text-align: right;">21,824,983</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_54"></a>
    <div id="header_page_54">
        <p style="text-align: center;">- 52 -</p>
    </div>
    <p style="text-align: center;"><b>PRIOR SALES</b></p>
    <p style="text-align: justify;">The following table summarizes details of the following securities that are not listed or quoted on a marketplace issued by the Company during the period between September 1, 2019 and August 31, 2020:</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;" border="1" cellspacing="0" cellpadding="3">
        <tr>
            <td style="background-color: #e6e6e6; width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Date of Issuance</b></p>
            </td>
            <td style="width: 24%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Security</b></p>
            </td>
            <td style="width: 25%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Issuance/Exercise <br>Price Per Security ($)</b></p>
            </td>
            <td style="background-color: #e6e6e6; width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Number of Securities</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">September 30, 2019</p>
            </td>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">Options</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$5.05</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">220,000</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">October 7, 2019</p>
            </td>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">PSUs</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$4.64</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">142,187</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">October 7, 2019</p>
            </td>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">RSUs</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$4.64</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">218,370</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">October 24, 2019</p>
            </td>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">Options</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$4.71</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">200,000</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">December 30, 2019</p>
            </td>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">Options</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$3.15</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">570,000</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">January 31, 2020</p>
            </td>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">Options</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$3.57</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">350,000</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">April 23, 2020</p>
            </td>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">Options</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$2.17</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">725,000</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">April 23, 2020</p>
            </td>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">RSUs</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$2.17</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: right;">46,888</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">June 9, 2020</p>
            </td>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">Options</p>
            </td>
            <td style="width: 25%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">$2.53</p>
            </td>
            <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: right;">60,000</p>
            </td>
        </tr>
    </table>
    <p style="text-align: center;"><b>DIRECTORS AND EXECUTIVE OFFICERS</b></p>
    <p style="text-align: justify;"><i><b>Name, Occupation and Security Holding</b></i></p>
    <p style="text-align: justify;">Below are the names, province and country of residence, principal occupation and periods of service of the directors and executive officers of the Company as of the date hereof.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="1" cellspacing="0" cellpadding="3">
        <tr>
            <td style="background-color: #e6e6e6; width: 23%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Name, Province and <br>Country of Residence</b></p>
            </td>
            <td style="width: 28%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Principal Occupation for the <br>Past Five Years</b></p>
            </td>
            <td style="width: 21%; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Position and Offices <br>held with the <br>Company</b><sup><b>(1)</b></sup></p>
            </td>
            <td style="background-color: #e6e6e6; width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Number of Shares<br>Beneficially Owned<br>or Controlled</b><sup><b>(2)</b></sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 23%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p><b>Greg Engel</b> <br>Toronto, Ontario Canada</p>
            </td>
            <td style="width: 28%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">November 2010 to August 2014 - <i>General Manager of Forest Laboratories Canada</i>; January 2015 to June 2016 - <i>Chief Executive Officer of Tilray Canada Inc</i>; March 2017 to present - <i>Chief Executive Officer of the Company</i></p>
            </td>
            <td style="width: 21%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">Director and Chief Executive Officer since March 13, 2017</p>
            </td>
            <td style="width: 17%; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">75,000</p>
                <p style="text-align: center;">(&#126;0.0323%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 23%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: justify;"><b>Derrick West, CPA</b> <br>Oakville, Ontario Canada</p>
            </td>
            <td style="width: 28%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">March 2008 to June 2012 &#8211; <i>Chief Financial Officer of Landdrill International Inc.</i>; March 2014 to December 2019 &#8211; <i>Chief Financial Officer of Partners Real Estate Investment Trust</i></p>
            </td>
            <td style="width: 21%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">Director from December 19, 2017 to March 4, 2020; and Chief Financial Officer since March 4, 2020</p>
            </td>
            <td style="width: 17%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle;">
                <p style="text-align: center;">9,470</p>
                <p style="text-align: center;">(&#126;0.0041%)</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_55"></a>
    <div id="header_page_55">
        <p style="text-align: center;">- 53 -</p>
    </div>
    <table style="width: 100%; border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="background-color: #e6e6e6; width: 150.42px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Name, Province and <br>Country of Residence</b></p>
            </td>
            <td style="border-bottom: 0.75pt solid #000000; width: 183.12px; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-left: 0.75pt solid #000000; white-space: nowrap;">
                <p style="text-align: center;"><b>Principal Occupation for the <br>Past Five Years</b></p>
            </td>
            <td style="border-bottom: 0.75pt solid #000000; width: 137.34px; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-left: 0.75pt solid #000000; white-space: nowrap;">
                <p style="text-align: center;"><b>Position and Offices <br>held with the <br>Company</b><sup><b>(1)</b></sup></p>
            </td>
            <td style="background-color: #e6e6e6; width: 111.18px; vertical-align: top; border-left: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Number of Shares <br>Beneficially Owned <br>or Controlled</b><sup><b>(2)</b></sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 150.42px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p><b>Paolo De Luca, CPA, CFA</b> <br>Woodbridge, Ontario Canada</p>
            </td>
            <td style="width: 183.12px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: justify;">December 2013 to December 2017 - <i>Chief Financial Officer, Meridian LNG (a West Face Capital portfolio company)</i>; December 2017 to present - <i>Chief Financial Officer of the Company</i>; September 2011 to July 2013 - <i>Chief Financial Officer and Consultant, Potash Ridge Corporation</i></p>
            </td>
            <td style="width: 137.34px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Chief Strategy Officer since March 4, 2020; and Chief Financial Officer from December 19, 2017 to March 3, 2020.</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 111.18px; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">45,950</p>
                <p style="text-align: center;">(&#126;0.0198%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 150.42px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: justify;"><b>Timothy Emberg</b> <br>Ottawa, Ontario Canada</p>
            </td>
            <td style="width: 183.12px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: justify;">April 2012 to September 2017 - <i>Executive Director of Marketing of Roche Diabetes Care-Canada</i>; October 2017 to present - <i>Senior Vice President, Sales and Commercial Operations of the Company</i></p>
            </td>
            <td style="width: 137.34px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Senior Vice President, Sales and Commercial Operations since September 9, 2018; Vice President of Sales and Commercial Operations from October 2, 2017 to September 8, 2018</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 111.18px; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">0</p>
                <p style="text-align: center;">(0%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 150.42px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: justify;"><b>Helen Martin </b><br>Toronto, Ontario <br>Canada</p>
            </td>
            <td style="width: 183.12px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: justify;">November 2014 - October 2018 - <i>Chief Operating Officer of Crosswinds Holdings Inc.</i>; November 2018 to present - <i>Vice-President, Strategic Initiatives and Legal Affairs of the Company</i></p>
            </td>
            <td style="width: 137.34px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Senior Vice President, Strategic and Legal Affairs since April 5, 2019; Vice President, Strategic Initiatives and Legal Affairs from November 26, 2018 to April 4, 2019; Corporate Secretary since March 4, 2019</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 111.18px; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">0</p>
                <p style="text-align: center;">(0%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 150.42px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p style="text-align: justify;"><b>Matthew Rogers </b><br>Moncton, New Brunswick Canada</p>
            </td>
            <td style="width: 183.12px; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: justify;">April 2014-March 2015 - <i>Supply Chain Manager at Ganong Bros. Limited</i>; March 2015-March 2016 - <i>Director of Customer Experience and Business Analytics of the Company</i>; March 2016 - August 2016 - <i>Director of Operations and Plant Manager of the Company</i>; August 2016-present - <i>Vice President, Operation of the Company</i></p>
            </td>
            <td style="width: 137.34px; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Senior Vice President, Operations since May 15, 2020; Vice President, Operations from August 20, 2019 to May 14, 2020; Plant Manager from September 9, 2018 to August 19, 2019; Director of Operations from June 1, 2016 to September 8, 2018; Director of Production from February 22, 2016 to May 31, 2016; Director of Customer Experience &amp; Business Analytics from March 16, 2015 to February 21, 2016</p>
            </td>
            <td style="width: 111.18px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;">22,300</p>
                <p style="text-align: center;">(&#126;0.0096%)</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_56"></a>
    <div id="header_page_56">
        <p style="text-align: center;">- 54 -</p>
    </div>
    <table style="width: 100%; border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="background-color: #e6e6e6; width: 150px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Name, Province and <br>Country of Residence</b></p>
            </td>
            <td style="border-bottom: 0.75pt solid #000000; width: 183px; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-left: 0.75pt solid #000000; white-space: nowrap;">
                <p style="text-align: center;"><b>Principal Occupation for the <br>Past Five Years</b></p>
            </td>
            <td style="border-bottom: 0.75pt solid #000000; width: 137px; vertical-align: top; background-color: #e6e6e6; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-left: 0.75pt solid #000000; white-space: nowrap;">
                <p style="text-align: center;"><b>Position and Offices<br>held with the <br>Company</b><sup><b>(1)</b></sup></p>
            </td>
            <td style="background-color: #e6e6e6; width: 111px; vertical-align: top; border-left: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; white-space: nowrap;">
                <p style="text-align: center;"><b>Number of Shares <br>Beneficially Owned <br>or Controlled</b><sup><b>(2)</b></sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 150px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000;">
                <p><b>Geoffrey Machum</b><sup>(4)(5)</sup><br>Toronto, Ontario, Canada</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 183px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">1985 to present - <i>Commercial Litigation Partner at Steward McKelvey LLP; 2016</i> to present - <i>Director of WildBrain Ltd.</i></p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 137px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">Director since February 25, 2020</p>
                <p style="text-align: center;">Chair of the Governance and Nominating Committee</p>
            </td>
            <td style="width: 111px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;">4,500</p>
                <p style="text-align: center;">(&#126;0.0019%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 150px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p><b>Ken Manget</b><sup>(3)</sup><sup>(5)</sup><sup>(6</sup><sup>)</sup><br>Toronto, Ontario, Canada</p>
            </td>
            <td style="width: 183px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>2014 to 2019 - <i>Global Head of Relationship Investing at Ontario Teachers' Pension Plan Board; 2019</i> to present - <i>Director at Canadian Ditchley Foundation; 2020 to present - CFO &amp; Director, Northern Genesis Acquisition Corp.</i></p>
            </td>
            <td style="width: 137px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Director since February 25, 2020</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 111px; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">0</p>
                <p style="text-align: center;">(0%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 150px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p><b>Stephen Smith</b><sup>(3)</sup><sup>(6</sup><sup>)</sup><br>Etobicoke, Ontario, Canada</p>
            </td>
            <td style="width: 183px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: justify;">2018 to present &#8211; <i>Director of MAV Beauty Brands Inc.;</i> 2018 to 2019 &#8211; <i>Director of Newstrike Brands Ltd.; 2020 to present &#8211; Director of Freshii Inc.; 2014 to 2018 - EVP and Advisory Board Director, Jackman Reinvention Inc</i><i>.</i></p>
            </td>
            <td style="width: 137px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Director since February 25, 2020</p>
                <p style="text-align: center;">Chair of the Audit Committee</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 111px; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">10,300</p>
                <p style="text-align: center;">(&#126;0.0044%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 150px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: justify;"><b>Peter Amirault</b><sup>(5)</sup> <br>Toronto, Ontario Canada</p>
            </td>
            <td style="width: 183px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: justify;">2009 to present - <i>President of BML Group Limited</i>.</p>
            </td>
            <td style="width: 137px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Director since June 2, 2016</p>
                <p style="text-align: center;">Chairman of the Board of Directors</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 111px; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">160,000</p>
                <p style="text-align: center;">(&#126;0.0689%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 150px; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p><b>Sherry Porter, CM</b><sup>(4)</sup><sup>(5)</sup> <br>Halifax, Nova Scotia <br>Canada</p>
            </td>
            <td style="width: 183px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: justify;">2010 to 2017 - <i>Board member of the Nova Scotia Liquor Corporation</i>; 2014 to present - <i>Board member of the Halifax International Airport Authority</i>; March 2015 to present - <i>Board member of Pharmasave Drugs (Atlantic) Limited</i></p>
            </td>
            <td style="width: 137px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Director since December 17, 2018</p>
                <p style="text-align: center;">Chair of the Compensation Committee</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 111px; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">19,500</p>
                <p style="text-align: center;">(&#126;0.0084%)</p>
            </td>
        </tr>
        <tr>
            <td style="width: 150px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p style="text-align: justify;"><b>Dexter John</b><sup>(3)</sup><sup>(4)(6</sup><sup>)</sup><br>Toronto, Ontario <br>Canada</p>
            </td>
            <td style="width: 183px; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: justify;">June 2014 to April 2019 - <i>Executive Vice President of D.F. King (Canada)</i>; April 2019 - present - <i>President and CEO of Gryphon Advisors Inc.</i></p>
            </td>
            <td style="width: 137px; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Director since December 17, 2018</p>
                <p style="text-align: center;">Chair of the Investment Committee</p>
            </td>
            <td style="width: 111px; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;">6,110</p>
                <p style="text-align: center;">(&#126;0.0026%)</p>
            </td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><u>Notes</u>:</p>
    <p style="margin-top: 0pt; margin-left: 21.6pt; text-indent: -21.6pt; text-align: justify; margin-bottom: 0pt;">(1)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>The previous term of the current directors of the Company expired at the conclusion of the Annual Meeting of the Shareholders held on February 25, 2020 (the "<b>2020 Shareholder Meeting</b>"), excluding the new directors elected at the 2020 Shareholder Meeting. All of the directors noted above were re-elected and their terms will expire at the conclusion of the next Annual Meeting of Shareholders. Geoffrey Machum , Ken Manget and Stephen Smith were elected to the Company's board of directors at the 2020 Shareholder Meeting and their terms as directors will also expire at the next following Annual Meeting of Shareholders.</p>
    <p style="margin-left: 21.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify; margin-top: 0pt;">(2)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>As of November 20, 2020,, all directors and executive officers noted above of the Company, as a group, beneficially own, directly or indirectly, or exercise control or direction over 353,130 Common Shares of the Company, representing 0.1522% of the Company's outstanding Common Shares. The total number of issued and outstanding shares as of November 20, 2020, is 232,088,219 Common Shares.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_57"></a>
    <div id="header_page_57">
        <p style="text-align: center;">- 55 -</p>
    </div>
    <p style="margin-top: 0pt; margin-left: 21.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">(3)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of the Audit Committee.</p>
    <p style="margin-top: 0pt; margin-left: 21.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">(4)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of the Governance and Nominating Committee.</p>
    <p style="margin-top: 0pt; margin-left: 21.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">(5)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of the Compensation Committee.</p>
    <p style="margin-top: 0pt; margin-left: 21.6pt; text-indent: -21.6pt; text-align: justify;">(6)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of the Investment Committee.</p>
    <p style="text-align: center;"><b>DIRECTOR &amp; EXECUTIVE OFFICER BIOGRAPHIES</b></p>
    <p style="text-align: justify;"><i>Greg Engel - Director and Chief Executive Officer</i></p>
    <p style="text-align: justify;">Mr. Engel is a senior executive with 30 years of national and international experience in the pharmaceutical, biotechnology, cannabis and consumer packaged goods industries. Mr. Engel has led the creation, development and growth of several companies over the span of his career. An articulate and trusted voice in the burgeoning Canadian cannabis space, prior to joining Organiram Mr. Engel was the Chief Executive Officer at a competitive licensed producer which became the first Canadian exporter of medical cannabis. As the leader at Organigram, Mr. Engel is focused on reputational excellence through product quality and safety, expansion of the Moncton Campus, and production efficiencies to position the Company as a leader in the medical and adult-use recreational cannabis industries. Mr. Engel graduated from the University of Guelph with an Honours Bachelor of Science in Microbiology.</p>
    <p style="text-align: justify;"><i>Derrick West - Chief Financial Officer</i></p>
    <p style="text-align: justify;">Mr. West was formerly the Chief Financial Officer and Corporate Secretary of Partners Real Estate Investment Trust (TSX:PAR.UN), an open end real estate investment trust focused on managing a portfolio of retail community centres across Canada. Mr. West previously served as the Chief Financial Officer of Landdrill International Inc. (TSXV:LDI), an international mining services corporation with operations in Canada, Russia, Mongolia, and Mexico. Additionally, Mr. West served as the Vice-President of Accounting and Administration for Plazacorp Retail Properties Limited (renamed Plaza Retail REIT, TSX:PLZ.UN). Mr. West has 30 years business experience, the last 16 in senior positions with publicly traded enterprises. He has financial reporting, finance, treasury management, internal control, human resource, strategy and business development experience. Mr. West is a Chartered Professional Accountant, obtaining his Chartered Accountancy designation in New Brunswick with Grant Thornton LLP. He holds a Bachelor of Commerce degree from Mount Allison University.</p>
    <p style="text-align: justify;"><i>Paolo De Luca, CPA, CA, CFA - Chief Strategy Officer</i></p>
    <p style="text-align: justify;">Mr. De Luca assumed the role as the Company's Chief Strategy Officer on March 4, 2020. With more than 20 years of diversified financial business experience, Mr. De Luca has held senior financial, investor relations, and accounting leadership roles at companies, including West Face Capital, one of Canada's leading alternative asset management firms; Meridian LNG; Potash Ridge; C.A. Bancorp; and TD Securities. With this diverse industry and international background, he has extensive experience with both traditional and non-traditional financings and debt offerings as well as M&amp;A activities. Mr. De Luca is a graduate of York University's Schulich School of Business, is a Chartered Professional Accountant and a member of the Chartered Professional Accountants of Ontario, and is a CFA Charterholder.</p>
    <p style="text-align: justify;"><i>Timothy Emberg - Senior Vice President, Sales and Commercial Operations</i></p>
    <p style="text-align: justify;">Mr. Emberg, Senior Vice President, Sales and Commercial Operations, is an accomplished, bilingual, senior sales and marketing leader with a proven track record in healthcare, over-the-counter and consumer packaged goods organizations including Roche Canada, Jamieson Laboratories and Frito-Lay Canada. Mr. Emberg also brings an extensive knowledge of the Canadian market access and regulatory environments to the role, which will be an asset moving forward. As Senior Vice President of Sales and Commercial Operations, his role is to lead both recreational and medical cannabis sales while ensuring that the Company is well established and strongly represented nationally. Mr. Emberg will also play a key role in other commercially driven initiatives that will help set the stage for future growth and development of the organization while further enhancing the Company's position as an industry leader in Canada.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_58"></a>
    <div id="header_page_58">
        <p style="text-align: center;">- 56 -</p>
    </div>
    <p style="text-align: justify;"><i>Helen Martin - Senior Vice President, Strategic and Legal Affairs, and Corporate Secretary</i></p>
    <p style="text-align: justify;">Ms. Martin joined the Company as its Vice President Strategic Initiatives and Legal Affairs in November 2018 and was appointed Corporate Secretary in March 2019. She was promoted to Senior Vice President, Strategic and Legal Affairs, in April 2019. Prior to joining Organigram, she was the Chief Operating Officer of Crosswinds Holdings Inc. from November 2014 to October 2018. She was Senior Legal Counsel at AUM Law Professional Corporation where she held various legal roles since 2011. Ms. Martin was employed as General Counsel and Corporate Secretary of C.A. Bancorp Inc. from 2009 to 2011 and In-House Counsel at Sentry Select Capital Corp. from 2007 to 2008. Prior to joining Sentry Select, Ms. Martin was a lawyer in the securities group at Blake, Cassels &amp; Graydon LLP from 2005 to 2007. Ms. Martin is a member of the Law Society of Ontario. She received her law degree from the University of Toronto and a Bachelor of Arts (Honours) from the University of Victoria.</p>
    <p style="text-align: justify;"><i>Matthew Rogers - Senior Vice President, Operations</i></p>
    <p style="text-align: justify;">As Senior Vice President, Operations, Mr. Rogers brings a strong analytical and cost control background into his role from his previous work at Ganong Bros. Limited as Financial and Operational Analyst advising the Executive Team while reporting to the President &amp; CEO. Mr. Rogers joined OrganiGram as one of the first employees in 2014 and served in various roles such as: Director of Business Analytics &amp; Customer Experience, Director of Operations, Plant Manager, VP Operations, and now Senior VP Operations. His breath of roles has allowed him to work in many functions of the business gathering a well-rounded perspective to add to the Executive Team. His work has been instrumental in both scaling the infrastructure and staff base of OrganiGram while maintaining prudent cost controls while working in exponential growth mode. Mr. Rogers attended the University of New Brunswick where he majored in Both Accounting and Finance.</p>
    <p style="text-align: justify;"><i>Peter Amirault - Chairman of the Board</i></p>
    <p style="text-align: justify;">Mr. Amirault is currently the President of BML Group Limited in Toronto, a holding company with interests in real estate development and private investments. Prior to joining BML Group, Mr. Amirault held varying executive roles including: President of Swiss Chalet North America for the Cara Group of Companies, CEO of Creemore Springs Brewery Ltd, Senior Vice President of Molson Coors Canada, Managing Director of Sleeman Brewing Ltd, along with senior roles at Nestle Canada and The Premium Beer Company of Toronto. Mr. Amirault holds a Bachelor of Business Administration from Acadia University and a Master of Business Administration from The Schulich School of Business. Mr. Amirault's previous board experience and roles at senior management levels will bring a wealth of knowledge to the corporate director team at the Company.</p>
    <p style="text-align: justify;"><i>Geoffrey Machum - Director</i></p>
    <p style="text-align: justify;">Mr. Machum is a commercial litigation partner at Stewart McKelvey LLP, Atlantic Canada's largest law firm and one of the top 15 largest firms in Canada. He currently serves on the firm's Compensation Committee, and previously served as Chairman of the firm's Regional Partnership Board and on its Human Resources and Governance Committee, and its Audit and Finance Committee. Mr. Machum was awarded Queens Counsel in 2003, and has received repeated recognition by Lexpert, Best Lawyers, and Benchmark Canada for his extensive experience in practice areas including commercial litigation, directors and officers liability, corporate governance, insurance, construction law, and products liability. Mr. Machum currently serves on the board of WildBrain Ltd., where he is the Chair of its Governance and Nomination Committee and member of its Human Resources and Compensation Committee and previously served on the Board's Special Strategic Review Committee. Previously, he chaired the board of Halifax Port Authority, and served on the Governance, Human Resources and Audit and Finance Committees. Mr. Machum holds a BA in Economics Political Science from Dalhousie University, and University of New Brunswick. Mr. Machum also received ICD.D designation from Rotman School of Management in 2015.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_59"></a>
    <div id="header_page_59">
        <p style="text-align: center;">- 57 -</p>
    </div>
    <p style="text-align: justify;"><i>Ken Manget - Director</i></p>
    <p style="text-align: justify;">Mr. Manget is the former Global Head of Relationship Investing at Ontario Teachers' Pension Plan Board where he was responsible for a global team in Hong Kong, London &amp; Toronto and ran a multi-billion portfolio of pre-IPO, public and private equity investments. Mr. Manget started his career at Schlumberger Limited as a Field Engineer in Venezuela. His finance background includes stints at Salomon Brothers in London and New York, at BMO Capital Markets where he has had exposure to all facets of the capital markets including: M&amp;A, equities, fixed income, derivatives and securitization and at Desjardins Capital Markets where he was Head of Investment Banking. Mr. Manget holds a Mechanical Engineering degree from the University of Toronto and a Master of Business Administration from the Harvard Business School. Mr. Manget is a past board member of St. Joseph's Health Centre Foundation, the Heart and Stroke Foundation and currently serves as a member of the Board of the Canadian Ditchley Foundation and as an alumnus volunteer for Harvard University. In August 2020, he was appointed CFO and Director of Northern Genesis Acquisition Corp.</p>
    <p style="text-align: justify;"><i>Dexter John - Director</i></p>
    <p style="text-align: justify;">Mr. John is currently the President and CEO of Gryphon Advisors Inc. Prior to that he was the Executive Vice President of D.F. King (Canada) and was responsible for sales across the Canadian enterprise. Mr. John has over 20 years of experience in the capital markets and has spent six years in structured finance where he executed over $4 billion in transactions. He has worked at a major Canadian law firm as a securities associate, focusing on the public equities market with emphasis on mergers and acquisitions. In addition, Mr. John also has regulatory experience through his tenure at Investment Industry Regulatory Organization of Canada, the Ontario Securities Commission and the Toronto Stock Exchange. Mr. John holds a Bachelor of Laws degree from Queens University and the ICD.D designation.</p>
    <p style="text-align: justify;"><i>Sherry Porter, CM - Director</i></p>
    <p style="text-align: justify;">Ms. Porter is a seasoned executive with 30 years of experience with a myriad of organizations in Canada. She has held senior corporate roles with Sobeys Inc., Nova Scotia Power, Shoppers Drug Mart and The Caldwell Partners. She also has experience with trade associations in the grocery and retail drug area. She was the founding President and CEO of the Canadian Association of Chain Drug Stores, working with the chief executive officers of the traditional drug chains, mass merchants and grocery operations in Canada. Ms. Porter chaired the Board of Directors of the Nova Scotia Liquor Corporation from 2010-2017 and is currently a board member of the Halifax International Airport Authority and Pharmasave Atlantic. She is a Vice Chair of Dalhousie University, where she serves as Chair of the Governance, Human Resources and Nomination committee, and she also serves as a board member of the QEII Health Sciences Centre Foundation and the Symphony Nova Scotia Foundation.</p>
    <p style="text-align: justify;"><i>Stephen Smith - Director</i></p>
    <p style="text-align: justify; margin-left: 2pt;">Mr. Smith currently serves on the board of directors of MAV Beauty Brands Inc. (Audit Committee Chair), and Freshii Inc. (Lead Director and Audit Committee Chair). From 2018 to 2019, Mr. Smith served on the board of directors of Newstrike Brands Ltd. (Lead Director and Audit Committee Chair). From 2013 to 2017, Mr. Smith served on the board of directors of CST Brands Inc., an SEC registrant (Audit Committee and Executive Committee). From 2014 to 2018, Mr. Smith held the position of Executive Vice President and Advisory Board Director of Jackman Reinvention, Inc., a privately held brand and strategy consulting firm in Toronto. From 2007 until 2013, Mr. Smith served as co-Chief Executive Officer and Chief Financial Officer of Cara Operations Limited (now Recipe Unlimited), Canada's oldest and largest full-service restaurant company. From 1985 to 2007, Mr. Smith held various senior and executive level positions, including Executive Vice President, from 1999 to 2006, with Loblaw Companies Limited, the leading food and pharmacy retailer in Canada. Mr. Smith is a Chartered Professional Accountant (CPA, CA) and holds a Bachelor of Commerce degree from the University of Toronto.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_60"></a>
    <div id="header_page_60">
        <p style="text-align: center;">- 58 -</p>
    </div>
    <p style="text-align: center;"><b>CEASE TRADE ORDERS, BANKRUPTCIES, PENALTIES OR SANCTIONS</b></p>
    <p style="text-align: justify;">Other than as set out below, no director or executive officer of the Company is, as of the date of this Annual Information Form or within ten years prior to the date of this Annual Information Form has been, a director, chief executive officer of chief financial officer of any company (including the Company) that:</p>
    <p style="margin-left: 108pt; text-indent: -36pt; text-align: justify;">(i)<font style="width: 25.62pt; text-indent: 0pt; display: inline-block;">&#160;</font>was subject to a cease trade order, an order similar to a cease trade order or an order that denied the relevant company access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days, and was issued while the director or executive officer was acting in the capacity as director, chief executive officer or chief financial officer; or</p>
    <p style="margin-left: 108pt; text-indent: -36pt; text-align: justify;">(ii)<font style="width: 23.06pt; text-indent: 0pt; display: inline-block;">&#160;</font>was subject to a cease trade order, an order similar to a cease trade order or an order that denied the relevant company access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days, that was issued after the director or executive officer ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer.</p>
    <p style="text-align: justify;">Other than as set out below, no director or executive officer of the Company, or a shareholder holding a sufficient number of securities of the Company to affect materially the control of the Company:</p>
    <p style="margin-left: 108pt; text-indent: -36pt; text-align: justify;">(i)<font style="width: 25.62pt; text-indent: 0pt; display: inline-block;">&#160;</font>is, or within ten years prior to the date of this Annual Information Form has been, a director or executive officer of any company (including the Company) that, while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets; or</p>
    <p style="margin-left: 108pt; text-indent: -36pt; text-align: justify;">(ii)<font style="width: 23.06pt; text-indent: 0pt; display: inline-block;">&#160;</font>has, within ten years prior to the date of this Annual Information Form, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold the assets of the director, executive officer or shareholder.</p>
    <p style="text-align: justify;">No director or executive officer of the Company, or a shareholder holding a sufficient number of securities of the Company to affect materially the control of the Company, has been subject to (i) any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority; or (ii) any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable investor in making an investment decision.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_61"></a>
    <div id="header_page_61">
        <p style="text-align: center;">- 59 -</p>
    </div>
    <p style="text-align: justify;">Derrick West acted for Landdrill International Ltd. ("<b>Landdrill</b>") as its Chief Financial Officer from March 2007 through June 2012. On October 12, 2012, the New Brunswick Securities Commission issued a cease trade order against Landdrill under Section 188.2 of the <i>Securities Act</i> (New Brunswick) for failure to file interim financial statements together with the related Management's Discussion and Analysis and certification of interim filings for the period ended June 30, 2012. On October 15, 2012, the British Columbia Securities Commission issued a similar cease trade order under Section 164 of the Securities Act (British Columbia) against Landdrill. On January 11, 2013, the Alberta Securities Commission issued a cease trade order under Section 33.1 of the <i>Securities Act</i> (Alberta) for failure to file interim financial statements together with the related Management's Discussion and Analysis and certification of interim filings for the periods ended June 30, 2012, and September 30, 2012. The filing deficiencies were attributable to Landdrill having had made a filing under the <i>Companies' Creditors Arrangement Act</i> (Canada) in an effort to restructure its affairs in order to continue as a going concern. The TSX-V suspended trading in Landdrill's shares on October 12, 2012. On May 30, 2013, Landdrill was declared bankrupt pursuant to the <i>Bankruptcy and Insolvency Act</i> (Canada).</p>
    <p style="text-align: center;"><b>CONFLICTS OF INTEREST</b></p>
    <p style="text-align: justify;">The Company may from time to time become involved in transactions which conflict with the interests of the directors and the officers of the Company. The interest of these persons could conflict with those of the Company. Conflicts of interest, if any, will be subject to the procedures and remedies provided under applicable laws.</p>
    <p style="text-align: justify;">In particular, in the event that such a conflict of interest arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from voting for or against the approval of such participation or such terms. In accordance with applicable laws, the board of directors of the Company are required to act honestly, in good faith and in the best interest of the Company.</p>
    <p style="text-align: center;"><b>LEGAL PROCEEDINGS AND REGULATORY ACTIONS</b></p>
    <p style="text-align: justify;">On March 3, 2017, a claim (the "<b>Claim</b>") in connection with a proposed class action lawsuit was filed with the Nova Scotia Supreme Court seeking to represent a class of persons and entities who purchased medical cannabis that was the subject of the Company's product recalls in December 2016 and January 2017, as it may have contained trace elements of the pesticides myclobutanil and bifenazate which are not approved for use in cannabis production. The Claim identifies several causes of action including, among others: (i) negligent design, development and testing, (ii) negligent manufacturing, (iii) negligent distribution, marketing and sale, (iv) breach of contract, (v) unjust enrichment, and (vi) breach of the <i>Competition Act</i>, the <i>Consumer Protection Act</i>, and the <i>Sale of Goods Act</i>, and is seeking remedy in the form of, among other things, the disgorgement of profits accrued to the Company for the sale of contaminated products, exemplary or punitive damages and certain costs. The Claim was amended on November 16, 2017, to include a claim for alleged adverse health consequences caused as a result of using the recalled product. As at the date hereof, the Company has not received any medical information demonstrating adverse health effects caused as a result of using the recalled product. The class action alleges damages for two main types of claims: 1) consumer based claims relating to the transaction costs for the product and 2) claims for damages resulting from adverse health effects of the recalled product.</p>
    <p style="text-align: justify;">The Nova Scotia Supreme Court certified the Claim as a class action on January 18, 2019. Certification is not a decision on the merits of the lawsuit, but deals with the proper procedure and allows it to continue to the next stage of litigation. The Company filed an appeal of the certification of the claims alleging adverse health effects with the Nova Scotia Court of Appeal. On April 30, 2020, the Nova Scotia Court of Appeal partially overturned the certification, thereby significantly reducing the scope of the claim against the Company. On June 26, 2020, the plaintiff filed an application for leave to appeal the Nova Scotia Court of Appeal's decision to the Supreme Court of Canada. On November 5, 2020, the Supreme Court of Canada dismissed the leave to appeal with costs.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_62"></a>
    <div id="header_page_62">
        <p style="text-align: center;">- 60 -</p>
    </div>
    <p style="text-align: justify;">Notwithstanding the decision by the Supreme Court of Canada to dismissed the leave to appeal, any person or entity is still permitted to bring an individual claim against the Company in relation to health impacts alleged to have been suffered as a result of use of the recalled product. Despite the dismissal of the leave to appeal the Nova Scotia Court of Appeal decision, the consumer based claims remain. Class members have been notified of the appeal decision and have a period of time during which they may opt-out of the class action. As of the date hereof, one individual has filed an action against the Company in relation to the alleged adverse health consequences caused by using the recalled product.</p>
    <p style="text-align: justify;">The Company is contesting the remainder of the Claim. The Company reported the Claim to its insurance provider which appointed counsel to defend the Claim. Insurance may be available to cover all or a portion of the fees or damages which may be associated with the Claim although the Company's coverage may be subject to varying limits and exclusions.</p>
    <p style="text-align: justify;">The litigation process will continue into the foreseeable future unless settled out of court. No amount has been recorded in the consolidated financial statements since the amount cannot be reliably measured at this point.</p>
    <p style="text-align: justify;">On June 16, 2020, a legal action was commenced in the Court of Queen's Bench in Alberta, which action seeks damages against many of the largest Canadian cannabis companies, including the Company. The action is not certified, and does not particularize the claims against the Company or any other companies.</p>
    <p style="text-align: center;"><b>INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS</b></p>
    <p style="text-align: justify;">No director, executive officer, or principal shareholder of the Company and no associate or affiliate of the foregoing have had a material interest, direct or indirect, in any transaction in which the Company has participated within the three most recently completed financial years or during the current financial year, which has materially affected or is reasonably expected to materially affect the Company.</p>
    <p style="text-align: center;"><b>TRANSFER AGENT AND REGISTRAR</b></p>
    <p style="text-align: justify;">The transfer agent and registrar of the Company is TSX Trust Company at its offices in Vancouver, British Columbia and Toronto, Ontario. VStock Transfer, LLC is the Company's co-transfer agent in the United States.</p>
    <p style="text-align: center;"><b>MATERIAL CONTRACTS</b></p>
    <p style="text-align: justify;">Except for contracts entered into in the ordinary course of business, there are no contracts entered into by the Company during the twelve-month period ending August 31, 2020, which are material or entered into before the twelve-month period ending August 31, 2020, but are still in effect which are material, except as disclosed below:</p>
    <p style="margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the License (as described under "<i>General Development of the Business - Licenses" and "Description of the Business - Organigram Licenses</i>");</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Amended and Restated Credit Agreement; and</p>
    <p style="margin-top: 0pt; margin-left: 57.6pt; text-indent: -21.6pt; text-align: justify;">&#8226;<font style="width: 18pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Warrant Indenture (as described under "<i>Capital Structure - Warrants</i>").</p>
    <p style="text-align: justify;">Copies of the License, the Credit Agreement, as amended, and the Warrant Indenture are available under the Company&#8217;s corporate profile on the Canadian Securities Administrators&#8217; SEDAR website at <u><font style="color: #0000ff;">www.sedar.com</font></u> and on the United States Securities and Exchange Commission&#8217;s EDGAR website at <font style="color: #0000ff;"><u>www.sec.gov</u></font>.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_63"></a>
    <div id="header_page_63">
        <p style="text-align: center;">- 61 -</p>
    </div>
    <p style="text-align: center;"><b>INTERESTS OF EXPERTS</b></p>
    <p style="text-align: justify;">Deloitte LLP are the auditors of the Corporation. Deloitte LLP is independent of the Corporation within the meaning of the Rules of Professional Conduct of the Chartered Professional Accountants of New Brunswick and within the meaning of the United States Securities Act of 1933, as amended and the applicable rules and regulations thereunder adopted by the Securities Exchange Commission and the Public Company Accounting Oversight Board (United States).</p>
    <p style="text-align: center;"><b>AUDIT COMMITTEE INFORMATION</b></p>
    <p style="text-align: justify;"><i><b>Audit Committee Charter</b></i></p>
    <p style="text-align: justify;">The charter of the Company's Audit Committee is attached to this Annual Information Form as Appendix "A".</p>
    <p style="text-align: justify;"><i><b>Composition of Audit Committee &amp; Relevant Education and Experience</b></i></p>
    <p style="text-align: justify;">As of August 31, 2020 and the date hereof, the members of the Audit Committee are Stephen Smith (Chair), Dexter John, and Ken Manget, each of whom is independent and financially literate within the meaning of National Instrument 52-110. The education and experience of each Audit Committee member are described in this Annual Information Form under the section entitled "<i>Directors and Executive Officers</i>".</p>
    <p style="text-align: justify;">Each of the Audit Committee members has an understanding of the accounting principles used to prepare the Company's financial statements, experience preparing, auditing, analyzing or evaluating comparable financial statements and experience as to the general application of relevant accounting principles, as well as an understanding of the internal controls and procedures necessary for financial reporting.</p>
    <p style="text-align: justify;">The Company&#8217;s Board of Directors has determined that Stephen Smith qualifies as an &#8220;audit committee financial expert&#8221; (as defined in paragraph (8)(b) of General Instruction B to Form 40-F under the Exchange Act). The United States Securities and Exchange Commission has indicated that the designation of a director as an audit committee financial expert does not make such director an "expert" for any other purpose, impose any duties, obligations or liability on such director that are greater than those imposed on members of the Audit Committee and Board who do not carry this designation or affect the duties, obligations or liability of any other member of the Audit Committee.</p>
    <p style="text-align: justify;">The Audit Committee has the primary function of fulfilling its responsibilities in relation to reviewing the integrity of the Company's financial statements, financial disclosures and internal controls over financial reporting; monitoring the system of internal control; monitoring the Company's compliance with legal and regulatory requirements, selecting the external auditor for shareholder approval; reviewing the qualifications, independence and performance of the external auditor; and reviewing the qualifications, independence and performance of the Company's internal auditors. The Audit Committee has specific responsibilities relating to the Company's financial reports; the external auditor; the internal audit function; internal controls; regulatory reports and returns; legal or compliance matters that have a material impact on the Company; and the Company's whistleblowing procedures. In fulfilling its responsibilities, the Audit Committee meets regularly with the internal and external auditor and key management members. Information concerning the relevant education and experience of the Audit Committee members can be found in "<i>Directors and Executive Officers</i>" above. The full text of the Audit Committee's charter is disclosed in Appendix "A".</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_64"></a>
    <div id="header_page_64">
        <p style="text-align: center;">- 62 -</p>
    </div>
    <p style="text-align: justify;"><i><b>Audit Committee Oversight</b></i></p>
    <p style="text-align: justify;">At no time since the commencement of the Company's most recently completed financial year have any recommendations by the Audit Committee respecting the appointment and/or compensation of the Company's external auditor not been adopted by the board of directors of the Company.</p>
    <p style="text-align: justify;"><i><b>Pre-Approval Policies and Procedures</b></i></p>
    <p style="text-align: justify;">The Audit Committee will pre-approve all non-audit services to be provided to the Company or any subsidiary entities by its external auditors or by the external auditors of such subsidiary entities. The Audit Committee may delegate to one or more of its members the authority to pre-approve non- audit services but preapproval by such member or members so delegated shall be presented to the full Audit Committee at its first scheduled meeting following such pre-approval.</p>
    <p style="text-align: justify;"><i><b>External Auditor Service Fees.</b></i></p>
    <p style="text-align: justify;">The following table sets forth, by category, the fees for all services rendered by the Company's external auditors, Deloitte LLP, for the financial years ended August 31, 2020 and 2019, are as set out below (including estimates).</p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;" border="1" cellspacing="0" cellpadding="3">
        <tr>
            <td style="background-color: #d9d9d9; width: 24%; vertical-align: middle; padding-right: 5.03pt; padding-left: 5.03pt;" rowspan="2">
                <p><b>Type of Work</b></p>
            </td>
            <td style="width: 38%; vertical-align: top; background-color: #d9d9d9; padding-right: 5.03pt; padding-left: 5.03pt;" colspan="2">
                <p style="text-align: center;"><b>Year ended 31-Aug-20</b></p>
            </td>
            <td style="background-color: #d9d9d9; width: 36%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;" colspan="2">
                <p style="text-align: center;"><b>Year ended 31-Aug-19</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 18%; vertical-align: top; background-color: #d9d9d9; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Fees</b></p>
            </td>
            <td style="width: 18%; vertical-align: top; background-color: #d9d9d9; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Percentage</b></p>
            </td>
            <td style="width: 17%; vertical-align: top; background-color: #d9d9d9; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Fees</b></p>
            </td>
            <td style="width: 17%; vertical-align: top; background-color: #d9d9d9; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Percentage</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">Audit fees<sup>(1)</sup></p>
            </td>
            <td style="width: 18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$762,683</p>
            </td>
            <td style="width: 18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">94%</p>
            </td>
            <td style="width: 17%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$734,200</p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">91%</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">Audit-related fees<sup>(2)</sup></p>
            </td>
            <td style="width: 18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$2,562</p>
            </td>
            <td style="width: 18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">1%</p>
            </td>
            <td style="width: 17%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$1,854</p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">1%</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">Tax fees<sup>(3)</sup></p>
            </td>
            <td style="width: 18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$43,817</p>
            </td>
            <td style="width: 18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">5%</p>
            </td>
            <td style="width: 17%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$68,299</p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">8%</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">All other fees</p>
            </td>
            <td style="width: 18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$-</p>
            </td>
            <td style="width: 18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">-%</p>
            </td>
            <td style="width: 17%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$-</p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">-%</p>
            </td>
        </tr>
        <tr>
            <td style="width: 24%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: justify;"><b>Total</b></p>
            </td>
            <td style="width: 18%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>$809,062</b></p>
            </td>
            <td style="width: 18%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>100%</b></p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>$804,353</b></p>
            </td>
            <td style="width: 17%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;"><b>100%</b></p>
            </td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: justify;"><u>Notes</u>:</p>
    <p style="margin-top: 0pt; margin-left: 21.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">(1)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>For the year ended August 31, 2020 (&#8220;<b>FY&#8217;2020</b>&#8221;) and for the year ended August 31, 2019 (&#8220;<b>FY&#8217;201</b><b>9</b>&#8221;) audit fees were comprised of quarterly reviews, the annual audit and includes fees for auditor comfort letters provided with respect to a base shelf prospectus and two prospectus supplement documents filed by the Company.</p>
    <p style="margin-top: 0pt; margin-left: 21.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">(2)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>For FY&#8217;2020 audit related fees were comprised of fees for Canadian Public Accountability Board (CPAB) participation while for FY&#8217;2019 audit related fees are comprised of CPAB participation fees.</p>
    <p style="margin-top: 0pt; margin-left: 21.6pt; margin-bottom: 0pt; text-indent: -21.6pt; text-align: justify;">(3)<font style="width: 10.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>Includes fees for all tax services other than those included in &#8220;Audit Fees&#8221; and &#8220;Audit-Related Fees&#8221; for work done during the designated periods . This category includes fees for tax compliance and advisory work.&#160; The FY&#8217;2019 tax fees includes tax advice related to mergers and acquisitions, and requests for rulings or technical advice from tax authorities.</p>
    <p style="text-align: center;"><b>ADDITIONAL INFORMATION</b></p>
    <p style="text-align: justify;">Additional information, including directors&#8217; and officers&#8217; remuneration and indebtedness, principal holders of securities of the Company and securities authorized for issuance under equity compensation plans, is contained in the Company&#8217;s Management Information Circular relating to the most recent annual meeting of shareholders of the Company. Additional financial information is contained in the Company&#8217;s financial statements and management discussion and analysis for the year ended August 31, 2020. Additional information relating to the Company may also be found on the Canadian Securities Administrators&#8217; SEDAR website at <font style="color: #0000ff;"><u>www.sedar.com</u></font> and on the United States Securities and Exchange Commission&#8217;s EDGAR website at <font style="color: #0000ff;"><u>www.sec.gov</u></font>. Copies of all of these documents may be obtained upon request from Organigram&#8217;s Investor Relations department at 35 English Drive, Moncton, New Brunswick E1E 3X3.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_65"></a>
    <div id="header_page_65">
        <p style="text-align: center;">- 63 -</p>
    </div>
    <p style="text-align: center;"><b>APPENDIX "A" - AUDIT COMMITTEE CHARTER</b></p>
    <p style="text-align: center;"><b>ORGANIGRAM HOLDINGS INC. </b><br><b>(THE "CORPORATION")</b><br><i><b>CHARTER OF THE AUDIT COMMITTEE</b></i></p>
    <p style="text-align: justify;">This Charter of the Audit Committee (the "<b>Charter</b>") was adopted by the board of directors of the Corporation (the "<b>Board</b>") on August 26, 2019, and last reviewed on August 26, 2020.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>1.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Purpose</b></u></p>
    <p style="text-align: justify;">The Audit Committee (the "<b>Committee</b>") is a committee of the Board.&#160; The members of the Committee and the chair of the Committee (the "<b>Chair</b>") are appointed by the Board on an annual basis (or until their successors are duly appointed) for the purpose of overseeing the Corporation's financial controls and reporting and monitoring whether the Corporation complies with financial covenants and legal and regulatory requirements governing financial disclosure matters and financial risk management.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>2.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Composition</b></u></p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(a)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Committee should be comprised of a minimum of three directors of the Corporation.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(b)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>All members of the Committee must meet the independence and audit committee composition requirements promulgated by all governmental and regulatory bodies having jurisdiction over the Corporation as may be in effect from time to time, including Rule 10A-3 of the United States Securities Exchange Act of 1934, as amended (the "<b>Exchange Act</b>"), Rule 5605 of the Nasdaq Marketplace Rules, National Instrument 52-110 - <i>Audit Committees</i> ("<b>NI 52-110</b>"), and the relevant rules of any other stock exchanges on which the Corporation's securities are listed.&#160; In general, each member of the Committee must be free from any relationship that, in the view of the Board, could be reasonably expected to interfere with the exercise of his or her independent judgment as a member of the Committee.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(c)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>All members of the Committee must be financially literate (which is defined as the ability to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Corporation's financial statements).&#160; At least one member of the Committee must satisfy the definition of "financial expert" as set out in Item 407(d)(5)(ii) of Regulation S-K under the United States Securities Act of 1933, as amended, and the Exchange Act.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(d)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Board shall designate the Chair of the Committee, who shall have responsibility for overseeing that the Committee fulfills its mandate and duties effectively. If the Board does not designate a Chair, the Committee will elect a Chair from among their members.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(e)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>Any member of the Committee may be removed or replaced at any time by the Board and will cease to be a member of the Committee on ceasing to be a director of the Corporation.&#160; The Board may fill vacancies on the Committee by election from among the Board.&#160; If and whenever a vacancy will exist on the Committee, the remaining members may exercise all powers of the Committee so long as a quorum remains.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_66"></a>
    <div id="header_page_66">
        <p style="text-align: center;">- 64 -</p>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(f)<font style="width: 26.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>No members of the Committee shall receive, directly or indirectly, other than for service on the Board or the Committee or other committees of the Board, any consulting, advisory, or other compensatory fee from the Corporation or any of its related parties or subsidiaries.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>3.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Limitations on Committee's Duties</b></u></p>
    <p style="text-align: justify;">In contributing to the Committee's discharge of its duties under this Charter, each member of the Committee will be obliged only to exercise the care, diligence and skill that a reasonably prudent person would exercise in comparable circumstances. Nothing in this Charter is intended or may be construed as imposing on any member of the Committee a standard of care or diligence that is in any way more onerous or extensive than the standard to which any member of the Board may be otherwise subject.</p>
    <p style="text-align: justify;">Members of the Committee are entitled to rely, absent actual knowledge to the contrary, on (a) the integrity of the persons and organizations from whom they receive information, (b) the accuracy and completeness of the information provided, (c) representations made by management of the Corporation ("<b>Management</b>") as to the non-audit services provided to the Corporation by the external auditor, (d) financial statements of the Corporation represented to them by a member of Management or in a written report of the external auditors to present fairly the financial position of the Corporation in accordance with applicable generally accepted accounting principles, and (e) any report of a lawyer, accountant, engineer, appraiser or other person whose profession lends credibility to a statement made by any such person.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>4.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Meetings</b></u></p>
    <p style="text-align: justify;">The Committee shall meet regularly, but not less frequently than quarterly.&#160; A quorum for the transaction of business at any meeting of the Committee will be a majority of the members of the Committee or such greater number as the Committee will by resolution determine.&#160; The Committee will keep minutes of each meeting of the Committee.&#160; A copy of the minutes will be provided to each member of the Committee.</p>
    <p style="text-align: justify;">Meetings of the Committee will be held from time to time and at such place as any member of the Committee will determine upon two days' prior notice to each of the other Committee members.&#160; The members of the Committee may waive the requirement for notice.&#160; In addition, each of the Chief Executive Officer, the Chief Financial Officer and the external auditor will be entitled to request that the Chair call a meeting.</p>
    <p style="text-align: justify;">The Committee may ask members of Management and employees of the Corporation (including, for greater certainty, its affiliates and subsidiaries) or others (including the external auditor) to attend meetings and provide such information as the Committee requests.&#160; Members of the Committee will have full access to information of the Corporation (including, for greater certainty, its affiliates, subsidiaries and their respective operations) and will be permitted to discuss such information and any other matters relating to the results of operations and financial position of the Corporation with Management, employees, the external auditor and others as they consider appropriate.</p>
    <p style="text-align: justify;">The Committee or its Chair should meet at least once per year with Management and the external auditor in separate sessions to discuss any matters that the Committee or either of these groups desires to discuss privately.&#160; In addition, the Committee or its Chair should meet with Management quarterly in connection with the Corporation's interim financial statements.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_67"></a>
    <div id="header_page_67">
        <p style="text-align: center;">- 65 -</p>
    </div>
    <p style="text-align: justify;">The Committee will determine any desired agenda items.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>5.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Committee Responsibilities</b></u></p>
    <p style="text-align: justify;">As part of its function in assisting the Board in fulfilling its oversight responsibilities (and without limiting the generality of the Committee's role), the Committee is mandated to carry out the following responsibilities:</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>External Auditors </i></p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(a)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>Subject to applicable law, appointing, compensating, overseeing and terminating the external auditors. The external auditors shall report directly to the Committee and shall be accountable to the Board and the Committee as representatives of the shareholders.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(b)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Pre-approving all non-audit mandates and fees for services the external auditor shall undertake, and considering whether the nature of such services will harm the firm's independence in carrying out its audit function.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(c)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing, negotiating and either signing or recommending to the Board the execution of all engagement letters of the external auditors, both for audit and non-audit services.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(d)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Satisfying itself, on behalf of the Board, that the external auditor is independent of Management. In assessing such independence, the Committee shall discuss with the external auditors, and may require a letter from the external auditor outlining any relationships between the external auditors and the Corporation or its affiliates.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(e)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the audit plan of the external auditors, the integration of the external audit with the internal control program, and the results of the audit, which shall include reviewing the external auditor's letter to Management and Management's response thereto and other material written communications between Management and the external auditors.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(f)<font style="width: 26.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the performance of the external auditors, including the compensation, scope, and timeliness of the audits and all other related services and any non-audit services provided by the external auditors.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(g)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Satisfying itself, annually or more frequently as the Committee considers appropriate, as to the external auditors' internal quality control procedures and any material issues raised by the most recent internal quality control review, or peer review, of the external auditor, or by any public enquiry, review, or investigation by governmental, professional or other regulatory authorities.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(h)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Periodically reviewing and discussing with Management and the external auditors the quality and acceptability of the Corporation's accounting policies and practices, the materiality levels which the external auditors propose to employ, any significant changes in the accounting policies and any proposed changes in accounting or financial reporting that may have a significant impact on the Corporation.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_68"></a>
    <div id="header_page_68">
        <p style="text-align: center;">- 66 -</p>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(i)<font style="width: 26.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>Discussing with Management and the external auditors of the Corporation all alternative treatments of financial information within International Financial Reporting Standards ("<b>IFRS</b>") accounting principles that have been discussed with Management by the external auditors, the ramifications of these alternative treatments and the treatment preferred by the external auditors.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(j)<font style="width: 26.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing, where there is to be a change of external auditors, all issues related to the change, including the information to be included in the notice of change of auditor called for under National Instrument 51-102 - <i>Continuous Disclosure Obligations</i> or any successor legislation ("<b>NI 51-102</b>"), and the planned steps for an orderly transition. The Committee shall further review all reportable events, including disagreements, unresolved issues and consultations, as defined in NI 51-102 or any successor legislation, on a routine basis, whether or not there is to be a change of external auditor.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(k)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Establishing and overseeing policies with regards to the hiring by the Corporation of any partners, employees, and any former partners or employees of any present or former firms that acted as external auditors of the Corporation.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Financial Information </i></p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(l)<font style="width: 26.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>Ensuring, through discussions with Management and the external auditors, that the audited annual financial statements and the unaudited quarterly financial statements, as applicable, present fairly (in accordance with IFRS) in all material respects the financial condition, results of operations and cash flows of the Corporation as of and for the periods presented and, where appropriate, recommending for approval to the Board such financial statements of the Corporation.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(m)<font style="width: 20.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing any errors or omissions in the current or prior year's financial statements.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(n)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing with the external auditors the level of co-operation they received from Management, employees and personnel of the Corporation during the audit process, any issues encountered by the auditors and any impediments on the external auditor's work.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(o)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing and resolving any disagreements between Management and the external auditors with respect to accounting practices and principles.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(p)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Monitoring the objectivity and credibility of the Corporation's financial reports.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(q)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the status of material contingent liabilities as reported to the Committee by the Corporation's Management, and the manner in which any material contingent liability has been disclosed in the Corporation's financial statements.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(r)<font style="width: 26.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing any legal matters or claims that could have a material impact on the financial statements of the Corporation, and the manner in which any such legal matters or claims have been disclosed in the Corporation's financial statements.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_69"></a>
    <div id="header_page_69">
        <p style="text-align: center;">- 67 -</p>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(s)<font style="width: 25.34pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing any reserves, accruals, provisions, estimates or adopted programs and policies, including factors that affect asset and liability carrying values and the timing of revenue and expense recognition that may have a material effect upon the financial statements of the Corporation.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(t)<font style="width: 26.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the use of special purpose entities and the business purpose and economic effect of off-balance sheet transactions, arrangements, obligations, guarantees and other relationships of the Corporation and their impact on the reported financial results of the Corporation.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(u)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the treatment for financial reporting purposes of any significant transactions which are not a normal part of the Corporation's operations.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(v)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing Management's determination of tangible or intangible asset impairment, if any, as required by applicable accounting standards.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(w)<font style="width: 21.34pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the annual report to shareholders and other financial information (including the annual and quarterly management's discussion and analysis, the annual information form and any prospectus, offering circular or other disclosure document issued by the Corporation or on behalf of the Corporation) prepared by the Corporation with Management and, where appropriate, recommending such documents for approval to the Board and for filing with regulatory bodies.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(x)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing any news releases and reports to be issued by the Corporation containing earnings guidance or financial information for research, analysts and rating agencies. The Committee shall also review the Corporation's policies relating to financial disclosure and the release of earnings guidance and the Corporation's compliance with financial disclosure rules and regulations.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(y)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Remaining apprised, through discussions with Management and the external auditors, of important trends and developments in financial reporting practices and requirements and their effect on the Corporation's financial statements, including consolidated financial statements.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(z)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the financial statements and other financial information of material subsidiaries of the Corporation and any auditor recommendations concerning such subsidiaries.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(aa)<font style="width: 19.36pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the financial reporting obligations of the Corporation pursuant to its by-laws, its borrowing covenants, the <i>Canada Business Corporations Act</i> and applicable securities regulation and monitor the Corporation's compliance thereunder.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Internal Control</i></p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(bb)<font style="width: 18.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Annually and in advance of each respective fiscal period, completing a financial review of the Corporation's strategic plan and annual budget, and reporting to the Board the results of its review.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_70"></a>
    <div id="header_page_70">
        <p style="text-align: center;">- 68 -</p>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(cc)<font style="width: 19.36pt; text-indent: 0pt; display: inline-block;">&#160;</font>Overseeing the adequacy and effectiveness of the Corporation's internal control systems, through discussions with the Corporation's external auditors and Management, and reporting its findings to the Board on an annual basis.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(dd)<font style="width: 18.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing and comparing Management's quarterly report of operating against its budget variances and reporting the results of such review and comparison to the Board.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(ee)<font style="width: 19.36pt; text-indent: 0pt; display: inline-block;">&#160;</font>Establishing procedures for:</p>
    <p style="margin-left: 108pt; text-indent: -21.6pt; text-align: justify;">(i)<font style="width: 12.27pt; text-indent: 0pt; display: inline-block;">&#160;</font>The receipt, retention, and treatment of complaints received by the Corporation regarding accounting, internal accounting controls, or auditing matters; and</p>
    <p style="margin-left: 108pt; text-indent: -21.6pt; text-align: justify;">(ii)<font style="width: 8.94pt; text-indent: 0pt; display: inline-block;">&#160;</font>The confidential, anonymous submission by employees of the Corporation of concerns regarding questionable accounting or auditing matters.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(ff)<font style="width: 22.02pt; text-indent: 0pt; display: inline-block;">&#160;</font>Annually reviewing the Corporation's Whistleblower Policy and its effectiveness and enforcement.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Compliance with Legal and Regulatory Requirements</i></p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(gg)<font style="width: 19.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing with Management, and/or any internal or external counsel as the Committee considers appropriate, any legal matters (including the status of pending litigation) that may have a material impact on the Corporation and any material reports.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(hh)<font style="width: 19.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing with Management and the Board any issues with regulatory agencies that are likely to have a significant financial impact on the Corporation.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(ii)<font style="width: 23.84pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing with counsel the adequacy and effectiveness of the Corporation's procedures to ensure compliance with the legal and regulatory responsibilities.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(jj)<font style="width: 23.34pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the status of income tax returns and any significant tax issues as they are reported to the Committee by Management or the Board.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(kk)<font style="width: 18.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing any inquiries, investigations, or audits of a financial nature by any government, regulatory, or taxation authorities.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(ll)<font style="width: 23.34pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing any legal matters or claims that could have a material impact on the Corporation's compliance policies or any material reports, inquiries, or other correspondence received from regulators or governmental agencies.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Other</i></p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(mm)<font style="width: 13.34pt; text-indent: 0pt; display: inline-block;">&#160;</font>Assisting the Board in the discharge of its duties relating to the Corporation's accounting policies and practices, reporting practices and internal controls, including under its by-laws, securities regulations and otherwise.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_71"></a>
    <div id="header_page_71">
        <p style="text-align: center;">- 69 -</p>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(nn)<font style="width: 19.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the appointments of the Corporation's Chief Financial Officer, internal auditor (or persons appointed to perform the internal audit function), and any key financial executives involved in the financial reporting process of the Corporation and any material subsidiary.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(oo)<font style="width: 19.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Establishing and overseeing the effectiveness of procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or auditing under the Corporation's Whistleblower Policy.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(pp)<font style="width: 19.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Ensuring that this Charter or an appropriate summary of it which has been granted approval by the Committee is properly disclosed in accordance with any securities laws or regulatory requirements.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(qq)<font style="width: 19.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing the integrity of the Corporation's financial reporting processes, both internal and external, in consultation with the external auditor.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(rr)<font style="width: 23.52pt; text-indent: 0pt; display: inline-block;">&#160;</font>Periodically assessing the Corporation's need for an internal audit function, if not present.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(ss)<font style="width: 22.17pt; text-indent: 0pt; display: inline-block;">&#160;</font>Reviewing all material balance sheet issues, material contingent obligations and material related party transactions.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(tt)<font style="width: 24.84pt; text-indent: 0pt; display: inline-block;">&#160;</font>Taking such other actions within the general scope of its responsibilities as the Committee shall deem appropriate or as directed by the Board.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>6.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Resources</b></u></p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(a)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Committee shall have the authority, in its sole discretion, to retain independent legal, accounting and other consultants to advise the Committee at the expense of the Corporation. The Committee shall be provided with the necessary funding to compensate the external auditors and any other advisors they engage.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(b)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Committee shall have access to such officers and employees of the Corporation and to the Corporation's external auditors and legal counsel, and any information with regards to the Corporation as it considers necessary in order to discharge its duties under this Charter.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(c)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Committee, through the Chair, may contact any director, member of Management or other officer or employee of the Corporation as it deems necessary, and any director, member of Management or other officer or employee of the Corporation may bring any matter before the Committee involving illegal, questionable, improper, or unethical practices or transactions.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(d)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>The external auditors shall be entitled to communicate directly with the Chair of the Committee and may meet separately with the Committee and any member of the Committee.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(e)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Committee may request any director, member of Management or other officer or employee of the Corporation or the Corporation's external counsel or external auditors to attend a meeting of the Committee or to meet with any member of, or consultants to, the Committee. The Committee shall have full access to all of the Corporation's books, records, properties, facilities and personnel, subject to compliance with any leases or similar contacts governing same.</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_72"></a>
    <div id="header_page_72">
        <p style="text-align: center;">- 70 -</p>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(f)<font style="width: 26.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Committee may delegate its authority and duties to subcommittees or individual members of the Committee as it deems appropriate from time to time.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>7.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Annual Evaluation</b></u></p>
    <p style="text-align: justify;">At least annually, the Committee shall, in a manner it determines to be appropriate:</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(a)<font style="width: 24.68pt; text-indent: 0pt; display: inline-block;">&#160;</font>Perform a review and evaluation of the performance of the Committee and its members, including the compliance of the Committee with this Charter.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(b)<font style="width: 24.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Review and assess the adequacy of this Charter and recommend to the Board any improvements to this Charter that the Committee believes to be appropriate.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>8.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Inconsistencies with Applicable Laws</b></u></p>
    <p style="text-align: justify;">In the event of any conflict or inconsistency between this Charter and the applicable laws, in each case as amended, restated or amended and restated from time to time, the provisions hereof shall be ineffective and shall be superseded by the provisions of such applicable laws to the extent necessary to resolve such conflict or inconsistency.</p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>8
<FILENAME>exhibit99-7.htm
<DESCRIPTION>EXHIBIT 99.7
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibt 99.7 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <div>
        <p style="text-align: center;"><img src="tmp-codexu001.jpg" style="width: 343px;" height="46"></p>
    </div>
    <p style="text-align: center;"><b>ORGANIGRAM HOLDINGS INC.</b><br><b>(the "Corporation")</b></p>
    <p style="text-align: center;"><i><b>CODE OF BUSINESS CONDUCT AND ETHICS</b></i></p>
    <p style="text-align: justify;">This Code of Business Conduct and Ethics (the "<b>Code</b>") was adopted by the board of directors of the Corporation (the "<b>Board</b>") on August 26, 2019 and last reviewed and revised on August 26, 2020.</p>
    <p style="text-align: justify;">The objective of this Code is to provide guidelines for maintaining the integrity, reputation, honesty, objectivity and impartiality of the Corporation and its subsidiaries (collectively, the "<b>Organigram Entities</b>"). This Code covers a wide range of business practices and procedures.&#160; It does not cover every issue that may arise, but sets out basic principles to guide all directors, managers, officers, employees and consultants of the Organigram Entities (collectively, "<b>Organigram Personnel</b>" or "<b>you</b>").&#160; All Organigram Personnel must conduct themselves accordingly and seek to avoid even the appearance of improper behavior.&#160; This Code and specific related policies and guidelines (including the Corporation's Insider Trading Policy) put in place from time to time by the Organigram Entities will govern your employment or other relationship with the Organigram Entities.</p>
    <p style="text-align: justify;">Each Organigram Personnel must act with integrity and observe the highest ethical standards of business conduct in his or her dealings with the Corporation's security holders, customers, suppliers, partners, service providers, competitors, employees and anyone else with whom he or she has contact in the course of performing his or her job. While the Code does not, and cannot, deal with every situation that may arise, the principles outlined in the Code should be seen as providing a baseline for honest and ethical decision-making. The Corporation shall ensure that each Organigram Personnel is provided with a copy of the Code and signs an acknowledgment of receipt and review in Section 5 hereto on an annual basis.</p>
    <p style="text-align: justify;">If a law conflicts with a policy in this Code, Organigram Personnel must comply with the law.&#160; If a local custom or policy conflicts with this Code, Organigram Personnel must comply with this Code.&#160; If you have any questions about these conflicts, you should ask a senior officer of the Corporation how to handle the situation.&#160; <b>Any questions regarding the Code should be addressed to your supervisor or the Chair of the Board of the Corporation. </b></p>
    <p style="text-align: justify;"><b>Organigram Personnel who violate the standards in this Code will be subject to disciplinary action, up to and including termination of their employment or other relationship with the Organigram Entities.&#160; If you are in a situation that you believe may violate or lead to a violation of this Code, follow the guidelines described below under "Compliance Procedures". </b></p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>1.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>The Code</b></u></p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>A.</b><font style="width: 24.33pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Compliance with Laws, Rules and Regulations (including Insider Trading Laws)</b></p>
    <p style="text-align: justify;">Obeying the law, both in letter and in spirit, is the foundation on which the Organigram Entities' ethical standards are built and is critical to our reputation and continued success.&#160; All Organigram Personnel must respect and obey the laws of the various jurisdictions in which the Organigram Entities operate and avoid even the appearance of impropriety.&#160; Although not all Organigram Personnel are expected to know the details of these laws, it is important to know enough to determine when to seek advice from senior management or other appropriate personnel.&#160; The Chair of the Board is available to assist in determining applicable legal requirements and to seek the advice of legal counsel where appropriate.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <div id="header_page_2">
        <p style="text-align: center;">- 2 -</p>
    </div>
    <p style="text-align: justify;">Organigram Personnel must cooperate fully with those (including the Chief Executive Officer and the Chief Financial Officer) responsible for preparing reports filed with the securities regulatory authorities and all other materials that are made available to the investing public to ensure those persons are aware in a timely manner of all information that is required to be disclosed. Organigram Personnel should also cooperate fully with the independent auditors in their audits and in assisting in the preparation of financial disclosure.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>B.</b><font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Conflicts of Interest</b></p>
    <p style="text-align: justify;">Organigram Personnel are required to act with honesty and integrity and to avoid or fully disclose any interest, relationship or activity that may be harmful or detrimental to the Corporation's best interests or that may give rise to real, potential or the appearance of a conflict of interest with the interests of any of the Organigram Entities.</p>
    <p style="text-align: justify;">A "<b>conflict of interest</b>" exists when a person's private interests interfere in any way with the interests of the Corporation.&#160; A conflict of interest can arise when Organigram Personnel take actions or have interests that may make it difficult for them to perform their work for the Corporation objectively and effectively.&#160; Conflicts of interest also may arise when Organigram Personnel or members of their families receive improper personal benefits as a result of their positions with any Organigram Entity.</p>
    <p style="text-align: justify;">Conflicts of interest are prohibited as a matter of policy, except as may be approved by the board of directors of the Corporation.&#160; Conflicts of interest may not always be clear-cut.&#160; If you have a question, you should consult with your supervisor or department head.&#160; Any Organigram Personnel who become aware of a conflict or potential conflict should bring it to the attention of a supervisor and consult the procedures described below under "Compliance Procedures".</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>C.</b><font style="width: 24.33pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Confidentiality</b></p>
    <p style="text-align: justify;">Organigram Personnel must maintain the confidentiality of confidential information entrusted to them by any Organigram Entity and persons with whom the Organigram Entities do business, except when disclosure is required by laws or regulations.&#160; Confidential information includes all non-public information that might be of use to competitors or harmful to any Organigram Entity or the person to whom it relates if disclosed.&#160; The obligation to preserve the confidentiality of confidential information continues even after Organigram Personnel cease to have a relationship with any of the Organigram Entities.</p>
    <p style="text-align: justify;">Organigram Personnel who have access to confidential information are not permitted to use or share that information for trading purposes or for any other purpose except the conduct of the Organigram Entities' business.&#160; All Organigram Personnel should read and abide by the Corporation's Disclosure and Confidential Information Policy.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <div id="header_page_3">
        <p style="text-align: center;">- 3 -</p>
    </div>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>D.</b><font style="width: 24.33pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Corporate Opportunities</b></p>
    <p style="text-align: justify;">Organigram Personnel are prohibited from taking for themselves personally opportunities that are discovered through the use of corporate property, information or positions without the consent of the Corporation's Board and from using corporate property, information or positions for improper personal gain.&#160; No Organigram Personnel may compete with the any of the Organigram Entities directly or indirectly.&#160; Organigram Personnel owe a duty to each Organigram Entity to advance its legitimate interests when the opportunity to do so arises.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>E.</b><font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Protection and Proper Use of&#160; the Organigram Entity Assets</b></p>
    <p style="text-align: justify;">All Organigram Personnel should endeavor to protect the Organigram Entity assets and ensure their efficient use.&#160; Theft, carelessness and waste have a direct impact on the profitability of the Organigram Entities.&#160; Any suspected incident of fraud or theft should be reported immediately to your immediate supervisor or the Chair of the Board of the Corporation for investigation.</p>
    <p style="text-align: justify;">The obligation of Organigram Personnel to protect the assets of the Organigram Entities includes the Organigram Entities' proprietary information.&#160; Proprietary information includes any information that is not known generally to the public or would be helpful to competitors of any of the Organigram Entities.&#160; Examples of proprietary information include intellectual property (such as trade secrets, patents, trademarks and copyrights), business, marketing and service plans, designs, databases, salary information and any unpublished financial data and reports.&#160; Unauthorized use or distribution of this information would violate the Organigram Entity policy and could be illegal and result in civil or criminal penalties.&#160;</p>
    <p style="text-align: justify;">The obligation to preserve the confidentiality of proprietary information continues even after Organigram Personnel cease to have a relationship with any of the Organigram Entities.</p>
    <p style="text-align: justify;">The Corporation's assets may never be used for illegal purposes.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>F.</b><font style="width: 25.67pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Information Protection</b></p>
    <p style="text-align: justify;">The Organigram Entities have physical and electronic safeguards in place to protect their information and all personal and confidential information entrusted to them. Organigram Personnel should use these safeguards to minimize the risk of unauthorized or accidental disclosure of such information. Unauthorized collection, use or disclosure of personal or confidential information can harm the Organigram Entities and their stakeholders and damage the trust that has been built. Breaches can be verbal, written or electronic and can be caused by error or malicious intent. If you become aware of a potential privacy, confidentiality or information security breach, you must promptly report it.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>G.</b><font style="width: 23.67pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Competition and Fair Dealing</b></p>
    <p style="text-align: justify;">The Organigram Entities seek to excel and to outperform any competitors fairly and honestly through superior performance and not through unethical or illegal business practices.&#160; Taking proprietary information without the owner's consent, inducing disclosure of that information by past or present employees of other persons or using that information is prohibited.&#160; Organigram Personnel should respect the rights of, and deal fairly with, the Organigram Entities' competitors and persons with whom the Organigram Entities have a business relationship.&#160; No Organigram Personnel should take unfair advantage of anyone through illegal conduct, manipulation, concealment, abuse of proprietary information, misrepresentation of material facts or any other intentional unfair-dealing practice.&#160; Nor should any Organigram Personnel act in a manner that may be anti-competitive under anti-trust laws.&#160; The Corporation's senior management and Chair of the Board are available to assist Organigram Personnel in determining the application of those laws and to seek the advice of legal counsel where appropriate.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <div id="header_page_4">
        <p style="text-align: center;">- 4 -</p>
    </div>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>H.</b><font style="width: 23.67pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Gifts and Entertainment</b></p>
    <p style="text-align: justify;">Business gifts and entertainment are customary courtesies designed to build goodwill and constructive relationships among business partners.&#160; These courtesies may include such things as meals and beverages, tickets to sporting or cultural events, discounts not available to the general public, accommodation and other merchandise or services.&#160; In some cultures, they play an important role in business relationships.&#160; However, a problem may arise when these courtesies compromise, or appear to compromise, an Organigram Entity's ability to make fair and objective business decisions or to gain an unfair advantage.</p>
    <p style="text-align: justify;">Offering or receiving any gift, gratuity or entertainment that might be perceived to unfairly influence a business relationship should be avoided.&#160; These guidelines apply at all times and do not change during traditional gift-giving seasons.</p>
    <p style="text-align: justify;">No gift or entertainment should ever be offered, given, provided, authorized or accepted by any Organigram Personnel or their family members unless it is consistent with customary business practices, is not excessive in value, cannot be construed as a bribe or payoff and does not violate any laws.&#160; If a disinterested third party would be likely to believe that the gift affected your judgment, then it must not be offered, given, provided, authorized or accepted.&#160; All business dealings must be on arm's-length terms and free from any favourable treatment resulting from the personal interests of Organigram Personnel.</p>
    <p style="text-align: justify;">Strict rules apply when an Organigram Entity does business with governmental agencies and officials (as discussed in more detail below). Organigram Personnel should discuss with senior management of the Corporation any gifts or proposed gifts about which they have any questions.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>I.</b><font style="width: 28.33pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Payments to Government Personnel</b></p>
    <p style="text-align: justify;">All Organigram Personnel must comply with all laws prohibiting improper payments to domestic and foreign officials.&#160; Other governments have laws regarding business gifts that may be accepted by government personnel.&#160; The promise, offer or delivery to an official or employee of various governments of a gift, favour or other gratuity in violation of these laws would not only violate the Organigram Entity's policies but could also be a criminal offence.&#160; Illegal payments should not be made to government officials of any country.&#160; The Corporation's Chair of the Board can provide guidance to Organigram Personnel in this area and seek the advice of legal counsel where appropriate.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>J.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Lobbying</b></p>
    <p style="text-align: justify;">Any contact with government personnel for the purpose of influencing legislation or rule making, including such activity in connection with marketing or procurement matters, is considered lobbying.&#160; You are responsible for knowing and adhering to all relevant lobbying laws and associated gift laws, if applicable and for compliance with all reporting requirements.&#160; You must obtain the prior approval of the Chair of the Board or Chief Executive Officer of the Corporation to lobby or authorize anyone else (for example, a consultant or agent) to lobby on behalf of any Organigram Entity, except when lobbying involves only normal marketing activities and not influencing legislation or rule making.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <div id="header_page_5">
        <p style="text-align: center;">- 5 -</p>
    </div>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>K.</b><font style="width: 23.67pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Discrimination and Harassment</b></p>
    <p style="text-align: justify;">The diversity of Organigram Personnel is a tremendous asset.&#160; The Organigram Entities are firmly committed to providing equal opportunity in all aspects of employment and will not tolerate any illegal discrimination, violence or harassment of any kind.&#160; Examples include derogatory comments based on any prohibited grounds of the Human Rights Act including but not limited to race, ethnicity, religion, sexual orientation, age or gender and sexual advances.&#160; Violence and threatening behavior are not permitted.&#160; Organigram Personnel are encouraged to speak with their supervisor, Human Resources or the Chief Executive Officer when a co-worker's conduct makes them uncomfortable and to report harassment when it occurs.&#160; Effective September 1, 2020. confidential reports of discrimination, violence or harassment can be made to the Organigram Entities' third party incident reporting website at <u>https://reporting.canaglobecompliance.com</u> or by phone at 1-888-650-7768.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>L.</b><font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Health, Safety and Respect</b></p>
    <p style="text-align: justify;">The Corporation strives to provide all Organigram Personnel with a safe and healthy work environment.&#160; All Organigram Personnel have responsibility for maintaining a safe and healthy workplace by following safety and health rules and practices and reporting accidents, injuries and unsafe equipment, practices or conditions to a supervisor or department head.&#160; Being under the influence, and the possession, of recreational and/or illegal drugs in the workplace will not be tolerated.&#160; Organigram Personnel should report to work in condition to perform their duties, free from the influence of recreational and/or illegal drugs or alcohol.</p>
    <p style="text-align: justify;">The Corporation expects Organigram Personnel to interact with other Organigram Entity employees, customers and business partners with respect, honesty, and integrity.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>M.</b><font style="width: 21.67pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Accuracy of Records and Reporting</b></p>
    <p style="text-align: justify;">The Organigram Entities require honest and accurate recording and reporting of information of the Corporation to make responsible business decisions.&#160; The Corporation's accounting records are relied upon to produce reports for management, directors, managers, securityholders, governmental agencies and persons with whom the Corporation does business.&#160; All of the Corporation's financial statements and the books, records and accounts on which they are based must appropriately reflect the Corporation's activities and conform to applicable legal, accounting and auditing requirements and to the Corporation's system of internal controls.&#160; Unrecorded or "off the books" funds or assets should not be maintained unless required by applicable law or regulation.</p>
    <p style="text-align: justify;">All Organigram Personnel have a responsibility, within the scope of their positions, to ensure that the Corporation's accounting records do not contain any false or intentionally misleading entries.&#160; The Corporation does not permit intentional misclassification of transactions as to accounts, departments or accounting records.&#160; All transactions must be supported by accurate documentation in reasonable detail and recorded in the proper accounts and in the proper accounting period.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <div id="header_page_6">
        <p style="text-align: center;">- 6 -</p>
    </div>
    <p style="text-align: justify;">Organigram Personnel business expense accounts must be documented and recorded accurately.&#160; If Organigram Personnel are not sure whether a certain expense is legitimate, a supervisor or department head can provide advice.&#160; General rules and guidelines are available from the Corporation's Chief Executive Officer or Chair of the Board.</p>
    <p style="text-align: justify;">Business records and communications often become public through legal or regulatory proceedings or the media.&#160; Organigram Personnel should avoid exaggeration, derogatory remarks, guesswork or inappropriate characterizations that can be misunderstood.&#160; This requirement applies equally to communications of all kinds, including e-mail, informal notes, internal memos and formal reports.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>N.</b><font style="width: 24.33pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Use of E-mail and Internet Services</b></p>
    <p style="text-align: justify;">E-mail and internet services are provided to assist Organigram Personnel in carrying out their work.&#160; Incidental and occasional personal use is permitted, but never for personal gain or any improper purpose.&#160; Organigram Personnel may not access, send or download any information that could be insulting or offensive to another person, such as sexually explicit messages, cartoons, jokes, unwelcome propositions, derogatory messages based on racial or ethnic characteristics, or any other message that could reasonably be viewed as harassment.&#160; Flooding Organigram Entities' system with junk mail and trivia hampers the ability of the system to handle legitimate business and is prohibited.</p>
    <p style="text-align: justify;">Messages (including voice-mail) and computer information sent, received or created by Organigram Personnel are considered property of the Organigram Entities and Organigram Personnel should recognize that these messages and information are not "private".&#160; Unless prohibited by law, the Organigram Entities reserve the right to access and disclose those messages and information as necessary for business purposes.&#160; Organigram Personnel should use good judgment and not access, send messages or store any information that they would not want to be seen or heard by others.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>O.</b><font style="width: 23.67pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Fraud and Similar Irregularities </b></p>
    <p style="text-align: justify;">The Corporation's policy prohibits fraud and establishes procedures to be followed concerning the recognition, reporting and investigation of suspected fraud. Fraud includes, but is not limited to:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p>Dishonest or fraudulent act;</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p>Embezzlement;</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p>Forgery or alteration of negotiable instruments such as corporate checks and drafts;</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p>Misappropriation of Corporation, employee, customer, partner or supplier assets;</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p>Conversion to person use of cash, securities, supplies or any other corporate asset;</p>
        </li>
    </ul>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <div id="header_page_7">
        <p style="text-align: center;">- 7 -</p>
    </div>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p>Unauthorized handling or reporting of corporate transactions; and</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p>Falsification of the Corporation's records or financial statements for personal or other reasons.</p>
        </li>
    </ul>
    <p style="text-align: justify;">Directors and employees are obligated to protect the Corporation's assets and ensure their efficient use. Theft, carelessness and waste of corporate assets by Directors and employees are prohibited since such actions and conduct have a direct and negative impact on the Corporation's profitability. All of the Corporation's assets shall only be used for the legitimate business purposes of the Corporation.&#160;</p>
    <p style="text-align: justify;">Any director, employee or agent who suspects that any fraudulent activity may have occurred is required to report such a concern to one of the following individuals: Legal Counsel, Director of Internal Audit, Chair of the Audit Committee, the Security Department or the Chief Financial Officer.</p>
    <p style="text-align: justify;">All fraud investigations will be conducted under the direction of the Legal Department.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>2.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Waivers of the Code</b></u></p>
    <p style="text-align: justify;">Any waiver of this Code for directors or officers may be made only by the directors of the Corporation (or a committee of the Board to whom that authority has been delegated) and will be promptly disclosed as required by law or stock exchange regulation.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>3.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Reporting and Illegal or Unethical Behavior</b></u></p>
    <p style="text-align: justify;">Each of the Organigram Entities has a strong commitment to the conduct of its business in a lawful and ethical manner.&#160; Organigram Personnel are encouraged to talk to supervisors, managers or other appropriate personnel about observed illegal or unethical behavior and when in doubt about the best course of action in a particular situation.&#160; It is the policy of the Organigram Entities to maintain confidentiality and not to allow retaliation for reports of misconduct by others made in good faith.&#160; It is, at the same time, unacceptable to file a report knowing that it is false.&#160; All Organigram Personnel are expected to cooperate in internal investigations of misconduct.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>4.</b><font style="width: 27pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Compliance Procedures</b></u></p>
    <p style="text-align: justify;">All Organigram Personnel must work to ensure prompt and consistent action against violations of this Code.&#160; However, in some situations it is difficult to know right from wrong.&#160; Since we cannot anticipate every situation that will arise, it is important that the Organigram Entities have a way to approach a new question or problem.&#160; These are the steps to keep in mind:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p><u>Make sure you have all the facts.</u>&#160; In order to reach the right solutions, we must be as fully informed as possible.</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p><u>Ask yourself: What specifically am I being asked to do?&#160; Does it seem unethical or improper?</u>&#160; This will help you to focus on the specific question you are faced with and the alternatives you have.&#160; Use your judgement and common sense - if something seems like it might possibly be unethical or improper, it probably is.</p>
        </li>
    </ul>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <div id="header_page_8">
        <p style="text-align: center;">- 8 -</p>
    </div>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p><u>Clarify your responsibility and role.</u>&#160; In most situations, there is shared responsibility.&#160; Are your colleagues informed?&#160; It may help to get others involved and discuss the problem.</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p><u>Discuss the problem with your manager.</u>&#160; This is the basic guidance for all situations.&#160; In many cases, your manager will be more knowledgeable about the question and will appreciate being brought into the decision-making process.&#160; Remember that it is your manager's responsibility to help solve problems.</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p><u>Seek help from internal resources.</u>&#160; In the rare case where it may not be appropriate to discuss an issue with your manager, or where you do not feel comfortable approaching your manager with your question, discuss it locally with your "two-up".&#160; If that is not appropriate for any reason, contact the Corporation's Chief Financial Officer, Chief Executive Officer or the Chair of the Board.</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p><u>You may report ethical violations without fear of retaliation.</u>&#160; If your situation requires that your identity be kept secret, your anonymity will be protected to the extent possible. The Organigram Entities do not permit retaliation of any kind against employees for good faith reports of ethical violations.</p>
        </li>
        <li style="margin-left: 28.52pt; text-align: justify; padding-left: 7.48pt;">
            <p><u>Always ask first, act later: </u> If you are unsure of what to do in any situation, seek guidance before you act.</p>
        </li>
    </ul>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;"><b>5.</b><font style="width: 28pt; text-indent: 0pt; display: inline-block;">&#160;</font><u><b>Acknowledgement of Receipt and Review</b></u></p>
    <p style="text-align: justify;">I, ________________________ (name), acknowledge that on ______________________ (date), I received a copy of Organigram Holdings Inc.'s Code of Business Conduct and Ethics and I read it, understood it and agree to comply with it.</p>
    <p style="margin-bottom: 0pt; text-align: justify;">________________________</p>
    <p style="margin-top: 0pt; text-align: justify;">Signature</p>
    <p style="margin-bottom: 0pt; text-align: justify;">________________________</p>
    <p style="margin-top: 0pt; text-align: justify;">Printed Name</p>
    <p style="margin-bottom: 0pt; text-align: justify;">________________________</p>
    <p style="margin-top: 0pt; text-align: justify;">Date</p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.8
<SEQUENCE>9
<FILENAME>exhibit99-8.htm
<DESCRIPTION>EXHIBIT 99.8
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibit 99.8 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a><br>
    <p style="text-align: justify;"><b>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>
    <p style="text-align: justify;">We consent to the incorporation by reference in Registration Statement No. 333-234564 on Form F-10 and to the use of our report dated November 29, 2020 relating to the consolidated financial statements of Organigram Holdings Inc. appearing in this Annual Report on Form 40-F for the year ended August 31, 2020.</p>
    <p style="text-align: justify;"><i>/s/ Deloitte LLP </i><br><br>Chartered Professional Accountants<br>Moncton, Canada<br>November 29, 2020</p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>10
<FILENAME>ogi-20200831.xml
<DESCRIPTION>XBRL TAXONOMY INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL-->
 <xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ogi="http://www.organigram.ca/20200831" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































  <link:schemaRef xlink:href="ogi-20200831.xsd" xlink:type="simple"></link:schemaRef>
  <context id="C_20201127_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiAmendmentAndRestatementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ogi:CreditFacilityAmendmentAxis">ogi:AmendmentAndRestatementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-11-27</instant>
    </period>
  </context>
  <context id="C_20201101to20201127_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiAmendmentAndRestatementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ogi:CreditFacilityAmendmentAxis">ogi:AmendmentAndRestatementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-11-01</startDate>
      <endDate>2020-11-27</endDate>
    </period>
  </context>
  <context id="C_20201101to20201112_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiUnderwritersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ogi:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:UnderwritersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-11-01</startDate>
      <endDate>2020-11-12</endDate>
    </period>
  </context>
  <context id="C_20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ogi:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-10-23</instant>
    </period>
  </context>
  <context id="C_20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiAchievementOfContractualProductionRelatedMilestoneMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ogi:AchievementOfContractualProductionRelatedMilestoneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-10-23</instant>
    </period>
  </context>
  <context id="C_20201001to20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ogi:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-10-01</startDate>
      <endDate>2020-10-23</endDate>
    </period>
  </context>
  <context id="C_20201001to20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiAchievementOfContractualProductionRelatedMilestoneMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ogi:AchievementOfContractualProductionRelatedMilestoneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-10-01</startDate>
      <endDate>2020-10-23</endDate>
    </period>
  </context>
  <context id="C_20200831">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiReceivablesAxis_ogiZeroToSixtyDaysMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ReceivablesAxis">ogi:ZeroToSixtyDaysMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ogiContractualCashFlowsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ogi:ContractualCashFlowsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiReceivablesAxis_ogiSixtyOneToOneTwentyDaysMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ReceivablesAxis">ogi:SixtyOneToOneTwentyDaysMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:EquityReserveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullBiologicalAssetsByGroupAxis_ifrsfullPlantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ifrs-full:PlantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ExpirationPeriodAxis">ogi:ExpirationPeriodYearOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ExpirationPeriodAxis">ogi:ExpirationPeriodYearTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ExpirationPeriodAxis">ogi:ExpirationPeriodYearFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ExpirationPeriodAxis">ogi:ExpirationPeriodYearFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ExpirationPeriodAxis">ogi:ExpirationPeriodYearThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:DryCannabisMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullBiologicalAssetsByGroupAxis_ogiOtherBiologicalAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ogi:OtherBiologicalAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfFinancialInstrumentsAxis_ogiPrepaidExpensesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ogi:PrepaidExpensesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FormulatedExtractsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfFinancialInstrumentsAxis_ogiOtherLiabilitiesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ogi:OtherLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiConcentratedExtractMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:ConcentratedExtractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiPlantsInDryingStageMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:PlantsInDryingStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiShortTermInvestmentsAxis_ogiEquitySecuritiesInVivoCannabisIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:EquitySecuritiesInVivoCannabisIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanThreeYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanFourYearsAndNotLaterThanFiveYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanTwoYearsAndNotLaterThanThreeYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFiveYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFourYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:RestrictedStockUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:AlphaCannabisPharmaGmbhMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:EvianaHealthCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:PerformanceShareUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullBorrowingsByNameAxis_ogiVehicleLoansFiveYearTermMaturingJune172024Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:VehicleLoansFiveYearTermMaturingJune172024Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullComponentsOfEquityAxis_ifrsfullAccumulatedOtherComprehensiveIncomeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFlowerAndTrimAvailableForExtractionMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FlowerAndTrimAvailableForExtractionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiInventoryMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:InventoryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiLongTermAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:LongTermAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiBiologicalAssetMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:BiologicalAssetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiShareIssuanceCostsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:ShareIssuanceCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullLeaseLiabilitiesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullRightofuseAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ogi:AdjustmentOnAdoptionOfIFRS16Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiOtherDeferredTaxLiabilitiesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:OtherDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullAllowanceForCreditLossesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullPropertyPlantAndEquipmentSubjectToOperatingLeasesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:PropertyPlantAndEquipmentSubjectToOperatingLeasesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:DryCannabisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherTemporaryDifferencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:DryCannabisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FormulatedExtractsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiConcentratedExtractMember_ifrsfullMeasurementAxis_ifrsfullAtCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:ConcentratedExtractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiPlantsInDryingStageMember_ifrsfullMeasurementAxis_ifrsfullAtCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:PlantsInDryingStageMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FormulatedExtractsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiConcentratedExtractMember_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:ConcentratedExtractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiPlantsInDryingStageMember_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:PlantsInDryingStageMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceFourPointSixSixToSevenPointSixSevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceFourPointSixSixToSevenPointSixSevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceTwoPointThreeNineToFourPointSixFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceTwoPointThreeNineToFourPointSixFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceOnePointFourNineToTwoPointThreeEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceOnePointFourNineToTwoPointThreeEightMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceZeroPointThreeZeroToOnePointFourEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceZeroPointThreeZeroToOnePointFourEightMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember_ifrsfullBusinessCombinationsAxis_ogiSwearNetLimitedMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ogi:SwearNetLimitedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullBorrowingsByNameAxis_ogiAtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFlowerAndTrimAvailableForExtractionMember_ifrsfullMeasurementAxis_ifrsfullAtCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FlowerAndTrimAvailableForExtractionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFlowerAndTrimAvailableForExtractionMember_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FlowerAndTrimAvailableForExtractionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200705to20200829">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>



              <startDate>2020-07-05</startDate>
      <endDate>2020-08-29</endDate>
    </period>
  </context>
  <context id="C_20200701to20200716">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>



              <startDate>2020-07-01</startDate>
      <endDate>2020-07-16</endDate>
    </period>
  </context>
  <context id="C_20200601to20200608_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:AprilTwoThousandTwentyAtMarketEquityProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-06-01</startDate>
      <endDate>2020-06-08</endDate>
    </period>
  </context>
  <context id="C_20200528_ogiCreditFacilityAmendmentAxis_ogiSecondAmendmentMember_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ogi:CreditFacilityAmendmentAxis">ogi:SecondAmendmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-05-28</instant>
    </period>
  </context>
  <context id="C_20200501to20200528_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiSecondAmendmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ogi:CreditFacilityAmendmentAxis">ogi:SecondAmendmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-05-01</startDate>
      <endDate>2020-05-28</endDate>
    </period>
  </context>
  <context id="C_20200422_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:AprilTwoThousandTwentyAtMarketEquityProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-04-22</instant>
    </period>
  </context>
  <context id="C_20200401to20200421">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>



              <startDate>2020-04-01</startDate>
      <endDate>2020-04-21</endDate>
    </period>
  </context>
  <context id="C_20200301to20200531_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:AprilTwoThousandTwentyAtMarketEquityProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-03-01</startDate>
      <endDate>2020-05-31</endDate>
    </period>
  </context>
  <context id="C_20200301to20200531_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiSecondAmendmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ogi:CreditFacilityAmendmentAxis">ogi:SecondAmendmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-03-01</startDate>
      <endDate>2020-05-31</endDate>
    </period>
  </context>
  <context id="C_20191204_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:DecemberTwoThousandNineteenAtMarketEquityProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-04</instant>
    </period>
  </context>
  <context id="C_20191201to20200229_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:DecemberTwoThousandNineteenAtMarketEquityProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-12-01</startDate>
      <endDate>2020-02-29</endDate>
    </period>
  </context>
  <context id="C_20191101to20191115_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilityAmendmentAxis_ogiFirstAmendmentMember_ogiCreditFacilitiesAxis_ogiTermLoanMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ogi:CreditFacilityAmendmentAxis">ogi:FirstAmendmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-11-01</startDate>
      <endDate>2019-11-15</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ogiAntidilutiveSecuritiesAxis_ogiStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:AntidilutiveSecuritiesAxis">ogi:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:EquityReserveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiOtherRevenueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:OtherRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullBiologicalAssetsByGroupAxis_ifrsfullPlantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ifrs-full:PlantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ogiCreditFacilitiesAxis_ogiRevolvingCreditFacilitiesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:RevolvingCreditFacilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullBiologicalAssetsByGroupAxis_ogiOtherBiologicalAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ogi:OtherBiologicalAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiDirectToPatientMedicalRevenueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:DirectToPatientMedicalRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiInternationalBusinessToBusinessMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:InternationalBusinessToBusinessMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiStockOptionPlanMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:StockOptionPlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiWholesaleToLicensedProducersRevenueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:WholesaleToLicensedProducersRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiAdultUseRecreationalWholesaleRevenueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:AdultUseRecreationalWholesaleRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:RestrictedStockUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:AlphaCannabisPharmaGmbhMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:EvianaHealthCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:PerformanceShareUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiVehicleLoansFiveYearTermMaturingJune172024Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:VehicleLoansFiveYearTermMaturingJune172024Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullFixturesAndFittingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ifrsfullAccumulatedOtherComprehensiveIncomeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiInventoryMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:InventoryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiMonctonCampusPhase4CAssetSpecificMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:MonctonCampusPhase4CAssetSpecificMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiBiologicalAssetMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:BiologicalAssetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ogiReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiShareIssuanceCostsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:ShareIssuanceCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullLeaseLiabilitiesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullRightofuseAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:AprilTwoThousandTwentyAtMarketEquityProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullAllowanceForCreditLossesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherTemporaryDifferencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceFourPointSixSixToSevenPointSixSevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceFourPointSixSixToSevenPointSixSevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceTwoPointThreeNineToFourPointSixFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceTwoPointThreeNineToFourPointSixFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceOnePointFourNineToTwoPointThreeEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceOnePointFourNineToTwoPointThreeEightMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceZeroPointThreeZeroToOnePointFourEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceZeroPointThreeZeroToOnePointFourEightMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">ogi:ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember_ifrsfullBusinessCombinationsAxis_ogiSwearNetLimitedMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ogi:SwearNetLimitedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiAtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:RestrictedStockUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:PerformanceShareUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiFirstAmendmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ogi:CreditFacilityAmendmentAxis">ogi:FirstAmendmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="C_20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:EquityReserveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_ConcentratedExtractMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:ConcentratedExtractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_PlantsInDryingStageMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:PlantsInDryingStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ReceivablesAxis_ZeroToSixtyDaysMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ReceivablesAxis">ogi:ZeroToSixtyDaysMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_PlantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ifrs-full:PlantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_FlowerAndTrimAvailableForExtractionMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FlowerAndTrimAvailableForExtractionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_InventoryMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:InventoryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiReceivablesAxis_ogiSixtyOneToOneTwentyDaysMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ReceivablesAxis">ogi:SixtyOneToOneTwentyDaysMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ogi:OtherBiologicalAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_BiologicalAssetMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:BiologicalAssetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ShareIssuanceCostsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:ShareIssuanceCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:DryCannabisMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_ConcentratedExtractMember_MeasurementAxis_AtCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:ConcentratedExtractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_PlantsInDryingStageMember_MeasurementAxis_AtCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:PlantsInDryingStageMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_AllowanceForCreditLossesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ShortTermInvestmentsAxis_EquitySecuritiesInVivoCannabisIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:EquitySecuritiesInVivoCannabisIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_OtherTemporaryDifferencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ShortTermInvestmentsAxis_GuaranteedInvestmentCertificatesOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ShortTermInvestmentsAxis_GuaranteedInvestmentCertificatesTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:RestrictedStockUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_ConcentratedExtractMember_MeasurementAxis_AtFairValueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:ConcentratedExtractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_PlantsInDryingStageMember_MeasurementAxis_AtFairValueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:PlantsInDryingStageMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FormulatedExtractsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:AlphaCannabisPharmaGmbhMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:EvianaHealthCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_BorrowingsByNameAxis_VehicleLoansFiveYearTermMaturingJune172024Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:VehicleLoansFiveYearTermMaturingJune172024Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_UnsecuredConvertibleDebenturesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:UnsecuredConvertibleDebenturesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:ShortTermInvestmentsAxis">ogi:GuaranteedInvestmentCertificatesThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_FlowerAndTrimAvailableForExtractionMember_MeasurementAxis_AtCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FlowerAndTrimAvailableForExtractionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:PerformanceShareUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullComponentsOfEquityAxis_ifrsfullAccumulatedOtherComprehensiveIncomeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_FlowerAndTrimAvailableForExtractionMember_MeasurementAxis_AtFairValueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FlowerAndTrimAvailableForExtractionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:DryCannabisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiLongTermAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:LongTermAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:DryCannabisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FormulatedExtractsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullLeaseLiabilitiesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullRightofuseAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ogi:FormulatedExtractsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ogi:AdjustmentOnAdoptionOfIFRS16Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiOtherDeferredTaxLiabilitiesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:OtherDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ogi:SwearNetLimitedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_BorrowingsByNameAxis_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_26_Jul_2019T00_00_00_TO_26_Jul_2019T00_00_00_TypeOfArrangementsAxis_PaymentAgreementMember_ClassesOfFinancialInstrumentsAxis_SecuredLoanMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:PaymentAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ogi:SecuredLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-07-26</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-05-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_CreditFacilitiesAxis_TermLoanMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-05-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_CreditFacilitiesAxis_RevolvingCreditFacilityMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:RevolvingCreditFacilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-05-31</instant>
    </period>
  </context>
  <context id="Context_Custom_01_Feb_2019T00_00_00_TO_27_Feb_2019T00_00_00_BorrowingsByNameAxis_ConvertibleDebenturesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:ConvertibleDebenturesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-02-01</startDate>
      <endDate>2019-02-27</endDate>
    </period>
  </context>
  <context id="Context_Custom_01_Jan_2019T00_00_00_TO_18_Jan_2019T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-01-18</endDate>
    </period>
  </context>
  <context id="Context_As_Of_16-Oct-2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_VivoCannabisIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ogi:VivoCannabisIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-10-16</instant>
    </period>
  </context>
  <context id="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ogi:TraumaHealingCentersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-10-16</instant>
    </period>
  </context>
  <context id="Context_As_Of_10_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:AlphaCannabisPharmaGmbhMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-10-10</instant>
    </period>
  </context>
  <context id="Context_Custom_04_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:AlphaCannabisPharmaGmbhMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-10-04</startDate>
      <endDate>2018-10-10</endDate>
    </period>
  </context>
  <context id="Context_As_Of_02-Oct-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:EvianaHealthCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-10-02</instant>
    </period>
  </context>
  <context id="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:EvianaHealthCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-10-01</startDate>
      <endDate>2018-10-02</endDate>
    </period>
  </context>
  <context id="Context_As_Of_12_Sep_2018T00_00_00_TO_12_Sep_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-09-12</instant>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember_ogiSalesOfStockAxis_ogiAdvisoryServicesAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_ogiCannabisConsultantMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ogi:SalesOfStockAxis">ogi:AdvisoryServicesAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ogi:CannabisConsultantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:RestrictedStockUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:EquityReserveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_TopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_BottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_PlantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ifrs-full:PlantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_OtherRevenueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:OtherRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ifrsfullAccumulatedOtherComprehensiveIncomeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_AntidilutiveSecuritiesAxis_StockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:AntidilutiveSecuritiesAxis">ogi:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ogi:OtherBiologicalAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_DirectToPatientMedicalRevenueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:DirectToPatientMedicalRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_InternationalBusinessToBusinessMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:InternationalBusinessToBusinessMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionPlanMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:StockOptionPlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_WholesaleToLicensedProducersRevenueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:WholesaleToLicensedProducersRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_AdultUseRecreationalWholesaleRevenueMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">ogi:AdultUseRecreationalWholesaleRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:RestrictedStockUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:EvianaHealthCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_InventoryMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:InventoryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CategoriesOfRelatedPartiesAxis_KeyManagementPersonnelOfEntityOrParentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:AlphaCannabisPharmaGmbhMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:PerformanceShareUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_BiologicalAssetMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:BiologicalAssetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ShareIssuanceCostsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:ShareIssuanceCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_AllowanceForCreditLossesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_OtherTemporaryDifferencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_UnsecuredConvertibleDebenturesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:UnsecuredConvertibleDebenturesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ogi:AdjustmentOnAdoptionOfIFRS16Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ogi:SwearNetLimitedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ogiSalesOfStockAxis_ogiAdvisoryServicesAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_ogiCannabisConsultantMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:SalesOfStockAxis">ogi:AdvisoryServicesAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ogi:CannabisConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember_CategoriesOfRelatedPartiesAxis_KeyManagementPersonnelOfEntityOrParentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:RestrictedStockUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:CreditFacilitiesAxis">ogi:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ogi:BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:PerformanceShareUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2019-08-31</endDate>
    </period>
  </context>
  <context id="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ogi:TraumaHealingCentersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2018-10-16</endDate>
    </period>
  </context>
  <context id="Context_0ME_01-Sep-2018T00_00_00_TO_12-Sep-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2018-09-12</endDate>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="C_20180831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:EquityReserveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_BiologicalAssetsByGroupAxis_PlantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ifrs-full:PlantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_InventoryMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:InventoryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByGroupAxis">ogi:OtherBiologicalAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_BiologicalAssetMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:BiologicalAssetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ShareIssuanceCostsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:ShareIssuanceCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_AllowanceForCreditLossesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_OtherTemporaryDifferencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_UnsecuredConvertibleDebenturesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:UnsecuredConvertibleDebenturesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:HyasynthBiologicalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:RestrictedStockUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:AlphaCannabisPharmaGmbhMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ogi:EvianaHealthCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ogi:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ogi:GrowingProcessingEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ogi:SupplyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-08-31</instant>
    </period>
  </context>
  <context id="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-01-31</endDate>
    </period>
  </context>
  <context id="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-01-31</endDate>
    </period>
  </context>
  <context id="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:EquityFinancingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2017-12-01</startDate>
      <endDate>2017-12-18</endDate>
    </period>
  </context>
  <context id="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:EquityFinancingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2017-12-01</startDate>
      <endDate>2017-12-18</endDate>
    </period>
  </context>
  <context id="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ogi:ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ogi:EquityFinancingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2017-12-01</startDate>
      <endDate>2017-12-18</endDate>
    </period>
  </context>
  <context id="Context_As_Of_23_Oct_2017T00_00_00_TO_23_Oct_2017T00_00_00_SalesOfStockAxis_AdvisoryServicesAgreementMember_CategoriesOfRelatedPartiesAxis_CannabisConsultantMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:SalesOfStockAxis">ogi:AdvisoryServicesAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ogi:CannabisConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-10-23</instant>
    </period>
  </context>
  <context id="Context_Custom_01_Oct_2017T00_00_00_TO_23_Oct_2017T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
    </entity>
    <period>



              <startDate>2017-10-01</startDate>
      <endDate>2017-10-23</endDate>
    </period>
  </context>
  <context id="Context_Custom_01_Oct_2017T00_00_00_TO_23_Oct_2017T00_00_00_SalesOfStockAxis_AdvisoryServicesAgreementMember_CategoriesOfRelatedPartiesAxis_CannabisConsultantMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:SalesOfStockAxis">ogi:AdvisoryServicesAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ogi:CannabisConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2017-10-01</startDate>
      <endDate>2017-10-23</endDate>
    </period>
  </context>
  <context id="Context_Custom_01_Jul_2017T00_00_00_TO_14_Jul_2017T00_00_00_SalesOfStockAxis_AdvisoryServicesAgreementMember_CategoriesOfRelatedPartiesAxis_CannabisConsultantMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:SalesOfStockAxis">ogi:AdvisoryServicesAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ogi:CannabisConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2017-07-01</startDate>
      <endDate>2017-07-14</endDate>
    </period>
  </context>
  <context id="Context_Custom_01_Oct_2016T00_00_00_TO_04_Oct_2016T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001620737</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ogi:TypeOfArrangementsAxis">ogi:LicensingAndEndorsementAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">ogi:SwearNetLimitedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2016-10-01</startDate>
      <endDate>2016-10-04</endDate>
    </period>
  </context>
  <unit id="CAD">


        <measure>iso4217:CAD</measure>
  </unit>
  <unit id="CAD_per_Gram">


        <divide>



              <unitNumerator>


                    <measure>iso4217:CAD</measure>
      </unitNumerator>
      <unitDenominator>


                    <measure>ogi:Gram</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="CAD_per_Share">


        <divide>



              <unitNumerator>


                    <measure>iso4217:CAD</measure>
      </unitNumerator>
      <unitDenominator>


                    <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Debenture">


        <measure>ogi:Debenture</measure>
  </unit>
  <unit id="EUR">


        <measure>iso4217:EUR</measure>
  </unit>
  <unit id="Gram">


        <measure>ogi:Gram</measure>
  </unit>
  <unit id="Kilogram">


        <measure>ogi:Kilogram</measure>
  </unit>
  <unit id="Share">


        <measure>ogi:Share</measure>
  </unit>
  <unit id="Year">


        <measure>ogi:Year</measure>
  </unit>
  <unit id="pure">


        <measure>pure</measure>
  </unit>
  <unit id="shares">


        <measure>shares</measure>
  </unit>
  <ifrs-full:DisposalsBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" id="Fxbrl_20201124102658573" unitRef="CAD" xsi:nil="true"></ifrs-full:DisposalsBiologicalAssets>
  <ifrs-full:DisposalsBiologicalAssets contextRef="C_20190901to20200831_ifrsfullBiologicalAssetsByGroupAxis_ifrsfullPlantsMember" decimals="-3" id="Fxbrl_20201124102405889" unitRef="CAD">5048000</ifrs-full:DisposalsBiologicalAssets>
  <ifrs-full:DisposalsBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124102424191" unitRef="CAD">5048000</ifrs-full:DisposalsBiologicalAssets>
  <ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" id="Fxbrl_20201124141330907" unitRef="CAD" xsi:nil="true"></ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions>
  <ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201124141255622" unitRef="CAD">52000</ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" id="Fxbrl_20201124141751265" unitRef="Share" xsi:nil="true"></ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ogiSalesOfStockAxis_ogiAdvisoryServicesAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_ogiCannabisConsultantMember" decimals="INF" id="Fxbrl_20201124141835035" unitRef="Share">105000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember_ogiSalesOfStockAxis_ogiAdvisoryServicesAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_ogiCannabisConsultantMember" decimals="INF" id="Fxbrl_20201124141912460" unitRef="Share">84000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember" decimals="0" id="Fxbrl_20201124115229969" unitRef="Share">879635</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember" decimals="0" id="Fxbrl_20201124115235563" unitRef="Share">265258</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" decimals="0" id="Fxbrl_20201124125402886" unitRef="Share">142187</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" decimals="0" id="Fxbrl_20200916012923509" unitRef="Share">211981</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember_CategoriesOfRelatedPartiesAxis_KeyManagementPersonnelOfEntityOrParentMember" decimals="0" id="Fxbrl_20200916012957910" unitRef="Share">631949</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="C_20190901to20200831_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" decimals="0" id="Fxbrl_20201124141747399" unitRef="Share">88910</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ogi:AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" id="Fxbrl_20201124141812756" unitRef="CAD" xsi:nil="true"></ogi:AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel>
  <ogi:AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel contextRef="C_20190901to20200831_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" decimals="-3" id="Fxbrl_20201124141805792" unitRef="CAD">191000</ogi:AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel>
  <ogi:EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" id="Fxbrl_20201124115709193" unitRef="CAD" xsi:nil="true"></ogi:EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted>
  <ogi:EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" decimals="-3" id="Fxbrl_20201124115652951" unitRef="CAD">305000</ogi:EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" id="Fxbrl_20201124115741663" unitRef="CAD" xsi:nil="true"></ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200916172148481_2209_8902" unitRef="CAD">7796000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200916172148481_2214_3528" unitRef="CAD">14894000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiStockOptionPlanMember" decimals="-3" id="F6622_10036" unitRef="CAD">6127000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionPlanMember" decimals="-3" id="F6622_4649" unitRef="CAD">10036000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember" decimals="-3" id="Fxbrl_20201124120008546" unitRef="CAD">1576000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember" decimals="-3" id="Fxbrl_20201124120019994" unitRef="CAD">3475000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" decimals="-3" id="Fxbrl_20201124115733072" unitRef="CAD">272000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ogi:ChargesRelatedToReducedWorkforce contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" id="Fxbrl_20201124161328542" unitRef="CAD" xsi:nil="true"></ogi:ChargesRelatedToReducedWorkforce>
  <ogi:ChargesRelatedToReducedWorkforce contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161313616" unitRef="CAD">6095000</ogi:ChargesRelatedToReducedWorkforce>
  <ogi:ChargesForUnabsorbedFixedOverhead contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" id="Fxbrl_20201124161508719" unitRef="CAD" xsi:nil="true"></ogi:ChargesForUnabsorbedFixedOverhead>
  <ogi:ChargesForUnabsorbedFixedOverhead contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161452688" unitRef="CAD">5434000</ogi:ChargesForUnabsorbedFixedOverhead>
  <dei:EntityCentralIndexKey contextRef="C_20190901to20200831" id="Fdei_EntityCentralIndexKey_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">0001620737</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="C_20190901to20200831" id="Fdei_EntityCurrentReportingStatus_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">Yes</dei:EntityCurrentReportingStatus>
  <dei:CurrentFiscalYearEndDate contextRef="C_20190901to20200831" id="Fdei_CurrentFiscalYearEndDate_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">--08-31</dei:CurrentFiscalYearEndDate>
  <dei:AmendmentFlag contextRef="C_20190901to20200831" id="Fdei_AmendmentFlag_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">false</dei:AmendmentFlag>
  <dei:DocumentFiscalYearFocus contextRef="C_20190901to20200831" id="Fdei_DocumentFiscalYearFocus_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">2020</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="C_20190901to20200831" id="Fdei_DocumentFiscalPeriodFocus_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityEmergingGrowthCompany contextRef="C_20190901to20200831" id="Fdei_EntityEmergingGrowthCompany_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">true</dei:EntityEmergingGrowthCompany>
  <dei:EntityExTransitionPeriod contextRef="C_20190901to20200831" id="Fdei_EntityExTransitionPeriod_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">false</dei:EntityExTransitionPeriod>
  <dei:EntityRegistrantName contextRef="C_20190901to20200831" id="Fdei_EntityRegistrantName_Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00">ORGANIGRAM HOLDINGS INC.</dei:EntityRegistrantName>
  <ogi:InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" id="Fxbrl_20201124115201864" unitRef="CAD" xsi:nil="true"></ogi:InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction>
  <ogi:InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124115146258" unitRef="CAD">20251000</ogi:InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction>
  <ifrs-full:InventoryWritedown2011 contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" id="Fxbrl_20201124115425104" unitRef="CAD" xsi:nil="true"></ifrs-full:InventoryWritedown2011>
  <ifrs-full:InventoryWritedown2011 contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124115414956" unitRef="CAD">2753000</ifrs-full:InventoryWritedown2011>
  <dei:DocumentType contextRef="C_20190901to20200831" id="Fxbrl_20200918002256994">40-F</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="C_20190901to20200831" id="Fxbrl_20200918185720620">2020-08-31</dei:DocumentPeriodEndDate>
  <dei:EntityCommonStockSharesOutstanding contextRef="C_20200831" decimals="0" id="Fxbrl_20201128115257315" unitRef="shares">156196347</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityInteractiveDataCurrent contextRef="C_20190901to20200831" id="Fxbrl_20200918193709078">Yes</dei:EntityInteractiveDataCurrent>
  <ifrs-full:Cash contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715302_285_47555" unitRef="CAD">24600000</ifrs-full:Cash>
  <ifrs-full:Cash contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715302_291_55064" unitRef="CAD">47555000</ifrs-full:Cash>
  <ifrs-full:Cash contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00" decimals="-3" id="F2862_1957" unitRef="CAD">55064000</ifrs-full:Cash>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715314_xbrl_20200908191439547" unitRef="CAD">50128000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715314_xbrl_20200908191943007" unitRef="CAD">380000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesOneMember" decimals="-3" id="Fxbrl_20201124130437864" unitRef="CAD">10000000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ShortTermInvestmentsAxis_GuaranteedInvestmentCertificatesOneMember" decimals="-3" id="Fxbrl_20201124130448447" unitRef="CAD">0</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesTwoMember" decimals="-3" id="Fxbrl_20201124130510351" unitRef="CAD">10000000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ShortTermInvestmentsAxis_GuaranteedInvestmentCertificatesTwoMember" decimals="-3" id="Fxbrl_20201124130534534" unitRef="CAD">0</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesThreeMember" decimals="-3" id="Fxbrl_20201124130631719" unitRef="CAD">10000000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesThreeMember" decimals="-3" id="Fxbrl_20201124130812831" unitRef="CAD">0</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFourMember" decimals="-3" id="Fxbrl_20201124130643527" unitRef="CAD">10000000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFourMember" decimals="-3" id="Fxbrl_20201124130808951" unitRef="CAD">0</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFiveMember" decimals="-3" id="Fxbrl_20201124130654039" unitRef="CAD">10000000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFiveMember" decimals="-3" id="Fxbrl_20201124130834047" unitRef="CAD">0</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiEquitySecuritiesInVivoCannabisIncMember" decimals="-3" id="Fxbrl_20201124130551367" unitRef="CAD">128000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentHeldtomaturityInvestments contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ShortTermInvestmentsAxis_EquitySecuritiesInVivoCannabisIncMember" decimals="-3" id="Fxbrl_20201124130600481" unitRef="CAD">380000</ifrs-full:CurrentHeldtomaturityInvestments>
  <ifrs-full:CurrentTradeReceivables contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715325_xbrl_20200908192002913" unitRef="CAD">14747000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715325_xbrl_20200908192013361" unitRef="CAD">16541000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentLoansAndReceivables contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154842085_xbrl_20201124154715325_xbrl_20200908192002913" unitRef="CAD">2229000</ifrs-full:CurrentLoansAndReceivables>
  <ifrs-full:CurrentLoansAndReceivables contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154842085_xbrl_20201124154715325_xbrl_20200908192013361" unitRef="CAD">909000</ifrs-full:CurrentLoansAndReceivables>
  <ifrs-full:CurrentBiologicalAssets contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715336_xbrl_20200908192108556" unitRef="CAD">5394000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715336_xbrl_20200908192122666" unitRef="CAD">20652000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember" decimals="-3" id="F3548_6" unitRef="CAD">599000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_BiologicalAssetsByGroupAxis_PlantsMember" decimals="-3" id="F3551_2774" unitRef="CAD">19259000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00" decimals="-3" id="F3554_2780" unitRef="CAD">19858000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember" decimals="-3" id="F3644_599" unitRef="CAD">3000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_PlantsMember" decimals="-3" id="F3647_19259" unitRef="CAD">20649000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="C_20200831_ifrsfullBiologicalAssetsByGroupAxis_ogiOtherBiologicalAssetsMember" decimals="-3" id="F3740_3" unitRef="CAD">16000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="C_20200831_ifrsfullBiologicalAssetsByGroupAxis_ifrsfullPlantsMember" decimals="-3" id="F3743_20649" unitRef="CAD">5378000</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:Inventories contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715347_xbrl_20200908192233823" unitRef="CAD">66365000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715347_xbrl_20200908192254715" unitRef="CAD">93144000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiPlantsInDryingStageMember_ifrsfullMeasurementAxis_ifrsfullAtCostMember" decimals="-3" id="Fxbrl_20201124110019138_xbrl_20200918162643212" unitRef="CAD">2036000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiPlantsInDryingStageMember_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember" decimals="-3" id="Fxbrl_20201124110019138_xbrl_20200918162821512" unitRef="CAD">1841000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiPlantsInDryingStageMember" decimals="-3" id="Fxbrl_20201124110019138_xbrl_20200918170742579" unitRef="CAD">3877000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFlowerAndTrimAvailableForExtractionMember_ifrsfullMeasurementAxis_ifrsfullAtCostMember" decimals="-3" id="Fxbrl_20201124110403972_xbrl_20200918162717743" unitRef="CAD">849000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFlowerAndTrimAvailableForExtractionMember_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember" decimals="-3" id="Fxbrl_20201124110403972_xbrl_20200918162912311" unitRef="CAD">1062000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFlowerAndTrimAvailableForExtractionMember" decimals="-3" id="Fxbrl_20201124110403972_xbrl_20200918170819276" unitRef="CAD">1911000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiConcentratedExtractMember_ifrsfullMeasurementAxis_ifrsfullAtCostMember" decimals="-3" id="Fxbrl_20201124110427251_xbrl_20200918162730964" unitRef="CAD">13252000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiConcentratedExtractMember_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember" decimals="-3" id="Fxbrl_20201124110427251_xbrl_20200918162921401" unitRef="CAD">6130000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiConcentratedExtractMember" decimals="-3" id="Fxbrl_20201124110427251_xbrl_20200918170829383" unitRef="CAD">19382000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember" decimals="-3" id="Fxbrl_20201124110707240" unitRef="CAD">46958000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember" decimals="-3" id="Fxbrl_20201124110717689" unitRef="CAD">19407000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_PlantsInDryingStageMember_MeasurementAxis_AtCostMember" decimals="-3" id="Fxbrl_20201124111337457_1599693843" unitRef="CAD">1945000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_PlantsInDryingStageMember_MeasurementAxis_AtFairValueMember" decimals="-3" id="Fxbrl_20201124111337457_1599693885" unitRef="CAD">4256000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_PlantsInDryingStageMember" decimals="-3" id="Fxbrl_20201124111337457_1599693779" unitRef="CAD">6201000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_FlowerAndTrimAvailableForExtractionMember_MeasurementAxis_AtCostMember" decimals="-3" id="Fxbrl_20201124111543466_1599693849" unitRef="CAD">4433000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_FlowerAndTrimAvailableForExtractionMember_MeasurementAxis_AtFairValueMember" decimals="-3" id="Fxbrl_20201124111543466_1599693891" unitRef="CAD">12193000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_FlowerAndTrimAvailableForExtractionMember" decimals="-3" id="Fxbrl_20201124111543466_1599693799" unitRef="CAD">16626000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_ConcentratedExtractMember_MeasurementAxis_AtCostMember" decimals="-3" id="Fxbrl_20201124111556514_1599693855" unitRef="CAD">15393000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_ConcentratedExtractMember_MeasurementAxis_AtFairValueMember" decimals="-3" id="Fxbrl_20201124111556514_1599693897" unitRef="CAD">21573000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31-Aug-2019T00_00_00_CategoriesOfFinancialAssetsAxis_ConcentratedExtractMember" decimals="-3" id="Fxbrl_20201124111556514_1599693807" unitRef="CAD">36966000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember" decimals="-3" id="Fxbrl_20201124111717009" unitRef="CAD">38309000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember" decimals="-3" id="Fxbrl_20201124111734833" unitRef="CAD">54835000</ifrs-full:Inventories>
  <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715359_358_17100" unitRef="CAD">6741000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
  <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715359_363_3372" unitRef="CAD">17100000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
  <ifrs-full:CurrentAssets contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124155048261" unitRef="CAD">170204000</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155057873" unitRef="CAD">196281000</ifrs-full:CurrentAssets>
  <ifrs-full:RestrictedCashAndCashEquivalents contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124155119850_xbrl_20201124154715359_358_17100" unitRef="CAD">8032000</ifrs-full:RestrictedCashAndCashEquivalents>
  <ifrs-full:RestrictedCashAndCashEquivalents contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155119850_xbrl_20201124154715359_363_3372" unitRef="CAD">0</ifrs-full:RestrictedCashAndCashEquivalents>
  <ifrs-full:LoansAndReceivables contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715371_xbrl_20200908192036942" unitRef="CAD">0</ifrs-full:LoansAndReceivables>
  <ifrs-full:LoansAndReceivables contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155159411" unitRef="CAD">0</ifrs-full:LoansAndReceivables>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715378_xbrl_20200908195446374" unitRef="CAD">247420000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715378_xbrl_20200908200554470" unitRef="CAD">218470000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4679_2205" unitRef="CAD">2205000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4682_47101" unitRef="CAD">47101000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4685_11993" unitRef="CAD">11993000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4688_40493" unitRef="CAD">40493000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4691_2922" unitRef="CAD">2922000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124095239098" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4694_104714" unitRef="CAD">104714000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F5199_2211" unitRef="CAD">2211000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F5202_70774" unitRef="CAD">70774000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F5205_65515" unitRef="CAD">65515000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F5208_87931" unitRef="CAD">87931000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F5211_7538" unitRef="CAD">6697000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124101956697" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F5214_233969" unitRef="CAD">233128000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212540456" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4922_1997" unitRef="CAD">-1997000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213105025" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4928_2956" unitRef="CAD">-2956000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4931_1122" unitRef="CAD">-1122000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213246529" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4934_6075" unitRef="CAD">-6075000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212620703" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5402_4237" unitRef="CAD">-4237000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213016374" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5408_8618" unitRef="CAD">-8618000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5411_2068" unitRef="CAD">-1803000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213318693" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5414_14923" unitRef="CAD">-14658000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124104638468_5199_2211" unitRef="CAD">4075000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124104638468_5202_70774" unitRef="CAD">127022000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124104638468_5205_65515" unitRef="CAD">2128000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124104638468_5208_87931" unitRef="CAD">132991000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124104638468_5211_7538" unitRef="CAD">8677000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124104638468_xbrl_20201124101956697" unitRef="CAD">4464000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124104638468_5214_233969" unitRef="CAD">279357000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124214533632" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124113005971_xbrl_20201124111742942_4922_1997" unitRef="CAD">-8203000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124214735637" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124113005971_xbrl_20201124111742942_4928_2956" unitRef="CAD">-20041000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124113005971_xbrl_20201124111742942_4931_1122" unitRef="CAD">-3136000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124113005971_xbrl_20201124111742942_4934_6075" unitRef="CAD">-557000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124113152910" unitRef="CAD">-31937000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember" decimals="-3" id="F5519_2211" unitRef="CAD">2211000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember" decimals="-3" id="F5522_66537" unitRef="CAD">66537000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember" decimals="-3" id="F5525_65515" unitRef="CAD">65515000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember" decimals="-3" id="F5528_79313" unitRef="CAD">79313000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember" decimals="-3" id="F5531_5470" unitRef="CAD">4894000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="Fxbrl_20201124215220781" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember" decimals="-3" id="Fxbrl_20201124104114499" unitRef="CAD">4075000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" decimals="-3" id="Fxbrl_20201124104120814" unitRef="CAD">118819000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember" decimals="-3" id="Fxbrl_20201124104132363" unitRef="CAD">2128000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember" decimals="-3" id="Fxbrl_20201124104300415" unitRef="CAD">112950000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" decimals="-3" id="Fxbrl_20201124104307057" unitRef="CAD">5541000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="Fxbrl_20201124104317026" unitRef="CAD">3907000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715389_xbrl_20200908200444938" unitRef="CAD">1772000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155246158" unitRef="CAD">2074000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember" decimals="-3" id="Fxbrl_20201124134144250_22" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember" decimals="-3" id="Fxbrl_20201124134144250_25" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember" decimals="-3" id="Fxbrl_20201124134144250_28" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134144250_211" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134759250_xbrl_20201124134144250_272" unitRef="CAD">1530000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134759250_xbrl_20201124134144250_275" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134759250_xbrl_20201124134144250_278" unitRef="CAD">841000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134759250_xbrl_20201124134144250_2711" unitRef="CAD">2371000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember" decimals="-3" id="Fxbrl_20201124134144250_82" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember" decimals="-3" id="Fxbrl_20201124134144250_85" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember" decimals="-3" id="Fxbrl_20201124134144250_88" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124134144250_811" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124134738673_xbrl_20201124134144250_272" unitRef="CAD">-32000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124134738673_xbrl_20201124134144250_275" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124134738673_xbrl_20201124134144250_278" unitRef="CAD">-265000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124134738673_xbrl_20201124134144250_2711" unitRef="CAD">-297000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134822492_xbrl_20201124134144250_262" unitRef="CAD">227000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134822492_xbrl_20201124134144250_265" unitRef="CAD">198000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134822492_xbrl_20201124134144250_268" unitRef="CAD">2041000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134822492_xbrl_20201124134144250_2611" unitRef="CAD">2466000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124141055626_xbrl_20201124134937297_xbrl_20201124134822492_xbrl_20201124134144250_262" unitRef="CAD">-227000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124141055626_xbrl_20201124134937297_xbrl_20201124134822492_xbrl_20201124134144250_265" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124141055626_xbrl_20201124134937297_xbrl_20201124134822492_xbrl_20201124134144250_268" unitRef="CAD">-467000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124141055626_xbrl_20201124134937297_xbrl_20201124134822492_xbrl_20201124134144250_2611" unitRef="CAD">-694000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember" decimals="-3" id="Fxbrl_20201124134958113_xbrl_20201124134759250_xbrl_20201124134144250_272" unitRef="CAD">1498000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember" decimals="-3" id="Fxbrl_20201124134958113_xbrl_20201124134759250_xbrl_20201124134144250_275" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember" decimals="-3" id="Fxbrl_20201124134958113_xbrl_20201124134759250_xbrl_20201124134144250_278" unitRef="CAD">576000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember" decimals="-3" id="Fxbrl_20201124134937297_xbrl_20201124134822492_xbrl_20201124134144250_262" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember" decimals="-3" id="Fxbrl_20201124134937297_xbrl_20201124134822492_xbrl_20201124134144250_265" unitRef="CAD">198000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember" decimals="-3" id="Fxbrl_20201124134937297_xbrl_20201124134822492_xbrl_20201124134144250_268" unitRef="CAD">1574000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:PrepaymentsAndAccruedIncome contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715396_418_592" unitRef="CAD">698000</ifrs-full:PrepaymentsAndAccruedIncome>
  <ifrs-full:PrepaymentsAndAccruedIncome contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715396_423_714" unitRef="CAD">592000</ifrs-full:PrepaymentsAndAccruedIncome>
  <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715405_430_11108" unitRef="CAD">7001000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
  <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155228036" unitRef="CAD">11108000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
  <ifrs-full:Assets contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715410_xbrl_20200908200649578" unitRef="CAD">435127000</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715410_xbrl_20200908200702874" unitRef="CAD">428525000</ifrs-full:Assets>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715420_xbrl_20200917042502311" unitRef="CAD">17486000</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715420_xbrl_20200917043146688" unitRef="CAD">40355000</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20200831_ifrsfullMaturityAxis_ogiContractualCashFlowsMember" decimals="-3" id="Fxbrl_20200916230904915" unitRef="CAD">17486000</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" decimals="-3" id="Fxbrl_20200916230916114" unitRef="CAD">17486000</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanThreeYearsMember" decimals="-3" id="Fxbrl_20200916231020489" unitRef="CAD">0</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" decimals="-3" id="Fxbrl_20200916231132334" unitRef="CAD">0</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" decimals="-3" id="Fxbrl_20200916231156484" unitRef="CAD">0</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715429_xbrl_20200908200819763" unitRef="CAD">11595000</ifrs-full:CurrentPortionOfLongtermBorrowings>
  <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715429_xbrl_20200908200830752" unitRef="CAD">3509000</ifrs-full:CurrentPortionOfLongtermBorrowings>
  <ifrs-full:CurrentLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124155509946" unitRef="CAD">29081000</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155522624" unitRef="CAD">43864000</ifrs-full:CurrentLiabilities>
  <ifrs-full:LongtermBorrowings contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715440_xbrl_20200908201021760" unitRef="CAD">103671000</ifrs-full:LongtermBorrowings>
  <ifrs-full:LongtermBorrowings contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715440_xbrl_20200908201032144" unitRef="CAD">46067000</ifrs-full:LongtermBorrowings>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124155425360_xbrl_20201124154715440_xbrl_20200908201021760" unitRef="CAD">2848000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155425360_xbrl_20201124154715440_xbrl_20200908201032144" unitRef="CAD">1117000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:NetDeferredTaxLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715450_591_10471" unitRef="CAD">0</ifrs-full:NetDeferredTaxLiabilities>
  <ifrs-full:NetDeferredTaxLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715450_596_7980" unitRef="CAD">10471000</ifrs-full:NetDeferredTaxLiabilities>
  <ifrs-full:Liabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124155514244" unitRef="CAD">135600000</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155526796" unitRef="CAD">101519000</ifrs-full:Liabilities>
  <ifrs-full:IssuedCapital contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715461_xbrl_20200908201926333" unitRef="CAD">420673000</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715461_xbrl_20200908201948806" unitRef="CAD">318125000</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20191204_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="-3" id="Fxbrl_20201124150855456" unitRef="CAD">55000000</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20200422_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="-3" id="Fxbrl_20201124150925977" unitRef="CAD">49000000</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="Context_As_Of_23_Oct_2017T00_00_00_TO_23_Oct_2017T00_00_00_SalesOfStockAxis_AdvisoryServicesAgreementMember_CategoriesOfRelatedPartiesAxis_CannabisConsultantMember" decimals="-3" id="Fxbrl_20201124141818479" unitRef="CAD">144000</ifrs-full:IssuedCapital>
  <ifrs-full:ReserveOfSharebasedPayments contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715472_652_17707" unitRef="CAD">23744000</ifrs-full:ReserveOfSharebasedPayments>
  <ifrs-full:ReserveOfSharebasedPayments contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715472_657_26045" unitRef="CAD">17707000</ifrs-full:ReserveOfSharebasedPayments>
  <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715484_664_43" unitRef="CAD">50000</ifrs-full:AccumulatedOtherComprehensiveIncome>
  <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155539893" unitRef="CAD">-43000</ifrs-full:AccumulatedOtherComprehensiveIncome>
  <ifrs-full:RetainedEarnings contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715491_679_8783" unitRef="CAD">-144940000</ifrs-full:RetainedEarnings>
  <ifrs-full:RetainedEarnings contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715491_687_759" unitRef="CAD">-8783000</ifrs-full:RetainedEarnings>
  <ifrs-full:Equity contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124155558462" unitRef="CAD">299527000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124155605446" unitRef="CAD">327006000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember" decimals="-3" id="Fxbrl_20201124161129344_1420_99531" unitRef="CAD">157790000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20180831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124161129344_1425_3081" unitRef="CAD">26045000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_01_Sep_2017T00_00_00_TO_31_Aug_2018T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember" decimals="-3" id="Fxbrl_20201124161129344_1435_19755" unitRef="CAD">759000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00" decimals="-3" id="Fxbrl_20201124161129344_1441_82857" unitRef="CAD">184594000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember" decimals="-3" id="Fxbrl_20201124161848577_2088_318125" unitRef="CAD">318125000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124161848577_2093_17707" unitRef="CAD">17707000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullComponentsOfEquityAxis_ifrsfullAccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fxbrl_20201124161848577_2098_43" unitRef="CAD">-43000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember" decimals="-3" id="Fxbrl_20201124161848577_2104_8783" unitRef="CAD">-8783000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20200831_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" decimals="-3" id="Fxbrl_20201124162344546_2088_318125" unitRef="CAD">420673000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20200831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124162344546_2093_17707" unitRef="CAD">23744000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20200831_ifrsfullComponentsOfEquityAxis_ifrsfullAccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fxbrl_20201124162344546_2098_43" unitRef="CAD">50000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20200831_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="-3" id="Fxbrl_20201124162344546_2104_8783" unitRef="CAD">-144940000</ifrs-full:Equity>
  <ifrs-full:EquityAndLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124154715503_xbrl_20200908203416212" unitRef="CAD">435127000</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124154715503_xbrl_20200908203429185" unitRef="CAD">428525000</ifrs-full:EquityAndLiabilities>
  <ogi:GrossRevenue contextRef="C_20190901to20200831" decimals="-3" id="F1599578349" unitRef="CAD">103387000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578350" unitRef="CAD">97547000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiAdultUseRecreationalWholesaleRevenueMember" decimals="-3" id="F7489_85018" unitRef="CAD">73938000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_AdultUseRecreationalWholesaleRevenueMember" decimals="-3" id="Fxbrl_20200910173127453" unitRef="CAD">85018000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiWholesaleToLicensedProducersRevenueMember" decimals="-3" id="F7507_709" unitRef="CAD">15184000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_WholesaleToLicensedProducersRevenueMember" decimals="-3" id="Fxbrl_20200910173225690" unitRef="CAD">709000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiDirectToPatientMedicalRevenueMember" decimals="-3" id="F7498_11192" unitRef="CAD">10748000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_DirectToPatientMedicalRevenueMember" decimals="-3" id="F7502_11002" unitRef="CAD">11192000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiInternationalBusinessToBusinessMember" decimals="-3" id="F7516_98" unitRef="CAD">3272000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_InternationalBusinessToBusinessMember" decimals="-3" id="Fxbrl_20200910173617443" unitRef="CAD">98000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="C_20190901to20200831_ifrsfullProductsAndServicesAxis_ogiOtherRevenueMember" decimals="-3" id="F7525_530" unitRef="CAD">245000</ogi:GrossRevenue>
  <ogi:GrossRevenue contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_ProductsAndServicesAxis_OtherRevenueMember" decimals="-3" id="F7529_1427" unitRef="CAD">530000</ogi:GrossRevenue>
  <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200909170145275" unitRef="CAD">16592000</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
  <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161535561" unitRef="CAD">17134000</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
  <ifrs-full:Revenue contextRef="C_20190901to20200831" decimals="-3" id="F1599578353" unitRef="CAD">86795000</ifrs-full:Revenue>
  <ifrs-full:Revenue contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200909170019608" unitRef="CAD">80413000</ifrs-full:Revenue>
  <ifrs-full:Revenue contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659601_xbrl_20200910104602617" unitRef="CAD">138000</ifrs-full:Revenue>
  <ifrs-full:CostOfSales contextRef="C_20190901to20200831" decimals="-3" id="F1599578355" unitRef="CAD">105004000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578356" unitRef="CAD">42521000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659611_xbrl_20200910104627582" unitRef="CAD">54000</ifrs-full:CostOfSales>
  <ogi:GrossMarginBeforeFairValueAdjustments contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161846684" unitRef="CAD">-18209000</ogi:GrossMarginBeforeFairValueAdjustments>
  <ogi:GrossMarginBeforeFairValueAdjustments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200909170429856" unitRef="CAD">37892000</ogi:GrossMarginBeforeFairValueAdjustments>
  <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161857255" unitRef="CAD">-38281000</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
  <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578362" unitRef="CAD">10577000</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
  <ifrs-full:GrossProfit contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161905879" unitRef="CAD">-56490000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578364" unitRef="CAD">48469000</ifrs-full:GrossProfit>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="C_20190901to20200831" decimals="-3" id="F1599578367" unitRef="CAD">27996000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578368" unitRef="CAD">18593000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659625_xbrl_20200910104723437" unitRef="CAD">75000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SalesAndMarketingExpense contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200909165834226" unitRef="CAD">16528000</ifrs-full:SalesAndMarketingExpense>
  <ifrs-full:SalesAndMarketingExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578370" unitRef="CAD">14625000</ifrs-full:SalesAndMarketingExpense>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="C_20190901to20200831" decimals="-3" id="F1599578371" unitRef="CAD">4725000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578372" unitRef="CAD">9151000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831" decimals="-3" id="F1599578373" unitRef="CAD">39771000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124162038403" unitRef="CAD">613000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204321570" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204547779" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204907682" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F5168_613" unitRef="CAD">613000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124212426528" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124101716245" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F5174_613" unitRef="CAD">613000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213754759" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124114126935" unitRef="CAD">37214000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213938573" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124114221679" unitRef="CAD">-48000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124214119272" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124214123272" unitRef="CAD">0</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124114233617" unitRef="CAD">37166000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ExpenseByNature contextRef="C_20190901to20200831" decimals="-3" id="F1599578375" unitRef="CAD">89020000</ifrs-full:ExpenseByNature>
  <ifrs-full:ExpenseByNature contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578376" unitRef="CAD">42982000</ifrs-full:ExpenseByNature>
  <ifrs-full:ExpenseByNature contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659631_xbrl_20200910104854383" unitRef="CAD">75000</ifrs-full:ExpenseByNature>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124162818889" unitRef="CAD">-145510000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200917045508072" unitRef="CAD">5487000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:FinanceCosts contextRef="C_20190901to20200831" decimals="-3" id="F1599578379" unitRef="CAD">6008000</ifrs-full:FinanceCosts>
  <ifrs-full:FinanceCosts contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578380" unitRef="CAD">9668000</ifrs-full:FinanceCosts>
  <ifrs-full:FinanceIncome contextRef="C_20190901to20200831" decimals="-3" id="F1599578381" unitRef="CAD">308000</ifrs-full:FinanceIncome>
  <ifrs-full:FinanceIncome contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200909130041595" unitRef="CAD">662000</ifrs-full:FinanceIncome>
  <ifrs-full:FinanceIncome contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659637_xbrl_20201124144529291" unitRef="CAD">0</ifrs-full:FinanceIncome>
  <ogi:IncomeFromGovernmentSubsidies contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124170218110" unitRef="CAD">7883000</ogi:IncomeFromGovernmentSubsidies>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="C_20190901to20200831" decimals="-3" id="F1599578383" unitRef="CAD">-1187000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124162902388" unitRef="CAD">-1261000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201129122753453" unitRef="CAD">-50000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201129122856918" unitRef="CAD">-734000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201129123012235" unitRef="CAD">-477000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="F6955_50" unitRef="CAD">-75000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember" decimals="-3" id="F6958_734" unitRef="CAD">-0</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="F6961_477" unitRef="CAD">-1112000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates contextRef="C_20190901to20200831" decimals="-3" id="F1599578385" unitRef="CAD">-3000000</ifrs-full:OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates>
  <ifrs-full:OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124162910336" unitRef="CAD">-950000</ifrs-full:OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates>
  <ogi:UnrealizedGainLossOnChangesInFairValueOfContingentConsideration contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124162926926" unitRef="CAD">886000</ogi:UnrealizedGainLossOnChangesInFairValueOfContingentConsideration>
  <ogi:UnrealizedGainLossOnChangesInFairValueOfContingentConsideration contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124162930890" unitRef="CAD">-145000</ogi:UnrealizedGainLossOnChangesInFairValueOfContingentConsideration>
  <ifrs-full:ProfitLossBeforeTax contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200917050934819" unitRef="CAD">-146628000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124162849097" unitRef="CAD">-5875000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659643_xbrl_20200917151410382" unitRef="CAD">9000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124163125936" unitRef="CAD">-10471000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200917051136091" unitRef="CAD">3629000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:ProfitLossFromContinuingOperations contextRef="C_20190901to20200831" decimals="-3" id="F1599578393" unitRef="CAD">-136157000</ifrs-full:ProfitLossFromContinuingOperations>
  <ifrs-full:ProfitLossFromContinuingOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124163236643" unitRef="CAD">-9504000</ifrs-full:ProfitLossFromContinuingOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599578396" unitRef="CAD">-38000</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659660_xbrl_20200910105050375" unitRef="CAD">-38000</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLoss contextRef="C_20190901to20200831" decimals="-3" id="F1599578397" unitRef="CAD">-136157000</ifrs-full:ProfitLoss>
  <ifrs-full:ProfitLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124163419469" unitRef="CAD">-9542000</ifrs-full:ProfitLoss>
  <ifrs-full:ProfitLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember" decimals="-3" id="Fxbrl_20201124161755945_xbrl_20200916215454080" unitRef="CAD">-9542000</ifrs-full:ProfitLoss>
  <ifrs-full:ProfitLoss contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="-3" id="Fxbrl_20201124162321681_xbrl_20200916215454080" unitRef="CAD">-136157000</ifrs-full:ProfitLoss>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="C_20190901to20200831" decimals="-3" id="F1599578399" unitRef="CAD">94000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124163650028" unitRef="CAD">-43000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:ComprehensiveIncome contextRef="C_20190901to20200831" decimals="-3" id="F1599578401" unitRef="CAD">-136063000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124163921817" unitRef="CAD">-9585000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations contextRef="C_20190901to20200831" decimals="3" id="F1599578403" unitRef="CAD_per_Share">-0.789</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="3" id="Fxbrl_20201124163931493" unitRef="CAD_per_Share">-0.067</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations contextRef="C_20190901to20200831" decimals="3" id="F1599578405" unitRef="CAD_per_Share">-0.789</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="3" id="Fxbrl_20201124170404391" unitRef="CAD_per_Share">-0.067</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124163811212" unitRef="CAD_per_Share">0</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20200916220225107" unitRef="CAD_per_Share">0</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124163822694" unitRef="CAD_per_Share">0</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20200916220344777" unitRef="CAD_per_Share">0</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:BasicEarningsLossPerShare contextRef="C_20190901to20200831" decimals="3" id="F1599578411" unitRef="CAD_per_Share">-0.789</ifrs-full:BasicEarningsLossPerShare>
  <ifrs-full:BasicEarningsLossPerShare contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="3" id="Fxbrl_20201124163956979" unitRef="CAD_per_Share">-0.068</ifrs-full:BasicEarningsLossPerShare>
  <ifrs-full:DilutedEarningsLossPerShare contextRef="C_20190901to20200831" decimals="3" id="F1599578413" unitRef="CAD_per_Share">-0.789</ifrs-full:DilutedEarningsLossPerShare>
  <ifrs-full:DilutedEarningsLossPerShare contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="3" id="Fxbrl_20201124164006248" unitRef="CAD_per_Share">-0.068</ifrs-full:DilutedEarningsLossPerShare>
  <ifrs-full:NumberOfSharesOutstanding contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00" decimals="INF" id="Fxbrl_20201124161129344_1415_103521404" unitRef="shares">125207938</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124161848577_2083_156196347" unitRef="shares">156196347</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20200831" decimals="INF" id="Fxbrl_20201124162344546_2083_156196347" unitRef="shares">194511061</ifrs-full:NumberOfSharesOutstanding>
  <ogi:IssuanceOfSharesShareBasedCompensation contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124161255322_1850_41000" unitRef="shares">41000</ogi:IssuanceOfSharesShareBasedCompensation>
  <ogi:IncreaseDecreaseThroughShareBasedCompensation contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember" decimals="-3" id="Fxbrl_20201124161255322_1854_180" unitRef="CAD">180000</ogi:IncreaseDecreaseThroughShareBasedCompensation>
  <ogi:IncreaseDecreaseThroughShareBasedCompensation contextRef="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124161255322_1858_14608" unitRef="CAD">14608000</ogi:IncreaseDecreaseThroughShareBasedCompensation>
  <ogi:IncreaseDecreaseThroughShareBasedCompensation contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161255322_1870_14788" unitRef="CAD">14788000</ogi:IncreaseDecreaseThroughShareBasedCompensation>
  <ogi:IncreaseDecreaseThroughShareBasedCompensation contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124162153196_1850_41000" unitRef="CAD">7519000</ogi:IncreaseDecreaseThroughShareBasedCompensation>
  <ogi:IncreaseDecreaseThroughShareBasedCompensation contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124162153196_1854_180" unitRef="CAD">7519000</ogi:IncreaseDecreaseThroughShareBasedCompensation>
  <ogi:IssuanceOfSharesExerciseOfStockOptions contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124161418914_1504_504801" unitRef="shares">2167864</ogi:IssuanceOfSharesExerciseOfStockOptions>
  <ogi:IssuanceOfSharesExerciseOfStockOptions contextRef="C_20190901to20200831" decimals="INF" id="Fxbrl_20201124162219110_1877_2167864" unitRef="shares">879240</ogi:IssuanceOfSharesExerciseOfStockOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember" decimals="-3" id="Fxbrl_20201124161418914_1508_1183" unitRef="CAD">6588000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124161418914_1512_462" unitRef="CAD">-2418000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161418914_1525_721" unitRef="CAD">4170000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" decimals="-3" id="Fxbrl_20201124162219110_1881_6588" unitRef="CAD">1786000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124162219110_1885_2418" unitRef="CAD">-717000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124162219110_1898_4170" unitRef="CAD">1069000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ogiReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" decimals="-3" id="Fxbrl_20201124141550680" unitRef="CAD">-717000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" decimals="-3" id="Fxbrl_20201124141609355" unitRef="CAD">-2418000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ogi:IssuanceOfSharesExerciseOfWarrants contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124161452368_1532_4330837" unitRef="shares">7751700</ogi:IssuanceOfSharesExerciseOfWarrants>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember" decimals="-3" id="Fxbrl_20201124161452368_1536_6693" unitRef="CAD">39257000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124161452368_1540_739" unitRef="CAD">-8281000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161452368_1553_5954" unitRef="CAD">30976000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" decimals="-3" id="Fxbrl_20201124102831634" unitRef="CAD">-8281000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ogi:IssuanceOfSharesExerciseOfRestrictedShareUnits contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124161519070_1935_182473" unitRef="shares">182473</ogi:IssuanceOfSharesExerciseOfRestrictedShareUnits>
  <ogi:IssuanceOfSharesExerciseOfRestrictedShareUnits contextRef="C_20190901to20200831" decimals="INF" id="Fxbrl_20201124162243770_1935_182473" unitRef="shares">154062</ogi:IssuanceOfSharesExerciseOfRestrictedShareUnits>
  <ogi:IncreaseDecreaseThroughExerciseOfRestrictedShareUnits contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember" decimals="-3" id="Fxbrl_20201124161519070_1939_837" unitRef="CAD">837000</ogi:IncreaseDecreaseThroughExerciseOfRestrictedShareUnits>
  <ogi:IncreaseDecreaseThroughExerciseOfRestrictedShareUnits contextRef="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124161519070_1943_837" unitRef="CAD">-837000</ogi:IncreaseDecreaseThroughExerciseOfRestrictedShareUnits>
  <ogi:IncreaseDecreaseThroughExerciseOfRestrictedShareUnits contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" decimals="-3" id="Fxbrl_20201124162243770_1939_837" unitRef="CAD">765000</ogi:IncreaseDecreaseThroughExerciseOfRestrictedShareUnits>
  <ogi:IncreaseDecreaseThroughExerciseOfRestrictedShareUnits contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124162243770_1943_837" unitRef="CAD">-765000</ogi:IncreaseDecreaseThroughExerciseOfRestrictedShareUnits>
  <ogi:IssuanceOfSharesConversionOfDebentures contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124161622605_1965_20845372" unitRef="shares">20845372</ogi:IssuanceOfSharesConversionOfDebentures>
  <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember" decimals="-3" id="Fxbrl_20201124161622605_1969_112166" unitRef="CAD">112166000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
  <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments contextRef="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124161622605_1973_11247" unitRef="CAD">-11247000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
  <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161622605_1986_100919" unitRef="CAD">100919000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
  <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" decimals="-3" id="F6234_11247" unitRef="CAD">-11247000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
  <ogi:IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember" decimals="-3" id="Fxbrl_20201124161654792_1999_1307" unitRef="CAD">1307000</ogi:IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts>
  <ogi:IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts contextRef="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ogiEquityReserveMember" decimals="-3" id="Fxbrl_20201124161654792_2003_163" unitRef="CAD">-163000</ogi:IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts>
  <ogi:IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161654792_2016_1144" unitRef="CAD">1144000</ogi:IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts>
  <ogi:IncreaseDecreaseThroughForeignCurrencyTranslation contextRef="C_20180901to20190831_ifrsfullComponentsOfEquityAxis_ifrsfullAccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fxbrl_20201124161734864_2037_43" unitRef="CAD">-43000</ogi:IncreaseDecreaseThroughForeignCurrencyTranslation>
  <ogi:IncreaseDecreaseThroughForeignCurrencyTranslation contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161734864_2046_43" unitRef="CAD">-43000</ogi:IncreaseDecreaseThroughForeignCurrencyTranslation>
  <ogi:IncreaseDecreaseThroughForeignCurrencyTranslation contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ifrsfullAccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fxbrl_20201124162306706_2037_43" unitRef="CAD">93000</ogi:IncreaseDecreaseThroughForeignCurrencyTranslation>
  <ogi:IncreaseDecreaseThroughForeignCurrencyTranslation contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124162306706_2046_43" unitRef="CAD">93000</ogi:IncreaseDecreaseThroughForeignCurrencyTranslation>
  <ogi:IssueCostAtMarketEquityFinancing contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124164456716" unitRef="CAD">3754000</ogi:IssueCostAtMarketEquityFinancing>
  <ogi:IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124163306592" unitRef="shares">37281412</ogi:IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts>
  <ogi:IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts contextRef="C_20190901to20200831_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" decimals="-3" id="Fxbrl_20201124163548801" unitRef="CAD">99997000</ogi:IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts>
  <ogi:IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124163602048" unitRef="CAD">99997000</ogi:IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="C_20190901to20200831" decimals="-3" id="F2209_8902" unitRef="CAD">17958000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2214_3528" unitRef="CAD">8902000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
  <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831" decimals="-3" id="F2221_133" unitRef="CAD">-778000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2226_39" unitRef="CAD">-133000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190901to20200831" decimals="-3" id="F2233_1563" unitRef="CAD">42771000</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201125052506426" unitRef="CAD">1563000</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="F2245_8060" unitRef="CAD">2853000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets>
  <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2253_10736" unitRef="CAD">8060000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets>
  <ifrs-full:AdjustmentsForFinanceCosts contextRef="C_20190901to20200831" decimals="-3" id="F2261_9668" unitRef="CAD">6008000</ifrs-full:AdjustmentsForFinanceCosts>
  <ifrs-full:AdjustmentsForFinanceCosts contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2266_10093" unitRef="CAD">9668000</ifrs-full:AdjustmentsForFinanceCosts>
  <ifrs-full:AdjustmentsForInterestIncome contextRef="C_20190901to20200831" decimals="-3" id="F2273_662" unitRef="CAD">308000</ifrs-full:AdjustmentsForInterestIncome>
  <ifrs-full:AdjustmentsForInterestIncome contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2281_1455" unitRef="CAD">662000</ifrs-full:AdjustmentsForInterestIncome>
  <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod contextRef="C_20190901to20200831" decimals="-3" id="F2289_1261" unitRef="CAD">-1201000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161623331" unitRef="CAD">-1261000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
  <ogi:AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration contextRef="C_20190901to20200831" decimals="-3" id="F2301_145" unitRef="CAD">886000</ogi:AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration>
  <ogi:AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161635305" unitRef="CAD">-145000</ogi:AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration>
  <ifrs-full:AdjustmentsForDeferredTaxExpense contextRef="C_20190901to20200831" decimals="-3" id="F2313_3635" unitRef="CAD">-10471000</ifrs-full:AdjustmentsForDeferredTaxExpense>
  <ifrs-full:AdjustmentsForDeferredTaxExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2318_5653" unitRef="CAD">3635000</ifrs-full:AdjustmentsForDeferredTaxExpense>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="C_20190901to20200831" decimals="-3" id="F2349_13134" unitRef="CAD">1794000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2357_337" unitRef="CAD">-13134000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="F2364_7266" unitRef="CAD">18111000</ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2369_6342" unitRef="CAD">7266000</ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="C_20190901to20200831" decimals="-3" id="F2377_48175" unitRef="CAD">27530000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2385_42342" unitRef="CAD">-48175000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="C_20190901to20200831" decimals="-3" id="F2393_10562" unitRef="CAD">-27995000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2398_3982" unitRef="CAD">10562000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
  <ogi:AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges contextRef="C_20190901to20200831" decimals="-3" id="F2405_13540" unitRef="CAD">9598000</ogi:AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges>
  <ogi:AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2413_2169" unitRef="CAD">-13540000</ogi:AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations contextRef="C_20190901to20200831" decimals="-3" id="F2421_35046" unitRef="CAD">-45125000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2429_12255" unitRef="CAD">-35046000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161731467" unitRef="CAD">-35000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20200910110159440" unitRef="CAD">-35000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="C_20190901to20200831" decimals="-3" id="F2453_35081" unitRef="CAD">-45125000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2461_12704" unitRef="CAD">-35081000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <ifrs-full:ShareIssueRelatedCost contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201125112445634" unitRef="CAD">3754000</ifrs-full:ShareIssueRelatedCost>
  <ifrs-full:ShareIssueRelatedCost contextRef="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember" decimals="-3" id="F6213_3678" unitRef="CAD">3678000</ifrs-full:ShareIssueRelatedCost>
  <ifrs-full:ShareIssueRelatedCost contextRef="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember" decimals="-3" id="F6213_3116" unitRef="CAD">3116000</ifrs-full:ShareIssueRelatedCost>
  <ifrs-full:ShareIssueRelatedCost contextRef="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember" decimals="-3" id="F6213_562" unitRef="CAD">562000</ifrs-full:ShareIssueRelatedCost>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20190901to20200831" decimals="-3" id="F2498_57500" unitRef="CAD">99997000</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20191201to20200229_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201125024513839" unitRef="CAD">54966000</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20200301to20200531_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124151715389" unitRef="CAD">31069000</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20200601to20200608_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152639628" unitRef="CAD">17915000</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152645940" unitRef="CAD">48785000</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20201101to20201112_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiUnderwritersMember" decimals="-3" id="Fxbrl_20201124142818714" unitRef="CAD">69144000</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124163143800" unitRef="CAD">897000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="C_20190901to20200831" decimals="-3" id="F2543_12674" unitRef="CAD">55000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2551_388" unitRef="CAD">12674000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="C_20201101to20201127_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiAmendmentAndRestatementMember" decimals="-3" id="Fxbrl_20201127102710066" unitRef="CAD">55000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ogi:DebtIssuesCost contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124164014502" unitRef="CAD">705000</ogi:DebtIssuesCost>
  <ogi:DebtIssuesCost contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124164023352" unitRef="CAD">1250000</ogi:DebtIssuesCost>
  <ifrs-full:ProceedsFromNoncurrentBorrowings contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161819783" unitRef="CAD">64295000</ifrs-full:ProceedsFromNoncurrentBorrowings>
  <ifrs-full:ProceedsFromNoncurrentBorrowings contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161825055" unitRef="CAD">58851000</ifrs-full:ProceedsFromNoncurrentBorrowings>
  <ogi:ProceedsFromStockOptionsWarrantsAndUnitsExercised contextRef="C_20190901to20200831" decimals="-3" id="F2571_35146" unitRef="CAD">1069000</ogi:ProceedsFromStockOptionsWarrantsAndUnitsExercised>
  <ogi:ProceedsFromStockOptionsWarrantsAndUnitsExercised contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2576_6673" unitRef="CAD">35146000</ogi:ProceedsFromStockOptionsWarrantsAndUnitsExercised>
  <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="C_20190901to20200831" decimals="-3" id="F2583_6995" unitRef="CAD">4043000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
  <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2591_4201" unitRef="CAD">6995000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="C_20190901to20200831" decimals="-3" id="F2599_74328" unitRef="CAD">160366000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2604_163910" unitRef="CAD">74328000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190901to20200831" decimals="-3" id="F2640_174200" unitRef="CAD">50000000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190901to20200831" decimals="-3" id="F2648_75000" unitRef="CAD">135000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2653_131200" unitRef="CAD">75000000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="C_20190901to20200831" decimals="-3" id="F2660_1637" unitRef="CAD">393000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
  <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2665_1455" unitRef="CAD">1637000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfInterestsInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124162439460" unitRef="CAD">12758000</ifrs-full:PurchaseOfInterestsInAssociates>
  <ifrs-full:PurchaseOfInterestsInAssociates contextRef="Context_Custom_04_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201124134853260" unitRef="EUR">1625000</ifrs-full:PurchaseOfInterestsInAssociates>
  <ifrs-full:PurchaseOfInterestsInAssociates contextRef="Context_Custom_04_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember" decimals="-3" id="F7129_2436" unitRef="CAD">2436000</ifrs-full:PurchaseOfInterestsInAssociates>
  <ifrs-full:PurchaseOfInterestsInAssociates contextRef="Context_0ME_01-Sep-2018T00_00_00_TO_12-Sep-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="-3" id="F7150_10000" unitRef="CAD">10000000</ifrs-full:PurchaseOfInterestsInAssociates>
  <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124162903729" unitRef="CAD">-8000000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents>
  <ifrs-full:DividendsReceivedFromAssociatesClassifiedAsInvestingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124162409664" unitRef="CAD">374000</ifrs-full:DividendsReceivedFromAssociatesClassifiedAsInvestingActivities>
  <ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="C_20190901to20200831" decimals="-3" id="F2699_909" unitRef="CAD">2071000</ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities>
  <ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201125053456849" unitRef="CAD">909000</ifrs-full:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2719_15" unitRef="CAD">168000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200916172322302_2714_168" unitRef="CAD">77223000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200916172322302_2719_15" unitRef="CAD">108764000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="C_20190901to20200831" decimals="-3" id="F2742_1530" unitRef="CAD">1430000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161936602" unitRef="CAD">1530000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="C_20190901to20200831" decimals="-3" id="F2786_46782" unitRef="CAD">-138196000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2794_97997" unitRef="CAD">-46782000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2814_26" unitRef="CAD">26000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="C_20190901to20200831" decimals="-3" id="F2827_7509" unitRef="CAD">-22955000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F2836_53209" unitRef="CAD">-7509000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ogi:DisclosureOfNatureOfOperationsExplanatory contextRef="C_20190901to20200831" id="F6b862d60-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;1.&lt;/span&gt;&lt;span style="width:6.89pt;display:inline-block"&gt; &lt;/span&gt;&lt;span style="color:#86b4cd"&gt;NATURE OF OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Organigram Holdings Inc. (the "Company") is a publicly traded corporation with its common shares trading on the Toronto Stock Exchange ("TSX") and on the Nasdaq Global Select Market ("NASDAQ") under the symbol "OGI". The head and the registered address of the Company is 35 English Drive, Moncton, New Brunswick, Canada, E1E 3X3.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company's major wholly-owned subsidiaries are: (i) Organigram Inc., a licensed producer ("LP" or "Licensed Producer") of cannabis and cannabis-derived products in Canada regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada), and (ii) 10870277 Canada Inc., a special purpose holding company for the Company. Organigram Inc. was incorporated under the Business Corporation Act (New Brunswick), on March 1, 2013.&amp;#160; Organigram Holdings Inc. was&amp;#160;incorporated under the Canada Business Corporations Act ("CBCA") on April 6, 2016.&amp;#160; 10870277 Canada Inc. was incorporated under the CBCA on July 4, 2018.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfNatureOfOperationsExplanatory>
  <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="C_20190901to20200831" id="F6b862d61-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;2.&lt;/span&gt;&lt;span style="width:6.89pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;span style="color:#86b4cd"&gt;BASIS OF PREPARATION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;i) Statement of compliance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;These consolidated financial statements have been prepared in accordance with the International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB") and interpretations of the IFRS Interpretations Committee ("IFRIC").&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;These consolidated financial statements were approved and authorized for issue by the Board of Directors of the Company on November 29, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;ii) Basis of measurement&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;These consolidated financial statements have been prepared on a historical cost basis except for biological assets, short-term investments, share-based compensation, and contingent share consideration, which are measured at fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Historical cost is the fair value of the consideration given in exchange for goods and services, which is generally based upon the fair value of the consideration given in exchange for assets at the time of the transaction.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;iii) Basis of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;These consolidated financial statements include the accounts of the Company and its subsidiaries on a consolidated basis after elimination of intercompany transactions and balances. Subsidiaries are entities that the Company controls when it is exposed, or has rights, to variable returns from its involvement and has the ability to affect those returns through its power to direct the relevant activities of the entity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;iv) COVID-19 estimation uncertainty&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In March 2020, the World Health Organization declared the outbreak of a novel strain of coronavirus ("COVID-19"), a global pandemic.&amp;#160; Government measures to limit the spread of COVID-19, including the closure of non-essential businesses, disrupted the Company's operations during the year ended August 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The production and sale of cannabis have been recognized as essential services across Canada, however COVID-19-related challenges have persisted, including, but not limited to, reduced staffing levels, production inefficiencies resulting from increased health and safety measures, and limited supply chain issues.&amp;#160; For the year ended August 31, 2020, the Company recorded impairments against its assets (inventories and property, plant and equipment) due in part to the COVID-19 pandemic.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Due to the ongoing developments and uncertainty surrounding COVID-19, it is not possible to predict the continuing impact that COVID-19 will have on the Company, its financial position, and/or its operating results in the future.&amp;#160; In addition, it is possible that estimates in the Company's financial statements will change in the near-term as a result of COVID-19, and the effect of any such changes could be material, which could result in, among other things, further impairment of inventories and long-lived assets including intangible assets. The Company is closely monitoring the impact of the COVID-19 on all aspects of its business.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;vi) Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Functional and presentation currency&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;These consolidated financial statements are presented in Canadian dollars, which is the Company's and its subsidiaries' functional currency, except for the Company's investment in its associate, alpha-cannabis Pharma GmbH ("ACG"), for which the functional currency has been determined to be Euros.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Transactions and balances&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Foreign currency transactions are translated into the functional currency using the exchange rate in effect on the date of the applicable transaction. Foreign exchange gains and losses resulting from the settlement of foreign currency transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in currencies other than an operation's functional currency are recognized in the consolidated statements of (loss) income and comprehensive (loss) income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&amp;#160;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Foreign operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on acquisition, are translated to Canadian dollars at the exchange rate in effect on the reporting date. The income and expenses of foreign operations are translated to Canadian dollars using average exchange rates for the month during which the transactions occurred. Foreign currency differences are recognized in other comprehensive income (loss) in the accumulated other comprehensive loss account.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;When the Company disposes of its entire interest in a foreign operation, or loses control over a foreign operation, the foreign currency gains or losses accumulated in other comprehensive income (loss) related to the foreign operation are recognized in profit or loss. If the Company disposes of part of an interest in a foreign operation that remains a subsidiary, a proportionate amount of foreign currency gains or losses accumulated in other comprehensive income (loss) related to the subsidiary is reallocated between controlling and non-controlling interests.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
  <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="C_20190901to20200831" id="F6b865470-f198-11ea-af0e-4f71386cf7c7">&lt;span style="color:#86b4cd"&gt;&lt;span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span&gt;3. SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;i) Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Cash is a financial asset that is measured at amortized cost, which approximates fair value and includes cash-on-hand and deposits held with financing institutions.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;ii) Short-term investments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;The Company considers short-term investments in the form of guaranteed investment certificates to be an investing activity. These investments are measured at amortized cost. The Company also has equity securities that are carried at fair value through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;iii) Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;While the Company's biological assets are within the scope of IAS 41 Agriculture, the direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2 Inventories. This includes the direct cost of seeds and growing materials as well as other indirect costs such as utilities and supplies used in the growing process. Indirect labour cost for individuals involved in the growing and quality control process is also included, as well as depreciation of manufacturing assets. All direct and indirect costs of biological assets are capitalized as they are incurred. Unrealized fair value gains/losses on growth of biological assets are recorded on the consolidated statements of (loss) income and comprehensive (loss) income. Biological assets are measured at their fair value less costs to sell on the consolidated statement of financial position.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;iv) Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Inventories for finished goods and packaging and supplies are initially valued at cost, and subsequently at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less the estimated costs to sell. The Company reviews inventories for obsolete, redundant and slow-moving goods and any such inventories identified are written down to net realizable value. The direct and indirect costs of finished goods inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labour and depreciation expense on equipment involved in packaging, labeling and inspection. All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of sales on the consolidated statements of (loss) income and comprehensive (loss) income at the time the cannabis is sold. Inventory is measured at lower of cost or net realizable value on the statement of financial position.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;v) Property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Property, plant and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company's management. Property, plant and equipment are subsequently measured at cost, less accumulated depreciation and impairment losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Depreciation is recognized on a straight-line basis to reduce the cost, less estimated residual value, of depreciable fixed assets. The following useful lives are applied:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;div style="text-align:center"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin-left:20%;width:60%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Growing equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets, and are recognized as profit or loss within other income or other expenses.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Assets in process are transferred to the appropriate asset class when available for use and depreciation of these assets commences at that point.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;An asset's residual value, useful life and depreciation method are reviewed during each financial year and adjusted if appropriate. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) and depreciated accordingly.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="line-height:115%"&gt;vi) Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%;color:black"&gt;Goodwill represents the future economic benefits arising from a business combination that are not individually identified and separately recognized. Goodwill is carried at cost less accumulated impairment losses. Refer to Note 3(viii) for a description of impairment testing procedures.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;vii) Assets held for sale&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;Assets and liabilities held for sale are no longer depreciated and are presented separately in the statement of financial position at the lower of their carrying amount and fair value less costs to sell. An asset is regarded as held for sale if its carrying amount will be recovered principally through a sale transaction, rather than through continuing use. For this to be the case, the asset must be available for immediate sale and its sale must be highly probable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;viii) Impairment of long-lived and intangible&amp;#160;assets&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;Long-lived assets, including property, plant and equipment are reviewed each reporting period for indicators of impairment. Goodwill is assessed for indicators of impairment at each reporting date and is tested annually or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs of disposal, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Except for goodwill, where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;ix) Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense in profit or loss over the vesting period based on the Company's estimate of equity instruments that will eventually vest. Fair value for options is determined using the Black-Scholes pricing model and fair value for Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") is determined using the Company's share price at the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Expected forfeitures are estimated at the date of the grant and subsequently adjusted if further information indicates actual forfeitures may vary from the original estimate.&amp;#160; The impact of the revision of the original estimate is recognized in profit or loss such that the cumulative expenses reflect the revised estimate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;For stock options granted to non-employees, the expense is measured at the fair value of the goods and services received except when the fair value cannot be estimated in which case it is measured at the fair value of the equity instrument granted.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Consideration paid by employees or non-employees on the exercise of options is recorded as an increase to share capital and the related share-based expense is transferred from equity reserves to share capital.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;&lt;span&gt;x) Investments in associates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Associates are companies over which the Company has significant influence and are accounted for under the equity method. Significant influence is presumed when the Company has an ownership interest greater than 20%, unless certain qualitative factors overcome this assumption. Conversely, where the Company has an ownership interest less than 20%, it is presumed that the Company does not have significant influence, unless certain qualitative factors overcome this assumption. In assessing significant influence and the ownership interest, potential voting rights that are currently exercisable are taken into consideration.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Investments in associates are accounted for using the equity method and are initially recognized at cost, inclusive of transaction costs. The consolidated financial statements include the Company&amp;#x2019;s share of the income or loss and equity movement of equity accounted associates. In accordance with IFRS, the associate&amp;#x2019;s most recent available financial statements are used in the application of the equity method. Where the associate&amp;#x2019;s reporting period differs from the Company&amp;#x2019;s, the associate prepares financial information as of the same period end as the Company, unless it is impracticable to do so. Otherwise, the Company will adjust for its share of income and expenses and equity movement based on the associate&amp;#x2019;s most recently completed financial statements, adjusted for the effects of significant transactions. The Company does not recognize losses exceeding the carrying value of its interest in the associate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;xi) Intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any, except for off-market supply agreements, where amortization is provided based on the actual output received versus the estimated output forecast to be received over the life of the agreement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively. Intangible assets with an indefinite life or not yet available for use are not subject to amortization.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Research costs are expensed as incurred. Development expenditures are capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development to use or sell the asset. Research costs and other development expenditures are recognized as general and administrative expenses on the consolidated statement of income (loss) and comprehensive income (loss) as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;&lt;span&gt;xii) Earnings (loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Basic earnings (loss) per share is calculated by dividing net income (loss) attributable to common shareholders by the weighted-average number of shares outstanding during the period.&amp;#160; Diluted earnings (loss) per share is calculated in a similar manner, but with adjustments to give effect to all dilutive potential common shares outstanding during the period. The dilutive effect of warrants, options, RSUs and PSUs is calculated using the treasury stock method. The if-converted method, which assumes that all convertible debt has been converted if the debt is in-the-money, is used to calculate the dilutive effect of convertible debt.&amp;#160; Anti-dilutive effects of potential conversions of securities are ignored for this calculation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;xiii) Revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#000000"&gt;Revenue from the direct sale of cannabis and cannabis oil for a fixed price is recognized when the Company transfers control of the good to the customer, which is at point of delivery for medical cannabis and recreational cannabis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Revenue includes excise taxes, which the Company pays as principal, but excludes duties and taxes collected on behalf of third parties. Revenue also includes the net consideration to which the Company expects to be entitled. Revenue is recognized to the extent that it is highly probable that a significant reversal will not occur. Therefore, revenue is stated net of expected price discounts, allowances for customer returns and certain promotional activities and similar items. Generally, payment of the transaction price is due within credit terms that are consistent with industry practices, with no element of financing.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Net revenue is revenue less excise taxes. Excise taxes are effectively a production tax which becomes payable when the product is removed from the Company's premises and may or may not be directly related to the value of revenue depending on the province of sale. It is generally not included as a separate item on external invoices; increases in excise tax are not always passed on to the customer and where a customer fails to pay for product received the Company cannot reclaim the excise tax. The Company therefore recognizes excise tax, unless it regards itself as an agent of the regulatory authorities, as a cost and reduction to revenue for the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;xiv) Income taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The measurement of income taxes payable and deferred income tax assets and liabilities requires management to make judgments in the interpretation and application of the relevant tax laws. The actual amount of income taxes only becomes final upon filing and acceptance of the tax return by the relevant authorities, which occurs subsequent to the issuance of the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Income tax expense (recovery) in the statements of income (loss) and comprehensive income (loss) is the sum of current and deferred tax as explained below.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Current tax is the expected income tax payable (recoverable) on the taxable income (loss) for the period, using tax rates enacted, or substantively enacted, as at the end of the reporting period.&amp;#160; Current tax expense (recovery) included in the statements of income (loss) and comprehensive income (loss) reflects the current tax for the reporting period, plus adjustments to the current tax of prior periods, less current tax recorded directly in other comprehensive income (loss) or equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Deferred taxes are accounted for under the liability method and are the taxes expected to be payable or recoverable on the temporary differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable income.&amp;#160; Deferred tax liabilities are generally recognized for all taxable temporary differences and deferred tax assets are recognized to the extent that it is probable that taxable income will be available against which deductible temporary differences and unused tax losses and tax credits can be utilized.&amp;#160; Deferred tax is calculated on a non-discounted basis, using enacted or substantively enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&amp;#160; The carrying amounts of individual deferred tax assets are reviewed at the end of each reporting period, but are only recognized for the proportion on which it is probable that sufficient taxable profits will be available for such assets to be recovered.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Deferred tax is not recognized for: i) temporary differences related to the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss; ii) differences relating to investments in subsidiaries to the extent that it is probable that they will not reverse in the foreseeable future; and, iii) differences arising on the initial recognition of goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;&lt;span&gt;xv) Borrowing costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time that the assets are substantially ready for their intended use or sale. Other borrowing costs are expensed in the period in which they are incurred and reported in finance costs. No borrowing costs were capitalized during the periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;xvi) Discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;A disposal group is presented as a discontinued operation if all of the following conditions are met: i) it is a component of the Company for which operations and cash flows can be clearly distinguished operationally and financially from the rest of the Company, ii) it represents a separate major line of business or operations that either has been disposed of or is classified as held for sale; and iii) it is part of a single coordinated plan to dispose of a separate major line of business of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Assets in a disposal group classified as held for sale are presented separately in the consolidated statements of financial position. Discontinued operations are presented separately from continuing operations in the consolidated statements of income (loss) and comprehensive income (loss) and consolidated statements of cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="line-height:115%"&gt;xvii) Government subsidies&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%;color:black"&gt;Government subsidies are recognized when there is reasonable assurance that the subsidy will be received, and all the attached conditions will be complied with. Subsidies are recognized as income in the statement of income (loss) and comprehensive income (loss) on a systematic basis over the periods in which the expenses are recognized for the related costs for which the subsidies are intended to compensate, which in the case of subsidies related to assets requires setting it up as deferred income or deducting it from the carrying amount of the asset.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;xviii) Critical accounting estimates and judgments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimates are revised and in any future years affected.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The following are the estimates and judgments made by management in applying the accounting policies of the Company that have the most significant effect on the financial statements.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;1) Biological assets and inventories&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Determination of the fair value of biological assets requires management to make a number of estimates, including estimating harvesting costs, selling costs, sales prices, wastage, oil conversion factor, expected yields, and post-harvest costs of the cannabis plant. The Company records obsolete and unsaleable inventories at the lower of cost and net realizable value. Adjustments to the carrying value of inventories are based on obsolescence trends, historical experience, and forecast demand and pricing for obsolete and unsaleable inventories. Refer to Notes 7 and 8 for further information. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(2) Estimated useful lives and impairment of property, plant and equipment&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Amortization of property, plant and equipment requires estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts, taking into consideration factors such as economic and market conditions and the useful lives of assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(3) Share-based payments&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In determining the fair value of options and related expenses, management estimates the expected life of the option, the volatility of the Company's share price, the risk-free interest rate, and the rate of forfeitures. Refer to Note 12 for further information. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(4) Warrants&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In determining the value of warrants, management estimates the expected life of the warrant, the volatility of the Company's share price, and the risk-free interest rate. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(5) Adult-use recreational cannabis revenue - provision for returns and price adjustments &lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Government customers typically have the right to return products, and in some cases, the right to pricing adjustments for products that are subsequently discounted or sold for a lower price in another jurisdiction. The estimation of potential future returns and pricing adjustments includes the use of management estimates and assumptions that may not be certain given the evolving nature of the industry.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(6) Investments in associates&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:17.85pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Management has applied significant judgment in the determination of whether the Company exerts significant influence with respect to its investments, which then allows the Company to account for its investments under the equity accounting method. Further, management has applied significant judgment and made use of management estimates and assumptions in determining and quantifying any impairment losses that may need to be recorded against its investments in associates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(7) Impairment of long-lived and intangible assets&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:17.85pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In determining the recoverable amount of the Company's Moncton campus (the "Moncton Campus") CGU, management has applied significant judgment in the aggregation of the CGU and has made various estimates with respect to the forecast cash flows, terminal growth rate, post-tax discount rate, and income taxes utilized in the discounted cash flow model to estimate fair value less costs of disposal.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;NEW STANDARDS AND INTERPRETATIONS ADOPTED&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;New or amended standards effective September 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company has adopted the following new or amended IFRS standard for the annual period beginning on September 1, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;&lt;strong&gt;&lt;span style="line-height:115%"&gt;IFRS 16 - Leases&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;In January 2016, the IASB issued IFRS 16 Leases, which replaced IAS 17 Leases. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than twelve months, unless the underlying asset is of low value. A lessee is required to recognize a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. The standard was effective for annual periods beginning on or after January 1, 2019 and has been adopted by the Company effective September 1, 2019 using the modified retrospective approach where comparative figures were not restated.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;As a result of adopting IFRS 16, the Company recognized right-of use ("ROU") assets of $4,464 recorded under property, plant and equipment (Note 9), lease liabilities of $4,439 recorded under other liabilities (Note 13), and a reduction to prepaid expenses of $25 as a result of the leasing arrangements in place at September 1, 2019 and entered during the year ended August 31, 2020 by the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The ROU asset was measured as the amount of the lease liability, using the Company's incremental borrowing rate on September 1, 2019 that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. The weighted average interest rate as of September 1, 2019 to measure the lease liabilities was 5.70%.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The Company elected to use the following practical expedients on adoption of IFRS 16 on all of its leases:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(a)&amp;#160;In accordance with IFRS 16.C3, an election is being taken to not reassess whether a contract is or contains a lease at the date of initial application, and instead to only apply IFRS 16 to contracts that were in the scope of IAS 17;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(b)&amp;#160;In accordance with IFRS 16.C8(b)(ii), an election is being taken to measure the ROU asset on September 1, 2019 as an amount equal to the lease liability, adjusted for prepaid or accrued lease payments;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(c)&amp;#160;In accordance with IFRS 16.C10(a), an election is being taken to apply a single discount rate to a portfolio of leases with reasonably similar characteristics;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(d)&amp;#160;In accordance with IFRS 16.C10(b), an election is being taken to rely on the IAS 37 assessment of whether leases are onerous instead of performing an impairment review;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(e)&amp;#160;In accordance with IFRS 16.C10(c), an election is being taken to exclude leases for which the term ends within 12 months from September 1, 2019;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(f)&amp;#160;In accordance with IFRS 16.C10(d), an election is being taken to exclude initial direct costs from the measurement of the ROU asset on September 1, 2019;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(g)&amp;#160;In accordance with IFRS 16.15, an election is being taken, by class of underlying asset, not to separate non-lease components from lease components, and instead account for each lease component and any associated non-lease components as a single lease component where the non-lease components are not significant compared to the lease components;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(h)&amp;#160;In accordance with IFRS 16.5(a), an election is being taken to not recognize a ROU asset and lease liability for leases for which the lease has a term less than 12 months; and&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(i)&amp;#160;In accordance with IFRS 16.5(b), an election is being taken to not recognize a ROU asset and lease liability for leases for which the underlying asset is of low value, which is defined to mean less than $5,000 USD when new.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The following is a reconciliation between the Company's operating lease commitments disclosed applying IAS 17 as at August 31, 2019 and the lease liabilities as at September 1, 2019 after adopting IFRS 16:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;p&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Reconciliation - IAS 17 to IFRS 16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Operating lease obligations as at August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;3,049&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Minimum future payments not related to lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(411&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Lease payments for renewal options reasonably expected to be exercised but not contractually obligated&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;655&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Relief option for short-term leases&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(538&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Relief option for leases of low-value assets&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(76&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Gross lease liabilities at September 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,679&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Discounting&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(459&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Present value of lease liabilities at September 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,220&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;New Accounting Pronouncements&amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The following IFRS standards have been recently issued by the IASB. Pronouncements that are irrelevant or not expected to have a significant impact have been excluded.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;&lt;strong&gt;&lt;span style="line-height:115%"&gt;Amendments to IFRS 3: Definition of a Business&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;In October 2018, the IASB issued "Definition of a Business (Amendments to IFRS 3)". The amendments clarify the definition of a business, with the objective of assisting entities to determine whether a transaction should be accounted for as a business combination or as an asset acquisition. The amendment provides an assessment framework to determine when a series of integrated activities is not a business. The amendments are effective for business combinations occurring on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements resulting from any future transactions.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;&lt;strong&gt;&lt;span style="line-height:115%"&gt;Amendments to IAS 1: Classification of Liabilities as Current or Non-Current&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The amendments to IAS 1 clarify the requirements relating to determining whether a liability should be presented as current or non-current in the statement of financial position. Under the new requirements, the assessment of whether a liability is presented as current or non-current is based on the contractual arrangements in place as at the reporting date and does not impact the amount or timing of recognition. The amendment applies retrospectively for annual reporting periods beginning on or after January 1, 2023. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="C_20190901to20200831" id="Fxbrl_20200909231157074">&lt;div&gt;&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;i) Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Cash is a financial asset that is measured at amortized cost, which approximates fair value and includes cash-on-hand and deposits held with financing institutions.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
  <ifrs-full:DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232507502">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;ii) Short-term investments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;The Company considers short-term investments in the form of guaranteed investment certificates to be an investing activity. These investments are measured at amortized cost. The Company also has equity securities that are carried at fair value through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232517817">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;iii) Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;While the Company's biological assets are within the scope of IAS 41 Agriculture, the direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2 Inventories. This includes the direct cost of seeds and growing materials as well as other indirect costs such as utilities and supplies used in the growing process. Indirect labour cost for individuals involved in the growing and quality control process is also included, as well as depreciation of manufacturing assets. All direct and indirect costs of biological assets are capitalized as they are incurred. Unrealized fair value gains/losses on growth of biological assets are recorded on the consolidated statements of (loss) income and comprehensive (loss) income. Biological assets are measured at their fair value less costs to sell on the consolidated statement of financial position.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="C_20190901to20200831" id="Fxbrl_20200909232524872">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;iv) Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Inventories for finished goods and packaging and supplies are initially valued at cost, and subsequently at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less the estimated costs to sell. The Company reviews inventories for obsolete, redundant and slow-moving goods and any such inventories identified are written down to net realizable value. The direct and indirect costs of finished goods inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labour and depreciation expense on equipment involved in packaging, labeling and inspection. All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of sales on the consolidated statements of (loss) income and comprehensive (loss) income at the time the cannabis is sold. Inventory is measured at lower of cost or net realizable value on the statement of financial position.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
  <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232533168">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;v) Property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Property, plant and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company's management. Property, plant and equipment are subsequently measured at cost, less accumulated depreciation and impairment losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Depreciation is recognized on a straight-line basis to reduce the cost, less estimated residual value, of depreciable fixed assets. The following useful lives are applied:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;div style="text-align:center"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin-left:20%;width:60%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Growing equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets, and are recognized as profit or loss within other income or other expenses.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Assets in process are transferred to the appropriate asset class when available for use and depreciation of these assets commences at that point.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;An asset's residual value, useful life and depreciation method are reviewed during each financial year and adjusted if appropriate. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) and depreciated accordingly.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20190901to20200831" id="Fxbrl_20201124181615488">straight-line basis</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ogi:DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory contextRef="C_20190901to20200831" id="F6b943720-f198-11ea-af0e-4f71386cf7c7">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin-left:20%;width:60%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Growing equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left;width:30%"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:30%"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ogi:DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" id="Fxbrl_20200909225512001">25 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" id="Fxbrl_20200909225944499">10 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" id="Fxbrl_20200909225948605">5 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" id="Fxbrl_20200909225954968">5 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullFixturesAndFittingsMember" id="Fxbrl_20200909230000816">10 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" id="Fxbrl_20201124102424240">5 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201125001418501">&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="line-height:115%"&gt;vi) Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%;color:black"&gt;Goodwill represents the future economic benefits arising from a business combination that are not individually identified and separately recognized. Goodwill is carried at cost less accumulated impairment losses. Refer to Note 3(viii) for a description of impairment testing procedures.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232545968">&lt;p style="margin:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;vii) Assets held for sale&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;Assets and liabilities held for sale are no longer depreciated and are presented separately in the statement of financial position at the lower of their carrying amount and fair value less costs to sell. An asset is regarded as held for sale if its carrying amount will be recovered principally through a sale transaction, rather than through continuing use. For this to be the case, the asset must be available for immediate sale and its sale must be highly probable.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232552088">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;viii) Impairment of long-lived and intangible&amp;#160;assets&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;Long-lived assets, including property, plant and equipment are reviewed each reporting period for indicators of impairment. Goodwill is assessed for indicators of impairment at each reporting date and is tested annually or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs of disposal, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Except for goodwill, where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201125001600741">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;ix) Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense in profit or loss over the vesting period based on the Company's estimate of equity instruments that will eventually vest. Fair value for options is determined using the Black-Scholes pricing model and fair value for Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") is determined using the Company's share price at the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Expected forfeitures are estimated at the date of the grant and subsequently adjusted if further information indicates actual forfeitures may vary from the original estimate.&amp;#160; The impact of the revision of the original estimate is recognized in profit or loss such that the cumulative expenses reflect the revised estimate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;For stock options granted to non-employees, the expense is measured at the fair value of the goods and services received except when the fair value cannot be estimated in which case it is measured at the fair value of the equity instrument granted.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Consideration paid by employees or non-employees on the exercise of options is recorded as an increase to share capital and the related share-based expense is transferred from equity reserves to share capital.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociates contextRef="C_20190901to20200831" id="Fxbrl_20200909232604270">&lt;div&gt;&lt;p style="margin:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;&lt;span&gt;x) Investments in associates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Associates are companies over which the Company has significant influence and are accounted for under the equity method. Significant influence is presumed when the Company has an ownership interest greater than 20%, unless certain qualitative factors overcome this assumption. Conversely, where the Company has an ownership interest less than 20%, it is presumed that the Company does not have significant influence, unless certain qualitative factors overcome this assumption. In assessing significant influence and the ownership interest, potential voting rights that are currently exercisable are taken into consideration.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Investments in associates are accounted for using the equity method and are initially recognized at cost, inclusive of transaction costs. The consolidated financial statements include the Company&amp;#x2019;s share of the income or loss and equity movement of equity accounted associates. In accordance with IFRS, the associate&amp;#x2019;s most recent available financial statements are used in the application of the equity method. Where the associate&amp;#x2019;s reporting period differs from the Company&amp;#x2019;s, the associate prepares financial information as of the same period end as the Company, unless it is impracticable to do so. Otherwise, the Company will adjust for its share of income and expenses and equity movement based on the associate&amp;#x2019;s most recently completed financial statements, adjusted for the effects of significant transactions. The Company does not recognize losses exceeding the carrying value of its interest in the associate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociates>
  <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232611450">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;xi) Intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any, except for off-market supply agreements, where amortization is provided based on the actual output received versus the estimated output forecast to be received over the life of the agreement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively. Intangible assets with an indefinite life or not yet available for use are not subject to amortization.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Research costs are expensed as incurred. Development expenditures are capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development to use or sell the asset. Research costs and other development expenditures are recognized as general and administrative expenses on the consolidated statement of income (loss) and comprehensive income (loss) as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232618271">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;&lt;span&gt;xii) Earnings (loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Basic earnings (loss) per share is calculated by dividing net income (loss) attributable to common shareholders by the weighted-average number of shares outstanding during the period.&amp;#160; Diluted earnings (loss) per share is calculated in a similar manner, but with adjustments to give effect to all dilutive potential common shares outstanding during the period. The dilutive effect of warrants, options, RSUs and PSUs is calculated using the treasury stock method. The if-converted method, which assumes that all convertible debt has been converted if the debt is in-the-money, is used to calculate the dilutive effect of convertible debt.&amp;#160; Anti-dilutive effects of potential conversions of securities are ignored for this calculation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="C_20190901to20200831" id="Fxbrl_20200909232624151">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;xiii) Revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#000000"&gt;Revenue from the direct sale of cannabis and cannabis oil for a fixed price is recognized when the Company transfers control of the good to the customer, which is at point of delivery for medical cannabis and recreational cannabis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Revenue includes excise taxes, which the Company pays as principal, but excludes duties and taxes collected on behalf of third parties. Revenue also includes the net consideration to which the Company expects to be entitled. Revenue is recognized to the extent that it is highly probable that a significant reversal will not occur. Therefore, revenue is stated net of expected price discounts, allowances for customer returns and certain promotional activities and similar items. Generally, payment of the transaction price is due within credit terms that are consistent with industry practices, with no element of financing.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Net revenue is revenue less excise taxes. Excise taxes are effectively a production tax which becomes payable when the product is removed from the Company's premises and may or may not be directly related to the value of revenue depending on the province of sale. It is generally not included as a separate item on external invoices; increases in excise tax are not always passed on to the customer and where a customer fails to pay for product received the Company cannot reclaim the excise tax. The Company therefore recognizes excise tax, unless it regards itself as an agent of the regulatory authorities, as a cost and reduction to revenue for the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
  <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232632151">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;xiv) Income taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The measurement of income taxes payable and deferred income tax assets and liabilities requires management to make judgments in the interpretation and application of the relevant tax laws. The actual amount of income taxes only becomes final upon filing and acceptance of the tax return by the relevant authorities, which occurs subsequent to the issuance of the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Income tax expense (recovery) in the statements of income (loss) and comprehensive income (loss) is the sum of current and deferred tax as explained below.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Current tax is the expected income tax payable (recoverable) on the taxable income (loss) for the period, using tax rates enacted, or substantively enacted, as at the end of the reporting period.&amp;#160; Current tax expense (recovery) included in the statements of income (loss) and comprehensive income (loss) reflects the current tax for the reporting period, plus adjustments to the current tax of prior periods, less current tax recorded directly in other comprehensive income (loss) or equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Deferred taxes are accounted for under the liability method and are the taxes expected to be payable or recoverable on the temporary differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable income.&amp;#160; Deferred tax liabilities are generally recognized for all taxable temporary differences and deferred tax assets are recognized to the extent that it is probable that taxable income will be available against which deductible temporary differences and unused tax losses and tax credits can be utilized.&amp;#160; Deferred tax is calculated on a non-discounted basis, using enacted or substantively enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&amp;#160; The carrying amounts of individual deferred tax assets are reviewed at the end of each reporting period, but are only recognized for the proportion on which it is probable that sufficient taxable profits will be available for such assets to be recovered.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Deferred tax is not recognized for: i) temporary differences related to the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss; ii) differences relating to investments in subsidiaries to the extent that it is probable that they will not reverse in the foreseeable future; and, iii) differences arising on the initial recognition of goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForBorrowingCostsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232638415">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;&lt;span&gt;xv) Borrowing costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time that the assets are substantially ready for their intended use or sale. Other borrowing costs are expensed in the period in which they are incurred and reported in finance costs. No borrowing costs were capitalized during the periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForBorrowingCostsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124095750552">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;xvi) Discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;A disposal group is presented as a discontinued operation if all of the following conditions are met: i) it is a component of the Company for which operations and cash flows can be clearly distinguished operationally and financially from the rest of the Company, ii) it represents a separate major line of business or operations that either has been disposed of or is classified as held for sale; and iii) it is part of a single coordinated plan to dispose of a separate major line of business of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Assets in a disposal group classified as held for sale are presented separately in the consolidated statements of financial position. Discontinued operations are presented separately from continuing operations in the consolidated statements of income (loss) and comprehensive income (loss) and consolidated statements of cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants contextRef="C_20190901to20200831" id="Fxbrl_20201124103024733">&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="line-height:115%"&gt;xvii) Government subsidies&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%;color:black"&gt;Government subsidies are recognized when there is reasonable assurance that the subsidy will be received, and all the attached conditions will be complied with. Subsidies are recognized as income in the statement of income (loss) and comprehensive income (loss) on a systematic basis over the periods in which the expenses are recognized for the related costs for which the subsidies are intended to compensate, which in the case of subsidies related to assets requires setting it up as deferred income or deducting it from the carrying amount of the asset.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
  <ogi:DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200909232657207">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;xviii) Critical accounting estimates and judgments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimates are revised and in any future years affected.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The following are the estimates and judgments made by management in applying the accounting policies of the Company that have the most significant effect on the financial statements.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;1) Biological assets and inventories&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Determination of the fair value of biological assets requires management to make a number of estimates, including estimating harvesting costs, selling costs, sales prices, wastage, oil conversion factor, expected yields, and post-harvest costs of the cannabis plant. The Company records obsolete and unsaleable inventories at the lower of cost and net realizable value. Adjustments to the carrying value of inventories are based on obsolescence trends, historical experience, and forecast demand and pricing for obsolete and unsaleable inventories. Refer to Notes 7 and 8 for further information. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(2) Estimated useful lives and impairment of property, plant and equipment&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Amortization of property, plant and equipment requires estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts, taking into consideration factors such as economic and market conditions and the useful lives of assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(3) Share-based payments&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In determining the fair value of options and related expenses, management estimates the expected life of the option, the volatility of the Company's share price, the risk-free interest rate, and the rate of forfeitures. Refer to Note 12 for further information. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(4) Warrants&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In determining the value of warrants, management estimates the expected life of the warrant, the volatility of the Company's share price, and the risk-free interest rate. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(5) Adult-use recreational cannabis revenue - provision for returns and price adjustments &lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Government customers typically have the right to return products, and in some cases, the right to pricing adjustments for products that are subsequently discounted or sold for a lower price in another jurisdiction. The estimation of potential future returns and pricing adjustments includes the use of management estimates and assumptions that may not be certain given the evolving nature of the industry.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(6) Investments in associates&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:17.85pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Management has applied significant judgment in the determination of whether the Company exerts significant influence with respect to its investments, which then allows the Company to account for its investments under the equity accounting method. Further, management has applied significant judgment and made use of management estimates and assumptions in determining and quantifying any impairment losses that may need to be recorded against its investments in associates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;i&gt;&lt;strong&gt;(7) Impairment of long-lived and intangible assets&lt;/strong&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:17.85pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In determining the recoverable amount of the Company's Moncton campus (the "Moncton Campus") CGU, management has applied significant judgment in the aggregation of the CGU and has made various estimates with respect to the forecast cash flows, terminal growth rate, post-tax discount rate, and income taxes utilized in the discounted cash flow model to estimate fair value less costs of disposal.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory>
  <ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements contextRef="C_20190901to20200831" id="Fxbrl_20200909232709601">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;NEW STANDARDS AND INTERPRETATIONS ADOPTED&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;New or amended standards effective September 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company has adopted the following new or amended IFRS standard for the annual period beginning on September 1, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;&lt;strong&gt;&lt;span style="line-height:115%"&gt;IFRS 16 - Leases&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;In January 2016, the IASB issued IFRS 16 Leases, which replaced IAS 17 Leases. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than twelve months, unless the underlying asset is of low value. A lessee is required to recognize a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. The standard was effective for annual periods beginning on or after January 1, 2019 and has been adopted by the Company effective September 1, 2019 using the modified retrospective approach where comparative figures were not restated.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;As a result of adopting IFRS 16, the Company recognized right-of use ("ROU") assets of $4,464 recorded under property, plant and equipment (Note 9), lease liabilities of $4,439 recorded under other liabilities (Note 13), and a reduction to prepaid expenses of $25 as a result of the leasing arrangements in place at September 1, 2019 and entered during the year ended August 31, 2020 by the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The ROU asset was measured as the amount of the lease liability, using the Company's incremental borrowing rate on September 1, 2019 that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. The weighted average interest rate as of September 1, 2019 to measure the lease liabilities was 5.70%.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The Company elected to use the following practical expedients on adoption of IFRS 16 on all of its leases:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(a)&amp;#160;In accordance with IFRS 16.C3, an election is being taken to not reassess whether a contract is or contains a lease at the date of initial application, and instead to only apply IFRS 16 to contracts that were in the scope of IAS 17;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(b)&amp;#160;In accordance with IFRS 16.C8(b)(ii), an election is being taken to measure the ROU asset on September 1, 2019 as an amount equal to the lease liability, adjusted for prepaid or accrued lease payments;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(c)&amp;#160;In accordance with IFRS 16.C10(a), an election is being taken to apply a single discount rate to a portfolio of leases with reasonably similar characteristics;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(d)&amp;#160;In accordance with IFRS 16.C10(b), an election is being taken to rely on the IAS 37 assessment of whether leases are onerous instead of performing an impairment review;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(e)&amp;#160;In accordance with IFRS 16.C10(c), an election is being taken to exclude leases for which the term ends within 12 months from September 1, 2019;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(f)&amp;#160;In accordance with IFRS 16.C10(d), an election is being taken to exclude initial direct costs from the measurement of the ROU asset on September 1, 2019;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(g)&amp;#160;In accordance with IFRS 16.15, an election is being taken, by class of underlying asset, not to separate non-lease components from lease components, and instead account for each lease component and any associated non-lease components as a single lease component where the non-lease components are not significant compared to the lease components;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(h)&amp;#160;In accordance with IFRS 16.5(a), an election is being taken to not recognize a ROU asset and lease liability for leases for which the lease has a term less than 12 months; and&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;(i)&amp;#160;In accordance with IFRS 16.5(b), an election is being taken to not recognize a ROU asset and lease liability for leases for which the underlying asset is of low value, which is defined to mean less than $5,000 USD when new.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The following is a reconciliation between the Company's operating lease commitments disclosed applying IAS 17 as at August 31, 2019 and the lease liabilities as at September 1, 2019 after adopting IFRS 16:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;p&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Reconciliation - IAS 17 to IFRS 16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Operating lease obligations as at August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;3,049&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Minimum future payments not related to lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(411&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Lease payments for renewal options reasonably expected to be exercised but not contractually obligated&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;655&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Relief option for short-term leases&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(538&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Relief option for leases of low-value assets&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(76&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Gross lease liabilities at September 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,679&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Discounting&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(459&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Present value of lease liabilities at September 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,220&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;New Accounting Pronouncements&amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The following IFRS standards have been recently issued by the IASB. Pronouncements that are irrelevant or not expected to have a significant impact have been excluded.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;&lt;strong&gt;&lt;span style="line-height:115%"&gt;Amendments to IFRS 3: Definition of a Business&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;In October 2018, the IASB issued "Definition of a Business (Amendments to IFRS 3)". The amendments clarify the definition of a business, with the objective of assisting entities to determine whether a transaction should be accounted for as a business combination or as an asset acquisition. The amendment provides an assessment framework to determine when a series of integrated activities is not a business. The amendments are effective for business combinations occurring on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements resulting from any future transactions.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;&lt;strong&gt;&lt;span style="line-height:115%"&gt;Amendments to IAS 1: Classification of Liabilities as Current or Non-Current&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"&gt;The amendments to IAS 1 clarify the requirements relating to determining whether a liability should be presented as current or non-current in the statement of financial position. Under the new requirements, the assessment of whether a liability is presented as current or non-current is based on the contractual arrangements in place as at the reporting date and does not impact the amount or timing of recognition. The amendment applies retrospectively for annual reporting periods beginning on or after January 1, 2023. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements>
  <ifrs-full:RightofuseAssets contextRef="C_20200831_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullPropertyPlantAndEquipmentSubjectToOperatingLeasesMember" decimals="-3" id="Fxbrl_20201124125026945" unitRef="CAD">4464000</ifrs-full:RightofuseAssets>
  <ifrs-full:LeaseLiabilities contextRef="C_20200831_ifrsfullClassesOfFinancialInstrumentsAxis_ogiOtherLiabilitiesMember" decimals="-3" id="Fxbrl_20201124125012509" unitRef="CAD">4439000</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="C_20200831_ifrsfullClassesOfFinancialInstrumentsAxis_ogiPrepaidExpensesMember" decimals="-3" id="Fxbrl_20201124125042704" unitRef="CAD">-25000</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124173643330" unitRef="CAD">0</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="C_20200831_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124173658886" unitRef="CAD">2219000</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124173708388" unitRef="CAD">3705000</ifrs-full:LeaseLiabilities>
  <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 contextRef="C_20200831" decimals="4" id="Fxbrl_20201124125058678" unitRef="pure">0.0570</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
  <ifrs-full:StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption contextRef="C_20190901to20200831" id="Fxbrl_20201126002144888">In accordance with IFRS 16.5(b), an election is being taken to not recognize a ROU asset and lease liability for leases for which the underlying asset is of low value, which is defined to mean less than $5,000 USD when new.</ifrs-full:StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption>
  <ogi:DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124220546666">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Operating lease obligations as at August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;3,049&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Minimum future payments not related to lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(411&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Lease payments for renewal options reasonably expected to be exercised but not contractually obligated&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;655&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Relief option for short-term leases&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(538&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Relief option for leases of low-value assets&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(76&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Gross lease liabilities at September 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,679&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Discounting&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(459&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Present value of lease liabilities at September 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,220&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory>
  <ogi:OperatingLeaseObligations contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124115902896" unitRef="CAD">3049000</ogi:OperatingLeaseObligations>
  <ogi:MinimumFuturePaymentsNotRelatedToLeasePayments contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124115952777" unitRef="CAD">-411000</ogi:MinimumFuturePaymentsNotRelatedToLeasePayments>
  <ogi:LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124120137069" unitRef="CAD">655000</ogi:LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated>
  <ogi:ReliefOptionForShortTermLeases contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124120159903" unitRef="CAD">-538000</ogi:ReliefOptionForShortTermLeases>
  <ogi:ReliefOptionForLeasesOfLowValueAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124120235852" unitRef="CAD">-76000</ogi:ReliefOptionForLeasesOfLowValueAssets>
  <ifrs-full:GrossLeaseLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124120407670" unitRef="CAD">2679000</ifrs-full:GrossLeaseLiabilities>
  <ogi:DiscountingOperatingLease contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124120429231" unitRef="CAD">459000</ogi:DiscountingOperatingLease>
  <ifrs-full:CurrentLeaseLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ogiAdjustmentOnAdoptionOfIFRS16Member" decimals="-3" id="Fxbrl_20201124120448956" unitRef="CAD">2220000</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124173724961" unitRef="CAD">-1088000</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory contextRef="C_20190901to20200831" id="F6b865471-f198-11ea-af0e-4f71386cf7c7">&lt;p style="text-align:justify"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4. SHORT TERM INVESTMENTS &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The Company's short-term investments included the following on August 31, 2020 and August 31, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;DESCRIPTION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;INTEREST %&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:rgb(166, 164, 164);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:rgb(166, 164, 164);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:rgb(166, 164, 164)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing September 16, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.95%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing September 24, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.95%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing December 15, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.16%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing December 23, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.16%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing June 17, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.93%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equity securities in VIVO Cannabis Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:1px solid #000000;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:1px solid #000000;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:1px solid #000000;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:1px solid #000000;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;380&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:3px double #000000;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:3px double #000000;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:3px double rgb(0, 0, 0);background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:3px double #000000;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:3px double #000000;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;380&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:3px double rgb(0, 0, 0);background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;On October 16, 2018, the Company sold its wholly-owned subsidiary, Trauma Healing Centers, Incorporated ("THCI"), in exchange for consideration consisting of common shares in the purchaser (an unaffiliated publicly-traded company), VIVO Cannabis Inc. ("VIVO") (the "VIVO Shares").&amp;#160; The VIVO Shares are carried at fair value through profit or loss. Subsequent to August 31, 2020, all of the VIVO Shares were sold.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory>
  <ogi:DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124131300689">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;DESCRIPTION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;INTEREST %&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:rgb(166, 164, 164);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:rgb(166, 164, 164);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:rgb(166, 164, 164)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing September 16, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.95%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing September 24, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.95%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing December 15, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.16%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing December 23, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.16%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GIC - maturing June 17, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.93%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equity securities in VIVO Cannabis Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:1px solid #000000;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:1px solid #000000;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:1px solid #000000;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:1px solid #000000;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;380&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:46.3488%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:18.6977%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:3px double #000000;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:3px double #000000;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:3px double rgb(0, 0, 0);background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:3px double #000000;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:3px double #000000;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;380&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:3px double rgb(0, 0, 0);background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory>
  <ogi:InvestmentsInterestRate contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesOneMember" decimals="4" id="Fxbrl_20201124130403220" unitRef="pure">0.0095</ogi:InvestmentsInterestRate>
  <ogi:InvestmentsInterestRate contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesTwoMember" decimals="4" id="Fxbrl_20201124130411079" unitRef="pure">0.0095</ogi:InvestmentsInterestRate>
  <ogi:InvestmentsInterestRate contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesThreeMember" decimals="4" id="Fxbrl_20201124130414848" unitRef="pure">0.0116</ogi:InvestmentsInterestRate>
  <ogi:InvestmentsInterestRate contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFourMember" decimals="4" id="Fxbrl_20201124130419599" unitRef="pure">0.0116</ogi:InvestmentsInterestRate>
  <ogi:InvestmentsInterestRate contextRef="C_20200831_ogiShortTermInvestmentsAxis_ogiGuaranteedInvestmentCertificatesFiveMember" decimals="4" id="Fxbrl_20201124130426160" unitRef="pure">0.0093</ogi:InvestmentsInterestRate>
  <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124121505819">&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;5.&lt;/span&gt;&lt;span style="width:6.89pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;span style="color:#86b4cd"&gt;ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;The Company's accounts receivable included the following balances as of August 31, 2020 and August 31, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;AUGUS 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Trade receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;11,096&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;11,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Harmonized sales taxes receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;728&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,741&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Government programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,936&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Less: Provision for doubtful accounts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(268&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,747&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16,541&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;On April 1, 2020, Department of Finance Canada announced the Canada Emergency Wage Subsidy ("CEWS"), which would subsidize 75% of employee wages, retroactive to March 15, 2020, to Canadian employers whose businesses had been affected by COVID-19 in order to enable them to re-hire workers previously laid off as a result of pandemic, help prevent further job losses, and to better position companies to resume normal operations following the crisis.&amp;#160; At August 31, 2020, under this program, the Company applied for a wage subsidy of $2,936 for the period July 5, 2020 to August 29, 2020, which is included under government programs above.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
  <ogi:DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124121345476">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;AUGUS 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Trade receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;11,096&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;11,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Harmonized sales taxes receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;728&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,741&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Government programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,936&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Less: Provision for doubtful accounts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(268&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,747&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16,541&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory>
  <ifrs-full:TradeReceivables contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124121303989_3427_11900" unitRef="CAD">11096000</ifrs-full:TradeReceivables>
  <ifrs-full:TradeReceivables contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124121303989_3431_817" unitRef="CAD">11900000</ifrs-full:TradeReceivables>
  <ogi:HarmonizedSalesTaxesReceivable contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124121303995_3436_4741" unitRef="CAD">728000</ogi:HarmonizedSalesTaxesReceivable>
  <ogi:HarmonizedSalesTaxesReceivable contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124121303995_3440_2526" unitRef="CAD">4741000</ogi:HarmonizedSalesTaxesReceivable>
  <ogi:GovernmentProgramsReceivable contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124121303999_3454_168" unitRef="CAD">2936000</ogi:GovernmentProgramsReceivable>
  <ogi:GovernmentProgramsReceivable contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124121303999_3458_80" unitRef="CAD">168000</ogi:GovernmentProgramsReceivable>
  <ogi:ProvisionForDoubtfulAccount contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124121304003_3472_268" unitRef="CAD">13000</ogi:ProvisionForDoubtfulAccount>
  <ogi:ProvisionForDoubtfulAccount contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124121304003_3476_24" unitRef="CAD">268000</ogi:ProvisionForDoubtfulAccount>
  <ogi:PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy contextRef="C_20190901to20200831" decimals="2" id="Fxbrl_20201124122600953" unitRef="pure">0.75</ogi:PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy>
  <ogi:AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy contextRef="C_20200705to20200829" decimals="-3" id="Fxbrl_20201124122638716" unitRef="CAD">2936000</ogi:AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy>
  <ogi:DisclosureOfLoanReceivablesExplanatory contextRef="C_20190901to20200831" id="F6b865473-f198-11ea-af0e-4f71386cf7c7">&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;6.&lt;/span&gt;&lt;span style="width:6.89pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;span style="color:#86b4cd"&gt;LOAN RECEIVABLE &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;On July 26, 2019, the Company entered into an advance payment and support agreement ("Payment Agreement") with 703454 N.B. Inc. (carrying on business as 1812 Hemp) ("1812 Hemp"). Under the terms of the Payment Agreement, the Company advanced $3,000 to 1812 Hemp in the form of a secured loan. This&amp;#160;amount&amp;#160;may be applied against future purchases of hemp under the Supply Agreement described in Note 10. The aggregate amount of advances outstanding as of January 1, 2020 accrue interest of 9.0% per annum, calculated monthly, until the entire balance of advances is paid.&amp;#160; At August 31, 2020, $2,229 in principal was outstanding under the Payment Agreement.&amp;#160; Subsequent to August 31, 2020, the Company demanded repayment of the entire amount owing by 1812 Hemp to the Company under the Payment Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</ogi:DisclosureOfLoanReceivablesExplanatory>
  <ogi:AdvancePayment contextRef="Context_As_Of_26_Jul_2019T00_00_00_TO_26_Jul_2019T00_00_00_TypeOfArrangementsAxis_PaymentAgreementMember_ClassesOfFinancialInstrumentsAxis_SecuredLoanMember" decimals="-3" id="Fxbrl_20201124120931431" unitRef="CAD">3000000</ogi:AdvancePayment>
  <ogi:PercentagesOfAccruedInterestReceivable contextRef="Context_As_Of_26_Jul_2019T00_00_00_TO_26_Jul_2019T00_00_00_TypeOfArrangementsAxis_PaymentAgreementMember_ClassesOfFinancialInstrumentsAxis_SecuredLoanMember" decimals="3" id="Fxbrl_20201124121016545" unitRef="pure">0.090</ogi:PercentagesOfAccruedInterestReceivable>
  <ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory contextRef="C_20190901to20200831" id="F6b865474-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;7.&lt;/span&gt;&lt;span style="width:6.89pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;span style="color:#86b4cd"&gt;BIOLOGICAL ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;The Company measures biological assets, which consist of cannabis plants, at fair value less costs to sell up to the point of harvest, which then becomes the basis for the cost of finished goods inventories after harvest. Subsequent expenditures incurred on these finished goods inventories after harvest are capitalized based on IAS 2 Inventories.&lt;i&gt; &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;The changes in the carrying value of biological assets as of August 31, 2020 are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;OTHER&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;BIOLOGICAL ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;CANNABIS ON PLANTS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Carrying amount, August 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;599&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;19,259&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;19,858&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Add net production costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(596 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;37,534&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;36,938&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Net change in fair value less costs to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(8,060&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(8,060&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(28,084&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(28,084&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Carrying amount, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;20,649&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;20,652&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Add net production costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;41,039&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;41,052&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Net change in fair value less costs to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(2,853&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(2,853&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Deduct net abnormal plant destruction costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(5,048&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(5,048&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(48,409&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(48,409&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Carrying amount, August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;5,378&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;5,394&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;During the year ended August 31, 2020, the Company had to cull plants with a carrying value of $5,048 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124102658573"&gt;nil&lt;/span&gt;) due to lack of sufficient staffing as a result of COVID-19. These costs were expensed to cost of sales.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;The fair value less costs to sell of biological assets is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred, such as post-harvest costs. The following unobservable inputs, all of which are classified as Level 3 on the fair value hierarchy (see Note 16), are used in determining the fair value of biological assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:center;width:5%" valign="top"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;i. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Average selling price per gram - calculated as the weighted average current selling price of cannabis sold by the Company, adjusted for expectations about future pricing;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:center;width:5%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:center;width:5%" valign="top"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;ii. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Yield by plant - represents the number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:center;width:5%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:center;width:5%" valign="top"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;iii. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Wastage of plants based on their various stages of growth - represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested; and&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:center;width:5%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:center;width:5%" valign="top"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;iv. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Post-harvest costs - calculated as the cost per gram of harvested cannabis to complete the sale of cannabis plants post-harvest, consisting of the cost of direct and indirect materials and labour related to drying, labelling and packaging.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;The Company estimates the harvest yields for the cannabis on plants at various stages of growth. As of August 31, 2020, it is expected that the Company's biological assets will yield 5,096 kg (August 31, 2019 - 16,595 kg) of cannabis when eventually harvested. The Company's estimates are, by their nature, subject to change, and differences from the anticipated yield will be reflected in the fair value adjustment to biological assets in future periods. The Company accretes fair value on a straight-line basis according to stage of growth. As a result, a cannabis plant that is 50% through its 19-week growing cycle would be ascribed approximately 50% of its harvest date expected fair value less costs to sell (subject to wastage adjustments).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Management believes the most significant unobservable inputs and their impact on fair value are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;SIGNIFICANT INPUTS &amp;amp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="text-align:center;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;WEIGHTED AVERAGE INPUT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="text-align:center;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;EFFECT ON FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;ASSUMPTIONS &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUG. 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUG. 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;SENSITIVITY&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUG. 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUG. 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Average net selling price per gram&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;p style="font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;3.36&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;p style="font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;5.65&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Increase or decrease by $ 1.00 per gram&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160; 1,602 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;3,657&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Average yield per plant&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;101 grams&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;151 grams&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Increase or decrease by  10  grams&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;532&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;1,367&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;During the three months ended May 31, 2020, management ceased the harvesting of trim from the cannabis plants and therefore the average yield per plant at August 31, 2020 primarily reflects the average yield of the flower component of the plant.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;The fair value adjustment to biological assets and inventory sold consists of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"&gt;&lt;tbody&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#87b5cf"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:12%;background-color:#87b5cf"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:2%;background-color:#87b5cf"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:1%;background-color:#aeaaaa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:12%;background-color:#aeaaaa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#aeaaaa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:12%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:2%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:2%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Realized fair value amounts included in inventory sold&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;(39,455&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;(50,477&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Increase (decrease) in fair value on growth of biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;73,975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;75,338&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Adjustment to net realizable value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:right;width:12%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(72,801&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:right;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(14,284&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Fair value adjustment to biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 3px double;text-align:left;width:1%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 3px double;text-align:right;width:12%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(38,281&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#e1eaed"&gt;)&lt;/td&gt;&lt;td style="text-align:left;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 3px double;text-align:left;width:1%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 3px double;text-align:right;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;10,577&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The adjustment to net realizable value is related to the write-down of the fair value component of dry cannabis available for packaging, flower and trim available for extraction, concentrated extract, and packaged inventories due to excess or obsolete quantities as well as the decrease in the estimated net realizable value of these inventories based on the evolving nature of the adult-use market.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory>
  <ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory contextRef="C_20190901to20200831" id="F6ba3a070-f198-11ea-af0e-4f71386cf7c7">&lt;table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;OTHER&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;BIOLOGICAL ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;CANNABIS ON PLANTS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Carrying amount, August 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;599&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;19,259&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;19,858&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Add net production costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(596 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;37,534&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;36,938&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Net change in fair value less costs to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(8,060&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(8,060&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(28,084&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(28,084&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Carrying amount, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;20,649&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;20,652&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Add net production costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;41,039&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;41,052&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Net change in fair value less costs to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(2,853&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(2,853&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Deduct net abnormal plant destruction costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(5,048&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(5,048&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(48,409&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(48,409&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="text-indent:-15pt;margin-left:15pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Carrying amount, August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;5,378&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;5,394&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember" decimals="-3" id="Fxbrl_20201124100931170" unitRef="CAD">-596000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_PlantsMember" decimals="-3" id="F3575_14357" unitRef="CAD">37534000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F3578_14950" unitRef="CAD">36938000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets contextRef="C_20190901to20200831_ifrsfullBiologicalAssetsByGroupAxis_ogiOtherBiologicalAssetsMember" decimals="-3" id="F3668_596" unitRef="CAD">13000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets contextRef="C_20190901to20200831_ifrsfullBiologicalAssetsByGroupAxis_ifrsfullPlantsMember" decimals="-3" id="F3671_37534" unitRef="CAD">41039000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="F3674_36938" unitRef="CAD">41052000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets>
  <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember" decimals="-3" id="Fxbrl_20200910001927297" unitRef="CAD">0</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
  <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_PlantsMember" decimals="-3" id="Fxbrl_20201124100947713" unitRef="CAD">-8060000</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
  <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124100958269" unitRef="CAD">-8060000</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
  <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="C_20190901to20200831_ifrsfullBiologicalAssetsByGroupAxis_ifrsfullPlantsMember" decimals="-3" id="F3695_8060" unitRef="CAD">-2853000</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
  <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="F3698_8060" unitRef="CAD">-2853000</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
  <ifrs-full:DecreaseDueToHarvestBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember" decimals="-3" id="Fxbrl_20200910001943757" unitRef="CAD">0</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
  <ifrs-full:DecreaseDueToHarvestBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_PlantsMember" decimals="-3" id="Fxbrl_20200910001950503" unitRef="CAD">28084000</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
  <ifrs-full:DecreaseDueToHarvestBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910002005151" unitRef="CAD">28084000</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
  <ifrs-full:DecreaseDueToHarvestBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_BiologicalAssetsByGroupAxis_OtherBiologicalAssetsMember" decimals="-3" id="Fxbrl_20200910002035439" unitRef="CAD">-0</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
  <ifrs-full:DecreaseDueToHarvestBiologicalAssets contextRef="C_20190901to20200831_ifrsfullBiologicalAssetsByGroupAxis_ifrsfullPlantsMember" decimals="-3" id="Fxbrl_20200910002032128" unitRef="CAD">48409000</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
  <ifrs-full:DecreaseDueToHarvestBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910002028767" unitRef="CAD">48409000</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
  <ifrs-full:OutputOfAgriculturalProduce contextRef="C_20190901to20200831" decimals="0" id="F3783_16595" unitRef="Kilogram">5096</ifrs-full:OutputOfAgriculturalProduce>
  <ifrs-full:OutputOfAgriculturalProduce contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="F3783_11036" unitRef="Kilogram">16595</ifrs-full:OutputOfAgriculturalProduce>
  <ogi:DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory contextRef="C_20190901to20200831" id="F6ba3ee90-f198-11ea-af0e-4f71386cf7c7">&lt;table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;SIGNIFICANT INPUTS &amp;amp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="text-align:center;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;WEIGHTED AVERAGE INPUT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="text-align:center;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;EFFECT ON FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;ASSUMPTIONS &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUG. 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUG. 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;SENSITIVITY&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUG. 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUG. 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Average net selling price per gram&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;p style="font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;3.36&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;p style="font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;5.65&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Increase or decrease by $ 1.00 per gram&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160; 1,602 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;3,657&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Average yield per plant&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;101 grams&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;151 grams&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Increase or decrease by  10  grams&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;532&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;1,367&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ogi:DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory>
  <ogi:AverageSellingPriceInputValuesPerGram contextRef="C_20200831" decimals="2" id="Fxbrl_20200918001526279" unitRef="Gram">3.36</ogi:AverageSellingPriceInputValuesPerGram>
  <ogi:AverageSellingPriceInputValuesPerGram contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="2" id="Fxbrl_20200918001545608" unitRef="Gram">5.65</ogi:AverageSellingPriceInputValuesPerGram>
  <ogi:SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram contextRef="C_20190901to20200831" decimals="2" id="Fxbrl_20200918004501140" unitRef="CAD_per_Gram">1.00</ogi:SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram>
  <ogi:EffectOnFairValueAverageNetSellingPricePerGram contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124095248552" unitRef="CAD">1602000</ogi:EffectOnFairValueAverageNetSellingPricePerGram>
  <ogi:EffectOnFairValueAverageNetSellingPricePerGram contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599677952" unitRef="CAD">3657000</ogi:EffectOnFairValueAverageNetSellingPricePerGram>
  <ogi:AverageYieldPerPlantInputValuesPerGram contextRef="C_20190901to20200831" decimals="0" id="F1599677945" unitRef="Gram">101</ogi:AverageYieldPerPlantInputValuesPerGram>
  <ogi:AverageYieldPerPlantInputValuesPerGram contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="F1599677946" unitRef="Gram">151</ogi:AverageYieldPerPlantInputValuesPerGram>
  <ogi:SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20200910003102450" unitRef="Gram">10</ogi:SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram>
  <ogi:EffectOnFairValueAverageYieldPerPlant contextRef="C_20200831" decimals="-3" id="F1599677953" unitRef="CAD">532000</ogi:EffectOnFairValueAverageYieldPerPlant>
  <ogi:EffectOnFairValueAverageYieldPerPlant contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1599677954" unitRef="CAD">1367000</ogi:EffectOnFairValueAverageYieldPerPlant>
  <ogi:DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory contextRef="C_20190901to20200831" id="F6ba43cb0-f198-11ea-af0e-4f71386cf7c7">&lt;table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"&gt;&lt;tbody&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#87b5cf"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:12%;background-color:#87b5cf"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:2%;background-color:#87b5cf"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:1%;background-color:#aeaaaa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:12%;background-color:#aeaaaa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#aeaaaa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:12%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:2%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:1%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:2%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Realized fair value amounts included in inventory sold&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;(39,455&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;(50,477&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Increase (decrease) in fair value on growth of biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;73,975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;width:1%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;75,338&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Adjustment to net realizable value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#e1eaed"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:right;width:12%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(72,801&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 1px solid;text-align:right;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(14,284&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr valign="top"&gt;&lt;td style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Fair value adjustment to biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 3px double;text-align:left;width:1%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 3px double;text-align:right;width:12%;background-color:#e1eaed"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(38,281&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#e1eaed"&gt;)&lt;/td&gt;&lt;td style="text-align:left;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 3px double;text-align:left;width:1%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:#000000 3px double;text-align:right;width:12%;background-color:#d6d6d6"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;10,577&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;width:2%;background-color:#d6d6d6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ogi:DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory>
  <ogi:RealizedFairValueAmountsIncludedInInventorySold contextRef="C_20190901to20200831" decimals="-3" id="F3920_50477" unitRef="CAD">39455000</ogi:RealizedFairValueAmountsIncludedInInventorySold>
  <ogi:RealizedFairValueAmountsIncludedInInventorySold contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F3924_5822" unitRef="CAD">50477000</ogi:RealizedFairValueAmountsIncludedInInventorySold>
  <ogi:IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="F3929_75338" unitRef="CAD">73975000</ogi:IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets>
  <ogi:IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F3933_51840" unitRef="CAD">75338000</ogi:IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets>
  <ogi:AdjustmentToNetRealizableValueBiologicalAssets contextRef="C_20190901to20200831" decimals="-3" id="F3938_14284" unitRef="CAD">72801000</ogi:AdjustmentToNetRealizableValueBiologicalAssets>
  <ogi:AdjustmentToNetRealizableValueBiologicalAssets contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124101025270" unitRef="CAD">14284000</ogi:AdjustmentToNetRealizableValueBiologicalAssets>
  <ifrs-full:DisclosureOfInventoriesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200918010120505">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;8. INVENTORIES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;The Company's inventories are comprised of the following balances as of August 31, 2020 and August 31, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#86b4cd;width:1.02326%"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;text-align:center;background-color:#86b4cd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#86b4cd;width:1.95349%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#d3e3e5"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;background-color:#d3e3e5"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#d3e3e5"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;CAPITALIZED COST&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;ADJUSTMENT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;CARRY ING VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;background-color:#d3e3e5"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Plants in drying stage&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,036&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,877&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Dry cannabis&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Available for packaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13,124&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7,808&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;20,932&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Packaged inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,707&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,956&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,663&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Flower and trim available for extraction&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;849&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,062&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,911&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Concentrated extract&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13,252&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,130&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;19,382&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Formulated extracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Available for packaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,097&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;384&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,481&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Packaged inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,045&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;226&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,271&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Packaging and supplies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1.95349%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;46,958&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;19,407&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;66,365&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1.95349%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="9" style="text-align:center;vertical-align:bottom;background-color:#a6a4a4"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.95349%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:0.976745%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.95349%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;CAPITALIZED COST&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;ADJUSTMENT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:0.976745%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;CARRY ING VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.95349%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Plants in drying stage&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,945&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,256&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,201&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Dry cannabis&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Available for packaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,261&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,718&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;17,979&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Packaged inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,205&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,549&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,754&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Flower and trim available for extraction&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,433&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,193&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16,626&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Concentrated extract&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;15,393&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21,573&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;36,966&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Formulated extracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Available for packaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;754&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,121&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,875&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Packaged inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;728&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;425&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,153&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Packaging and supplies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,590&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,590&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;38,309&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;54,835&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;93,144&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;Flower and trim available for extraction &lt;/span&gt;&lt;span style="color:#000000"&gt;are converted into concentrated extract, which can then be used for oil formulation (combining with a carrier oil) or other products such as edibles, and beverage and vaporizable products.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;The amount of inventory expensed in cost of sales for the year ended August 31, 2020 was $42,872 (August 31, 2019 - $35,224). The amount of inventory write-down, provision, and plant waste included in cost of sales for the year ended August 31, 2020 was $45,270 (August 31, 2019 - $4,733), which relates to the production or purchase costs of these inventories and biological assets (refer to Note 7 for the write-down and provisions against the fair value component of these inventories).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;Inventory write-down and provision relating to excess and unsaleable inventories for the year ended August 31, 2020 was $32,831 (August 31, 2019 - $744), of which $20,251 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124115201864"&gt;nil&lt;/span&gt;) related to concentrated extract and flower and trim available for extraction.&amp;#160; Inventory write-down related to adjustments to net realizable value during the year ended August 31, 2020 was $2,753 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124115425104"&gt;nil&lt;/span&gt;).&amp;#160; Inventory write-offs for the year ended August 31, 2020 related to abnormal plant waste due to lack of sufficient staffing as a result of COVID-19 was $5,048 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124115446465"&gt;nil&lt;/span&gt;).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
  <ogi:DisclosureOfDetailedInformationAboutInventoriesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124115555032">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#86b4cd;width:1.02326%"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;text-align:center;background-color:#86b4cd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#86b4cd;width:1.95349%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#d3e3e5"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;background-color:#d3e3e5"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#d3e3e5"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;CAPITALIZED COST&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;ADJUSTMENT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;CARRY ING VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;background-color:#d3e3e5"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Plants in drying stage&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,036&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,877&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Dry cannabis&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Available for packaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13,124&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7,808&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;20,932&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Packaged inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,707&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,956&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,663&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Flower and trim available for extraction&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;849&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,062&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,911&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Concentrated extract&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13,252&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,130&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;19,382&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Formulated extracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Available for packaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,097&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;384&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,481&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Packaged inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,045&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;226&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,271&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Packaging and supplies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1.95349%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;46,958&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;19,407&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;66,365&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1.95349%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="9" style="text-align:center;vertical-align:bottom;background-color:#a6a4a4"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.95349%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:0.976745%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.95349%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;CAPITALIZED COST&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;ADJUSTMENT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:0.976745%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#ffffff"&gt;CARRY ING VALUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.95349%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Plants in drying stage&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,945&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,256&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,201&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Dry cannabis&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Available for packaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,261&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,718&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;17,979&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Packaged inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,205&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,549&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,754&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Flower and trim available for extraction&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,433&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,193&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16,626&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Concentrated extract&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;15,393&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21,573&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;36,966&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Formulated extracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Available for packaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;754&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,121&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,875&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#160; &amp;#160;Packaged inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;728&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;425&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,153&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Packaging and supplies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,590&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,590&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.0698%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;38,309&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;54,835&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;93,144&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutInventoriesExplanatory>
  <ifrs-full:WorkInProgress contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124110318733_xbrl_20200918162652632" unitRef="CAD">13124000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124110318733_xbrl_20200918162842113" unitRef="CAD">7808000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124110318733_xbrl_20200918170755866" unitRef="CAD">20932000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124110542065_xbrl_20200918162652632" unitRef="CAD">1097000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124110542065_xbrl_20200918162842113" unitRef="CAD">384000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124110542065_xbrl_20200918170755866" unitRef="CAD">1481000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124111409931_1599693831" unitRef="CAD">5261000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124111409931_1599693873" unitRef="CAD">12718000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124111409931_1599693767" unitRef="CAD">17979000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124111412268_1599693831" unitRef="CAD">754000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124111412268_1599693873" unitRef="CAD">1121000</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124111412268_1599693767" unitRef="CAD">1875000</ifrs-full:WorkInProgress>
  <ifrs-full:FinishedGoods contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124110348859_xbrl_20200918162707133" unitRef="CAD">3707000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124110348859_xbrl_20200918162852425" unitRef="CAD">1956000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124110348859_xbrl_20200918170808684" unitRef="CAD">5663000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124110553266_xbrl_20200918162707133" unitRef="CAD">1045000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124110553266_xbrl_20200918162852425" unitRef="CAD">226000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="C_20200831_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124110553266_xbrl_20200918170808684" unitRef="CAD">1271000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124111422633_1599693833" unitRef="CAD">4205000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124111422633_1599693875" unitRef="CAD">2549000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfFinancialAssetsAxis_ogiDryCannabisMember" decimals="-3" id="Fxbrl_20201124111422633_1599693769" unitRef="CAD">6754000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124111425572_1599693833" unitRef="CAD">728000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124111425572_1599693875" unitRef="CAD">425000</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullCategoriesOfFinancialAssetsAxis_ogiFormulatedExtractsMember" decimals="-3" id="Fxbrl_20201124111425572_1599693769" unitRef="CAD">1153000</ifrs-full:FinishedGoods>
  <ifrs-full:CurrentPackagingAndStorageMaterials contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtCostMember" decimals="-3" id="Fxbrl_20201124110502749_xbrl_20200918162804378" unitRef="CAD">11848000</ifrs-full:CurrentPackagingAndStorageMaterials>
  <ifrs-full:CurrentPackagingAndStorageMaterials contextRef="C_20200831_ifrsfullMeasurementAxis_ifrsfullAtFairValueMember" decimals="-3" id="Fxbrl_20201124232925977" unitRef="CAD">0</ifrs-full:CurrentPackagingAndStorageMaterials>
  <ifrs-full:CurrentPackagingAndStorageMaterials contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124110519281" unitRef="CAD">11848000</ifrs-full:CurrentPackagingAndStorageMaterials>
  <ifrs-full:CurrentPackagingAndStorageMaterials contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtCostMember" decimals="-3" id="Fxbrl_20201124111615906_1599693784" unitRef="CAD">5590000</ifrs-full:CurrentPackagingAndStorageMaterials>
  <ifrs-full:CurrentPackagingAndStorageMaterials contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_MeasurementAxis_AtFairValueMember" decimals="-3" id="Fxbrl_20201124234125844" unitRef="CAD">0</ifrs-full:CurrentPackagingAndStorageMaterials>
  <ifrs-full:CurrentPackagingAndStorageMaterials contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124111622541" unitRef="CAD">5590000</ifrs-full:CurrentPackagingAndStorageMaterials>
  <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124114720988" unitRef="CAD">42872000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
  <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124114727896" unitRef="CAD">35224000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
  <ogi:InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124114750252" unitRef="CAD">45270000</ogi:InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales>
  <ogi:InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124114844317" unitRef="CAD">4733000</ogi:InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales>
  <ogi:InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124114859226" unitRef="CAD">32831000</ogi:InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories>
  <ogi:InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124114914619" unitRef="CAD">744000</ogi:InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories>
  <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="C_20190901to20200831" id="F6b867b81-f198-11ea-af0e-4f71386cf7c7">&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;9.&lt;/span&gt;&lt;span style="width:6.89pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;span style="color:#86b4cd"&gt;PROPERTY, PLANT AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Most of the additions during the year ended August 31, 2020 were related to the expansion of the Company's facility located in Moncton (the "Moncton Campus").&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RIGHT- OF-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GROWING &amp;amp;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;USE LEASE&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CONSTRUCTION&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PROCESSING&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;OTHER&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;LAND&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BUILDINGS&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IN PROCESS&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EQUIPMENT&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(NOTE A)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(NOTE B)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,205&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47,101&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,993&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,493&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;104,714&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,753&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105,512&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,554&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,366&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;130,191&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Construction completed&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,042&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(51,990&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,698&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(323&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(613&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(613&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassification of&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; computer software&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; (NOTE A)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,774&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,697&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;233,128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,997&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,956&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,075&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,245&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,679&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(946&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,870&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassification of&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; computer software&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; (NOTE A)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;265&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;265&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,618&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,803&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,658&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,774&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,697&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;233,128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transition to IFRS 16&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions (Note C)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,864&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,316&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,847&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,597&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,335&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;82,179&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Construction completed&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;71,663&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(110,234&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,851&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;720&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(517&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(436&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment loss (Note D)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37,166&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,075&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;127,022&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132,991&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,677&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,464&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;279,357&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,618&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,803&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,658&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,074&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,568&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,362&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(557&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,561&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,203&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,041&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,136&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(557&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,937&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net book value&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,537&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79,313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,894&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;218,470&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,075&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;118,819&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;112,950&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,541&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,907&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;247,420&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;A) Other - Computer Software&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;During the three months ended November 30, 2019, the Company determined that due to the increasing value of its computer software, it should be reclassified from property, plant and equipment to intangible assets. Computer software has historically been included in the "other" category within property, plant and equipment due to its relatively insignificant value. The August 31, 2019 cost of $841 and accumulated amortization of $265 relating to computer software have been reclassified from property, plant and equipment to intangible assets (Note 10) as a result.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;B) Right-of-Use Assets and Transition to IFRS 16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;As described in Note 4, the Company adopted IFRS 16 effective September 1, 2019. As a result, certain lease obligations were capitalized as ROU assets on the transition date and depreciated for the year ended August 31, 2020. ROU assets mostly comprise of office and warehouse space.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;C) Reconciliation of property, plant and equipment additions to the statements of cash flows&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The following table reconciles additions of property, plant and equipment per the above table to the purchases of property, plant and equipment per the statements of cash flows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;82,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;130,191&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions related to IFRS 16 Leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,220&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net change in accounts payable and accrued liabilities related to purchases of&lt;br/&gt;property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,736&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,427&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;77,223&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;108,764&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;D) Impairment&lt;span style="color:#000000"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company reviews the carrying value of its property, plant and equipment at each reporting period for indicators of impairment. During the year ended August 31, 2020, management noted indicators of impairment and recorded impairments at an asset specific level.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;strong&gt;Moncton Campus - Phase 4C (asset specific)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The construction of Phase 4C of the Moncton Campus, which was intended to house grow rooms with a previously estimated cultivation capacity of 24,000 kg per annum, was indefinitely deferred during the three months ended May 31, 2020 based on available capacity and forecast market demand. Phase 4C of the Moncton Campus has effectively been left partially completed and, due to the specialized and integrated nature of Phase 4C, without any foreseeable near-term use. Management estimated the fair value less cost to dispose ("FVLCD") of Phase 4C to approximate the purchase cost of the land and movable equipment, which is $1,328. As a result, the Company recognized an impairment loss of $37,749 in relation to this asset for the year ended August 31, 2020. The entire amount of the impairment loss was recorded against the building infrastructure of Phase 4C. In addition, subsequently incurred and contractually committed future costs totaling $1,050 with respect to Phase 4C at August 31, 2020 were included in the impairment loss for the year ended August 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
  <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="C_20190901to20200831" id="F6bc33660-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RIGHT- OF-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GROWING &amp;amp;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;USE LEASE&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CONSTRUCTION&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PROCESSING&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;OTHER&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;LAND&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BUILDINGS&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IN PROCESS&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EQUIPMENT&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(NOTE A)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(NOTE B)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,205&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47,101&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,993&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,493&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;104,714&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,753&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105,512&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,554&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,366&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;130,191&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Construction completed&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,042&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(51,990&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,698&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(323&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(613&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(613&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassification of&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; computer software&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; (NOTE A)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,774&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,697&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;233,128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,997&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,956&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,075&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,245&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,679&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(946&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,870&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassification of&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; computer software&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; (NOTE A)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;265&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;265&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,618&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,803&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,658&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,774&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,931&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,697&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;233,128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transition to IFRS 16&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions (Note C)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,864&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,316&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,847&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,597&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,335&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;82,179&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Construction completed&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;71,663&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(110,234&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,851&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;720&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(517&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(436&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment loss (Note D)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37,166&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,075&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;127,022&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132,991&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,677&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,464&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;279,357&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,237&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,618&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,803&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,658&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,074&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,568&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,362&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(557&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,561&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,203&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,041&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,136&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(557&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,937&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net book value&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,537&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,515&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79,313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,894&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;218,470&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,075&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;118,819&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;112,950&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,541&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,907&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;247,420&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4519_765" unitRef="CAD">6000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4522_15536" unitRef="CAD">15753000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4525_34851" unitRef="CAD">105512000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4528_4986" unitRef="CAD">5554000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4531_791" unitRef="CAD">3366000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124101542723" unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4534_56929" unitRef="CAD">130191000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124111146930_4519_765" unitRef="CAD">1864000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124111146930_4522_15536" unitRef="CAD">22316000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124111146930_4525_34851" unitRef="CAD">46847000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124111146930_4528_4986" unitRef="CAD">7597000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124111146930_4531_791" unitRef="CAD">1335000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124111146930_xbrl_20201124101542723" unitRef="CAD">2220000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124111146930_4534_56929" unitRef="CAD">82179000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190901to20200831" decimals="-3" id="F5576_130191" unitRef="CAD">82179000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F5580_56929" unitRef="CAD">130191000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204139569" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4562_17415" unitRef="CAD">8042000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4565_45058" unitRef="CAD">-51990000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4568_27609" unitRef="CAD">42698000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4571_34" unitRef="CAD">1250000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124101633561" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124214432311" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213739637" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="F5082_8042" unitRef="CAD">71663000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="F5085_51990" unitRef="CAD">-110234000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="F5088_42698" unitRef="CAD">37851000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="F5091_1250" unitRef="CAD">720000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124214137799" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124214143760" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204237797" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4608_10" unitRef="CAD">122000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204806301" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4611_42" unitRef="CAD">-201000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124212402567" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124101654612" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="F4614_52" unitRef="CAD">323000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212601439" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4848_2" unitRef="CAD">-5000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213007522" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4851_6" unitRef="CAD">-17000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213309492" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213312328" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4854_8" unitRef="CAD">-22000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213746245" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="F5122_122" unitRef="CAD">517000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213928738" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="F5128_201" unitRef="CAD">436000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="F5134_323" unitRef="CAD">75000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124214131137" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124114402869" unitRef="CAD">1028000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124214713476" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5362_5" unitRef="CAD">-108000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124214716162" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5368_17" unitRef="CAD">-145000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5374_22" unitRef="CAD">-29000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="Fxbrl_20201124214719940" unitRef="CAD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124113426185" unitRef="CAD">-282000</ifrs-full:DisposalsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204357491" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204715747" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124204958251" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124205541220" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124115435221" unitRef="CAD">-841000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124212519322" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124222231013" unitRef="CAD">-841000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212612800" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212818351" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212821639" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212825098" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124115605654" unitRef="CAD">265000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212838146" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124115609631" unitRef="CAD">265000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124212551945" unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4802_1181" unitRef="CAD">2245000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ConstructionInProgressMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213000365" unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_GrowingProcessingEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4808_1844" unitRef="CAD">5679000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_OtherPropertyPlantAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4811_479" unitRef="CAD">946000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124213300860" unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F4814_3504" unitRef="CAD">8870000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124214951949" unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5322_2245" unitRef="CAD">4074000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124215006202" unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5328_5679" unitRef="CAD">11568000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="F5331_946" unitRef="CAD">1362000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="F5334_8870" unitRef="CAD">557000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124114028264" unitRef="CAD">17561000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213702038" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213710155" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213713620" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiGrowingProcessingEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213721006" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124213724392" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullRightofuseAssetsMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124115743051" unitRef="CAD">2244000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124115819382" unitRef="CAD">2244000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
  <ogi:DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124125729258">&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;82,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;130,191&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions related to IFRS 16 Leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,220&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net change in accounts payable and accrued liabilities related to purchases of&lt;br/&gt;property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,736&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,427&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;77,223&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;108,764&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ogi:DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory>
  <ogi:AdditionsRelatedToIFRS16Leases contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124120913552" unitRef="CAD">2220000</ogi:AdditionsRelatedToIFRS16Leases>
  <ogi:ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment contextRef="C_20190901to20200831" decimals="-3" id="F5594_21427" unitRef="CAD">-2736000</ogi:ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment>
  <ogi:ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F5598_462" unitRef="CAD">-21427000</ogi:ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment>
  <ogi:FairValueLessCostToDispose contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiMonctonCampusPhase4CAssetSpecificMember" decimals="-3" id="Fxbrl_20201124125454894" unitRef="CAD">1328000</ogi:FairValueLessCostToDispose>
  <ifrs-full:ImpairmentLoss contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiMonctonCampusPhase4CAssetSpecificMember" decimals="-3" id="Fxbrl_20201124125523226" unitRef="CAD">37749000</ifrs-full:ImpairmentLoss>
  <ogi:ContractuallyCommittedFutureCosts contextRef="C_20190901to20200831_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ogiMonctonCampusPhase4CAssetSpecificMember" decimals="-3" id="Fxbrl_20201124125542931" unitRef="CAD">1050000</ogi:ContractuallyCommittedFutureCosts>
  <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="C_20190901to20200831" id="F6b867b82-f198-11ea-af0e-4f71386cf7c7">&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;10. INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&amp;#160;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;SUPPLY&lt;br/&gt;AGREEMENT&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;LICENSE&lt;br/&gt;AGREEMENT&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;COMPUTER&lt;br/&gt;SOFTWARE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Reclassification of computer software (NOTE A)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,371&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Accumulated amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Reclassification of computer software (NOTE A)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(265&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(265&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(265&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(297&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,371&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;198&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,430&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Impairment (NOTE B)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(1,303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(1,303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Disposal&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;227&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;198&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,041&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,466&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Accumulated amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(265&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(297&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(195&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(202&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(397&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(227&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(467&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(694&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net book value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;576&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,074&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;198&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,574&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,772&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;A) Other - Computer Software&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;During the three months ended November 30, 2019, the Company determined that due to the increasing value of its computer software, it should be reclassified from property, plant and equipment to intangible assets.&amp;#160; Computer software has historically been included in the "other" category within property, plant and equipment due to its relatively insignificant value.&amp;#160; The August 31, 2019 cost of $841 and accumulated amortization of $265 relating to computer software have been reclassified from property, plant and equipment to intangible assets as a result.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#86b4cd"&gt;B) Impairment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="color:#000000"&gt;On January 18, 2019, the Company entered into an agreement with 1812 Hemp to secure supply of hemp (the "Supply&amp;#160; Agreement"). Pursuant to the Supply Agreement, the Company is to receive a 25% discount on the price per kilogram of dried hemp flower harvested that is purchased from 1812 Hemp. The term of the Supply Agreement is from December 17, 2018 to December 16, 2023 and the Company has the option to renew it for an additional five-year period upon six months' notice. In addition, the Company has a right-of-first refusal on the future procurement of high cannabidiol (CBD) hemp from 1812. The Company paid $1,500 to 1812 Hemp plus transaction costs of $30 in connection with this transaction, which it has recorded as an intangible asset with a finite useful life that will be amortized based on the actual volume of dried hemp flower purchased as a proportion of its forecast purchase volumes. During the three months ended August 31, 2020, management became aware that 1812 Hemp was facing financial hardship due to a lack of customer demand and a change in market conditions and as a result, 1812 Hemp had significantly scaled back operations.&amp;#160; Separately, the Company's forecast hemp purchases have decreased significantly as a result of slower than expected progression in Canadian hemp and CBD regulations. Thus, as a result of the aforementioned challenges, management impaired the Supply Agreement intangible asset to its recoverable amount, which was estimated to be $nil, by recording an impairment charge of $1,303 at August 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
  <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124155413232">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;SUPPLY&lt;br/&gt;AGREEMENT&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;LICENSE&lt;br/&gt;AGREEMENT&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;COMPUTER&lt;br/&gt;SOFTWARE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Reclassification of computer software (NOTE A)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,371&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Accumulated amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Reclassification of computer software (NOTE A)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(265&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(265&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(265&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(297&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;841&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,371&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;198&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,430&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Impairment (NOTE B)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(1,303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(1,303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Disposal&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;227&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;198&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,041&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,466&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Accumulated amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(265&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(297&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(195&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(202&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(397&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(227&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(467&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(694&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net book value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;576&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,074&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;198&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,574&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,772&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember" decimals="-3" id="Fxbrl_20201124134144250_32" unitRef="CAD">1530000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember" decimals="-3" id="Fxbrl_20201124134144250_35" unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember" decimals="-3" id="Fxbrl_20201124134144250_38" unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134144250_311" unitRef="CAD">1530000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134144250_152" unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134144250_155" unitRef="CAD">198000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134144250_158" unitRef="CAD">1232000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134144250_1511" unitRef="CAD">1430000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember" decimals="-3" id="Fxbrl_20201124134144250_42" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember" decimals="-3" id="Fxbrl_20201124134144250_45" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember" decimals="-3" id="Fxbrl_20201124134144250_48" unitRef="CAD">841000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124134144250_411" unitRef="CAD">841000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember" decimals="-3" id="Fxbrl_20201124140609146_xbrl_20201124134144250_92" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember" decimals="-3" id="Fxbrl_20201124140609146_xbrl_20201124134144250_95" unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember" decimals="-3" id="Fxbrl_20201124140609146_xbrl_20201124134144250_98" unitRef="CAD">-265000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124140609146_xbrl_20201124134144250_911" unitRef="CAD">-265000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember" decimals="-3" id="Fxbrl_20201124134144250_92" unitRef="CAD">32000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember" decimals="-3" id="Fxbrl_20201124134144250_95" unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember" decimals="-3" id="Fxbrl_20201124134144250_98" unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124134144250_911" unitRef="CAD">32000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124141348806_xbrl_20201124134144250_152" unitRef="CAD">195000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124141348806_xbrl_20201124134144250_155" unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124141348806_xbrl_20201124134144250_158" unitRef="CAD">202000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="-3" id="Fxbrl_20201124141348806_xbrl_20201124134144250_1511" unitRef="CAD">397000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124141603908_xbrl_20201124134144250_152" unitRef="CAD">1303000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124141603908_xbrl_20201124134144250_155" unitRef="CAD">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124141603908_xbrl_20201124134144250_158" unitRef="CAD">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124141603908_xbrl_20201124134144250_1511" unitRef="CAD">1303000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ogiSupplyAgreementMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124141606187_xbrl_20201124134144250_152" unitRef="CAD">0</ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124141606187_xbrl_20201124134144250_155" unitRef="CAD">0</ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullComputerSoftwareMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124141606187_xbrl_20201124134144250_158" unitRef="CAD">32000</ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill contextRef="C_20190901to20200831_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="-3" id="Fxbrl_20201124141606187_xbrl_20201124134144250_1511" unitRef="CAD">32000</ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill>
  <ogi:PercentageOfDiscountPricePerKilogramOfDriedHempFlower contextRef="Context_Custom_01_Jan_2019T00_00_00_TO_18_Jan_2019T00_00_00" decimals="2" id="Fxbrl_20201124153829551" unitRef="pure">0.25</ogi:PercentageOfDiscountPricePerKilogramOfDriedHempFlower>
  <ogi:RenewalTermOfAgreement contextRef="Context_Custom_01_Jan_2019T00_00_00_TO_18_Jan_2019T00_00_00" id="Fxbrl_20201124153849468">P5Y</ogi:RenewalTermOfAgreement>
  <ogi:PaymentsForIntangibleAssetsOther contextRef="Context_Custom_01_Jan_2019T00_00_00_TO_18_Jan_2019T00_00_00" decimals="-3" id="Fxbrl_20201124153904269" unitRef="CAD">1500000</ogi:PaymentsForIntangibleAssetsOther>
  <ogi:TransactionCostsIntangibleAssetsOtherThanGoodwill contextRef="Context_Custom_01_Jan_2019T00_00_00_TO_18_Jan_2019T00_00_00" decimals="-3" id="Fxbrl_20201124153929068" unitRef="CAD">30000</ogi:TransactionCostsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisclosureOfBorrowingsExplanatory contextRef="C_20190901to20200831" id="F6b867b83-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;11. LONG-TERM DEBT&lt;/span&gt;&lt;/span&gt;&lt;span style="text-align:left"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bank of Montreal ("BMO") senior secured term loan ("Term Loan")&lt;br/&gt;&amp;#160; maturing May 31, 2022 with principal repayments starting November 30, 2020&lt;br/&gt;&amp;#160; based on a 10 year amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Atlantic Canada Opportunities Agency ("ACOA")&lt;br/&gt;&amp;#160; Business Development Program loan maturing September 1, 2024 with a 7 year&lt;br/&gt;&amp;#160; amortization, bearing interest at an interest rate of 0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;311&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;346&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicle loans - five year term maturing June 17, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred financing costs, net of loan modification loss on BMO Term Loan&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(123&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(868&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,266&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,576&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: current portion of long term debt&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,595&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,509&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term portion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103,671&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,067&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;BMO CREDIT FACILITY&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On May 31, 2019, the Company entered into&amp;#160;a credit facility with Bank of Montreal ("BMO") as lead arranger and agent and a syndicate including three other lenders. The facility consists of a $115,000 term loan ("Term Loan") and a $25,000 revolving credit facility ("Revolver", and together with the Term Loan, as amended, the "Facilities"), both of which mature on May 31, 2022. Included in the facility was an uncommitted option to increase the Facilities by an incremental $35,000 to a total of $175,000, subject to agreement by BMO and the syndicate lenders and satisfaction of certain legal and business conditions.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Facilities are secured by assets of the Company and its subsidiaries. The proceeds of the Term Loan have been used to fund the Phase 4 and 5 expansions of the Moncton Campus and were also used to refinance the Company's long-term debt with Farm Credit Canada. The Revolver may be used for general corporate and working capital purposes.&amp;#160; Availability under the Revolver is based on a percentage of the Company's trade receivables at the end of each month and remains undrawn at August 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;First Amendment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On November 15, 2019, the Company amended its Facilities with BMO to: i) extend the final draw deadline of the Term Loan ("Amended Term Loan") from November 30, 2019 to March 31, 2020; ii) postpone the commencement of scheduled principal repayments on the Term Loan from February 28, 2020 to May 31, 2020; and iii) realign the financial covenants structure, effective November 30, 2019, to be more consistent with industry norms up to and including May 31, 2020.&amp;#160; Prior to the Second Amendment, as described below, the financial covenants were to revert to the original structure on August 31, 2020.&amp;#160; The Company incurred an amendment fee of $140 plus customary legal expenses in connection with the first amendment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The amended Facilities were further amended on February 28, 2020 to extend the final draw deadline of the Amended Term Loan from March 31, 2020 to May 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In accordance with IFRS 9, such modification to the Facilities as outlined above is not an extinguishment of debt either qualitatively or quantitatively, rather it is a non-substantial modification. Therefore, as per the provisions of IFRS 9 the Company recorded a loss on debt restructuring based on the difference in the present value of the restructured net cash flows discounted at the original effective interest rate ("EIR") versus the present value of the original net cash flows discounted at the original EIR.&amp;#160; This loss of $831 has been recorded under financing costs in the statement of (loss) income and comprehensive (loss) income for the year ended August 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;Second Amendment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On May 28, 2020, the Company further amended its Facilities ("Second Amendment") with BMO to: (i) extend the final draw deadline of the Term Loan to July 31, 2020; (ii) postpone the commencement of principal repayments on the Amended Term Loan to November 30, 2020; (iii) adjust certain financial ratios to be maintained by the Company both before and after November 30, 2021 (the "Conversion Date"); (iv) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (v) remove the uncommitted option to increase the Amended Facilities by an incremental $35 million.&amp;#160; The financial covenants will revert to the original structure, albeit at different ratios, on November 30, 2021.&amp;#160; The interest rate margin will be fixed during this period.&amp;#160; The Company incurred an amendment fee of $490 plus customary legal expenses in connection with the second amendment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;As a result of the Second Amendment, the Company recorded a loan modification loss of $813 under financing costs in the statement of (loss) income and comprehensive (loss) income for the three months ended May 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;As part of the Second Amendment, the Company is also required to establish and maintain with BMO a cash collateral of $8,000 at all times.&amp;#160; As a result, the Company purchased a two-year GIC not redeemable before maturity, which is to be held by BMO as a pledged deposit.&amp;#160; Since the GIC is restricted from being exchanged or used for any other purpose for greater than one year, the Company has classified it as a restricted investment on the statement of financial position under non-current assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Pursuant to the agreed upon conditions of the Second Amendment, the Company drew down additional funds up to the $115,000 Term Loan commitment during June 2020.&amp;#160; Principal repayments on the Amended Term Loan will commence on November 30, 2020 at a rate of 2.5% per quarter of the total Amended Term Loan balance.&amp;#160; The Company may, at its discretion, repay the balance of the Amended Facilities without penalty, at any time.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(134, 180, 205)"&gt;Amendment and Restatement&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent to the year-end, on November 27, 2020, the Company further amended its Facilities pursuant to an amended and restated credit agreement ("Amendment and Restatement") with BMO to: (i) reduce the Term Loan amount from $115,000 to $60,000 based on a repayment of $55,000 to be made on December 1, 2020 of the outstanding Term Loan balance of $115,000; (ii) have repayments on the balance of the Term Loan commence on February 28, 2021 in an amount equal to $1,500 per quarter; (iii) reduce the Revolver commitment to $2,000 from up to $25,000; (iv) adjust the minimum quarterly EBITDA covenants to be maintained by the Company commencing on February 28, 2021 and continuing through to maturity, thereby removing this covenant for the fiscal period ended November 30, 2020 and eliminating the reversion of the financial covenants to that of the original structure on November 30, 2021;&amp;#160;(v) modify the applicable margin pricing and standby fee terms to reflect current market conditions;&amp;#160;and (vi) reduce the minimum unrestricted cash balance requirement to $20,000, which is already inclusive of the $8,000 restricted investment currently outstanding. &amp;#160;The interest rate margin will be fixed from November 27, 2020 through to maturity on May 31, 2021. &amp;#160;The Company incurred an amendment fee of $217 plus customary legal expenses in connection with the amendment and restatement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;Other Terms and Conditions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Under the terms of the Facilities, the Company can elect, at its sole discretion, to receive advances under the Amended Term Loan through certain availment options, which includes prime rate loans and bankers' acceptances with maturity dates between 28 and 182 days. The Company, therefore, has the choice to continuously roll over the bankers' acceptances upon their maturities or to convert the then outstanding principal and interest into prime rate loans at any time before May 31, 2022.&amp;#160; The interest rate of the Amended Facilities is a set margin over the above-noted availment options, which shall remain fixed until November 30, 2021, at which point it may subsequently increase or decrease based on a pricing grid linked to the Company's debt to EBITDA coverage at each quarter-end.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;During the year ended August 31, 2019, the Company converted its $50,000 outstanding principal amount under the Term Loan to bankers' acceptances, which reduced the cash interest rate from 5.70% (EIR of 6.39%) as at May 31, 2019 to 4.46% (EIR of 5.18%) as at August 31, 2019.&amp;#160; In accordance with IFRS 9, the loan conversion was determined to not be a modification of the loan terms.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;During the year ended August 31, 2020, the Company drew an additional $65,000 under the Term Loan, in three tranches, and similar to the initial draw noted above, converted the balances from prime rate loans to bankers' acceptances.&amp;#160; During the year ended August 31, 2020, the Company rolled over $115,000 of the Term Loan balance on a monthly basis through bankers' acceptances with an average cash interest rate of approximately 4.25%.&amp;#160; Based on the current availment option of bankers acceptances' the applicable margin rate is 3.75% above the applicable bankers acceptances' rate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Transaction costs incurred with respect to the Amended Facilities have totaled $2,085 to date, which have been allocated against the Term Loan ($1,899) and Revolver ($186 split between prepaid assets and deferred charges).&amp;#160; The weighted-average effective interest rate for the Term Loan based on these capitalized transaction costs, the loan modification loss, and the current cash interest rate was approximately 4.3% at August 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Facilities contain customary financial and restrictive covenants. At August 31, 2020, the Company was in compliance with these covenants.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Principal repayments required on the long-term debt for the next five years as at August 31, 2020 are as follows:&lt;/span&gt;&lt;span style="text-align:left"&gt;&amp;#160;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:60%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 1 year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,605&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1 to 2 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103,580&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 to 3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3 to 4 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Thereafter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,389&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfBorrowingsExplanatory>
  <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124124417045">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bank of Montreal ("BMO") senior secured term loan ("Term Loan")&lt;br/&gt;&amp;#160; maturing May 31, 2022 with principal repayments starting November 30, 2020&lt;br/&gt;&amp;#160; based on a 10 year amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Atlantic Canada Opportunities Agency ("ACOA")&lt;br/&gt;&amp;#160; Business Development Program loan maturing September 1, 2024 with a 7 year&lt;br/&gt;&amp;#160; amortization, bearing interest at an interest rate of 0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;311&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;346&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicle loans - five year term maturing June 17, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred financing costs, net of loan modification loss on BMO Term Loan&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(123&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(868&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,266&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,576&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: current portion of long term debt&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,595&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,509&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term portion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103,671&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,067&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory>
  <ifrs-full:BorrowingsMaturity contextRef="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" id="Fxbrl_20201124130853208">May 31, 2022</ifrs-full:BorrowingsMaturity>
  <ifrs-full:BorrowingsMaturity contextRef="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiAtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" id="Fxbrl_20201124131208565">September 1, 2024</ifrs-full:BorrowingsMaturity>
  <ifrs-full:BorrowingsMaturity contextRef="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiVehicleLoansFiveYearTermMaturingJune172024Member" id="Fxbrl_20201124131504094">June 17, 2024</ifrs-full:BorrowingsMaturity>
  <ogi:BorrowingsYearAmortization contextRef="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" id="Fxbrl_20201124130730566">P10Y</ogi:BorrowingsYearAmortization>
  <ogi:BorrowingsYearAmortization contextRef="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiAtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" id="Fxbrl_20201124131238742">P7Y</ogi:BorrowingsYearAmortization>
  <ogi:BorrowingsYearAmortization contextRef="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiVehicleLoansFiveYearTermMaturingJune172024Member" id="Fxbrl_20201124131432359">P5Y</ogi:BorrowingsYearAmortization>
  <ifrs-full:Borrowings contextRef="C_20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124125431647" unitRef="CAD">115000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124125441874" unitRef="CAD">50000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831_ifrsfullBorrowingsByNameAxis_ogiAtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" decimals="-3" id="Fxbrl_20201124125449354" unitRef="CAD">311000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_BorrowingsByNameAxis_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" decimals="-3" id="Fxbrl_20201124125541472" unitRef="CAD">346000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831_ifrsfullBorrowingsByNameAxis_ogiVehicleLoansFiveYearTermMaturingJune172024Member" decimals="-3" id="Fxbrl_20201124125611073" unitRef="CAD">78000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_BorrowingsByNameAxis_VehicleLoansFiveYearTermMaturingJune172024Member" decimals="-3" id="Fxbrl_20201124125614410" unitRef="CAD">98000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124130044182" unitRef="CAD">115266000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124130226778" unitRef="CAD">49576000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124144533157" unitRef="CAD">50000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124150721837" unitRef="CAD">65000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831_ifrsfullMaturityAxis_ogiContractualCashFlowsMember" decimals="-3" id="F7372_50412" unitRef="CAD">115388000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" decimals="-3" id="F1600201253" unitRef="CAD">11605000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanThreeYearsMember" decimals="-3" id="F1600201267" unitRef="CAD">103660000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" decimals="-3" id="F1600201281" unitRef="CAD">123000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" decimals="-3" id="F1600201232" unitRef="CAD">0</ifrs-full:Borrowings>
  <ifrs-full:BorrowingsInterestRate contextRef="C_20200831_ifrsfullBorrowingsByNameAxis_ogiAtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" decimals="2" id="Fxbrl_20201124131136242" unitRef="pure">0</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:BorrowingsInterestRate contextRef="Context_As_Of_02-Oct-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="2" id="Fxbrl_20200916174136654" unitRef="pure">0.10</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:BorrowingsInterestRate contextRef="Context_As_Of_12_Sep_2018T00_00_00_TO_12_Sep_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="3" id="Fxbrl_20200916175225677" unitRef="pure">0.080</ifrs-full:BorrowingsInterestRate>
  <ogi:DeferredFinancingCosts contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124125850494" unitRef="CAD">-123000</ogi:DeferredFinancingCosts>
  <ogi:DeferredFinancingCosts contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124125856737" unitRef="CAD">-868000</ogi:DeferredFinancingCosts>
  <ogi:CommittedBorrowingFacilities contextRef="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_CreditFacilitiesAxis_TermLoanMember" decimals="-3" id="Fxbrl_20201124132250402" unitRef="CAD">115000000</ogi:CommittedBorrowingFacilities>
  <ogi:CommittedBorrowingFacilities contextRef="C_20200528_ogiCreditFacilityAmendmentAxis_ogiSecondAmendmentMember_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124143738889" unitRef="CAD">115000000</ogi:CommittedBorrowingFacilities>
  <ogi:CommittedBorrowingFacilities contextRef="C_20201127_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiAmendmentAndRestatementMember" decimals="-3" id="Fxbrl_20201127102726981" unitRef="CAD">60000000</ogi:CommittedBorrowingFacilities>
  <ogi:CommittedBorrowingFacilities contextRef="C_20200831_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124151117638" unitRef="CAD">115000000</ogi:CommittedBorrowingFacilities>
  <ifrs-full:UndrawnBorrowingFacilities contextRef="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_CreditFacilitiesAxis_RevolvingCreditFacilityMember" decimals="-3" id="Fxbrl_20201124133337030" unitRef="CAD">25000000</ifrs-full:UndrawnBorrowingFacilities>
  <ogi:IncrementalUncommittedOptionToIncreaseFacilities contextRef="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124133650910" unitRef="CAD">35000000</ogi:IncrementalUncommittedOptionToIncreaseFacilities>
  <ogi:CommittedAndUncommittedBorrowingFacilities contextRef="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124133618914" unitRef="CAD">175000000</ogi:CommittedAndUncommittedBorrowingFacilities>
  <ifrs-full:BorrowingCostsIncurred contextRef="C_20191101to20191115_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilityAmendmentAxis_ogiFirstAmendmentMember_ogiCreditFacilitiesAxis_ogiTermLoanMember" decimals="-3" id="Fxbrl_20201124134715153" unitRef="CAD">140000</ifrs-full:BorrowingCostsIncurred>
  <ifrs-full:BorrowingCostsIncurred contextRef="C_20200501to20200528_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiSecondAmendmentMember" decimals="-3" id="Fxbrl_20201124142728918" unitRef="CAD">490000</ifrs-full:BorrowingCostsIncurred>
  <ifrs-full:BorrowingCostsIncurred contextRef="C_20201101to20201127_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiAmendmentAndRestatementMember" decimals="-3" id="Fxbrl_20201127102558788" unitRef="CAD">217000</ifrs-full:BorrowingCostsIncurred>
  <ifrs-full:BorrowingCostsIncurred contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124151331514" unitRef="CAD">2085000</ifrs-full:BorrowingCostsIncurred>
  <ifrs-full:BorrowingCostsIncurred contextRef="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember" decimals="-3" id="Fxbrl_20201124151400842" unitRef="CAD">1899000</ifrs-full:BorrowingCostsIncurred>
  <ifrs-full:BorrowingCostsIncurred contextRef="C_20190901to20200831_ogiCreditFacilitiesAxis_ogiRevolvingCreditFacilitiesMember" decimals="-3" id="Fxbrl_20201124151443120" unitRef="CAD">186000</ifrs-full:BorrowingCostsIncurred>
  <ifrs-full:OtherFinanceCost contextRef="C_20190901to20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiFirstAmendmentMember" decimals="-3" id="Fxbrl_20201124135701394" unitRef="CAD">831000</ifrs-full:OtherFinanceCost>
  <ifrs-full:OtherFinanceCost contextRef="C_20200301to20200531_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiSecondAmendmentMember" decimals="-3" id="Fxbrl_20201124143000185" unitRef="CAD">813000</ifrs-full:OtherFinanceCost>
  <ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities contextRef="C_20200528_ogiCreditFacilityAmendmentAxis_ogiSecondAmendmentMember_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="-3" id="Fxbrl_20201124143707592" unitRef="CAD">8000000</ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities>
  <ogi:BorrowingsPrincipalPaymentAmortizationRatePerQuarter contextRef="C_20200501to20200528_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiSecondAmendmentMember" decimals="3" id="Fxbrl_20201124143838830" unitRef="pure">0.025</ogi:BorrowingsPrincipalPaymentAmortizationRatePerQuarter>
  <ogi:QuarterlyRepayments contextRef="C_20201101to20201127_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiAmendmentAndRestatementMember" decimals="-3" id="Fxbrl_20201127102946359" unitRef="CAD">1500000</ogi:QuarterlyRepayments>
  <ogi:ReductionInRevolverCommitment contextRef="C_20201127_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiAmendmentAndRestatementMember" decimals="-3" id="Fxbrl_20201127103051560" unitRef="CAD">2000000</ogi:ReductionInRevolverCommitment>
  <ogi:MinimumUnrestrictedCashBalanceRequirement contextRef="C_20201127_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_ogiCreditFacilitiesAxis_ogiTermLoanMember_ogiCreditFacilityAmendmentAxis_ogiAmendmentAndRestatementMember" decimals="-3" id="Fxbrl_20201127102901480" unitRef="CAD">20000000</ogi:MinimumUnrestrictedCashBalanceRequirement>
  <ogi:BorrowingsCashInterestRate contextRef="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_CreditFacilitiesAxis_TermLoanMember" decimals="4" id="Fxbrl_20201124144905517" unitRef="pure">0.0570</ogi:BorrowingsCashInterestRate>
  <ogi:BorrowingsCashInterestRate contextRef="C_20200831_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="4" id="Fxbrl_20201124151147985" unitRef="pure">0.0425</ogi:BorrowingsCashInterestRate>
  <ogi:BorrowingsCashInterestRate contextRef="C_20200831_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="3" id="Fxbrl_20201124151531799" unitRef="pure">0.043</ogi:BorrowingsCashInterestRate>
  <ogi:BorrowingsEffectiveInterestRate contextRef="Context_As_Of_31_May_2019T00_00_00_TO_31_May_2019T00_00_00_BorrowingsByNameAxis_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_CreditFacilitiesAxis_TermLoanMember" decimals="4" id="Fxbrl_20201124145450855" unitRef="pure">0.0639</ogi:BorrowingsEffectiveInterestRate>
  <ogi:BorrowingsReducedCashInterestRate contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="4" id="Fxbrl_20201124145739150" unitRef="pure">0.0446</ogi:BorrowingsReducedCashInterestRate>
  <ogi:BorrowingsReducedEffectiveInterestRate contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="4" id="Fxbrl_20201124150009425" unitRef="pure">0.0518</ogi:BorrowingsReducedEffectiveInterestRate>
  <ogi:ApplicableMarginRate contextRef="C_20200831_ogiCreditFacilitiesAxis_ogiTermLoanMember_ifrsfullBorrowingsByNameAxis_ogiBankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" decimals="4" id="Fxbrl_20201124151208488" unitRef="pure">0.0375</ogi:ApplicableMarginRate>
  <ogi:DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124124432202">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:60%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 1 year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,605&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1 to 2 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103,580&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 to 3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3 to 4 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Thereafter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,389&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory>
  <ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124151629229" unitRef="CAD">11605000</ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124151641463" unitRef="CAD">103580000</ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo>
  <ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124151651326" unitRef="CAD">80000</ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree>
  <ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124151655814" unitRef="CAD">78000</ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour>
  <ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124151659880" unitRef="CAD">46000</ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive>
  <ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124151703549" unitRef="CAD">0</ogi:LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter>
  <ifrs-full:NotionalAmount contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124151715921" unitRef="CAD">115389000</ifrs-full:NotionalAmount>
  <ifrs-full:DisclosureOfIssuedCapitalExplanatory contextRef="C_20190901to20200831" id="F6b86a290-f198-11ea-af0e-4f71386cf7c7">&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;12. SHARE CAPITAL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;(i) Authorized share capital&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The authorized share capital of the Company is an unlimited number of common shares without par value and an unlimited number of preferred shares without par value. All issued shares, consisting only of common shares, are fully paid and non-assessable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;(ii) Issued share capital&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;As at August 31, 2020, the Company's issued and outstanding share capital consisted of 194,511,061 (August 31, 2019 - 156,196,347) common shares with a stated value of $420,673 (August 31, 2019 - $318,125).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;(iii) Issuances of share capital&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;At-the-market ("ATM") equity financing - December 2019 Offering&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;On December 4, 2019, the Company established an at-the-market equity program (the "December 2019 ATM Program") that allowed the Company to issue up to $55,000 (or its U.S. dollar equivalent) of common shares from treasury to the public. Common shares sold in the December 2019 ATM Program were sold through the TSX or the NASDAQ at the prevailing market price at the time of sale.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Subject to securities laws and stock exchange requirements, the volume and timing of distributions under the December 2019 ATM Program were determined in the Company's sole discretion. All of the common shares issuable pursuant to the December 2019 ATM Program, were issued as of February 13, 2020. The Company has used, and intends to continue to use, the net proceeds of the December 2019 ATM Program to fund capital projects, for general corporate purposes and to repay indebtedness.&amp;#160; As common shares distributed in the December 2019 ATM Program were issued and sold at the prevailing market price at the time of the sale, prices varied among purchasers during the period of the distribution.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Distributions of the common shares through the December 2019 ATM Program were made pursuant to the terms of an equity distribution agreement dated December 4, 2019 among the Company, BMO Nesbitt Burns Inc., as Canadian agent, and BMO Capital Markets Corp., as U.S. agent (collectively, the "agents").&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The Company issued 16,201,183 common shares during the three months ended February 29, 2020 for gross proceeds of $54,966 at a weighted average price of $3.39 per common share. Net proceeds realized were $52,885 after agents' commissions of $1,100, regulatory fees of $12, and legal and professional fees of $969. Proceeds were raised in both USD (for shares sold through the NASDAQ) and CAD (for shares sold through the TSX) and the weighted average share price was calculated using the spot rate on the day of settlement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;ATM equity financing - April 2020 Offering&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;On April 22, 2020, the Company established an at-the-market equity program (the "April 2020 ATM Program") that allowed the Company to issue up to $49,000 (or its U.S. dollar equivalent) of common shares from treasury to the public. Common shares sold in the April 2020 ATM Program were sold through the TSX or the NASDAQ at the prevailing market price at the time of sale.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Subject to securities laws and stock exchange requirements, the volume and timing of distributions under the April 2020 ATM Program were determined in the Company's sole discretion. All of the common shares issuable pursuant to the April 2020 ATM Program, were issued as of June 8, 2020. The Company has used, and intends to continue to use, the net proceeds of the April 2020 ATM Program to fund capital projects, for general corporate purposes and to repay indebtedness.&amp;#160; As common shares distributed in the April 2020 ATM Program were issued and sold at the prevailing market price at the time of the sale, prices varied among purchasers during the period of the distribution.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Distributions of the common shares through the April 2020 ATM Program were made pursuant to the terms of an equity distribution agreement dated April 22, 2020 among the Company and the agents.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The Company issued 14,035,278 common shares during the three months ended May 31, 2020 for gross proceeds of $31,069 at a weighted average price of $2.21 per common share. The Company subsequently completed its April 2020 ATM Program on June 8, 2020, by issuing the remaining shares under the ATM, which comprised of 7,044,951 common shares for gross proceeds of $17,915 at a weighted average price of $2.54 per common share.&amp;#160; In aggregate, the Company issued 21,080,229 common shares under the April 2020 ATM Program during the year ended August 31, 2020 for gross proceeds of $48,785 at a weighted average price of $2.31 per common share. Net proceeds realized were $47,112 after agents' commissions of $975, regulatory fees of $1, and legal and professional fees of $697. Proceeds were raised in both USD (for shares sold through the NASDAQ) and CAD (for shares sold through the TSX) and the weighted average share price was calculated using the spot rate on the day of settlement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Equity financing&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;On December 18, 2017, the Company issued 16,428,572 units by way of a bought deal at $3.50 per unit share for total gross consideration of $48,711 recorded to share capital and an increase of $8,789 to the reserve for options and warrants. Each unit consisted of one common share and one-half common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant entitled the holder thereof to acquire one common share of the Company at a price of $4.00 until June 18, 2019. Total issue costs were $3,678, with $3,116 charged to share capital and the remaining $562 charged to the reserve for options and warrants. These Warrants are measured at fair value at the date of grant. In determining the amount of reserve for the Warrants, the Company used the Black-Scholes option pricing model to establish the fair value of Warrants granted using the following assumptions: &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin:auto" width="40%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="width:191px;background-color:rgb(255, 255, 255);text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Risk free interest rate %&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected life of Warrants (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected annualized volatility %&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;64.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected dividend yield %&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Volatility was estimated by using the weighted average historical volatility of the Company and other companies that the Company considers comparable. The expected life in years represents the period of time that the Warrants granted are expected to be outstanding. The risk-free rate is based on government of Canada bonds with a remaining term equal to the expected life of the Warrants. A forfeiture rate of zero percent was used as the Company anticipated all Warrants will be exercised.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;During the prior fiscal year, all except for 347,432 Warrants were exercised prior to expiry on June 18, 2019 on a one-for-one basis.&amp;#160; The 347,432 Warrants that remained unexercised at the expiry time expired as a result. The Warrants were delisted from the TSX Venture Exchange on June 18, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Convertible debenture financing&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;On January 31, 2018, 115,000 convertible debentures were sold at a price of $1,000 per convertible debenture, for aggregate gross proceeds of $115,000 resulting in an increase to the reserve for options and warrants of $12,003, net of deferred tax of $4,902, related to the embedded conversion feature in the convertible debenture. Total issue cost was $7,155 with $6,094 charged to the debenture liability and the remaining $756, net of deferred tax of $305, charged to the reserve for options and warrants.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Conversion of debentures&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;For the year ended August 31, 2019, the Company issued 20,845,372 common shares at a price per share of $5.42 on the conversion of convertible debentures for an increase of $112,166 to share capital and a decrease of $11,247 to the reserve for options and warrants, respectively. This non-cash financing activity has been excluded from the Company's statement of cash flows as it did not provide or use any cash.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;On February 27, 2019, the Company elected to exercise its right under the indenture governing the convertible unsecured debentures to convert all of the principal amount outstanding of the remaining debentures on April 1, 2019 into common shares of the Company on the basis of the daily volume-weighted average price ("VWAP") of the common shares exceeding $7.05 for any 10 consecutive trading days. As of April 1, 2019, all of the convertible unsecured debentures issued were converted to common shares of the Company and no further liability or obligation exists with respect to the convertible unsecured debentures.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;On July 14, 2017, the Company entered into an advisory services agreement with a cannabis consultant that resulted in the grant of 125,000 common shares that vested over various service periods up to and including October 14, 2018. The fair value of the grant was measured based on the average monthly share price of the Company over the various tranches and vesting periods resulting in a cumulative expense of $539.&amp;#160; On October 23, 2017, the Company issued 50,000 common shares, of which 20,000 related to the advisory services agreement, as share consideration to the consultant and recognized $144 to share capital. During the year ended August 31, 2019, the Company settled the remaining balance of 105,000 common shares due to the consultant in the form of 41,000 common shares of the Company and 84,000 restricted stock units, which vest immediately, to purchase 84,000 common shares of the Company, which fully settled the Company's obligations relating to this agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Exercise of stock options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;During the year ended August 31, 2020, 879,240 (August 31, 2019 - 2,167,864) share options were exercised at an average exercise price of $1.21 (August 31, 2019 - $1.92) for an increase of $1,786 (August 31, 2019 - $6,588) to share capital and a decrease to the reserve for options and warrants of $717 (August 31, 2019 - $2,418).&lt;/span&gt;&lt;span style="color:#000000"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;(iv) Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;During the year ended August 31, 2019, 7,739,205 Warrants were exercised at an average price of $4.00 for a value of $39,257 to share capital and a decrease to the reserve for options and warrants of $8,281. All the outstanding Warrants at June 18, 2019 that were not exercised into common shares prior to expiry on June 18, 2019 lapsed and therefore no further Warrants remain outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;(v) Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;On February 25, 2020 (the "Approval Date"), the Company's shareholders approved a new omnibus equity incentive plan (the "New Equity Incentive Plan") that governs grants made on or after the Approval Date.&amp;#160; Grants made prior to the Approval Date will continue to be governed under the terms of the plan under which they were granted including the Company's 2011 stock option plan and its 2017 equity incentive plan (the "2017 Equity Incentive Plan"), however, no new grants may be made under such plans.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Stock options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The following table summarizes changes in the Company's outstanding stock options for the years ended August 31, 2020 and 2019:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;WEIGHTED AVERAGE&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NUMBER&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;EXERCISE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7,709,746&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;3,589,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.59&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(2,167,864&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.92&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Cancelled / Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(298,188&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;6.41&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;8,833,194&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4.23&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,125,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;3.21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(879,240&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Cancelled / Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(1,050,050&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;6.20&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;9,028,904&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double;text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4.06&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double;text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;The following is a summary of the outstanding stock options as at August 31, 2020:&lt;span style="font-size:10pt"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#000000"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;OPTIONS OUTSTANDING&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;OPTIONS EXERCISABLE&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Range of Exercise&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Weighted Average Remaining&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Prices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Quantity Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Contractual Life (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Quantity Exercisable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$0.30 - $1.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,440,599&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,376,683&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$1.49 - $2.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,204,333&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,652,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$2.39 - $4.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,069,854&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,217,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$4.66 - $7.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,886,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;8.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,276,194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$7.68 - $11.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,427,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;8.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;949,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;9,028,904&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;6,473,114&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span&gt;Options outstanding have exercise prices that range from $0.30 to $11.27 with a weighted average remaining life of 7.5 years. Total share-based compensation charges, including related to production employees that are charged to biological assets and inventory, for the year ended August 31, 2020 was $7,796 (August 31, 2019 - $14,894) of which $6,127 (August 31, 2019 - $10,036) related to the Company's stock option plan. The fair value of options granted during the year ended August 31, 2020 was $3,743 (August 31, 2019 - $13,848). These options are measured at fair value at the date of grant and are expensed over the option's vesting period, which typically range from two to three-year terms with options vesting in annual tranches evenly over this time period. In determining the amount of share-based compensation related to the options, the Company used the Black-Scholes option pricing model to establish the fair value of options granted.&lt;/span&gt;&lt;span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;The following is the range of assumptions for the years ended August 31, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#86b4cd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#a6a4a4"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;0.45%- 1.65%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.20%- 2.42%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected life of options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5.0 - 6.0 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5.0 -6.5 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected annualized volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;72% - 85%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;64%-71%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Forfeiture Rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;8.0% - 8.7%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.3%- 8.0%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Volatility was estimated by using the weighted average historical volatility of the Company and other companies that the Company considers comparable. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate is based on government of Canada bonds with a remaining term equal to the expected life of the options. The forfeiture rate is calculated based on historical experience.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Equity incentive plan&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;As of August 31, 2020, the Company has granted both restricted share units ("RSUs") and performance share units ("PSUs") under the 2017 Equity Incentive Plan and RSUs under the New Equity Incentive Plan. The grant price of any RSU or PSU was determined based on market price calculated in accordance with TSX rules at the time of grant and with respect to PSUs, adjusted for any non-market and market performance vesting conditions in accordance with IFRS 2.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The following table summarizes the movements in the Company's outstanding RSUs:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NUMBER&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;145,200&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;879,635&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(182,473&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;842,362&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;265,258&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(154,062&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Cancelled/Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(60,387&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;893,171&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The estimated fair value of the equity settled RSUs granted during the year ended August 31, 2020 was $1,037 (August 31, 2019 - $4,543), which was based on the Company's share price at the grant date and will be recognized as an expense over the vesting period of the RSUs, which is over a period of one year for most grants. For the year ended August 31, 2020, $1,576 (August 31, 2019 - $3,475) has been recognized as share-based compensation expense.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The following table summarizes the movements in the Company's outstanding PSUs:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NUMBER&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;142,187&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(15,502&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;126,685&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The estimated fair value of the equity settled PSUs granted during the year ended August 31, 2020 was $305 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124115709193"&gt;nil&lt;/span&gt;), which was based on the Company's share price at the grant date, adjusted for an estimate of likelihood of achievement, and will be recognized as an expense over the vesting period of the PSUs, which is during the fiscal year-ended August 31, 2020. For the year ended August 31, 2020, $272 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124115741663"&gt;nil&lt;/span&gt;) has been recognized as share-based compensation expense.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;(vi) Earnings (Loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Earnings (loss) per share represents net income (loss) attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Diluted (loss) income per share is calculated by dividing the applicable net (loss) income by the sum of the weighted average number of common shares outstanding and all additional common shares that would have been outstanding if potentially dilutive common shares had been issued during the year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The reconciliation of the weighted average number of shares, for the purposes of diluted earnings per share, to the weighted average number of ordinary shares, used in the calculation of basic earnings per share, is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:164px;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:165px;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Weighted average number of shares used in basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;172,668,816&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;140,923,324&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4,540,182&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5,194,827&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4,738,388&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Restricted share units&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;727,275&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;684,534&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;126,685&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Weighted average number of shares used in diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;178,062,958&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;151,541,073&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The outstanding number and type of securities that could potentially dilute basic net (loss) income per share in the future but that were not included in the computation of diluted net income (loss) per share because to do so would have increased (decreased) the net (loss) income per share (anti-dilutive) are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:164px;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:165px;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4,382,918&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,847,500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4,382,918&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,847,500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIssuedCapitalExplanatory>
  <ifrs-full:NumberOfSharesIssued contextRef="C_20200831" decimals="INF" id="Fxbrl_20201124095129109" unitRef="shares">194511061</ifrs-full:NumberOfSharesIssued>
  <ifrs-full:NumberOfSharesIssued contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124095203146" unitRef="shares">156196347</ifrs-full:NumberOfSharesIssued>
  <ogi:NumberOfCommonSharesIssued contextRef="C_20191201to20200229_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember" decimals="0" id="Fxbrl_20201124151208500" unitRef="shares">16201183</ogi:NumberOfCommonSharesIssued>
  <ogi:NumberOfCommonSharesIssued contextRef="C_20200301to20200531_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="0" id="Fxbrl_20201124151230566" unitRef="shares">14035278</ogi:NumberOfCommonSharesIssued>
  <ogi:NumberOfCommonSharesIssued contextRef="C_20200601to20200608_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="0" id="Fxbrl_20201124152618673" unitRef="shares">7044951</ogi:NumberOfCommonSharesIssued>
  <ogi:NumberOfCommonSharesIssued contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="0" id="Fxbrl_20201124152625689" unitRef="shares">21080229</ogi:NumberOfCommonSharesIssued>
  <ogi:NumberOfCommonSharesIssued contextRef="Context_Custom_01_Jul_2017T00_00_00_TO_14_Jul_2017T00_00_00_SalesOfStockAxis_AdvisoryServicesAgreementMember_CategoriesOfRelatedPartiesAxis_CannabisConsultantMember" decimals="0" id="Fxbrl_20201124141711569" unitRef="shares">125000</ogi:NumberOfCommonSharesIssued>
  <ogi:NumberOfCommonSharesIssued contextRef="Context_Custom_01_Oct_2017T00_00_00_TO_23_Oct_2017T00_00_00" decimals="INF" id="Fxbrl_20201124141745144" unitRef="shares">50000</ogi:NumberOfCommonSharesIssued>
  <ogi:NumberOfCommonSharesIssued contextRef="Context_Custom_01_Oct_2017T00_00_00_TO_23_Oct_2017T00_00_00_SalesOfStockAxis_AdvisoryServicesAgreementMember_CategoriesOfRelatedPartiesAxis_CannabisConsultantMember" decimals="INF" id="Fxbrl_20201124141800386" unitRef="shares">20000</ogi:NumberOfCommonSharesIssued>
  <ogi:NumberOfCommonSharesIssued contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ogiSalesOfStockAxis_ogiAdvisoryServicesAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_ogiCannabisConsultantMember" decimals="INF" id="Fxbrl_20201124141852009" unitRef="shares">41000</ogi:NumberOfCommonSharesIssued>
  <ifrs-full:WeightedAverageSharePrice2019 contextRef="C_20191201to20200229_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember" decimals="2" id="Fxbrl_20201124151805250" unitRef="CAD_per_Share">3.39</ifrs-full:WeightedAverageSharePrice2019>
  <ifrs-full:WeightedAverageSharePrice2019 contextRef="C_20200301to20200531_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="2" id="Fxbrl_20201124151852516" unitRef="CAD_per_Share">2.21</ifrs-full:WeightedAverageSharePrice2019>
  <ifrs-full:WeightedAverageSharePrice2019 contextRef="C_20200601to20200608_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="2" id="Fxbrl_20201124152656152" unitRef="CAD_per_Share">2.54</ifrs-full:WeightedAverageSharePrice2019>
  <ifrs-full:WeightedAverageSharePrice2019 contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="2" id="Fxbrl_20201124152701363" unitRef="CAD_per_Share">2.31</ifrs-full:WeightedAverageSharePrice2019>
  <ogi:NetProceedsFromIssueOfOrdinaryShares contextRef="C_20191201to20200229_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152005037" unitRef="CAD">52885000</ogi:NetProceedsFromIssueOfOrdinaryShares>
  <ogi:NetProceedsFromIssueOfOrdinaryShares contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152749503" unitRef="CAD">47112000</ogi:NetProceedsFromIssueOfOrdinaryShares>
  <ifrs-full:OtherFeeAndCommissionExpense contextRef="C_20191201to20200229_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152011529" unitRef="CAD">1100000</ifrs-full:OtherFeeAndCommissionExpense>
  <ifrs-full:OtherFeeAndCommissionExpense contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152802513" unitRef="CAD">975000</ifrs-full:OtherFeeAndCommissionExpense>
  <ogi:RegulatoryFees contextRef="C_20191201to20200229_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152016021" unitRef="CAD">12000</ogi:RegulatoryFees>
  <ogi:RegulatoryFees contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152814684" unitRef="CAD">1000</ogi:RegulatoryFees>
  <ifrs-full:ProfessionalFeesExpense contextRef="C_20191201to20200229_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiDecemberTwoThousandNineteenAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152021732" unitRef="CAD">969000</ifrs-full:ProfessionalFeesExpense>
  <ifrs-full:ProfessionalFeesExpense contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiAprilTwoThousandTwentyAtMarketEquityProgramMember" decimals="-3" id="Fxbrl_20201124152829028" unitRef="CAD">697000</ifrs-full:ProfessionalFeesExpense>
  <ifrs-full:ProfessionalFeesExpense contextRef="C_20190901to20200831" decimals="-3" id="F8357_4636" unitRef="CAD">5367000</ifrs-full:ProfessionalFeesExpense>
  <ifrs-full:ProfessionalFeesExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F8361_684" unitRef="CAD">4636000</ifrs-full:ProfessionalFeesExpense>
  <ogi:IssuanceOfEquityFinancingShares contextRef="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember" decimals="INF" id="Fxbrl_20200916230921062" unitRef="shares">16428572</ogi:IssuanceOfEquityFinancingShares>
  <ogi:IssuanceOfEquityFinancingShares contextRef="C_20201101to20201112_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiUnderwritersMember" decimals="INF" id="Fxbrl_20201124142709757" unitRef="shares">37375000</ogi:IssuanceOfEquityFinancingShares>
  <ogi:UnitsIssuedInPeriodPricePerUnit contextRef="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember" decimals="2" id="F6213_350" unitRef="CAD_per_Share">3.50</ogi:UnitsIssuedInPeriodPricePerUnit>
  <ogi:UnitsIssuedInPeriodPricePerUnit contextRef="C_20201101to20201112_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiUnderwritersMember" decimals="2" id="Fxbrl_20201124142755692" unitRef="CAD_per_Share">1.85</ogi:UnitsIssuedInPeriodPricePerUnit>
  <ifrs-full:IssueOfEquity contextRef="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_ComponentsOfEquityAxis_IssuedCapitalMember_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember" decimals="-3" id="F6213_48711" unitRef="CAD">48711000</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember" decimals="-3" id="F6213_8789" unitRef="CAD">8789000</ifrs-full:IssueOfEquity>
  <ogi:WeightedAverageExercisePriceOfWarrantsGranted contextRef="Context_0ME_01-Dec-2017T00_00_00_TO_18-Dec-2017T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_EquityFinancingMember" decimals="2" id="Fxbrl_20200916231110146" unitRef="CAD_per_Share">4.00</ogi:WeightedAverageExercisePriceOfWarrantsGranted>
  <ogi:WeightedAverageExercisePriceOfWarrantsGranted contextRef="C_20201101to20201112_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiUnderwritersMember" decimals="2" id="Fxbrl_20201124142845067" unitRef="CAD_per_Share">2.50</ogi:WeightedAverageExercisePriceOfWarrantsGranted>
  <ogi:DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory contextRef="C_20190901to20200831" id="F6bd14020-f198-11ea-af0e-4f71386cf7c7">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin:auto" width="40%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="width:191px;background-color:rgb(255, 255, 255);text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Risk free interest rate %&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected life of Warrants (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected annualized volatility %&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;64.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)" valign="top"&gt;&lt;td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected dividend yield %&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ogi:DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory>
  <ogi:DescriptionOfRiskFreeInterestRateWarrantsGranted contextRef="C_20190901to20200831" decimals="3" id="Fxbrl_20200910141607306" unitRef="pure">0.016</ogi:DescriptionOfRiskFreeInterestRateWarrantsGranted>
  <ogi:DescriptionOfExpectedLifeOfWarrantsGranted contextRef="C_20190901to20200831" decimals="1" id="Fxbrl_20200910141618083" unitRef="Year">1.5</ogi:DescriptionOfExpectedLifeOfWarrantsGranted>
  <ogi:DescriptionOfExpectedVolatilityWarrantsGranted contextRef="C_20190901to20200831" decimals="3" id="Fxbrl_20200910141622582" unitRef="pure">0.646</ogi:DescriptionOfExpectedVolatilityWarrantsGranted>
  <ogi:ExpectedDividendAsPercentageWarrantsGranted contextRef="C_20190901to20200831" decimals="2" id="Fxbrl_20200917135406645" unitRef="pure">0</ogi:ExpectedDividendAsPercentageWarrantsGranted>
  <ogi:NumberOfWarrantsExpired contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20201125031641881" unitRef="Share">347432</ogi:NumberOfWarrantsExpired>
  <ogi:NumberOfConvertibleDebenturesSold contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00" decimals="INF" id="Fxbrl_20200918042716391" unitRef="Debenture">115000</ogi:NumberOfConvertibleDebenturesSold>
  <ogi:PricePerConvertibleDebentureIssued contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00" decimals="0" id="F6232_1000" unitRef="CAD">1000</ogi:PricePerConvertibleDebentureIssued>
  <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00" decimals="-3" id="Fxbrl_20200918042856555" unitRef="CAD">115000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
  <ogi:IncreaseDecreaseThroughConvertibleDebentureFinancing contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" decimals="-3" id="F6232_12003" unitRef="CAD">12003000</ogi:IncreaseDecreaseThroughConvertibleDebentureFinancing>
  <ogi:DeferredTaxOnConvertibleDebentureFinancing contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00" decimals="-3" id="F6232_4902" unitRef="CAD">4902000</ogi:DeferredTaxOnConvertibleDebentureFinancing>
  <ogi:DeferredTaxOnConvertibleDebentureFinancing contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" decimals="-3" id="F6232_305" unitRef="CAD">305000</ogi:DeferredTaxOnConvertibleDebentureFinancing>
  <ogi:ConvertibleDebentureIssueCosts contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00" decimals="-3" id="F6232_7155" unitRef="CAD">7155000</ogi:ConvertibleDebentureIssueCosts>
  <ogi:ConvertibleDebentureIssueCosts contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00_ComponentsOfEquityAxis_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" decimals="-3" id="F6232_756" unitRef="CAD">756000</ogi:ConvertibleDebentureIssueCosts>
  <ogi:ConvertibleDebentureIssueCostsChargedToDebentureLiability contextRef="Context_1ME_01-Jan-2018T00_00_00_TO_31-Jan-2018T00_00_00" decimals="-3" id="F6232_6094" unitRef="CAD">6094000</ogi:ConvertibleDebentureIssueCostsChargedToDebentureLiability>
  <ogi:ConversionOfDebenturesPricePerShare contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="2" id="F6234_542" unitRef="CAD_per_Share">5.42</ogi:ConversionOfDebenturesPricePerShare>
  <ogi:ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares contextRef="Context_Custom_01_Feb_2019T00_00_00_TO_27_Feb_2019T00_00_00_BorrowingsByNameAxis_ConvertibleDebenturesMember" decimals="2" id="F6245_705" unitRef="CAD_per_Share">7.05</ogi:ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="Context_Custom_01_Jul_2017T00_00_00_TO_14_Jul_2017T00_00_00_SalesOfStockAxis_AdvisoryServicesAgreementMember_CategoriesOfRelatedPartiesAxis_CannabisConsultantMember" decimals="-3" id="Fxbrl_20201124141728329" unitRef="CAD">539000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="C_20190901to20200831" decimals="INF" id="Fxbrl_20201124141340073" unitRef="Share">879240</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124141408173" unitRef="Share">2167864</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="C_20190901to20200831" decimals="2" id="Fxbrl_20201124141431939" unitRef="CAD_per_Share">1.21</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="2" id="Fxbrl_20201124141450170" unitRef="CAD_per_Share">1.92</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ogi:NumberOfWarrantsExpiredOrReleased contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124102739301" unitRef="shares">7739205</ogi:NumberOfWarrantsExpiredOrReleased>
  <ogi:WeightedAverageExercisePriceOfWarrantsExercisedOrReleased contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="2" id="Fxbrl_20201124102801266" unitRef="CAD_per_Share">4.00</ogi:WeightedAverageExercisePriceOfWarrantsExercisedOrReleased>
  <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124110606887">&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;WEIGHTED AVERAGE&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NUMBER&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;EXERCISE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7,709,746&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;3,589,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.59&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(2,167,864&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.92&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Cancelled / Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(298,188&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;6.41&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;8,833,194&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4.23&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,125,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;3.21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(879,240&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Cancelled / Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(1,050,050&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;6.20&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;9,028,904&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double;text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:13px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:199px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4.06&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double;text-align:left;vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00" decimals="INF" id="Fxbrl_20201124110433275_xbrl_20200917012321656" unitRef="Share">7709746</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124110433316_xbrl_20200917012606520" unitRef="Share">8833194</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20200831" decimals="INF" id="Fxbrl_20201124110433356_xbrl_20201124104312479" unitRef="Share">9028904</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceZeroPointThreeZeroToOnePointFourEightMember" decimals="INF" id="Fxbrl_20201124112828974_1599720500" unitRef="Share">1440599</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceOnePointFourNineToTwoPointThreeEightMember" decimals="INF" id="Fxbrl_20201124112829006_1599720515" unitRef="Share">2204333</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceTwoPointThreeNineToFourPointSixFiveMember" decimals="INF" id="Fxbrl_20201124112829018_1599720530" unitRef="Share">2069854</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceFourPointSixSixToSevenPointSixSevenMember" decimals="INF" id="Fxbrl_20201124112829029_1599720545" unitRef="Share">1886518</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember" decimals="INF" id="Fxbrl_20201124112829041_1599720560" unitRef="Share">1427600</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00" decimals="2" id="Fxbrl_20201124110433275_6510_210" unitRef="CAD_per_Share">2.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="2" id="Fxbrl_20201124110433316_6574_423" unitRef="CAD_per_Share">4.23</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20200831" decimals="2" id="Fxbrl_20201124110433356_xbrl_20201124104329961" unitRef="CAD_per_Share">4.06</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20200831_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="F6622_030" unitRef="CAD_per_Share">0.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20200831_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="F6622_1127" unitRef="CAD_per_Share">11.27</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124110433291_xbrl_20200917011404893" unitRef="Share">3589500</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="C_20190901to20200831" decimals="INF" id="Fxbrl_20201124110433326_xbrl_20201124103917507" unitRef="Share">2125000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="C_20190901to20200831_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" decimals="0" id="Fxbrl_20200916012645576" unitRef="Share">790000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CategoriesOfRelatedPartiesAxis_KeyManagementPersonnelOfEntityOrParentMember" decimals="0" id="Fxbrl_20200916012841053" unitRef="Share">685000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="Context_Custom_01_Oct_2016T00_00_00_TO_04_Oct_2016T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember" decimals="-3" id="Fxbrl_20200910114142151" unitRef="CAD">150000000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="C_20190901to20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember" decimals="-3" id="Fxbrl_20200910115226735" unitRef="CAD">350000000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="2" id="Fxbrl_20201124110433291_xbrl_20200917011554474" unitRef="CAD_per_Share">7.59</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="C_20190901to20200831" decimals="2" id="Fxbrl_20201124110433326_xbrl_20201124104555428" unitRef="CAD_per_Share">3.21</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="C_20190901to20200831_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" decimals="2" id="Fxbrl_20200917183849468" unitRef="CAD_per_Share">2.48</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CategoriesOfRelatedPartiesAxis_KeyManagementPersonnelOfEntityOrParentMember" decimals="2" id="Fxbrl_20200917183859925" unitRef="CAD_per_Share">4.75</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="INF" id="Fxbrl_20201124110433311_xbrl_20200917012149906" unitRef="Share">298188</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement contextRef="C_20190901to20200831" decimals="INF" id="Fxbrl_20201124110433346_xbrl_20201124104233377" unitRef="Share">1050050</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="2" id="Fxbrl_20201124110433311_xbrl_20200917012255298" unitRef="CAD_per_Share">6.41</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 contextRef="C_20190901to20200831" decimals="2" id="Fxbrl_20201124110433346_xbrl_20201124104641321" unitRef="CAD_per_Share">6.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
  <ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124112855722">&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;OPTIONS OUTSTANDING&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;OPTIONS EXERCISABLE&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Range of Exercise&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Weighted Average Remaining&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Prices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Quantity Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Contractual Life (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Quantity Exercisable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$0.30 - $1.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,440,599&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,376,683&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$1.49 - $2.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,204,333&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,652,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$2.39 - $4.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,069,854&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,217,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$4.66 - $7.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,886,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;8.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,276,194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$7.68 - $11.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,427,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;8.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;949,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;width:334px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;9,028,904&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;width:333px"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;6,473,114&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceZeroPointThreeZeroToOnePointFourEightMember" id="Fxbrl_20201124112828974_1599720503">P4Y8M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceOnePointFourNineToTwoPointThreeEightMember" id="Fxbrl_20201124112829006_1599720518">P7Y6M</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceTwoPointThreeNineToFourPointSixFiveMember" id="Fxbrl_20201124112829018_1599720533">P7Y10M24D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceFourPointSixSixToSevenPointSixSevenMember" id="Fxbrl_20201124112829029_1599720548">P8Y2M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190901to20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember" id="Fxbrl_20201124112829041_1599720563">P8Y8M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190901to20200831" id="Fxbrl_20201124112829054_1599720488">P7Y6M</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceZeroPointThreeZeroToOnePointFourEightMember" decimals="INF" id="Fxbrl_20201124112828974_1599720506" unitRef="Share">1376683</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceOnePointFourNineToTwoPointThreeEightMember" decimals="INF" id="Fxbrl_20201124112829006_1599720521" unitRef="Share">1652833</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceTwoPointThreeNineToFourPointSixFiveMember" decimals="INF" id="Fxbrl_20201124112829018_1599720536" unitRef="Share">1217504</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceFourPointSixSixToSevenPointSixSevenMember" decimals="INF" id="Fxbrl_20201124112829029_1599720551" unitRef="Share">1276194</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20200831_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_ogiExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember" decimals="INF" id="Fxbrl_20201124112829041_1599720566" unitRef="Share">949900</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20200831" decimals="INF" id="Fxbrl_20201124112829054_1599720491" unitRef="Share">6473114</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ogi:FairValueOfOptionsGranted contextRef="C_20190901to20200831" decimals="-3" id="F6622_13848" unitRef="CAD">3743000</ogi:FairValueOfOptionsGranted>
  <ogi:FairValueOfOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F6622_4124" unitRef="CAD">13848000</ogi:FairValueOfOptionsGranted>
  <ogi:DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions contextRef="C_20190901to20200831" id="Fxbrl_20201124122620551">&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#86b4cd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#a6a4a4"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;0.45%- 1.65%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1.20%- 2.42%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected life of options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5.0 - 6.0 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5.0 -6.5 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected annualized volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;72% - 85%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;64%-71%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Forfeiture Rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="text-align:center;background-color:#e2f5fa"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;8.0% - 8.7%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:center;background-color:#dfdddd"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;7.3%- 8.0%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20201124121753890" unitRef="pure">0.0045</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20201124121802956" unitRef="pure">0.0165</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_BottomOfRangeMember" decimals="4" id="Fxbrl_20201124121811958" unitRef="pure">0.0120</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_TopOfRangeMember" decimals="4" id="Fxbrl_20201124121827254" unitRef="pure">0.0242</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="INF" id="Fxbrl_20201124121836339" unitRef="Year">5.0</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="INF" id="Fxbrl_20201124121847623" unitRef="Year">6.0</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_BottomOfRangeMember" decimals="INF" id="Fxbrl_20201124121855729" unitRef="Year">5.0</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_TopOfRangeMember" decimals="INF" id="Fxbrl_20201124121905132" unitRef="Year">6.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20201124121915572" unitRef="pure">0.72</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20201124121923121" unitRef="pure">0.85</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_BottomOfRangeMember" decimals="2" id="Fxbrl_20201124121932204" unitRef="pure">0.64</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_TopOfRangeMember" decimals="2" id="Fxbrl_20201124121943004" unitRef="pure">0.71</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="C_20190901to20200831" decimals="2" id="Fxbrl_20201124121953584" unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
  <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="2" id="Fxbrl_20201124122002836" unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
  <ogi:DescriptionOfForfeitureRateShareOptionsGranted contextRef="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="3" id="Fxbrl_20201124122011791" unitRef="pure">0.080</ogi:DescriptionOfForfeitureRateShareOptionsGranted>
  <ogi:DescriptionOfForfeitureRateShareOptionsGranted contextRef="C_20190901to20200831_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="3" id="Fxbrl_20201124122023701" unitRef="pure">0.087</ogi:DescriptionOfForfeitureRateShareOptionsGranted>
  <ogi:DescriptionOfForfeitureRateShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_BottomOfRangeMember" decimals="3" id="Fxbrl_20201124122057166" unitRef="pure">0.073</ogi:DescriptionOfForfeitureRateShareOptionsGranted>
  <ogi:DescriptionOfForfeitureRateShareOptionsGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_RangeAxis_TopOfRangeMember" decimals="3" id="Fxbrl_20201124122104800" unitRef="pure">0.080</ogi:DescriptionOfForfeitureRateShareOptionsGranted>
  <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124115037866">&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NUMBER&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;145,200&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;879,635&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(182,473&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;842,362&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;265,258&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(154,062&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Cancelled/Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(60,387&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;893,171&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
  <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember" decimals="0" id="Fxbrl_20201124115111169" unitRef="Share">145200</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember" decimals="0" id="Fxbrl_20201124115116086" unitRef="Share">842362</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="C_20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember" decimals="0" id="Fxbrl_20201124115120053" unitRef="Share">893171</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" decimals="0" id="Fxbrl_20201124125412188" unitRef="Share">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="C_20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" decimals="0" id="Fxbrl_20201124125344090" unitRef="Share">126685</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember" decimals="0" id="Fxbrl_20201124115329067" unitRef="Share">182473</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember" decimals="0" id="Fxbrl_20201124115323814" unitRef="Share">154062</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiPerformanceShareUnitsMember" decimals="0" id="Fxbrl_20201124125354671" unitRef="Share">15502</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember" decimals="0" id="Fxbrl_20201124115356553" unitRef="Share">60387</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
  <ogi:EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember" decimals="-3" id="Fxbrl_20201124115937501" unitRef="CAD">1037000</ogi:EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted>
  <ogi:EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember" decimals="-3" id="Fxbrl_20201124115946000" unitRef="CAD">4543000</ogi:EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted>
  <ogi:DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124115050139">&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NUMBER&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;142,187&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(15,502&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Balance - August 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:159px;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;126,685&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory>
  <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124121315738">&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:164px;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:165px;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Weighted average number of shares used in basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;172,668,816&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;140,923,324&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4,540,182&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5,194,827&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4,738,388&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Restricted share units&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;727,275&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;684,534&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;126,685&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Weighted average number of shares used in diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;178,062,958&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;151,541,073&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
  <ifrs-full:WeightedAverageShares contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124121349017_xbrl_20200910095800469_12" unitRef="shares">172668816</ifrs-full:WeightedAverageShares>
  <ifrs-full:WeightedAverageShares contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20201124121349017_xbrl_20200910095800469_15" unitRef="shares">140923324</ifrs-full:WeightedAverageShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124121349035_xbrl_20200910095800469_22" unitRef="shares">4540182</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20201124121349035_xbrl_20200910095800469_25" unitRef="shares">5194827</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ogi:DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124121349045_xbrl_20200910095800469_32" unitRef="shares">0</ogi:DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares>
  <ogi:DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20201124121349045_xbrl_20200910095800469_35" unitRef="shares">4738388</ogi:DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares>
  <ogi:DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124125026900_xbrl_20201124121349035_xbrl_20200910095800469_22" unitRef="shares">727275</ogi:DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares>
  <ogi:DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20201124125026900_xbrl_20201124121349035_xbrl_20200910095800469_25" unitRef="shares">684534</ogi:DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares>
  <ogi:DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124125029728_xbrl_20201124121349035_xbrl_20200910095800469_22" unitRef="shares">126685</ogi:DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares>
  <ogi:DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20201124125029728_xbrl_20201124121349035_xbrl_20200910095800469_25" unitRef="shares">0</ogi:DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124121349056_xbrl_20200910095800469_52" unitRef="shares">178062958</ifrs-full:AdjustedWeightedAverageShares>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20201124121349056_xbrl_20200910095800469_55" unitRef="shares">151541073</ifrs-full:AdjustedWeightedAverageShares>
  <ifrs-full:EarningsPerShareExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124121335782">&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:164px;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:165px;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:27px;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4,382,918&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,847,500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:897px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;4,382,918&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:27px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;1,847,500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:EarningsPerShareExplanatory>
  <ogi:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare contextRef="C_20190901to20200831_ogiAntidilutiveSecuritiesAxis_ogiStockOptionsMember" decimals="0" id="Fxbrl_20201124121412443_xbrl_20200909161459225_12" unitRef="shares">4382918</ogi:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare>
  <ogi:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_AntidilutiveSecuritiesAxis_StockOptionsMember" decimals="0" id="Fxbrl_20201124121412443_xbrl_20200909161459225_15" unitRef="shares">1847500</ogi:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare>
  <ogi:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare contextRef="C_20190901to20200831" decimals="0" id="Fxbrl_20201124121458429" unitRef="shares">4382918</ogi:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare>
  <ogi:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="0" id="Fxbrl_20201124121503492" unitRef="shares">1847500</ogi:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare>
  <ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory contextRef="C_20190901to20200831" id="F6b86a291-f198-11ea-af0e-4f71386cf7c7">&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif;color:#86b4cd"&gt;&lt;span&gt;14. INVESTMENTS IN ASSOCIATES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ALPHA-CANNABIS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EVIANA HEALTH&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;HYASYNTH&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PHARMA GMBH&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CORPORATION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BIOLOGICALS INC.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(A)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(B)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(C)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Participating share &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25.0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19.9%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43.4%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Transaction costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;322&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Distributions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(374&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(374&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Share of net loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(734&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(477&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(1,261&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Foreign currency translation gain (loss)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,496&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,612&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,108&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share of net loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,112&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,187&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Elimination of proportionate share of&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; transactions with associates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation gain (loss)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2020 &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,501&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,001&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 1: % Interest includes the potential ownership interest that could result from the conversion of debentures and exercise of warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 2: The Company utilizes the most recently issued quarterly financial statements of its associates in its results with a two month&amp;#160;lag since the Company does not have the same reporting date as its associates (for the year ended August 31, 2020, the Company utilized its associates' June 30, 2020 results)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;a) alpha-cannabis Pharma GmbH&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On October 10, 2018, the Company executed an investment agreement with alpha-cannabis&amp;#xae; Pharma GmbH ("ACG") pursuant to which the Company acquired 8,333 common shares of ACG, representing a 25% stake in the capital of ACG, for aggregate proceeds of &amp;#x20ac;1,625 ($2,436). Established in 2016, ACG is a privately held company that is strategically positioned to serve the German medical cannabis market.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has a commitment to deliver additional consideration of up to &amp;#x20ac;875 in the form of the Company's common shares contingent on the achievement of certain gross margin-based milestones. The Company has estimated the fair value of these contingent shares as &amp;#x20ac;649 ($972) as of the investment date and has included a corresponding long-term liability under other liabilities in the statement of financial position. Refer to Note 12 for further information.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concurrent with the Company's investment in ACG, the parties entered into a CBD supply agreement, whereby ACG may supply the Company with synthetic CBD, as well as a cannabis supply agreement, whereby the Company may supply ACG with dried cannabis flowers.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;b) Eviana Health Corporation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On October 2, 2018, the Company participated in the debenture offering of Eviana Health Corporation ("Eviana") by way of private placement. Eviana is a Canadian Securities Exchange ("CSE") listed company that was established with the aim of delivering customized consumer health care products using natural hemp strains of cannabis sativa for cannabinoid-based topical creams and products. The Company's investment is in the form of convertible debentures and share purchase warrants, which together provide a potential ownership interest of up to 21.4%, which is capped at 19.9% based on certain contractual obligations. In addition to this ownership interest, the Company also considered various qualitative factors in arriving at the determination that significant influence exists, including representation rights on Eviana's board of directors, and thereby concluding that the equity method of accounting is appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The convertible debentures have a face value of $5,000, bear interest at 10% per annum, are non-redeemable, and mature on October 2, 2020. The convertible debentures are convertible at the option of the holder at any time at a price of $1.15 per share, or into 4,347,826 common shares of Eviana. Conversion of the debentures may be forced by Eviana in the event that the volume weighted average price of the common shares of Eviana for ten consecutive days is greater than $2.15, subject to a minimum volume of 100,000 shares in each of those 10 days.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The share purchase warrants were acquired for no additional consideration, concurrent with the debenture offering, are transferrable, and are exercisable until October 2, 2020. 2,500 share purchase warrant units were acquired, each of which is convertible into 870 common shares per unit, or 2,175,000 common shares in aggregate, at an exercise price of $1.30 per share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concurrent with the Company&amp;#x2019;s investment in Eviana, the parties entered into a CBD oil supply agreement, whereby the Company has the right, but not obligation, to purchase up to 25% of Eviana&amp;#x2019;s annual CBD oil at 95% of the agreed raw CBD oil wholesale market price for a period of 5 years from the date on which the CBD oil is first made commercially available by Eviana for wholesale.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On October 28, 2019, Eviana provided a default announcement in accordance with National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). Eviana made an application to the British Columbia Securities Commission, as its principal regulator, for a management cease trade order ("MCTO") under NP 12-203 in respect of an anticipated default regarding its annual filings. On November 1, 2019, a cease trade order ("CTO") was issued by the British Columbia Securities Commission and the Ontario Securities Commission.&amp;#160; On November 5, 2019, Eviana was suspended from the CSE in accordance with CSE Policy 3 which is considered a regulatory halt as defined in National Instrument 23-101 - Trading Rules.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;At May 31, 2020, the Company identified indicators of impairment with respect to its investment in Eviana. The Company determined the recoverable amount of Eviana to approximate $nil based on the higher of fair value less costs to sell ("FVLCS") and value-in-use ("VIU").&amp;#160; An impairment loss of $3,000 has been included in the statement of (loss) income and comprehensive (loss) income for the year ended August 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;On June 18, 2020, the Company served Eviana with a notice of default and demand letter with respect to the non-payment of interest relating to its convertible debentures as well as other applicable events of default under the debenture agreement.&amp;#160; As of the date these financial statements were approved, the Company has not yet received its December 31, 2019 or June 30, 2020 interest payment on the Eviana convertible debenture.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;c) Hyasynth Biologicals Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On September 12, 2018, the Company invested in Hyasynth Biologicals Inc. ("Hyasynth") by way of convertible secured debentures, to be purchased in three tranches and valued in the aggregate at $10,000. Tranche 1 was issued on that date, Tranche 2 was issued on October 23, 2020 (as described below), and one additional tranche that may be issued based on the achievement of a specific milestone. Hyasynth is a privately held biotechnology company based in Montreal, Quebec and is a leader in the field of cannabinoid science and biosynthesis. The Company's investment is in the form of convertible debentures, which provide a potential ownership interest of up to 43.4% based on Tranche 1. In addition to the ownership interest, the Company also considered various qualitative factors in arriving at the determination that significant influence exists, including representation on Hyasynth's board of directors, and thereby concluded that the equity method of accounting is appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tranche 1 of the convertible debentures has a face value of $5,000, bears interest at 8.0% per annum, are secured, and mature on the earlier of August 31, 2023 or the closing date of a qualified sale transaction, unless an automatic or optional conversion has occurred. Tranche 1 of the convertible debentures are convertible at the option of the holder at any time at a price of $40 per share, or into 125,000 common shares. Conversion of the debentures may be automatically triggered based on the completion of a qualified transaction or Hyasynth's facility reaching a pre-defined production capacity. Tranche 2 and 3 of the convertible debentures, each of which commits $2.5 million for an aggregate of $5 million, have certain production-related milestones that must be achieved within a 24- and 36-month period, respectively, for issuance to occur.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concurrent with the Company&amp;#x2019;s investment in Hyasynth, the parties entered into a CBD supply agreement, whereby the Company has the ability to purchase up to 100% of Hyasynth&amp;#x2019;s annual cannabinoid or cannabinoid-related production at a 10% discount to the agreed upon wholesale market price for a period of 10 years from the date Hyasynth commences commercial production of the products.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent to the year end, on October 23, 2020, the Company advanced an additional $2,500 to Hyasynth by way of convertible debentures as a result of Hyasynth's achievement of the contractual production-related milestone for Tranche 2 of the convertible debentures.&amp;#160; This brings the Company's total face value of convertible debentures investment in Hyasynth to $7,500, which provides the Company with a potential ownership interest of up to 46.5% on a fully diluted basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory>
  <ifrs-full:DisclosureOfInterestsInAssociatesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124173901708">&lt;div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ALPHA-CANNABIS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EVIANA HEALTH&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;HYASYNTH&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PHARMA GMBH&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CORPORATION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BIOLOGICALS INC.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(A)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(B)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(C)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Participating share &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25.0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19.9%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43.4%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Balance, August 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Transaction costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;322&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Distributions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(374&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(374&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Share of net loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(734&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(477&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(1,261&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Foreign currency translation gain (loss)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,496&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,612&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,108&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share of net loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,112&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,187&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Elimination of proportionate share of&lt;br/&gt;&amp;#160;&amp;#160;&amp;#160; transactions with associates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation gain (loss)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2020 &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,501&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,001&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInterestsInAssociatesExplanatory>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="3" id="Fxbrl_20201124173628027" unitRef="pure">0.250</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember" decimals="3" id="Fxbrl_20201124173643247" unitRef="pure">0.199</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="3" id="Fxbrl_20200916163319811" unitRef="pure">0.434</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="Context_Custom_04_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember" decimals="2" id="Fxbrl_20200916171303312" unitRef="pure">0.25</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="3" id="F7143_214" unitRef="pure">0.214</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="Context_0ME_01-Sep-2018T00_00_00_TO_12-Sep-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="3" id="F7150_434" unitRef="pure">0.434</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:InvestmentsInAssociates contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201129122112840" unitRef="CAD">0</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201129122455473" unitRef="CAD">0</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201129122614862" unitRef="CAD">0</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00" decimals="-3" id="Fxbrl_20201129122700221" unitRef="CAD">0</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="Context_As_Of_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201124133431507_6998_3496" unitRef="CAD">3496000</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201124133431507_7001_3000" unitRef="CAD">3000000</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201124133431507_7004_4612" unitRef="CAD">4612000</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124133431507_7007_11108" unitRef="CAD">11108000</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="C_20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="F6998_3496" unitRef="CAD">3501000</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="C_20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember" decimals="-3" id="F7001_3000" unitRef="CAD">0</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="C_20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="F7004_4612" unitRef="CAD">3500000</ifrs-full:InvestmentsInAssociates>
  <ifrs-full:InvestmentsInAssociates contextRef="C_20200831" decimals="-3" id="F7007_11108" unitRef="CAD">7001000</ifrs-full:InvestmentsInAssociates>
  <ogi:AdditionsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201129125608335" unitRef="CAD">3408000</ogi:AdditionsOfInvestmentInAssociates>
  <ogi:AdditionsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201129125622937" unitRef="CAD">5000000</ogi:AdditionsOfInvestmentInAssociates>
  <ogi:AdditionsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201129125648256" unitRef="CAD">5000000</ogi:AdditionsOfInvestmentInAssociates>
  <ogi:AdditionsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201129125711342" unitRef="CAD">13408000</ogi:AdditionsOfInvestmentInAssociates>
  <ogi:TransactionCostsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201129125908703" unitRef="CAD">160000</ogi:TransactionCostsOfInvestmentInAssociates>
  <ogi:TransactionCostsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201129125919288" unitRef="CAD">73000</ogi:TransactionCostsOfInvestmentInAssociates>
  <ogi:TransactionCostsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201129125942950" unitRef="CAD">89000</ogi:TransactionCostsOfInvestmentInAssociates>
  <ogi:TransactionCostsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201129130007998" unitRef="CAD">322000</ogi:TransactionCostsOfInvestmentInAssociates>
  <ogi:DistributionsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201129130107189" unitRef="CAD">0</ogi:DistributionsOfInvestmentInAssociates>
  <ogi:DistributionsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201129130226676" unitRef="CAD">374000</ogi:DistributionsOfInvestmentInAssociates>
  <ogi:DistributionsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201129130129775" unitRef="CAD">0</ogi:DistributionsOfInvestmentInAssociates>
  <ogi:DistributionsOfInvestmentInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201129130234110" unitRef="CAD">374000</ogi:DistributionsOfInvestmentInAssociates>
  <ogi:ImpairmentLossOfInvestmentsInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201129125022535" unitRef="CAD">0</ogi:ImpairmentLossOfInvestmentsInAssociates>
  <ogi:ImpairmentLossOfInvestmentsInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201129125125294" unitRef="CAD">950000</ogi:ImpairmentLossOfInvestmentsInAssociates>
  <ogi:ImpairmentLossOfInvestmentsInAssociates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201129125209344" unitRef="CAD">950000</ogi:ImpairmentLossOfInvestmentsInAssociates>
  <ogi:ImpairmentLossOfInvestmentsInAssociates contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20200916163801778" unitRef="CAD">0</ogi:ImpairmentLossOfInvestmentsInAssociates>
  <ogi:ImpairmentLossOfInvestmentsInAssociates contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember" decimals="-3" id="F6972_950" unitRef="CAD">3000000</ogi:ImpairmentLossOfInvestmentsInAssociates>
  <ogi:ImpairmentLossOfInvestmentsInAssociates contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20200916163836251" unitRef="CAD">0</ogi:ImpairmentLossOfInvestmentsInAssociates>
  <ogi:ImpairmentLossOfInvestmentsInAssociates contextRef="C_20190901to20200831" decimals="-3" id="F6978_950" unitRef="CAD">3000000</ogi:ImpairmentLossOfInvestmentsInAssociates>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201129125247763" unitRef="CAD">-22000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201129125315072" unitRef="CAD">-15000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201129125424895" unitRef="CAD">0</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201129125453388" unitRef="CAD">-37000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="F6983_22" unitRef="CAD">94000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember" decimals="-3" id="F6986_15" unitRef="CAD">-0</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20200916163913440" unitRef="CAD">0</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="C_20190901to20200831" decimals="-3" id="F6992_37" unitRef="CAD">94000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ogi:EliminationOfProportionateShareOfTransactionsWithAssociates contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiAlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201124134157133" unitRef="CAD">-14000</ogi:EliminationOfProportionateShareOfTransactionsWithAssociates>
  <ogi:EliminationOfProportionateShareOfTransactionsWithAssociates contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiEvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20201124134229863" unitRef="CAD">0</ogi:EliminationOfProportionateShareOfTransactionsWithAssociates>
  <ogi:EliminationOfProportionateShareOfTransactionsWithAssociates contextRef="C_20190901to20200831_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201124134226759" unitRef="CAD">0</ogi:EliminationOfProportionateShareOfTransactionsWithAssociates>
  <ogi:EliminationOfProportionateShareOfTransactionsWithAssociates contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124134219433" unitRef="CAD">-14000</ogi:EliminationOfProportionateShareOfTransactionsWithAssociates>
  <ogi:NumberOfSharesAcquired contextRef="Context_Custom_04_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember" decimals="INF" id="F7129_8333" unitRef="shares">8333</ogi:NumberOfSharesAcquired>
  <ogi:CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones contextRef="Context_As_Of_10_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201124134751209" unitRef="EUR">875000</ogi:CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones>
  <ogi:CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124181422664" unitRef="EUR">875000</ogi:CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones>
  <ogi:FairValueOfContingentShares contextRef="Context_As_Of_10_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember" decimals="-3" id="Fxbrl_20201124134835313" unitRef="EUR">649000</ogi:FairValueOfContingentShares>
  <ogi:FairValueOfContingentShares contextRef="Context_As_Of_10_Oct_2018T00_00_00_TO_10_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_AlphaCannabisPharmaGmbhMember" decimals="-3" id="F7132_972" unitRef="CAD">972000</ogi:FairValueOfContingentShares>
  <ogi:PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations contextRef="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="3" id="F7143_199" unitRef="pure">0.199</ogi:PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations>
  <ogi:ConvertibleDebenturesReceivableFaceValue contextRef="Context_As_Of_02-Oct-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20200916173610966" unitRef="CAD">5000000</ogi:ConvertibleDebenturesReceivableFaceValue>
  <ogi:ConvertibleDebenturesReceivableFaceValue contextRef="Context_As_Of_12_Sep_2018T00_00_00_TO_12_Sep_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20200916175109985" unitRef="CAD">5000000</ogi:ConvertibleDebenturesReceivableFaceValue>
  <ogi:ConvertibleDebenturesReceivableFaceValue contextRef="C_20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiAchievementOfContractualProductionRelatedMilestoneMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201124140120384" unitRef="CAD">7500000</ogi:ConvertibleDebenturesReceivableFaceValue>
  <ogi:ConvertibleDebenturesReceivableFaceValue contextRef="C_20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201124142650097" unitRef="CAD">7500000</ogi:ConvertibleDebenturesReceivableFaceValue>
  <ogi:ConversionOfDebenturesDescription contextRef="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" id="Fxbrl_20200916174358072">The convertible debentures are convertible at the option of the holder at any time at a price of $1.15 per share, or into 4,347,826 common shares of Eviana. Conversion of the debentures may be forced by Eviana in the event that the volume weighted average price of the common shares of Eviana for ten consecutive days is greater than $2.15, subject to a minimum volume of 100,000 shares in each of those 10 days.</ogi:ConversionOfDebenturesDescription>
  <ogi:ConvertibleDebenturesConversionPrice contextRef="Context_As_Of_02-Oct-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="2" id="F7146_115" unitRef="CAD_per_Share">1.15</ogi:ConvertibleDebenturesConversionPrice>
  <ogi:ConvertibleDebenturesConversionPrice contextRef="Context_As_Of_12_Sep_2018T00_00_00_TO_12_Sep_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="0" id="F7153_40" unitRef="CAD_per_Share">40</ogi:ConvertibleDebenturesConversionPrice>
  <ogi:ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion contextRef="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="INF" id="F7146_4347826" unitRef="shares">4347826</ogi:ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion>
  <ogi:ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion contextRef="Context_0ME_01-Sep-2018T00_00_00_TO_12-Sep-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="INF" id="F7153_125000" unitRef="shares">125000</ogi:ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion>
  <ogi:NumberOfSharePurchaseWarrantUnitsAcquired contextRef="Context_As_Of_02-Oct-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="INF" id="F7147_2500" unitRef="shares">2500</ogi:NumberOfSharePurchaseWarrantUnitsAcquired>
  <ogi:SharesAvailablePerSharePurchaseWarrantUnitUponConversion contextRef="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="INF" id="F7147_870" unitRef="shares">870</ogi:SharesAvailablePerSharePurchaseWarrantUnitUponConversion>
  <ogi:SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion contextRef="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="INF" id="F7147_2175000" unitRef="shares">2175000</ogi:SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion>
  <ogi:SharePurchaseWarrantExercisePricePerShare contextRef="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="2" id="F7147_130" unitRef="CAD_per_Share">1.30</ogi:SharePurchaseWarrantExercisePricePerShare>
  <ogi:MaximumPercentageOfAnnualCbdOilPurchased contextRef="Context_As_Of_02-Oct-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="2" id="Fxbrl_20201124135302375" unitRef="pure">0.25</ogi:MaximumPercentageOfAnnualCbdOilPurchased>
  <ogi:PercentageOfAgreedRawCbdOilWholesaleMarketPrice contextRef="Context_Custom_01_Oct_2018T00_00_00_TO_02_Oct_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="2" id="F7148_95" unitRef="pure">0.95</ogi:PercentageOfAgreedRawCbdOilWholesaleMarketPrice>
  <ogi:CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months contextRef="Context_As_Of_12_Sep_2018T00_00_00_TO_12_Sep_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="-5" id="F7153_25" unitRef="CAD">2500000</ogi:CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months>
  <ogi:AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths contextRef="Context_As_Of_12_Sep_2018T00_00_00_TO_12_Sep_2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="-6" id="Fxbrl_20201124135927924" unitRef="CAD">5000000</ogi:AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths>
  <ogi:AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction contextRef="Context_0ME_01-Sep-2018T00_00_00_TO_12-Sep-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="2" id="F7154_100" unitRef="pure">1</ogi:AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction>
  <ogi:PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears contextRef="Context_0ME_01-Sep-2018T00_00_00_TO_12-Sep-2018T00_00_00_SignificantInvestmentsInAssociatesAxis_HyasynthBiologicalsIncMember" decimals="2" id="Fxbrl_20200916175703238" unitRef="pure">0.10</ogi:PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears>
  <ogi:AdvanceGivenAsConvertibleDebentures contextRef="C_20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiAchievementOfContractualProductionRelatedMilestoneMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201124160034308" unitRef="CAD">2500000</ogi:AdvanceGivenAsConvertibleDebentures>
  <ogi:PotentialProportionOfOwnershipInterestInAssociate contextRef="C_20201001to20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiAchievementOfContractualProductionRelatedMilestoneMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="3" id="Fxbrl_20201129082816451" unitRef="pure">0.465</ogi:PotentialProportionOfOwnershipInterestInAssociate>
  <ogi:PotentialProportionOfOwnershipInterestInAssociate contextRef="C_20201001to20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="3" id="Fxbrl_20201129083519569" unitRef="pure">0.465</ogi:PotentialProportionOfOwnershipInterestInAssociate>
  <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="C_20190901to20200831" id="F6b86c9a0-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;15. RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly. The key management personnel of the Company are the members of the Company's executive management team and Board of Directors. The transactions are conducted at arm's length and in the normal course of operations. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;(i) Management and Board compensation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;For the years ended August 31, 2020 and 2019, the Company's expenses included the following management and board compensation:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:center;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:center;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:center;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:center;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:center;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,521&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,155&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total key management compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,703&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,676&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;During the year ended August 31, 2020, 790,000 stock options (August 31, 2019 - 685,000) were granted to key management personnel at an average exercise price of $2.48 (August 31, 2019 - $4.75) and aggregate fair value of $1,794 (August 31, 2019 - $1,736). In addition, during the year ended August 31, 2020, 211,981 RSUs (August 31, 2019 - 631,949), were granted to key management personnel with an aggregate fair value of $902 (August 31, 2019 - $3,002). For the year ended August 31, 2020, 88,910 PSUs (August 31, 2019 - &lt;span style="-sec-ix-hidden:Fxbrl_20201124141751265"&gt;nil&lt;/span&gt;) were issued to key management personnel with an aggregate fair value of $191 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124141812756"&gt;nil&lt;/span&gt;).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;(ii) Significant transactions with associates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;For the year ended August 31, 2020, the Company received no interest income (August 31, 2019 - $374) on its convertible debenture investment in Eviana as disclosed in Note 14, which is being recorded as distributions under the equity accounting method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;For the year ended August 31, 2020, the Company earned revenues of $52 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124141330907"&gt;nil&lt;/span&gt;) on product sold to ACG, which has been proportionately eliminated from the consolidated financial statements based on the Company's proportionate share of investment in ACG.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
  <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory contextRef="C_20190901to20200831" id="F6bd42650-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:center;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:center;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:center;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:center;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:center;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,521&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,155&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total key management compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,703&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,676&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="C_20190901to20200831" decimals="-3" id="F1600199754" unitRef="CAD">2953000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1600199755" unitRef="CAD">2521000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="C_20190901to20200831" decimals="-3" id="F1600199756" unitRef="CAD">2750000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1600199757" unitRef="CAD">5155000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="C_20190901to20200831" decimals="-3" id="F1600199758" unitRef="CAD">5703000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1600199759" unitRef="CAD">7676000</ifrs-full:KeyManagementPersonnelCompensation>
  <ogi:AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement contextRef="C_20190901to20200831_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" decimals="-3" id="F7209_1736" unitRef="CAD">1794000</ogi:AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement>
  <ogi:AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_CategoriesOfRelatedPartiesAxis_KeyManagementPersonnelOfEntityOrParentMember" decimals="-3" id="F7209_2417" unitRef="CAD">1736000</ogi:AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement>
  <ogi:KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement contextRef="C_20190901to20200831_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ogiRestrictedStockUnitsMember_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" decimals="-3" id="F7209_3002" unitRef="CAD">902000</ogi:KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement>
  <ogi:KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_RestrictedStockUnitsMember_CategoriesOfRelatedPartiesAxis_KeyManagementPersonnelOfEntityOrParentMember" decimals="-3" id="F7209_856" unitRef="CAD">3002000</ogi:KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement>
  <ifrs-full:RevenueFromInterest contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_SignificantInvestmentsInAssociatesAxis_EvianaHealthCorporationMember" decimals="-3" id="Fxbrl_20200917172937640" unitRef="CAD">374000</ifrs-full:RevenueFromInterest>
  <ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory contextRef="C_20190901to20200831" id="F6b86c9a1-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;16. CAPITAL MANAGEMENT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company considers its capital to consist of share capital, equity reserves, long-term debt, accumulated other comprehensive income, and retained earnings, which is disclosed in the August 31, 2020 consolidated statement of financial position as $414,793 (August 31, 2019 - $376,582). Equity reserves is comprised of any amounts recorded with respect to the recognition of share-based compensation expense (options, RSUs, or PSUs) or the fair value of warrants issued. Accumulated other comprehensive income is entirely comprised of foreign currency translation gains and losses recorded on the Company's investment in ACG.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company manages its capital structure and adjusts it based on funds available to the Company, in order to fund its expansion and construction of its facility. The Board of Directors does not establish quantitative return on capital criteria for management, but rather relies on the expertise of the Company's management to sustain future development of the business.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative stage of the Company, is reasonable. There has been no chan&lt;/span&gt;&lt;span style="color:#000000"&gt;ge in how the Company defines or manages capital during the period.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory>
  <ogi:CapitalConsideration contextRef="C_20200831" decimals="-3" id="F7217_376582" unitRef="CAD">414793000</ogi:CapitalConsideration>
  <ogi:CapitalConsideration contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F7217_283758" unitRef="CAD">376582000</ogi:CapitalConsideration>
  <ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200918010438331">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;17. FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;i) Fair value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly fashion between market participants. The Company records certain financial instruments at fair value. The Company's financial instruments include cash, short-term investments (including marketable securities), accounts receivable, loan receivable, accounts payable and accrued liabilities, long-term debt, and contingent share consideration. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Fair value measurements are categorized into Level 1, 2 or 3 based on the degree to which the inputs to the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are described as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:21.6pt;text-indent:-12.95pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#87b5cf"&gt;&amp;#x2022;&lt;/span&gt;&lt;span style="text-indent:0pt;display:inline-block;width:8.47pt"&gt; &lt;/span&gt;&lt;span style="color:#000000"&gt;Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:21.6pt;text-indent:-12.95pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#87b5cf"&gt;&amp;#x2022;&lt;/span&gt;&lt;span style="text-indent:0pt;display:inline-block;width:8.47pt"&gt; &lt;/span&gt;&lt;span style="color:#000000"&gt;Level 2 inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly or indirectly; and &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:26.45pt;text-indent:-17.45pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#87b5cf"&gt;&amp;#x2022; &lt;/span&gt;&lt;span style="width:6.08pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;&lt;span style="color:#000000"&gt;Level 3 inputs are unobservable inputs for the asset or liability.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The fair value of cash, short-term investments, accounts receivable, loan receivable, accounts payable and accrued liabilities approximate their carrying amounts due to their short-term nature. The fair value of marketable securities is based on quoted prices in active markets and is reflected in the carrying value of these financial assets. The fair value of long-term debt approximates $115,389 based on the face value of debt outstanding, which carries a floating interest rate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The fair value of the contingent share consideration is primarily based on Level 3 unobservable inputs. The determination of the fair value of this liability is primarily driven by the Company's expectations of the investment in associate achieving certain milestones. The expected milestones were assigned probabilities and the expected related cash flows were discounted to derive the fair value of the contingent consideration. At August 31, 2020, the probability of achieving the milestones was estimated to be 68% and the discount rate was estimated to be 20%. If the probabilities of achieving the milestones increased or decreased by 10%, the estimated fair value of the contingent share consideration would increase or decrease by approximately $33. If the discount rates increased or decreased by 5%, the estimated fair value of contingent consideration would decrease or increase, respectively, by approximately $12.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;a id="page_34"/&gt;&lt;/span&gt;&lt;/span&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;During the period, there were no transfers of amounts between Levels 1, 2 and 3.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;ii) Financial risk factors&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company is exposed to various risks through its financial instruments, as follows: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;(i) &lt;strong&gt;Credit risk&lt;/strong&gt; arises from deposits with banks, short-term investments (excluding investments in equity securities), outstanding trade and loan receivables, and restricted investments. For trade receivables, the Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance. For other receivables, out of the normal course of business such as the loan receivable, management generally obtains guarantees and general security agreements. The maximum exposure to credit risk of cash, short-term investments, accounts receivable, loans receivable, and restricted investment on the statement of financial position at August 31, 2020 approximates $99,736 (August 31, 2019 - $65,385).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;As of August 31, 2020, the Company's aging of trade receivables was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0-60 days&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,748&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61-120 days&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;152&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross trade receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,096&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Provision for doubtful accounts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(268&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,083&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,632&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;(ii)&lt;strong&gt; Liquidity risk - &lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#000000"&gt;The Company's liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company manages its liquidity risk by reviewing on an ongoing basis its capital requirements. At August 31, 2020, the Company had $24,600 (August 31, 2019 - $47,555) of cash and working capital of $141,123 (August 31, 2019 - $152,417). Further, the Company may further consider accessing equity capital through the capital markets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company is obligated to the following contractual maturities relating to their undiscounted cash flows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;Carrying&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;Amount&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;Contractual&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;Cash Flows&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;Less than&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap;width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap;width:60px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;1 to 3 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;3 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;More than&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(226, 245, 250);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(226, 245, 250);width:60px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,486&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,486&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,486&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,266&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,388&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,605&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103,660&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,729&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,682&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,047&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132,752&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;140,603&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;106,707&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The contractual maturities noted above are based on contractual due dates of the respective financial liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In connection with the Company's Moncton Campus expansion plans, the Company is contractually committed to approximately $1,600 of capital expenditures.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;(iii) &lt;/span&gt;&lt;span style="color:#000000"&gt;&lt;strong&gt;Market risk&lt;/strong&gt; is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk for the Company comprises of:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;&lt;strong&gt;Interest rate risk&lt;/strong&gt; is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk at &lt;/span&gt;&lt;span style="color:#000000"&gt;August 31, 2020 &lt;/span&gt;&lt;span style="color:#000000"&gt;pursuant to the variable rate loans described in Note 11. A 1% change in benchmark interest rates will increase or decrease the Company's interest expense by $1,150 (August 31, 2019 - $500) per year.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory>
  <ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets contextRef="C_20190901to20200831" id="Fxbrl_20201126041954006">At August 31, 2020, the probability of achieving the milestones was estimated to be 68% and the discount rate was estimated to be 20%. If the probabilities of achieving the milestones increased or decreased by 10%, the estimated fair value of the contingent share consideration would increase or decrease by approximately $33. If the discount rates increased or decreased by 5%, the estimated fair value of contingent consideration would decrease or increase, respectively, by approximately $12.</ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets>
  <ifrs-full:MaximumExposureToCreditRisk contextRef="C_20200831" decimals="-3" id="F7251_64476" unitRef="CAD">99736000</ifrs-full:MaximumExposureToCreditRisk>
  <ifrs-full:MaximumExposureToCreditRisk contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F7251_133800" unitRef="CAD">65385000</ifrs-full:MaximumExposureToCreditRisk>
  <ogi:DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory contextRef="C_20190901to20200831" id="F6bd4c290-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0-60 days&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,748&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61-120 days&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;152&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross trade receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,096&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Provision for doubtful accounts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(268&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,083&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,632&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory>
  <ogi:TradeReceivablesGross contextRef="C_20200831_ogiReceivablesAxis_ogiZeroToSixtyDaysMember" decimals="-3" id="F1600201200" unitRef="CAD">11023000</ogi:TradeReceivablesGross>
  <ogi:TradeReceivablesGross contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ReceivablesAxis_ZeroToSixtyDaysMember" decimals="-3" id="F1600201201" unitRef="CAD">11748000</ogi:TradeReceivablesGross>
  <ogi:TradeReceivablesGross contextRef="C_20200831_ogiReceivablesAxis_ogiSixtyOneToOneTwentyDaysMember" decimals="-3" id="F1600201206" unitRef="CAD">73000</ogi:TradeReceivablesGross>
  <ogi:TradeReceivablesGross contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ogiReceivablesAxis_ogiSixtyOneToOneTwentyDaysMember" decimals="-3" id="F1600201207" unitRef="CAD">152000</ogi:TradeReceivablesGross>
  <ogi:TradeReceivablesGross contextRef="C_20200831" decimals="-3" id="F1600201190" unitRef="CAD">11096000</ogi:TradeReceivablesGross>
  <ogi:TradeReceivablesGross contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F1600201191" unitRef="CAD">11900000</ogi:TradeReceivablesGross>
  <ogi:ProvisionForDoubtfulTradeReceivables contextRef="C_20200831" decimals="-3" id="F1600201192" unitRef="CAD">13000</ogi:ProvisionForDoubtfulTradeReceivables>
  <ogi:ProvisionForDoubtfulTradeReceivables contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200918025523929" unitRef="CAD">268000</ogi:ProvisionForDoubtfulTradeReceivables>
  <ogi:TradeReceivablesNet contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124224645308" unitRef="CAD">11083000</ogi:TradeReceivablesNet>
  <ogi:TradeReceivablesNet contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124224702712" unitRef="CAD">11632000</ogi:TradeReceivablesNet>
  <ogi:WorkingCapital contextRef="C_20200831" decimals="-3" id="F7315_152417" unitRef="CAD">141123000</ogi:WorkingCapital>
  <ogi:WorkingCapital contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F7315_191964" unitRef="CAD">152417000</ogi:WorkingCapital>
  <ogi:DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory contextRef="C_20190901to20200831" id="F6bd510b0-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;Carrying&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;Amount&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;Contractual&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;Cash Flows&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;Less than&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap;width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap;width:60px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;1 to 3 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;3 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;More than&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(226, 245, 250);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(226, 245, 250);width:60px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,486&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,486&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,486&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,266&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,388&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,605&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103,660&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,729&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,682&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,047&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132,752&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;140,603&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;106,707&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory>
  <ifrs-full:InterestPayable contextRef="C_20200831" decimals="-3" id="Fxbrl_20200916231227717" unitRef="CAD">0</ifrs-full:InterestPayable>
  <ifrs-full:InterestPayable contextRef="C_20200831_ifrsfullMaturityAxis_ogiContractualCashFlowsMember" decimals="-3" id="F1600201241" unitRef="CAD">7729000</ifrs-full:InterestPayable>
  <ifrs-full:InterestPayable contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" decimals="-3" id="F1600201255" unitRef="CAD">4682000</ifrs-full:InterestPayable>
  <ifrs-full:InterestPayable contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanThreeYearsMember" decimals="-3" id="F1600201269" unitRef="CAD">3047000</ifrs-full:InterestPayable>
  <ifrs-full:InterestPayable contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" decimals="-3" id="Fxbrl_20200916231322640" unitRef="CAD">0</ifrs-full:InterestPayable>
  <ifrs-full:InterestPayable contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" decimals="-3" id="Fxbrl_20200916231352734" unitRef="CAD">0</ifrs-full:InterestPayable>
  <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="C_20200831" decimals="-3" id="Fxbrl_20200917161943799" unitRef="CAD">132752000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
  <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="C_20200831_ifrsfullMaturityAxis_ogiContractualCashFlowsMember" decimals="-3" id="F1600201245" unitRef="CAD">140603000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
  <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" decimals="-3" id="F1600201259" unitRef="CAD">33773000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
  <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanThreeYearsMember" decimals="-3" id="F1600201273" unitRef="CAD">106707000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
  <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" decimals="-3" id="F1600201287" unitRef="CAD">123000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
  <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" decimals="-3" id="F1600201237" unitRef="CAD">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
  <ifrs-full:ContractualCapitalCommitments contextRef="C_20200831" decimals="-3" id="Fxbrl_20201127095029898" unitRef="CAD">1600000</ifrs-full:ContractualCapitalCommitments>
  <ogi:ChangeInBenchmarkInterestRates contextRef="C_20190901to20200831" decimals="2" id="Fxbrl_20201124231307911" unitRef="pure">0.01</ogi:ChangeInBenchmarkInterestRates>
  <ifrs-full:ValueAtRisk contextRef="C_20200831" decimals="-3" id="F7450_500" unitRef="CAD">1150000</ifrs-full:ValueAtRisk>
  <ifrs-full:ValueAtRisk contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F7450_29" unitRef="CAD">500000</ifrs-full:ValueAtRisk>
  <ifrs-full:DisclosureOfRevenueExplanatory contextRef="C_20190901to20200831" id="F6b86c9a3-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;18. REVENUE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Net revenue for the Company is defined as gross revenue, which is net of any customer discounts, rebates, and sales returns and recoveries, less excise taxes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#000000"&gt;Revenues for the years ended August 31, 2020 and 2019 are disaggregated as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:157px;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:25px;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:26px;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:158px;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:26px;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Adult-use recreational wholesale revenue (Canadian)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;73,938&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;85,018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Wholesale to Licensed Producers revenue (Canadian)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;15,184&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;709&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Direct to patient medical revenue (Canadian)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;10,748&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;11,192&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;International (business to business)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;3,272&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;98&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Other revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;245&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;530&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Gross revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;103,387&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;97,547&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Excise taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(16,592&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(17,134&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Net revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;86,795&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;80,413&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Recreational revenue is primarily comprised of provincial government bodies and large retailers that sell cannabis through their respective distribution models, whereas wholesale revenue is comprised of wholesale shipments to other cannabis companies, including licensed producers, for further processing and sales onto their end customers.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;During the year ended August 31, 2020, the Company had three customers (August 31, 2019 - two customers) that individually represented more than 10% of the Company's net revenue.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfRevenueExplanatory>
  <ogi:DisclosureOfDetailedInformationAboutRevenuesExplantory contextRef="C_20190901to20200831" id="Fxbrl_20201124051626277">&lt;div&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:157px;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:25px;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:26px;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:158px;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:26px;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Adult-use recreational wholesale revenue (Canadian)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;73,938&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;85,018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Wholesale to Licensed Producers revenue (Canadian)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;15,184&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;709&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Direct to patient medical revenue (Canadian)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;10,748&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;11,192&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;International (business to business)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;3,272&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;98&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Other revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;245&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;530&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Gross revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;103,387&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;97,547&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Excise taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(16,592&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(17,134&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:853px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Net revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;86,795&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double;vertical-align:bottom;width:26px;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;80,413&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutRevenuesExplantory>
  <ogi:ExciseTaxesExpenses contextRef="C_20190901to20200831" decimals="-3" id="F7543_17134" unitRef="CAD">16592000</ogi:ExciseTaxesExpenses>
  <ogi:ExciseTaxesExpenses contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910173657178" unitRef="CAD">17134000</ogi:ExciseTaxesExpenses>
  <ifrs-full:InformationAboutMajorCustomers contextRef="C_20190901to20200831" id="Fxbrl_20201124051322442">During the year ended August 31, 2020, the Company had three customers (August 31, 2019 - two customers) that individually represented more than 10% of the Company's net revenue.</ifrs-full:InformationAboutMajorCustomers>
  <ifrs-full:DisclosureOfContingentLiabilitiesExplanatory contextRef="C_20190901to20200831" id="F6b86c9a5-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;20. CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company recognizes loss contingency provisions for probable losses when management can reasonably estimate the loss. When the estimated loss lies within a range, the Company records a loss contingency provision based on its best estimate of the probable loss. If no particular amount within that range is a better estimate than any other amount, the mid-point of the range is used. As information becomes known a loss contingency provision is recorded when a reasonable estimate can be made. The estimates are reviewed at each reporting date and the estimates are changed when expectations are revised. An outcome that deviates from the Company's estimate may result in an additional expense or release in a future accounting period.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;During 2015, the Company was named as a defendant in a lawsuit in New Brunswick for breach of confidence, conversion, breach of contract, conspiracy and breach of trust, breach of fiduciary duty, and negligent misrepresentation. The Company believes the lawsuit to be without merit though it will rigorously defend the action. No amount has been accrued in relation to the consolidated&amp;#160;financial statements for the claim. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On March 3, 2017, a claim in connection with a proposed class-action lawsuit (the "Claim") was filed with the Supreme Court of Nova Scotia (the "Court") seeking to represent a class who purchased medical marijuana that was the subject of the Company's product recalls in December 2016 and January 2017 as it may have contained trace elements of the pesticides myclobutanil and bifenazate which are not approved for use by licensed producers. The Claim identifies several causes of action including, among others: (i) negligent design, development and testing, (ii) negligent manufacturing, (iii) negligent distribution, marketing and sale, (iv) breach of contract, and (v) breach of the Competition Act, the Consumer Protection Act, and the Sale of Goods Act, and is seeking remedy in the form of, among other things, the disgorgement of profits accrued to the Company for the sale of contaminated products, exemplary or punitive damages and certain costs. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Claim was amended on November 16, 2017, to include a claim for alleged adverse health consequences caused as a result of using the recalled product. As at the date hereof, the Company has not received any medical information demonstrating adverse health effects caused as a result of using the recalled product.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The amended Claim also contained a request for an order certifying the proceeding as a class proceeding.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;During late June 2018, certification hearings were heard before the Court. On January 18, 2019, the Court issued its decision granting certification. On March 4, 2019, the Company filed a notice for leave to appeal the certification of the class action brought against it. Leave to appeal was granted and the appeal was heard on October 15, 2019 and the decision was reserved.&amp;#160; On April 30, 2020, the Nova Scotia Court of Appeal ruled that the plaintiff failed to present any evidence that the cannabis purchased by medical customers in 2016 could cause any particular adverse health effects.&amp;#160; As a result, class members would not be able to bring claims for damages for adverse health effects in the class proceeding.&amp;#160; On June 26, 2020, the plaintiff filed an application for leave to appeal the Nova Scotia Court of Appeal's decision with the Supreme Court of Canada.&amp;#160; On November 5, 2020, the application for leave to appeal was dismissed by the Supreme Court of Canada.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The Company is contesting what remains of the litigation. The Company reported the Claim to its insurance provider which appointed counsel to defend the Claim. Insurance may be available to cover all or a portion of the fees or damages which may be associated with the Claim although the Company's coverage may be subject to varying limits and exclusions. The litigation process will continue into the foreseeable future unless settled out of court. No amount has been recorded in the&amp;#160;consolidated&amp;#160;financial statements as the Company has not yet determined a reasonable estimate of the cost to resolve this class action.&amp;#160; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On June 16, 2020, a claim in connection with a proposed national consumer protection class-action lawsuit was filed with the Court of Queen's Bench in Alberta (the "Alberta Claim") seeking damages against several Canadian cannabis companies including the Company.&amp;#160; The Alberta Claim does not particularize all of the claims against the companies however it makes allegations with respect to the content of THC and CBD in the companies' products. The proposed action is not certified.&amp;#160; The Company has reported the Alberta Claim to its insurers.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfContingentLiabilitiesExplanatory>
  <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="C_20190901to20200831" id="F6b86f0b0-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;23. INCOME TAXES&lt;/span&gt;&lt;span style="color:#86b4cd"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;There are no current income taxes payable or recoverable for the years ended August 31, 2020 and 2019.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Components of deferred income tax expense are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Origination and reversal of temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37,875&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,987&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in tax rate and rate differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;421&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;281&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in unrecognized temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27,245&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,349&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prior period adjustments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(262&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total income tax (recovery) expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,629&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A reconciliation of income tax expense at the statutory rate to amounts recorded in the consolidated financial statements is provided below.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(146,628&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,875&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statutory income tax rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29.0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29.0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax calculated at statutory rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(42,522&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,704&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible (non-taxable) items&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,643&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,742&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Difference between current and future tax rates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;421&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;281&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefit of deductible temporary differences not recognized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27,245&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,349&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of tax rates in other jurisdictions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,016&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(274&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(39&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax (recovery) expense per financial statements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,629&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognized deferred tax assets and liabilities consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred tax assets are attributable to the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6,670&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;7,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Set-off of tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(7,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Net deferred tax asset&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred tax liabilities are attributable to the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Long-term assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(4,983&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(170&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(5,367&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(15,200&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Right-of-use lease assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,096&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(114&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,179&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Set-off of tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net deferred tax liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The changes in temporary differences during the years ended August 31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;NET BALANCE AT&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;RECOGNIZED IN&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;PROFIT OR LOSS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;RECOGNIZED&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;DIRECTLY IN&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;EQUITY &amp;amp; OCI&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;NET BALANCE AT&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,039&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,669&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PP&amp;amp;E&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,983&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;791&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(170&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,200&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,833&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,367&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-use lease assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,096&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,096&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(78&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(113&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Net tax assets (liabilities)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;NET BALANCE AT&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;RECOGNIZED IN&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;PROFIT OR LOSS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;RECOGNIZED&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;DIRECTLY IN&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;EQUITY &amp;amp; OCI&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;NET BALANCE AT&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8,604&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,723&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(619&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,657&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,657&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PP&amp;amp;E&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,275&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,983&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,346&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,385&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,815&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,200&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unsecured convertible debentures&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,306&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(108&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,414&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(67&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net tax assets (liabilities)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,980&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,629&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,138&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At August 31, 2020, the Company has non-capital loss carryforwards available to offset future taxable income in Canada, which expire as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;width:1.02326%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;width:12%;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2035&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,070&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2037&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,727&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,296&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2039&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,746&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2040&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81,205&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,044&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes tax benefits on losses or other deductible amounts where the probable criteria for the recognition of deferred tax assets has been met. &amp;#160;The Company's unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:center;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:center;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:center;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:center;background-color:rgb(166, 164, 164);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:center;background-color:rgb(166, 164, 164);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:rgb(166, 164, 164)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deductible temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,348&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,010&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Tax losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;102,183&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,809&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;119,531&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,819&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
  <ifrs-full:DisclosureOfDeferredIncomeExplanatory contextRef="C_20190901to20200831" id="F6be2cc50-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Origination and reversal of temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37,875&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,987&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in tax rate and rate differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;421&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;281&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in unrecognized temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27,245&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,349&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prior period adjustments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(262&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total income tax (recovery) expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,629&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDeferredIncomeExplanatory>
  <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124184411028" unitRef="CAD">-37875000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
  <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124151827318" unitRef="CAD">1987000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
  <ifrs-full:TaxEffectFromChangeInTaxRate contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910121725750" unitRef="CAD">421000</ifrs-full:TaxEffectFromChangeInTaxRate>
  <ifrs-full:TaxEffectFromChangeInTaxRate contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124151920495" unitRef="CAD">281000</ifrs-full:TaxEffectFromChangeInTaxRate>
  <ogi:ChangeInUnrecognizedTemporaryDifferences contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910121800201" unitRef="CAD">27245000</ogi:ChangeInUnrecognizedTemporaryDifferences>
  <ogi:ChangeInUnrecognizedTemporaryDifferences contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124151952307" unitRef="CAD">1349000</ogi:ChangeInUnrecognizedTemporaryDifferences>
  <ifrs-full:AdjustmentsForDeferredTaxOfPriorPeriods contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910121827103" unitRef="CAD">-262000</ifrs-full:AdjustmentsForDeferredTaxOfPriorPeriods>
  <ifrs-full:AdjustmentsForDeferredTaxOfPriorPeriods contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124152030984" unitRef="CAD">12000</ifrs-full:AdjustmentsForDeferredTaxOfPriorPeriods>
  <ogi:DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200917124147386">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(146,628&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,875&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statutory income tax rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29.0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29.0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax calculated at statutory rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(42,522&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,704&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible (non-taxable) items&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,643&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,742&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Difference between current and future tax rates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;421&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;281&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefit of deductible temporary differences not recognized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27,245&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,349&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of tax rates in other jurisdictions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,016&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(274&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(39&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax (recovery) expense per financial statements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,629&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory>
  <ifrs-full:ApplicableTaxRate contextRef="C_20190901to20200831" decimals="3" id="Fxbrl_20201124151028077" unitRef="pure">0.290</ifrs-full:ApplicableTaxRate>
  <ifrs-full:ApplicableTaxRate contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="3" id="Fxbrl_20201124151034301" unitRef="pure">0.290</ifrs-full:ApplicableTaxRate>
  <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910125008590" unitRef="CAD">-42522000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
  <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910125052992" unitRef="CAD">-1704000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
  <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910125114888" unitRef="CAD">2643000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910125120129" unitRef="CAD">3742000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <ogi:DifferenceBetweenCurrentAndFutureTaxRates contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124191514666" unitRef="CAD">421000</ogi:DifferenceBetweenCurrentAndFutureTaxRates>
  <ogi:DifferenceBetweenCurrentAndFutureTaxRates contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124191521039" unitRef="CAD">281000</ogi:DifferenceBetweenCurrentAndFutureTaxRates>
  <ogi:IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124191610675" unitRef="CAD">27245000</ogi:IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized>
  <ogi:IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124191617221" unitRef="CAD">1349000</ogi:IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized>
  <ifrs-full:TaxEffectOfForeignTaxRates contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124160542973" unitRef="CAD">2016000</ifrs-full:TaxEffectOfForeignTaxRates>
  <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910125231206" unitRef="CAD">-274000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
  <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910125238616" unitRef="CAD">-39000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
  <ifrs-full:DisclosureOfDeferredTaxesExplanatory contextRef="C_20190901to20200831" id="F6be38fa0-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred tax assets are attributable to the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6,670&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;7,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Set-off of tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(7,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Net deferred tax asset&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred tax liabilities are attributable to the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Long-term assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(4,983&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(170&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(5,367&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(15,200&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Right-of-use lease assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,096&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(114&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,179&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Set-off of tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net deferred tax liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
  <ifrs-full:DeferredTaxAssets contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullAllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20200910125709098" unitRef="CAD">6670000</ifrs-full:DeferredTaxAssets>
  <ifrs-full:DeferredTaxAssets contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_AllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20201124164516892" unitRef="CAD">10708000</ifrs-full:DeferredTaxAssets>
  <ifrs-full:DeferredTaxAssets contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullLeaseLiabilitiesMember" decimals="-3" id="Fxbrl_20201124155011480" unitRef="CAD">1038000</ifrs-full:DeferredTaxAssets>
  <ifrs-full:DeferredTaxAssets contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124184614878" unitRef="CAD">7708000</ifrs-full:DeferredTaxAssets>
  <ifrs-full:DeferredTaxAssets contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910125931793" unitRef="CAD">10708000</ifrs-full:DeferredTaxAssets>
  <ogi:SetOffOfDeferredTaxAssets contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124184719773" unitRef="CAD">-7708000</ogi:SetOffOfDeferredTaxAssets>
  <ogi:SetOffOfDeferredTaxAssets contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910130018577" unitRef="CAD">-10708000</ogi:SetOffOfDeferredTaxAssets>
  <ifrs-full:NetDeferredTaxAssets contextRef="C_20200831" decimals="-3" id="Fxbrl_20200910130034599" unitRef="CAD">0</ifrs-full:NetDeferredTaxAssets>
  <ifrs-full:NetDeferredTaxAssets contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910130045063" unitRef="CAD">0</ifrs-full:NetDeferredTaxAssets>
  <ifrs-full:DeferredTaxLiabilities contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiLongTermAssetsMember" decimals="-3" id="Fxbrl_20200910145825458" unitRef="CAD">961000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiLongTermAssetsMember" decimals="-3" id="Fxbrl_20200910145834382" unitRef="CAD">4983000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiBiologicalAssetMember" decimals="-3" id="Fxbrl_20200910145844969" unitRef="CAD">170000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_BiologicalAssetMember" decimals="-3" id="Fxbrl_20200910145900024" unitRef="CAD">961000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiInventoryMember" decimals="-3" id="Fxbrl_20200910150055827" unitRef="CAD">5367000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_InventoryMember" decimals="-3" id="Fxbrl_20200910150545067" unitRef="CAD">15200000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="Fxbrl_20201124160234433" unitRef="CAD">1096000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiOtherDeferredTaxLiabilitiesMember" decimals="-3" id="Fxbrl_20200910151327636" unitRef="CAD">114000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiOtherDeferredTaxLiabilitiesMember" decimals="-3" id="Fxbrl_20200910151338076" unitRef="CAD">35000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124184645175" unitRef="CAD">7708000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124185548242" unitRef="CAD">21179000</ifrs-full:DeferredTaxLiabilities>
  <ogi:SetOffOfDeferredTaxLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124184746672" unitRef="CAD">7708000</ogi:SetOffOfDeferredTaxLiabilities>
  <ogi:SetOffOfDeferredTaxLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910151451244" unitRef="CAD">10708000</ogi:SetOffOfDeferredTaxLiabilities>
  <ogi:DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory contextRef="C_20190901to20200831" id="F6be404d0-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;NET BALANCE AT&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;RECOGNIZED IN&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;PROFIT OR LOSS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;RECOGNIZED&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;DIRECTLY IN&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;EQUITY &amp;amp; OCI&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;NET BALANCE AT&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,039&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,669&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PP&amp;amp;E&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,983&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;791&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(170&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,200&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,833&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,367&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-use lease assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,096&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,096&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(78&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(113&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Net tax assets (liabilities)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;NET BALANCE AT&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;RECOGNIZED IN&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;PROFIT OR LOSS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;RECOGNIZED&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;DIRECTLY IN&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;EQUITY &amp;amp; OCI&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;NET BALANCE AT&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8,604&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,723&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(619&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,657&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,657&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PP&amp;amp;E&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,275&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,708&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,983&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,346&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,385&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,815&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,200&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unsecured convertible debentures&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,306&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(108&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,414&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(67&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net tax assets (liabilities)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,980&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,629&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,138&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,471&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_AllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20200910160035435" unitRef="CAD">-10708000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullAllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20200910160425840" unitRef="CAD">-6669000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ShareIssuanceCostsMember" decimals="-3" id="Fxbrl_20200910160042057" unitRef="CAD">0</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiShareIssuanceCostsMember" decimals="-3" id="Fxbrl_20200910160431384" unitRef="CAD">0</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember" decimals="-3" id="Fxbrl_20201125054656901" unitRef="CAD">4983000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember" decimals="-3" id="Fxbrl_20201125055345074" unitRef="CAD">961000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_BiologicalAssetMember" decimals="-3" id="Fxbrl_20200910160055410" unitRef="CAD">961000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiBiologicalAssetMember" decimals="-3" id="Fxbrl_20200910160436546" unitRef="CAD">170000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_InventoryMember" decimals="-3" id="Fxbrl_20200910160059988" unitRef="CAD">15200000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiInventoryMember" decimals="-3" id="Fxbrl_20200910160439048" unitRef="CAD">5367000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullLeaseLiabilitiesMember" decimals="-3" id="Fxbrl_20201124154313540_xbrl_20200910160059988" unitRef="CAD">0</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullLeaseLiabilitiesMember" decimals="-3" id="Fxbrl_20201124154313540_xbrl_20200910160439048" unitRef="CAD">-1038000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="Fxbrl_20201124154315859_xbrl_20200910160059988" unitRef="CAD">0</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="Fxbrl_20201124154315859_xbrl_20200910160439048" unitRef="CAD">1096000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_OtherTemporaryDifferencesMember" decimals="-3" id="Fxbrl_20201124194035787" unitRef="CAD">35000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherTemporaryDifferencesMember" decimals="-3" id="Fxbrl_20200910160444522" unitRef="CAD">113000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910160118554" unitRef="CAD">10471000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="C_20200831" decimals="-3" id="Fxbrl_20200910160446746" unitRef="CAD">0</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_AllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20200910160628474" unitRef="CAD">-8604000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ShareIssuanceCostsMember" decimals="-3" id="Fxbrl_20200910160911416" unitRef="CAD">-1657000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember" decimals="-3" id="Fxbrl_20201125055555443" unitRef="CAD">1275000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_BiologicalAssetMember" decimals="-3" id="Fxbrl_20200910160926834" unitRef="CAD">3307000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_InventoryMember" decimals="-3" id="Fxbrl_20200910160932345" unitRef="CAD">10385000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_UnsecuredConvertibleDebenturesMember" decimals="-3" id="Fxbrl_20200910160935865" unitRef="CAD">3306000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_UnsecuredConvertibleDebenturesMember" decimals="-3" id="Fxbrl_20200910160659393" unitRef="CAD">0</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31-Aug-2018T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_OtherTemporaryDifferencesMember" decimals="-3" id="Fxbrl_20200910160939298" unitRef="CAD">-32000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00" decimals="-3" id="Fxbrl_20200910160947601" unitRef="CAD">7980000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullAllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20200910160141072" unitRef="CAD">4039000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiShareIssuanceCostsMember" decimals="-3" id="Fxbrl_20200910160207645" unitRef="CAD">0</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember" decimals="-3" id="Fxbrl_20201125055134562" unitRef="CAD">-4022000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiBiologicalAssetMember" decimals="-3" id="Fxbrl_20200910160220858" unitRef="CAD">-791000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiInventoryMember" decimals="-3" id="Fxbrl_20200910160224235" unitRef="CAD">-9833000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullLeaseLiabilitiesMember" decimals="-3" id="Fxbrl_20201124154313540_xbrl_20200910160224235" unitRef="CAD">-1038000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="Fxbrl_20201124154315859_xbrl_20200910160224235" unitRef="CAD">1096000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherTemporaryDifferencesMember" decimals="-3" id="Fxbrl_20200910160246753" unitRef="CAD">78000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910160251681" unitRef="CAD">-10471000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_AllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20200910160807833" unitRef="CAD">-2723000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ShareIssuanceCostsMember" decimals="-3" id="Fxbrl_20200910160810746" unitRef="CAD">0</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember" decimals="-3" id="Fxbrl_20201125055612382" unitRef="CAD">3708000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_BiologicalAssetMember" decimals="-3" id="Fxbrl_20200910160829857" unitRef="CAD">-2346000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_InventoryMember" decimals="-3" id="Fxbrl_20200910160840738" unitRef="CAD">4815000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_UnsecuredConvertibleDebenturesMember" decimals="-3" id="Fxbrl_20200910160845786" unitRef="CAD">108000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_OtherTemporaryDifferencesMember" decimals="-3" id="Fxbrl_20200910160850217" unitRef="CAD">67000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910160852993" unitRef="CAD">3629000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullAllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20200910160315529" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiShareIssuanceCostsMember" decimals="-3" id="Fxbrl_20200910160319984" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember" decimals="-3" id="Fxbrl_20201125055313062" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiBiologicalAssetMember" decimals="-3" id="Fxbrl_20200910160329656" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiInventoryMember" decimals="-3" id="Fxbrl_20200910160334416" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullLeaseLiabilitiesMember" decimals="-3" id="Fxbrl_20201124154313540_xbrl_20200910160334416" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullRightofuseAssetsMember" decimals="-3" id="Fxbrl_20201124154315859_xbrl_20200910160334416" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherTemporaryDifferencesMember" decimals="-3" id="Fxbrl_20200910160345151" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20200910160348473" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_AllowanceForCreditLossesMember" decimals="-3" id="Fxbrl_20200910160728370" unitRef="CAD">619000</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ShareIssuanceCostsMember" decimals="-3" id="Fxbrl_20200910160731258" unitRef="CAD">1657000</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ogiPropertyPlantAndEquipmentsMember" decimals="-3" id="Fxbrl_20201125055619385" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_BiologicalAssetMember" decimals="-3" id="Fxbrl_20200910160736850" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_InventoryMember" decimals="-3" id="Fxbrl_20200910160741650" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_UnsecuredConvertibleDebenturesMember" decimals="-3" id="Fxbrl_20200910160744664" unitRef="CAD">-3414000</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="Context_12ME_01-Sep-2018T00_00_00_TO_31-Aug-2019T00_00_00_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_OtherTemporaryDifferencesMember" decimals="-3" id="Fxbrl_20200910164702899" unitRef="CAD">0</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910160747825" unitRef="CAD">-1138000</ogi:DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome>
  <ogi:DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory contextRef="C_20190901to20200831" id="F6be42be0-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;width:1.02326%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;width:12%;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2035&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,070&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2037&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,727&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,296&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2039&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,746&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 31, 2040&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81,205&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,044&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory>
  <ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome contextRef="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearOneMember" decimals="-3" id="Fxbrl_20201124191851481" unitRef="CAD">1070000</ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome>
  <ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome contextRef="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearTwoMember" decimals="-3" id="Fxbrl_20200910170149473" unitRef="CAD">11727000</ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome>
  <ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome contextRef="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearThreeMember" decimals="-3" id="Fxbrl_20200910170201202" unitRef="CAD">14296000</ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome>
  <ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome contextRef="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearFourMember" decimals="-3" id="Fxbrl_20200910170206776" unitRef="CAD">16746000</ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome>
  <ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome contextRef="C_20200831_ogiExpirationPeriodAxis_ogiExpirationPeriodYearFiveMember" decimals="-3" id="Fxbrl_20201124153356177" unitRef="CAD">81205000</ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome>
  <ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome contextRef="C_20200831" decimals="-3" id="Fxbrl_20200910170243627" unitRef="CAD">125044000</ogi:NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome>
  <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory contextRef="C_20190901to20200831" id="F6be42be1-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:center;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:center;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:center;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:center;background-color:rgb(166, 164, 164);white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:center;background-color:rgb(166, 164, 164);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:rgb(166, 164, 164)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deductible temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,348&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,010&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Tax losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;102,183&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,809&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;119,531&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,819&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
  <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20200831" decimals="-3" id="Fxbrl_20200910170709241" unitRef="CAD">17348000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
  <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124152427092" unitRef="CAD">12010000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
  <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised contextRef="C_20200831" decimals="-3" id="Fxbrl_20200910170724008" unitRef="CAD">102183000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
  <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124152433203" unitRef="CAD">3809000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
  <ogi:TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised contextRef="C_20200831" decimals="-3" id="Fxbrl_20200910170738095" unitRef="CAD">119531000</ogi:TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised>
  <ogi:TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124152440491" unitRef="CAD">15819000</ogi:TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised>
  <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="C_20190901to20200831" id="F6b86f0b1-f198-11ea-af0e-4f71386cf7c7">&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;21. OPERATING SEGMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;The Company previously operated in two operating segments - production and sale of cannabis and patient counselling, operating as Trauma Healing Centers, Incorporated ("THCI"). THCI was disposed of on October 16, 2018 (see Note 24). As a result, the Company currently operates in only one operating segment, the production and sale of cannabis. All assets for the production and sale of cannabis segment are domiciled within Canada and effectively all revenues are generated in Canada, except those revenues disclosed in Note 18.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
  <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory contextRef="C_20190901to20200831" id="F6b86f0b3-f198-11ea-af0e-4f71386cf7c7">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-style:initial;text-decoration-color:initial;color:#86b4cd"&gt;22. GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office and general&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,819&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,942&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wages and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,611&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,443&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,367&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,636&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,510&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;664&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,269&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Travel and accommodation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;456&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Utilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total general and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27,996&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,593&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
  <ogi:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124052649837">&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office and general&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,819&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,942&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wages and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,611&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,443&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,367&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,636&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,510&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;664&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,269&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Travel and accommodation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;456&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Utilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total general and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27,996&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,593&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory>
  <ifrs-full:GeneralAndAdministrativeExpense contextRef="C_20190901to20200831" decimals="-3" id="F8348_7942" unitRef="CAD">11819000</ifrs-full:GeneralAndAdministrativeExpense>
  <ifrs-full:GeneralAndAdministrativeExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F8352_1465" unitRef="CAD">7942000</ifrs-full:GeneralAndAdministrativeExpense>
  <ifrs-full:WagesAndSalaries contextRef="C_20190901to20200831" decimals="-3" id="F8366_4443" unitRef="CAD">7611000</ifrs-full:WagesAndSalaries>
  <ifrs-full:WagesAndSalaries contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F8370_2520" unitRef="CAD">4443000</ifrs-full:WagesAndSalaries>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="C_20190901to20200831" decimals="-3" id="F8375_664" unitRef="CAD">1510000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F8379_509" unitRef="CAD">664000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="C_20190901to20200831" decimals="-3" id="F8393_409" unitRef="CAD">1269000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20200910120147184" unitRef="CAD">409000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:TravelExpense contextRef="C_20190901to20200831" decimals="-3" id="F8384_456" unitRef="CAD">383000</ifrs-full:TravelExpense>
  <ifrs-full:TravelExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F8388_345" unitRef="CAD">456000</ifrs-full:TravelExpense>
  <ifrs-full:UtilitiesExpense contextRef="C_20190901to20200831" decimals="-3" id="F8402" unitRef="CAD">37000</ifrs-full:UtilitiesExpense>
  <ifrs-full:UtilitiesExpense contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="F8406" unitRef="CAD">43000</ifrs-full:UtilitiesExpense>
  <ogi:DisclosureOfLicensingAndEndorsementAgreementExplanatory contextRef="C_20190901to20200831" id="F6b86f0b4-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;24. LICENSING AGREEMENT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On October 4, 2016, the Company entered into a licensing agreement with Swear Net Inc. (the Trailer Park Boys Inc. "TPB") for an exclusive product and branding partnership superseded by a licensing agreement with TPB dated April 15, 2020 and terminated on September 14, 2020 subject to transitionary licensing provisions until April 30, 2021.&amp;#160;In exchange for services, the Company paid $100 in cash and issued 150,000 options at a strike price of $1.52 per share. The fee is being recognized over the life of the agreement of five years as services are delivered. For the year ended August 31, 2020, $22 (August 31, 2019 - $99) has been amortized to share-based compensation and $32 (August 31, 2019 - $32) has been amortized to selling and marketing expenses. At August 31, 2020, the Company has recorded the current portion of the cash payment and stock options fee of $57 (August 31, 2019 - $89) as a prepaid expense and the long-term portion of the fee of $2 (August 31, 2019 - $24) in deferred charges on the consolidated statements of financial position.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the agreement, the Company issued an additional 350,000 in options at a price of $1.52 which vest in accordance with certain conditions being met. As of August 31, 2020, these conditions have been met. For the year ended August 31, 2020, $51 has been expensed (August 31, 2019 - $51) to share-based compensation. At August 31, 2020, the Company has recorded the current portion of the stock options fee of $51 (August 31, 2019 - $51) as a prepaid expense and the long-term portion of the fee of $4 (August 31, 2019 - $55) in deferred charges on the consolidated statements of financial position.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfLicensingAndEndorsementAgreementExplanatory>
  <ifrs-full:PaymentsToSuppliersForGoodsAndServices contextRef="Context_Custom_01_Oct_2016T00_00_00_TO_04_Oct_2016T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember" decimals="-3" id="F8420_100" unitRef="CAD">100000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="Context_Custom_01_Oct_2016T00_00_00_TO_04_Oct_2016T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember" decimals="2" id="Fxbrl_20200910115004182" unitRef="CAD_per_Share">1.52</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190901to20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember" decimals="2" id="Fxbrl_20200910115419735" unitRef="CAD_per_Share">1.52</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ogi:AmortizedToShareBasedCompensation contextRef="C_20190901to20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember_ifrsfullBusinessCombinationsAxis_ogiSwearNetLimitedMember" decimals="-3" id="F8420_99" unitRef="CAD">22000</ogi:AmortizedToShareBasedCompensation>
  <ogi:AmortizedToShareBasedCompensation contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember" decimals="-3" id="F8420_120" unitRef="CAD">99000</ogi:AmortizedToShareBasedCompensation>
  <ogi:AmortizedToShareBasedCompensation contextRef="C_20190901to20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember" decimals="-3" id="Fxbrl_20200910115535110" unitRef="CAD">51000</ogi:AmortizedToShareBasedCompensation>
  <ogi:AmortizedToShareBasedCompensation contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember" decimals="-3" id="F8421_155" unitRef="CAD">51000</ogi:AmortizedToShareBasedCompensation>
  <ogi:AmortizedToSellingAndMarketingExpenses contextRef="C_20190901to20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember_ifrsfullBusinessCombinationsAxis_ogiSwearNetLimitedMember" decimals="-3" id="F8420_32" unitRef="CAD">32000</ogi:AmortizedToSellingAndMarketingExpenses>
  <ogi:AmortizedToSellingAndMarketingExpenses contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember" decimals="-3" id="Fxbrl_20200910120845916" unitRef="CAD">32000</ogi:AmortizedToSellingAndMarketingExpenses>
  <ogi:CashPaymentAndStockOptionsFeeCurrent contextRef="C_20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember_ifrsfullBusinessCombinationsAxis_ogiSwearNetLimitedMember" decimals="-3" id="F8420_89" unitRef="CAD">57000</ogi:CashPaymentAndStockOptionsFeeCurrent>
  <ogi:CashPaymentAndStockOptionsFeeCurrent contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember" decimals="-3" id="F8420_122" unitRef="CAD">89000</ogi:CashPaymentAndStockOptionsFeeCurrent>
  <ogi:CashPaymentAndStockOptionsFeeCurrent contextRef="C_20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember" decimals="-3" id="Fxbrl_20200910115631991" unitRef="CAD">51000</ogi:CashPaymentAndStockOptionsFeeCurrent>
  <ogi:CashPaymentAndStockOptionsFeeCurrent contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember" decimals="-3" id="Fxbrl_20200910115643255" unitRef="CAD">51000</ogi:CashPaymentAndStockOptionsFeeCurrent>
  <ogi:CashPaymentAndStockOptionFeeNoncurrent contextRef="C_20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember_ifrsfullBusinessCombinationsAxis_ogiSwearNetLimitedMember" decimals="-3" id="F8420_24" unitRef="CAD">2000</ogi:CashPaymentAndStockOptionFeeNoncurrent>
  <ogi:CashPaymentAndStockOptionFeeNoncurrent contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember_BusinessCombinationsAxis_SwearNetLimitedMember" decimals="-3" id="F8420_46" unitRef="CAD">24000</ogi:CashPaymentAndStockOptionFeeNoncurrent>
  <ogi:PrepaidExpenseAndLongTermPortionOfFeeCurrent contextRef="C_20200831_ogiTypeOfArrangementsAxis_ogiLicensingAndEndorsementAgreementMember" decimals="-3" id="Fxbrl_20200910115806633" unitRef="CAD">4000</ogi:PrepaidExpenseAndLongTermPortionOfFeeCurrent>
  <ogi:PrepaidExpenseAndLongTermPortionOfFeeCurrent contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00_TypeOfArrangementsAxis_LicensingAndEndorsementAgreementMember" decimals="-3" id="F8421_106" unitRef="CAD">55000</ogi:PrepaidExpenseAndLongTermPortionOfFeeCurrent>
  <ogi:DisclosureOfOperationsOfTraumaHealingCentersExplanatory contextRef="C_20190901to20200831" id="F6b86f0b5-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;26. OPERATIONS OF TRAUMA HEALING CENTERS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#000000"&gt;THCI previously offered a multi-disciplinary approach to post traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine. On October 16, 2018, the Company sold THCI to Harvest Medicine ("HMED"). HMED is a wholly owned subsidiary of VIVO Cannabis Inc. ("VIVO"). The transaction resulted in HMED acquiring 100% of the issued and outstanding shares of THCI from the Company. The total purchase price for the shares was $1,141 which was satisfied by the issuance of 864,678 common shares in the capital of VIVO at a share price of $1.32. This non-cash investing activity has been excluded from the statement of cash flows as it did not use or provide any cash. The derecognized assets and liabilities on October 16, 2018 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognized assets and liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accounts receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;880&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(70&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Net assets disposed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,141&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value of consideration received&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,141&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gain/(loss) on disposal&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#000000"&gt;During the fourth quarter of fiscal year 2018, management decided to divest the operations of THCI. Consequently, assets and liabilities allocable to THCI were classified as a disposal group. Revenue and expenses, gains and losses relating to the discontinuation of THCI have been eliminated from profit or loss from the Company's continuing operations and are shown as a single line item in the statements of income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Operating income (loss) of THCI and the loss from re-measurement of assets and liabilities classified as discontinued operations are summarized as follows up to the date of disposal (see below):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="color:#ffffff"&gt;FOR THE PERIOD&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="color:#ffffff"&gt;SEPTEMBER 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="color:#ffffff"&gt;TO OCTOBER 16, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Revenue&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160; &amp;#160;Sales&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;$&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;138&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160; &amp;#160;Cost of sales&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;54&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160; &amp;#160;Gross margin from discontinued operations&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;84&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Expenses&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160; &amp;#160;General and administrative&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;75&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Total expenses&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;75&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Investment income (expense)&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Income (loss) from operations&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;$&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;9&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Loss on remeasurement to fair value less costs to sell&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;(47&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Loss on discontinued operations&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;$&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;(38&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Cash flows generated by THCI for the reporting periods are summarized as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;FOR THE PERIOD&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;SEPTEMBER 1, 2018&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;TO OCTOBER 16,2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Operating activities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Investing activities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Cash used by discounted operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfOperationsOfTraumaHealingCentersExplanatory>
  <ogi:ProportionOfOwnershipInterestInSubsidiarySold contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="2" id="Fxbrl_20201124143638160" unitRef="pure">1</ogi:ProportionOfOwnershipInterestInSubsidiarySold>
  <ifrs-full:ConsiderationPaidReceived contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143701300" unitRef="CAD">-1141000</ifrs-full:ConsiderationPaidReceived>
  <ifrs-full:EquityInstrumentsHeld contextRef="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143739353" unitRef="CAD">864678000</ifrs-full:EquityInstrumentsHeld>
  <ogi:EquityInstrumentsHeldSharePrice contextRef="Context_As_Of_16-Oct-2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_VivoCannabisIncMember" decimals="2" id="Fxbrl_20201124143749682" unitRef="CAD_per_Share">1.32</ogi:EquityInstrumentsHeldSharePrice>
  <ogi:DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124143608720">&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognized assets and liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accounts receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;880&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(70&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Net assets disposed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,141&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value of consideration received&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,141&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gain/(loss) on disposal&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ogi:DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory>
  <ogi:DerecognizedAssetsAndLiabilitiesCash contextRef="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143511288_xbrl_20200910110811983" unitRef="CAD">96000</ogi:DerecognizedAssetsAndLiabilitiesCash>
  <ogi:DerecognizedAssetsAndLiabilitiesAccountsReceivable contextRef="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143511292_xbrl_20200910110823614" unitRef="CAD">140000</ogi:DerecognizedAssetsAndLiabilitiesAccountsReceivable>
  <ogi:DerecognizedAssetsAndLiabilitiesOtherCurrentAssets contextRef="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143511294_xbrl_20200910110835399" unitRef="CAD">9000</ogi:DerecognizedAssetsAndLiabilitiesOtherCurrentAssets>
  <ogi:DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment contextRef="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143511296_xbrl_20200910110858112" unitRef="CAD">86000</ogi:DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment>
  <ogi:DerecognizedAssetsAndLiabilitiesGoodwill contextRef="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143511299_xbrl_20200910110919192" unitRef="CAD">880000</ogi:DerecognizedAssetsAndLiabilitiesGoodwill>
  <ogi:DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables contextRef="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143511301_xbrl_20200910110934814" unitRef="CAD">70000</ogi:DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables>
  <ogi:DerecognizedAssetsAndLiabilitiesNetAssetsDisposed contextRef="Context_As_Of_16_Oct_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143511303_xbrl_20200910110952294" unitRef="CAD">1141000</ogi:DerecognizedAssetsAndLiabilitiesNetAssetsDisposed>
  <ifrs-full:GainsOnDisposalsOfInvestments contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124143511307_xbrl_20200910111027021" unitRef="CAD">0</ifrs-full:GainsOnDisposalsOfInvestments>
  <ogi:DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124174742758">&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="color:#ffffff"&gt;FOR THE PERIOD&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="color:#ffffff"&gt;SEPTEMBER 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="color:#ffffff"&gt;TO OCTOBER 16, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Revenue&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160; &amp;#160;Sales&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;$&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;138&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160; &amp;#160;Cost of sales&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;54&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160; &amp;#160;Gross margin from discontinued operations&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;84&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Expenses&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160; &amp;#160;General and administrative&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;75&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Total expenses&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;75&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Investment income (expense)&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Income (loss) from operations&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;$&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;9&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Loss on remeasurement to fair value less costs to sell&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;(47&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;Loss on discontinued operations&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa"&gt;$&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa"&gt;(38&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;</ogi:DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory>
  <ogi:GrossMarginFromDiscontinuedOperations contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659618_xbrl_20200910104702657" unitRef="CAD">84000</ogi:GrossMarginFromDiscontinuedOperations>
  <ogi:LossOnRemeasurementToFairValueLessCostsToSell contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20201124174659653_xbrl_20200910105037927" unitRef="CAD">-47000</ogi:LossOnRemeasurementToFairValueLessCostsToSell>
  <ogi:DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory contextRef="C_20190901to20200831" id="F6bf14b40-f198-11ea-af0e-4f71386cf7c7">&lt;div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:#ffffff"&gt;FOR THE PERIOD&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;SEPTEMBER 1, 2018&lt;/span&gt;&lt;br/&gt;&lt;span style="color:#ffffff"&gt;TO OCTOBER 16,2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Operating activities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Investing activities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Cash used by discounted operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ogi:DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20200910110225013" unitRef="CAD">0</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations contextRef="Context_Custom_01_Sep_2018T00_00_00_TO_16_Oct_2018T00_00_00_ContinuingAndDiscontinuedOperationsAxis_TraumaHealingCentersMember" decimals="-3" id="Fxbrl_20200910110251238" unitRef="CAD">-35000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations>
  <ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20200917024351244">&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;27. SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;i) Hyasynth Tranche 2 convertible debentures issuance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;On October 23, 2020, the Company advanced an additional $2,500 to Hyasynth by way of convertible debentures as a result of Hyasynth's achievement of the contractual production-related milestone for Tranche 2 of the convertible debentures.&amp;#160; This brings the Company's total face value of convertible debentures investment in Hyasynth to $7,500, which provides the Company with a potential ownership interest of up to 46.5% on a fully diluted basis as of October 23, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;ii) Unit offering&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;&lt;span style="color:#000000"&gt;On November 12, 2020 the Company closed an underwritten public offering of&amp;#160;&amp;#160;37,375,000 units of&amp;#160;the Company at a price of $1.85 per unit, including a full exercise of the over-allotment option, underwritten by a syndicate of underwriters led by Canaccord Genuity Corp.,&amp;#160;for total gross proceeds of $69,144.&amp;#160; Each unit is comprised of one Common Share of the Company and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a "Warrant").&amp;#160; Each Warrant will be exercisable to acquire one common share of the Company (a "Warrant Share") for a period of three years following the closing date of the Offering at an exercise price of $2.50 per Warrant Share, subject to adjustment in certain events.&amp;#160; The Company expects to use the net proceeds from the Offering to repay indebtedness and for working capital and other general corporate purposes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;iii) Credit facility amendment and restatement&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span&gt;&lt;span style="color:#86b4cd"&gt;&lt;span&gt;&lt;span style="color:#000000"&gt;On November 27, 2020, the Company further amended its Facilities pursuant to an amended and restated credit agreement ("Amendment and Restatement") with BMO to: (i) reduce the Term Loan amount from $115,000 to $60,000 based on a repayment of $55,000 to be made on December 1, 2020 of the outstanding Term Loan balance of $115,000; (ii) have repayments on the balance of the Term Loan commence on February 28, 2021 in an amount equal to $1,500 per quarter; (iii) reduce the Revolver commitment to $2,000 from up to $25,000; (iv) adjust the minimum quarterly EBITDA covenants to be maintained by the Company commencing on February 28, 2021 and continuing through to maturity, thereby removing this covenant for the fiscal period ended November 30, 2020 and eliminating the reversion of the financial covenants to that of the original structure on November 30, 2021; (v) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (vi) reduce the minimum unrestricted cash balance requirement to $20,000, which is already inclusive of the $8,000 restricted investment currently outstanding. &amp;#160;The interest rate margin will be fixed from November 27, 2020 through to maturity on May 31, 2021. &amp;#160;The Company incurred an amendment fee of $217 plus customary legal expenses in connection with the amendment and restatement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory>
  <ifrs-full:NotesAndDebenturesIssued contextRef="C_20201023_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_ogiEventsAfterReportingPeriodMember_ifrsfullSignificantInvestmentsInAssociatesAxis_ogiHyasynthBiologicalsIncMember" decimals="-3" id="Fxbrl_20201124142613610" unitRef="CAD">2500000</ifrs-full:NotesAndDebenturesIssued>
  <ifrs-full:DisclosureOfCostOfSalesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124134533657">&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;19. COST OF SALES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;Cost of sales is comprised of the cost of inventories sold during the period, shipping expenses, the production cost of late-stage biological assets that are disposed of, provisions and write-downs for inventory that does not pass the Company's quality assurance standards and obsolete products and packaging, and other production overhead. For the three months ended November 30, 2019, the Company determined that the classification of indirect production is more accurately reflected as and most comparable to industry peers as a component of cost of sales rather than a separate line in the statement of operations.&amp;#160; As a result, indirect production of $4,733 has been reclassified from indirect production to cost of sales for the year ended August 31, 2019 to conform to the current period presentation. This change in presentation has no impact on gross margin before fair value adjustments.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;During the year ended August 31, 2020, the Company recorded write-downs and provisions in relation to excess and obsolete inventories and biological assets as well as adjustments to net realizable value totaling $35,584 (August 31, 2019 - $4,733), which are detailed in Note 8.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;During the year ended August 31, 2020, the Company recorded charges of $6,095 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124161328542"&gt;nil&lt;/span&gt;) related to a reduced workforce due to COVID-19, which was comprised of $5,048 in plant culling, $1,047 mostly related to lump-sum payments paid to temporarily laid-off workers.&amp;#160; The Company also recorded $5,434 (August 31, 2019 - $&lt;span style="-sec-ix-hidden:Fxbrl_20201124161508719"&gt;nil&lt;/span&gt;) in charges for unabsorbed fixed overhead related to reduced production volumes.&lt;/span&gt;&lt;span style="color:#86b4cd"&gt;&amp;#160;&amp;#160;&lt;/span&gt;&lt;span style="color:#000000"&gt;These charges were expensed to cost of sales.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfCostOfSalesExplanatory>
  <ogi:IndirectProductionCostOfSale contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124184711758" unitRef="CAD">4733000</ogi:IndirectProductionCostOfSale>
  <ogi:InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161250161" unitRef="CAD">35584000</ogi:InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue>
  <ogi:InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue contextRef="Context_FYE_01_Sep_2018T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124161302219" unitRef="CAD">4733000</ogi:InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue>
  <ogi:ChargesRelatedToPlantCulling contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161416037" unitRef="CAD">5048000</ogi:ChargesRelatedToPlantCulling>
  <ogi:LumpSumPaymentsPaidToTemporarilyLaidOffWorkers contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124161435248" unitRef="CAD">1047000</ogi:LumpSumPaymentsPaidToTemporarilyLaidOffWorkers>
  <ifrs-full:DisclosureOfGovernmentGrantsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124151402950">&lt;div&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#86b4cd"&gt;25. GOVERNMENT SUBSIDIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"&gt;&lt;span style="color:#000000"&gt;On April 1, 2020, Department of Finance Canada announced the CEWS, which would subsidize 75% of employee wages, retroactive to March 15, 2020, to Canadian employers whose business had been affected by COVID-19 to enable them to re-hire workers previously laid off as a result of pandemic, help prevent further job losses, and to better position companies to resume normal operations following the crisis. Under this program, the Company applied for a wage subsidy of $7,883 for the period March 15, 2020 to August 29, 2020, which has been included as government subsidies in the statements of (loss) income and comprehensive (loss) income.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfGovernmentGrantsExplanatory>
  <ifrs-full:DisclosureOfOtherLiabilitiesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124164718428">&lt;div&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;13. OTHER LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&amp;#160;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The carrying value of other liabilities consists of:&lt;/span&gt;&lt;span style="color:#000000"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.95349%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent share consideration&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;231&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,117&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,617&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,848&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,117&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;(i) Contingent share consideration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify"&gt;In connection with the Company's investment in alpha-cannabis&amp;#xae; Pharma GmbH as described in Note 14, the Company has a commitment to deliver additional consideration of up to &amp;#x20ac;&lt;/span&gt;875&lt;span style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify"&gt; in the form of the Company's common shares contingent on the achievement of certain gross margin-based milestones. At August 31, 2020, the Company revalued the contingent liability and recorded a corresponding gain in the statement of operations of $&lt;/span&gt;886&lt;span style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify"&gt; for the year ended August 31, 2020 (August 31, 2019 - loss of $&lt;/span&gt;145&lt;span style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify"&gt;).&lt;/span&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#86b4cd"&gt;(ii) Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;In connection with the Company's adoption of IFRS 16 effective September 1, 2019, lease liabilities were recorded as described in Note 3.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On March 13, 2020, the Company entered into a lease amending agreement for its Toronto corporate office: i) extending the lease of its existing 5,007 square feet of office space (the "Existing Premises") originally expiring on August 31, 2020; and ii) leasing an additional 6,572 square feet of office space adjacent to the Existing Premises (the "Additional Premises"). The term of the lease for Existing Premises will be extended for a period of five years and two months commencing on September 1, 2020 and expiring on October 31, 2025.&amp;#160; As this amending lease agreement for the Existing Premises is effectively a modification to the original lease agreement, the Company has recognized the ROU asset and corresponding lease liability pertaining to the Existing Premises as of the effective date of the lease amending agreement, which was March 13, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On April 21, 2020, the Company, as sub-landlord, entered into a sublease agreement with a subtenant, pursuant to which the Company agreed to sublease 3,099 square feet of its Additional Premises noted above for a period of five years and two months commencing on September 1, 2020 and expiring on October 30, 2025 for a total of $251 per annum for an aggregate rental income of $1,296 over the term of the sublease. Under the currently contemplated terms, both parties have the mutual right to terminate the sublease upon six months' written notice to either party, which shall not occur prior to August 31, 2023. This sublease agreement has no impact on the amount of lease liabilities as it is a net investment in the sublease by the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;On July 16, 2020, the Company, as sublandlord, entered into a sublease agreement with a subtenant, pursuant to which the Company agreed to sublease 3,473 square feet of its rented premises for a period of five years and two months commencing on September 1, 2020 and expiring on October 30, 2025 for a total of $282 per annum for an aggregate rental income of $1,431 over the term of the sublease. Under the terms, the sub-landlord has a right to terminate the sublease upon six months' written notice to the subtenant, which shall not occur prior to April 30, 2021, whereas the subtenant have a right to terminate the sublease upon eight months' written notice to the sublandlord, which shall not occur prior to February 28, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The following is a continuity schedule of lease liabilities for the year ended August 31, 2020:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IFRS 16 transition&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,219&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,220&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(897&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest expense on lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;163&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,705&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current portion included in accounts payable and accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,088&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term portion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,617&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt; &lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;The undiscounted contractual payments relating to the current and future lease liabilities at August 31, 2020 is:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:60%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 1 year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,553&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1 to 2 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,049&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 to 3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,045&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3 to 4 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;998&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;768&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Thereafter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;606&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt; &lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#000000"&gt;Included in the undiscounted contractual payments relating to current and future lease liabilities above is the Additional Premises as noted above, the term of which will commences on September 1, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherLiabilitiesExplanatory>
  <ifrs-full:DisclosureOfOtherNoncurrentLiabilitiesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124164744227">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#ffffff"&gt;AUGUST 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align:center;vertical-align:bottom;width:1.95349%;background-color:#a6a4a4"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent share consideration&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;231&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,117&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,617&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.0465%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,848&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,117&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherNoncurrentLiabilitiesExplanatory>
  <ogi:ContingentShareConsideration contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124172851172" unitRef="CAD">231000</ogi:ContingentShareConsideration>
  <ogi:ContingentShareConsideration contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124172934500" unitRef="CAD">1117000</ogi:ContingentShareConsideration>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124221141305" unitRef="CAD">2617000</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="Context_As_Of_31_Aug_2019T00_00_00_TO_31_Aug_2019T00_00_00" decimals="-3" id="Fxbrl_20201124172943989" unitRef="CAD">0</ifrs-full:NoncurrentLeaseLiabilities>
  <ogi:SubleaseAnnualRentalIncome contextRef="C_20200401to20200421" decimals="-3" id="Fxbrl_20201124181821979" unitRef="CAD">251000</ogi:SubleaseAnnualRentalIncome>
  <ogi:SubleaseAnnualRentalIncome contextRef="C_20200701to20200716" decimals="-3" id="Fxbrl_20201124181901933" unitRef="CAD">282000</ogi:SubleaseAnnualRentalIncome>
  <ogi:RentalIncomeOverSubleaseTerm contextRef="C_20200401to20200421" decimals="-3" id="Fxbrl_20201124181839174" unitRef="CAD">1296000</ogi:RentalIncomeOverSubleaseTerm>
  <ogi:RentalIncomeOverSubleaseTerm contextRef="C_20200701to20200716" decimals="-3" id="Fxbrl_20201124181910440" unitRef="CAD">1431000</ogi:RentalIncomeOverSubleaseTerm>
  <ogi:DisclosureOfContinuityOfLeaseLiabilitiesExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124164801185">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IFRS 16 transition&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,219&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,220&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(897&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest expense on lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;163&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, August 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,705&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current portion included in accounts payable and accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,088&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term portion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,617&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ogi:DisclosureOfContinuityOfLeaseLiabilitiesExplanatory>
  <ogi:AdditionsToLeaseLiabilities contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124173810554" unitRef="CAD">2220000</ogi:AdditionsToLeaseLiabilities>
  <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="C_20190901to20200831" decimals="-3" id="Fxbrl_20201124173916786" unitRef="CAD">163000</ifrs-full:InterestExpenseOnLeaseLiabilities>
  <ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory contextRef="C_20190901to20200831" id="Fxbrl_20201124164813553">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:60%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 1 year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,553&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1 to 2 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,049&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 to 3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,045&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3 to 4 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;998&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;768&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Thereafter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;606&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory>
  <ogi:UndiscountedOperatingLeasePaymentsToBePaid contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" decimals="-3" id="Fxbrl_20201124174717037" unitRef="CAD">1553000</ogi:UndiscountedOperatingLeasePaymentsToBePaid>
  <ogi:UndiscountedOperatingLeasePaymentsToBePaid contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" decimals="-3" id="Fxbrl_20201124174720783" unitRef="CAD">1049000</ogi:UndiscountedOperatingLeasePaymentsToBePaid>
  <ogi:UndiscountedOperatingLeasePaymentsToBePaid contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanTwoYearsAndNotLaterThanThreeYearsMember" decimals="-3" id="Fxbrl_20201124174724710" unitRef="CAD">1045000</ogi:UndiscountedOperatingLeasePaymentsToBePaid>
  <ogi:UndiscountedOperatingLeasePaymentsToBePaid contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFourYearsMember" decimals="-3" id="Fxbrl_20201124174728245" unitRef="CAD">998000</ogi:UndiscountedOperatingLeasePaymentsToBePaid>
  <ogi:UndiscountedOperatingLeasePaymentsToBePaid contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanFourYearsAndNotLaterThanFiveYearsMember" decimals="-3" id="Fxbrl_20201124174731407" unitRef="CAD">768000</ogi:UndiscountedOperatingLeasePaymentsToBePaid>
  <ogi:UndiscountedOperatingLeasePaymentsToBePaid contextRef="C_20200831_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" decimals="-3" id="Fxbrl_20201124174734933" unitRef="CAD">606000</ogi:UndiscountedOperatingLeasePaymentsToBePaid>
  <ogi:UndiscountedOperatingLeasePaymentsToBePaid contextRef="C_20200831" decimals="-3" id="Fxbrl_20201124174707778" unitRef="CAD">6019000</ogi:UndiscountedOperatingLeasePaymentsToBePaid>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>ogi-20200831.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:ogi="http://www.organigram.ca/20200831" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" targetNamespace="http://www.organigram.ca/20200831" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd"/>
  <import namespace="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.organigram.ca/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfFinancialPosition" id="ConsolidatedStatementsOfFinancialPosition">
        <link:definition>0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome" id="ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome">
        <link:definition>0003 - Statement - CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfChangesInEquity" id="ConsolidatedStatementsOfChangesInEquity">
        <link:definition>0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals" id="CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals">
        <link:definition>0005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals" id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals">
        <link:definition>0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/NatureOfOperations" id="NatureOfOperations">
        <link:definition>0008 - Disclosure - NATURE OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/BasisOfPreparation" id="BasisOfPreparation">
        <link:definition>0009 - Disclosure - BASIS OF PREPARATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>0010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/ShortTermInvestments" id="ShortTermInvestments">
        <link:definition>0011 - Disclosure - SHORT TERM INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/AccountsReceivable" id="AccountsReceivable">
        <link:definition>0012 - Disclosure - ACCOUNTS RECEIVABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/LoanReceivable" id="LoanReceivable">
        <link:definition>0013 - Disclosure - LOAN RECEIVABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/BiologicalAssets" id="BiologicalAssets">
        <link:definition>0014 - Disclosure - BIOLOGICAL ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/Inventories" id="Inventories">
        <link:definition>0015 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/PropertyPlantAndEquipment" id="PropertyPlantAndEquipment">
        <link:definition>0016 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/IntangibleAssets" id="IntangibleAssets">
        <link:definition>0017 - Disclosure - INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/LongTermDebt" id="LongTermDebt">
        <link:definition>0018 - Disclosure - LONG-TERM DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/ShareCapital" id="ShareCapital">
        <link:definition>0019 - Disclosure - SHARE CAPITAL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OTHERLIABILITIES" id="OTHERLIABILITIES">
        <link:definition>0020 - Disclosure - OTHER LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/InvestmentsInAssociates" id="InvestmentsInAssociates">
        <link:definition>0021 - Disclosure - INVESTMENTS IN ASSOCIATES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>0022 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/CapitalManagement" id="CapitalManagement">
        <link:definition>0023 - Disclosure - CAPITAL MANAGEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/FairValueOfFinancialInstrumentsAndFinancialRiskFactors" id="FairValueOfFinancialInstrumentsAndFinancialRiskFactors">
        <link:definition>0024 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/Revenue" id="Revenue">
        <link:definition>0025 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/COSTOFSALES" id="COSTOFSALES">
        <link:definition>0026 - Disclosure - COST OF SALES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/Contingencies" id="Contingencies">
        <link:definition>0027 - Disclosure - CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SegmentedInformation" id="SegmentedInformation">
        <link:definition>0028 - Disclosure - OPERATING SEGMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/GeneralAndAdministrativeExpensesByNatureExcludingDiscontinuedOperations" id="GeneralAndAdministrativeExpensesByNatureExcludingDiscontinuedOperations">
        <link:definition>0029 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>0030 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/LicensingAndEndorsementAgreement" id="LicensingAndEndorsementAgreement">
        <link:definition>0031 - Disclosure - LICENSING AGREEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/GOVERNMENTSUBSIDIES" id="GOVERNMENTSUBSIDIES">
        <link:definition>0032 - Disclosure - GOVERNMENT SUBSIDIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OperationsOfTraumaHealingCenters" id="OperationsOfTraumaHealingCenters">
        <link:definition>0033 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/IndirectProduction" id="IndirectProduction">
        <link:definition>0034 - Disclosure - INDIRECT PRODUCTION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SUBSEQUENTEVENTS" id="SUBSEQUENTEVENTS">
        <link:definition>0035 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" id="SIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESTables" id="SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SHORTTERMINVESTMENTSTables" id="SHORTTERMINVESTMENTSTables">
        <link:definition>0038 - Disclosure - SHORT TERM INVESTMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/ACCOUNTSRECEIVABLETables" id="ACCOUNTSRECEIVABLETables">
        <link:definition>0039 - Disclosure - ACCOUNTS RECEIVABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/BIOLOGICALASSETSTables" id="BIOLOGICALASSETSTables">
        <link:definition>0040 - Disclosure - BIOLOGICAL ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/INVENTORIESTables" id="INVENTORIESTables">
        <link:definition>0041 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTTables" id="PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>0042 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/INTANGIBLEASSETSTables" id="INTANGIBLEASSETSTables">
        <link:definition>0043 - Disclosure - INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/LONGTERMDEBTTables" id="LONGTERMDEBTTables">
        <link:definition>0044 - Disclosure - Long-term debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SHARECAPITALTables" id="SHARECAPITALTables">
        <link:definition>0045 - Disclosure - SHARE CAPITAL (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OTHERLIABILITIESTables" id="OTHERLIABILITIESTables">
        <link:definition>0046 - Disclosure - OTHER LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/INVESTMENTSINASSOCIATESTables" id="INVESTMENTSINASSOCIATESTables">
        <link:definition>0047 - Disclosure - INVESTMENTS IN ASSOCIATES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSTables" id="RELATEDPARTYTRANSACTIONSTables">
        <link:definition>0048 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSTables" id="FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSTables">
        <link:definition>0049 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/REVENUETables" id="REVENUETables">
        <link:definition>0050 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/GENERALANDADMINISTRATIVEEXPENSESBYNATUREexcludingdiscontinuedoperationsTables" id="GENERALANDADMINISTRATIVEEXPENSESBYNATUREexcludingdiscontinuedoperationsTables">
        <link:definition>0051 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/INCOMETAXESTables" id="INCOMETAXESTables">
        <link:definition>0052 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSTables" id="OPERATIONSOFTRAUMAHEALINGCENTERSTables">
        <link:definition>0053 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail" id="SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail">
        <link:definition>0054 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails" id="DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails">
        <link:definition>0055 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about estimated useful lives of property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail" id="DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail">
        <link:definition>0056 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES  - Disclosure of detailed information about reconciliation of operating leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails" id="DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails">
        <link:definition>0057 - Disclosure - SHORT TERM INVESTMENTS - Disclosure of detailed information about short term investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/AccountsReceivableNarrativeDetails" id="AccountsReceivableNarrativeDetails">
        <link:definition>0058 - Disclosure - ACCOUNTS RECEIVABLE (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAccountsReceivableDetails" id="DisclosureOfDetailedInformationAboutAccountsReceivableDetails">
        <link:definition>0059 - Disclosure - ACCOUNTS RECEIVABLE - Disclosure of detailed information about accounts receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/LoanReceivableNarrativeDetails" id="LoanReceivableNarrativeDetails">
        <link:definition>0060 - Disclosure - LOAN RECEIVABLE (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/BiologicalAssetsNarrativeDetails" id="BiologicalAssetsNarrativeDetails">
        <link:definition>0061 - Disclosure - BIOLOGICAL ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails" id="DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails">
        <link:definition>0062 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about changes in carrying value of biological assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueDetails" id="DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueDetails">
        <link:definition>0063 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about unobservable inputs and their impact on fair value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails" id="DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails">
        <link:definition>0064 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about fair value adjustment to biological assets and inventory sold (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/InventoriesNarrativeDetails" id="InventoriesNarrativeDetails">
        <link:definition>0065 - Disclosure - INVENTORIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutInventoriesDetails" id="DisclosureOfDetailedInformationAboutInventoriesDetails">
        <link:definition>0066 - Disclosure - INVENTORIES - Disclosure of detailed information about inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails" id="PROPERTYPLANTANDEQUIPMENTNarrativeDetails">
        <link:definition>0067 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" id="DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails">
        <link:definition>0068 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Disclosure of detailed information about property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAdditionsOfPropertyPlantAndEquipmentDetails" id="DisclosureOfDetailedInformationAboutAdditionsOfPropertyPlantAndEquipmentDetails">
        <link:definition>0069 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Disclosure of detailed information about additions of property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/IntangibleAssetsNarrativeDetails" id="IntangibleAssetsNarrativeDetails">
        <link:definition>0070 - Disclosure - INTANGIBLE ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutIntangibleAssetsDetails" id="DisclosureOfDetailedInformationAboutIntangibleAssetsDetails">
        <link:definition>0071 - Disclosure - INTANGIBLE ASSETS - Disclosure of detailed information about intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/LongTermDebtNarrativeDetails" id="LongTermDebtNarrativeDetails">
        <link:definition>0072 - Disclosure - LONG-TERM DEBT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfLongTermDebtDetails" id="DisclosureOfLongTermDebtDetails">
        <link:definition>0073 - Disclosure - LONG-TERM DEBT - Disclosure of long term debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfLongTermDebtParentheticalsDetails" id="DisclosureOfLongTermDebtParentheticalsDetails">
        <link:definition>0074 - Disclosure - LONG-TERM DEBT - Disclosure of long term debt (Parentheticals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails" id="DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails">
        <link:definition>0075 - Disclosure - LONG-TERM DEBT - Disclosure of principal repayments required on long-term debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SHARECAPITALDetails8" id="SHARECAPITALDetails8">
        <link:definition>0076 - Disclosure - SHARE CAPITAL (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsDetails" id="DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsDetails">
        <link:definition>0077 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about warrants, valuation assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" id="DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails">
        <link:definition>0078 - Disclosure - SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails" id="DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails">
        <link:definition>0079 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about outstanding stock options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails" id="DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails">
        <link:definition>0080 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about options, valuation assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingRsusDetails" id="DisclosureOfDetailedInformationAboutOutstandingRsusDetails">
        <link:definition>0081 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about outstanding RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SHARECAPITALPerformanceShareUnits" id="SHARECAPITALPerformanceShareUnits">
        <link:definition>0082 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about outstanding PSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutLossPerShareDetails" id="DisclosureOfDetailedInformationAboutLossPerShareDetails">
        <link:definition>0083 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails" id="DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails">
        <link:definition>0084 - Disclosure - SHARE CAPITAL - Disclosure of anti-dilutive securities excluded from computation of diluted earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetailTextuals" id="OTHERLIABILITIESDetailTextuals">
        <link:definition>0085 - Disclosure - OTHER LIABILITIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails" id="OTHERLIABILITIESDetails">
        <link:definition>0086 - Disclosure - OTHER LIABILITIES - Disclosure of detailed information about carrying value of other liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails1" id="OTHERLIABILITIESDetails1">
        <link:definition>0087 - Disclosure - OTHER LIABILITIES - Disclosure of detailed information about lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails2" id="OTHERLIABILITIESDetails2">
        <link:definition>0088 - Disclosure - OTHER LIABILITIES - Disclosure of detailed information about undiscounted contractual payments relating to current and future lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/InvestmentsInAssociatesNarrativeDetails" id="InvestmentsInAssociatesNarrativeDetails">
        <link:definition>0089 - Disclosure - INVESTMENTS IN ASSOCIATES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails" id="DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails">
        <link:definition>0090 - Disclosure - INVESTMENTS IN ASSOCIATES - Disclosure of detailed information about carrying value of investments in associates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSDetails1" id="RELATEDPARTYTRANSACTIONSDetails1">
        <link:definition>0091 - Disclosure - RELATED PARTY TRANSACTIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails" id="DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails">
        <link:definition>0092 - Disclosure - RELATED PARTY TRANSACTIONS - Disclosure of detailed information about management and board compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/CAPITALMANAGEMENTDetails" id="CAPITALMANAGEMENTDetails">
        <link:definition>0093 - Disclosure - CAPITAL MANAGEMENT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSDetails2" id="FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSDetails2">
        <link:definition>0094 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails" id="DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails">
        <link:definition>0095 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Disclosure of detailed information about aging of trade receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails" id="DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails">
        <link:definition>0096 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Disclosure of detailed information about contractual maturities relating to their undiscounted cash flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/RevenueNarrativeDetails" id="RevenueNarrativeDetails">
        <link:definition>0097 - Disclosure - REVENUE (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRevenuesDetails" id="DisclosureOfDetailedInformationAboutRevenuesDetails">
        <link:definition>0098 - Disclosure - REVENUE - Disclosure of detailed information about revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/COSTOFSALESDetailTextuals" id="COSTOFSALESDetailTextuals">
        <link:definition>0099 - Disclosure - COST OF SALES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails" id="DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails">
        <link:definition>0100 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) - Disclosure of detailed information about general and administrative expenses by nature (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutComponentsOfDeferredIncomeTaxExpenseDetails" id="DisclosureOfDetailedInformationAboutComponentsOfDeferredIncomeTaxExpenseDetails">
        <link:definition>0101 - Disclosure - INCOME TAXES - Disclosure of detailed information about components of deferred income tax expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails" id="DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails">
        <link:definition>0102 - Disclosure - INCOME TAXES - Disclosure of detailed information about reconciliation of income tax expense at the statutory rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails" id="DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>0103 - Disclosure - INCOME TAXES - Disclosure of detailed information about recognized deferred tax assets and liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails" id="DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails">
        <link:definition>0104 - Disclosure - INCOME TAXES - Disclosure of detailed information about changes in temporary differences (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails" id="DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails">
        <link:definition>0105 - Disclosure - INCOME TAXES - Disclosure of detailed information about non-capital loss carryforwards available to offset future taxable income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails" id="DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails">
        <link:definition>0106 - Disclosure - INCOME TAXES - Disclosure of detailed information about unrecognized deductible temporary differences and unused tax losses for no deferred tax asset recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/LicensingAndEndorsementAgreementNarrativeDetails" id="LicensingAndEndorsementAgreementNarrativeDetails">
        <link:definition>0107 - Disclosure - LICENSING AGREEMENT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/GOVERNMENTSUBSIDIESDetailTextuals" id="GOVERNMENTSUBSIDIESDetailTextuals">
        <link:definition>0108 - Disclosure - GOVERNMENT SUBSIDIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSDetails4" id="OPERATIONSOFTRAUMAHEALINGCENTERSDetails4">
        <link:definition>0109 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDerecognizedAssetsAndLiabilitiesDetails" id="DisclosureOfDerecognizedAssetsAndLiabilitiesDetails">
        <link:definition>0110 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of derecognized assets and liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" id="DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails">
        <link:definition>0111 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of detailed information about Operating income (loss) of THCI and loss from remeasurement of assets and liabilities classified as held for sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails" id="DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails">
        <link:definition>0112 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of Cash flows generated by THCI for reporting periods (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.organigram.ca/role/SubsequentEventsNarrativeDetails" id="SubsequentEventsNarrativeDetails">
        <link:definition>0113 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ogi-20200831_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ogi-20200831_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ogi-20200831_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ogi-20200831_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction" id="ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AccountsReceivableAbstract" id="ogi_AccountsReceivableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AchievementOfContractualProductionRelatedMilestoneMember" id="ogi_AchievementOfContractualProductionRelatedMilestoneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" id="ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdditionsOfInvestmentInAssociates" id="ogi_AdditionsOfInvestmentInAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionsRelatedToIFRS16Leases" id="ogi_AdditionsRelatedToIFRS16Leases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionsToLeaseLiabilities" id="ogi_AdditionsToLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentOnAdoptionOfIFRS16Member" id="ogi_AdjustmentOnAdoptionOfIFRS16Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges" id="ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration" id="ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration" id="ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentToNetRealizableValueBiologicalAssets" id="ogi_AdjustmentToNetRealizableValueBiologicalAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdultUseRecreationalWholesaleRevenueMember" id="ogi_AdultUseRecreationalWholesaleRevenueMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdvanceGivenAsConvertibleDebentures" id="ogi_AdvanceGivenAsConvertibleDebentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdvancePayment" id="ogi_AdvancePayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdvisoryServicesAgreementMember" id="ogi_AdvisoryServicesAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths" id="ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel" id="ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement" id="ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateNumberOfCommonSharesConverted" id="ogi_AggregateNumberOfCommonSharesConverted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AllocationToReserveForOptionsAndWarrantsForDebentureDiscount" id="ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AlphaCannabisPharmaGmbhMember" id="ogi_AlphaCannabisPharmaGmbhMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmendmentAndRestatementMember" id="ogi_AmendmentAndRestatementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmendmentFee" id="ogi_AmendmentFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmortizationOfDebentureDiscount" id="ogi_AmortizationOfDebentureDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmortizationOfIssueCosts" id="ogi_AmortizationOfIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmortizedToSellingAndMarketingExpenses" id="ogi_AmortizedToSellingAndMarketingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmortizedToShareBasedCompensation" id="ogi_AmortizedToShareBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy" id="ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy" id="ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AntidilutiveSecuritiesAxis" id="ogi_AntidilutiveSecuritiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="AntidilutiveSecuritiesDomain" id="ogi_AntidilutiveSecuritiesDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare" id="ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ApplicableMarginRate" id="ogi_ApplicableMarginRate" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AprilTwoThousandTwentyAtMarketEquityProgramMember" id="ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" id="ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageSellingPriceInputValuesPerGram" id="ogi_AverageSellingPriceInputValuesPerGram" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageYieldPerPlantInputValuesPerGram" id="ogi_AverageYieldPerPlantInputValuesPerGram" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BalanceSheetLocationsDomain" id="ogi_BalanceSheetLocationsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" id="ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasisOfPreparationAbstract" id="ogi_BasisOfPreparationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiologicalAssetMember" id="ogi_BiologicalAssetMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BmoCreditFacilityMember" id="ogi_BmoCreditFacilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BmoTermLoanCreditFacilityMember" id="ogi_BmoTermLoanCreditFacilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingsCashInterestRate" id="ogi_BorrowingsCashInterestRate" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingsEffectiveInterestRate" id="ogi_BorrowingsEffectiveInterestRate" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingsPrincipalPaymentAmortizationRatePerQuarter" id="ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingsReducedCashInterestRate" id="ogi_BorrowingsReducedCashInterestRate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingsReducedEffectiveInterestRate" id="ogi_BorrowingsReducedEffectiveInterestRate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingsYearAmortization" id="ogi_BorrowingsYearAmortization" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BottledAndPackagedOil" id="ogi_BottledAndPackagedOil" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BottledAndPackagedOilMember" id="ogi_BottledAndPackagedOilMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BulkFormulatedOil" id="ogi_BulkFormulatedOil" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BulkFormulatedOilMember" id="ogi_BulkFormulatedOilMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CannabisConsultantMember" id="ogi_CannabisConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CapitalConsideration" id="ogi_CapitalConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CapitalizedTransactionCostsAndEquityDiscount" id="ogi_CapitalizedTransactionCostsAndEquityDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CapitalManagementAbstract" id="ogi_CapitalManagementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CashCollateral" id="ogi_CashCollateral" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashPaymentAndStockOptionFeeNoncurrent" id="ogi_CashPaymentAndStockOptionFeeNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashPaymentAndStockOptionsFeeCurrent" id="ogi_CashPaymentAndStockOptionsFeeCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashPositionAbstract" id="ogi_CashPositionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment" id="ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ChangeInBenchmarkInterestRates" id="ogi_ChangeInBenchmarkInterestRates" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInUnrecognizedTemporaryDifferences" id="ogi_ChangeInUnrecognizedTemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ChargesForUnabsorbedFixedOverhead" id="ogi_ChargesForUnabsorbedFixedOverhead" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ChargesRelatedToPlantCulling" id="ogi_ChargesRelatedToPlantCulling" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ChargesRelatedToReducedWorkforce" id="ogi_ChargesRelatedToReducedWorkforce" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months" id="ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months" id="ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones" id="ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CommittedAndUncommittedBorrowingFacilities" id="ogi_CommittedAndUncommittedBorrowingFacilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CommittedBorrowingFacilities" id="ogi_CommittedBorrowingFacilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConcentratedExtractMember" id="ogi_ConcentratedExtractMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContingenciesAbstract" id="ogi_ContingenciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContingentShareConsideration" id="ogi_ContingentShareConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ContractualCashFlowsMember" id="ogi_ContractualCashFlowsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContractuallyCommittedFutureCosts" id="ogi_ContractuallyCommittedFutureCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConversionOfConvertibleDebenturesAmountConverted" id="ogi_ConversionOfConvertibleDebenturesAmountConverted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConversionOfConvertibleDebenturesSharesIssued" id="ogi_ConversionOfConvertibleDebenturesSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConversionOfDebenturesDescription" id="ogi_ConversionOfDebenturesDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConversionOfDebenturesPricePerShare" id="ogi_ConversionOfDebenturesPricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleDebentureIssueCosts" id="ogi_ConvertibleDebentureIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConvertibleDebentureIssueCostsChargedToDebentureLiability" id="ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConvertibleDebenturesChangeInControlPercentage" id="ogi_ConvertibleDebenturesChangeInControlPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleDebenturesConversionPrice" id="ogi_ConvertibleDebenturesConversionPrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleDebenturesEffectiveAnnualizedDiscountRate" id="ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleDebenturesEffectiveInterestRate" id="ogi_ConvertibleDebenturesEffectiveInterestRate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleDebenturesFaceValue" id="ogi_ConvertibleDebenturesFaceValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConvertibleDebenturesMember" id="ogi_ConvertibleDebenturesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleDebenturesReceivableFaceValue" id="ogi_ConvertibleDebenturesReceivableFaceValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion" id="ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts" id="ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CreditFacilitiesAxis" id="ogi_CreditFacilitiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="CreditFacilitiesDomain" id="ogi_CreditFacilitiesDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditFacilityAmendmentAxis" id="ogi_CreditFacilityAmendmentAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="CreditFacilityAmendmentDomain" id="ogi_CreditFacilityAmendmentDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CumulativeConvertedDebentures" id="ogi_CumulativeConvertedDebentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" id="ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DebtIssueRelatedCost" id="ogi_DebtIssueRelatedCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DebtIssueRelatedCostAllocatedToEquity" id="ogi_DebtIssueRelatedCostAllocatedToEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DebtIssuesCost" id="ogi_DebtIssuesCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DecemberTwoThousandNineteenAtMarketEquityProgramMember" id="ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredFinancingCosts" id="ogi_DeferredFinancingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxLiabilityAbstract" id="ogi_DeferredTaxLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxOnConvertibleDebentureFinancing" id="ogi_DeferredTaxOnConvertibleDebentureFinancing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome" id="ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DerecognizedAssetsAndLiabilitiesAccountsReceivable" id="ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerecognizedAssetsAndLiabilitiesCash" id="ogi_DerecognizedAssetsAndLiabilitiesCash" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerecognizedAssetsAndLiabilitiesGoodwill" id="ogi_DerecognizedAssetsAndLiabilitiesGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerecognizedAssetsAndLiabilitiesNetAssetsDisposed" id="ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerecognizedAssetsAndLiabilitiesOtherCurrentAssets" id="ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment" id="ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables" id="ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory" id="ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfBusinessAbstract" id="ogi_DescriptionOfBusinessAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfExpectedLifeOfWarrantsGranted" id="ogi_DescriptionOfExpectedLifeOfWarrantsGranted" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfExpectedVolatilityWarrantsGranted" id="ogi_DescriptionOfExpectedVolatilityWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfForfeitureRateShareOptionsGranted" id="ogi_DescriptionOfForfeitureRateShareOptionsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfOptionLifeSharesOptionsGranted" id="ogi_DescriptionOfOptionLifeSharesOptionsGranted" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfRiskFreeInterestRateWarrantsGranted" id="ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DifferenceBetweenCurrentAndFutureTaxRates" id="ogi_DifferenceBetweenCurrentAndFutureTaxRates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares" id="ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares" id="ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares" id="ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectToPatientMedicalRevenueMember" id="ogi_DirectToPatientMedicalRevenueMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAccountsReceivableLineItems" id="ogi_DisclosureOfAccountsReceivableLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory" id="ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfContinuityOfLeaseLiabilitiesExplanatory" id="ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCostOfSalesAbstract" id="ogi_DisclosureOfCostOfSalesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory" id="ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory" id="ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInventoriesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory" id="ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory" id="ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutRevenuesExplantory" id="ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory" id="ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions" id="ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory" id="ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory" id="ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory" id="ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory" id="ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants" id="ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory" id="ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory" id="ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory" id="ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory" id="ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfIndirectProductionExplanatory" id="ogi_DisclosureOfIndirectProductionExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfLicensingAndEndorsementAgreementExplanatory" id="ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfLoanReceivablesExplanatory" id="ogi_DisclosureOfLoanReceivablesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory" id="ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNatureOfOperationsExplanatory" id="ogi_DisclosureOfNatureOfOperationsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory" id="ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOperationsOfTraumaHealingCentersAbstract" id="ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOperationsOfTraumaHealingCentersExplanatory" id="ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherLiabilitiesAbstract" id="ogi_DisclosureOfOtherLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfPriorPeriodReclassificationExplanatory" id="ogi_DisclosureOfPriorPeriodReclassificationExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShareCapitalInformationAbstract" id="ogi_DisclosureOfShareCapitalInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShortTermInvestmentsLineItems" id="ogi_DisclosureOfShortTermInvestmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShortTermInvestmentsTable" id="ogi_DisclosureOfShortTermInvestmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfSignificantAccountingPoliciesAbstract" id="ogi_DisclosureOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DiscountingOperatingLease" id="ogi_DiscountingOperatingLease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DistributionsOfInvestmentInAssociates" id="ogi_DistributionsOfInvestmentInAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DocumentAndEntityInformationAbstract" id="ogi_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DryCannabisAbstract" id="ogi_DryCannabisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DryCannabisAvailableForPackagingMember" id="ogi_DryCannabisAvailableForPackagingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DryCannabisMember" id="ogi_DryCannabisMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DryCannabisPackagedInventoryMember" id="ogi_DryCannabisPackagedInventoryMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfTaxRatesInOtherJurisdictions" id="ogi_EffectOfTaxRatesInOtherJurisdictions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EffectOnFairValueAverageNetSellingPricePerGram" id="ogi_EffectOnFairValueAverageNetSellingPricePerGram" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EffectOnFairValueAverageYieldPerPlant" id="ogi_EffectOnFairValueAverageYieldPerPlant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EliminationOfProportionateShareOfTransactionsWithAssociates" id="ogi_EliminationOfProportionateShareOfTransactionsWithAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EquityFinancingMember" id="ogi_EquityFinancingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityIncentivePlanMember" id="ogi_EquityIncentivePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityInstrumentsHeldSharePrice" id="ogi_EquityInstrumentsHeldSharePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityIssuancePricePerShare" id="ogi_EquityIssuancePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityReserveMember" id="ogi_EquityReserveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquitySecuritiesFairValuePerShare" id="ogi_EquitySecuritiesFairValuePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquitySecuritiesInVivoCannabisIncMember" id="ogi_EquitySecuritiesInVivoCannabisIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedFairValueOfEmployeeOptionsIssued" id="ogi_EstimatedFairValueOfEmployeeOptionsIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted" id="ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted" id="ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EstimatedFairValueOfPerformanceStockUnitsIssued" id="ogi_EstimatedFairValueOfPerformanceStockUnitsIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EstimatedFairValueOfRestrictedStockUnitsIssued" id="ogi_EstimatedFairValueOfRestrictedStockUnitsIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EventsAfterReportingPeriodMember" id="ogi_EventsAfterReportingPeriodMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EvianaHealthCorporationMember" id="ogi_EvianaHealthCorporationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExciseTaxesExpenses" id="ogi_ExciseTaxesExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExercisePriceFourPointSixSixToSevenPointSixSevenMember" id="ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOnePointFourNineToTwoPointThreeEightMember" id="ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember" id="ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwoPointThreeNineToFourPointSixFiveMember" id="ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceZeroPointThreeZeroToOnePointFourEightMember" id="ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendAsPercentageWarrantsGranted" id="ogi_ExpectedDividendAsPercentageWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpirationPeriodAxis" id="ogi_ExpirationPeriodAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ExpirationPeriodDomain" id="ogi_ExpirationPeriodDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpirationPeriodYearFiveMember" id="ogi_ExpirationPeriodYearFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpirationPeriodYearFourMember" id="ogi_ExpirationPeriodYearFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpirationPeriodYearOneMember" id="ogi_ExpirationPeriodYearOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpirationPeriodYearThreeMember" id="ogi_ExpirationPeriodYearThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpirationPeriodYearTwoMember" id="ogi_ExpirationPeriodYearTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueLessCostToDispose" id="ogi_FairValueLessCostToDispose" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfContingentShares" id="ogi_FairValueOfContingentShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfOptionsGranted" id="ogi_FairValueOfOptionsGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember" id="ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FccRealPropertyLoanRefinancedWithBmoTermLoanMember" id="ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember" id="ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FirstAmendmentMember" id="ogi_FirstAmendmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FlowerAndTrimAvailableForExtractionMember" id="ogi_FlowerAndTrimAvailableForExtractionMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FormulatedExtractsMember" id="ogi_FormulatedExtractsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GovernmentProgramsReceivable" id="ogi_GovernmentProgramsReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GovernmentSubsidiesAbstract" id="ogi_GovernmentSubsidiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrossMarginBeforeFairValueAdjustments" id="ogi_GrossMarginBeforeFairValueAdjustments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GrossMarginFromDiscontinuedOperations" id="ogi_GrossMarginFromDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GrossRevenue" id="ogi_GrossRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GrowingProcessingEquipmentMember" id="ogi_GrowingProcessingEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GuaranteedInvestmentCertificatesFiveMember" id="ogi_GuaranteedInvestmentCertificatesFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GuaranteedInvestmentCertificatesFourMember" id="ogi_GuaranteedInvestmentCertificatesFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GuaranteedInvestmentCertificatesOneMember" id="ogi_GuaranteedInvestmentCertificatesOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GuaranteedInvestmentCertificatesThreeMember" id="ogi_GuaranteedInvestmentCertificatesThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GuaranteedInvestmentCertificatesTwoMember" id="ogi_GuaranteedInvestmentCertificatesTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HarmonizedSalesTaxesReceivable" id="ogi_HarmonizedSalesTaxesReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="Hemp1812With703454NBIncMember" id="ogi_Hemp1812With703454NBIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HyasynthBiologicalsIncMember" id="ogi_HyasynthBiologicalsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImpairmentLossOfInvestmentsInAssociates" id="ogi_ImpairmentLossOfInvestmentsInAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncludedInAssetsForSale" id="ogi_IncludedInAssetsForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeFromGovernmentSubsidies" id="ogi_IncomeFromGovernmentSubsidies" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncomeFromSubleasingAggregateRent" id="ogi_IncomeFromSubleasingAggregateRent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized" id="ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets" id="ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseInNonCashWorkingCapitalAbstract" id="ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts" id="ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughConstructionCompleted" id="ogi_IncreaseDecreaseThroughConstructionCompleted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughConvertibleDebentureFinancing" id="ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncreaseDecreaseThroughExerciseOfRestrictedShareUnits" id="ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughForeignCurrencyTranslation" id="ogi_IncreaseDecreaseThroughForeignCurrencyTranslation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughShareBasedCompensation" id="ogi_IncreaseDecreaseThroughShareBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures" id="ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts" id="ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncrementalUncommittedOptionToIncreaseFacilities" id="ogi_IncrementalUncommittedOptionToIncreaseFacilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IndirectProduction" id="ogi_IndirectProduction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IndirectProductionCostOfSale" id="ogi_IndirectProductionCostOfSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InitiallyDrawnAmount" id="ogi_InitiallyDrawnAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InterestRateOnPromissoryNoteReceivable" id="ogi_InterestRateOnPromissoryNoteReceivable" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InternationalBusinessToBusinessMember" id="ogi_InternationalBusinessToBusinessMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InventoriesAbstract" id="ogi_InventoriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue" id="ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InventoriesLineItems" id="ogi_InventoriesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InventoriesTable" id="ogi_InventoriesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="InventoryMember" id="ogi_InventoryMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction" id="ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories" id="ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales" id="ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InvestmentInAssociatesRestrictedInvestment" id="ogi_InvestmentInAssociatesRestrictedInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InvestmentsInterestRate" id="ogi_InvestmentsInterestRate" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfEquityFinancingShares" id="ogi_IssuanceOfEquityFinancingShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesConversionOfDebentures" id="ogi_IssuanceOfSharesConversionOfDebentures" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesExerciseOfRestrictedShareUnits" id="ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesExerciseOfStockOptions" id="ogi_IssuanceOfSharesExerciseOfStockOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesExerciseOfWarrants" id="ogi_IssuanceOfSharesExerciseOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesShareBasedCompensation" id="ogi_IssuanceOfSharesShareBasedCompensation" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesShareBasedPayments" id="ogi_IssuanceOfSharesShareBasedPayments" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts" id="ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssueCostAtMarketEquityFinancing" id="ogi_IssueCostAtMarketEquityFinancing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" id="ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LeaseLiabilityMember" id="ogi_LeaseLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated" id="ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LicensingAndEndorsementAgreementAbstract" id="ogi_LicensingAndEndorsementAgreementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicensingAndEndorsementAgreementLineItems" id="ogi_LicensingAndEndorsementAgreementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicensingAndEndorsementAgreementMember" id="ogi_LicensingAndEndorsementAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicensingAndEndorsementAgreementTable" id="ogi_LicensingAndEndorsementAgreementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="LoanReceivableLineItems" id="ogi_LoanReceivableLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LoanReceivableTable" id="ogi_LoanReceivableTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="LoansReceivablesAbstract" id="ogi_LoansReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LongTermAssetsMember" id="ogi_LongTermAssetsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" id="ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive" id="ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour" id="ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter" id="ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree" id="ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo" id="ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LossOnRemeasurementToFairValueLessCostsToSell" id="ogi_LossOnRemeasurementToFairValueLessCostsToSell" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LumpSumPaymentsPaidToTemporarilyLaidOffWorkers" id="ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MaximumCommitmentToDeliverAdditionalConsideration" id="ogi_MaximumCommitmentToDeliverAdditionalConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement" id="ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaximumPercentageOfAnnualCbdOilPurchased" id="ogi_MaximumPercentageOfAnnualCbdOilPurchased" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement" id="ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MinimumFuturePayments" id="ogi_MinimumFuturePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MinimumFuturePaymentsNotRelatedToLeasePayments" id="ogi_MinimumFuturePaymentsNotRelatedToLeasePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MinimumUnrestrictedCashBalanceRequirement" id="ogi_MinimumUnrestrictedCashBalanceRequirement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MonctonCampusPhase4CAssetSpecificMember" id="ogi_MonctonCampusPhase4CAssetSpecificMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetProceedsFromIssueOfOrdinaryShares" id="ogi_NetProceedsFromIssueOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome" id="ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCurrentContingentShareConsideration" id="ogi_NonCurrentContingentShareConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NumberOfCommonSharesIssued" id="ogi_NumberOfCommonSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfConvertibleDebenturesSold" id="ogi_NumberOfConvertibleDebenturesSold" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOutstandingWarrants" id="ogi_NumberOfOutstandingWarrants" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharePurchaseWarrantUnitsAcquired" id="ogi_NumberOfSharePurchaseWarrantUnitsAcquired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesAcquired" id="ogi_NumberOfSharesAcquired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsExercisedOrReleased" id="ogi_NumberOfWarrantsExercisedOrReleased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsExpired" id="ogi_NumberOfWarrantsExpired" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsExpiredOrReleased" id="ogi_NumberOfWarrantsExpiredOrReleased" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsGranted" id="ogi_NumberOfWarrantsGranted" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLeaseObligations" id="ogi_OperatingLeaseObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OperationsOfTraumaHealingCentersLineItems" id="ogi_OperationsOfTraumaHealingCentersLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperationsOfTraumaHealingCentersTable" id="ogi_OperationsOfTraumaHealingCentersTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="OtherBiologicalAssetsMember" id="ogi_OtherBiologicalAssetsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherDeferredTaxAssetsMember" id="ogi_OtherDeferredTaxAssetsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherDeferredTaxLiabilitiesMember" id="ogi_OtherDeferredTaxLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherLiabilitiesMember" id="ogi_OtherLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherRevenueMember" id="ogi_OtherRevenueMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentAgreementMember" id="ogi_PaymentAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentsForIntangibleAssetsOther" id="ogi_PaymentsForIntangibleAssetsOther" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PercentageOfAgreedRawCbdOilWholesaleMarketPrice" id="ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears" id="ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfDiscountPricePerKilogramOfDriedHempFlower" id="ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture" id="ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy" id="ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations" id="ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentagesOfAccruedInterestReceivable" id="ogi_PercentagesOfAccruedInterestReceivable" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PerformanceShareUnitsMember" id="ogi_PerformanceShareUnitsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PlantsInDryingStageMember" id="ogi_PlantsInDryingStageMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PotentialChangeInImpairmentLossDueToChangeInDiscountRate" id="ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PotentialProportionOfOwnershipInterestInAssociate" id="ogi_PotentialProportionOfOwnershipInterestInAssociate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrepaidExpenseAndLongTermPortionOfFeeCurrent" id="ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PrepaidExpensesMember" id="ogi_PrepaidExpensesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PricePerConvertibleDebentureIssued" id="ogi_PricePerConvertibleDebentureIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PriorPeriodReclassificationAbstract" id="ogi_PriorPeriodReclassificationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsDrawnFromTermLoanCreditFacilities" id="ogi_ProceedsDrawnFromTermLoanCreditFacilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromStockOptionsWarrantsAndUnitsExercised" id="ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PromissoryNoteMember" id="ogi_PromissoryNoteMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PropertyPlantAndEquipmentsMember" id="ogi_PropertyPlantAndEquipmentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProportionOfOwnershipInterestInSubsidiarySold" id="ogi_ProportionOfOwnershipInterestInSubsidiarySold" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProvisionForDoubtfulAccount" id="ogi_ProvisionForDoubtfulAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ProvisionForDoubtfulTradeReceivables" id="ogi_ProvisionForDoubtfulTradeReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PurchaseCostOfLandAndMovableEquipment" id="ogi_PurchaseCostOfLandAndMovableEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="QuantityOfInventory" id="ogi_QuantityOfInventory" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuarterlyRepayments" id="ogi_QuarterlyRepayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RealizedFairValueAmountsIncludedInInventorySold" id="ogi_RealizedFairValueAmountsIncludedInInventorySold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReceivablesAxis" id="ogi_ReceivablesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ReceivablesDomain" id="ogi_ReceivablesDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReclassificationOfComputerSoftware" id="ogi_ReclassificationOfComputerSoftware" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReclassificationOfSalesReturnsToGrossRevenue" id="ogi_ReclassificationOfSalesReturnsToGrossRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RecoverableAmountBasedOnValueInUse" id="ogi_RecoverableAmountBasedOnValueInUse" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReductionInRevolverCommitment" id="ogi_ReductionInRevolverCommitment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RegulatoryFees" id="ogi_RegulatoryFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReliefOptionForLeasesOfLowValueAssets" id="ogi_ReliefOptionForLeasesOfLowValueAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReliefOptionForShortTermLeases" id="ogi_ReliefOptionForShortTermLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RenewalTermOfAgreement" id="ogi_RenewalTermOfAgreement" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RentalIncomeOverSubleaseTerm" id="ogi_RentalIncomeOverSubleaseTerm" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" id="ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestrictedInvestment" id="ogi_RestrictedInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RestrictedStockUnitsMember" id="ogi_RestrictedStockUnitsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RevolvingCreditFacilitiesMember" id="ogi_RevolvingCreditFacilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RightToPurchaseUpToAnnualCbdOil" id="ogi_RightToPurchaseUpToAnnualCbdOil" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RoyaltyPaymentPercentage" id="ogi_RoyaltyPaymentPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SalesOfStockAxis" id="ogi_SalesOfStockAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="SalesOfStockDomain" id="ogi_SalesOfStockDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecondAmendmentMember" id="ogi_SecondAmendmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuredLoanMember" id="ogi_SecuredLoanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram" id="ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram" id="ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SetOffOfDeferredTaxAssets" id="ogi_SetOffOfDeferredTaxAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SetOffOfDeferredTaxLiabilities" id="ogi_SetOffOfDeferredTaxLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareIssuanceCostsMember" id="ogi_ShareIssuanceCostsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit" id="ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePurchaseWarrantExercisePricePerShare" id="ogi_SharePurchaseWarrantExercisePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion" id="ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesAvailablePerSharePurchaseWarrantUnitUponConversion" id="ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales" id="ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShortTermInvestmentAbstract" id="ogi_ShortTermInvestmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortTermInvestmentsAxis" id="ogi_ShortTermInvestmentsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ShortTermInvestmentsDomain" id="ogi_ShortTermInvestmentsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SignificantAccountingPoliciesLineItems" id="ogi_SignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SignificantAccountingPoliciesTable" id="ogi_SignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="SixtyOneToOneTwentyDaysMember" id="ogi_SixtyOneToOneTwentyDaysMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockOptionPlanMember" id="ogi_StockOptionPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockOptionsMember" id="ogi_StockOptionsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubleaseAnnualRentalIncome" id="ogi_SubleaseAnnualRentalIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SupplyAgreementMember" id="ogi_SupplyAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SwearNetLimitedMember" id="ogi_SwearNetLimitedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised" id="ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TermLoanMember" id="ogi_TermLoanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TgsInternationalLlcMember" id="ogi_TgsInternationalLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares" id="ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrademarkLicensingAgreement" id="ogi_TrademarkLicensingAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TradeReceivablesGross" id="ogi_TradeReceivablesGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TradeReceivablesNet" id="ogi_TradeReceivablesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TransactionCostsIntangibleAssetsOtherThanGoodwill" id="ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TransactionCostsOfInvestmentInAssociates" id="ogi_TransactionCostsOfInvestmentInAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TransactionInExchangeForTrademarkLicensingAgreementMember" id="ogi_TransactionInExchangeForTrademarkLicensingAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TransitionToIfrs16" id="ogi_TransitionToIfrs16" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TraumaHealingCentersMember" id="ogi_TraumaHealingCentersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TypeOfArrangementsAxis" id="ogi_TypeOfArrangementsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="TypeOfArrangementsDomain" id="ogi_TypeOfArrangementsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures" id="ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UnderwritersMember" id="ogi_UnderwritersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UndiscountedOperatingLeasePaymentsToBePaid" id="ogi_UndiscountedOperatingLeasePaymentsToBePaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UnitsIssuedInPeriodPricePerUnit" id="ogi_UnitsIssuedInPeriodPricePerUnit" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnrealizedGainLossOnChangesInFairValueOfContingentConsideration" id="ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UnrealizedLossOnChangesInFairValueOfContingentConsideration" id="ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UnsecuredConvertibleDebenturesMember" id="ogi_UnsecuredConvertibleDebenturesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnsecuredConvertibleDebenturesOutstandingFaceValue" id="ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UsefulLiveOfPropertyPlantAndEquipment" id="ogi_UsefulLiveOfPropertyPlantAndEquipment" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VehicleLoansFiveYearTermMaturingJune172024Member" id="ogi_VehicleLoansFiveYearTermMaturingJune172024Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VestingPeriodOfPerformanceStockUnits" id="ogi_VestingPeriodOfPerformanceStockUnits" type="us-types:durationStringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VestingPeriodOfRestrictedStockUnits" id="ogi_VestingPeriodOfRestrictedStockUnits" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VivoCannabisIncMember" id="ogi_VivoCannabisIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsMember" id="ogi_WarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceOfWarrantsExercisedOrReleased" id="ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceOfWarrantsExpired" id="ogi_WeightedAverageExercisePriceOfWarrantsExpired" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceOfWarrantsGranted" id="ogi_WeightedAverageExercisePriceOfWarrantsGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceOfWarrantsOutstanding" id="ogi_WeightedAverageExercisePriceOfWarrantsOutstanding" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WholesaleToLicensedProducersRevenueMember" id="ogi_WholesaleToLicensedProducersRevenueMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WorkingCapital" id="ogi_WorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ZeroToSixtyDaysMember" id="ogi_ZeroToSixtyDaysMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>ogi-20200831_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ConsolidatedStatementsOfFinancialPosition" roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfFinancialPosition"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome" roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutAccountsReceivableDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAccountsReceivableDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails" roleURI="http://www.organigram.ca/role/DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutLossPerShareDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutLossPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIESDetails" roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ConsolidatedStatementsOfFinancialPosition">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentHeldtomaturityInvestments" xlink:label="loc_ifrs-full_CurrentHeldtomaturityInvestments_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLoansAndReceivables" xlink:label="loc_ifrs-full_CurrentLoansAndReceivables_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:label="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LoansAndReceivables" xlink:label="loc_ifrs-full_LoansAndReceivables_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrepaymentsAndAccruedIncome" xlink:label="loc_ifrs-full_PrepaymentsAndAccruedIncome_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncome_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_26"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_CurrentAssets_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_Cash_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentHeldtomaturityInvestments_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentTradeReceivables_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentLoansAndReceivables_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_Inventories_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_RestrictedCashAndCashEquivalents_9" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_LoansAndReceivables_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_11" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_12" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_PrepaymentsAndAccruedIncome_13" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_14" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_15" xlink:to="loc_ifrs-full_Liabilities_16" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_16" xlink:to="loc_ifrs-full_CurrentLiabilities_16" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_16" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_16" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_16" xlink:to="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_17" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_16" xlink:to="loc_ifrs-full_LongtermBorrowings_19" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_16" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_20" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_16" xlink:to="loc_ifrs-full_NetDeferredTaxLiabilities_21" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_15" xlink:to="loc_ifrs-full_Equity_23" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_23" xlink:to="loc_ifrs-full_IssuedCapital_23" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_23" xlink:to="loc_ifrs-full_ReserveOfSharebasedPayments_24" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_23" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncome_25" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_23" xlink:to="loc_ifrs-full_RetainedEarnings_26" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossMarginBeforeFairValueAdjustments" xlink:label="loc_ogi_GrossMarginBeforeFairValueAdjustments_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossRevenue" xlink:label="loc_ogi_GrossRevenue_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="loc_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates" xlink:label="loc_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_18"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncomeFromGovernmentSubsidies" xlink:label="loc_ogi_IncomeFromGovernmentSubsidies_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_1" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_1" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_GrossProfit_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_1" xlink:to="loc_ogi_GrossMarginBeforeFairValueAdjustments_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ogi_GrossMarginBeforeFairValueAdjustments_1" xlink:to="loc_ifrs-full_Revenue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_1" xlink:to="loc_ogi_GrossRevenue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_1" xlink:to="loc_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ogi_GrossMarginBeforeFairValueAdjustments_1" xlink:to="loc_ifrs-full_CostOfSales_4" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_1" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_ExpenseByNature_8" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_8" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_9" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_11" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ifrs-full_FinanceCosts_14" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ifrs-full_FinanceIncome_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_16" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_17" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_18" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ogi_IncomeFromGovernmentSubsidies_19" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_1" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_21" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_1" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_23" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_25" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForDebtIssueCosts" xlink:label="loc_ifrs-full_PaymentsForDebtIssueCosts_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised" xlink:label="loc_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_4" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_5" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_6" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_7" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ifrs-full_PaymentsForDebtIssueCosts_8" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_9" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_10" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_11" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_4" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_12" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_15" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_16" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_17" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_18" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_19" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_PurchaseOfInterestsInAssociates_20" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_21" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_22" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_14" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_23" order="90" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_25" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAccountsReceivableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HarmonizedSalesTaxesReceivable" xlink:label="loc_ogi_HarmonizedSalesTaxesReceivable_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GovernmentProgramsReceivable" xlink:label="loc_ogi_GovernmentProgramsReceivable_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProvisionForDoubtfulAccount" xlink:label="loc_ogi_ProvisionForDoubtfulAccount_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_ifrs-full_TradeReceivables_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_ogi_HarmonizedSalesTaxesReceivable_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_ogi_GovernmentProgramsReceivable_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_ogi_ProvisionForDoubtfulAccount_4" order="30" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RealizedFairValueAmountsIncludedInInventorySold" xlink:label="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets" xlink:label="loc_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentToNetRealizableValueBiologicalAssets" xlink:label="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0" xlink:to="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0" xlink:to="loc_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0" xlink:to="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_3" order="20" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NotionalAmount_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NotionalAmount_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NotionalAmount_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NotionalAmount_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NotionalAmount_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NotionalAmount_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_6" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutLossPerShareDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_0" xlink:to="loc_ifrs-full_WeightedAverageShares_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_0" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_0" xlink:to="loc_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_0" xlink:to="loc_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_0" xlink:to="loc_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_5" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TradeReceivablesNet" xlink:label="loc_ogi_TradeReceivablesNet_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TradeReceivablesGross" xlink:label="loc_ogi_TradeReceivablesGross_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProvisionForDoubtfulTradeReceivables" xlink:label="loc_ogi_ProvisionForDoubtfulTradeReceivables_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ogi_TradeReceivablesNet_0" xlink:to="loc_ogi_TradeReceivablesGross_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ogi_TradeReceivablesNet_0" xlink:to="loc_ogi_ProvisionForDoubtfulTradeReceivables_2" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DifferenceBetweenCurrentAndFutureTaxRates" xlink:label="loc_ogi_DifferenceBetweenCurrentAndFutureTaxRates_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized" xlink:label="loc_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ogi_DifferenceBetweenCurrentAndFutureTaxRates_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_6" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised" xlink:label="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_0" xlink:to="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_0" xlink:to="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-full_TravelExpense_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UtilitiesExpense" xlink:label="loc_ifrs-full_UtilitiesExpense_7"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_ifrs-full_WagesAndSalaries_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_ifrs-full_TravelExpense_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_ifrs-full_UtilitiesExpense_7" order="60" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIESDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContingentShareConsideration" xlink:label="loc_ogi_ContingentShareConsideration_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_0" xlink:to="loc_ogi_ContingentShareConsideration_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_0" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_2" order="10" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>ogi-20200831_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ConsolidatedStatementsOfChangesInEquity" roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LoanReceivableNarrativeDetails" roleURI="http://www.organigram.ca/role/LoanReceivableNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#IntangibleAssetsNarrativeDetails" roleURI="http://www.organigram.ca/role/IntangibleAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LongTermDebtNarrativeDetails" roleURI="http://www.organigram.ca/role/LongTermDebtNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SHARECAPITALDetails8" roleURI="http://www.organigram.ca/role/SHARECAPITALDetails8"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#InvestmentsInAssociatesNarrativeDetails" roleURI="http://www.organigram.ca/role/InvestmentsInAssociatesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#RELATEDPARTYTRANSACTIONSDetails1" roleURI="http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LicensingAndEndorsementAgreementNarrativeDetails" roleURI="http://www.organigram.ca/role/LicensingAndEndorsementAgreementNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OPERATIONSOFTRAUMAHEALINGCENTERSDetails4" roleURI="http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSDetails4"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SubsequentEventsNarrativeDetails" roleURI="http://www.organigram.ca/role/SubsequentEventsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutInventoriesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutIntangibleAssetsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfLongTermDebtDetails" roleURI="http://www.organigram.ca/role/DisclosureOfLongTermDebtDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfLongTermDebtParentheticalsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfLongTermDebtParentheticalsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutOutstandingRsusDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingRsusDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails" roleURI="http://www.organigram.ca/role/DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutRevenuesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRevenuesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDerecognizedAssetsAndLiabilitiesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDerecognizedAssetsAndLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail" roleURI="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#PROPERTYPLANTANDEQUIPMENTNarrativeDetails" roleURI="http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SHARECAPITALPerformanceShareUnits" roleURI="http://www.organigram.ca/role/SHARECAPITALPerformanceShareUnits"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIESDetails1" roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails1"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIESDetails2" roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails2"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ConsolidatedStatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityReserveMember" xlink:label="loc_ogi_EquityReserveMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts" xlink:label="loc_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts" xlink:label="loc_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughShareBasedCompensation" xlink:label="loc_ogi_IncreaseDecreaseThroughShareBasedCompensation_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesShareBasedCompensation" xlink:label="loc_ogi_IssuanceOfSharesShareBasedCompensation_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesShareBasedPayments" xlink:label="loc_ogi_IssuanceOfSharesShareBasedPayments_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfStockOptions" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfStockOptions_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfWarrants" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfWarrants_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits" xlink:label="loc_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_23"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesConversionOfDebentures" xlink:label="loc_ogi_IssuanceOfSharesConversionOfDebentures_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfEquityFinancingShares" xlink:label="loc_ogi_IssuanceOfEquityFinancingShares_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_27"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DebtIssueRelatedCost" xlink:label="loc_ogi_DebtIssueRelatedCost_28"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts" xlink:label="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_29"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures" xlink:label="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_30"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughForeignCurrencyTranslation" xlink:label="loc_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_32"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ogi_EquityReserveMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_Equity_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IncreaseDecreaseThroughShareBasedCompensation_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfSharesShareBasedCompensation_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_15" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfSharesShareBasedPayments_16" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_17" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfSharesExerciseOfStockOptions_18" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_19" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfSharesExerciseOfWarrants_20" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_21" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_22" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_23" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfSharesConversionOfDebentures_24" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_25" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfEquityFinancingShares_26" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfConvertibleInstruments_27" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_DebtIssueRelatedCost_28" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_29" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_30" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_31" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_32" order="240" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LoanReceivableNarrativeDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoanReceivableLineItems" xlink:label="loc_ogi_LoanReceivableLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoanReceivableTable" xlink:label="loc_ogi_LoanReceivableTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsAxis" xlink:label="loc_ogi_TypeOfArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsDomain" xlink:label="loc_ogi_TypeOfArrangementsDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PaymentAgreementMember" xlink:label="loc_ogi_PaymentAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsDomain" xlink:label="loc_ogi_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SecuredLoanMember" xlink:label="loc_ogi_SecuredLoanMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLoansAndReceivables" xlink:label="loc_ifrs-full_CurrentLoansAndReceivables_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvancePayment" xlink:label="loc_ogi_AdvancePayment_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentagesOfAccruedInterestReceivable" xlink:label="loc_ogi_PercentagesOfAccruedInterestReceivable_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_LoanReceivableLineItems_0" xlink:to="loc_ogi_LoanReceivableTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_LoanReceivableTable_1" xlink:to="loc_ogi_TypeOfArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_TypeOfArrangementsAxis_1" xlink:to="loc_ogi_TypeOfArrangementsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_TypeOfArrangementsDomain_1" xlink:to="loc_ogi_PaymentAgreementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_TypeOfArrangementsAxis_1" xlink:to="loc_ogi_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_LoanReceivableTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_5" xlink:to="loc_ogi_SecuredLoanMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LoanReceivableLineItems_0" xlink:to="loc_ifrs-full_CurrentLoansAndReceivables_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LoanReceivableLineItems_0" xlink:to="loc_ogi_AdvancePayment_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LoanReceivableLineItems_0" xlink:to="loc_ogi_PercentagesOfAccruedInterestReceivable_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/IntangibleAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_Hemp1812With703454NBIncMember" xlink:label="loc_ogi_Hemp1812With703454NBIncMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower" xlink:label="loc_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RenewalTermOfAgreement" xlink:label="loc_ogi_RenewalTermOfAgreement_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PaymentsForIntangibleAssetsOther" xlink:label="loc_ogi_PaymentsForIntangibleAssetsOther_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_1" xlink:to="loc_ogi_Hemp1812With703454NBIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5" xlink:to="loc_ifrs-full_CarryingAmountMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_5" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_5" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ogi_RenewalTermOfAgreement_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ogi_PaymentsForIntangibleAssetsOther_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_16" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LongTermDebtNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember" xlink:label="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesAxis" xlink:label="loc_ogi_CreditFacilitiesAxis_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesDomain" xlink:label="loc_ogi_CreditFacilitiesDomain_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TermLoanMember" xlink:label="loc_ogi_TermLoanMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RevolvingCreditFacilitiesMember" xlink:label="loc_ogi_RevolvingCreditFacilitiesMember_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesDomain" xlink:label="loc_ogi_CreditFacilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentAxis" xlink:label="loc_ogi_CreditFacilityAmendmentAxis_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentDomain" xlink:label="loc_ogi_CreditFacilityAmendmentDomain_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FirstAmendmentMember" xlink:label="loc_ogi_FirstAmendmentMember_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SecondAmendmentMember" xlink:label="loc_ogi_SecondAmendmentMember_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmendmentAndRestatementMember" xlink:label="loc_ogi_AmendmentAndRestatementMember_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentDomain" xlink:label="loc_ogi_CreditFacilityAmendmentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingCostsIncurred" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncrementalUncommittedOptionToIncreaseFacilities" xlink:label="loc_ogi_IncrementalUncommittedOptionToIncreaseFacilities_22"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommittedAndUncommittedBorrowingFacilities" xlink:label="loc_ogi_CommittedAndUncommittedBorrowingFacilities_23"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommittedBorrowingFacilities" xlink:label="loc_ogi_CommittedBorrowingFacilities_24"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InitiallyDrawnAmount" xlink:label="loc_ogi_InitiallyDrawnAmount_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_26"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter" xlink:label="loc_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_27"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsCashInterestRate" xlink:label="loc_ogi_BorrowingsCashInterestRate_28"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsEffectiveInterestRate" xlink:label="loc_ogi_BorrowingsEffectiveInterestRate_29"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsReducedCashInterestRate" xlink:label="loc_ogi_BorrowingsReducedCashInterestRate_30"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsReducedEffectiveInterestRate" xlink:label="loc_ogi_BorrowingsReducedEffectiveInterestRate_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-full_OtherFinanceCost_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_33"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ApplicableMarginRate" xlink:label="loc_ogi_ApplicableMarginRate_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_35"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_QuarterlyRepayments" xlink:label="loc_ogi_QuarterlyRepayments_36"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReductionInRevolverCommitment" xlink:label="loc_ogi_ReductionInRevolverCommitment_37"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumUnrestrictedCashBalanceRequirement" xlink:label="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_38"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ogi_CreditFacilitiesAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_CreditFacilitiesAxis_6" xlink:to="loc_ogi_CreditFacilitiesDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilitiesDomain_6" xlink:to="loc_ogi_TermLoanMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilitiesDomain_6" xlink:to="loc_ogi_RevolvingCreditFacilitiesMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_CreditFacilitiesAxis_6" xlink:to="loc_ogi_CreditFacilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ogi_CreditFacilityAmendmentAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_CreditFacilityAmendmentAxis_11" xlink:to="loc_ogi_CreditFacilityAmendmentDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_11" xlink:to="loc_ogi_FirstAmendmentMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_11" xlink:to="loc_ogi_SecondAmendmentMember_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_11" xlink:to="loc_ogi_AmendmentAndRestatementMember_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_CreditFacilityAmendmentAxis_11" xlink:to="loc_ogi_CreditFacilityAmendmentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_Borrowings_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_21" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_IncrementalUncommittedOptionToIncreaseFacilities_22" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_CommittedAndUncommittedBorrowingFacilities_23" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_CommittedBorrowingFacilities_24" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_InitiallyDrawnAmount_25" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRate_26" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_27" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_BorrowingsCashInterestRate_28" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_BorrowingsEffectiveInterestRate_29" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_BorrowingsReducedCashInterestRate_30" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_BorrowingsReducedEffectiveInterestRate_31" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_OtherFinanceCost_32" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_33" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_ApplicableMarginRate_34" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_35" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_QuarterlyRepayments_36" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_ReductionInRevolverCommitment_37" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_38" order="210" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SHARECAPITALDetails8">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesMember" xlink:label="loc_ogi_ConvertibleDebenturesMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember" xlink:label="loc_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember" xlink:label="loc_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RestrictedStockUnitsMember" xlink:label="loc_ogi_RestrictedStockUnitsMember_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityFinancingMember" xlink:label="loc_ogi_EquityFinancingMember_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PerformanceShareUnitsMember" xlink:label="loc_ogi_PerformanceShareUnitsMember_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_StockOptionPlanMember" xlink:label="loc_ogi_StockOptionPlanMember_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityIncentivePlanMember" xlink:label="loc_ogi_EquityIncentivePlanMember_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SalesOfStockAxis" xlink:label="loc_ogi_SalesOfStockAxis_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SalesOfStockDomain" xlink:label="loc_ogi_SalesOfStockDomain_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionInExchangeForTrademarkLicensingAgreementMember" xlink:label="loc_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvisoryServicesAgreementMember" xlink:label="loc_ogi_AdvisoryServicesAgreementMember_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SalesOfStockDomain" xlink:label="loc_ogi_SalesOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TgsInternationalLlcMember" xlink:label="loc_ogi_TgsInternationalLlcMember_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CannabisConsultantMember" xlink:label="loc_ogi_CannabisConsultantMember_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_30"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" xlink:label="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_38"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfCommonSharesIssued" xlink:label="loc_ogi_NumberOfCommonSharesIssued_39"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityIssuancePricePerShare" xlink:label="loc_ogi_EquityIssuancePricePerShare_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_42"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NetProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ogi_NetProceedsFromIssueOfOrdinaryShares_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFeeAndCommissionExpense" xlink:label="loc_ifrs-full_OtherFeeAndCommissionExpense_44"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RegulatoryFees" xlink:label="loc_ogi_RegulatoryFees_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_46"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TrademarkLicensingAgreement" xlink:label="loc_ogi_TrademarkLicensingAgreement_47"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionsFeeCurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_48"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionFeeNoncurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_49"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizedToShareBasedCompensation" xlink:label="loc_ogi_AmortizedToShareBasedCompensation_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_51"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_53"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_54"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_55"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_56"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfEquityFinancingShares" xlink:label="loc_ogi_IssuanceOfEquityFinancingShares_57"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnitsIssuedInPeriodPricePerUnit" xlink:label="loc_ogi_UnitsIssuedInPeriodPricePerUnit_58"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsGranted" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_59"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_60"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExpiredOrReleased" xlink:label="loc_ogi_NumberOfWarrantsExpiredOrReleased_61"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_62"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExpired" xlink:label="loc_ogi_NumberOfWarrantsExpired_63"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfConvertibleDebenturesSold" xlink:label="loc_ogi_NumberOfConvertibleDebenturesSold_64"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PricePerConvertibleDebentureIssued" xlink:label="loc_ogi_PricePerConvertibleDebentureIssued_65"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_66"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing" xlink:label="loc_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_67"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxOnConvertibleDebentureFinancing" xlink:label="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_68"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebentureIssueCosts" xlink:label="loc_ogi_ConvertibleDebentureIssueCosts_69"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability" xlink:label="loc_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_70"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesConversionOfDebentures" xlink:label="loc_ogi_IssuanceOfSharesConversionOfDebentures_71"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfDebenturesPricePerShare" xlink:label="loc_ogi_ConversionOfDebenturesPricePerShare_72"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_73"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares" xlink:label="loc_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_74"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_75"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_76"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_77"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_78"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_79"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueOfOptionsGranted" xlink:label="loc_ogi_FairValueOfOptionsGranted_80"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement" xlink:label="loc_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_81"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted" xlink:label="loc_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_82"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted" xlink:label="loc_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_83"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6" xlink:to="loc_ifrs-full_BorrowingsByNameMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_6" xlink:to="loc_ogi_ConvertibleDebenturesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_RestrictedStockUnitsMember_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_EquityFinancingMember_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_PerformanceShareUnitsMember_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_StockOptionPlanMember_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_EquityIncentivePlanMember_16" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ogi_SalesOfStockAxis_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_SalesOfStockAxis_20" xlink:to="loc_ogi_SalesOfStockDomain_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SalesOfStockDomain_20" xlink:to="loc_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SalesOfStockDomain_20" xlink:to="loc_ogi_AdvisoryServicesAgreementMember_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_SalesOfStockAxis_20" xlink:to="loc_ogi_SalesOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_25" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_25" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_25" xlink:to="loc_ogi_TgsInternationalLlcMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_25" xlink:to="loc_ogi_CannabisConsultantMember_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_25" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_30" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_30" xlink:to="loc_ifrs-full_EquityMember_30" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_30" xlink:to="loc_ifrs-full_IssuedCapitalMember_30" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_30" xlink:to="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_31" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_30" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_36" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_37" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssuedCapital_38" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_NumberOfCommonSharesIssued_39" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_EquityIssuancePricePerShare_40" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_41" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_42" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_NetProceedsFromIssueOfOrdinaryShares_43" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_OtherFeeAndCommissionExpense_44" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_RegulatoryFees_45" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_46" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_TrademarkLicensingAgreement_47" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_48" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_49" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_AmortizedToShareBasedCompensation_50" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_51" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_52" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_53" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_54" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_55" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_56" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfEquityFinancingShares_57" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_UnitsIssuedInPeriodPricePerUnit_58" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_59" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_60" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_NumberOfWarrantsExpiredOrReleased_61" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_62" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_NumberOfWarrantsExpired_63" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_NumberOfConvertibleDebenturesSold_64" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_PricePerConvertibleDebentureIssued_65" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_66" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_67" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_68" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_ConvertibleDebentureIssueCosts_69" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_70" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_IssuanceOfSharesConversionOfDebentures_71" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_ConversionOfDebenturesPricePerShare_72" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_73" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_74" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_75" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_76" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_77" order="420" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_78" order="430" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_79" order="440" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_FairValueOfOptionsGranted_80" order="450" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_81" order="460" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_82" order="470" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_83" order="480" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/InvestmentsInAssociatesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesMember" xlink:label="loc_ogi_ConvertibleDebenturesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AlphaCannabisPharmaGmbhMember" xlink:label="loc_ogi_AlphaCannabisPharmaGmbhMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EvianaHealthCorporationMember" xlink:label="loc_ogi_EvianaHealthCorporationMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HyasynthBiologicalsIncMember" xlink:label="loc_ogi_HyasynthBiologicalsIncMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AchievementOfContractualProductionRelatedMilestoneMember" xlink:label="loc_ogi_AchievementOfContractualProductionRelatedMilestoneMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CapitalizedTransactionCostsAndEquityDiscount" xlink:label="loc_ogi_CapitalizedTransactionCostsAndEquityDiscount_16"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfSharesAcquired" xlink:label="loc_ogi_NumberOfSharesAcquired_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones" xlink:label="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueOfContingentShares" xlink:label="loc_ogi_FairValueOfContingentShares_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_22"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations" xlink:label="loc_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_23"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesReceivableFaceValue" xlink:label="loc_ogi_ConvertibleDebenturesReceivableFaceValue_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesConversionPrice" xlink:label="loc_ogi_ConvertibleDebenturesConversionPrice_26"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion" xlink:label="loc_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_27"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfConvertibleDebenturesSharesIssued" xlink:label="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_28"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfDebenturesDescription" xlink:label="loc_ogi_ConversionOfDebenturesDescription_29"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfSharePurchaseWarrantUnitsAcquired" xlink:label="loc_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_30"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit" xlink:label="loc_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_31"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion" xlink:label="loc_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_32"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateNumberOfCommonSharesConverted" xlink:label="loc_ogi_AggregateNumberOfCommonSharesConverted_33"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion" xlink:label="loc_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_34"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantExercisePricePerShare" xlink:label="loc_ogi_SharePurchaseWarrantExercisePricePerShare_35"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RightToPurchaseUpToAnnualCbdOil" xlink:label="loc_ogi_RightToPurchaseUpToAnnualCbdOil_36"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MaximumPercentageOfAnnualCbdOilPurchased" xlink:label="loc_ogi_MaximumPercentageOfAnnualCbdOilPurchased_37"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice" xlink:label="loc_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_38"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RecoverableAmountBasedOnValueInUse" xlink:label="loc_ogi_RecoverableAmountBasedOnValueInUse_39"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture" xlink:label="loc_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_40"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ImpairmentLossOfInvestmentsInAssociates" xlink:label="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_41"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate" xlink:label="loc_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_42"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months" xlink:label="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_43"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths" xlink:label="loc_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_44"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction" xlink:label="loc_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_45"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months" xlink:label="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_46"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears" xlink:label="loc_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_47"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvanceGivenAsConvertibleDebentures" xlink:label="loc_ogi_AdvanceGivenAsConvertibleDebentures_48"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PotentialProportionOfOwnershipInterestInAssociate" xlink:label="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_49"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_ConvertibleDebenturesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_5" xlink:to="loc_ogi_AlphaCannabisPharmaGmbhMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_5" xlink:to="loc_ogi_EvianaHealthCorporationMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_5" xlink:to="loc_ogi_HyasynthBiologicalsIncMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_11" xlink:to="loc_ifrs-full_NonadjustingEventsMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_11" xlink:to="loc_ogi_AchievementOfContractualProductionRelatedMilestoneMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_11" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_CapitalizedTransactionCostsAndEquityDiscount_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_NumberOfSharesAcquired_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_PurchaseOfInterestsInAssociates_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_FairValueOfContingentShares_21" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_22" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_23" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_ConvertibleDebenturesReceivableFaceValue_24" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRate_25" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_ConvertibleDebenturesConversionPrice_26" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_27" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_28" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_ConversionOfDebenturesDescription_29" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_30" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_31" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_32" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_AggregateNumberOfCommonSharesConverted_33" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_34" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_SharePurchaseWarrantExercisePricePerShare_35" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_RightToPurchaseUpToAnnualCbdOil_36" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_MaximumPercentageOfAnnualCbdOilPurchased_37" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_38" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_RecoverableAmountBasedOnValueInUse_39" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_40" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_41" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_42" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_43" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_44" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_45" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_46" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_47" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_AdvanceGivenAsConvertibleDebentures_48" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_49" order="340" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EvianaHealthCorporationMember" xlink:label="loc_ogi_EvianaHealthCorporationMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AlphaCannabisPharmaGmbhMember" xlink:label="loc_ogi_AlphaCannabisPharmaGmbhMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RestrictedStockUnitsMember" xlink:label="loc_ogi_RestrictedStockUnitsMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PerformanceShareUnitsMember" xlink:label="loc_ogi_PerformanceShareUnitsMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement" xlink:label="loc_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:label="loc_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel" xlink:label="loc_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExpiredOrReleased" xlink:label="loc_ogi_NumberOfWarrantsExpiredOrReleased_22"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_25"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_EvianaHealthCorporationMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_AlphaCannabisPharmaGmbhMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_RestrictedStockUnitsMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_10" xlink:to="loc_ogi_PerformanceShareUnitsMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_21" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ogi_NumberOfWarrantsExpiredOrReleased_22" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_23" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_RevenueFromInterest_24" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_25" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LicensingAndEndorsementAgreementNarrativeDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementLineItems" xlink:label="loc_ogi_LicensingAndEndorsementAgreementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementTable" xlink:label="loc_ogi_LicensingAndEndorsementAgreementTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsAxis" xlink:label="loc_ogi_TypeOfArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsDomain" xlink:label="loc_ogi_TypeOfArrangementsDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementMember" xlink:label="loc_ogi_LicensingAndEndorsementAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsDomain" xlink:label="loc_ogi_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SwearNetLimitedMember" xlink:label="loc_ogi_SwearNetLimitedMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServices_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RoyaltyPaymentPercentage" xlink:label="loc_ogi_RoyaltyPaymentPercentage_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizedToShareBasedCompensation" xlink:label="loc_ogi_AmortizedToShareBasedCompensation_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizedToSellingAndMarketingExpenses" xlink:label="loc_ogi_AmortizedToSellingAndMarketingExpenses_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionsFeeCurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_16"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent" xlink:label="loc_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionFeeNoncurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ogi_LicensingAndEndorsementAgreementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_LicensingAndEndorsementAgreementTable_1" xlink:to="loc_ogi_TypeOfArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_TypeOfArrangementsAxis_1" xlink:to="loc_ogi_TypeOfArrangementsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_TypeOfArrangementsDomain_1" xlink:to="loc_ogi_LicensingAndEndorsementAgreementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_TypeOfArrangementsAxis_1" xlink:to="loc_ogi_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_LicensingAndEndorsementAgreementTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_ogi_SwearNetLimitedMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServices_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ogi_RoyaltyPaymentPercentage_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ogi_AmortizedToShareBasedCompensation_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ogi_AmortizedToSellingAndMarketingExpenses_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_0" xlink:to="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_18" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSDetails4">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VivoCannabisIncMember" xlink:label="loc_ogi_VivoCannabisIncMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProportionOfOwnershipInterestInSubsidiarySold" xlink:label="loc_ogi_ProportionOfOwnershipInterestInSubsidiarySold_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityInstrumentsHeldSharePrice" xlink:label="loc_ogi_EquityInstrumentsHeldSharePrice_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInstrumentsHeld" xlink:label="loc_ifrs-full_EquityInstrumentsHeld_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_TraumaHealingCentersMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_VivoCannabisIncMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_ProportionOfOwnershipInterestInSubsidiarySold_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_EquityInstrumentsHeldSharePrice_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_EquityInstrumentsHeld_11" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SubsequentEventsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EventsAfterReportingPeriodMember" xlink:label="loc_ogi_EventsAfterReportingPeriodMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HyasynthBiologicalsIncMember" xlink:label="loc_ogi_HyasynthBiologicalsIncMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnderwritersMember" xlink:label="loc_ogi_UnderwritersMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesAxis" xlink:label="loc_ogi_CreditFacilitiesAxis_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesDomain" xlink:label="loc_ogi_CreditFacilitiesDomain_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TermLoanMember" xlink:label="loc_ogi_TermLoanMember_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RevolvingCreditFacilitiesMember" xlink:label="loc_ogi_RevolvingCreditFacilitiesMember_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesDomain" xlink:label="loc_ogi_CreditFacilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentAxis" xlink:label="loc_ogi_CreditFacilityAmendmentAxis_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentDomain" xlink:label="loc_ogi_CreditFacilityAmendmentDomain_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SecondAmendmentMember" xlink:label="loc_ogi_SecondAmendmentMember_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmendmentAndRestatementMember" xlink:label="loc_ogi_AmendmentAndRestatementMember_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentDomain" xlink:label="loc_ogi_CreditFacilityAmendmentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NotesAndDebenturesIssued_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesReceivableFaceValue" xlink:label="loc_ogi_ConvertibleDebenturesReceivableFaceValue_26"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PotentialProportionOfOwnershipInterestInAssociate" xlink:label="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_27"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfEquityFinancingShares" xlink:label="loc_ogi_IssuanceOfEquityFinancingShares_28"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnitsIssuedInPeriodPricePerUnit" xlink:label="loc_ogi_UnitsIssuedInPeriodPricePerUnit_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_30"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsGranted" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_31"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommittedBorrowingFacilities" xlink:label="loc_ogi_CommittedBorrowingFacilities_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_33"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_QuarterlyRepayments" xlink:label="loc_ogi_QuarterlyRepayments_34"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReductionInRevolverCommitment" xlink:label="loc_ogi_ReductionInRevolverCommitment_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_36"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumUnrestrictedCashBalanceRequirement" xlink:label="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingCostsIncurred" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_39"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_ogi_EventsAfterReportingPeriodMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_5" xlink:to="loc_ogi_HyasynthBiologicalsIncMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_5" xlink:to="loc_ogi_UnderwritersMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_10" xlink:to="loc_ifrs-full_BorrowingsByNameMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_10" xlink:to="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_10" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ogi_CreditFacilitiesAxis_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_CreditFacilitiesAxis_14" xlink:to="loc_ogi_CreditFacilitiesDomain_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilitiesDomain_14" xlink:to="loc_ogi_TermLoanMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilitiesDomain_14" xlink:to="loc_ogi_RevolvingCreditFacilitiesMember_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_CreditFacilitiesAxis_14" xlink:to="loc_ogi_CreditFacilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ogi_CreditFacilityAmendmentAxis_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_CreditFacilityAmendmentAxis_19" xlink:to="loc_ogi_CreditFacilityAmendmentDomain_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_19" xlink:to="loc_ogi_SecondAmendmentMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_19" xlink:to="loc_ogi_AmendmentAndRestatementMember_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_CreditFacilityAmendmentAxis_19" xlink:to="loc_ogi_CreditFacilityAmendmentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_NotesAndDebenturesIssued_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_ConvertibleDebenturesReceivableFaceValue_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_27" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_IssuanceOfEquityFinancingShares_28" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_UnitsIssuedInPeriodPricePerUnit_29" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_30" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_31" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_CommittedBorrowingFacilities_32" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_33" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_QuarterlyRepayments_34" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_ReductionInRevolverCommitment_35" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_36" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_37" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_38" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_39" order="150" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OfficeEquipmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_VehiclesMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_12" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShortTermInvestmentsLineItems" xlink:label="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShortTermInvestmentsTable" xlink:label="loc_ogi_DisclosureOfShortTermInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentsAxis" xlink:label="loc_ogi_ShortTermInvestmentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentsDomain" xlink:label="loc_ogi_ShortTermInvestmentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesOneMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesOneMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesTwoMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesThreeMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesFourMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesFourMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesFiveMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquitySecuritiesInVivoCannabisIncMember" xlink:label="loc_ogi_EquitySecuritiesInVivoCannabisIncMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentsDomain" xlink:label="loc_ogi_ShortTermInvestmentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InvestmentsInterestRate" xlink:label="loc_ogi_InvestmentsInterestRate_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentHeldtomaturityInvestments" xlink:label="loc_ifrs-full_CurrentHeldtomaturityInvestments_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_0" xlink:to="loc_ogi_DisclosureOfShortTermInvestmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsTable_1" xlink:to="loc_ogi_ShortTermInvestmentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_ShortTermInvestmentsAxis_1" xlink:to="loc_ogi_ShortTermInvestmentsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesOneMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesTwoMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesThreeMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesFourMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesFiveMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_EquitySecuritiesInVivoCannabisIncMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_ShortTermInvestmentsAxis_1" xlink:to="loc_ogi_ShortTermInvestmentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_0" xlink:to="loc_ogi_InvestmentsInterestRate_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_0" xlink:to="loc_ifrs-full_CurrentHeldtomaturityInvestments_12" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsByGroupAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByGroupAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsGroupMember" xlink:label="loc_ifrs-full_BiologicalAssetsGroupMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherBiologicalAssetsMember" xlink:label="loc_ogi_OtherBiologicalAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlantsMember" xlink:label="loc_ifrs-full_PlantsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsGroupMember" xlink:label="loc_ifrs-full_BiologicalAssetsGroupMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsBiologicalAssets" xlink:label="loc_ifrs-full_DisposalsBiologicalAssets_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_1" xlink:to="loc_ifrs-full_BiologicalAssetsByGroupAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BiologicalAssetsByGroupAxis_1" xlink:to="loc_ifrs-full_BiologicalAssetsGroupMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BiologicalAssetsGroupMember_1" xlink:to="loc_ogi_OtherBiologicalAssetsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BiologicalAssetsGroupMember_1" xlink:to="loc_ifrs-full_PlantsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BiologicalAssetsByGroupAxis_1" xlink:to="loc_ifrs-full_BiologicalAssetsGroupMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0" xlink:to="loc_ifrs-full_DisposalsBiologicalAssets_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0" xlink:to="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_11" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutInventoriesDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesLineItems" xlink:label="loc_ogi_InventoriesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesTable" xlink:label="loc_ogi_InventoriesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtCostMember" xlink:label="loc_ifrs-full_AtCostMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PlantsInDryingStageMember" xlink:label="loc_ogi_PlantsInDryingStageMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisMember" xlink:label="loc_ogi_DryCannabisMember_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisAvailableForPackagingMember" xlink:label="loc_ogi_DryCannabisAvailableForPackagingMember_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisPackagedInventoryMember" xlink:label="loc_ogi_DryCannabisPackagedInventoryMember_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FlowerAndTrimAvailableForExtractionMember" xlink:label="loc_ogi_FlowerAndTrimAvailableForExtractionMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConcentratedExtractMember" xlink:label="loc_ogi_ConcentratedExtractMember_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FormulatedExtractsMember" xlink:label="loc_ogi_FormulatedExtractsMember_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPackagingAndStorageMaterials" xlink:label="loc_ifrs-full_CurrentPackagingAndStorageMaterials_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_InventoriesLineItems_0" xlink:to="loc_ogi_InventoriesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_InventoriesTable_1" xlink:to="loc_ifrs-full_MeasurementAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1" xlink:to="loc_ifrs-full_AtCostMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1" xlink:to="loc_ifrs-full_AtFairValueMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_InventoriesTable_1" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ogi_PlantsInDryingStageMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ogi_DryCannabisMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ogi_DryCannabisAvailableForPackagingMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ogi_DryCannabisPackagedInventoryMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ogi_FlowerAndTrimAvailableForExtractionMember_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ogi_ConcentratedExtractMember_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ogi_FormulatedExtractsMember_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_InventoriesLineItems_0" xlink:to="loc_ifrs-full_WorkInProgress_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_InventoriesLineItems_0" xlink:to="loc_ifrs-full_FinishedGoods_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_InventoriesLineItems_0" xlink:to="loc_ifrs-full_CurrentPackagingAndStorageMaterials_19" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_InventoriesLineItems_0" xlink:to="loc_ifrs-full_Inventories_20" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrowingProcessingEquipmentMember" xlink:label="loc_ogi_GrowingProcessingEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_23"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncludedInAssetsForSale" xlink:label="loc_ogi_IncludedInAssetsForSale_24"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LandMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ConstructionInProgressMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ogi_GrowingProcessingEquipmentMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_RightofuseAssetsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_10" xlink:to="loc_ifrs-full_CarryingAmountMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_10" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_10" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_10" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_21" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_22" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_23" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ogi_IncludedInAssetsForSale_24" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentPropertyLineItems" xlink:label="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentPropertyTable" xlink:label="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SupplyAgreementMember" xlink:label="loc_ogi_SupplyAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ogi_SupplyAgreementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_LicencesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_ComputerSoftwareMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" xlink:to="loc_ifrs-full_CarryingAmountMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_7" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_7" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_17" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0" xlink:to="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_18" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfLongTermDebtDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" xlink:label="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VehicleLoansFiveYearTermMaturingJune172024Member" xlink:label="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredFinancingCosts" xlink:label="loc_ogi_DeferredFinancingCosts_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_DeferredFinancingCosts_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_Borrowings_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_LongtermBorrowings_11" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfLongTermDebtParentheticalsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" xlink:label="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VehicleLoansFiveYearTermMaturingJune172024Member" xlink:label="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsYearAmortization" xlink:label="loc_ogi_BorrowingsYearAmortization_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRate_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ogi_BorrowingsYearAmortization_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xlink:to="loc_ifrs-full_BorrowingsMaturity_10" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember" xlink:label="loc_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember" xlink:label="loc_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember" xlink:label="loc_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember" xlink:label="loc_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember" xlink:label="loc_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfForfeitureRateShareOptionsGranted" xlink:label="loc_ogi_DescriptionOfForfeitureRateShareOptionsGranted_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_ogi_DescriptionOfForfeitureRateShareOptionsGranted_11" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingRsusDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RestrictedStockUnitsMember" xlink:label="loc_ogi_RestrictedStockUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_ogi_RestrictedStockUnitsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_9" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesAxis" xlink:label="loc_ogi_AntidilutiveSecuritiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesDomain" xlink:label="loc_ogi_AntidilutiveSecuritiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_StockOptionsMember" xlink:label="loc_ogi_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesDomain" xlink:label="loc_ogi_AntidilutiveSecuritiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare" xlink:label="loc_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_EarningsPerShareTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ogi_AntidilutiveSecuritiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_AntidilutiveSecuritiesAxis_1" xlink:to="loc_ogi_AntidilutiveSecuritiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_AntidilutiveSecuritiesDomain_1" xlink:to="loc_ogi_StockOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_AntidilutiveSecuritiesAxis_1" xlink:to="loc_ogi_AntidilutiveSecuritiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_6" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AlphaCannabisPharmaGmbhMember" xlink:label="loc_ogi_AlphaCannabisPharmaGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EvianaHealthCorporationMember" xlink:label="loc_ogi_EvianaHealthCorporationMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HyasynthBiologicalsIncMember" xlink:label="loc_ogi_HyasynthBiologicalsIncMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-full_InvestmentsInAssociates_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdditionsOfInvestmentInAssociates" xlink:label="loc_ogi_AdditionsOfInvestmentInAssociates_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionCostsOfInvestmentInAssociates" xlink:label="loc_ogi_TransactionCostsOfInvestmentInAssociates_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DistributionsOfInvestmentInAssociates" xlink:label="loc_ogi_DistributionsOfInvestmentInAssociates_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ImpairmentLossOfInvestmentsInAssociates" xlink:label="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EliminationOfProportionateShareOfTransactionsWithAssociates" xlink:label="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_AlphaCannabisPharmaGmbhMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_EvianaHealthCorporationMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_HyasynthBiologicalsIncMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_InvestmentsInAssociates_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_AdditionsOfInvestmentInAssociates_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_TransactionCostsOfInvestmentInAssociates_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_DistributionsOfInvestmentInAssociates_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_13" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_14" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_15" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_16" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReceivablesAxis" xlink:label="loc_ogi_ReceivablesAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReceivablesDomain" xlink:label="loc_ogi_ReceivablesDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ZeroToSixtyDaysMember" xlink:label="loc_ogi_ZeroToSixtyDaysMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SixtyOneToOneTwentyDaysMember" xlink:label="loc_ogi_SixtyOneToOneTwentyDaysMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReceivablesDomain" xlink:label="loc_ogi_ReceivablesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TradeReceivablesGross" xlink:label="loc_ogi_TradeReceivablesGross_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProvisionForDoubtfulTradeReceivables" xlink:label="loc_ogi_ProvisionForDoubtfulTradeReceivables_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TradeReceivablesNet" xlink:label="loc_ogi_TradeReceivablesNet_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ogi_ReceivablesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_ReceivablesAxis_1" xlink:to="loc_ogi_ReceivablesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ReceivablesDomain_1" xlink:to="loc_ogi_ZeroToSixtyDaysMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ReceivablesDomain_1" xlink:to="loc_ogi_SixtyOneToOneTwentyDaysMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_ReceivablesAxis_1" xlink:to="loc_ogi_ReceivablesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ogi_TradeReceivablesGross_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ogi_ProvisionForDoubtfulTradeReceivables_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ogi_TradeReceivablesNet_9" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContractualCashFlowsMember" xlink:label="loc_ogi_ContractualCashFlowsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPayable" xlink:label="loc_ifrs-full_InterestPayable_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ogi_ContractualCashFlowsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_Borrowings_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_InterestPayable_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_13" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRevenuesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-full_ProductsAndServicesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdultUseRecreationalWholesaleRevenueMember" xlink:label="loc_ogi_AdultUseRecreationalWholesaleRevenueMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WholesaleToLicensedProducersRevenueMember" xlink:label="loc_ogi_WholesaleToLicensedProducersRevenueMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DirectToPatientMedicalRevenueMember" xlink:label="loc_ogi_DirectToPatientMedicalRevenueMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InternationalBusinessToBusinessMember" xlink:label="loc_ogi_InternationalBusinessToBusinessMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherRevenueMember" xlink:label="loc_ogi_OtherRevenueMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-full_ProductsAndServicesMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossRevenue" xlink:label="loc_ogi_GrossRevenue_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExciseTaxesExpenses" xlink:label="loc_ogi_ExciseTaxesExpenses_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_1" xlink:to="loc_ifrs-full_ProductsAndServicesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_AdultUseRecreationalWholesaleRevenueMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_WholesaleToLicensedProducersRevenueMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_DirectToPatientMedicalRevenueMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_InternationalBusinessToBusinessMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_OtherRevenueMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_1" xlink:to="loc_ifrs-full_ProductsAndServicesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ogi_GrossRevenue_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ogi_ExciseTaxesExpenses_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_Revenue_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllowanceForCreditLossesMember" xlink:label="loc_ifrs-full_AllowanceForCreditLossesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShareIssuanceCostsMember" xlink:label="loc_ogi_ShareIssuanceCostsMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PropertyPlantAndEquipmentsMember" xlink:label="loc_ogi_PropertyPlantAndEquipmentsMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherDeferredTaxAssetsMember" xlink:label="loc_ogi_OtherDeferredTaxAssetsMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermAssetsMember" xlink:label="loc_ogi_LongTermAssetsMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BiologicalAssetMember" xlink:label="loc_ogi_BiologicalAssetMember_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryMember" xlink:label="loc_ogi_InventoryMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnsecuredConvertibleDebenturesMember" xlink:label="loc_ogi_UnsecuredConvertibleDebenturesMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherDeferredTaxLiabilitiesMember" xlink:label="loc_ogi_OtherDeferredTaxLiabilitiesMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_16"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SetOffOfDeferredTaxAssets" xlink:label="loc_ogi_SetOffOfDeferredTaxAssets_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_18"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxLiabilityAbstract" xlink:label="loc_ogi_DeferredTaxLiabilityAbstract_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SetOffOfDeferredTaxLiabilities" xlink:label="loc_ogi_SetOffOfDeferredTaxLiabilities_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_AllowanceForCreditLossesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_ShareIssuanceCostsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_PropertyPlantAndEquipmentsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_OtherDeferredTaxAssetsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_LongTermAssetsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_BiologicalAssetMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_InventoryMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_RightofuseAssetsMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_UnsecuredConvertibleDebenturesMember_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_OtherDeferredTaxLiabilitiesMember_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_DeferredTaxAssets_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_16" xlink:to="loc_ogi_SetOffOfDeferredTaxAssets_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_NetDeferredTaxAssets_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ogi_DeferredTaxLiabilityAbstract_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_DeferredTaxLiabilityAbstract_20" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_DeferredTaxLiabilityAbstract_20" xlink:to="loc_ogi_SetOffOfDeferredTaxLiabilities_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_DeferredTaxLiabilityAbstract_20" xlink:to="loc_ifrs-full_NetDeferredTaxLiabilities_22" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllowanceForCreditLossesMember" xlink:label="loc_ifrs-full_AllowanceForCreditLossesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShareIssuanceCostsMember" xlink:label="loc_ogi_ShareIssuanceCostsMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PropertyPlantAndEquipmentsMember" xlink:label="loc_ogi_PropertyPlantAndEquipmentsMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BiologicalAssetMember" xlink:label="loc_ogi_BiologicalAssetMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryMember" xlink:label="loc_ogi_InventoryMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnsecuredConvertibleDebenturesMember" xlink:label="loc_ogi_UnsecuredConvertibleDebenturesMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract" xlink:label="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome" xlink:label="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_AllowanceForCreditLossesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_ShareIssuanceCostsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_PropertyPlantAndEquipmentsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_BiologicalAssetMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_InventoryMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_RightofuseAssetsMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_UnsecuredConvertibleDebenturesMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_14" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_14" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_14" xlink:to="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_16" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodAxis" xlink:label="loc_ogi_ExpirationPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodDomain" xlink:label="loc_ogi_ExpirationPeriodDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearOneMember" xlink:label="loc_ogi_ExpirationPeriodYearOneMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearTwoMember" xlink:label="loc_ogi_ExpirationPeriodYearTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearThreeMember" xlink:label="loc_ogi_ExpirationPeriodYearThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearFourMember" xlink:label="loc_ogi_ExpirationPeriodYearFourMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearFiveMember" xlink:label="loc_ogi_ExpirationPeriodYearFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodDomain" xlink:label="loc_ogi_ExpirationPeriodDomain_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome" xlink:label="loc_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ogi_ExpirationPeriodAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ogi_ExpirationPeriodAxis_1" xlink:to="loc_ogi_ExpirationPeriodDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearOneMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearTwoMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearThreeMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearFourMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearFiveMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ogi_ExpirationPeriodAxis_1" xlink:to="loc_ogi_ExpirationPeriodDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_10" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossMarginFromDiscontinuedOperations" xlink:label="loc_ogi_GrossMarginFromDiscontinuedOperations_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LossOnRemeasurementToFairValueLessCostsToSell" xlink:label="loc_ogi_LossOnRemeasurementToFairValueLessCostsToSell_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_TraumaHealingCentersMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossAbstract_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProfitLossAbstract_6" xlink:to="loc_ifrs-full_Revenue_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProfitLossAbstract_6" xlink:to="loc_ifrs-full_CostOfSales_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProfitLossAbstract_6" xlink:to="loc_ogi_GrossMarginFromDiscontinuedOperations_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProfitLossAbstract_6" xlink:to="loc_ifrs-full_ExpenseByNatureAbstract_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_ExpenseByNature_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProfitLossAbstract_6" xlink:to="loc_ifrs-full_FinanceIncome_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProfitLossAbstract_6" xlink:to="loc_ogi_LossOnRemeasurementToFairValueLessCostsToSell_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_18" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_TraumaHealingCentersMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_8" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDerecognizedAssetsAndLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesCash" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesCash_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesGoodwill" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsOnDisposalsOfInvestments_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_TraumaHealingCentersMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesCash_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_0" xlink:to="loc_ifrs-full_GainsOnDisposalsOfInvestments_14" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SignificantAccountingPoliciesLineItems" xlink:label="loc_ogi_SignificantAccountingPoliciesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SignificantAccountingPoliciesTable" xlink:label="loc_ogi_SignificantAccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentOnAdoptionOfIFRS16Member" xlink:label="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperatingLeaseObligations" xlink:label="loc_ogi_OperatingLeaseObligations_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumFuturePaymentsNotRelatedToLeasePayments" xlink:label="loc_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated" xlink:label="loc_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReliefOptionForShortTermLeases" xlink:label="loc_ogi_ReliefOptionForShortTermLeases_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReliefOptionForLeasesOfLowValueAssets" xlink:label="loc_ogi_ReliefOptionForLeasesOfLowValueAssets_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DiscountingOperatingLease" xlink:label="loc_ogi_DiscountingOperatingLease_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ogi_SignificantAccountingPoliciesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ogi_SignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" xlink:to="loc_ifrs-full_RestatedMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_1" xlink:to="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" xlink:to="loc_ifrs-full_RestatedMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ogi_OperatingLeaseObligations_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ogi_ReliefOptionForShortTermLeases_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ogi_ReliefOptionForLeasesOfLowValueAssets_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ogi_DiscountingOperatingLease_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_0" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_13" order="80" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherLiabilitiesMember" xlink:label="loc_ogi_OtherLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PrepaidExpensesMember" xlink:label="loc_ogi_PrepaidExpensesMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption" xlink:label="loc_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_ogi_OtherLiabilitiesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_ogi_PrepaidExpensesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_RightofuseAssets_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_LeaseLiabilities_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_11" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MonctonCampusPhase4CAssetSpecificMember" xlink:label="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReclassificationOfComputerSoftware" xlink:label="loc_ogi_ReclassificationOfComputerSoftware_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueLessCostToDispose" xlink:label="loc_ogi_FairValueLessCostToDispose_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContractuallyCommittedFutureCosts" xlink:label="loc_ogi_ContractuallyCommittedFutureCosts_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5" xlink:to="loc_ifrs-full_CarryingAmountMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_5" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_5" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ogi_ReclassificationOfComputerSoftware_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ogi_FairValueLessCostToDispose_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLoss_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ogi_ContractuallyCommittedFutureCosts_15" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SHARECAPITALPerformanceShareUnits">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PerformanceShareUnitsMember" xlink:label="loc_ogi_PerformanceShareUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_ogi_PerformanceShareUnitsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_8" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIESDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentOnAdoptionOfIFRS16Member" xlink:label="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdditionsToLeaseLiabilities" xlink:label="loc_ogi_AdditionsToLeaseLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" xlink:to="loc_ifrs-full_RestatedMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_1" xlink:to="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" xlink:to="loc_ifrs-full_RestatedMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_LeaseLiabilitiesAbstract_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_6" xlink:to="loc_ifrs-full_LeaseLiabilities_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_6" xlink:to="loc_ogi_AdditionsToLeaseLiabilities_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_6" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_6" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_6" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_6" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_11" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIESDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_Default"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UndiscountedOperatingLeasePaymentsToBePaid" xlink:label="loc_ogi_UndiscountedOperatingLeasePaymentsToBePaid_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ogi_UndiscountedOperatingLeasePaymentsToBePaid_11" order="10" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>ogi-20200831_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncome_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts" xlink:label="loc_ifrs-full_AdjustmentsForFinanceCosts_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForInterestIncome" xlink:label="loc_ifrs-full_AdjustmentsForInterestIncome_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllowanceForCreditLossesMember" xlink:label="loc_ifrs-full_AllowanceForCreditLossesMember_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_42"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtCostMember" xlink:label="loc_ifrs-full_AtCostMember_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor" xlink:label="loc_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_46"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_47"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsByGroupAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByGroupAxis_51"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsGroupMember" xlink:label="loc_ifrs-full_BiologicalAssetsGroupMember_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingCostsIncurred" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_53"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_54"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_55"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_56"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_57"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_58"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_59"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_60"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_61"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_62"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_63"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_64"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_65"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_66"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_68"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_69"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_70"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_71"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_72"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_73"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_74"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_75"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_76"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_77"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_78"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_79"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_80"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_81"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_82"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_83"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_84"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_85"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_86"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_87"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_88"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember_89"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_90"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_91"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_92"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_93"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_94"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_95"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_96"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_97"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_98"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="loc_ifrs-full_CurrentGovernmentGrants_99"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentHeldtomaturityInvestments" xlink:label="loc_ifrs-full_CurrentHeldtomaturityInvestments_100"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_101"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_102"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_103"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLoansAndReceivables" xlink:label="loc_ifrs-full_CurrentLoansAndReceivables_104"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_105"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPackagingAndStorageMaterials" xlink:label="loc_ifrs-full_CurrentPackagingAndStorageMaterials_106"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_107"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:label="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_108"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_109"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtInstrumentsHeldAbstract" xlink:label="loc_ifrs-full_DebtInstrumentsHeldAbstract_110"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_111"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_112"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_113"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_114"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_115"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_116"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_117"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_118"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_119"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_120"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_121"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_122"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_123"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_124"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_125"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_126"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_127"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_128"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_129"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_130"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_131"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_132"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_133"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_134"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_135"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_136"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_137"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_138"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_139"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_140"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_141"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_142"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements" xlink:label="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_143"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_144"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_145"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_146"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_147"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_148"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_149"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_150"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_151"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_152"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_153"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_154"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredIncomeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredIncomeExplanatory_155"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_156"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_157"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_158"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_159"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_160"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_161"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_162"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_163"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_164"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_165"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_166"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_167"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_168"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_169"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_170"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_171"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_172"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_173"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_174"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_175"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_176"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_177"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_178"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_179"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentPropertyLineItems" xlink:label="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_180"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentPropertyTable" xlink:label="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_181"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_182"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_183"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_184"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_185"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_186"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_187"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_188"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_189"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_190"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_191"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_192"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_193"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_194"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_195"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_196"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_197"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_198"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_199"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_200"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_202"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_203"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_204"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_205"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_206"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_207"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_208"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_209"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_210"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_211"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_212"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_213"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_214"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRevenueExplanatory_215"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_216"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_217"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_218"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_219"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_220"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_221"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_222"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_223"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_224"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_225"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_226"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_227"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_228"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_229"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_230"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsBiologicalAssets" xlink:label="loc_ifrs-full_DisposalsBiologicalAssets_231"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_232"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_233"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_234"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DonationsAndSubsidiesExpense" xlink:label="loc_ifrs-full_DonationsAndSubsidiesExpense_235"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_236"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_237"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_238"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_239"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_240"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_241"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_242"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_243"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_244"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_245"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_246"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInstrumentsHeld" xlink:label="loc_ifrs-full_EquityInstrumentsHeld_247"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_248"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_249"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_250"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_251"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_252"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_253"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_254"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_255"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_256"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:label="loc_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_257"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_258"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_259"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_260"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_261"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_262"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_263"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_264"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_265"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_266"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsOnDisposalsOfInvestments_267"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_268"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_269"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_270"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_271"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_272"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_273"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_274"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_275"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_276"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_277"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_278"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_279"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_280"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_281"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_282"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_283"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_284"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_285"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_286"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_287"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_288"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_289"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InformationAboutMajorCustomers" xlink:label="loc_ifrs-full_InformationAboutMajorCustomers_290"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_291"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_292"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_293"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_294"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_295"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPayable" xlink:label="loc_ifrs-full_InterestPayable_296"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_297"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_298"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_299"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-full_InvestmentsInAssociates_300"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_301"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_302"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_303"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_304"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_305"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_306"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_307"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_308"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_309"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_310"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_311"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_312"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_313"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_314"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_315"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_316"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_317"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_318"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_319"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_320"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_321"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_322"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_323"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_324"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LoansAndReceivables" xlink:label="loc_ifrs-full_LoansAndReceivables_325"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_326"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_327"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_328"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_329"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_330"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_331"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_332"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_333"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_334"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_335"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_336"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_337"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_338"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NotesAndDebenturesIssued_339"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_340"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_341"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_342"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_343"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_344"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_345"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_346"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_347"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_348"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_349"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_350"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_351"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_352"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_353"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_354"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_355"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets_356"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFeeAndCommissionExpense" xlink:label="loc_ifrs-full_OtherFeeAndCommissionExpense_357"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-full_OtherFinanceCost_358"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates" xlink:label="loc_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_359"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_360"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_361"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_362"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_363"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_364"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OutputOfAgriculturalProduce" xlink:label="loc_ifrs-full_OutputOfAgriculturalProduce_365"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForDebtIssueCosts" xlink:label="loc_ifrs-full_PaymentsForDebtIssueCosts_366"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_367"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_368"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServices_369"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_370"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlantsMember" xlink:label="loc_ifrs-full_PlantsMember_371"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrepaymentsAndAccruedIncome" xlink:label="loc_ifrs-full_PrepaymentsAndAccruedIncome_372"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_373"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_374"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_375"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_376"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_377"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_378"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_379"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-full_ProductsAndServicesMember_380"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_381"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_382"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract_383"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_384"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_385"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_386"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_387"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_388"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_389"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_390"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_391"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_392"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_393"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates_394"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_395"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_396"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_397"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_398"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_399"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_400"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract" xlink:label="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_401"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_402"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RentalIncome" xlink:label="loc_ifrs-full_RentalIncome_403"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_404"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_405"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_406"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_407"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_408"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_409"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_410"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_411"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_412"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_413"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_414"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_415"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_416"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_417"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_418"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_419"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_420"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_421"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_422"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_423"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_424"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_425"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_426"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_427"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_428"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_429"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_430"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_431"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_432"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption" xlink:label="loc_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_433"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate" xlink:label="loc_ifrs-full_TaxEffectFromChangeInTaxRate_434"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_435"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_436"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_437"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="loc_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_438"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_439"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_440"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_441"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_442"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_443"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_444"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-full_TravelExpense_445"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_446"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived" xlink:label="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_447"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_448"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_449"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UtilitiesExpense" xlink:label="loc_ifrs-full_UtilitiesExpense_450"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_451"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_452"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_453"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_454"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_455"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_456"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_457"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_458"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_459"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_460"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_461"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_462"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WritedownsReversalsOfWritedownsOfInventoriesAbstract" xlink:label="loc_ifrs-full_WritedownsReversalsOfWritedownsOfInventoriesAbstract_463"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction" xlink:label="loc_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_464"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AccountsReceivableAbstract" xlink:label="loc_ogi_AccountsReceivableAbstract_465"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AchievementOfContractualProductionRelatedMilestoneMember" xlink:label="loc_ogi_AchievementOfContractualProductionRelatedMilestoneMember_466"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:label="loc_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_467"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdditionsOfInvestmentInAssociates" xlink:label="loc_ogi_AdditionsOfInvestmentInAssociates_468"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdditionsRelatedToIFRS16Leases" xlink:label="loc_ogi_AdditionsRelatedToIFRS16Leases_469"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdditionsToLeaseLiabilities" xlink:label="loc_ogi_AdditionsToLeaseLiabilities_470"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentOnAdoptionOfIFRS16Member" xlink:label="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_471"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges" xlink:label="loc_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_472"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_473"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_474"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentToNetRealizableValueBiologicalAssets" xlink:label="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_475"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdultUseRecreationalWholesaleRevenueMember" xlink:label="loc_ogi_AdultUseRecreationalWholesaleRevenueMember_476"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvanceGivenAsConvertibleDebentures" xlink:label="loc_ogi_AdvanceGivenAsConvertibleDebentures_477"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvancePayment" xlink:label="loc_ogi_AdvancePayment_478"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvisoryServicesAgreementMember" xlink:label="loc_ogi_AdvisoryServicesAgreementMember_479"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths" xlink:label="loc_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_480"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel" xlink:label="loc_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_481"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement" xlink:label="loc_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_482"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateNumberOfCommonSharesConverted" xlink:label="loc_ogi_AggregateNumberOfCommonSharesConverted_483"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount" xlink:label="loc_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_484"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AlphaCannabisPharmaGmbhMember" xlink:label="loc_ogi_AlphaCannabisPharmaGmbhMember_485"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmendmentAndRestatementMember" xlink:label="loc_ogi_AmendmentAndRestatementMember_486"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmendmentFee" xlink:label="loc_ogi_AmendmentFee_487"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizationOfDebentureDiscount" xlink:label="loc_ogi_AmortizationOfDebentureDiscount_488"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizationOfIssueCosts" xlink:label="loc_ogi_AmortizationOfIssueCosts_489"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizedToSellingAndMarketingExpenses" xlink:label="loc_ogi_AmortizedToSellingAndMarketingExpenses_490"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizedToShareBasedCompensation" xlink:label="loc_ogi_AmortizedToShareBasedCompensation_491"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy" xlink:label="loc_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_492"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy" xlink:label="loc_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_493"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesAxis" xlink:label="loc_ogi_AntidilutiveSecuritiesAxis_494"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesDomain" xlink:label="loc_ogi_AntidilutiveSecuritiesDomain_495"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare" xlink:label="loc_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_496"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ApplicableMarginRate" xlink:label="loc_ogi_ApplicableMarginRate_497"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember" xlink:label="loc_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_498"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" xlink:label="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_499"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AverageSellingPriceInputValuesPerGram" xlink:label="loc_ogi_AverageSellingPriceInputValuesPerGram_500"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AverageYieldPerPlantInputValuesPerGram" xlink:label="loc_ogi_AverageYieldPerPlantInputValuesPerGram_501"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BalanceSheetLocationsDomain" xlink:label="loc_ogi_BalanceSheetLocationsDomain_502"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_503"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BasisOfPreparationAbstract" xlink:label="loc_ogi_BasisOfPreparationAbstract_504"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BiologicalAssetMember" xlink:label="loc_ogi_BiologicalAssetMember_505"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BmoCreditFacilityMember" xlink:label="loc_ogi_BmoCreditFacilityMember_506"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BmoTermLoanCreditFacilityMember" xlink:label="loc_ogi_BmoTermLoanCreditFacilityMember_507"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsCashInterestRate" xlink:label="loc_ogi_BorrowingsCashInterestRate_508"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsEffectiveInterestRate" xlink:label="loc_ogi_BorrowingsEffectiveInterestRate_509"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter" xlink:label="loc_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_510"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsReducedCashInterestRate" xlink:label="loc_ogi_BorrowingsReducedCashInterestRate_511"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsReducedEffectiveInterestRate" xlink:label="loc_ogi_BorrowingsReducedEffectiveInterestRate_512"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsYearAmortization" xlink:label="loc_ogi_BorrowingsYearAmortization_513"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BottledAndPackagedOil" xlink:label="loc_ogi_BottledAndPackagedOil_514"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BottledAndPackagedOilMember" xlink:label="loc_ogi_BottledAndPackagedOilMember_515"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BulkFormulatedOil" xlink:label="loc_ogi_BulkFormulatedOil_516"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BulkFormulatedOilMember" xlink:label="loc_ogi_BulkFormulatedOilMember_517"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CannabisConsultantMember" xlink:label="loc_ogi_CannabisConsultantMember_518"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CapitalConsideration" xlink:label="loc_ogi_CapitalConsideration_519"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CapitalizedTransactionCostsAndEquityDiscount" xlink:label="loc_ogi_CapitalizedTransactionCostsAndEquityDiscount_520"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CapitalManagementAbstract" xlink:label="loc_ogi_CapitalManagementAbstract_521"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashCollateral" xlink:label="loc_ogi_CashCollateral_522"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionFeeNoncurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_523"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionsFeeCurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_524"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPositionAbstract" xlink:label="loc_ogi_CashPositionAbstract_525"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment" xlink:label="loc_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_526"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChangeInBenchmarkInterestRates" xlink:label="loc_ogi_ChangeInBenchmarkInterestRates_527"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChangeInUnrecognizedTemporaryDifferences" xlink:label="loc_ogi_ChangeInUnrecognizedTemporaryDifferences_528"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChargesForUnabsorbedFixedOverhead" xlink:label="loc_ogi_ChargesForUnabsorbedFixedOverhead_529"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChargesRelatedToPlantCulling" xlink:label="loc_ogi_ChargesRelatedToPlantCulling_530"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChargesRelatedToReducedWorkforce" xlink:label="loc_ogi_ChargesRelatedToReducedWorkforce_531"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months" xlink:label="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_532"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months" xlink:label="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_533"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones" xlink:label="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_534"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommittedAndUncommittedBorrowingFacilities" xlink:label="loc_ogi_CommittedAndUncommittedBorrowingFacilities_535"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommittedBorrowingFacilities" xlink:label="loc_ogi_CommittedBorrowingFacilities_536"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConcentratedExtractMember" xlink:label="loc_ogi_ConcentratedExtractMember_537"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContingenciesAbstract" xlink:label="loc_ogi_ContingenciesAbstract_538"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContingentShareConsideration" xlink:label="loc_ogi_ContingentShareConsideration_539"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContractualCashFlowsMember" xlink:label="loc_ogi_ContractualCashFlowsMember_540"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContractuallyCommittedFutureCosts" xlink:label="loc_ogi_ContractuallyCommittedFutureCosts_541"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfConvertibleDebenturesAmountConverted" xlink:label="loc_ogi_ConversionOfConvertibleDebenturesAmountConverted_542"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfConvertibleDebenturesSharesIssued" xlink:label="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_543"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfDebenturesDescription" xlink:label="loc_ogi_ConversionOfDebenturesDescription_544"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfDebenturesPricePerShare" xlink:label="loc_ogi_ConversionOfDebenturesPricePerShare_545"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebentureIssueCosts" xlink:label="loc_ogi_ConvertibleDebentureIssueCosts_546"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability" xlink:label="loc_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_547"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesChangeInControlPercentage" xlink:label="loc_ogi_ConvertibleDebenturesChangeInControlPercentage_548"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesConversionPrice" xlink:label="loc_ogi_ConvertibleDebenturesConversionPrice_549"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate" xlink:label="loc_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_550"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesEffectiveInterestRate" xlink:label="loc_ogi_ConvertibleDebenturesEffectiveInterestRate_551"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesFaceValue" xlink:label="loc_ogi_ConvertibleDebenturesFaceValue_552"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesMember" xlink:label="loc_ogi_ConvertibleDebenturesMember_553"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesReceivableFaceValue" xlink:label="loc_ogi_ConvertibleDebenturesReceivableFaceValue_554"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion" xlink:label="loc_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_555"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts" xlink:label="loc_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_556"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesAxis" xlink:label="loc_ogi_CreditFacilitiesAxis_557"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesDomain" xlink:label="loc_ogi_CreditFacilitiesDomain_558"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentAxis" xlink:label="loc_ogi_CreditFacilityAmendmentAxis_559"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentDomain" xlink:label="loc_ogi_CreditFacilityAmendmentDomain_560"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CumulativeConvertedDebentures" xlink:label="loc_ogi_CumulativeConvertedDebentures_561"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="loc_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_562"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DebtIssueRelatedCost" xlink:label="loc_ogi_DebtIssueRelatedCost_563"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DebtIssueRelatedCostAllocatedToEquity" xlink:label="loc_ogi_DebtIssueRelatedCostAllocatedToEquity_564"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DebtIssuesCost" xlink:label="loc_ogi_DebtIssuesCost_565"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember" xlink:label="loc_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_566"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredFinancingCosts" xlink:label="loc_ogi_DeferredFinancingCosts_567"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxLiabilityAbstract" xlink:label="loc_ogi_DeferredTaxLiabilityAbstract_568"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxOnConvertibleDebentureFinancing" xlink:label="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_569"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome" xlink:label="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_570"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_571"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesCash" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesCash_572"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesGoodwill" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_573"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_574"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_575"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_576"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_577"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory" xlink:label="loc_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_578"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfBusinessAbstract" xlink:label="loc_ogi_DescriptionOfBusinessAbstract_579"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfExpectedLifeOfWarrantsGranted" xlink:label="loc_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_580"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfExpectedVolatilityWarrantsGranted" xlink:label="loc_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_581"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfForfeitureRateShareOptionsGranted" xlink:label="loc_ogi_DescriptionOfForfeitureRateShareOptionsGranted_582"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfOptionLifeSharesOptionsGranted" xlink:label="loc_ogi_DescriptionOfOptionLifeSharesOptionsGranted_583"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted" xlink:label="loc_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_584"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DifferenceBetweenCurrentAndFutureTaxRates" xlink:label="loc_ogi_DifferenceBetweenCurrentAndFutureTaxRates_585"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_586"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_587"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_588"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DirectToPatientMedicalRevenueMember" xlink:label="loc_ogi_DirectToPatientMedicalRevenueMember_589"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfAccountsReceivableLineItems" xlink:label="loc_ogi_DisclosureOfAccountsReceivableLineItems_590"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory" xlink:label="loc_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_591"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory" xlink:label="loc_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_592"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfCostOfSalesAbstract" xlink:label="loc_ogi_DisclosureOfCostOfSalesAbstract_593"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_594"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_595"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_596"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_597"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_598"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_599"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_600"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_601"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_602"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_603"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_604"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_605"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_606"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_607"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_608"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_609"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_610"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_611"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_612"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants" xlink:label="loc_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_613"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_614"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory_615"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_616"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_617"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfIndirectProductionExplanatory" xlink:label="loc_ogi_DisclosureOfIndirectProductionExplanatory_618"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory" xlink:label="loc_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_619"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfLoanReceivablesExplanatory" xlink:label="loc_ogi_DisclosureOfLoanReceivablesExplanatory_620"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory" xlink:label="loc_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_621"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfNatureOfOperationsExplanatory" xlink:label="loc_ogi_DisclosureOfNatureOfOperationsExplanatory_622"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory" xlink:label="loc_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_623"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_624"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_625"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOtherLiabilitiesAbstract" xlink:label="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_626"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfPriorPeriodReclassificationExplanatory" xlink:label="loc_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_627"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_628"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShortTermInvestmentsLineItems" xlink:label="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_629"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShortTermInvestmentsTable" xlink:label="loc_ogi_DisclosureOfShortTermInvestmentsTable_630"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_631"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DiscountingOperatingLease" xlink:label="loc_ogi_DiscountingOperatingLease_632"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DistributionsOfInvestmentInAssociates" xlink:label="loc_ogi_DistributionsOfInvestmentInAssociates_633"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DocumentAndEntityInformationAbstract" xlink:label="loc_ogi_DocumentAndEntityInformationAbstract_634"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisAbstract" xlink:label="loc_ogi_DryCannabisAbstract_635"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisAvailableForPackagingMember" xlink:label="loc_ogi_DryCannabisAvailableForPackagingMember_636"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisMember" xlink:label="loc_ogi_DryCannabisMember_637"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisPackagedInventoryMember" xlink:label="loc_ogi_DryCannabisPackagedInventoryMember_638"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EffectOfTaxRatesInOtherJurisdictions" xlink:label="loc_ogi_EffectOfTaxRatesInOtherJurisdictions_639"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EffectOnFairValueAverageNetSellingPricePerGram" xlink:label="loc_ogi_EffectOnFairValueAverageNetSellingPricePerGram_640"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EffectOnFairValueAverageYieldPerPlant" xlink:label="loc_ogi_EffectOnFairValueAverageYieldPerPlant_641"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EliminationOfProportionateShareOfTransactionsWithAssociates" xlink:label="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_642"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityFinancingMember" xlink:label="loc_ogi_EquityFinancingMember_643"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityIncentivePlanMember" xlink:label="loc_ogi_EquityIncentivePlanMember_644"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityInstrumentsHeldSharePrice" xlink:label="loc_ogi_EquityInstrumentsHeldSharePrice_645"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityIssuancePricePerShare" xlink:label="loc_ogi_EquityIssuancePricePerShare_646"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityReserveMember" xlink:label="loc_ogi_EquityReserveMember_647"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquitySecuritiesFairValuePerShare" xlink:label="loc_ogi_EquitySecuritiesFairValuePerShare_648"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquitySecuritiesInVivoCannabisIncMember" xlink:label="loc_ogi_EquitySecuritiesInVivoCannabisIncMember_649"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfEmployeeOptionsIssued" xlink:label="loc_ogi_EstimatedFairValueOfEmployeeOptionsIssued_650"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted" xlink:label="loc_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_651"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted" xlink:label="loc_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_652"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfPerformanceStockUnitsIssued" xlink:label="loc_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_653"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfRestrictedStockUnitsIssued" xlink:label="loc_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_654"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EventsAfterReportingPeriodMember" xlink:label="loc_ogi_EventsAfterReportingPeriodMember_655"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EvianaHealthCorporationMember" xlink:label="loc_ogi_EvianaHealthCorporationMember_656"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExciseTaxesExpenses" xlink:label="loc_ogi_ExciseTaxesExpenses_657"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember" xlink:label="loc_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_658"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember" xlink:label="loc_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_659"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember" xlink:label="loc_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_660"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember" xlink:label="loc_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_661"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember" xlink:label="loc_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_662"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpectedDividendAsPercentageWarrantsGranted" xlink:label="loc_ogi_ExpectedDividendAsPercentageWarrantsGranted_663"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodAxis" xlink:label="loc_ogi_ExpirationPeriodAxis_664"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodDomain" xlink:label="loc_ogi_ExpirationPeriodDomain_665"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearFiveMember" xlink:label="loc_ogi_ExpirationPeriodYearFiveMember_666"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearFourMember" xlink:label="loc_ogi_ExpirationPeriodYearFourMember_667"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearOneMember" xlink:label="loc_ogi_ExpirationPeriodYearOneMember_668"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearThreeMember" xlink:label="loc_ogi_ExpirationPeriodYearThreeMember_669"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearTwoMember" xlink:label="loc_ogi_ExpirationPeriodYearTwoMember_670"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueLessCostToDispose" xlink:label="loc_ogi_FairValueLessCostToDispose_671"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueOfContingentShares" xlink:label="loc_ogi_FairValueOfContingentShares_672"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueOfOptionsGranted" xlink:label="loc_ogi_FairValueOfOptionsGranted_673"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember" xlink:label="loc_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_674"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember" xlink:label="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_675"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember" xlink:label="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_676"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FirstAmendmentMember" xlink:label="loc_ogi_FirstAmendmentMember_677"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FlowerAndTrimAvailableForExtractionMember" xlink:label="loc_ogi_FlowerAndTrimAvailableForExtractionMember_678"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FormulatedExtractsMember" xlink:label="loc_ogi_FormulatedExtractsMember_679"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GovernmentProgramsReceivable" xlink:label="loc_ogi_GovernmentProgramsReceivable_680"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GovernmentSubsidiesAbstract" xlink:label="loc_ogi_GovernmentSubsidiesAbstract_681"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossMarginBeforeFairValueAdjustments" xlink:label="loc_ogi_GrossMarginBeforeFairValueAdjustments_682"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossMarginFromDiscontinuedOperations" xlink:label="loc_ogi_GrossMarginFromDiscontinuedOperations_683"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossRevenue" xlink:label="loc_ogi_GrossRevenue_684"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrowingProcessingEquipmentMember" xlink:label="loc_ogi_GrowingProcessingEquipmentMember_685"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesFiveMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesFiveMember_686"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesFourMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesFourMember_687"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesOneMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesOneMember_688"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesThreeMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesThreeMember_689"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesTwoMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesTwoMember_690"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HarmonizedSalesTaxesReceivable" xlink:label="loc_ogi_HarmonizedSalesTaxesReceivable_691"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_Hemp1812With703454NBIncMember" xlink:label="loc_ogi_Hemp1812With703454NBIncMember_692"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HyasynthBiologicalsIncMember" xlink:label="loc_ogi_HyasynthBiologicalsIncMember_693"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ImpairmentLossOfInvestmentsInAssociates" xlink:label="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_694"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncludedInAssetsForSale" xlink:label="loc_ogi_IncludedInAssetsForSale_695"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncomeFromGovernmentSubsidies" xlink:label="loc_ogi_IncomeFromGovernmentSubsidies_696"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncomeFromSubleasingAggregateRent" xlink:label="loc_ogi_IncomeFromSubleasingAggregateRent_697"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized" xlink:label="loc_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_698"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets" xlink:label="loc_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_699"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract" xlink:label="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_700"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts" xlink:label="loc_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_701"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughConstructionCompleted" xlink:label="loc_ogi_IncreaseDecreaseThroughConstructionCompleted_702"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing" xlink:label="loc_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_703"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits" xlink:label="loc_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_704"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughForeignCurrencyTranslation" xlink:label="loc_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_705"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughShareBasedCompensation" xlink:label="loc_ogi_IncreaseDecreaseThroughShareBasedCompensation_706"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures" xlink:label="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_707"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts" xlink:label="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_708"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncrementalUncommittedOptionToIncreaseFacilities" xlink:label="loc_ogi_IncrementalUncommittedOptionToIncreaseFacilities_709"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IndirectProduction" xlink:label="loc_ogi_IndirectProduction_710"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IndirectProductionCostOfSale" xlink:label="loc_ogi_IndirectProductionCostOfSale_711"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InitiallyDrawnAmount" xlink:label="loc_ogi_InitiallyDrawnAmount_712"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InterestRateOnPromissoryNoteReceivable" xlink:label="loc_ogi_InterestRateOnPromissoryNoteReceivable_713"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InternationalBusinessToBusinessMember" xlink:label="loc_ogi_InternationalBusinessToBusinessMember_714"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesAbstract" xlink:label="loc_ogi_InventoriesAbstract_715"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue" xlink:label="loc_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_716"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesLineItems" xlink:label="loc_ogi_InventoriesLineItems_717"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesTable" xlink:label="loc_ogi_InventoriesTable_718"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryMember" xlink:label="loc_ogi_InventoryMember_719"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction" xlink:label="loc_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_720"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories" xlink:label="loc_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_721"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales" xlink:label="loc_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_722"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InvestmentInAssociatesRestrictedInvestment" xlink:label="loc_ogi_InvestmentInAssociatesRestrictedInvestment_723"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InvestmentsInterestRate" xlink:label="loc_ogi_InvestmentsInterestRate_724"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfEquityFinancingShares" xlink:label="loc_ogi_IssuanceOfEquityFinancingShares_725"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesConversionOfDebentures" xlink:label="loc_ogi_IssuanceOfSharesConversionOfDebentures_726"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_727"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfStockOptions" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfStockOptions_728"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfWarrants" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfWarrants_729"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesShareBasedCompensation" xlink:label="loc_ogi_IssuanceOfSharesShareBasedCompensation_730"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesShareBasedPayments" xlink:label="loc_ogi_IssuanceOfSharesShareBasedPayments_731"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts" xlink:label="loc_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_732"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssueCostAtMarketEquityFinancing" xlink:label="loc_ogi_IssueCostAtMarketEquityFinancing_733"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:label="loc_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_734"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LeaseLiabilityMember" xlink:label="loc_ogi_LeaseLiabilityMember_735"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated" xlink:label="loc_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_736"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementAbstract" xlink:label="loc_ogi_LicensingAndEndorsementAgreementAbstract_737"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementLineItems" xlink:label="loc_ogi_LicensingAndEndorsementAgreementLineItems_738"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementMember" xlink:label="loc_ogi_LicensingAndEndorsementAgreementMember_739"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementTable" xlink:label="loc_ogi_LicensingAndEndorsementAgreementTable_740"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoanReceivableLineItems" xlink:label="loc_ogi_LoanReceivableLineItems_741"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoanReceivableTable" xlink:label="loc_ogi_LoanReceivableTable_742"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoansReceivablesAbstract" xlink:label="loc_ogi_LoansReceivablesAbstract_743"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermAssetsMember" xlink:label="loc_ogi_LongTermAssetsMember_744"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_745"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_746"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_747"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_748"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_749"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_750"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LossOnRemeasurementToFairValueLessCostsToSell" xlink:label="loc_ogi_LossOnRemeasurementToFairValueLessCostsToSell_751"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers" xlink:label="loc_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_752"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MaximumCommitmentToDeliverAdditionalConsideration" xlink:label="loc_ogi_MaximumCommitmentToDeliverAdditionalConsideration_753"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement" xlink:label="loc_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_754"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MaximumPercentageOfAnnualCbdOilPurchased" xlink:label="loc_ogi_MaximumPercentageOfAnnualCbdOilPurchased_755"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement" xlink:label="loc_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_756"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumFuturePayments" xlink:label="loc_ogi_MinimumFuturePayments_757"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumFuturePaymentsNotRelatedToLeasePayments" xlink:label="loc_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_758"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumUnrestrictedCashBalanceRequirement" xlink:label="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_759"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MonctonCampusPhase4CAssetSpecificMember" xlink:label="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_760"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NetProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ogi_NetProceedsFromIssueOfOrdinaryShares_761"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome" xlink:label="loc_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_762"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NonCurrentContingentShareConsideration" xlink:label="loc_ogi_NonCurrentContingentShareConsideration_763"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfCommonSharesIssued" xlink:label="loc_ogi_NumberOfCommonSharesIssued_764"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfConvertibleDebenturesSold" xlink:label="loc_ogi_NumberOfConvertibleDebenturesSold_765"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfOutstandingWarrants" xlink:label="loc_ogi_NumberOfOutstandingWarrants_766"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfSharePurchaseWarrantUnitsAcquired" xlink:label="loc_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_767"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfSharesAcquired" xlink:label="loc_ogi_NumberOfSharesAcquired_768"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExercisedOrReleased" xlink:label="loc_ogi_NumberOfWarrantsExercisedOrReleased_769"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExpired" xlink:label="loc_ogi_NumberOfWarrantsExpired_770"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExpiredOrReleased" xlink:label="loc_ogi_NumberOfWarrantsExpiredOrReleased_771"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsGranted" xlink:label="loc_ogi_NumberOfWarrantsGranted_772"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperatingLeaseObligations" xlink:label="loc_ogi_OperatingLeaseObligations_773"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_774"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_775"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherBiologicalAssetsMember" xlink:label="loc_ogi_OtherBiologicalAssetsMember_776"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherDeferredTaxAssetsMember" xlink:label="loc_ogi_OtherDeferredTaxAssetsMember_777"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherDeferredTaxLiabilitiesMember" xlink:label="loc_ogi_OtherDeferredTaxLiabilitiesMember_778"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherLiabilitiesMember" xlink:label="loc_ogi_OtherLiabilitiesMember_779"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherRevenueMember" xlink:label="loc_ogi_OtherRevenueMember_780"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PaymentAgreementMember" xlink:label="loc_ogi_PaymentAgreementMember_781"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PaymentsForIntangibleAssetsOther" xlink:label="loc_ogi_PaymentsForIntangibleAssetsOther_782"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice" xlink:label="loc_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_783"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears" xlink:label="loc_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_784"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower" xlink:label="loc_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_785"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture" xlink:label="loc_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_786"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy" xlink:label="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_787"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations" xlink:label="loc_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_788"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentagesOfAccruedInterestReceivable" xlink:label="loc_ogi_PercentagesOfAccruedInterestReceivable_789"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PerformanceShareUnitsMember" xlink:label="loc_ogi_PerformanceShareUnitsMember_790"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PlantsInDryingStageMember" xlink:label="loc_ogi_PlantsInDryingStageMember_791"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate" xlink:label="loc_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_792"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PotentialProportionOfOwnershipInterestInAssociate" xlink:label="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_793"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent" xlink:label="loc_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_794"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PrepaidExpensesMember" xlink:label="loc_ogi_PrepaidExpensesMember_795"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PricePerConvertibleDebentureIssued" xlink:label="loc_ogi_PricePerConvertibleDebentureIssued_796"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PriorPeriodReclassificationAbstract" xlink:label="loc_ogi_PriorPeriodReclassificationAbstract_797"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProceedsDrawnFromTermLoanCreditFacilities" xlink:label="loc_ogi_ProceedsDrawnFromTermLoanCreditFacilities_798"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised" xlink:label="loc_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_799"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PromissoryNoteMember" xlink:label="loc_ogi_PromissoryNoteMember_800"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PropertyPlantAndEquipmentsMember" xlink:label="loc_ogi_PropertyPlantAndEquipmentsMember_801"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProportionOfOwnershipInterestInSubsidiarySold" xlink:label="loc_ogi_ProportionOfOwnershipInterestInSubsidiarySold_802"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProvisionForDoubtfulAccount" xlink:label="loc_ogi_ProvisionForDoubtfulAccount_803"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProvisionForDoubtfulTradeReceivables" xlink:label="loc_ogi_ProvisionForDoubtfulTradeReceivables_804"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PurchaseCostOfLandAndMovableEquipment" xlink:label="loc_ogi_PurchaseCostOfLandAndMovableEquipment_805"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_QuantityOfInventory" xlink:label="loc_ogi_QuantityOfInventory_806"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_QuarterlyRepayments" xlink:label="loc_ogi_QuarterlyRepayments_807"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RealizedFairValueAmountsIncludedInInventorySold" xlink:label="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_808"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReceivablesAxis" xlink:label="loc_ogi_ReceivablesAxis_809"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReceivablesDomain" xlink:label="loc_ogi_ReceivablesDomain_810"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReclassificationOfComputerSoftware" xlink:label="loc_ogi_ReclassificationOfComputerSoftware_811"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReclassificationOfSalesReturnsToGrossRevenue" xlink:label="loc_ogi_ReclassificationOfSalesReturnsToGrossRevenue_812"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RecoverableAmountBasedOnValueInUse" xlink:label="loc_ogi_RecoverableAmountBasedOnValueInUse_813"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReductionInRevolverCommitment" xlink:label="loc_ogi_ReductionInRevolverCommitment_814"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RegulatoryFees" xlink:label="loc_ogi_RegulatoryFees_815"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReliefOptionForLeasesOfLowValueAssets" xlink:label="loc_ogi_ReliefOptionForLeasesOfLowValueAssets_816"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReliefOptionForShortTermLeases" xlink:label="loc_ogi_ReliefOptionForShortTermLeases_817"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RenewalTermOfAgreement" xlink:label="loc_ogi_RenewalTermOfAgreement_818"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RentalIncomeOverSubleaseTerm" xlink:label="loc_ogi_RentalIncomeOverSubleaseTerm_819"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" xlink:label="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_820"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RestrictedInvestment" xlink:label="loc_ogi_RestrictedInvestment_821"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RestrictedStockUnitsMember" xlink:label="loc_ogi_RestrictedStockUnitsMember_822"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RevolvingCreditFacilitiesMember" xlink:label="loc_ogi_RevolvingCreditFacilitiesMember_823"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RightToPurchaseUpToAnnualCbdOil" xlink:label="loc_ogi_RightToPurchaseUpToAnnualCbdOil_824"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RoyaltyPaymentPercentage" xlink:label="loc_ogi_RoyaltyPaymentPercentage_825"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SalesOfStockAxis" xlink:label="loc_ogi_SalesOfStockAxis_826"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SalesOfStockDomain" xlink:label="loc_ogi_SalesOfStockDomain_827"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SecondAmendmentMember" xlink:label="loc_ogi_SecondAmendmentMember_828"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SecuredLoanMember" xlink:label="loc_ogi_SecuredLoanMember_829"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram" xlink:label="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_830"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram" xlink:label="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_831"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SetOffOfDeferredTaxAssets" xlink:label="loc_ogi_SetOffOfDeferredTaxAssets_832"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SetOffOfDeferredTaxLiabilities" xlink:label="loc_ogi_SetOffOfDeferredTaxLiabilities_833"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShareIssuanceCostsMember" xlink:label="loc_ogi_ShareIssuanceCostsMember_834"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit" xlink:label="loc_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_835"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantExercisePricePerShare" xlink:label="loc_ogi_SharePurchaseWarrantExercisePricePerShare_836"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion" xlink:label="loc_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_837"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion" xlink:label="loc_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_838"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales" xlink:label="loc_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_839"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentAbstract" xlink:label="loc_ogi_ShortTermInvestmentAbstract_840"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentsAxis" xlink:label="loc_ogi_ShortTermInvestmentsAxis_841"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentsDomain" xlink:label="loc_ogi_ShortTermInvestmentsDomain_842"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SignificantAccountingPoliciesLineItems" xlink:label="loc_ogi_SignificantAccountingPoliciesLineItems_843"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SignificantAccountingPoliciesTable" xlink:label="loc_ogi_SignificantAccountingPoliciesTable_844"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SixtyOneToOneTwentyDaysMember" xlink:label="loc_ogi_SixtyOneToOneTwentyDaysMember_845"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_StockOptionPlanMember" xlink:label="loc_ogi_StockOptionPlanMember_846"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_StockOptionsMember" xlink:label="loc_ogi_StockOptionsMember_847"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SubleaseAnnualRentalIncome" xlink:label="loc_ogi_SubleaseAnnualRentalIncome_848"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SupplyAgreementMember" xlink:label="loc_ogi_SupplyAgreementMember_849"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SwearNetLimitedMember" xlink:label="loc_ogi_SwearNetLimitedMember_850"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised" xlink:label="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_851"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TermLoanMember" xlink:label="loc_ogi_TermLoanMember_852"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TgsInternationalLlcMember" xlink:label="loc_ogi_TgsInternationalLlcMember_853"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares" xlink:label="loc_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_854"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TrademarkLicensingAgreement" xlink:label="loc_ogi_TrademarkLicensingAgreement_855"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TradeReceivablesGross" xlink:label="loc_ogi_TradeReceivablesGross_856"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TradeReceivablesNet" xlink:label="loc_ogi_TradeReceivablesNet_857"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_858"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionCostsOfInvestmentInAssociates" xlink:label="loc_ogi_TransactionCostsOfInvestmentInAssociates_859"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionInExchangeForTrademarkLicensingAgreementMember" xlink:label="loc_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_860"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransitionToIfrs16" xlink:label="loc_ogi_TransitionToIfrs16_861"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_862"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsAxis" xlink:label="loc_ogi_TypeOfArrangementsAxis_863"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsDomain" xlink:label="loc_ogi_TypeOfArrangementsDomain_864"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures" xlink:label="loc_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_865"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnderwritersMember" xlink:label="loc_ogi_UnderwritersMember_866"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UndiscountedOperatingLeasePaymentsToBePaid" xlink:label="loc_ogi_UndiscountedOperatingLeasePaymentsToBePaid_867"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnitsIssuedInPeriodPricePerUnit" xlink:label="loc_ogi_UnitsIssuedInPeriodPricePerUnit_868"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_869"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_870"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnsecuredConvertibleDebenturesMember" xlink:label="loc_ogi_UnsecuredConvertibleDebenturesMember_871"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue" xlink:label="loc_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_872"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UsefulLiveOfPropertyPlantAndEquipment" xlink:label="loc_ogi_UsefulLiveOfPropertyPlantAndEquipment_873"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VehicleLoansFiveYearTermMaturingJune172024Member" xlink:label="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_874"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VestingPeriodOfPerformanceStockUnits" xlink:label="loc_ogi_VestingPeriodOfPerformanceStockUnits_875"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VestingPeriodOfRestrictedStockUnits" xlink:label="loc_ogi_VestingPeriodOfRestrictedStockUnits_876"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VivoCannabisIncMember" xlink:label="loc_ogi_VivoCannabisIncMember_877"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WarrantsMember" xlink:label="loc_ogi_WarrantsMember_878"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_879"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsExpired" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsExpired_880"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsGranted" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_881"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsOutstanding" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_882"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WholesaleToLicensedProducersRevenueMember" xlink:label="loc_ogi_WholesaleToLicensedProducersRevenueMember_883"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WorkingCapital" xlink:label="loc_ogi_WorkingCapital_884"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ZeroToSixtyDaysMember" xlink:label="loc_ogi_ZeroToSixtyDaysMember_885"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract_0" xml:lang="en-US">Cover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain_0" xml:lang="en-US">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis_0" xml:lang="en-US">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1" xml:lang="en-US">Accumulated depreciation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" xml:lang="en-US">Accumulated amortization [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncome_0" xml:lang="en-US">Accumulated other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncome_1" xml:lang="en-US">Accumulated other comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_0" xml:lang="en-US">Accumulated other comprehensive income [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_1" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE LOSS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_2" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE LOSS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_2" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_0" xml:lang="en-US">Adjusted weighted average number of ordinary shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_1" xml:lang="en-US">Weighted average number of shares used in diluted earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_2" xml:lang="en-US">Weighted average number of shares used in diluted earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_0" xml:lang="en-US">Adjustments for decrease (increase) in biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1" xml:lang="en-US">Net change in biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0" xml:lang="en-US">Adjustments for decrease (increase) in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1" xml:lang="en-US">Net change in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0" xml:lang="en-US">Adjustments for decrease (increase) in trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1" xml:lang="en-US">Net change in accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_0" xml:lang="en-US">Adjustments for deferred tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_1" xml:lang="en-US">Deferred tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_0" xml:lang="en-US">Adjustments for deferred tax of prior periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_1" xml:lang="en-US">Prior period adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0" xml:lang="en-US">Adjustments for depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_1" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFinanceCosts_0" xml:lang="en-US">Adjustments for finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForFinanceCosts_1" xml:lang="en-US">Financing costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_0" xml:lang="en-US">Loss on disposal of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_1" xml:lang="en-US">Adjustments for gain (loss) on disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_2" xml:lang="en-US">Loss on disposal of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_0" xml:lang="en-US">Fair value adjustment to biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1" xml:lang="en-US">Adjustments for gains (losses) on change in fair value less costs to sell, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2" xml:lang="en-US">Fair value adjustment to biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0" xml:lang="en-US">Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1" xml:lang="en-US">Impairment losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1" xml:lang="en-US">Net change in accounts payable and accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForInterestIncome_0" xml:lang="en-US">Investment income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForInterestIncome_1" xml:lang="en-US">Adjustments for interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForInterestIncome_2" xml:lang="en-US">Investment income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1" xml:lang="en-US">Items not affecting cash:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_0" xml:lang="en-US">Adjustments for share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedMeasurementMember_0" xml:lang="en-US">Aggregated measurement [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember_0" xml:lang="en-US">Aggregated time bands [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AllowanceForCreditLossesMember_0" xml:lang="en-US">Allowance for credit losses [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AllowanceForCreditLossesMember_1" xml:lang="en-US">Non-capital losses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ApplicableTaxRate_0" xml:lang="en-US">Applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ApplicableTaxRate_1" xml:lang="en-US">Statutory income tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAbstract_0" xml:lang="en-US">ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AtCostMember_0" xml:lang="en-US">At cost [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AtCostMember_1" xml:lang="en-US">CAPITALIZED COST [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AtFairValueMember_0" xml:lang="en-US">FAIR VALUE ADJUSTMENT [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_0" xml:lang="en-US">Authorised capital commitments but not contracted for</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_1" xml:lang="en-US">Uncommitted capital expenditure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_0" xml:lang="en-US">Bank borrowings, undiscounted cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_1" xml:lang="en-US">Contractual maturities relating to undiscounted cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_2" xml:lang="en-US">Contractual maturities relating to undiscounted cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_1" xml:lang="en-US">Net loss per common share, basic (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_0" xml:lang="en-US">Basic earnings (loss) per share from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_1" xml:lang="en-US">Net loss from continuing operations per common share, basic (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_0" xml:lang="en-US">Basic earnings (loss) per share from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_1" xml:lang="en-US">Net loss from discontinued operations per common share, basic (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssetsByGroupAxis_0" xml:lang="en-US">Biological assets by group [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssetsGroupMember_0" xml:lang="en-US">Biological assets, group [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingCostsIncurred_0" xml:lang="en-US">Borrowing costs incurred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingCostsIncurred_1" xml:lang="en-US">Amendment fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BorrowingCostsIncurred_2" xml:lang="en-US">Transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Borrowings_0" xml:lang="en-US">Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Borrowings_1" xml:lang="en-US">Long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Borrowings_2" xml:lang="en-US">Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameAxis_0" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameMember_0" xml:lang="en-US">Borrowings by name [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRate_0" xml:lang="en-US">Interest rate on borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsInterestRate_1" xml:lang="en-US">Borrowings, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRate_2" xml:lang="en-US">Percentage of interest rate on convertible debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRate_3" xml:lang="en-US">Promissory note bearing interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsMaturity_0" xml:lang="en-US">Borrowings, maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember_0" xml:lang="en-US">Bottom of range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BuildingsMember_0" xml:lang="en-US">Buildings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BuildingsMember_1" xml:lang="en-US">BUILDINGS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BuildingsMember_2" xml:lang="en-US">Building [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsAxis_0" xml:lang="en-US">Business combinations [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountMember_0" xml:lang="en-US">Carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Cash_0" xml:lang="en-US">End of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Cash_1" xml:lang="en-US">Beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Cash_2" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Cash_3" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_0" xml:lang="en-US">Loan advance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_1" xml:lang="en-US">Cash advances and loans made to other parties, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_0" xml:lang="en-US">Cash flows from (used in) decrease (increase) in restricted cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_1" xml:lang="en-US">Investment in GIC - restricted investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1" xml:lang="en-US">FINANCING ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0" xml:lang="en-US">Net cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1" xml:lang="en-US">Net cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1" xml:lang="en-US">INVESTING ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_0" xml:lang="en-US">Net cash used in investing activities related to discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1" xml:lang="en-US">Investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xml:lang="en-US">OPERATING ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2" xml:lang="en-US">CASH PROVIDED (USED) OPERATING ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_0" xml:lang="en-US">Cash flows from (used in) operating activities, continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_1" xml:lang="en-US">Net cash used in continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2" xml:lang="en-US">Net cash used in continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_0" xml:lang="en-US">Net cash used in discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_1" xml:lang="en-US">Cash flows from (used in) operating activities, discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2" xml:lang="en-US">Net cash used in operating activities related to discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_3" xml:lang="en-US">Operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_0" xml:lang="en-US">Categories of financial assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis_0" xml:lang="en-US">Classes of assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsMember_0" xml:lang="en-US">Assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_0" xml:lang="en-US">Financial instruments, class [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_0" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract_0" xml:lang="en-US">Classes of current inventories [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_0" xml:lang="en-US">Components of equity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_0" xml:lang="en-US">Net income and comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncome_1" xml:lang="en-US">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_2" xml:lang="en-US">Comprehensive income (loss) to shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_3" xml:lang="en-US">COMPREHENSIVE LOSS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_4" xml:lang="en-US">COMPREHENSIVE (LOSS) INCOME</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComputerEquipmentMember_0" xml:lang="en-US">Computer equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComputerEquipmentMember_1" xml:lang="en-US">Computer equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComputerSoftwareMember_0" xml:lang="en-US">Computer software [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComputerSoftwareMember_1" xml:lang="en-US">COMPUTER SOFTWARE [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ConsiderationPaidReceived_0" xml:lang="en-US">Fair value of consideration received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ConsiderationPaidReceived_1" xml:lang="en-US">Fair value of consideration received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ConstructionInProgressMember_0" xml:lang="en-US">Construction in progress [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ConstructionInProgressMember_1" xml:lang="en-US">Moncton Campus - Phase 4C (asset specific) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ConstructionInProgressMember_2" xml:lang="en-US">CONSTRUCTION IN PROCESS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_0" xml:lang="en-US">Continuing and discontinued operations [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContractualCapitalCommitments_0" xml:lang="en-US">Contractual capital commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ContractualCapitalCommitments_1" xml:lang="en-US">Contractual capital expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_0" xml:lang="en-US">Cost of inventories recognised as expense during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_1" xml:lang="en-US">Inventory expensed in cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfSales_0" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CostOfSales_1" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentAssets_2" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_0" xml:lang="en-US">Current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_1" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_2" xml:lang="en-US">Current Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_0" xml:lang="en-US">Carrying amount ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_1" xml:lang="en-US">Carrying amount opening balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_2" xml:lang="en-US">Current biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_3" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CurrentGovernmentGrants_0" xml:lang="en-US">Government programs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentGovernmentGrants_1" xml:lang="en-US">Current government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentGovernmentGrants_2" xml:lang="en-US">Government programs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentHeldtomaturityInvestments_0" xml:lang="en-US">Short term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentHeldtomaturityInvestments_1" xml:lang="en-US">Short-term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_0" xml:lang="en-US">Current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_1" xml:lang="en-US">Current portion included in accounts payable and accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_2" xml:lang="en-US">Present value of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_2" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_0" xml:lang="en-US">Current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_1" xml:lang="en-US">Current Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_2" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLoansAndReceivables_0" xml:lang="en-US">Loan receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLoansAndReceivables_1" xml:lang="en-US">Advance to 1812 Hemp</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLoansAndReceivables_2" xml:lang="en-US">Loan receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_0" xml:lang="en-US">Less: current portion of debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_1" xml:lang="en-US">Current notes and debentures issued and current portion of non-current notes and debentures issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPackagingAndStorageMaterials_0" xml:lang="en-US">Current packaging and storage materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentPackagingAndStorageMaterials_1" xml:lang="en-US">Packaging and supplies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_0" xml:lang="en-US">Less: current portion of long term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_1" xml:lang="en-US">Current portion of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_2" xml:lang="en-US">Current portion of long term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_0" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTradeReceivables_0" xml:lang="en-US">Accounts receivable (Note 5)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables_1" xml:lang="en-US">Gross trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables_2" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables_3" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DebtInstrumentsHeldAbstract_0" xml:lang="en-US">Debt instruments held [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_0" xml:lang="en-US">Transferred to inventory upon harvest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_1" xml:lang="en-US">Decrease due to harvest, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2" xml:lang="en-US">Transferred to inventory upon harvest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Unrecognized deductible temporary differences and unused tax losses which no deferred tax asset is recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">Deductible temporary differences for which no deferred tax asset is recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Deductible temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_3" xml:lang="en-US">Unrecognized deductible temporary differences and unused tax losses which no deferred tax asset is recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_4" xml:lang="en-US">Benefit of deductible temporary differences not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxAssets_0" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxAssets_1" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_0" xml:lang="en-US">Deferred tax assets and liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_1" xml:lang="en-US">Deferred tax assets are attributable to the following:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_0" xml:lang="en-US">Recognized in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_1" xml:lang="en-US">Deferred tax expense (income) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_2" xml:lang="en-US">RECOGNIZED IN PROFIT OR LOSS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_0" xml:lang="en-US">Deferred tax expense (income) relating to origination and reversal of temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_1" xml:lang="en-US">Origination and reversal of temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_0" xml:lang="en-US">Deferred tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_1" xml:lang="en-US">Deferred tax liability (Note 21)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_2" xml:lang="en-US">Deferred tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_0" xml:lang="en-US">Net tax assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_1" xml:lang="en-US">Net tax assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_2" xml:lang="en-US">Net tax assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_3" xml:lang="en-US">Net tax assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_4" xml:lang="en-US">Deferred tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_1" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_0" xml:lang="en-US">Depreciation method, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_1" xml:lang="en-US">Depreciation method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_1" xml:lang="en-US">Depreciation, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_2" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_0" xml:lang="en-US">Description of accounting policy for biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_1" xml:lang="en-US">Biological assets [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_0" xml:lang="en-US">Description of accounting policy for borrowing costs [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_1" xml:lang="en-US">Borrowing costs [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0" xml:lang="en-US">Description of accounting policy for discontinued operations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_1" xml:lang="en-US">Discontinued operations [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0" xml:lang="en-US">Description of accounting policy for earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1" xml:lang="en-US">Earnings (loss) per share [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_1" xml:lang="en-US">Goodwill [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_0" xml:lang="en-US">Description of accounting policy for government grants [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_1" xml:lang="en-US">Government subsidies [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_0" xml:lang="en-US">Description of accounting policy for held-to-maturity investments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_1" xml:lang="en-US">Short-term investments [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_0" xml:lang="en-US">Description of accounting policy for impairment of assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_1" xml:lang="en-US">Impairment of long-lived and intangible assets [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_0" xml:lang="en-US">Description of accounting policy for income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_1" xml:lang="en-US">Income taxes [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1" xml:lang="en-US">Intangible assets [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_0" xml:lang="en-US">Description of accounting policy for investment in associates [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_1" xml:lang="en-US">Investments in associates [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1" xml:lang="en-US">Inventories [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_0" xml:lang="en-US">Description of accounting policy for non-current assets or disposal groups classified as held for sale [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_1" xml:lang="en-US">Assets held for sale [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, plant and equipment [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1" xml:lang="en-US">Revenue recognition [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1" xml:lang="en-US">Share-based payments [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1" xml:lang="en-US">Cash [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_0" xml:lang="en-US">Description of arrangement for contingent consideration arrangements and indemnification assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_1" xml:lang="en-US">Description of estimated fair value of contingent share consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0" xml:lang="en-US">Expected volatility, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1" xml:lang="en-US">Expected annualized volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_0" xml:lang="en-US">Description of maximum term of options granted for share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0" xml:lang="en-US">Option life, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_1" xml:lang="en-US">Vesting period of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2" xml:lang="en-US">Expected life of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_0" xml:lang="en-US">Description of other accounting policies relevant to understanding of financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_1" xml:lang="en-US">NEW STANDARDS AND INTERPRETATIONS ADOPTED [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_1" xml:lang="en-US">Risk free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0" xml:lang="en-US">Description of useful life, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_1" xml:lang="en-US">Useful lives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_0" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_1" xml:lang="en-US">Net loss per common share, diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_0" xml:lang="en-US">Diluted earnings (loss) per share from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_1" xml:lang="en-US">Net loss from continuing operations per common share, diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_0" xml:lang="en-US">Diluted earnings (loss) per share from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_1" xml:lang="en-US">Net loss from discontinued operations per common share, diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_0" xml:lang="en-US">Dilutive effect of share options on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_1" xml:lang="en-US">Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1" xml:lang="en-US">BASIS OF PREPARATION [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_0" xml:lang="en-US">Disclosure of borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_1" xml:lang="en-US">LONG-TERM DEBT [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1" xml:lang="en-US">CONTINGENCIES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_0" xml:lang="en-US">Disclosure of cost of sales [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_1" xml:lang="en-US">COST OF SALES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_0" xml:lang="en-US">Disclosure of debt instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_1" xml:lang="en-US">UNSECURED CONVERTIBLE DEBENTURES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDeferredIncomeExplanatory_0" xml:lang="en-US">Disclosure of deferred income [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDeferredIncomeExplanatory_1" xml:lang="en-US">Disclosure of detailed information about components of deferred income tax expense [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0" xml:lang="en-US">Disclosure of deferred taxes [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1" xml:lang="en-US">Disclosure of detailed information about recognized deferred tax assets and liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xml:lang="en-US">Disclosure of detailed information about biological assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1" xml:lang="en-US">BIOLOGICAL ASSETS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xml:lang="en-US">Disclosure of detailed information about borrowings [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about long term debt [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_0" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about intangible assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Disclosure of detailed information about property plant and equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_0" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" xml:lang="en-US">Disclosure of detailed information about reconciliation of weighted average number of shares [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of fair value of financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_1" xml:lang="en-US">FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0" xml:lang="en-US">Disclosure of general and administrative expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1" xml:lang="en-US">GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_0" xml:lang="en-US">Disclosure of government grants [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_1" xml:lang="en-US">GOVERNMENT SUBSIDIES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" xml:lang="en-US">INCOME TAXES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0" xml:lang="en-US">Disclosure of information about key management personnel [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1" xml:lang="en-US">Disclosure of information about key management personnel [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0" xml:lang="en-US">Disclosure of intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" xml:lang="en-US">INTANGIBLE ASSETS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_0" xml:lang="en-US">Disclosure of interests in associates [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_1" xml:lang="en-US">Disclosure of detailed information about carrying value of investments in associates [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0" xml:lang="en-US">Disclosure of inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1" xml:lang="en-US">INVENTORIES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0" xml:lang="en-US">Disclosure of detailed information about investment property [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInvestmentPropertyTable_0" xml:lang="en-US">Disclosure of detailed information about investment property [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0" xml:lang="en-US">Disclosure of investments other than investments accounted for using equity method [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1" xml:lang="en-US">SHORT TERM INVESTMENTS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIssuedCapitalExplanatory_0" xml:lang="en-US">Disclosure of issued capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIssuedCapitalExplanatory_1" xml:lang="en-US">SHARE CAPITAL [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about undiscounted contractual payments relating to the current and future lease liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" xml:lang="en-US">SUBSEQUENT EVENTS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of other equity instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about number and weighted average exercise prices of restricted stock unit [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about number and weighted average exercise prices of share options [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_1" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_0" xml:lang="en-US">Disclosure of objectives, policies and processes for managing capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1" xml:lang="en-US">CAPITAL MANAGEMENT [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xml:lang="en-US">Disclosure of operating segments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0" xml:lang="en-US">Disclosure of operating segments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1" xml:lang="en-US">OPERATING SEGMENTS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of other liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_1" xml:lang="en-US">OTHER LIABILITIES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of other non-current liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure of detailed information about carrying value of other liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_0" xml:lang="en-US">Disclosure of range of exercise prices of outstanding share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about range of exercise prices of outstanding share options [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_0" xml:lang="en-US">Disclosure of range of exercise prices of outstanding share options [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure of reconciliation of changes in biological assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0" xml:lang="en-US">Disclosure of reconciliation of changes in biological assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_0" xml:lang="en-US">Disclosure of reconciliation of changes in biological assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_0" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0" xml:lang="en-US">Disclosure of related party [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" xml:lang="en-US">RELATED PARTY TRANSACTIONS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRevenueExplanatory_0" xml:lang="en-US">Disclosure of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfRevenueExplanatory_1" xml:lang="en-US">REVENUE [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0" xml:lang="en-US">Disclosure of associates [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_0" xml:lang="en-US">Disclosure of associates [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_1" xml:lang="en-US">INVESTMENTS IN ASSOCIATES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xml:lang="en-US">Disclosure of associates [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_0" xml:lang="en-US">Disclosure of associates [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0" xml:lang="en-US">Disclosure of significant accounting policies [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about unrecognized deductible temporary differences and unused tax losses [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_1" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">Disclosure of trade and other receivables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">ACCOUNTS RECEIVABLE [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xml:lang="en-US">Disclosure of transactions between related parties [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0" xml:lang="en-US">Disclosure of transactions between related parties [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DiscontinuedOperationsMember_0" xml:lang="en-US">Discontinued operations [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DisposalsBiologicalAssets_0" xml:lang="en-US">Deduct net abnormal plant destruction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalsBiologicalAssets_1" xml:lang="en-US">Disposals, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisposalsBiologicalAssets_2" xml:lang="en-US">Inventory write-offs related to abnormal plant waste due to lack of sufficient staff</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisposalsBiologicalAssets_3" xml:lang="en-US">Abnormal plant waste due to lack of sufficient staff</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Disposals, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_0" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_1" xml:lang="en-US">Disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_2" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_0" xml:lang="en-US">Dividends received from associates, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_1" xml:lang="en-US">Distributions received from investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DonationsAndSubsidiesExpense_0" xml:lang="en-US">Government subsidies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DonationsAndSubsidiesExpense_1" xml:lang="en-US">Donations and subsidies expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DonationsAndSubsidiesExpense_2" xml:lang="en-US">Government subsidies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_0" xml:lang="en-US">Earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_1" xml:lang="en-US">Disclosure of detailed information about outstanding number and type of securities that could potentially dilute basic net income (loss) per share [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareLineItems_0" xml:lang="en-US">Earnings per share [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareTable_0" xml:lang="en-US">Earnings per share [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0" xml:lang="en-US">Effects of foreign exchange on cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForAssociatesMember_0" xml:lang="en-US">Entity's total for associates [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_0" xml:lang="en-US">Entity's total for business combinations [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0" xml:lang="en-US">Entity's total for related parties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity_2" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Equity_3" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity_4" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAbstract_0" xml:lang="en-US">Equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAbstract_1" xml:lang="en-US">SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities_0" xml:lang="en-US">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities_1" xml:lang="en-US">Total equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract_0" xml:lang="en-US">Equity and liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityInstrumentsHeld_0" xml:lang="en-US">Equity instruments held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityMember_0" xml:lang="en-US">Equity [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0" xml:lang="en-US">Exercise price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_1" xml:lang="en-US">Strike price of stock option granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0" xml:lang="en-US">Expected dividend as percentage, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseByNature_0" xml:lang="en-US">Expenses, by nature</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseByNature_1" xml:lang="en-US">Total expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ExpenseByNature_2" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_0" xml:lang="en-US">Expenses by nature [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_1" xml:lang="en-US">OPERATING EXPENSES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_2" xml:lang="en-US">Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0" xml:lang="en-US">Expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_1" xml:lang="en-US">Share based payment cumulative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_0" xml:lang="en-US">Expense from share-based payment transactions with employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1" xml:lang="en-US">Share- based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_0" xml:lang="en-US">Expense relating to leases of low-value assets for which recognition exemption has been used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_1" xml:lang="en-US">Relief option for leases of low-value assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_0" xml:lang="en-US">Expense relating to short-term leases for which recognition exemption has been used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_1" xml:lang="en-US">Relief option for short-term leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_0" xml:lang="en-US">Expense relating to variable lease payments not included in measurement of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_1" xml:lang="en-US">Lease payments for renewal options reasonably expected to be exercised but not contractually obligated</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceCosts_0" xml:lang="en-US">Financing costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts_1" xml:lang="en-US">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinanceCosts_2" xml:lang="en-US">Financing costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceIncome_0" xml:lang="en-US">Investment income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncome_1" xml:lang="en-US">Finance income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinanceIncome_2" xml:lang="en-US">Investment income (expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinanceIncome_3" xml:lang="en-US">Investment income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsCategoryMember_0" xml:lang="en-US">Financial assets, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_0" xml:lang="en-US">Financial assets pledged as collateral for liabilities or contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_1" xml:lang="en-US">Cash collateral</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinishedGoods_0" xml:lang="en-US">Current finished goods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinishedGoods_1" xml:lang="en-US">Packaged inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FixturesAndFittingsMember_0" xml:lang="en-US">Fixtures and fittings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FixturesAndFittingsMember_1" xml:lang="en-US">Furniture and fixtures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0" xml:lang="en-US">Foreign exchange gain (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1" xml:lang="en-US">Foreign currency translation gain (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment attributable to price changes, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_1" xml:lang="en-US">Net change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_1" xml:lang="en-US">Fair value adjustment to biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2" xml:lang="en-US">Fair value changes to biological assets and changes in inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsOnDisposalsOfInvestments_0" xml:lang="en-US">Gain/(loss) on disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_1" xml:lang="en-US">Office and general</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_2" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Goodwill_0" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_0" xml:lang="en-US">Gross carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_1" xml:lang="en-US">Cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_2" xml:lang="en-US">CARRYING VALUE [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossLeaseLiabilities_0" xml:lang="en-US">Gross lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GrossLeaseLiabilities_1" xml:lang="en-US">Gross lease liabilities at September 1, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossProfit_0" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GrossProfit_1" xml:lang="en-US">Gross margin</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLoss_0" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ImpairmentLoss_1" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_0" xml:lang="en-US">Impairment loss recognised in profit or loss, goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_1" xml:lang="en-US">Impairment of goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1" xml:lang="en-US">Reversal of impairment loss (impairment loss) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_2" xml:lang="en-US">Impairment of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeStatementAbstract_0" xml:lang="en-US">Profit or loss [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xml:lang="en-US">Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1" xml:lang="en-US">Tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2" xml:lang="en-US">Income tax (recovery) expense Deferred, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_3" xml:lang="en-US">Income tax (recovery) expense per financial statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_4" xml:lang="en-US">Total income tax (recovery) expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xml:lang="en-US">INCREASE (DECREASE) IN CASH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1" xml:lang="en-US">DECREASE IN CASH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents, discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_1" xml:lang="en-US">Cash used by discounted operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_2" xml:lang="en-US">Cash included in disposal group</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_0" xml:lang="en-US">Increase (decrease) through conversion of convertible instruments, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_1" xml:lang="en-US">Conversion of debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_2" xml:lang="en-US">Convertible debentures converted in to number of common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0" xml:lang="en-US">Increase (decrease) through exercise of options, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1" xml:lang="en-US">Exercise of stock options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0" xml:lang="en-US">Increase (decrease) through exercise of warrants, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1" xml:lang="en-US">Exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_0" xml:lang="en-US">Increase (decrease) through other changes, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_1" xml:lang="en-US">Transition to IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_0" xml:lang="en-US">Increase (decrease) through other changes, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_1" xml:lang="en-US">Add net production costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_0" xml:lang="en-US">Increase (decrease) through transfers from construction in progress, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_1" xml:lang="en-US">Construction completed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Reclassification of computer software</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Increase (decrease) through transfers, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Reclassification of computer software</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_0" xml:lang="en-US">Reclassification of computer software</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_1" xml:lang="en-US">Increase (decrease) through transfers, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_2" xml:lang="en-US">Reclassification of computer software</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_3" xml:lang="en-US">Increase (decrease) through transfers, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InformationAboutMajorCustomers_0" xml:lang="en-US">Information about major customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwillMember_0" xml:lang="en-US">Intangible assets and goodwill [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_3" xml:lang="en-US">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0" xml:lang="en-US">Intangible assets other than goodwill [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0" xml:lang="en-US">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1" xml:lang="en-US">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_0" xml:lang="en-US">Interest paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_1" xml:lang="en-US">Interest paid, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_2" xml:lang="en-US">Interest paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestPayable_0" xml:lang="en-US">Interest payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_0" xml:lang="en-US">Interest received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_1" xml:lang="en-US">Investment income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Inventories_0" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Inventories_1" xml:lang="en-US">Total inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoryWritedown2011_0" xml:lang="en-US">Inventory write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InventoryWritedown2011_1" xml:lang="en-US">Inventory write-down related to adjustments to net realizable value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_InvestmentsInAssociates_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_InvestmentsInAssociates_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentsInAssociates_2" xml:lang="en-US">Investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_0" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_1" xml:lang="en-US">Investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital_0" xml:lang="en-US">Issued capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssuedCapital_1" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapitalMember_0" xml:lang="en-US">Issued capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssuedCapitalMember_1" xml:lang="en-US">Share Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssuedCapitalMember_2" xml:lang="en-US">SHARE CAPITAL [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfConvertibleInstruments_0" xml:lang="en-US">Issue of convertible instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssueOfConvertibleInstruments_1" xml:lang="en-US">Convertible debenture allocation of discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssueOfConvertibleInstruments_2" xml:lang="en-US">Equity component</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfEquity_0" xml:lang="en-US">Issue of equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssueOfEquity_1" xml:lang="en-US">Equity financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_0" xml:lang="en-US">Key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_1" xml:lang="en-US">Total key management compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0" xml:lang="en-US">Key management personnel compensation, share-based payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" xml:lang="en-US">Salaries and consulting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2" xml:lang="en-US">Wages And Salaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0" xml:lang="en-US">Key management personnel of entity or parent [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_1" xml:lang="en-US">Key management personnel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LandMember_0" xml:lang="en-US">Land [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LandMember_1" xml:lang="en-US">LAND [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_0" xml:lang="en-US">Later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_1" xml:lang="en-US">Thereafter [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_2" xml:lang="en-US">More than 5 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">Later than four years and not later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1" xml:lang="en-US">4 to 5 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_0" xml:lang="en-US">Later than one year and not later than three years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_1" xml:lang="en-US">1 to 3 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0" xml:lang="en-US">Later than one year and not later than two years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1" xml:lang="en-US">1 to 2 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">Later than three years and not later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_1" xml:lang="en-US">3 to 5 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_0" xml:lang="en-US">Later than three years and not later than four years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_1" xml:lang="en-US">3 to 4 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_0" xml:lang="en-US">Later than two years and not later than three years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_1" xml:lang="en-US">2 to 3 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember_0" xml:lang="en-US">Leasehold improvements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember_1" xml:lang="en-US">Leasehold improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities_1" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_2" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_3" xml:lang="en-US">Operating lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_4" xml:lang="en-US">Operating lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilitiesAbstract_0" xml:lang="en-US">Lease liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember_0" xml:lang="en-US">Lease liabilities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember_1" xml:lang="en-US">Lease Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesAbstract_0" xml:lang="en-US">Liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LiabilitiesAbstract_1" xml:lang="en-US">LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LicencesMember_0" xml:lang="en-US">Licences [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LicencesMember_1" xml:lang="en-US">LICENSE AGREEMENT [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LoansAndReceivables_0" xml:lang="en-US">Loans and receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LoansAndReceivables_1" xml:lang="en-US">Loan receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LongtermBorrowings_0" xml:lang="en-US">Non-current portion of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_1" xml:lang="en-US">Long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_2" xml:lang="en-US">Long-term portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xml:lang="en-US">Major components of tax expense (income) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAxis_0" xml:lang="en-US">Maturity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk_0" xml:lang="en-US">Maximum exposure to credit risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk_1" xml:lang="en-US">Maximum exposure to credit risk approximates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MeasurementAxis_0" xml:lang="en-US">Measurement [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetDeferredTaxAssets_0" xml:lang="en-US">Net deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NetDeferredTaxLiabilities_0" xml:lang="en-US">Net deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NetDeferredTaxLiabilities_1" xml:lang="en-US">Net deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NetDeferredTaxLiabilities_2" xml:lang="en-US">Net deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetDeferredTaxLiabilities_3" xml:lang="en-US">Net deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NetDeferredTaxLiabilities_4" xml:lang="en-US">Deferred tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsMember_0" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssets_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_2" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_0" xml:lang="en-US">Non-current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_1" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_2" xml:lang="en-US">Long-term portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_2" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_0" xml:lang="en-US">Non-current portion of non-current notes and debentures issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_1" xml:lang="en-US">Unsecured convertible debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_2" xml:lang="en-US">Long-term portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_3" xml:lang="en-US">Long-term portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_0" xml:lang="en-US">Advanced additional convertible debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_1" xml:lang="en-US">Notes and debentures issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_2" xml:lang="en-US">Unsecured convertible debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_3" xml:lang="en-US">Debentures - carrying value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_4" xml:lang="en-US">Debentures - carrying value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotionalAmount_0" xml:lang="en-US">Notional amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotionalAmount_1" xml:lang="en-US">Fair value of long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NotionalAmount_2" xml:lang="en-US">Long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_0" xml:lang="en-US">Not later than one year [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_1" xml:lang="en-US">Less than 1 year [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2" xml:lang="en-US">Number of units granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_0" xml:lang="en-US">Cancelled/Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of other equity instruments forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0" xml:lang="en-US">Outstanding, Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1" xml:lang="en-US">Outstanding, Opening balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_0" xml:lang="en-US">Outstanding, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_1" xml:lang="en-US">Outstanding, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_2" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_3" xml:lang="en-US">Quantity Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0" xml:lang="en-US">Options outstanding, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1" xml:lang="en-US">Exercised during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3" xml:lang="en-US">Exercised during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_4" xml:lang="en-US">Share options exercised during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0" xml:lang="en-US">Cancelled / Forfeited during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2" xml:lang="en-US">Options upstanding, Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_3" xml:lang="en-US">Cancelled / Forfeited during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/exampleGuidance" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of employee options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share option issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2" xml:lang="en-US">Stock options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_3" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_4" xml:lang="en-US">Granted during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5" xml:lang="en-US">Number of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesIssued_0" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_0" xml:lang="en-US">Balance (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_1" xml:lang="en-US">Balance (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_2" xml:lang="en-US">Number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OfficeEquipmentMember_0" xml:lang="en-US">Office equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OfficeEquipmentMember_1" xml:lang="en-US">Growing equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_0" xml:lang="en-US">Other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_1" xml:lang="en-US">Other comprehensive income (loss) to shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1" xml:lang="en-US">Other comprehensive gain (loss) Foreign currency translation gain (loss), net of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentAssets_0" xml:lang="en-US">Other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherFeeAndCommissionExpense_0" xml:lang="en-US">Other fee and commission expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherFeeAndCommissionExpense_1" xml:lang="en-US">Agents' commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherFinanceCost_0" xml:lang="en-US">Other finance cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherFinanceCost_1" xml:lang="en-US">Loss on debt restructuring recorded under financing cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_0" xml:lang="en-US">Impairment of investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_1" xml:lang="en-US">Other income (expense) from subsidiaries, jointly controlled entities and associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_2" xml:lang="en-US">Impairment of investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialLiabilities_0" xml:lang="en-US">Other non-current financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialLiabilities_1" xml:lang="en-US">Other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialLiabilities_2" xml:lang="en-US">Total other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_0" xml:lang="en-US">Other property, plant and equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_1" xml:lang="en-US">OTHER [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherRevenue_0" xml:lang="en-US">Other revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherRevenue_1" xml:lang="en-US">Other revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_0" xml:lang="en-US">Other tax effects for reconciliation between accounting profit and tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_1" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember_0" xml:lang="en-US">Other temporary differences [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember_1" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OutputOfAgriculturalProduce_0" xml:lang="en-US">Output of agricultural produce</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OutputOfAgriculturalProduce_1" xml:lang="en-US">Estimated harvest yields for the cannabis on plants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsForDebtIssueCosts_0" xml:lang="en-US">Payment of convertible debenture issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsForDebtIssueCosts_1" xml:lang="en-US">Payments for debt issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PaymentsForDebtIssueCosts_2" xml:lang="en-US">Payment of convertible debenture issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_0" xml:lang="en-US">Payment of share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_1" xml:lang="en-US">Payments for share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_2" xml:lang="en-US">Payment of share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0" xml:lang="en-US">Lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1" xml:lang="en-US">Payment of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_3" xml:lang="en-US">Payment of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsToSuppliersForGoodsAndServices_0" xml:lang="en-US">Payments to suppliers for goods and services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PaymentsToSuppliersForGoodsAndServices_1" xml:lang="en-US">Paid in cash for services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfEntitysRevenue_0" xml:lang="en-US">Percentage of entity's revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PlantsMember_0" xml:lang="en-US">Plants [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PlantsMember_1" xml:lang="en-US">CANNABIS ON PLANTS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PrepaymentsAndAccruedIncome_0" xml:lang="en-US">Prepayments and accrued income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PrepaymentsAndAccruedIncome_1" xml:lang="en-US">Deferred charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_0" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1" xml:lang="en-US">Proceeds from issuance of convertible debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_0" xml:lang="en-US">Proceeds from issue of bonds, notes and debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_1" xml:lang="en-US">Proceeds from convertible debenture issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_0" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_1" xml:lang="en-US">Gross proceeds from equity issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_2" xml:lang="en-US">Proceeds from equity financing, net of issue costs of $3,754</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_0" xml:lang="en-US">Proceeds from non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_1" xml:lang="en-US">Proceeds from long-term debt, net of fees of $705 (2019 - $1,250)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Proceeds from short-term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Proceeds on sale of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProductsAndServicesAxis_0" xml:lang="en-US">Products and services [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProductsAndServicesMember_0" xml:lang="en-US">Products and services [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_0" xml:lang="en-US">Professional fees expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_1" xml:lang="en-US">Legal and professional fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_2" xml:lang="en-US">Professional fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProfitLoss_0" xml:lang="en-US">Net Income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss_1" xml:lang="en-US">Profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLoss_2" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss_3" xml:lang="en-US">NET LOSS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLoss_4" xml:lang="en-US">Net income (loss) to shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAbstract_0" xml:lang="en-US">Profit (loss) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossAbstract_1" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAbstract_2" xml:lang="en-US">REVENUES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_0" xml:lang="en-US">Income (loss) from operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_1" xml:lang="en-US">Profit (loss) before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_2" xml:lang="en-US">Income (loss) from continuing operations before income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_3" xml:lang="en-US">Loss from continuing operations before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_4" xml:lang="en-US">(Loss) income from continuing operations before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_0" xml:lang="en-US">Net loss from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_1" xml:lang="en-US">Profit (loss) from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_2" xml:lang="en-US">Net (loss) income from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_3" xml:lang="en-US">Net loss from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_4" xml:lang="en-US">Net (loss) income from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_0" xml:lang="en-US">Profit (loss) from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_1" xml:lang="en-US">Loss from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_2" xml:lang="en-US">Loss from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_1" xml:lang="en-US">(LOSS) INCOME FROM OPERATIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_0" xml:lang="en-US">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_1" xml:lang="en-US">Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_3" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Property, plant and equipment [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentMember_0" xml:lang="en-US">Property, plant and equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_0" xml:lang="en-US">Property, plant and equipment subject to operating leases [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_1" xml:lang="en-US">Property, plant and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_0" xml:lang="en-US">Proportion of ownership interest in associate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfInterestsInAssociates_0" xml:lang="en-US">Investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfInterestsInAssociates_1" xml:lang="en-US">Purchase of interests in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Purchase of short-term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Purchase of investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_3" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis_0" xml:lang="en-US">Range [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesMember_0" xml:lang="en-US">Ranges [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges of exercise prices for outstanding share options [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_0" xml:lang="en-US">Reconciliation of changes in deferred tax liability (asset) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RelatedPartyTransactionsAbstract_0" xml:lang="en-US">Related party transactions [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RentalIncome_0" xml:lang="en-US">Rental income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RentalIncome_1" xml:lang="en-US">Total per annum rental income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_0" xml:lang="en-US">Repayments of borrowings, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1" xml:lang="en-US">Repayment of loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_0" xml:lang="en-US">Payment of long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_1" xml:lang="en-US">Repayments of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_2" xml:lang="en-US">Payment of long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_3" xml:lang="en-US">Repayments of borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfSharebasedPayments_0" xml:lang="en-US">Reserve of share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReserveOfSharebasedPayments_1" xml:lang="en-US">Equity reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RestatedMember_0" xml:lang="en-US">Currently stated [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RestrictedCashAndCashEquivalents_0" xml:lang="en-US">Restricted cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RestrictedCashAndCashEquivalents_1" xml:lang="en-US">Restricted investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarnings_0" xml:lang="en-US">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_2" xml:lang="en-US">Working capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember_0" xml:lang="en-US">Retained earnings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarningsMember_1" xml:lang="en-US">RETAINED EARNINGS/(ACCUMULATED DEFICIT) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_0" xml:lang="en-US">Retrospective application and retrospective restatement [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_Revenue_0" xml:lang="en-US">Net revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Revenue_1" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Revenue_2" xml:lang="en-US">Sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Revenue_3" xml:lang="en-US">Net revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Revenue_4" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueAbstract_0" xml:lang="en-US">Revenue [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromInterest_0" xml:lang="en-US">Interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RevenueFromInterest_1" xml:lang="en-US">Amount of interest income received on convertible debenture investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_0" xml:lang="en-US">Revenue from sale of goods, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_1" xml:lang="en-US">Revenues on product sold to related party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssets_0" xml:lang="en-US">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RightofuseAssets_1" xml:lang="en-US">Right to use of assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssetsMember_0" xml:lang="en-US">Right-of-use assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RightofuseAssetsMember_1" xml:lang="en-US">RIGHT- OF- USELEASE ASSETS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RightofuseAssetsMember_2" xml:lang="en-US">Right-of-use lease assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SalesAndMarketingExpense_0" xml:lang="en-US">Sales and marketing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SalesAndMarketingExpense_1" xml:lang="en-US">Sales and marketing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xml:lang="en-US">Total selling, general and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_1" xml:lang="en-US">Total general and administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_2" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xml:lang="en-US">Selling, general and administrative expense [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember_0" xml:lang="en-US">Share-based payment arrangements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_0" xml:lang="en-US">Equity financing issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_1" xml:lang="en-US">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_2" xml:lang="en-US">Equity financing issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_3" xml:lang="en-US">Issue cost of at-the-market equity financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_0" xml:lang="en-US">Share of loss from investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_1" xml:lang="en-US">Share of profit (loss) of associates accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_2" xml:lang="en-US">Share of loss from investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_0" xml:lang="en-US">Share of loss from investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_1" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_2" xml:lang="en-US">Share of net income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_3" xml:lang="en-US">Share of net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis_0" xml:lang="en-US">Associates [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract_0" xml:lang="en-US">Statement of changes in equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems_0" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable_0" xml:lang="en-US">Statement of changes in equity [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xml:lang="en-US">Statement of comprehensive income [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_1" xml:lang="en-US">Statement of comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of financial position [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract_1" xml:lang="en-US">Statement of financial position</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_0" xml:lang="en-US">Statement that lessee accounts for short-term leases using recognition exemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_1" xml:lang="en-US">Statement that lessee accounts for short-term leases using recognition exemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectFromChangeInTaxRate_0" xml:lang="en-US">Tax effect from change in tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxEffectFromChangeInTaxRate_1" xml:lang="en-US">Change in tax rate and rate differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_0" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1" xml:lang="en-US">Non-deductible (non-taxable) items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates_0" xml:lang="en-US">Tax effect of foreign tax rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates_1" xml:lang="en-US">Effect of tax rates in other jurisdictions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_0" xml:lang="en-US">Tax expense (income) at applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1" xml:lang="en-US">Tax calculated at statutory rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_0" xml:lang="en-US">Excise taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_1" xml:lang="en-US">Tax expense other than income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2" xml:lang="en-US">Excise taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember_0" xml:lang="en-US">Top of range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_0" xml:lang="en-US">Trade and other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_1" xml:lang="en-US">Accounts payable and accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_0" xml:lang="en-US">Trade and other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_1" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeReceivables_0" xml:lang="en-US">Trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeReceivables_1" xml:lang="en-US">Gross trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeReceivables_2" xml:lang="en-US">Trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TravelExpense_0" xml:lang="en-US">Travel expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TravelExpense_1" xml:lang="en-US">Travel and accommodation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_0" xml:lang="en-US">Undiscounted operating lease payments to be received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_1" xml:lang="en-US">Undiscounted contractual payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UndrawnBorrowingFacilities_0" xml:lang="en-US">Undrawn borrowing facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_0" xml:lang="en-US">Unused tax losses for which no deferred tax asset recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_1" xml:lang="en-US">Tax losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UtilitiesExpense_0" xml:lang="en-US">Utilities expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UtilitiesExpense_1" xml:lang="en-US">Utilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ValueAtRisk_0" xml:lang="en-US">Value at risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ValueAtRisk_1" xml:lang="en-US">Increase or decrease in interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_VehiclesMember_0" xml:lang="en-US">Vehicles [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_VehiclesMember_1" xml:lang="en-US">Vehicles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WagesAndSalaries_0" xml:lang="en-US">Wages and salaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WagesAndSalaries_1" xml:lang="en-US">Wages and benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WagesAndSalaries_2" xml:lang="en-US">Salaries and consulting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Exercised during period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Cancelled / Forfeited during period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Exercise price of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Granted during period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Outstanding, end of period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Outstanding, beginning of period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3" xml:lang="en-US">Exercise price of share options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_4" xml:lang="en-US">Outstanding, beginning of period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_0" xml:lang="en-US">Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_1" xml:lang="en-US">Weighted average interest rate of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1" xml:lang="en-US">Weighted average remaining life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_2" xml:lang="en-US">Weighted Average Remaining Contractual Life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019_0" xml:lang="en-US">Weighted average share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019_1" xml:lang="en-US">Weighted average price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares_0" xml:lang="en-US">Weighted average number of ordinary shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares_1" xml:lang="en-US">Weighted average number of shares used in basic earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WorkInProgress_0" xml:lang="en-US">Current work in progress</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WorkInProgress_1" xml:lang="en-US">Available for packaging</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WritedownsReversalsOfWritedownsOfInventoriesAbstract_0" xml:lang="en-US">Write-downs (reversals of write-downs) of inventories [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_0" xml:lang="en-US">Represents ability to purchase up to annual cannabinoid or cannabinoid related production.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_1" xml:lang="en-US">Ability To Purchase Up To Annual Cannabinoid Or Cannabinoid Related Production</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_2" xml:lang="en-US">Ability to purchase up to annual cannabinoid or cannabinoid related production</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AccountsReceivableAbstract_0" xml:lang="en-US">Accounts Receivable [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AchievementOfContractualProductionRelatedMilestoneMember_0" xml:lang="en-US">Achievement of contractual production-related milestone for Tranche 2 of the convertible debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AchievementOfContractualProductionRelatedMilestoneMember_1" xml:lang="en-US">Achievement Of Contractual Production Related Milestone [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AchievementOfContractualProductionRelatedMilestoneMember_2" xml:lang="en-US">Achievement of contractual production-related milestone</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_0" xml:lang="en-US">Represent the acquisitions related to discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_1" xml:lang="en-US">Acquisitions related to discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_2" xml:lang="en-US">Acquisitions Related To Discontinued Operations Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_3" xml:lang="en-US">Acquisitions related to discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdditionsOfInvestmentInAssociates_0" xml:lang="en-US">Represents amount of additions of investment in associates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdditionsOfInvestmentInAssociates_1" xml:lang="en-US">Additions Of Investment In Associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdditionsOfInvestmentInAssociates_2" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdditionsRelatedToIFRS16Leases_0" xml:lang="en-US">Additions related to IFRS 16 Leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_AdditionsRelatedToIFRS16Leases_1" xml:lang="en-US">Additions related to IFRS 16 Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdditionsRelatedToIFRS16Leases_2" xml:lang="en-US">Additions Related To I F R S 16 Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AdditionsRelatedToIFRS16Leases_3" xml:lang="en-US">Additions related to IFRS 16 Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdditionsToLeaseLiabilities_0" xml:lang="en-US">Represents the amount of additions to lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdditionsToLeaseLiabilities_1" xml:lang="en-US">Additions To Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AdditionsToLeaseLiabilities_2" xml:lang="en-US">Lease additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdjustmentOnAdoptionOfIFRS16Member_0" xml:lang="en-US">This member stands for IFRS 16 adjustment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdjustmentOnAdoptionOfIFRS16Member_1" xml:lang="en-US">Adjustment On Adoption Of I F R S 16 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdjustmentOnAdoptionOfIFRS16Member_2" xml:lang="en-US">IFRS 16 transition [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid expenses and deferred charges to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_1" xml:lang="en-US">Adjustments For Decrease Increase In Net Change In Prepaid Expenses And Deferred Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_2" xml:lang="en-US">Net change in prepaid expenses and deferred charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_0" xml:lang="en-US">Adjustments for unrealized gain (loss) on changes in fair value of contingent consideration to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_1" xml:lang="en-US">Unrealized loss on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_2" xml:lang="en-US">Unrealized gain on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_3" xml:lang="en-US">Adjustments For Unrealized Gain Loss On Changes In Fair Value Of Contingent Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_4" xml:lang="en-US">Unrealized loss on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_0" xml:lang="en-US">Adjustments for unrealized loss on changes in fair value of contingent consideration to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_1" xml:lang="en-US">Unrealized loss on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_2" xml:lang="en-US">Unrealized gain on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_3" xml:lang="en-US">Adjustments For Unrealized Loss On Changes In Fair Value Of Contingent Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_4" xml:lang="en-US">Unrealized loss on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdjustmentToNetRealizableValueBiologicalAssets_0" xml:lang="en-US">Represent the value adjustment to net realizable value biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_AdjustmentToNetRealizableValueBiologicalAssets_1" xml:lang="en-US">Adjustment to net realizable value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdjustmentToNetRealizableValueBiologicalAssets_2" xml:lang="en-US">Adjustment To Net Realizable Value Biological Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdjustmentToNetRealizableValueBiologicalAssets_3" xml:lang="en-US">Adjustment to net realizable value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdultUseRecreationalWholesaleRevenueMember_0" xml:lang="en-US">This member stands for adult-use recreational wholesale revenue (Canadian).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdultUseRecreationalWholesaleRevenueMember_1" xml:lang="en-US">Adult Use Recreational Wholesale Revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdultUseRecreationalWholesaleRevenueMember_2" xml:lang="en-US">Adult-use recreational wholesale revenue (Canadian) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdvanceGivenAsConvertibleDebentures_0" xml:lang="en-US">Represents the amount of advance given as convertible debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdvanceGivenAsConvertibleDebentures_1" xml:lang="en-US">Advance Given As Convertible Debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdvanceGivenAsConvertibleDebentures_2" xml:lang="en-US">Advance given as convertible debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdvancePayment_0" xml:lang="en-US">Represents maximum amount related to advances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdvancePayment_1" xml:lang="en-US">Advance Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdvancePayment_2" xml:lang="en-US">Maximum advance payment in the form of secured loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AdvisoryServicesAgreementMember_0" xml:lang="en-US">Advisory Services Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AdvisoryServicesAgreementMember_1" xml:lang="en-US">Advisory Services Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AdvisoryServicesAgreementMember_2" xml:lang="en-US">Advisory services agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_0" xml:lang="en-US">Represents the aggregate amount of commitment for Convertible Debentures on achievement of production related milestones within twenty four months.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_1" xml:lang="en-US">Aggregate Commitment For Convertible Debentures On Achievement Of Production Related Milestones Within Twenty Four Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_2" xml:lang="en-US">Aggregate commitment for convertible debentures on achievement of production related milestones within 24 months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_0" xml:lang="en-US">Represents aggregate fair value of Performance share units granted to key management personnel.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_1" xml:lang="en-US">Aggregate Fair Value Of Performance Share Units Granted To Key Management Personnel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_2" xml:lang="en-US">Aggregate fair value of PSUs granted to key management personnel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_0" xml:lang="en-US">Represents amount of stock option aggregate fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_1" xml:lang="en-US">Aggregate Fair Value Of Share Options Granted In Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_2" xml:lang="en-US">Aggregate fair value stock options granted to key management personnel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AggregateNumberOfCommonSharesConverted_0" xml:lang="en-US">Aggregate Number Of Common Shares Converted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AggregateNumberOfCommonSharesConverted_1" xml:lang="en-US">Aggregate Number Of Common Shares Converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AggregateNumberOfCommonSharesConverted_2" xml:lang="en-US">Aggregate number of common shares converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_0" xml:lang="en-US">Represents amount of allocation to reserve for options and warrants for debenture discount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_1" xml:lang="en-US">Less: allocation to reserve for options and warrants for debenture discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_2" xml:lang="en-US">Allocation To Reserve For Options And Warrants For Debenture Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AlphaCannabisPharmaGmbhMember_0" xml:lang="en-US">Represents information of alpha-cannabis? Pharma GmbH (?ACG?).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AlphaCannabisPharmaGmbhMember_1" xml:lang="en-US">Alpha Cannabis Pharma Gmbh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AlphaCannabisPharmaGmbhMember_2" xml:lang="en-US">ALPHA-CANNABIS PHARMA GMBH [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AlphaCannabisPharmaGmbhMember_3" xml:lang="en-US">Alpha-cannabis Pharma GmbH ("ACG") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AmendmentAndRestatementMember_0" xml:lang="en-US">Amendment And Restatement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AmendmentAndRestatementMember_1" xml:lang="en-US">Amendment And Restatement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AmendmentAndRestatementMember_2" xml:lang="en-US">Amendment and Restatement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AmendmentFee_0" xml:lang="en-US">Represents amount of amendment fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AmendmentFee_1" xml:lang="en-US">Amendment Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AmendmentFee_2" xml:lang="en-US">Amendment fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AmortizationOfDebentureDiscount_0" xml:lang="en-US">Represents amount of amortization of debenture discount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AmortizationOfDebentureDiscount_1" xml:lang="en-US">Amortization Of Debenture Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AmortizationOfDebentureDiscount_2" xml:lang="en-US">Amortization of debenture discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AmortizationOfIssueCosts_0" xml:lang="en-US">Represents amount of Amortization of issue costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_AmortizationOfIssueCosts_1" xml:lang="en-US">Amortization of issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AmortizationOfIssueCosts_2" xml:lang="en-US">Amortization Of Issue Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AmortizationOfIssueCosts_3" xml:lang="en-US">Amortization of issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AmortizedToSellingAndMarketingExpenses_0" xml:lang="en-US">Amortized To Selling And Marketing Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AmortizedToSellingAndMarketingExpenses_1" xml:lang="en-US">Amortized To Selling And Marketing Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AmortizedToSellingAndMarketingExpenses_2" xml:lang="en-US">Amortized to selling and marketing expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AmortizedToShareBasedCompensation_0" xml:lang="en-US">Represents amount of amortized to share-based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AmortizedToShareBasedCompensation_1" xml:lang="en-US">Amortized To Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AmortizedToShareBasedCompensation_2" xml:lang="en-US">Amortized to share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_0" xml:lang="en-US">Represent the amount of employee wages applied for Canada Emergency Wage Subsidy.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_1" xml:lang="en-US">Amount Of Employee Wages Applied For Canada Emergency Wage Subsidy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_2" xml:lang="en-US">Amount of employee wages applied for Canada Emergency Wage Subsidy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_0" xml:lang="en-US">Represent the amount of employee wages applied for under Canada Emergency Wage Subsidy.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_1" xml:lang="en-US">Amount Of Employee Wages Applied For Under Canada Emergency Wage Subsidy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_2" xml:lang="en-US">Amount of employee wages applied for under Canada Emergency Wage Subsidy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AntidilutiveSecuritiesAxis_0" xml:lang="en-US">Information by type of antidilutive security.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AntidilutiveSecuritiesAxis_1" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AntidilutiveSecuritiesDomain_0" xml:lang="en-US">Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AntidilutiveSecuritiesDomain_1" xml:lang="en-US">Antidilutive Securities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_0" xml:lang="en-US">Securities that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_1" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_2" xml:lang="en-US">Antidilutive securities excluded from computation of diluted earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ApplicableMarginRate_0" xml:lang="en-US">Amount of applicable margin rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ApplicableMarginRate_1" xml:lang="en-US">Applicable Margin Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ApplicableMarginRate_2" xml:lang="en-US">Applicable margin rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_0" xml:lang="en-US">Information about april two thousand twenty at the market equity program.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_1" xml:lang="en-US">April Two Thousand Twenty At Market Equity Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_2" xml:lang="en-US">April 2020 ATM Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_0" xml:lang="en-US">Name of member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_1" xml:lang="en-US">Atlantic Canada Opportunities Agency ("Acoa") Business Development Program Loan Maturing September 1, 2024 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2" xml:lang="en-US">Atlantic Canada Opportunities Agency ("ACOA") Business Development Program loan maturing September 1, 2024 with a 7 year amortization, bearing interest at an interest rate of 0% [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AverageSellingPriceInputValuesPerGram_0" xml:lang="en-US">Represents amount related to per gram amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AverageSellingPriceInputValuesPerGram_1" xml:lang="en-US">Average Selling Price Input Values Per Gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AverageSellingPriceInputValuesPerGram_2" xml:lang="en-US">Average selling price input values per gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_AverageYieldPerPlantInputValuesPerGram_0" xml:lang="en-US">Represents information related to average yield per plant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_AverageYieldPerPlantInputValuesPerGram_1" xml:lang="en-US">Average Yield Per Plant Input Values Per Gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_AverageYieldPerPlantInputValuesPerGram_2" xml:lang="en-US">Average yield per plant input values per gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BalanceSheetLocationsDomain_0" xml:lang="en-US">Location in the balance sheet (statement of financial position).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BalanceSheetLocationsDomain_1" xml:lang="en-US">Balance Sheet Locations [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_0" xml:lang="en-US">Name of member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1" xml:lang="en-US">Bank Of Montreal ("Bmo") Senior Secured Term Loan ("Term Loan") Maturing May 31, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_2" xml:lang="en-US">Bank of Montreal [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_3" xml:lang="en-US">Bank of Montreal ("BMO") senior secured term loan ("Term Loan") maturing May 31, 2022 with principal repayments starting November 30, 2020 based on a 10 year amortization [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BasisOfPreparationAbstract_0" xml:lang="en-US">Basis Of Preparation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BiologicalAssetMember_0" xml:lang="en-US">This member stands for temporary differences related to biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BiologicalAssetMember_1" xml:lang="en-US">Biological Asset [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BiologicalAssetMember_2" xml:lang="en-US">Biological assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BmoCreditFacilityMember_0" xml:lang="en-US">Represents information of BMO Credit Facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BmoCreditFacilityMember_1" xml:lang="en-US">Bmo Credit Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_BmoCreditFacilityMember_2" xml:lang="en-US">BMO Credit Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BmoTermLoanCreditFacilityMember_0" xml:lang="en-US">Information of BMO Term Loan credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BmoTermLoanCreditFacilityMember_1" xml:lang="en-US">Bmo Term Loan Credit Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BmoTermLoanCreditFacilityMember_2" xml:lang="en-US">BMO Term Loan credit facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BorrowingsCashInterestRate_0" xml:lang="en-US">Represents percentage of cash interest rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BorrowingsCashInterestRate_1" xml:lang="en-US">Borrowings, Cash Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BorrowingsCashInterestRate_2" xml:lang="en-US">Borrowings, cash interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BorrowingsEffectiveInterestRate_0" xml:lang="en-US">Represents percentage of effective rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BorrowingsEffectiveInterestRate_1" xml:lang="en-US">Borrowings, Effective Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BorrowingsEffectiveInterestRate_2" xml:lang="en-US">Borrowings, effective interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_0" xml:lang="en-US">Represents the amortization rate per quarter on the principal repayment of borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_1" xml:lang="en-US">Borrowings Principal Payment Amortization Rate Per Quarter</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_2" xml:lang="en-US">Borrowings, principal payment amortization rate per quarter</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BorrowingsReducedCashInterestRate_0" xml:lang="en-US">Represents percentage of reduction in cash interest rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BorrowingsReducedCashInterestRate_1" xml:lang="en-US">Borrowings, Reduced Cash Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BorrowingsReducedCashInterestRate_2" xml:lang="en-US">Borrowings, reduced cash interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BorrowingsReducedEffectiveInterestRate_0" xml:lang="en-US">Represents percentage of reduction of effective interest rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BorrowingsReducedEffectiveInterestRate_1" xml:lang="en-US">Borrowings, Reduced Effective Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BorrowingsReducedEffectiveInterestRate_2" xml:lang="en-US">Borrowings, reduced effective interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BorrowingsYearAmortization_0" xml:lang="en-US">Represents amount of borrowing year amortization.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BorrowingsYearAmortization_1" xml:lang="en-US">Borrowings, Year Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BorrowingsYearAmortization_2" xml:lang="en-US">Borrowings, year amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BottledAndPackagedOil_0" xml:lang="en-US">Represents amount related to Bottled and packaged oil.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BottledAndPackagedOil_1" xml:lang="en-US">Bottled And Packaged Oil</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BottledAndPackagedOil_2" xml:lang="en-US">Bottled and packaged oil</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BottledAndPackagedOilMember_0" xml:lang="en-US">Member stands for bottled and packaged oil.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BottledAndPackagedOilMember_1" xml:lang="en-US">Bottled And Packaged Oil [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BottledAndPackagedOilMember_2" xml:lang="en-US">Bottled and packaged oil [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BulkFormulatedOil_0" xml:lang="en-US">Represents amount related to Bulk formulated oil.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BulkFormulatedOil_1" xml:lang="en-US">Bulk Formulated Oil</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BulkFormulatedOil_2" xml:lang="en-US">Bulk formulated oil</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_BulkFormulatedOilMember_0" xml:lang="en-US">Member stands for bulk formulated oil.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_BulkFormulatedOilMember_1" xml:lang="en-US">Bulk Formulated Oil [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_BulkFormulatedOilMember_2" xml:lang="en-US">Bulk formulated oil [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CannabisConsultantMember_0" xml:lang="en-US">Cannabis consultant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CannabisConsultantMember_1" xml:lang="en-US">Cannabis Consultant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_CannabisConsultantMember_2" xml:lang="en-US">Cannabis consultant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CapitalConsideration_0" xml:lang="en-US">Represents amount of capital consideration consist of share capital, reserve for options and warrants, long-term debt, unsecured convertible debentures, accumulated other comprehensive income, and retained earnings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CapitalConsideration_1" xml:lang="en-US">Capital Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_CapitalConsideration_2" xml:lang="en-US">Share capital, reserve for options and warrants, long-term debt, unsecured convertible debentures, accumulated other comprehensive income, and retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CapitalizedTransactionCostsAndEquityDiscount_0" xml:lang="en-US">Represents amount of capitalized transaction costs and equity discount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CapitalizedTransactionCostsAndEquityDiscount_1" xml:lang="en-US">Capitalized Transaction Costs And Equity Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_CapitalizedTransactionCostsAndEquityDiscount_2" xml:lang="en-US">Capitalized transaction costs and equity discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CapitalManagementAbstract_0" xml:lang="en-US">Capital Management [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CashCollateral_0" xml:lang="en-US">Amount of cash collateral.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CashCollateral_1" xml:lang="en-US">Cash Collateral</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_CashCollateral_2" xml:lang="en-US">Cash collateral</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CashPaymentAndStockOptionFeeNoncurrent_0" xml:lang="en-US">Represents amount of long-term portion of cash payment and stock options fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CashPaymentAndStockOptionFeeNoncurrent_1" xml:lang="en-US">Cash Payment And Stock Option Fee Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_CashPaymentAndStockOptionFeeNoncurrent_2" xml:lang="en-US">Long-term portion of cash payment and stock options fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CashPaymentAndStockOptionsFeeCurrent_0" xml:lang="en-US">Represents amount of cash payment and stock options fee, current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CashPaymentAndStockOptionsFeeCurrent_1" xml:lang="en-US">Cash Payment And Stock Options Fee, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_CashPaymentAndStockOptionsFeeCurrent_2" xml:lang="en-US">Current portion of cash payment and stock options fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CashPositionAbstract_0" xml:lang="en-US">Cash Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_CashPositionAbstract_1" xml:lang="en-US">CASH POSITION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_0" xml:lang="en-US">Represent the amount of change in accounts payable and accrued liabilities related to purchases of property plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_1" xml:lang="en-US">Net change in accounts payable and accrued liabilities related to purchases of PP&amp;E</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_2" xml:lang="en-US">Change In Accounts Payable And Accrued Liabilities Related To Purchases Of Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_3" xml:lang="en-US">Net change in accounts payable and accrued liabilities related to purchases of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ChangeInBenchmarkInterestRates_0" xml:lang="en-US">Represents percentage of change in benchmark interest rates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ChangeInBenchmarkInterestRates_1" xml:lang="en-US">Change In Benchmark Interest Rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ChangeInBenchmarkInterestRates_2" xml:lang="en-US">Change in benchmark interest rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ChangeInUnrecognizedTemporaryDifferences_0" xml:lang="en-US">Represents amount of change in unrecognized temporary differences.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ChangeInUnrecognizedTemporaryDifferences_1" xml:lang="en-US">Change In Unrecognized Temporary Differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ChangeInUnrecognizedTemporaryDifferences_2" xml:lang="en-US">Change in unrecognized temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ChargesForUnabsorbedFixedOverhead_0" xml:lang="en-US">Represents amount of charges for unabsorbed fixed overhead.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ChargesForUnabsorbedFixedOverhead_1" xml:lang="en-US">Charges For Unabsorbed Fixed Overhead</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ChargesForUnabsorbedFixedOverhead_2" xml:lang="en-US">Charges for unabsorbed fixed overhead</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ChargesRelatedToPlantCulling_0" xml:lang="en-US">Represents amount related to plant culling.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ChargesRelatedToPlantCulling_1" xml:lang="en-US">Charges Related To Plant Culling</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ChargesRelatedToPlantCulling_2" xml:lang="en-US">Plant culling</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ChargesRelatedToReducedWorkforce_0" xml:lang="en-US">Represents charges related to reduced workforce.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ChargesRelatedToReducedWorkforce_1" xml:lang="en-US">Charges Related To Reduced Workforce</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ChargesRelatedToReducedWorkforce_2" xml:lang="en-US">Charges related to reduced workforce due to COVID-19</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_0" xml:lang="en-US">Represents amount of commitment for convertible debentures on achievement of production related milestones within 24 Months.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_1" xml:lang="en-US">Commitment For Convertible Debentures On Achievement Of Production Related Milestones Within 24 Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_2" xml:lang="en-US">Commitment for convertible debentures on achievement of production related milestones within 24 months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_0" xml:lang="en-US">Represents amount of commitment for convertible debentures on achievement of production related milestones within 36 Months.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_1" xml:lang="en-US">Commitment For Convertible Debentures On Achievement Of Production Related Milestones Within 36 Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_2" xml:lang="en-US">Commitment for convertible debentures on achievement of production related milestones within 36 months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_0" xml:lang="en-US">Represents amount of commitment to deliver additional consideration in the form of OHI shares contingent on the achievement of gross margin based milestones.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_1" xml:lang="en-US">Commitment To Deliver Additional Consideration On Achievement Of Gross Margin Based Milestones</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_2" xml:lang="en-US">Commitment to deliver additional consideration on achievement of gross margin based milestones</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CommittedAndUncommittedBorrowingFacilities_0" xml:lang="en-US">The total amount of committed and uncommitted borrowing facilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CommittedAndUncommittedBorrowingFacilities_1" xml:lang="en-US">Committed And Uncommitted Borrowing Facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_CommittedAndUncommittedBorrowingFacilities_2" xml:lang="en-US">Committed and uncommitted borrowing facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CommittedBorrowingFacilities_0" xml:lang="en-US">The amount of committed borrowing facilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CommittedBorrowingFacilities_1" xml:lang="en-US">Committed Borrowing Facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_CommittedBorrowingFacilities_2" xml:lang="en-US">Committed borrowing facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConcentratedExtractMember_0" xml:lang="en-US">Member stands for concentrated extract.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConcentratedExtractMember_1" xml:lang="en-US">Concentrated Extract [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConcentratedExtractMember_2" xml:lang="en-US">Concentrated extract [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ContingenciesAbstract_0" xml:lang="en-US">Contingencies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ContingentShareConsideration_0" xml:lang="en-US">The amount of contingent share consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ContingentShareConsideration_1" xml:lang="en-US">Contingent Share Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ContingentShareConsideration_2" xml:lang="en-US">Contingent share consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ContractualCashFlowsMember_0" xml:lang="en-US">Represents information related to contractual cash flows.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ContractualCashFlowsMember_1" xml:lang="en-US">Contractual Cash Flows [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ContractuallyCommittedFutureCosts_0" xml:lang="en-US">Represents contractually committed future costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ContractuallyCommittedFutureCosts_1" xml:lang="en-US">Contractually Committed Future Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ContractuallyCommittedFutureCosts_2" xml:lang="en-US">Contractually committed future costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConversionOfConvertibleDebenturesAmountConverted_0" xml:lang="en-US">Represents amount of conversion of convertible debentures, amount converted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConversionOfConvertibleDebenturesAmountConverted_1" xml:lang="en-US">Conversion Of Convertible Debentures Amount Converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ConversionOfConvertibleDebenturesAmountConverted_2" xml:lang="en-US">Conversion of convertible debentures, amount converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConversionOfConvertibleDebenturesSharesIssued_0" xml:lang="en-US">Represents shares of conversion of convertible debentures, shares issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConversionOfConvertibleDebenturesSharesIssued_1" xml:lang="en-US">Conversion Of Convertible Debentures Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ConversionOfConvertibleDebenturesSharesIssued_2" xml:lang="en-US">Conversion of convertible debentures, shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConversionOfConvertibleDebenturesSharesIssued_3" xml:lang="en-US">Convertible Debentures Converted In To Number Of Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConversionOfDebenturesDescription_0" xml:lang="en-US">Description for conversion of debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConversionOfDebenturesDescription_1" xml:lang="en-US">Conversion Of Debentures Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConversionOfDebenturesDescription_2" xml:lang="en-US">Description, Conversion of debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConversionOfDebenturesPricePerShare_0" xml:lang="en-US">Conversion of debentures Price Per Share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConversionOfDebenturesPricePerShare_1" xml:lang="en-US">Conversion Of Debentures Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConversionOfDebenturesPricePerShare_2" xml:lang="en-US">Conversion of debentures price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebentureIssueCosts_0" xml:lang="en-US">Represents amount of convertible debenture issue cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_ConvertibleDebentureIssueCosts_1" xml:lang="en-US">Less: issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebentureIssueCosts_2" xml:lang="en-US">Convertible Debenture Issue Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ConvertibleDebentureIssueCosts_3" xml:lang="en-US">Issue cost of convertible debenture</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_0" xml:lang="en-US">Convertible debenture issue cost charged to the debenture liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_1" xml:lang="en-US">Convertible Debenture Issue Costs Charged To Debenture Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_2" xml:lang="en-US">Convertible debenture issue costs charged to debenture liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesChangeInControlPercentage_0" xml:lang="en-US">Represents percentage of change in control.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesChangeInControlPercentage_1" xml:lang="en-US">Convertible Debentures, Change In Control Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebenturesChangeInControlPercentage_2" xml:lang="en-US">Convertible debentures, change in control percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesConversionPrice_0" xml:lang="en-US">Represents conversion price of convertible debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesConversionPrice_1" xml:lang="en-US">Convertible Debentures Conversion Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ConvertibleDebenturesConversionPrice_2" xml:lang="en-US">Convertible debentures, Conversion price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_0" xml:lang="en-US">Represents percentage of effective annualized discount rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_1" xml:lang="en-US">Convertible Debentures, Effective Annualized Discount Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_2" xml:lang="en-US">Effective annualized discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesEffectiveInterestRate_0" xml:lang="en-US">Represents percentage of effective interest rate on the debt component, inclusive of the equity discount and issue costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesEffectiveInterestRate_1" xml:lang="en-US">Convertible Debentures, Effective Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebenturesEffectiveInterestRate_2" xml:lang="en-US">Effective interest rate on debt component</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesFaceValue_0" xml:lang="en-US">Represents amount of convertible debentures face value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesFaceValue_1" xml:lang="en-US">Convertible Debentures Face Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ConvertibleDebenturesFaceValue_2" xml:lang="en-US">Debentures - maturing January 31, 2020 bearing interest at an interest rate of 6.00% - face value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebenturesFaceValue_3" xml:lang="en-US">Convertible debentures, face value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesMember_0" xml:lang="en-US">Represents information of convertible debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesMember_1" xml:lang="en-US">Convertible Debentures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ConvertibleDebenturesMember_2" xml:lang="en-US">Convertible debentures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebenturesMember_3" xml:lang="en-US">Unsecured Convertible Debentures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesReceivableFaceValue_0" xml:lang="en-US">Represents amount of convertible deventures receivable face value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesReceivableFaceValue_1" xml:lang="en-US">Convertible Debentures Receivable Face Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ConvertibleDebenturesReceivableFaceValue_2" xml:lang="en-US">Convertible debentures receivable, face value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebenturesReceivableFaceValue_3" xml:lang="en-US">Convertible debentures, face value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_0" xml:lang="en-US">Represents shares of convertible debentures, total number of shares available upon conversion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_1" xml:lang="en-US">Convertible Debentures Total Number Of Shares Available Upon Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_2" xml:lang="en-US">Convertible debentures, total number of shares available upon conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_0" xml:lang="en-US">Represents amount of valuation of the debt component before issue costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_1" xml:lang="en-US">Convertible Debentures, Valuation Of Debt Component Before Issue Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_2" xml:lang="en-US">Valuation of the debt component before issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CreditFacilitiesAxis_0" xml:lang="en-US">Information by type of credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CreditFacilitiesAxis_1" xml:lang="en-US">Credit Facilities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CreditFacilitiesDomain_0" xml:lang="en-US">Type of credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CreditFacilitiesDomain_1" xml:lang="en-US">Credit Facilities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CreditFacilityAmendmentAxis_0" xml:lang="en-US">Information of amendment in credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CreditFacilityAmendmentAxis_1" xml:lang="en-US">Credit Facility Amendment [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CreditFacilityAmendmentDomain_0" xml:lang="en-US">Information of amendment in credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CreditFacilityAmendmentDomain_1" xml:lang="en-US">Credit Facility Amendment [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CumulativeConvertedDebentures_0" xml:lang="en-US">Represents amount of cumulative converted debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_CumulativeConvertedDebentures_1" xml:lang="en-US">Less: conversion of debentures, cumulative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CumulativeConvertedDebentures_2" xml:lang="en-US">Cumulative Converted Debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_0" xml:lang="en-US">The amount of current assets included in disposal groups classified as held for sale.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_1" xml:lang="en-US">Current Assets Or Disposal Groups Classified As Held For Sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_2" xml:lang="en-US">Assets classified as held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DebtIssueRelatedCost_0" xml:lang="en-US">The amount of cost related to the issuance of debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_DebtIssueRelatedCost_1" xml:lang="en-US">Convertible debenture issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DebtIssueRelatedCost_2" xml:lang="en-US">Debt Issue Related Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DebtIssueRelatedCost_3" xml:lang="en-US">Convertible debenture issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DebtIssueRelatedCost_4" xml:lang="en-US">Issue costs allocated to equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/zeroVerboseLabel" xlink:label="lab_ogi_DebtIssueRelatedCost_5" xml:lang="en-US">Convertible debenture issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DebtIssueRelatedCostAllocatedToEquity_0" xml:lang="en-US">Debt Issue Related Cost Allocated To Equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_DebtIssueRelatedCostAllocatedToEquity_1" xml:lang="en-US">Issue costs allocated to equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DebtIssueRelatedCostAllocatedToEquity_2" xml:lang="en-US">Debt Issue Related Cost Allocated To Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DebtIssueRelatedCostAllocatedToEquity_3" xml:lang="en-US">Issue costs allocated to equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DebtIssuesCost_0" xml:lang="en-US">The amount of cost related to the issuance of debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DebtIssuesCost_1" xml:lang="en-US">Debt Issues Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DebtIssuesCost_2" xml:lang="en-US">Issue costs of long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_0" xml:lang="en-US">Information about december two thousand nineteen at the market equity program.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_1" xml:lang="en-US">December Two Thousand Nineteen At Market Equity Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_2" xml:lang="en-US">December 2019 ATM Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DeferredFinancingCosts_0" xml:lang="en-US">Represents deferred financing costs as of balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DeferredFinancingCosts_1" xml:lang="en-US">Deferred Financing Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DeferredFinancingCosts_2" xml:lang="en-US">Deferred financing costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DeferredTaxLiabilityAbstract_0" xml:lang="en-US">Deferred Tax Liability Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DeferredTaxLiabilityAbstract_1" xml:lang="en-US">Deferred tax liabilities are attributable to the following:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DeferredTaxOnConvertibleDebentureFinancing_0" xml:lang="en-US">Deferred tax on Convertible debenture financing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DeferredTaxOnConvertibleDebentureFinancing_1" xml:lang="en-US">Deferred Tax On Convertible Debenture Financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DeferredTaxOnConvertibleDebentureFinancing_2" xml:lang="en-US">Deferred tax related to convertible debenture</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DeferredTaxOnConvertibleDebentureFinancing_3" xml:lang="en-US">Deferred Tax On Convertible debenture financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_0" xml:lang="en-US">Represents amount of deferred tax related to items recognized directly in equity and OCI.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_1" xml:lang="en-US">Recognized directly in equity &amp; oci</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_2" xml:lang="en-US">Deferred Tax Relating To Items Recognized Directly In Equity And Other Comprehensive Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_3" xml:lang="en-US">Recognized directly in equity &amp; oci</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_0" xml:lang="en-US">Accounts receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_1" xml:lang="en-US">Derecognized Assets And Liabilities Accounts Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_2" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesCash_0" xml:lang="en-US">Derecognized assets and liabilities Cash.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesCash_1" xml:lang="en-US">Derecognized Assets And Liabilities Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesCash_2" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_0" xml:lang="en-US">Derecognized assets and liabilities Goodwill.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_1" xml:lang="en-US">Derecognized Assets And Liabilities Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_2" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_0" xml:lang="en-US">Derecognized assets and liabilities net assets disposed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_1" xml:lang="en-US">Derecognized Assets And Liabilities Net Assets Disposed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_2" xml:lang="en-US">Net assets disposed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_0" xml:lang="en-US">Derecognized assets and liabilities Other current assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_1" xml:lang="en-US">Derecognized Assets And Liabilities Other Current Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_2" xml:lang="en-US">Other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_0" xml:lang="en-US">Derecognized Assets And Liabilities Property, Plant And Equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_1" xml:lang="en-US">Derecognized Assets And Liabilities Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_0" xml:lang="en-US">Derecognized assets and liabilities Trade and other payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_1" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_2" xml:lang="en-US">Derecognized Assets And Liabilities Trade And Other Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_3" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for critical accounting estimates and judgments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Critical Accounting Estimates And Judgments Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_2" xml:lang="en-US">Critical accounting estimates and judgments [policy text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DescriptionOfBusinessAbstract_0" xml:lang="en-US">Description Of Business [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_0" xml:lang="en-US">Represents expected life of warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_1" xml:lang="en-US">Description Of Expected Life Of Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_2" xml:lang="en-US">Expected life of warrants (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_0" xml:lang="en-US">The expected volatility of the share price used to calculate the fair value of the warrants granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_1" xml:lang="en-US">Description Of Expected Volatility Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_2" xml:lang="en-US">Expected annualized volatility %</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DescriptionOfForfeitureRateShareOptionsGranted_0" xml:lang="en-US">The expected forfeiture of the share price used to calculate the fair value of the share price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DescriptionOfForfeitureRateShareOptionsGranted_1" xml:lang="en-US">Description Of Forfeiture Rate Share Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DescriptionOfForfeitureRateShareOptionsGranted_2" xml:lang="en-US">Forfeiture Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DescriptionOfOptionLifeSharesOptionsGranted_0" xml:lang="en-US">Represents the period of option life shares options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DescriptionOfOptionLifeSharesOptionsGranted_1" xml:lang="en-US">Description Of Option Life Shares Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DescriptionOfOptionLifeSharesOptionsGranted_2" xml:lang="en-US">Vesting period of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_0" xml:lang="en-US">Expected risk-free interest rate, warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_1" xml:lang="en-US">Description Of Risk Free Interest Rate Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_2" xml:lang="en-US">Risk free interest rate %</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DifferenceBetweenCurrentAndFutureTaxRates_0" xml:lang="en-US">Represents amount of  Difference between current and future tax rates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DifferenceBetweenCurrentAndFutureTaxRates_1" xml:lang="en-US">Difference Between Current And Future Tax Rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DifferenceBetweenCurrentAndFutureTaxRates_2" xml:lang="en-US">Difference between current and future tax rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_0" xml:lang="en-US">Information about dilutive effect of performance shares units on number of ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_1" xml:lang="en-US">Dilutive Effect Of Performance Shares Units On Number Of Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_2" xml:lang="en-US">Performance share units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_0" xml:lang="en-US">The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's Restricted shares units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_1" xml:lang="en-US">Dilutive Effect Of Restricted Shares Units On Number Of Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_2" xml:lang="en-US">Restricted shares units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_0" xml:lang="en-US">The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_1" xml:lang="en-US">Dilutive Effect Of Warrants On Number Of Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_2" xml:lang="en-US">Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DirectToPatientMedicalRevenueMember_0" xml:lang="en-US">This member stands for direct to patient medical revenue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DirectToPatientMedicalRevenueMember_1" xml:lang="en-US">Direct To Patient Medical Revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DirectToPatientMedicalRevenueMember_2" xml:lang="en-US">Direct to patient medical revenue (Canadian) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfAccountsReceivableLineItems_0" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfAccountsReceivableLineItems_1" xml:lang="en-US">Disclosure Of Accounts Receivable [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_0" xml:lang="en-US">Disclosure Of Carrying Amounts Of Assets And Liabilities In Disposal Group Explanatory [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_1" xml:lang="en-US">Disclosure Of Carrying Amounts Of Assets And Liabilities In Disposal Group Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_2" xml:lang="en-US">Disclosure of detailed information about carrying amounts of assets and liabilities in this disposal group [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_0" xml:lang="en-US">Represents information of disclosure of continuity of lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Continuity Of Lease Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about lease liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfCostOfSalesAbstract_0" xml:lang="en-US">Disclosure Of Cost Of Sales [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_0" xml:lang="en-US">Represents detailed information about aging of trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Aging Of Trade Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about aging of trade receivables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About Balances Of Accounts Receivables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Balances Of Accounts Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about balances of accounts receivables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_0" xml:lang="en-US">Disclosure of Cash flows generated by THC for reporting periods Explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Cash Flows Generated By T H C I For Reporting Periods Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about Cash flows generated by THC for reporting periods [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_0" xml:lang="en-US">Represents disclosure of disclosure of detailed information about changes in temporary differences in net tax assets (liabilities).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Changes In Temporary Differences In Net Tax Assets Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about changes in temporary differences in net tax assets and liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of derecognized assets and liabilities Explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Derecognized Assets And Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about derecognized assets and liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_0" xml:lang="en-US">The disclosure of detailed information about fair value adjustment to biological assets and inventory sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Fair Value Adjustment To Biological Assets And Inventory Sold Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_2" xml:lang="en-US">Disclosure of detailed information about fair value adjustment to biological assets and inventory sold [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_0" xml:lang="en-US">Disclosure of detailed information about general and administrative expenses explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About General And Administrative Expenses Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about general and administrative expenses [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0" xml:lang="en-US">Represents detailed information about inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Inventories Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about inventories [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of non-capital losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Non Capital Losses Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about non-capital losses [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_0" xml:lang="en-US">The disclosure of detailed information about principal repayments required on the long-term debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Principal Repayments Required On Long Term Borrowing Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_2" xml:lang="en-US">Disclosure of detailed information about principal repayments required on long-term debt [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">The disclosure of detailed information about reconciliation of additions of property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Reconciliation Of Additions To Property Plant And Equipment Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_2" xml:lang="en-US">Disclosure of detailed information about reconciliation of additions to property, plant and equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_0" xml:lang="en-US">Represents information related detail information about operating leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Reconciliation Operating Leases Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about reconciliation of operating leases [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_0" xml:lang="en-US">Represents information related to revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_1" xml:lang="en-US">Disclosure Of Detailed Information About Revenues Explantory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_2" xml:lang="en-US">Disclosure of detailed information about revenues [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_0" xml:lang="en-US">Tabular disclosure of detailed information about short term investment explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Short Term Investments Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about short term investments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_0" xml:lang="en-US">Disclosure of detailed information about stock option valuation assumptions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_1" xml:lang="en-US">Disclosure Of Detailed Information About Stock Option Valuation Assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_2" xml:lang="en-US">Disclosure of detailed information about stock option valuation assumptions [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_0" xml:lang="en-US">The disclosure of detailed information about unobservable inputs and their impact on fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Unobservable Inputs And Their Impact On Fair Value Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_2" xml:lang="en-US">Disclosure of detailed information about unobservable inputs and their impact on fair value [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about unsecured convertible debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Unsecured Convertible Debentures Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about unsecured convertible debentures [Table text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_0" xml:lang="en-US">Represents information related useful life of assets and describe method of depreciation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Useful Life Of Tangible Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about estimated useful lives of property, plant and equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about warrants valuation assumptions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Warrants Valuation Assumptions Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about warrants valuation assumptions [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_1" xml:lang="en-US">Disclosure Of Detailed Information Number And Weighted Average Exercise Prices Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_2" xml:lang="en-US">Disclosure of detailed information about number and weighted average exercise prices of warrants [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_0" xml:lang="en-US">Represents the disclosure of reconciliation of income tax expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information Reconciliation Of Income Tax Expense Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_2" xml:lang="en-US">Disclosure of detailed information about reconciliation of income tax expense [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory_0" xml:lang="en-US">Represents information related to operating leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information Reconciliation Operating Leasesexplanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_0" xml:lang="en-US">Disclosure Of Statement Of Financial Position And Comprehensive Loss Of Entities Material Investments In Equity Method Investees Explanatory [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information Statement Of Financial Position And Comprehensive Loss Of Entities Material Investments In Equity Method Investees Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_2" xml:lang="en-US">Disclosure of detailed information current and non-current assets, current and non-current liabilities as well as revenues and net loss of the Company's material investments in equity method investees [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_0" xml:lang="en-US">Disclosure Of Undiscounted Cash Flows Contractual Maturities Explanatory [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information Undiscounted Cash Flows Contractual Maturities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about undiscounted cash flows contractual maturities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfIndirectProductionExplanatory_0" xml:lang="en-US">The entire disclosure for indirect production costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfIndirectProductionExplanatory_1" xml:lang="en-US">Disclosure Of Indirect Production Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfIndirectProductionExplanatory_2" xml:lang="en-US">INDIRECT PRODUCTION [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_0" xml:lang="en-US">The entire disclosure for licensing and endorsement agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_1" xml:lang="en-US">Disclosure Of Licensing And Endorsement Agreement Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_2" xml:lang="en-US">LICENSING AGREEMENT [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfLoanReceivablesExplanatory_0" xml:lang="en-US">The entire disclosure for loan receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfLoanReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Loan Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfLoanReceivablesExplanatory_2" xml:lang="en-US">LOAN RECEIVABLE [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_0" xml:lang="en-US">Disclosure Of loss from re-measurement of assets and liabilities classified as held for sale Explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_1" xml:lang="en-US">Disclosure Of Loss From Re Measurement Of Assets And Liabilities Classified As Held For Sale Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_2" xml:lang="en-US">Disclosure of detailed information about loss from re-measurement of assets and liabilities classified as held for sale [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfNatureOfOperationsExplanatory_0" xml:lang="en-US">The entire disclosure for nature of operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfNatureOfOperationsExplanatory_1" xml:lang="en-US">Disclosure Of Nature Of Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfNatureOfOperationsExplanatory_2" xml:lang="en-US">NATURE OF OPERATIONS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_0" xml:lang="en-US">Information about disclosure of number and weighted average exercise prices of performance share units explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_1" xml:lang="en-US">Disclosure Of Number And Weighted Average Exercise Prices Of Performance Share Units Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about number and weighted average exercise prices of performance share units [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xml:lang="en-US">Disclosure Of Operations Of Trauma Healing Centers [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_0" xml:lang="en-US">The entire disclosure for operations of trauma healing centers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_1" xml:lang="en-US">Disclosure Of Operations Of Trauma Healing Centers Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_2" xml:lang="en-US">OPERATIONS OF TRAUMA HEALING CENTERS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xml:lang="en-US">Disclosure Of Other Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_0" xml:lang="en-US">The entire disclosure for prior period reclassification.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_1" xml:lang="en-US">Disclosure Of Prior Period Reclassification Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_2" xml:lang="en-US">PRIOR PERIOD RECLASSIFICATION [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfShareCapitalInformationAbstract_0" xml:lang="en-US">Disclosure Of Share Capital Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfShortTermInvestmentsLineItems_0" xml:lang="en-US">Represents short term investments line item.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfShortTermInvestmentsLineItems_1" xml:lang="en-US">Disclosure Of Short Term Investments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DisclosureOfShortTermInvestmentsLineItems_2" xml:lang="en-US">Disclosure Of Short Term Investments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DisclosureOfShortTermInvestmentsTable_0" xml:lang="en-US">Represents short term investments table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfShortTermInvestmentsTable_1" xml:lang="en-US">Disclosure Of Short Term Investments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DisclosureOfShortTermInvestmentsTable_2" xml:lang="en-US">Disclosure Of Short Term Investments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xml:lang="en-US">Disclosure Of Significant Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DiscountingOperatingLease_0" xml:lang="en-US">Represents amount related to operating leases discount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_DiscountingOperatingLease_1" xml:lang="en-US">Discounting</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DiscountingOperatingLease_2" xml:lang="en-US">Discounting Operating Lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DistributionsOfInvestmentInAssociates_0" xml:lang="en-US">Distributions Of Investment In Associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_DistributionsOfInvestmentInAssociates_1" xml:lang="en-US">Distributions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DistributionsOfInvestmentInAssociates_2" xml:lang="en-US">Distributions Of Investment In Associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DistributionsOfInvestmentInAssociates_3" xml:lang="en-US">Distributions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DocumentAndEntityInformationAbstract_0" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DryCannabisAbstract_0" xml:lang="en-US">Dry Cannabis [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DryCannabisAbstract_1" xml:lang="en-US">Dry cannabis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DryCannabisAvailableForPackagingMember_0" xml:lang="en-US">This member stands for available for packaging.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DryCannabisAvailableForPackagingMember_1" xml:lang="en-US">Dry Cannabis Available For Packaging [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_DryCannabisAvailableForPackagingMember_2" xml:lang="en-US">Dry cannabis, Available for packaging [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DryCannabisMember_0" xml:lang="en-US">This member stands for Dry cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DryCannabisMember_1" xml:lang="en-US">Dry Cannabis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_DryCannabisPackagedInventoryMember_0" xml:lang="en-US">This member stands for Packaged inventory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_DryCannabisPackagedInventoryMember_1" xml:lang="en-US">Dry Cannabis Packaged Inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_DryCannabisPackagedInventoryMember_2" xml:lang="en-US">Dry cannabis, Packaged inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EffectOfTaxRatesInOtherJurisdictions_0" xml:lang="en-US">Effect of tax rates in other jurisdictions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EffectOfTaxRatesInOtherJurisdictions_1" xml:lang="en-US">Effect Of Tax Rates In Other Jurisdictions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EffectOfTaxRatesInOtherJurisdictions_2" xml:lang="en-US">Effect of tax rates in other jurisdictions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EffectOnFairValueAverageNetSellingPricePerGram_0" xml:lang="en-US">Represents amount related to per gram amount effect on fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EffectOnFairValueAverageNetSellingPricePerGram_1" xml:lang="en-US">Effect On Fair Value Average Net Selling Price Per Gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EffectOnFairValueAverageNetSellingPricePerGram_2" xml:lang="en-US">Effect on fair value average net selling price per gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EffectOnFairValueAverageYieldPerPlant_0" xml:lang="en-US">Represents information related to average yield per plant effect on fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EffectOnFairValueAverageYieldPerPlant_1" xml:lang="en-US">Effect On Fair Value Average Yield Per Plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EffectOnFairValueAverageYieldPerPlant_2" xml:lang="en-US">Effect on fair value average yield per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_0" xml:lang="en-US">Represents the amount of elimination of proportionate share of transactions with associates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_1" xml:lang="en-US">Elimination of proportionate share of transactions with associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_2" xml:lang="en-US">Elimination Of Proportionate Share Of Transactions With Associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_3" xml:lang="en-US">Elimination of proportionate share of transactions with associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EquityFinancingMember_0" xml:lang="en-US">Information about equity financing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EquityFinancingMember_1" xml:lang="en-US">Equity Financing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EquityFinancingMember_2" xml:lang="en-US">Equity financing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EquityIncentivePlanMember_0" xml:lang="en-US">Equity Incentive Plan (the "Equity Plan")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EquityIncentivePlanMember_1" xml:lang="en-US">Equity Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EquityInstrumentsHeldSharePrice_0" xml:lang="en-US">Represents per share price of equity instrument.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EquityInstrumentsHeldSharePrice_1" xml:lang="en-US">Equity Instruments Held Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EquityInstrumentsHeldSharePrice_2" xml:lang="en-US">Equity instruments held, share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EquityIssuancePricePerShare_0" xml:lang="en-US">Equity Issuance, Price per Share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EquityIssuancePricePerShare_1" xml:lang="en-US">Equity Issuance Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_EquityIssuancePricePerShare_2" xml:lang="en-US">Equity issuance price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EquityReserveMember_0" xml:lang="en-US">Equity Reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EquityReserveMember_1" xml:lang="en-US">Equity Reserve [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_EquityReserveMember_2" xml:lang="en-US">EQUITY RESERVES [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EquityReserveMember_3" xml:lang="en-US">Reserve for options and warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EquitySecuritiesFairValuePerShare_0" xml:lang="en-US">Represents amount relate to equity securities fair value per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EquitySecuritiesFairValuePerShare_1" xml:lang="en-US">Equity Securities Fair Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EquitySecuritiesFairValuePerShare_2" xml:lang="en-US">Equity securities, fair value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EquitySecuritiesInVivoCannabisIncMember_0" xml:lang="en-US">Represents equity securities in VIVO Cannabis Inc. member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EquitySecuritiesInVivoCannabisIncMember_1" xml:lang="en-US">Equity Securities In Vivo Cannabis Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EquitySecuritiesInVivoCannabisIncMember_2" xml:lang="en-US">Equity securities in VIVO Cannabis Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EstimatedFairValueOfEmployeeOptionsIssued_0" xml:lang="en-US">Represents information of estimated fair value of employee options issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EstimatedFairValueOfEmployeeOptionsIssued_1" xml:lang="en-US">Estimated Fair Value Of Employee Options Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EstimatedFairValueOfEmployeeOptionsIssued_2" xml:lang="en-US">Estimated fair value of employee options issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_0" xml:lang="en-US">Represents amount of Estimated fair value of equity settled performance share unit granted .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_1" xml:lang="en-US">Estimated Fair Value Of Equity Settled Performance Share Unit Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_2" xml:lang="en-US">Estimated fair value of the equity settled PSUs granted during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_0" xml:lang="en-US">Represents amount of estimated fair value of the equity settled restricted stock unit granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_1" xml:lang="en-US">Estimated Fair Value Of Equity Settled Restricted Stock Unit Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_2" xml:lang="en-US">Estimated fair value of the equity settled RSUs granted during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_0" xml:lang="en-US">Represents amount of estimated fair value of performance stock units issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_1" xml:lang="en-US">Estimated Fair Value Of Performance Stock Units Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_2" xml:lang="en-US">Estimated fair value of performance stock units issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_0" xml:lang="en-US">Represents amount of estimated fair value of restricted stock units issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_1" xml:lang="en-US">Estimated Fair Value Of Restricted Stock Units Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_2" xml:lang="en-US">Estimated fair value of restricted stock units issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EventsAfterReportingPeriodMember_0" xml:lang="en-US">Represents information of events after the reporting Period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EventsAfterReportingPeriodMember_1" xml:lang="en-US">Events After Reporting Period Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EventsAfterReportingPeriodMember_2" xml:lang="en-US">Events After Reporting Period [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_EvianaHealthCorporationMember_0" xml:lang="en-US">Represents information of Eviana Health Corporation (?Eviana?).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_EvianaHealthCorporationMember_1" xml:lang="en-US">Eviana Health Corporation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_EvianaHealthCorporationMember_2" xml:lang="en-US">EVIANA HEALTH CORPORATION [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_EvianaHealthCorporationMember_3" xml:lang="en-US">Eviana Health Corporation ("Eviana") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExciseTaxesExpenses_0" xml:lang="en-US">Total amount of excise taxes	paid during the year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_ExciseTaxesExpenses_1" xml:lang="en-US">Excise taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExciseTaxesExpenses_2" xml:lang="en-US">Excise Taxes Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ExciseTaxesExpenses_3" xml:lang="en-US">Excise taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_0" xml:lang="en-US">Range of exercise prices between $4.66-$7.67.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_1" xml:lang="en-US">Exercise Price Four Point Six Six To Seven Point Six Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_2" xml:lang="en-US">$4.66-$7.67 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_0" xml:lang="en-US">Range of exercise price between $1.49-$2.38.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_1" xml:lang="en-US">Exercise Price One Point Four Nine To Two Point Three Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_2" xml:lang="en-US">$1.49-$2.38 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_0" xml:lang="en-US">Range of exercise prices between $7.68-$11.27.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_1" xml:lang="en-US">Exercise Price Seven Point Six Eight To One One Point Two Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_2" xml:lang="en-US">$7.68-$11.27 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_0" xml:lang="en-US">Range of exercise price between $2.39-$4.65.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_1" xml:lang="en-US">Exercise Price Two Point Three Nine To Four Point Six Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_2" xml:lang="en-US">$2.39-$4.65 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_0" xml:lang="en-US">Range of Exercise prices between $0.30-$1.48.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_1" xml:lang="en-US">Exercise Price Zero Point Three Zero To One Point Four Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_2" xml:lang="en-US">$0.30-$1.48 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExpectedDividendAsPercentageWarrantsGranted_0" xml:lang="en-US">The percentage of an expected dividend used to calculate the fair value of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExpectedDividendAsPercentageWarrantsGranted_1" xml:lang="en-US">Expected Dividend As Percentage Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ExpectedDividendAsPercentageWarrantsGranted_2" xml:lang="en-US">Expected dividend yield %</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExpirationPeriodAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExpirationPeriodAxis_1" xml:lang="en-US">Expiration Period [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExpirationPeriodDomain_0" xml:lang="en-US">Represents domain information related to expiration period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExpirationPeriodDomain_1" xml:lang="en-US">Expiration Period [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExpirationPeriodYearFiveMember_0" xml:lang="en-US">Expiration Period Year Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExpirationPeriodYearFiveMember_1" xml:lang="en-US">Expiration Period Year Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ExpirationPeriodYearFiveMember_2" xml:lang="en-US">August 31, 2040 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExpirationPeriodYearFourMember_0" xml:lang="en-US">Represents information related to expiration period year four.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExpirationPeriodYearFourMember_1" xml:lang="en-US">Expiration Period Year Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ExpirationPeriodYearFourMember_2" xml:lang="en-US">August 31, 2039 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExpirationPeriodYearOneMember_0" xml:lang="en-US">Represents information related to expiration period year one.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExpirationPeriodYearOneMember_1" xml:lang="en-US">Expiration Period Year One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ExpirationPeriodYearOneMember_2" xml:lang="en-US">August 31, 2035 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExpirationPeriodYearThreeMember_0" xml:lang="en-US">Represents information related to expiration period year three.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExpirationPeriodYearThreeMember_1" xml:lang="en-US">Expiration Period Year Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ExpirationPeriodYearThreeMember_2" xml:lang="en-US">August 31, 2038 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ExpirationPeriodYearTwoMember_0" xml:lang="en-US">Represents information related to expiration period year two.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ExpirationPeriodYearTwoMember_1" xml:lang="en-US">Expiration Period Year Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ExpirationPeriodYearTwoMember_2" xml:lang="en-US">August 31, 2037 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FairValueLessCostToDispose_0" xml:lang="en-US">Represents fair value less cost to dispose.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FairValueLessCostToDispose_1" xml:lang="en-US">Fair Value Less Cost To Dispose</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_FairValueLessCostToDispose_2" xml:lang="en-US">Fair value less cost to dispose</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FairValueOfContingentShares_0" xml:lang="en-US">Represents amount of fair value of these contingent shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FairValueOfContingentShares_1" xml:lang="en-US">Fair Value Of Contingent Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_FairValueOfContingentShares_2" xml:lang="en-US">Fair value of contingent shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FairValueOfOptionsGranted_0" xml:lang="en-US">Represents fair value of options granted during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FairValueOfOptionsGranted_1" xml:lang="en-US">Fair Value Of Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_FairValueOfOptionsGranted_2" xml:lang="en-US">Fair value of options granted during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_0" xml:lang="en-US">Name of member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_1" xml:lang="en-US">Farm Credit Canada ("Fcc") Credit Facility Refinanced With Bmo Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_2" xml:lang="en-US">Farm Credit Canada ("FCC") credit facility refinanced with BM O Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_0" xml:lang="en-US">Name of member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_1" xml:lang="en-US">Fcc Real Property Loan Refinanced With Bmo Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_2" xml:lang="en-US">FCC real property loan refinanced with BMO Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_0" xml:lang="en-US">Name of member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_1" xml:lang="en-US">Fcc Real Property Loan Refinanced With Bmo Term Loan Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_2" xml:lang="en-US">FCC [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_3" xml:lang="en-US">FCC real property loan refinanced with BM O Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FirstAmendmentMember_0" xml:lang="en-US">First Amendment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FirstAmendmentMember_1" xml:lang="en-US">First Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FlowerAndTrimAvailableForExtractionMember_0" xml:lang="en-US">Members stands for flower and trim available for extraction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FlowerAndTrimAvailableForExtractionMember_1" xml:lang="en-US">Flower And Trim Available For Extraction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_FlowerAndTrimAvailableForExtractionMember_2" xml:lang="en-US">Flower and trim available for extraction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_FormulatedExtractsMember_0" xml:lang="en-US">This member stands for Formulated extracts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_FormulatedExtractsMember_1" xml:lang="en-US">Formulated Extracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GovernmentProgramsReceivable_0" xml:lang="en-US">Represents amount of government programs receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_GovernmentProgramsReceivable_1" xml:lang="en-US">Government programs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GovernmentProgramsReceivable_2" xml:lang="en-US">Government Programs Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_GovernmentProgramsReceivable_3" xml:lang="en-US">Government programs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GovernmentSubsidiesAbstract_0" xml:lang="en-US">Government Subsidies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GrossMarginBeforeFairValueAdjustments_0" xml:lang="en-US">The amount of revenue less cost of sales and other production related expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GrossMarginBeforeFairValueAdjustments_1" xml:lang="en-US">Gross Margin Before Fair Value Adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_GrossMarginBeforeFairValueAdjustments_2" xml:lang="en-US">Gross margin before fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ogi_GrossMarginBeforeFairValueAdjustments_3" xml:lang="en-US">Gross margin before fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GrossMarginFromDiscontinuedOperations_0" xml:lang="en-US">Gross margin from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GrossMarginFromDiscontinuedOperations_1" xml:lang="en-US">Gross Margin From Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_GrossMarginFromDiscontinuedOperations_2" xml:lang="en-US">Gross margin from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GrossRevenue_0" xml:lang="en-US">Total amount of sales recognized for a reporting period, prior to the excise taxes deductions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GrossRevenue_1" xml:lang="en-US">Gross Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_GrossRevenue_2" xml:lang="en-US">Gross revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GrowingProcessingEquipmentMember_0" xml:lang="en-US">This member stands for a class of property, plant and equipment representing growing &amp; processing equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GrowingProcessingEquipmentMember_1" xml:lang="en-US">Growing &amp; Processing Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_GrowingProcessingEquipmentMember_2" xml:lang="en-US">GROWING &amp; PROCESSING EQUIPMENT [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesFiveMember_0" xml:lang="en-US">Represents Guaranteed Investment Certificates Five member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesFiveMember_1" xml:lang="en-US">Guaranteed Investment Certificates Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesFiveMember_2" xml:lang="en-US">GIC - maturing June 17, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesFourMember_0" xml:lang="en-US">Represents Guaranteed Investment Certificates four.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesFourMember_1" xml:lang="en-US">Guaranteed Investment Certificates Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesFourMember_2" xml:lang="en-US">GIC - maturing December 23, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesOneMember_0" xml:lang="en-US">Represents Guaranteed Investment Certificates one member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesOneMember_1" xml:lang="en-US">Guaranteed Investment Certificates One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesOneMember_2" xml:lang="en-US">GIC - maturing September 16, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesThreeMember_0" xml:lang="en-US">Represents Guaranteed Investment Certificates three member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesThreeMember_1" xml:lang="en-US">Guaranteed Investment Certificates Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesThreeMember_2" xml:lang="en-US">GIC - maturing December 15, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesTwoMember_0" xml:lang="en-US">Represents Guaranteed Investment Certificates two member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesTwoMember_1" xml:lang="en-US">Guaranteed Investment Certificates Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_GuaranteedInvestmentCertificatesTwoMember_2" xml:lang="en-US">GIC - maturing September 24, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_HarmonizedSalesTaxesReceivable_0" xml:lang="en-US">Information about harmonized sales taxes receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_HarmonizedSalesTaxesReceivable_1" xml:lang="en-US">Harmonized Sales Taxes Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_HarmonizedSalesTaxesReceivable_2" xml:lang="en-US">Harmonized sales taxes receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_Hemp1812With703454NBIncMember_0" xml:lang="en-US">Hemp 1812 with 703454 N.B. Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_Hemp1812With703454NBIncMember_1" xml:lang="en-US">Hemp 1812 With 703454 N B Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_Hemp1812With703454NBIncMember_2" xml:lang="en-US">Hemp 1812 with 703454 N.B. Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_HyasynthBiologicalsIncMember_0" xml:lang="en-US">Represents information of Hyasynth Biologicals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_HyasynthBiologicalsIncMember_1" xml:lang="en-US">Hyasynth Biologicals Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_HyasynthBiologicalsIncMember_2" xml:lang="en-US">Hyasynth Biologicals Inc. ("Hyasynth") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_HyasynthBiologicalsIncMember_3" xml:lang="en-US">HYASYNTH BIOLOGICALS INC. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ImpairmentLossOfInvestmentsInAssociates_0" xml:lang="en-US">Represents amount of impairment loss of investments in associates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_ImpairmentLossOfInvestmentsInAssociates_1" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ImpairmentLossOfInvestmentsInAssociates_2" xml:lang="en-US">Impairment Loss Of Investments In Associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ImpairmentLossOfInvestmentsInAssociates_3" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncludedInAssetsForSale_0" xml:lang="en-US">Represent the increase (decrease) amount of property, plant and equipment included in assets for sale.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncludedInAssetsForSale_1" xml:lang="en-US">Included In Assets For Sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncludedInAssetsForSale_2" xml:lang="en-US">Included in assets for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncomeFromGovernmentSubsidies_0" xml:lang="en-US">Represents amount of income from government subsidies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_IncomeFromGovernmentSubsidies_1" xml:lang="en-US">Government subsidies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncomeFromGovernmentSubsidies_2" xml:lang="en-US">Income From Government Subsidies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncomeFromGovernmentSubsidies_3" xml:lang="en-US">Government subsidies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncomeFromSubleasingAggregateRent_0" xml:lang="en-US">The amount of income from subleasing aggregate rent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncomeFromSubleasingAggregateRent_1" xml:lang="en-US">Income From Subleasing Aggregate Rent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IncomeFromSubleasingAggregateRent_2" xml:lang="en-US">Aggregate rental income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_0" xml:lang="en-US">Represents amount of income tax  benefit of deductible temporary differences not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_1" xml:lang="en-US">Income Tax Benefit Of Deductible Temporary Differences Not Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_2" xml:lang="en-US">Benefit of deductible temporary differences not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_0" xml:lang="en-US">Represent the increase (decrease) in fair value on growth of biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_1" xml:lang="en-US">Increase (Decrease) In Fair Value On Growth Of Biological Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_2" xml:lang="en-US">Increase (decrease) in fair value on growth of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_0" xml:lang="en-US">Increase Decrease In Non Cash Working Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_1" xml:lang="en-US">Changes in non-cash working capital:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_0" xml:lang="en-US">Increase (Decrease) Through at the market equity financing, net of issue costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_1" xml:lang="en-US">Increase (Decrease) Through At Market Equity Financing, Net Of Issue Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_2" xml:lang="en-US">At-the-market equity financing, net of issue costs of $3,754</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseThroughConstructionCompleted_0" xml:lang="en-US">Represent the amount of increase (decrease) through construction completed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseThroughConstructionCompleted_1" xml:lang="en-US">Increase (Decrease) Through Construction Completed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncreaseDecreaseThroughConstructionCompleted_2" xml:lang="en-US">Construction completed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_0" xml:lang="en-US">Increase decrease through convertible debenture financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_1" xml:lang="en-US">Increase Decrease Through Convertible Debenture Financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_2" xml:lang="en-US">Increase through convertible debenture financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_0" xml:lang="en-US">The increase (decrease) in equity resulting from exercise of restricted share units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_1" xml:lang="en-US">Increase Decrease Through Exercise Of Restricted Share Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_2" xml:lang="en-US">Exercise of restricted share units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_0" xml:lang="en-US">The increase (decrease) in equity resulting from foreign currency translation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_1" xml:lang="en-US">Increase Decrease Through Foreign Currency Translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_2" xml:lang="en-US">Foreign currency translation gain, net of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseThroughShareBasedCompensation_0" xml:lang="en-US">The increase (decrease) in equity resulting from Share-based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseThroughShareBasedCompensation_1" xml:lang="en-US">Increase Decrease Through Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IncreaseDecreaseThroughShareBasedCompensation_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_0" xml:lang="en-US">The increase (decrease) in equity resulting from tax impact of equity and convertible debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_1" xml:lang="en-US">Increase Decrease Through Tax Impact Of Equity And Convertible Debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_2" xml:lang="en-US">Tax impact of equity and convertible debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_0" xml:lang="en-US">The increase (decrease) in equity resulting from tax impact of equity issue costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_1" xml:lang="en-US">Increase Decrease Through Tax Impact Of Equity Issue Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_2" xml:lang="en-US">Tax impact of equity issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IncrementalUncommittedOptionToIncreaseFacilities_0" xml:lang="en-US">Represents amount of incremental uncommitted option to increase the Facilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IncrementalUncommittedOptionToIncreaseFacilities_1" xml:lang="en-US">Incremental Uncommitted Option To Increase Facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IncrementalUncommittedOptionToIncreaseFacilities_2" xml:lang="en-US">Uncommitted option to increase the Facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IndirectProduction_0" xml:lang="en-US">The production cost of late-stage biological assets that are disposed of, inventory that does not pass the Company's quality assurance standards, and obsolete packaging are expensed to indirect production was recorded as indirect production.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IndirectProduction_1" xml:lang="en-US">Indirect Production</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IndirectProduction_2" xml:lang="en-US">Indirect production</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IndirectProductionCostOfSale_0" xml:lang="en-US">Represents amount related to the indirect production cost of sale.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IndirectProductionCostOfSale_1" xml:lang="en-US">Indirect Production Cost Of Sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IndirectProductionCostOfSale_2" xml:lang="en-US">Indirect production to cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InitiallyDrawnAmount_0" xml:lang="en-US">Represents amount of initially drawn.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InitiallyDrawnAmount_1" xml:lang="en-US">Initially Drawn Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_InitiallyDrawnAmount_2" xml:lang="en-US">Initially drawn amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InterestRateOnPromissoryNoteReceivable_0" xml:lang="en-US">The interest rate on promissory note receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InterestRateOnPromissoryNoteReceivable_1" xml:lang="en-US">Interest Rate On Promissory Note Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_InterestRateOnPromissoryNoteReceivable_2" xml:lang="en-US">Interest rate on promissory note receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InternationalBusinessToBusinessMember_0" xml:lang="en-US">This member stands for international (business to business).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InternationalBusinessToBusinessMember_1" xml:lang="en-US">International Business To Business [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_InternationalBusinessToBusinessMember_2" xml:lang="en-US">International (business to business) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InventoriesAbstract_0" xml:lang="en-US">Inventories [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_0" xml:lang="en-US">The amount of expense related to inventory and biological assets written down, provision and net realizable value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_1" xml:lang="en-US">Inventories And Biological Assets Write Down Provision And Adjustments To Net Realizable Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_2" xml:lang="en-US">Write-downs and provisions in relation to excess and obsolete inventories and biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InventoriesLineItems_0" xml:lang="en-US">Represents inventories line item.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InventoriesLineItems_1" xml:lang="en-US">Inventories [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InventoriesTable_0" xml:lang="en-US">Represents inventories table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InventoriesTable_1" xml:lang="en-US">Inventories [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InventoryMember_0" xml:lang="en-US">This member stands for temporary differences related to inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InventoryMember_1" xml:lang="en-US">Inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_InventoryMember_2" xml:lang="en-US">Inventories [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_0" xml:lang="en-US">The amount of expense recognised related to the write-down of inventories to net realisable value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_1" xml:lang="en-US">Inventory Write Down And Provision Relating To Concentrated Extract And Flower And Trim Available For Extraction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_2" xml:lang="en-US">Inventory write-down and provision relating to concentrated extract and flower and trim available for extraction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_0" xml:lang="en-US">The amount of expense recognised related to the write-down of inventories to net realisable value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_1" xml:lang="en-US">Inventory Write Down And Provision Relating To Excess And Unsaleable Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_2" xml:lang="en-US">Inventory write-down and provision relating to excess and unsaleable inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_0" xml:lang="en-US">The amount of expense recognised related to the write-down of inventories to net realisable value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_1" xml:lang="en-US">Inventory Write Down Provision And Plant Waste Included In Cost Of Sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_2" xml:lang="en-US">Inventory write-down, provision, and plant waste included in cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InvestmentInAssociatesRestrictedInvestment_0" xml:lang="en-US">Investment in GIC - restricted investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InvestmentInAssociatesRestrictedInvestment_1" xml:lang="en-US">Investment In Associates Restricted Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_InvestmentInAssociatesRestrictedInvestment_2" xml:lang="en-US">Investment in GIC - restricted investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_InvestmentsInterestRate_0" xml:lang="en-US">Represents percentages related of investments interest rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_InvestmentsInterestRate_1" xml:lang="en-US">Investments Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_InvestmentsInterestRate_2" xml:lang="en-US">Interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssuanceOfEquityFinancingShares_0" xml:lang="en-US">issuance of equity financing shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssuanceOfEquityFinancingShares_1" xml:lang="en-US">Issuance Of Equity Financing Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IssuanceOfEquityFinancingShares_2" xml:lang="en-US">Units sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IssuanceOfEquityFinancingShares_3" xml:lang="en-US">Equity financing (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssuanceOfSharesConversionOfDebentures_0" xml:lang="en-US">Number of shares issued for conversion of debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssuanceOfSharesConversionOfDebentures_1" xml:lang="en-US">Issuance Of Shares Conversion Of Debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IssuanceOfSharesConversionOfDebentures_2" xml:lang="en-US">Conversion of debentures (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_0" xml:lang="en-US">Number of shares issued for exercise of restricted share units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_1" xml:lang="en-US">Issuance Of Shares Exercise Of Restricted Share Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_2" xml:lang="en-US">Exercise of restricted share units (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfStockOptions_0" xml:lang="en-US">Number of shares issued for exercise of stock options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfStockOptions_1" xml:lang="en-US">Issuance Of Shares Exercise Of Stock Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfStockOptions_2" xml:lang="en-US">Exercise of stock options (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfWarrants_0" xml:lang="en-US">Number of shares issued for exercise of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfWarrants_1" xml:lang="en-US">Issuance Of Shares Exercise Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IssuanceOfSharesExerciseOfWarrants_2" xml:lang="en-US">Exercise of warrants (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssuanceOfSharesShareBasedCompensation_0" xml:lang="en-US">Number of shares issued for exercise Share-based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssuanceOfSharesShareBasedCompensation_1" xml:lang="en-US">Issuance Of Shares Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IssuanceOfSharesShareBasedCompensation_2" xml:lang="en-US">Share-based compensation (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssuanceOfSharesShareBasedPayments_0" xml:lang="en-US">Number of shares issued for exercise Share-based payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssuanceOfSharesShareBasedPayments_1" xml:lang="en-US">Issuance Of Shares Share Based Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IssuanceOfSharesShareBasedPayments_2" xml:lang="en-US">Share-based payments (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_0" xml:lang="en-US">Represents the issuance of shares through at the market equity financing, net of issue costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_1" xml:lang="en-US">Issuance Of Shares Through At Market Equity Financing, Net Of Issue Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_2" xml:lang="en-US">At-the-market equity financing, net of issue costs of $3,754 (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_IssueCostAtMarketEquityFinancing_0" xml:lang="en-US">Represents issue cost of At-the-market equity financing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_IssueCostAtMarketEquityFinancing_1" xml:lang="en-US">Issue Cost At Market Equity Financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_IssueCostAtMarketEquityFinancing_2" xml:lang="en-US">Issue cost of At-the-market equity financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_0" xml:lang="en-US">Represents aggregate fair value of other equity instruments granted in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_1" xml:lang="en-US">Key Management Personnel Aggregate Fair Value Of Other Equity Instruments Granted In Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_2" xml:lang="en-US">Aggregate fair value of RSUs granted to key management personnel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LeaseLiabilityMember_0" xml:lang="en-US">Lease Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LeaseLiabilityMember_1" xml:lang="en-US">Lease Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_0" xml:lang="en-US">Represents amount related to lease payments for renewal options reasonably expected to be exercised but not contractually obligated.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_1" xml:lang="en-US">Lease Payments For Renewal Options Reasonably Expected To Be Exercised But Not Contractually Obligated</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_2" xml:lang="en-US">Lease payments for renewal options reasonably expected to be exercised but not contractually obligated</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LicensingAndEndorsementAgreementAbstract_0" xml:lang="en-US">Licensing And Endorsement Agreement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LicensingAndEndorsementAgreementLineItems_0" xml:lang="en-US">Represents licensing and endorsement agreement line item.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LicensingAndEndorsementAgreementLineItems_1" xml:lang="en-US">Licensing And Endorsement Agreement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LicensingAndEndorsementAgreementMember_0" xml:lang="en-US">Type of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LicensingAndEndorsementAgreementMember_1" xml:lang="en-US">Licensing And Endorsement Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LicensingAndEndorsementAgreementTable_0" xml:lang="en-US">Represents licensing and endorsement agreement table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LicensingAndEndorsementAgreementTable_1" xml:lang="en-US">Licensing And Endorsement Agreement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LoanReceivableLineItems_0" xml:lang="en-US">Represents loan receivable line item.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LoanReceivableLineItems_1" xml:lang="en-US">Loan Receivable [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LoanReceivableTable_0" xml:lang="en-US">Represents loan receivable table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LoanReceivableTable_1" xml:lang="en-US">Loan Receivable [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LoansReceivablesAbstract_0" xml:lang="en-US">Loans Receivables [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LongTermAssetsMember_0" xml:lang="en-US">This member stands for long-term assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LongTermAssetsMember_1" xml:lang="en-US">Long Term Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LongTermAssetsMember_2" xml:lang="en-US">Long-term assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0" xml:lang="en-US">Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" xml:lang="en-US">Long Term Borrowing , Maturities, Repayments Of Principal In Next Twelve Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2" xml:lang="en-US">Less than 1 year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_0" xml:lang="en-US">Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_1" xml:lang="en-US">Long Term Borrowing , Maturities, Repayments Of Principal In Year Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_2" xml:lang="en-US">4 to 5 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_0" xml:lang="en-US">Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_1" xml:lang="en-US">Long Term Borrowing , Maturities, Repayments Of Principal In Year Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_2" xml:lang="en-US">3 to 4 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_0" xml:lang="en-US">Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_1" xml:lang="en-US">Long Term Borrowing , Maturities, Repayments Of Principal In Year Thereafter</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_2" xml:lang="en-US">Thereafter</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_0" xml:lang="en-US">Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_1" xml:lang="en-US">Long Term Borrowing , Maturities, Repayments Of Principal In Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_2" xml:lang="en-US">2 to 3 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_0" xml:lang="en-US">Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_1" xml:lang="en-US">Long Term Borrowing , Maturities, Repayments Of Principal In Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_2" xml:lang="en-US">1 to 2 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LossOnRemeasurementToFairValueLessCostsToSell_0" xml:lang="en-US">Loss on remeasurement to fair value less costs to sell.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LossOnRemeasurementToFairValueLessCostsToSell_1" xml:lang="en-US">Loss On Remeasurement To Fair Value Less Costs To Sell</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_LossOnRemeasurementToFairValueLessCostsToSell_2" xml:lang="en-US">Loss on remeasurement to fair value less costs to sell</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_0" xml:lang="en-US">Represents amount of lump-sum payments paid to temporarily laid-off workers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_1" xml:lang="en-US">Lump Sum Payments Paid To Temporarily Laid Off Workers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_2" xml:lang="en-US">Lump-sum payments paid to temporarily laid-off workers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_MaximumCommitmentToDeliverAdditionalConsideration_0" xml:lang="en-US">Represents the amount of maximum commitment to deliver additional consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_MaximumCommitmentToDeliverAdditionalConsideration_1" xml:lang="en-US">Maximum Commitment To Deliver Additional Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_0" xml:lang="en-US">Maximum number of common shares authorised for share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_1" xml:lang="en-US">Maximum Number Of Common Shares Authorised For Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_2" xml:lang="en-US">Maximum number of common shares authorised for share based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_MaximumPercentageOfAnnualCbdOilPurchased_0" xml:lang="en-US">Represents the maximum percentage of annual CBD oil purchased.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_MaximumPercentageOfAnnualCbdOilPurchased_1" xml:lang="en-US">Maximum Percentage Of Annual Cbd Oil Purchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_MaximumPercentageOfAnnualCbdOilPurchased_2" xml:lang="en-US">Maximum percentage of annual CBD oil purchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_0" xml:lang="en-US">Maximum percentage of issued and outstanding equity securities authorised for share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_1" xml:lang="en-US">Maximum Percentage Of Issued And Outstanding Equity Securities Authorised For Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_2" xml:lang="en-US">Maximum percentage of issued and outstanding equity securities authorised for share based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_MinimumFuturePayments_0" xml:lang="en-US">Represents amount not related future lease payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_MinimumFuturePayments_1" xml:lang="en-US">Minimum Future Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_MinimumFuturePayments_2" xml:lang="en-US">Minimum future payments not related to lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_0" xml:lang="en-US">Represents amount of minimum future payments not related to lease payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_1" xml:lang="en-US">Minimum Future Payments Not Related To Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_2" xml:lang="en-US">Minimum future payments not related to lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_MinimumUnrestrictedCashBalanceRequirement_0" xml:lang="en-US">Minimum unrestricted cash balance requirement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_MinimumUnrestrictedCashBalanceRequirement_1" xml:lang="en-US">Minimum Unrestricted Cash Balance Requirement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_MinimumUnrestrictedCashBalanceRequirement_2" xml:lang="en-US">Minimum unrestricted cash balance requirement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_MonctonCampusPhase4CAssetSpecificMember_0" xml:lang="en-US">Represents information of Moncton Campus - Phase 4C (asset specific).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_MonctonCampusPhase4CAssetSpecificMember_1" xml:lang="en-US">Moncton Campus Phase 4C Asset Specific [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_MonctonCampusPhase4CAssetSpecificMember_2" xml:lang="en-US">Moncton Campus - Phase 4C (asset specific) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_MonctonCampusPhase4CAssetSpecificMember_3" xml:lang="en-US">CONSTRUCTION IN PROCESS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NetProceedsFromIssueOfOrdinaryShares_0" xml:lang="en-US">Information about proceeds from issue of ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NetProceedsFromIssueOfOrdinaryShares_1" xml:lang="en-US">Net Proceeds From Issue Of Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_NetProceedsFromIssueOfOrdinaryShares_2" xml:lang="en-US">Net proceeds from issue of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_0" xml:lang="en-US">Represents amount of non-capital loss carryforwards available to offset future taxable income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_1" xml:lang="en-US">Non Capital Loss Carryforwards Available Offset Future Taxable Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_2" xml:lang="en-US">Non capital loss carryforwards available to offset future taxable income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NonCurrentContingentShareConsideration_0" xml:lang="en-US">The amount of contingent share consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NonCurrentContingentShareConsideration_1" xml:lang="en-US">Non Current Contingent Share Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_NonCurrentContingentShareConsideration_2" xml:lang="en-US">Contingent share consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfCommonSharesIssued_0" xml:lang="en-US">Represents the number of common shares issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfCommonSharesIssued_1" xml:lang="en-US">Number Of Common Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_NumberOfCommonSharesIssued_2" xml:lang="en-US">Number of common shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfConvertibleDebenturesSold_0" xml:lang="en-US">Represents number of convertible debentures sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfConvertibleDebenturesSold_1" xml:lang="en-US">Number Of Convertible Debentures Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_NumberOfConvertibleDebenturesSold_2" xml:lang="en-US">Number of convertible debentures sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfOutstandingWarrants_0" xml:lang="en-US">Number of warrants outstanding in share-based payment arrangement at beginning of period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ogi_NumberOfOutstandingWarrants_1" xml:lang="en-US">Outstanding, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ogi_NumberOfOutstandingWarrants_2" xml:lang="en-US">Outstanding, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfOutstandingWarrants_3" xml:lang="en-US">Number Of Outstanding Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_0" xml:lang="en-US">Represents number of share purchase warrant units were acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_1" xml:lang="en-US">Number Of Share Purchase Warrant Units Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_2" xml:lang="en-US">Number of share purchase warrant units acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfSharesAcquired_0" xml:lang="en-US">Represents number of shares acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfSharesAcquired_1" xml:lang="en-US">Number Of Shares Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_NumberOfSharesAcquired_2" xml:lang="en-US">Number of shares acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfWarrantsExercisedOrReleased_0" xml:lang="en-US">Represents number of warrants exercised or released.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_NumberOfWarrantsExercisedOrReleased_1" xml:lang="en-US">Exercised/Released during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfWarrantsExercisedOrReleased_2" xml:lang="en-US">Number Of Warrants Exercised Or Released</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_NumberOfWarrantsExercisedOrReleased_3" xml:lang="en-US">Number of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_NumberOfWarrantsExercisedOrReleased_4" xml:lang="en-US">Value of share purchase warrant exercised by key management personnel and directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/zeroVerboseLabel" xlink:label="lab_ogi_NumberOfWarrantsExercisedOrReleased_5" xml:lang="en-US">Exercised/Released during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfWarrantsExpired_0" xml:lang="en-US">Number of warrants expired in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_NumberOfWarrantsExpired_1" xml:lang="en-US">Expired/Lapsed during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfWarrantsExpired_2" xml:lang="en-US">Number Of Warrants Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_NumberOfWarrantsExpired_3" xml:lang="en-US">Expired during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_NumberOfWarrantsExpired_4" xml:lang="en-US">Warrants expired during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfWarrantsExpiredOrReleased_0" xml:lang="en-US">Number of warrants exercised or released in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfWarrantsExpiredOrReleased_1" xml:lang="en-US">Number Of Warrants Expired Or Released</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_NumberOfWarrantsExpiredOrReleased_2" xml:lang="en-US">Number of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_NumberOfWarrantsExpiredOrReleased_3" xml:lang="en-US">Value of share purchase warrant exercised by key management personnel and directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/zeroVerboseLabel" xlink:label="lab_ogi_NumberOfWarrantsExpiredOrReleased_4" xml:lang="en-US">Exercised/Released during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_NumberOfWarrantsGranted_0" xml:lang="en-US">Number of warrants granted in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_NumberOfWarrantsGranted_1" xml:lang="en-US">Number Of Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_NumberOfWarrantsGranted_2" xml:lang="en-US">Granted during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_OperatingLeaseObligations_0" xml:lang="en-US">Represents amount related to operating lease obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_OperatingLeaseObligations_1" xml:lang="en-US">Operating Lease Obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_OperatingLeaseObligations_2" xml:lang="en-US">Operating lease obligations as at August 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_OperationsOfTraumaHealingCentersLineItems_0" xml:lang="en-US">Operations Of Trauma Healing Centers [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_OperationsOfTraumaHealingCentersLineItems_1" xml:lang="en-US">Operations Of Trauma Healing Centers [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_OperationsOfTraumaHealingCentersTable_0" xml:lang="en-US">Operations Of Trauma Healing Centers [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_OperationsOfTraumaHealingCentersTable_1" xml:lang="en-US">Operations Of Trauma Healing Centers [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_OtherBiologicalAssetsMember_0" xml:lang="en-US">This member stands for other biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_OtherBiologicalAssetsMember_1" xml:lang="en-US">Other Biological Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_OtherBiologicalAssetsMember_2" xml:lang="en-US">OTHER BIOLOGICAL ASSETS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_OtherDeferredTaxAssetsMember_0" xml:lang="en-US">This member stands for other deferred tax asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_OtherDeferredTaxAssetsMember_1" xml:lang="en-US">Other Deferred Tax Assets Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_OtherDeferredTaxAssetsMember_2" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_OtherDeferredTaxLiabilitiesMember_0" xml:lang="en-US">This member stands for other deferred tax liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_OtherDeferredTaxLiabilitiesMember_1" xml:lang="en-US">Other Deferred Tax Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_OtherDeferredTaxLiabilitiesMember_2" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_OtherLiabilitiesMember_0" xml:lang="en-US">Represents other liabilities member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_OtherLiabilitiesMember_1" xml:lang="en-US">Other Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_OtherLiabilitiesMember_2" xml:lang="en-US">Other liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_OtherRevenueMember_0" xml:lang="en-US">This member stands for other revenue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_OtherRevenueMember_1" xml:lang="en-US">Other Revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_OtherRevenueMember_2" xml:lang="en-US">Other revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PaymentAgreementMember_0" xml:lang="en-US">Represents payment agreement member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PaymentAgreementMember_1" xml:lang="en-US">Payment Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PaymentAgreementMember_2" xml:lang="en-US">Advance payment and support agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PaymentsForIntangibleAssetsOther_0" xml:lang="en-US">Represents amount of payment of intangible assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PaymentsForIntangibleAssetsOther_1" xml:lang="en-US">Payments For Intangible Assets Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PaymentsForIntangibleAssetsOther_2" xml:lang="en-US">Payments for intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_0" xml:lang="en-US">Represents right to purchase up to annual CBD oil of agreed raw CBD oil wholesale market price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_1" xml:lang="en-US">Percentage Of Agreed Raw Cbd Oil Wholesale Market Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_2" xml:lang="en-US">Percentage of agreed raw CBD oil wholesale market price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_0" xml:lang="en-US">Represents percentage of discount agreed upon wholesale market price for a period of 10 Years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_1" xml:lang="en-US">Percentage Of Discount Agreed Upon Wholesale Market Price For Period Of Ten Years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_2" xml:lang="en-US">Percentage of discount agreed upon wholesale market price for period of 10 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_0" xml:lang="en-US">Information about discount to the price per kilogram of dried hemp flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_1" xml:lang="en-US">Percentage Of Discount Price Per Kilogram Of Dried Hemp Flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_2" xml:lang="en-US">Percentage of discount price per kilogram of dried hemp flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_0" xml:lang="en-US">Represents percentage of discount rate to forecast interest and principal payments of convertible debenture.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_1" xml:lang="en-US">Percentage Of Discount Rate To Forecast Interest And Principal Payments Of Convertible Debenture</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_2" xml:lang="en-US">Percentage of discount rate to forecast interest and principal payments of convertible debenture</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_0" xml:lang="en-US">Represent the percentage of employee wages covered under Canada Emergency Wage Subsidy.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_1" xml:lang="en-US">Percentage Of Employee Wages Covered Under Canada Emergency Wage Subsidy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_2" xml:lang="en-US">Percentage of employee wages covered under Canada Emergency Wage Subsidy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_3" xml:lang="en-US">Percentage of employee wages covered under CEWS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_0" xml:lang="en-US">Represents percentage of potential ownership interest capped based on certain Canadian securities regulations and contractual obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_1" xml:lang="en-US">Percentage Of Potential Ownership Interest Capped Based On Certain Canadian Securities Regulations And Contractual Obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_2" xml:lang="en-US">Percentage of potential ownership interest capped based on certain Canadian securities regulations and contractual obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PercentagesOfAccruedInterestReceivable_0" xml:lang="en-US">Represents percentages related to interest receivable on advance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PercentagesOfAccruedInterestReceivable_1" xml:lang="en-US">Percentages Of Accrued Interest Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PercentagesOfAccruedInterestReceivable_2" xml:lang="en-US">Percentages of accrued interest receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PerformanceShareUnitsMember_0" xml:lang="en-US">Performance Share Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_PerformanceShareUnitsMember_1" xml:lang="en-US">Performance share units ("PSUs") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PlantsInDryingStageMember_0" xml:lang="en-US">Member stands for plants in drying stage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PlantsInDryingStageMember_1" xml:lang="en-US">Plants In Drying Stage [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PlantsInDryingStageMember_2" xml:lang="en-US">Plants in drying stage [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_0" xml:lang="en-US">Represents amount of potential change in impairment loss due to change in discount rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_1" xml:lang="en-US">Potential Change In Impairment Loss Due To Change In Discount Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_2" xml:lang="en-US">Potential change in impairment loss due to change in discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PotentialProportionOfOwnershipInterestInAssociate_0" xml:lang="en-US">Potential Proportion Of Ownership Interest In Associate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PotentialProportionOfOwnershipInterestInAssociate_1" xml:lang="en-US">The potential proportion of ownership interest in an associate attributable to the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PotentialProportionOfOwnershipInterestInAssociate_2" xml:lang="en-US">Potential proportion of ownership interest in associate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_0" xml:lang="en-US">Represents amount of prepaid expense and the long-term portion of the fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_1" xml:lang="en-US">Prepaid Expense And Long Term Portion Of Fee Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_2" xml:lang="en-US">Prepaid expense and long-term portion fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PrepaidExpensesMember_0" xml:lang="en-US">Represents prepaid expenses member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PrepaidExpensesMember_1" xml:lang="en-US">Prepaid Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PrepaidExpensesMember_2" xml:lang="en-US">Prepaid expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PricePerConvertibleDebentureIssued_0" xml:lang="en-US">Represents amount of price per convertible debenture issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PricePerConvertibleDebentureIssued_1" xml:lang="en-US">Price Per Convertible Debenture Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PricePerConvertibleDebentureIssued_2" xml:lang="en-US">Price per convertible debenture issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PriorPeriodReclassificationAbstract_0" xml:lang="en-US">Prior Period Reclassification [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ProceedsDrawnFromTermLoanCreditFacilities_0" xml:lang="en-US">Proceeds drawn from term loan credit facilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ProceedsDrawnFromTermLoanCreditFacilities_1" xml:lang="en-US">Proceeds Drawn From Term Loan Credit Facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ProceedsDrawnFromTermLoanCreditFacilities_2" xml:lang="en-US">Proceeds drawn from term loan credit facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_0" xml:lang="en-US">Proceeds from  Stock options, warrants and units exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_1" xml:lang="en-US">Proceeds From Stock Options Warrants And Units Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_2" xml:lang="en-US">Stock options, warrants and units exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PromissoryNoteMember_0" xml:lang="en-US">Information about promissory note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PromissoryNoteMember_1" xml:lang="en-US">Promissory Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_PromissoryNoteMember_2" xml:lang="en-US">Promissory note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PropertyPlantAndEquipmentsMember_0" xml:lang="en-US">Property Plant And Equipments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_PropertyPlantAndEquipmentsMember_1" xml:lang="en-US">PP&amp;E [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ProportionOfOwnershipInterestInSubsidiarySold_0" xml:lang="en-US">Represents proportion of ownership interest in subsidiary sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ProportionOfOwnershipInterestInSubsidiarySold_1" xml:lang="en-US">Proportion Of Ownership Interest In Subsidiary Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ProportionOfOwnershipInterestInSubsidiarySold_2" xml:lang="en-US">Proportion of ownership interest in subsidiary sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ProvisionForDoubtfulAccount_0" xml:lang="en-US">Information about provision for doubtful accounts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_ProvisionForDoubtfulAccount_1" xml:lang="en-US">Less: Provision for doubtful accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ProvisionForDoubtfulAccount_2" xml:lang="en-US">Provision For Doubtful Account</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ProvisionForDoubtfulAccount_3" xml:lang="en-US">Less: Provision for doubtful accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ProvisionForDoubtfulTradeReceivables_0" xml:lang="en-US">Provision For Doubtful Trade Receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_ProvisionForDoubtfulTradeReceivables_1" xml:lang="en-US">Less: Provision for doubtful accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ProvisionForDoubtfulTradeReceivables_2" xml:lang="en-US">Provision For Doubtful Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ProvisionForDoubtfulTradeReceivables_3" xml:lang="en-US">Less: Provision for doubtful accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_PurchaseCostOfLandAndMovableEquipment_0" xml:lang="en-US">purchase cost of the land and movable equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_PurchaseCostOfLandAndMovableEquipment_1" xml:lang="en-US">Purchase Cost Of Land And Movable Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_PurchaseCostOfLandAndMovableEquipment_2" xml:lang="en-US">Purchase cost of land and movable equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_QuantityOfInventory_0" xml:lang="en-US">Description of quantity of inventory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_QuantityOfInventory_1" xml:lang="en-US">Quantity Of Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_QuantityOfInventory_2" xml:lang="en-US">QUANTITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_QuarterlyRepayments_0" xml:lang="en-US">The amount of quarterly repayments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_QuarterlyRepayments_1" xml:lang="en-US">Quarterly Repayments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_QuarterlyRepayments_2" xml:lang="en-US">Quarterly repayments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RealizedFairValueAmountsIncludedInInventorySold_0" xml:lang="en-US">Represent the realized fair value amounts included in inventory sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_RealizedFairValueAmountsIncludedInInventorySold_1" xml:lang="en-US">Realized fair value amounts included in inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RealizedFairValueAmountsIncludedInInventorySold_2" xml:lang="en-US">Realized Fair Value Amounts Included In Inventory Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_RealizedFairValueAmountsIncludedInInventorySold_3" xml:lang="en-US">Realized fair value amounts included in inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ReceivablesAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ReceivablesAxis_1" xml:lang="en-US">Receivables [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ReceivablesDomain_0" xml:lang="en-US">This member stands for trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ReceivablesDomain_1" xml:lang="en-US">Receivables [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ReclassificationOfComputerSoftware_0" xml:lang="en-US">Reclassification of computer software.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_ReclassificationOfComputerSoftware_1" xml:lang="en-US">Reclassification of computer software</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ReclassificationOfComputerSoftware_2" xml:lang="en-US">Reclassification Of Computer Software</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ReclassificationOfComputerSoftware_3" xml:lang="en-US">Reclassification of computer software</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ReclassificationOfSalesReturnsToGrossRevenue_0" xml:lang="en-US">Information for sales recoveries reclassified from sales returns to gross revenue to conform to current year presentation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ReclassificationOfSalesReturnsToGrossRevenue_1" xml:lang="en-US">Reclassification Of Sales Returns To Gross Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ReclassificationOfSalesReturnsToGrossRevenue_2" xml:lang="en-US">Sales returns to gross revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RecoverableAmountBasedOnValueInUse_0" xml:lang="en-US">Represents recoverable amount based on a value in use.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RecoverableAmountBasedOnValueInUse_1" xml:lang="en-US">Recoverable Amount Based On Value In Use</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_RecoverableAmountBasedOnValueInUse_2" xml:lang="en-US">Recoverable amount based on value in use</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ReductionInRevolverCommitment_0" xml:lang="en-US">Reduction in Revolver commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ReductionInRevolverCommitment_1" xml:lang="en-US">Reduction In Revolver Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ReductionInRevolverCommitment_2" xml:lang="en-US">Reduction in Revolver commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RegulatoryFees_0" xml:lang="en-US">Information related to regulatory fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RegulatoryFees_1" xml:lang="en-US">Regulatory Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_RegulatoryFees_2" xml:lang="en-US">Regulatory fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ReliefOptionForLeasesOfLowValueAssets_0" xml:lang="en-US">Represents amount related to relief option for leases of low-value assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ReliefOptionForLeasesOfLowValueAssets_1" xml:lang="en-US">Relief Option For Leases Of Low Value Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ReliefOptionForLeasesOfLowValueAssets_2" xml:lang="en-US">Relief option for leases of low-value assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ReliefOptionForShortTermLeases_0" xml:lang="en-US">Represents amount of Relief option for short-term leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ReliefOptionForShortTermLeases_1" xml:lang="en-US">Relief Option For Short Term Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ReliefOptionForShortTermLeases_2" xml:lang="en-US">Relief option for short-term leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RenewalTermOfAgreement_0" xml:lang="en-US">Represents amount of renewal term of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RenewalTermOfAgreement_1" xml:lang="en-US">Renewal Term Of Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_RenewalTermOfAgreement_2" xml:lang="en-US">Renewal term of agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RentalIncomeOverSubleaseTerm_0" xml:lang="en-US">Represents rental income over sublease term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RentalIncomeOverSubleaseTerm_1" xml:lang="en-US">Rental Income Over Sublease Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_RentalIncomeOverSubleaseTerm_2" xml:lang="en-US">Rental income over sublease term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_0" xml:lang="en-US">This member stands for a component of equity representing the accumulated change in the value of the time value of options and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_1" xml:lang="en-US">Reserve Of Change In Value Of Time Value Of Options And Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_2" xml:lang="en-US">RESERVE FOR OPTIONS AND WARRANTS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_3" xml:lang="en-US">Reserve for options and warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RestrictedInvestment_0" xml:lang="en-US">Information related to restricted investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RestrictedInvestment_1" xml:lang="en-US">Restricted Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_RestrictedInvestment_2" xml:lang="en-US">Restricted investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RestrictedStockUnitsMember_0" xml:lang="en-US">Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RestrictedStockUnitsMember_1" xml:lang="en-US">Restricted Stock Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_RestrictedStockUnitsMember_2" xml:lang="en-US">RSUs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RevolvingCreditFacilitiesMember_0" xml:lang="en-US">Name of member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RevolvingCreditFacilitiesMember_1" xml:lang="en-US">Revolving Credit Facilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RightToPurchaseUpToAnnualCbdOil_0" xml:lang="en-US">Represents right to purchase up to annual CBD oil.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RightToPurchaseUpToAnnualCbdOil_1" xml:lang="en-US">Right To Purchase Up To Annual Cbd Oil</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_RightToPurchaseUpToAnnualCbdOil_2" xml:lang="en-US">Right to purchase up to annual CBD oil</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_RoyaltyPaymentPercentage_0" xml:lang="en-US">Represents percentage of royalty payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_RoyaltyPaymentPercentage_1" xml:lang="en-US">Royalty Payment Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_RoyaltyPaymentPercentage_2" xml:lang="en-US">Royalty payment percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SalesOfStockAxis_0" xml:lang="en-US">Information by type of sale of the entity's stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SalesOfStockAxis_1" xml:lang="en-US">Sales Of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SalesOfStockDomain_0" xml:lang="en-US">Information by type of sale of the entity's stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SalesOfStockDomain_1" xml:lang="en-US">Sales Of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SecondAmendmentMember_0" xml:lang="en-US">Second Amendment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SecondAmendmentMember_1" xml:lang="en-US">Second Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SecuredLoanMember_0" xml:lang="en-US">Represents secured loan member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SecuredLoanMember_1" xml:lang="en-US">Secured Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SecuredLoanMember_2" xml:lang="en-US">Secured loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_0" xml:lang="en-US">Represents sensitivity analysis impact of increase or decrease in average net selling price per gram amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_1" xml:lang="en-US">Sensitivity Analysis Impact Of Increase Or Decrease Average Net Selling Price Per Gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_2" xml:lang="en-US">Sensitivity analysis impact of increase or decrease average net selling price per gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_0" xml:lang="en-US">Represents sensitivity analysis impact of increase or decrease in average yield per plant gram.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_1" xml:lang="en-US">Sensitivity Analysis Impact Of Increase Or Decrease Average Yield Per Plant Gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_2" xml:lang="en-US">Sensitivity analysis impact of increase or decrease average yield per plant gram</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SetOffOfDeferredTaxAssets_0" xml:lang="en-US">Represents amount of deferred set-off of tax assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SetOffOfDeferredTaxAssets_1" xml:lang="en-US">Set Off Of Deferred Tax Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SetOffOfDeferredTaxAssets_2" xml:lang="en-US">Set-off of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SetOffOfDeferredTaxLiabilities_0" xml:lang="en-US">Represents amount of deferred set off of tax liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SetOffOfDeferredTaxLiabilities_1" xml:lang="en-US">Set Off Of Deferred Tax Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SetOffOfDeferredTaxLiabilities_2" xml:lang="en-US">Set-off of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ShareIssuanceCostsMember_0" xml:lang="en-US">This member stands for temporary differences related to share issuance costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ShareIssuanceCostsMember_1" xml:lang="en-US">Share Issuance Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ShareIssuanceCostsMember_2" xml:lang="en-US">Share issuance costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_0" xml:lang="en-US">Represents each share purchase warrant converted in to number of common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_1" xml:lang="en-US">Share Purchase Warrant Converted In To Number Of Common Shares Per Unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_2" xml:lang="en-US">Each share purchase warrant converted in to number of common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SharePurchaseWarrantExercisePricePerShare_0" xml:lang="en-US">Represents share purchase warrant exercise price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SharePurchaseWarrantExercisePricePerShare_1" xml:lang="en-US">Share Purchase Warrant Exercise Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_SharePurchaseWarrantExercisePricePerShare_2" xml:lang="en-US">Share purchase warrant exercise price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_0" xml:lang="en-US">Represents share purchase warrant units, total number of shares available upon conversion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_1" xml:lang="en-US">Share Purchase Warrant Units Total Number Of Shares Available Upon Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_2" xml:lang="en-US">Share purchase warrant units, total number of shares available upon conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_0" xml:lang="en-US">Represents shares available per share purchase warrant unit upon conversion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_1" xml:lang="en-US">Shares Available Per Share Purchase Warrant Unit Upon Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_2" xml:lang="en-US">Shares available per share purchase warrant unit upon conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_0" xml:lang="en-US">Represents amount of Shipping expenses reclassified from sales and marketing expenses to cost of sales.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_1" xml:lang="en-US">Shipping Expenses Reclassified From Sales And Marketing Expenses To Cost Of Sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_2" xml:lang="en-US">Shipping expenses reclassified from sales and marketing expenses to cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ShortTermInvestmentAbstract_0" xml:lang="en-US">Short Term Investment Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ShortTermInvestmentsAxis_0" xml:lang="en-US">Represents short term investment axis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ShortTermInvestmentsAxis_1" xml:lang="en-US">Short Term Investments [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ShortTermInvestmentsDomain_0" xml:lang="en-US">Represents short term investment domain.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ShortTermInvestmentsDomain_1" xml:lang="en-US">Short Term Investments [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SignificantAccountingPoliciesLineItems_0" xml:lang="en-US">Represents information of significant accounting policies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SignificantAccountingPoliciesLineItems_1" xml:lang="en-US">Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SignificantAccountingPoliciesTable_0" xml:lang="en-US">Represents information of significant accounting policies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SignificantAccountingPoliciesTable_1" xml:lang="en-US">Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SixtyOneToOneTwentyDaysMember_0" xml:lang="en-US">Represents information related to trade receivables 61-120 days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SixtyOneToOneTwentyDaysMember_1" xml:lang="en-US">Sixty One To One Twenty Days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SixtyOneToOneTwentyDaysMember_2" xml:lang="en-US">61-120 days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_StockOptionPlanMember_0" xml:lang="en-US">Stock Option Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_StockOptionPlanMember_1" xml:lang="en-US">Stock Option Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_StockOptionPlanMember_2" xml:lang="en-US">Stock Option Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_StockOptionsMember_0" xml:lang="en-US">An arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_StockOptionsMember_1" xml:lang="en-US">Stock Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_StockOptionsMember_2" xml:lang="en-US">Stock options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SubleaseAnnualRentalIncome_0" xml:lang="en-US">Represents amount of sublease annual rental income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SubleaseAnnualRentalIncome_1" xml:lang="en-US">Sublease Annual Rental Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SubleaseAnnualRentalIncome_2" xml:lang="en-US">Sublease annual rental income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SupplyAgreementMember_0" xml:lang="en-US">This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SupplyAgreementMember_1" xml:lang="en-US">Supply Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_SupplyAgreementMember_2" xml:lang="en-US">SUPPLY AGREEMENT [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_SwearNetLimitedMember_0" xml:lang="en-US">Represents Swear Net Inc member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_SwearNetLimitedMember_1" xml:lang="en-US">Swear Net Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_SwearNetLimitedMember_2" xml:lang="en-US">Swear Net Inc. (the Trailer Park Boys "TPB") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_0" xml:lang="en-US">Temporary differences for which deferred tax assets have not been recognised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_1" xml:lang="en-US">Temporary Differences For Which Deferred Tax Assets Have Not Been Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_2" xml:lang="en-US">Temporary differences for which deferred tax liabilities have not been recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TermLoanMember_0" xml:lang="en-US">Name of member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TermLoanMember_1" xml:lang="en-US">Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TgsInternationalLlcMember_0" xml:lang="en-US">TGS International LLC ("TGS").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TgsInternationalLlcMember_1" xml:lang="en-US">Tgs International Llc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_TgsInternationalLlcMember_2" xml:lang="en-US">TGS International LLC ("TGS") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_0" xml:lang="en-US">Represents per share of threshold limit of daily volume weighted average trading price of common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_1" xml:lang="en-US">Threshold Limit Of Daily Volume Weighted Average Trading Price Of Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_2" xml:lang="en-US">Threshold limit of daily volume weighted average trading price of common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TrademarkLicensingAgreement_0" xml:lang="en-US">Trademark Licensing Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_TrademarkLicensingAgreement_1" xml:lang="en-US">Trademark licensing agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TradeReceivablesGross_0" xml:lang="en-US">Trade Receivables Gross.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TradeReceivablesGross_1" xml:lang="en-US">Trade Receivables Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_TradeReceivablesGross_2" xml:lang="en-US">Gross trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TradeReceivablesNet_0" xml:lang="en-US">Represents amount of trade receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TradeReceivablesNet_1" xml:lang="en-US">Trade Receivables Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ogi_TradeReceivablesNet_2" xml:lang="en-US">Net trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Represents amount of transaction costs of intangible assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Transaction Costs Intangible Assets Other Than Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Transaction cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TransactionCostsOfInvestmentInAssociates_0" xml:lang="en-US">Represents amount of transaction costs of investment in associates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TransactionCostsOfInvestmentInAssociates_1" xml:lang="en-US">Transaction Costs Of Investment In Associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_TransactionCostsOfInvestmentInAssociates_2" xml:lang="en-US">Transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_0" xml:lang="en-US">Transaction in exchange for a trademark licensing agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_1" xml:lang="en-US">Transaction In Exchange For Trademark Licensing Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_2" xml:lang="en-US">Transaction in exchange for trademark licensing agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TransitionToIfrs16_0" xml:lang="en-US">Transition to IFRS 16.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TransitionToIfrs16_1" xml:lang="en-US">Transition To Ifrs 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_TransitionToIfrs16_2" xml:lang="en-US">Transition to IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TraumaHealingCentersMember_0" xml:lang="en-US">Trauma Healing Centers, Incorporated (?THC?) offered a multi-disciplinary approach to post traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TraumaHealingCentersMember_1" xml:lang="en-US">Trauma Healing Centers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_TraumaHealingCentersMember_2" xml:lang="en-US">Trauma Healing Centers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TypeOfArrangementsAxis_0" xml:lang="en-US">Information by category of arrangements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TypeOfArrangementsAxis_1" xml:lang="en-US">Type Of Arrangements [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_TypeOfArrangementsDomain_0" xml:lang="en-US">Information by category of arrangements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_TypeOfArrangementsDomain_1" xml:lang="en-US">Type Of Arrangements [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_0" xml:lang="en-US">Represents amount of unamortized discount and issue costs transferred to equity upon conversion of debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_1" xml:lang="en-US">Unamortized discount and issue costs transferred to equity upon conversion of debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_2" xml:lang="en-US">Unamortized Discount And Issue Costs Transferred To Equity Upon Conversion Of Debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_3" xml:lang="en-US">Unamortized discount and issue costs transferred to equity upon conversion of debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_4" xml:lang="en-US">Unamortized discount and issue costs transferred to equity upon conversion of debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UnderwritersMember_0" xml:lang="en-US">This member stands for underwriters.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UnderwritersMember_1" xml:lang="en-US">Underwriters [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UndiscountedOperatingLeasePaymentsToBePaid_0" xml:lang="en-US">The amount of undiscounted operating lease payments to be paid. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UndiscountedOperatingLeasePaymentsToBePaid_1" xml:lang="en-US">Undiscounted Operating Lease Payments To Be Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_UndiscountedOperatingLeasePaymentsToBePaid_2" xml:lang="en-US">Undiscounted contractual payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UnitsIssuedInPeriodPricePerUnit_0" xml:lang="en-US">Units issued in period, price per unit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UnitsIssuedInPeriodPricePerUnit_1" xml:lang="en-US">Units Issued In Period Price Per Unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_UnitsIssuedInPeriodPricePerUnit_2" xml:lang="en-US">Units issued in period, price per unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_0" xml:lang="en-US">Represents amount of unrealized gain (loss) on changes in fair value of contingent consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_1" xml:lang="en-US">Unrealized (gain) on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_2" xml:lang="en-US">Gain (loss) on contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_3" xml:lang="en-US">Unrealized Gain Loss On Changes In Fair Value Of Contingent Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_4" xml:lang="en-US">Unrealized loss on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_5" xml:lang="en-US">Loss on contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_0" xml:lang="en-US">Represents amount of unrealized loss on changes in fair value of contingent consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_1" xml:lang="en-US">Unrealized (gain) on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_2" xml:lang="en-US">Gain (loss) on contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_3" xml:lang="en-US">Unrealized Loss On Changes In Fair Value Of Contingent Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_4" xml:lang="en-US">Unrealized loss on changes in fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_5" xml:lang="en-US">Loss on contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UnsecuredConvertibleDebenturesMember_0" xml:lang="en-US">This member stands for temporary differences related to unsecured convertible debentures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UnsecuredConvertibleDebenturesMember_1" xml:lang="en-US">Unsecured Convertible Debentures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_UnsecuredConvertibleDebenturesMember_2" xml:lang="en-US">Unsecured convertible debentures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_0" xml:lang="en-US">Represents face amount of convertible debenture.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_1" xml:lang="en-US">Unsecured Convertible Debentures Outstanding Face Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_2" xml:lang="en-US">Debentures - outstanding face value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_3" xml:lang="en-US">Debentures - outstanding face value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_UsefulLiveOfPropertyPlantAndEquipment_0" xml:lang="en-US">Represents information related to useful live of property plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_UsefulLiveOfPropertyPlantAndEquipment_1" xml:lang="en-US">Useful Live Of Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_UsefulLiveOfPropertyPlantAndEquipment_2" xml:lang="en-US">Useful lives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_0" xml:lang="en-US">Name of member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_1" xml:lang="en-US">Vehicle Loans Five Year Term Maturing June 17, 2024 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_2" xml:lang="en-US">Vehicle loans - five year term maturing June 17, 2024 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_VestingPeriodOfPerformanceStockUnits_0" xml:lang="en-US">Represents information of vesting period of performance stock units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_VestingPeriodOfPerformanceStockUnits_1" xml:lang="en-US">Vesting Period Of Performance Stock Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_VestingPeriodOfPerformanceStockUnits_2" xml:lang="en-US">Vesting period of performance stock units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_VestingPeriodOfRestrictedStockUnits_0" xml:lang="en-US">Represents vesting period of restricted stock units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_VestingPeriodOfRestrictedStockUnits_1" xml:lang="en-US">Vesting Period Of Restricted Stock Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_VestingPeriodOfRestrictedStockUnits_2" xml:lang="en-US">Vesting period of restricted stock units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_VivoCannabisIncMember_0" xml:lang="en-US">Name of entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_VivoCannabisIncMember_1" xml:lang="en-US">Vivo Cannabis Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_WarrantsMember_0" xml:lang="en-US">Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_WarrantsMember_1" xml:lang="en-US">Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_WarrantsMember_2" xml:lang="en-US">Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_0" xml:lang="en-US">Weighted average exercise price of warrants exercised or released in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_1" xml:lang="en-US">Warrants exercised, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_2" xml:lang="en-US">Weighted Average Exercise Price Of Warrants Exercised Or Released</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_3" xml:lang="en-US">Exercised/Released during period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_4" xml:lang="en-US">Average exercise price of warrants exercised during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsExpired_0" xml:lang="en-US">Weighted average exercise price of warrants expired in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsExpired_1" xml:lang="en-US">Weighted Average Exercise Price Of Warrants Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsExpired_2" xml:lang="en-US">Expired/Lapsed during period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsGranted_0" xml:lang="en-US">Weighted average exercise price of warrants granted in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsGranted_1" xml:lang="en-US">Weighted Average Exercise Price Of Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsGranted_2" xml:lang="en-US">Warrants granted during period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsGranted_3" xml:lang="en-US">Weighted average exercise price of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_0" xml:lang="en-US">Weighted average exercise price of warrants outstanding in share-based payment arrangement at beginning of period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_1" xml:lang="en-US">Outstanding, end of period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_2" xml:lang="en-US">Outstanding, beginning of period, weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_3" xml:lang="en-US">Weighted Average Exercise Price Of Warrants Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_4" xml:lang="en-US">Weighted average exercise price of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_WholesaleToLicensedProducersRevenueMember_0" xml:lang="en-US">This member stands for wholesale to Licensed Producers revenue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_WholesaleToLicensedProducersRevenueMember_1" xml:lang="en-US">Wholesale To Licensed Producers Revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_WholesaleToLicensedProducersRevenueMember_2" xml:lang="en-US">Wholesale to Licensed Producers revenue (Canadian) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_WorkingCapital_0" xml:lang="en-US">Represents amount of working capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_WorkingCapital_1" xml:lang="en-US">Working Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ogi_WorkingCapital_2" xml:lang="en-US">Working capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ogi_ZeroToSixtyDaysMember_0" xml:lang="en-US">Represents information related to trade receivables zero to sixty days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ogi_ZeroToSixtyDaysMember_1" xml:lang="en-US">Zero To Sixty Days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ogi_ZeroToSixtyDaysMember_2" xml:lang="en-US">0-60 days [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_1" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_2" xlink:to="lab_dei_CoverAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_3" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_4" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_5" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_6" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_7" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_8" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_9" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_10" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_11" xlink:to="lab_dei_EntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_12" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_13" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_14" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_15" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_16" xlink:to="lab_dei_LegalEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_17" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_17" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_17" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedOtherComprehensiveIncome_18" xlink:to="lab_ifrs-full_AccumulatedOtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedOtherComprehensiveIncome_18" xlink:to="lab_ifrs-full_AccumulatedOtherComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_19" xlink:to="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_19" xlink:to="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_19" xlink:to="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_20" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_20" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_21" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_21" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_21" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_22" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_22" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_22" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_23" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_23" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_24" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_24" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_25" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_25" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_26" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_26" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_27" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_27" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_28" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_28" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceCosts_29" xlink:to="lab_ifrs-full_AdjustmentsForFinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceCosts_29" xlink:to="lab_ifrs-full_AdjustmentsForFinanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_30" xlink:to="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_30" xlink:to="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_30" xlink:to="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_31" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_31" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_31" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_32" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_32" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_33" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_33" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestIncome_34" xlink:to="lab_ifrs-full_AdjustmentsForInterestIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestIncome_34" xlink:to="lab_ifrs-full_AdjustmentsForInterestIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestIncome_34" xlink:to="lab_ifrs-full_AdjustmentsForInterestIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_35" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_35" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_36" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_36" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_36" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_37" xlink:to="lab_ifrs-full_AggregatedMeasurementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_38" xlink:to="lab_ifrs-full_AggregatedTimeBandsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllowanceForCreditLossesMember_39" xlink:to="lab_ifrs-full_AllowanceForCreditLossesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllowanceForCreditLossesMember_39" xlink:to="lab_ifrs-full_AllowanceForCreditLossesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_40" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_40" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_40" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_41" xlink:to="lab_ifrs-full_ApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_41" xlink:to="lab_ifrs-full_ApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_42" xlink:to="lab_ifrs-full_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_42" xlink:to="lab_ifrs-full_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract_43" xlink:to="lab_ifrs-full_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtCostMember_44" xlink:to="lab_ifrs-full_AtCostMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtCostMember_44" xlink:to="lab_ifrs-full_AtCostMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtFairValueMember_45" xlink:to="lab_ifrs-full_AtFairValueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_46" xlink:to="lab_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_46" xlink:to="lab_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_47" xlink:to="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_47" xlink:to="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_47" xlink:to="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_48" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_48" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_49" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_49" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_50" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_50" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssetsByGroupAxis_51" xlink:to="lab_ifrs-full_BiologicalAssetsByGroupAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssetsGroupMember_52" xlink:to="lab_ifrs-full_BiologicalAssetsGroupMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsIncurred_53" xlink:to="lab_ifrs-full_BorrowingCostsIncurred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsIncurred_53" xlink:to="lab_ifrs-full_BorrowingCostsIncurred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsIncurred_53" xlink:to="lab_ifrs-full_BorrowingCostsIncurred_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_54" xlink:to="lab_ifrs-full_Borrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_54" xlink:to="lab_ifrs-full_Borrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_54" xlink:to="lab_ifrs-full_Borrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_55" xlink:to="lab_ifrs-full_BorrowingsByNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameMember_56" xlink:to="lab_ifrs-full_BorrowingsByNameMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_57" xlink:to="lab_ifrs-full_BorrowingsInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_57" xlink:to="lab_ifrs-full_BorrowingsInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_57" xlink:to="lab_ifrs-full_BorrowingsInterestRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_57" xlink:to="lab_ifrs-full_BorrowingsInterestRate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsMaturity_58" xlink:to="lab_ifrs-full_BorrowingsMaturity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_59" xlink:to="lab_ifrs-full_BottomOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_60" xlink:to="lab_ifrs-full_BuildingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_60" xlink:to="lab_ifrs-full_BuildingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_60" xlink:to="lab_ifrs-full_BuildingsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_61" xlink:to="lab_ifrs-full_BusinessCombinationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_62" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember_63" xlink:to="lab_ifrs-full_CarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_64" xlink:to="lab_ifrs-full_Cash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_64" xlink:to="lab_ifrs-full_Cash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_64" xlink:to="lab_ifrs-full_Cash_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_64" xlink:to="lab_ifrs-full_Cash_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_65" xlink:to="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_65" xlink:to="lab_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_66" xlink:to="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_66" xlink:to="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_68" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_68" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_69" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_69" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_70" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_70" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_71" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_71" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_72" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_72" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_73" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_73" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_73" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_74" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_74" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_74" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_75" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_75" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_75" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_75" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_76" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_77" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_78" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_79" xlink:to="lab_ifrs-full_ClassesOfAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_80" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_81" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_82" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_83" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_84" xlink:to="lab_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_85" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_86" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_87" xlink:to="lab_ifrs-full_ComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_87" xlink:to="lab_ifrs-full_ComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_87" xlink:to="lab_ifrs-full_ComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_87" xlink:to="lab_ifrs-full_ComprehensiveIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_87" xlink:to="lab_ifrs-full_ComprehensiveIncome_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_88" xlink:to="lab_ifrs-full_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_88" xlink:to="lab_ifrs-full_ComputerEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftwareMember_89" xlink:to="lab_ifrs-full_ComputerSoftwareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftwareMember_89" xlink:to="lab_ifrs-full_ComputerSoftwareMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConsiderationPaidReceived_90" xlink:to="lab_ifrs-full_ConsiderationPaidReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConsiderationPaidReceived_90" xlink:to="lab_ifrs-full_ConsiderationPaidReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConstructionInProgressMember_91" xlink:to="lab_ifrs-full_ConstructionInProgressMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConstructionInProgressMember_91" xlink:to="lab_ifrs-full_ConstructionInProgressMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConstructionInProgressMember_91" xlink:to="lab_ifrs-full_ConstructionInProgressMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_92" xlink:to="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments_93" xlink:to="lab_ifrs-full_ContractualCapitalCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments_93" xlink:to="lab_ifrs-full_ContractualCapitalCommitments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_94" xlink:to="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_94" xlink:to="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_95" xlink:to="lab_ifrs-full_CostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_95" xlink:to="lab_ifrs-full_CostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_96" xlink:to="lab_ifrs-full_CurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_96" xlink:to="lab_ifrs-full_CurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_96" xlink:to="lab_ifrs-full_CurrentAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_97" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_97" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_97" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_98" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_98" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_98" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_98" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentGovernmentGrants_99" xlink:to="lab_ifrs-full_CurrentGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentGovernmentGrants_99" xlink:to="lab_ifrs-full_CurrentGovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentGovernmentGrants_99" xlink:to="lab_ifrs-full_CurrentGovernmentGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentHeldtomaturityInvestments_100" xlink:to="lab_ifrs-full_CurrentHeldtomaturityInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentHeldtomaturityInvestments_100" xlink:to="lab_ifrs-full_CurrentHeldtomaturityInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_101" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_101" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_101" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_102" xlink:to="lab_ifrs-full_CurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_102" xlink:to="lab_ifrs-full_CurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_102" xlink:to="lab_ifrs-full_CurrentLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_103" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_103" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_103" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLoansAndReceivables_104" xlink:to="lab_ifrs-full_CurrentLoansAndReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLoansAndReceivables_104" xlink:to="lab_ifrs-full_CurrentLoansAndReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLoansAndReceivables_104" xlink:to="lab_ifrs-full_CurrentLoansAndReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_105" xlink:to="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_105" xlink:to="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPackagingAndStorageMaterials_106" xlink:to="lab_ifrs-full_CurrentPackagingAndStorageMaterials_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPackagingAndStorageMaterials_106" xlink:to="lab_ifrs-full_CurrentPackagingAndStorageMaterials_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_107" xlink:to="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_107" xlink:to="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_107" xlink:to="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_108" xlink:to="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_109" xlink:to="lab_ifrs-full_CurrentTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_109" xlink:to="lab_ifrs-full_CurrentTradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_109" xlink:to="lab_ifrs-full_CurrentTradeReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_109" xlink:to="lab_ifrs-full_CurrentTradeReceivables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DebtInstrumentsHeldAbstract_110" xlink:to="lab_ifrs-full_DebtInstrumentsHeldAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_111" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_111" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_111" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_112" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_112" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_112" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_112" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_112" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_113" xlink:to="lab_ifrs-full_DeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_113" xlink:to="lab_ifrs-full_DeferredTaxAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_114" xlink:to="lab_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_114" xlink:to="lab_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_115" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_115" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_115" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_116" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_116" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_117" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_117" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_117" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_118" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_118" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_118" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_118" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_118" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_119" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_119" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_120" xlink:to="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_120" xlink:to="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_121" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_121" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_121" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_122" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_122" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_123" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_123" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_124" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_124" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_125" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_125" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_126" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_126" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_127" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_127" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_128" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_128" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_129" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_129" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_130" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_130" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_131" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_131" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_132" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_132" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_133" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_133" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_134" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_134" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_135" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_135" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_136" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_136" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_137" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_137" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_138" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_138" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_139" xlink:to="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_139" xlink:to="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_140" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_140" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_141" xlink:to="lab_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_142" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_142" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_142" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_143" xlink:to="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_143" xlink:to="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_144" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_144" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_145" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_145" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_146" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_146" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_147" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_147" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_148" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_148" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_149" xlink:to="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_149" xlink:to="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_150" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_150" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_151" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_151" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_152" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_152" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_153" xlink:to="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_153" xlink:to="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_154" xlink:to="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_154" xlink:to="lab_ifrs-full_DisclosureOfDebtSecuritiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredIncomeExplanatory_155" xlink:to="lab_ifrs-full_DisclosureOfDeferredIncomeExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredIncomeExplanatory_155" xlink:to="lab_ifrs-full_DisclosureOfDeferredIncomeExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_156" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_156" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_157" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_158" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_158" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_159" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_160" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_160" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_161" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_162" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_163" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_163" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_164" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_164" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_165" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_166" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_166" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_167" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_167" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_168" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_168" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_169" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_170" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_171" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_172" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_172" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_173" xlink:to="lab_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_173" xlink:to="lab_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_174" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_174" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_175" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_175" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_176" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_177" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_177" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_178" xlink:to="lab_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_178" xlink:to="lab_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_179" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_179" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_180" xlink:to="lab_ifrs-full_DisclosureOfInvestmentPropertyLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_181" xlink:to="lab_ifrs-full_DisclosureOfInvestmentPropertyTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_182" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_182" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_183" xlink:to="lab_ifrs-full_DisclosureOfIssuedCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_183" xlink:to="lab_ifrs-full_DisclosureOfIssuedCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_184" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_184" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_185" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_186" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_187" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_188" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_188" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_189" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_190" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_191" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_191" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_192" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_192" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_193" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_193" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_194" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_194" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_195" xlink:to="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_195" xlink:to="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_196" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_197" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_197" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_198" xlink:to="lab_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_198" xlink:to="lab_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_199" xlink:to="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_199" xlink:to="lab_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_200" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_200" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_202" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_203" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_204" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_205" xlink:to="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_205" xlink:to="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_206" xlink:to="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_207" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_208" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_209" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_210" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_211" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_212" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_213" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_214" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_214" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRevenueExplanatory_215" xlink:to="lab_ifrs-full_DisclosureOfRevenueExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRevenueExplanatory_215" xlink:to="lab_ifrs-full_DisclosureOfRevenueExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_216" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_217" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_217" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_218" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_219" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_220" xlink:to="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_221" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_221" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_222" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_222" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_223" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_223" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_224" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_224" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_225" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_226" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_227" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_227" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_228" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_229" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_230" xlink:to="lab_ifrs-full_DiscontinuedOperationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsBiologicalAssets_231" xlink:to="lab_ifrs-full_DisposalsBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsBiologicalAssets_231" xlink:to="lab_ifrs-full_DisposalsBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsBiologicalAssets_231" xlink:to="lab_ifrs-full_DisposalsBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsBiologicalAssets_231" xlink:to="lab_ifrs-full_DisposalsBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_232" xlink:to="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_232" xlink:to="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_232" xlink:to="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_233" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_233" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_233" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_234" xlink:to="lab_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_234" xlink:to="lab_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DonationsAndSubsidiesExpense_235" xlink:to="lab_ifrs-full_DonationsAndSubsidiesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DonationsAndSubsidiesExpense_235" xlink:to="lab_ifrs-full_DonationsAndSubsidiesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DonationsAndSubsidiesExpense_235" xlink:to="lab_ifrs-full_DonationsAndSubsidiesExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_236" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_236" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_237" xlink:to="lab_ifrs-full_EarningsPerShareLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareTable_238" xlink:to="lab_ifrs-full_EarningsPerShareTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_239" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_240" xlink:to="lab_ifrs-full_EntitysTotalForAssociatesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_241" xlink:to="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_242" xlink:to="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_243" xlink:to="lab_ifrs-full_Equity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_243" xlink:to="lab_ifrs-full_Equity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_243" xlink:to="lab_ifrs-full_Equity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_243" xlink:to="lab_ifrs-full_Equity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_243" xlink:to="lab_ifrs-full_Equity_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_244" xlink:to="lab_ifrs-full_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_244" xlink:to="lab_ifrs-full_EquityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_245" xlink:to="lab_ifrs-full_EquityAndLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_245" xlink:to="lab_ifrs-full_EquityAndLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_246" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInstrumentsHeld_247" xlink:to="lab_ifrs-full_EquityInstrumentsHeld_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityMember_248" xlink:to="lab_ifrs-full_EquityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_249" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_249" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_250" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_250" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNature_251" xlink:to="lab_ifrs-full_ExpenseByNature_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNature_251" xlink:to="lab_ifrs-full_ExpenseByNature_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNature_251" xlink:to="lab_ifrs-full_ExpenseByNature_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_252" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_252" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_252" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_253" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_253" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_254" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_254" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_255" xlink:to="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_255" xlink:to="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_256" xlink:to="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_256" xlink:to="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_257" xlink:to="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_257" xlink:to="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_258" xlink:to="lab_ifrs-full_FinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_258" xlink:to="lab_ifrs-full_FinanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_258" xlink:to="lab_ifrs-full_FinanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_259" xlink:to="lab_ifrs-full_FinanceIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_259" xlink:to="lab_ifrs-full_FinanceIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_259" xlink:to="lab_ifrs-full_FinanceIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_259" xlink:to="lab_ifrs-full_FinanceIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_260" xlink:to="lab_ifrs-full_FinancialAssetsCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_261" xlink:to="lab_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_261" xlink:to="lab_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods_262" xlink:to="lab_ifrs-full_FinishedGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods_262" xlink:to="lab_ifrs-full_FinishedGoods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember_263" xlink:to="lab_ifrs-full_FixturesAndFittingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember_263" xlink:to="lab_ifrs-full_FixturesAndFittingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_264" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_264" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_265" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_265" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_266" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_266" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_266" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsOnDisposalsOfInvestments_267" xlink:to="lab_ifrs-full_GainsOnDisposalsOfInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_268" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_268" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_268" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Goodwill_269" xlink:to="lab_ifrs-full_Goodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_270" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_270" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_270" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLeaseLiabilities_271" xlink:to="lab_ifrs-full_GrossLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLeaseLiabilities_271" xlink:to="lab_ifrs-full_GrossLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_272" xlink:to="lab_ifrs-full_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_272" xlink:to="lab_ifrs-full_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLoss_273" xlink:to="lab_ifrs-full_ImpairmentLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLoss_273" xlink:to="lab_ifrs-full_ImpairmentLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_274" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_274" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_274" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_275" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_275" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_276" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_276" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_276" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_276" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract_277" xlink:to="lab_ifrs-full_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_278" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_278" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_278" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_278" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_278" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_279" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_279" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_280" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_280" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_280" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_281" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_281" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_281" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_282" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_282" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_283" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_283" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_284" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_284" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_285" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_285" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_286" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_286" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_287" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_287" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_288" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_288" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_288" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_289" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_289" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_289" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_289" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InformationAboutMajorCustomers_290" xlink:to="lab_ifrs-full_InformationAboutMajorCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_291" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwillMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_292" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_292" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_292" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_292" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_293" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_294" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_294" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_295" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_295" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_295" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPayable_296" xlink:to="lab_ifrs-full_InterestPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_297" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_297" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_298" xlink:to="lab_ifrs-full_Inventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_298" xlink:to="lab_ifrs-full_Inventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_299" xlink:to="lab_ifrs-full_InventoryWritedown2011_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_299" xlink:to="lab_ifrs-full_InventoryWritedown2011_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInAssociates_300" xlink:to="lab_ifrs-full_InvestmentsInAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInAssociates_300" xlink:to="lab_ifrs-full_InvestmentsInAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInAssociates_300" xlink:to="lab_ifrs-full_InvestmentsInAssociates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_301" xlink:to="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_301" xlink:to="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_302" xlink:to="lab_ifrs-full_IssuedCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_302" xlink:to="lab_ifrs-full_IssuedCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_303" xlink:to="lab_ifrs-full_IssuedCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_303" xlink:to="lab_ifrs-full_IssuedCapitalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_303" xlink:to="lab_ifrs-full_IssuedCapitalMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfConvertibleInstruments_304" xlink:to="lab_ifrs-full_IssueOfConvertibleInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfConvertibleInstruments_304" xlink:to="lab_ifrs-full_IssueOfConvertibleInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfConvertibleInstruments_304" xlink:to="lab_ifrs-full_IssueOfConvertibleInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_305" xlink:to="lab_ifrs-full_IssueOfEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_305" xlink:to="lab_ifrs-full_IssueOfEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_306" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_306" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_307" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_307" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_307" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_308" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_308" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_308" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_309" xlink:to="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_309" xlink:to="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandMember_310" xlink:to="lab_ifrs-full_LandMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandMember_310" xlink:to="lab_ifrs-full_LandMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_311" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_311" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_311" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_312" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_312" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_313" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_313" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_314" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_314" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_315" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_315" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_316" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_316" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_317" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_317" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseholdImprovementsMember_318" xlink:to="lab_ifrs-full_LeaseholdImprovementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseholdImprovementsMember_318" xlink:to="lab_ifrs-full_LeaseholdImprovementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_319" xlink:to="lab_ifrs-full_LeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_319" xlink:to="lab_ifrs-full_LeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_319" xlink:to="lab_ifrs-full_LeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_319" xlink:to="lab_ifrs-full_LeaseLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_319" xlink:to="lab_ifrs-full_LeaseLiabilities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_320" xlink:to="lab_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember_321" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember_321" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_322" xlink:to="lab_ifrs-full_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_322" xlink:to="lab_ifrs-full_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract_323" xlink:to="lab_ifrs-full_LiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract_323" xlink:to="lab_ifrs-full_LiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesMember_324" xlink:to="lab_ifrs-full_LicencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesMember_324" xlink:to="lab_ifrs-full_LicencesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansAndReceivables_325" xlink:to="lab_ifrs-full_LoansAndReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansAndReceivables_325" xlink:to="lab_ifrs-full_LoansAndReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_326" xlink:to="lab_ifrs-full_LongtermBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_326" xlink:to="lab_ifrs-full_LongtermBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_326" xlink:to="lab_ifrs-full_LongtermBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_327" xlink:to="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis_328" xlink:to="lab_ifrs-full_MaturityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRisk_329" xlink:to="lab_ifrs-full_MaximumExposureToCreditRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRisk_329" xlink:to="lab_ifrs-full_MaximumExposureToCreditRisk_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementAxis_330" xlink:to="lab_ifrs-full_MeasurementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_331" xlink:to="lab_ifrs-full_NetDeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxLiabilities_332" xlink:to="lab_ifrs-full_NetDeferredTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxLiabilities_332" xlink:to="lab_ifrs-full_NetDeferredTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxLiabilities_332" xlink:to="lab_ifrs-full_NetDeferredTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxLiabilities_332" xlink:to="lab_ifrs-full_NetDeferredTaxLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxLiabilities_332" xlink:to="lab_ifrs-full_NetDeferredTaxLiabilities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_333" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember_334" xlink:to="lab_ifrs-full_NonadjustingEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_335" xlink:to="lab_ifrs-full_NoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_335" xlink:to="lab_ifrs-full_NoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_335" xlink:to="lab_ifrs-full_NoncurrentAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_336" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_336" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_336" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_337" xlink:to="lab_ifrs-full_NoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_337" xlink:to="lab_ifrs-full_NoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_337" xlink:to="lab_ifrs-full_NoncurrentLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_338" xlink:to="lab_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_338" xlink:to="lab_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_338" xlink:to="lab_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_338" xlink:to="lab_ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_339" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_339" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_339" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_339" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_339" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotionalAmount_340" xlink:to="lab_ifrs-full_NotionalAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotionalAmount_340" xlink:to="lab_ifrs-full_NotionalAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotionalAmount_340" xlink:to="lab_ifrs-full_NotionalAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_341" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_341" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_342" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_342" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_342" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_343" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_343" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_344" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_344" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_345" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_345" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_345" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_346" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_346" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_346" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_346" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_347" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_347" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_348" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_348" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_348" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_348" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_348" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_349" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_349" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_349" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_349" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_350" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_350" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_350" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_350" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_350" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_350" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_351" xlink:to="lab_ifrs-full_NumberOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_352" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_352" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_352" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OfficeEquipmentMember_353" xlink:to="lab_ifrs-full_OfficeEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OfficeEquipmentMember_353" xlink:to="lab_ifrs-full_OfficeEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_354" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_354" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_355" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_355" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentAssets_356" xlink:to="lab_ifrs-full_OtherCurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFeeAndCommissionExpense_357" xlink:to="lab_ifrs-full_OtherFeeAndCommissionExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFeeAndCommissionExpense_357" xlink:to="lab_ifrs-full_OtherFeeAndCommissionExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceCost_358" xlink:to="lab_ifrs-full_OtherFinanceCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceCost_358" xlink:to="lab_ifrs-full_OtherFinanceCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_359" xlink:to="lab_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_359" xlink:to="lab_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_359" xlink:to="lab_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_360" xlink:to="lab_ifrs-full_OtherNoncurrentFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_360" xlink:to="lab_ifrs-full_OtherNoncurrentFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_360" xlink:to="lab_ifrs-full_OtherNoncurrentFinancialLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_361" xlink:to="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_361" xlink:to="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRevenue_362" xlink:to="lab_ifrs-full_OtherRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRevenue_362" xlink:to="lab_ifrs-full_OtherRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_363" xlink:to="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_363" xlink:to="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTemporaryDifferencesMember_364" xlink:to="lab_ifrs-full_OtherTemporaryDifferencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTemporaryDifferencesMember_364" xlink:to="lab_ifrs-full_OtherTemporaryDifferencesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OutputOfAgriculturalProduce_365" xlink:to="lab_ifrs-full_OutputOfAgriculturalProduce_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OutputOfAgriculturalProduce_365" xlink:to="lab_ifrs-full_OutputOfAgriculturalProduce_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForDebtIssueCosts_366" xlink:to="lab_ifrs-full_PaymentsForDebtIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForDebtIssueCosts_366" xlink:to="lab_ifrs-full_PaymentsForDebtIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForDebtIssueCosts_366" xlink:to="lab_ifrs-full_PaymentsForDebtIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_367" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_367" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_367" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_368" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_368" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_368" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_368" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServices_369" xlink:to="lab_ifrs-full_PaymentsToSuppliersForGoodsAndServices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServices_369" xlink:to="lab_ifrs-full_PaymentsToSuppliersForGoodsAndServices_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfEntitysRevenue_370" xlink:to="lab_ifrs-full_PercentageOfEntitysRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlantsMember_371" xlink:to="lab_ifrs-full_PlantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlantsMember_371" xlink:to="lab_ifrs-full_PlantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PrepaymentsAndAccruedIncome_372" xlink:to="lab_ifrs-full_PrepaymentsAndAccruedIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PrepaymentsAndAccruedIncome_372" xlink:to="lab_ifrs-full_PrepaymentsAndAccruedIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_373" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_373" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_374" xlink:to="lab_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_374" xlink:to="lab_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_375" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_375" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_375" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_376" xlink:to="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_376" xlink:to="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_377" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_378" xlink:to="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_379" xlink:to="lab_ifrs-full_ProductsAndServicesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesMember_380" xlink:to="lab_ifrs-full_ProductsAndServicesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_381" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_381" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_381" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_382" xlink:to="lab_ifrs-full_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_382" xlink:to="lab_ifrs-full_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_382" xlink:to="lab_ifrs-full_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_382" xlink:to="lab_ifrs-full_ProfitLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_382" xlink:to="lab_ifrs-full_ProfitLoss_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract_383" xlink:to="lab_ifrs-full_ProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract_383" xlink:to="lab_ifrs-full_ProfitLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract_383" xlink:to="lab_ifrs-full_ProfitLossAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_384" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_384" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_384" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_384" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_384" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_385" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_385" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_385" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_385" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_385" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_386" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_386" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_386" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_387" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_387" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_388" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_388" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_388" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_388" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_389" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_390" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_391" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_391" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_392" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_393" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_393" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInterestsInAssociates_394" xlink:to="lab_ifrs-full_PurchaseOfInterestsInAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInterestsInAssociates_394" xlink:to="lab_ifrs-full_PurchaseOfInterestsInAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_395" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_395" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_396" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_396" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_396" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_396" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis_397" xlink:to="lab_ifrs-full_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember_398" xlink:to="lab_ifrs-full_RangesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_399" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_400" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_401" xlink:to="lab_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_402" xlink:to="lab_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RentalIncome_403" xlink:to="lab_ifrs-full_RentalIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RentalIncome_403" xlink:to="lab_ifrs-full_RentalIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_404" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_404" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_405" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_405" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_405" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_405" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_406" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_406" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPayments_407" xlink:to="lab_ifrs-full_ReserveOfSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPayments_407" xlink:to="lab_ifrs-full_ReserveOfSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestatedMember_408" xlink:to="lab_ifrs-full_RestatedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestrictedCashAndCashEquivalents_409" xlink:to="lab_ifrs-full_RestrictedCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestrictedCashAndCashEquivalents_409" xlink:to="lab_ifrs-full_RestrictedCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_410" xlink:to="lab_ifrs-full_RetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_410" xlink:to="lab_ifrs-full_RetainedEarnings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_410" xlink:to="lab_ifrs-full_RetainedEarnings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_411" xlink:to="lab_ifrs-full_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_411" xlink:to="lab_ifrs-full_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_412" xlink:to="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_413" xlink:to="lab_ifrs-full_Revenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_413" xlink:to="lab_ifrs-full_Revenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_413" xlink:to="lab_ifrs-full_Revenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_413" xlink:to="lab_ifrs-full_Revenue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_413" xlink:to="lab_ifrs-full_Revenue_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueAbstract_414" xlink:to="lab_ifrs-full_RevenueAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromInterest_415" xlink:to="lab_ifrs-full_RevenueFromInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromInterest_415" xlink:to="lab_ifrs-full_RevenueFromInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_416" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_416" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_417" xlink:to="lab_ifrs-full_RightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_417" xlink:to="lab_ifrs-full_RightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsMember_418" xlink:to="lab_ifrs-full_RightofuseAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsMember_418" xlink:to="lab_ifrs-full_RightofuseAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsMember_418" xlink:to="lab_ifrs-full_RightofuseAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_419" xlink:to="lab_ifrs-full_SalesAndMarketingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_419" xlink:to="lab_ifrs-full_SalesAndMarketingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_420" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_420" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_420" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_421" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_422" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_423" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_423" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_423" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_423" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_424" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_424" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_424" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_425" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_425" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_425" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_425" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_426" xlink:to="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_427" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_428" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_429" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_430" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_431" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_431" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_432" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_432" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_433" xlink:to="lab_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_433" xlink:to="lab_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectFromChangeInTaxRate_434" xlink:to="lab_ifrs-full_TaxEffectFromChangeInTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectFromChangeInTaxRate_434" xlink:to="lab_ifrs-full_TaxEffectFromChangeInTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_435" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_435" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates_436" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates_436" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_437" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_437" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_438" xlink:to="lab_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_438" xlink:to="lab_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_438" xlink:to="lab_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_439" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_440" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_441" xlink:to="lab_ifrs-full_TopOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_442" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_442" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_443" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_443" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables_444" xlink:to="lab_ifrs-full_TradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables_444" xlink:to="lab_ifrs-full_TradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables_444" xlink:to="lab_ifrs-full_TradeReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TravelExpense_445" xlink:to="lab_ifrs-full_TravelExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TravelExpense_445" xlink:to="lab_ifrs-full_TravelExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_446" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_447" xlink:to="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_447" xlink:to="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndrawnBorrowingFacilities_448" xlink:to="lab_ifrs-full_UndrawnBorrowingFacilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_449" xlink:to="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_449" xlink:to="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UtilitiesExpense_450" xlink:to="lab_ifrs-full_UtilitiesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UtilitiesExpense_450" xlink:to="lab_ifrs-full_UtilitiesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValueAtRisk_451" xlink:to="lab_ifrs-full_ValueAtRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValueAtRisk_451" xlink:to="lab_ifrs-full_ValueAtRisk_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_VehiclesMember_452" xlink:to="lab_ifrs-full_VehiclesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_VehiclesMember_452" xlink:to="lab_ifrs-full_VehiclesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_453" xlink:to="lab_ifrs-full_WagesAndSalaries_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_453" xlink:to="lab_ifrs-full_WagesAndSalaries_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_453" xlink:to="lab_ifrs-full_WagesAndSalaries_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_454" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_454" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_454" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_455" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_455" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_456" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_456" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_456" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_457" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_457" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_457" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_457" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_457" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_458" xlink:to="lab_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_458" xlink:to="lab_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_459" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_459" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_459" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePrice2019_460" xlink:to="lab_ifrs-full_WeightedAverageSharePrice2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePrice2019_460" xlink:to="lab_ifrs-full_WeightedAverageSharePrice2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_461" xlink:to="lab_ifrs-full_WeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_461" xlink:to="lab_ifrs-full_WeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress_462" xlink:to="lab_ifrs-full_WorkInProgress_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress_462" xlink:to="lab_ifrs-full_WorkInProgress_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WritedownsReversalsOfWritedownsOfInventoriesAbstract_463" xlink:to="lab_ifrs-full_WritedownsReversalsOfWritedownsOfInventoriesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_464" xlink:to="lab_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_464" xlink:to="lab_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_464" xlink:to="lab_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AccountsReceivableAbstract_465" xlink:to="lab_ogi_AccountsReceivableAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AchievementOfContractualProductionRelatedMilestoneMember_466" xlink:to="lab_ogi_AchievementOfContractualProductionRelatedMilestoneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AchievementOfContractualProductionRelatedMilestoneMember_466" xlink:to="lab_ogi_AchievementOfContractualProductionRelatedMilestoneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AchievementOfContractualProductionRelatedMilestoneMember_466" xlink:to="lab_ogi_AchievementOfContractualProductionRelatedMilestoneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_467" xlink:to="lab_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_467" xlink:to="lab_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_467" xlink:to="lab_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_467" xlink:to="lab_ogi_AcquisitionsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsOfInvestmentInAssociates_468" xlink:to="lab_ogi_AdditionsOfInvestmentInAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsOfInvestmentInAssociates_468" xlink:to="lab_ogi_AdditionsOfInvestmentInAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsOfInvestmentInAssociates_468" xlink:to="lab_ogi_AdditionsOfInvestmentInAssociates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsRelatedToIFRS16Leases_469" xlink:to="lab_ogi_AdditionsRelatedToIFRS16Leases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsRelatedToIFRS16Leases_469" xlink:to="lab_ogi_AdditionsRelatedToIFRS16Leases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsRelatedToIFRS16Leases_469" xlink:to="lab_ogi_AdditionsRelatedToIFRS16Leases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsRelatedToIFRS16Leases_469" xlink:to="lab_ogi_AdditionsRelatedToIFRS16Leases_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsToLeaseLiabilities_470" xlink:to="lab_ogi_AdditionsToLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsToLeaseLiabilities_470" xlink:to="lab_ogi_AdditionsToLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdditionsToLeaseLiabilities_470" xlink:to="lab_ogi_AdditionsToLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_471" xlink:to="lab_ogi_AdjustmentOnAdoptionOfIFRS16Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_471" xlink:to="lab_ogi_AdjustmentOnAdoptionOfIFRS16Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_471" xlink:to="lab_ogi_AdjustmentOnAdoptionOfIFRS16Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_472" xlink:to="lab_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_472" xlink:to="lab_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_472" xlink:to="lab_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_473" xlink:to="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_473" xlink:to="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_473" xlink:to="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_473" xlink:to="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_473" xlink:to="lab_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_474" xlink:to="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_474" xlink:to="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_474" xlink:to="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_474" xlink:to="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_474" xlink:to="lab_ogi_AdjustmentsForUnrealizedLossOnChangesInFairValueOfContingentConsideration_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_475" xlink:to="lab_ogi_AdjustmentToNetRealizableValueBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_475" xlink:to="lab_ogi_AdjustmentToNetRealizableValueBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_475" xlink:to="lab_ogi_AdjustmentToNetRealizableValueBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_475" xlink:to="lab_ogi_AdjustmentToNetRealizableValueBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdultUseRecreationalWholesaleRevenueMember_476" xlink:to="lab_ogi_AdultUseRecreationalWholesaleRevenueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdultUseRecreationalWholesaleRevenueMember_476" xlink:to="lab_ogi_AdultUseRecreationalWholesaleRevenueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdultUseRecreationalWholesaleRevenueMember_476" xlink:to="lab_ogi_AdultUseRecreationalWholesaleRevenueMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvanceGivenAsConvertibleDebentures_477" xlink:to="lab_ogi_AdvanceGivenAsConvertibleDebentures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvanceGivenAsConvertibleDebentures_477" xlink:to="lab_ogi_AdvanceGivenAsConvertibleDebentures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvanceGivenAsConvertibleDebentures_477" xlink:to="lab_ogi_AdvanceGivenAsConvertibleDebentures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvancePayment_478" xlink:to="lab_ogi_AdvancePayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvancePayment_478" xlink:to="lab_ogi_AdvancePayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvancePayment_478" xlink:to="lab_ogi_AdvancePayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvisoryServicesAgreementMember_479" xlink:to="lab_ogi_AdvisoryServicesAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvisoryServicesAgreementMember_479" xlink:to="lab_ogi_AdvisoryServicesAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AdvisoryServicesAgreementMember_479" xlink:to="lab_ogi_AdvisoryServicesAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_480" xlink:to="lab_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_480" xlink:to="lab_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_480" xlink:to="lab_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_481" xlink:to="lab_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_481" xlink:to="lab_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_481" xlink:to="lab_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_482" xlink:to="lab_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_482" xlink:to="lab_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_482" xlink:to="lab_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateNumberOfCommonSharesConverted_483" xlink:to="lab_ogi_AggregateNumberOfCommonSharesConverted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateNumberOfCommonSharesConverted_483" xlink:to="lab_ogi_AggregateNumberOfCommonSharesConverted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AggregateNumberOfCommonSharesConverted_483" xlink:to="lab_ogi_AggregateNumberOfCommonSharesConverted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_484" xlink:to="lab_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_484" xlink:to="lab_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_484" xlink:to="lab_ogi_AllocationToReserveForOptionsAndWarrantsForDebentureDiscount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AlphaCannabisPharmaGmbhMember_485" xlink:to="lab_ogi_AlphaCannabisPharmaGmbhMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AlphaCannabisPharmaGmbhMember_485" xlink:to="lab_ogi_AlphaCannabisPharmaGmbhMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AlphaCannabisPharmaGmbhMember_485" xlink:to="lab_ogi_AlphaCannabisPharmaGmbhMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AlphaCannabisPharmaGmbhMember_485" xlink:to="lab_ogi_AlphaCannabisPharmaGmbhMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmendmentAndRestatementMember_486" xlink:to="lab_ogi_AmendmentAndRestatementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmendmentAndRestatementMember_486" xlink:to="lab_ogi_AmendmentAndRestatementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmendmentAndRestatementMember_486" xlink:to="lab_ogi_AmendmentAndRestatementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmendmentFee_487" xlink:to="lab_ogi_AmendmentFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmendmentFee_487" xlink:to="lab_ogi_AmendmentFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmendmentFee_487" xlink:to="lab_ogi_AmendmentFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizationOfDebentureDiscount_488" xlink:to="lab_ogi_AmortizationOfDebentureDiscount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizationOfDebentureDiscount_488" xlink:to="lab_ogi_AmortizationOfDebentureDiscount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizationOfDebentureDiscount_488" xlink:to="lab_ogi_AmortizationOfDebentureDiscount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizationOfIssueCosts_489" xlink:to="lab_ogi_AmortizationOfIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizationOfIssueCosts_489" xlink:to="lab_ogi_AmortizationOfIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizationOfIssueCosts_489" xlink:to="lab_ogi_AmortizationOfIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizationOfIssueCosts_489" xlink:to="lab_ogi_AmortizationOfIssueCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizedToSellingAndMarketingExpenses_490" xlink:to="lab_ogi_AmortizedToSellingAndMarketingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizedToSellingAndMarketingExpenses_490" xlink:to="lab_ogi_AmortizedToSellingAndMarketingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizedToSellingAndMarketingExpenses_490" xlink:to="lab_ogi_AmortizedToSellingAndMarketingExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizedToShareBasedCompensation_491" xlink:to="lab_ogi_AmortizedToShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizedToShareBasedCompensation_491" xlink:to="lab_ogi_AmortizedToShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmortizedToShareBasedCompensation_491" xlink:to="lab_ogi_AmortizedToShareBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_492" xlink:to="lab_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_492" xlink:to="lab_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_492" xlink:to="lab_ogi_AmountOfEmployeeWagesAppliedForCanadaEmergencyWageSubsidy_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_493" xlink:to="lab_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_493" xlink:to="lab_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_493" xlink:to="lab_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AntidilutiveSecuritiesAxis_494" xlink:to="lab_ogi_AntidilutiveSecuritiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AntidilutiveSecuritiesAxis_494" xlink:to="lab_ogi_AntidilutiveSecuritiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AntidilutiveSecuritiesDomain_495" xlink:to="lab_ogi_AntidilutiveSecuritiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AntidilutiveSecuritiesDomain_495" xlink:to="lab_ogi_AntidilutiveSecuritiesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_496" xlink:to="lab_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_496" xlink:to="lab_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_496" xlink:to="lab_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ApplicableMarginRate_497" xlink:to="lab_ogi_ApplicableMarginRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ApplicableMarginRate_497" xlink:to="lab_ogi_ApplicableMarginRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ApplicableMarginRate_497" xlink:to="lab_ogi_ApplicableMarginRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_498" xlink:to="lab_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_498" xlink:to="lab_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_498" xlink:to="lab_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_499" xlink:to="lab_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_499" xlink:to="lab_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_499" xlink:to="lab_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AverageSellingPriceInputValuesPerGram_500" xlink:to="lab_ogi_AverageSellingPriceInputValuesPerGram_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AverageSellingPriceInputValuesPerGram_500" xlink:to="lab_ogi_AverageSellingPriceInputValuesPerGram_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AverageSellingPriceInputValuesPerGram_500" xlink:to="lab_ogi_AverageSellingPriceInputValuesPerGram_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AverageYieldPerPlantInputValuesPerGram_501" xlink:to="lab_ogi_AverageYieldPerPlantInputValuesPerGram_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AverageYieldPerPlantInputValuesPerGram_501" xlink:to="lab_ogi_AverageYieldPerPlantInputValuesPerGram_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_AverageYieldPerPlantInputValuesPerGram_501" xlink:to="lab_ogi_AverageYieldPerPlantInputValuesPerGram_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BalanceSheetLocationsDomain_502" xlink:to="lab_ogi_BalanceSheetLocationsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BalanceSheetLocationsDomain_502" xlink:to="lab_ogi_BalanceSheetLocationsDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_503" xlink:to="lab_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_503" xlink:to="lab_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_503" xlink:to="lab_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_503" xlink:to="lab_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BasisOfPreparationAbstract_504" xlink:to="lab_ogi_BasisOfPreparationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BiologicalAssetMember_505" xlink:to="lab_ogi_BiologicalAssetMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BiologicalAssetMember_505" xlink:to="lab_ogi_BiologicalAssetMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BiologicalAssetMember_505" xlink:to="lab_ogi_BiologicalAssetMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BmoCreditFacilityMember_506" xlink:to="lab_ogi_BmoCreditFacilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BmoCreditFacilityMember_506" xlink:to="lab_ogi_BmoCreditFacilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BmoCreditFacilityMember_506" xlink:to="lab_ogi_BmoCreditFacilityMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BmoTermLoanCreditFacilityMember_507" xlink:to="lab_ogi_BmoTermLoanCreditFacilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BmoTermLoanCreditFacilityMember_507" xlink:to="lab_ogi_BmoTermLoanCreditFacilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BmoTermLoanCreditFacilityMember_507" xlink:to="lab_ogi_BmoTermLoanCreditFacilityMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsCashInterestRate_508" xlink:to="lab_ogi_BorrowingsCashInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsCashInterestRate_508" xlink:to="lab_ogi_BorrowingsCashInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsCashInterestRate_508" xlink:to="lab_ogi_BorrowingsCashInterestRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsEffectiveInterestRate_509" xlink:to="lab_ogi_BorrowingsEffectiveInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsEffectiveInterestRate_509" xlink:to="lab_ogi_BorrowingsEffectiveInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsEffectiveInterestRate_509" xlink:to="lab_ogi_BorrowingsEffectiveInterestRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_510" xlink:to="lab_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_510" xlink:to="lab_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_510" xlink:to="lab_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsReducedCashInterestRate_511" xlink:to="lab_ogi_BorrowingsReducedCashInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsReducedCashInterestRate_511" xlink:to="lab_ogi_BorrowingsReducedCashInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsReducedCashInterestRate_511" xlink:to="lab_ogi_BorrowingsReducedCashInterestRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsReducedEffectiveInterestRate_512" xlink:to="lab_ogi_BorrowingsReducedEffectiveInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsReducedEffectiveInterestRate_512" xlink:to="lab_ogi_BorrowingsReducedEffectiveInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsReducedEffectiveInterestRate_512" xlink:to="lab_ogi_BorrowingsReducedEffectiveInterestRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsYearAmortization_513" xlink:to="lab_ogi_BorrowingsYearAmortization_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsYearAmortization_513" xlink:to="lab_ogi_BorrowingsYearAmortization_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BorrowingsYearAmortization_513" xlink:to="lab_ogi_BorrowingsYearAmortization_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BottledAndPackagedOil_514" xlink:to="lab_ogi_BottledAndPackagedOil_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BottledAndPackagedOil_514" xlink:to="lab_ogi_BottledAndPackagedOil_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BottledAndPackagedOil_514" xlink:to="lab_ogi_BottledAndPackagedOil_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BottledAndPackagedOilMember_515" xlink:to="lab_ogi_BottledAndPackagedOilMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BottledAndPackagedOilMember_515" xlink:to="lab_ogi_BottledAndPackagedOilMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BottledAndPackagedOilMember_515" xlink:to="lab_ogi_BottledAndPackagedOilMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BulkFormulatedOil_516" xlink:to="lab_ogi_BulkFormulatedOil_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BulkFormulatedOil_516" xlink:to="lab_ogi_BulkFormulatedOil_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BulkFormulatedOil_516" xlink:to="lab_ogi_BulkFormulatedOil_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BulkFormulatedOilMember_517" xlink:to="lab_ogi_BulkFormulatedOilMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BulkFormulatedOilMember_517" xlink:to="lab_ogi_BulkFormulatedOilMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_BulkFormulatedOilMember_517" xlink:to="lab_ogi_BulkFormulatedOilMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CannabisConsultantMember_518" xlink:to="lab_ogi_CannabisConsultantMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CannabisConsultantMember_518" xlink:to="lab_ogi_CannabisConsultantMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CannabisConsultantMember_518" xlink:to="lab_ogi_CannabisConsultantMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CapitalConsideration_519" xlink:to="lab_ogi_CapitalConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CapitalConsideration_519" xlink:to="lab_ogi_CapitalConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CapitalConsideration_519" xlink:to="lab_ogi_CapitalConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CapitalizedTransactionCostsAndEquityDiscount_520" xlink:to="lab_ogi_CapitalizedTransactionCostsAndEquityDiscount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CapitalizedTransactionCostsAndEquityDiscount_520" xlink:to="lab_ogi_CapitalizedTransactionCostsAndEquityDiscount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CapitalizedTransactionCostsAndEquityDiscount_520" xlink:to="lab_ogi_CapitalizedTransactionCostsAndEquityDiscount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CapitalManagementAbstract_521" xlink:to="lab_ogi_CapitalManagementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashCollateral_522" xlink:to="lab_ogi_CashCollateral_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashCollateral_522" xlink:to="lab_ogi_CashCollateral_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashCollateral_522" xlink:to="lab_ogi_CashCollateral_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_523" xlink:to="lab_ogi_CashPaymentAndStockOptionFeeNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_523" xlink:to="lab_ogi_CashPaymentAndStockOptionFeeNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_523" xlink:to="lab_ogi_CashPaymentAndStockOptionFeeNoncurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_524" xlink:to="lab_ogi_CashPaymentAndStockOptionsFeeCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_524" xlink:to="lab_ogi_CashPaymentAndStockOptionsFeeCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_524" xlink:to="lab_ogi_CashPaymentAndStockOptionsFeeCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashPositionAbstract_525" xlink:to="lab_ogi_CashPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CashPositionAbstract_525" xlink:to="lab_ogi_CashPositionAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_526" xlink:to="lab_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_526" xlink:to="lab_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_526" xlink:to="lab_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_526" xlink:to="lab_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInBenchmarkInterestRates_527" xlink:to="lab_ogi_ChangeInBenchmarkInterestRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInBenchmarkInterestRates_527" xlink:to="lab_ogi_ChangeInBenchmarkInterestRates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInBenchmarkInterestRates_527" xlink:to="lab_ogi_ChangeInBenchmarkInterestRates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInUnrecognizedTemporaryDifferences_528" xlink:to="lab_ogi_ChangeInUnrecognizedTemporaryDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInUnrecognizedTemporaryDifferences_528" xlink:to="lab_ogi_ChangeInUnrecognizedTemporaryDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChangeInUnrecognizedTemporaryDifferences_528" xlink:to="lab_ogi_ChangeInUnrecognizedTemporaryDifferences_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesForUnabsorbedFixedOverhead_529" xlink:to="lab_ogi_ChargesForUnabsorbedFixedOverhead_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesForUnabsorbedFixedOverhead_529" xlink:to="lab_ogi_ChargesForUnabsorbedFixedOverhead_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesForUnabsorbedFixedOverhead_529" xlink:to="lab_ogi_ChargesForUnabsorbedFixedOverhead_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesRelatedToPlantCulling_530" xlink:to="lab_ogi_ChargesRelatedToPlantCulling_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesRelatedToPlantCulling_530" xlink:to="lab_ogi_ChargesRelatedToPlantCulling_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesRelatedToPlantCulling_530" xlink:to="lab_ogi_ChargesRelatedToPlantCulling_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesRelatedToReducedWorkforce_531" xlink:to="lab_ogi_ChargesRelatedToReducedWorkforce_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesRelatedToReducedWorkforce_531" xlink:to="lab_ogi_ChargesRelatedToReducedWorkforce_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ChargesRelatedToReducedWorkforce_531" xlink:to="lab_ogi_ChargesRelatedToReducedWorkforce_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_532" xlink:to="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_532" xlink:to="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_532" xlink:to="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_533" xlink:to="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_533" xlink:to="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_533" xlink:to="lab_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_534" xlink:to="lab_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_534" xlink:to="lab_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_534" xlink:to="lab_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommittedAndUncommittedBorrowingFacilities_535" xlink:to="lab_ogi_CommittedAndUncommittedBorrowingFacilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommittedAndUncommittedBorrowingFacilities_535" xlink:to="lab_ogi_CommittedAndUncommittedBorrowingFacilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommittedAndUncommittedBorrowingFacilities_535" xlink:to="lab_ogi_CommittedAndUncommittedBorrowingFacilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommittedBorrowingFacilities_536" xlink:to="lab_ogi_CommittedBorrowingFacilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommittedBorrowingFacilities_536" xlink:to="lab_ogi_CommittedBorrowingFacilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CommittedBorrowingFacilities_536" xlink:to="lab_ogi_CommittedBorrowingFacilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConcentratedExtractMember_537" xlink:to="lab_ogi_ConcentratedExtractMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConcentratedExtractMember_537" xlink:to="lab_ogi_ConcentratedExtractMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConcentratedExtractMember_537" xlink:to="lab_ogi_ConcentratedExtractMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContingenciesAbstract_538" xlink:to="lab_ogi_ContingenciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContingentShareConsideration_539" xlink:to="lab_ogi_ContingentShareConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContingentShareConsideration_539" xlink:to="lab_ogi_ContingentShareConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContingentShareConsideration_539" xlink:to="lab_ogi_ContingentShareConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContractualCashFlowsMember_540" xlink:to="lab_ogi_ContractualCashFlowsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContractualCashFlowsMember_540" xlink:to="lab_ogi_ContractualCashFlowsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContractuallyCommittedFutureCosts_541" xlink:to="lab_ogi_ContractuallyCommittedFutureCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContractuallyCommittedFutureCosts_541" xlink:to="lab_ogi_ContractuallyCommittedFutureCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ContractuallyCommittedFutureCosts_541" xlink:to="lab_ogi_ContractuallyCommittedFutureCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfConvertibleDebenturesAmountConverted_542" xlink:to="lab_ogi_ConversionOfConvertibleDebenturesAmountConverted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfConvertibleDebenturesAmountConverted_542" xlink:to="lab_ogi_ConversionOfConvertibleDebenturesAmountConverted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfConvertibleDebenturesAmountConverted_542" xlink:to="lab_ogi_ConversionOfConvertibleDebenturesAmountConverted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_543" xlink:to="lab_ogi_ConversionOfConvertibleDebenturesSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_543" xlink:to="lab_ogi_ConversionOfConvertibleDebenturesSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_543" xlink:to="lab_ogi_ConversionOfConvertibleDebenturesSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_543" xlink:to="lab_ogi_ConversionOfConvertibleDebenturesSharesIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfDebenturesDescription_544" xlink:to="lab_ogi_ConversionOfDebenturesDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfDebenturesDescription_544" xlink:to="lab_ogi_ConversionOfDebenturesDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfDebenturesDescription_544" xlink:to="lab_ogi_ConversionOfDebenturesDescription_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfDebenturesPricePerShare_545" xlink:to="lab_ogi_ConversionOfDebenturesPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfDebenturesPricePerShare_545" xlink:to="lab_ogi_ConversionOfDebenturesPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConversionOfDebenturesPricePerShare_545" xlink:to="lab_ogi_ConversionOfDebenturesPricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebentureIssueCosts_546" xlink:to="lab_ogi_ConvertibleDebentureIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebentureIssueCosts_546" xlink:to="lab_ogi_ConvertibleDebentureIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebentureIssueCosts_546" xlink:to="lab_ogi_ConvertibleDebentureIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebentureIssueCosts_546" xlink:to="lab_ogi_ConvertibleDebentureIssueCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_547" xlink:to="lab_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_547" xlink:to="lab_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_547" xlink:to="lab_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesChangeInControlPercentage_548" xlink:to="lab_ogi_ConvertibleDebenturesChangeInControlPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesChangeInControlPercentage_548" xlink:to="lab_ogi_ConvertibleDebenturesChangeInControlPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesChangeInControlPercentage_548" xlink:to="lab_ogi_ConvertibleDebenturesChangeInControlPercentage_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesConversionPrice_549" xlink:to="lab_ogi_ConvertibleDebenturesConversionPrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesConversionPrice_549" xlink:to="lab_ogi_ConvertibleDebenturesConversionPrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesConversionPrice_549" xlink:to="lab_ogi_ConvertibleDebenturesConversionPrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_550" xlink:to="lab_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_550" xlink:to="lab_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_550" xlink:to="lab_ogi_ConvertibleDebenturesEffectiveAnnualizedDiscountRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesEffectiveInterestRate_551" xlink:to="lab_ogi_ConvertibleDebenturesEffectiveInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesEffectiveInterestRate_551" xlink:to="lab_ogi_ConvertibleDebenturesEffectiveInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesEffectiveInterestRate_551" xlink:to="lab_ogi_ConvertibleDebenturesEffectiveInterestRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesFaceValue_552" xlink:to="lab_ogi_ConvertibleDebenturesFaceValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesFaceValue_552" xlink:to="lab_ogi_ConvertibleDebenturesFaceValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesFaceValue_552" xlink:to="lab_ogi_ConvertibleDebenturesFaceValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesFaceValue_552" xlink:to="lab_ogi_ConvertibleDebenturesFaceValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesMember_553" xlink:to="lab_ogi_ConvertibleDebenturesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesMember_553" xlink:to="lab_ogi_ConvertibleDebenturesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesMember_553" xlink:to="lab_ogi_ConvertibleDebenturesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesMember_553" xlink:to="lab_ogi_ConvertibleDebenturesMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesReceivableFaceValue_554" xlink:to="lab_ogi_ConvertibleDebenturesReceivableFaceValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesReceivableFaceValue_554" xlink:to="lab_ogi_ConvertibleDebenturesReceivableFaceValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesReceivableFaceValue_554" xlink:to="lab_ogi_ConvertibleDebenturesReceivableFaceValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesReceivableFaceValue_554" xlink:to="lab_ogi_ConvertibleDebenturesReceivableFaceValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_555" xlink:to="lab_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_555" xlink:to="lab_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_555" xlink:to="lab_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_556" xlink:to="lab_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_556" xlink:to="lab_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_556" xlink:to="lab_ogi_ConvertibleDebenturesValuationOfDebtComponentBeforeIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CreditFacilitiesAxis_557" xlink:to="lab_ogi_CreditFacilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CreditFacilitiesAxis_557" xlink:to="lab_ogi_CreditFacilitiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CreditFacilitiesDomain_558" xlink:to="lab_ogi_CreditFacilitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CreditFacilitiesDomain_558" xlink:to="lab_ogi_CreditFacilitiesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CreditFacilityAmendmentAxis_559" xlink:to="lab_ogi_CreditFacilityAmendmentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CreditFacilityAmendmentAxis_559" xlink:to="lab_ogi_CreditFacilityAmendmentAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_560" xlink:to="lab_ogi_CreditFacilityAmendmentDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_560" xlink:to="lab_ogi_CreditFacilityAmendmentDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CumulativeConvertedDebentures_561" xlink:to="lab_ogi_CumulativeConvertedDebentures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CumulativeConvertedDebentures_561" xlink:to="lab_ogi_CumulativeConvertedDebentures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CumulativeConvertedDebentures_561" xlink:to="lab_ogi_CumulativeConvertedDebentures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_562" xlink:to="lab_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_562" xlink:to="lab_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_562" xlink:to="lab_ogi_CurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCost_563" xlink:to="lab_ogi_DebtIssueRelatedCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCost_563" xlink:to="lab_ogi_DebtIssueRelatedCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCost_563" xlink:to="lab_ogi_DebtIssueRelatedCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCost_563" xlink:to="lab_ogi_DebtIssueRelatedCost_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCost_563" xlink:to="lab_ogi_DebtIssueRelatedCost_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCost_563" xlink:to="lab_ogi_DebtIssueRelatedCost_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCostAllocatedToEquity_564" xlink:to="lab_ogi_DebtIssueRelatedCostAllocatedToEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCostAllocatedToEquity_564" xlink:to="lab_ogi_DebtIssueRelatedCostAllocatedToEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCostAllocatedToEquity_564" xlink:to="lab_ogi_DebtIssueRelatedCostAllocatedToEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssueRelatedCostAllocatedToEquity_564" xlink:to="lab_ogi_DebtIssueRelatedCostAllocatedToEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssuesCost_565" xlink:to="lab_ogi_DebtIssuesCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssuesCost_565" xlink:to="lab_ogi_DebtIssuesCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DebtIssuesCost_565" xlink:to="lab_ogi_DebtIssuesCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_566" xlink:to="lab_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_566" xlink:to="lab_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_566" xlink:to="lab_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredFinancingCosts_567" xlink:to="lab_ogi_DeferredFinancingCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredFinancingCosts_567" xlink:to="lab_ogi_DeferredFinancingCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredFinancingCosts_567" xlink:to="lab_ogi_DeferredFinancingCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxLiabilityAbstract_568" xlink:to="lab_ogi_DeferredTaxLiabilityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxLiabilityAbstract_568" xlink:to="lab_ogi_DeferredTaxLiabilityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_569" xlink:to="lab_ogi_DeferredTaxOnConvertibleDebentureFinancing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_569" xlink:to="lab_ogi_DeferredTaxOnConvertibleDebentureFinancing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_569" xlink:to="lab_ogi_DeferredTaxOnConvertibleDebentureFinancing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_569" xlink:to="lab_ogi_DeferredTaxOnConvertibleDebentureFinancing_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_570" xlink:to="lab_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_570" xlink:to="lab_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_570" xlink:to="lab_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_570" xlink:to="lab_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_571" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_571" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_571" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesCash_572" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesCash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesCash_572" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesCash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesCash_572" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesCash_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_573" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_573" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_573" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_574" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_574" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_574" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_575" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_575" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_575" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_576" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_576" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_576" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_577" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_577" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_577" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_577" xlink:to="lab_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_578" xlink:to="lab_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_578" xlink:to="lab_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_578" xlink:to="lab_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfBusinessAbstract_579" xlink:to="lab_ogi_DescriptionOfBusinessAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_580" xlink:to="lab_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_580" xlink:to="lab_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_580" xlink:to="lab_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_581" xlink:to="lab_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_581" xlink:to="lab_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_581" xlink:to="lab_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfForfeitureRateShareOptionsGranted_582" xlink:to="lab_ogi_DescriptionOfForfeitureRateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfForfeitureRateShareOptionsGranted_582" xlink:to="lab_ogi_DescriptionOfForfeitureRateShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfForfeitureRateShareOptionsGranted_582" xlink:to="lab_ogi_DescriptionOfForfeitureRateShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfOptionLifeSharesOptionsGranted_583" xlink:to="lab_ogi_DescriptionOfOptionLifeSharesOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfOptionLifeSharesOptionsGranted_583" xlink:to="lab_ogi_DescriptionOfOptionLifeSharesOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfOptionLifeSharesOptionsGranted_583" xlink:to="lab_ogi_DescriptionOfOptionLifeSharesOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_584" xlink:to="lab_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_584" xlink:to="lab_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_584" xlink:to="lab_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DifferenceBetweenCurrentAndFutureTaxRates_585" xlink:to="lab_ogi_DifferenceBetweenCurrentAndFutureTaxRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DifferenceBetweenCurrentAndFutureTaxRates_585" xlink:to="lab_ogi_DifferenceBetweenCurrentAndFutureTaxRates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DifferenceBetweenCurrentAndFutureTaxRates_585" xlink:to="lab_ogi_DifferenceBetweenCurrentAndFutureTaxRates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_586" xlink:to="lab_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_586" xlink:to="lab_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_586" xlink:to="lab_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_587" xlink:to="lab_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_587" xlink:to="lab_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_587" xlink:to="lab_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_588" xlink:to="lab_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_588" xlink:to="lab_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_588" xlink:to="lab_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DirectToPatientMedicalRevenueMember_589" xlink:to="lab_ogi_DirectToPatientMedicalRevenueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DirectToPatientMedicalRevenueMember_589" xlink:to="lab_ogi_DirectToPatientMedicalRevenueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DirectToPatientMedicalRevenueMember_589" xlink:to="lab_ogi_DirectToPatientMedicalRevenueMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfAccountsReceivableLineItems_590" xlink:to="lab_ogi_DisclosureOfAccountsReceivableLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfAccountsReceivableLineItems_590" xlink:to="lab_ogi_DisclosureOfAccountsReceivableLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_591" xlink:to="lab_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_591" xlink:to="lab_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_591" xlink:to="lab_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_592" xlink:to="lab_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_592" xlink:to="lab_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_592" xlink:to="lab_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfCostOfSalesAbstract_593" xlink:to="lab_ogi_DisclosureOfCostOfSalesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_594" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_594" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_594" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_595" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_595" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_595" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_596" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_596" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_596" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_597" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_597" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_597" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_598" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_598" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_598" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_599" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_599" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_599" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_600" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_600" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_600" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_601" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_601" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_601" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_602" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_602" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_602" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_603" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_603" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_603" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_604" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_604" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_604" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_605" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_605" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_605" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_606" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_606" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_606" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_607" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_607" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_607" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_608" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_608" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_608" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_609" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_609" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_609" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_610" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_610" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_610" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUnsecuredConvertibleDebenturesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_611" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_611" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_611" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_612" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_612" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_612" xlink:to="lab_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_613" xlink:to="lab_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_613" xlink:to="lab_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_613" xlink:to="lab_ogi_DisclosureOfDetailedInformationNumberAndWeightedAverageExercisePricesOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_614" xlink:to="lab_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_614" xlink:to="lab_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_614" xlink:to="lab_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory_615" xlink:to="lab_ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory_615" xlink:to="lab_ogi_DisclosureOfDetailedInformationReconciliationOperatingLeasesexplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_616" xlink:to="lab_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_616" xlink:to="lab_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_616" xlink:to="lab_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_617" xlink:to="lab_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_617" xlink:to="lab_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_617" xlink:to="lab_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfIndirectProductionExplanatory_618" xlink:to="lab_ogi_DisclosureOfIndirectProductionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfIndirectProductionExplanatory_618" xlink:to="lab_ogi_DisclosureOfIndirectProductionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfIndirectProductionExplanatory_618" xlink:to="lab_ogi_DisclosureOfIndirectProductionExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_619" xlink:to="lab_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_619" xlink:to="lab_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_619" xlink:to="lab_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLoanReceivablesExplanatory_620" xlink:to="lab_ogi_DisclosureOfLoanReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLoanReceivablesExplanatory_620" xlink:to="lab_ogi_DisclosureOfLoanReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLoanReceivablesExplanatory_620" xlink:to="lab_ogi_DisclosureOfLoanReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_621" xlink:to="lab_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_621" xlink:to="lab_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_621" xlink:to="lab_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfNatureOfOperationsExplanatory_622" xlink:to="lab_ogi_DisclosureOfNatureOfOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfNatureOfOperationsExplanatory_622" xlink:to="lab_ogi_DisclosureOfNatureOfOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfNatureOfOperationsExplanatory_622" xlink:to="lab_ogi_DisclosureOfNatureOfOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_623" xlink:to="lab_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_623" xlink:to="lab_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_623" xlink:to="lab_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_624" xlink:to="lab_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_625" xlink:to="lab_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_625" xlink:to="lab_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_625" xlink:to="lab_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_626" xlink:to="lab_ogi_DisclosureOfOtherLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_627" xlink:to="lab_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_627" xlink:to="lab_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_627" xlink:to="lab_ogi_DisclosureOfPriorPeriodReclassificationExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_628" xlink:to="lab_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_629" xlink:to="lab_ogi_DisclosureOfShortTermInvestmentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_629" xlink:to="lab_ogi_DisclosureOfShortTermInvestmentsLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_629" xlink:to="lab_ogi_DisclosureOfShortTermInvestmentsLineItems_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsTable_630" xlink:to="lab_ogi_DisclosureOfShortTermInvestmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsTable_630" xlink:to="lab_ogi_DisclosureOfShortTermInvestmentsTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsTable_630" xlink:to="lab_ogi_DisclosureOfShortTermInvestmentsTable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_631" xlink:to="lab_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DiscountingOperatingLease_632" xlink:to="lab_ogi_DiscountingOperatingLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DiscountingOperatingLease_632" xlink:to="lab_ogi_DiscountingOperatingLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DiscountingOperatingLease_632" xlink:to="lab_ogi_DiscountingOperatingLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DistributionsOfInvestmentInAssociates_633" xlink:to="lab_ogi_DistributionsOfInvestmentInAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DistributionsOfInvestmentInAssociates_633" xlink:to="lab_ogi_DistributionsOfInvestmentInAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DistributionsOfInvestmentInAssociates_633" xlink:to="lab_ogi_DistributionsOfInvestmentInAssociates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DistributionsOfInvestmentInAssociates_633" xlink:to="lab_ogi_DistributionsOfInvestmentInAssociates_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DocumentAndEntityInformationAbstract_634" xlink:to="lab_ogi_DocumentAndEntityInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisAbstract_635" xlink:to="lab_ogi_DryCannabisAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisAbstract_635" xlink:to="lab_ogi_DryCannabisAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisAvailableForPackagingMember_636" xlink:to="lab_ogi_DryCannabisAvailableForPackagingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisAvailableForPackagingMember_636" xlink:to="lab_ogi_DryCannabisAvailableForPackagingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisAvailableForPackagingMember_636" xlink:to="lab_ogi_DryCannabisAvailableForPackagingMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisMember_637" xlink:to="lab_ogi_DryCannabisMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisMember_637" xlink:to="lab_ogi_DryCannabisMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisPackagedInventoryMember_638" xlink:to="lab_ogi_DryCannabisPackagedInventoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisPackagedInventoryMember_638" xlink:to="lab_ogi_DryCannabisPackagedInventoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_DryCannabisPackagedInventoryMember_638" xlink:to="lab_ogi_DryCannabisPackagedInventoryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOfTaxRatesInOtherJurisdictions_639" xlink:to="lab_ogi_EffectOfTaxRatesInOtherJurisdictions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOfTaxRatesInOtherJurisdictions_639" xlink:to="lab_ogi_EffectOfTaxRatesInOtherJurisdictions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOfTaxRatesInOtherJurisdictions_639" xlink:to="lab_ogi_EffectOfTaxRatesInOtherJurisdictions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOnFairValueAverageNetSellingPricePerGram_640" xlink:to="lab_ogi_EffectOnFairValueAverageNetSellingPricePerGram_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOnFairValueAverageNetSellingPricePerGram_640" xlink:to="lab_ogi_EffectOnFairValueAverageNetSellingPricePerGram_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOnFairValueAverageNetSellingPricePerGram_640" xlink:to="lab_ogi_EffectOnFairValueAverageNetSellingPricePerGram_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOnFairValueAverageYieldPerPlant_641" xlink:to="lab_ogi_EffectOnFairValueAverageYieldPerPlant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOnFairValueAverageYieldPerPlant_641" xlink:to="lab_ogi_EffectOnFairValueAverageYieldPerPlant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EffectOnFairValueAverageYieldPerPlant_641" xlink:to="lab_ogi_EffectOnFairValueAverageYieldPerPlant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_642" xlink:to="lab_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_642" xlink:to="lab_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_642" xlink:to="lab_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_642" xlink:to="lab_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityFinancingMember_643" xlink:to="lab_ogi_EquityFinancingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityFinancingMember_643" xlink:to="lab_ogi_EquityFinancingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityFinancingMember_643" xlink:to="lab_ogi_EquityFinancingMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityIncentivePlanMember_644" xlink:to="lab_ogi_EquityIncentivePlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityIncentivePlanMember_644" xlink:to="lab_ogi_EquityIncentivePlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityInstrumentsHeldSharePrice_645" xlink:to="lab_ogi_EquityInstrumentsHeldSharePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityInstrumentsHeldSharePrice_645" xlink:to="lab_ogi_EquityInstrumentsHeldSharePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityInstrumentsHeldSharePrice_645" xlink:to="lab_ogi_EquityInstrumentsHeldSharePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityIssuancePricePerShare_646" xlink:to="lab_ogi_EquityIssuancePricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityIssuancePricePerShare_646" xlink:to="lab_ogi_EquityIssuancePricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityIssuancePricePerShare_646" xlink:to="lab_ogi_EquityIssuancePricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityReserveMember_647" xlink:to="lab_ogi_EquityReserveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityReserveMember_647" xlink:to="lab_ogi_EquityReserveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityReserveMember_647" xlink:to="lab_ogi_EquityReserveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquityReserveMember_647" xlink:to="lab_ogi_EquityReserveMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquitySecuritiesFairValuePerShare_648" xlink:to="lab_ogi_EquitySecuritiesFairValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquitySecuritiesFairValuePerShare_648" xlink:to="lab_ogi_EquitySecuritiesFairValuePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquitySecuritiesFairValuePerShare_648" xlink:to="lab_ogi_EquitySecuritiesFairValuePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquitySecuritiesInVivoCannabisIncMember_649" xlink:to="lab_ogi_EquitySecuritiesInVivoCannabisIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquitySecuritiesInVivoCannabisIncMember_649" xlink:to="lab_ogi_EquitySecuritiesInVivoCannabisIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EquitySecuritiesInVivoCannabisIncMember_649" xlink:to="lab_ogi_EquitySecuritiesInVivoCannabisIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEmployeeOptionsIssued_650" xlink:to="lab_ogi_EstimatedFairValueOfEmployeeOptionsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEmployeeOptionsIssued_650" xlink:to="lab_ogi_EstimatedFairValueOfEmployeeOptionsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEmployeeOptionsIssued_650" xlink:to="lab_ogi_EstimatedFairValueOfEmployeeOptionsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_651" xlink:to="lab_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_651" xlink:to="lab_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_651" xlink:to="lab_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_652" xlink:to="lab_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_652" xlink:to="lab_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_652" xlink:to="lab_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_653" xlink:to="lab_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_653" xlink:to="lab_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_653" xlink:to="lab_ogi_EstimatedFairValueOfPerformanceStockUnitsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_654" xlink:to="lab_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_654" xlink:to="lab_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_654" xlink:to="lab_ogi_EstimatedFairValueOfRestrictedStockUnitsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EventsAfterReportingPeriodMember_655" xlink:to="lab_ogi_EventsAfterReportingPeriodMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EventsAfterReportingPeriodMember_655" xlink:to="lab_ogi_EventsAfterReportingPeriodMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EventsAfterReportingPeriodMember_655" xlink:to="lab_ogi_EventsAfterReportingPeriodMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EvianaHealthCorporationMember_656" xlink:to="lab_ogi_EvianaHealthCorporationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EvianaHealthCorporationMember_656" xlink:to="lab_ogi_EvianaHealthCorporationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EvianaHealthCorporationMember_656" xlink:to="lab_ogi_EvianaHealthCorporationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_EvianaHealthCorporationMember_656" xlink:to="lab_ogi_EvianaHealthCorporationMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExciseTaxesExpenses_657" xlink:to="lab_ogi_ExciseTaxesExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExciseTaxesExpenses_657" xlink:to="lab_ogi_ExciseTaxesExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExciseTaxesExpenses_657" xlink:to="lab_ogi_ExciseTaxesExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExciseTaxesExpenses_657" xlink:to="lab_ogi_ExciseTaxesExpenses_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_658" xlink:to="lab_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_658" xlink:to="lab_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_658" xlink:to="lab_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_659" xlink:to="lab_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_659" xlink:to="lab_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_659" xlink:to="lab_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_660" xlink:to="lab_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_660" xlink:to="lab_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_660" xlink:to="lab_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_661" xlink:to="lab_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_661" xlink:to="lab_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_661" xlink:to="lab_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_662" xlink:to="lab_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_662" xlink:to="lab_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_662" xlink:to="lab_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpectedDividendAsPercentageWarrantsGranted_663" xlink:to="lab_ogi_ExpectedDividendAsPercentageWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpectedDividendAsPercentageWarrantsGranted_663" xlink:to="lab_ogi_ExpectedDividendAsPercentageWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpectedDividendAsPercentageWarrantsGranted_663" xlink:to="lab_ogi_ExpectedDividendAsPercentageWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodAxis_664" xlink:to="lab_ogi_ExpirationPeriodAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodAxis_664" xlink:to="lab_ogi_ExpirationPeriodAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodDomain_665" xlink:to="lab_ogi_ExpirationPeriodDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodDomain_665" xlink:to="lab_ogi_ExpirationPeriodDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearFiveMember_666" xlink:to="lab_ogi_ExpirationPeriodYearFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearFiveMember_666" xlink:to="lab_ogi_ExpirationPeriodYearFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearFiveMember_666" xlink:to="lab_ogi_ExpirationPeriodYearFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearFourMember_667" xlink:to="lab_ogi_ExpirationPeriodYearFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearFourMember_667" xlink:to="lab_ogi_ExpirationPeriodYearFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearFourMember_667" xlink:to="lab_ogi_ExpirationPeriodYearFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearOneMember_668" xlink:to="lab_ogi_ExpirationPeriodYearOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearOneMember_668" xlink:to="lab_ogi_ExpirationPeriodYearOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearOneMember_668" xlink:to="lab_ogi_ExpirationPeriodYearOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearThreeMember_669" xlink:to="lab_ogi_ExpirationPeriodYearThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearThreeMember_669" xlink:to="lab_ogi_ExpirationPeriodYearThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearThreeMember_669" xlink:to="lab_ogi_ExpirationPeriodYearThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearTwoMember_670" xlink:to="lab_ogi_ExpirationPeriodYearTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearTwoMember_670" xlink:to="lab_ogi_ExpirationPeriodYearTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ExpirationPeriodYearTwoMember_670" xlink:to="lab_ogi_ExpirationPeriodYearTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueLessCostToDispose_671" xlink:to="lab_ogi_FairValueLessCostToDispose_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueLessCostToDispose_671" xlink:to="lab_ogi_FairValueLessCostToDispose_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueLessCostToDispose_671" xlink:to="lab_ogi_FairValueLessCostToDispose_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueOfContingentShares_672" xlink:to="lab_ogi_FairValueOfContingentShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueOfContingentShares_672" xlink:to="lab_ogi_FairValueOfContingentShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueOfContingentShares_672" xlink:to="lab_ogi_FairValueOfContingentShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueOfOptionsGranted_673" xlink:to="lab_ogi_FairValueOfOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueOfOptionsGranted_673" xlink:to="lab_ogi_FairValueOfOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FairValueOfOptionsGranted_673" xlink:to="lab_ogi_FairValueOfOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_674" xlink:to="lab_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_674" xlink:to="lab_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_674" xlink:to="lab_ogi_FarmCreditCanadaFccCreditFacilityRefinancedWithBmoTermLoanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_675" xlink:to="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_675" xlink:to="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_675" xlink:to="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_676" xlink:to="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_676" xlink:to="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_676" xlink:to="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_676" xlink:to="lab_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FirstAmendmentMember_677" xlink:to="lab_ogi_FirstAmendmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FirstAmendmentMember_677" xlink:to="lab_ogi_FirstAmendmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FlowerAndTrimAvailableForExtractionMember_678" xlink:to="lab_ogi_FlowerAndTrimAvailableForExtractionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FlowerAndTrimAvailableForExtractionMember_678" xlink:to="lab_ogi_FlowerAndTrimAvailableForExtractionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FlowerAndTrimAvailableForExtractionMember_678" xlink:to="lab_ogi_FlowerAndTrimAvailableForExtractionMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FormulatedExtractsMember_679" xlink:to="lab_ogi_FormulatedExtractsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_FormulatedExtractsMember_679" xlink:to="lab_ogi_FormulatedExtractsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GovernmentProgramsReceivable_680" xlink:to="lab_ogi_GovernmentProgramsReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GovernmentProgramsReceivable_680" xlink:to="lab_ogi_GovernmentProgramsReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GovernmentProgramsReceivable_680" xlink:to="lab_ogi_GovernmentProgramsReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GovernmentProgramsReceivable_680" xlink:to="lab_ogi_GovernmentProgramsReceivable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GovernmentSubsidiesAbstract_681" xlink:to="lab_ogi_GovernmentSubsidiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossMarginBeforeFairValueAdjustments_682" xlink:to="lab_ogi_GrossMarginBeforeFairValueAdjustments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossMarginBeforeFairValueAdjustments_682" xlink:to="lab_ogi_GrossMarginBeforeFairValueAdjustments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossMarginBeforeFairValueAdjustments_682" xlink:to="lab_ogi_GrossMarginBeforeFairValueAdjustments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossMarginBeforeFairValueAdjustments_682" xlink:to="lab_ogi_GrossMarginBeforeFairValueAdjustments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossMarginFromDiscontinuedOperations_683" xlink:to="lab_ogi_GrossMarginFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossMarginFromDiscontinuedOperations_683" xlink:to="lab_ogi_GrossMarginFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossMarginFromDiscontinuedOperations_683" xlink:to="lab_ogi_GrossMarginFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossRevenue_684" xlink:to="lab_ogi_GrossRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossRevenue_684" xlink:to="lab_ogi_GrossRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrossRevenue_684" xlink:to="lab_ogi_GrossRevenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrowingProcessingEquipmentMember_685" xlink:to="lab_ogi_GrowingProcessingEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrowingProcessingEquipmentMember_685" xlink:to="lab_ogi_GrowingProcessingEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GrowingProcessingEquipmentMember_685" xlink:to="lab_ogi_GrowingProcessingEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesFiveMember_686" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesFiveMember_686" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesFiveMember_686" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesFourMember_687" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesFourMember_687" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesFourMember_687" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesOneMember_688" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesOneMember_688" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesOneMember_688" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesThreeMember_689" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesThreeMember_689" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesThreeMember_689" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesTwoMember_690" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesTwoMember_690" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_GuaranteedInvestmentCertificatesTwoMember_690" xlink:to="lab_ogi_GuaranteedInvestmentCertificatesTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_HarmonizedSalesTaxesReceivable_691" xlink:to="lab_ogi_HarmonizedSalesTaxesReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_HarmonizedSalesTaxesReceivable_691" xlink:to="lab_ogi_HarmonizedSalesTaxesReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_HarmonizedSalesTaxesReceivable_691" xlink:to="lab_ogi_HarmonizedSalesTaxesReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_Hemp1812With703454NBIncMember_692" xlink:to="lab_ogi_Hemp1812With703454NBIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_Hemp1812With703454NBIncMember_692" xlink:to="lab_ogi_Hemp1812With703454NBIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_Hemp1812With703454NBIncMember_692" xlink:to="lab_ogi_Hemp1812With703454NBIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_HyasynthBiologicalsIncMember_693" xlink:to="lab_ogi_HyasynthBiologicalsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_HyasynthBiologicalsIncMember_693" xlink:to="lab_ogi_HyasynthBiologicalsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_HyasynthBiologicalsIncMember_693" xlink:to="lab_ogi_HyasynthBiologicalsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_HyasynthBiologicalsIncMember_693" xlink:to="lab_ogi_HyasynthBiologicalsIncMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_694" xlink:to="lab_ogi_ImpairmentLossOfInvestmentsInAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_694" xlink:to="lab_ogi_ImpairmentLossOfInvestmentsInAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_694" xlink:to="lab_ogi_ImpairmentLossOfInvestmentsInAssociates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_694" xlink:to="lab_ogi_ImpairmentLossOfInvestmentsInAssociates_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncludedInAssetsForSale_695" xlink:to="lab_ogi_IncludedInAssetsForSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncludedInAssetsForSale_695" xlink:to="lab_ogi_IncludedInAssetsForSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncludedInAssetsForSale_695" xlink:to="lab_ogi_IncludedInAssetsForSale_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeFromGovernmentSubsidies_696" xlink:to="lab_ogi_IncomeFromGovernmentSubsidies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeFromGovernmentSubsidies_696" xlink:to="lab_ogi_IncomeFromGovernmentSubsidies_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeFromGovernmentSubsidies_696" xlink:to="lab_ogi_IncomeFromGovernmentSubsidies_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeFromGovernmentSubsidies_696" xlink:to="lab_ogi_IncomeFromGovernmentSubsidies_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeFromSubleasingAggregateRent_697" xlink:to="lab_ogi_IncomeFromSubleasingAggregateRent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeFromSubleasingAggregateRent_697" xlink:to="lab_ogi_IncomeFromSubleasingAggregateRent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeFromSubleasingAggregateRent_697" xlink:to="lab_ogi_IncomeFromSubleasingAggregateRent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_698" xlink:to="lab_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_698" xlink:to="lab_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_698" xlink:to="lab_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_699" xlink:to="lab_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_699" xlink:to="lab_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_699" xlink:to="lab_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_700" xlink:to="lab_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_700" xlink:to="lab_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_701" xlink:to="lab_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_701" xlink:to="lab_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_701" xlink:to="lab_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughConstructionCompleted_702" xlink:to="lab_ogi_IncreaseDecreaseThroughConstructionCompleted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughConstructionCompleted_702" xlink:to="lab_ogi_IncreaseDecreaseThroughConstructionCompleted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughConstructionCompleted_702" xlink:to="lab_ogi_IncreaseDecreaseThroughConstructionCompleted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_703" xlink:to="lab_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_703" xlink:to="lab_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_703" xlink:to="lab_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_704" xlink:to="lab_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_704" xlink:to="lab_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_704" xlink:to="lab_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_705" xlink:to="lab_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_705" xlink:to="lab_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_705" xlink:to="lab_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughShareBasedCompensation_706" xlink:to="lab_ogi_IncreaseDecreaseThroughShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughShareBasedCompensation_706" xlink:to="lab_ogi_IncreaseDecreaseThroughShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughShareBasedCompensation_706" xlink:to="lab_ogi_IncreaseDecreaseThroughShareBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_707" xlink:to="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_707" xlink:to="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_707" xlink:to="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_708" xlink:to="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_708" xlink:to="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_708" xlink:to="lab_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncrementalUncommittedOptionToIncreaseFacilities_709" xlink:to="lab_ogi_IncrementalUncommittedOptionToIncreaseFacilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncrementalUncommittedOptionToIncreaseFacilities_709" xlink:to="lab_ogi_IncrementalUncommittedOptionToIncreaseFacilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IncrementalUncommittedOptionToIncreaseFacilities_709" xlink:to="lab_ogi_IncrementalUncommittedOptionToIncreaseFacilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IndirectProduction_710" xlink:to="lab_ogi_IndirectProduction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IndirectProduction_710" xlink:to="lab_ogi_IndirectProduction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IndirectProduction_710" xlink:to="lab_ogi_IndirectProduction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IndirectProductionCostOfSale_711" xlink:to="lab_ogi_IndirectProductionCostOfSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IndirectProductionCostOfSale_711" xlink:to="lab_ogi_IndirectProductionCostOfSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IndirectProductionCostOfSale_711" xlink:to="lab_ogi_IndirectProductionCostOfSale_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InitiallyDrawnAmount_712" xlink:to="lab_ogi_InitiallyDrawnAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InitiallyDrawnAmount_712" xlink:to="lab_ogi_InitiallyDrawnAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InitiallyDrawnAmount_712" xlink:to="lab_ogi_InitiallyDrawnAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InterestRateOnPromissoryNoteReceivable_713" xlink:to="lab_ogi_InterestRateOnPromissoryNoteReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InterestRateOnPromissoryNoteReceivable_713" xlink:to="lab_ogi_InterestRateOnPromissoryNoteReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InterestRateOnPromissoryNoteReceivable_713" xlink:to="lab_ogi_InterestRateOnPromissoryNoteReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InternationalBusinessToBusinessMember_714" xlink:to="lab_ogi_InternationalBusinessToBusinessMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InternationalBusinessToBusinessMember_714" xlink:to="lab_ogi_InternationalBusinessToBusinessMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InternationalBusinessToBusinessMember_714" xlink:to="lab_ogi_InternationalBusinessToBusinessMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoriesAbstract_715" xlink:to="lab_ogi_InventoriesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_716" xlink:to="lab_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_716" xlink:to="lab_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_716" xlink:to="lab_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoriesLineItems_717" xlink:to="lab_ogi_InventoriesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoriesLineItems_717" xlink:to="lab_ogi_InventoriesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoriesTable_718" xlink:to="lab_ogi_InventoriesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoriesTable_718" xlink:to="lab_ogi_InventoriesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryMember_719" xlink:to="lab_ogi_InventoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryMember_719" xlink:to="lab_ogi_InventoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryMember_719" xlink:to="lab_ogi_InventoryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_720" xlink:to="lab_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_720" xlink:to="lab_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_720" xlink:to="lab_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_721" xlink:to="lab_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_721" xlink:to="lab_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_721" xlink:to="lab_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_722" xlink:to="lab_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_722" xlink:to="lab_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_722" xlink:to="lab_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InvestmentInAssociatesRestrictedInvestment_723" xlink:to="lab_ogi_InvestmentInAssociatesRestrictedInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InvestmentInAssociatesRestrictedInvestment_723" xlink:to="lab_ogi_InvestmentInAssociatesRestrictedInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InvestmentInAssociatesRestrictedInvestment_723" xlink:to="lab_ogi_InvestmentInAssociatesRestrictedInvestment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InvestmentsInterestRate_724" xlink:to="lab_ogi_InvestmentsInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InvestmentsInterestRate_724" xlink:to="lab_ogi_InvestmentsInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_InvestmentsInterestRate_724" xlink:to="lab_ogi_InvestmentsInterestRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfEquityFinancingShares_725" xlink:to="lab_ogi_IssuanceOfEquityFinancingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfEquityFinancingShares_725" xlink:to="lab_ogi_IssuanceOfEquityFinancingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfEquityFinancingShares_725" xlink:to="lab_ogi_IssuanceOfEquityFinancingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfEquityFinancingShares_725" xlink:to="lab_ogi_IssuanceOfEquityFinancingShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesConversionOfDebentures_726" xlink:to="lab_ogi_IssuanceOfSharesConversionOfDebentures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesConversionOfDebentures_726" xlink:to="lab_ogi_IssuanceOfSharesConversionOfDebentures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesConversionOfDebentures_726" xlink:to="lab_ogi_IssuanceOfSharesConversionOfDebentures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_727" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_727" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_727" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfStockOptions_728" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfStockOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfStockOptions_728" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfStockOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfStockOptions_728" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfStockOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfWarrants_729" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfWarrants_729" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesExerciseOfWarrants_729" xlink:to="lab_ogi_IssuanceOfSharesExerciseOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesShareBasedCompensation_730" xlink:to="lab_ogi_IssuanceOfSharesShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesShareBasedCompensation_730" xlink:to="lab_ogi_IssuanceOfSharesShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesShareBasedCompensation_730" xlink:to="lab_ogi_IssuanceOfSharesShareBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesShareBasedPayments_731" xlink:to="lab_ogi_IssuanceOfSharesShareBasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesShareBasedPayments_731" xlink:to="lab_ogi_IssuanceOfSharesShareBasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesShareBasedPayments_731" xlink:to="lab_ogi_IssuanceOfSharesShareBasedPayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_732" xlink:to="lab_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_732" xlink:to="lab_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_732" xlink:to="lab_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssueCostAtMarketEquityFinancing_733" xlink:to="lab_ogi_IssueCostAtMarketEquityFinancing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssueCostAtMarketEquityFinancing_733" xlink:to="lab_ogi_IssueCostAtMarketEquityFinancing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_IssueCostAtMarketEquityFinancing_733" xlink:to="lab_ogi_IssueCostAtMarketEquityFinancing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_734" xlink:to="lab_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_734" xlink:to="lab_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_734" xlink:to="lab_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LeaseLiabilityMember_735" xlink:to="lab_ogi_LeaseLiabilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LeaseLiabilityMember_735" xlink:to="lab_ogi_LeaseLiabilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_736" xlink:to="lab_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_736" xlink:to="lab_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_736" xlink:to="lab_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LicensingAndEndorsementAgreementAbstract_737" xlink:to="lab_ogi_LicensingAndEndorsementAgreementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_738" xlink:to="lab_ogi_LicensingAndEndorsementAgreementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_738" xlink:to="lab_ogi_LicensingAndEndorsementAgreementLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LicensingAndEndorsementAgreementMember_739" xlink:to="lab_ogi_LicensingAndEndorsementAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LicensingAndEndorsementAgreementMember_739" xlink:to="lab_ogi_LicensingAndEndorsementAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LicensingAndEndorsementAgreementTable_740" xlink:to="lab_ogi_LicensingAndEndorsementAgreementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LicensingAndEndorsementAgreementTable_740" xlink:to="lab_ogi_LicensingAndEndorsementAgreementTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LoanReceivableLineItems_741" xlink:to="lab_ogi_LoanReceivableLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LoanReceivableLineItems_741" xlink:to="lab_ogi_LoanReceivableLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LoanReceivableTable_742" xlink:to="lab_ogi_LoanReceivableTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LoanReceivableTable_742" xlink:to="lab_ogi_LoanReceivableTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LoansReceivablesAbstract_743" xlink:to="lab_ogi_LoansReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermAssetsMember_744" xlink:to="lab_ogi_LongTermAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermAssetsMember_744" xlink:to="lab_ogi_LongTermAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermAssetsMember_744" xlink:to="lab_ogi_LongTermAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_745" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_745" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_745" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_746" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_746" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_746" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_747" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_747" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_747" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_748" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_748" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_748" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_749" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_749" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_749" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_750" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_750" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_750" xlink:to="lab_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LossOnRemeasurementToFairValueLessCostsToSell_751" xlink:to="lab_ogi_LossOnRemeasurementToFairValueLessCostsToSell_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LossOnRemeasurementToFairValueLessCostsToSell_751" xlink:to="lab_ogi_LossOnRemeasurementToFairValueLessCostsToSell_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LossOnRemeasurementToFairValueLessCostsToSell_751" xlink:to="lab_ogi_LossOnRemeasurementToFairValueLessCostsToSell_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_752" xlink:to="lab_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_752" xlink:to="lab_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_752" xlink:to="lab_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumCommitmentToDeliverAdditionalConsideration_753" xlink:to="lab_ogi_MaximumCommitmentToDeliverAdditionalConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumCommitmentToDeliverAdditionalConsideration_753" xlink:to="lab_ogi_MaximumCommitmentToDeliverAdditionalConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_754" xlink:to="lab_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_754" xlink:to="lab_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_754" xlink:to="lab_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumPercentageOfAnnualCbdOilPurchased_755" xlink:to="lab_ogi_MaximumPercentageOfAnnualCbdOilPurchased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumPercentageOfAnnualCbdOilPurchased_755" xlink:to="lab_ogi_MaximumPercentageOfAnnualCbdOilPurchased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumPercentageOfAnnualCbdOilPurchased_755" xlink:to="lab_ogi_MaximumPercentageOfAnnualCbdOilPurchased_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_756" xlink:to="lab_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_756" xlink:to="lab_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_756" xlink:to="lab_ogi_MaximumPercentageOfIssuedAndOutstandingEquitySecuritiesAuthorisedForShareBasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumFuturePayments_757" xlink:to="lab_ogi_MinimumFuturePayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumFuturePayments_757" xlink:to="lab_ogi_MinimumFuturePayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumFuturePayments_757" xlink:to="lab_ogi_MinimumFuturePayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_758" xlink:to="lab_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_758" xlink:to="lab_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_758" xlink:to="lab_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_759" xlink:to="lab_ogi_MinimumUnrestrictedCashBalanceRequirement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_759" xlink:to="lab_ogi_MinimumUnrestrictedCashBalanceRequirement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_759" xlink:to="lab_ogi_MinimumUnrestrictedCashBalanceRequirement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_760" xlink:to="lab_ogi_MonctonCampusPhase4CAssetSpecificMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_760" xlink:to="lab_ogi_MonctonCampusPhase4CAssetSpecificMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_760" xlink:to="lab_ogi_MonctonCampusPhase4CAssetSpecificMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_760" xlink:to="lab_ogi_MonctonCampusPhase4CAssetSpecificMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NetProceedsFromIssueOfOrdinaryShares_761" xlink:to="lab_ogi_NetProceedsFromIssueOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NetProceedsFromIssueOfOrdinaryShares_761" xlink:to="lab_ogi_NetProceedsFromIssueOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NetProceedsFromIssueOfOrdinaryShares_761" xlink:to="lab_ogi_NetProceedsFromIssueOfOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_762" xlink:to="lab_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_762" xlink:to="lab_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_762" xlink:to="lab_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NonCurrentContingentShareConsideration_763" xlink:to="lab_ogi_NonCurrentContingentShareConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NonCurrentContingentShareConsideration_763" xlink:to="lab_ogi_NonCurrentContingentShareConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NonCurrentContingentShareConsideration_763" xlink:to="lab_ogi_NonCurrentContingentShareConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfCommonSharesIssued_764" xlink:to="lab_ogi_NumberOfCommonSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfCommonSharesIssued_764" xlink:to="lab_ogi_NumberOfCommonSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfCommonSharesIssued_764" xlink:to="lab_ogi_NumberOfCommonSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfConvertibleDebenturesSold_765" xlink:to="lab_ogi_NumberOfConvertibleDebenturesSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfConvertibleDebenturesSold_765" xlink:to="lab_ogi_NumberOfConvertibleDebenturesSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfConvertibleDebenturesSold_765" xlink:to="lab_ogi_NumberOfConvertibleDebenturesSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfOutstandingWarrants_766" xlink:to="lab_ogi_NumberOfOutstandingWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfOutstandingWarrants_766" xlink:to="lab_ogi_NumberOfOutstandingWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfOutstandingWarrants_766" xlink:to="lab_ogi_NumberOfOutstandingWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfOutstandingWarrants_766" xlink:to="lab_ogi_NumberOfOutstandingWarrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_767" xlink:to="lab_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_767" xlink:to="lab_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_767" xlink:to="lab_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfSharesAcquired_768" xlink:to="lab_ogi_NumberOfSharesAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfSharesAcquired_768" xlink:to="lab_ogi_NumberOfSharesAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfSharesAcquired_768" xlink:to="lab_ogi_NumberOfSharesAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExercisedOrReleased_769" xlink:to="lab_ogi_NumberOfWarrantsExercisedOrReleased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExercisedOrReleased_769" xlink:to="lab_ogi_NumberOfWarrantsExercisedOrReleased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExercisedOrReleased_769" xlink:to="lab_ogi_NumberOfWarrantsExercisedOrReleased_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExercisedOrReleased_769" xlink:to="lab_ogi_NumberOfWarrantsExercisedOrReleased_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExercisedOrReleased_769" xlink:to="lab_ogi_NumberOfWarrantsExercisedOrReleased_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExercisedOrReleased_769" xlink:to="lab_ogi_NumberOfWarrantsExercisedOrReleased_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpired_770" xlink:to="lab_ogi_NumberOfWarrantsExpired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpired_770" xlink:to="lab_ogi_NumberOfWarrantsExpired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpired_770" xlink:to="lab_ogi_NumberOfWarrantsExpired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpired_770" xlink:to="lab_ogi_NumberOfWarrantsExpired_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpired_770" xlink:to="lab_ogi_NumberOfWarrantsExpired_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpiredOrReleased_771" xlink:to="lab_ogi_NumberOfWarrantsExpiredOrReleased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpiredOrReleased_771" xlink:to="lab_ogi_NumberOfWarrantsExpiredOrReleased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpiredOrReleased_771" xlink:to="lab_ogi_NumberOfWarrantsExpiredOrReleased_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpiredOrReleased_771" xlink:to="lab_ogi_NumberOfWarrantsExpiredOrReleased_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsExpiredOrReleased_771" xlink:to="lab_ogi_NumberOfWarrantsExpiredOrReleased_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsGranted_772" xlink:to="lab_ogi_NumberOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsGranted_772" xlink:to="lab_ogi_NumberOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_NumberOfWarrantsGranted_772" xlink:to="lab_ogi_NumberOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OperatingLeaseObligations_773" xlink:to="lab_ogi_OperatingLeaseObligations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OperatingLeaseObligations_773" xlink:to="lab_ogi_OperatingLeaseObligations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OperatingLeaseObligations_773" xlink:to="lab_ogi_OperatingLeaseObligations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_774" xlink:to="lab_ogi_OperationsOfTraumaHealingCentersLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_774" xlink:to="lab_ogi_OperationsOfTraumaHealingCentersLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_775" xlink:to="lab_ogi_OperationsOfTraumaHealingCentersTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_775" xlink:to="lab_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherBiologicalAssetsMember_776" xlink:to="lab_ogi_OtherBiologicalAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherBiologicalAssetsMember_776" xlink:to="lab_ogi_OtherBiologicalAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherBiologicalAssetsMember_776" xlink:to="lab_ogi_OtherBiologicalAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherDeferredTaxAssetsMember_777" xlink:to="lab_ogi_OtherDeferredTaxAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherDeferredTaxAssetsMember_777" xlink:to="lab_ogi_OtherDeferredTaxAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherDeferredTaxAssetsMember_777" xlink:to="lab_ogi_OtherDeferredTaxAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherDeferredTaxLiabilitiesMember_778" xlink:to="lab_ogi_OtherDeferredTaxLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherDeferredTaxLiabilitiesMember_778" xlink:to="lab_ogi_OtherDeferredTaxLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherDeferredTaxLiabilitiesMember_778" xlink:to="lab_ogi_OtherDeferredTaxLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherLiabilitiesMember_779" xlink:to="lab_ogi_OtherLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherLiabilitiesMember_779" xlink:to="lab_ogi_OtherLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherLiabilitiesMember_779" xlink:to="lab_ogi_OtherLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherRevenueMember_780" xlink:to="lab_ogi_OtherRevenueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherRevenueMember_780" xlink:to="lab_ogi_OtherRevenueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_OtherRevenueMember_780" xlink:to="lab_ogi_OtherRevenueMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PaymentAgreementMember_781" xlink:to="lab_ogi_PaymentAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PaymentAgreementMember_781" xlink:to="lab_ogi_PaymentAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PaymentAgreementMember_781" xlink:to="lab_ogi_PaymentAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PaymentsForIntangibleAssetsOther_782" xlink:to="lab_ogi_PaymentsForIntangibleAssetsOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PaymentsForIntangibleAssetsOther_782" xlink:to="lab_ogi_PaymentsForIntangibleAssetsOther_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PaymentsForIntangibleAssetsOther_782" xlink:to="lab_ogi_PaymentsForIntangibleAssetsOther_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_783" xlink:to="lab_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_783" xlink:to="lab_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_783" xlink:to="lab_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_784" xlink:to="lab_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_784" xlink:to="lab_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_784" xlink:to="lab_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_785" xlink:to="lab_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_785" xlink:to="lab_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_785" xlink:to="lab_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_786" xlink:to="lab_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_786" xlink:to="lab_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_786" xlink:to="lab_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_787" xlink:to="lab_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_787" xlink:to="lab_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_787" xlink:to="lab_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_787" xlink:to="lab_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_788" xlink:to="lab_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_788" xlink:to="lab_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_788" xlink:to="lab_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentagesOfAccruedInterestReceivable_789" xlink:to="lab_ogi_PercentagesOfAccruedInterestReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentagesOfAccruedInterestReceivable_789" xlink:to="lab_ogi_PercentagesOfAccruedInterestReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PercentagesOfAccruedInterestReceivable_789" xlink:to="lab_ogi_PercentagesOfAccruedInterestReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PerformanceShareUnitsMember_790" xlink:to="lab_ogi_PerformanceShareUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PerformanceShareUnitsMember_790" xlink:to="lab_ogi_PerformanceShareUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PlantsInDryingStageMember_791" xlink:to="lab_ogi_PlantsInDryingStageMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PlantsInDryingStageMember_791" xlink:to="lab_ogi_PlantsInDryingStageMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PlantsInDryingStageMember_791" xlink:to="lab_ogi_PlantsInDryingStageMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_792" xlink:to="lab_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_792" xlink:to="lab_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_792" xlink:to="lab_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_793" xlink:to="lab_ogi_PotentialProportionOfOwnershipInterestInAssociate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_793" xlink:to="lab_ogi_PotentialProportionOfOwnershipInterestInAssociate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_793" xlink:to="lab_ogi_PotentialProportionOfOwnershipInterestInAssociate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_794" xlink:to="lab_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_794" xlink:to="lab_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_794" xlink:to="lab_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PrepaidExpensesMember_795" xlink:to="lab_ogi_PrepaidExpensesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PrepaidExpensesMember_795" xlink:to="lab_ogi_PrepaidExpensesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PrepaidExpensesMember_795" xlink:to="lab_ogi_PrepaidExpensesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PricePerConvertibleDebentureIssued_796" xlink:to="lab_ogi_PricePerConvertibleDebentureIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PricePerConvertibleDebentureIssued_796" xlink:to="lab_ogi_PricePerConvertibleDebentureIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PricePerConvertibleDebentureIssued_796" xlink:to="lab_ogi_PricePerConvertibleDebentureIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PriorPeriodReclassificationAbstract_797" xlink:to="lab_ogi_PriorPeriodReclassificationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProceedsDrawnFromTermLoanCreditFacilities_798" xlink:to="lab_ogi_ProceedsDrawnFromTermLoanCreditFacilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProceedsDrawnFromTermLoanCreditFacilities_798" xlink:to="lab_ogi_ProceedsDrawnFromTermLoanCreditFacilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProceedsDrawnFromTermLoanCreditFacilities_798" xlink:to="lab_ogi_ProceedsDrawnFromTermLoanCreditFacilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_799" xlink:to="lab_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_799" xlink:to="lab_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_799" xlink:to="lab_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PromissoryNoteMember_800" xlink:to="lab_ogi_PromissoryNoteMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PromissoryNoteMember_800" xlink:to="lab_ogi_PromissoryNoteMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PromissoryNoteMember_800" xlink:to="lab_ogi_PromissoryNoteMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PropertyPlantAndEquipmentsMember_801" xlink:to="lab_ogi_PropertyPlantAndEquipmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PropertyPlantAndEquipmentsMember_801" xlink:to="lab_ogi_PropertyPlantAndEquipmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProportionOfOwnershipInterestInSubsidiarySold_802" xlink:to="lab_ogi_ProportionOfOwnershipInterestInSubsidiarySold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProportionOfOwnershipInterestInSubsidiarySold_802" xlink:to="lab_ogi_ProportionOfOwnershipInterestInSubsidiarySold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProportionOfOwnershipInterestInSubsidiarySold_802" xlink:to="lab_ogi_ProportionOfOwnershipInterestInSubsidiarySold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProvisionForDoubtfulAccount_803" xlink:to="lab_ogi_ProvisionForDoubtfulAccount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProvisionForDoubtfulAccount_803" xlink:to="lab_ogi_ProvisionForDoubtfulAccount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProvisionForDoubtfulAccount_803" xlink:to="lab_ogi_ProvisionForDoubtfulAccount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProvisionForDoubtfulAccount_803" xlink:to="lab_ogi_ProvisionForDoubtfulAccount_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProvisionForDoubtfulTradeReceivables_804" xlink:to="lab_ogi_ProvisionForDoubtfulTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProvisionForDoubtfulTradeReceivables_804" xlink:to="lab_ogi_ProvisionForDoubtfulTradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProvisionForDoubtfulTradeReceivables_804" xlink:to="lab_ogi_ProvisionForDoubtfulTradeReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ProvisionForDoubtfulTradeReceivables_804" xlink:to="lab_ogi_ProvisionForDoubtfulTradeReceivables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PurchaseCostOfLandAndMovableEquipment_805" xlink:to="lab_ogi_PurchaseCostOfLandAndMovableEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PurchaseCostOfLandAndMovableEquipment_805" xlink:to="lab_ogi_PurchaseCostOfLandAndMovableEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_PurchaseCostOfLandAndMovableEquipment_805" xlink:to="lab_ogi_PurchaseCostOfLandAndMovableEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_QuantityOfInventory_806" xlink:to="lab_ogi_QuantityOfInventory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_QuantityOfInventory_806" xlink:to="lab_ogi_QuantityOfInventory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_QuantityOfInventory_806" xlink:to="lab_ogi_QuantityOfInventory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_QuarterlyRepayments_807" xlink:to="lab_ogi_QuarterlyRepayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_QuarterlyRepayments_807" xlink:to="lab_ogi_QuarterlyRepayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_QuarterlyRepayments_807" xlink:to="lab_ogi_QuarterlyRepayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_808" xlink:to="lab_ogi_RealizedFairValueAmountsIncludedInInventorySold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_808" xlink:to="lab_ogi_RealizedFairValueAmountsIncludedInInventorySold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_808" xlink:to="lab_ogi_RealizedFairValueAmountsIncludedInInventorySold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_808" xlink:to="lab_ogi_RealizedFairValueAmountsIncludedInInventorySold_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReceivablesAxis_809" xlink:to="lab_ogi_ReceivablesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReceivablesAxis_809" xlink:to="lab_ogi_ReceivablesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReceivablesDomain_810" xlink:to="lab_ogi_ReceivablesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReceivablesDomain_810" xlink:to="lab_ogi_ReceivablesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReclassificationOfComputerSoftware_811" xlink:to="lab_ogi_ReclassificationOfComputerSoftware_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReclassificationOfComputerSoftware_811" xlink:to="lab_ogi_ReclassificationOfComputerSoftware_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReclassificationOfComputerSoftware_811" xlink:to="lab_ogi_ReclassificationOfComputerSoftware_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReclassificationOfComputerSoftware_811" xlink:to="lab_ogi_ReclassificationOfComputerSoftware_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReclassificationOfSalesReturnsToGrossRevenue_812" xlink:to="lab_ogi_ReclassificationOfSalesReturnsToGrossRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReclassificationOfSalesReturnsToGrossRevenue_812" xlink:to="lab_ogi_ReclassificationOfSalesReturnsToGrossRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReclassificationOfSalesReturnsToGrossRevenue_812" xlink:to="lab_ogi_ReclassificationOfSalesReturnsToGrossRevenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RecoverableAmountBasedOnValueInUse_813" xlink:to="lab_ogi_RecoverableAmountBasedOnValueInUse_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RecoverableAmountBasedOnValueInUse_813" xlink:to="lab_ogi_RecoverableAmountBasedOnValueInUse_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RecoverableAmountBasedOnValueInUse_813" xlink:to="lab_ogi_RecoverableAmountBasedOnValueInUse_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReductionInRevolverCommitment_814" xlink:to="lab_ogi_ReductionInRevolverCommitment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReductionInRevolverCommitment_814" xlink:to="lab_ogi_ReductionInRevolverCommitment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReductionInRevolverCommitment_814" xlink:to="lab_ogi_ReductionInRevolverCommitment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RegulatoryFees_815" xlink:to="lab_ogi_RegulatoryFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RegulatoryFees_815" xlink:to="lab_ogi_RegulatoryFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RegulatoryFees_815" xlink:to="lab_ogi_RegulatoryFees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReliefOptionForLeasesOfLowValueAssets_816" xlink:to="lab_ogi_ReliefOptionForLeasesOfLowValueAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReliefOptionForLeasesOfLowValueAssets_816" xlink:to="lab_ogi_ReliefOptionForLeasesOfLowValueAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReliefOptionForLeasesOfLowValueAssets_816" xlink:to="lab_ogi_ReliefOptionForLeasesOfLowValueAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReliefOptionForShortTermLeases_817" xlink:to="lab_ogi_ReliefOptionForShortTermLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReliefOptionForShortTermLeases_817" xlink:to="lab_ogi_ReliefOptionForShortTermLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReliefOptionForShortTermLeases_817" xlink:to="lab_ogi_ReliefOptionForShortTermLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RenewalTermOfAgreement_818" xlink:to="lab_ogi_RenewalTermOfAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RenewalTermOfAgreement_818" xlink:to="lab_ogi_RenewalTermOfAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RenewalTermOfAgreement_818" xlink:to="lab_ogi_RenewalTermOfAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RentalIncomeOverSubleaseTerm_819" xlink:to="lab_ogi_RentalIncomeOverSubleaseTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RentalIncomeOverSubleaseTerm_819" xlink:to="lab_ogi_RentalIncomeOverSubleaseTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RentalIncomeOverSubleaseTerm_819" xlink:to="lab_ogi_RentalIncomeOverSubleaseTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_820" xlink:to="lab_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_820" xlink:to="lab_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_820" xlink:to="lab_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_820" xlink:to="lab_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RestrictedInvestment_821" xlink:to="lab_ogi_RestrictedInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RestrictedInvestment_821" xlink:to="lab_ogi_RestrictedInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RestrictedInvestment_821" xlink:to="lab_ogi_RestrictedInvestment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RestrictedStockUnitsMember_822" xlink:to="lab_ogi_RestrictedStockUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RestrictedStockUnitsMember_822" xlink:to="lab_ogi_RestrictedStockUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RestrictedStockUnitsMember_822" xlink:to="lab_ogi_RestrictedStockUnitsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RevolvingCreditFacilitiesMember_823" xlink:to="lab_ogi_RevolvingCreditFacilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RevolvingCreditFacilitiesMember_823" xlink:to="lab_ogi_RevolvingCreditFacilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RightToPurchaseUpToAnnualCbdOil_824" xlink:to="lab_ogi_RightToPurchaseUpToAnnualCbdOil_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RightToPurchaseUpToAnnualCbdOil_824" xlink:to="lab_ogi_RightToPurchaseUpToAnnualCbdOil_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RightToPurchaseUpToAnnualCbdOil_824" xlink:to="lab_ogi_RightToPurchaseUpToAnnualCbdOil_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RoyaltyPaymentPercentage_825" xlink:to="lab_ogi_RoyaltyPaymentPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RoyaltyPaymentPercentage_825" xlink:to="lab_ogi_RoyaltyPaymentPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_RoyaltyPaymentPercentage_825" xlink:to="lab_ogi_RoyaltyPaymentPercentage_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SalesOfStockAxis_826" xlink:to="lab_ogi_SalesOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SalesOfStockAxis_826" xlink:to="lab_ogi_SalesOfStockAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SalesOfStockDomain_827" xlink:to="lab_ogi_SalesOfStockDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SalesOfStockDomain_827" xlink:to="lab_ogi_SalesOfStockDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SecondAmendmentMember_828" xlink:to="lab_ogi_SecondAmendmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SecondAmendmentMember_828" xlink:to="lab_ogi_SecondAmendmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SecuredLoanMember_829" xlink:to="lab_ogi_SecuredLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SecuredLoanMember_829" xlink:to="lab_ogi_SecuredLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SecuredLoanMember_829" xlink:to="lab_ogi_SecuredLoanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_830" xlink:to="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_830" xlink:to="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_830" xlink:to="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_831" xlink:to="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_831" xlink:to="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_831" xlink:to="lab_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SetOffOfDeferredTaxAssets_832" xlink:to="lab_ogi_SetOffOfDeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SetOffOfDeferredTaxAssets_832" xlink:to="lab_ogi_SetOffOfDeferredTaxAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SetOffOfDeferredTaxAssets_832" xlink:to="lab_ogi_SetOffOfDeferredTaxAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SetOffOfDeferredTaxLiabilities_833" xlink:to="lab_ogi_SetOffOfDeferredTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SetOffOfDeferredTaxLiabilities_833" xlink:to="lab_ogi_SetOffOfDeferredTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SetOffOfDeferredTaxLiabilities_833" xlink:to="lab_ogi_SetOffOfDeferredTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShareIssuanceCostsMember_834" xlink:to="lab_ogi_ShareIssuanceCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShareIssuanceCostsMember_834" xlink:to="lab_ogi_ShareIssuanceCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShareIssuanceCostsMember_834" xlink:to="lab_ogi_ShareIssuanceCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_835" xlink:to="lab_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_835" xlink:to="lab_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_835" xlink:to="lab_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantExercisePricePerShare_836" xlink:to="lab_ogi_SharePurchaseWarrantExercisePricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantExercisePricePerShare_836" xlink:to="lab_ogi_SharePurchaseWarrantExercisePricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantExercisePricePerShare_836" xlink:to="lab_ogi_SharePurchaseWarrantExercisePricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_837" xlink:to="lab_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_837" xlink:to="lab_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_837" xlink:to="lab_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_838" xlink:to="lab_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_838" xlink:to="lab_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_838" xlink:to="lab_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_839" xlink:to="lab_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_839" xlink:to="lab_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_839" xlink:to="lab_ogi_ShippingExpensesReclassifiedFromSalesAndMarketingExpensesToCostOfSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShortTermInvestmentAbstract_840" xlink:to="lab_ogi_ShortTermInvestmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShortTermInvestmentsAxis_841" xlink:to="lab_ogi_ShortTermInvestmentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShortTermInvestmentsAxis_841" xlink:to="lab_ogi_ShortTermInvestmentsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShortTermInvestmentsDomain_842" xlink:to="lab_ogi_ShortTermInvestmentsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ShortTermInvestmentsDomain_842" xlink:to="lab_ogi_ShortTermInvestmentsDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_843" xlink:to="lab_ogi_SignificantAccountingPoliciesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_843" xlink:to="lab_ogi_SignificantAccountingPoliciesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SignificantAccountingPoliciesTable_844" xlink:to="lab_ogi_SignificantAccountingPoliciesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SignificantAccountingPoliciesTable_844" xlink:to="lab_ogi_SignificantAccountingPoliciesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SixtyOneToOneTwentyDaysMember_845" xlink:to="lab_ogi_SixtyOneToOneTwentyDaysMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SixtyOneToOneTwentyDaysMember_845" xlink:to="lab_ogi_SixtyOneToOneTwentyDaysMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SixtyOneToOneTwentyDaysMember_845" xlink:to="lab_ogi_SixtyOneToOneTwentyDaysMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_StockOptionPlanMember_846" xlink:to="lab_ogi_StockOptionPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_StockOptionPlanMember_846" xlink:to="lab_ogi_StockOptionPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_StockOptionPlanMember_846" xlink:to="lab_ogi_StockOptionPlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_StockOptionsMember_847" xlink:to="lab_ogi_StockOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_StockOptionsMember_847" xlink:to="lab_ogi_StockOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_StockOptionsMember_847" xlink:to="lab_ogi_StockOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SubleaseAnnualRentalIncome_848" xlink:to="lab_ogi_SubleaseAnnualRentalIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SubleaseAnnualRentalIncome_848" xlink:to="lab_ogi_SubleaseAnnualRentalIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SubleaseAnnualRentalIncome_848" xlink:to="lab_ogi_SubleaseAnnualRentalIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SupplyAgreementMember_849" xlink:to="lab_ogi_SupplyAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SupplyAgreementMember_849" xlink:to="lab_ogi_SupplyAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SupplyAgreementMember_849" xlink:to="lab_ogi_SupplyAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SwearNetLimitedMember_850" xlink:to="lab_ogi_SwearNetLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SwearNetLimitedMember_850" xlink:to="lab_ogi_SwearNetLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_SwearNetLimitedMember_850" xlink:to="lab_ogi_SwearNetLimitedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_851" xlink:to="lab_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_851" xlink:to="lab_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_851" xlink:to="lab_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TermLoanMember_852" xlink:to="lab_ogi_TermLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TermLoanMember_852" xlink:to="lab_ogi_TermLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TgsInternationalLlcMember_853" xlink:to="lab_ogi_TgsInternationalLlcMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TgsInternationalLlcMember_853" xlink:to="lab_ogi_TgsInternationalLlcMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TgsInternationalLlcMember_853" xlink:to="lab_ogi_TgsInternationalLlcMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_854" xlink:to="lab_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_854" xlink:to="lab_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_854" xlink:to="lab_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TrademarkLicensingAgreement_855" xlink:to="lab_ogi_TrademarkLicensingAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TrademarkLicensingAgreement_855" xlink:to="lab_ogi_TrademarkLicensingAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TradeReceivablesGross_856" xlink:to="lab_ogi_TradeReceivablesGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TradeReceivablesGross_856" xlink:to="lab_ogi_TradeReceivablesGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TradeReceivablesGross_856" xlink:to="lab_ogi_TradeReceivablesGross_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TradeReceivablesNet_857" xlink:to="lab_ogi_TradeReceivablesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TradeReceivablesNet_857" xlink:to="lab_ogi_TradeReceivablesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TradeReceivablesNet_857" xlink:to="lab_ogi_TradeReceivablesNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_858" xlink:to="lab_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_858" xlink:to="lab_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_858" xlink:to="lab_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionCostsOfInvestmentInAssociates_859" xlink:to="lab_ogi_TransactionCostsOfInvestmentInAssociates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionCostsOfInvestmentInAssociates_859" xlink:to="lab_ogi_TransactionCostsOfInvestmentInAssociates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionCostsOfInvestmentInAssociates_859" xlink:to="lab_ogi_TransactionCostsOfInvestmentInAssociates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_860" xlink:to="lab_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_860" xlink:to="lab_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_860" xlink:to="lab_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransitionToIfrs16_861" xlink:to="lab_ogi_TransitionToIfrs16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransitionToIfrs16_861" xlink:to="lab_ogi_TransitionToIfrs16_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TransitionToIfrs16_861" xlink:to="lab_ogi_TransitionToIfrs16_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TraumaHealingCentersMember_862" xlink:to="lab_ogi_TraumaHealingCentersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TraumaHealingCentersMember_862" xlink:to="lab_ogi_TraumaHealingCentersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TraumaHealingCentersMember_862" xlink:to="lab_ogi_TraumaHealingCentersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TypeOfArrangementsAxis_863" xlink:to="lab_ogi_TypeOfArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TypeOfArrangementsAxis_863" xlink:to="lab_ogi_TypeOfArrangementsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TypeOfArrangementsDomain_864" xlink:to="lab_ogi_TypeOfArrangementsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_TypeOfArrangementsDomain_864" xlink:to="lab_ogi_TypeOfArrangementsDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_865" xlink:to="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_865" xlink:to="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_865" xlink:to="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_865" xlink:to="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_865" xlink:to="lab_ogi_UnamortizedDiscountAndIssueCostsTransferredToEquityUponConversionOfDebentures_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnderwritersMember_866" xlink:to="lab_ogi_UnderwritersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnderwritersMember_866" xlink:to="lab_ogi_UnderwritersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UndiscountedOperatingLeasePaymentsToBePaid_867" xlink:to="lab_ogi_UndiscountedOperatingLeasePaymentsToBePaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UndiscountedOperatingLeasePaymentsToBePaid_867" xlink:to="lab_ogi_UndiscountedOperatingLeasePaymentsToBePaid_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UndiscountedOperatingLeasePaymentsToBePaid_867" xlink:to="lab_ogi_UndiscountedOperatingLeasePaymentsToBePaid_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnitsIssuedInPeriodPricePerUnit_868" xlink:to="lab_ogi_UnitsIssuedInPeriodPricePerUnit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnitsIssuedInPeriodPricePerUnit_868" xlink:to="lab_ogi_UnitsIssuedInPeriodPricePerUnit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnitsIssuedInPeriodPricePerUnit_868" xlink:to="lab_ogi_UnitsIssuedInPeriodPricePerUnit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_869" xlink:to="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_869" xlink:to="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_869" xlink:to="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_869" xlink:to="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_869" xlink:to="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_869" xlink:to="lab_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_870" xlink:to="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_870" xlink:to="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_870" xlink:to="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_870" xlink:to="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_870" xlink:to="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_870" xlink:to="lab_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnsecuredConvertibleDebenturesMember_871" xlink:to="lab_ogi_UnsecuredConvertibleDebenturesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnsecuredConvertibleDebenturesMember_871" xlink:to="lab_ogi_UnsecuredConvertibleDebenturesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnsecuredConvertibleDebenturesMember_871" xlink:to="lab_ogi_UnsecuredConvertibleDebenturesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_872" xlink:to="lab_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_872" xlink:to="lab_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_872" xlink:to="lab_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_872" xlink:to="lab_ogi_UnsecuredConvertibleDebenturesOutstandingFaceValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UsefulLiveOfPropertyPlantAndEquipment_873" xlink:to="lab_ogi_UsefulLiveOfPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UsefulLiveOfPropertyPlantAndEquipment_873" xlink:to="lab_ogi_UsefulLiveOfPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_UsefulLiveOfPropertyPlantAndEquipment_873" xlink:to="lab_ogi_UsefulLiveOfPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_874" xlink:to="lab_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_874" xlink:to="lab_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_874" xlink:to="lab_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VestingPeriodOfPerformanceStockUnits_875" xlink:to="lab_ogi_VestingPeriodOfPerformanceStockUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VestingPeriodOfPerformanceStockUnits_875" xlink:to="lab_ogi_VestingPeriodOfPerformanceStockUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VestingPeriodOfPerformanceStockUnits_875" xlink:to="lab_ogi_VestingPeriodOfPerformanceStockUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VestingPeriodOfRestrictedStockUnits_876" xlink:to="lab_ogi_VestingPeriodOfRestrictedStockUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VestingPeriodOfRestrictedStockUnits_876" xlink:to="lab_ogi_VestingPeriodOfRestrictedStockUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VestingPeriodOfRestrictedStockUnits_876" xlink:to="lab_ogi_VestingPeriodOfRestrictedStockUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VivoCannabisIncMember_877" xlink:to="lab_ogi_VivoCannabisIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_VivoCannabisIncMember_877" xlink:to="lab_ogi_VivoCannabisIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WarrantsMember_878" xlink:to="lab_ogi_WarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WarrantsMember_878" xlink:to="lab_ogi_WarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WarrantsMember_878" xlink:to="lab_ogi_WarrantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_879" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_879" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_879" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_879" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_879" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsExpired_880" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsExpired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsExpired_880" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsExpired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsExpired_880" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsExpired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_881" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_881" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_881" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_881" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_882" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_882" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_882" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_882" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_882" xlink:to="lab_ogi_WeightedAverageExercisePriceOfWarrantsOutstanding_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WholesaleToLicensedProducersRevenueMember_883" xlink:to="lab_ogi_WholesaleToLicensedProducersRevenueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WholesaleToLicensedProducersRevenueMember_883" xlink:to="lab_ogi_WholesaleToLicensedProducersRevenueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WholesaleToLicensedProducersRevenueMember_883" xlink:to="lab_ogi_WholesaleToLicensedProducersRevenueMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WorkingCapital_884" xlink:to="lab_ogi_WorkingCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WorkingCapital_884" xlink:to="lab_ogi_WorkingCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_WorkingCapital_884" xlink:to="lab_ogi_WorkingCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ZeroToSixtyDaysMember_885" xlink:to="lab_ogi_ZeroToSixtyDaysMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ZeroToSixtyDaysMember_885" xlink:to="lab_ogi_ZeroToSixtyDaysMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ogi_ZeroToSixtyDaysMember_885" xlink:to="lab_ogi_ZeroToSixtyDaysMember_2"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>ogi-20200831_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DocumentAndEntityInformation" roleURI="http://www.organigram.ca/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ConsolidatedStatementsOfFinancialPosition" roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfFinancialPosition"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome" roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ConsolidatedStatementsOfChangesInEquity" roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.organigram.ca/role/ConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals" roleURI="http://www.organigram.ca/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#NatureOfOperations" roleURI="http://www.organigram.ca/role/NatureOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#BasisOfPreparation" roleURI="http://www.organigram.ca/role/BasisOfPreparation"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SignificantAccountingPolicies" roleURI="http://www.organigram.ca/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ShortTermInvestments" roleURI="http://www.organigram.ca/role/ShortTermInvestments"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#AccountsReceivable" roleURI="http://www.organigram.ca/role/AccountsReceivable"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LoanReceivable" roleURI="http://www.organigram.ca/role/LoanReceivable"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#BiologicalAssets" roleURI="http://www.organigram.ca/role/BiologicalAssets"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#Inventories" roleURI="http://www.organigram.ca/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#PropertyPlantAndEquipment" roleURI="http://www.organigram.ca/role/PropertyPlantAndEquipment"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#IntangibleAssets" roleURI="http://www.organigram.ca/role/IntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LongTermDebt" roleURI="http://www.organigram.ca/role/LongTermDebt"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ShareCapital" roleURI="http://www.organigram.ca/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#InvestmentsInAssociates" roleURI="http://www.organigram.ca/role/InvestmentsInAssociates"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#RelatedPartyTransactions" roleURI="http://www.organigram.ca/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#CapitalManagement" roleURI="http://www.organigram.ca/role/CapitalManagement"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#FairValueOfFinancialInstrumentsAndFinancialRiskFactors" roleURI="http://www.organigram.ca/role/FairValueOfFinancialInstrumentsAndFinancialRiskFactors"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#Revenue" roleURI="http://www.organigram.ca/role/Revenue"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#IndirectProduction" roleURI="http://www.organigram.ca/role/IndirectProduction"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#Contingencies" roleURI="http://www.organigram.ca/role/Contingencies"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#IncomeTaxes" roleURI="http://www.organigram.ca/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SegmentedInformation" roleURI="http://www.organigram.ca/role/SegmentedInformation"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#GeneralAndAdministrativeExpensesByNatureExcludingDiscontinuedOperations" roleURI="http://www.organigram.ca/role/GeneralAndAdministrativeExpensesByNatureExcludingDiscontinuedOperations"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LicensingAndEndorsementAgreement" roleURI="http://www.organigram.ca/role/LicensingAndEndorsementAgreement"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OperationsOfTraumaHealingCenters" roleURI="http://www.organigram.ca/role/OperationsOfTraumaHealingCenters"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SHORTTERMINVESTMENTSTables" roleURI="http://www.organigram.ca/role/SHORTTERMINVESTMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#ACCOUNTSRECEIVABLETables" roleURI="http://www.organigram.ca/role/ACCOUNTSRECEIVABLETables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#BIOLOGICALASSETSTables" roleURI="http://www.organigram.ca/role/BIOLOGICALASSETSTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#INVENTORIESTables" roleURI="http://www.organigram.ca/role/INVENTORIESTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#INTANGIBLEASSETSTables" roleURI="http://www.organigram.ca/role/INTANGIBLEASSETSTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LONGTERMDEBTTables" roleURI="http://www.organigram.ca/role/LONGTERMDEBTTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SHARECAPITALTables" roleURI="http://www.organigram.ca/role/SHARECAPITALTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#INVESTMENTSINASSOCIATESTables" roleURI="http://www.organigram.ca/role/INVESTMENTSINASSOCIATESTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#RELATEDPARTYTRANSACTIONSTables" roleURI="http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSTables" roleURI="http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#REVENUETables" roleURI="http://www.organigram.ca/role/REVENUETables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#INCOMETAXESTables" roleURI="http://www.organigram.ca/role/INCOMETAXESTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#GENERALANDADMINISTRATIVEEXPENSESBYNATUREexcludingdiscontinuedoperationsTables" roleURI="http://www.organigram.ca/role/GENERALANDADMINISTRATIVEEXPENSESBYNATUREexcludingdiscontinuedoperationsTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OPERATIONSOFTRAUMAHEALINGCENTERSTables" roleURI="http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#AccountsReceivableNarrativeDetails" roleURI="http://www.organigram.ca/role/AccountsReceivableNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LoanReceivableNarrativeDetails" roleURI="http://www.organigram.ca/role/LoanReceivableNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#BiologicalAssetsNarrativeDetails" roleURI="http://www.organigram.ca/role/BiologicalAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#InventoriesNarrativeDetails" roleURI="http://www.organigram.ca/role/InventoriesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#IntangibleAssetsNarrativeDetails" roleURI="http://www.organigram.ca/role/IntangibleAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LongTermDebtNarrativeDetails" roleURI="http://www.organigram.ca/role/LongTermDebtNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SHARECAPITALDetails8" roleURI="http://www.organigram.ca/role/SHARECAPITALDetails8"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#InvestmentsInAssociatesNarrativeDetails" roleURI="http://www.organigram.ca/role/InvestmentsInAssociatesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#RELATEDPARTYTRANSACTIONSDetails1" roleURI="http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#CAPITALMANAGEMENTDetails" roleURI="http://www.organigram.ca/role/CAPITALMANAGEMENTDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSDetails2" roleURI="http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSDetails2"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#RevenueNarrativeDetails" roleURI="http://www.organigram.ca/role/RevenueNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#LicensingAndEndorsementAgreementNarrativeDetails" roleURI="http://www.organigram.ca/role/LicensingAndEndorsementAgreementNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OPERATIONSOFTRAUMAHEALINGCENTERSDetails4" roleURI="http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSDetails4"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SubsequentEventsNarrativeDetails" roleURI="http://www.organigram.ca/role/SubsequentEventsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutAccountsReceivableDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAccountsReceivableDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutInventoriesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutAdditionsOfPropertyPlantAndEquipmentDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAdditionsOfPropertyPlantAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutIntangibleAssetsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfLongTermDebtDetails" roleURI="http://www.organigram.ca/role/DisclosureOfLongTermDebtDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfLongTermDebtParentheticalsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfLongTermDebtParentheticalsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails" roleURI="http://www.organigram.ca/role/DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutOutstandingRsusDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingRsusDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutLossPerShareDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutLossPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails" roleURI="http://www.organigram.ca/role/DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutRevenuesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRevenuesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutComponentsOfDeferredIncomeTaxExpenseDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutComponentsOfDeferredIncomeTaxExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails" roleURI="http://www.organigram.ca/role/DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDerecognizedAssetsAndLiabilitiesDetails" roleURI="http://www.organigram.ca/role/DisclosureOfDerecognizedAssetsAndLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail" roleURI="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail" roleURI="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#PROPERTYPLANTANDEQUIPMENTNarrativeDetails" roleURI="http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SHARECAPITALPerformanceShareUnits" roleURI="http://www.organigram.ca/role/SHARECAPITALPerformanceShareUnits"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#COSTOFSALESDetailTextuals" roleURI="http://www.organigram.ca/role/COSTOFSALESDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#COSTOFSALES" roleURI="http://www.organigram.ca/role/COSTOFSALES"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#GOVERNMENTSUBSIDIES" roleURI="http://www.organigram.ca/role/GOVERNMENTSUBSIDIES"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#GOVERNMENTSUBSIDIESDetailTextuals" roleURI="http://www.organigram.ca/role/GOVERNMENTSUBSIDIESDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIESDetails1" roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails1"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIESDetails" roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIESDetailTextuals" roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIES" roleURI="http://www.organigram.ca/role/OTHERLIABILITIES"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIESTables" roleURI="http://www.organigram.ca/role/OTHERLIABILITIESTables"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#OTHERLIABILITIESDetails2" roleURI="http://www.organigram.ca/role/OTHERLIABILITIESDetails2"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals" roleURI="http://www.organigram.ca/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals"/>
  <roleRef xlink:type="simple" xlink:href="ogi-20200831.xsd#SUBSEQUENTEVENTS" roleURI="http://www.organigram.ca/role/SUBSEQUENTEVENTS"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityCurrentReportingStatus_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentType_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AmendmentFlag_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityExTransitionPeriod_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ConsolidatedStatementsOfFinancialPosition">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentHeldtomaturityInvestments" xlink:label="loc_ifrs-full_CurrentHeldtomaturityInvestments_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLoansAndReceivables" xlink:label="loc_ifrs-full_CurrentLoansAndReceivables_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:label="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LoansAndReceivables" xlink:label="loc_ifrs-full_LoansAndReceivables_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrepaymentsAndAccruedIncome" xlink:label="loc_ifrs-full_PrepaymentsAndAccruedIncome_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncome_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_AssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_Cash_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentHeldtomaturityInvestments_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentTradeReceivables_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentLoansAndReceivables_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_Inventories_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentAssets_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_RestrictedCashAndCashEquivalents_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_LoansAndReceivables_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_PrepaymentsAndAccruedIncome_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_Assets_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_18" xlink:to="loc_ifrs-full_LiabilitiesAbstract_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_18" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_18" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_18" xlink:to="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_18" xlink:to="loc_ifrs-full_CurrentLiabilities_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_18" xlink:to="loc_ifrs-full_LongtermBorrowings_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_18" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_18" xlink:to="loc_ifrs-full_NetDeferredTaxLiabilities_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_18" xlink:to="loc_ifrs-full_Liabilities_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_18" xlink:to="loc_ifrs-full_EquityAbstract_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_26" xlink:to="loc_ifrs-full_IssuedCapital_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_26" xlink:to="loc_ifrs-full_ReserveOfSharebasedPayments_27" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_26" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncome_28" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_26" xlink:to="loc_ifrs-full_RetainedEarnings_29" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_26" xlink:to="loc_ifrs-full_Equity_30" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_18" xlink:to="loc_ifrs-full_EquityAndLiabilities_32" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossRevenue" xlink:label="loc_ogi_GrossRevenue_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="loc_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossMarginBeforeFairValueAdjustments" xlink:label="loc_ogi_GrossMarginBeforeFairValueAdjustments_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncomeFromGovernmentSubsidies" xlink:label="loc_ogi_IncomeFromGovernmentSubsidies_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates" xlink:label="loc_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_34"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_1" xlink:to="loc_ogi_GrossRevenue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_1" xlink:to="loc_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_1" xlink:to="loc_ifrs-full_Revenue_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_CostOfSales_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ogi_GrossMarginBeforeFairValueAdjustments_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_GrossProfit_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ExpenseByNatureAbstract_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_ExpenseByNature_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceCosts_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceIncome_17" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ogi_IncomeFromGovernmentSubsidies_18" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_19" order="100" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates_20" order="110" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_21" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_22" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_23" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_24" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_25" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLoss_26" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_27" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_28" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_29" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_30" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_31" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_32" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_33" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_34" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ConsolidatedStatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityReserveMember" xlink:label="loc_ogi_EquityReserveMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts" xlink:label="loc_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts" xlink:label="loc_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughShareBasedCompensation" xlink:label="loc_ogi_IncreaseDecreaseThroughShareBasedCompensation_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesShareBasedCompensation" xlink:label="loc_ogi_IssuanceOfSharesShareBasedCompensation_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesShareBasedPayments" xlink:label="loc_ogi_IssuanceOfSharesShareBasedPayments_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfStockOptions" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfStockOptions_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfWarrants" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfWarrants_18"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits" xlink:label="loc_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits" xlink:label="loc_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesConversionOfDebentures" xlink:label="loc_ogi_IssuanceOfSharesConversionOfDebentures_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_23"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfEquityFinancingShares" xlink:label="loc_ogi_IssuanceOfEquityFinancingShares_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DebtIssueRelatedCost" xlink:label="loc_ogi_DebtIssueRelatedCost_26"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts" xlink:label="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_27"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures" xlink:label="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_28"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughForeignCurrencyTranslation" xlink:label="loc_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ogi_EquityReserveMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_Equity_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IncreaseDecreaseThroughShareBasedCompensation_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IssuanceOfSharesShareBasedCompensation_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IssuanceOfSharesShareBasedPayments_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IssuanceOfSharesExerciseOfStockOptions_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IssuanceOfSharesExerciseOfWarrants_18" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits_19" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits_20" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_21" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IssuanceOfSharesConversionOfDebentures_22" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IssueOfEquity_23" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IssuanceOfEquityFinancingShares_24" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IssueOfConvertibleInstruments_25" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_DebtIssueRelatedCost_26" order="190" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts_27" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IncreaseDecreaseThroughTaxImpactOfEquityAndConvertibleDebentures_28" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation_29" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_ProfitLoss_30" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_Equity_31" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_32" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts" xlink:label="loc_ifrs-full_AdjustmentsForFinanceCosts_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForInterestIncome" xlink:label="loc_ifrs-full_AdjustmentsForInterestIncome_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract" xlink:label="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges" xlink:label="loc_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForDebtIssueCosts" xlink:label="loc_ifrs-full_PaymentsForDebtIssueCosts_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_29"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised" xlink:label="loc_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_42"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_46"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPositionAbstract" xlink:label="loc_ogi_CashPositionAbstract_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_50"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForFinanceCosts_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForInterestIncome_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" xlink:to="loc_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract_12" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_25" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_PaymentsForDebtIssueCosts_27" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_28" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_29" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised_30" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_31" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_23" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_32" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_34" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_35" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_36" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_PurchaseOfInterestsInAssociates_37" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_38" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_39" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_40" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_41" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_42" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_43" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_44" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_45" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_34" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_46" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ogi_CashPositionAbstract_48" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CashPositionAbstract_48" xlink:to="loc_ifrs-full_Cash_48" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CashPositionAbstract_48" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_49" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CashPositionAbstract_48" xlink:to="loc_ifrs-full_Cash_50" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DebtIssuesCost" xlink:label="loc_ogi_DebtIssuesCost_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ogi_DebtIssuesCost_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/NatureOfOperations">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfBusinessAbstract" xlink:label="loc_ogi_DescriptionOfBusinessAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfNatureOfOperationsExplanatory" xlink:label="loc_ogi_DisclosureOfNatureOfOperationsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DescriptionOfBusinessAbstract_0" xlink:to="loc_ogi_DisclosureOfNatureOfOperationsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/BasisOfPreparation">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BasisOfPreparationAbstract" xlink:label="loc_ogi_BasisOfPreparationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_BasisOfPreparationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ShortTermInvestments">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentAbstract" xlink:label="loc_ogi_ShortTermInvestmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/AccountsReceivable">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AccountsReceivableAbstract" xlink:label="loc_ogi_AccountsReceivableAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LoanReceivable">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoansReceivablesAbstract" xlink:label="loc_ogi_LoansReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfLoanReceivablesExplanatory" xlink:label="loc_ogi_DisclosureOfLoanReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LoansReceivablesAbstract_0" xlink:to="loc_ogi_DisclosureOfLoanReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/BiologicalAssets">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/Inventories">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesAbstract" xlink:label="loc_ogi_InventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/PropertyPlantAndEquipment">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/IntangibleAssets">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LongTermDebt">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ShareCapital">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/InvestmentsInAssociates">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/CapitalManagement">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CapitalManagementAbstract" xlink:label="loc_ogi_CapitalManagementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CapitalManagementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/FairValueOfFinancialInstrumentsAndFinancialRiskFactors">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/Revenue">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRevenueExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRevenueExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/IndirectProduction">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WritedownsReversalsOfWritedownsOfInventoriesAbstract" xlink:label="loc_ifrs-full_WritedownsReversalsOfWritedownsOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfIndirectProductionExplanatory" xlink:label="loc_ogi_DisclosureOfIndirectProductionExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WritedownsReversalsOfWritedownsOfInventoriesAbstract_0" xlink:to="loc_ogi_DisclosureOfIndirectProductionExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/Contingencies">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContingenciesAbstract" xlink:label="loc_ogi_ContingenciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ContingenciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SegmentedInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/GeneralAndAdministrativeExpensesByNatureExcludingDiscontinuedOperations">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LicensingAndEndorsementAgreement">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementAbstract" xlink:label="loc_ogi_LicensingAndEndorsementAgreementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory" xlink:label="loc_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementAbstract_0" xlink:to="loc_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OperationsOfTraumaHealingCenters">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory" xlink:label="loc_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements" xlink:label="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_19"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SHORTTERMINVESTMENTSTables">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentAbstract" xlink:label="loc_ogi_ShortTermInvestmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/ACCOUNTSRECEIVABLETables">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AccountsReceivableAbstract" xlink:label="loc_ogi_AccountsReceivableAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/BIOLOGICALASSETSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/INVENTORIESTables">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesAbstract" xlink:label="loc_ogi_InventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/INTANGIBLEASSETSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LONGTERMDEBTTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SHARECAPITALTables">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory" xlink:label="loc_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareExplanatory_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/INVESTMENTSINASSOCIATESTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationStatementOfFinancialPositionAndComprehensiveLossOfEntitiesMaterialInvestmentsInEquityMethodInvesteesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/REVENUETables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/INCOMETAXESTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredIncomeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredIncomeExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDeferredIncomeExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/GENERALANDADMINISTRATIVEEXPENSESBYNATUREexcludingdiscontinuedoperationsTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSTables">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory" xlink:label="loc_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory" xlink:label="loc_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory" xlink:label="loc_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_DisclosureOfCarryingAmountsOfAssetsAndLiabilitiesInDisposalGroupExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/AccountsReceivableNarrativeDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AccountsReceivableAbstract" xlink:label="loc_ogi_AccountsReceivableAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy" xlink:label="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy" xlink:label="loc_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LoanReceivableNarrativeDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoansReceivablesAbstract" xlink:label="loc_ogi_LoansReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoanReceivableTable" xlink:label="loc_ogi_LoanReceivableTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsAxis" xlink:label="loc_ogi_TypeOfArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsDomain" xlink:label="loc_ogi_TypeOfArrangementsDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PaymentAgreementMember" xlink:label="loc_ogi_PaymentAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SecuredLoanMember" xlink:label="loc_ogi_SecuredLoanMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LoanReceivableLineItems" xlink:label="loc_ogi_LoanReceivableLineItems_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLoansAndReceivables" xlink:label="loc_ifrs-full_CurrentLoansAndReceivables_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvancePayment" xlink:label="loc_ogi_AdvancePayment_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentagesOfAccruedInterestReceivable" xlink:label="loc_ogi_PercentagesOfAccruedInterestReceivable_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LoansReceivablesAbstract_0" xlink:to="loc_ogi_LoanReceivableTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LoanReceivableTable_1" xlink:to="loc_ogi_TypeOfArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_TypeOfArrangementsAxis_1" xlink:to="loc_ogi_TypeOfArrangementsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_TypeOfArrangementsDomain_1" xlink:to="loc_ogi_PaymentAgreementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LoanReceivableTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_4" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_4" xlink:to="loc_ogi_SecuredLoanMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LoanReceivableTable_1" xlink:to="loc_ogi_LoanReceivableLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LoanReceivableLineItems_7" xlink:to="loc_ifrs-full_CurrentLoansAndReceivables_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LoanReceivableLineItems_7" xlink:to="loc_ogi_AdvancePayment_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LoanReceivableLineItems_7" xlink:to="loc_ogi_PercentagesOfAccruedInterestReceivable_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/BiologicalAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsBiologicalAssets" xlink:label="loc_ifrs-full_DisposalsBiologicalAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OutputOfAgriculturalProduce" xlink:label="loc_ifrs-full_OutputOfAgriculturalProduce_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DisposalsBiologicalAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_OutputOfAgriculturalProduce_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/InventoriesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales" xlink:label="loc_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories" xlink:label="loc_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction" xlink:label="loc_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsBiologicalAssets" xlink:label="loc_ifrs-full_DisposalsBiologicalAssets_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_InventoryWritedown2011_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_DisposalsBiologicalAssets_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/IntangibleAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_Hemp1812With703454NBIncMember" xlink:label="loc_ogi_Hemp1812With703454NBIncMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower" xlink:label="loc_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RenewalTermOfAgreement" xlink:label="loc_ogi_RenewalTermOfAgreement_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PaymentsForIntangibleAssetsOther" xlink:label="loc_ogi_PaymentsForIntangibleAssetsOther_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_1" xlink:to="loc_ogi_Hemp1812With703454NBIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4" xlink:to="loc_ifrs-full_CarryingAmountMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_4" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_4" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_8" xlink:to="loc_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_8" xlink:to="loc_ogi_RenewalTermOfAgreement_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_8" xlink:to="loc_ogi_PaymentsForIntangibleAssetsOther_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_8" xlink:to="loc_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_8" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_8" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LongTermDebtNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember" xlink:label="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesAxis" xlink:label="loc_ogi_CreditFacilitiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesDomain" xlink:label="loc_ogi_CreditFacilitiesDomain_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TermLoanMember" xlink:label="loc_ogi_TermLoanMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RevolvingCreditFacilitiesMember" xlink:label="loc_ogi_RevolvingCreditFacilitiesMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentAxis" xlink:label="loc_ogi_CreditFacilityAmendmentAxis_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentDomain" xlink:label="loc_ogi_CreditFacilityAmendmentDomain_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FirstAmendmentMember" xlink:label="loc_ogi_FirstAmendmentMember_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SecondAmendmentMember" xlink:label="loc_ogi_SecondAmendmentMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmendmentAndRestatementMember" xlink:label="loc_ogi_AmendmentAndRestatementMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingCostsIncurred" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncrementalUncommittedOptionToIncreaseFacilities" xlink:label="loc_ogi_IncrementalUncommittedOptionToIncreaseFacilities_18"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommittedAndUncommittedBorrowingFacilities" xlink:label="loc_ogi_CommittedAndUncommittedBorrowingFacilities_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommittedBorrowingFacilities" xlink:label="loc_ogi_CommittedBorrowingFacilities_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InitiallyDrawnAmount" xlink:label="loc_ogi_InitiallyDrawnAmount_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_22"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter" xlink:label="loc_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_23"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsCashInterestRate" xlink:label="loc_ogi_BorrowingsCashInterestRate_24"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsEffectiveInterestRate" xlink:label="loc_ogi_BorrowingsEffectiveInterestRate_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsReducedCashInterestRate" xlink:label="loc_ogi_BorrowingsReducedCashInterestRate_26"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsReducedEffectiveInterestRate" xlink:label="loc_ogi_BorrowingsReducedEffectiveInterestRate_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-full_OtherFinanceCost_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_29"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ApplicableMarginRate" xlink:label="loc_ogi_ApplicableMarginRate_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_31"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_QuarterlyRepayments" xlink:label="loc_ogi_QuarterlyRepayments_32"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReductionInRevolverCommitment" xlink:label="loc_ogi_ReductionInRevolverCommitment_33"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumUnrestrictedCashBalanceRequirement" xlink:label="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_34"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_FccRealPropertyLoanRefinancedWithBmoTermLoanTwoMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ogi_CreditFacilitiesAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilitiesAxis_5" xlink:to="loc_ogi_CreditFacilitiesDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilitiesDomain_5" xlink:to="loc_ogi_TermLoanMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilitiesDomain_5" xlink:to="loc_ogi_RevolvingCreditFacilitiesMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ogi_CreditFacilityAmendmentAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilityAmendmentAxis_9" xlink:to="loc_ogi_CreditFacilityAmendmentDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_9" xlink:to="loc_ogi_FirstAmendmentMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_9" xlink:to="loc_ogi_SecondAmendmentMember_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_9" xlink:to="loc_ogi_AmendmentAndRestatementMember_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ifrs-full_Borrowings_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_IncrementalUncommittedOptionToIncreaseFacilities_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_CommittedAndUncommittedBorrowingFacilities_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_CommittedBorrowingFacilities_20" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_InitiallyDrawnAmount_21" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ifrs-full_BorrowingsInterestRate_22" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter_23" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_BorrowingsCashInterestRate_24" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_BorrowingsEffectiveInterestRate_25" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_BorrowingsReducedCashInterestRate_26" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_BorrowingsReducedEffectiveInterestRate_27" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ifrs-full_OtherFinanceCost_28" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_29" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_ApplicableMarginRate_30" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_31" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_QuarterlyRepayments_32" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_ReductionInRevolverCommitment_33" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_14" xlink:to="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_34" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SHARECAPITALDetails8">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesMember" xlink:label="loc_ogi_ConvertibleDebenturesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember" xlink:label="loc_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember" xlink:label="loc_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RestrictedStockUnitsMember" xlink:label="loc_ogi_RestrictedStockUnitsMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityFinancingMember" xlink:label="loc_ogi_EquityFinancingMember_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PerformanceShareUnitsMember" xlink:label="loc_ogi_PerformanceShareUnitsMember_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_StockOptionPlanMember" xlink:label="loc_ogi_StockOptionPlanMember_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityIncentivePlanMember" xlink:label="loc_ogi_EquityIncentivePlanMember_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SalesOfStockAxis" xlink:label="loc_ogi_SalesOfStockAxis_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SalesOfStockDomain" xlink:label="loc_ogi_SalesOfStockDomain_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionInExchangeForTrademarkLicensingAgreementMember" xlink:label="loc_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvisoryServicesAgreementMember" xlink:label="loc_ogi_AdvisoryServicesAgreementMember_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TgsInternationalLlcMember" xlink:label="loc_ogi_TgsInternationalLlcMember_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CannabisConsultantMember" xlink:label="loc_ogi_CannabisConsultantMember_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember" xlink:label="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_31"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfCommonSharesIssued" xlink:label="loc_ogi_NumberOfCommonSharesIssued_32"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityIssuancePricePerShare" xlink:label="loc_ogi_EquityIssuancePricePerShare_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_35"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NetProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ogi_NetProceedsFromIssueOfOrdinaryShares_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFeeAndCommissionExpense" xlink:label="loc_ifrs-full_OtherFeeAndCommissionExpense_37"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RegulatoryFees" xlink:label="loc_ogi_RegulatoryFees_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_39"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TrademarkLicensingAgreement" xlink:label="loc_ogi_TrademarkLicensingAgreement_40"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionsFeeCurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_41"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionFeeNoncurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_42"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizedToShareBasedCompensation" xlink:label="loc_ogi_AmortizedToShareBasedCompensation_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_46"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_47"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_49"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfEquityFinancingShares" xlink:label="loc_ogi_IssuanceOfEquityFinancingShares_50"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnitsIssuedInPeriodPricePerUnit" xlink:label="loc_ogi_UnitsIssuedInPeriodPricePerUnit_51"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsGranted" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_53"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExpiredOrReleased" xlink:label="loc_ogi_NumberOfWarrantsExpiredOrReleased_54"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_55"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExpired" xlink:label="loc_ogi_NumberOfWarrantsExpired_56"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfConvertibleDebenturesSold" xlink:label="loc_ogi_NumberOfConvertibleDebenturesSold_57"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PricePerConvertibleDebentureIssued" xlink:label="loc_ogi_PricePerConvertibleDebentureIssued_58"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_59"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing" xlink:label="loc_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_60"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxOnConvertibleDebentureFinancing" xlink:label="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_61"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebentureIssueCosts" xlink:label="loc_ogi_ConvertibleDebentureIssueCosts_62"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability" xlink:label="loc_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_63"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfSharesConversionOfDebentures" xlink:label="loc_ogi_IssuanceOfSharesConversionOfDebentures_64"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfDebenturesPricePerShare" xlink:label="loc_ogi_ConversionOfDebenturesPricePerShare_65"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_66"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares" xlink:label="loc_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_67"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_68"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_69"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_70"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_71"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_72"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueOfOptionsGranted" xlink:label="loc_ogi_FairValueOfOptionsGranted_73"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement" xlink:label="loc_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_74"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted" xlink:label="loc_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_75"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted" xlink:label="loc_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_76"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_5" xlink:to="loc_ifrs-full_BorrowingsByNameMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_5" xlink:to="loc_ogi_ConvertibleDebenturesMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_RestrictedStockUnitsMember_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_EquityFinancingMember_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_PerformanceShareUnitsMember_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_StockOptionPlanMember_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_EquityIncentivePlanMember_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ogi_SalesOfStockAxis_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SalesOfStockAxis_17" xlink:to="loc_ogi_SalesOfStockDomain_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SalesOfStockDomain_17" xlink:to="loc_ogi_TransactionInExchangeForTrademarkLicensingAgreementMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SalesOfStockDomain_17" xlink:to="loc_ogi_AdvisoryServicesAgreementMember_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_21" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_21" xlink:to="loc_ogi_TgsInternationalLlcMember_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_21" xlink:to="loc_ogi_CannabisConsultantMember_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_25" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_25" xlink:to="loc_ifrs-full_EquityMember_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_25" xlink:to="loc_ifrs-full_IssuedCapitalMember_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_25" xlink:to="loc_ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_NumberOfSharesIssued_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_IssuedCapital_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_NumberOfCommonSharesIssued_32" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_EquityIssuancePricePerShare_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_34" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_35" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_NetProceedsFromIssueOfOrdinaryShares_36" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_OtherFeeAndCommissionExpense_37" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_RegulatoryFees_38" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_39" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_TrademarkLicensingAgreement_40" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_41" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_42" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_AmortizedToShareBasedCompensation_43" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_44" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_45" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_46" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_47" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_48" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_IssueOfEquity_49" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_IssuanceOfEquityFinancingShares_50" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_UnitsIssuedInPeriodPricePerUnit_51" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_52" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_53" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_NumberOfWarrantsExpiredOrReleased_54" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_55" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_NumberOfWarrantsExpired_56" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_NumberOfConvertibleDebenturesSold_57" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_PricePerConvertibleDebentureIssued_58" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_59" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing_60" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_DeferredTaxOnConvertibleDebentureFinancing_61" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_ConvertibleDebentureIssueCosts_62" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability_63" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_IssuanceOfSharesConversionOfDebentures_64" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_ConversionOfDebenturesPricePerShare_65" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_66" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares_67" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_68" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_69" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_70" order="410" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_71" order="420" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_72" order="430" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_FairValueOfOptionsGranted_73" order="440" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_MaximumNumberOfCommonSharesAuthorisedForShareBasedPaymentArrangement_74" order="450" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted_75" order="460" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_29" xlink:to="loc_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted_76" order="470" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/InvestmentsInAssociatesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesMember" xlink:label="loc_ogi_ConvertibleDebenturesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AlphaCannabisPharmaGmbhMember" xlink:label="loc_ogi_AlphaCannabisPharmaGmbhMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EvianaHealthCorporationMember" xlink:label="loc_ogi_EvianaHealthCorporationMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HyasynthBiologicalsIncMember" xlink:label="loc_ogi_HyasynthBiologicalsIncMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AchievementOfContractualProductionRelatedMilestoneMember" xlink:label="loc_ogi_AchievementOfContractualProductionRelatedMilestoneMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CapitalizedTransactionCostsAndEquityDiscount" xlink:label="loc_ogi_CapitalizedTransactionCostsAndEquityDiscount_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfSharesAcquired" xlink:label="loc_ogi_NumberOfSharesAcquired_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones" xlink:label="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_16"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueOfContingentShares" xlink:label="loc_ogi_FairValueOfContingentShares_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_18"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations" xlink:label="loc_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesReceivableFaceValue" xlink:label="loc_ogi_ConvertibleDebenturesReceivableFaceValue_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesConversionPrice" xlink:label="loc_ogi_ConvertibleDebenturesConversionPrice_22"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion" xlink:label="loc_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_23"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfConvertibleDebenturesSharesIssued" xlink:label="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_24"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConversionOfDebenturesDescription" xlink:label="loc_ogi_ConversionOfDebenturesDescription_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfSharePurchaseWarrantUnitsAcquired" xlink:label="loc_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_26"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit" xlink:label="loc_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_27"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion" xlink:label="loc_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_28"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateNumberOfCommonSharesConverted" xlink:label="loc_ogi_AggregateNumberOfCommonSharesConverted_29"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion" xlink:label="loc_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_30"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SharePurchaseWarrantExercisePricePerShare" xlink:label="loc_ogi_SharePurchaseWarrantExercisePricePerShare_31"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RightToPurchaseUpToAnnualCbdOil" xlink:label="loc_ogi_RightToPurchaseUpToAnnualCbdOil_32"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MaximumPercentageOfAnnualCbdOilPurchased" xlink:label="loc_ogi_MaximumPercentageOfAnnualCbdOilPurchased_33"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice" xlink:label="loc_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_34"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RecoverableAmountBasedOnValueInUse" xlink:label="loc_ogi_RecoverableAmountBasedOnValueInUse_35"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture" xlink:label="loc_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_36"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ImpairmentLossOfInvestmentsInAssociates" xlink:label="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_37"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate" xlink:label="loc_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_38"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months" xlink:label="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_39"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths" xlink:label="loc_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_40"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction" xlink:label="loc_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_41"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months" xlink:label="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_42"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears" xlink:label="loc_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_43"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdvanceGivenAsConvertibleDebentures" xlink:label="loc_ogi_AdvanceGivenAsConvertibleDebentures_44"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PotentialProportionOfOwnershipInterestInAssociate" xlink:label="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_45"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_ConvertibleDebenturesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4" xlink:to="loc_ogi_AlphaCannabisPharmaGmbhMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4" xlink:to="loc_ogi_EvianaHealthCorporationMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4" xlink:to="loc_ogi_HyasynthBiologicalsIncMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9" xlink:to="loc_ifrs-full_NonadjustingEventsMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_9" xlink:to="loc_ogi_AchievementOfContractualProductionRelatedMilestoneMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_CapitalizedTransactionCostsAndEquityDiscount_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_NumberOfSharesAcquired_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ifrs-full_PurchaseOfInterestsInAssociates_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_FairValueOfContingentShares_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_UnrealizedLossOnChangesInFairValueOfContingentConsideration_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_ConvertibleDebenturesReceivableFaceValue_20" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ifrs-full_BorrowingsInterestRate_21" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_ConvertibleDebenturesConversionPrice_22" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion_23" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_ConversionOfConvertibleDebenturesSharesIssued_24" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_ConversionOfDebenturesDescription_25" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_NumberOfSharePurchaseWarrantUnitsAcquired_26" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_SharePurchaseWarrantConvertedInToNumberOfCommonSharesPerUnit_27" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion_28" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_AggregateNumberOfCommonSharesConverted_29" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion_30" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_SharePurchaseWarrantExercisePricePerShare_31" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_RightToPurchaseUpToAnnualCbdOil_32" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_MaximumPercentageOfAnnualCbdOilPurchased_33" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice_34" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_RecoverableAmountBasedOnValueInUse_35" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_PercentageOfDiscountRateToForecastInterestAndPrincipalPaymentsOfConvertibleDebenture_36" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_37" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_PotentialChangeInImpairmentLossDueToChangeInDiscountRate_38" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months_39" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths_40" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction_41" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin36Months_42" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears_43" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_AdvanceGivenAsConvertibleDebentures_44" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_12" xlink:to="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_45" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EvianaHealthCorporationMember" xlink:label="loc_ogi_EvianaHealthCorporationMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AlphaCannabisPharmaGmbhMember" xlink:label="loc_ogi_AlphaCannabisPharmaGmbhMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RestrictedStockUnitsMember" xlink:label="loc_ogi_RestrictedStockUnitsMember_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PerformanceShareUnitsMember" xlink:label="loc_ogi_PerformanceShareUnitsMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement" xlink:label="loc_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:label="loc_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_16"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel" xlink:label="loc_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_17"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NumberOfWarrantsExpiredOrReleased" xlink:label="loc_ogi_NumberOfWarrantsExpiredOrReleased_18"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_EvianaHealthCorporationMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_AlphaCannabisPharmaGmbhMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_8" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_RestrictedStockUnitsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_8" xlink:to="loc_ogi_PerformanceShareUnitsMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ogi_NumberOfWarrantsExpiredOrReleased_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ifrs-full_RevenueFromInterest_20" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_12" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_21" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/CAPITALMANAGEMENTDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CapitalManagementAbstract" xlink:label="loc_ogi_CapitalManagementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CapitalConsideration" xlink:label="loc_ogi_CapitalConsideration_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CapitalManagementAbstract_0" xlink:to="loc_ogi_CapitalConsideration_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WorkingCapital" xlink:label="loc_ogi_WorkingCapital_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor" xlink:label="loc_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChangeInBenchmarkInterestRates" xlink:label="loc_ogi_ChangeInBenchmarkInterestRates_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_NotionalAmount_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_Cash_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ogi_WorkingCapital_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_ContractualCapitalCommitments_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_AuthorisedCapitalCommitmentsButNotContractedFor_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ogi_ChangeInBenchmarkInterestRates_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_ValueAtRisk_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/RevenueNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReclassificationOfSalesReturnsToGrossRevenue" xlink:label="loc_ogi_ReclassificationOfSalesReturnsToGrossRevenue_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InformationAboutMajorCustomers" xlink:label="loc_ifrs-full_InformationAboutMajorCustomers_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_0" xlink:to="loc_ogi_ReclassificationOfSalesReturnsToGrossRevenue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_0" xlink:to="loc_ifrs-full_InformationAboutMajorCustomers_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/LicensingAndEndorsementAgreementNarrativeDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementAbstract" xlink:label="loc_ogi_LicensingAndEndorsementAgreementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementTable" xlink:label="loc_ogi_LicensingAndEndorsementAgreementTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsAxis" xlink:label="loc_ogi_TypeOfArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TypeOfArrangementsDomain" xlink:label="loc_ogi_TypeOfArrangementsDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementMember" xlink:label="loc_ogi_LicensingAndEndorsementAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SwearNetLimitedMember" xlink:label="loc_ogi_SwearNetLimitedMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LicensingAndEndorsementAgreementLineItems" xlink:label="loc_ogi_LicensingAndEndorsementAgreementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServices_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RoyaltyPaymentPercentage" xlink:label="loc_ogi_RoyaltyPaymentPercentage_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizedToShareBasedCompensation" xlink:label="loc_ogi_AmortizedToShareBasedCompensation_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmortizedToSellingAndMarketingExpenses" xlink:label="loc_ogi_AmortizedToSellingAndMarketingExpenses_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionsFeeCurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent" xlink:label="loc_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CashPaymentAndStockOptionFeeNoncurrent" xlink:label="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementAbstract_0" xlink:to="loc_ogi_LicensingAndEndorsementAgreementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementTable_1" xlink:to="loc_ogi_TypeOfArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_TypeOfArrangementsAxis_1" xlink:to="loc_ogi_TypeOfArrangementsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_TypeOfArrangementsDomain_1" xlink:to="loc_ogi_LicensingAndEndorsementAgreementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_4" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" xlink:to="loc_ogi_SwearNetLimitedMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementTable_1" xlink:to="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ifrs-full_PaymentsToSuppliersForGoodsAndServices_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ogi_RoyaltyPaymentPercentage_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ogi_AmortizedToShareBasedCompensation_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ogi_AmortizedToSellingAndMarketingExpenses_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ogi_CashPaymentAndStockOptionsFeeCurrent_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_LicensingAndEndorsementAgreementLineItems_7" xlink:to="loc_ogi_CashPaymentAndStockOptionFeeNoncurrent_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSDetails4">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VivoCannabisIncMember" xlink:label="loc_ogi_VivoCannabisIncMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProportionOfOwnershipInterestInSubsidiarySold" xlink:label="loc_ogi_ProportionOfOwnershipInterestInSubsidiarySold_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInstrumentsHeld" xlink:label="loc_ifrs-full_EquityInstrumentsHeld_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquityInstrumentsHeldSharePrice" xlink:label="loc_ogi_EquityInstrumentsHeldSharePrice_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_TraumaHealingCentersMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_VivoCannabisIncMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_5" xlink:to="loc_ogi_ProportionOfOwnershipInterestInSubsidiarySold_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_5" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_5" xlink:to="loc_ifrs-full_EquityInstrumentsHeld_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_5" xlink:to="loc_ogi_EquityInstrumentsHeldSharePrice_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SubsequentEventsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EventsAfterReportingPeriodMember" xlink:label="loc_ogi_EventsAfterReportingPeriodMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HyasynthBiologicalsIncMember" xlink:label="loc_ogi_HyasynthBiologicalsIncMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnderwritersMember" xlink:label="loc_ogi_UnderwritersMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesAxis" xlink:label="loc_ogi_CreditFacilitiesAxis_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilitiesDomain" xlink:label="loc_ogi_CreditFacilitiesDomain_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TermLoanMember" xlink:label="loc_ogi_TermLoanMember_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RevolvingCreditFacilitiesMember" xlink:label="loc_ogi_RevolvingCreditFacilitiesMember_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentAxis" xlink:label="loc_ogi_CreditFacilityAmendmentAxis_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CreditFacilityAmendmentDomain" xlink:label="loc_ogi_CreditFacilityAmendmentDomain_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SecondAmendmentMember" xlink:label="loc_ogi_SecondAmendmentMember_15"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AmendmentAndRestatementMember" xlink:label="loc_ogi_AmendmentAndRestatementMember_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NotesAndDebenturesIssued_19"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConvertibleDebenturesReceivableFaceValue" xlink:label="loc_ogi_ConvertibleDebenturesReceivableFaceValue_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PotentialProportionOfOwnershipInterestInAssociate" xlink:label="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_21"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssuanceOfEquityFinancingShares" xlink:label="loc_ogi_IssuanceOfEquityFinancingShares_22"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnitsIssuedInPeriodPricePerUnit" xlink:label="loc_ogi_UnitsIssuedInPeriodPricePerUnit_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_24"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WeightedAverageExercisePriceOfWarrantsGranted" xlink:label="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_25"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommittedBorrowingFacilities" xlink:label="loc_ogi_CommittedBorrowingFacilities_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_27"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_QuarterlyRepayments" xlink:label="loc_ogi_QuarterlyRepayments_28"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReductionInRevolverCommitment" xlink:label="loc_ogi_ReductionInRevolverCommitment_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_30"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumUnrestrictedCashBalanceRequirement" xlink:label="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities" xlink:label="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingCostsIncurred" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_33"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_ogi_EventsAfterReportingPeriodMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4" xlink:to="loc_ogi_HyasynthBiologicalsIncMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4" xlink:to="loc_ogi_UnderwritersMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_8" xlink:to="loc_ifrs-full_BorrowingsByNameMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_8" xlink:to="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ogi_CreditFacilitiesAxis_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilitiesAxis_11" xlink:to="loc_ogi_CreditFacilitiesDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilitiesDomain_11" xlink:to="loc_ogi_TermLoanMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilitiesDomain_11" xlink:to="loc_ogi_RevolvingCreditFacilitiesMember_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ogi_CreditFacilityAmendmentAxis_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilityAmendmentAxis_15" xlink:to="loc_ogi_CreditFacilityAmendmentDomain_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_15" xlink:to="loc_ogi_SecondAmendmentMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_CreditFacilityAmendmentDomain_15" xlink:to="loc_ogi_AmendmentAndRestatementMember_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ifrs-full_NotesAndDebenturesIssued_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_ConvertibleDebenturesReceivableFaceValue_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_PotentialProportionOfOwnershipInterestInAssociate_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_IssuanceOfEquityFinancingShares_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_UnitsIssuedInPeriodPricePerUnit_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_WeightedAverageExercisePriceOfWarrantsGranted_25" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_CommittedBorrowingFacilities_26" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_27" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_QuarterlyRepayments_28" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_ReductionInRevolverCommitment_29" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_30" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ogi_MinimumUnrestrictedCashBalanceRequirement_31" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_32" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_19" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_33" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OfficeEquipmentMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_VehiclesMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_9" xlink:to="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_9" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentAbstract" xlink:label="loc_ogi_ShortTermInvestmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShortTermInvestmentsTable" xlink:label="loc_ogi_DisclosureOfShortTermInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentsAxis" xlink:label="loc_ogi_ShortTermInvestmentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShortTermInvestmentsDomain" xlink:label="loc_ogi_ShortTermInvestmentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesOneMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesOneMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesTwoMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesThreeMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesFourMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesFourMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GuaranteedInvestmentCertificatesFiveMember" xlink:label="loc_ogi_GuaranteedInvestmentCertificatesFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EquitySecuritiesInVivoCannabisIncMember" xlink:label="loc_ogi_EquitySecuritiesInVivoCannabisIncMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShortTermInvestmentsLineItems" xlink:label="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InvestmentsInterestRate" xlink:label="loc_ogi_InvestmentsInterestRate_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentHeldtomaturityInvestments" xlink:label="loc_ifrs-full_CurrentHeldtomaturityInvestments_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentAbstract_0" xlink:to="loc_ogi_DisclosureOfShortTermInvestmentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsTable_1" xlink:to="loc_ogi_ShortTermInvestmentsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentsAxis_1" xlink:to="loc_ogi_ShortTermInvestmentsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesOneMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesTwoMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesThreeMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesFourMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_GuaranteedInvestmentCertificatesFiveMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ShortTermInvestmentsDomain_1" xlink:to="loc_ogi_EquitySecuritiesInVivoCannabisIncMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsTable_1" xlink:to="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_9" xlink:to="loc_ogi_InvestmentsInterestRate_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShortTermInvestmentsLineItems_9" xlink:to="loc_ifrs-full_CurrentHeldtomaturityInvestments_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAccountsReceivableDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AccountsReceivableAbstract" xlink:label="loc_ogi_AccountsReceivableAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HarmonizedSalesTaxesReceivable" xlink:label="loc_ogi_HarmonizedSalesTaxesReceivable_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GovernmentProgramsReceivable" xlink:label="loc_ogi_GovernmentProgramsReceivable_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProvisionForDoubtfulAccount" xlink:label="loc_ogi_ProvisionForDoubtfulAccount_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ifrs-full_TradeReceivables_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ogi_HarmonizedSalesTaxesReceivable_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ogi_GovernmentProgramsReceivable_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ogi_ProvisionForDoubtfulAccount_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AccountsReceivableAbstract_0" xlink:to="loc_ifrs-full_CurrentTradeReceivables_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsByGroupAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByGroupAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsGroupMember" xlink:label="loc_ifrs-full_BiologicalAssetsGroupMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherBiologicalAssetsMember" xlink:label="loc_ogi_OtherBiologicalAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlantsMember" xlink:label="loc_ifrs-full_PlantsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsBiologicalAssets" xlink:label="loc_ifrs-full_DisposalsBiologicalAssets_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_1" xlink:to="loc_ifrs-full_BiologicalAssetsByGroupAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BiologicalAssetsByGroupAxis_1" xlink:to="loc_ifrs-full_BiologicalAssetsGroupMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BiologicalAssetsGroupMember_1" xlink:to="loc_ogi_OtherBiologicalAssetsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BiologicalAssetsGroupMember_1" xlink:to="loc_ifrs-full_PlantsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_5" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_5" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_5" xlink:to="loc_ifrs-full_DisposalsBiologicalAssets_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_5" xlink:to="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems_5" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AverageSellingPriceInputValuesPerGram" xlink:label="loc_ogi_AverageSellingPriceInputValuesPerGram_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AverageYieldPerPlantInputValuesPerGram" xlink:label="loc_ogi_AverageYieldPerPlantInputValuesPerGram_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram" xlink:label="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram" xlink:label="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EffectOnFairValueAverageNetSellingPricePerGram" xlink:label="loc_ogi_EffectOnFairValueAverageNetSellingPricePerGram_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EffectOnFairValueAverageYieldPerPlant" xlink:label="loc_ogi_EffectOnFairValueAverageYieldPerPlant_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_AverageSellingPriceInputValuesPerGram_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_AverageYieldPerPlantInputValuesPerGram_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_EffectOnFairValueAverageNetSellingPricePerGram_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_EffectOnFairValueAverageYieldPerPlant_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RealizedFairValueAmountsIncludedInInventorySold" xlink:label="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets" xlink:label="loc_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentToNetRealizableValueBiologicalAssets" xlink:label="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_RealizedFairValueAmountsIncludedInInventorySold_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ogi_AdjustmentToNetRealizableValueBiologicalAssets_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutInventoriesDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesAbstract" xlink:label="loc_ogi_InventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesTable" xlink:label="loc_ogi_InventoriesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtCostMember" xlink:label="loc_ifrs-full_AtCostMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PlantsInDryingStageMember" xlink:label="loc_ogi_PlantsInDryingStageMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisMember" xlink:label="loc_ogi_DryCannabisMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisAvailableForPackagingMember" xlink:label="loc_ogi_DryCannabisAvailableForPackagingMember_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DryCannabisPackagedInventoryMember" xlink:label="loc_ogi_DryCannabisPackagedInventoryMember_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FlowerAndTrimAvailableForExtractionMember" xlink:label="loc_ogi_FlowerAndTrimAvailableForExtractionMember_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ConcentratedExtractMember" xlink:label="loc_ogi_ConcentratedExtractMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FormulatedExtractsMember" xlink:label="loc_ogi_FormulatedExtractsMember_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesLineItems" xlink:label="loc_ogi_InventoriesLineItems_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPackagingAndStorageMaterials" xlink:label="loc_ifrs-full_CurrentPackagingAndStorageMaterials_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesAbstract_0" xlink:to="loc_ogi_InventoriesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesTable_1" xlink:to="loc_ifrs-full_MeasurementAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1" xlink:to="loc_ifrs-full_AtCostMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1" xlink:to="loc_ifrs-full_AtFairValueMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesTable_1" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_5" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_5" xlink:to="loc_ogi_PlantsInDryingStageMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_5" xlink:to="loc_ogi_DryCannabisMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_5" xlink:to="loc_ogi_DryCannabisAvailableForPackagingMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_5" xlink:to="loc_ogi_DryCannabisPackagedInventoryMember_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_5" xlink:to="loc_ogi_FlowerAndTrimAvailableForExtractionMember_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_5" xlink:to="loc_ogi_ConcentratedExtractMember_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_5" xlink:to="loc_ogi_FormulatedExtractsMember_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesTable_1" xlink:to="loc_ogi_InventoriesLineItems_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesLineItems_14" xlink:to="loc_ifrs-full_WorkInProgress_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesLineItems_14" xlink:to="loc_ifrs-full_FinishedGoods_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesLineItems_14" xlink:to="loc_ifrs-full_CurrentPackagingAndStorageMaterials_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_InventoriesLineItems_14" xlink:to="loc_ifrs-full_Inventories_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrowingProcessingEquipmentMember" xlink:label="loc_ogi_GrowingProcessingEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_20"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncludedInAssetsForSale" xlink:label="loc_ogi_IncludedInAssetsForSale_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_22"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LandMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ConstructionInProgressMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ogi_GrowingProcessingEquipmentMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_RightofuseAssetsMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" xlink:to="loc_ifrs-full_CarryingAmountMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_18" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_19" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_20" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ogi_IncludedInAssetsForSale_21" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_13" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_22" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAdditionsOfPropertyPlantAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdditionsRelatedToIFRS16Leases" xlink:label="loc_ogi_AdditionsRelatedToIFRS16Leases_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment" xlink:label="loc_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ogi_AdditionsRelatedToIFRS16Leases_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentPropertyTable" xlink:label="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SupplyAgreementMember" xlink:label="loc_ogi_SupplyAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentPropertyLineItems" xlink:label="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ogi_SupplyAgreementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_LicencesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_ComputerSoftwareMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" xlink:to="loc_ifrs-full_CarryingAmountMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_6" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_6" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyTable_1" xlink:to="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10" xlink:to="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInvestmentPropertyLineItems_10" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfLongTermDebtDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" xlink:label="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VehicleLoansFiveYearTermMaturingJune172024Member" xlink:label="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredFinancingCosts" xlink:label="loc_ogi_DeferredFinancingCosts_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" xlink:to="loc_ogi_DeferredFinancingCosts_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" xlink:to="loc_ifrs-full_Borrowings_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" xlink:to="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" xlink:to="loc_ifrs-full_LongtermBorrowings_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfLongTermDebtParentheticalsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member" xlink:label="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member" xlink:label="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_VehicleLoansFiveYearTermMaturingJune172024Member" xlink:label="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BorrowingsYearAmortization" xlink:label="loc_ogi_BorrowingsYearAmortization_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_ogi_VehicleLoansFiveYearTermMaturingJune172024Member_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_1" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" xlink:to="loc_ifrs-full_BorrowingsInterestRate_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" xlink:to="loc_ogi_BorrowingsYearAmortization_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6" xlink:to="loc_ifrs-full_BorrowingsMaturity_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter" xlink:label="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_NotionalAmount_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted" xlink:label="loc_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfExpectedLifeOfWarrantsGranted" xlink:label="loc_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfExpectedVolatilityWarrantsGranted" xlink:label="loc_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpectedDividendAsPercentageWarrantsGranted" xlink:label="loc_ogi_ExpectedDividendAsPercentageWarrantsGranted_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DescriptionOfExpectedLifeOfWarrantsGranted_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DescriptionOfExpectedVolatilityWarrantsGranted_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_ExpectedDividendAsPercentageWarrantsGranted_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember" xlink:label="loc_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember" xlink:label="loc_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember" xlink:label="loc_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember" xlink:label="loc_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember" xlink:label="loc_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_8" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_8" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_8" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DescriptionOfForfeitureRateShareOptionsGranted" xlink:label="loc_ogi_DescriptionOfForfeitureRateShareOptionsGranted_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_5" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_5" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_5" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_5" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_5" xlink:to="loc_ogi_DescriptionOfForfeitureRateShareOptionsGranted_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingRsusDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RestrictedStockUnitsMember" xlink:label="loc_ogi_RestrictedStockUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_ogi_RestrictedStockUnitsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutLossPerShareDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares" xlink:label="loc_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageShares_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesAxis" xlink:label="loc_ogi_AntidilutiveSecuritiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesDomain" xlink:label="loc_ogi_AntidilutiveSecuritiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_StockOptionsMember" xlink:label="loc_ogi_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare" xlink:label="loc_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ogi_AntidilutiveSecuritiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AntidilutiveSecuritiesAxis_1" xlink:to="loc_ogi_AntidilutiveSecuritiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_AntidilutiveSecuritiesDomain_1" xlink:to="loc_ogi_StockOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_EarningsPerShareLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_4" xlink:to="loc_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AlphaCannabisPharmaGmbhMember" xlink:label="loc_ogi_AlphaCannabisPharmaGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EvianaHealthCorporationMember" xlink:label="loc_ogi_EvianaHealthCorporationMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_HyasynthBiologicalsIncMember" xlink:label="loc_ogi_HyasynthBiologicalsIncMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-full_InvestmentsInAssociates_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdditionsOfInvestmentInAssociates" xlink:label="loc_ogi_AdditionsOfInvestmentInAssociates_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TransactionCostsOfInvestmentInAssociates" xlink:label="loc_ogi_TransactionCostsOfInvestmentInAssociates_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DistributionsOfInvestmentInAssociates" xlink:label="loc_ogi_DistributionsOfInvestmentInAssociates_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ImpairmentLossOfInvestmentsInAssociates" xlink:label="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_12"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_EliminationOfProportionateShareOfTransactionsWithAssociates" xlink:label="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-full_InvestmentsInAssociates_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_AlphaCannabisPharmaGmbhMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_EvianaHealthCorporationMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_1" xlink:to="loc_ogi_HyasynthBiologicalsIncMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ifrs-full_InvestmentsInAssociates_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ogi_AdditionsOfInvestmentInAssociates_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ogi_TransactionCostsOfInvestmentInAssociates_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ogi_DistributionsOfInvestmentInAssociates_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ogi_ImpairmentLossOfInvestmentsInAssociates_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_14" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_6" xlink:to="loc_ifrs-full_InvestmentsInAssociates_15" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReceivablesAxis" xlink:label="loc_ogi_ReceivablesAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReceivablesDomain" xlink:label="loc_ogi_ReceivablesDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ZeroToSixtyDaysMember" xlink:label="loc_ogi_ZeroToSixtyDaysMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SixtyOneToOneTwentyDaysMember" xlink:label="loc_ogi_SixtyOneToOneTwentyDaysMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TradeReceivablesGross" xlink:label="loc_ogi_TradeReceivablesGross_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ProvisionForDoubtfulTradeReceivables" xlink:label="loc_ogi_ProvisionForDoubtfulTradeReceivables_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TradeReceivablesNet" xlink:label="loc_ogi_TradeReceivablesNet_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ogi_ReceivablesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ReceivablesAxis_1" xlink:to="loc_ogi_ReceivablesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ReceivablesDomain_1" xlink:to="loc_ogi_ZeroToSixtyDaysMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ReceivablesDomain_1" xlink:to="loc_ogi_SixtyOneToOneTwentyDaysMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" xlink:to="loc_ogi_TradeReceivablesGross_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" xlink:to="loc_ogi_ProvisionForDoubtfulTradeReceivables_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" xlink:to="loc_ogi_TradeReceivablesNet_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContractualCashFlowsMember" xlink:label="loc_ogi_ContractualCashFlowsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPayable" xlink:label="loc_ifrs-full_InterestPayable_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ogi_ContractualCashFlowsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_8" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_8" xlink:to="loc_ifrs-full_Borrowings_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_8" xlink:to="loc_ifrs-full_InterestPayable_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_8" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRevenuesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-full_ProductsAndServicesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdultUseRecreationalWholesaleRevenueMember" xlink:label="loc_ogi_AdultUseRecreationalWholesaleRevenueMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_WholesaleToLicensedProducersRevenueMember" xlink:label="loc_ogi_WholesaleToLicensedProducersRevenueMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DirectToPatientMedicalRevenueMember" xlink:label="loc_ogi_DirectToPatientMedicalRevenueMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InternationalBusinessToBusinessMember" xlink:label="loc_ogi_InternationalBusinessToBusinessMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherRevenueMember" xlink:label="loc_ogi_OtherRevenueMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossRevenue" xlink:label="loc_ogi_GrossRevenue_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExciseTaxesExpenses" xlink:label="loc_ogi_ExciseTaxesExpenses_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_1" xlink:to="loc_ifrs-full_ProductsAndServicesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_AdultUseRecreationalWholesaleRevenueMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_WholesaleToLicensedProducersRevenueMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_DirectToPatientMedicalRevenueMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_InternationalBusinessToBusinessMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_1" xlink:to="loc_ogi_OtherRevenueMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_8" xlink:to="loc_ogi_GrossRevenue_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_8" xlink:to="loc_ogi_ExciseTaxesExpenses_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_8" xlink:to="loc_ifrs-full_Revenue_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutComponentsOfDeferredIncomeTaxExpenseDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate" xlink:label="loc_ifrs-full_TaxEffectFromChangeInTaxRate_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChangeInUnrecognizedTemporaryDifferences" xlink:label="loc_ogi_ChangeInUnrecognizedTemporaryDifferences_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_TaxEffectFromChangeInTaxRate_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ogi_ChangeInUnrecognizedTemporaryDifferences_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DifferenceBetweenCurrentAndFutureTaxRates" xlink:label="loc_ogi_DifferenceBetweenCurrentAndFutureTaxRates_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized" xlink:label="loc_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_ApplicableTaxRate_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ogi_DifferenceBetweenCurrentAndFutureTaxRates_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllowanceForCreditLossesMember" xlink:label="loc_ifrs-full_AllowanceForCreditLossesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShareIssuanceCostsMember" xlink:label="loc_ogi_ShareIssuanceCostsMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PropertyPlantAndEquipmentsMember" xlink:label="loc_ogi_PropertyPlantAndEquipmentsMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherDeferredTaxAssetsMember" xlink:label="loc_ogi_OtherDeferredTaxAssetsMember_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LongTermAssetsMember" xlink:label="loc_ogi_LongTermAssetsMember_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BiologicalAssetMember" xlink:label="loc_ogi_BiologicalAssetMember_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryMember" xlink:label="loc_ogi_InventoryMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnsecuredConvertibleDebenturesMember" xlink:label="loc_ogi_UnsecuredConvertibleDebenturesMember_10"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherDeferredTaxLiabilitiesMember" xlink:label="loc_ogi_OtherDeferredTaxLiabilitiesMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_14"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SetOffOfDeferredTaxAssets" xlink:label="loc_ogi_SetOffOfDeferredTaxAssets_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_16"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxLiabilityAbstract" xlink:label="loc_ogi_DeferredTaxLiabilityAbstract_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_18"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SetOffOfDeferredTaxLiabilities" xlink:label="loc_ogi_SetOffOfDeferredTaxLiabilities_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_AllowanceForCreditLossesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_ShareIssuanceCostsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_PropertyPlantAndEquipmentsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_OtherDeferredTaxAssetsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_LongTermAssetsMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_BiologicalAssetMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_InventoryMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_RightofuseAssetsMember_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_UnsecuredConvertibleDebenturesMember_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_OtherDeferredTaxLiabilitiesMember_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_14" xlink:to="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_14" xlink:to="loc_ifrs-full_DeferredTaxAssets_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_14" xlink:to="loc_ogi_SetOffOfDeferredTaxAssets_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_14" xlink:to="loc_ifrs-full_NetDeferredTaxAssets_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_14" xlink:to="loc_ogi_DeferredTaxLiabilityAbstract_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DeferredTaxLiabilityAbstract_18" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DeferredTaxLiabilityAbstract_18" xlink:to="loc_ogi_SetOffOfDeferredTaxLiabilities_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DeferredTaxLiabilityAbstract_18" xlink:to="loc_ifrs-full_NetDeferredTaxLiabilities_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllowanceForCreditLossesMember" xlink:label="loc_ifrs-full_AllowanceForCreditLossesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ShareIssuanceCostsMember" xlink:label="loc_ogi_ShareIssuanceCostsMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PropertyPlantAndEquipmentsMember" xlink:label="loc_ogi_PropertyPlantAndEquipmentsMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_BiologicalAssetMember" xlink:label="loc_ogi_BiologicalAssetMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoryMember" xlink:label="loc_ogi_InventoryMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnsecuredConvertibleDebenturesMember" xlink:label="loc_ogi_UnsecuredConvertibleDebenturesMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract" xlink:label="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome" xlink:label="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_AllowanceForCreditLossesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_ShareIssuanceCostsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_PropertyPlantAndEquipmentsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_BiologicalAssetMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_InventoryMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_RightofuseAssetsMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ogi_UnsecuredConvertibleDebenturesMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_12" xlink:to="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_12" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_12" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_12" xlink:to="loc_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_12" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodAxis" xlink:label="loc_ogi_ExpirationPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodDomain" xlink:label="loc_ogi_ExpirationPeriodDomain_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearOneMember" xlink:label="loc_ogi_ExpirationPeriodYearOneMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearTwoMember" xlink:label="loc_ogi_ExpirationPeriodYearTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearThreeMember" xlink:label="loc_ogi_ExpirationPeriodYearThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearFourMember" xlink:label="loc_ogi_ExpirationPeriodYearFourMember_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ExpirationPeriodYearFiveMember" xlink:label="loc_ogi_ExpirationPeriodYearFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome" xlink:label="loc_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ogi_ExpirationPeriodAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ExpirationPeriodAxis_1" xlink:to="loc_ogi_ExpirationPeriodDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearOneMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearTwoMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearThreeMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearFourMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_ExpirationPeriodDomain_1" xlink:to="loc_ogi_ExpirationPeriodYearFiveMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_8" xlink:to="loc_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised" xlink:label="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-full_TravelExpense_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UtilitiesExpense" xlink:label="loc_ifrs-full_UtilitiesExpense_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_WagesAndSalaries_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_TravelExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_UtilitiesExpense_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GrossMarginFromDiscontinuedOperations" xlink:label="loc_ogi_GrossMarginFromDiscontinuedOperations_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_13"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LossOnRemeasurementToFairValueLessCostsToSell" xlink:label="loc_ogi_LossOnRemeasurementToFairValueLessCostsToSell_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_TraumaHealingCentersMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ifrs-full_ProfitLossAbstract_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_4" xlink:to="loc_ifrs-full_Revenue_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_4" xlink:to="loc_ifrs-full_CostOfSales_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_4" xlink:to="loc_ogi_GrossMarginFromDiscontinuedOperations_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_4" xlink:to="loc_ifrs-full_ExpenseByNatureAbstract_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_ExpenseByNature_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_4" xlink:to="loc_ifrs-full_FinanceIncome_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_4" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_4" xlink:to="loc_ogi_LossOnRemeasurementToFairValueLessCostsToSell_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_TraumaHealingCentersMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDerecognizedAssetsAndLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract" xlink:label="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersTable" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_TraumaHealingCentersMember" xlink:label="loc_ogi_TraumaHealingCentersMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperationsOfTraumaHealingCentersLineItems" xlink:label="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesCash" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesCash_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesGoodwill" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed" xlink:label="loc_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsOnDisposalsOfInvestments_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract_0" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_1" xlink:to="loc_ogi_TraumaHealingCentersMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersTable_1" xlink:to="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesCash_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesGoodwill_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_OperationsOfTraumaHealingCentersLineItems_4" xlink:to="loc_ifrs-full_GainsOnDisposalsOfInvestments_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SignificantAccountingPoliciesTable" xlink:label="loc_ogi_SignificantAccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentOnAdoptionOfIFRS16Member" xlink:label="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SignificantAccountingPoliciesLineItems" xlink:label="loc_ogi_SignificantAccountingPoliciesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OperatingLeaseObligations" xlink:label="loc_ogi_OperatingLeaseObligations_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MinimumFuturePaymentsNotRelatedToLeasePayments" xlink:label="loc_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated" xlink:label="loc_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_6"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReliefOptionForShortTermLeases" xlink:label="loc_ogi_ReliefOptionForShortTermLeases_7"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReliefOptionForLeasesOfLowValueAssets" xlink:label="loc_ogi_ReliefOptionForLeasesOfLowValueAssets_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DiscountingOperatingLease" xlink:label="loc_ogi_DiscountingOperatingLease_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ogi_SignificantAccountingPoliciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" xlink:to="loc_ifrs-full_RestatedMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_1" xlink:to="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesTable_1" xlink:to="loc_ogi_SignificantAccountingPoliciesLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_4" xlink:to="loc_ogi_OperatingLeaseObligations_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_4" xlink:to="loc_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_4" xlink:to="loc_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_4" xlink:to="loc_ogi_ReliefOptionForShortTermLeases_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_4" xlink:to="loc_ogi_ReliefOptionForLeasesOfLowValueAssets_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_4" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_4" xlink:to="loc_ogi_DiscountingOperatingLease_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_SignificantAccountingPoliciesLineItems_4" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_OtherLiabilitiesMember" xlink:label="loc_ogi_OtherLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PrepaidExpensesMember" xlink:label="loc_ogi_PrepaidExpensesMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption" xlink:label="loc_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_ogi_OtherLiabilitiesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_ogi_PrepaidExpensesMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_6" xlink:to="loc_ifrs-full_RightofuseAssets_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_6" xlink:to="loc_ifrs-full_LeaseLiabilities_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_6" xlink:to="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_6" xlink:to="loc_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_MonctonCampusPhase4CAssetSpecificMember" xlink:label="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ReclassificationOfComputerSoftware" xlink:label="loc_ogi_ReclassificationOfComputerSoftware_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_FairValueLessCostToDispose" xlink:label="loc_ogi_FairValueLessCostToDispose_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_11"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContractuallyCommittedFutureCosts" xlink:label="loc_ogi_ContractuallyCommittedFutureCosts_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ogi_MonctonCampusPhase4CAssetSpecificMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_4" xlink:to="loc_ifrs-full_CarryingAmountMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_4" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_4" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8" xlink:to="loc_ogi_ReclassificationOfComputerSoftware_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8" xlink:to="loc_ogi_FairValueLessCostToDispose_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8" xlink:to="loc_ifrs-full_ImpairmentLoss_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8" xlink:to="loc_ogi_ContractuallyCommittedFutureCosts_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SHARECAPITALPerformanceShareUnits">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfShareCapitalInformationAbstract" xlink:label="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PerformanceShareUnitsMember" xlink:label="loc_ogi_PerformanceShareUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfShareCapitalInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_ogi_PerformanceShareUnitsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/COSTOFSALESDetailTextuals">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfCostOfSalesAbstract" xlink:label="loc_ogi_DisclosureOfCostOfSalesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IndirectProductionCostOfSale" xlink:label="loc_ogi_IndirectProductionCostOfSale_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue" xlink:label="loc_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChargesRelatedToReducedWorkforce" xlink:label="loc_ogi_ChargesRelatedToReducedWorkforce_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChargesRelatedToPlantCulling" xlink:label="loc_ogi_ChargesRelatedToPlantCulling_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers" xlink:label="loc_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_5"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ChargesForUnabsorbedFixedOverhead" xlink:label="loc_ogi_ChargesForUnabsorbedFixedOverhead_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfCostOfSalesAbstract_0" xlink:to="loc_ogi_IndirectProductionCostOfSale_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfCostOfSalesAbstract_0" xlink:to="loc_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfCostOfSalesAbstract_0" xlink:to="loc_ogi_ChargesRelatedToReducedWorkforce_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfCostOfSalesAbstract_0" xlink:to="loc_ogi_ChargesRelatedToPlantCulling_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfCostOfSalesAbstract_0" xlink:to="loc_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfCostOfSalesAbstract_0" xlink:to="loc_ogi_ChargesForUnabsorbedFixedOverhead_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/COSTOFSALES">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfCostOfSalesAbstract" xlink:label="loc_ogi_DisclosureOfCostOfSalesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfCostOfSalesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/GOVERNMENTSUBSIDIES">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GovernmentSubsidiesAbstract" xlink:label="loc_ogi_GovernmentSubsidiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_GovernmentSubsidiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/GOVERNMENTSUBSIDIESDetailTextuals">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_GovernmentSubsidiesAbstract" xlink:label="loc_ogi_GovernmentSubsidiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy" xlink:label="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IncomeFromGovernmentSubsidies" xlink:label="loc_ogi_IncomeFromGovernmentSubsidies_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_GovernmentSubsidiesAbstract_0" xlink:to="loc_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_GovernmentSubsidiesAbstract_0" xlink:to="loc_ogi_IncomeFromGovernmentSubsidies_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIESDetails1">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOtherLiabilitiesAbstract" xlink:label="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdjustmentOnAdoptionOfIFRS16Member" xlink:label="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_4"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_AdditionsToLeaseLiabilities" xlink:label="loc_ogi_AdditionsToLeaseLiabilities_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_1" xlink:to="loc_ifrs-full_RestatedMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_1" xlink:to="loc_ogi_AdjustmentOnAdoptionOfIFRS16Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_4" xlink:to="loc_ifrs-full_LeaseLiabilitiesAbstract_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_4" xlink:to="loc_ifrs-full_LeaseLiabilities_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_4" xlink:to="loc_ogi_AdditionsToLeaseLiabilities_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_4" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_4" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_4" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_4" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIESDetails">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOtherLiabilitiesAbstract" xlink:label="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_ContingentShareConsideration" xlink:label="loc_ogi_ContingentShareConsideration_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ogi_ContingentShareConsideration_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIESDetailTextuals">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOtherLiabilitiesAbstract" xlink:label="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones" xlink:label="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration" xlink:label="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_2"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_SubleaseAnnualRentalIncome" xlink:label="loc_ogi_SubleaseAnnualRentalIncome_3"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_RentalIncomeOverSubleaseTerm" xlink:label="loc_ogi_RentalIncomeOverSubleaseTerm_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ogi_SubleaseAnnualRentalIncome_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ogi_RentalIncomeOverSubleaseTerm_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIES">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOtherLiabilitiesAbstract" xlink:label="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIESTables">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOtherLiabilitiesAbstract" xlink:label="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory" xlink:label="loc_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/OTHERLIABILITIESDetails2">
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_DisclosureOfOtherLiabilitiesAbstract" xlink:label="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_UndiscountedOperatingLeasePaymentsToBePaid" xlink:label="loc_ogi_UndiscountedOperatingLeasePaymentsToBePaid_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ogi_DisclosureOfOtherLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_9" xlink:to="loc_ogi_UndiscountedOperatingLeasePaymentsToBePaid_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="ogi-20200831.xsd#ogi_IssueCostAtMarketEquityFinancing" xlink:label="loc_ogi_IssueCostAtMarketEquityFinancing_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ogi_IssueCostAtMarketEquityFinancing_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.organigram.ca/role/SUBSEQUENTEVENTS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>exhibit99-4xu001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-4xu001.jpg
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M:KT'XT-$&;)Y]J?2$T@ # Z8%(J!.@IV:3G- P('7'-!]J4C--9PO4@4 *2
M,DX%0@M*^"05'.*5AYQ&!A?4T]QMVD=!Q3$/P/0?E1112&-W_P"R?RIK-AE.
MT^E24WJ_L/YTQ!O_ -DT;S_=-.HI -WG^X:-Y_N&G44QC-[?W#37<X!VD8-2
MTUN64?B: $WM_<-&\_W#3Z* &;V_N&C>?[AI]%(!F\_W#07S_ WY4^D8X!/I
M3$,1R$'RL?<4OF?[#?E2H,(![4Z@!GF?[+?E1YG^RWY4^B@8SS1_=;\J/-'H
MWY4^B@1%Y@#]#@^U.\T>A_*A?F<GL.!3Z &>:OO^5'FK[_E3Z*0QGG+ZG\J/
M-0CK^E/I"=HR>U,"..55RI/ Z&G><G]ZB,9!8]6I^*!#/.3^]1YR?WJ?BC I
M ,\U/[PH\U#_ !"G8'H*" !T%,"-)%7*D\#H:=YJ?WA21KG+$=>GTI^!Z"@!
MOFI_>%'FI_>%.P/048'H* &^:A[TU)57Y<Y'8U(< 9(&*:BY)8CD]!Z"@ \Y
M/6CSD]:=@>@I<"C0"/ST]?TH\]/?\JDQ10!'YR^A_*FK*%)&#CM4I(49-(BG
MECU/Z4 -\[_9;\J/._V&_*I** (_,;_GF::[LR\H1CG.>E34QOWC8_A'6@!H
M>0@?)2YE]%J2B@"/]Z>ZBFN'"G+#'IBI68*,FFJI8[FZ]AZ4 ,6)]H^<CVIW
MDD]7-24C,%_PHN!&T2J.230L"XR1^'I3PISENOIZ4ZBX#!$@_A%#;4'09[ "
ME+\X7D_RH"A?F)R?4T -5"QW-^ ]*DSBH_,+<(,^YZ4"+/+G<?TH 4RCHH+'
MVIRDD<C%'"CL!418S'"\+W-  SF4[5Z=S39%Y"*,XZU.JA!@4R+EW/OB@"!4
M+$#UIZH57) (_E3@N8B1U!R*=O"X;LW44Q#4VL> *DSCC;BHGB#<IP?2E2;'
MROP?6@9)N';/U-&X#N"3[T!U8\$9I>OL:0PR.N11D'O1UH Q0 %@.XHR/44N
M!0*0"9!-&?K^5'O2T (#GG!H)..E'2ESF@!.?:@Y]:6B@!,4N!1THH *0D 9
M/2HC.0<%>?K3OG;(X6G80><N<*"Q]J0QF0Y8!?8=:<D04YZGUI] "8 P!Q0Z
M[E(H_B_"EI#*OG-ZT5/Y2T50AS' XZGI0!@8H [GK2U(PHHHH ****  G IJ
M#J3U-!^8X[#K3J "BBB@ HHHH *:_( ]33J:O))_ 4 .HHHH **** "FN<#C
MJ>!3J:OS'=^5 "J-H I:** "BBB@ IC?.VWL.32LVWIR3T%"+M&._<TQ#J**
M*0PHHHH *8_S$(/QIS-M'J>PI$7:.>2>M,0ZBBBD,***:Q/0=30 A^=L?PCK
M3Z0 *,"EH **** "BBF_?/\ L_SH 0?.<_PCI3Z** "BBFLV.!R: !FYVCJ?
MTI54*,"A5V^Y[FEH$%(S;1F@MC@<GTH"X.3R:!B!23N;KV'I3J*3)/3IZT !
M;L.30JXY/)]:4#%(3Z<F@!2<#)IIRW^R/UIK.%//S-Z"FX:0_,IQZ=*8AV\#
MY4&:41Y.7.X^G:@!\8 511L8]7/X<4 /Z4A=1U(J-HT498D_4U$4S@@8!. *
M+ 2?-.?1!4O"+P.!2@8&!TJ.7G"^M #D)*9/UIL ^3/J<TLK!8S^0I8_]6N/
M2@!L/W3]32+PQ7MG-+%PSCWI).'4^M,!P&#M//IFAHPPYY^M*XW+^(YI%STR
M012 B:(K[C]:55+'*OR.QJ;GZU'(A)#)PU,+ QER.!^%+YI'!4YH$N< _*?>
MI ,4@(EF&.05I3.HQW'M4E-51M' H 03)ZTAF4-@9/N*>5#=10!CL!0 SSE]
M_P J:)\GE3GVJ20E4)'44Q'\R0'T'-  TK'A5.?<4NZ0?PC\Z63C##MU^E/Z
MCVH A*.YS]W\:?Y0/5F/XT[I]*6BX#5C5>@I3PP/X4M(1D8I#%HI%.1[T-SQ
MZT "\C/K2T44 %%%% !112 @]#F@!:**.E !32<\#\32\M["E P*    8'2B
MBB@ HHHH ***0GL.O\J $/)VC\:=TI ,"EH **** "BBD)SP/Q- "'YSCMWI
MU &!@44 %%%% !2,VT9H) %( <Y/7T]* !5.<GJ?TIU%% !1110 4A(49-!(
M49-(!DY/X#TH %&3N/7L/2G444 %%%!.!0 C':*%&.3U-( 2<G\!3J!!1110
M,**"<"DQNZ]/2@!/O_[O\Z=110 44=*3EO84 !))P.OKZ4*H7_&D+*F!Z]A3
MB<4P"DSGI^=&,]>GI3'EQPN,^O84"'@8I<U&D@6,;FYHWLWW5X]30 YB ,L>
M/2HS,=X[+[T\1\Y8[C[TI5<Y(&?>@!OF[ON@M]*-KMU.T>@IV]?7\J-_H"?P
MH 54"=!2TW>?[AI-S?W/UH ?37<(,G\J8\Q3JO/UH2/)WOR?3TH %0R'<_X"
ME;F51Z#-24R/EF;U.* ']*C5LEI#TZ"ASN.P?4FE4;B#CY1T% $<BDC+=2<
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M+NU8]R@9?T.?TKH].\<:#JN/(U2#<>BR-Y9_)L5+A);HWC7I3VDC<=L+QU/
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MIG.VG@Y%% $:GRSM;[O8U)TI" PP>143JRJ0/F7]13$3'I1UID3Y&#PPIXI
M%)_$?I2TG>@8$9^OK1G'7\Z6B@ I,YZ<TA'S8'3TI0?P-, Y]J*6BD!\MA*>
M$J0)3PE>D?&V(@E."U*(Z<L>: L1JE2+'FI%CQBI HH*2(TCQUJ0+BG!<FI
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MQ7LM(RAU*L 0>H/>CG?4YY82#^'0\0"T\+7I.L^"+&^5I(!]DFZY0?*?J/\
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MR2?ZU3N\E2,"1.Q'45\M.HY-R9^ATJ:A%0CLC3TM[>WN[29$-Q:JV50=2O\
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MY0=OU&<5H!0HP*\U^ FN76I^#KBWOW+75E>21;-A!C0X=%/IPW3L,#M7I!E
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M/O0(=1110,*0G )I:3[S >E #HTSQ^=3J.:1(\"I57->36J<\C-ZL113PM*
M*>JDUSW$(!4J)FG)'TJ=$QVJ&QV&I'CFIE7BG(E3)$2*ALT41BI1<SK8V[2M
MUZ*/4U:6,+_C7-ZM??;+@A3^Z3A??WK6A3]M.SV6YJURHIR2-*[.QRS')-:7
MASG4A_N'^E91(49/2M/PLI?5-S?W#@?E7L5]*,O0B&LD=<H_*G@4JJ3T%3)'
M^=?+-GJ*(BKFIE7@4*M3)&2.E9M]S:,!JK4T<1-.2*IE6LG(Z5 15P,5E^+U
MQX<N_P#@/_H0K9 P.*Q_& _XIV[]/E_]"%:8?^-#U055^[EZ'F#KD<=1R*53
MN4'UI::ORN1V/(K[4^9'4444#$_B^HILQQ&:<>HILO(4>IIB' 8Q0<DX'XT$
M^G6E P*0P P,"BBB@ IJ_P"L?\*=34ZL?>F ZBBBD T?*<=CTIU(PR* <B@!
M:C/^M'L*<SA,9Z'O3"<N_L*:$2)]T4M%)G)P/SI# G''>E Q2 8I: &3'$9]
M^*<,* *CE8>8H/0<TGS%U8\9. *8B:H"K-NYS@]*GJ,_)*#V;C\:$ L;%EY&
M"*=C'2EHI#&MGJ!S3AT&.E%)]T^QH 6D%+2#J?K0 M%%% #?F]A6?XCT.'Q+
MH&I:3=$_9KZVDMI,?W74J?YUI44-75F--Q=T?D=XM\+W/AC7K_3I5.;65X&?
M'#%21D?B*Y.X@*R!QE6SU'7-?1/[4>FM;?%_Q'&8Q$'N!(,# (:)&S_X]7C5
MIH_VNY53]P$$D?6OB:M+V<VNQ^H4I>VIQGW29ZOX9U]-/\/:AHS@,ZZ4UQ@\
M'<%(/Z2-7HWPKLTQIVG2@M]HT]+NWD' \O)25<]L$$CZGO@'PBZOH]/\7IYQ
M/V>2W-M+_NLK _S%>U>$]2:W\&:-J" 32:)</;W'EGYI+290#CUVL,_\#KYW
M,DU>W7_+0^IRMJ2L]X_YGVE\./$+ZAITFCZLN_SH@\$C?QO$H20'W*=?J:^;
M#\+F^'/B/Q3=7Y6_:74)(=)7=]SS9&82,.^Q,#CNWM77Z*^I^&=5L'6:2]M;
MEUO[69B=LRD >8AY^\I*NN?O#/<%N_OO <^N^,VU*^96TU762.+<=Q.WD$=N
M:^=R[#8G$5)4L.KWM?RUW?8]K&U\'@;5\5*RLVO-KHN[9N>"[-K3PW9H(]BE
M%VJXQM155$&/]U03[DGO6XL(5LD\^U/50H    X %+7[;@L+'!8>&'C]E?>]
MV_O/Y]S+&RS'%U,5)6YGHNRV2^204445VGFA1110 4444 %! (P1D444 ,Y3
MIROI0ZK-$R]588I],?\ =_,/Q'K3W$<X8BCE3U!Q3U7%6;V/_26(& W(J(+B
MO/EHVC"UA%6G4H&:>L9-1<!N,]*<L=2*E2*E2V.PP)3PN*?M[4H3-3<+%FW.
M8A[5+44' (J6O2IN\$S9; >!34&%'OS0_(QZ\4ZM!A1110 $XJ6"/C<:9&AD
M< =.]7E3 'M7%B:O*N1=1,8J9-2!12@$].E2*GM7E-BL-6/-3)'BGI'[5.D>
M:EL:B,2,^E2JE/5*F2//:H<C6,!J1U.B<4J1XYI;B=+2W>63[JC/U]JC=V1T
M*)EZ]J'V6 0H?GDZG^ZM<[4ES.UW,\C\EC^55F8J-G\705]'0I*E#EZ]3EE*
M[N+_ *U_]A?U-;?A4;M5_P" '^E8ZJ% %;?A(9U;'_3-OZ4L3_!EZ%4E[Z.R
M5*E5">U/2+UJ94P.*^0<NQ[L8#4BQ[U,J8H44\"LVSI4;"KQ3@*5$)[5*D?<
M]:@T2&JGJ*R?&28\,WA_W/\ T(5O(G%8WC=,>&+S_@'_ *&*UP\OWT/5$UHV
MI2]&>44U^"#[TZD894BON3Y,6BD!R :6@!#VIAYE'HHS3SQ3(OFRWJ:8AX'?
MO2T44AA112,X7KU]!0 M-C^X/?FFMN())VC]:%)C49Y7U]*8B2BBBD,*3HWU
MI:0CB@!LPS&:8L95>#G.*E;E#[BF*<HE,0[:3]XY]J=112&%%%% #%B 8L>3
M22?>C^M/[TR3_6(/>F(DIKKO7%.H/2D,9&VX8/4=13NE0^;DA@,'O[U,K!AD
M4V(7.:",B@C-)R.^:0P!]>M"]_K36)ZA>:<OW13 6BBBD 452U36].T.'SM1
MO[73XO\ GI=3+&OYL17EGCW]JGX?>"=/E>#6K?7]0 (BLM+D$NYO]IQ\JCU)
M.?0&DVEN:0ISJ.T5<^>/VRC#-\6&55"LEC )".[?,<G\"M>&6"O)<I&@PNX<
M>IK>\:^/[[XD^*;_ %_48@;BZ8'8G"(H "J/8  5#HVI+ITZRFPCF*\@.Y']
M*^9Q4)SE*44?I> 4:5.$)O9(P/B'"T>NR%00?E.,>V?\:]?_ &>=5M]3M;C3
M9I 1-&89(F;;M/8Y]"/E)[?*>F2/.=9M3XEU1[ZY/DER,)'T  QCGKTKL? D
MUEX3NH[Z*#=/%M/7B0*<E2!_>P!D=*^?Q^%J5*#26OD>[@*\*.*O?W7W/J'X
M3:DMK?CP1K4;3"QG-WH]U-G?$AQNCSQP0>G3.?05[M7$^'_"6FZC/H?B.SE^
MT6[6WFPRGAF5P&3</7!!^OTKM=ON?SKT>%:#CAIUY1LYO\O^"?*\9XJ%7%TZ
M%.5U!;=FW_D+12;?<T8(Z'/U%?;'YZ+13=Q'5?RI0P;H: %HHHH **** "BD
M9@HYIN&?[W ]*!"ER3A>3Z]A0J8.3\S>M.  &!Q13 S;]-KJ*K!,UHWR953^
M%5ECK@K:3):(U0"I A-2!,5(%S7,Y!8B"5($J01\4\)4MCL1JGM3@GI4@C)J
M58L"I;#E(D3;3Z>Z87-,Z5Z6'=Z8]A.K?2EI!T]Z6ND8R5]B$CKVIRYVCUQ4
M,A\S)_ "KMA;O,^]AA%Z#U-14FJ<')@M66+>#RTYZGK5A8\]:E6*I5BSBOG9
MU'-N3-5 B6,5,D52I!WJ=8JR<BE"Y$D-2K%[5*D1]*F2/'6LW(WC3(DBS4R1
MX[5(J9_QJ41YZ5FYFZID:I7,>(=1^TS^0AS%&>2.[5M:]J']GVFU3B>3A?8=
MS7&[?]HU[& HW_>R^1S5Y<ON(6H91O<!2=P].U*Q8MM5L^OM4BJ$&!7M['$-
M2((<]6]:Z#P8,ZS_ -LV_I6$3CK6]X(^;6^A_P!4W/Y5RXK^!/T-Z'\6*\SO
M0M2!:4+VJ18Z^+;/IDAJKFI4C'?FG*F.V34JKCZU#9JHB*E2*E*B9J9%_*LW
M(U41$3FL3QRN/"UZ?]S_ -#%;X6L/QV/^*4O?^ ?^AK6N&?[^'JOS(KQ_<S]
M&>04445]^?&"+TH9@N,]SBA>_P!:CN.0H'6F(64YPHZFG@;1BH%EPS,PYQP*
MFC)*Y;O0 ZBBF_?]E]?6D,"Q)POXFE50ON?4TH&**!#9/N&G8XILG( ]2*=3
M 9_J_P#=_E3Z*:ORG;V[&@!U%%%(8G8BHXS\B?6I>]11?=3ZFF(EHHHI#"@G
M%%(/F.>U "BHSS,OL,U)4:<RN?3BF(DHHSFBD,C"@.R$9!Y%"QE&^4_*>H-+
M*IP&'5>:<IW $=Z8A:*,T4AA2=#CL>E+2$9% "T4W<_]T44[ ?CS>:M=:O>-
M<7MU-=SMRTUQ(7<_4DYID;DMQ^'O6C8J[RA0/O=A7I7AC1XX8E>9$;C^( C'
M>O&FW!7;U/MZ<^=V4=#S^WU!["/#= >:V;.]2ZC#1GFJ?CBUM/[29+1!"!RR
MQ_=S]/\ "H]'TJ[MK472_-: @,X_A)Z9'Z?_ *Q62E*UY+0[8U$Y<L6;:R3,
M<#CM6K873V\!WCFH=-"SQ!^_2K26AF;YCM0<U+E$ZTGW/I_X)_M$:-X?\#:?
M9>,M5T[08;:Y;3[:5DG)>,(K(2$5P.&(W$J#@XQ@U]':9J-AKVGQ:AI&I6>L
M:?*-R75A.LL;#Z@U^>FDZG?>'+R"6QN"DLIPT)!*%<#&X=&'!.#QG![5WEEX
M[U.%U>ZU*XCW#)V2&%1QG[JX'IT%<<,1B:$O<DG#LU^5C@Q>!PF*;?*U-]5K
MKW=^_D?:M%?-7@+]HNWT9UMM3NI=0T\D S,[2/#]&.<CGH3Q[=#]&:;J5KK%
MA!>V4Z75I.@>.:,Y5@>XKZ'#XFGB%>._8^.Q>!K8.5JBT>S[EFD*ANM+174<
M WYE_P!H?K2JP89%+4<F <@X?V[TQ$E,WEN%_,]*109!ENGI4E #50*<]3ZF
MG444AA1110!'.NY/H:A">@JRPR,&@1UYF)=IHI1N0+%ZU($J=8L]JE6'':N)
MS+Y"N$)[4]8SBK"Q5((O7I4\Q7(5Q'3UBJRL5/6+VJ',I0*<\>(B:J'DXK5N
MX]MLY^G\ZR^U>M@W>F_4RJ+E85#(^\[%Y]:'D+G:GYTY(M@X//>O0V,B6W@,
MDBHO+'OZ5O0VPB0*O05'I%BT<7F.,._0>@K42#%?/XS$<\^5;([*=/2Y D%3
M+#[5,(JE2*O,<SI5.Y"L?M4R09[9J=8L<U(J9XK)S-XTB)8L'BI%BYJ=8O:I
M!'P*R<SHC3(%BI972VB>60[409)]*L*F*Y3Q=JOF2?8HC\JG,A'<]A6^&I/$
M5%!?,55JC!R9B:E?/J-V\S< \*OH.PJG(Q48'WCP*<3@5$A!)<\9Z9K[2,5!
M*,=D?.R;D[L>BA!_,TO)]J%(89'-+3$)M&<]371>!AG7/^V3?TKGJZ/P'SKO
M_;)OZ5RXO^!/T.G#_P :/J>AJF#_ %J15IRIFI%%?#.1]:HB*G%2JGMQ0JY]
MJE5*S;-$A%7\JE"T!>.*>!Z5%S51$"UA>/1CPI??\ _]#6NA K!\?ICPC?G_
M '/_ $-:Z<+_ !X>J_,RQ"_<S]&>-4445^@GPP@[_6F]9O\ =%.' -,BY#-Z
MFF(1E#2 8]S4M1Q<[F]33SZ4 !^;CM2T 8HI#"BBB@!K<LGUS3J:?]8/I3J8
M@I"-PQ2T4AB*<CGJ*6D/!S^=+0 P2 ANQ':D086.F21DR\'&14I&"@_STIB'
M44$@#)X%-Y?V'\Z0Q?O<=J6BB@ )P,U"K$( /OMS4C@LA ZFDCCV#GDTQ#8A
MM9UZU+48XG;W%24, J-?W;E>QY%24UU#C'?M2 <1FDY%-C?<,'[PZT^@ !S1
M2$ ]J,'L30,6BDP?7]** /R:T!52Z5F&>:]%MYT>U*H1N Z&O,M,N_*E#,O2
MNJ@U..1,I\K =,UX%2\V?=T[11R>LAVU*4'+-O.?SKT+P992:C8II8562? D
M';;[UR']GO>Z@TQ. S9+5Z3X-N+/P_&+Z]F\J*/(0XYD/H!WJ:\^6.@Z,&Y7
M9E3:$^AN .;:=YO();+!8YI(B&]\QG\,'O4:L9;M(3PN1^-3ZAK']HWEME-B
MR&XG;)_B>7</I\A4'WS2$!)A-MR4YKSZ<I2C>6Y[=51C*T-M/R5_Q&W]Q=:?
MXM0P.H ML?O!E"Q&1G/X#-9&FZA<ZC<YO)"V&R(C]U3GTH\5:O']G9T4B1S]
M_.,>N/Y?G67X;F4RB25MJ#DFL,0U+1=#KPBY)<[6Y[/X6O)$";"0!Z5[;\.?
MB%)X4A-K]C26QD?>R1_*5;N0.G/?UKYOT;4[S4Y5BL4\J(<!CU->V_#WP[=O
ML^TN6^M>-.O/!/VT)6:/J50HYI3^K5X<T7_6C/H_0O$MAXC@\RSERP&6B<;7
M7ZC_  K4)P,GBO-[#P_/I4T5U;,5=#NXKT*V?[1#'*>K ''I7U>2YS'-%*$E
M:<?Q7<_+>)^&_P"PY0JT9-TYZ*^Z?;STV8_)?[O ]:<JA?KZTM%?3'PHQ.&<
M>^:?31_K&^@IU !1110,**** %4;G4>IJVD'XU#9IYEVH] 36JL/M7B8V=JB
M7D==*-XW*JPT\1<5:$7M3UASVKS7,Z/9E41>U2"$DU:6#VIXB]JAU"U3*RPX
MIXAS5I8O:GB'-9N9:IF7J2A+&5B.!C^=<^V7^]P.RCO74ZTGEZ;*0,G(_F*Y
MI5QR>37T.7.])OS//Q"M)(1$VCU-:.D:>;VXRP_=)RWO[52CC::140;F8X %
M=II^GK96RQ+R>K'U-5CL1[&G9?$PP]+VDK]$*L6#TJ0(>PJ98JE5!TKY1R/9
M5,A2+U%2*GM4JQU*D8%9N9M&F1+'4JI4BI3PN*S<[FZ@1[:<HJ18\]J>56-&
M=R%51DD] *B_0U4.IF:]J2Z1I[2\>:WRQK[^OT%><NYD8LQ+,QR2>]:.OZR=
M9OVD4GR$^6,>WK^-93,=VU.O?VK[7 8;ZO2][XGO_D?,8NO[:I[NRV!W &,;
MB>PIBP#.6_*I$0)[GN:=7IG" &.E%(2!1D]A2&+72_#\9U__ +9-_2N9^;V'
MZUTWP[4_\)#R<_N6_F*X\9_N]3T.K"_QX>IZ8%J14IP%2*GXU\#<^TY1%3BI
M%6E"U(%Q[U/,:*(U5S4@CIZK4BKSQ4\QHH#4CYK ^(2X\'W_ *_)_P"AK72J
MM<]\1!CP;J'K\G_H:UOA7_M%/U7YF6)5J$[=F>(444=17Z.?GPR0XC]SQ0WR
M1'V%(3ND]DYIK2"2,\8/I3$2(-J#Z4X444@"BBD)P.:!BTTN <=3Z"CENO ]
M.]* !T&* &;B')*]NU2 @C(IJ_??\*"N#E>#Z>M,!U%(#GZ^E+2 *0<<>E+1
M0!'*/F3MSBA@PQR#SWI9>B_[PI7Z#ZBF( G.2=QIU%%(84444 %'>BD% #/^
M6_\ P&I*C_Y;C_=J2F(*BF7E6SCMFI:1UW*12 B8."#C)'<5(C;ADC!]*(V+
M+[]#3J8!1112&%%%% 'X]6^I2 @$Y_"MO3YFNLA01ZX-<W9Q-+( !7;Z+8M9
M0 ,H+'ECZ5\JIOJ?HG*C3TVV/E!<<],^E>D>)_"=I+X4B>.6..>TC+B3^^I'
MS+]> 1[CWKG])LXX+7<7!DDZJ.2:W5T[4[BPN0B(L+1.H\YB 20>GXUA.7,S
M9*QPC'-TH7CR4[^Y'_Q-)K.IBRM05/[V;Y(U/=O\C-43*\>L;;D>4PW1F-N"
M&&#S^1KV7X:?!S1OB5IUS+=M,VHBQDFL7MYPJJ3\O0@@G!'YFHJU8T8\\CKA
M"567+$^>/$>II=A-C J%51CO@=:CT**ZU>YCM[<'8#R1WK,U^\DU+Q1JB/#]
MGF-W)OB"[1&=QRH';'3'M7K7PC\/I-?0_+TQ@5Q5)<J<F>CA8.O-4T>D?#'P
M).@B:0$GBOI;PCH MHDWJ0>E8_@7PY'!;H=@Z5Z);JMJ ,8Q7YYF6.=6;BC]
M8P6"AAZ:2-);-(;=0 ,5/;+L@4#H*K6TC7TRP0_-(W;VK9&DW( 'E]/]H5]/
MP93Y*M7$U':-K:]7>_X'YGX@8B+HT<'%7E?F?DK6_&_X%2BK?]E7/_//_P >
M%']E77_//_QX5^J_6*/\Z^\_$_8U/Y64A]]OH*=4LUG-:G,B;0QX.<U%6T91
MFKQ=T9.+B[-!1115""BBD;I]>* +^BQ&2>1L9P*VA#FJGAVVS!))ZL%'X?\
MZZV!%BOD\=5O7DET/;PU/]VF51#4@AJR(J>(J\[F.OD*RQ>U2"*K*Q4]8JAS
M12IE814\158$5/6+BIYRE3,+Q(/+TW_><#^?^%<K75^,#LM+=/[SD_D/_KUA
M:/IK:I>K$,A!\SMZ"OJL!-4\+[26VK/%Q4'*OR1WT-?POI7R_:Y%Z\1@^G<U
MTBQX/2I8X!$BHJ[448 '84\1U\SB,3*O4<V>W2H*E!11"$SVJ18A4@3TI=M<
MO,="@,VTX"GJE2",4KFB@,5>*D5,TX)4H6H;-5$8JURWC?6?(B&GPM\[C,I'
M8=A^/^>M=#J^I1Z1827+\E>$7^\W85Y7>7;W$TD\K;I'.XD^M>[E6%]K/VT]
MEMZ_\ \G,<1[*'LH[O\ +_@E;YD<JO?]*D10@P/SIB,J#)8;CUJ12&&1S7V#
M/F ^E&/QI:*0P Q1110 5U/PX&?$7_;%OYBN6KJOAM_R,?\ VQ;^8KBQO^[5
M/0Z\)_O$/4]31<4\"E4=Z>@YK\\;/NU$ I%2*E*HW5(B9-2Y&B0*GX4\ ]!3
MU4?A3U7/2IN:6$5<5SGQ'7'@S4/^ ?\ H:UU &.*YOXD+CP7J/KA/_0UKJPG
M^\4_5?F<V*7^SU/1_D>$G@&H(WQ'@?>SQ4DIQ&:$B"G/?%?I9^<D3#RB1U+"
MG2H%"GTX-2,@9E)[4.0%8D9 IW 8K&63/15J6F1+M0>IYIY.*0"$XH YR>3_
M "H [GK2TAA1110 U/XOK3J;']W\33J $(SR.M .12TA&#D4 +0: <TV1=R$
M4 -E/"?[PITGW#42N9&0'J.34S#*D>U,0M%(IRH/M2TAA1103@9H 0\G%+2
M=^YI: (QS.?I4E0,Q,C!>IXJ2(DK@]0<4V(?1112&1GY),]F_G4A%(RAU(--
MC;/RG[PIB'9]>M+01FDY'O[4ABT4F[V-% 'Y(>$K%HP\\RC"G"D]/>NKL?$5
MCI\ZB:+[1&3A@HYK"\*>,-.MM*BM[O3]TT.1YW+*X)SDKD<CI5G6/%EK/;@6
M=O#:L#GS3; =.F"2:^22YMC]';Y=SU#2/'^D0Q*(-+N)5/\ $D636AXJ^(NF
MP:9&R*QN)%^2'[K+]1VKYTN_&^IPP-B[EE5C@#?M7\A3- ^(=[9ZI:R74226
M:R@RQ*@!D7N-W7]:R:IQ>K'[TCU;PY'8MXPM]<\503_V= PN&MXD+-.!]V(*
M3_%CJQ  '49%=-X+^-]GX%CEO_#&BW=WIBSW+VEE<RI"\<+L6$9(+]&)QC/
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MU_WVO_Q-;?VQA>[^XS_LG$]E]YYM17I?_"M=,_Y[W7_?:_\ Q-'_  K33/\
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M3L4"YCYC/KZK^-;VP4;:VHUYT*BJ0>J,JM&-:#A-:,\]\%:*UQ?-=2H1';G
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M5$VU_70X,T4T'Y W;%-B<N6S^ K]!/@"2BBCI2&!.*;RW^R/UH W<GIV%.H
M8J\<,1S2[B/O#CU%"]6^M.IB '-%(5[C@T Y^M(8M0I(5)#\C.,U-4; "3GH
MW!IH0'_7#Z4\H"<]#ZBF+&5D!SE1TJ2@!OS#T8?E37?ID$$'TJ2D(R"/6@!
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M"YW:R/U%6OJ=0MC?W%TT-YYMJ%(4DKC:>.",@]#5/4]+NM+FBAF"M&P,D,Z
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MH&.BXR34WVG=C:, ?G7Y&_(_7% [T:_;C^*GKK\!Z&N#CG8U82=^E0S101W
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MJ0QJ>H%;>RIJ*ARJR,GB:[ES.;OZF;IWA;1M)1$LM+L[8( J^7 H( Z<XK4
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M88;RZAB#D ]>#7/&JW926K.N=!)MQDK*_P"!S,4$D[%8HVD8*7(122 !DGZ
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M1MD,D@]589!_ UF272M;A%MH4(;/F*#N/MUQ6EIVJO:VH$I#P G9&W(1B/O
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MKD?=?Y;?D<_4<@*L''T-=--HZ7Z_N4$4J EF7^+ZBL*YM9+60I(I'H>QK[S
M9MA\>K0=I=GO\NY\#C\JQ& =YJ\>ZV^?8A'(!'2@'-1C]TV#]P]/:I<9KVCQ
M@HI,$=#^=&['4$4ABT4@(/0YI: "BBK.G-;)?V[7HD:T$BF58@"Q7/(&2.:
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MW'POJ'_"&Z'+=96?6;T@>H+]E'^P@/X_C7DOAK3CIT\4DL;?:Y@# C#E$/\
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M_*C ':D9P@Y_*FX:3K\J^G>F(5I,G"C<?TICJ4(<_-ZU*JA1@# I2,C!HN
MY%%1QG:2A[=*DI %-7DL?4TK':I/I0HVJ!0,6FNF\>A[&G44 ,1]WRMU_G2D
M9!4]Z;L#H/7L:2.4.,'ANQIB#!:-E/WEIZ$,H..<4U_E8/\ @11'P67TY% $
ME(1GD<&E!S12&(K9]CZ4M(RY]CZT@;G!X/\ .@0C\2(?J*?3)?X3Z&G,VT?T
MI@(W/RCOUIW2D48'/4]:6D,*:Y^1C[4XG J.7[@7N3BF(=&,(OTIU'2BD,**
M** /SUT5+2SM9[N?<-.M8GD6 ];N0D ;CW!?;QWP>PK9M_#ELOAYIM5E,@.
MB6\IC+S%<R9?T V@X^ZL:DD%L'FHKF2_MH8 I%N)$DV#U4$+S[;F/X^U7?$=
M]%+'!%=WJ6=K!&(Q&> 0QX7CH&.,]R/8U\C)'Z*CH/#FGZ7K?A=K#2[R73_%
M?S26T=Y)_HUS!@XRYP8W;!7YRV5;H"<CE- L;SX8/<ZKJ>DA=<>0VR0R!EV9
MY9CD]^,$8!&2.E+?>#IM*NK>UEU);K5 XGF5&VF.0CY.,E@(U_A [UZ?%>:5
MX_AMO#NK2+#J-DC#3-2DW%)#V67@97.?<#D#&17.XV?,]5^1IS:61P?@SPJV
MM7;ZE<(TEO+*7:>Y; E?.2",#//8<5ZDOBQHI6TZU9[=E"JUW @WD=XUYX'N
M*\M?^W= \0/9ZTS17MH3$L#ML1%_V,9&#V/X^E=#;W\PRRP^1<$9\S<I55YY
M4@]>O\Z^>Q;E5G:*7EY?U]Y]?@84H4N>M)O;1;/MZ_/3RZB^//$0-J+)5M1Y
M+1(LLZ 285MQ8-GKE5&.OS,>U-&L6TT]]JEY FA0R1Q0"WM-YC9P,D+DEN?O
M=>/Q%<AX@<ZMJUM8Y$+('>2=F'RJ2 6]L*IJY/*FH7+2.5@M+2,O:Z>_!*#(
M:1AW;(&1UY]!7N8>BJ5*$5M8^:Q55UJTYO=MD-]?3:_>EW+$*%54Z[5[?UJ#
M5F72I%59"D,H/R@ X /'OGH:?HUU;M!]JD9ENVCQ@<(^6^7.?NX&1Z?='O6=
M)!JOC#7FM],TRYO9(OE$=I TC*1QR *[$F]$CE;4=7L7-!L8;3Q (M0@6\E0
MQR"%6 5) 7!SZUL77B<V5Q_;%VI6U=GC*1MAW4LJXW8Y4'V['VKIM#_9O\=:
MYJ-LUW9-I=FR+'-<23() JDY*KDG<00!D=>372/^S)XONK9&N(M)+0J%MK-;
MAO+A4?<7)3YMN!R>IY.><CPM6;^![?U8Q>,P\-ZB^\\SM;6&Y&LQV>%6[!EB
M0HP*#))!YYX[\9&#@ UF65C#I>LR-%,HW1I%P?WA.X$D^G0#V Z5ZKHOP!\<
MZ)(&DT^U667S/.EM[A7^]G^^<DG/7L3D=*\LD\)>(/!^NW][XA\/WUC$['RY
MI8655QTVM]T] .M4Z-2FK2BQPQ%*J_<FG\ST_3D_L'PWXEO//@:Z8+8Q>9AF
M?S/ONKG)4!1R<$\XR,T^[U9#)<&UC>.>RM+<R6N%60JJQ@L><%3D<@G@^QQP
M,FL_VVLD\$<:Q22G<NSRT<,V0.,8P!@8[YK9NX[4G4[K6[E;9HK9FVVTN-S;
M/W2+D'/S;%(X[]A7G.GR<TGJW_P-#LOS678S?&%Y#XQ\5V=IJ%XUO#Y!\V0Y
M8D@$J  .I)_3->.:R?L-[<0VUP7A0_(PZE3R#^5=I::F^E6%QJT6V.9G.8R
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M (O9<:3JF('5CM2,C_5LH]CP?9B37V*L>>7_  '85^?^G>(;;28X7GAFGOY
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M8_0M6I;VT$5E,_RGS!/ ^_Y<A,,._P#TV/YU'96:VE];^8)44[E/FMG&05&
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M)'45<MM5%VS&2S^T6P9"Q%QD$L"N"-A'(C/&?6LU/![67C>_T3:L5Y;1X<=
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M<4ABD9ZTSRE[#'TIX.>E% #-C#HY_&C$G]X?E3Z*8B#;Y<@W8P?3I3I(MW3
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MXJT[SC&UW=OY)7_.QUTXVA*7E^;M_F>?V;+=^+(9YF6X$US;M,V/E;#C?^&
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MC-W#G\)!7U?7R'HUY]KU#2.X6[B.?^!BOKK>.P)^E?I7"W\.MZK\F?E7&_\
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M>,HX[F(L&N1#&0>%?S5!S_P'</\ @5?<7[2<RVWP;U]IG.UEC12!_&9%"_\
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MULK?=^9X/%4XSH5N>-FN6WFK[_/<]FHHHK]5/QP**** "BBB@ HHHH ****
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M9)/X6C\ML?B",_B/2O2IK(+X:TO7+5\B64QSG.<$$X_0?RKB[N=D:W!:-2I
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MI7/^.?'.D_#SP[<:SK,XAMHAA47EY7[(@[L?_KG@$U+:2NRHQ<FHQ6I'X_\
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M!$BW"+[F-"0/8^M;7Q-UQA^T9'('VM96"0G_ &LVQ?;^/F$?C7+_ !,U&Z\
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MT6?-7*'L<QGFOA^(\/&K*D_M/W;_ 'O\S],X0Q$J=.M'[,?>:^Y/\&R7X?Z
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M0X_V?+('ZFN=$LK74B*W[N1E4'MD,,FOQUT*>(H<LU>RM\]3]_565&M>'?\
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M5T75=3MQ$Q:SFNX(_P"Z8F@G*Y'_ 'SCZFNM6YBGM_ 009#VL:DMV/VZ\'Z
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M8!;NTE0HR-V8 \[3VKJ*\.HIJ7+/='T-)PE'FIK1A11169L>2?M&?\BSIO\
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M9V/WF/4FM0"1&X&!Z$U]IEF ^H4%3;O+K_DO3\3\VS;,GF.(<TK16R_5^;_
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MI>O-J<I)_=L1*OT=0P_G3+BZ&DZ%)(>'886J&N7)N]#T>Z;EI;<*3_N$H/\
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M_7H<5\"WUAJ7A31=/O$D:2#1+W3YH ,D1HP>4\]AYLC_ (M7>>&[N_\ #7Q
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MY/X/MI(O!-I%(A22."5"OH1]H;^E:_A[5&T[_A(?G,[C36C\T\9+3Q$M^/\
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MY_(5[#\18S#\.;MHQLEG\/Z9IV_N?-G@? _"!_UK6I&\6TNJ_1&:FTTO)H\
M\1QFV\-Z9:C@EER/=(QG]9#6_P"(+(GP]X!T=.9)[>2[8?[4URT8_P#'8E_.
MF^)K&T-IIT]PWWVD<(#T4MMS_P".5WFI>$BWQ'\)"-MT6GQ:;#)$>RK'&Y(_
MX$QS]:Z)0=S*YTWC:\#WOBB=.1->00Q_[BRQ(P_[Y6NI^$=H(]>U"]<9%O9S
M-GT9;=(5_P#'I&KB=5/VB" D?Z^]+-]',I!_..O2/AK:B'0=:N6ZR>5!G_?D
M:8_HJU%96I.*\E^01>MV<)\=/&;^(?B'H7@ZU4)IMC-!>W^/^6\HC#+GV6+
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M:\N;Z:XLK4;'E+GS#$JL.3UW _C7H'@S2I[^X\-7:L[N+*:VE9CGYS:;E/\
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M&_W6?Z/[CQJ5-T,3R)W:=OONOU_$\^TEPFDK<_Q N!]2!6?)&)9(I3\WE@D
M?I2IOL]'BM6XD$K%AZ< 5!9$P0$GGD\&O3W2.#8L6:2W$=FY&625Y#[?+G^E
M01NR:5'&>JS%OT%:5HX73)IVX* G'UXK(GFSI9E7H)<?F/\ ZU<]1+W6:P>Y
MH7T8A%G&!\H<L/H3G^M:6DSB/7;H@?+*@'UX!_I6=<2B:QTV;^]$%/U!*_TI
M=/G4>(],C8_*S1!OH0!63U5_4T3MH2>*U6WOB5X7D#\ZJBZ(U2< 8WY/Y\U<
M\;Q&)(R?O([1GZY/^%7/ 7@/5OB5XVT_1='B\RXN(8WDE/W($V+ND<]@/U.
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M%&/D_P T>O\ [8FH"\\;:0@/-MI=G#^<$;_^S5R.AZFEI%X0OIC\MO<XD/\
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MHI#(X_F=V]\5)4,+C[O<Y-3$XIL2 G%,=R!Z9Z#N:';8,GD]J$3!W-RQ_2@
MC3;R3EC0[XX'+&E=]H&.2>E(J%1G.6]: %1 @]2>IILC$$ #(QDBI <BF?\
M+4?2@ B.Y,9SCC-/'-(J!2<=Z"/2@ 7T]*!TIN[YL=S3^E(8BJ%& .*;'\N5
M].GTI_I3&XD4^O%,0^D(##!&:1'#Y]C3J0$:GRVVGH>E/5PQ(':AE#C!J$*T
21+'D?SI[@3T4SSE]:*+!<__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>exhibit99-4xu004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-4xu004.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;CL1CHA356#Y?B7XK_@?D<TZKI37/\+T]'Y^3_/U/3J***YSI"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "F2RI#&\DC*D: LS,<  =233Z\XUS43X]O+FUAD=/"]@VV\FB^]
M>RYXA0]US@$]R?I6U.G[1]DM_P"N_8QJU/9K35O9?UT[G-_$/QA=>+;"X2Q,
MD.@J=BLN0]^^[: /]C=P/7!]#CT+X<^#8_!7AN&UP#>2_O;F0=W/;Z#H/S[U
MS]AI0UCQW;6C1HMKHL:W4\<8_=BX88BC'LB=/<9[UZ377B*BC3C1AHM_\O\
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M"GQ5K]YXHE&ZU7=::8IZ"('#R#W8C\A7;4JSY4J?W^O;Y?G<=%<S=7[O3O\
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MJ5JZE]C_ "_S?Y'0ZC_INJV-F.4C/VJ4>RGY!_WUS_P"L'QR?MWB+PCIF?\
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M(\3>&[2\;BY"^5<QD8*2KPX([<_SIUY_Q(=4^VCY;"[94N1VCDX"R?0\*?\
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MV.L7AT_2[JX49=(R4'JW11^)Q6<VG)X?T#3+:)LQ6+0)N(ZJ"%)_(YJ?7/\
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M9/, P/\ @1_QKR#X96TMM\0O[%?FWT6"Y>!FZE9'0C/X-7K=ZWD:I82=%??
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MU]^06/K^O75=1J*]FOF^[_R7^;,Z2<G[27R79?YO_)!1117.=(4444 %%%%
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M\(<K<7["V0+][!^\0/\ =S^8KN:SM4TO3KF6WO[ZWCFDL=TD,D@SY>0,D>_
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M!O\ @5-U*_N/%5]+I&ERO!90MLO]0C."/6*,_P![U/\ #]:Z)0YIMK;?Y/\
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M759IF&H22_?\Y3@K[ <8'ICUKJJSJ^Z_9KI^?];>7J:4O>7M'U_!=O\ /S]
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M-XN^C"BBBI*,'PT0E]K\/3;J!8#V:*,_S)K>K!TH>3XMUZ+&-\=M<#\0Z?\
MM.MZM:GQ7]/R1E3^&WK^;"BBLO6YVD$.GPL5N+LE2R]4C'WW_(@#W85"5W8N
M3Y5<?I+?:VN+[^&=ML1_Z9KD*?H3EOHPK#\','\1^+R.GV]!^4*5U44201)'
M&H2- %51T '05YEX;\;Z9H6L:PEV[^?J>NR6\*1@' "HNYN1A<\?_JKIIQ=2
M,^5=OS_X!RU91IRI\SMO^7_!/4****Y#L"BBB@ HHHH **** "BBB@ HHHH
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MTRX;V?YH_P -RG\ZWHZN4>Z_+7]#GKZ*,NS7XZ?J=7IIA-E&+>);>-<@Q(H
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M>P[%_5ORK>$4ESRT7XO^NK_4PG)M\D-9?@OZZ+]";PAX=NH[F;7=:VOK5XH
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MY(CN'X[6;_OFNAN[N&QM9;BXD6*")2[NQP% ZFM:FLE)=?Z_,QI/EBXOI?\
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M_7_@G%0;IR=%O5:KTO\ H;@((R#D'O2UD/HLMF2^E7/V3O\ 9I!O@/T7JG_
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MX:2]N1B^U-VOISCN_('X+@5LZ00]UJSCO=X_*.,?TK11%C144!548 '85E:
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M]12]I+I^2_R*]E'^F_\ ,R(/">DPL&-FMPXZ/=.T[#\7)K51%C4*JA5'0 8
MKE_&'Q%T[P;(L-Q#=75TZ;UBMXB>,D<L>!TKC=-\5ZG\4KF>PAU)- C\MG%E
M"KM<2 <?-(0 H.1]WFMXT*M2/M):1[LYY8BE2E[.&LNR_P SJ/%7CJ>&6?2O
M#=K_ &QK:H2ZQ\QVX]7/3/HN:9\,7TF6RN)8)Y9]<<@ZDUX-MSYGHR_PJ.0
M./QK<\(Z=IVF:.D&FVHLT5BLL75Q(/O;CU)]_IVJIXH\%1:U/'J-C,=,UR ?
MN;Z(<G_9<?Q*?0T^:G9TEIY_Y^7IZZBY*EU6W?;_ "??UWVT.FHKSF_\8ZI<
M^']5TJ4_V/XMM(#,@0;DN%3YBT6>"& (QU&?:F>'_%?BN/2+6_EM(/$=C)&K
MLUI^YND!YY3[K?ACI4_5IVO=??\ ET_$KZU#FM9_=MZK?3T/2:*Q?#OB_2_%
M$;FRN/W\?$MM*-DT1]&4\_CTK:KFE%P=I*S.J,HS7-%W04445)04444 %%%%
M '"_%W3H+S0;":[3S+*VOXGN!T_=ME&/X;Q70>$M(@\/:-'I<#RLML2,2MN(
M!)(P?[O/'_UJNZSI4.N:3=Z?<#,-S$T38ZC(ZCW'6N:\%7MSJ6D_9+AA#KVC
MM]DGW='Q]TGU5@ <^O-=:DYT.6^B?Y]?OT.-Q4*_/;5K\MU]VIU-[IUMJ"A;
MB%)=O*L1\R^X/4?A6)KOA<3Z1=I;W=\&$9:.,W+L-R\KU)/4#O6S9Z@ER[1.
MIAN4&7A8\CW'J/<?SXJW6"E*#.APC-%'18+.+3H9+*(1PSH)0>I;(SDD\D\]
M35N61(8WD=@B("S,>@ ZFLOPT?*L9;,];.=X #V0'*?^.%:=>O\ VG?+81\P
MQXDNF'3'58_J>I'I]13:O-W$I6@K'-?$:8V_PTUB>8%)+D*Q4]1N=0!]0N!^
M%5Y;5[E+?QEX1(GDGC'VJR/RK>(.#QVD4@\^WY]7XJT>TUS1I;:\0R1!ED"9
MP"P.5!]LXXK \$6OV5O%.A([0I;WKF$H<-''*@88],$MBNJ$TJ3:W3U[6=D<
M=2#=9)[-:=TU=F[X9\5V'BJT,MHY6:,[9K:4;986[JR]16SUKPOPIX%NM5O+
MB[D\0WNF^(;.X:UEF;]X&8?=SD@X(QC)(->VV$4\-E!'=3"XN50"255VAVQR
M<=LUGB*4*4K0E?\ K\4:8:M4JQO.-OZ_!F9>^#]*O9C.+<VET>?M%F[0R9]2
M5(S^.:J-H.NV7_'AXA:9!TCU*W67\-R[3^>:Z6BL55DM&[^NIT.E!ZI6]-/R
M.6:^\86GW]+TN_ [V]T\1/X,I_G4;^*O$,/^L\(7!_ZXWL3_ .%=;15>TCU@
MOQ_S)]G+I-_@_P!#SCQ1JFM>*=$NM.?P;>H91F.5KJ-3&XY5@?4'%2_"N.XU
M*75-7U>3S-?$GV*>,C!MU3&% _VC\V>]>A5P_B'_ (H[Q=:Z^GRZ=J&VSU #
MHC?\LI3_ .@D^]=$*GM(.E%6OMO]VO?\T<TZ3IS5:4KVWV^_3M?[F=Q1117
M>@%8'AIOM>HZ[>_PR7?D(?\ 9B14/_C^^M+6=231])O+Z3[EO$TA'K@<#\:J
M^$M/?3/#EA!-_KS'YLW_ %T<EW_\>8UJM(-]]/U_R,GK42[:_I_F:]4-217F
ML590RM,R,#W!C?(J_6=JA_TO2AZW1_\ 14E1'<J6QS?P[)T:XUGPS(>--G\R
MVSWMY/F7ZX.X?E7:,H=2K %2,$'O7&:T#I/Q*T&^7Y8]1@EL)3V)4>8GXY!%
M=I6U;5J?\RO\]G^*,:'NQ=/^5V^6Z_!_@<)X/1?#>M:CX1N?GLRINM/\SD-
MQ^>/WVDG\*Z*&Y;0KB.SNG+6<C!+:Y;G:3TC<^OH>_3KUXGXS:G=:7=^'9=.
MLGGU))I)H)XSEE"@;TVXY#*3G_=KLO#>O6/CGPXETL8>&93'-;RC.QOXD(K>
MI%N"K-:2W]>_S_S,*4HJ<J">L=O3>WR_R-VBN>-S<^%?EN3)>:0/NW'+2VP]
M'[LO^UU'?/6MV">.YA26&198G&Y70Y##U!KCE&VO0[8R4M.I)7+>&?\ B6^*
M/$6EGY4>1-0A'J)!A\?\"0_G74UROB#_ (EGC+P_J(XCN?,TZ4]CN&^/_P >
M0C\:NGKS1[K\M?\ ,SJZ<L^S_/3_ ".JJ"_O8=-LI[NX<1P0(9'8]@!DU/7,
MZR__  D.NP:+'\UI;%;F_8=#@YCB_$C<1Z#WJ81YGKMU+G+E6F_0O>%K6:'3
M/M%TA2\O7-U,IZJ6Z+_P%0J_A6Q14-Y<"TLYYSTBC9S^ S4MN<K]RDE"-NQP
M_ALC3/B/J4*\1:I8I>#_ 'XW9#^A!KOJX74H&T[QMX);^)[>XMI,^T8;^8KN
MJWKZN,NZ_*Z_0Y\/HI1[/\[/]0HHHKF.H**** "BBB@ HHHH **** "BBB@
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MM>;3'U6&&]A<QO',#&-PX(#, "?H:F5&:?NJZWNNQ4:\&O>=GM9]SHZ*0$,
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M?[0TOS( /0+UZ8P<UV4H<S<Z:Z/3MI^1PU:G(E"H^JU[J_YZ:K[CT\L%!)(
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M^??\_,E4Y4_X7W=/EV_+R-BBN&T;Q%J'A75(=#\2RB:.8[;'5B,+-Z))Z/\
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MZ%:%82KS33CI;;R_KON=$:$&FI:WWOU_KML1V]O%:6\4$*+%#$H1$48"J!@
M?A14E%<IU[!7(:!"DWQ$\4W&Q=\,=K"'QR,QECS^(KKZY+P3^^UOQ;<]2VH^
M5^"1(/\ &MZ>D)OR_5'/4UG!>?Z,ZVBBH+V]ATZUDN+AQ'%&,D_T'J3Z5BE?
M1&[=M61ZE?BQA4JOFSR-Y<,6<%W/;Z=23V )KFO&=[+X=\*31P/YVKZBXMHF
M'!>:3C(] !T] !6UIEO+-*^IWR^5,ZXBA8_ZB/K@_P"T>"Q^@[9/F<'CR#Q/
M\5-/*VLMUI\#M:V+CB/S"/GE]S@8 ].:[:%-R;:5U'5_Y?UYG#B*JC%)NSEH
MOGN_Z\CU+0-'B\/Z+9:=#S';1+&#_>(')_$Y-6;V\BT^SGNIW"00HTCL>R@9
M)J>N/^)\CSZ'::5&Q5]5O(;,D=D+9<_]\@US03JU$F]WK^ITS:I4VXK9:?DO
MT*/@FUFO<:[>*1?:U<>>%;_EE;H"8U'_ (Z?Q%=]64D:+KEO!&H6.UM#A1T&
MY@%_2,UJTZLN>5_Z\OP%1AR1Y?Z\_P 3%U%L>*-%7UBN#^B5M5A:PWE^)_#[
M?WS<1_G'N_\ 9:W:F>T?3]67#>7K^B"FR1K*C(X#*P((/<4ZJ6L:O:Z#IEQ?
MWLHBMH%+,Q_D/4GIBH2;=D6VDKO8X+3/&"^#_!TEBRF[U2RNY--M;4??F8']
MWQZ;67FNC\#^%)-"MY[W4)!<ZY?GS;N?K@]D7T4=*Y'P_P"![[Q3JLOB^XNI
M=$O;IM]K#%&KF./:%#-N!^8@#I76#PWX@C'R>+)O^VEC$W^%>C6Y%>,9)-[[
M[]M.E_Q]#S**F[3E%M+X=MN^O5K[EZG4T5S T+Q,K9_X2E&7T;34_HPJ5='\
M0C.[Q'$?IIZC_P!FKCY(_P R_'_([O:2_D?X?YG145A+HVLG[_B"3_MG:1#^
M8-/7P]._^NUO49?4*T<8_P#'4!_6IY8_S?F5S2_E_(VJH2Z[8Q2&)9Q/,.L-
MN#(X^H7)'XU OA?3S_KXY+P_]/<SS#\F)%1ZYXATCP7IOG7DL5I"HQ'#&HW.
M?15'6FHJ3M&[8I2<5S2LD27>H3I:RW,Y32K*-2\DTY!<+W..B_B3]*\[N+FQ
M\12)K.L1R+X?1RMA8."T^I2]-Y7J1_='3GL*A,WB'XHWJ3'3#:Z+&P:""\)2
M%SV>0#F3V4<>_KZ#H?A&WTJY^VW,KZCJA78;N8 ;%_NQJ.$7V%=MHX9>\_>\
MNGS[^?3HKZG!>6*?NKW?/K\NWEUZNVAR?ASPGXAT.:76K18!),OEKHUU(SF*
M '*HLI)PV23C!'.*ZS1_&5EJ5U]AN$DTS5 .;*\&US[H>CCW%;]4-8T*PU^U
M^SZA:QW,74;QRI]5/4'W%<TJJJN]1?-?UK^?F=4:+I*U-_)_UI^7D7Z*Y'^S
M_$'A7FPF.OZ<O_+I=OMN4'^Q)T;Z-^=:>A^+].UZ1H(G>WO4_P!9972^7,GU
M4]?J,BHE3:7-'5?UOV_K4TC53?++1_UL]G_6AMUSOCHA=&@8]1?6N,>OG)71
M5S'CIO,BT6T'WKG4X%P/129#^B44?XB_KN%;^&_Z['3T445B;!6=X@T]M3T>
MY@B.V?;OA;^[(IW(?P8"M&BFFXM-":4DTRGHVHKJ^E6EZ@P)XU?;Z$CD?@>*
MN5S_ (5/V6XUC33P+6[9XQ_TSD D'ZLX_"N@JII1DTB*;<HIO<CN(([J"2&5
M \4BE&4]"#P16=H=S(IGTZX<O<VF!O;K)&?N/^A!]U-:M87B4G33;ZS&"?L9
M(N /XH&QO_[YP&_X"?6G#WO=[_F$_=]_M^7]:ES7]!L_$NE3Z?>Q^9#*.H^\
MA[,I[$5X[X:\&I<^,]=T/Q!"EW?>4D]M<OE3*J_+N##GD8R1T(/7FO<E8.H9
M2"",@CO4#Z?:R7L=XUO&UW&I1)RHWJIZ@'TK>CB)4HRBNOX/^MSGK8:-:49O
MI^*_K8X6WTSQ)X70R:+>/K=E$<2:5J3#SX_9)._MGCZUT?ACQII_B@21PE[:
M_AXGL;@;)HC[CN/<5HW]K)N%U:X%U&,;2<"5?[I_H>Q^IKD_%EKX>U^"'4&U
M6#1M6AY@O?-6.:)AP589Y&<@@^]4G&M\2U[I?FEOZ[DN,J'P/3LW^3>WIMZ%
M/XN-?6%UX:U'2H4;4([WR4=CC=N'^K)SC#8QS77QV]U)!%?P1BRO)45I[25L
MHQQR"1T8=-P_$'BO-KWQ6/&7AR[T#49(/[97Y[&]MV#6]W)&05V-V8]"OO\
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MB/8:3'X>UF!YOEBBD@7>YSRV-^3R<DGWKM+I_MNI0VB\QPXGG],_P+^8W?\
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MV3YM5(XNIA_RT/\ LJ>%]3D]A6WXCT>#7M#O;*>))EEB95#J#M;!P1[@U2\
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MU,9N;F59DFE;]W'\BJRG^\PVYVCGYAG K?T[2X[#>^YI[F3'FW$G+O\ X#T
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M+0"&VLUFB;5;U"(G#[<[%ZMC:#GI6Q:_#6PDE%WKMU/X@NQR7O6Q$G^[&/E
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M].P'8 #M6C5R:^&.R)@G\4MW_5@K/UW4SI6GM)&@EN78101'^.1CA1],\GT
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MA\B&[+N< ##(3^'EC\Q26UM+XCGCO+R-HM/C(>VM'&"Y[22#^2]NIYQC*NM
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M?C4'A?2)-(TI5N&\R^G8W%U)_>E;K^ X ]@*N/NKG^[^O+\R)^]+D^_^O/\
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MW"@&LZ:R&L7/B2Q8[%G@2#=C.-T;#/ZUT &T #H*QM*?=XBUT?W6A'_D//\
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MR0RVT3V[(UN5!C,9&TKCC&.U<WJ!_P"$D\5Q:</FL-+V7-UZ/,>8D/T^^?\
M@->:ESRUV7]?>_S/4;Y(Z:M_U]R_(N^&K"<B75;]=NH7H!,9_P"6$8^Y&/IG
M)]23[5N445E*7,[FL8J*LC%\5:G-8V$=O9D#4;Z06UMG^%CU?Z*,M^%7]*TV
M'1].M[. 8BA0*">I]2?<GD_6L+23_;WBW4-1/S6NG V%MZ%^#*X_':O_  $U
MTLLT<$9>5UC0=6<X _&M)^ZE#YO^O)?F90]YN;]%Z?\ !?Y#Z*Y74OB=X<TZ
M0PC4%O;CH(+)3,Q/_ 01^M4QXQ\1:O\ \@?PM-%&>EQJLH@ ]]@RQIJA4:NU
M9>>GYB>(IIV3N_+7\B[XH;^UM>T715YC,AOKD?\ 3.,C:#]7*_\ ?)KH[J\@
ML8C+<31P1#J\K!0/Q->4ZQH_B;3]<.K:UJQLK&ZB6&XN=&CS]G"DE02PW*O)
M)8=^M=7I_P ,_#LGEW<Z2:Y(P#+<7\[3[@>^"=OZ5T3ITXQC>6GDKZ]==$<]
M.I4E*7+&S\W;3IIJR2[^*/A^"4PVUU)JEQ_SRT^)IB?Q''ZU"WB?Q-JZE=,\
M,M:(PXN-5G$>/^ +DUUEG86VGPB*UMXK:(=$A0*/R%3UASTX_#&_J_T5C?DJ
MR^*=O1?J[L\D\$Z1K<JS^'KWQ#)H\]BS%K.T@4/*C,6\Q93DD$D\@<5UUO\
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MHUEO=2Q?3,XSR[L5'/H%!'UK#U::U^)7B+2O#:2.VEV$'F7<D9QNE*;5 /\
ML\_K7H?AG3HM(CGL(2S0V8BMT+G+$+$N,_G53C[&DX_:EJ_3I_G]Q,).M54O
MLQT7KU_R^\L^'V#Z:6!SF><_^17KGO%VLSZ1KUO%8J7N[ZU:(NL;2>0%<8D9
M5!)'S/CU.!5RVUR+0=(O_,5I9H;Z6&*!/ORN[ET0>Y#C\.:O^'=&ET^.6ZO6
M6;5+LA[B5>@_NQK_ +*]!^)[UBK0DYR6GY_U_P  V=ZD5"+L^_;?\_\ @E71
M;NSTFPCM;2TU"8#+-(]JX:5SRS,S 9)/)K174+V?_5::Z#UN950?^.[C^E6[
MF[@LTWSS)"GK(P _6L37/&VGZ%:&XG<1Q_PO-E-Y]%7&YC]!CWJ$G4>D;MFC
M:IQ]Z5DBOK_BVS\/#_B;:Q!:.1D6MLFZ8^PSDGZ[16 NFZO\0I!YL,^A>'S]
MXS,3>7:^G/\ JU/I572_!DWC_P 0IXDUNQ2PLT(:VM?+"338Z-*>N.!@9_\
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M$?94HI:_\-<YG3-#N/$FMR^)(;IK"WD;_1(FB#[QM"F;#="P  X^Z!ZUT?\
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1-*DUZ/[U_P  ****P.@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>exhibit99-4xu006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-4xu006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M._LES?!J*+XB>*]8@^(-]'*TUQ:VMX4TYR2(U14C,<F %)W;LDG! Q7)?\%
M/!M[X,_:R\=+=QLL.IW":I:R,.)8ID5LCV#[T^J&O5/V;/V<_P!E_P"+_P -
M=.U'Q1\3M5\*^+HT*:GIE[K5C9(L@)^:$309:,C!&&;&<'D4#Z'S_P#LI^/[
M_P"&'[1W@35],N6"G5X+*XV9 GMII!%*I'?*,2,]" >HKUG_ (*B?\G::O\
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M\14+:QRR@+Y:+UR<Y]J_'/X5:]9^%OBAX/UK4':+3].UBSO+AU4L5CCG1W(
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>.<*F*AS.&VK7G9]UY'-5P].LTYJ]@HHHKV3H/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>exhibit99-4xu007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-4xu007.jpg
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M&%%%% !5>7]_,(Q]U>6J2:3RTXY8\ >]$$7EISRQY)IB>NA)THHHI#"BBB@
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M4=:3$B]"''OP:?14E$?F,.L;?A@T>:>T;G\*DHI@0N))1C:$'J3DTMN $/\
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M:(IRV7;U-.W<5[[#))_/4JD9<'N:;%:S!2"^U3VZU<Z447"W<KK8QCJ2U3J
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M38EL%%%%(85'#RK-_>8FG2MMC8]^U*B[%"^@Q3 6CI2$@$#/)I'Y^7L>OTI
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MY:?>[GT%21H(U"CI3V%N,6%E  E( ]A2^4W_ #T?]/\ "I**+CL1^2.[,?\
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M+(T<Y;;D*2%STJ[)((D+-TJ""$NWFR#D\A?2J1+UT)(#(RDR8&>@J6@D 9/
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MDDRQ=>2>@'4U'Y;S',GRK_<']:8K@9VD.V(9]6/04^. (=Q.Y_[QIZJ%  &
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M:L#I3$(J!%PHP*6BBD,**** "HH^993[@?I4M10<JS?WF)I@2T444@"BBB@
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M5B"0"1TIDC^6LC>G(HN%BM:JTLQ9_P"&KM0VJ;(1GJ>34K,%&328UHA'?:,
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MD;7#!Y!A>RU9Z4]A;E&.8^9(50NS'@5,MNTAW3-G_9'2IPH7H /I2T7%;N(
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M5$%[]3]:DH8D%5;D[G6/^\1FK55B-U\/]D9H0,L]!3!\[9_A'3ZTKGC ZFE
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M 8"P+94]*GI,I!1@>E%%(".7YGC7WS^525&GS2,W8?**DI@%%%%( I"0HR>
M*6F-\[;?X1R?\* ",'!8]6YI]%(2%!). * %) &3P*IRN;@,W2)?U-.R;QB
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M P 1_(5"\<LEPS*-HZ FIT_UT@^AJ2B]@M<A2U53N;YV]34U%%(=K!1110!
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MV^6=#_>!4_SH DHHHI %,?ED'OG]*?33S(OL#0#'57D_>W*+V3YC4[,%4D\
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MLGI]:8$;S%G0HA(!(R>,\5*MPN<-E#Z-1-P$/HPIY4,,$9'O0+46BHO+,?\
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MKTZL:;  )92. /E%42WJ6!RQ/85 Q-V^U?\ 5#J?6FR.9OW<9P@^\]26T;Q
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M_0_AWIU( HHHH ****  C-5X?W,K1'[IY6K%0W,99 R_>7D4T)]R:BFQ2"5
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M[OKZ?YE.C3II*JW?LEMZW_(XGR[I/W3QF)DX(D&"#3OLI;_62,WMT%>EZ?\
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MQB:(^5N< R;AA=H[Y)&,5\Q?%&YM;OQG?WMI?P:C!=$2K);@@+QC:<]QC_\
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MP?TK3\0?\F_>&?\ L(/_ .A7%9GQ+&/#G@@'K_9@_I6GX@_Y-^\,_P#80?\
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MXF!=\'(X-24 %,7Y6*]NHI],DXVMZ&@!](P/4=12T4 -95F3!&0:KQVFTL&
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MI/4F@!JPKC+<L>21Q2[&7[KY]FI]%,+#/,*_?4CW'(I)'#1-M(/TJ2HG197
MQ]WJW]*!$M%1[77[IW#T;_&E\X#AP4^O3\Z!BR+E3CKU'UI5;<H(Z&E^AS3(
MN%(]"10 ^F)\K%?Q'TI],EX4,.J\_AWI /INP]F('H*<#D44 %(S!5)/04M1
M']])C^!>ON: %C!)WMU/0>@J2BB@ HHHH 9,^Q"1U/ ^M+&GEH%]*8W[RX"]
MDY/UJ6F(****0PJ!/WERS=D&!]:F=MBEO09J.U7$()ZMR:8NI+1112&%%%->
M5$^\P'XT .J"U^;S)/[S4DETK*P0,S8["F6[RF(+&% '<FJMH3?4MTC.J=6
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M-]]>#3ZBF_=L)0.G# =Q3 >D:IG:,9.32-\AS_">O^-/!R,B@\C%("&>#?\
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MF[%6JKVPRTP/]XT(3)8H_*0+G..]*05.X<CN*53D<]1P:6D,B1MX(7U/-2
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MU1>KMGZT:!=EFBJ4JB$9$C@]AFB"Z<*00TC=J+"YB[15?=</T54^M'E3MUE
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M\,4(\6=JE<^@J2@1%F9NBJGU.:/)9OOR,?8<5+11<=B-((TZ*,^IJ2D+!>I
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M;_>%&@:C?MJ=@WY4?;,_=B<_A2[YEZQJW^Z:/M87[Z,GU% 7\Q/.F;[L./\
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M%+AAT.?K07V_>&WW[49+=.!ZFD,/, Z_*?0T;SV5C2;0)%[G!Y-/H&(R*W4
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M:06)**;NQU&*4,#T(-26+1110 444UI%3[Q H =4$RJAR,B0]-O4TXN[_<7
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09N9(B4#9"\9-.UR;\I__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>exhibit99-4xz001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-4xz001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" !D ' # 2(  A$! Q$!_\0
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A]237-_\ -&_^X_\ ^V]%%:Q^)?\ ;OY,PEK!O_%^:/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>exhibit99-5xu001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-5xu001.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!9_^(KQ0<U,HQ79]6I=CQO[2Q7\_X(]H'[1LQ_Y@,?\ X%'_ .(I1^T9,?\
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M[S=53\.I]\>E;4J;JS44<>+Q$<+2=1[]/4\V\9^*[CQEXANM3GR%<[8HR?\
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M%%>*?H 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA;7LC'0KY@MPIY$+=!*![=_4?05Y&.POMH\\/B7XGT649@\+/V51^X_P??\
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M/9A1115F(4444 %%%% !1110!\X_M1_#L*T/BVRBZE8+X*/P20_^@G_@-?/
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M:[/X8IMUZ7_KW;_T):Y54''%=?\ #9<:[+_UP;^:UA*1W8>-JD3TRBBBLCZ
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *^$O^"NMPUK\$?"4L=D))5UX,M[SF#$$AV_\"QW_
M +M?=M>&_MK?"EOC%^S3XTT*"-9-1AM?[0LLC)$L!\S ]V563_@54G9C6Y^!
M>J7"-.9H<JCC=L(X4]P/:LPWKR2+&@ /TK5N[9H))8]IVJ>IK+MK<Q7\)0#)
M<8SSWJVVV6X\NQ]4_#%8/AS\+'NXY!'K&LS1Q7,J*-T-IGE<]<N<9'H,<[R*
M]%\ Z39^)OBII,^2C&_$CY(Z%O+B5?RS^E>,7NL6]SX U33R2TUF8D)'7]X4
M'_M,_G7K'PS\^WOB8)O*U;3Y(B<<\#]Y$_T;^9/MGYW'/V?.[ZZGU>!IJ:BE
M_6_^1]#Z]9/\._%6N:JJ1KI%T$OV69"T15@1)N ]&5F/H&'T)K?BWPWXAT]X
M+!--2[CP[V-]<\'WCD9@I'<%2#CL*ZN&>V^)O@C4-.D_<W:+)"JOU$4HRGX!
ME5?P-?(/@'P-=Z-H:2^)!+;:J\HTZU@&?E"@>=)Z@*" .^<CMD?+T84ZR=2<
MK25OF>Y^\O[%1/T=_8MT!-$^']TT,$5K#/+O\J%BR@EY'R"22<JZ')/.:^B*
M\L_9OT!]%^&%C/)%Y#W[&Y2+M'$>(D'L$"BO4Z^XP2E]7BY;O7[V?!X_E6*F
MH[)V^[_@W"BBBNTX HHHH **** "BBB@ KYM_:C\)"VU/3O$,*82Y7[-<$#^
M-1E"?<KD?\!KZ2KC/B_X;'BCX>ZO:JF^>.+[1#QSO3YN/J 1^-=.&J>SJJ1Y
M^/H?6,-*/7=>J/BL"G!*<J<U(JU]3<_.+#52I%6E5:>!BH;&(%IU&/2GJF:5
MQB*N36WX2U8Z#XFTO4 <"WN4=C_L[AN_3-9(7FI%7%1*S5F5%N$E)=#[K5@Z
M@@Y!Y!%.K \!ZG_;/@S1;PG<TMK'O/\ M!0&_4&M^OE6K-IGZA"2G%274***
M*184444 %5=3U&#2-/N+VZD$5O AD=CV JU7AGQU\;_:KE?#UG)^ZA(>[*G[
MS?PI^'4^^/2M:5-U)*)QXO$1PM)U'OT]3SGQAXFN/%_B"YU&?*JYVQ1D_P"K
MC'W5_P ]R:R%% 7-/ Q7N*R22V/SN<I5).<MV %/ .:%7)J=(^:&R;")'TS4
MZ1XI42ID2LVRDA%2IDCSVI40&K$:8%9MF\8=Q(X<D #))P *]^^'GA,>&=&!
ME7%]<8>8]U]%_#^>:X7X4^$O[3O_ .U+A,VMLW[L$</)_@.OUQ7LM<%:=_=1
M]5EF%Y5[:2]/\PKS?XS#-KI?^_)_):](KSKXPC=;:9_OR?R%80^)'I8S6A+^
MNIY8J^U3)'^=.1,5*J9/ KK;/F8P$5:E6/-2)%CKS4RITK)R['3& Q(NYJ95
MXXI1@"G 9K)NYNHV% Q76?#C_D.2_P#7!O\ T):Y95R.:ZSX=KMUJ0_],&_F
MM2SIHK]XCT>BBBI/:"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "HKF".ZMY894$D4BE'0]"",
M$5+2'I0!_/#\8]%CTKX@>(].@A\F*UU&YA2,]45)F4+SZ!<5Q>BZ0UQJ]LV
M!'(K$_C7T)^VMI-GI_[3GQ#M[)1';#5'D*CIO<!W_P#'V:O(?#P#:E;HJ )Y
M@)]377-)+F.JE'GLF.M+HR:UKMCNQ]KC38/5D974?CR/QKZ(\,:LUO?^']1M
MG6W_ +7LDTV:=Q\B74+CRMW'1D*_K7ROXE+67B"9D)&)#@CTSBOHOX5P)XR\
M$3:<TP#-B>&4 ':1U/7@@GG_ &3[''S6:027.]NOS_I'TF3S<FZ?5;?U]Y]"
M?#WQ9J.E^(;2RU#?YD>ZT?/WA&6)"2#/WD<8![J<\@@GU7X6_L\:QXZ^*B77
MBS3[JPT*S,MQ$)4V_:P&3A3Z-N!)],@'TY3]FV&U^,OB[P_#JBF+Q%I;"WU.
M,X"W,,>2LA']_P"7:2/7Z5^AZQ(I!"@$#:#CH/2O+RW QJMU*BV?WG;FF92P
MLO9T5[THZOMZ>8D$$=M#'%$BQQ(H5448"@= !4E%%?7'PFX4444 %%%% !11
M10 4444 %(RAE((R#P0:6D- 'PUXOT/_ (1[Q5JVF@86VN7C3/\ =S\OZ8K+
M"@5Z?^T1I?\ 9_Q&FF"X%Y;QSY]2 4/_ *!7F87-?4TI\\(R\C\SQ-+V5:<.
MS8@&:<J$\T]4Q4@6KN<]ABQU(JTX+BG 9%*X[#=M/"YI0M/'H*BX6/I_X!W_
M -L^'=M%G)M9Y8?UW?\ LU>C5XU^S5<YT36+7/\ J[A),?[RX_\ 9:]EKYZN
MK59'Z)@)<^%IOR_(****P.\***9)*L*,[L$11EF;@ =S0!S7Q#\81^#?#LUW
MD-=R?N[:,_Q.>_T'4_\ UZ^7)I9+J>2:9S)+(Q=W;DLQ.2375_$KQBWC+Q%)
M+&Q^P09BME_V<\M]3U^F*Y54SUKUZ,/9QUW9\)F.*^LU;1^%;?YC *D1,T]8
MZG2/\ZWN>58C2.K"I3TB]:F6/-0Y&D8W&(M3(G_ZJ<L6:F2/VK-LWC 2./':
MM70M&GUW5+>RMQ\\K8)[*.Y/T%452O:?AAX4_L;3/M]PF+RZ4$ CE(^P_'J?
MPK"=3E6AZ6$PSKU%%[=3K-)TN#1M.@LK9=L,*[1ZGU)]R>:N445YY]DDHJR"
MO/?BZ-UMIF/[\G\A7H5<%\5EW6VF_P"^_P#(54=&<V*5Z,D>:)$2.:G5<4JK
M4@6M&SPXPL(HQ3P.:4+FI4C]:BYLD,5<C.*E1.,T]$Q4JI^-0Y&BB-5*ZKP
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MQMG'U]*\/!4EAZ2HN5Y+<>85:F(KNI-673T+5%%%>@>8%%%% !1110 4444
M%%%% !1110!\_?M0:>!?Z#> <O'+"3]"I'_H1KP\)7T;^TS;!_#NCSX^Y=LF
M?JA/_LM?/ 'IS7OX65Z*/@\TA;%R\[?D-5*>%IRQGO4@05T7/+L,"4X+BI M
M2*GM2;'8B5">U2"/%2!:>%S4A8]@_9NFV:EK<&>'AB?'T+#_ -FKW>OGW]GE
M]GBN^3^]9D_DZU]!5XN)_BL^YRM_[+'U?YA1117*>L%>5?&[QK_9UB-"M),7
M-RNZX93RD?\ =^K?R^M>@>)O$%OX9T6YU"X.4B7Y4S@NW91]37R[JNH7&MZG
M<7UT_F7$[EV/;Z#V'3\*ZJ$.9\SV1XF9XGV5/V4=Y?E_P3.6/UJ94)QQ4J09
MZU.L-=[DCY#E($BYJPL8':I%BZ8J5(,GI4.9K&F1HN:G2/UZU*D..@J01>M9
M.9T1ID:IV'YU,J9IZQU;L-/EU"[AM8$+S2L%51ZUDYG3&EV.B^'7A/\ M_51
M/.F;*V(9\]';LO\ 4_\ UZ]M P!6;X=T.'P]I,-G%@E!EW_OL>IK3KFE+F9]
M3AJ"H0MUZA1114'6%<'\4QFWT[_??^0KO*X;XHC-OIW^^_\ (4T<]?\ AL\\
M"]JD5/7I3U3!J15_&AL\I1$5,=JE"XZT(M2JF:S<C51$1,\_K4JI2JOY5(%K
M)LT41%6NE\##&K2?]<3_ #%<\!71^"!_Q-I/^N)_F*([HZ(*TD=S11170=@4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!_-186<<S>7Y*G=TXYKT'0?!NG20;[FU7)')4E2/RK
MF_#,$9N 9,<]Z] FD\NP8Q\D+VKZ2M+[,3R:,7\39Y9XFTY;747@MI2T2G^/
MKGOR*N:,+FU5%F0JA&58]&]<&L^Z9I;PYR6)Y)[UZ9H^D#Q!I-OI:KY3@^9Y
MH&3'@=?ICK422IJZ-Z524I:F=:0*\?F 9R,U/#:O,X[(II;*TFLX(8YXFB=X
MTE4.,91U#*P]BK CV(JW9,;B\2-1A5;)]ZP=:ZNCU''ET:-73VLHKJVBU;1+
M+6E4,\"70.Z#)SD,.5'?:,9)ZU[OX+_:$\8^%3#_ &7KUQI:PKB-(B9% '\.
M92^1[$D>U?-YUN;3M;U@O!]I6WCRG."I_BQZX_D*BT[6[S69%:YD*Q_=\M#M
MR.O)'6O,KQIQ=Y1NSHHTZV(DXJ5HGZQ_L[?ML:3X_N[7PWXON+73_$$K".WO
M8\)!=MT"D$_(Y].A/ID _5-?ASX=L["1%22R@=?4)AOJ&'(_ U^@O[.'[7NE
MV?A^Q\->-;NZCGMAY5OK%QF57C_A65OO9'3<<Y &3G)/#[:+=GH=U;*JM.'/
M3?-Z;GV#1573-4L]9L8;RPNH;VTF7='/ X=''J".#5JMSQ6K:,****!!1110
M 4444 %%%% 'E7[1L8?P39G^[?)_Z ]?.(CQ[5](_M$<^";5?6^3_P! >OG9
M8OQKU\+*U,^,S57Q+]$1*F:>L>.U3B+VIXC_  KJYSR>4A6*GB.IA'[4Y8\F
MH<Q\I$(Z>L=3K%BGB+VJ'(I0/0O@&-GC2;WLW_\ 0DKZ$KP#X%ICQI*?2T?_
M -"6O?Z\RN[S/L,K5L/\V%(>E+7%?%#Q=_PCNBFWMWQ?W8*(1U1?XF_H/?Z5
M@E=V/1J5(TH.<MD>;?%OQ>?$6L_V?;/FPLV(R#Q))T+?AT'X^M<-'!BK"1<]
M*E$?I7>GRJR/BZCE7FZDNI L6*F2$FIDAJ9(\=!4.81I$*0XJ98\]!BI4BSU
MJ98_:LG,Z8TB%8L5*$]JDV^U/5,]JS<CH5,8J5ZA\,/"_P!F@.K7"?O91M@!
M_A7NWX_R^M<EX0\--X@U5(V!%M'\\S>WI^/2O:XHUBC5$4*JC  Z >E3>YZ>
M%H:\['T445)ZH4444 %<3\3!F#3_ />?^0KMJXSXD#,%C_O/_(4F[(RJJ\&C
M@E6I56@)FI%7.*R;//405,_2I57-"K^ J4+^51<T41 O%/"^E*!FGA*FYJD(
M%KH?!:XU20_],C_,5B)'S70>#UQJ;G_ID?YBB,O>1M&.MV=E11176;!1110
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M]:D KF;.91$5:D50,<4JK4BI4-FJB(BX^M2!?3DTY5IX'I4MFB0*N/>MWPF
M-1?U\H_S%8ZI6UX6&-1;_KF?YBG!^\BK'64445Z PHHHH *Y[QWXWL/A]X>D
MU;4$FG'F1V\%K:KOFNIY&"QQ1J2,LS$ 9('<D $UT->>?&OPGJGB70=&O=%@
M6]U30-7MM9AL&<(+ORB0\08\!BC-M)XW!<XZTGT^7W7U_K_(:_S_ "T_$KZC
M\4M?\'Q6VH^,/"D&C:!/-'#)?V.J_;&LB[!4:YC,485=Q +1M( 3SQS7I76O
M%OB;KUY\8?!-[X,T'P[KMM>:RJVMY=:OI<UG!I\)8>:[22J%E8*"%$1?+8Y
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MCM7N/P>\+I-<J=@_*O(_#6G076H7MU9QR)8O,WV=9@-XCS\H..^,?E7T_P#
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M*L2 FKVEWPT^X,K(7!7;@'%45Y-2 4TVG=%61T/_  DJ?\\&_P"^J4>(T/\
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MGX15Z!\-_$OE,-*N7^0G,#'L>Z_X5O2J:V9K#W=#T&XGCM8))I6"QQJ69CV
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MFME/(6Y&XX/XUT7ACQ*R63Z9%.JW%]*9"[#@L0 J>W2O.G+FT/3IM1=SVCP
M@ET&UECZQ-)%P<X <X_3%>8_M$::\>N:7J;*<SPF$MZE&S_)Q6]\+_$-YHNH
MW7AZ[A*WD\OG6X<$!R5&X#(_V0?SKM?C9X GUOP+:WDFV"2WD,N7/1=C$_\
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MO+;W5K)>V4-PT-\JK.A9 2'"@#=SS@ >PZ5NU<DXMQ?0E/F5T%%%%2,****
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M$TR6AG0\T;O8TC'%&[--$-"THI,T9S5$V'9 I0<TW-*.!FK'8>II0.::.M2
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M&7-=1\/-5ETC7M*U*.3"R 6=P"?4_*3ZC@#\!7.[NZZETVE--G?_ !S\*O\
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M3]3FO-N=/*B<' IRMS40-2"BXTB0'%2#I4(/K4B_2E<NQ*IJ:VMI;MRD*%V
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M%B<U6_LP6E^@V_N[E1,H]'4!6_,%3^!K-QUN4HZW/0K07#:>VIV-W]CU.)0
M2-T<H)"L&7OC.X'J"ON:K_#3XCSS^)TCU#<M[YNUY@02S XZD<8].15>S=I]
M&MBDACVS /CN!VKSQ+PV/C>]6,X:._D0@?\ 70UR8E7@UW.[#2Y*L7V:/TDO
M- 36_#%E<++Y4L4I>&4(&.&'/7Z#\JZ7PEJWB'P]/;SV?B&]CDC(+QP2%$8
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MI?"SUZ\%7PZJK=:'OE%5["^@U.SANK:02V\RAT<="#5BOK-SP@HHHH ****
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M=@J1 88XKS)TF=T<33>AVFF:J;U W"D=B:V(9'('<5QMA"+B18HHWED<_*B
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M:%JDQ71-1D"[G/%O/T#>P/ /X'L:^SP<C->\U8\N,N9"T444BPHHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHE_71+=GKT\%3JK67*DKM]E_FWHD?+-UI&J^*-;EGN+JR:^O)?NF[1F)/0
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M"SR<[>^0.IR ?6NZ>(:A9]3Q5AHJ?/VZ&!%IX,;R%F?@DJ%HT]!)#)(Z9DB
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MP1@^J#]:^OQU/GIN75W7X6N>!@*KC44>B_K^NYT&FZ]>:;\0<V\9V"Q"E-K
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MG9K.WA5=Q :6[F+$*H!_A);\EP.].UCP0=0T O?2QV:PR$!&A63S9"!D@ C
MR& ^8?*BG&,FN^21BO,\I\#^#9O%VI!6W1647,TW_LH]_P"7Y ]/XCO_ /A-
M/$>F>%M%5(-*L&,$6W[K-_RTF;V 'Y+[UWLOAV3PS\.8]8\.M%J5O)"_VF"R
MS]HLQG!=T8;L$E<. 5VELD':!R_P\%AX&LI]:NT=M1O4:"QBE&0GJS$=B<#/
MLW3%<K2GI'YG4IV]Y_(Z37;J+2)X=%TU#&(X4@ /WDB'(!]"Q)=O=OSVM&9K
M.Q LI)(X7.VXOE7(!_NQYZGL3T'N:Y;P5X9FUO49)[R22Y#/OG8#:9,\]>P/
M\NE>Q1:W:6J+::5':K=P_*7E'RV^!QY8(VY]\\8Z5XN/D[JZV^Y?+J_P[]CZ
M;+6H1Y:=[OMN[^?V8_B^EMSB_$VG0Q^%E:[D-NEPQ5) ?,FRS!3E<YYSU;UK
M2:)=*@,=K$R7955'F$,]N&X )X ?'7CY1@=<XS?&6NZ:^LZ=,(+IEBNP9&MY
MHR=J+AMJD<-EP03P2&]*+2^C6'5[JVN?^)8;G,9O %F9 N1D9(R>2<$UZ^';
M]A"]]NI\WBTOK%1Z;O;;302&"#P]J-]<:C"L]V=L,2!PRDX^\3[=<5FZSX^>
M^$:R3\PIMC"GA?3Z5C:C?R:]JCR!O)BDDP !C ( )Q]!5"XD;3XY[81(&<"3
M'5C@' Y^IZ>U=B@DT^IS;IIFOIGB\6EP!-=%'F+*TQ&W/ [ <\$5TVG:A#([
M6MU9))"5+HZY5CR.X_#K7!^&-)LYM5\[5W939RM(L&TMYF40@DCZ=*Z.SUFV
MN;W_ $Z;[);7!!AE<%RKY(S&!TX'3OM!Z@8RG)J_*M/ZV+44]SK[9]-M/#,O
ME7(M+J%W54O95VY9F*J&^Z.AQG'8'FJO@?7X+3XA6MVL4A%C97$LDD[ ;VV<
M%!G+?Q=/6N"CTN63PU-:D S?:>\@8$-_%D'IDG_/-3^#Y-1T?49((9G(^T)]
MG$P#*"%()13P,DXR.PZUDZ"E"2[E*;4D^QU>GWR76J,;SRDA7<S%B>.IXZY)
MZ"L3Q#X"NO&<TU]H>[3KZ)'9I$E9/M(7. 0H^\%[^@.>E=3;:5;V?@ZXU"YM
MF>YN[U+*WGZ",K\TIV!O[O&[! YZ<&MJ?7(M'UB[O[-XS;SWK/'(#N$I.?NX
MXP?RQ64JCE=T]UIY:;E*/*US=3YGFUKQ#X5U%DOQ.9=N#%>Y;((ZJ3['@@_G
M7HD7C2V\>:&B3QJXLK?[%:VC.<P%FW&8XZD\ =N.F15CQYI]U\0O$6IP6GE"
MWMHA=.6RJK\H4=C[_P Z\A:\:QE$;0+M1]K)T)P>1GL?>NE6J6;W7X7*V5D?
M07P&\8VTUQ>^%M2;*7&X6TBC<%<=1D=FQUZ<"N-\3QIH&H7DFH6R+<32R>9!
M)RP))VY&>2 <#MP*KO!:Z-X9L?%&E,(&AO(E-N',A=' XQURK84D<98_6O3_
M (@:#IWBCPM;^,7ACDB*K%=C8&82#&WKTSTR/ZUR.:I5DWM+3Y_\$VC'F@VM
MU^1X;J.J+=H6X@@3 6V5R<< 9.>_KCUZ4[48;:QM+%TN5*7<9-PI3#PA2I.U
ML\EB2O;%+>>*=*CT_4K3[#%'-<E CPQ >6JMD]AR<=JP9KJ*2>*-R\OV=6PX
M9=K E>G7D8KM>I*-.>^EUB[^T72[;&U'[JT4XVKGY4 [$G&3UZGH*]W_ &+/
MB3J7P<^+#>);F\DMM'F3[/J-FHW?:49LY*=1MY93Z\#(+5X;;VK/_HL:@1*X
MEG=#DL[#A01Z8_5C7JMMI]AX1TORU8%4&Z4*V2SXY_7BLU"[;85:EH*$3]K]
M'U>SU_2K/4M/N$NK&[B6>">,Y5T89!'X&KE?"7_!.']HN7Q(-3^'.LOL:#?>
MZ,2>D6?WL&>Y!.\?5_05]VUDU8YFK.S"BBBD(**** "BBJNJ:G;:-I]Q>WDR
MP6T"%Y)'. H%)M)78TKNR/+_ -HOXR1?"OPF(;2Y2+Q#J8:&R++N$/9IF'HN
M1CU)'!YK\]-+^WW1O(+N0W-W%<W,<TI)=B6E$H?C.[<)!CU)'K76?$GXC7?Q
MO^(%Y?2(T$CR>3;@,3%';C.Q.>CXR3C@DDD*.:R[6XLX-)OM*LXV*I?29O"=
M[,XM@Q50/NJ??KUX!(KYW'XU1G3C3O>^ODGU_P"!]]CWL%A7RS=1:6T\_(98
MZ?'%JC>7+Y4QL+B$0H^3\P4*"PZDL6)QV)IMM.+?P5X3M8"8PNGI/N5OXF 0
M_P#HH?G6';W2KI]_<>1).);:YMX9(WVLA 3+CZ%L5T5]]EMFL["0+$EM9V\2
M2(N2A\I2P/J-S'W'Z5Y>$HM9O-/51N]O[J7X79ZN-J)Y3![-V7XM_HC4TK4X
MKS37L[R)[QT=+B H=LFY74R 'OE >N?NBH<0-,!8RR3QL,[95".OMUP?P/X5
MF6D\NB:O:SQ*?M%O()02?E88/Y@Y'U!JYK426^IR_9N+63$D63T5AG'X=/PK
MZ2,.3$24=I*_E=;Z?<_O/G&^;#Q<E>S?KKM^319#2DK'(K*_*G/!ZG _[Y*T
MW0':V\-ZC>O\K1/&BN1QS&C]<CIO'7M3+*Z>6)H%? WJ_)[D8_\ 9!3+^R$'
MA._4Y=)H([G@ C*JL>.G/^J_&OF\YERTX4GU;7ZGU.113J5)^29J7RP%I)O.
M+K# ;9(<\)(%0%E..3CS%)Z<5H2ZJNGR7L$:&6VDOE:YF\P!1E=H12 3NR5)
MXQQ@D=^(\2:S)IGA:ZGNR6=U:X@C=-S,0,9)Y Y;[QY.<#GFN@BMX]0T-UO)
M?,M4N8A$H4K@LDF.1@=$X(ZDCN.?)H1G448K2/-'_/\ #4]'$J%+FE+5V:MZ
M:?Y&\MS$T6%)/MTQ7+_$2W270TMP9'>598T#.S<A-_<_6E:UNM.D4Z?=M<Q#
MDV]\2W_?,@^8?\"W5<U*X75-(TMYHFM+M=3$0AE()._RH_E(.&&)">O;D"O=
MS/EI45-K6_\ 7Y'AY=S2K))Z?U_F4?[7-OJ$^H3[)EW&5G' V>;'*",]3\Z@
M_C7I'A+Q5]AM#<2S":RGWI/,@RI1@5WKZJ"<@]U4=>M>.>'XKG4D@M[9V$BV
MJJS@XVABL<C ^H08'HPKMK&R.G6%WI2Y^RM&_P!GZDJC9!3_ ("3Q[$5Y&'I
M4\31J*6W-IY/2WX_UJ>MC;T)TX];*_IK_7_#'JW@'3CIBW?V@8==A S@8DEF
M8<?0"B:X,USKJ9R8@)P/8@@G\P*/AMJ+:MI;7<I#LUAI\TK'IGRIB?U_E69)
MK TR>2<*KO<P/#GL<]2?Q4X^M?,X>A.MB)U*:^%IKYWO^!V5*WLX<M36ZL_P
MM^)4U^0-H=^ 0P,;#\^*VM.OI+= %/F;WPRL>"N[K^ Y_"N=U%H[C3[A>1G:
M#SQRP']:U;.,02LP)W!3@,>G;^1-?65ESRE#^ZCPX/E@G_>9J7D$D%^D8P/,
M;"DCKQD5<MKC,49 .[J2>,'TQ6?J:S:GI)D1S]LM2'3CA@.1_A^-4-&U4ZG"
MTR@D%MW7LRAQ^C44ZDJCY7TW]?ZU(E348<R.FUB#S(+>[R0H9920,G*,"<?E
M^M/MKE;B4.IRAD# CI@@<CVYHM-1BDTNXMY#AXB)$!]#P?Z5D^&[U$@:T&<V
M\GE%CT"@X3_QTK7E5FHMU/M1=OEK8[(1;CR]'K^5S?DNUG</$6*8P QSCG%-
M:,EN00>_-#VAM],78BJ58C/KR:K!9N29@!Z566U75H)OS_-DXR"C4?+MI^1Z
M5\)O&3:+?_V9=L18W+80L>(Y#T_ ]/R]Z]OKY&MG9PTAEXW$#'MQ_2OH?X7^
M+O\ A)="6*=]U]: )(3U=?X6_H?<5]KEN)O^YE\O\CYG&T+/VD?F=G1117OG
MDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?@K]I6\>QAC!BBAE,I*?Q' "<?[(R1[L?2KWB6YO]8'V
M>UAWVD$6Q($89?/+*,]W/WF/4 #ITS;JYBT@LJD2M'\O'\3?7TS^?ZU1L&:T
M\0C6=68W%OI@^T16Y.1<7;#]V#[+Z>S?2O3DNJ1SHVM 'BCPMXDLY$F:TU*<
MJ+A(AE9&./W9 S\B)C'7KT-=OXM\+Z=X\L/[<T& //IL'^E:+ @C+G^)XNGR
M\$[1[D>A\3U7Q]=:'8W$DDK7NM:D2R/,Q98$+<R =-S'('H 3W%/\%_$G7O#
M=[#K,=Q$D\)59Q)&H:3!X!Q@\YZ'IU[US3DD]'JC:,)2U/0_#OC&ZD1%,8M;
M*--L=M:QDJ@[L<?>)]3[]*VK348X%:2W_>3/DE3_ ,LQZM[_ %^O05E:UK>@
M>*;"/Q)HVZSU9W_T_2U; !/26,8Y'J!['UK-?Q!-=:4\EK)'#+N!,UZ2@)[+
MCHV>W(Z'W->'/"NI/G:O^I]/1QZHT?9PT?73;Y]V5=0D;5?$5O#;SM&%5&G=
MB52/DLS'Z**FU*X_M*)KQH7BT>U#BV0$*\AX)=\\*6R"..@ '3-0)I5[I.G2
MZA>PM+-<.J2#&Y43L6/0@D#C/<9XZY<T\]_-<Z?!%<SWE\8H5@B4NS$$!0%
M);TP.>37T2BEL?+N5V;VEQQP6TEV\J&-]A\L<M&Q&&'TXX/^T,^_.7VL&\U[
MSK;*R0N/*W]B#\I_.OM?]GW_ ()T>)/%MC::O\1KF3PI9MLD32[7#7LBXY5\
MY6(')!'S'CD"OM/X9_LK?"OX2PP_\(_X-TY;R/&-0OHQ=71/KYDF2OT7 ]JR
M=2*TW'8_(7PG\-/&?B^_O#H7AW69[1XS+)<V>GRSE8M@W;<*=SG&U1W;'09(
MZ?5_V?OB1>P0W]Q\-O%$,-N%:&PATFXDP5! !PF3C/MD^E?M2J*BA5 51P !
MP*7%8<[O>Q=]+'XC6W@GQ-X5TJ[_ +8\,ZSI[&U#N^IV4D&P+@G[R < ?=[9
M]!BN$\!:I%/J37M_<2*%N RJSE1LSSAAR#S^E?OFZ+(I5U#*>"",@UY=\0_V
M7OA;\48)4U[P9ICSR YO+.+[+<9]?,CVL?Q)%6JG<FQ^1O\ PD$MW]ABW7$]
MLDGF^7$X9E?.6 'H< 9]?I5F\%X=(\0ZE]J%A;>8+JXA=,EY/-VA0,X#9D)_
M ^]?5?Q=_P""<^N^$G75/AQJSZYIT,AE?1;X*ERBX/W'&%E(XX(4\<9)KX=U
M&_O-7U#Q%%JUI?Z*-/:13I5\K1S_ &K?Y<:NIP0RAMQ!Z<CO0TFK1_K4N.]V
M56N8H-/GO+N!;J74%D2*:0 M&22%XP>3M8YSQ@>M<EJ.G_;KH&T1F>4;O+'4
MOW 'X=/?%=7XOM#8I-:H>+62*(,IRK/'& Q!]"X8_C7/Z1>9U33#\L;"\'[U
MN0,E=N1Z BMDDM>X^9E>#5+BXTO2M-L]I:*=KJ9B,A>R ^IR6('T]*^@?@5K
M.FZE'J/@J_U%KN#4H6!$K!0CJ<*54'CUXY..:^;+O7(/,OO[-4Q)<W<D@*\%
M(PV(U!]AD_\  JV?ASJU]H'B6RU.VCF"P2;S* 0NT<MSWX[5QXJC[>C**WW7
MJMCJH3]G-2>POC;PP?"OB>[TZ]CD5;>5HF*<$=0&&>OK@XSZC.:SO"\(>ZO)
MY(DN8[4*XC<?*P+XQSU^]^>*^A?VF?"]OXCTK2/&6FH/)NH=ERX(QO7H1CKD
M'K[5\X:9%=-,LD/R2*W]W/& 02#P1S^E3A:WUBE&IUV?JMRZT/9S<>GZ'83:
M+INE64<Z7LL-^K*$D@.5?YLNV#U4<J/7'I5J?Q)<:K&AO'CEC1MSD#RT<^K'
M/!]AQ7.3V]S)<1QH%FE9OF8#"*.YK:T?0/LZ7=U>LS7-N@DA#MA8_F 9B/R
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MBLZ31G EW2'%5-?OD.GP6PSFXG2-@.RYRWX8!KDR"HZE"7D_T#'TE"K&._\
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M$89Y2_'8#(JS+H%V^BP7ZJ#;1J(V)89+LS$ #OP1^=&H0"#2K50>3_\ 6/\
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M">QZX!]*Y[Q-<RV5P]T[+=:A))*1*>2HW;@.>I^?K6RY1[F^#AS*]XT:*O\
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M &<_!-G*FRYN+(7TW&"6F)D&?HK*/PKV.OMX145H?'UI.<VPHHHK0Q"BBB@
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M **** "BBB@ KX9_X*U^*ETSX)^&=##@2ZEJ[7)7/+1PP29_#=+'7W-7Y/\
M_!7'QZFM_%CPYX8@EW#0M*D>5 ?NRW#QD@_\ 2(_C6E/X@/B&$PSZGI=I/\
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MR%&$IX*I.3MRMV^4K_YGU4OW>+C!+XE^:_X8[KQ7=23?!2S"9:2W^PJA/^W
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M=SY5S'&WSR@@\%W+,KCD*$KQ6]?0+J["V=[=Z6EPQ+QWT0G"J,8Q(@!."3_
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M>E.$84H2EU3=OG;]#N?",EM:^&+N[<_OHK:2./C WR2H!S_N)-^=?K]^P?\
M"*+X3?L^Z42WFWWB"5M:N)6C*,5E"B$$'D$1+'D<@,6P2.:_*_\ 9N^$US\8
M/B-X3\&HC/:WMU#)?D<;;5=TTK?A'+@>Y%?NI:VT5E;16\$:PP1((TC0855
MP !Z 5V333W//D]+6):***@S/"OVW]332_V8/&LCOY8D2V@#9Q@O=1+GZ<U^
M9GA3$GPS\8KTFM;N6<#/(WQ!?_:KU^@?_!2O4!I_[*&N[GV":_L8_K^_5O\
MV7/X5^:/@_5;^Z\,>(6M _[UK0W.Q-_[H1NLC-Z#(0Y]<5YF8QYJ5-_WE^-T
M>WECM*I_A?X69D>&TN(/"^HF&=TN[A')@R00NV2,,#G@[I OT<U+%-JR:RRW
M;W$EK=.T2&?)5AD E6/7M^=7O!,2:C\6'TR$"\M[S,,2.,JZBY5G&/<1N./P
MK:TJ&V'B75;*\NVGM=-LI([<A_D6Z958D>O*JI_.E*2E*O22UY4_O3_5&L4X
MQHU'W:_%?YF+H^KW%DETK(N!HRR1@C!(Q"_\EJQX*\0S:WKMJIC5$A<33$=
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M*F^'NKR:#JD]\)"LJI^X8C)$Y^X__ <D_7%9MN#DTM2XI2Y8MZ'NGQ"$&G_
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MFRTADY2;7K52O][$<S ?FHK\[/A:[:?H^O6\.=\NBW"DL."VS*_^BS7Z%_\
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MD!VF9B >^./Y5\ECJ<IYA3MUL_NN>UA:CIT)M^:^^QROA"3S--U'S&P(Y4E
M[%23_P#6JYK-^L7Q4\-W#  .+0%3V!< _I7'>!7GDT?4[=G*M("T9)_A!Q_/
M-1^,=3DM]=LKH$[K6WA(;_: !KT9P3;IM:M2_'_AS!?%S+;0Z5="0:CXDFFD
M$)L9Y412>2=Q%8+ZDR:7$-WRK)C'XM5OXP3/9?$K6K>!RL$MVTN >#NPW]:P
M)(3/I,C!L;'.,^O^36U"7M*,)=TOR15K/5GLG[-5P+C]H3P XZK>,#_W[?\
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ME\?[MM*:_7"O<RW^$WYGR&=_[Q'T_5A1117K'SP4444 %%%% !1110 4444
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MO1?J%%%%>H>$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML5I))/(9/E>2/[6T:X'KF4$CW]J\B,''$5IS?*I75_50_5V.K14Z?*KM)/\
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M_(UU1Y94TX[7?XMF>L9M2WLOPL=GX;6/_A(O$\KCFUMYGC]FS@?SJYXA#?\
M"5)?Q_+%/#$Y;U,D97_&N<NK\Z;JOB$J=OVG<GX%@?Z5I^(=3 \(^&I1_K9=
M@9O:-F 'ZBLI14O9M]4U^"?Z&JDXN:\T_N;-*'Y=)N(P<!IDE*_57-9?A:99
M]4^3@MO4?BI%75E"&XY_=M9(5/;<K$']&-&CZ"N@7MA<2W D69T8;1]ULD%3
M72[)V?4R3T;/I[_@E_I1E^*_B6^=?FM=%:#/^]/&?Y(:_2RO@3_@EYI?_$V^
M)MZ0<0M9VJ'U^:=F_DM??=>]@U:BOF?'9I+FQ4OE^04445VGE!1110 4444
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M*NBKQK]G'_CTUW_?A_D]>RU\YBJ4:-:5..R/JL'5E7H1J3W84445RG8%%%%
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M_P #7,N^[\*ZFWE GG[-<9D0_P#?8F_2OM*NUZ'BR5G8****1(4444 %%%%
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M>\TNZ:0DNTV_)ZY;)-=5-6J-+9)?J1+6*?\ 70OI"R:7IQ88\^265?=00O\
M-6KH!I*R75G#(,RZG/!,Q[K;PPC/X,S-^,59=S&9'TNUC!+6]C&I _O.Q?\
M]J"M^TO?-O=1U"5AY5C:P:3;GMN.$./J1(?QIR;FXKSO]VWXEQM!2?R^_?\
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MOIT6EZ+IT8CA@C')[EF/5F8Y)8\DDFNEHHKJ//"BBB@ HHHH **** "BBB@
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M9&5$,+!\'V9F1/\ @=?ME7I8.-HN7R/%S.I>2A\_P"BBBO1/#"BBB@ HHHH
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MD21)LS,IPQ8$XX_NAJYV[_;5^.$<NGQI\3-<!-MND99P0S&60@_=ZA=@_P"
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M&$;:WVGYA_>7R@/YXK:UJ-A\-;.=5(%Q+!$6]U3:/T+?E7'BUS147U:7RO\
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M_ G%+[U<^URB:H974:>^O_@*;_.QX7X<N+>3P]K-M/\ ,TTUE:#_ '3YF_\
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MG3Y8A*;21)7C/.]6$)./3(DSD?6LIM)6ZTJ\ACA\QYIY)%8'[K+NP?Q"!?\
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M:Z=X7TS$]P@\V_ORN&N[@_?<^W91V4 >IKTNBBNI*VB/(;<G=A1113$%%%%
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M-/\ R+MC8A?!UY#O$2-#;0[OJ1*1^;D5NZ=I"Z-\+H/G\^&&[O3O]"\,*_\
MLU<+ )==M_$$+3O!% _G*J?["2E5_P#'1^5=MX?G:3X#,6.3]LDY/?,ML/Y"
MO-KKEC9]9_H>GAYOF4ETA_[<CF+^^.I:IXJNBI0+9P1*#Z*T2Y_'&?QKH/AR
M)+>Z::-0YBL))64_W2,-^AK/OX(CIGB)U0(?*1./03H*N^')S86MU*@Y\N.$
MCIE?/@!'XAB*ZZE-*,:?2Z_)'+&H^:4^MG^;-WQ';Q-;-=VVYI[>9K"Z&,X4
MX\MS[$%1[?**M^.Y)/"VEWMNK@M=SS(SK_<V;!^@4UE:1=2/KVO6@8K#,D,D
MB]=VTKP?J50_515KXT 6>GO!S(\5R4$C'DC<0?SJ:L73G2A)WN_^#^?X$T6J
MD:DHZ67_  #HM(E/_"EQ&/F-R;92_<@3W6?U(KRSP BZOXO\ &%P+C^T4L2O
M?B=9%;_R-C_@->F:"[/\-/#4&<)/*0W_  &=L?\ H1KS#X,AK?XM:#;AMR6V
MH"=,CHT89@?_ !T5P4URT:\NJ<G^#1WUO>JT(]U%?BF7/C_JJZM\3-:U&)MT
M4][=2HWJIF8C]#26>K2PV/A_5(GQ/ ,#'8HP(_G7,>+Y&N(]/D<Y9X,D^IS5
M_0[AI--B@;E(WROXCG^0KVJ=%1C&GT22_!(\B55\[J+>]_QN=%\7-,FA\06%
MX4"_VA:).H7NP41N?Q:-C^->>QVDL4P8KC]U@_7->I^/YVO/A_X2OI.;BVNK
MBS#'^*,10L!^!WG_ (&:\UANWGFVOSE=_P".:PP=W0C&6\;K[FU_D=.+M[>4
MH[2U^]7_ ,PU=3_9D..[Y/\ WS4AT]=1T%5\S;*DI,8[,2HX_P#':;JK?\2Y
M![BDD8Q>'H95X<7&0?\ OJKK:./JOU,:>M_0=" =%L@W$D,[*1Z!DR/U4UUO
M@/X9>*?B[XVL-#\(:1/K&LR7"[4A'RQIM!+R-T1!W8D"NC_9S^#T/Q[^,&B>
M#KC4WT:WU/$LMS%")64(I)"J2!DC(SVST/2OVQ^"?P#\%_ 'PRNC>$-*2T#A
M?M5]+A[J[91@-+)C)]@,*,G %"I-OYD5*R@K=;'GG[*W['V@?L]:?_:MX(=8
M\<7<>+G4RGRVZG),4&>57G!;JW? P!]$445U'F-N3NPHHHH$%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>exhibit99-5xu006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-5xu006.jpg
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MNP["I*8@HHHI#"BBHV8N=J'ZMZ4 #DR$HIP/XCZ>U/50J@ 8 H50BX P*6@
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MD5<XX)S3HW.=CC#C]: %\Y/[PI),,AV;6;ZU)2%%;JH/X4 4(_,MI-S*0O?
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M&3P*BA3RHPJ_,?7M3]F3EN3_ "H*$RS]/E7U[TY5"C &*6D+!1DG ]Z0"T5
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M-(EME\L%Z]?04FTM][@>E5EN)"Q58P".I8T.9@NYY @] .:+#N6BRHO)"@5
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M&.)F'J : )***9(Y7 '+'@"@!'8NWEJ?]XCL*>H"@ < 4D:>6N.IZDGN:=0
MQHE<Y(Y]1P:/+(Z2-^/-/HH 9L?^_P#I1Y9/5V/Z4^B@!HC4=N?4TDLRQ#)Z
MGH!U-1R70W;(\,WKV%.B@VG>QWN>YI^HO08L9)\V7C'(7L*KLS2S)(> 6P!4
MTK&XE\I3\H^\:9<MB6-$&=HX JD2RR\JQ@NQ]A4*1M<L'D&$'1:=';EFWRX9
MNR]A5BIV':^X=****10445')/'']YAGT% $A.!DU5:Y:9ML0X_O4[[4S\)$6
M'J:A-K(YR%6/Z&J2[DM]B>*V"')&YO[S5*58]6Q]!3($D0'>^[TJ6DV-#/*4
M]<M]32B-5Z*!^%.HI#"BBB@ HHHH *0J&Z@'ZBEHH B:VB;^ #Z<5%)#Y"EE
ME*@=CS4\LJPKEC]!ZU72-[IM\G"=EJD2[$:%[Q@KMA0,\5>1 B@*,"H  MX
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MU%53&1(Q +1J?N4;BV)S,F< [C_LC-&]CTC/XD"E0JR@IC'M3J!C-S_W0/\
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M11*,LV[_ &>@%%@N.\U<X!W?3FEW,>B?F:<  ,#BBD,:"_HOYTOS>@_.EHH
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M[LCK^.: ):*A*S+T=6_WABCSI$^_$<>JG-%A7)J*B2YC?@-@^AXJ6D,****
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M>0:B3]RP0GY#]TGM[5+2,H=2#R#2&+13(V()1OO#OZBGT -;J#^%0V7^I/\
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M*<G!8>AHN)+2S([>?S%(;AUZYID8^TR^8?N+PHIMU'F90G#-P<>E3JNT!$X
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MK,T$3)@;T/YBK3\#(ZCFH+R+>F]>HZ_2FA/R'172RX5QM)['H:=Y1CYC./\
M9/2H88UG@4-] ?2GPRM&_E2=?X6]:/0%YDB3!CM8;&]#4E-=%<889J/;(G"L
MK#_;ZBD,2*01VZLQQ0D;2MYDG_ 5]*BBC>,@O&6 Z 'I4_GXZQN/PI^@EYDM
M(SJ@RQ 'O4!NB_RQ*6;W[4):[CNE;>WIV%*W<=^P&Y:0XA3=_M'I2?96DYED
M+>PJR %& ,"BB_8+=QB0I']U0/>GT44AA1110 4444 %%%% !1110 =:B:W&
M<H3&WM4M% $'G/$<2KD?WEJ96#C*D$>U+UZU5G MSNC;:Q_@[&GN+8LLP49)
MP/>JYD>Y.(_EC[L>])$ANOGD/R]E%6@,# X%&P;C(HEB7"CZGUI]%%(84R7_
M %3_ $-/IDYQ"_T- "6_^H3Z5)3(!B%/H*?0""BBB@ J)/FG<^@"U*2 "3TJ
M. ?N\GJWS&F!)1112 *8GS%F]>!]*5R3\HZFHYIO+PD8RYX ]*8F-N)"[>2G
MWCU/H*FCC$:!14<4:VZ_,<N>I]:?EF[;1[]: 7<B>VBS]TECS@&F2HL.%11Y
MC<#':I995@7 &7/0=S4<,1\[<YR^,GVIB)XHQ%&%':GT45)04S.)#Z8I]5KU
M]BC'4@BFA/02#,TCR>O /H*L@ # JK!< ;8XT)]35NA@@HHIKR+&,L<4ACJ*
MA\UW^XF!_>;B@P._WY"1Z+P*8KDC2(GWF _&HS>1#H2?H*<MO&O\ /UYIEP/
ME6-1@N<<>E&@.X6GSAY.['\JGJLR_99%8<1MP1Z>]6:&""BBBD,C^Y-[./U%
M24R7@!O[IS3Z8$<DWERHI'#=ZBD^>YC3L"6--O06DC"]<$BEM"97>0]>!3Z7
M(W=BU11TJ$YG.!E8O7NU26#2M(2L7XN>@IT<*QG/WF/5CUIZJ%& ,#TI:8K$
M,G-Q$/J:=+#YGS [7'0TT\W8]D_K4U $<4N_*L-KCJ*DJ.6,MAUXD7H?7VIT
M;B1<C\1Z4#'4UUW+COVIU%("*8[[9C_LYIH.;0>Z@4Z3B*4>Q/Z5''S#"/4B
MJ)+(X%%%%24%1S1JZ889/:I*8OSMN[#@4 1%9;=25<.H[-UH6\! +*R@]\9%
M.NFVV[_E3XEVQ(/:J)ZZ%5Y8UFWJP9&^\*L*B*P.T9[,.].:%''*CZXJ")C"
M_DR<J?NFC<-BU4;?NVW?PG[W^-+DIUY7U[BG<$>HI%"]:;']W'IQ34^1MAZ=
M5IR?>?Z_T% A=H"X  'M4<L8GC]&['T-2TT<,1^- R"*:1QL"@.O4L:5(4F&
MXN9#ZYZ47*F-UF7MPP]15:.)I"Q1B!GM5$>1?DD6)<L<"JX$ET<G,<7IW-,C
M99GWR,I/92< 5;&6Z,/PI;#W".-8UPHP*4NHZL!^-)Y8[Y/U-*% Z #\*DH;
MYJ>N?I1YR^C?]\FGT4 1^<O?(^JFE$R$_>'XT^D(!Z@'ZTP%!!Z'-%1F!#T&
MT^J\4FR1/NON'H_^- $M%1"< XD!C/OT_.I:0!1110 4444 %%-=UC&6.!4/
MSW/K'%^IIBN*]P6;9$-S=V["G10!#N8[G[L:>D:QKA1@4ZBX6[D-M\ID7T8U
M-4,?%Q*/7!J:A@@HHHI#"HKHX@?Z5+45SRJ+_>8"FA/8D484#T%+112&%%%%
M $<W("?WCC\*DIB_-(S?W?E']:?3 CN)O)CW=3T IX;Y QXXJA<L9LL/N*<#
MW-2_O+K 7,<8[^M.Q-]1SSEFVQC=(>I[+2Q6I3)+G<>I'6I8HEB7"BGTK]AV
M[C50+T'/KWJ*>Y$7"_,_IZ4^<N(SY8RU58[>4=PI/?J::$WT0JXC(E:17;/(
MSVJS#\P+G^(Y_#M5>TB!DDS\P'&34\)V,8CVY7W%#!$M%%%24%5KEB\BQI@M
MW]JDGF\H +R[=!1!#Y2\\N>IIK343UT%AA6%,#KW/K3V8(,DX%-,A)P@R>Y[
M"A8\'<QW-ZFCU#T&Y>3H/+7U/6G)"J'.,MZGDT^BD.P4444 %01?O9FD_A7Y
M5I]P^R(X^\>!2Q1^7&J^E,74<Z"1"IZ&H[=CM*-]Y.*EJ&3]W,C]F^4T ^Y-
M1112&(R[E(]1BD0Y13[4ZFQ\*1Z$T 0M\UZOLM3@ =!BH(_FNY#Z#%2.2YV#
MC^\?2FQ(0_OSC_EF/_'JEZ4 !1@# %%(84444 0IS<R'T %35#!R\I_VL5-3
M8D%1./*?>/NGAO\ &I:0@,"#T-(8M%1Q$@%#U7]1VJ0G R>E $5QQ&Y]5(ID
M(XA'HI-%S('MBRG(-.B&),?W4 JNA/4FHHJ,N9#A.%[M_A4E"L?,)4=/XC_2
MGC@8I%4*,#@4M %>[^;RT_O-4^0#C(SZ55>5?M)=ONQCCW-,A9GNE=N-V<"J
ML3?4O5GNLCM(/O8;H>U:%5C^[NN?NR#]:2!BVDQD4JWWEJ4QX.5.T_I2@X.#
MU/?UIU T1/N(Y3D<@J:6 E@Q/#9Y'I4E1N/+;>.G1O\ &@"2FMPZ_B*=3)#@
MI_O4ACF4,I!Z&L]7-L[J?6M&H9K59GW$D'VIIDM7V(G>U_N@_05"QB;_ %:/
MGV-64LD!RQ+G]*G50HP  /:G<5FRM;1S*V6)"^A-6J**3=RDK!1112&%%%%
M!1110 A 8$$9'H:B,;0\QG*_W#_2IJ* &1RK*,C@CJ#U%/J*6$LV]/E<?K2Q
M3!U)/RD?>![4Q$E12SA#M4;W/84PR-.<1_*G=S_2I8H5B'RCGN3U-&P;[$:0
M%FWRG<W8=A4]%%(=@HHHH A7BZ;W45-40_X^6_W1_.I:8D%%%%(85$_S3H/[
MH)J6HX_FED;WVC\*8F24444AA37;:O'4\"G4P?,^[L.!0 Y5"* *@G<RMY2=
M3]X^E.N)BF$3F1NGM3H(1"OJQZFGYBWT%6)50)@$#UI]%(SJO4@?6D,6BF^9
MN^ZI/N>!1M+?>.?8=*  MDX7GW[4R=_)C)SESP*D)"#)X JO&#<2^8?N+]T4
MQ,EMX_*B [GDT3*<!U^\O(]_:I**!V$5@ZAAT/-)(XC0L>@J-/W4I3^%N5_J
M*9*?/GV?P)RU%A7%MT+$S/U/3/85+S)[+^II<;NHP.PIU%P2$ "C &!2T44A
MA1110 444R:3RHRWY4 1_P"MN?\ 9C_G4]1VZ%(QG[QY/UJ2FQ(*9,F^)AW[
M4^BD,;&V^-6]13JB@&T.O]UC4M (*:IP7]C_ $IU03OLAD/<G I@QML<([XR
M7;@5.B[!ZGN?6HX$VHO^R,#^M34,2"BBBD,***@DNE7(4%V'I0%["VO^K)]6
M)J:J]I*IC5/NL!T/>K%-B6P4444AC)/E97].#]*?2$!@0>AI(R2@!ZC@T 9X
MC?>R*"RAN15J.8EY,(Q)(&.F*(_ENY1Z@&I(?XSZL:ID)"")GYD.1_='2I0,
M445)84C$A20,G'2EHH IP6Q_UDH]]M/D&+F'\:G8Y8+^)J&3F\B'L:JY-K%B
MHKF+S8^/O#D5+14E$4,@GB![]_K3]VWANG]ZJQ80R^8A#1MPV.U6P01D<@TV
M)!1UIFPK]TX]CTH\S;]X%??M2&)&=C%#VY7Z4K_>0>_]*' D4%2"PY!IJ.))
M 1T Y'O_ )%,1+1112&%%,\Y/4_D://C/\8_.G8!]%("#T.?I2T@"BBB@ HH
MHH **** "BBH&F:4E8AGU<]!0%Q\LZQ<=6/11UJO+$Q(ED  R,J/2K$4"Q<\
MLQZL:<Z[T*GN,4[V%:XH  XZ4M16S;H0#U'!J6D,**** "BBB@")>;ASZ "I
M:BBYDE/OC]*EIL$%%%%(!';8I8] ,TV%2L:@]>I^M)+\Q5/4Y/T%24P"F&51
M($_B/-.)"@D\ 53MW,ERSGIBA(3=BVY[#J:CEF$*A5&6/04QK@[BL8W2'OV%
M20P",[F.Z0]30+?89%:C&Z3YG//7I4GD+ZL/^!&I**+CL,\E/0GZDFE6-4Z*
M!]!3J*0PH) &3P!37=8URQP*JO)]H/S-Y<0[$\FFD)NPXDW;8'$0/)]:LJH4
M  8 JLDD3N$CW*?45-ND7JH<>J\4V)$E%1_:$'WB5_WABG"5#T<'\:DH9<#,
M1/=>0152&X\L?=+.3FK$TY9A'%RY[]A3X8%B&?O.>I-5LM27J]!T19D!<;6]
M!3Z**DH**C,ZYPN7/HO-)F9^@5![\FG8+DM-9U7JP'U-1_9RWWY&;V' I5M8
ME_@!^M M0-U$/XQ^%1[Q<S*!RB\GW-22!(8RVT<>U0&(P*DO5A]X4Q.Y<HH!
M# $=#14E!1110!&O$S^X!J2F'B9?=2/Y4^F""JC_ +V9$'0?,?K3H[G,<I8\
MKTHM4V*78X+>M/8F]RR   !THHHJ2@ILDBQKECC^M)))LX W,>@IL<6&WN=S
M_P J8#=CW'W\HG]T=3]:=*JQ6[A0 ,=JEJ*Z_P!5CU('ZT"$: /&HZ,H&".U
M+%*2=CC#C]?>I:9+%Y@!'#CH: MV'T4R*3>"#PPX(I](84P?+(?]H9I]-?\
MA/H: (>E[]5J2#[A/J3_ #IC\7D?T-/M_P#5#ZG^=5T)6Y)1114E!2$@ D\
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MZ_2@!%^=MQZ#I_C3Z!THI#"BBB@ J+K=?1/ZTLDRQG!.6] ,FH5GVSNS(5&
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M(NY3D4ZHG0HQ=!_O+ZT;AL2T4BL'4$'(-+2&-<;EXZCD4H.X ^M+35X)'XT
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MQF<QH<*/O-_2HIV*2MLS@CYL#.*L0-'L 0Y I^8EV'JH0 #@"EHHJ2@HHHH
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M]!30F1(Y:1?,.Y <*V.IJW36B5T*8XQ3(6)!1OO+Q]?>C<%H2T444AA1110
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M.#+EO[JBI[6.103(QY[$TZ&!8AZMW8U+3;$EU"BBBI*"BBB@ HHILCB-2QH
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MYY=FW59@A(;S'Y<]O2J(5Q\$/E)SRQY)J2BBI+(!^XN".B2<CV-3U'/'YD9
M^\.0?>B"3S8PW?H?K3$24UW$:%CT%.J&3][*$'1>6_H*!L= I5,G[S<FI***
M0$%M]^8?[52CEV/IQ4,'%Q,/H:F4@*2>.]-B0ZBBBD,***CDD(.Q!ES^0H 6
M218Q\QQGH.YJ."=/+12=I QSQ3TA"G<3N?NQI(0&CVD @$CGZTQ:DM%1>24Y
MC.W_ &3R*<DN3M8;6]#0.X^BBBD PR(7,>1NQTJ*ZYMF!ZBH[J/]^C [=W&?
M0TDDQ,3HXVR8Y]ZI(ALG421J"OSKCH>HIR3HYQG:WHW!IT7,:?04/&L@PR@T
MBAU10?*73^ZWZ&D\AE_U<A7V/(J(QR&?:[ !ASM[XH$R0DW#;1Q&#R?7VJ<
M#IQ2*H4  8 [4M(H**** &NVU"?04JKM4#T%-?YG1??)_"GT 5Y?^/N'\:L5
M3N9?+N5;KA:LPR>;&&Z9[4V)/4?1112&17,?F0L.XY%+!)YL2MW[U)5:+]S.
MT?\ "W*TQ;,F)\L_[)_2GT$9'-1G?'PJ[E[>U Q8^=S>II](B[4 ]!2T@"BB
MB@"*#[TO^]4M11<33#W!_2I:;!!1112 *AN00JN.J'/X5-39"JHQ;[N.::!C
M9)ECC#YR#T'K38(CDR/RY_2JT092KLC,@^[[5;2YC?HPSZ'BGL2G?<DHHHJ2
M@HHHH **** "BBB@ HIID4'&<GT'- 9CT7 ]6H 5UWH5R1GN*JK9J#P[$^U6
M=F?O'/MVJ.>;R\(G+GH!VIHEI=2L( TX16)QRQ]*OU'!"(4QU8\DU)0W<:5@
MJ*:X$7 ^9ST44D\Y4[$&9#^E+# (OF)W.>I- 7[#$MS(V^8[CV7L*L 8&!P*
M**!I6"BBBD 4444 %1.Y9MB'GN?2ED<EMB?>[GTIR((UP*8MP1 B@#I3J**0
MR.<9A?Z4]3D TDO^K?Z&E3A%^E,.HM%%%( IK<LH_&G4U>69OP% #JK2?Z3.
M$'W%Y;WJ2XF\M<+R[< 4V*%X5^4J2>2".]-">NA-M'''3I2U%YK+]Z-OJO-'
MVF/."=I]QB@=R6BF":,_QK^=+O7^\/SI .JN/W%QZ))_.IC*@ZNOYU!<2Q/&
M1O&>HQ30F32R")"W4]AZFD@CV)D_>;DU# 3<L';HO  ]?6K5&P+74****0RN
M/DNV_P!I<U'>N<!!S@9-/N3Y<T;GI@@U"PW022GJQP/I5HA]B[$,1)]!3J1>
M%'TI:@L9(Y4  98\ 4L:!!ZD\D^M-C&]C(>_ ^E24Q!4<7#2#T:I*C7B=QZ@
M&@9)370.,$9IU%(",,8R%8Y'9O\ &I*" 1@C(IBY0[2<@]#_ $I@-NH_,A..
MHY%,,:W<*L>&QUJQUJO:_(\D?8'(^E!+W)T7:H'H,4M%%(H*AN/EV/\ W6_2
MIJ9,F^)E[D4T#'T4R%]\2MZBGT@"BBHYF*I@?>;@4 $?SLS]N@^E24B*$4*.
M@I: *ODF2Y=F'RKT]Z6U_=O)'Z'(JP_W6^E5V^2\0]F&*K<FUBS1114E!56]
M=5V\D..15JJ4I$MX%(R!Q30GL6H9!+&&'XT^J\$312''^K/8]0:L4,$%%%%(
M84444 0CBZ8>JYJ:H)3MN(F['(J>FQ(****0P)P*K#_2I,_\LE_4T2,;B3RE
M.%'WFJPJA% ' %/86XM->)'^\H-.HI#(?LJC[K,GT-'ERCI+D>XJ:BG<5B+]
M^.Z'\Z,S?W4_.I:*!V(\S?W4'XFC$I[H/P-244 1^6YZR'\ !2^4O?+?4YI]
M%(+   , 8%%(2%&2<#U-5VG:<[81@=W-,3=A\UQL.Q/FD/;TH@@\OYF.Z0]3
M3H8%A''+'J34E 6[A4-Q,4PJ<R-T%.FE$*%CU["HX$(R[<R-U)Z"A WT'PPB
M%26.6/+$T_?G[HS[]J8)(V<+N#-Z5+0"&;7/5L?[HH\I3UR?J:?12&,\F/\
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M_B.*<IRH/M3?O2#V%(H>!@8'2BBBD 5&W$Z'U!%25'-P%;^ZP_PI@R2BBBD
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M)'*.QP:2[?$>Q>K']*K<G8L(X=0PZ&EJ&T.;=*FJ2D1RD\*#@M^@IZJ%4 <
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M?G3J;D;LYX(HCD61<J<BI*$ W,^?]W_/YT(-T>UN<<&EC_B^II/NR^S?SIB
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MV["*;<LWRQ@_._Z4OF16J;!\S>@ZDTR=B4_,X'9>33;B+S4 SM&<DU$GGN.
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M!JL5"73*1E7&<&K,<:QKA>G6FP5QO^I/_3,_^.__ %JDHQFHN8#SS'_Z#_\
M6I%;$M%'6BD!!'\MU(/4 U/4#_+=H?[RD5/38D%1G]Y-C^%.?QI97\M">IZ
M>IHB38F#R>I/O0,?2.<*32TU^64>^:0$,0Q=2CV%6*KP\W4WX58IL2"BBBD,
M0L%&20![TSS0WW06^G2E6%%.=N3ZGDT^@!F';J0H]!2J@4Y Y]3UI6=4&6(
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M1\T1_P#':G#!@"#D'O2U"8VA):/E3U3_  I[BV)J*9'*L@R/Q'<4^D,****
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M3L9=CC^'_"I:9)$L@YZ]B.HI@=H.)/F7^^/ZT;AL344@(8 @Y'K2TAA1110
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M(( 4YR?<G\J\WN()+6>2&52DL;%'4]00<$5],? R#R?AU9/C_6RRO_X^5_\
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M]:)($FPZ':W9A34N&B.V88_VNQH#U)([I'.,[6]&XJ*[B*D3)PPZU.\23#D
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M6EG1!X7T\RB?[+IJP>:!@/M.,_CBI_$'_)OWAG_L(/\ ^A7%<$6G3HM?S?\
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M^O\ ;_T7'7GOQ#\07'A7X[7>J6Q_>0^22N<!U\E RGZC(JY4/K&*JQ3UU:_
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M"6-OO(#^5 !,V;-!W.!4@?RHW[D-@?6H4^<VZ=A\QIQ#O<-M (!SD] :8B9
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M0XSN'H:LK?1D?,"I]*5F-207;9 C'?D_2BS7:)/][%0B1Y'=EC)SP/I2I#<
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M9652?<9P:H4Q^'0^^*&E)6:$I.+O%V.CO?B#XEU"(Q3ZW>M&>JK,5!^N,9K
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M*3^E5:VA-[ZFW-XT\07,,D,VN:E+%(I1T>[D*L#P003R*1?&.OI;BW76]16
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M!ZHEG@\SYE^60=#4B;B@W@;L<U4\VX@^^-P]34L=ZC_>RIHLPNB)@;.<,/\
M5MVI;P8Q*G1A@U8=4N(R,@@]Q56,XCEA<]!D4T)KH) VW=)_=4*/K4K,8(UC
M7F5N:K0, V6/RK\V/4TY969F<#+GN>@%%B4R0GR/D3YI6ZGTJ1+50,-\[GDD
M]J2!5B!/,DI].:DC+LI PI/7/)I%(<%'W%X4=?>D=UW!20%')S_*FK'L #EB
M/4'BGB-1\T> ?T-!0-,-I*JS'V%)&S;1A.O.2>M/#Y."-I]#2%=I)7\1ZT@
M^80>5!^F:;&&QC?@CMBI P/'0^AH9%;J,T ,=XV7!92/K4:R8=022H_BQ5@
M#M2$!A@C(H"PM%19,/J8_P!14H.1D<BD,*9#]S'H2*?3(^'D'OG]* 'T444
M-<9&1U'-*K;@".AI:8ORN5['D?UH CGM]_SIPX_6H'DWJK[=LD9^9?:KU0W%
ML)AE>']?6J3):["- DH&1UZ,*B$+VQR%$B_3FI[>-EA"N.:>K<[3U_G1<+#$
MN5D'RY+?W:=AFZG;["F2VRR<CY&]13%G:%MDWX.*7H%^Y8"@=!44ML)I 68E
M?[M1M<R"8J%##J/>G"[ .'4QGWHLPNF3)&L8PH IU,,RX&#N)Z 4!"W+G/\
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MG>0R73V=O:QAW9%!9B3@ 9Z=#S77>*?A)H/A:6SMWO=8O[V\W^1;6-LDKMM
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MG0]^]. ^?Z"HT<J[*%W+G(_K2*(&_P!#<.ARC?PTV#=+.9& *]\]JDNRKA5
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>exhibit99-5xz001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-5xz001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )D!.(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#F[KQ]X9L[N:UN-3V30NT<B^1(<,#@C(7'45:TCQ9HFO7;VNFW
MOGS(AD9?*=<*"!G+ #J17(?%;3-/MO#T-W;V-M%<RWR^9-'$JN^4<G+ 9.3S
M5WQ5JUGX%U#2I=/TC3XH[IG6Y>*V"R>6I0D*05YY/7C(%,#K-7UO3]!M$NM2
MN/(A=Q&K;&;+$$XPH)Z UH5YIXSU'4SX.6?7]$LTD.IA8;9Y68"/RV*L6C<9
M;[PZ@>U7=4\;:U;>-KOP_I^F6UXX0"V!<HV\QA\L2<$#YN.,^M%@.^HKSFV\
M;>*;^ROH+/08)-4TZ7;=;6W)CY\@+N#;LJ ,%L\].*ZGPCXA7Q-X?BORBI.&
M,4Z)G"N/3/8@@]\9QDXI ;4LL<$3RRNL<:*6=W. H'))/85@6/CKPUJ-[%9V
MVJ*T\S;8U:)T#'L,LH&3V]3Q6!\21)JE[H/AY&6);RYWO*ZX"X^48)(4G#-\
MN<D[?49Z)_!'AI_LV=&MA]FQLV@C.,??P?GZ#[V>_J:8&_574[W^SM)O+[R_
M,^S0/-LSC=M4G&>W2L*Q\1WES\0=2T!XX!:6ML)4<*=Y)$9Y.<8^<]O2LK_A
M([S6M/\ '%E<QP)'IT4T4)C4@L,2CYLDY/RCICO2 Z?PYK/_  D&@6VJ?9_L
M_G[OW>_?MVL5ZX'IGI4NKZWI^@VB76I7'D0NXC5MC-EB"<84$] :\8U:74_^
M%;Z%#]GB_LK>S^?GY_/\R8;<9Z;>>GX]JZ?Q?>:F?!T%WXFT/3S>KJ'E11EF
MP(S&3D%),Y)'3..!QT-.P'J%9\6B:?!K4^L1V^V_G01R2[V.Y1MXQG ^ZO0=
MJR+?Q'>0^.IO#VHQP+'-%YUC-&I!<<DJPRW/#<_+]P\?,*S=$\7ZUK6LZY#:
M6-C=VEAO$!CE,9E._"#>2PY4,<@8R!R :0'<T5YS#X_U&RU#38M5DT&X@O6"
M.;"Z)-J25R9#EEP QZ<'!YXYP+Z^\7M\0=-GGTJS36EMB+>W##8Z8DR2=_7E
M_P"(=!^+L!ZP^KV$>L1Z2]RJWTD7G)"0067)&0>A/!XSG )Z5=KB;&>"Y^+F
MI0/IUF)K6S#)=!6\TY$?7G;G#D9QG&!G%5%\:^)-5EGO= T*"[TBVE:-W,G[
MR4+R2HR""5*X&UCD]^E%@/0:*X/6/B!)'X*LM>TJ& R37(@EAG._RSM8D?*1
MS\H(SV(..:(O&'B+3_$=C9^(-&@M;34)3%;^3('=3N &2&((&X \#KD=,4K
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M6M9=2;4I(K,J]TYR7.8L@\GD?=Z]J+ =SX<U>\UK3Y+F]TF?3)%E,8AFSE@
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M8]M;FR@,NT[=H/S#"\$N!U#$'ZB ]EBECGB26)UDC=0R.AR&!Y!![BGUYMX
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MLY 6, *OS<@D?*&RO/!&/4L/"FJZ/I/B][N>*]FU*"0QF!3OD;;)U7& 27'
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M/_"UU<+#'J\2NV<&6-XUX&>68 #\34M[XW\-6&SSM9MFWYQY!,W3UV XZ]Z
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M'_A:ZN%ACU>)7;.#+&\:\#/+, !^)J6]\;^&K#9YVLVS;\X\@F;IZ[ <=>]
M&_16!9>-_#5_O\G6;9=F,^>3#U]-X&>G:J\OQ#\*PRO$VK*61BI*0R,,CT(7
M!'N.* .GHK"D\9^&XK(7;:S9F,J&VK)N?!QCY!\V>>1C([U!;>/_  M=7"PQ
MZO$KMG!EC>->!GEF  _$T =)17.WGCOPQ8RB*76(&8KNS"&E&/J@(SQTZU+9
M^,_#=]$98M9LU4-MQ-)Y1S]'P<<]>E &[17,2_$/PK#*\3:LI9&*DI#(PR/0
MA<$>XXJU)XS\-Q60NVUFS,94-M63<^#C'R#YL\\C&1WH W:*YNV\?^%KJX6&
M/5XE=LX,L;QKP,\LP 'XFG7GCOPQ8RB*76(&8KNS"&E&/J@(SQTZT =%16%9
M^,_#=]$98M9LU4-MQ-)Y1S]'P<<]>E4_^%C^$_\ H*_^2\O_ ,30!U-%8MSX
MO\.VMNTTFM6+(N,B*82-R<<*N2?P%5;;Q_X6NKA88]7B5VS@RQO&O SRS  ?
MB: .DHKG;SQWX8L91%+K$#,5W9A#2C'U0$9XZ=:EL_&?AN^B,L6LV:J&VXFD
M\HY^CX..>O2@#=HKEO\ A8_A/_H*_P#DO+_\35R\\9^&[&(2RZS9LI;;B&3S
M3GZ)DXXZ]* -VBN=L_'?AB^E,46L0*P7=F8-$,?5P!GGIUHO/'?ABQE$4NL0
M,Q7=F$-*,?5 1GCIUH Z*BL*S\9^&[Z(RQ:S9JH;;B:3RCGZ/@XYZ]*I_P#"
MQ_"?_05_\EY?_B: .IHK"O/&?ANQB$LNLV;*6VXAD\TY^B9...O2HK/QWX8O
MI3%%K$"L%W9F#1#'U< 9YZ=: .BHKF[GQ_X6M;AH9-7B9UQDQ1O(O(SPR@@_
M@:Z2@ HHHH **** "BBB@ HHHH **** "BH+ZY^QZ?<W6S?Y,32;<XS@$XS^
M%<7_ ,+(_P"H3_Y,?_8UI"E.>L485<12I-*;M<[NBN$_X61_U"?_ "8_^QH_
MX61_U"?_ "8_^QJ_JU7L9?7\/_-^#.[HKA/^%D?]0G_R8_\ L:/^%D?]0G_R
M8_\ L:/JU7L'U_#_ ,WX,[NBN$_X61_U"?\ R8_^QH_X61_U"?\ R8_^QH^K
M5>P?7\/_ #?@SNZ*X3_A9'_4)_\ )C_[&C_A9'_4)_\ )C_[&CZM5[!]?P_\
MWX,[NBN$_P"%D?\ 4)_\F/\ [&C_ (61_P!0G_R8_P#L:/JU7L'U_#_S?@SN
MZ*X3_A9'_4)_\F/_ +&C_A9'_4)_\F/_ +&CZM5[!]?P_P#-^#.[HKA/^%D?
M]0G_ ,F/_L:/^%D?]0G_ ,F/_L:/JU7L'U_#_P WX,[NBN$_X61_U"?_ "8_
M^QH_X61_U"?_ "8_^QH^K5>P?7\/_-^#.[HKA/\ A9'_ %"?_)C_ .QH_P"%
MD?\ 4)_\F/\ [&CZM5[!]?P_\WX,[NBN$_X61_U"?_)C_P"QH_X61_U"?_)C
M_P"QH^K5>P?7\/\ S?@SNZ*X3_A9'_4)_P#)C_[&C_A9'_4)_P#)C_[&CZM5
M[!]?P_\ -^#.[HKA/^%D?]0G_P F/_L:/^%D?]0G_P F/_L:/JU7L'U_#_S?
M@SNZ*X3_ (61_P!0G_R8_P#L:/\ A9'_ %"?_)C_ .QH^K5>P?7\/_-^#.[H
MKA/^%D?]0G_R8_\ L:/^%D?]0G_R8_\ L:/JU7L'U_#_ ,WX,[NBN$_X61_U
M"?\ R8_^QJ>Q\?\ VS4+:U_LS9YTJQ[O/SC) SC;[T/#55K8:QV';LI?@SM*
M***P.L**** "N7\=_P#(#A_Z^5_]!:NHKE_'?_(#A_Z^5_\ 06KGQ7\"7H14
M^!GGM%%%?.G %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:NHKE_'?_(#A_P"OE?\ T%JY\5_ EZ$5/@9Y[1117SIP!1110 4444 %%%%
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M ^0@3!"X;;D9(R-HZ=*T>&7(HMV?O=-[:E>S5K==3A**VGU*Z_X12*PDL/\
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M_P"VO_HUZZFH&%%%% %#7/\ D :E_P!>LO\ Z":\7KVC7/\ D :E_P!>LO\
MZ":\7KT<%\+/$S7XX^GZA11178>6%%%% !1110 4444 %%%% !1110 4444
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M$[1R)9S,CH<%2$)!![&O /\ A)M?_P"@YJ7_ (%R?XU[YXF_Y%36/^O&?_T
MU\W4T!J_\)-K_P#T'-2_\"Y/\:/^$FU__H.:E_X%R?XUE450C5_X2;7_ /H.
M:E_X%R?XT?\ "3:__P!!S4O_  +D_P :RJ* -7_A)M?_ .@YJ7_@7)_C1_PD
MVO\ _0<U+_P+D_QK*HH U?\ A)M?_P"@YJ7_ (%R?XUE444 %%%% !1110 4
M444 >R^.O$VF:+K<-M>^&[34Y&MED$TQ7*@LPV\H>.">O>N=\,B+7=;UK6H#
M%H>F6\ >9;6)&EB'ELO[MMF4X5R2H!YQSU'"7E]>:A*);VZGN9 NT/-(7('7
M&3VY/YU?T>]U[1XI=3TIKN&W1@LLR(6BST ?(*D_-QGID4K =MXSU!=1^&^G
MR(NI>6E\B))J**LLJ^4Y#9'##! W=\=^M=?_ ,U6_P"X'_[7KQ+4-<U75MPO
M]1N;A"_F>7)(2@;GD+T'4]!Q1_;NK_:_M?\ :M]]IV>7YWVA]^S.=N[.<9YQ
M18#0\0>+M0U]/LKB*#38W#6]G%&H6(*"J@'&3P3[<]!P!2\/ZHVBZ_8ZB"P6
M"4&38H)*'AP >,E21^/:LVB@#W'Q&;+P_;ZIXOLI(FO+RUC@MW$G#,3C>N20
MWR[&QCI'[FN6\,VYTOP=;:M=ZE?01W-TJ6EOI4,8FF<,P =BN9.=V%8XP.^0
M!P,^IW]S:1VEQ?7,MM%CRX9)69$P,#"DX&!Q5W3O%.N:5926=EJ4\-NZE=@(
M(4'.=N?N'DG*X.:+ >P:PJMX]\(W!M_*FD2Z#A@N\ 19"D@D'!8]"1R<=:I:
M5%)/X9\<11(TDCW]^J(@R6)0  #N:\DDUW5Y;B&XDU6^>:'=Y4C7#EH\C!VG
M.1D=<5-IGB36-'N[BZL;^6.:X_US-A_,.<Y(8$$YSSUY/J:+ =CK5K):?"30
MK:_BGMF6_/FJT7SH"9CG:<<X.0"1GUKL[G6$T>ZLX;+3]>N=/BMD$*V%O'/;
MRIMPIW\OD#'\0Z \@Y/BNH:YJNK;A?ZC<W"%_,\N20E W/(7H.IZ#BKMGXR\
M0V&GFQM]5G2W*[0IPQ08QA6()4 #C!&.U%@*OB"\L]0U^^O;$3K;W$IE G #
M@MRW3C&XG'MBLVGRRR3RO+*[22.Q9W<Y+$\DD]S4\^F7]M:1W=Q8W,5M+CRY
MI(F5'R,C#$8.1S3 JT444 %%%% !1110 5]!>!-7M]7\*6GV=)5^QHEI)Y@
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M_P (SH'_ $ ]-_\  2/_  H_X1G0/^@'IO\ X"1_X4K@?-U%?2/_  C.@?\
M0#TW_P !(_\ "C_A&= _Z >F_P#@)'_A1<#YNHKZ)OO".B7>GW-M%I6GV\DL
M31I,EHF8R00&' Y'7K7SM0F 4444P"BBB@#5\-Z1_;WB*RTTOL29_G;."$ +
M-C@\X!QQUQ7HOQ%L[/Q!I]W>Z>5DO=%E\JY"$$F,@$],G"DGK@#;)Z5B_#J[
MT[1-/UC6KJYM/M:1&.WMWN DCA1O8!3V8[ #@G(/X[7A_P"(&B:AJLUG=:):
M:;'?*WGW#2)LD."<295<@Y;DYY.,<T@.!\-^%-1\4RW"6+0(MNH,CS.0 3G
MX!.3@]L<?2NTFT*_\/?"?7;+4(U20WBNA1PP==\0##V.#UP?:C2[?1#H'B'P
MHVO6EO&;Q98;MYD9'C.QEP<KN8;,-C@$]Z9J']E:1\--5T6W\1VVI2B=&C57
M"D O&Q5%W'(ZG(XR6[@T 6/%7A:YU'6?#>D75]:!I(IH4N(+'RR%C0, PWX(
M] -H&3@<UR>B>#?[8\5ZCH?V_P G['YO[[R=V_8X3[NX8SG/4UZ1XNU"WTOQ
MCX3N[IML(>X1FR %WJB@DD@  MDGTS5/1;?P_HOC&_U?_A*M/F:^69A"'4!
MTBMR^XC(X&.">2.AI#.&T+P0VIZ4FJZCJUII>GRLR12S,"78''0D #AN^?EZ
M8YKI/ 'A33!JMZ;V^TK4Y(E,0MDVS(01&WFJ3V&2OW>N>:9X(U>[B\.Q6=UJ
MGA^/3O/*-;7TH$I@8GS. V.I. PYR<X&,OT;5?#.E?$^Z;3IEAL)[9XFE+*L
M"RY#':21A/EP/<\<8IB,6S\!V>H>)CI%EXA@N8Q9_:3<PQ!P#OV[,!^O(/7O
MTIL_PTUC[.'T^XL=1D1S%/';SC,3@G(); X&W/0Y;&.,UL^$;;2/"OC:5/\
MA(+&ZMI-.)^T^8B(',B_)G<1G"YZ]ZR_!6IV]MX4\56EU?11>;:GR(990N]R
MD@.U2>2?E''M[4 86O\ A34?#T5M<7#07%I<J#'<VSEXR3R!G Y(Y'8CIG!Q
M=MO &L3HJR2V-M>2(9(;&XN MQ*N,Y"=NA')&"#G&*T+[4;+_A5.AVHFMI[F
M&^+R6IE^;;NE/S*"& .1SQUZUW%]XP:5(KS3-8\/P6;6OFO'>R,UPKX)V[$;
M_=! R0<\'@$ \W\+^";CQ+_:<?VG['<V.U?*EB/S.=WRMSE<%<'@]>G%/OO
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M_P"VO_HUZZFH&%%%% %#7/\ D :E_P!>LO\ Z":\7KVC7/\ D :E_P!>LO\
MZ":\7KT<%\+/$S7XX^GZA11178>6%%%% %W1W2+6["21E1%N8V9F.  &&237
M1^,=;F_M>+^S=4?R?(&[[-<';NW-UVG&<8_2N/HJ)4U*:D^AM&O*--TUU=SJ
M?"-I;:C=WLMTT$]]MS;QW3961R&)+#JV,<_4GKBM;5YX8/".H64TND1W?FK^
MXL& '#)G*GG=P<^PK@**B5'FES7[?@:0Q/)3Y%'777U_KN>B>(-//BNSL[^P
MO;=;>*-C()I !'D*>2H.#CJ">,#WJ#3]=M=$\,:8'-O<317+K+$DBLZ*3)EE
MP?IST(/7G-<%14K#^[RMZ(MXQ\[J15I-:_AT^1WK2VO_  FMEJXUBWGM)0WW
MYE#0?NVPI'&!SZ=3@\\F2;4;$W?BMA>6Y$]LBQ'S5_>'RF&%YYYXXKSZBG]7
M7?R_&XOKCUM'=M]>JL=39WT/_"O+^TDND\[SQY<+2#=MW(>%ZXSN/'O6MK4=
MIX@O=/OH=?M;.-8@=DDP#Q-]X$ -][H#R,;1UK@*WXM9T.-8,^'%=H0 &>[/
MS8.<L-N#SZCVZ<4ITFGS1WU[=?4=/$*4>2=K62Z]&^WJ7?B%_P A^#_KU7_T
M)ZL> ;ZTL_[0^U74$&_R]OFR!<XW9QGZUSFM:O/K>HM=S*J#&R-%_@49P,]^
MIY]_PK.IJE>DJ<B98A1Q+K0UU.IE\,Z3 (W/B*UG7S8U9$* [2X!.=QQ@$GI
MVKJ(X;;2]4MYE70;;32O[F4G;.PV=0QX/)ZYZ'WKRZBB5&4MY#IXJ--WC"WS
M?ZW._L;K3AHNNV2ZA:VOGWDR0X=0-K;57 P?D/3(' STQFJM[9CP]X+O=+O+
MJW:[N)EDCCC8DE<KS@@'^!N>E<510J%GOUO]PGB[QMRZV:^3WT/1-:TY_&=M
M97NEW47E(&5DF.-C''' )SZY..F.N3)_;-F_Q @\B>*6.6T^S&17&U6W%Q@]
M#G@<=SZ\5YO126'TLWIK;YEO&Z\RCK=-Z]OR/0GMX=)7Q/\ :;^R\R]5VCA$
MPWC(<@%3CD[AZUB7UU;O\/M-MEGB:X2Y+-$'!91F3DCJ.H_.N8HJHT;:M]OP
M5C.>*NFE&RLU][N%%%%;'*%%%% !5_0_^0_IO_7U%_Z$*H5?T/\ Y#^F_P#7
MU%_Z$*4_A9=/XUZK\T>T4445X9]8%%%% !7+^._^0'#_ -?*_P#H+5U%<OX[
M_P"0'#_U\K_Z"U<^*_@2]"*GP,\]HHHKYTX HHHH **** "BBB@ KL?&&I7M
MCK=N+6[FB40*^U7(4G<W4=#T[UQU=C?Z_P"&M3G6:\T^\DD5=@/3C)/9_<UU
M4&O9RCS6>GZFD'[K5[$FIXU;P1'JETB?;$Q^\50"P#E,'VYS@=Z6?PY!=>)A
M97%Y>S(+/S0\DH9P=^,9(Z5AZGXA-[IT>G6MHEI9I@[%<L21GJ>,CG/(ZC.:
MU_\ A++#_A(O[0\JY\G[)Y&W:N[=OW>O3%='M*,Y>\_Y;^>]_P!#3F@WKY&:
MFE:9=7<6E6-S)-=M+A[IE BV ,3M .3VZ]<<$ U?7PE;W/G6]NU_#=0\>9<P
MXBE(R/E(Z G'<\'H:P-&U)M*U2&Z&=@.)%'\2'J.HSZCW K:NM>T^474D-YK
MBS2!C&IF 1&)R, 'IV[\>]94Y47&\TK]O(F+@UJ5;'1+%=&35=4NY$@D++''
M N6+#/<@CG:WMTYK9\*1:3#K-REC<7,\GEL5=T"ILRO'J6![X ]JR].UO2_[
M#CTW5K2:989"\?E<#!R>3N'.6;]*BT[5]/TCQ UU9QS_ &*1"K(ZC>F><#YN
M>0.3VS]:NG*E"4)*W2^]_,<7%-,RK_[!YZ_V?]I\G;S]HV[MV3Z=L8K=\,?\
M@3Q!_P!>W_LKUBZK)837S2Z>DR0OEBDH4;6)/"@=%QC%:/AW6++3(+Z&^BFD
MCNE5"(P.F&!SR/6L*3C&MJU;7TV9$6E/4PT"EU#DJF1N*C) ]AD9KKXO"-I>
M6>ZTDO-S1AH[B4*L4AX_A^^ >>H]^>,T)-2\/0W%G/8:=.CQ7"NYD).4&<X^
M?KG!'TK3B\4Z5%J<E\S:I*[*4$<FPH@)!^4 \?=']:UHPHQ;51IE04%\3(M#
MCMI?!5ZEY.8+<W0\R15+$#]WT'OT_&J.IZ!8KI#:II5\9[="%=9!\V<X]!CJ
M.".G.>E&C:SIEKHD^G:C;SS)++O(CQ@C"XYW ]5HU#7;%-+%CHD$]JC2B61G
M;G(QC')/4 YR.GO3<J3I+FMHO.]_R'>+CKV^99D\.:/I^RUU+57COI%#+M3]
MVN>!GCD9!YR./2H[+PH#X@FTV^D?8L!FCDB(!8;@ >0<=^/:I[G7_#^I^5-J
M6GW,ETL81BG"YZG'S],DTRW\5PCQ+/J-Q'-Y!@\F)%"EE&0>>1Z$]^N*IK#\
MRVM?SV\P_=W_ *_$S='TF#4-.U2XE>17M(M\80@ G#'GC_9%:3Z)HFGZ98ZA
M?3W+":-7-NI&9&(4G'3"CG/U'.>JCQ!H=MIU]9V%A/"+B(J&."2Q!'.6)P..
M_<\>N9K&K0:AIVEV\22*]I%LD+@ $X4<<_[)J/W,(=&[?C?_ "%[J7=_\$QJ
M***X3$**** "BBB@ HHHH *[7X?_ /,1_P"V7_LU<57:_#__ )B/_;+_ -FK
MKP7\>/\ 70UH_&CM:***]\[3*\3?\BIK'_7C/_Z :^;J^D?$W_(J:Q_UXS_^
M@&OFZJ0@K5\,_P#(UZ/_ -?T'_H8K*K5\,_\C7H__7]!_P"ABF!](T445 PH
MHHH S]=N9;/P]J5U;OLFAM99(VP#A@A(.#QU%?--?3U]9QZAI]S92EECN(FB
M<H<$!@0<>_-?,-- %%%%4(**** "BBB@ JQ8W$=IJ%M<RP+<1Q2K(\+]) ""
M5/!X/3I5>B@#I_&/C&3Q;+:$V2VL=LK;5$F\DMC))P./E'&/7GTYBBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O<OAAJ5WJ/A0_:Y?,^S3
M_9XOE VQJB8' YZGD\UX;7T%X$TBWTCPI:?9WE;[8B7<GF$'#NBY P!QQ28'
M25P=C\-K9_$=]J^L.MP)+QYX+9.4*EB1YF1R>1P...<@XKO**D8R**.")(HD
M6.-%"HB# 4#@ #L*?110!YC\8KF5;32;57Q#(\LCK@<LH4*<]> [?G7D]>P?
M&"SC?1-/O26\R*Y,2@'@AU).??Y!^M>/U2$%%%%, HHHH **** "BBB@"_HM
M_;Z7J\%Y=6,5]#'NW6\N-KY4@9R"."<].U:?B_Q5)XKU""Y-NUM'#%Y:PF;S
M!G))8<#!/ Z?PBN=HI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH M:;J5WI%_%?6,OE7,6=C[0V,@@\$$=":^G*^<_">D6^O>)K/3;IY4AFW[F
MB(##",PQD$=1Z5]&5+&%%%%( KP/XC_\C[J?_;+_ -%)7OE>!_$?_D?=3_[9
M?^BDIH#E:***H1[[\./^1"TS_MK_ .C7KJ:Y;X<?\B%IG_;7_P!&O74U PHH
MHH H:Y_R -2_Z]9?_037B]>T:Y_R -2_Z]9?_037B]>C@OA9XF:_''T_4***
M*[#RPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *OZ'_R']-_Z^HO_0A5"K^A_P#(?TW_ *^HO_0A2G\++I_&
MO5?FCVBBBBO#/K HHHH *Y?QW_R X?\ KY7_ -!:NHKE_'?_ " X?^OE?_06
MKGQ7\"7H14^!GGM%%%?.G %%%% !6UX<T,:W/<I([QQQQY#KCAR?ER#U'!_+
MJ*Q:]#M;./2-&M;(ZI!879=;B;S&'S_[.-PXX R#SM/J:ZL+24YWELC2G&[U
MV//YH7MYY(95VR1L489S@@X->A?V;8?\)AY'V*V\G[!O\OREV[O,QG&.N.]8
MWC73U$T.JP$-%< *[*<@MCY2.><J.W'R^]='_P SO_W#?_:E=5"C[.;B^Z^[
M4TA&S:?='F%%=GI6W1/"!UBV@$EW*<,[\A5W[<=0<<=N<D=APSQ (]1\.Z?J
MDUM';7<\H623:1\I!&3QDCY01U('3WY7AK0O?6U[>7J9^STO<X^BNSUS5)/#
MQ&D6-K MNUN-SR1@ER05+<'!Z=QU![5!I?VG3-&AGFU2#3(YR3&1:B260<_>
MXS@=0>?O=>E#PZ4^2^V^FWWL.36USG=.L)=3OX[.%D623."Y(' )[?2HKF!K
M6ZFMW(+Q.R,5Z$@XXKT!732_&4=C9V\,4-[ 'E"KC!4/C ' Z#M67/<RZUXR
MM]/OX46&VGDV*%(+J!N&[.<@A1]0:N6%BHVO[U[>73_A_P "G325NMSCJ*]%
MN=2T>)[G3]4N(7B5L1V_V-U\D8P #SGCH1CJ<<8Q0TJ8Z)X).I6L(>>5\N7
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M - -?-U?2/B;_D5-8_Z\9_\ T U\W52$%:OAG_D:]'_Z_H/_ $,5E5J^&?\
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M<%K_ &'YS[=WVC'!/_//TKQU-;B-QL9-L62/,R3QV.,5Z?\ M!_\RY_V\_\
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MV\B$S'RFSC;RW'KP*YZBCD0>VE<WI];BC<"%/-7&=V2O/IR*L?VM9?\ /?\
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ME8.MH->U>?4KK*33;=RQ<*,*%&,Y/0>M.>%GS/E6@J68TU!*;=^NAR5%;O\
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MSGX-_P"1Y\/_ /82MO\ T:M?7U9N;A)21K&DJM-P;MZ'A%%>J:_X0L]65YX
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M5Q_WRO\ C1_PE-C_ ,\KC_OE?\:Y&BC^T*_E]P?4*/G]YUW_  E-C_SRN/\
MOE?\:/\ A*;'_GE<?]\K_C7(T4?VA7\ON#ZA1\_O.N_X2FQ_YY7'_?*_XT?\
M)38_\\KC_OE?\:Y&BC^T*_E]P?4*/G]YUW_"4V/_ #RN/^^5_P :/^$IL?\
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MKT?P^DGA#Q-KFAMIVH7D5Q$)8GM/]9Y2AB#GY><,1E2/F&!DD5<U8WUCXO\
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MXXP:.=V'[.-U_5SS&^^#7B^RTZ"Z6"VN9)&16MK>7=)&6X^;("X!(!() Z]
M2,?Q=X UOP7]G?45AEMY^%N+9F:,-S\A) (; STY&<9P<>C_  _FEN?@KXQG
MGE>6:1KUWD=BS,QMU)))ZDGO6)XBFEG_ &>O#+S2O(PU H&=B2%4W"J.>P
M [ "FI.]B7"/+==KF#\(_P#DJ&C_ /;;_P!$R5ZWJ?Q&\1V.JWEI!\/=5NH8
M)WB2X0R;955B XQ$>"!GJ>M>2?"/_DJ&C_\ ;;_T3)6IXE^*/C+3_%6L65KK
M'EV]O?311)]FA.U5<@#)3)X'>E)7D.$N6&_4Z+P;_P 5[\']4\.W'^DZAIF?
ML@_C'!:'YWR!E@\?!&$&..I@^%\C^$_AOXE\5RML\S"6R2PML=D!"'(Y96DD
MVG&,;3SUQR_PA\0OHGCJVMGFV6>H_P"C2J=Q!8_ZL@#^+?A<D' =NF<UUGQR
MO[:PLM,\.6:HHDGEU*="&+*S,V""3C#,\Q([8'0=1K7E[C37+S]5H>+5[U\%
M]*M;'PK-=:BF?[?N3:PQ2 /'-'&CG& #C.)@=W!"CUY\,L[.?4+ZWLK5/,N+
MB58HDR!N9C@#)X')[U[?XT\;Z+X3O=+\+G17U9=$6VFBD>\:%HID7Y,X3#':
M5/H=V,<4YZZ(BE9>\SR'Q5HC>'?%.I:25<+;3LL6]@S&,\H21QDJ5/;KT'2O
M4?AY\,?$&A>)]#\078MOLQ5FDA#L)H0\+XWJRC!!(4@$D$^F2)O&TFDMK_@W
MXAV\2-IUS/$MY(Q&$((92PC.XR* X/+ &)5(XP='4O!=U<?%2S\9)K^FVFEW
M-S;M;N+@B2?]VH$:\!6W[2.&.58\'I2<KHN,$I7,[7---QX[^(.HMH^E:E#9
M:?$76^D=6CS;AMT>T')PA_NMTPR\Y\NN_"5_9^#+'Q3)-;&QO9S!'&K-Y@8%
MQDC;C'[L]SU%>TWG_(7^+7_8-@_])'K$TOPQ=>-_@?H>EZ5=6:W%K?223>=(
M0$PTORG:"0V)%.".ASZ4E*P2A=_?^9YW>> -;M8_#YB6&[EUV+S;2&W9BX&U
M6^?( & X).2!@DG S6KK'PC\1:+)8+<3Z:Z7EREJLD=P0$D=@J@AE#'.2?E#
M$!6)Z5Z;X@@;3O$/PZ30KFPECM8)X[>2^N@B31^7%& '4?,S!AMV@\D'! -9
M_P 5/#FG?\(3=:S?Z7INF:Q'<@PM8S;OM)=EW!R8T+MC>V,$C;G."PIJ;T!T
MTD_(RO&/P@%EX5LKW2TLX+C3[%Y=5=IY6\]E122@((ZJ_P#=ZC\.=T[X,^)=
M4L;"]M[C31;WELMRCO,XV!@I56&S.XANV1\IYZ9ZGQ;X8NO%/PN\+ZIIUU9F
MWTC2&DN-\ARVV*/<J[01N!C8$$C!X]:?KLTJP?"" 2N(7:V=HPQVLRBW )'<
M@,V#[GUI*3MN#C&][=CDX?@MXLFCOFVV:/:RM&L;RL#<84,&C.W:5;( )(YR
M#C!K!\,^!-=\5:C=65C;I"UHVRZ>Z;RQ QW8##[V<H1@ X/7%>HR:E>2?M+Q
M6[7#B&.#[.J+\H,?V8R[3C[PWDMSGG'H,:/A*^TZYD\8Z Z:;>:A+X@N94TZ
M_DV).NX<\JV['EL>%.-HSC(-/F=@]G%L\@\7> -;\%_9WU%89;>?A;BV9FC#
M<_(20"&P,].1G&<''3#X%>*C.\9NM*"JJL)#,^UB2<@?)G(P"<@#YA@GG'0_
M%75&TKP@GAV?0=$M5F97@2RO@[6Q#[MXB,2$!L2+N7CELGG!V]>FE;]H'PO
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M(]#R>1S4]%9)VU1NTFK,S-$T6'0[66V@E>2-Y3(-^,C*J,9'7IZ=Z\6^(_\
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M""/P&<:^U=W=;'/]7BU%I_%Y>9RM%=[JQ@U+P7=7<E^NIRV\P\NX^S^28\E
M5QWX/ZCTJ?6M1?P9;65EI=K%Y3AF9YAG>PQSP0<^N1CICI@2J[>B6I;PBC>4
MI>[9/OOIT?ZG&:=HUQJ5G?7,+Q*EG'YD@<D$C!/&!_LFBRM]-ETZ\DN[UH;I
M1_HT:H6W$<G=QCG@#GCG-=1X5U:];0=:_>J!:0F2 +&H",0['  ]>W2K.BWM
MQJ'@S7+JZD\R9_.W-@#.(5 X''04I59)N_1HNGAZ<E%K=IO7R^?];^1Y[17=
MW.H-X1T72AIL5K*UW$7EF=#ESP0<C:<?.<9YQBK:Z?;6_BG0+V"T^R27<4C2
MP 8"$1=,8&#\V#].G6G[?K;36WR(6#N[<VNE]-K_ )GG-%>F:;J@UG6-5T*\
MLK<VJ&0C8",XDP<\]23G(QSS]*'A;4K*+2;.PM=0BM=0DF9Y$EA9UD)R .H
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M\:]5^:/:****\,^L"BBB@ K-\0?\@2X_X#_Z$*TJS?$'_($N/^ _^A"LJ_\
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M_D"7'_ ?_0A6E6;X@_Y EQ_P'_T(5E7_ (4O1FM#^+'U1P]%%%?,GT@4444
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MY&O1_P#K^@_]#%95:OAG_D:]'_Z_H/\ T,4P/I&BBBH&%%%% !1110 4444
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MZFN6^''_ "(6F?\ ;7_T:]=34#"BBB@"AKG_ " -2_Z]9?\ T$UXO7M&N?\
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M610JL=T?W1U'?K^M9T_AG3)=,OWT^]G>]T_/VA)EPIV[@<8'&=I(Y/H?;/\
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M73^->J_-'M%%%%>&?6!1110 5F^(/^0)<?\  ?\ T(5I5F^(/^0)<?\  ?\
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M[X?_ .*H_P"%B:O_ ,^]E_WP_P#\51]7F'*STRBO,_\ A8FK_P#/O9?]\/\
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M#_R#'_\ $U?U:0<C/6Z*\D_X33Q!_P!!#_R#'_\ $T?\)IX@_P"@A_Y!C_\
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M37B]>T:Y_P @#4O^O67_ -!->+UZ."^%GB9K\<?3]0HHHKL/+"BBB@ HHHH
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M_FB P/ESVQ_#T^G.?2K#4+34[47-G,LL1)7(!&".Q!Y%8SIRAN2U8\M\:?\
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M*/KO]T/[*_O_ (?\$\(HKW>BCZ[_ '0_LK^_^'_!/"**]WHH^N_W0_LK^_\
MA_P3PBBO=Z*/KO\ =#^RO[_X?\$\(HKW>BCZ[_=#^RO[_P"'_!/"**]WHH^N
M_P!T/[*_O_A_P3PBBO=Z*/KO]T/[*_O_ (?\$\(HKW>BCZ[_ '0_LK^_^'_!
M/"**]WHH^N_W0_LK^_\ A_P3PBBO=Z*/KO\ =#^RO[_X?\$\(HKW>BCZ[_=#
M^RO[_P"'_!/"*OZ'_P A_3?^OJ+_ -"%>T44GC+JW*5'*^62?/\ A_P0HHHK
MA/6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,KQ-_
MR*FL?]>,_P#Z :^;J^D?$W_(J:Q_UXS_ /H!KYNJD(*U?#/_ "->C_\ 7]!_
MZ&*RJU?#/_(UZ/\ ]?T'_H8I@?2-%%%0,**** .2^(G_ "+\'_7TO_H#UYG7
MIGQ$_P"1?@_Z^E_] >O,Z[L/\!I'8****V*"BBB@ HHHH *[;2]0\1)IUG;7
M&BKJ.GS +&KQC[HP%R>BC.#EASUSW'$UL6_BK7+6,I'J,K G/[T"0_FP)_"H
MG%R6@FKG=Z=HECHWBW_0FVK-9.3 6R4PZ#.2<X//7N#] W2+NYUJ\\1:=>SL
MUO'(8(PJJI1274X..> .N>E>>S:WJ=Q>M>/?3BX9-A=&V';Z?+C [X]>:AAU
M&^MY)9(;VXC>4[I&25@7/J2#SU/YUE[%O=ZBY3I-0_Y)GI7_ %]-_.6N@\1W
MWB*VUNVCTB*62W:-2P$ 9"VXY#-CCC&>1CVKSAKJX>V2V:XE:W0[EB+DJIYY
M Z#J?SKK?$/C"<:HKZ)J#?9S"H?]WQN#-V<<<$<CV]*<H.ZZ[A8Z541/B [*
MBJ7TS<Q QN/F 9/KP /PJMHUSK=YK^H6NJP/]@V2!$>$>6?F  #;1N&,]>HK
MEO">M0V6NSWNJ7;_ +RW*>;)N<L<K@<9/0?I6<_B36);!K*2_E>!@58-@L03
MD@MC=^O3CI4^R=[>2%RG3_\ -)O\_P#/>M/6]>OK'Q;I>GP,@MYMGF*5R6WN
M5Z]L8R,=^N:\X^W7?V3[)]JG^S?\\?,.SKG[O3KS1+?7<]PEQ-=3R3)C9(\A
M++@Y&#U'-7['77S_ !'RGHMG&D/BOQ'):11&^6%#!&3C<2F6XR.K;<GWZ\U#
MI]WK=UX8ULZS$Z[;=_*:2(1L?D.1CC@<<X[GGTY;P_*USK#W%UKCV4Q3B9V)
M,A X#$\;1@9#'G '?CJ;[4[:QT+4?M6OIJ=Q<Q&&-8M@"Y! ^53QU)+'L .P
MSG*-G;?831YQ111746%%%% !1110 4444 %=[_S2;_/_ #WK@J],T73?[7^'
MD%CYWE>;N^?;NQB4GID>E95G9)ON3(\SHKO?^%;?]1;_ ,EO_LJX*KC.,MAI
MIA5_1IM2AU.+^RF<7;Y10@!W ]00>,=^>!C/:K^@^%+[6]LW_'O9G/[]AG)'
M95R">>_3@\Y&*],TK1K'1K<PV46W=C>['+.0,9)_H..3Q6=2K&.FXG)(\L\3
M/=2:_.][$D5R4C,B1MD ^6O?_P#7]3UK(K>\:?\ (VWW_;/_ -%K6#6D/A12
MV"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\@R?_$UY%11[:0?V;2[L]=_X37P]_P!!#_R#)_\ $T?\)KX>_P"@A_Y!D_\
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MX37P]_T$/_(,G_Q->144>VD']FTN[/7?^$U\/?\ 00_\@R?_ !-'_":^'O\
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MX?\ ^@?_ .1I/_BJ/K,0YT>245ZW_P (7X?_ .@?_P"1I/\ XJC_ (0OP_\
M] __ ,C2?_%4?68ASH\DHKUO_A"_#_\ T#__ "-)_P#%4?\ "%^'_P#H'_\
MD:3_ .*H^LQ#G1Y)17K?_"%^'_\ H'_^1I/_ (JC_A"_#_\ T#__ "-)_P#%
M4?68ASH\DHKUO_A"_#__ $#_ /R-)_\ %4?\(7X?_P"@?_Y&D_\ BJ/K,0YT
M>245ZW_PA?A__H'_ /D:3_XJC_A"_#__ $#_ /R-)_\ %4?68ASH\DHKUO\
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M,MS:K.2WS=@H_P!GC:><+CGH*G-J5N@V]3A:T=&T:XUR\>VMGB1UC,A,I(&
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M^1]U/_ME_P"BDKWRO _B/_R/NI_]LO\ T4E- <K1115"/??AQ_R(6F?]M?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1QGC\:PKN9+B\GFCB6%))&=8UZ("<@#Z=*S:ZH[:<G?D>Z2U.HU#_DF.E?\
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M ,C1_P#Q5-)O8B52$/B=C HK?_X0KQ#_ - __P C1_\ Q5'_  A7B'_H'_\
MD:/_ .*I\DNQ'MZ7\R^\P**VKKPGK=G:375Q9;(84:21O-0X4#). <]!7-?V
ME:?\]?\ QT_X4<DNP>WI?S+[RW153^TK3_GK_P".G_"IK6YAO+N&UMWWS3.L
M<:X(RQ. ,GCJ:.278/K%+^9?>2T5O_\ "%>(?^@?_P"1H_\ XJC_ (0KQ#_T
M#_\ R-'_ /%4<DNP>WI?S+[S HK?_P"$*\0_] __ ,C1_P#Q5'_"%>(?^@?_
M .1H_P#XJCDEV#V]+^9?>8%%;_\ PA7B'_H'_P#D:/\ ^*H_X0KQ#_T#_P#R
M-'_\51R2[![>E_,OO,"BM_\ X0KQ#_T#_P#R-'_\51_PA7B'_H'_ /D:/_XJ
MCDEV#V]+^9?>8%%;_P#PA7B'_H'_ /D:/_XJC_A"O$/_ $#_ /R-'_\ %4<D
MNP>WI?S+[S HK?\ ^$*\0_\ 0/\ _(T?_P 51_PA7B'_ *!__D:/_P"*HY)=
M@]O2_F7WF!16_P#\(5XA_P"@?_Y&C_\ BJ/^$*\0_P#0/_\ (T?_ ,51R2[!
M[>E_,OO,"BM__A"O$/\ T#__ "-'_P#%4?\ "%>(?^@?_P"1H_\ XJCDEV#V
M]+^9?>8%%;__  A7B'_H'_\ D:/_ .*H_P"$*\0_] __ ,C1_P#Q5')+L'MZ
M7\R^\P**W_\ A"O$/_0/_P#(T?\ \51_PA7B'_H'_P#D:/\ ^*HY)=@]O2_F
M7WF!16__ ,(5XA_Z!_\ Y&C_ /BJ/^$*\0_] _\ \C1__%4<DNP>WI?S+[S
MHK?_ .$*\0_] _\ \C1__%4?\(5XA_Z!_P#Y&C_^*HY)=@]O2_F7WF!16_\
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M-J=I]EG$J*J>6R97<ASACGJ3^5>=5,U:R1IAI.?-*6]_7HMF%%%%0=04444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KD?B+_P B_;_]?2_^@/775R/Q%_Y%^W_Z^E_] >HJ?"SHPG\>
M/J>8T445QGT84444 %%>P:M=^(+?4(AIFG075IL!D+N%;.3D EACC'.#UKE_
M$'A@7WBH6>EQVUL39B=P<JG#%>  <=NU:RIM;'%2QJE\2MI?>_W]CAZ*U;WP
M]?Z?-9V\XB^U79PD"R NO.!N[#)Z'/8^E:%SX%UNWLQ<".*4XRT,3Y=>,GC&
M#Z8!/MFHY9=CH=>FK7DM3)U/6M0UCROM]QYWE9V?(JXSC/0#T%.L+G5=&4:C
M:++ DH,0G,64;G) )&.J_I4VB^&]0U[S&M0B11\&64D+G^Z, Y/?_P#6*Z'Q
M#83Z7X!T^RN0HEBO"#M.0?\ 6$$?4$&FDW[S,IU*<6J2MJ[6.)CD>*19(W9'
M0AE93@@CH0:V9_%VN7-O+!-?;HI4*.OE(,@C!'"U'?\ AV[T[6+73)I(&GN=
MFQD8E1N8J,Y&>H]*;+X=U%=;DTF*-;BZC 9O*/RXP#G)QCJ.O>E:2+<J,[-V
M?7Y%*RO;C3KM+JUD\N>/.UMH.,@@\'CH34DVJ7EQJ8U*6;==AU<2;0.5Q@XQ
MCL.U:M]X0O=.GMHKJ\L(Q<%@LC3%57 SSD ^V0#SC.,BM7Q#X6M+;5;8:>]C
M$C>6OV2:=]\C,^W..NWD9P>QI\LK$NO1<EUNGJ<]%XDU>&_GOH[QEN)P!*VQ
M<-@8'RXQQCKCU]:)?$FKS7\%])>,UQ "(FV+A<C!^7&.<]<>GI6GXDT[5K[Q
M+#;3P6;7T\(8"U)57 W<DMCG"G\ *BU/P5JNF6+W;F":./EQ"S$J/[V"!P/\
M\9H:EK8494'RMV3:_P" 9-OJ]_::E)J$%RR74A8NX ^;<<G(QCKSC%2:EKVI
MZO&D=]=M*B'<J[549]< #/\ ^OUK0TWP=J6J6%O>V[VWE3%@-SD%<$C)X]1C
MC/4>^,_6-$O=#NE@NU7#C*2(24?UP?;T_P 12M)+R+4J,IV5N9?>17>J7E_;
MVT%S-OBM4V0KM VC &.!ST'6KH\5ZV+QKL7S"9HQ&3Y:X*@DCC&.I/.,\FI/
M">CP:WK7D7+,(8HS*RK_ !X(&W/;K_GK6W)\09;:_:*ULK9M.C)2)5RC%0,
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MN8D# /3(_.J4)6OU,98BCSJ.G*UOZ=#C;WQ/K&HVCVMU>>9!)C<OE(,X((Y
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M_P" [_X4?V'J_P#T"[W_ ,!W_P *]JHH^LOL'.>*_P!AZO\ ] N]_P# =_\
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MWRGIR& /'>N!HIJ2M9JXJE&3ESTY6;WZG8>)?$5LL-AINDR,ZZ?(K"X8 Y9
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MJI""M7PS_P C7H__ %_0?^ABLJM7PS_R->C_ /7]!_Z&*8'TC1114#"BBB@
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M7WF!16__ ,(5XA_Z!_\ Y&C_ /BJ/^$*\0_] _\ \C1__%4<DNP>WI?S+[S
MHK?_ .$*\0_] _\ \C1__%4?\(5XA_Z!_P#Y&C_^*HY)=@]O2_F7WF!16_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O _B/\ \C[J?_;+_P!%)7OE>!_$?_D?=3_[9?\
MHI*: Y6BBBJ$>^_#C_D0M,_[:_\ HUZZFN6^''_(A:9_VU_]&O74U PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#*\3?\BIK'_7C/_P"@&OFZOI'Q-_R*FL?]>,__
M * :^;JI""M7PS_R->C_ /7]!_Z&*RJU?#/_ "->C_\ 7]!_Z&*8'TC1114#
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** ///BEJ6JZ3_8]UIUU<VZ!Y/,
M:)B$+?(5##H>C<'KS[UR4GQ5\2/9"!39QR;0/M"P_.2,9."2N3W^7'/&*ZKX
MP7D::)I]D0WF2W)E4@< (I!S[_./UKQ^J0CK[;XF>*8+A9)+V*X09S%+ @5N
M.^T ^_!J6]^*7B6ZV>3+;6>W.?(A!W?7?NZ>V.M<7118#M++XI>);7?YTMM>
M;L8\^$#;]-FWK[YZ57E^)7BJ25W745C5F)");QX4>@RI.![DFN3HHL!VTGQ5
M\2/9"!39QR;0/M"P_.2,9."2N3W^7'/&*@MOB9XI@N%DDO8KA!G,4L"!6X[[
M0#[\&N0HHL!V-Y\3_$]S*'BN8+10N-D,"D$^OS[CG\<<5+9_%7Q);1%)39W;
M%L[YH<$#T^0J,?AGFN)HHL!UDOQ*\522NZZBL:LQ(1+>/"CT&5)P/<DU:D^*
MOB1[(0*;..3:!]H6'YR1C)P25R>_RXYXQ7$T46 Z^V^)GBF"X622]BN$&<Q2
MP(%;COM /OP:=>?$_P 3W,H>*Y@M%"XV0P*03Z_/N.?QQQ7'446 [:S^*OB2
MVB*2FSNV+9WS0X('I\A48_#/-4_^%C^+/^@K_P"2\7_Q-<K118#N;GXK^(I[
M=HXTL;=SC$L41++SVW,1[<BJMM\3/%,%PLDE[%<(,YBE@0*W'?: ??@UR%%%
M@.QO/B?XGN90\5S!:*%QLA@4@GU^?<<_CCBI;/XJ^)+:(I*;.[8MG?-#@@>G
MR%1C\,\UQ-%%@.J_X6/XL_Z"O_DO%_\ $U<O/BKXDN8@D1L[1@V=\,.21Z?.
M6&/PSQ7$T46 [&S^)_B>VE+RW,%VI7&R:!0 ?7Y-IS^..:+SXG^)[F4/%<P6
MBA<;(8%()]?GW'/XXXKCJ*+ =M9_%7Q);1%)39W;%L[YH<$#T^0J,?AGFJ?_
M  L?Q9_T%?\ R7B_^)KE:*+ =M>?%7Q)<Q!(C9VC!L[X8<DCT^<L,?AGBHK/
MXG^)[:4O+<P7:E<;)H% !]?DVG/XXYKCJ*+ =9>>-_%GB&Z%O;7,Z,[;DM]/
M0J<A><%?G(QDD$D?D,>]5\Y^$]7M]!\36>I722O##OW+$ 6.491C) ZGUKZ,
MI,84444@"O _B/\ \C[J?_;+_P!%)7OE>!_$?_D?=3_[9?\ HI*: Y6BBBJ$
M>^_#C_D0M,_[:_\ HUZZFN6^''_(A:9_VU_]&O74U PHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:/\ A)M?_P"@YJ7_ (%R?XT6 ^D:*^;O^$FU_P#Z#FI?^!<G^-'_  DVO_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!E>)O^14U
MC_KQG_\ 0#7S=7TCXF_Y%36/^O&?_P! -?-U4A!1113 **** "BBB@ HHHH
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M?^$9T#_H!Z;_ . D?^%:M% &5_PC.@?] /3?_ 2/_"C_ (1G0/\ H!Z;_P"
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MT#_H!Z;_ . D?^%:M% &5_PC.@?] /3?_ 2/_"C_ (1G0/\ H!Z;_P" D?\
MA6K10!E?\(SH'_0#TW_P$C_PH_X1G0/^@'IO_@)'_A6K10!E?\(SH'_0#TW_
M ,!(_P#"C_A&= _Z >F_^ D?^%:M% &5_P (SH'_ $ ]-_\  2/_  H_X1G0
M/^@'IO\ X"1_X5JT4 97_",Z!_T ]-_\!(_\*/\ A&= _P"@'IO_ ("1_P"%
M:M% &5_PC.@?] /3?_ 2/_"C_A&= _Z >F_^ D?^%:M% &5_PC.@?] /3?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB_BOK'3_ "KF+.Q_.D;&00>"Q'0FI=7\)Z)KUVEUJ5EY\R((U;S77"@DXPI
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>exhibit99-5xz004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-5xz004.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBO._VAG,?P*\?,K,I_L6[ V_]<FH ]$H
MKP/PU\+=!\:?#:[T>/X<_P#"$75[ID*KK*6NGQM),NUHY%:WD:3Y9%63YE6H
M/@]K5_XSO]7^(OBRVECN=#M_^$<M[:SMVNF6>/;]OGCCA5F;S)OE7;\VV/\
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M30?AFN@6>MF'7M7EUO6)4ENM<G-NUW\B[8U5?)\E551C;Y>WYFJKX&^$G_"
MZ;J]EI_BS79H]1DGN-URMDS6]Q*VZ2:/;;+\V[^%MR_[->BT4 <5X<^'R>']
M>N=;NM8U+Q#K4\/V1=0U5H=T,.[=Y4<<,<<:KN&YL+N;C<QVK7:T44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\WLNVO3: "BBB@ HJC/?06MQ!%+.B2W+LD,;/M:1E7=M7^]\JLU7J "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0ZZ_XHTZPFC&6MWF5I_^_:_-^E>(^*O^"@O@326ECT72]5UZ1?NR>6MO W_
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M)[F.UB:29UBC7JS&@"88J"ZO(;2%I)Y5BC'5F;%<3KGQ&5-T6F+N/_/:0?\
MH*]ZXJ^U&ZU&;S+F:29O]IONUTT\/*7Q''4Q$8_">@:G\2+2W#+9Q-<O_>;Y
M5KD]1\;:MJ/_ "\?9E_NP_+_ /95AT5V1H1B<,JU20LLK2MN=F9O[S-2445L
M8A1110!WNF/O31F_Z9Q_^A5\:_!NW^T?'C2O^F=]-)_WRLC?^RU]BZ V^UT5
MO4?^UFKY!^!__)=K9O[K7[?^2\]?$8&/+BL7_B/J:G\&G_A/I.BBBO<.8*=%
M+);R;HF:)O[RMMIM% &[8>,]3L/O3?:5_NS?-_X]73Z=X]M+K"W*M:.?XOO+
M7G=% 'M-O<1W,2R1.LD;=&4Y!J6O'+#4[G3'WVTK1MZ+_%79Z-X^AG"QWR^0
M_P#ST7[M '845%'*LR*R,K(W1E-2T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P?B?X1:%XL\5V^M
MZC_:#O'&D<ME#?S16=V$?S(_M$"MLFV,6V[E_B;.[Y:T[SP?#'#XHGTEAI>L
MZVF9M1.Z4K*L/DQ/M+?=557Y5V_Q'[S,U=310!P47P@\/+K.GZG<)J-_>V9A
MD!O-3N9(IIH8UCCN)+?S/)DF 5?WC1[MRJV?E6M"]^'&@W^B>(-&FLI/L'B"
M2634UBN9HGN&D55D_>*VY=RJJ_*P^4 5UM5;B[BLK>2>=UA@C5FDDD;:JJO4
MT <YX<\ :7X2T>;3-.GU8VDV#B\UF\NWC & L<DTK-&/966L_P 4Z?H_A71;
MK49]>N=%\A?,6\O]7N# C?P[EDDVLO\ LUX-\:_V[M#\+&;3/ T4?B'5%X;4
M)3_H47TQ\TG_  '"_P"U7Q5X^^)_BKXGZI]N\3:U<:K)N_=Q2-MBA_W8U^5:
M^7QV?8?#>[3]Z7_DI]1@>'\1BO?K>['_ ,F/L_XC?\% /#>BPO!X5TR;7]0V
M\W,[>3:1MM_[ZDVM_LK_ +U?+_C_ /:F^)'Q$:1+WQ#-IME)_P N>D_Z/'_N
M_+\S+_O,U>3=*2OBL5FV,Q?Q2]W^Z?>X7)L%A/AC[W]X5W9FW-\S4E%%>.>V
M>C?"/=?Z5X^T?S=B76@27,<7]Z2WFAN-W_?N.3_OIJX^NI^ TL"_%GP_:W/_
M ![ZE))I3?\ ;U"UO_[6KF)8FBD:-UVNK;65OX:_2^&ZG-@Y1_ED?EO$U/EQ
MD9?S1&U]B>,I?-_8_P#A\W_3Q;K_ .0[M:^.Z^NM=E\[]CCP"W_3\J?]\M>K
M7T=3XJ?^+_VV1\G'X9'A]%%%;DA1110 5W?@WXW>-/ S1+INO7#6R_\ +I=M
MYT&W^[M;[O\ P';7"44 ?7G@/]L_3;YH[?Q7IKZ;(W6]LMTL0_WH_O+_ ,!W
M5]!>'?%.D^+;!;W1]0M]1M6_Y:V\FX"OS!K6\->*]8\'ZDNH:)J%QIEXO_+6
M!MN[_>7^)?\ 9:@#]0**^7?A;^V';WGD:?XU@6TE^ZNJ6B_NS_UTC_A_WE_[
MY6OI;3M1M=7L8;RRGBN[69=T<T+[U=?4,* +E%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "8XI.U+Z5P_BGQTMKYEII[;I_NM-_"O^[3C"4Y6B95*D:<>:1L>(/%MIH:-
M&?W]T5RL*G_T+^[7FVL:[=ZY/ON9,)_#$OW5K/>5I9&9V9F;[S-_%25Z=.G&
MD>54K2J!1116YB%%%% !1110 4444 =SX>_X\=&_WF_]&-7RE^S[!YOQ@U63
M_GWL[V3_ +Z^7_V:OJGPT^ZPTG_9G9?_ !Y:^7_V=CCXF>+&]--N?_2J%?\
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M[.:_O/B#)_T]6T7_ (].W_LM?*4_]^Q/_;O_ *2?21_@4SUNBBBO0,PHHHH
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MSQ\<X/B=HRZ=J4BQ^);)!YRE=OVB/_GHO_LU 'M-%%% !1110 4444 %%%%
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MQ;R6MQ+#*NV6-F5E_NM7TS9ON_8T\.?[/B:1?_(=S7[)(_$#RNBBBJ ****
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MX_\ XJMJ-/GD<]>IR1,.BBBO5/'"BBB@ HHHH *5&965E;:R_=9:2B@#YO\
MVI_@<MY;WGQ \/6_[Q6W:Y8P+_Y-*O\ Z,_VOF_B:OE6OT]BE\J3=M5OX65E
MW*R_Q*R_W:^,OVE?@8OP^U;_ (2'0+=O^$3U"3;Y:_-_9\W_ #Q;_9_B5O\
M@/\ #7Y9Q%DOL)?6\-\/VC]<X9SSV\?J6)E[WV3PZBBBO@C]$"K6DZG<:)JE
MIJ%JVVYLYEFA;^ZRMN6JM% 'IGQLTV/2_BQXLAB^6VDU"2YAV_\ /.9O,C_\
M=9:]?T:7?^QSI2_\\_%C+_Y+R5Y'\4_+O&\(ZO$_FKJ7ARP9F_O26Z_96_\
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MI_A _P#&)4@_ZGC_ -L%K]<R>I[3 TY'XQG5+V>85(_U[QP]%%%>R>,%%%%
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M_*T<3,OUH \EU^[_ +0UN[GSN5I/E8?W5^5:SZ**]I*VAX/Q!1113)"BBB@
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M(]17COB^7[1XFOF_Z:;?^^5VUT8?XSCQ7\,QZ***],\L**** "BBB@ HHHH
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MHU_[YKUVBB*Y?A,Y1C+XCY3\0_\ !-_X?7]M_P 2/Q9XDT.X_O:A';W\2_\
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M* &]Z\Y^)]KMU"TG_P">D;+_ -\__M5Z,W6N1^(UAY^BK<C&Z"3<?]UOE_\
MB:VHRY:ASUX\U,\THHHKU3QPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JU%JU]!'M2ZF6/\
MN^9\O_?-5:*"SKOA9X7TBTU'5-<MM#TNTU2XVQ27]I80PSS+][:TBJK-V^]7
MI@[US?@:T%KX=@8_>ES(WX]/TQ71]C7D5)<TCUJ,>6F.HHHK,W"BBB@ HHHH
M **** "BBB@ HHHH **** &D<5C>+K7[5X<O8_\ IGO_ .^?F_\ 9:VB<5'+
M$LL3(RY5AM-..CN1)<T;'A-%37D#6=Y/;G[T<C*U0U[1X04444 %%%% !111
M0 4444 %%%<#\3O%>J>'[K2H;74+?P]I\VZ2ZUV^T^2]MK=EDCVPR;9%6-9%
M:3]XS*J[=OWF5E"H^\=]17 W_P 1+S_A/M#T?38[>\TJ::2VOKO:VYIOLDDR
MQP-NV_*L:[MV[_6+_M5D?"KXM7'C?7(K&ZOM%O);K3?[2^S:7N6?36615:WN
M5:1OWG[Q?FVQ_,K?+4<T2N61ZK17CUQ\8M6M_B-J>AHNGWBV;7;-I,5O(MSY
M<-JLBR+<;O+D9F:-?)5=RK)N;[K4WPS\7=4\06.KPVNL>']:O+>SM+U;[1+.
MXNXK=9F99(VMX9))))%V_P ++NW?P[:7M(A[.1['17-_#GQ'=>*_!NGZI>_9
M_M,WF+)]F7:ORR,OW69FC;Y?FC9MRMN5OF6NDK004444$!1110 \D&&:%D66
M"6-HY8)55HYE;[RLK?*R_P"RU?._CS]C;3)=<?Q3\)_$%U\+/& ^98K2:1=-
MF;^[\O[R'=_L[H]J[?+6OH6BA.4?A(E&,OB/@;QQ\1-6\(:\FD?M"_#>0WMR
M&\GQ?X:\NTN[I=RLTFY?]%O/X/[K+N^\M%G\);;QU82ZA\+_ !)9>/K>./S9
MM,B7[+JUNNWYMUG)\S?W=T;-NK[QU?2]/\1Z+<Z/K>FV>M:-<?Z[3]0A6:"3
M_:VM_%_M+\RU\B_%[_@G[$]TVO?"'5I-)U*%O.CT"_N=OS?].UTWW6^[M63_
M +^5[F"S?$83W83]W_R7_P"U/G\;DV'Q/O2C_P"VR_\ MCPB_L[G2KVXL[VV
MEMKR%O+FAGC:.2-O[K*WW:@4%^^?:NAN_P!HWQOX.U/_ (0_XX>#CXR6S_=_
M\3V-K36;>/\ A:.\7YF7=\WS>8K?WMM=-I'@_P  _%M8Q\,_&8BUB3[OA;Q<
M8[*^9O[L,W^IF9F_A^6ONL+Q#AZGNXCW?_2?_ O_ )(^&Q615J?^[^]_Z5_X
M#_\ (GFVVCH:V/$_A'6O!FIM8:[I=WI5VO\ RSNHFCW+_>7^\O\ M+\M8[=:
M^JA.%2'/ ^7G"4)<L@)S5K2]5OM%N5NM/OKC3[E?NS6TS1LO_ EJJ!2J<4W[
MZ)YN7X3U'0_VF/B9H,?E0^,+N^B_YYZFJWF[_O\ *U>A:)^W'XBMW7^VO#6B
MZJO\36GF6DC?^/,O_CM?-?'K1Q[UY%;)<NQ/\2A$]JAG&88?^%6D?:.A_MJ>
M"[^)%U71=;T>5O\ G@T=Y$O_  +]VW_CM?67PEU_2_%?@6RUK1IWO-,OBTL4
MDD31,<-M^ZW^[7Y HK2QA%3>S':JK_%7[#?"OPJ/!/PZ\-Z X42V-A!"^WHS
MJB[C_P!]9K\TXDRG Y9"D\-I*1^F<,YOCLTG4CB7S1B=E1117PI^@!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %4M6LUU'3;FV/_+6-E%7:* /
M!75D9E;Y66DKH?'&E_V=KLC!?W=Q^\7_ -FKGJ]J,N:/,>#*/++E"BBBF2%%
M%% !14-[+);VL\D$/VF=8V:.#=M\QO[NZO(K#XA^))?!]Y?1:E:ZGK2WEHMQ
MIJ^';O[3H\<FW<LEJLGG2;5^96^7=][YEI<W*5&/,>QT5YCK?C?7/^%=KXDT
M;7M%O/)5HY%ET.9?M5QYGEK"L;7:M"WF;8]K;FW5K^/O&NH>#=%T.-5CEU?5
M+A;1I(-/N+V*%O):223[/#^\D7]VRJJ_WEW-MW5','*=O17FVI>-]>B\,Z1K
MVFZAH^IV,TEM T7]GW$,^H323>6T<:M)NMV5?[WF-NW;MNVM"?5O%%K\1M,T
MG^T-'O-,NEN+N:VCTV2.>UMX_E5FF^TLK-YDD:_ZM=W[QOX:.8.4[FBBBM"0
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J:SM6O+J"W3[
MTC*JU#75?#K2_MNL/='_ %=NN[_@3?Y:LY2Y8\QI3CS2Y3TJU@6UMXX4&U$5
M5%3T45Y![@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D_CS3C8
MZ])(%_=W"^8/_9JYRO2_B'I_VK2%N0,O;M_XZW^5KS2O4H2YHGC5H\M0****
MW, HHHH **** "BBB@ KF/&7@VZ\5R6RP>(M2T6V\N2"\@LEC9;J%E^[^\5M
MK;OXE^;;N7^ZR]/106<5+\&_!KZUHNK1>']/@OM+F6>&>*UC\V1EC:-?,9EW
M-M^5E^;[RJW\-/E\$:E91WEY9^(+R^U^XCCMH]2U18?]%A\Q6D6...%8_N[F
M^9?F955FV_=[*BERQ%S2.(B^%5G%K7VY=8U3R%OIM4M]/9H?(M[N165I%_=^
M8W^LD;:S,OS?=^[5F+X>-%;WC?\ "3:XVKW#1LVL[K=;E5CW;8]JP^3Y?S2?
M+Y?\3?Q5UU%'+$.:1D^%_#-OX5TG[#;S7%SNDDGFN;MMTLTDC;I)&V[5^9F_
MA55_NK6M113)"BBB@ HHHH **** "BBB@##\=> _#7Q0T/\ L?QAH=MX@TU/
M]2MR=LENW]Z&9?FCZ?PM\W\6ZOB'XR?\$\M;\/I-J?PUO9/%6GJNYM&O0L>I
M1K_L[=L=Q_P':W_3-J^^J*JG.5/X#*I2IUOB/RU\&_M3_$+X;P2>%O$*1>+/
M#]I)Y,WAGQ?;?:5MV7Y=JLW[R%E_V6^7^[7I&B:M\&?C"471-;E^%GB*3[NC
M^)IOM&ER-_=CO%^:-?\ :F6OLOXK_!'P/\<+/R_&&BK<WRQ^7#K=DWDZA;K_
M  _O/^6BK_=D5EKX2^-G["WC;X9BYU7P[N\<^&8_F:ZTZ#;>6J_]-[?YF_X%
M'N7Y=S;:]3"8ZI0E>A+D_P#23QL7E\:R_>1]I'_R;_Y(U_'WPC\5_#1XSKNC
MS164X5K?4HOWUI<*WW=LR_*VY?FV_>KC,[<8;/M7'_"K]HWQY\&V,'AW6I%T
MB3_CXT2_7[3I]PK?>5H6^7YO[R[6_P!JO:](^+_P9^+\JQ>)=+N/A+XAEY_M
M'1(FN]&E;^\UO_K(?[JK'\OWF:OM\+Q!;W<7#_MZ/_R/_P"T?%XC(5+WL)+_
M +=E_P#)?#_Z2<$<FA< \UZ7XK^ GB?PYI']NZ9]C\8>%I-S1Z]X<F^V6VW^
M+=M^:/;_ !;EV_[5>:GYN:^KH8JABX\U"?,?*XC#5L-+V=:/*>I_LS>"6\>?
M&WPKIK1^;;6]TM]<97<OEP_O/F_V6957_@5?K,",$>E?%?\ P3P^'C6]CXD\
M;74>U[EUTZS)Z^6OS2M_NLWE_P#?MJ^TA@\CO7XYQ5C/K.8.G'X:?NG[/PIA
M/JV ]I+XJGO'+V?Q/\)W_B+6M$MO$FF2ZMH\'VC4+);I=UK'_$TG]W;_ !?W
M=R[L;EK3\.^*]&\8Z6NI:#J]AKNGLQC%UIUREQ$S#[R[E)7->&>&->EL[[Q)
MH&E6OB/5O!T-OJ$VJ:9J6@-]KTB[:19O+MY)(_+O%83.RQ;9F^ZV]E95;>^$
M.LIX7DU]M3GU6:VU[7U&GZGK>ER6>H:K.;./<9+?RX]NU;=D5O)A5EA^ZW^L
M?X\^U/1K/XD^$]1M=7N[3Q1H]U:Z1N_M*:&_B9+';NW><RM^[^ZWWO[IILGQ
M,\(P>%X_$TGBG1H_#LS>7%K#7\(M)&W,N%FW;3\RLOWNJUX%J4P\;0ZGXAL_
M"_B#3_L$NCQ1>'6\.7EHRZ19:BLTGWH56:1E9F^SQLWRJJ[=VZHM<TK53XL'
MC2 >+?#_ (?N-;U*ZL&T?0&NK^%Y+"SA61K.:VDDC622WO?F:)?]<OS+YGS
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M2_O)/K7G_@[1/[8U==Z_Z-#^\D_^)KUWH,5PXB7V3OPM/[0ZBBBN(]$****
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M:_IGA[XC> V@\3ZI<1VD'B7P6JPW,TTC*J^=;M^[D9F^\WWO[JU[G\:/V%O
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M[.1A6I^TB>*T5>UK19]#NV@F7C_EG)_"RU1KT_C/(^$****HD**** "BBB@
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ME_UB[F;YE967[W\2U7LY#YHGL%UXUN+\!;BSL)E'W?,A9O\ V:J__"2)_P!
M?2O_  &KY]7XL>((M2TBUUO6/#/@[^T-+;5-VKV[-MW3;8X?^/F/YO+^9O\
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M]J^C_:+VZTG4U9F^SZAHTC-!=1_WMK;MO]W;YDGW?O?PU$E*(>Z=K_PDB?\
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M^@\?_ .2I[3PIIM_,L%MK?F3'D+]D9<UBUM^"_\ D9;3Z-_Z"U'M:@?5Z?\
M*<O1117JGC!1110 4444 %%%% !1110 4444 %%%*OS_ ': $KH/"WA&;7'6
M27='9+]YO[W^[6KX8\!R3NMSJ2^5'_#;?Q'_ 'J] CC6) B*%5>@6N.K7^S$
M[:.'YO>D):VD5E!'#"BQQ1C:JKVJ>BBN ],**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KEOB'_ ,@2#_KX7_T%JZFN6^(?_($@_P"OA?\ T%J
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MI<<8I!BG5Q2E*7Q'H1C&/PA1112+"BBB@ HHHH **** "BBB@ HHHH ****
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MC-*3BL7)O<WC&,?A%HHHI%A1110 4444 %%%% !1110 4444 %%%% !1110
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M7FF_\]KK_OI?_B:/^%>:;_SVNO\ OI?_ (F@#SJBO1?^%>:;_P ]KK_OI?\
MXFC_ (5YIO\ SVNO^^E_^)H \ZK;\%?\C+:?1O\ T%JZK_A7FF_\]KK_ +Z7
M_P")J?3/!EEI5['=02SM+'G:KLNW[NW^[0!T5%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME_:<\)^#VTPZJEY:2WMBNHO#<2V\,MM:,VV.1XY)E9F;YF\N(22!5.Y5;:I
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MZI'N;C=N/WF;GYF9LLW+>$?@IJ6CZ7X:T;6_$L&KZ%X==9[.RL=-:S:69?\
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MNO\ @#QI+8_!:S\5>+KG4(Q%I_\ :-Y<:FEN)-GE^9N5;?Y=O]U?]9]W=\U
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M\^V0WCW5WJ-Q<SM-&K+&[222,S;5D9?F_AQ_=6N;UCXV7\80Z7X8826^@?\
M"1:C;:[=MILUM!N9?+56C;=(/+DW;MBKA?F^:N6F^+?B>ZC\6ZC.G]G:1;0:
M-=6:Z;=1M<P_:6CW+^\M65MVYMWWF^7:OWMR@'MJ^'K!/$LNOK!G59+-;)KC
MS&YA5VD5=OW?O,W-8&I_"7PMJR8FL)XI!=W%Z+FRO;BVN!+-_KMLT4BNJ/QN
MCW;3M7Y?E7'GTW[2EQ8>'$URZ\.0_8M0T.ZUW2$M]4622:&%5?;<KY?^CLRN
MOW6F56W+N^7YM@?'"_C66QE\.VL7B5M4L]+@M!JG^ALUQ"9HVDN/)W)^[#97
MRV^;:J[MVZ@#L;KX5^$KZP@M)O#]@UI;6+:=#"80%2V+*QC'^SNC4_A3_$?P
M\T;Q/J$5_>IJ$%['$8?M.E:G=6$CQ[MVQVMY8S(JMRJMG;N;;C<U>?:%\1-1
M\8_$;PU;3P_V5]ENM9TZ]LK/4&N8)I;=;?Y]P5=VUF;;N7<O/W6^6HM'M-=U
MKX]^+Y L]YI.EWUBB^9XFOK5+56LXF;;9QJT,V6;=^\*]: .T\5?"K3O$?A6
M_P##]NYTW3]4U);_ %-61IOM2M,LDT?S-\OF;=N?X5/W:U]<\ Z)K]V+J_L%
MN+A=/N-,#K-)'BVFV>;'A6_BVK\WWEQ\M>.^#_C9J6C> ; _8/[=FTG01KFL
MW>IZG]GE^SM)(J^1N5O.D_<R_>:-5^1=WS?+OS?M'V5A?)IU]H-]%K,BOY=I
M!ND0R2*K64?F;5_X^5;"_+\KQR*WW=U ';CX8Z!%JMMJ-K!?V5S (%*V6J75
MM'+Y.%C\Z..15F^557]XK;E55;Y:WO#OAZP\,Z1#IVF6_P!FLH=^R+>S;=S,
MS?,WS?>9J\QO?CO?6GCYO#B>$=0ODL9K6UU.[T^"\N?(FF56+1E;7RVCC61&
M9I)(VV[ML;?+NZ+PY\3'UB\U>74K?3M"T:TU:71X+RYU+$MS<+)Y87RVC51N
MXVC>S%OEV]Z &1? WP2D.H0_V,SV]U!):_9Y+RX:.WAD8,\=LK2;;=6;'RP[
M5^5?[HKK?$.A67BC1KO3=0M_M5E.NUXPQ7I\RLK#YE96"LK+AE959<5Y[XW^
M,]UX3\8:EI:Z%'<Z;I=K87=[?M?>7(J75PT*^7#Y;;V5EW?,R_\ Q5?0/CC=
M>(?'=YHMGX3U&32TO;C38]4^SW>U9X=P9IO]'\F.-I%9=RS,WW=T:_-M .O3
MX8:$UA;6%Q_:>HVEO=K?K'J6K7EV&E7&S?YTK;U4JK+&VY590VW=\U9^G?!7
MPEHMY:76FV-_ITEJ-B&SU6\AS&K;EC95D^:-26VQM\J[FVJ-QK&\ ?$S4K;X
M(W7C/Q=']HDL(KRZF_LUO.>:&)W[>7&JM\I7'W?EW,WWMO&_$3XK>*M2BL?#
M TBSTO5[J\TJ:9M-\1R>5):7%SY?E_:(X%DC9F7:S*OW6W*S?=H ]3@^#WA-
M/L$1TZ>>TT^-H+?3[F_N)K-5VLOS6[R-$S;9&^9EW?-6IX7\$:;X/BGBT^;4
MVBE55V7^JW5ZJJN=H3SI7\O[W\.WM_=K"^(GQ(?X9>'=(==)N-6U*_NH].@M
M8FN)E\W86;?)'#)*554;E8V9C_#]YEYKQ%\>[SPM\/\ 3/%E[X4O+>*XN)K2
MYL+N1K6YAF56VM&LT2>9"WEO(TC>6RQ_-M^5E4 Z^3X1^%;GQ"-9>PG-[]M7
M4EC2^N%MENE_Y;K;B3R5E/\ $P7<VYMWWFS#<_!3P;=ZAJ%U<:0\LM\TC3(U
MY<>4K22+)(T<?F;8F=U5F:-5W8^:N8F^*^O:MI7BXV6E6-K;>';647^H6^LY
MG6X6U\__ $:-[5EDC^9 LDFW=\S;#M^;/US]H*[\'P7 U+P]<-!%86\]C/--
M(UQJDDGD+^[6.V\O;YDZJVUO,7:S+#]U2 >ER^#WU#Q]9^([RZ6>/3K.2VL+
M)8<?9Y)"OG2,^[YF9515^5=J[O[U=97$?#;QS>>.M,N9[_0KS0;NUN# T=U!
M<QQS#:K+)$;B"&1E^8K\T:_,K=MK-YY8_%36O&/C3P!>Q62Z?H>K1:E<6,5K
MJ9EENXXX?E^TP^6OEM]SY5:3:S,K,K*NX ]ZHKYTU/\ :!UW7#X!3P_I5M:S
M:W%INHW'VF_^58YY)(VM_P#4-_=_UGRM7?6'Q3U*?X@KX/G\-O!JZRM<2R"Z
M+6PT[;\MTLGE_,S2;8_+VK\V[YMJ[F /3:*** "BBB@ HHHH **** (8QS_#
M^%<;XO\ A+X5\=ZBE_K>E?;+Q(1"LOVB6,K'ECCY67^\U=FHQTP!7RA^U/\
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M?\(/X=_X2C_A(_\ A']*_P"$AS_R%_L$?VO_ %?E_P"NQN^Y\OWON_+7144
M4=-TNSTBU2VLK6*TMTW%8;= B+N.YL*OO6/I7P_\+:#:FUTSPWI.G6WGI=>1
M9V$<2><I^67:J_>7;\K5TU% &5K>A:?XFTF?3=6T^VU33YMOF6E["LT4FUMR
M[E;Y6^95;\*H6?@3PWI4=FMCX=TJR6SCDAM5M[*-/L\<C;I$3:ORJQ^\J\-7
M244 <@GPK\&+-;S?\(CH22P0FWA<:9#NCAVLOEJ=ORKAF^7I\S5,OP[\+6UU
MJ%S%X:TB*XU&W-I>2I8Q*]U"5VM'(VWYU*JORM\O KJ:* ,/P[X1T7P?9-9Z
M#I-AHEI+)YSVVG6T=O$TFU5W;%7[VU5_[Y%5]/\  ?AO2-7N=5L/#VDV>JW$
MC3S7UM91QSR2-NW.TBKN9FW/\W^TU=)10!S6G> ?#.CSS2Z?X<TJR:6=;N1K
M:RCC\R9=VV1MJ_?&YOF^]S1I'A*WTOQ'K6M"XGO=0U/RHGDN2I\F&,-LACVJ
MNV/<SM_%\TC5TM% !1110 4444 %%%% !1110 4444 9=YHFGZE+&]U8VUU)
M&DD:--"K,JR?+(OS?PL!\W]ZLC4?AGX.U>UT^TO_  GHE];:>GE6<-SIL,B6
MJ_W8U9?E7C^&NKHH Y9OA[X6EU6]U-O#.DMJ5YM-S=_8(?.FPRR+O?;N;YHX
MV^;^)%_NBIM1\!^&]:UNUUN_\/:5>ZS;;?L^I7-E')<Q;6W+LD*[EVMSQ71T
M4 <V? 'AAM?;73X<TG^VV96;4OL4?VDLNW;^]V[OX5_[YI]QX,T"XLTM)=#T
MR2TCADMXX'LXVC2.3_6QJNW[K8^9?XJZ&B@#GM*\&:#H=OIT-CH>G6,.GR22
MV<5K:1QK:LRLK-&JJ-K,K,&V]=S5!??#7PCJ<6GPWGA71;R+31MLH[C3H76U
M_P"N6Y?D_P" UU%% &78:+8:09VLK*VM&G92[6\2Q[]JJJ[MO7:JJO\ NKBK
M26D$-S),D2">0*'D"_,VW[NYJM44 </J?PB\'WECKL,/A_3M*N=8MYX+K4-.
MLH8KEO-5ED;S-N=QWM\Q_O5I^%_ F@>#[.>#1M%L-/6X"_:FM;2.)KIE_BEV
MJNYN6Y/]ZNEHH XB'X,> +=/*3P-X;CBWK(%32+=5W+]UL;?O?,>:T?"G@S3
M_".B2Z7:^;>13W$US<379622XDFD:21I&Q\WWB.?X0J]JZ:B@# ;P;H#VQMF
MT/36MS9KII@-I'L-HOW;<KM_U:Y^Y]WFHM"\"^'?#:P_V1X>TK25ADDDA6RL
MHX1&SJ%9E"K\K,JJK'OM%=)10!@:QX,T#Q)?6-WJ^B:=JUW8/NM;F]M(YI;=
ML[LQLRY4Y5?N_P!T5H0:;;6U[<7D5M%%=W 59IDC59)0OW=S?Q;=S5?HH YK
M4_A[X7U_6(M6U/PWI&HZI"%6.]N[".6>,#IMD9=WZU)!X)\/6?V7R-!TR$VE
MNUI;^5:1KY,+?>C3Y?E5O[OW:Z&B@#D;7X7^#;*R:QM_".A0:>WF;K:/3(5B
M8R;!)\NW;\WEQ[O[VQ?[M)>?"KP7?V>GV=SX1T.YM-/#+9V\VFPO':ACN;RU
M*X3G^[77T4 96N^'M*\4:;)8:OIUIJ]@Y5GM+V!9HG*G*_*WRUE3?#3PC/:6
MME+X6T26SM9/.@MGTV%HX9/[ZKMPK?*OS?[(KJJ* .3\4> =,\6V%]97"R6L
M.HR1-J!M51&O8XR/W,K;2S1LORM_%MRH9:ZRBB@ HHHH **** "BBB@ HHHH
M **** ,&[\):+J<LLEWHUA<O+<1WCM/;1NS3QKMCD.Y?O*JKM;JN*JR?#SPO
M)K=QK+>&M(.KW"LLVH"PB^T2*R[65I-NYMR_+_NUU%% '.:%X%\.>%VB&C>'
M]*T@0B3RQ8V,4'E^9L\S;M7^+RX]W][RU_NTS3/A_P"&- U"]O=,\.:3I][?
M!ENKBTL8XY+A6;<PD8+\VYO[U=-10!R>G?#/PAHMM-;Z?X6T2P@FV^9%:Z=#
M&LFUMR[@J_-\RJW_  $5+K?P^\+^)6E&L>'-(U433BYD^W:?'-OE$:QB1MR_
M>V*J[O[JA:Z>B@#$N?#.D7S7,EQI5E<O<F%IWDMU8S>2VZ$OD?-L;YES]WM5
M=?A]X737FUQ?#FD?VT[>8VH_88_M);^]YFW=71T4 8-UX+T"_P##\>@W6B:=
M<Z&BJJZ9/:1O;*J_=7RRNW"U2D^&'@YM)M=+;PGH9TNUF^TV]B--A\F&7_GH
ML>W:K?[5=710!S4O@3PY):M:/X?TJ2VDBB@:!K&,QM%')YD:;=OW5D9F4?PL
MV[K3]+\#^'="MK:VTW0-,T^VM+C[5;P6EG'$D4VUD\Q55?E;:S+N_NM7144
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F1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>exhibit99-6xu002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-6xu002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M(RJ***]$84444 %%%% !1110 4444 %%%% !70:!_P B_K?TC_G7/UT&@?\
M(OZW](_YU4=Q/IZK\S/HHHK,]$**** "BBB@ HHHH **** "BBB@ I#2TAH
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MR@@E4)..:]+K\?Y/BQXS^(5I^SAK5[J-OJ?B.X\5VD]G8QVWDHT@D*EY&4Y
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M=P\J1Q+$BE5,:C&_:NX[N<5?TOP_\9->N5^Q_#K2O#UM':K:1O/'%YBQ9^5
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M% &AH_WI?PHHT?[TOX45SSW.B&QIT445!84444 %%%% !1110 4444 %%%%
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MYW][_P S^L/[(RW_ *!J?_@N'_R!W'_"\?B'_P!#MKW_ (,)?\:/^%X_$/\
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M=+31]/F6VA$94.\"L[992<D\]:\-_P"&U?CC_P!%'U7_ +XA_P#B*Z/_ (*
M_P#)QD__ & ]+_\ 29:^<*_I/"TX.A!N*V7Y'^0V9UZL,=6C&;24I=?-GMG_
M  VK\<?^BCZK_P!\0_\ Q%'_  VK\<?^BCZK_P!\0_\ Q%>)T5T^RI_RK[CS
M/K-?^=_>SVS_ (;5^./_ $4?5?\ OB'_ .(H_P"&U?CC_P!%'U7_ +XA_P#B
M*\3KI_"/PS\3^/+:6XT#1[C4X8KE+21X0"(Y7CDD0-Z96*0YZ?+2=.DM7%?@
M5&OB).T9M_-GHO\ PVK\<?\ HH^J_P#?$/\ \11_PVK\<?\ HH^J_P#?$/\
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M4/\ G@O_ ']3_P"*H_X1_4/^>"_]_4_^*K/ZAB_^?4ON8_;4OYE]YGT5H?\
M"/ZA_P \%_[^I_\ %4?\(_J'_/!?^_J?_%4?4,7_ ,^I?<P]M2_F7WE&+_6I
M_O#^=?#?[6__ "<O\0_^PD/_ $5'7WI%X?U 2I^X'WA_RU3U_P!ZOC#]J;X;
M>)=6_:)\>WEIIJS6TVH!HY#>6Z;AY48Z-(".G<5^Z>&F'K4:>,]I!J[ANO\
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M-RHI+$)DG;&@SUPH':JFH_M"_$'5(A'-X@95"&,&&VAB;&[=U5 <YYSUK/\
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M")7=%)#$';D,V/D+@CYL[>: /7**RK75)KW7KRUB6/[%:(J22$'<9F^;:.V
MN"?]X>AK5H **** "BLI?$EF_B5]##'[:EN+DCMM)QCZ]ZU: "BBB@ HHHH
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M2ZC58^1>C$Q/<OR>2<FM'[) 'W^3'OSNW;1G/K]:FH **** "BBB@#@_C/\
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M5_R$_B9_URL?YS45\[C?X\OE^1]QE7^Z0^?YGZ MK^M!B!X7N6 /!^UP<_\
MC])_PD&M_P#0K77_ (%P?_%UT5%<)ZQSO_"0:W_T*UU_X%P?_%T?\)!K?_0K
M77_@7!_\77144 <[_P )!K?_ $*UU_X%P?\ Q='_  D&M_\ 0K77_@7!_P#%
MUT5% '._\)!K?_0K77_@7!_\71_PD&M_]"M=?^!<'_Q==%10!SO_  D&M_\
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M:_LO;_5H\MKWYGY_WK]'T^97MH<W)[1W]%_D5/L%G_T$XO\ OS)_A1]@L_\
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MOCQ_NZ5_Z/-#:Y)Z?9E^3-*-.7UK#>^_XM+M_P _(^1YO_PBWAW_ *'2S_\
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M=ZH05&&*_, >HYKTV[_;)\<PVEE;Z)/::1'#9&UN7F@AO'O'; :=S)'A9,
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M@+_H9/$'_?4/_P ;KY7^P,?_ "K[T?T)_P 1<X4_Y^S_ /!<O\S\X**_1_\
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M]"MXH+/7)T@AMOL<4<JI*L47SX5 X.TCS9.1@X=AG!K[P_X=H^ O^AD\0?\
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1JYQV/KL!1GA\/&G/=7_,_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>exhibit99-6xz001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-6xz001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1"  J 9D# 2(  A$! Q$!_\0
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M0/L^N>'\7*7$0P[Q*<L">^W[P^A'>NV^%/B-?%OP]TO7PH5[R &90.%D4E7
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+K!@\(L.I)2O<_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>exhibit99-6xz002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-6xz002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" #] AT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[^HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y?XW>)+[P=\
M%_%_B[3(K>:^T#P_?:E:QW*LT3RPV[R('"D$J649 (.,X(H ZBBOB#X6_'G]
MN7XC>!+'QEX-^#GP_P!2T34O,^R7?G"'S/+D>)_DEU%7&'C<<@9QD<8-=!_P
ML/\ X*&?]$)^'_\ X'1?_+.@#Z_HKY _X6'_ ,%#/^B$_#__ ,#HO_EG1_PL
M/_@H9_T0GX?_ /@=%_\ +.@#Z_HKY _X6'_P4,_Z(3\/_P#P.B_^6='_  L/
M_@H9_P!$)^'_ /X'1?\ RSH ^OZ*^0/^%A_\%#/^B$_#_P#\#HO_ )9T?\+#
M_P""AG_1"?A__P"!T7_RSH ^OZ*^0/\ A8?_  4,_P"B$_#_ /\  Z+_ .6=
M'_"P_P#@H9_T0GX?_P#@=%_\LZ /K^BOD#_A8?\ P4,_Z(3\/_\ P.B_^6='
M_"P_^"AG_1"?A_\ ^!T7_P LZ /K^BOD#_A8?_!0S_HA/P__ / Z+_Y9T?\
M"P_^"AG_ $0GX?\ _@=%_P#+.@#Z_HKY _X6'_P4,_Z(3\/_ /P.B_\ EG1_
MPL/_ (*&?]$)^'__ ('1?_+.@#Z_HKY _P"%A_\ !0S_ *(3\/\ _P #HO\
MY9T?\+#_ ."AG_1"?A__ .!T7_RSH ^OZ*^0/^%A_P#!0S_HA/P__P# Z+_Y
M9T?\+#_X*&?]$)^'_P#X'1?_ "SH ^OZ*^0/^%A_\%#/^B$_#_\ \#HO_EG1
M_P +#_X*&?\ 1"?A_P#^!T7_ ,LZ /K^BOD#_A8?_!0S_HA/P_\ _ Z+_P"6
M=8\O[1G[6'@[XT?#SPC\6OAIX'T"Q\<^(+?38I+8M/*\1N((YBABO9 C*LZ8
M+C&2.#@B@#[7HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KS_]K'_DUGXE_P#8F:M_Z12UZ!7G_P"UC_R:S\2_^Q,U;_TBEH \_P#^
M"7'_ "8GX%_[B/\ Z<KJOH"OG_\ X)<?\F)^!?\ N(_^G*ZKZ H Y_QUXTT#
MPC]E35Y-0EN+W>;>STO2;K4KJ1$V[Y!;VL<DOEJ7C#2;=BM)&"074&QX)\4:
M-XLTJ2_T6>X98)C!<07=E-9W5K*%5MDUO.B2Q,4=' =5)21'&5=2>'\0:]H?
M@/X^ZYXG\:ZSI_A[1-=\,Z38:?JFJ726]K-<VMSJ<DT!E<A$D"7<#*C$-(OF
M% PBEV>8?'CQ5I]SJFK_ !%\/?$__A'/#FHWO@S1+3Q/IFHVD<&H21:Q>/>Q
M133*Z31Q6]X)'9,QDPRQN66*YBH ^GZ*^8/VGY;3PC>3>#9?&7B#1[>^\,^3
MX1U&[^(5QI::7J<DMWYUW>7=S>12WT:E[(^6ANWA2$CRHQ-&)SXX>.;3X?\
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M&I?%6QM5UCPY;?&[1_#-K%J?A.[LI=$^)J^(VD$VK30Z@?MNI1>8%2W2"22
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP  &*^6/^"CO_)TW[,?_ &.;?^EFF4 ?7]%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %>?_M8_\FL_$O\ [$S5O_2*6O0*\_\ VL?^
M36?B7_V)FK?^D4M 'G__  2X_P"3$_ O_<1_].5U7T!7S_\ \$N/^3$_ O\
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M_LQ?]$S_ /*_J7_R11_PQ+^S%_T3/_ROZE_\D4 ?0%%?/_\ PQ+^S%_T3/\
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MT3/_ ,K^I?\ R11_PQ+^S%_T3/\ \K^I?_)% 'T!17S_ /\ #$O[,7_1,_\
MROZE_P#)%'_#$O[,7_1,_P#ROZE_\D4 ?0%%?/\ _P ,2_LQ?]$S_P#*_J7_
M ,D4?\,2_LQ?]$S_ /*_J7_R10!] 45\_P#_  Q+^S%_T3/_ ,K^I?\ R11_
MPQ+^S%_T3/\ \K^I?_)% 'T!7R!_P4=_Y.F_9C_['-O_ $LTRN__ .&)?V8O
M^B9_^5_4O_DBM#PG^R!^SMX9\5:9XDT3X>?9=3T>]AOK&?\ MO4'\F>)P\;[
M6G*MAE!PP(..0: /<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X/]JC_ )-A^(__ &)^
MJ_\ I'+7>5P?[5'_ ";#\1_^Q/U7_P!(Y: .\HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BO/_ -IIKC_A5T-O;W^H
M6/V[Q-X?L9IM/OI;2?R)]9LH946:%ED3='(ZDJP.&/-'_"F_"/\ T%_B!_X<
M?7O_ ),H ] HKS__ (4WX1_Z"_Q _P##CZ]_\F4?\*;\(_\ 07^('_AQ]>_^
M3* /0**\_P#^%-^$?^@O\0/_  X^O?\ R91_PIOPC_T%_B!_X<?7O_DR@#T"
MBO/_ /A3?A'_ *"_Q _\./KW_P F4?\ "F_"/_07^('_ (<?7O\ Y,H ] HK
MS_\ X4WX1_Z"_P 0/_#CZ]_\F4?\*;\(_P#07^('_AQ]>_\ DR@#T"BO/_\
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M@#T"BO/_ /A3?A'_ *"_Q _\./KW_P F4?\ "F_"/_07^('_ (<?7O\ Y,H
M] HKS_\ X4WX1_Z"_P 0/_#CZ]_\F4?\*;\(_P#07^('_AQ]>_\ DR@#T"BO
M/_\ A3?A'_H+_$#_ ,./KW_R91_PIOPC_P!!?X@?^''U[_Y,H ] HKS_ /X4
MWX1_Z"_Q _\ #CZ]_P#)E'_"F_"/_07^('_AQ]>_^3* /0**\_\ ^%-^$?\
MH+_$#_PX^O?_ "91_P *;\(_]!?X@?\ AQ]>_P#DR@#T"BO/_P#A3?A'_H+_
M ! _\./KW_R91_PIOPC_ -!?X@?^''U[_P"3* /0**\__P"%-^$?^@O\0/\
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M1]ONMJ+ C#]UEVV-YFAJ'P[LM7T'QMI^NZC/<R^.89[.]NH$$<EI9-"8(K>
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M .&)?V8O^B9_^5_4O_DBC_AB7]F+_HF?_E?U+_Y(H ] _P"%[?!#_HLGP_\
M_"HLO_CE'_"]O@A_T63X?_\ A467_P <KS__ (8E_9B_Z)G_ .5_4O\ Y(H_
MX8E_9B_Z)G_Y7]2_^2* +'[0?QG^#VH^ ]/M]/\ BOX'NYD\6^'9VC@\1VDC
M+%%K=E)(Y DR%2-'=CT55). #7<?\+V^"'_19/A__P"%19?_ !RO/_\ AB7]
MF+_HF?\ Y7]2_P#DBC_AB7]F+_HF?_E?U+_Y(H ] _X7M\$/^BR?#_\ \*BR
M_P#CE'_"]O@A_P!%D^'_ /X5%E_\<KS_ /X8E_9B_P"B9_\ E?U+_P"2*/\
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M?V8O^B9_^5_4O_DB@#T#_A>WP0_Z+)\/_P#PJ++_ ..4?\+V^"'_ $63X?\
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MTV"YMKCQ':1RP2+:QJR.C2 JP(((/((JE_PQ+^S%_P!$S_\ *_J7_P D4?\
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M_P#\*BR_^.5Y_P#\,2_LQ?\ 1,__ "OZE_\ )%'_  Q+^S%_T3/_ ,K^I?\
MR10!Z!_PO;X(?]%D^'__ (5%E_\ '*/^%[?!#_HLGP__ /"HLO\ XY7G_P#P
MQ+^S%_T3/_ROZE_\D4?\,2_LQ?\ 1,__ "OZE_\ )% 'K'@GXE?#KQCJLFF>
M$?'WA?7[Z*$SR6NE:S;W4J1!E4N4C<D*"RC.,98#O745\0?LE^"/#'PY_P""
MJ_Q)\&^#-,_LW1--\&)]EM/M$DWE^8-+E?YY69SEW8\D]<#C K[?H *^0/\
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M75R\<<$.'D6>7?)/ GF0Q21*TN&=?+E\OS#1?@!XXL_ASKW@^?XE>'YK?6/
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M&?$6GZ>^@_V9%X0ANM)EN8]*M;.PNK(6EQ_I*-=Q[;^\D1@T4JR2C?)*B*@
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MWU5I(;FSL(;/218M]DDNC/%%>.)7%TULO[N!PL6Q9;@D.TS, #N**** //\
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M#;^#]2U"\&H?;GGLM/TRR;['%:_9-/LX-D5OY< 2$_OI;R;<D:8^T^6 $C0
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MUBZ9I(KBW>PN8;>::26._N$>8PQ2R">!9RC-+]D$+>S_ /"]O@A_T63X?_\
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M_P#X5%E_\<H ] HKS_\ X7M\$/\ HLGP_P#_  J++_XY1_PO;X(?]%D^'_\
MX5%E_P#'* /0**\__P"%[?!#_HLGP_\ _"HLO_CE'_"]O@A_T63X?_\ A467
M_P <H ] HKS_ /X7M\$/^BR?#_\ \*BR_P#CE'_"]O@A_P!%D^'_ /X5%E_\
M<H \ ^#O_*9+XK_]B9;_ /HK2*^OZ^,/V<]>T/Q-_P %=/BAK?AO6=/UC3+K
MP9#Y%]I]TEQ!+M32D;;(A*MAE93@\$$=J^SZ "N'U;X,?![5-5N=3U/X3^![
MV^O9GGNKJY\.6DDL\KL6=W=HR69F))).222:[BB@#S__ (43\$/^B-_#_P#\
M)>R_^-T?\*)^"'_1&_A__P"$O9?_ !NO0** //\ _A1/P0_Z(W\/_P#PE[+_
M .-T?\*)^"'_ $1OX?\ _A+V7_QNO0** //_ /A1/P0_Z(W\/_\ PE[+_P"-
MT?\ "B?@A_T1OX?_ /A+V7_QNO0** //_P#A1/P0_P"B-_#_ /\ "7LO_C='
M_"B?@A_T1OX?_P#A+V7_ ,;KT"B@#S__ (43\$/^B-_#_P#\)>R_^-T?\*)^
M"'_1&_A__P"$O9?_ !NO0** //\ _A1/P0_Z(W\/_P#PE[+_ .-T?\*)^"'_
M $1OX?\ _A+V7_QNO0** //_ /A1/P0_Z(W\/_\ PE[+_P"-T?\ "B?@A_T1
MOX?_ /A+V7_QNO0** //_P#A1/P0_P"B-_#_ /\ "7LO_C='_"B?@A_T1OX?
M_P#A+V7_ ,;KT"B@#S__ (43\$/^B-_#_P#\)>R_^-T?\*)^"'_1&_A__P"$
MO9?_ !NO0** //\ _A1/P0_Z(W\/_P#PE[+_ .-T?\*)^"'_ $1OX?\ _A+V
M7_QNO0** //_ /A1/P0_Z(W\/_\ PE[+_P"-T?\ "B?@A_T1OX?_ /A+V7_Q
MNO0** //_P#A1/P0_P"B-_#_ /\ "7LO_C==QI-A8Z7I5MIFF65O96-E"D%K
M:VT2QQ01(H5$1% "JJ@  #   %6** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Q_&GA3PMXQTE-+\7>&M'U^QCF$Z6NJV$5U$D@!4.$D4@, S
M#.,X8^M<O_PHGX(?]$;^'_\ X2]E_P#&Z] HH \__P"%$_!#_HC?P_\ _"7L
MO_C='_"B?@A_T1OX?_\ A+V7_P ;KT"B@#S_ /X43\$/^B-_#_\ \)>R_P#C
M='_"B?@A_P!$;^'_ /X2]E_\;KT"B@#S_P#X43\$/^B-_#__ ,)>R_\ C='_
M  HGX(?]$;^'_P#X2]E_\;KT"B@#S_\ X43\$/\ HC?P_P#_  E[+_XW1_PH
MGX(?]$;^'_\ X2]E_P#&Z] HH \__P"%$_!#_HC?P_\ _"7LO_C='_"B?@A_
MT1OX?_\ A+V7_P ;KT"B@#S_ /X43\$/^B-_#_\ \)>R_P#C='_"B?@A_P!$
M;^'_ /X2]E_\;KT"B@#S_P#X43\$/^B-_#__ ,)>R_\ C='_  HGX(?]$;^'
M_P#X2]E_\;KT"B@#S_\ X43\$/\ HC?P_P#_  E[+_XW1_PHGX(?]$;^'_\
MX2]E_P#&Z] HH \__P"%$_!#_HC?P_\ _"7LO_C='_"B?@A_T1OX?_\ A+V7
M_P ;KT"B@#S_ /X43\$/^B-_#_\ \)>R_P#C='_"B?@A_P!$;^'_ /X2]E_\
M;KT"B@#S_P#X43\$/^B-_#__ ,)>R_\ C='_  HGX(?]$;^'_P#X2]E_\;KT
M"B@#E_!/PU^'7@[59-3\(^ /"^@7TL)@DNM*T:WM97B+*Q0O&@)4E5.,XRH/
M:NHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tmp-codexu001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmp-codexu001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
M+@%7 P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _5.H)KN"V \Z>.'_ 'W _G4]<7K>JP6US>W+-)%%;3+!<RJ
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MRL?0U%%%<1W#/6O&[_Q3!HGQ5US3K_G3=32."7/(1B@ 8^W.*]D[5\S?%_\
MY*'JG_;/_P! %=^"@JLI1?;_ ".#&3=."DNY'IGC74/"PO=%E5-1TH.\+6ES
MDC )'RGJM<Y<6T<]RWV!998F!<1E=SH.X..N/6J\TSW$K22-N=CDL>IKTGX"
MFS7Q5=&>2,7)MRL",?F/(W8_ 5[D[4(2J):GC0O6DJ;>AYH>"0>".M>\?L^_
M\BUJ'_7W_P"R+72^(OAQIGB+6;"_GAC06[,TL2H/](R!@,?8BM+P_86&ESZA
M;:>88X8W13!"N!$VP<'W.0?QKRL1BXUJ7*EJ>G0PLJ-3F;T/*?CVI\5_$'X<
M>"I>=.OKU[Z\CSQ(D(R%/MUKW%$6-0J@*JC  & !7AOQSF_X17XK?#/Q;/\
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M,')4C/% '3?;K?\ Y[Q?]]BIZ^6OCW\!/!_@+X9ZAK6C6MU!J$$L*I(]Y(X
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M\9([_P -2:*=$5+5K?[.N)_N@# /W>V :ZHTZE*G3C!>;.:52G5G.4WZ'0_
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*RDE%%%<1W'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132039896744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2020 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ORGANIGRAM HOLDINGS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001620737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--08-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">156,196,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">40-F<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 31,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037979080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">$ 24,600<span></span>
</td>
<td class="nump">$ 47,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentHeldtomaturityInvestments', window );">Short-term investments</a></td>
<td class="nump">50,128<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">14,747<span></span>
</td>
<td class="nump">16,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLoansAndReceivables', window );">Loan receivable</a></td>
<td class="nump">2,229<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Biological assets</a></td>
<td class="nump">5,394<span></span>
</td>
<td class="nump">20,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">66,365<span></span>
</td>
<td class="nump">93,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets', window );">Prepaid expenses and deposits</a></td>
<td class="nump">6,741<span></span>
</td>
<td class="nump">17,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">170,204<span></span>
</td>
<td class="nump">196,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Restricted investment</a></td>
<td class="nump">8,032<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LoansAndReceivables', window );">Loan receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">247,420<span></span>
</td>
<td class="nump">218,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">1,772<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrepaymentsAndAccruedIncome', window );">Deferred charges</a></td>
<td class="nump">698<span></span>
</td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Investments in associates</a></td>
<td class="nump">7,001<span></span>
</td>
<td class="nump">11,108<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">435,127<span></span>
</td>
<td class="nump">428,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">17,486<span></span>
</td>
<td class="nump">40,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Current portion of long term debt</a></td>
<td class="nump">11,595<span></span>
</td>
<td class="nump">3,509<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">29,081<span></span>
</td>
<td class="nump">43,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="nump">103,671<span></span>
</td>
<td class="nump">46,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Other liabilities</a></td>
<td class="nump">2,848<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,471<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">135,600<span></span>
</td>
<td class="nump">101,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">420,673<span></span>
</td>
<td class="nump">318,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Equity reserves</a></td>
<td class="nump">23,744<span></span>
</td>
<td class="nump">17,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AccumulatedOtherComprehensiveIncome', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">50<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(144,940)<span></span>
</td>
<td class="num">(8,783)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">299,527<span></span>
</td>
<td class="nump">327,006<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total equity and liabilities</a></td>
<td class="nump">$ 435,127<span></span>
</td>
<td class="nump">$ 428,525<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccumulatedOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccumulatedOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of resources: (a) controlled by the entity as a result of past events; and (b) from which future economic benefits are expected to flow to the entity.
Effective 2020-01-01: The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentHeldtomaturityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current held-to-maturity investments. [Refer: Held-to-maturity investments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 8<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_b&amp;doctype=Standard&amp;book=b<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentHeldtomaturityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current loans and receivables. [Refer: Loans and receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 8<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPortionOfLongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPortionOfLongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of present obligations of the entity arising from past events, the settlement of which is expected to result in an outflow from the entity of resources embodying economic benefits.
Effective 2020-01-01: The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 8<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrepaymentsAndAccruedIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of prepayments and accrued income. [Refer: Prepayments; Accrued income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrepaymentsAndAccruedIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity resulting from share-based payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040407848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossRevenue', window );">Gross revenue</a></td>
<td class="nump">$ 103,387<span></span>
</td>
<td class="nump">$ 97,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense', window );">Excise taxes</a></td>
<td class="num">(16,592)<span></span>
</td>
<td class="num">(17,134)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">86,795<span></span>
</td>
<td class="nump">80,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">105,004<span></span>
</td>
<td class="nump">42,521<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossMarginBeforeFairValueAdjustments', window );">Gross margin before fair value adjustments</a></td>
<td class="num">(18,209)<span></span>
</td>
<td class="nump">37,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Fair value changes to biological assets and changes in inventory sold</a></td>
<td class="num">(38,281)<span></span>
</td>
<td class="nump">10,577<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross margin</a></td>
<td class="num">(56,490)<span></span>
</td>
<td class="nump">48,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">27,996<span></span>
</td>
<td class="nump">18,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">16,528<span></span>
</td>
<td class="nump">14,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share- based compensation</a></td>
<td class="nump">4,725<span></span>
</td>
<td class="nump">9,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment of property, plant and equipment</a></td>
<td class="nump">39,771<span></span>
</td>
<td class="nump">613<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total operating expenses</a></td>
<td class="nump">89,020<span></span>
</td>
<td class="nump">42,982<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">(LOSS) INCOME FROM OPERATIONS</a></td>
<td class="num">(145,510)<span></span>
</td>
<td class="nump">5,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financing costs</a></td>
<td class="nump">6,008<span></span>
</td>
<td class="nump">9,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Investment income</a></td>
<td class="num">(308)<span></span>
</td>
<td class="num">(662)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncomeFromGovernmentSubsidies', window );">Government subsidies</a></td>
<td class="num">(7,883)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of loss from investments in associates</a></td>
<td class="nump">1,187<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates', window );">Impairment of investments in associates</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration', window );">Unrealized (gain) on changes in fair value of contingent consideration</a></td>
<td class="num">(886)<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss from continuing operations before tax</a></td>
<td class="num">(146,628)<span></span>
</td>
<td class="num">(5,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax (recovery) expense Deferred, net</a></td>
<td class="num">(10,471)<span></span>
</td>
<td class="nump">3,629<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="num">(136,157)<span></span>
</td>
<td class="num">(9,504)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">NET LOSS</a></td>
<td class="num">(136,157)<span></span>
</td>
<td class="num">(9,542)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Other comprehensive gain (loss) Foreign currency translation gain (loss), net of tax</a></td>
<td class="nump">94<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">COMPREHENSIVE LOSS</a></td>
<td class="num">$ (136,063)<span></span>
</td>
<td class="num">$ (9,585)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations', window );">Net loss from continuing operations per common share, basic (in dollars per share)</a></td>
<td class="num">$ (0.789)<span></span>
</td>
<td class="num">$ (0.067)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations', window );">Net loss from continuing operations per common share, diluted (in dollars per share)</a></td>
<td class="num">(0.789)<span></span>
</td>
<td class="num">(0.067)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Net loss from discontinued operations per common share, basic (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Net loss from discontinued operations per common share, diluted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="num">(0.789)<span></span>
</td>
<td class="num">(0.068)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.789)<span></span>
</td>
<td class="num">$ (0.068)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations [member]; Diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss or reversal of impairment loss recognised in profit or loss. [Refer: Impairment loss recognised in profit or loss; Reversal of impairment loss recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income or expense from subsidiaries, jointly controlled entities and associates that the entity does not separately disclose in the same statement or note. [Refer: Associates [member]; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2019-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in economic benefits during the accounting period in the form of inflows or enhancements of assets or decreases of liabilities that result in an increase in equity, other than those relating to contributions from equity participants.
Effective 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense exclusive of income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseOtherThanIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_GrossMarginBeforeFairValueAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales and other production related expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_GrossMarginBeforeFairValueAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_GrossRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of sales recognized for a reporting period, prior to the excise taxes deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_GrossRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncomeFromGovernmentSubsidies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of income from government subsidies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncomeFromGovernmentSubsidies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of unrealized gain (loss) on changes in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037650648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>SHARE CAPITAL [Member]</div></th>
<th class="th"><div>EQUITY RESERVES [Member]</div></th>
<th class="th"><div>ACCUMULATED OTHER COMPREHENSIVE LOSS [Member]</div></th>
<th class="th"><div>RETAINED EARNINGS/(ACCUMULATED DEFICIT) [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Aug. 31, 2018</a></td>
<td class="nump">$ 157,790<span></span>
</td>
<td class="nump">$ 26,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 759<span></span>
</td>
<td class="nump">$ 184,594<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Balance (shares) at Aug. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,207,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">14,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesShareBasedCompensation', window );">Share-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of stock options</a></td>
<td class="nump">6,588<span></span>
</td>
<td class="num">(2,418)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesExerciseOfStockOptions', window );">Exercise of stock options (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,167,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercise of warrants</a></td>
<td class="nump">39,257<span></span>
</td>
<td class="num">(8,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesExerciseOfWarrants', window );">Exercise of warrants (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,751,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits', window );">Exercise of restricted share units</a></td>
<td class="nump">837<span></span>
</td>
<td class="num">(837)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits', window );">Exercise of restricted share units (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion of debentures</a></td>
<td class="nump">112,166<span></span>
</td>
<td class="num">(11,247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesConversionOfDebentures', window );">Conversion of debentures (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,845,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts', window );">Tax impact of equity issue costs</a></td>
<td class="nump">1,307<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation', window );">Foreign currency translation gain, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,542)<span></span>
</td>
<td class="num">(9,542)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Aug. 31, 2019</a></td>
<td class="nump">318,125<span></span>
</td>
<td class="nump">17,707<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(8,783)<span></span>
</td>
<td class="nump">$ 327,006<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Balance (shares) at Aug. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,196,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts', window );">At-the-market equity financing, net of issue costs of $3,754</a></td>
<td class="nump">99,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts', window );">At-the-market equity financing, net of issue costs of $3,754 (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,281,412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of stock options</a></td>
<td class="nump">1,786<span></span>
</td>
<td class="num">(717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesExerciseOfStockOptions', window );">Exercise of stock options (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">879,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits', window );">Exercise of restricted share units</a></td>
<td class="nump">765<span></span>
</td>
<td class="num">(765)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits', window );">Exercise of restricted share units (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation', window );">Foreign currency translation gain, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136,157)<span></span>
</td>
<td class="num">(136,157)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Aug. 31, 2020</a></td>
<td class="nump">$ 420,673<span></span>
</td>
<td class="nump">$ 23,744<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">$ (144,940)<span></span>
</td>
<td class="nump">$ 299,527<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Balance (shares) at Aug. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,511,061<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the conversion of convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through at the market equity financing, net of issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncreaseDecreaseThroughAtMarketEquityFinancingNetOfIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from exercise of restricted share units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncreaseDecreaseThroughExerciseOfRestrictedShareUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncreaseDecreaseThroughForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncreaseDecreaseThroughForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncreaseDecreaseThroughShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from Share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncreaseDecreaseThroughShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from tax impact of equity issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncreaseDecreaseThroughTaxImpactOfEquityIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfSharesConversionOfDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for conversion of debentures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfSharesConversionOfDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for exercise of restricted share units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfSharesExerciseOfRestrictedShareUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfSharesExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfSharesExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for exercise Share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the issuance of shares through at the market equity financing, net of issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfSharesThroughAtMarketEquityFinancingNetOfIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132092746600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parentheticals)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_StatementOfChangesInEquityAbstract', window );"><strong>Statement of changes in equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssueCostAtMarketEquityFinancing', window );">Issue cost of At-the-market equity financing</a></td>
<td class="nump">$ 3,754<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfChangesInEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfChangesInEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssueCostAtMarketEquityFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents issue cost of At-the-market equity financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssueCostAtMarketEquityFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037878360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>CASH PROVIDED (USED) OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="num">$ (136,157)<span></span>
</td>
<td class="num">$ (9,504)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Items not affecting cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="nump">7,796<span></span>
</td>
<td class="nump">14,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">17,958<span></span>
</td>
<td class="nump">8,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment', window );">Loss on disposal of property, plant and equipment</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment losses</a></td>
<td class="nump">42,771<span></span>
</td>
<td class="nump">1,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets', window );">Fair value adjustment to biological assets</a></td>
<td class="num">(2,853)<span></span>
</td>
<td class="num">(8,060)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceCosts', window );">Financing costs</a></td>
<td class="nump">6,008<span></span>
</td>
<td class="nump">9,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestIncome', window );">Investment income</a></td>
<td class="num">(308)<span></span>
</td>
<td class="num">(662)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod', window );">Share of loss from investments in associates</a></td>
<td class="nump">1,201<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration', window );">Unrealized gain on changes in fair value of contingent consideration</a></td>
<td class="num">(886)<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDeferredTaxExpense', window );">Deferred tax expense</a></td>
<td class="num">(10,471)<span></span>
</td>
<td class="nump">3,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract', window );"><strong>Changes in non-cash working capital:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Net change in accounts receivable</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="num">(13,134)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets', window );">Net change in biological assets</a></td>
<td class="nump">18,111<span></span>
</td>
<td class="nump">7,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Net change in inventories</a></td>
<td class="nump">27,530<span></span>
</td>
<td class="num">(48,175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Net change in accounts payable and accrued liabilities</a></td>
<td class="num">(27,995)<span></span>
</td>
<td class="nump">10,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges', window );">Net change in prepaid expenses and deferred charges</a></td>
<td class="nump">9,598<span></span>
</td>
<td class="num">(13,540)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in continuing operations</a></td>
<td class="num">(45,125)<span></span>
</td>
<td class="num">(35,046)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash used in discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(45,125)<span></span>
</td>
<td class="num">(35,081)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from equity financing, net of issue costs of $3,754</a></td>
<td class="nump">99,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payment of lease liabilities</a></td>
<td class="num">(897)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Payment of long-term debt</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(12,674)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromNoncurrentBorrowings', window );">Proceeds from long-term debt, net of fees of $705 (2019 - $1,250)</a></td>
<td class="nump">64,295<span></span>
</td>
<td class="nump">58,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised', window );">Stock options, warrants and units exercised</a></td>
<td class="nump">1,069<span></span>
</td>
<td class="nump">35,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid</a></td>
<td class="num">(4,043)<span></span>
</td>
<td class="num">(6,995)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">160,366<span></span>
</td>
<td class="nump">74,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Purchase of short-term investments</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from short-term investments</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities', window );">Investment income</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInterestsInAssociates', window );">Investments in associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,758)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents', window );">Investment in GIC - restricted investment</a></td>
<td class="num">(8,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities', window );">Distributions received from investments in associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities', window );">Loan advance</a></td>
<td class="num">(2,071)<span></span>
</td>
<td class="num">(909)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds on sale of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(77,223)<span></span>
</td>
<td class="num">(108,764)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Purchase of intangible assets</a></td>
<td class="num">(1,430)<span></span>
</td>
<td class="num">(1,530)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(138,196)<span></span>
</td>
<td class="num">(46,782)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effects of foreign exchange on cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">DECREASE IN CASH</a></td>
<td class="num">(22,955)<span></span>
</td>
<td class="num">(7,509)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CashPositionAbstract', window );"><strong>CASH POSITION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Cash', window );">Beginning of period</a></td>
<td class="nump">47,555<span></span>
</td>
<td class="nump">55,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Cash', window );">End of period</a></td>
<td class="nump">$ 24,600<span></span>
</td>
<td class="nump">$ 47,555<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDeferredTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDeferredTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value less costs to sell of biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest income expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest income; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash advances and loans made to other parties (other than advances and loans made by a financial institution), classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) due to a decrease (increase) in restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow representing dividends received from associates, classified as investing activities. [Refer: Associates [member]; Dividends received]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from non-current borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInterestsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of interests in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInterestsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of investments other than investments accounted for using equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in prepaid expenses and deferred charges to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AdjustmentsForDecreaseIncreaseInNetChangeInPrepaidExpensesAndDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for unrealized gain (loss) on changes in fair value of contingent consideration to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AdjustmentsForUnrealizedGainLossOnChangesInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CashPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CashPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncreaseDecreaseInNonCashWorkingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from  Stock options, warrants and units exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ProceedsFromStockOptionsWarrantsAndUnitsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132093029576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_StatementOfCashFlowsAbstract', window );"><strong>Statement of cash flows [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Equity financing issue costs</a></td>
<td class="nump">$ 3,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DebtIssuesCost', window );">Issue costs of long-term debt</a></td>
<td class="nump">$ 705<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DebtIssuesCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DebtIssuesCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132039833080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DescriptionOfBusinessAbstract', window );"><strong>Description Of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfNatureOfOperationsExplanatory', window );">NATURE OF OPERATIONS [Text Block]</a></td>
<td class="text"><div><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">1.</span><span style="width:6.89pt;display:inline-block"> </span><span style="color:#86b4cd">NATURE OF OPERATIONS</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Organigram Holdings Inc. (the "Company") is a publicly traded corporation with its common shares trading on the Toronto Stock Exchange ("TSX") and on the Nasdaq Global Select Market ("NASDAQ") under the symbol "OGI". The head and the registered address of the Company is 35 English Drive, Moncton, New Brunswick, Canada, E1E 3X3.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company's major wholly-owned subsidiaries are: (i) Organigram Inc., a licensed producer ("LP" or "Licensed Producer") of cannabis and cannabis-derived products in Canada regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada), and (ii) 10870277 Canada Inc., a special purpose holding company for the Company. Organigram Inc. was incorporated under the Business Corporation Act (New Brunswick), on March 1, 2013.&#160; Organigram Holdings Inc. was&#160;incorporated under the Canada Business Corporations Act ("CBCA") on April 6, 2016.&#160; 10870277 Canada Inc. was incorporated under the CBCA on July 4, 2018.</span></span></span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfNatureOfOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for nature of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfNatureOfOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037505112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BasisOfPreparationAbstract', window );"><strong>Basis Of Preparation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">BASIS OF PREPARATION [Text Block]</a></td>
<td class="text"><div><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">2.</span><span style="width:6.89pt;display:inline-block">&#160;</span><span style="color:#86b4cd">BASIS OF PREPARATION</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">i) Statement of compliance</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">These consolidated financial statements have been prepared in accordance with the International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB") and interpretations of the IFRS Interpretations Committee ("IFRIC").</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">These consolidated financial statements were approved and authorized for issue by the Board of Directors of the Company on November 29, 2020.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">ii) Basis of measurement</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">These consolidated financial statements have been prepared on a historical cost basis except for biological assets, short-term investments, share-based compensation, and contingent share consideration, which are measured at fair value.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Historical cost is the fair value of the consideration given in exchange for goods and services, which is generally based upon the fair value of the consideration given in exchange for assets at the time of the transaction.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">iii) Basis of consolidation</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">These consolidated financial statements include the accounts of the Company and its subsidiaries on a consolidated basis after elimination of intercompany transactions and balances. Subsidiaries are entities that the Company controls when it is exposed, or has rights, to variable returns from its involvement and has the ability to affect those returns through its power to direct the relevant activities of the entity.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">iv) COVID-19 estimation uncertainty</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In March 2020, the World Health Organization declared the outbreak of a novel strain of coronavirus ("COVID-19"), a global pandemic.&#160; Government measures to limit the spread of COVID-19, including the closure of non-essential businesses, disrupted the Company's operations during the year ended August 31, 2020.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The production and sale of cannabis have been recognized as essential services across Canada, however COVID-19-related challenges have persisted, including, but not limited to, reduced staffing levels, production inefficiencies resulting from increased health and safety measures, and limited supply chain issues.&#160; For the year ended August 31, 2020, the Company recorded impairments against its assets (inventories and property, plant and equipment) due in part to the COVID-19 pandemic.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Due to the ongoing developments and uncertainty surrounding COVID-19, it is not possible to predict the continuing impact that COVID-19 will have on the Company, its financial position, and/or its operating results in the future.&#160; In addition, it is possible that estimates in the Company's financial statements will change in the near-term as a result of COVID-19, and the effect of any such changes could be material, which could result in, among other things, further impairment of inventories and long-lived assets including intangible assets. The Company is closely monitoring the impact of the COVID-19 on all aspects of its business.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">vi) Foreign currency translation</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Functional and presentation currency</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">These consolidated financial statements are presented in Canadian dollars, which is the Company's and its subsidiaries' functional currency, except for the Company's investment in its associate, alpha-cannabis Pharma GmbH ("ACG"), for which the functional currency has been determined to be Euros.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Transactions and balances</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Foreign currency transactions are translated into the functional currency using the exchange rate in effect on the date of the applicable transaction. Foreign exchange gains and losses resulting from the settlement of foreign currency transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in currencies other than an operation's functional currency are recognized in the consolidated statements of (loss) income and comprehensive (loss) income.</span></span></span></p>&#160;<p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Foreign operations</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on acquisition, are translated to Canadian dollars at the exchange rate in effect on the reporting date. The income and expenses of foreign operations are translated to Canadian dollars using average exchange rates for the month during which the transactions occurred. Foreign currency differences are recognized in other comprehensive income (loss) in the accumulated other comprehensive loss account.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">When the Company disposes of its entire interest in a foreign operation, or loses control over a foreign operation, the foreign currency gains or losses accumulated in other comprehensive income (loss) related to the foreign operation are recognized in profit or loss. If the Company disposes of part of an interest in a foreign operation that remains a subsidiary, a proportionate amount of foreign currency gains or losses accumulated in other comprehensive income (loss) related to the subsidiary is reallocated between controlling and non-controlling interests.</span></span></span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_BasisOfPreparationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_BasisOfPreparationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132092727224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">SIGNIFICANT ACCOUNTING POLICIES [Text Block]</a></td>
<td class="text"><span style="color:#86b4cd"><span><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span>3. SIGNIFICANT ACCOUNTING POLICIES</span></span></span></span><div><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">i) Cash</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Cash is a financial asset that is measured at amortized cost, which approximates fair value and includes cash-on-hand and deposits held with financing institutions.</span></span></span></p></div></div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">ii) Short-term investments</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">The Company considers short-term investments in the form of guaranteed investment certificates to be an investing activity. These investments are measured at amortized cost. The Company also has equity securities that are carried at fair value through profit or loss.</span></span></span></p></div></div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">iii) Biological assets</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">While the Company's biological assets are within the scope of IAS 41 Agriculture, the direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2 Inventories. This includes the direct cost of seeds and growing materials as well as other indirect costs such as utilities and supplies used in the growing process. Indirect labour cost for individuals involved in the growing and quality control process is also included, as well as depreciation of manufacturing assets. All direct and indirect costs of biological assets are capitalized as they are incurred. Unrealized fair value gains/losses on growth of biological assets are recorded on the consolidated statements of (loss) income and comprehensive (loss) income. Biological assets are measured at their fair value less costs to sell on the consolidated statement of financial position.</span></span></span></p></div></div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">iv) Inventories</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Inventories for finished goods and packaging and supplies are initially valued at cost, and subsequently at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less the estimated costs to sell. The Company reviews inventories for obsolete, redundant and slow-moving goods and any such inventories identified are written down to net realizable value. The direct and indirect costs of finished goods inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labour and depreciation expense on equipment involved in packaging, labeling and inspection. All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of sales on the consolidated statements of (loss) income and comprehensive (loss) income at the time the cannabis is sold. Inventory is measured at lower of cost or net realizable value on the statement of financial position.</span></span></span></p></div></div><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">v) Property, plant and equipment</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Property, plant and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company's management. Property, plant and equipment are subsequently measured at cost, less accumulated depreciation and impairment losses.</span></span></span></p></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Depreciation is recognized on a straight-line basis to reduce the cost, less estimated residual value, of depreciable fixed assets. The following useful lives are applied:</span></span></p><p style="margin:0pt">&#160;</p><div style="text-align:center"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin-left:20%;width:60%"><tbody><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Building</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">25 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Growing equipment</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">10 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Computer equipment</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Vehicles</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Furniture and fixtures</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">10 years</span></td></tr><tr><td style="text-align:left;width:30%"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Leasehold improvements</span></p></td><td style="text-align:right;width:30%"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></p></td></tr></tbody></table></div><p style="margin:0pt">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets, and are recognized as profit or loss within other income or other expenses.</span></span></p><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Assets in process are transferred to the appropriate asset class when available for use and depreciation of these assets commences at that point.</span></p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">An asset's residual value, useful life and depreciation method are reviewed during each financial year and adjusted if appropriate. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) and depreciated accordingly.</span></p></div><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="line-height:115%">vi) Goodwill</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%;color:black">Goodwill represents the future economic benefits arising from a business combination that are not individually identified and separately recognized. Goodwill is carried at cost less accumulated impairment losses. Refer to Note 3(viii) for a description of impairment testing procedures.</span></p></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span>vii) Assets held for sale</span></span><br/>Assets and liabilities held for sale are no longer depreciated and are presented separately in the statement of financial position at the lower of their carrying amount and fair value less costs to sell. An asset is regarded as held for sale if its carrying amount will be recovered principally through a sale transaction, rather than through continuing use. For this to be the case, the asset must be available for immediate sale and its sale must be highly probable.</span></p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span>viii) Impairment of long-lived and intangible&#160;assets</span></span><br/>Long-lived assets, including property, plant and equipment are reviewed each reporting period for indicators of impairment. Goodwill is assessed for indicators of impairment at each reporting date and is tested annually or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs of disposal, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Except for goodwill, where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</span></p><div><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">ix) Share-based payments</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense in profit or loss over the vesting period based on the Company's estimate of equity instruments that will eventually vest. Fair value for options is determined using the Black-Scholes pricing model and fair value for Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") is determined using the Company's share price at the grant date.</span></span></span></p></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Expected forfeitures are estimated at the date of the grant and subsequently adjusted if further information indicates actual forfeitures may vary from the original estimate.&#160; The impact of the revision of the original estimate is recognized in profit or loss such that the cumulative expenses reflect the revised estimate.</span></span></span></span></p><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>For stock options granted to non-employees, the expense is measured at the fair value of the goods and services received except when the fair value cannot be estimated in which case it is measured at the fair value of the equity instrument granted.</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Consideration paid by employees or non-employees on the exercise of options is recorded as an increase to share capital and the related share-based expense is transferred from equity reserves to share capital.</span></span></span></span></p></div><p style="margin:0pt">&#160;</p></div><div><p style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="color:#86b4cd"><span><span>x) Investments in associates</span></span></span></span></span></span></p><p style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Associates are companies over which the Company has significant influence and are accounted for under the equity method. Significant influence is presumed when the Company has an ownership interest greater than 20%, unless certain qualitative factors overcome this assumption. Conversely, where the Company has an ownership interest less than 20%, it is presumed that the Company does not have significant influence, unless certain qualitative factors overcome this assumption. In assessing significant influence and the ownership interest, potential voting rights that are currently exercisable are taken into consideration.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Investments in associates are accounted for using the equity method and are initially recognized at cost, inclusive of transaction costs. The consolidated financial statements include the Company&#x2019;s share of the income or loss and equity movement of equity accounted associates. In accordance with IFRS, the associate&#x2019;s most recent available financial statements are used in the application of the equity method. Where the associate&#x2019;s reporting period differs from the Company&#x2019;s, the associate prepares financial information as of the same period end as the Company, unless it is impracticable to do so. Otherwise, the Company will adjust for its share of income and expenses and equity movement based on the associate&#x2019;s most recently completed financial statements, adjusted for the effects of significant transactions. The Company does not recognize losses exceeding the carrying value of its interest in the associate.</span></span></span></p></div><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span style="color:#86b4cd">xi) Intangible assets</span></span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any, except for off-market supply agreements, where amortization is provided based on the actual output received versus the estimated output forecast to be received over the life of the agreement.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively. Intangible assets with an indefinite life or not yet available for use are not subject to amortization.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Research costs are expensed as incurred. Development expenditures are capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development to use or sell the asset. Research costs and other development expenditures are recognized as general and administrative expenses on the consolidated statement of income (loss) and comprehensive income (loss) as incurred.</span></span></span></span></p></div><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span><span>xii) Earnings (loss) per share</span></span></span><br/><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Basic earnings (loss) per share is calculated by dividing net income (loss) attributable to common shareholders by the weighted-average number of shares outstanding during the period.&#160; Diluted earnings (loss) per share is calculated in a similar manner, but with adjustments to give effect to all dilutive potential common shares outstanding during the period. The dilutive effect of warrants, options, RSUs and PSUs is calculated using the treasury stock method. The if-converted method, which assumes that all convertible debt has been converted if the debt is in-the-money, is used to calculate the dilutive effect of convertible debt.&#160; Anti-dilutive effects of potential conversions of securities are ignored for this calculation.</span></span></span></p><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#86b4cd">xiii) Revenue recognition</span></span></span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000">Revenue from the direct sale of cannabis and cannabis oil for a fixed price is recognized when the Company transfers control of the good to the customer, which is at point of delivery for medical cannabis and recreational cannabis.</span></span></span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Revenue includes excise taxes, which the Company pays as principal, but excludes duties and taxes collected on behalf of third parties. Revenue also includes the net consideration to which the Company expects to be entitled. Revenue is recognized to the extent that it is highly probable that a significant reversal will not occur. Therefore, revenue is stated net of expected price discounts, allowances for customer returns and certain promotional activities and similar items. Generally, payment of the transaction price is due within credit terms that are consistent with industry practices, with no element of financing.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Net revenue is revenue less excise taxes. Excise taxes are effectively a production tax which becomes payable when the product is removed from the Company's premises and may or may not be directly related to the value of revenue depending on the province of sale. It is generally not included as a separate item on external invoices; increases in excise tax are not always passed on to the customer and where a customer fails to pay for product received the Company cannot reclaim the excise tax. The Company therefore recognizes excise tax, unless it regards itself as an agent of the regulatory authorities, as a cost and reduction to revenue for the Company.</span></span></span></span></p></div><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">xiv) Income taxes</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The measurement of income taxes payable and deferred income tax assets and liabilities requires management to make judgments in the interpretation and application of the relevant tax laws. The actual amount of income taxes only becomes final upon filing and acceptance of the tax return by the relevant authorities, which occurs subsequent to the issuance of the consolidated financial statements.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Income tax expense (recovery) in the statements of income (loss) and comprehensive income (loss) is the sum of current and deferred tax as explained below.</span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Current tax is the expected income tax payable (recoverable) on the taxable income (loss) for the period, using tax rates enacted, or substantively enacted, as at the end of the reporting period.&#160; Current tax expense (recovery) included in the statements of income (loss) and comprehensive income (loss) reflects the current tax for the reporting period, plus adjustments to the current tax of prior periods, less current tax recorded directly in other comprehensive income (loss) or equity.</span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Deferred taxes are accounted for under the liability method and are the taxes expected to be payable or recoverable on the temporary differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable income.&#160; Deferred tax liabilities are generally recognized for all taxable temporary differences and deferred tax assets are recognized to the extent that it is probable that taxable income will be available against which deductible temporary differences and unused tax losses and tax credits can be utilized.&#160; Deferred tax is calculated on a non-discounted basis, using enacted or substantively enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&#160; The carrying amounts of individual deferred tax assets are reviewed at the end of each reporting period, but are only recognized for the proportion on which it is probable that sufficient taxable profits will be available for such assets to be recovered.</span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Deferred tax is not recognized for: i) temporary differences related to the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss; ii) differences relating to investments in subsidiaries to the extent that it is probable that they will not reverse in the foreseeable future; and, iii) differences arising on the initial recognition of goodwill.</span></span></span></span></p></div><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span><span>xv) Borrowing costs</span></span></span><br/><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time that the assets are substantially ready for their intended use or sale. Other borrowing costs are expensed in the period in which they are incurred and reported in finance costs. No borrowing costs were capitalized during the periods presented.</span></span></span></p><div><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">xvi) Discontinued operations</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">A disposal group is presented as a discontinued operation if all of the following conditions are met: i) it is a component of the Company for which operations and cash flows can be clearly distinguished operationally and financially from the rest of the Company, ii) it represents a separate major line of business or operations that either has been disposed of or is classified as held for sale; and iii) it is part of a single coordinated plan to dispose of a separate major line of business of operations.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Assets in a disposal group classified as held for sale are presented separately in the consolidated statements of financial position. Discontinued operations are presented separately from continuing operations in the consolidated statements of income (loss) and comprehensive income (loss) and consolidated statements of cash flows.</span></span></p></div><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="line-height:115%">xvii) Government subsidies</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%;color:black">Government subsidies are recognized when there is reasonable assurance that the subsidy will be received, and all the attached conditions will be complied with. Subsidies are recognized as income in the statement of income (loss) and comprehensive income (loss) on a systematic basis over the periods in which the expenses are recognized for the related costs for which the subsidies are intended to compensate, which in the case of subsidies related to assets requires setting it up as deferred income or deducting it from the carrying amount of the asset.</span></p></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></div><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">xviii) Critical accounting estimates and judgments</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimates are revised and in any future years affected.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The following are the estimates and judgments made by management in applying the accounting policies of the Company that have the most significant effect on the financial statements.</span></p><div><div><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>1) Biological assets and inventories</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Determination of the fair value of biological assets requires management to make a number of estimates, including estimating harvesting costs, selling costs, sales prices, wastage, oil conversion factor, expected yields, and post-harvest costs of the cannabis plant. The Company records obsolete and unsaleable inventories at the lower of cost and net realizable value. Adjustments to the carrying value of inventories are based on obsolescence trends, historical experience, and forecast demand and pricing for obsolete and unsaleable inventories. Refer to Notes 7 and 8 for further information. </span></span></span></p><p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(2) Estimated useful lives and impairment of property, plant and equipment</strong></i></span></span></span></p><p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Amortization of property, plant and equipment requires estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts, taking into consideration factors such as economic and market conditions and the useful lives of assets.</span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(3) Share-based payments</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In determining the fair value of options and related expenses, management estimates the expected life of the option, the volatility of the Company's share price, the risk-free interest rate, and the rate of forfeitures. Refer to Note 12 for further information. </span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(4) Warrants</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In determining the value of warrants, management estimates the expected life of the warrant, the volatility of the Company's share price, and the risk-free interest rate. </span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(5) Adult-use recreational cannabis revenue - provision for returns and price adjustments </strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Government customers typically have the right to return products, and in some cases, the right to pricing adjustments for products that are subsequently discounted or sold for a lower price in another jurisdiction. The estimation of potential future returns and pricing adjustments includes the use of management estimates and assumptions that may not be certain given the evolving nature of the industry.</span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(6) Investments in associates</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:17.85pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Management has applied significant judgment in the determination of whether the Company exerts significant influence with respect to its investments, which then allows the Company to account for its investments under the equity accounting method. Further, management has applied significant judgment and made use of management estimates and assumptions in determining and quantifying any impairment losses that may need to be recorded against its investments in associates.</span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(7) Impairment of long-lived and intangible assets</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:17.85pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In determining the recoverable amount of the Company's Moncton campus (the "Moncton Campus") CGU, management has applied significant judgment in the aggregation of the CGU and has made various estimates with respect to the forecast cash flows, terminal growth rate, post-tax discount rate, and income taxes utilized in the discounted cash flow model to estimate fair value less costs of disposal.</span></span></span></p></div></div></div><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">NEW STANDARDS AND INTERPRETATIONS ADOPTED</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">New or amended standards effective September 1, 2019</span></span></span></p><p style="margin:0pt">&#160;</p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company has adopted the following new or amended IFRS standard for the annual period beginning on September 1, 2019:</span></span></span></p></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"><strong><span style="line-height:115%">IFRS 16 - Leases</span></strong></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">In January 2016, the IASB issued IFRS 16 Leases, which replaced IAS 17 Leases. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than twelve months, unless the underlying asset is of low value. A lessee is required to recognize a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. The standard was effective for annual periods beginning on or after January 1, 2019 and has been adopted by the Company effective September 1, 2019 using the modified retrospective approach where comparative figures were not restated.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">As a result of adopting IFRS 16, the Company recognized right-of use ("ROU") assets of $4,464 recorded under property, plant and equipment (Note 9), lease liabilities of $4,439 recorded under other liabilities (Note 13), and a reduction to prepaid expenses of $25 as a result of the leasing arrangements in place at September 1, 2019 and entered during the year ended August 31, 2020 by the Company.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The ROU asset was measured as the amount of the lease liability, using the Company's incremental borrowing rate on September 1, 2019 that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. The weighted average interest rate as of September 1, 2019 to measure the lease liabilities was 5.70%.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The Company elected to use the following practical expedients on adoption of IFRS 16 on all of its leases:</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(a)&#160;In accordance with IFRS 16.C3, an election is being taken to not reassess whether a contract is or contains a lease at the date of initial application, and instead to only apply IFRS 16 to contracts that were in the scope of IAS 17;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(b)&#160;In accordance with IFRS 16.C8(b)(ii), an election is being taken to measure the ROU asset on September 1, 2019 as an amount equal to the lease liability, adjusted for prepaid or accrued lease payments;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(c)&#160;In accordance with IFRS 16.C10(a), an election is being taken to apply a single discount rate to a portfolio of leases with reasonably similar characteristics;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(d)&#160;In accordance with IFRS 16.C10(b), an election is being taken to rely on the IAS 37 assessment of whether leases are onerous instead of performing an impairment review;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(e)&#160;In accordance with IFRS 16.C10(c), an election is being taken to exclude leases for which the term ends within 12 months from September 1, 2019;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(f)&#160;In accordance with IFRS 16.C10(d), an election is being taken to exclude initial direct costs from the measurement of the ROU asset on September 1, 2019;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(g)&#160;In accordance with IFRS 16.15, an election is being taken, by class of underlying asset, not to separate non-lease components from lease components, and instead account for each lease component and any associated non-lease components as a single lease component where the non-lease components are not significant compared to the lease components;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(h)&#160;In accordance with IFRS 16.5(a), an election is being taken to not recognize a ROU asset and lease liability for leases for which the lease has a term less than 12 months; and</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(i)&#160;In accordance with IFRS 16.5(b), an election is being taken to not recognize a ROU asset and lease liability for leases for which the underlying asset is of low value, which is defined to mean less than $5,000 USD when new.</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The following is a reconciliation between the Company's operating lease commitments disclosed applying IAS 17 as at August 31, 2019 and the lease liabilities as at September 1, 2019 after adopting IFRS 16:</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"><tbody><tr><td style="vertical-align:bottom"><p><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Reconciliation - IAS 17 to IFRS 16</span></p></td></tr></tbody></table><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Operating lease obligations as at August 31, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">3,049</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Minimum future payments not related to lease payments</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(411</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Lease payments for renewal options reasonably expected to be exercised but not contractually obligated</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">655</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Relief option for short-term leases</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(538</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Relief option for leases of low-value assets</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(76</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Gross lease liabilities at September 1, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,679</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Discounting</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(459</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Present value of lease liabilities at September 1, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:3px double #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,220</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000">&#160;</td></tr></tbody></table></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">New Accounting Pronouncements&#160;</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The following IFRS standards have been recently issued by the IASB. Pronouncements that are irrelevant or not expected to have a significant impact have been excluded.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"><strong><span style="line-height:115%">Amendments to IFRS 3: Definition of a Business</span></strong></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">In October 2018, the IASB issued "Definition of a Business (Amendments to IFRS 3)". The amendments clarify the definition of a business, with the objective of assisting entities to determine whether a transaction should be accounted for as a business combination or as an asset acquisition. The amendment provides an assessment framework to determine when a series of integrated activities is not a business. The amendments are effective for business combinations occurring on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements resulting from any future transactions.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"><strong><span style="line-height:115%">Amendments to IAS 1: Classification of Liabilities as Current or Non-Current</span></strong></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The amendments to IAS 1 clarify the requirements relating to determining whether a liability should be presented as current or non-current in the statement of financial position. Under the new requirements, the assessment of whether a liability is presented as current or non-current is based on the contractual arrangements in place as at the reporting date and does not impact the amount or timing of recognition. The amendment applies retrospectively for annual reporting periods beginning on or after January 1, 2023. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132047929320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT TERM INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ShortTermInvestmentAbstract', window );"><strong>Short Term Investment Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory', window );">SHORT TERM INVESTMENTS [Text Block]</a></td>
<td class="text"><p style="text-align:justify"><span style="color:#86b4cd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>4. SHORT TERM INVESTMENTS </span></span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The Company's short-term investments included the following on August 31, 2020 and August 31, 2019:</span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:46.3488%"><span style="color:#86b4cd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DESCRIPTION</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTEREST %</span></span></td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:rgb(134, 180, 205);white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:rgb(134, 180, 205);white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:rgb(166, 164, 164);white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:rgb(166, 164, 164);white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:rgb(166, 164, 164)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing September 16, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.95%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing September 24, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.95%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing December 15, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.16%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing December 23, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.16%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing June 17, 2021</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.93%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity securities in VIVO Cannabis Inc.</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:1px solid #000000;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:1px solid #000000;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">128</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:1px solid #000000;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:1px solid #000000;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">380</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:18.6977%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:3px double #000000;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:3px double #000000;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,128</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:3px double rgb(0, 0, 0);background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:3px double #000000;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:3px double #000000;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">380</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:3px double rgb(0, 0, 0);background-color:rgb(223, 221, 221)">&#160;</td></tr></tbody></table></div><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">On October 16, 2018, the Company sold its wholly-owned subsidiary, Trauma Healing Centers, Incorporated ("THCI"), in exchange for consideration consisting of common shares in the purchaser (an unaffiliated publicly-traded company), VIVO Cannabis Inc. ("VIVO") (the "VIVO Shares").&#160; The VIVO Shares are carried at fair value through profit or loss. Subsequent to August 31, 2020, all of the VIVO Shares were sold.</span></span></span></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments other than investments accounted for using the equity method. [Refer: Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ShortTermInvestmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ShortTermInvestmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132039809928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AccountsReceivableAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">ACCOUNTS RECEIVABLE [Text Block]</a></td>
<td class="text"><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">5.</span><span style="width:6.89pt;display:inline-block">&#160;</span><span style="color:#86b4cd">ACCOUNTS RECEIVABLE</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">The Company's accounts receivable included the following balances as of August 31, 2020 and August 31, 2019:</span></span></span></p><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">AUGUS 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Trade receivables</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11,096</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11,900</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Harmonized sales taxes receivable</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">728</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,741</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Government programs</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,936</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">168</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Less: Provision for doubtful accounts</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(13</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(268</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,747</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16,541</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><p style="margin:0pt">&#160;</p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">On April 1, 2020, Department of Finance Canada announced the Canada Emergency Wage Subsidy ("CEWS"), which would subsidize 75% of employee wages, retroactive to March 15, 2020, to Canadian employers whose businesses had been affected by COVID-19 in order to enable them to re-hire workers previously laid off as a result of pandemic, help prevent further job losses, and to better position companies to resume normal operations following the crisis.&#160; At August 31, 2020, under this program, the Company applied for a wage subsidy of $2,936 for the period July 5, 2020 to August 29, 2020, which is included under government programs above.</span></span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AccountsReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AccountsReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132039801784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOAN RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LoansReceivablesAbstract', window );"><strong>Loans Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfLoanReceivablesExplanatory', window );">LOAN RECEIVABLE [Text Block]</a></td>
<td class="text"><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">6.</span><span style="width:6.89pt;display:inline-block">&#160;</span><span style="color:#86b4cd">LOAN RECEIVABLE </span></span></span><br/><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">On July 26, 2019, the Company entered into an advance payment and support agreement ("Payment Agreement") with 703454 N.B. Inc. (carrying on business as 1812 Hemp) ("1812 Hemp"). Under the terms of the Payment Agreement, the Company advanced $3,000 to 1812 Hemp in the form of a secured loan. This&#160;amount&#160;may be applied against future purchases of hemp under the Supply Agreement described in Note 10. The aggregate amount of advances outstanding as of January 1, 2020 accrue interest of 9.0% per annum, calculated monthly, until the entire balance of advances is paid.&#160; At August 31, 2020, $2,229 in principal was outstanding under the Payment Agreement.&#160; Subsequent to August 31, 2020, the Company demanded repayment of the entire amount owing by 1812 Hemp to the Company under the Payment Agreement.</span></span></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfLoanReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfLoanReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LoansReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LoansReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040047480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory', window );">BIOLOGICAL ASSETS [Text Block]</a></td>
<td class="text"><div><div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">7.</span><span style="width:6.89pt;display:inline-block">&#160;</span><span style="color:#86b4cd">BIOLOGICAL ASSETS</span></span></span></div></div><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The Company measures biological assets, which consist of cannabis plants, at fair value less costs to sell up to the point of harvest, which then becomes the basis for the cost of finished goods inventories after harvest. Subsequent expenditures incurred on these finished goods inventories after harvest are capitalized based on IAS 2 Inventories.<i> </i></span></span></span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The changes in the carrying value of biological assets as of August 31, 2020 are as follows:</span></span></span></span></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"><tbody><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>OTHER</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>BIOLOGICAL ASSETS</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>CANNABIS ON PLANTS</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>TOTAL</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Carrying amount, August 31, 2018</span></span></span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;599</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;19,259</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;19,858</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Add net production costs</span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(596 </span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>37,534</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>36,938</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Net change in fair value less costs to sell due to biological transformation</span></span></span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#x2014;</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(8,060</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(8,060</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Transferred to inventory upon harvest</span></span></span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#x2014;</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(28,084</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(28,084</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Carrying amount, August 31, 2019</span></span></span></span></p></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;3</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;20,649</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;20,652</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Add net production costs</span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>13</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>41,039</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>41,052</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Net change in fair value less costs to sell due to biological transformation</span></span></span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#x2014;</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(2,853</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(2,853</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Deduct net abnormal plant destruction costs</span></span></p></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(5,048</span></span></p></td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(5,048</span></span></p></td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Transferred to inventory upon harvest</span></span></span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#x2014;</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(48,409</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(48,409</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Carrying amount, August 31, 2020</span></span></span></span></p></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;16</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;5,378</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;5,394</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr></tbody></table><p style="margin:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">During the year ended August 31, 2020, the Company had to cull plants with a carrying value of $5,048 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124102658573">nil</span>) due to lack of sufficient staffing as a result of COVID-19. These costs were expensed to cost of sales.</span></span></p><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The fair value less costs to sell of biological assets is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred, such as post-harvest costs. The following unobservable inputs, all of which are classified as Level 3 on the fair value hierarchy (see Note 16), are used in determining the fair value of biological assets:</span></span></span></span></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"><tbody><tr><td style="text-align:center;width:5%" valign="top"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>i. </span></span></span></span></span></td><td><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Average selling price per gram - calculated as the weighted average current selling price of cannabis sold by the Company, adjusted for expectations about future pricing;</span></span></p></td></tr><tr><td style="text-align:center;width:5%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>&#160;</span></span></span></span></span></td><td>&#160;</td></tr><tr><td style="text-align:center;width:5%" valign="top"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>ii. </span></span></span></span></span></td><td><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Yield by plant - represents the number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant;</span></span></p></td></tr><tr><td style="text-align:center;width:5%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>&#160;</span></span></span></span></span></td><td>&#160;</td></tr><tr><td style="text-align:center;width:5%" valign="top"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>iii. </span></span></span></span></span></td><td><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Wastage of plants based on their various stages of growth - represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested; and</span></span></p></td></tr><tr><td style="text-align:center;width:5%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>&#160;</span></span></span></span></span></td><td>&#160;</td></tr><tr><td style="text-align:center;width:5%" valign="top"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>iv. </span></span></span></span></span></td><td><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Post-harvest costs - calculated as the cost per gram of harvested cannabis to complete the sale of cannabis plants post-harvest, consisting of the cost of direct and indirect materials and labour related to drying, labelling and packaging.</span></span></p></td></tr></tbody></table><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The Company estimates the harvest yields for the cannabis on plants at various stages of growth. As of August 31, 2020, it is expected that the Company's biological assets will yield 5,096 kg (August 31, 2019 - 16,595 kg) of cannabis when eventually harvested. The Company's estimates are, by their nature, subject to change, and differences from the anticipated yield will be reflected in the fair value adjustment to biological assets in future periods. The Company accretes fair value on a straight-line basis according to stage of growth. As a result, a cannabis plant that is 50% through its 19-week growing cycle would be ascribed approximately 50% of its harvest date expected fair value less costs to sell (subject to wastage adjustments).</span></span></span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Management believes the most significant unobservable inputs and their impact on fair value are as follows:</span></span></span></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"><tbody><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>SIGNIFICANT INPUTS &amp; </span></span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="text-align:center;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>WEIGHTED AVERAGE INPUT</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="text-align:center;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>EFFECT ON FAIR VALUE</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>ASSUMPTIONS </span></span></span></span></span></td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUG. 31, 2020</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUG. 31, 2019</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>SENSITIVITY</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUG. 31, 2020</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUG. 31, 2019</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Average net selling price per gram</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><p style="font-family:Times New Roman, Times, serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160;3.36</span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><p style="font-family:Times New Roman, Times, serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160;5.65</span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Increase or decrease by $ 1.00 per gram</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160; 1,602 </span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;3,657</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Average yield per plant</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>101 grams</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>151 grams</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Increase or decrease by  10  grams</span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;532</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;1,367</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr></tbody></table><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>During the three months ended May 31, 2020, management ceased the harvesting of trim from the cannabis plants and therefore the average yield per plant at August 31, 2020 primarily reflects the average yield of the flower component of the plant.</span></span></span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The fair value adjustment to biological assets and inventory sold consists of the following:</span></span></span></span></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"><tbody><tr valign="top"><td style="text-align:left">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#87b5cf">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:12%;background-color:#87b5cf"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUGUST 31, 2020</span></span></span></span></td><td style="text-align:center;width:2%;background-color:#87b5cf">&#160;</td><td style="text-align:center;width:1%">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:1%;background-color:#aeaaaa">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:12%;background-color:#aeaaaa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:left;width:2%;background-color:#aeaaaa">&#160;</td></tr><tr><td style="text-align:left">&#160;</td><td style="text-align:center;width:1%;background-color:#e1eaed">&#160;</td><td style="text-align:center;width:12%;background-color:#e1eaed">&#160;</td><td style="text-align:center;width:2%;background-color:#e1eaed">&#160;</td><td style="text-align:center;width:1%">&#160;</td><td style="text-align:center;width:1%;background-color:#d6d6d6">&#160;</td><td style="text-align:center;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>&#160;</span></span></span></span></span></td><td style="text-align:center;width:2%;background-color:#d6d6d6">&#160;</td></tr><tr valign="top"><td style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Realized fair value amounts included in inventory sold</span></span></span></span></td><td style="text-align:left;width:1%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;(39,455</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="text-align:left;width:1%">&#160;</td><td style="text-align:left;width:1%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;(50,477</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr valign="top"><td style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Increase (decrease) in fair value on growth of biological assets</span></span></span></span></td><td style="text-align:left;width:1%;background-color:#e1eaed">&#160;</td><td style="text-align:right;width:12%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>73,975</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#e1eaed">&#160;</td><td style="text-align:left;width:1%">&#160;</td><td style="text-align:left;width:1%;background-color:#d6d6d6">&#160;</td><td style="text-align:right;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>75,338</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#d6d6d6">&#160;</td></tr><tr valign="top"><td style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Adjustment to net realizable value</span></span></span></span></td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#e1eaed">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:right;width:12%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(72,801</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="text-align:left;width:1%">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#d6d6d6">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:right;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(14,284</span></span></td><td style="text-align:left;width:2%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr valign="top"><td style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Fair value adjustment to biological assets</span></span></span></span></td><td style="BORDER-BOTTOM:#000000 3px double;text-align:left;width:1%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="BORDER-BOTTOM:#000000 3px double;text-align:right;width:12%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(38,281</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#e1eaed">)</td><td style="text-align:left;width:1%">&#160;</td><td style="BORDER-BOTTOM:#000000 3px double;text-align:left;width:1%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="BORDER-BOTTOM:#000000 3px double;text-align:right;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;10,577</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#d6d6d6">&#160;</td></tr></tbody></table><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The adjustment to net realizable value is related to the write-down of the fair value component of dry cannabis available for packaging, flower and trim available for extraction, concentrated extract, and packaged inventories due to excess or obsolete quantities as well as the decrease in the estimated net realizable value of these inventories based on the evolving nature of the adult-use market.</span></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 43<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132092407496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">INVENTORIES [Text Block]</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">8. INVENTORIES</span></span></span></p><div><div><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">The Company's inventories are comprised of the following balances as of August 31, 2020 and August 31, 2019:</span></span></span></p><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:50%">&#160;</td><td style="vertical-align:bottom;background-color:#86b4cd;width:1.02326%">&#160;</td><td colspan="9" style="vertical-align:bottom;text-align:center;background-color:#86b4cd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="vertical-align:bottom;background-color:#86b4cd;width:1.95349%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#d3e3e5">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">FAIR VALUE</span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.95349%;background-color:#d3e3e5">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#d3e3e5">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">CAPITALIZED COST</span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">ADJUSTMENT</span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">CARRY ING VALUE</span></span></span></td><td style="vertical-align:bottom;width:1.95349%;background-color:#d3e3e5">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Plants in drying stage</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,036</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,841</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,877</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Dry cannabis</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Available for packaging</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13,124</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7,808</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">20,932</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Packaged inventory</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,707</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,956</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,663</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Flower and trim available for extraction</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">849</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,062</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,911</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Concentrated extract</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13,252</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">6,130</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19,382</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Formulated extracts</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Available for packaging</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,097</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">384</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,481</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Packaged inventory</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,045</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">226</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,271</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Packaging and supplies</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11,848</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11,848</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1.95349%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">46,958</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19,407</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">66,365</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1.95349%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td></tr></tbody></table><p>&#160;</p><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:50.0698%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4">&#160;</td><td colspan="9" style="text-align:center;vertical-align:bottom;background-color:#a6a4a4"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:1.95349%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221);white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">FAIR VALUE</span></span></span></td><td style="text-align:right;vertical-align:bottom;width:0.976745%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.95349%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">CAPITALIZED COST</span></span></span></td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221);white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">ADJUSTMENT</span></span></span></td><td style="text-align:right;vertical-align:bottom;width:0.976745%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">CARRY ING VALUE</span></span></span></td><td style="text-align:right;vertical-align:bottom;width:1.95349%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Plants in drying stage</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,945</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,256</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">6,201</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Dry cannabis</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Available for packaging</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,261</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12,718</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17,979</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Packaged inventory</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,205</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,549</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">6,754</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Flower and trim available for extraction</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,433</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12,193</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16,626</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Concentrated extract</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">15,393</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21,573</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">36,966</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Formulated extracts</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Available for packaging</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">754</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,121</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,875</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Packaged inventory</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">728</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">425</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,153</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Packaging and supplies</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,590</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,590</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">38,309</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">54,835</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">93,144</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr></tbody></table></div><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">&#160;</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">Flower and trim available for extraction </span><span style="color:#000000">are converted into concentrated extract, which can then be used for oil formulation (combining with a carrier oil) or other products such as edibles, and beverage and vaporizable products.</span></span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">The amount of inventory expensed in cost of sales for the year ended August 31, 2020 was $42,872 (August 31, 2019 - $35,224). The amount of inventory write-down, provision, and plant waste included in cost of sales for the year ended August 31, 2020 was $45,270 (August 31, 2019 - $4,733), which relates to the production or purchase costs of these inventories and biological assets (refer to Note 7 for the write-down and provisions against the fair value component of these inventories).</span></span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">Inventory write-down and provision relating to excess and unsaleable inventories for the year ended August 31, 2020 was $32,831 (August 31, 2019 - $744), of which $20,251 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124115201864">nil</span>) related to concentrated extract and flower and trim available for extraction.&#160; Inventory write-down related to adjustments to net realizable value during the year ended August 31, 2020 was $2,753 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124115425104">nil</span>).&#160; Inventory write-offs for the year ended August 31, 2020 related to abnormal plant waste due to lack of sufficient staffing as a result of COVID-19 was $5,048 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124115446465">nil</span>).</span></span></span></p></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_InventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_InventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132092741656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">PROPERTY, PLANT AND EQUIPMENT [Text Block]</a></td>
<td class="text"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#86b4cd">9.</span><span style="width:6.89pt;display:inline-block">&#160;</span><span style="color:#86b4cd">PROPERTY, PLANT AND EQUIPMENT</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400">&#160;</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#000000">Most of the additions during the year ended August 31, 2020 were related to the expansion of the Company's facility located in Moncton (the "Moncton Campus").</span></span></p><div><div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">RIGHT- OF-</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">GROWING &amp;</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">USE LEASE</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">CONSTRUCTION</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">PROCESSING</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">OTHER</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">ASSETS</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">LAND</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">BUILDINGS</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">IN PROCESS</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">EQUIPMENT</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">(NOTE A)</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">(NOTE B)</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">TOTAL</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Cost</span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2018</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,205</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">47,101</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">11,993</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">40,493</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,922</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">104,714</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Additions</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">6</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">15,753</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">105,512</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">5,554</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">3,366</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">130,191</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Construction completed</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">8,042</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(51,990</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">42,698</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">1,250</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Disposals</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(122</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(201</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(323</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Impairment loss</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(613</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(613</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Reclassification of<br/>&#160;&#160;&#160; computer software<br/>&#160;&#160;&#160; (NOTE A)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(841</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(841</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,211</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">70,774</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">65,515</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">87,931</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">6,697</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">233,128</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2018</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,997</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(2,956</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,122</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(6,075</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(2,245</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(5,679</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(946</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(8,870</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Disposals</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">5</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">17</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">22</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Reclassification of<br/>&#160;&#160;&#160; computer software<br/>&#160;&#160;&#160; (NOTE A)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">265</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">265</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(4,237</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(8,618</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,803</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(14,658</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Cost</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,211</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">70,774</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">65,515</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">87,931</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">6,697</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">233,128</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Transition to IFRS 16</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,244</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,244</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Additions (Note C)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">1,864</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">22,316</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">46,847</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">7,597</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">1,335</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,220</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">82,179</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Construction completed</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">71,663</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(110,234</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">37,851</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">720</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Disposals</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(517</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(436</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(75</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,028</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Impairment loss (Note D)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(37,214</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">48</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(37,166</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2020</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">4,075</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">127,022</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,128</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">132,991</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">8,677</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">4,464</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">279,357</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(4,237</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(8,618</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,803</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(14,658</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(4,074</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(11,568</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,362</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(557</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(17,561</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Disposals</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">108</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">145</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">29</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">282</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2020</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(8,203</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(20,041</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(3,136</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(557</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(31,937</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Net book value</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">August 31, 2019</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,211</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">66,537</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">65,515</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">79,313</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">4,894</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">218,470</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">August 31, 2020</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">4,075</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">118,819</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,128</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">112,950</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">5,541</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">3,907</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">247,420</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div></div></div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">A) Other - Computer Software</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">During the three months ended November 30, 2019, the Company determined that due to the increasing value of its computer software, it should be reclassified from property, plant and equipment to intangible assets. Computer software has historically been included in the "other" category within property, plant and equipment due to its relatively insignificant value. The August 31, 2019 cost of $841 and accumulated amortization of $265 relating to computer software have been reclassified from property, plant and equipment to intangible assets (Note 10) as a result.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">B) Right-of-Use Assets and Transition to IFRS 16</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">As described in Note 4, the Company adopted IFRS 16 effective September 1, 2019. As a result, certain lease obligations were capitalized as ROU assets on the transition date and depreciated for the year ended August 31, 2020. ROU assets mostly comprise of office and warehouse space.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">C) Reconciliation of property, plant and equipment additions to the statements of cash flows</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The following table reconciles additions of property, plant and equipment per the above table to the purchases of property, plant and equipment per the statements of cash flows:</span></span></span></p><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">82,179</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">130,191</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions related to IFRS 16 Leases</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,220</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net change in accounts payable and accrued liabilities related to purchases of<br/>property, plant and equipment</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,736</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,427</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property, plant and equipment</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">77,223</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">108,764</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)">&#160;</td></tr></tbody></table><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">D) Impairment<span style="color:#000000"> </span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company reviews the carrying value of its property, plant and equipment at each reporting period for indicators of impairment. During the year ended August 31, 2020, management noted indicators of impairment and recorded impairments at an asset specific level.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><strong>Moncton Campus - Phase 4C (asset specific)</strong></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The construction of Phase 4C of the Moncton Campus, which was intended to house grow rooms with a previously estimated cultivation capacity of 24,000 kg per annum, was indefinitely deferred during the three months ended May 31, 2020 based on available capacity and forecast market demand. Phase 4C of the Moncton Campus has effectively been left partially completed and, due to the specialized and integrated nature of Phase 4C, without any foreseeable near-term use. Management estimated the fair value less cost to dispose ("FVLCD") of Phase 4C to approximate the purchase cost of the land and movable equipment, which is $1,328. As a result, the Company recognized an impairment loss of $37,749 in relation to this asset for the year ended August 31, 2020. The entire amount of the impairment loss was recorded against the building infrastructure of Phase 4C. In addition, subsequently incurred and contractually committed future costs totaling $1,050 with respect to Phase 4C at August 31, 2020 were included in the impairment loss for the year ended August 31, 2020.</span></span></span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037747608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">INTANGIBLE ASSETS [Text Block]</a></td>
<td class="text"><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">10. INTANGIBLE ASSETS</span></span></span></p><div><div>&#160;<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SUPPLY<br/>AGREEMENT</span></span></td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">LICENSE<br/>AGREEMENT</span></span></td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">COMPUTER<br/>SOFTWARE</span></span></td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">TOTAL</span></span></td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Cost</span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2018</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Additions</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,530</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,530</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Reclassification of computer software (NOTE A)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">841</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">841</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2019</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,530</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">841</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,371</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Accumulated amortization</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2018</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Amortization</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Reclassification of computer software (NOTE A)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(265</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(265</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2019</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(265</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(297</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Cost</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2019</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,530</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">841</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,371</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Additions</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">198</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,232</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,430</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Impairment (NOTE B)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(1,303</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(1,303</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Disposal</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2020</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">227</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">198</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,041</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,466</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Accumulated amortization</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2019</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(265</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(297</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Amortization</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(195</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(202</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(397</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2020</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(227</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(467</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(694</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net book value</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">August 31, 2019</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,498</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">576</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,074</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">August 31, 2020</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">198</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,574</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,772</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">A) Other - Computer Software</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">During the three months ended November 30, 2019, the Company determined that due to the increasing value of its computer software, it should be reclassified from property, plant and equipment to intangible assets.&#160; Computer software has historically been included in the "other" category within property, plant and equipment due to its relatively insignificant value.&#160; The August 31, 2019 cost of $841 and accumulated amortization of $265 relating to computer software have been reclassified from property, plant and equipment to intangible assets as a result.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">B) Impairment</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">On January 18, 2019, the Company entered into an agreement with 1812 Hemp to secure supply of hemp (the "Supply&#160; Agreement"). Pursuant to the Supply Agreement, the Company is to receive a 25% discount on the price per kilogram of dried hemp flower harvested that is purchased from 1812 Hemp. The term of the Supply Agreement is from December 17, 2018 to December 16, 2023 and the Company has the option to renew it for an additional five-year period upon six months' notice. In addition, the Company has a right-of-first refusal on the future procurement of high cannabidiol (CBD) hemp from 1812. The Company paid $1,500 to 1812 Hemp plus transaction costs of $30 in connection with this transaction, which it has recorded as an intangible asset with a finite useful life that will be amortized based on the actual volume of dried hemp flower purchased as a proportion of its forecast purchase volumes. During the three months ended August 31, 2020, management became aware that 1812 Hemp was facing financial hardship due to a lack of customer demand and a change in market conditions and as a result, 1812 Hemp had significantly scaled back operations.&#160; Separately, the Company's forecast hemp purchases have decreased significantly as a result of slower than expected progression in Canadian hemp and CBD regulations. Thus, as a result of the aforementioned challenges, management impaired the Supply Agreement intangible asset to its recoverable amount, which was estimated to be $nil, by recording an impairment charge of $1,303 at August 31, 2020.</span></span></span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040026552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBorrowingsExplanatory', window );">LONG-TERM DEBT [Text Block]</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#86b4cd">11. LONG-TERM DEBT</span></span><span style="text-align:left">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></span></span></p><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank of Montreal ("BMO") senior secured term loan ("Term Loan")<br/>&#160; maturing May 31, 2022 with principal repayments starting November 30, 2020<br/>&#160; based on a 10 year amortization</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,000</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,000</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Atlantic Canada Opportunities Agency ("ACOA")<br/>&#160; Business Development Program loan maturing September 1, 2024 with a 7 year<br/>&#160; amortization, bearing interest at an interest rate of 0%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">311</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">346</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle loans - five year term maturing June 17, 2024</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">98</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred financing costs, net of loan modification loss on BMO Term Loan</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(123</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(868</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,266</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,576</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: current portion of long term debt</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,595</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,509</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term portion</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103,671</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,067</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">BMO CREDIT FACILITY</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On May 31, 2019, the Company entered into&#160;a credit facility with Bank of Montreal ("BMO") as lead arranger and agent and a syndicate including three other lenders. The facility consists of a $115,000 term loan ("Term Loan") and a $25,000 revolving credit facility ("Revolver", and together with the Term Loan, as amended, the "Facilities"), both of which mature on May 31, 2022. Included in the facility was an uncommitted option to increase the Facilities by an incremental $35,000 to a total of $175,000, subject to agreement by BMO and the syndicate lenders and satisfaction of certain legal and business conditions.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Facilities are secured by assets of the Company and its subsidiaries. The proceeds of the Term Loan have been used to fund the Phase 4 and 5 expansions of the Moncton Campus and were also used to refinance the Company's long-term debt with Farm Credit Canada. The Revolver may be used for general corporate and working capital purposes.&#160; Availability under the Revolver is based on a percentage of the Company's trade receivables at the end of each month and remains undrawn at August 31, 2020.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">First Amendment</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On November 15, 2019, the Company amended its Facilities with BMO to: i) extend the final draw deadline of the Term Loan ("Amended Term Loan") from November 30, 2019 to March 31, 2020; ii) postpone the commencement of scheduled principal repayments on the Term Loan from February 28, 2020 to May 31, 2020; and iii) realign the financial covenants structure, effective November 30, 2019, to be more consistent with industry norms up to and including May 31, 2020.&#160; Prior to the Second Amendment, as described below, the financial covenants were to revert to the original structure on August 31, 2020.&#160; The Company incurred an amendment fee of $140 plus customary legal expenses in connection with the first amendment.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The amended Facilities were further amended on February 28, 2020 to extend the final draw deadline of the Amended Term Loan from March 31, 2020 to May 31, 2020.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In accordance with IFRS 9, such modification to the Facilities as outlined above is not an extinguishment of debt either qualitatively or quantitatively, rather it is a non-substantial modification. Therefore, as per the provisions of IFRS 9 the Company recorded a loss on debt restructuring based on the difference in the present value of the restructured net cash flows discounted at the original effective interest rate ("EIR") versus the present value of the original net cash flows discounted at the original EIR.&#160; This loss of $831 has been recorded under financing costs in the statement of (loss) income and comprehensive (loss) income for the year ended August 31, 2020.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">Second Amendment</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On May 28, 2020, the Company further amended its Facilities ("Second Amendment") with BMO to: (i) extend the final draw deadline of the Term Loan to July 31, 2020; (ii) postpone the commencement of principal repayments on the Amended Term Loan to November 30, 2020; (iii) adjust certain financial ratios to be maintained by the Company both before and after November 30, 2021 (the "Conversion Date"); (iv) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (v) remove the uncommitted option to increase the Amended Facilities by an incremental $35 million.&#160; The financial covenants will revert to the original structure, albeit at different ratios, on November 30, 2021.&#160; The interest rate margin will be fixed during this period.&#160; The Company incurred an amendment fee of $490 plus customary legal expenses in connection with the second amendment.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">As a result of the Second Amendment, the Company recorded a loan modification loss of $813 under financing costs in the statement of (loss) income and comprehensive (loss) income for the three months ended May 31, 2020.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">As part of the Second Amendment, the Company is also required to establish and maintain with BMO a cash collateral of $8,000 at all times.&#160; As a result, the Company purchased a two-year GIC not redeemable before maturity, which is to be held by BMO as a pledged deposit.&#160; Since the GIC is restricted from being exchanged or used for any other purpose for greater than one year, the Company has classified it as a restricted investment on the statement of financial position under non-current assets.</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Pursuant to the agreed upon conditions of the Second Amendment, the Company drew down additional funds up to the $115,000 Term Loan commitment during June 2020.&#160; Principal repayments on the Amended Term Loan will commence on November 30, 2020 at a rate of 2.5% per quarter of the total Amended Term Loan balance.&#160; The Company may, at its discretion, repay the balance of the Amended Facilities without penalty, at any time.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(134, 180, 205)">Amendment and Restatement</span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent to the year-end, on November 27, 2020, the Company further amended its Facilities pursuant to an amended and restated credit agreement ("Amendment and Restatement") with BMO to: (i) reduce the Term Loan amount from $115,000 to $60,000 based on a repayment of $55,000 to be made on December 1, 2020 of the outstanding Term Loan balance of $115,000; (ii) have repayments on the balance of the Term Loan commence on February 28, 2021 in an amount equal to $1,500 per quarter; (iii) reduce the Revolver commitment to $2,000 from up to $25,000; (iv) adjust the minimum quarterly EBITDA covenants to be maintained by the Company commencing on February 28, 2021 and continuing through to maturity, thereby removing this covenant for the fiscal period ended November 30, 2020 and eliminating the reversion of the financial covenants to that of the original structure on November 30, 2021;&#160;(v) modify the applicable margin pricing and standby fee terms to reflect current market conditions;&#160;and (vi) reduce the minimum unrestricted cash balance requirement to $20,000, which is already inclusive of the $8,000 restricted investment currently outstanding. &#160;The interest rate margin will be fixed from November 27, 2020 through to maturity on May 31, 2021. &#160;The Company incurred an amendment fee of $217 plus customary legal expenses in connection with the amendment and restatement.</span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">Other Terms and Conditions</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Under the terms of the Facilities, the Company can elect, at its sole discretion, to receive advances under the Amended Term Loan through certain availment options, which includes prime rate loans and bankers' acceptances with maturity dates between 28 and 182 days. The Company, therefore, has the choice to continuously roll over the bankers' acceptances upon their maturities or to convert the then outstanding principal and interest into prime rate loans at any time before May 31, 2022.&#160; The interest rate of the Amended Facilities is a set margin over the above-noted availment options, which shall remain fixed until November 30, 2021, at which point it may subsequently increase or decrease based on a pricing grid linked to the Company's debt to EBITDA coverage at each quarter-end.&#160;</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">During the year ended August 31, 2019, the Company converted its $50,000 outstanding principal amount under the Term Loan to bankers' acceptances, which reduced the cash interest rate from 5.70% (EIR of 6.39%) as at May 31, 2019 to 4.46% (EIR of 5.18%) as at August 31, 2019.&#160; In accordance with IFRS 9, the loan conversion was determined to not be a modification of the loan terms.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">During the year ended August 31, 2020, the Company drew an additional $65,000 under the Term Loan, in three tranches, and similar to the initial draw noted above, converted the balances from prime rate loans to bankers' acceptances.&#160; During the year ended August 31, 2020, the Company rolled over $115,000 of the Term Loan balance on a monthly basis through bankers' acceptances with an average cash interest rate of approximately 4.25%.&#160; Based on the current availment option of bankers acceptances' the applicable margin rate is 3.75% above the applicable bankers acceptances' rate.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Transaction costs incurred with respect to the Amended Facilities have totaled $2,085 to date, which have been allocated against the Term Loan ($1,899) and Revolver ($186 split between prepaid assets and deferred charges).&#160; The weighted-average effective interest rate for the Term Loan based on these capitalized transaction costs, the loan modification loss, and the current cash interest rate was approximately 4.3% at August 31, 2020.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Facilities contain customary financial and restrictive covenants. At August 31, 2020, the Company was in compliance with these covenants.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Principal repayments required on the long-term debt for the next five years as at August 31, 2020 are as follows:</span><span style="text-align:left">&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></span></span></p><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:60%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 1 year</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,605</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1 to 2 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103,580</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 to 3 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3 to 4 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4 to 5 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Thereafter</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,389</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132093063704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShareCapitalInformationAbstract', window );"><strong>Disclosure Of Share Capital Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIssuedCapitalExplanatory', window );">SHARE CAPITAL [Text Block]</a></td>
<td class="text"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#86b4cd">12. SHARE CAPITAL</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#86b4cd">(i) Authorized share capital</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The authorized share capital of the Company is an unlimited number of common shares without par value and an unlimited number of preferred shares without par value. All issued shares, consisting only of common shares, are fully paid and non-assessable.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#86b4cd">(ii) Issued share capital</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">As at August 31, 2020, the Company's issued and outstanding share capital consisted of 194,511,061 (August 31, 2019 - 156,196,347) common shares with a stated value of $420,673 (August 31, 2019 - $318,125).</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#86b4cd">(iii) Issuances of share capital</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">At-the-market ("ATM") equity financing - December 2019 Offering</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">On December 4, 2019, the Company established an at-the-market equity program (the "December 2019 ATM Program") that allowed the Company to issue up to $55,000 (or its U.S. dollar equivalent) of common shares from treasury to the public. Common shares sold in the December 2019 ATM Program were sold through the TSX or the NASDAQ at the prevailing market price at the time of sale.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Subject to securities laws and stock exchange requirements, the volume and timing of distributions under the December 2019 ATM Program were determined in the Company's sole discretion. All of the common shares issuable pursuant to the December 2019 ATM Program, were issued as of February 13, 2020. The Company has used, and intends to continue to use, the net proceeds of the December 2019 ATM Program to fund capital projects, for general corporate purposes and to repay indebtedness.&#160; As common shares distributed in the December 2019 ATM Program were issued and sold at the prevailing market price at the time of the sale, prices varied among purchasers during the period of the distribution.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Distributions of the common shares through the December 2019 ATM Program were made pursuant to the terms of an equity distribution agreement dated December 4, 2019 among the Company, BMO Nesbitt Burns Inc., as Canadian agent, and BMO Capital Markets Corp., as U.S. agent (collectively, the "agents").</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The Company issued 16,201,183 common shares during the three months ended February 29, 2020 for gross proceeds of $54,966 at a weighted average price of $3.39 per common share. Net proceeds realized were $52,885 after agents' commissions of $1,100, regulatory fees of $12, and legal and professional fees of $969. Proceeds were raised in both USD (for shares sold through the NASDAQ) and CAD (for shares sold through the TSX) and the weighted average share price was calculated using the spot rate on the day of settlement.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">ATM equity financing - April 2020 Offering</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">On April 22, 2020, the Company established an at-the-market equity program (the "April 2020 ATM Program") that allowed the Company to issue up to $49,000 (or its U.S. dollar equivalent) of common shares from treasury to the public. Common shares sold in the April 2020 ATM Program were sold through the TSX or the NASDAQ at the prevailing market price at the time of sale.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Subject to securities laws and stock exchange requirements, the volume and timing of distributions under the April 2020 ATM Program were determined in the Company's sole discretion. All of the common shares issuable pursuant to the April 2020 ATM Program, were issued as of June 8, 2020. The Company has used, and intends to continue to use, the net proceeds of the April 2020 ATM Program to fund capital projects, for general corporate purposes and to repay indebtedness.&#160; As common shares distributed in the April 2020 ATM Program were issued and sold at the prevailing market price at the time of the sale, prices varied among purchasers during the period of the distribution.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Distributions of the common shares through the April 2020 ATM Program were made pursuant to the terms of an equity distribution agreement dated April 22, 2020 among the Company and the agents.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The Company issued 14,035,278 common shares during the three months ended May 31, 2020 for gross proceeds of $31,069 at a weighted average price of $2.21 per common share. The Company subsequently completed its April 2020 ATM Program on June 8, 2020, by issuing the remaining shares under the ATM, which comprised of 7,044,951 common shares for gross proceeds of $17,915 at a weighted average price of $2.54 per common share.&#160; In aggregate, the Company issued 21,080,229 common shares under the April 2020 ATM Program during the year ended August 31, 2020 for gross proceeds of $48,785 at a weighted average price of $2.31 per common share. Net proceeds realized were $47,112 after agents' commissions of $975, regulatory fees of $1, and legal and professional fees of $697. Proceeds were raised in both USD (for shares sold through the NASDAQ) and CAD (for shares sold through the TSX) and the weighted average share price was calculated using the spot rate on the day of settlement.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Equity financing</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">On December 18, 2017, the Company issued 16,428,572 units by way of a bought deal at $3.50 per unit share for total gross consideration of $48,711 recorded to share capital and an increase of $8,789 to the reserve for options and warrants. Each unit consisted of one common share and one-half common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant entitled the holder thereof to acquire one common share of the Company at a price of $4.00 until June 18, 2019. Total issue costs were $3,678, with $3,116 charged to share capital and the remaining $562 charged to the reserve for options and warrants. These Warrants are measured at fair value at the date of grant. In determining the amount of reserve for the Warrants, the Company used the Black-Scholes option pricing model to establish the fair value of Warrants granted using the following assumptions: </span></p></div></div><div style="text-align:center"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin:auto" width="40%"><tbody><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="width:191px;background-color:rgb(255, 255, 255);text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Risk free interest rate %</span></td><td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.6%</span></td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected life of Warrants (years)</span></td><td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.5</span></td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected annualized volatility %</span></td><td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">64.6%</span></td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected dividend yield %</span></td><td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td></tr></tbody></table></div><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Volatility was estimated by using the weighted average historical volatility of the Company and other companies that the Company considers comparable. The expected life in years represents the period of time that the Warrants granted are expected to be outstanding. The risk-free rate is based on government of Canada bonds with a remaining term equal to the expected life of the Warrants. A forfeiture rate of zero percent was used as the Company anticipated all Warrants will be exercised.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">During the prior fiscal year, all except for 347,432 Warrants were exercised prior to expiry on June 18, 2019 on a one-for-one basis.&#160; The 347,432 Warrants that remained unexercised at the expiry time expired as a result. The Warrants were delisted from the TSX Venture Exchange on June 18, 2019.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Convertible debenture financing</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">On January 31, 2018, 115,000 convertible debentures were sold at a price of $1,000 per convertible debenture, for aggregate gross proceeds of $115,000 resulting in an increase to the reserve for options and warrants of $12,003, net of deferred tax of $4,902, related to the embedded conversion feature in the convertible debenture. Total issue cost was $7,155 with $6,094 charged to the debenture liability and the remaining $756, net of deferred tax of $305, charged to the reserve for options and warrants.</span></p></div></div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Conversion of debentures</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">For the year ended August 31, 2019, the Company issued 20,845,372 common shares at a price per share of $5.42 on the conversion of convertible debentures for an increase of $112,166 to share capital and a decrease of $11,247 to the reserve for options and warrants, respectively. This non-cash financing activity has been excluded from the Company's statement of cash flows as it did not provide or use any cash.</span></p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">On February 27, 2019, the Company elected to exercise its right under the indenture governing the convertible unsecured debentures to convert all of the principal amount outstanding of the remaining debentures on April 1, 2019 into common shares of the Company on the basis of the daily volume-weighted average price ("VWAP") of the common shares exceeding $7.05 for any 10 consecutive trading days. As of April 1, 2019, all of the convertible unsecured debentures issued were converted to common shares of the Company and no further liability or obligation exists with respect to the convertible unsecured debentures.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Share-based payments</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">On July 14, 2017, the Company entered into an advisory services agreement with a cannabis consultant that resulted in the grant of 125,000 common shares that vested over various service periods up to and including October 14, 2018. The fair value of the grant was measured based on the average monthly share price of the Company over the various tranches and vesting periods resulting in a cumulative expense of $539.&#160; On October 23, 2017, the Company issued 50,000 common shares, of which 20,000 related to the advisory services agreement, as share consideration to the consultant and recognized $144 to share capital. During the year ended August 31, 2019, the Company settled the remaining balance of 105,000 common shares due to the consultant in the form of 41,000 common shares of the Company and 84,000 restricted stock units, which vest immediately, to purchase 84,000 common shares of the Company, which fully settled the Company's obligations relating to this agreement.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Exercise of stock options</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">During the year ended August 31, 2020, 879,240 (August 31, 2019 - 2,167,864) share options were exercised at an average exercise price of $1.21 (August 31, 2019 - $1.92) for an increase of $1,786 (August 31, 2019 - $6,588) to share capital and a decrease to the reserve for options and warrants of $717 (August 31, 2019 - $2,418).</span><span style="color:#000000">&#160;</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#86b4cd">(iv) Warrants</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">During the year ended August 31, 2019, 7,739,205 Warrants were exercised at an average price of $4.00 for a value of $39,257 to share capital and a decrease to the reserve for options and warrants of $8,281. All the outstanding Warrants at June 18, 2019 that were not exercised into common shares prior to expiry on June 18, 2019 lapsed and therefore no further Warrants remain outstanding.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#86b4cd">(v) Share-based compensation</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">On February 25, 2020 (the "Approval Date"), the Company's shareholders approved a new omnibus equity incentive plan (the "New Equity Incentive Plan") that governs grants made on or after the Approval Date.&#160; Grants made prior to the Approval Date will continue to be governed under the terms of the plan under which they were granted including the Company's 2011 stock option plan and its 2017 equity incentive plan (the "2017 Equity Incentive Plan"), however, no new grants may be made under such plans.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Stock options</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The following table summarizes changes in the Company's outstanding stock options for the years ended August 31, 2020 and 2019:</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">WEIGHTED AVERAGE</span></td><td style="text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NUMBER</span></td><td style="border-bottom:1px solid;text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">EXERCISE PRICE</span></td><td style="border-bottom:1px solid;text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2018</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7,709,746</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2.10</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">3,589,500</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.59</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(2,167,864</span></td><td style="text-align:left;vertical-align:bottom;width:26px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.92</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Cancelled / Forfeited</span></td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(298,188</span></td><td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">6.41</span></td><td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2019</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">8,833,194</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4.23</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,125,000</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">3.21</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(879,240</span></td><td style="text-align:left;vertical-align:bottom;width:26px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.21</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Cancelled / Forfeited</span></td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(1,050,050</span></td><td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">6.20</span></td><td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2020</span></td><td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">9,028,904</span></td><td style="border-bottom:3px double;text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4.06</span></td><td style="border-bottom:3px double;text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr></tbody></table></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400">The following is a summary of the outstanding stock options as at August 31, 2020:<span style="font-size:10pt"><strong>&#160;</strong></span><span style="color:#000000">&#160;</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td style="border-bottom:1px solid #000000;text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">OPTIONS OUTSTANDING</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">OPTIONS EXERCISABLE</span></p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Range of Exercise</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Weighted Average Remaining</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td></tr><tr><td style="border-bottom:1px solid #000000;text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Prices</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Quantity Outstanding</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Contractual Life (years)</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Quantity Exercisable</span></p></td></tr><tr><td style="width:334px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="width:333px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="width:333px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="width:333px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$0.30 - $1.48</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,440,599</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4.7</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,376,683</span></p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$1.49 - $2.38</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,204,333</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.5</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,652,833</span></p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$2.39 - $4.65</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,069,854</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.9</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,217,504</span></p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$4.66 - $7.67</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,886,518</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">8.2</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,276,194</span></p></td></tr><tr><td style="border-bottom:1px solid #000000;text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$7.68 - $11.27</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,427,600</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">8.7</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">949,900</span></p></td></tr><tr><td style="border-bottom:1px solid #000000;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">9,028,904</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.5</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">6,473,114</span></p></td></tr></tbody></table></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><div><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span>Options outstanding have exercise prices that range from $0.30 to $11.27 with a weighted average remaining life of 7.5 years. Total share-based compensation charges, including related to production employees that are charged to biological assets and inventory, for the year ended August 31, 2020 was $7,796 (August 31, 2019 - $14,894) of which $6,127 (August 31, 2019 - $10,036) related to the Company's stock option plan. The fair value of options granted during the year ended August 31, 2020 was $3,743 (August 31, 2019 - $13,848). These options are measured at fair value at the date of grant and are expensed over the option's vesting period, which typically range from two to three-year terms with options vesting in annual tranches evenly over this time period. In determining the amount of share-based compensation related to the options, the Company used the Black-Scholes option pricing model to establish the fair value of options granted.</span><span> </span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">The following is the range of assumptions for the years ended August 31, 2020 and 2019:</span></p><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td colspan="3" style="text-align:center;background-color:#86b4cd"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#a6a4a4"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Risk free interest rate</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">0.45%- 1.65%</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#160; &#160;</span></p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.20%- 2.42%</span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected life of options</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5.0 - 6.0 years</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5.0 -6.5 years</span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected annualized volatility</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">72% - 85%</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">64%-71%</span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected dividend yield</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Forfeiture Rate</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">8.0% - 8.7%</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.3%- 8.0%</span></p></td></tr></tbody></table></div><div><div><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Volatility was estimated by using the weighted average historical volatility of the Company and other companies that the Company considers comparable. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate is based on government of Canada bonds with a remaining term equal to the expected life of the options. The forfeiture rate is calculated based on historical experience.</span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Equity incentive plan</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">As of August 31, 2020, the Company has granted both restricted share units ("RSUs") and performance share units ("PSUs") under the 2017 Equity Incentive Plan and RSUs under the New Equity Incentive Plan. The grant price of any RSU or PSU was determined based on market price calculated in accordance with TSX rules at the time of grant and with respect to PSUs, adjusted for any non-market and market performance vesting conditions in accordance with IFRS 2.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The following table summarizes the movements in the Company's outstanding RSUs:</span></span></p><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NUMBER</span></td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2018</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">145,200</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">879,635</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(182,473</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2019</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">842,362</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">265,258</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(154,062</span></td><td style="vertical-align:bottom;width:26px;text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Cancelled/Forfeited</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(60,387</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2020</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">893,171</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr></tbody></table></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The estimated fair value of the equity settled RSUs granted during the year ended August 31, 2020 was $1,037 (August 31, 2019 - $4,543), which was based on the Company's share price at the grant date and will be recognized as an expense over the vesting period of the RSUs, which is over a period of one year for most grants. For the year ended August 31, 2020, $1,576 (August 31, 2019 - $3,475) has been recognized as share-based compensation expense.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The following table summarizes the movements in the Company's outstanding PSUs:</span></span></p><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NUMBER</span></td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2019</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">142,187</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(15,502</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2020</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">126,685</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr></tbody></table></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The estimated fair value of the equity settled PSUs granted during the year ended August 31, 2020 was $305 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124115709193">nil</span>), which was based on the Company's share price at the grant date, adjusted for an estimate of likelihood of achievement, and will be recognized as an expense over the vesting period of the PSUs, which is during the fiscal year-ended August 31, 2020. For the year ended August 31, 2020, $272 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124115741663">nil</span>) has been recognized as share-based compensation expense.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#86b4cd">(vi) Earnings (Loss) per share</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Earnings (loss) per share represents net income (loss) attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Diluted (loss) income per share is calculated by dividing the applicable net (loss) income by the sum of the weighted average number of common shares outstanding and all additional common shares that would have been outstanding if potentially dilutive common shares had been issued during the year.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The reconciliation of the weighted average number of shares, for the purposes of diluted earnings per share, to the weighted average number of ordinary shares, used in the calculation of basic earnings per share, is as follows:</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"><tbody><tr><td style="vertical-align:bottom;width:897px">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:164px;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:27px;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:27px;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:165px;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></td><td style="text-align:center;vertical-align:bottom;width:27px;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Weighted average number of shares used in basic earnings per share</span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">172,668,816</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">140,923,324</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Options</span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4,540,182</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5,194,827</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Warrants</span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4,738,388</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Restricted share units</span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">727,275</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">684,534</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Performance share units</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">126,685</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Weighted average number of shares used in diluted earnings per share</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">178,062,958</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">151,541,073</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">The outstanding number and type of securities that could potentially dilute basic net (loss) income per share in the future but that were not included in the computation of diluted net income (loss) per share because to do so would have increased (decreased) the net (loss) income per share (anti-dilutive) are as follows:</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td style="vertical-align:bottom;width:897px">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:164px;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:27px;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:27px;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:165px;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></td><td style="text-align:center;vertical-align:bottom;width:27px;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Stock options</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4,382,918</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,847,500</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4,382,918</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,847,500</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfShareCapitalInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfShareCapitalInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037759960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfOtherLiabilitiesAbstract', window );"><strong>Disclosure Of Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory', window );">OTHER LIABILITIES [Text Block]</a></td>
<td class="text"><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">13. OTHER LIABILITIES</span></span></span></p>&#160;<p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The carrying value of other liabilities consists of:</span><span style="color:#000000">&#160;</span></span></span></p><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:1.95349%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:1.95349%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent share consideration</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">231</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,117</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,617</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,848</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,117</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">(i) Contingent share consideration</span></span></span></p><span style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify">In connection with the Company's investment in alpha-cannabis&#xae; Pharma GmbH as described in Note 14, the Company has a commitment to deliver additional consideration of up to &#x20ac;</span>875<span style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify"> in the form of the Company's common shares contingent on the achievement of certain gross margin-based milestones. At August 31, 2020, the Company revalued the contingent liability and recorded a corresponding gain in the statement of operations of $</span>886<span style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify"> for the year ended August 31, 2020 (August 31, 2019 - loss of $</span>145<span style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify">).</span><p style="margin-bottom:0pt;text-align:justify"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">(ii) Lease liabilities</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In connection with the Company's adoption of IFRS 16 effective September 1, 2019, lease liabilities were recorded as described in Note 3.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On March 13, 2020, the Company entered into a lease amending agreement for its Toronto corporate office: i) extending the lease of its existing 5,007 square feet of office space (the "Existing Premises") originally expiring on August 31, 2020; and ii) leasing an additional 6,572 square feet of office space adjacent to the Existing Premises (the "Additional Premises"). The term of the lease for Existing Premises will be extended for a period of five years and two months commencing on September 1, 2020 and expiring on October 31, 2025.&#160; As this amending lease agreement for the Existing Premises is effectively a modification to the original lease agreement, the Company has recognized the ROU asset and corresponding lease liability pertaining to the Existing Premises as of the effective date of the lease amending agreement, which was March 13, 2020.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On April 21, 2020, the Company, as sub-landlord, entered into a sublease agreement with a subtenant, pursuant to which the Company agreed to sublease 3,099 square feet of its Additional Premises noted above for a period of five years and two months commencing on September 1, 2020 and expiring on October 30, 2025 for a total of $251 per annum for an aggregate rental income of $1,296 over the term of the sublease. Under the currently contemplated terms, both parties have the mutual right to terminate the sublease upon six months' written notice to either party, which shall not occur prior to August 31, 2023. This sublease agreement has no impact on the amount of lease liabilities as it is a net investment in the sublease by the Company.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On July 16, 2020, the Company, as sublandlord, entered into a sublease agreement with a subtenant, pursuant to which the Company agreed to sublease 3,473 square feet of its rented premises for a period of five years and two months commencing on September 1, 2020 and expiring on October 30, 2025 for a total of $282 per annum for an aggregate rental income of $1,431 over the term of the sublease. Under the terms, the sub-landlord has a right to terminate the sublease upon six months' written notice to the subtenant, which shall not occur prior to April 30, 2021, whereas the subtenant have a right to terminate the sublease upon eight months' written notice to the sublandlord, which shall not occur prior to February 28, 2022.</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The following is a continuity schedule of lease liabilities for the year ended August 31, 2020:</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160;</span></p><div><table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IFRS 16 transition</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,219</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease additions</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,220</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease payments</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(897</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expense on lease liabilities</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2020</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,705</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current portion included in accounts payable and accrued liabilities</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,088</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="border-bottom:3px double #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term portion</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,617</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr></tbody></table></div> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The undiscounted contractual payments relating to the current and future lease liabilities at August 31, 2020 is:</span></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160;</span></p><div><table border="0" cellpadding="0" cellspacing="0" style="width:60%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 1 year</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,553</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1 to 2 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,049</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 to 3 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,045</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3 to 4 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">998</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4 to 5 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">768</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Thereafter</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">606</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,019</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td></tr></tbody></table></div> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Included in the undiscounted contractual payments relating to current and future lease liabilities above is the Additional Premises as noted above, the term of which will commences on September 1, 2020.</span></span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other liabilities. [Refer: Other liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037642120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN ASSOCIATES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract', window );"><strong>Disclosure of associates [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory', window );">INVESTMENTS IN ASSOCIATES [Text Block]</a></td>
<td class="text"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif;color:#86b4cd"><span>14. INVESTMENTS IN ASSOCIATES</span></span></span><div><div><div><div>&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ALPHA-CANNABIS</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EVIANA HEALTH</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">HYASYNTH</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PHARMA GMBH</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CORPORATION</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BIOLOGICALS INC.</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(A)</span></span></td><td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(B)</span></span></td><td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(C)</span></span></td><td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL</span></span></td><td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Participating share <sup>(1)</sup></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25.0%</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.9%</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43.4%</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Balance, August 31, 2018</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Additions</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,408</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13,408</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Transaction costs</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">160</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">73</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">89</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">322</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Distributions</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(374</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(374</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Share of net loss</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(50</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(734</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(477</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(1,261</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Impairment loss</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(950</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(950</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Foreign currency translation gain (loss)</span></p></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(37</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,496</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,612</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,108</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share of net loss</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(75</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,112</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,187</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment loss</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Elimination of proportionate share of<br/>&#160;&#160;&#160; transactions with associates</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation gain (loss)</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2020 <sup>(2)</sup></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,501</span></span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,500</span></span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,001</span></span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td></tr></tbody></table></div></div></div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 1: % Interest includes the potential ownership interest that could result from the conversion of debentures and exercise of warrants</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 2: The Company utilizes the most recently issued quarterly financial statements of its associates in its results with a two month&#160;lag since the Company does not have the same reporting date as its associates (for the year ended August 31, 2020, the Company utilized its associates' June 30, 2020 results)</span></span></p><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">a) alpha-cannabis Pharma GmbH</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On October 10, 2018, the Company executed an investment agreement with alpha-cannabis&#xae; Pharma GmbH ("ACG") pursuant to which the Company acquired 8,333 common shares of ACG, representing a 25% stake in the capital of ACG, for aggregate proceeds of &#x20ac;1,625 ($2,436). Established in 2016, ACG is a privately held company that is strategically positioned to serve the German medical cannabis market.</span></span></span></p></div></div><div><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has a commitment to deliver additional consideration of up to &#x20ac;875 in the form of the Company's common shares contingent on the achievement of certain gross margin-based milestones. The Company has estimated the fair value of these contingent shares as &#x20ac;649 ($972) as of the investment date and has included a corresponding long-term liability under other liabilities in the statement of financial position. Refer to Note 12 for further information.</span></span></div><div>&#160;</div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concurrent with the Company's investment in ACG, the parties entered into a CBD supply agreement, whereby ACG may supply the Company with synthetic CBD, as well as a cannabis supply agreement, whereby the Company may supply ACG with dried cannabis flowers.</span></span></p><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">b) Eviana Health Corporation</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On October 2, 2018, the Company participated in the debenture offering of Eviana Health Corporation ("Eviana") by way of private placement. Eviana is a Canadian Securities Exchange ("CSE") listed company that was established with the aim of delivering customized consumer health care products using natural hemp strains of cannabis sativa for cannabinoid-based topical creams and products. The Company's investment is in the form of convertible debentures and share purchase warrants, which together provide a potential ownership interest of up to 21.4%, which is capped at 19.9% based on certain contractual obligations. In addition to this ownership interest, the Company also considered various qualitative factors in arriving at the determination that significant influence exists, including representation rights on Eviana's board of directors, and thereby concluding that the equity method of accounting is appropriate.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The convertible debentures have a face value of $5,000, bear interest at 10% per annum, are non-redeemable, and mature on October 2, 2020. The convertible debentures are convertible at the option of the holder at any time at a price of $1.15 per share, or into 4,347,826 common shares of Eviana. Conversion of the debentures may be forced by Eviana in the event that the volume weighted average price of the common shares of Eviana for ten consecutive days is greater than $2.15, subject to a minimum volume of 100,000 shares in each of those 10 days.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The share purchase warrants were acquired for no additional consideration, concurrent with the debenture offering, are transferrable, and are exercisable until October 2, 2020. 2,500 share purchase warrant units were acquired, each of which is convertible into 870 common shares per unit, or 2,175,000 common shares in aggregate, at an exercise price of $1.30 per share.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concurrent with the Company&#x2019;s investment in Eviana, the parties entered into a CBD oil supply agreement, whereby the Company has the right, but not obligation, to purchase up to 25% of Eviana&#x2019;s annual CBD oil at 95% of the agreed raw CBD oil wholesale market price for a period of 5 years from the date on which the CBD oil is first made commercially available by Eviana for wholesale.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 28, 2019, Eviana provided a default announcement in accordance with National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). Eviana made an application to the British Columbia Securities Commission, as its principal regulator, for a management cease trade order ("MCTO") under NP 12-203 in respect of an anticipated default regarding its annual filings. On November 1, 2019, a cease trade order ("CTO") was issued by the British Columbia Securities Commission and the Ontario Securities Commission.&#160; On November 5, 2019, Eviana was suspended from the CSE in accordance with CSE Policy 3 which is considered a regulatory halt as defined in National Instrument 23-101 - Trading Rules.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#000000">At May 31, 2020, the Company identified indicators of impairment with respect to its investment in Eviana. The Company determined the recoverable amount of Eviana to approximate $nil based on the higher of fair value less costs to sell ("FVLCS") and value-in-use ("VIU").&#160; An impairment loss of $3,000 has been included in the statement of (loss) income and comprehensive (loss) income for the year ended August 31, 2020.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#000000">On June 18, 2020, the Company served Eviana with a notice of default and demand letter with respect to the non-payment of interest relating to its convertible debentures as well as other applicable events of default under the debenture agreement.&#160; As of the date these financial statements were approved, the Company has not yet received its December 31, 2019 or June 30, 2020 interest payment on the Eviana convertible debenture.</span></span></p><p style="margin:0pt">&#160;</p><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">c) Hyasynth Biologicals Inc.</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On September 12, 2018, the Company invested in Hyasynth Biologicals Inc. ("Hyasynth") by way of convertible secured debentures, to be purchased in three tranches and valued in the aggregate at $10,000. Tranche 1 was issued on that date, Tranche 2 was issued on October 23, 2020 (as described below), and one additional tranche that may be issued based on the achievement of a specific milestone. Hyasynth is a privately held biotechnology company based in Montreal, Quebec and is a leader in the field of cannabinoid science and biosynthesis. The Company's investment is in the form of convertible debentures, which provide a potential ownership interest of up to 43.4% based on Tranche 1. In addition to the ownership interest, the Company also considered various qualitative factors in arriving at the determination that significant influence exists, including representation on Hyasynth's board of directors, and thereby concluded that the equity method of accounting is appropriate.</span></span></span></p></div></div><div><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tranche 1 of the convertible debentures has a face value of $5,000, bears interest at 8.0% per annum, are secured, and mature on the earlier of August 31, 2023 or the closing date of a qualified sale transaction, unless an automatic or optional conversion has occurred. Tranche 1 of the convertible debentures are convertible at the option of the holder at any time at a price of $40 per share, or into 125,000 common shares. Conversion of the debentures may be automatically triggered based on the completion of a qualified transaction or Hyasynth's facility reaching a pre-defined production capacity. Tranche 2 and 3 of the convertible debentures, each of which commits $2.5 million for an aggregate of $5 million, have certain production-related milestones that must be achieved within a 24- and 36-month period, respectively, for issuance to occur.</span></span></div><div>&#160;</div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concurrent with the Company&#x2019;s investment in Hyasynth, the parties entered into a CBD supply agreement, whereby the Company has the ability to purchase up to 100% of Hyasynth&#x2019;s annual cannabinoid or cannabinoid-related production at a 10% discount to the agreed upon wholesale market price for a period of 10 years from the date Hyasynth commences commercial production of the products.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent to the year end, on October 23, 2020, the Company advanced an additional $2,500 to Hyasynth by way of convertible debentures as a result of Hyasynth's achievement of the contractual production-related milestone for Tranche 2 of the convertible debentures.&#160; This brings the Company's total face value of convertible debentures investment in Hyasynth to $7,500, which provides the Company with a potential ownership interest of up to 46.5% on a fully diluted basis.</span></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B4<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B4_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037642120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">RELATED PARTY TRANSACTIONS [Text Block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">15. RELATED PARTY TRANSACTIONS</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly. The key management personnel of the Company are the members of the Company's executive management team and Board of Directors. The transactions are conducted at arm's length and in the normal course of operations. </span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">(i) Management and Board compensation</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">For the years ended August 31, 2020 and 2019, the Company's expenses included the following management and board compensation:</span></span></span></p></div></div><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:center;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:center;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:center;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:center;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:center;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and consulting fees</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,953</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,521</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,750</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,155</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total key management compensation</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,703</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,676</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div><div><div><p style="margin:0pt">&#160;</p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">During the year ended August 31, 2020, 790,000 stock options (August 31, 2019 - 685,000) were granted to key management personnel at an average exercise price of $2.48 (August 31, 2019 - $4.75) and aggregate fair value of $1,794 (August 31, 2019 - $1,736). In addition, during the year ended August 31, 2020, 211,981 RSUs (August 31, 2019 - 631,949), were granted to key management personnel with an aggregate fair value of $902 (August 31, 2019 - $3,002). For the year ended August 31, 2020, 88,910 PSUs (August 31, 2019 - <span style="-sec-ix-hidden:Fxbrl_20201124141751265">nil</span>) were issued to key management personnel with an aggregate fair value of $191 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124141812756">nil</span>).</span></span></span></p><p style="margin:0pt">&#160;</p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">(ii) Significant transactions with associates</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">For the year ended August 31, 2020, the Company received no interest income (August 31, 2019 - $374) on its convertible debenture investment in Eviana as disclosed in Note 14, which is being recorded as distributions under the equity accounting method.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">For the year ended August 31, 2020, the Company earned revenues of $52 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124141330907">nil</span>) on product sold to ACG, which has been proportionately eliminated from the consolidated financial statements based on the Company's proportionate share of investment in ACG.</span></span></span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037504904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL MANAGEMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CapitalManagementAbstract', window );"><strong>Capital Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory', window );">CAPITAL MANAGEMENT [Text Block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">16. CAPITAL MANAGEMENT</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company considers its capital to consist of share capital, equity reserves, long-term debt, accumulated other comprehensive income, and retained earnings, which is disclosed in the August 31, 2020 consolidated statement of financial position as $414,793 (August 31, 2019 - $376,582). Equity reserves is comprised of any amounts recorded with respect to the recognition of share-based compensation expense (options, RSUs, or PSUs) or the fair value of warrants issued. Accumulated other comprehensive income is entirely comprised of foreign currency translation gains and losses recorded on the Company's investment in ACG.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company manages its capital structure and adjusts it based on funds available to the Company, in order to fund its expansion and construction of its facility. The Board of Directors does not establish quantitative return on capital criteria for management, but rather relies on the expertise of the Company's management to sustain future development of the business.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative stage of the Company, is reasonable. There has been no chan</span><span style="color:#000000">ge in how the Company defines or manages capital during the period.</span></span></span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040984504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS [Text Block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">17. FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">i) Fair value of financial instruments</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly fashion between market participants. The Company records certain financial instruments at fair value. The Company's financial instruments include cash, short-term investments (including marketable securities), accounts receivable, loan receivable, accounts payable and accrued liabilities, long-term debt, and contingent share consideration. </span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Fair value measurements are categorized into Level 1, 2 or 3 based on the degree to which the inputs to the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are described as follows:</span></span></span></p><p style="margin-left:21.6pt;text-indent:-12.95pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#87b5cf">&#x2022;</span><span style="text-indent:0pt;display:inline-block;width:8.47pt"> </span><span style="color:#000000">Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date;</span></span></span></p><p style="margin-left:21.6pt;text-indent:-12.95pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#87b5cf">&#x2022;</span><span style="text-indent:0pt;display:inline-block;width:8.47pt"> </span><span style="color:#000000">Level 2 inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly or indirectly; and </span></span></span></p><p style="margin-left:26.45pt;text-indent:-17.45pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#87b5cf">&#x2022; </span><span style="width:6.08pt;text-indent:0pt;display:inline-block"> </span><span style="color:#000000">Level 3 inputs are unobservable inputs for the asset or liability.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The fair value of cash, short-term investments, accounts receivable, loan receivable, accounts payable and accrued liabilities approximate their carrying amounts due to their short-term nature. The fair value of marketable securities is based on quoted prices in active markets and is reflected in the carrying value of these financial assets. The fair value of long-term debt approximates $115,389 based on the face value of debt outstanding, which carries a floating interest rate.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The fair value of the contingent share consideration is primarily based on Level 3 unobservable inputs. The determination of the fair value of this liability is primarily driven by the Company's expectations of the investment in associate achieving certain milestones. The expected milestones were assigned probabilities and the expected related cash flows were discounted to derive the fair value of the contingent consideration. At August 31, 2020, the probability of achieving the milestones was estimated to be 68% and the discount rate was estimated to be 20%. If the probabilities of achieving the milestones increased or decreased by 10%, the estimated fair value of the contingent share consideration would increase or decrease by approximately $33. If the discount rates increased or decreased by 5%, the estimated fair value of contingent consideration would decrease or increase, respectively, by approximately $12.</span></span></span></p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a id="page_34"/></span></span><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">During the period, there were no transfers of amounts between Levels 1, 2 and 3.</span></span></span></p><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">ii) Financial risk factors</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company is exposed to various risks through its financial instruments, as follows: </span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">(i) <strong>Credit risk</strong> arises from deposits with banks, short-term investments (excluding investments in equity securities), outstanding trade and loan receivables, and restricted investments. For trade receivables, the Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance. For other receivables, out of the normal course of business such as the loan receivable, management generally obtains guarantees and general security agreements. The maximum exposure to credit risk of cash, short-term investments, accounts receivable, loans receivable, and restricted investment on the statement of financial position at August 31, 2020 approximates $99,736 (August 31, 2019 - $65,385).</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">As of August 31, 2020, the Company's aging of trade receivables was as follows:</span></span></span></p></div></div><div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0-60 days</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,023</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,748</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61-120 days</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">73</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">152</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross trade receivables</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,096</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,900</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Provision for doubtful accounts</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(268</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,083</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,632</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div><div><div><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">(ii)<strong> Liquidity risk - </strong></span><span style="color:#000000">The Company's liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company manages its liquidity risk by reviewing on an ongoing basis its capital requirements. At August 31, 2020, the Company had $24,600 (August 31, 2019 - $47,555) of cash and working capital of $141,123 (August 31, 2019 - $152,417). Further, the Company may further consider accessing equity capital through the capital markets.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company is obligated to the following contractual maturities relating to their undiscounted cash flows:</span></span></span></p></div></div><div><div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">Carrying</span><br/><span style="color:#ffffff">Amount</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">Contractual</span><br/><span style="color:#ffffff">Cash Flows</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">Less than</span><br/><span style="color:#ffffff">1 year</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap;width:11px">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap;width:60px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">1 to 3 years</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">3 to 5 years</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">More than</span><br/><span style="color:#ffffff">5 years</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:rgb(226, 245, 250);width:11px">&#160;</td><td style="vertical-align:bottom;background-color:rgb(226, 245, 250);width:60px">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts payable and accrued liabilities</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,486</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,486</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,486</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term debt</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,266</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,388</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,605</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103,660</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest payments</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,729</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,682</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,047</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132,752</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">140,603</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,773</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">106,707</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr></tbody></table></div></div></div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The contractual maturities noted above are based on contractual due dates of the respective financial liabilities.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In connection with the Company's Moncton Campus expansion plans, the Company is contractually committed to approximately $1,600 of capital expenditures.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">(iii) </span><span style="color:#000000"><strong>Market risk</strong> is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk for the Company comprises of:</span></span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><strong>Interest rate risk</strong> is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk at </span><span style="color:#000000">August 31, 2020 </span><span style="color:#000000">pursuant to the variable rate loans described in Note 11. A 1% change in benchmark interest rates will increase or decrease the Company's interest expense by $1,150 (August 31, 2019 - $500) per year.</span></span></span></p></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132093021896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueExplanatory', window );">REVENUE [Text Block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:#86b4cd">18. REVENUE</span></span></span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Net revenue for the Company is defined as gross revenue, which is net of any customer discounts, rebates, and sales returns and recoveries, less excise taxes.</span></span></span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:#000000">Revenues for the years ended August 31, 2020 and 2019 are disaggregated as follows:</span></span></span></span></span></p></div></div><div><div><div><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"><tbody><tr><td style="vertical-align:bottom;width:853px">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:157px;background-color:#86b4cd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:25px;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:26px;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:158px;background-color:#a6a4a4;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:26px;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px">&#160;</td><td style="vertical-align:bottom;width:13px;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:157px;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:25px;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px">&#160;</td><td style="vertical-align:bottom;width:13px;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:158px;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:26px;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Adult-use recreational wholesale revenue (Canadian)</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>73,938</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>85,018</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Wholesale to Licensed Producers revenue (Canadian)</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>15,184</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>709</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Direct to patient medical revenue (Canadian)</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>10,748</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>11,192</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>International (business to business)</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>3,272</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>98</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Other revenue</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>245</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid;vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>530</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Gross revenue</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>103,387</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>97,547</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Excise taxes</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(16,592</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="border-bottom:1px solid;vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(17,134</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Net revenue</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>86,795</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double;vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>80,413</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div></div></div><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Recreational revenue is primarily comprised of provincial government bodies and large retailers that sell cannabis through their respective distribution models, whereas wholesale revenue is comprised of wholesale shipments to other cannabis companies, including licensed producers, for further processing and sales onto their end customers.</span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">During the year ended August 31, 2020, the Company had three customers (August 31, 2019 - two customers) that individually represented more than 10% of the Company's net revenue.</span></span></span></span></span></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040988440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COST OF SALES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfCostOfSalesAbstract', window );"><strong>Disclosure Of Cost Of Sales [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCostOfSalesExplanatory', window );">COST OF SALES [Text Block]</a></td>
<td class="text"><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#86b4cd">19. COST OF SALES</span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Cost of sales is comprised of the cost of inventories sold during the period, shipping expenses, the production cost of late-stage biological assets that are disposed of, provisions and write-downs for inventory that does not pass the Company's quality assurance standards and obsolete products and packaging, and other production overhead. For the three months ended November 30, 2019, the Company determined that the classification of indirect production is more accurately reflected as and most comparable to industry peers as a component of cost of sales rather than a separate line in the statement of operations.&#160; As a result, indirect production of $4,733 has been reclassified from indirect production to cost of sales for the year ended August 31, 2019 to conform to the current period presentation. This change in presentation has no impact on gross margin before fair value adjustments.</span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">During the year ended August 31, 2020, the Company recorded write-downs and provisions in relation to excess and obsolete inventories and biological assets as well as adjustments to net realizable value totaling $35,584 (August 31, 2019 - $4,733), which are detailed in Note 8.</span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">During the year ended August 31, 2020, the Company recorded charges of $6,095 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124161328542">nil</span>) related to a reduced workforce due to COVID-19, which was comprised of $5,048 in plant culling, $1,047 mostly related to lump-sum payments paid to temporarily laid-off workers.&#160; The Company also recorded $5,434 (August 31, 2019 - $<span style="-sec-ix-hidden:Fxbrl_20201124161508719">nil</span>) in charges for unabsorbed fixed overhead related to reduced production volumes.</span><span style="color:#86b4cd">&#160;&#160;</span><span style="color:#000000">These charges were expensed to cost of sales.</span></span></span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCostOfSalesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the cost of sales. [Refer: Cost of sales]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCostOfSalesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfCostOfSalesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfCostOfSalesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040411528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ContingenciesAbstract', window );"><strong>Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory', window );">CONTINGENCIES [Text Block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">20. CONTINGENCIES</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company recognizes loss contingency provisions for probable losses when management can reasonably estimate the loss. When the estimated loss lies within a range, the Company records a loss contingency provision based on its best estimate of the probable loss. If no particular amount within that range is a better estimate than any other amount, the mid-point of the range is used. As information becomes known a loss contingency provision is recorded when a reasonable estimate can be made. The estimates are reviewed at each reporting date and the estimates are changed when expectations are revised. An outcome that deviates from the Company's estimate may result in an additional expense or release in a future accounting period.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">During 2015, the Company was named as a defendant in a lawsuit in New Brunswick for breach of confidence, conversion, breach of contract, conspiracy and breach of trust, breach of fiduciary duty, and negligent misrepresentation. The Company believes the lawsuit to be without merit though it will rigorously defend the action. No amount has been accrued in relation to the consolidated&#160;financial statements for the claim. </span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On March 3, 2017, a claim in connection with a proposed class-action lawsuit (the "Claim") was filed with the Supreme Court of Nova Scotia (the "Court") seeking to represent a class who purchased medical marijuana that was the subject of the Company's product recalls in December 2016 and January 2017 as it may have contained trace elements of the pesticides myclobutanil and bifenazate which are not approved for use by licensed producers. The Claim identifies several causes of action including, among others: (i) negligent design, development and testing, (ii) negligent manufacturing, (iii) negligent distribution, marketing and sale, (iv) breach of contract, and (v) breach of the Competition Act, the Consumer Protection Act, and the Sale of Goods Act, and is seeking remedy in the form of, among other things, the disgorgement of profits accrued to the Company for the sale of contaminated products, exemplary or punitive damages and certain costs. </span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Claim was amended on November 16, 2017, to include a claim for alleged adverse health consequences caused as a result of using the recalled product. As at the date hereof, the Company has not received any medical information demonstrating adverse health effects caused as a result of using the recalled product.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The amended Claim also contained a request for an order certifying the proceeding as a class proceeding.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">During late June 2018, certification hearings were heard before the Court. On January 18, 2019, the Court issued its decision granting certification. On March 4, 2019, the Company filed a notice for leave to appeal the certification of the class action brought against it. Leave to appeal was granted and the appeal was heard on October 15, 2019 and the decision was reserved.&#160; On April 30, 2020, the Nova Scotia Court of Appeal ruled that the plaintiff failed to present any evidence that the cannabis purchased by medical customers in 2016 could cause any particular adverse health effects.&#160; As a result, class members would not be able to bring claims for damages for adverse health effects in the class proceeding.&#160; On June 26, 2020, the plaintiff filed an application for leave to appeal the Nova Scotia Court of Appeal's decision with the Supreme Court of Canada.&#160; On November 5, 2020, the application for leave to appeal was dismissed by the Supreme Court of Canada.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company is contesting what remains of the litigation. The Company reported the Claim to its insurance provider which appointed counsel to defend the Claim. Insurance may be available to cover all or a portion of the fees or damages which may be associated with the Claim although the Company's coverage may be subject to varying limits and exclusions. The litigation process will continue into the foreseeable future unless settled out of court. No amount has been recorded in the&#160;consolidated&#160;financial statements as the Company has not yet determined a reasonable estimate of the cost to resolve this class action.&#160; </span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On June 16, 2020, a claim in connection with a proposed national consumer protection class-action lawsuit was filed with the Court of Queen's Bench in Alberta (the "Alberta Claim") seeking damages against several Canadian cannabis companies including the Company.&#160; The Alberta Claim does not particularize all of the claims against the companies however it makes allegations with respect to the content of THC and CBD in the companies' products. The proposed action is not certified.&#160; The Company has reported the Alberta Claim to its insurers.</span></span></span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 86<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_86&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040988440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING SEGMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">OPERATING SEGMENTS [Text Block]</a></td>
<td class="text"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#86b4cd">21. OPERATING SEGMENTS</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#000000">The Company previously operated in two operating segments - production and sale of cannabis and patient counselling, operating as Trauma Healing Centers, Incorporated ("THCI"). THCI was disposed of on October 16, 2018 (see Note 24). As a result, the Company currently operates in only one operating segment, the production and sale of cannabis. All assets for the production and sale of cannabis segment are domiciled within Canada and effectively all revenues are generated in Canada, except those revenues disclosed in Note 18.</span></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040988440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) [Text Block]</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-style:initial;text-decoration-color:initial;color:#86b4cd">22. GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS)</span></span></span></p><div><div><div><p style="margin-bottom:0pt;text-align:justify">&#160;</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office and general</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,819</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,942</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wages and benefits</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,611</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,443</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,367</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,636</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,510</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">664</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,269</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">409</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Travel and accommodation</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">383</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">456</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Utilities</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total general and administrative expenses</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27,996</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,593</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)">&#160;</td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132047928856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">INCOME TAXES [Text Block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">23. INCOME TAXES</span><span style="color:#86b4cd">&#160;</span></span></span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">There are no current income taxes payable or recoverable for the years ended August 31, 2020 and 2019.</span></span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Components of deferred income tax expense are as follows:</span></span></span></span></span></p></div></div><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Origination and reversal of temporary differences</span></span></span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(37,875</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,987</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Change in tax rate and rate differences</span></span></span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">421</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">281</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Change in unrecognized temporary differences</span></span></span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">27,245</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,349</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Prior period adjustments</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(262</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">12</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Total income tax (recovery) expense</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,629</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div><p style="text-align:justify"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">A reconciliation of income tax expense at the statutory rate to amounts recorded in the consolidated financial statements is provided below.</span></span></span></span></p><div><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Income (loss) from continuing operations before income taxes</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(146,628</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(5,875</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Statutory income tax rate</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">29.0%</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">29.0%</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Tax calculated at statutory rate</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(42,522</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,704</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Non-deductible (non-taxable) items</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">2,643</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,742</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Difference between current and future tax rates</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">421</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">281</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Benefit of deductible temporary differences not recognized</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">27,245</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,349</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Effect of tax rates in other jurisdictions</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">2,016</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Other</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(274</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(39</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Income tax (recovery) expense per financial statements</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,629</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div></div><p style="text-align:justify"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Recognized deferred tax assets and liabilities consist of the following:</span></span></span></span></p><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Deferred tax assets are attributable to the following:</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Non-capital losses</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>6,670</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>10,708</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Lease liabilities</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,038</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#x2014;</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred tax assets</span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>7,708</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>10,708</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Set-off of tax</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(7,708</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(10,708</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net deferred tax asset</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#x2014;</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#x2014;</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Deferred tax liabilities are attributable to the following:</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Long-term assets</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(961</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(4,983</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Biological assets</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(170</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(961</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Inventories</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(5,367</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(15,200</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Right-of-use lease assets</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,096</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#x2014;</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Other</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(114</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(35</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred tax liabilities</span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(7,708</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(21,179</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span>)</span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Set-off of tax</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">7,708</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">10,708</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Net deferred tax liability</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr></tbody></table></div></div><p style="text-align:justify"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">The changes in temporary differences during the years ended August 31, 2020 and 2019 were as follows:</span></span></span></span></p><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">NET BALANCE AT</span><br/><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">RECOGNIZED IN</span><br/><span style="color:#ffffff">PROFIT OR LOSS</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">RECOGNIZED</span><br/><span style="color:#ffffff">DIRECTLY IN</span><br/><span style="color:#ffffff">EQUITY &amp; OCI</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">NET BALANCE AT</span><br/><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Non-capital losses</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">10,708</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(4,039</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">6,669</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Share issuance costs</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">PP&amp;E</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(4,983</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">4,022</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(961</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Biological assets</span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(961</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">791</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(170</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(15,200</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">9,833</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(5,367</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,038</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,038</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Right-of-use lease assets</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,096</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,096</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Other</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(35</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(78</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(113</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net tax assets (liabilities)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr></tbody></table></div></div><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">NET BALANCE AT</span><br/><span style="color:#ffffff">AUGUST 31, 2018</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">RECOGNIZED IN</span><br/><span style="color:#ffffff">PROFIT OR LOSS</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">RECOGNIZED</span><br/><span style="color:#ffffff">DIRECTLY IN</span><br/><span style="color:#ffffff">EQUITY &amp; OCI</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">NET BALANCE AT</span><br/><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Non-capital losses</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>8,604</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">2,723</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(619</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">10,708</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Share issuance costs</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,657</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,657</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">PP&amp;E</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,275</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(3,708</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(4,983</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Biological assets</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(3,307</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">2,346</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(961</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,385</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(4,815</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(15,200</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Unsecured convertible debentures</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(3,306</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(108</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,414</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Other</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">32</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(67</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(35</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Net tax assets (liabilities)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(7,980</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(3,629</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,138</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr></tbody></table></div></div><p style="text-align:justify"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">At August 31, 2020, the Company has non-capital loss carryforwards available to offset future taxable income in Canada, which expire as follows:</span></span></span></span></p><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;width:1.02326%">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;width:12%;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);width:2%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1%">&#160;</td><td style="vertical-align:bottom;width:12%">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2035</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,070</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2037</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">11,727</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2038</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">14,296</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2039</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">16,746</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2040</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">81,205</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">125,044</span></span></span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr></tbody></table></div></div><p style="text-align:justify"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">The Company recognizes tax benefits on losses or other deductible amounts where the probable criteria for the recognition of deferred tax assets has been met. &#160;The Company's unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:</span></span></span></span></p><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:center;background-color:rgb(134, 180, 205);white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:center;background-color:rgb(134, 180, 205);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:center;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:center;background-color:rgb(166, 164, 164);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:center;background-color:rgb(166, 164, 164);white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="vertical-align:bottom;width:2%;background-color:rgb(166, 164, 164)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Deductible temporary differences</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">17,348</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">12,010</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Tax losses</span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">102,183</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,809</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">119,531</span></span></span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">15,819</span></span></span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040050584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LICENSING AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LicensingAndEndorsementAgreementAbstract', window );"><strong>Licensing And Endorsement Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory', window );">LICENSING AGREEMENT [Text Block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">24. LICENSING AGREEMENT</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On October 4, 2016, the Company entered into a licensing agreement with Swear Net Inc. (the Trailer Park Boys Inc. "TPB") for an exclusive product and branding partnership superseded by a licensing agreement with TPB dated April 15, 2020 and terminated on September 14, 2020 subject to transitionary licensing provisions until April 30, 2021.&#160;In exchange for services, the Company paid $100 in cash and issued 150,000 options at a strike price of $1.52 per share. The fee is being recognized over the life of the agreement of five years as services are delivered. For the year ended August 31, 2020, $22 (August 31, 2019 - $99) has been amortized to share-based compensation and $32 (August 31, 2019 - $32) has been amortized to selling and marketing expenses. At August 31, 2020, the Company has recorded the current portion of the cash payment and stock options fee of $57 (August 31, 2019 - $89) as a prepaid expense and the long-term portion of the fee of $2 (August 31, 2019 - $24) in deferred charges on the consolidated statements of financial position.</span></span></span></p></div></div><div><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the agreement, the Company issued an additional 350,000 in options at a price of $1.52 which vest in accordance with certain conditions being met. As of August 31, 2020, these conditions have been met. For the year ended August 31, 2020, $51 has been expensed (August 31, 2019 - $51) to share-based compensation. At August 31, 2020, the Company has recorded the current portion of the stock options fee of $51 (August 31, 2019 - $51) as a prepaid expense and the long-term portion of the fee of $4 (August 31, 2019 - $55) in deferred charges on the consolidated statements of financial position.</span></span></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for licensing and endorsement agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfLicensingAndEndorsementAgreementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LicensingAndEndorsementAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LicensingAndEndorsementAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040486216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOVERNMENT SUBSIDIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GovernmentSubsidiesAbstract', window );"><strong>Government Subsidies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGovernmentGrantsExplanatory', window );">GOVERNMENT SUBSIDIES [Text Block]</a></td>
<td class="text"><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#86b4cd">25. GOVERNMENT SUBSIDIES</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#000000">On April 1, 2020, Department of Finance Canada announced the CEWS, which would subsidize 75% of employee wages, retroactive to March 15, 2020, to Canadian employers whose business had been affected by COVID-19 to enable them to re-hire workers previously laid off as a result of pandemic, help prevent further job losses, and to better position companies to resume normal operations following the crisis. Under this program, the Company applied for a wage subsidy of $7,883 for the period March 15, 2020 to August 29, 2020, which has been included as government subsidies in the statements of (loss) income and comprehensive (loss) income.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGovernmentGrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for government grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS20_g39-39_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGovernmentGrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_GovernmentSubsidiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_GovernmentSubsidiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040571640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATIONS OF TRAUMA HEALING CENTERS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract', window );"><strong>Disclosure Of Operations Of Trauma Healing Centers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory', window );">OPERATIONS OF TRAUMA HEALING CENTERS [Text Block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#86b4cd">26. OPERATIONS OF TRAUMA HEALING CENTERS</span></span></span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000">THCI previously offered a multi-disciplinary approach to post traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine. On October 16, 2018, the Company sold THCI to Harvest Medicine ("HMED"). HMED is a wholly owned subsidiary of VIVO Cannabis Inc. ("VIVO"). The transaction resulted in HMED acquiring 100% of the issued and outstanding shares of THCI from the Company. The total purchase price for the shares was $1,141 which was satisfied by the issuance of 864,678 common shares in the capital of VIVO at a share price of $1.32. This non-cash investing activity has been excluded from the statement of cash flows as it did not use or provide any cash. The derecognized assets and liabilities on October 16, 2018 were as follows:</span></span></span></span></span></p><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognized assets and liabilities</span></span></span></span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>96</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accounts receivable</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>140</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other current assets</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property, plant and equipment</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>880</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trade and other payables</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(70</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net assets disposed</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,141</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value of consideration received</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,141</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gain/(loss) on disposal</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr></tbody></table><p style="margin-bottom:0pt;text-align:justify">&#160;</p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000">During the fourth quarter of fiscal year 2018, management decided to divest the operations of THCI. Consequently, assets and liabilities allocable to THCI were classified as a disposal group. Revenue and expenses, gains and losses relating to the discontinuation of THCI have been eliminated from profit or loss from the Company's continuing operations and are shown as a single line item in the statements of income (loss) and comprehensive income (loss).</span></span></span></span></span></p></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Operating income (loss) of THCI and the loss from re-measurement of assets and liabilities classified as discontinued operations are summarized as follows up to the date of disposal (see below):</span></span></span></span></p><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="color:#ffffff">FOR THE PERIOD</span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="color:#ffffff">SEPTEMBER 1, 2018</span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="color:#ffffff">TO OCTOBER 16, 2018</span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">Revenue</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160; &#160;Sales</td><td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">$</td><td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">138</td><td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160; &#160;Cost of sales</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">54</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160; &#160;Gross margin from discontinued operations</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">84</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Expenses</td><td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160; &#160;General and administrative</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">75</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Total expenses</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">75</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Investment income (expense)</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">&#x2014;</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Income (loss) from operations</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">$</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">9</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Loss on remeasurement to fair value less costs to sell</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">(47</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">)</td></tr><tr><td style="vertical-align:bottom">Loss on discontinued operations</td><td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">$</td><td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">(38</td><td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">)</td></tr></tbody></table><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Cash flows generated by THCI for the reporting periods are summarized as follows:</span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#ffffff">FOR THE PERIOD</span><br/><span style="color:#ffffff">SEPTEMBER 1, 2018</span><br/><span style="color:#ffffff">TO OCTOBER 16,2018</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating activities</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(35</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Investing activities</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Cash used by discounted operations</span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(35</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operations of trauma healing centers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfOperationsOfTraumaHealingCentersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132047741160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory', window );">SUBSEQUENT EVENTS [Text Block]</a></td>
<td class="text"><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#86b4cd">27. SUBSEQUENT EVENTS</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#86b4cd">i) Hyasynth Tranche 2 convertible debentures issuance</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#000000">On October 23, 2020, the Company advanced an additional $2,500 to Hyasynth by way of convertible debentures as a result of Hyasynth's achievement of the contractual production-related milestone for Tranche 2 of the convertible debentures.&#160; This brings the Company's total face value of convertible debentures investment in Hyasynth to $7,500, which provides the Company with a potential ownership interest of up to 46.5% on a fully diluted basis as of October 23, 2020.</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#86b4cd">ii) Unit offering</span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span style="color:#86b4cd"><span style="color:#000000">On November 12, 2020 the Company closed an underwritten public offering of&#160;&#160;37,375,000 units of&#160;the Company at a price of $1.85 per unit, including a full exercise of the over-allotment option, underwritten by a syndicate of underwriters led by Canaccord Genuity Corp.,&#160;for total gross proceeds of $69,144.&#160; Each unit is comprised of one Common Share of the Company and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a "Warrant").&#160; Each Warrant will be exercisable to acquire one common share of the Company (a "Warrant Share") for a period of three years following the closing date of the Offering at an exercise price of $2.50 per Warrant Share, subject to adjustment in certain events.&#160; The Company expects to use the net proceeds from the Offering to repay indebtedness and for working capital and other general corporate purposes.</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span><span style="color:#86b4cd">iii) Credit facility amendment and restatement</span></span></span><br/><span style="font-size:13.3333px;color:rgb(0, 0, 0);font-family:Times New Roman;font-style:normal;font-weight:400"><span><span style="color:#86b4cd"><span><span style="color:#000000">On November 27, 2020, the Company further amended its Facilities pursuant to an amended and restated credit agreement ("Amendment and Restatement") with BMO to: (i) reduce the Term Loan amount from $115,000 to $60,000 based on a repayment of $55,000 to be made on December 1, 2020 of the outstanding Term Loan balance of $115,000; (ii) have repayments on the balance of the Term Loan commence on February 28, 2021 in an amount equal to $1,500 per quarter; (iii) reduce the Revolver commitment to $2,000 from up to $25,000; (iv) adjust the minimum quarterly EBITDA covenants to be maintained by the Company commencing on February 28, 2021 and continuing through to maturity, thereby removing this covenant for the fiscal period ended November 30, 2020 and eliminating the reversion of the financial covenants to that of the original structure on November 30, 2021; (v) modify the applicable margin pricing and standby fee terms to reflect current market conditions; and (vi) reduce the minimum unrestricted cash balance requirement to $20,000, which is already inclusive of the $8,000 restricted investment currently outstanding. &#160;The interest rate margin will be fixed from November 27, 2020 through to maturity on May 31, 2021. &#160;The Company incurred an amendment fee of $217 plus customary legal expenses in connection with the amendment and restatement.</span></span></span></span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036237304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash [policy text block]</a></td>
<td class="text"><div><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">i) Cash</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Cash is a financial asset that is measured at amortized cost, which approximates fair value and includes cash-on-hand and deposits held with financing institutions.</span></span></span></p></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory', window );">Short-term investments [policy text block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">ii) Short-term investments</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">The Company considers short-term investments in the form of guaranteed investment certificates to be an investing activity. These investments are measured at amortized cost. The Company also has equity securities that are carried at fair value through profit or loss.</span></span></span></p></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory', window );">Biological assets [policy text block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#86b4cd">iii) Biological assets</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">While the Company's biological assets are within the scope of IAS 41 Agriculture, the direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2 Inventories. This includes the direct cost of seeds and growing materials as well as other indirect costs such as utilities and supplies used in the growing process. Indirect labour cost for individuals involved in the growing and quality control process is also included, as well as depreciation of manufacturing assets. All direct and indirect costs of biological assets are capitalized as they are incurred. Unrealized fair value gains/losses on growth of biological assets are recorded on the consolidated statements of (loss) income and comprehensive (loss) income. Biological assets are measured at their fair value less costs to sell on the consolidated statement of financial position.</span></span></span></p></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories [policy text block]</a></td>
<td class="text"><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">iv) Inventories</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Inventories for finished goods and packaging and supplies are initially valued at cost, and subsequently at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less the estimated costs to sell. The Company reviews inventories for obsolete, redundant and slow-moving goods and any such inventories identified are written down to net realizable value. The direct and indirect costs of finished goods inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labour and depreciation expense on equipment involved in packaging, labeling and inspection. All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of sales on the consolidated statements of (loss) income and comprehensive (loss) income at the time the cannabis is sold. Inventory is measured at lower of cost or net realizable value on the statement of financial position.</span></span></span></p></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment [policy text block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">v) Property, plant and equipment</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Property, plant and equipment are initially recognized at acquisition cost or manufacturing cost, including any costs directly attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner intended by the Company's management. Property, plant and equipment are subsequently measured at cost, less accumulated depreciation and impairment losses.</span></span></span></p></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Depreciation is recognized on a straight-line basis to reduce the cost, less estimated residual value, of depreciable fixed assets. The following useful lives are applied:</span></span></p><p style="margin:0pt">&#160;</p><div style="text-align:center"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin-left:20%;width:60%"><tbody><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Building</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">25 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Growing equipment</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">10 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Computer equipment</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Vehicles</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Furniture and fixtures</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">10 years</span></td></tr><tr><td style="text-align:left;width:30%"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Leasehold improvements</span></p></td><td style="text-align:right;width:30%"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></p></td></tr></tbody></table></div><p style="margin:0pt">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amount of the assets, and are recognized as profit or loss within other income or other expenses.</span></span></p><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Assets in process are transferred to the appropriate asset class when available for use and depreciation of these assets commences at that point.</span></p><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">An asset's residual value, useful life and depreciation method are reviewed during each financial year and adjusted if appropriate. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) and depreciated accordingly.</span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory', window );">Goodwill [policy text block]</a></td>
<td class="text"><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="line-height:115%">vi) Goodwill</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%;color:black">Goodwill represents the future economic benefits arising from a business combination that are not individually identified and separately recognized. Goodwill is carried at cost less accumulated impairment losses. Refer to Note 3(viii) for a description of impairment testing procedures.</span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory', window );">Assets held for sale [policy text block]</a></td>
<td class="text"><p style="margin:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span>vii) Assets held for sale</span></span><br/>Assets and liabilities held for sale are no longer depreciated and are presented separately in the statement of financial position at the lower of their carrying amount and fair value less costs to sell. An asset is regarded as held for sale if its carrying amount will be recovered principally through a sale transaction, rather than through continuing use. For this to be the case, the asset must be available for immediate sale and its sale must be highly probable.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory', window );">Impairment of long-lived and intangible assets [policy text block]</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span>viii) Impairment of long-lived and intangible&#160;assets</span></span><br/>Long-lived assets, including property, plant and equipment are reviewed each reporting period for indicators of impairment. Goodwill is assessed for indicators of impairment at each reporting date and is tested annually or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs of disposal, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Except for goodwill, where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payments [policy text block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">ix) Share-based payments</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense in profit or loss over the vesting period based on the Company's estimate of equity instruments that will eventually vest. Fair value for options is determined using the Black-Scholes pricing model and fair value for Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") is determined using the Company's share price at the grant date.</span></span></span></p></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Expected forfeitures are estimated at the date of the grant and subsequently adjusted if further information indicates actual forfeitures may vary from the original estimate.&#160; The impact of the revision of the original estimate is recognized in profit or loss such that the cumulative expenses reflect the revised estimate.</span></span></span></span></p><p style="margin:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>For stock options granted to non-employees, the expense is measured at the fair value of the goods and services received except when the fair value cannot be estimated in which case it is measured at the fair value of the equity instrument granted.</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Consideration paid by employees or non-employees on the exercise of options is recorded as an increase to share capital and the related share-based expense is transferred from equity reserves to share capital.</span></span></span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates', window );">Investments in associates [policy text block]</a></td>
<td class="text"><div><p style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="color:#86b4cd"><span><span>x) Investments in associates</span></span></span></span></span></span></p><p style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Associates are companies over which the Company has significant influence and are accounted for under the equity method. Significant influence is presumed when the Company has an ownership interest greater than 20%, unless certain qualitative factors overcome this assumption. Conversely, where the Company has an ownership interest less than 20%, it is presumed that the Company does not have significant influence, unless certain qualitative factors overcome this assumption. In assessing significant influence and the ownership interest, potential voting rights that are currently exercisable are taken into consideration.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Investments in associates are accounted for using the equity method and are initially recognized at cost, inclusive of transaction costs. The consolidated financial statements include the Company&#x2019;s share of the income or loss and equity movement of equity accounted associates. In accordance with IFRS, the associate&#x2019;s most recent available financial statements are used in the application of the equity method. Where the associate&#x2019;s reporting period differs from the Company&#x2019;s, the associate prepares financial information as of the same period end as the Company, unless it is impracticable to do so. Otherwise, the Company will adjust for its share of income and expenses and equity movement based on the associate&#x2019;s most recently completed financial statements, adjusted for the effects of significant transactions. The Company does not recognize losses exceeding the carrying value of its interest in the associate.</span></span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets [policy text block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span style="color:#86b4cd">xi) Intangible assets</span></span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000">Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any, except for off-market supply agreements, where amortization is provided based on the actual output received versus the estimated output forecast to be received over the life of the agreement.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively. Intangible assets with an indefinite life or not yet available for use are not subject to amortization.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Research costs are expensed as incurred. Development expenditures are capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development to use or sell the asset. Research costs and other development expenditures are recognized as general and administrative expenses on the consolidated statement of income (loss) and comprehensive income (loss) as incurred.</span></span></span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Earnings (loss) per share [policy text block]</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span><span>xii) Earnings (loss) per share</span></span></span><br/><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Basic earnings (loss) per share is calculated by dividing net income (loss) attributable to common shareholders by the weighted-average number of shares outstanding during the period.&#160; Diluted earnings (loss) per share is calculated in a similar manner, but with adjustments to give effect to all dilutive potential common shares outstanding during the period. The dilutive effect of warrants, options, RSUs and PSUs is calculated using the treasury stock method. The if-converted method, which assumes that all convertible debt has been converted if the debt is in-the-money, is used to calculate the dilutive effect of convertible debt.&#160; Anti-dilutive effects of potential conversions of securities are ignored for this calculation.</span></span></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue recognition [policy text block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#86b4cd">xiii) Revenue recognition</span></span></span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000">Revenue from the direct sale of cannabis and cannabis oil for a fixed price is recognized when the Company transfers control of the good to the customer, which is at point of delivery for medical cannabis and recreational cannabis.</span></span></span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Revenue includes excise taxes, which the Company pays as principal, but excludes duties and taxes collected on behalf of third parties. Revenue also includes the net consideration to which the Company expects to be entitled. Revenue is recognized to the extent that it is highly probable that a significant reversal will not occur. Therefore, revenue is stated net of expected price discounts, allowances for customer returns and certain promotional activities and similar items. Generally, payment of the transaction price is due within credit terms that are consistent with industry practices, with no element of financing.</span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Net revenue is revenue less excise taxes. Excise taxes are effectively a production tax which becomes payable when the product is removed from the Company's premises and may or may not be directly related to the value of revenue depending on the province of sale. It is generally not included as a separate item on external invoices; increases in excise tax are not always passed on to the customer and where a customer fails to pay for product received the Company cannot reclaim the excise tax. The Company therefore recognizes excise tax, unless it regards itself as an agent of the regulatory authorities, as a cost and reduction to revenue for the Company.</span></span></span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income taxes [policy text block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">xiv) Income taxes</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The measurement of income taxes payable and deferred income tax assets and liabilities requires management to make judgments in the interpretation and application of the relevant tax laws. The actual amount of income taxes only becomes final upon filing and acceptance of the tax return by the relevant authorities, which occurs subsequent to the issuance of the consolidated financial statements.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Income tax expense (recovery) in the statements of income (loss) and comprehensive income (loss) is the sum of current and deferred tax as explained below.</span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Current tax is the expected income tax payable (recoverable) on the taxable income (loss) for the period, using tax rates enacted, or substantively enacted, as at the end of the reporting period.&#160; Current tax expense (recovery) included in the statements of income (loss) and comprehensive income (loss) reflects the current tax for the reporting period, plus adjustments to the current tax of prior periods, less current tax recorded directly in other comprehensive income (loss) or equity.</span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Deferred taxes are accounted for under the liability method and are the taxes expected to be payable or recoverable on the temporary differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable income.&#160; Deferred tax liabilities are generally recognized for all taxable temporary differences and deferred tax assets are recognized to the extent that it is probable that taxable income will be available against which deductible temporary differences and unused tax losses and tax credits can be utilized.&#160; Deferred tax is calculated on a non-discounted basis, using enacted or substantively enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&#160; The carrying amounts of individual deferred tax assets are reviewed at the end of each reporting period, but are only recognized for the proportion on which it is probable that sufficient taxable profits will be available for such assets to be recovered.</span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Deferred tax is not recognized for: i) temporary differences related to the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss; ii) differences relating to investments in subsidiaries to the extent that it is probable that they will not reverse in the foreseeable future; and, iii) differences arising on the initial recognition of goodwill.</span></span></span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory', window );">Borrowing costs [policy text block]</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span><span>xv) Borrowing costs</span></span></span><br/><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time that the assets are substantially ready for their intended use or sale. Other borrowing costs are expensed in the period in which they are incurred and reported in finance costs. No borrowing costs were capitalized during the periods presented.</span></span></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory', window );">Discontinued operations [policy text block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">xvi) Discontinued operations</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">A disposal group is presented as a discontinued operation if all of the following conditions are met: i) it is a component of the Company for which operations and cash flows can be clearly distinguished operationally and financially from the rest of the Company, ii) it represents a separate major line of business or operations that either has been disposed of or is classified as held for sale; and iii) it is part of a single coordinated plan to dispose of a separate major line of business of operations.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span style="color:#000000">Assets in a disposal group classified as held for sale are presented separately in the consolidated statements of financial position. Discontinued operations are presented separately from continuing operations in the consolidated statements of income (loss) and comprehensive income (loss) and consolidated statements of cash flows.</span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants', window );">Government subsidies [policy text block]</a></td>
<td class="text"><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#86b4cd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="line-height:115%">xvii) Government subsidies</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%;color:black">Government subsidies are recognized when there is reasonable assurance that the subsidy will be received, and all the attached conditions will be complied with. Subsidies are recognized as income in the statement of income (loss) and comprehensive income (loss) on a systematic basis over the periods in which the expenses are recognized for the related costs for which the subsidies are intended to compensate, which in the case of subsidies related to assets requires setting it up as deferred income or deducting it from the carrying amount of the asset.</span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory', window );">Critical accounting estimates and judgments [policy text block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">xviii) Critical accounting estimates and judgments</span></span></span></p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimates are revised and in any future years affected.</span></span></span></p></div></div><p style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The following are the estimates and judgments made by management in applying the accounting policies of the Company that have the most significant effect on the financial statements.</span></p><div><div><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>1) Biological assets and inventories</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Determination of the fair value of biological assets requires management to make a number of estimates, including estimating harvesting costs, selling costs, sales prices, wastage, oil conversion factor, expected yields, and post-harvest costs of the cannabis plant. The Company records obsolete and unsaleable inventories at the lower of cost and net realizable value. Adjustments to the carrying value of inventories are based on obsolescence trends, historical experience, and forecast demand and pricing for obsolete and unsaleable inventories. Refer to Notes 7 and 8 for further information. </span></span></span></p><p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(2) Estimated useful lives and impairment of property, plant and equipment</strong></i></span></span></span></p><p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Amortization of property, plant and equipment requires estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts, taking into consideration factors such as economic and market conditions and the useful lives of assets.</span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(3) Share-based payments</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In determining the fair value of options and related expenses, management estimates the expected life of the option, the volatility of the Company's share price, the risk-free interest rate, and the rate of forfeitures. Refer to Note 12 for further information. </span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(4) Warrants</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In determining the value of warrants, management estimates the expected life of the warrant, the volatility of the Company's share price, and the risk-free interest rate. </span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(5) Adult-use recreational cannabis revenue - provision for returns and price adjustments </strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Government customers typically have the right to return products, and in some cases, the right to pricing adjustments for products that are subsequently discounted or sold for a lower price in another jurisdiction. The estimation of potential future returns and pricing adjustments includes the use of management estimates and assumptions that may not be certain given the evolving nature of the industry.</span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(6) Investments in associates</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:17.85pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">Management has applied significant judgment in the determination of whether the Company exerts significant influence with respect to its investments, which then allows the Company to account for its investments under the equity accounting method. Further, management has applied significant judgment and made use of management estimates and assumptions in determining and quantifying any impairment losses that may need to be recorded against its investments in associates.</span></span></span></p><p style="margin-left:18pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000"><i><strong>(7) Impairment of long-lived and intangible assets</strong></i></span></span></span></p><p style="margin-top:0pt;margin-left:17.85pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">In determining the recoverable amount of the Company's Moncton campus (the "Moncton Campus") CGU, management has applied significant judgment in the aggregation of the CGU and has made various estimates with respect to the forecast cash flows, terminal growth rate, post-tax discount rate, and income taxes utilized in the discounted cash flow model to estimate fair value less costs of disposal.</span></span></span></p></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements', window );">NEW STANDARDS AND INTERPRETATIONS ADOPTED [policy text block]</a></td>
<td class="text"><div><div><div><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">NEW STANDARDS AND INTERPRETATIONS ADOPTED</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#86b4cd">New or amended standards effective September 1, 2019</span></span></span></p><p style="margin:0pt">&#160;</p><p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">The Company has adopted the following new or amended IFRS standard for the annual period beginning on September 1, 2019:</span></span></span></p></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"><strong><span style="line-height:115%">IFRS 16 - Leases</span></strong></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">In January 2016, the IASB issued IFRS 16 Leases, which replaced IAS 17 Leases. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than twelve months, unless the underlying asset is of low value. A lessee is required to recognize a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. The standard was effective for annual periods beginning on or after January 1, 2019 and has been adopted by the Company effective September 1, 2019 using the modified retrospective approach where comparative figures were not restated.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">As a result of adopting IFRS 16, the Company recognized right-of use ("ROU") assets of $4,464 recorded under property, plant and equipment (Note 9), lease liabilities of $4,439 recorded under other liabilities (Note 13), and a reduction to prepaid expenses of $25 as a result of the leasing arrangements in place at September 1, 2019 and entered during the year ended August 31, 2020 by the Company.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The ROU asset was measured as the amount of the lease liability, using the Company's incremental borrowing rate on September 1, 2019 that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. The weighted average interest rate as of September 1, 2019 to measure the lease liabilities was 5.70%.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The Company elected to use the following practical expedients on adoption of IFRS 16 on all of its leases:</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(a)&#160;In accordance with IFRS 16.C3, an election is being taken to not reassess whether a contract is or contains a lease at the date of initial application, and instead to only apply IFRS 16 to contracts that were in the scope of IAS 17;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(b)&#160;In accordance with IFRS 16.C8(b)(ii), an election is being taken to measure the ROU asset on September 1, 2019 as an amount equal to the lease liability, adjusted for prepaid or accrued lease payments;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(c)&#160;In accordance with IFRS 16.C10(a), an election is being taken to apply a single discount rate to a portfolio of leases with reasonably similar characteristics;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(d)&#160;In accordance with IFRS 16.C10(b), an election is being taken to rely on the IAS 37 assessment of whether leases are onerous instead of performing an impairment review;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(e)&#160;In accordance with IFRS 16.C10(c), an election is being taken to exclude leases for which the term ends within 12 months from September 1, 2019;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(f)&#160;In accordance with IFRS 16.C10(d), an election is being taken to exclude initial direct costs from the measurement of the ROU asset on September 1, 2019;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(g)&#160;In accordance with IFRS 16.15, an election is being taken, by class of underlying asset, not to separate non-lease components from lease components, and instead account for each lease component and any associated non-lease components as a single lease component where the non-lease components are not significant compared to the lease components;</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(h)&#160;In accordance with IFRS 16.5(a), an election is being taken to not recognize a ROU asset and lease liability for leases for which the lease has a term less than 12 months; and</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">(i)&#160;In accordance with IFRS 16.5(b), an election is being taken to not recognize a ROU asset and lease liability for leases for which the underlying asset is of low value, which is defined to mean less than $5,000 USD when new.</span></p><p style="margin-top:0pt;margin-left:42px;margin-bottom:0pt;text-align:justify;text-indent:-13.5pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The following is a reconciliation between the Company's operating lease commitments disclosed applying IAS 17 as at August 31, 2019 and the lease liabilities as at September 1, 2019 after adopting IFRS 16:</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"><tbody><tr><td style="vertical-align:bottom"><p><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Reconciliation - IAS 17 to IFRS 16</span></p></td></tr></tbody></table><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Operating lease obligations as at August 31, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">3,049</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Minimum future payments not related to lease payments</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(411</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Lease payments for renewal options reasonably expected to be exercised but not contractually obligated</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">655</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Relief option for short-term leases</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(538</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Relief option for leases of low-value assets</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(76</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Gross lease liabilities at September 1, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,679</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Discounting</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(459</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Present value of lease liabilities at September 1, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:3px double #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,220</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000">&#160;</td></tr></tbody></table></div></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">New Accounting Pronouncements&#160;</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The following IFRS standards have been recently issued by the IASB. Pronouncements that are irrelevant or not expected to have a significant impact have been excluded.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"><strong><span style="line-height:115%">Amendments to IFRS 3: Definition of a Business</span></strong></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">In October 2018, the IASB issued "Definition of a Business (Amendments to IFRS 3)". The amendments clarify the definition of a business, with the objective of assisting entities to determine whether a transaction should be accounted for as a business combination or as an asset acquisition. The amendment provides an assessment framework to determine when a series of integrated activities is not a business. The amendments are effective for business combinations occurring on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements resulting from any future transactions.</span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%"><strong><span style="line-height:115%">Amendments to IAS 1: Classification of Liabilities as Current or Non-Current</span></strong></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:115%">The amendments to IAS 1 clarify the requirements relating to determining whether a liability should be presented as current or non-current in the statement of financial position. Under the new requirements, the assessment of whether a liability is presented as current or non-current is based on the contractual arrangements in place as at the reporting date and does not impact the amount or timing of recognition. The amendment applies retrospectively for annual reporting periods beginning on or after January 1, 2023. The Company is currently evaluating the potential impact of these amendments on the Company's consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for interest and other costs that the entity incurs in connection with the borrowing of funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for discontinued operations. [Refer: Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2019-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for held-to-maturity investments. [Refer: Held-to-maturity investments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2021-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForHeldtomaturityInvestmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for investments in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for non-current assets or disposal groups classified as held for sale. [Refer: Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 46<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policies relevant to an understanding of financial statements, which the entity does not separately disclose.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for critical accounting estimates and judgments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DescriptionOfAccountingPolicyForCriticalAccountingEstimatesAndJudgmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040429528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory', window );">Disclosure of detailed information about estimated useful lives of property, plant and equipment [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin-left:20%;width:60%"><tbody><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Building</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">25 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Growing equipment</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">10 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Computer equipment</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Vehicles</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></td></tr><tr><td style="text-align:left;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Furniture and fixtures</span></td><td style="text-align:right;width:30%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">10 years</span></td></tr><tr><td style="text-align:left;width:30%"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Leasehold improvements</span></p></td><td style="text-align:right;width:30%"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5 years</span></p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory', window );">Disclosure of detailed information about reconciliation of operating leases [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:95%"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Operating lease obligations as at August 31, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">3,049</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Minimum future payments not related to lease payments</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(411</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Lease payments for renewal options reasonably expected to be exercised but not contractually obligated</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">655</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Relief option for short-term leases</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(538</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Relief option for leases of low-value assets</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(76</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Gross lease liabilities at September 1, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,679</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Discounting</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(459</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Present value of lease liabilities at September 1, 2019</span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa;border-bottom:3px double #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,220</span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa;border-bottom:3px double #000000">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related detail information about operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related useful life of assets and describe method of depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutUsefulLifeOfTangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040427016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT TERM INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ShortTermInvestmentAbstract', window );"><strong>Short Term Investment Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory', window );">Disclosure of detailed information about short term investments [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:46.3488%"><span style="color:#86b4cd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DESCRIPTION</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTEREST %</span></span></td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:rgb(134, 180, 205);white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:rgb(134, 180, 205);white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:rgb(166, 164, 164);white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:rgb(166, 164, 164);white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:rgb(166, 164, 164)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing September 16, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.95%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing September 24, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.95%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing December 15, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.16%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing December 23, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.16%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GIC - maturing June 17, 2021</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.93%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity securities in VIVO Cannabis Inc.</span></span></td><td style="text-align:center;vertical-align:bottom;width:18.6977%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:1px solid #000000;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:1px solid #000000;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">128</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:1px solid #000000;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:1px solid #000000;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">380</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:46.3488%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:18.6977%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:3px double #000000;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:3px double #000000;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,128</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:3px double rgb(0, 0, 0);background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;border-bottom:3px double #000000;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;border-bottom:3px double #000000;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">380</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;border-bottom:3px double rgb(0, 0, 0);background-color:rgb(223, 221, 221)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of detailed information about short term investment explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutShortTermInvestmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ShortTermInvestmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ShortTermInvestmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040571512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AccountsReceivableAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory', window );">Disclosure of detailed information about balances of accounts receivables [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">AUGUS 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Trade receivables</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11,096</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11,900</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Harmonized sales taxes receivable</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">728</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,741</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Government programs</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,936</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">168</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Less: Provision for doubtful accounts</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(13</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(268</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,747</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16,541</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AccountsReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AccountsReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Balances Of Accounts Receivables [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutBalancesOfAccountsReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037861208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory', window );">Disclosure of reconciliation of changes in biological assets [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"><tbody><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>OTHER</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>BIOLOGICAL ASSETS</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>CANNABIS ON PLANTS</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>TOTAL</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Carrying amount, August 31, 2018</span></span></span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;599</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;19,259</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;19,858</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Add net production costs</span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(596 </span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>37,534</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>36,938</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Net change in fair value less costs to sell due to biological transformation</span></span></span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#x2014;</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(8,060</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(8,060</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Transferred to inventory upon harvest</span></span></span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#x2014;</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(28,084</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(28,084</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Carrying amount, August 31, 2019</span></span></span></span></p></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;3</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;20,649</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;20,652</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Add net production costs</span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>13</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>41,039</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>41,052</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Net change in fair value less costs to sell due to biological transformation</span></span></span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#x2014;</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(2,853</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(2,853</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Deduct net abnormal plant destruction costs</span></span></p></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(5,048</span></span></p></td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(5,048</span></span></p></td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="background-color:rgb(255, 255, 255)">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Transferred to inventory upon harvest</span></span></span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#x2014;</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(48,409</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(48,409</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt">&#160;</p></td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><p style="text-indent:-15pt;margin-left:15pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Carrying amount, August 31, 2020</span></span></span></span></p></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;16</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;5,378</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;5,394</span></span></span></span></td><td style="text-align:left;width:2%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory', window );">Disclosure of detailed information about unobservable inputs and their impact on fair value [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"><tbody><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>SIGNIFICANT INPUTS &amp; </span></span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="text-align:center;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>WEIGHTED AVERAGE INPUT</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="text-align:center;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>EFFECT ON FAIR VALUE</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>ASSUMPTIONS </span></span></span></span></span></td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUG. 31, 2020</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUG. 31, 2019</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>SENSITIVITY</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUG. 31, 2020</span></span></span></span></td><td style="text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:2px solid rgb(0, 0, 0);text-align:center;width:11%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUG. 31, 2019</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:center;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Average net selling price per gram</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><p style="font-family:Times New Roman, Times, serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160;3.36</span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><p style="font-family:Times New Roman, Times, serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160;5.65</span></span></p></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Increase or decrease by $ 1.00 per gram</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160; 1,602 </span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;3,657</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:11%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Average yield per plant</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>101 grams</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>151 grams</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Increase or decrease by  10  grams</span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;532</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:11%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;1,367</span></span></span></span></td><td style="text-align:left;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory', window );">Disclosure of detailed information about fair value adjustment to biological assets and inventory sold [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLOR:black;FONT-SIZE:10pt;BORDER-COLLAPSE:collapse" width="100%"><tbody><tr valign="top"><td style="text-align:left">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#87b5cf">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:12%;background-color:#87b5cf"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>AUGUST 31, 2020</span></span></span></span></td><td style="text-align:center;width:2%;background-color:#87b5cf">&#160;</td><td style="text-align:center;width:1%">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:1%;background-color:#aeaaaa">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:center;width:12%;background-color:#aeaaaa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:left;width:2%;background-color:#aeaaaa">&#160;</td></tr><tr><td style="text-align:left">&#160;</td><td style="text-align:center;width:1%;background-color:#e1eaed">&#160;</td><td style="text-align:center;width:12%;background-color:#e1eaed">&#160;</td><td style="text-align:center;width:2%;background-color:#e1eaed">&#160;</td><td style="text-align:center;width:1%">&#160;</td><td style="text-align:center;width:1%;background-color:#d6d6d6">&#160;</td><td style="text-align:center;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>&#160;</span></span></span></span></span></td><td style="text-align:center;width:2%;background-color:#d6d6d6">&#160;</td></tr><tr valign="top"><td style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Realized fair value amounts included in inventory sold</span></span></span></span></td><td style="text-align:left;width:1%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;(39,455</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="text-align:left;width:1%">&#160;</td><td style="text-align:left;width:1%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="text-align:right;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;(50,477</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr valign="top"><td style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Increase (decrease) in fair value on growth of biological assets</span></span></span></span></td><td style="text-align:left;width:1%;background-color:#e1eaed">&#160;</td><td style="text-align:right;width:12%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>73,975</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#e1eaed">&#160;</td><td style="text-align:left;width:1%">&#160;</td><td style="text-align:left;width:1%;background-color:#d6d6d6">&#160;</td><td style="text-align:right;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>75,338</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#d6d6d6">&#160;</td></tr><tr valign="top"><td style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Adjustment to net realizable value</span></span></span></span></td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#e1eaed">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:right;width:12%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(72,801</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="text-align:left;width:1%">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:left;width:1%;background-color:#d6d6d6">&#160;</td><td style="BORDER-BOTTOM:#000000 1px solid;text-align:right;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(14,284</span></span></td><td style="text-align:left;width:2%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr valign="top"><td style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Fair value adjustment to biological assets</span></span></span></span></td><td style="BORDER-BOTTOM:#000000 3px double;text-align:left;width:1%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="BORDER-BOTTOM:#000000 3px double;text-align:right;width:12%;background-color:#e1eaed"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(38,281</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#e1eaed">)</td><td style="text-align:left;width:1%">&#160;</td><td style="BORDER-BOTTOM:#000000 3px double;text-align:left;width:1%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="BORDER-BOTTOM:#000000 3px double;text-align:right;width:12%;background-color:#d6d6d6"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#160;10,577</span></span></span></span></td><td style="text-align:left;width:2%;background-color:#d6d6d6">&#160;</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about fair value adjustment to biological assets and inventory sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about unobservable inputs and their impact on fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037982440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory', window );">Disclosure of detailed information about inventories [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:50%">&#160;</td><td style="vertical-align:bottom;background-color:#86b4cd;width:1.02326%">&#160;</td><td colspan="9" style="vertical-align:bottom;text-align:center;background-color:#86b4cd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="vertical-align:bottom;background-color:#86b4cd;width:1.95349%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#d3e3e5">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">FAIR VALUE</span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.95349%;background-color:#d3e3e5">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#d3e3e5">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">CAPITALIZED COST</span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">ADJUSTMENT</span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:right;background-color:rgb(211, 227, 229);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:right;background-color:#d3e3e5;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#d3e3e5;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">CARRY ING VALUE</span></span></span></td><td style="vertical-align:bottom;width:1.95349%;background-color:#d3e3e5">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Plants in drying stage</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,036</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,841</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,877</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Dry cannabis</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Available for packaging</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13,124</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7,808</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">20,932</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Packaged inventory</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,707</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,956</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,663</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Flower and trim available for extraction</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">849</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,062</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,911</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Concentrated extract</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13,252</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">6,130</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19,382</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Formulated extracts</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Available for packaging</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,097</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">384</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,481</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Packaged inventory</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,045</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">226</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,271</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Packaging and supplies</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11,848</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11,848</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1.95349%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50%">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">46,958</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19,407</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">66,365</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1.95349%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td></tr></tbody></table><p>&#160;</p><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:50.0698%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4">&#160;</td><td colspan="9" style="text-align:center;vertical-align:bottom;background-color:#a6a4a4"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:1.95349%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221);white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">FAIR VALUE</span></span></span></td><td style="text-align:right;vertical-align:bottom;width:0.976745%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.95349%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">CAPITALIZED COST</span></span></span></td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221);white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">ADJUSTMENT</span></span></span></td><td style="text-align:right;vertical-align:bottom;width:0.976745%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#ffffff">CARRY ING VALUE</span></span></span></td><td style="text-align:right;vertical-align:bottom;width:1.95349%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Plants in drying stage</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,945</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,256</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">6,201</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Dry cannabis</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Available for packaging</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,261</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12,718</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17,979</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Packaged inventory</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,205</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,549</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">6,754</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Flower and trim available for extraction</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,433</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12,193</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16,626</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Concentrated extract</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">15,393</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21,573</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">36,966</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Formulated extracts</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Available for packaging</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">754</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,121</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,875</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160; &#160;Packaged inventory</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">728</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">425</span></span></td><td style="vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,153</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Packaging and supplies</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,590</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,590</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr><tr><td style="vertical-align:bottom;width:50.0698%">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">38,309</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(238, 238, 238)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">54,835</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:0.976745%;text-align:left;background-color:#eeeeee">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#eeeeee"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">93,144</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#eeeeee">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents detailed information about inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_InventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_InventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132093024712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Disclosure of detailed information about property plant and equipment [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">RIGHT- OF-</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">GROWING &amp;</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">USE LEASE</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">CONSTRUCTION</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">PROCESSING</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">OTHER</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">ASSETS</span></td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">LAND</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">BUILDINGS</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">IN PROCESS</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">EQUIPMENT</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">(NOTE A)</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">(NOTE B)</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif">TOTAL</span></td><td style="text-align:center;border-bottom:1px solid transparent;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Cost</span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2018</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,205</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">47,101</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">11,993</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">40,493</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,922</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">104,714</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Additions</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">6</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">15,753</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">105,512</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">5,554</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">3,366</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">130,191</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Construction completed</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">8,042</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(51,990</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">42,698</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">1,250</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Disposals</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(122</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(201</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(323</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Impairment loss</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(613</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(613</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Reclassification of<br/>&#160;&#160;&#160; computer software<br/>&#160;&#160;&#160; (NOTE A)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(841</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(841</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,211</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">70,774</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">65,515</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">87,931</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">6,697</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">233,128</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2018</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,997</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(2,956</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,122</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(6,075</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(2,245</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(5,679</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(946</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(8,870</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Disposals</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">5</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">17</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">22</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Reclassification of<br/>&#160;&#160;&#160; computer software<br/>&#160;&#160;&#160; (NOTE A)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">265</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">265</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(4,237</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(8,618</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,803</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(14,658</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Cost</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,211</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">70,774</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">65,515</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">87,931</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">6,697</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">233,128</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Transition to IFRS 16</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,244</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,244</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Additions (Note C)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">1,864</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">22,316</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">46,847</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">7,597</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">1,335</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,220</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">82,179</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Construction completed</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">71,663</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(110,234</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">37,851</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">720</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Disposals</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(517</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(436</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(75</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,028</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Impairment loss (Note D)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(37,214</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">48</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(37,166</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2020</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">4,075</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">127,022</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,128</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">132,991</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">8,677</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">4,464</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">279,357</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(4,237</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(8,618</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,803</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(14,658</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(4,074</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(11,568</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(1,362</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(557</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(17,561</span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Disposals</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">108</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">145</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">29</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">282</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2020</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(8,203</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(20,041</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(3,136</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(557</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">(31,937</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">)</span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">Net book value</span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">August 31, 2019</span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,211</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">66,537</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">65,515</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">79,313</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">4,894</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">218,470</span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">August 31, 2020</span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">4,075</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">118,819</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">2,128</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">112,950</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">5,541</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">3,907</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">$</span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif">247,420</span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory', window );">Disclosure of detailed information about reconciliation of additions to property, plant and equipment [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">82,179</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">130,191</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions related to IFRS 16 Leases</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,220</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net change in accounts payable and accrued liabilities related to purchases of<br/>property, plant and equipment</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,736</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,427</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property, plant and equipment</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">77,223</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">108,764</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)">&#160;</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about reconciliation of additions of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutReconciliationOfAdditionsToPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037982440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Disclosure of detailed information about intangible assets [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SUPPLY<br/>AGREEMENT</span></span></td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">LICENSE<br/>AGREEMENT</span></span></td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">COMPUTER<br/>SOFTWARE</span></span></td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid transparent;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">TOTAL</span></span></td><td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Cost</span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2018</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Additions</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,530</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,530</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Reclassification of computer software (NOTE A)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">841</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">841</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2019</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,530</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">841</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,371</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Accumulated amortization</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2018</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Amortization</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Reclassification of computer software (NOTE A)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(265</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(265</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2019</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(265</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(297</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Cost</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2019</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,530</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">841</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,371</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Additions</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">198</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,232</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,430</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Impairment (NOTE B)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(1,303</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(1,303</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Disposal</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2020</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">227</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">198</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,041</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,466</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Accumulated amortization</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2019</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(32</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(265</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(297</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Amortization</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(195</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(202</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(397</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Balance, August 31, 2020</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(227</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(467</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(694</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net book value</span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">August 31, 2019</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,498</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">576</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,074</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">August 31, 2020</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">198</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,574</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,772</span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132093024712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory', window );">Disclosure of detailed information about long term debt [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank of Montreal ("BMO") senior secured term loan ("Term Loan")<br/>&#160; maturing May 31, 2022 with principal repayments starting November 30, 2020<br/>&#160; based on a 10 year amortization</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,000</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,000</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Atlantic Canada Opportunities Agency ("ACOA")<br/>&#160; Business Development Program loan maturing September 1, 2024 with a 7 year<br/>&#160; amortization, bearing interest at an interest rate of 0%</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">311</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">346</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle loans - five year term maturing June 17, 2024</span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">98</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred financing costs, net of loan modification loss on BMO Term Loan</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(123</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(868</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,266</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,576</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: current portion of long term debt</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,595</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,509</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term portion</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103,671</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,067</span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory', window );">Disclosure of detailed information about principal repayments required on long-term debt [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:60%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 1 year</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,605</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1 to 2 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103,580</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 to 3 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3 to 4 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4 to 5 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Thereafter</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,389</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about principal repayments required on the long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutPrincipalRepaymentsRequiredOnLongTermBorrowingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036298728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShareCapitalInformationAbstract', window );"><strong>Disclosure Of Share Capital Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory', window );">Disclosure of detailed information about warrants valuation assumptions [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:black;font-size:10pt;margin:auto" width="40%"><tbody><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="width:191px;background-color:rgb(255, 255, 255);text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Risk free interest rate %</span></td><td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.6%</span></td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected life of Warrants (years)</span></td><td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.5</span></td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected annualized volatility %</span></td><td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">64.6%</span></td></tr><tr style="background-color:rgb(255, 255, 255)" valign="top"><td style="text-align:left;width:191px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected dividend yield %</span></td><td style="text-align:center;width:78px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Disclosure of detailed information about number and weighted average exercise prices of share options [Table Text Block]</a></td>
<td class="text"><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">WEIGHTED AVERAGE</span></td><td style="text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NUMBER</span></td><td style="border-bottom:1px solid;text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">EXERCISE PRICE</span></td><td style="border-bottom:1px solid;text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2018</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7,709,746</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2.10</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">3,589,500</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.59</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(2,167,864</span></td><td style="text-align:left;vertical-align:bottom;width:26px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.92</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Cancelled / Forfeited</span></td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(298,188</span></td><td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">6.41</span></td><td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2019</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">8,833,194</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4.23</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,125,000</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">3.21</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(879,240</span></td><td style="text-align:left;vertical-align:bottom;width:26px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td><td style="text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.21</span></td><td style="text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Cancelled / Forfeited</span></td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(1,050,050</span></td><td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">6.20</span></td><td style="border-bottom:1px solid;text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2020</span></td><td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:13px">&#160;</td><td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">9,028,904</span></td><td style="border-bottom:3px double;text-align:left;vertical-align:bottom;width:26px">&#160;</td><td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:13px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td><td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:199px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4.06</span></td><td style="border-bottom:3px double;text-align:left;vertical-align:bottom;width:26px">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Disclosure of detailed information about range of exercise prices of outstanding share options [Table Text Block]</a></td>
<td class="text"><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td style="border-bottom:1px solid #000000;text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">OPTIONS OUTSTANDING</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">OPTIONS EXERCISABLE</span></p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Range of Exercise</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Weighted Average Remaining</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td></tr><tr><td style="border-bottom:1px solid #000000;text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Prices</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Quantity Outstanding</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Contractual Life (years)</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Quantity Exercisable</span></p></td></tr><tr><td style="width:334px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="width:333px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="width:333px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="width:333px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$0.30 - $1.48</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,440,599</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4.7</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,376,683</span></p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$1.49 - $2.38</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,204,333</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.5</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,652,833</span></p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$2.39 - $4.65</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,069,854</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.9</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,217,504</span></p></td></tr><tr><td style="text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$4.66 - $7.67</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,886,518</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">8.2</span></p></td><td style="text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,276,194</span></p></td></tr><tr><td style="border-bottom:1px solid #000000;text-align:right;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$7.68 - $11.27</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,427,600</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">8.7</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">949,900</span></p></td></tr><tr><td style="border-bottom:1px solid #000000;width:334px"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">9,028,904</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.5</span></p></td><td style="border-bottom:1px solid #000000;text-align:right;width:333px"><p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">6,473,114</span></p></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions', window );">Disclosure of detailed information about stock option valuation assumptions [Table Text Block]</a></td>
<td class="text"><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td colspan="3" style="text-align:center;background-color:#86b4cd"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#a6a4a4"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Risk free interest rate</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">0.45%- 1.65%</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#160; &#160;</span></p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1.20%- 2.42%</span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected life of options</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5.0 - 6.0 years</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5.0 -6.5 years</span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected annualized volatility</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">72% - 85%</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">64%-71%</span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Expected dividend yield</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></p></td></tr><tr><td><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Forfeiture Rate</span></p></td><td colspan="3" style="text-align:center;background-color:#e2f5fa"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">8.0% - 8.7%</span></p></td><td style="text-align:center"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></td><td style="text-align:center;background-color:#dfdddd"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7.3%- 8.0%</span></p></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Disclosure of detailed information about number and weighted average exercise prices of restricted stock unit [Table Text Block]</a></td>
<td class="text"><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NUMBER</span></td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2018</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">145,200</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">879,635</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(182,473</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2019</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">842,362</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">265,258</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(154,062</span></td><td style="vertical-align:bottom;width:26px;text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Cancelled/Forfeited</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(60,387</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2020</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">893,171</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory', window );">Disclosure of detailed information about number and weighted average exercise prices of performance share units [Table Text Block]</a></td>
<td class="text"><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NUMBER</span></td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2019</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Granted</span></td><td style="vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">142,187</span></td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Exercised</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(15,502</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Balance - August 31, 2020</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:159px;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">126,685</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Disclosure of detailed information about reconciliation of weighted average number of shares [Table Text Block]</a></td>
<td class="text"><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"><tbody><tr><td style="vertical-align:bottom;width:897px">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:164px;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:27px;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:27px;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:165px;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></td><td style="text-align:center;vertical-align:bottom;width:27px;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Weighted average number of shares used in basic earnings per share</span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">172,668,816</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">140,923,324</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Options</span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4,540,182</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5,194,827</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Warrants</span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4,738,388</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Restricted share units</span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">727,275</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">684,534</span></td><td style="vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Performance share units</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">126,685</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Weighted average number of shares used in diluted earnings per share</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">178,062,958</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">151,541,073</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Disclosure of detailed information about outstanding number and type of securities that could potentially dilute basic net income (loss) per share [Table Text Block]</a></td>
<td class="text"><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"><tbody><tr><td style="vertical-align:bottom;width:897px">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:164px;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></td><td style="text-align:center;vertical-align:bottom;width:27px;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:27px;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:165px;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></td><td style="text-align:center;vertical-align:bottom;width:27px;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Stock options</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4,382,918</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,847,500</span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:897px">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:164px;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">4,382,918</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:27px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:165px;text-align:right;background-color:#dfdddd"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1,847,500</span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:27px;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the range of exercise prices for outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about stock option valuation assumptions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutStockOptionValuationAssumptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about warrants valuation assumptions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about disclosure of number and weighted average exercise prices of performance share units explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfNumberAndWeightedAverageExercisePricesOfPerformanceShareUnitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfShareCapitalInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfShareCapitalInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040533512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfOtherLiabilitiesAbstract', window );"><strong>Disclosure Of Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory', window );">Disclosure of detailed information about carrying value of other liabilities [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:1.95349%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:1.95349%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent share consideration</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">231</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,117</span></span></td><td style="vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,617</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,848</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,117</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.95349%;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory', window );">Disclosure of detailed information about lease liabilities [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IFRS 16 transition</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,219</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease additions</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,220</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease payments</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(897</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expense on lease liabilities</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2020</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,705</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current portion included in accounts payable and accrued liabilities</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,088</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="border-bottom:3px double #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term portion</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,617</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory', window );">Disclosure of detailed information about undiscounted contractual payments relating to the current and future lease liabilities [Table Text Block]</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="width:60%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 1 year</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,553</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1 to 2 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,049</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 to 3 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,045</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3 to 4 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">998</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4 to 5 years</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">768</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Thereafter</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td><td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">606</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:22%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,019</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 97<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_97&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other non-current liabilities. [Refer: Other non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information of disclosure of continuity of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfContinuityOfLeaseLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037764616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN ASSOCIATES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract', window );"><strong>Disclosure of associates [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory', window );">Disclosure of detailed information about carrying value of investments in associates [Table Text Block]</a></td>
<td class="text"><div><div>&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ALPHA-CANNABIS</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EVIANA HEALTH</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">HYASYNTH</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PHARMA GMBH</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CORPORATION</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BIOLOGICALS INC.</span></span></td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(A)</span></span></td><td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(B)</span></span></td><td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(C)</span></span></td><td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL</span></span></td><td style="text-align:right;border-bottom:1px solid transparent;vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Participating share <sup>(1)</sup></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25.0%</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.9%</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43.4%</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Balance, August 31, 2018</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Additions</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,408</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13,408</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Transaction costs</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">160</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">73</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">89</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">322</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Distributions</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(374</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(374</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Share of net loss</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(50</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(734</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(477</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(1,261</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Impairment loss</span></span></span></p></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(950</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(950</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Foreign currency translation gain (loss)</span></p></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span>&#x2014;</span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(37</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2019</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,496</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,612</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,108</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share of net loss</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(75</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,112</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,187</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment loss</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,000</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Elimination of proportionate share of<br/>&#160;&#160;&#160; transactions with associates</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></td><td style="text-align:left;vertical-align:bottom;width:2%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation gain (loss)</span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, August 31, 2020 <sup>(2)</sup></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,501</span></span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,500</span></span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,001</span></span></td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interests in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 2<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_2_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInterestsInAssociatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132039817288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">Disclosure of information about key management personnel [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:center;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:center;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:center;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:center;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:center;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and consulting fees</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,953</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,521</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,750</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,155</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total key management compensation</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,703</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,676</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132087442792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory', window );">Disclosure of detailed information about aging of trade receivables [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0-60 days</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,023</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,748</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61-120 days</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">73</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">152</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross trade receivables</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,096</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,900</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Provision for doubtful accounts</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(268</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,083</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,632</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory', window );">Disclosure of detailed information about undiscounted cash flows contractual maturities [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">Carrying</span><br/><span style="color:#ffffff">Amount</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">Contractual</span><br/><span style="color:#ffffff">Cash Flows</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">Less than</span><br/><span style="color:#ffffff">1 year</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap;width:11px">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap;width:60px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">1 to 3 years</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">3 to 5 years</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">More than</span><br/><span style="color:#ffffff">5 years</span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:rgb(226, 245, 250);width:11px">&#160;</td><td style="vertical-align:bottom;background-color:rgb(226, 245, 250);width:60px">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts payable and accrued liabilities</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,486</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,486</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,486</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term debt</span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,266</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115,388</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,605</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103,660</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest payments</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,729</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,682</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,047</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132,752</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">140,603</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,773</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:11px;text-align:left;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:60px;text-align:right;background-color:rgb(226, 245, 250)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">106,707</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:9%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents detailed information about aging of trade receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Undiscounted Cash Flows Contractual Maturities Explanatory [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationUndiscountedCashFlowsContractualMaturitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037764488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory', window );">Disclosure of detailed information about revenues [Table Text Block]</a></td>
<td class="text"><div><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"><tbody><tr><td style="vertical-align:bottom;width:853px">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:157px;background-color:#86b4cd;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:25px;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:26px;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:13px;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:158px;background-color:#a6a4a4;white-space:nowrap"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:26px;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px">&#160;</td><td style="vertical-align:bottom;width:13px;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:157px;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:25px;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px">&#160;</td><td style="vertical-align:bottom;width:13px;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:158px;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:26px;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Adult-use recreational wholesale revenue (Canadian)</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>73,938</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>85,018</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Wholesale to Licensed Producers revenue (Canadian)</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>15,184</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>709</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Direct to patient medical revenue (Canadian)</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>10,748</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>11,192</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>International (business to business)</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>3,272</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>98</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Other revenue</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>245</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid;vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>530</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Gross revenue</span></span></span></span></td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>103,387</span></span></span></span></td><td style="vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>97,547</span></span></span></span></td><td style="vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Excise taxes</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(16,592</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td><td style="border-bottom:1px solid;vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(17,134</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:853px"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Net revenue</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e2f5fa"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>86,795</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:25px;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double;vertical-align:bottom;width:26px;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:13px;text-align:left;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:158px;text-align:right;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>80,413</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:26px;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutRevenuesExplantory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040031976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory', window );">Disclosure of detailed information about general and administrative expenses [Table Text Block]</a></td>
<td class="text"><div><p style="margin-bottom:0pt;text-align:justify">&#160;</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office and general</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,819</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,942</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wages and benefits</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,611</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,443</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,367</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,636</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,510</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">664</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,269</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">409</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Travel and accommodation</span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">383</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">456</span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Utilities</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43</span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total general and administrative expenses</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27,996</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,593</span></span></td><td style="border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(223, 221, 221)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about general and administrative expenses explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036218200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredIncomeExplanatory', window );">Disclosure of detailed information about components of deferred income tax expense [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Origination and reversal of temporary differences</span></span></span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(37,875</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,987</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Change in tax rate and rate differences</span></span></span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">421</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">281</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Change in unrecognized temporary differences</span></span></span></span></td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">27,245</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,349</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Prior period adjustments</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(262</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="border-bottom:1px solid transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">12</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Total income tax (recovery) expense</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="border-bottom:3px double transparent;vertical-align:bottom;width:2%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;text-align:left;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,629</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory', window );">Disclosure of detailed information about reconciliation of income tax expense [Table Text Block]</a></td>
<td class="text"><div><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Income (loss) from continuing operations before income taxes</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(146,628</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(5,875</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Statutory income tax rate</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">29.0%</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">29.0%</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Tax calculated at statutory rate</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(42,522</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,704</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Non-deductible (non-taxable) items</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">2,643</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,742</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Difference between current and future tax rates</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">421</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">281</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Benefit of deductible temporary differences not recognized</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">27,245</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,349</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Effect of tax rates in other jurisdictions</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">2,016</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Other</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(274</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(39</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Income tax (recovery) expense per financial statements</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,629</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Disclosure of detailed information about recognized deferred tax assets and liabilities [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Deferred tax assets are attributable to the following:</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Non-capital losses</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>6,670</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>10,708</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Lease liabilities</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,038</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#x2014;</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred tax assets</span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>7,708</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>10,708</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Set-off of tax</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(7,708</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(10,708</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net deferred tax asset</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#x2014;</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#x2014;</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Deferred tax liabilities are attributable to the following:</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Long-term assets</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(961</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(4,983</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Biological assets</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(170</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(961</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Inventories</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(5,367</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(15,200</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Right-of-use lease assets</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,096</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#x2014;</span></span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Other</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(114</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(35</span></span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred tax liabilities</span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(7,708</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(21,179</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span>)</span></span></span></td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Set-off of tax</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">7,708</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">10,708</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Net deferred tax liability</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr></tbody></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory', window );">Disclosure of detailed information about changes in temporary differences in net tax assets and liabilities [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">NET BALANCE AT</span><br/><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">RECOGNIZED IN</span><br/><span style="color:#ffffff">PROFIT OR LOSS</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">RECOGNIZED</span><br/><span style="color:#ffffff">DIRECTLY IN</span><br/><span style="color:#ffffff">EQUITY &amp; OCI</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">NET BALANCE AT</span><br/><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Non-capital losses</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">10,708</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(4,039</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">6,669</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Share issuance costs</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">PP&amp;E</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(4,983</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">4,022</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(961</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Biological assets</span></span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(961</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">791</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(170</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(15,200</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">9,833</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(5,367</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,038</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,038</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Right-of-use lease assets</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,096</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,096</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Other</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(35</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(78</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(113</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net tax assets (liabilities)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr></tbody></table></div></div><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="text-align:center;vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">NET BALANCE AT</span><br/><span style="color:#ffffff">AUGUST 31, 2018</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">RECOGNIZED IN</span><br/><span style="color:#ffffff">PROFIT OR LOSS</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">RECOGNIZED</span><br/><span style="color:#ffffff">DIRECTLY IN</span><br/><span style="color:#ffffff">EQUITY &amp; OCI</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">NET BALANCE AT</span><br/><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#a6a4a4">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Non-capital losses</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>8,604</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">2,723</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(619</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">10,708</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Share issuance costs</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,657</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,657</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">PP&amp;E</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(1,275</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(3,708</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(4,983</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Biological assets</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(3,307</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">2,346</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(961</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,385</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(4,815</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(15,200</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Unsecured convertible debentures</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(3,306</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(108</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,414</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Other</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">32</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(67</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(35</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Net tax assets (liabilities)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(7,980</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(3,629</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,138</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">(10,471</span></span></span></span></td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:2%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">)</span></span></span></span></td></tr></tbody></table></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory', window );">Disclosure of detailed information about non-capital losses [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;width:1.02326%">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;width:12%;white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);width:2%">&#160;</td><td style="text-align:center;vertical-align:bottom;width:2%">&#160;</td><td style="vertical-align:bottom;width:1%">&#160;</td><td style="vertical-align:bottom;width:12%">&#160;</td><td style="vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2035</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">1,070</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2037</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">11,727</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2038</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">14,296</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2039</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">16,746</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">August 31, 2040</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">81,205</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">125,044</span></span></span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Disclosure of detailed information about unrecognized deductible temporary differences and unused tax losses [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"><tbody><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="vertical-align:bottom;width:1.02326%;background-color:#86b4cd">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:center;background-color:rgb(134, 180, 205);white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2020</span></span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:center;background-color:rgb(134, 180, 205);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:center;white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:1.02326%;text-align:center;background-color:rgb(166, 164, 164);white-space:nowrap">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:center;background-color:rgb(166, 164, 164);white-space:nowrap"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif"><span style="color:#ffffff">AUGUST 31, 2019</span></span></span></span></span></td><td style="vertical-align:bottom;width:2%;background-color:rgb(166, 164, 164)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:right;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd">&#160;</td><td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">Deductible temporary differences</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">17,348</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">12,010</span></span></span></span></td><td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Tax losses</span></span></span></span></span></td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">102,183</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;border-bottom:1px solid transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:1px solid #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd">&#160;</td><td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">3,809</span></span></span></span></td><td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr><tr><td style="vertical-align:bottom;width:65.0465%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#e2f5fa"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">119,531</span></span></span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(226, 245, 250)">&#160;</td><td style="text-align:left;border-bottom:3px double transparent;vertical-align:bottom;width:2%">&#160;</td><td style="text-align:left;border-bottom:3px double #000000;vertical-align:bottom;width:1.02326%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">$</span></span></span></span></td><td style="text-align:right;border-bottom:3px double #000000;vertical-align:bottom;width:12%;background-color:#dfdddd"><span style="font-size:10pt"><span><span><span style="font-family:Times New Roman,Times,serif">15,819</span></span></span></span></td><td style="text-align:left;border-bottom:3px double rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(223, 221, 221)">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred income. [Refer: Deferred income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents disclosure of disclosure of detailed information about changes in temporary differences in net tax assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesInNetTaxAssetsLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of non-capital losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutNonCapitalLossesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the disclosure of reconciliation of income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationReconciliationOfIncomeTaxExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037976040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATIONS OF TRAUMA HEALING CENTERS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract', window );"><strong>Disclosure Of Operations Of Trauma Healing Centers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory', window );">Disclosure of detailed information about derecognized assets and liabilities [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognized assets and liabilities</span></span></span></span></td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td><td style="vertical-align:bottom">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>96</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accounts receivable</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>140</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other current assets</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property, plant and equipment</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>880</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trade and other payables</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(70</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net assets disposed</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,141</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value of consideration received</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,141</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gain/(loss) on disposal</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory', window );">Disclosure of detailed information about loss from re-measurement of assets and liabilities classified as held for sale [Table Text Block]</a></td>
<td class="text"><div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><table style="font-family:Times New Roman;text-decoration-style:initial;text-decoration-color:initial;border-collapse:collapse;font-size:13px;width:100%;border:0px"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="color:#ffffff">FOR THE PERIOD</span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="color:#ffffff">SEPTEMBER 1, 2018</span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd;white-space:nowrap"><span style="color:#ffffff">TO OCTOBER 16, 2018</span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom">Revenue</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td><td style="vertical-align:bottom;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160; &#160;Sales</td><td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">$</td><td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">138</td><td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160; &#160;Cost of sales</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">54</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160; &#160;Gross margin from discontinued operations</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">84</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Expenses</td><td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160; &#160;General and administrative</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">75</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Total expenses</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">75</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">&#160;</td><td style="text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Investment income (expense)</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">&#x2014;</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Income (loss) from operations</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">$</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">9</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom">Loss on remeasurement to fair value less costs to sell</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">(47</td><td style="border-bottom:1px solid #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">)</td></tr><tr><td style="vertical-align:bottom">Loss on discontinued operations</td><td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:8.66667px;background-color:#e2f5fa">$</td><td style="border-bottom:3px double #000000;text-align:right;vertical-align:bottom;width:133.333px;background-color:#e2f5fa">(38</td><td style="border-bottom:3px double #000000;text-align:left;vertical-align:bottom;width:17.3333px;background-color:#e2f5fa">)</td></tr></tbody></table><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory', window );">Disclosure of detailed information about Cash flows generated by THC for reporting periods [Table Text Block]</a></td>
<td class="text"><div><div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"><tbody><tr><td style="vertical-align:bottom">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td><td style="text-align:center;vertical-align:bottom;background-color:rgb(134, 180, 205);white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#ffffff">FOR THE PERIOD</span><br/><span style="color:#ffffff">SEPTEMBER 1, 2018</span><br/><span style="color:#ffffff">TO OCTOBER 16,2018</span></span></span></span></span></td><td style="text-align:center;vertical-align:bottom;background-color:#86b4cd">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating activities</span></span></span></span></td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(35</span></span></span></span></td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Investing activities</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa">&#160;</td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa">&#160;</td></tr><tr><td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Cash used by discounted operations</span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:15%;text-align:right;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(35</span></span></span></span></td><td style="border-bottom:3px double #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e2f5fa"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Cash flows generated by THC for reporting periods Explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutCashFlowsGeneratedByTHCIForReportingPeriodsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of derecognized assets and liabilities Explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfDetailedInformationAboutDerecognizedAssetsAndLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of loss from re-measurement of assets and liabilities classified as held for sale Explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfLossFromReMeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfOperationsOfTraumaHealingCentersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132038019144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 3,705<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average interest rate of lease liabilities</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption', window );">Statement that lessee accounts for short-term leases using recognition exemption</a></td>
<td class="text">In accordance with IFRS 16.5(b), an election is being taken to not recognize a ROU asset and lease liability for leases for which the underlying asset is of low value, which is defined to mean less than $5,000 USD when new.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember', window );">Property, plant and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right to use of assets</a></td>
<td class="nump">$ 4,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ogi_OtherLiabilitiesMember', window );">Other liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">4,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ogi_PrepaidExpensesMember', window );">Prepaid expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">$ (25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The statement that the lessee accounts for short-term leases using the recognition exemption in paragraph 6 of IFRS 16. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 60<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_60&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementThatLesseeAccountsForShorttermLeasesUsingRecognitionExemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph C12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_C12_a&amp;doctype=Appendix&amp;subtype=C<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ogi_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ogi_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ogi_PrepaidExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ogi_PrepaidExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036260312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about estimated useful lives of property, plant and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Depreciation method</a></td>
<td class="text">straight-line basis<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Growing equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The depreciation method used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationMethodPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036249224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES  - Disclosure of detailed information about reconciliation of operating leases (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Present value of lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,088)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ogi_AdjustmentOnAdoptionOfIFRS16Member', window );">IFRS 16 transition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_OperatingLeaseObligations', window );">Operating lease obligations as at August 31, 2019</a></td>
<td class="nump">$ 3,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments', window );">Minimum future payments not related to lease payments</a></td>
<td class="num">(411)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated', window );">Lease payments for renewal options reasonably expected to be exercised but not contractually obligated</a></td>
<td class="nump">655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ReliefOptionForShortTermLeases', window );">Relief option for short-term leases</a></td>
<td class="num">(538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ReliefOptionForLeasesOfLowValueAssets', window );">Relief option for leases of low-value assets</a></td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Gross lease liabilities at September 1, 2019</a></td>
<td class="nump">2,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DiscountingOperatingLease', window );">Discounting</a></td>
<td class="num">(459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 2,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 58<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_58&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph B11D<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B11D_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DiscountingOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to operating leases discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DiscountingOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to lease payments for renewal options reasonably expected to be exercised but not contractually obligated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LeasePaymentsForRenewalOptionsReasonablyExpectedToBeExercisedButNotContractuallyObligated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_MinimumFuturePaymentsNotRelatedToLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of minimum future payments not related to lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_MinimumFuturePaymentsNotRelatedToLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_OperatingLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to operating lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_OperatingLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ReliefOptionForLeasesOfLowValueAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to relief option for leases of low-value assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ReliefOptionForLeasesOfLowValueAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ReliefOptionForShortTermLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Relief option for short-term leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ReliefOptionForShortTermLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ogi_AdjustmentOnAdoptionOfIFRS16Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ogi_AdjustmentOnAdoptionOfIFRS16Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036434312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SHORT TERM INVESTMENTS - Disclosure of detailed information about short term investments (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShortTermInvestmentsLineItems', window );"><strong>Disclosure Of Short Term Investments [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentHeldtomaturityInvestments', window );">Short term investments</a></td>
<td class="nump">$ 50,128<span></span>
</td>
<td class="nump">$ 380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesOneMember', window );">GIC - maturing September 16, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShortTermInvestmentsLineItems', window );"><strong>Disclosure Of Short Term Investments [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InvestmentsInterestRate', window );">Interest rate</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentHeldtomaturityInvestments', window );">Short term investments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesTwoMember', window );">GIC - maturing September 24, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShortTermInvestmentsLineItems', window );"><strong>Disclosure Of Short Term Investments [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InvestmentsInterestRate', window );">Interest rate</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentHeldtomaturityInvestments', window );">Short term investments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesThreeMember', window );">GIC - maturing December 15, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShortTermInvestmentsLineItems', window );"><strong>Disclosure Of Short Term Investments [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InvestmentsInterestRate', window );">Interest rate</a></td>
<td class="nump">1.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentHeldtomaturityInvestments', window );">Short term investments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesFourMember', window );">GIC - maturing December 23, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShortTermInvestmentsLineItems', window );"><strong>Disclosure Of Short Term Investments [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InvestmentsInterestRate', window );">Interest rate</a></td>
<td class="nump">1.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentHeldtomaturityInvestments', window );">Short term investments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesFiveMember', window );">GIC - maturing June 17, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShortTermInvestmentsLineItems', window );"><strong>Disclosure Of Short Term Investments [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InvestmentsInterestRate', window );">Interest rate</a></td>
<td class="nump">0.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentHeldtomaturityInvestments', window );">Short term investments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ShortTermInvestmentsAxis=ogi_EquitySecuritiesInVivoCannabisIncMember', window );">Equity securities in VIVO Cannabis Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShortTermInvestmentsLineItems', window );"><strong>Disclosure Of Short Term Investments [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentHeldtomaturityInvestments', window );">Short term investments</a></td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">$ 380<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentHeldtomaturityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current held-to-maturity investments. [Refer: Held-to-maturity investments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 8<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_b&amp;doctype=Standard&amp;book=b<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentHeldtomaturityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfShortTermInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents short term investments line item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfShortTermInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_InvestmentsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentages related of investments interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_InvestmentsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ShortTermInvestmentsAxis=ogi_GuaranteedInvestmentCertificatesFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ShortTermInvestmentsAxis=ogi_EquitySecuritiesInVivoCannabisIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ShortTermInvestmentsAxis=ogi_EquitySecuritiesInVivoCannabisIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036215928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 29, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AccountsReceivableAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy', window );">Percentage of employee wages covered under Canada Emergency Wage Subsidy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy', window );">Amount of employee wages applied for under Canada Emergency Wage Subsidy</a></td>
<td class="nump">$ 2,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AccountsReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AccountsReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of employee wages applied for under Canada Emergency Wage Subsidy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AmountOfEmployeeWagesAppliedForUnderCanadaEmergencyWageSubsidy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of employee wages covered under Canada Emergency Wage Subsidy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037668488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE - Disclosure of detailed information about accounts receivable (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AccountsReceivableAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">$ 11,096<span></span>
</td>
<td class="nump">$ 11,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_HarmonizedSalesTaxesReceivable', window );">Harmonized sales taxes receivable</a></td>
<td class="nump">728<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GovernmentProgramsReceivable', window );">Government programs</a></td>
<td class="nump">2,936<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ProvisionForDoubtfulAccount', window );">Less: Provision for doubtful accounts</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">$ 14,747<span></span>
</td>
<td class="nump">$ 16,541<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AccountsReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AccountsReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_GovernmentProgramsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of government programs receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_GovernmentProgramsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_HarmonizedSalesTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about harmonized sales taxes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_HarmonizedSalesTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ProvisionForDoubtfulAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about provision for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ProvisionForDoubtfulAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037741720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LOAN RECEIVABLE (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Jul. 26, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LoanReceivableLineItems', window );"><strong>Loan Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLoansAndReceivables', window );">Loan receivable</a></td>
<td class="nump">$ 2,229<span></span>
</td>
<td class="nump">$ 909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TypeOfArrangementsAxis=ogi_PaymentAgreementMember', window );">Advance payment and support agreement [Member] | Secured loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LoanReceivableLineItems', window );"><strong>Loan Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdvancePayment', window );">Maximum advance payment in the form of secured loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PercentagesOfAccruedInterestReceivable', window );">Percentages of accrued interest receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current loans and receivables. [Refer: Loans and receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 8<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AdvancePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents maximum amount related to advances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AdvancePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LoanReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents loan receivable line item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LoanReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PercentagesOfAccruedInterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentages related to interest receivable on advance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PercentagesOfAccruedInterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_TypeOfArrangementsAxis=ogi_PaymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_TypeOfArrangementsAxis=ogi_PaymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ogi_SecuredLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ogi_SecuredLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040328392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($) </div>
<div>Kilogram</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>CAD ($) </div>
<div>Kilogram</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsBiologicalAssets', window );">Abnormal plant waste due to lack of sufficient staff | $</a></td>
<td class="nump">$ 5,048<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OutputOfAgriculturalProduce', window );">Estimated harvest yields for the cannabis on plants | Kilogram</a></td>
<td class="nump">5,096<span></span>
</td>
<td class="nump">16,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in biological assets resulting from disposals. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OutputOfAgriculturalProduce">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The output of entity's agricultural produce.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 46<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_46_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OutputOfAgriculturalProduce</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037478056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS - Disclosure of detailed information about changes in carrying value of biological assets (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems', window );"><strong>Disclosure of reconciliation of changes in biological assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Carrying amount opening balance</a></td>
<td class="nump">$ 20,652<span></span>
</td>
<td class="nump">$ 19,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets', window );">Add net production costs</a></td>
<td class="nump">41,052<span></span>
</td>
<td class="nump">36,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets', window );">Net change in fair value less costs to sell due to biological transformation</a></td>
<td class="num">(2,853)<span></span>
</td>
<td class="num">(8,060)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsBiologicalAssets', window );">Deduct net abnormal plant destruction costs</a></td>
<td class="num">(5,048)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseDueToHarvestBiologicalAssets', window );">Transferred to inventory upon harvest</a></td>
<td class="num">(48,409)<span></span>
</td>
<td class="num">(28,084)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Carrying amount ending balance</a></td>
<td class="nump">5,394<span></span>
</td>
<td class="nump">20,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsByGroupAxis=ogi_OtherBiologicalAssetsMember', window );">OTHER BIOLOGICAL ASSETS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems', window );"><strong>Disclosure of reconciliation of changes in biological assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Carrying amount opening balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets', window );">Add net production costs</a></td>
<td class="nump">13<span></span>
</td>
<td class="num">(596)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets', window );">Net change in fair value less costs to sell due to biological transformation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseDueToHarvestBiologicalAssets', window );">Transferred to inventory upon harvest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Carrying amount ending balance</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsByGroupAxis=ifrs-full_PlantsMember', window );">CANNABIS ON PLANTS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems', window );"><strong>Disclosure of reconciliation of changes in biological assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Carrying amount opening balance</a></td>
<td class="nump">20,649<span></span>
</td>
<td class="nump">19,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets', window );">Add net production costs</a></td>
<td class="nump">41,039<span></span>
</td>
<td class="nump">37,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets', window );">Net change in fair value less costs to sell due to biological transformation</a></td>
<td class="num">(2,853)<span></span>
</td>
<td class="num">(8,060)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsBiologicalAssets', window );">Deduct net abnormal plant destruction costs</a></td>
<td class="num">(5,048)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseDueToHarvestBiologicalAssets', window );">Transferred to inventory upon harvest</a></td>
<td class="num">(48,409)<span></span>
</td>
<td class="num">(28,084)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Carrying amount ending balance</a></td>
<td class="nump">$ 5,378<span></span>
</td>
<td class="nump">$ 20,649<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseDueToHarvestBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseDueToHarvestBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in biological assets resulting from disposals. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) arising from changes in fair value less costs to sell of biological assets due to price changes in the market. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 51<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Section Example 1 XYZ Dairy Ltd<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS41_IE_ex1_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in biological assets resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsByGroupAxis=ogi_OtherBiologicalAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsByGroupAxis=ogi_OtherBiologicalAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsByGroupAxis=ifrs-full_PlantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsByGroupAxis=ifrs-full_PlantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132038007832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS - Disclosure of detailed information about unobservable inputs and their impact on fair value (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($) </div>
<div>$ / Gram </div>
<div>Gram</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>CAD ($) </div>
<div>Gram</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AverageSellingPriceInputValuesPerGram', window );">Average selling price input values per gram</a></td>
<td class="nump">3.36<span></span>
</td>
<td class="nump">5.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AverageYieldPerPlantInputValuesPerGram', window );">Average yield per plant input values per gram</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram', window );">Sensitivity analysis impact of increase or decrease average net selling price per gram | $ / Gram</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram', window );">Sensitivity analysis impact of increase or decrease average yield per plant gram</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EffectOnFairValueAverageNetSellingPricePerGram', window );">Effect on fair value average net selling price per gram | $</a></td>
<td class="nump">$ 1,602<span></span>
</td>
<td class="nump">$ 3,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EffectOnFairValueAverageYieldPerPlant', window );">Effect on fair value average yield per plant | $</a></td>
<td class="nump">$ 532<span></span>
</td>
<td class="nump">$ 1,367<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AverageSellingPriceInputValuesPerGram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to per gram amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AverageSellingPriceInputValuesPerGram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AverageYieldPerPlantInputValuesPerGram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to average yield per plant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AverageYieldPerPlantInputValuesPerGram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_EffectOnFairValueAverageNetSellingPricePerGram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to per gram amount effect on fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_EffectOnFairValueAverageNetSellingPricePerGram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_EffectOnFairValueAverageYieldPerPlant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to average yield per plant effect on fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_EffectOnFairValueAverageYieldPerPlant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents sensitivity analysis impact of increase or decrease in average net selling price per gram amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageNetSellingPricePerGram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents sensitivity analysis impact of increase or decrease in average yield per plant gram.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SensitivityAnalysisImpactOfIncreaseOrDecreaseAverageYieldPerPlantGram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132039865240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS - Disclosure of detailed information about fair value adjustment to biological assets and inventory sold (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_RealizedFairValueAmountsIncludedInInventorySold', window );">Realized fair value amounts included in inventory sold</a></td>
<td class="num">$ (39,455)<span></span>
</td>
<td class="num">$ (50,477)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets', window );">Increase (decrease) in fair value on growth of biological assets</a></td>
<td class="nump">73,975<span></span>
</td>
<td class="nump">75,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdjustmentToNetRealizableValueBiologicalAssets', window );">Adjustment to net realizable value</a></td>
<td class="num">(72,801)<span></span>
</td>
<td class="num">(14,284)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Fair value adjustment to biological assets</a></td>
<td class="num">$ (38,281)<span></span>
</td>
<td class="nump">$ 10,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AdjustmentToNetRealizableValueBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the value adjustment to net realizable value biological assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AdjustmentToNetRealizableValueBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the increase (decrease) in fair value on growth of biological assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncreaseDecreaseInFairValueOnGrowthOfBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_RealizedFairValueAmountsIncludedInInventorySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the realized fair value amounts included in inventory sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_RealizedFairValueAmountsIncludedInInventorySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036474136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod', window );">Inventory expensed in cost of sales</a></td>
<td class="nump">$ 42,872<span></span>
</td>
<td class="nump">$ 35,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales', window );">Inventory write-down, provision, and plant waste included in cost of sales</a></td>
<td class="nump">45,270<span></span>
</td>
<td class="nump">4,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories', window );">Inventory write-down and provision relating to excess and unsaleable inventories</a></td>
<td class="nump">32,831<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction', window );">Inventory write-down and provision relating to concentrated extract and flower and trim available for extraction</a></td>
<td class="nump">20,251<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Inventory write-down related to adjustments to net realizable value</a></td>
<td class="nump">2,753<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsBiologicalAssets', window );">Inventory write-offs related to abnormal plant waste due to lack of sufficient staff</a></td>
<td class="nump">$ 5,048<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories recognised as an expense during the period. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in biological assets resulting from disposals. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_InventoryWriteDownAndProvisionRelatingToConcentratedExtractAndFlowerAndTrimAvailableForExtraction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_InventoryWriteDownAndProvisionRelatingToExcessAndUnsaleableInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_InventoryWriteDownProvisionAndPlantWasteIncludedInCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036533592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Disclosure of detailed information about inventories (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPackagingAndStorageMaterials', window );">Packaging and supplies</a></td>
<td class="nump">$ 11,848<span></span>
</td>
<td class="nump">$ 5,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">66,365<span></span>
</td>
<td class="nump">93,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_PlantsInDryingStageMember', window );">Plants in drying stage [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">3,877<span></span>
</td>
<td class="nump">6,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_DryCannabisMember', window );">Dry Cannabis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Available for packaging</a></td>
<td class="nump">20,932<span></span>
</td>
<td class="nump">17,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Packaged inventory</a></td>
<td class="nump">5,663<span></span>
</td>
<td class="nump">6,754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_FlowerAndTrimAvailableForExtractionMember', window );">Flower and trim available for extraction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">1,911<span></span>
</td>
<td class="nump">16,626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_ConcentratedExtractMember', window );">Concentrated extract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">19,382<span></span>
</td>
<td class="nump">36,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_FormulatedExtractsMember', window );">Formulated Extracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Available for packaging</a></td>
<td class="nump">1,481<span></span>
</td>
<td class="nump">1,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Packaged inventory</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtCostMember', window );">CAPITALIZED COST [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPackagingAndStorageMaterials', window );">Packaging and supplies</a></td>
<td class="nump">11,848<span></span>
</td>
<td class="nump">5,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">46,958<span></span>
</td>
<td class="nump">38,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtCostMember', window );">CAPITALIZED COST [Member] | Plants in drying stage [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">2,036<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtCostMember', window );">CAPITALIZED COST [Member] | Dry Cannabis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Available for packaging</a></td>
<td class="nump">13,124<span></span>
</td>
<td class="nump">5,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Packaged inventory</a></td>
<td class="nump">3,707<span></span>
</td>
<td class="nump">4,205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtCostMember', window );">CAPITALIZED COST [Member] | Flower and trim available for extraction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">849<span></span>
</td>
<td class="nump">4,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtCostMember', window );">CAPITALIZED COST [Member] | Concentrated extract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">13,252<span></span>
</td>
<td class="nump">15,393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtCostMember', window );">CAPITALIZED COST [Member] | Formulated Extracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Available for packaging</a></td>
<td class="nump">1,097<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Packaged inventory</a></td>
<td class="nump">1,045<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">FAIR VALUE ADJUSTMENT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPackagingAndStorageMaterials', window );">Packaging and supplies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">19,407<span></span>
</td>
<td class="nump">54,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">FAIR VALUE ADJUSTMENT [Member] | Plants in drying stage [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">1,841<span></span>
</td>
<td class="nump">4,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">FAIR VALUE ADJUSTMENT [Member] | Dry Cannabis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Available for packaging</a></td>
<td class="nump">7,808<span></span>
</td>
<td class="nump">12,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Packaged inventory</a></td>
<td class="nump">1,956<span></span>
</td>
<td class="nump">2,549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">FAIR VALUE ADJUSTMENT [Member] | Flower and trim available for extraction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">12,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">FAIR VALUE ADJUSTMENT [Member] | Concentrated extract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">6,130<span></span>
</td>
<td class="nump">21,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">FAIR VALUE ADJUSTMENT [Member] | Formulated Extracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Available for packaging</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Packaged inventory</a></td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPackagingAndStorageMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of packaging and storage materials. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPackagingAndStorageMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WorkInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WorkInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_InventoriesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents inventories line item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_InventoriesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_PlantsInDryingStageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_PlantsInDryingStageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_DryCannabisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_DryCannabisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_FlowerAndTrimAvailableForExtractionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_FlowerAndTrimAvailableForExtractionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_ConcentratedExtractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_ConcentratedExtractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_FormulatedExtractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ogi_FormulatedExtractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036487016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (841)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ogi_MonctonCampusPhase4CAssetSpecificMember', window );">Moncton Campus - Phase 4C (asset specific) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_FairValueLessCostToDispose', window );">Fair value less cost to dispose</a></td>
<td class="nump">$ 1,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment loss</a></td>
<td class="nump">37,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ContractuallyCommittedFutureCosts', window );">Contractually committed future costs</a></td>
<td class="nump">$ 1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 130<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_130_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 130<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_130_d_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ContractuallyCommittedFutureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents contractually committed future costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ContractuallyCommittedFutureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_FairValueLessCostToDispose">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents fair value less cost to dispose.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_FairValueLessCostToDispose</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ogi_MonctonCampusPhase4CAssetSpecificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ogi_MonctonCampusPhase4CAssetSpecificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132034109256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT - Disclosure of detailed information about property, plant and equipment (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">$ 218,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">82,179<span></span>
</td>
<td class="nump">$ 130,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss</a></td>
<td class="num">(39,771)<span></span>
</td>
<td class="num">(613)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">247,420<span></span>
</td>
<td class="nump">218,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">233,128<span></span>
</td>
<td class="nump">104,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Transition to IFRS 16</a></td>
<td class="nump">2,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">82,179<span></span>
</td>
<td class="nump">130,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Construction completed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(1,028)<span></span>
</td>
<td class="num">(323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss</a></td>
<td class="num">(37,166)<span></span>
</td>
<td class="num">(613)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(841)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">279,357<span></span>
</td>
<td class="nump">233,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(14,658)<span></span>
</td>
<td class="num">(6,075)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(17,561)<span></span>
</td>
<td class="num">(8,870)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(31,937)<span></span>
</td>
<td class="num">(14,658)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">LAND [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">2,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">4,075<span></span>
</td>
<td class="nump">2,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">LAND [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">2,211<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Transition to IFRS 16</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,864<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Construction completed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">4,075<span></span>
</td>
<td class="nump">2,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">LAND [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">BUILDINGS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">66,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">118,819<span></span>
</td>
<td class="nump">66,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">BUILDINGS [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">70,774<span></span>
</td>
<td class="nump">47,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Transition to IFRS 16</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">22,316<span></span>
</td>
<td class="nump">15,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Construction completed</a></td>
<td class="nump">71,663<span></span>
</td>
<td class="nump">8,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(517)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss</a></td>
<td class="num">(37,214)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">127,022<span></span>
</td>
<td class="nump">70,774<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">BUILDINGS [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(4,237)<span></span>
</td>
<td class="num">(1,997)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(4,074)<span></span>
</td>
<td class="num">(2,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(8,203)<span></span>
</td>
<td class="num">(4,237)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">CONSTRUCTION IN PROCESS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">65,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">2,128<span></span>
</td>
<td class="nump">65,515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">CONSTRUCTION IN PROCESS [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">65,515<span></span>
</td>
<td class="nump">11,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Transition to IFRS 16</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">46,847<span></span>
</td>
<td class="nump">105,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Construction completed</a></td>
<td class="num">(110,234)<span></span>
</td>
<td class="num">(51,990)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">2,128<span></span>
</td>
<td class="nump">65,515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">CONSTRUCTION IN PROCESS [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ogi_GrowingProcessingEquipmentMember', window );">GROWING &amp; PROCESSING EQUIPMENT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">79,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">112,950<span></span>
</td>
<td class="nump">79,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ogi_GrowingProcessingEquipmentMember', window );">GROWING &amp; PROCESSING EQUIPMENT [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">87,931<span></span>
</td>
<td class="nump">40,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Transition to IFRS 16</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">7,597<span></span>
</td>
<td class="nump">5,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Construction completed</a></td>
<td class="nump">37,851<span></span>
</td>
<td class="nump">42,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(436)<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss</a></td>
<td class="nump">48<span></span>
</td>
<td class="num">(613)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">132,991<span></span>
</td>
<td class="nump">87,931<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ogi_GrowingProcessingEquipmentMember', window );">GROWING &amp; PROCESSING EQUIPMENT [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(8,618)<span></span>
</td>
<td class="num">(2,956)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(11,568)<span></span>
</td>
<td class="num">(5,679)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(20,041)<span></span>
</td>
<td class="num">(8,618)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">OTHER [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">4,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">5,541<span></span>
</td>
<td class="nump">4,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">OTHER [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">6,697<span></span>
</td>
<td class="nump">2,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Transition to IFRS 16</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,335<span></span>
</td>
<td class="nump">3,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Construction completed</a></td>
<td class="nump">720<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(75)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(841)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">8,677<span></span>
</td>
<td class="nump">6,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">OTHER [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(1,803)<span></span>
</td>
<td class="num">(1,122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(1,362)<span></span>
</td>
<td class="num">(946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(3,136)<span></span>
</td>
<td class="num">(1,803)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_RightofuseAssetsMember', window );">RIGHT- OF- USELEASE ASSETS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">3,907<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_RightofuseAssetsMember', window );">RIGHT- OF- USELEASE ASSETS [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Transition to IFRS 16</a></td>
<td class="nump">2,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">2,220<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Construction completed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">4,464<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_RightofuseAssetsMember', window );">RIGHT- OF- USELEASE ASSETS [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(557)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">$ (557)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss or reversal of impairment loss recognised in profit or loss. [Refer: Impairment loss recognised in profit or loss; Reversal of impairment loss recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_ix&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers from construction in progress. [Refer: Property, plant and equipment; Construction in progress]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ogi_GrowingProcessingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ogi_GrowingProcessingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037947640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT - Disclosure of detailed information about additions of property, plant and equipment (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">$ 82,179<span></span>
</td>
<td class="nump">$ 130,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdditionsRelatedToIFRS16Leases', window );">Additions related to IFRS 16 Leases</a></td>
<td class="num">(2,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment', window );">Net change in accounts payable and accrued liabilities related to purchases of property, plant and equipment</a></td>
<td class="num">(2,736)<span></span>
</td>
<td class="num">(21,427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property, plant and equipment</a></td>
<td class="nump">$ 77,223<span></span>
</td>
<td class="nump">$ 108,764<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AdditionsRelatedToIFRS16Leases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additions related to IFRS 16 Leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AdditionsRelatedToIFRS16Leases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of change in accounts payable and accrued liabilities related to purchases of property plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ChangeInAccountsPayableAndAccruedLiabilitiesRelatedToPurchasesOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132038030952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 18, 2019</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower', window );">Percentage of discount price per kilogram of dried hemp flower</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_RenewalTermOfAgreement', window );">Renewal term of agreement</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PaymentsForIntangibleAssetsOther', window );">Payments for intangible assets</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill', window );">Transaction cost</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (265)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PaymentsForIntangibleAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of payment of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PaymentsForIntangibleAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about discount to the price per kilogram of dried hemp flower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PercentageOfDiscountPricePerKilogramOfDriedHempFlower</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_RenewalTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of renewal term of agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_RenewalTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of transaction costs of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_TransactionCostsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036618728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS - Disclosure of detailed information about intangible assets (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">$ 2,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">1,772<span></span>
</td>
<td class="nump">$ 2,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">2,371<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">1,430<span></span>
</td>
<td class="nump">1,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="num">(1,303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill', window );">Disposal</a></td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">2,466<span></span>
</td>
<td class="nump">2,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="num">(297)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(397)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="num">(694)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ogi_SupplyAgreementMember', window );">SUPPLY AGREEMENT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">1,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ogi_SupplyAgreementMember', window );">SUPPLY AGREEMENT [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">1,530<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="num">(1,303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill', window );">Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">1,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ogi_SupplyAgreementMember', window );">SUPPLY AGREEMENT [Member] | Accumulated amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="num">(32)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(195)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="num">(227)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">LICENSE AGREEMENT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">LICENSE AGREEMENT [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill', window );">Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">LICENSE AGREEMENT [Member] | Accumulated amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">COMPUTER SOFTWARE [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">COMPUTER SOFTWARE [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">841<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill', window );">Disposal</a></td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="nump">2,041<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">COMPUTER SOFTWARE [Member] | Accumulated amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems', window );"><strong>Disclosure of detailed information about investment property [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="num">(265)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(202)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Reclassification of computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance</a></td>
<td class="num">$ (467)<span></span>
</td>
<td class="num">$ (265)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentPropertyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentPropertyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in intangible assets other than goodwill resulting from disposals. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ogi_SupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ogi_SupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036735128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 27, 2020</div></th>
<th class="th"><div>May 28, 2020</div></th>
<th class="th"><div>Nov. 15, 2019</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,266<span></span>
</td>
<td class="nump">$ 49,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayments of borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">12,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CreditFacilitiesAxis=ogi_RevolvingCreditFacilitiesMember', window );">Revolving Credit Facilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncrementalUncommittedOptionToIncreaseFacilities', window );">Uncommitted option to increase the Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommittedAndUncommittedBorrowingFacilities', window );">Committed and uncommitted borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsCashInterestRate', window );">Borrowings, cash interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommittedBorrowingFacilities', window );">Committed borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsCashInterestRate', window );">Borrowings, cash interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsEffectiveInterestRate', window );">Borrowings, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.39%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsReducedCashInterestRate', window );">Borrowings, reduced cash interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsReducedEffectiveInterestRate', window );">Borrowings, reduced effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ApplicableMarginRate', window );">Applicable margin rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Term Loan [Member] | First Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceCost', window );">Loss on debt restructuring recorded under financing cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Term Loan [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommittedBorrowingFacilities', window );">Committed borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter', window );">Borrowings, principal payment amortization rate per quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceCost', window );">Loss on debt restructuring recorded under financing cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Cash collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Term Loan [Member] | Amendment and Restatement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommittedBorrowingFacilities', window );">Committed borrowing facilities</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayments of borrowings</a></td>
<td class="nump">55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_QuarterlyRepayments', window );">Quarterly repayments</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ReductionInRevolverCommitment', window );">Reduction in Revolver commitment</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_MinimumUnrestrictedCashBalanceRequirement', window );">Minimum unrestricted cash balance requirement</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Revolving Credit Facilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">Undrawn borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest and other costs that an entity incurs in connection with the borrowing of funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Contingent liabilities [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 14<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_14_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UndrawnBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UndrawnBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ApplicableMarginRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of applicable margin rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ApplicableMarginRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_BorrowingsCashInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of cash interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_BorrowingsCashInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_BorrowingsEffectiveInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of effective rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_BorrowingsEffectiveInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amortization rate per quarter on the principal repayment of borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_BorrowingsPrincipalPaymentAmortizationRatePerQuarter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_BorrowingsReducedCashInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of reduction in cash interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_BorrowingsReducedCashInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_BorrowingsReducedEffectiveInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of reduction of effective interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_BorrowingsReducedEffectiveInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CommittedAndUncommittedBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of committed and uncommitted borrowing facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CommittedAndUncommittedBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CommittedBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of committed borrowing facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CommittedBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncrementalUncommittedOptionToIncreaseFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of incremental uncommitted option to increase the Facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncrementalUncommittedOptionToIncreaseFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_MinimumUnrestrictedCashBalanceRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum unrestricted cash balance requirement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_MinimumUnrestrictedCashBalanceRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_QuarterlyRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of quarterly repayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_QuarterlyRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ReductionInRevolverCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Revolver commitment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ReductionInRevolverCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilitiesAxis=ogi_RevolvingCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilitiesAxis=ogi_RevolvingCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilitiesAxis=ogi_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilitiesAxis=ogi_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilityAmendmentAxis=ogi_FirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilityAmendmentAxis=ogi_FirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilityAmendmentAxis=ogi_SecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilityAmendmentAxis=ogi_SecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilityAmendmentAxis=ogi_AmendmentAndRestatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilityAmendmentAxis=ogi_AmendmentAndRestatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036495656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - Disclosure of long term debt (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredFinancingCosts', window );">Deferred financing costs</a></td>
<td class="num">$ (123)<span></span>
</td>
<td class="num">$ (868)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">115,266<span></span>
</td>
<td class="nump">49,576<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Less: current portion of long term debt</a></td>
<td class="num">(11,595)<span></span>
</td>
<td class="num">(3,509)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term portion</a></td>
<td class="nump">103,671<span></span>
</td>
<td class="nump">46,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal ("BMO") senior secured term loan ("Term Loan") maturing May 31, 2022 with principal repayments starting November 30, 2020 based on a 10 year amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">115,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member', window );">Atlantic Canada Opportunities Agency ("ACOA") Business Development Program loan maturing September 1, 2024 with a 7 year amortization, bearing interest at an interest rate of 0% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_VehicleLoansFiveYearTermMaturingJune172024Member', window );">Vehicle loans - five year term maturing June 17, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPortionOfLongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPortionOfLongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents deferred financing costs as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_VehicleLoansFiveYearTermMaturingJune172024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_VehicleLoansFiveYearTermMaturingJune172024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036471464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT - Disclosure of long term debt (Parentheticals) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal ("BMO") senior secured term loan ("Term Loan") maturing May 31, 2022 with principal repayments starting November 30, 2020 based on a 10 year amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsYearAmortization', window );">Borrowings, year amortization</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity</a></td>
<td class="text">May 31, 2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member', window );">Atlantic Canada Opportunities Agency ("ACOA") Business Development Program loan maturing September 1, 2024 with a 7 year amortization, bearing interest at an interest rate of 0% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsYearAmortization', window );">Borrowings, year amortization</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity</a></td>
<td class="text">September 1, 2024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_VehicleLoansFiveYearTermMaturingJune172024Member', window );">Vehicle loans - five year term maturing June 17, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_BorrowingsYearAmortization', window );">Borrowings, year amortization</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity</a></td>
<td class="text">June 17, 2024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_BorrowingsYearAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of borrowing year amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_BorrowingsYearAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_AtlanticCanadaOpportunitiesAgencyAcoaBusinessDevelopmentProgramLoanMaturingSeptember12024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_VehicleLoansFiveYearTermMaturingJune172024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_VehicleLoansFiveYearTermMaturingJune172024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132093660840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - Disclosure of principal repayments required on long-term debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Less than 1 year</a></td>
<td class="nump">$ 11,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo', window );">1 to 2 years</a></td>
<td class="nump">103,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree', window );">2 to 3 years</a></td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour', window );">3 to 4 years</a></td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive', window );">4 to 5 years</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Long-term debt</a></td>
<td class="nump">$ 115,389<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LongTermBorrowingMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132030693432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 08, 2020 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 14, 2017 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 27, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2018 </div>
<div>CAD ($) </div>
<div>Debenture</div>
</th>
<th class="th">
<div>Dec. 18, 2017 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 23, 2017 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($) </div>
<div>Share </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>CAD ($) </div>
<div>Share </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 22, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 04, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,511,061<span></span>
</td>
<td class="nump">156,196,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,511,061<span></span>
</td>
<td class="nump">156,196,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,207,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420,673,000<span></span>
</td>
<td class="nump">$ 318,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfCommonSharesIssued', window );">Number of common shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from equity issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,997,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Legal and professional fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,367,000<span></span>
</td>
<td class="nump">$ 4,636,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Share options exercised during period | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">879,240<span></span>
</td>
<td class="nump">2,167,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options exercised in share-based payment arrangement | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Increase (decrease) through exercise of options, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,069,000<span></span>
</td>
<td class="nump">$ 4,170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfWarrantsExpiredOrReleased', window );">Number of warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,739,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased', window );">Average exercise price of warrants exercised during period | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfWarrantsExpired', window );">Warrants expired during period | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">347,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfConvertibleDebenturesSold', window );">Number of convertible debentures sold | Debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PricePerConvertibleDebentureIssued', window );">Price per convertible debenture issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from issuance of convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxOnConvertibleDebentureFinancing', window );">Deferred tax related to convertible debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,902,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebentureIssueCosts', window );">Issue cost of convertible debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability', window );">Convertible debenture issue costs charged to debenture liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,094,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfSharesConversionOfDebentures', window );">Conversion of debentures (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,845,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConversionOfDebenturesPricePerShare', window );">Conversion of debentures price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion of debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,919,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Increase (decrease) through exercise of warrants, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,976,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of share options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.06<span></span>
</td>
<td class="nump">$ 4.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,796,000<span></span>
</td>
<td class="nump">$ 14,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_FairValueOfOptionsGranted', window );">Fair value of options granted during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,743,000<span></span>
</td>
<td class="nump">13,848,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember', window );">Share Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Increase (decrease) through exercise of options, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,786,000<span></span>
</td>
<td class="nump">6,588,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion of debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Increase (decrease) through exercise of warrants, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,257,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember', window );">Reserve for options and warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Increase (decrease) through exercise of options, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (717,000)<span></span>
</td>
<td class="num">(2,418,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing', window );">Increase through convertible debenture financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxOnConvertibleDebentureFinancing', window );">Deferred tax related to convertible debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebentureIssueCosts', window );">Issue cost of convertible debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 756,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion of debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,247,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Increase (decrease) through exercise of warrants, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,281,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SalesOfStockAxis=ogi_AdvisoryServicesAgreementMember', window );">Advisory services agreement [Member] | Cannabis consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfCommonSharesIssued', window );">Number of common shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share based payment cumulative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 539,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember', window );">December 2019 ATM Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfCommonSharesIssued', window );">Number of common shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,201,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from equity issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,966,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Weighted average price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NetProceedsFromIssueOfOrdinaryShares', window );">Net proceeds from issue of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,885,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFeeAndCommissionExpense', window );">Agents' commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_RegulatoryFees', window );">Regulatory fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Legal and professional fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 969,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember', window );">April 2020 ATM Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfCommonSharesIssued', window );">Number of common shares issued | shares</a></td>
<td class="nump">7,044,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,035,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,080,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from equity issued</a></td>
<td class="nump">$ 17,915,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,069,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,785,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Weighted average price | $ / shares</a></td>
<td class="nump">$ 2.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NetProceedsFromIssueOfOrdinaryShares', window );">Net proceeds from issue of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,112,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFeeAndCommissionExpense', window );">Agents' commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_RegulatoryFees', window );">Regulatory fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Legal and professional fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 697,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,258<span></span>
</td>
<td class="nump">879,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,576,000<span></span>
</td>
<td class="nump">$ 3,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted', window );">Estimated fair value of the equity settled RSUs granted during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,037,000<span></span>
</td>
<td class="nump">$ 4,543,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member] | Advisory services agreement [Member] | Cannabis consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_EquityFinancingMember', window );">Equity Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfEquityFinancingShares', window );">Equity financing (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,428,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UnitsIssuedInPeriodPricePerUnit', window );">Units issued in period, price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_WeightedAverageExercisePriceOfWarrantsGranted', window );">Warrants granted during period, weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,678,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_EquityFinancingMember', window );">Equity Financing [Member] | Share Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Equity financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,711,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,116,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_EquityFinancingMember', window );">Equity Financing [Member] | Reserve for options and warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Equity financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,789,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 562,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_PerformanceShareUnitsMember', window );">Performance share units ("PSUs") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 272,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted', window );">Estimated fair value of the equity settled PSUs granted during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_StockOptionPlanMember', window );">Stock Option Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,127,000<span></span>
</td>
<td class="nump">$ 10,036,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_ConvertibleDebenturesMember', window );">Convertible Debentures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares', window );">Threshold limit of daily volume weighted average trading price of common shares | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of share options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of share options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member] | December 2019 ATM Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member] | April 2020 ATM Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the conversion of convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFeeAndCommissionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fee and commission expense that the entity does not separately disclose in the same statement or note. [Refer: Fee and commission expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFeeAndCommissionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ConversionOfDebenturesPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion of debentures Price Per Share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ConversionOfDebenturesPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ConvertibleDebentureIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of convertible debenture issue cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ConvertibleDebentureIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible debenture issue cost charged to the debenture liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ConvertibleDebentureIssueCostsChargedToDebentureLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DeferredTaxOnConvertibleDebentureFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax on Convertible debenture financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DeferredTaxOnConvertibleDebentureFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Estimated fair value of equity settled performance share unit granted .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_EstimatedFairValueOfEquitySettledPerformanceShareUnitGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of estimated fair value of the equity settled restricted stock unit granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_EstimatedFairValueOfEquitySettledRestrictedStockUnitGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_FairValueOfOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents fair value of options granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_FairValueOfOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease through convertible debenture financing</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncreaseDecreaseThroughConvertibleDebentureFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfEquityFinancingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>issuance of equity financing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfEquityFinancingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfSharesConversionOfDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for conversion of debentures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfSharesConversionOfDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NetProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about proceeds from issue of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NetProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NumberOfCommonSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of common shares issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NumberOfCommonSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NumberOfConvertibleDebenturesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of convertible debentures sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NumberOfConvertibleDebenturesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NumberOfWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants expired in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NumberOfWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NumberOfWarrantsExpiredOrReleased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised or released in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NumberOfWarrantsExpiredOrReleased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PricePerConvertibleDebentureIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of price per convertible debenture issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PricePerConvertibleDebentureIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_RegulatoryFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information related to regulatory fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_RegulatoryFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents per share of threshold limit of daily volume weighted average trading price of common shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ThresholdLimitOfDailyVolumeWeightedAverageTradingPriceOfCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_UnitsIssuedInPeriodPricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Units issued in period, price per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_UnitsIssuedInPeriodPricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants exercised or released in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_WeightedAverageExercisePriceOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_WeightedAverageExercisePriceOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ogi_ReserveOfChangeInValueOfTimeValueOfOptionsAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SalesOfStockAxis=ogi_AdvisoryServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SalesOfStockAxis=ogi_AdvisoryServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ogi_CannabisConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ogi_CannabisConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_DecemberTwoThousandNineteenAtMarketEquityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_AprilTwoThousandTwentyAtMarketEquityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_EquityFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_EquityFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_PerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_PerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_ConvertibleDebenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_ConvertibleDebenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037750808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL - Disclosure of detailed information about warrants, valuation assumptions (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2020 </div>
<div>Year</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShareCapitalInformationAbstract', window );"><strong>Disclosure Of Share Capital Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted', window );">Risk free interest rate %</a></td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DescriptionOfExpectedLifeOfWarrantsGranted', window );">Expected life of warrants (years)</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DescriptionOfExpectedVolatilityWarrantsGranted', window );">Expected annualized volatility %</a></td>
<td class="nump">64.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ExpectedDividendAsPercentageWarrantsGranted', window );">Expected dividend yield %</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DescriptionOfExpectedLifeOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected life of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DescriptionOfExpectedLifeOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DescriptionOfExpectedVolatilityWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the warrants granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DescriptionOfExpectedVolatilityWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected risk-free interest rate, warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DescriptionOfRiskFreeInterestRateWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfShareCapitalInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfShareCapitalInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ExpectedDividendAsPercentageWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ExpectedDividendAsPercentageWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132068745400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShareCapitalInformationAbstract', window );"><strong>Disclosure Of Share Capital Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, beginning of period | Share</a></td>
<td class="nump">8,833,194<span></span>
</td>
<td class="nump">7,709,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding, beginning of period, weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 4.23<span></span>
</td>
<td class="nump">$ 2.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during period | Share</a></td>
<td class="nump">2,125,000<span></span>
</td>
<td class="nump">3,589,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during period, weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 3.21<span></span>
</td>
<td class="nump">$ 7.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during period | Share</a></td>
<td class="num">(879,240)<span></span>
</td>
<td class="num">(2,167,864)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised during period, weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Cancelled / Forfeited during period | Share</a></td>
<td class="num">(1,050,050)<span></span>
</td>
<td class="num">(298,188)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Cancelled / Forfeited during period, weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="nump">$ 6.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, end of period | Share</a></td>
<td class="nump">9,028,904<span></span>
</td>
<td class="nump">8,833,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding, end of period, weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 4.06<span></span>
</td>
<td class="nump">$ 4.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfShareCapitalInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfShareCapitalInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036157048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL - Disclosure of detailed information about outstanding stock options (Details) - Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Quantity Outstanding</a></td>
<td class="nump">9,028,904<span></span>
</td>
<td class="nump">8,833,194<span></span>
</td>
<td class="nump">7,709,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement</a></td>
<td class="nump">6,473,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember', window );">$0.30-$1.48 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Quantity Outstanding</a></td>
<td class="nump">1,440,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement</a></td>
<td class="nump">1,376,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember', window );">$1.49-$2.38 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Quantity Outstanding</a></td>
<td class="nump">2,204,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement</a></td>
<td class="nump">1,652,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember', window );">$2.39-$4.65 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Quantity Outstanding</a></td>
<td class="nump">2,069,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement</a></td>
<td class="nump">1,217,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember', window );">$4.66-$7.67 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Quantity Outstanding</a></td>
<td class="nump">1,886,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement</a></td>
<td class="nump">1,276,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember', window );">$7.68-$11.27 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Quantity Outstanding</a></td>
<td class="nump">1,427,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement</a></td>
<td class="nump">949,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceZeroPointThreeZeroToOnePointFourEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceOnePointFourNineToTwoPointThreeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceTwoPointThreeNineToFourPointSixFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceFourPointSixSixToSevenPointSixSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ogi_ExercisePriceSevenPointSixEightToOneOnePointTwoSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132030676088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL - Disclosure of detailed information about options, valuation assumptions (Details) - Year<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">0.45%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of options</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected annualized volatility</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DescriptionOfForfeitureRateShareOptionsGranted', window );">Forfeiture Rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="nump">2.42%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of options</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected annualized volatility</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">71.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DescriptionOfForfeitureRateShareOptionsGranted', window );">Forfeiture Rate</a></td>
<td class="nump">8.70%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DescriptionOfForfeitureRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected forfeiture of the share price used to calculate the fair value of the share price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DescriptionOfForfeitureRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037406072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL - Disclosure of detailed information about outstanding RSUs (Details) - Restricted Stock Units [Member] - Share<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Outstanding, Opening balance</a></td>
<td class="nump">842,362<span></span>
</td>
<td class="nump">145,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted</a></td>
<td class="nump">265,258<span></span>
</td>
<td class="nump">879,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Exercised</a></td>
<td class="num">(154,062)<span></span>
</td>
<td class="num">(182,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement', window );">Cancelled/Forfeited</a></td>
<td class="num">(60,387)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Outstanding, Ending balance</a></td>
<td class="nump">893,171<span></span>
</td>
<td class="nump">842,362<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040439784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL - Disclosure of detailed information about outstanding PSUs (Details) - Performance Share Units [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2020 </div>
<div>Share</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Outstanding, Opening balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted</a></td>
<td class="nump">142,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Exercised</a></td>
<td class="num">(15,502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Outstanding, Ending balance</a></td>
<td class="nump">126,685<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_PerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_PerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132047931176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL - Disclosure of detailed information about Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfShareCapitalInformationAbstract', window );"><strong>Disclosure Of Share Capital Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of shares used in basic earnings per share</a></td>
<td class="nump">172,668,816<span></span>
</td>
<td class="nump">140,923,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Options</a></td>
<td class="nump">4,540,182<span></span>
</td>
<td class="nump">5,194,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares', window );">Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,738,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares', window );">Restricted shares units</a></td>
<td class="nump">727,275<span></span>
</td>
<td class="nump">684,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares', window );">Performance share units</a></td>
<td class="nump">126,685<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of shares used in diluted earnings per share</a></td>
<td class="nump">178,062,958<span></span>
</td>
<td class="nump">151,541,073<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about dilutive effect of performance shares units on number of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DilutiveEffectOfPerformanceSharesUnitsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's Restricted shares units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DilutiveEffectOfRestrictedSharesUnitsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DilutiveEffectOfWarrantsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfShareCapitalInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfShareCapitalInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037953896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL - Disclosure of anti-dilutive securities excluded from computation of diluted earnings per share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare', window );">Antidilutive securities excluded from computation of diluted earnings per share</a></td>
<td class="nump">4,382,918<span></span>
</td>
<td class="nump">1,847,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AntidilutiveSecuritiesAxis=ogi_StockOptionsMember', window );">Stock options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare', window );">Antidilutive securities excluded from computation of diluted earnings per share</a></td>
<td class="nump">4,382,918<span></span>
</td>
<td class="nump">1,847,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AntidilutiveSecuritiesAxis=ogi_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AntidilutiveSecuritiesAxis=ogi_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037469048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES (Narrative) (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 16, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfOtherLiabilitiesAbstract', window );"><strong>Disclosure Of Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones', window );">Commitment to deliver additional consideration on achievement of gross margin based milestones | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration', window );">Gain (loss) on contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 886<span></span>
</td>
<td class="num">$ (145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SubleaseAnnualRentalIncome', window );">Sublease annual rental income</a></td>
<td class="nump">$ 282<span></span>
</td>
<td class="nump">$ 251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_RentalIncomeOverSubleaseTerm', window );">Rental income over sublease term</a></td>
<td class="nump">$ 1,431<span></span>
</td>
<td class="nump">$ 1,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of commitment to deliver additional consideration in the form of OHI shares contingent on the achievement of gross margin based milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_RentalIncomeOverSubleaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents rental income over sublease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_RentalIncomeOverSubleaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SubleaseAnnualRentalIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of sublease annual rental income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SubleaseAnnualRentalIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of unrealized gain (loss) on changes in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_UnrealizedGainLossOnChangesInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037641992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER LIABILITIES - Disclosure of detailed information about carrying value of other liabilities (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfOtherLiabilitiesAbstract', window );"><strong>Disclosure Of Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ContingentShareConsideration', window );">Contingent share consideration</a></td>
<td class="nump">$ 231<span></span>
</td>
<td class="nump">$ 1,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">2,617<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Total other liabilities</a></td>
<td class="nump">$ 2,848<span></span>
</td>
<td class="nump">$ 1,117<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ContingentShareConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent share consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ContingentShareConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036424120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES - Disclosure of detailed information about lease liabilities (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 3,705<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdditionsToLeaseLiabilities', window );">Lease additions</a></td>
<td class="nump">2,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Lease payments</a></td>
<td class="num">(897)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expense on lease liabilities</a></td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current portion included in accounts payable and accrued liabilities</a></td>
<td class="num">(1,088)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Long-term portion</a></td>
<td class="nump">2,617<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ogi_AdjustmentOnAdoptionOfIFRS16Member', window );">IFRS 16 transition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 2,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current portion included in accounts payable and accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AdditionsToLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of additions to lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AdditionsToLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ogi_AdjustmentOnAdoptionOfIFRS16Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ogi_AdjustmentOnAdoptionOfIFRS16Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036164264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER LIABILITIES - Disclosure of detailed information about undiscounted contractual payments relating to current and future lease liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UndiscountedOperatingLeasePaymentsToBePaid', window );">Undiscounted contractual payments</a></td>
<td class="nump">$ 6,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1 year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UndiscountedOperatingLeasePaymentsToBePaid', window );">Undiscounted contractual payments</a></td>
<td class="nump">1,553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">1 to 2 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UndiscountedOperatingLeasePaymentsToBePaid', window );">Undiscounted contractual payments</a></td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">2 to 3 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UndiscountedOperatingLeasePaymentsToBePaid', window );">Undiscounted contractual payments</a></td>
<td class="nump">1,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">3 to 4 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UndiscountedOperatingLeasePaymentsToBePaid', window );">Undiscounted contractual payments</a></td>
<td class="nump">998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">4 to 5 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UndiscountedOperatingLeasePaymentsToBePaid', window );">Undiscounted contractual payments</a></td>
<td class="nump">768<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Thereafter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UndiscountedOperatingLeasePaymentsToBePaid', window );">Undiscounted contractual payments</a></td>
<td class="nump">$ 606<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_UndiscountedOperatingLeasePaymentsToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of undiscounted operating lease payments to be paid. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_UndiscountedOperatingLeasePaymentsToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132035209128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN ASSOCIATES (Narrative) (Details)<br> $ / shares in Units, &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 10, 2018 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 10, 2018 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 02, 2018 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 12, 2018 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 10, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInterestsInAssociates', window );">Purchase of interests in associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones', window );">Commitment to deliver additional consideration on achievement of gross margin based milestones | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ImpairmentLossOfInvestmentsInAssociates', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember', window );">Alpha-cannabis Pharma GmbH ("ACG") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfSharesAcquired', window );">Number of shares acquired | shares</a></td>
<td class="nump">8,333<span></span>
</td>
<td class="nump">8,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInterestsInAssociates', window );">Purchase of interests in associates</a></td>
<td class="nump">$ 2,436<span></span>
</td>
<td class="nump">&#8364; 1,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones', window );">Commitment to deliver additional consideration on achievement of gross margin based milestones | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_FairValueOfContingentShares', window );">Fair value of contingent shares</a></td>
<td class="nump">$ 972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ImpairmentLossOfInvestmentsInAssociates', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember', window );">Eviana Health Corporation ("Eviana") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations', window );">Percentage of potential ownership interest capped based on certain Canadian securities regulations and contractual obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesReceivableFaceValue', window );">Convertible debentures receivable, face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Percentage of interest rate on convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesConversionPrice', window );">Convertible debentures, Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion', window );">Convertible debentures, total number of shares available upon conversion | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,347,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConversionOfDebenturesDescription', window );">Description, Conversion of debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The convertible debentures are convertible at the option of the holder at any time at a price of $1.15 per share, or into 4,347,826 common shares of Eviana. Conversion of the debentures may be forced by Eviana in the event that the volume weighted average price of the common shares of Eviana for ten consecutive days is greater than $2.15, subject to a minimum volume of 100,000 shares in each of those 10 days.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfSharePurchaseWarrantUnitsAcquired', window );">Number of share purchase warrant units acquired | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion', window );">Shares available per share purchase warrant unit upon conversion | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion', window );">Share purchase warrant units, total number of shares available upon conversion | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SharePurchaseWarrantExercisePricePerShare', window );">Share purchase warrant exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_MaximumPercentageOfAnnualCbdOilPurchased', window );">Maximum percentage of annual CBD oil purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice', window );">Percentage of agreed raw CBD oil wholesale market price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ImpairmentLossOfInvestmentsInAssociates', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember', window );">Hyasynth Biologicals Inc. ("Hyasynth") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInterestsInAssociates', window );">Purchase of interests in associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesReceivableFaceValue', window );">Convertible debentures receivable, face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Percentage of interest rate on convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesConversionPrice', window );">Convertible debentures, Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion', window );">Convertible debentures, total number of shares available upon conversion | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ImpairmentLossOfInvestmentsInAssociates', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months', window );">Commitment for convertible debentures on achievement of production related milestones within 24 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths', window );">Aggregate commitment for convertible debentures on achievement of production related milestones within 24 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction', window );">Ability to purchase up to annual cannabinoid or cannabinoid related production</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears', window );">Percentage of discount agreed upon wholesale market price for period of 10 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember', window );">Hyasynth Biologicals Inc. ("Hyasynth") [Member] | Achievement of contractual production-related milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesReceivableFaceValue', window );">Convertible debentures receivable, face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdvanceGivenAsConvertibleDebentures', window );">Advance given as convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PotentialProportionOfOwnershipInterestInAssociate', window );">Potential proportion of ownership interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInterestsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of interests in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInterestsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents ability to purchase up to annual cannabinoid or cannabinoid related production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AbilityToPurchaseUpToAnnualCannabinoidOrCannabinoidRelatedProduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AdvanceGivenAsConvertibleDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of advance given as convertible debentures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AdvanceGivenAsConvertibleDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate amount of commitment for Convertible Debentures on achievement of production related milestones within twenty four months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AggregateCommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithinTwentyFourMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of commitment for convertible debentures on achievement of production related milestones within 24 Months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CommitmentForConvertibleDebenturesOnAchievementOfProductionRelatedMilestonesWithin24Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of commitment to deliver additional consideration in the form of OHI shares contingent on the achievement of gross margin based milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CommitmentToDeliverAdditionalConsiderationOnAchievementOfGrossMarginBasedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ConversionOfDebenturesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description for conversion of debentures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ConversionOfDebenturesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ConvertibleDebenturesConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents conversion price of convertible debentures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ConvertibleDebenturesConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ConvertibleDebenturesReceivableFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of convertible deventures receivable face value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ConvertibleDebenturesReceivableFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents shares of convertible debentures, total number of shares available upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ConvertibleDebenturesTotalNumberOfSharesAvailableUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_FairValueOfContingentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of fair value of these contingent shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_FairValueOfContingentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ImpairmentLossOfInvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of impairment loss of investments in associates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ImpairmentLossOfInvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_MaximumPercentageOfAnnualCbdOilPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum percentage of annual CBD oil purchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_MaximumPercentageOfAnnualCbdOilPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NumberOfSharePurchaseWarrantUnitsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of share purchase warrant units were acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NumberOfSharePurchaseWarrantUnitsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NumberOfSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of shares acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NumberOfSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents right to purchase up to annual CBD oil of agreed raw CBD oil wholesale market price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PercentageOfAgreedRawCbdOilWholesaleMarketPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of discount agreed upon wholesale market price for a period of 10 Years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PercentageOfDiscountAgreedUponWholesaleMarketPriceForPeriodOfTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of potential ownership interest capped based on certain Canadian securities regulations and contractual obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PercentageOfPotentialOwnershipInterestCappedBasedOnCertainCanadianSecuritiesRegulationsAndContractualObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PotentialProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The potential proportion of ownership interest in an associate attributable to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PotentialProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SharePurchaseWarrantExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents share purchase warrant exercise price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SharePurchaseWarrantExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents share purchase warrant units, total number of shares available upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SharePurchaseWarrantUnitsTotalNumberOfSharesAvailableUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents shares available per share purchase warrant unit upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SharesAvailablePerSharePurchaseWarrantUnitUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ogi_AchievementOfContractualProductionRelatedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ogi_AchievementOfContractualProductionRelatedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037092472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN ASSOCIATES - Disclosure of detailed information about carrying value of investments in associates (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 10, 2018</div></th>
<th class="th"><div>Oct. 02, 2018</div></th>
<th class="th"><div>Sep. 12, 2018</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11,108<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdditionsOfInvestmentInAssociates', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TransactionCostsOfInvestmentInAssociates', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DistributionsOfInvestmentInAssociates', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,187)<span></span>
</td>
<td class="num">(1,261)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ImpairmentLossOfInvestmentsInAssociates', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="num">(950)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates', window );">Elimination of proportionate share of transactions with associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign currency translation gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,001<span></span>
</td>
<td class="nump">11,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember', window );">ALPHA-CANNABIS PHARMA GMBH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 3,496<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdditionsOfInvestmentInAssociates', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TransactionCostsOfInvestmentInAssociates', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DistributionsOfInvestmentInAssociates', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ImpairmentLossOfInvestmentsInAssociates', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates', window );">Elimination of proportionate share of transactions with associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign currency translation gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,501<span></span>
</td>
<td class="nump">3,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember', window );">EVIANA HEALTH CORPORATION [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdditionsOfInvestmentInAssociates', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TransactionCostsOfInvestmentInAssociates', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DistributionsOfInvestmentInAssociates', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="num">(734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ImpairmentLossOfInvestmentsInAssociates', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="num">(950)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates', window );">Elimination of proportionate share of transactions with associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign currency translation gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember', window );">HYASYNTH BIOLOGICALS INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.40%<span></span>
</td>
<td class="nump">43.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,612<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AdditionsOfInvestmentInAssociates', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TransactionCostsOfInvestmentInAssociates', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DistributionsOfInvestmentInAssociates', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,112)<span></span>
</td>
<td class="num">(477)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ImpairmentLossOfInvestmentsInAssociates', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates', window );">Elimination of proportionate share of transactions with associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign currency translation gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="nump">$ 4,612<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2019-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AdditionsOfInvestmentInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of additions of investment in associates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AdditionsOfInvestmentInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DistributionsOfInvestmentInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Distributions Of Investment In Associates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DistributionsOfInvestmentInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_EliminationOfProportionateShareOfTransactionsWithAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of elimination of proportionate share of transactions with associates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_EliminationOfProportionateShareOfTransactionsWithAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ImpairmentLossOfInvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of impairment loss of investments in associates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ImpairmentLossOfInvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_TransactionCostsOfInvestmentInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of transaction costs of investment in associates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_TransactionCostsOfInvestmentInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132033981288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Narrative) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($) </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>CAD ($) </div>
<div>Share </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Stock options granted</a></td>
<td class="nump">2,125,000<span></span>
</td>
<td class="nump">3,589,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 3.21<span></span>
</td>
<td class="nump">$ 7.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NumberOfWarrantsExpiredOrReleased', window );">Number of warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,739,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased', window );">Warrants exercised, weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember', window );">RSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement</a></td>
<td class="nump">265,258<span></span>
</td>
<td class="nump">879,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_PerformanceShareUnitsMember', window );">Performance share units ("PSUs") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement</a></td>
<td class="nump">142,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Stock options granted</a></td>
<td class="nump">790,000<span></span>
</td>
<td class="nump">685,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="nump">$ 4.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement', window );">Aggregate fair value stock options granted to key management personnel | $</a></td>
<td class="nump">$ 1,794<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel [Member] | RSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement</a></td>
<td class="nump">211,981<span></span>
</td>
<td class="nump">631,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement', window );">Aggregate fair value of RSUs granted to key management personnel | $</a></td>
<td class="nump">$ 902<span></span>
</td>
<td class="nump">$ 3,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel [Member] | Performance share units ("PSUs") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement</a></td>
<td class="nump">88,910<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel', window );">Aggregate fair value of PSUs granted to key management personnel | $</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember', window );">Eviana Health Corporation ("Eviana") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Amount of interest income received on convertible debenture investment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember', window );">Alpha-cannabis Pharma GmbH ("ACG") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions', window );">Revenues on product sold to related party | $</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods in related party transactions. [Refer: Revenue; Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents aggregate fair value of Performance share units granted to key management personnel.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AggregateFairValueOfPerformanceShareUnitsGrantedToKeyManagementPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of stock option aggregate fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AggregateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents aggregate fair value of other equity instruments granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_KeyManagementPersonnelAggregateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NumberOfWarrantsExpiredOrReleased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised or released in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NumberOfWarrantsExpiredOrReleased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants exercised or released in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_WeightedAverageExercisePriceOfWarrantsExercisedOrReleased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_PerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ogi_PerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_EvianaHealthCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_AlphaCannabisPharmaGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132039894376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS - Disclosure of detailed information about management and board compensation (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Salaries and consulting fees</a></td>
<td class="nump">$ 2,953<span></span>
</td>
<td class="nump">$ 2,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation</a></td>
<td class="nump">2,750<span></span>
</td>
<td class="nump">5,155<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total key management compensation</a></td>
<td class="nump">$ 5,703<span></span>
</td>
<td class="nump">$ 7,676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040427016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL MANAGEMENT (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CapitalManagementAbstract', window );"><strong>Capital Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CapitalConsideration', window );">Share capital, reserve for options and warrants, long-term debt, unsecured convertible debentures, accumulated other comprehensive income, and retained earnings</a></td>
<td class="nump">$ 414,793<span></span>
</td>
<td class="nump">$ 376,582<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CapitalConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of capital consideration consist of share capital, reserve for options and warrants, long-term debt, unsecured convertible debentures, accumulated other comprehensive income, and retained earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CapitalConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036161560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Fair value of long-term debt</a></td>
<td class="nump">$ 115,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets', window );">Description of estimated fair value of contingent share consideration</a></td>
<td class="text">At August 31, 2020, the probability of achieving the milestones was estimated to be 68% and the discount rate was estimated to be 20%. If the probabilities of achieving the milestones increased or decreased by 10%, the estimated fair value of the contingent share consideration would increase or decrease by approximately $33. If the discount rates increased or decreased by 5%, the estimated fair value of contingent consideration would decrease or increase, respectively, by approximately $12.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Maximum exposure to credit risk approximates</a></td>
<td class="nump">$ 99,736<span></span>
</td>
<td class="nump">$ 65,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">24,600<span></span>
</td>
<td class="nump">47,555<span></span>
</td>
<td class="nump">$ 55,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_WorkingCapital', window );">Working capital</a></td>
<td class="nump">141,123<span></span>
</td>
<td class="nump">152,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital expenditures</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ChangeInBenchmarkInterestRates', window );">Change in benchmark interest rates</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Increase or decrease in interest expense</a></td>
<td class="nump">$ 1,150<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractualCapitalCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractualCapitalCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the contingent consideration arrangements and the arrangements for indemnification assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_g_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaximumExposureToCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35K<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35K_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_36_a&amp;doctype=Standard&amp;book=b<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaximumExposureToCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValueAtRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The measure of a potential loss exposure as a result of future market movements, based on a specified confidence interval and measurement horizon.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 41<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_41&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValueAtRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ChangeInBenchmarkInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of change in benchmark interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ChangeInBenchmarkInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132041024072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Disclosure of detailed information about aging of trade receivables (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TradeReceivablesGross', window );">Gross trade receivables</a></td>
<td class="nump">$ 11,096<span></span>
</td>
<td class="nump">$ 11,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ProvisionForDoubtfulTradeReceivables', window );">Less: Provision for doubtful accounts</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TradeReceivablesNet', window );">Net trade receivables</a></td>
<td class="nump">11,083<span></span>
</td>
<td class="nump">11,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ReceivablesAxis=ogi_ZeroToSixtyDaysMember', window );">0-60 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TradeReceivablesGross', window );">Gross trade receivables</a></td>
<td class="nump">11,023<span></span>
</td>
<td class="nump">11,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ReceivablesAxis=ogi_SixtyOneToOneTwentyDaysMember', window );">61-120 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TradeReceivablesGross', window );">Gross trade receivables</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ProvisionForDoubtfulTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision For Doubtful Trade Receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ProvisionForDoubtfulTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_TradeReceivablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trade Receivables Gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_TradeReceivablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_TradeReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of trade receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_TradeReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ReceivablesAxis=ogi_ZeroToSixtyDaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ReceivablesAxis=ogi_ZeroToSixtyDaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ReceivablesAxis=ogi_SixtyOneToOneTwentyDaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ReceivablesAxis=ogi_SixtyOneToOneTwentyDaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036521848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Disclosure of detailed information about contractual maturities relating to their undiscounted cash flows (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">$ 17,486<span></span>
</td>
<td class="nump">$ 40,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Long-term debt</a></td>
<td class="nump">115,266<span></span>
</td>
<td class="nump">$ 49,576<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPayable', window );">Interest payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Contractual maturities relating to undiscounted cash flows</a></td>
<td class="nump">132,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ogi_ContractualCashFlowsMember', window );">Contractual Cash Flows [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">17,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Long-term debt</a></td>
<td class="nump">115,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPayable', window );">Interest payable</a></td>
<td class="nump">7,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Contractual maturities relating to undiscounted cash flows</a></td>
<td class="nump">140,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1 year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">17,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Long-term debt</a></td>
<td class="nump">11,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPayable', window );">Interest payable</a></td>
<td class="nump">4,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Contractual maturities relating to undiscounted cash flows</a></td>
<td class="nump">33,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">1 to 3 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Long-term debt</a></td>
<td class="nump">103,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPayable', window );">Interest payable</a></td>
<td class="nump">3,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Contractual maturities relating to undiscounted cash flows</a></td>
<td class="nump">106,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">3 to 5 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Long-term debt</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPayable', window );">Interest payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Contractual maturities relating to undiscounted cash flows</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More than 5 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPayable', window );">Interest payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Contractual maturities relating to undiscounted cash flows</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankBorrowingsUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph B11D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B11D&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph IG31A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG31A&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankBorrowingsUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest recognised as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ogi_ContractualCashFlowsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ogi_ContractualCashFlowsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132042463800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InformationAboutMajorCustomers', window );">Information about major customers</a></td>
<td class="text">During the year ended August 31, 2020, the Company had three customers (August 31, 2019 - two customers) that individually represented more than 10% of the Company's net revenue.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InformationAboutMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about the entity's major customers and the extent of the entity's reliance on them.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InformationAboutMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132030505352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Disclosure of detailed information about revenues (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossRevenue', window );">Gross revenue</a></td>
<td class="nump">$ 103,387<span></span>
</td>
<td class="nump">$ 97,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ExciseTaxesExpenses', window );">Excise taxes</a></td>
<td class="num">(16,592)<span></span>
</td>
<td class="num">(17,134)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">86,795<span></span>
</td>
<td class="nump">80,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=ogi_AdultUseRecreationalWholesaleRevenueMember', window );">Adult-use recreational wholesale revenue (Canadian) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossRevenue', window );">Gross revenue</a></td>
<td class="nump">73,938<span></span>
</td>
<td class="nump">85,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=ogi_WholesaleToLicensedProducersRevenueMember', window );">Wholesale to Licensed Producers revenue (Canadian) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossRevenue', window );">Gross revenue</a></td>
<td class="nump">15,184<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=ogi_DirectToPatientMedicalRevenueMember', window );">Direct to patient medical revenue (Canadian) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossRevenue', window );">Gross revenue</a></td>
<td class="nump">10,748<span></span>
</td>
<td class="nump">11,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=ogi_InternationalBusinessToBusinessMember', window );">International (business to business) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossRevenue', window );">Gross revenue</a></td>
<td class="nump">3,272<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=ogi_OtherRevenueMember', window );">Other revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossRevenue', window );">Gross revenue</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in economic benefits during the accounting period in the form of inflows or enhancements of assets or decreases of liabilities that result in an increase in equity, other than those relating to contributions from equity participants.
Effective 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ExciseTaxesExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of excise taxes	paid during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ExciseTaxesExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_GrossRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of sales recognized for a reporting period, prior to the excise taxes deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_GrossRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=ogi_AdultUseRecreationalWholesaleRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=ogi_AdultUseRecreationalWholesaleRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=ogi_WholesaleToLicensedProducersRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=ogi_WholesaleToLicensedProducersRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=ogi_DirectToPatientMedicalRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=ogi_DirectToPatientMedicalRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=ogi_InternationalBusinessToBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=ogi_InternationalBusinessToBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=ogi_OtherRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=ogi_OtherRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037339880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COST OF SALES (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DisclosureOfCostOfSalesAbstract', window );"><strong>Disclosure Of Cost Of Sales [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IndirectProductionCostOfSale', window );">Indirect production to cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue', window );">Write-downs and provisions in relation to excess and obsolete inventories and biological assets</a></td>
<td class="nump">$ 35,584<span></span>
</td>
<td class="nump">4,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ChargesRelatedToReducedWorkforce', window );">Charges related to reduced workforce due to COVID-19</a></td>
<td class="nump">6,095<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ChargesRelatedToPlantCulling', window );">Plant culling</a></td>
<td class="nump">5,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers', window );">Lump-sum payments paid to temporarily laid-off workers</a></td>
<td class="nump">1,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ChargesForUnabsorbedFixedOverhead', window );">Charges for unabsorbed fixed overhead</a></td>
<td class="nump">$ 5,434<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ChargesForUnabsorbedFixedOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of charges for unabsorbed fixed overhead.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ChargesForUnabsorbedFixedOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ChargesRelatedToPlantCulling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to plant culling.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ChargesRelatedToPlantCulling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ChargesRelatedToReducedWorkforce">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents charges related to reduced workforce.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ChargesRelatedToReducedWorkforce</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DisclosureOfCostOfSalesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DisclosureOfCostOfSalesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IndirectProductionCostOfSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to the indirect production cost of sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IndirectProductionCostOfSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense related to inventory and biological assets written down, provision and net realizable value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_InventoriesAndBiologicalAssetsWriteDownProvisionAndAdjustmentsToNetRealizableValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of lump-sum payments paid to temporarily laid-off workers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LumpSumPaymentsPaidToTemporarilyLaidOffWorkers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132105159144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) - Disclosure of detailed information about general and administrative expenses by nature (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">Office and general</a></td>
<td class="nump">$ 11,819<span></span>
</td>
<td class="nump">$ 7,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Wages and benefits</a></td>
<td class="nump">7,611<span></span>
</td>
<td class="nump">4,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="nump">5,367<span></span>
</td>
<td class="nump">4,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">1,510<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,269<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Travel and accommodation</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UtilitiesExpense', window );">Utilities</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Total general and administrative expenses</a></td>
<td class="nump">$ 27,996<span></span>
</td>
<td class="nump">$ 18,593<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from travel.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UtilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from purchased utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UtilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132068768584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Disclosure of detailed information about components of deferred income tax expense (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences', window );">Origination and reversal of temporary differences</a></td>
<td class="num">$ (37,875)<span></span>
</td>
<td class="nump">$ 1,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectFromChangeInTaxRate', window );">Change in tax rate and rate differences</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ChangeInUnrecognizedTemporaryDifferences', window );">Change in unrecognized temporary differences</a></td>
<td class="nump">27,245<span></span>
</td>
<td class="nump">1,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods', window );">Prior period adjustments</a></td>
<td class="num">(262)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Total income tax (recovery) expense</a></td>
<td class="num">$ (10,471)<span></span>
</td>
<td class="nump">$ 3,629<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments of tax expense (income) recognised in the period for the deferred tax of prior periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 80<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_80&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax expense or income relating to the creation or reversal of temporary differences. [Refer: Temporary differences [member]; Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 80<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_80_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ChangeInUnrecognizedTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of change in unrecognized temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ChangeInUnrecognizedTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036164552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Disclosure of detailed information about reconciliation of income tax expense at the statutory rate (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="num">$ (146,628)<span></span>
</td>
<td class="num">$ (5,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory income tax rate</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Tax calculated at statutory rate</a></td>
<td class="num">$ (42,522)<span></span>
</td>
<td class="num">$ (1,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Non-deductible (non-taxable) items</a></td>
<td class="nump">2,643<span></span>
</td>
<td class="nump">3,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DifferenceBetweenCurrentAndFutureTaxRates', window );">Difference between current and future tax rates</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized', window );">Benefit of deductible temporary differences not recognized</a></td>
<td class="nump">27,245<span></span>
</td>
<td class="nump">1,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfForeignTaxRates', window );">Effect of tax rates in other jurisdictions</a></td>
<td class="nump">2,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Other</a></td>
<td class="num">(274)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax (recovery) expense per financial statements</a></td>
<td class="num">$ (10,471)<span></span>
</td>
<td class="nump">$ 3,629<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DifferenceBetweenCurrentAndFutureTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of  Difference between current and future tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DifferenceBetweenCurrentAndFutureTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of income tax  benefit of deductible temporary differences not recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncomeTaxBenefitOfDeductibleTemporaryDifferencesNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036140488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Disclosure of detailed information about recognized deferred tax assets and liabilities (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax assets are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">$ 7,708<span></span>
</td>
<td class="nump">$ 10,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SetOffOfDeferredTaxAssets', window );">Set-off of tax</a></td>
<td class="num">(7,708)<span></span>
</td>
<td class="num">(10,708)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Net deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxLiabilityAbstract', window );"><strong>Deferred tax liabilities are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(7,708)<span></span>
</td>
<td class="num">(21,179)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_SetOffOfDeferredTaxLiabilities', window );">Set-off of tax</a></td>
<td class="nump">7,708<span></span>
</td>
<td class="nump">10,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,471)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_AllowanceForCreditLossesMember', window );">Non-capital losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax assets are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">6,670<span></span>
</td>
<td class="nump">10,708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax assets are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_LongTermAssetsMember', window );">Long-term assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxLiabilityAbstract', window );"><strong>Deferred tax liabilities are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(961)<span></span>
</td>
<td class="num">(4,983)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_BiologicalAssetMember', window );">Biological assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxLiabilityAbstract', window );"><strong>Deferred tax liabilities are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(170)<span></span>
</td>
<td class="num">(961)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_InventoryMember', window );">Inventories [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxLiabilityAbstract', window );"><strong>Deferred tax liabilities are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(5,367)<span></span>
</td>
<td class="num">(15,200)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use lease assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxLiabilityAbstract', window );"><strong>Deferred tax liabilities are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(1,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_OtherDeferredTaxLiabilitiesMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxLiabilityAbstract', window );"><strong>Deferred tax liabilities are attributable to the following:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">$ (114)<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DeferredTaxLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DeferredTaxLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SetOffOfDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of deferred set-off of tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SetOffOfDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_SetOffOfDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of deferred set off of tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_SetOffOfDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_AllowanceForCreditLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_AllowanceForCreditLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_LongTermAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_LongTermAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_BiologicalAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_BiologicalAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_OtherDeferredTaxLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_OtherDeferredTaxLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132037203144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Disclosure of detailed information about changes in temporary differences (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">$ (10,471)<span></span>
</td>
<td class="num">$ (7,980)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">10,471<span></span>
</td>
<td class="num">(3,629)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,471)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_AllowanceForCreditLossesMember', window );">Non-capital losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">10,708<span></span>
</td>
<td class="nump">8,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="num">(4,039)<span></span>
</td>
<td class="nump">2,723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(619)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">6,669<span></span>
</td>
<td class="nump">10,708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_ShareIssuanceCostsMember', window );">Share issuance costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_PropertyPlantAndEquipmentsMember', window );">PP&amp;E [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">(4,983)<span></span>
</td>
<td class="num">(1,275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">4,022<span></span>
</td>
<td class="num">(3,708)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">(961)<span></span>
</td>
<td class="num">(4,983)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_BiologicalAssetMember', window );">Biological assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">(961)<span></span>
</td>
<td class="num">(3,307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">791<span></span>
</td>
<td class="nump">2,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">(170)<span></span>
</td>
<td class="num">(961)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_InventoryMember', window );">Inventories [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">(15,200)<span></span>
</td>
<td class="num">(10,385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">9,833<span></span>
</td>
<td class="num">(4,815)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">(5,367)<span></span>
</td>
<td class="num">(15,200)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use lease assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="num">(1,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">(1,096)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_UnsecuredConvertibleDebenturesMember', window );">Unsecured convertible debentures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Reconciliation of changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome', window );">Recognized directly in equity &amp; oci</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net tax assets (liabilities)</a></td>
<td class="num">$ (113)<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of deferred tax related to items recognized directly in equity and OCI.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DeferredTaxRelatingToItemsRecognizedDirectlyInEquityAndOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_AllowanceForCreditLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_AllowanceForCreditLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_ShareIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_ShareIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_PropertyPlantAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_PropertyPlantAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_BiologicalAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_BiologicalAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_UnsecuredConvertibleDebenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ogi_UnsecuredConvertibleDebenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040283544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Disclosure of detailed information about non-capital loss carryforwards available to offset future taxable income (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome', window );">Non capital loss carryforwards available to offset future taxable income</a></td>
<td class="nump">$ 125,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearOneMember', window );">August 31, 2035 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome', window );">Non capital loss carryforwards available to offset future taxable income</a></td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearTwoMember', window );">August 31, 2037 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome', window );">Non capital loss carryforwards available to offset future taxable income</a></td>
<td class="nump">11,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearThreeMember', window );">August 31, 2038 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome', window );">Non capital loss carryforwards available to offset future taxable income</a></td>
<td class="nump">14,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearFourMember', window );">August 31, 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome', window );">Non capital loss carryforwards available to offset future taxable income</a></td>
<td class="nump">16,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearFiveMember', window );">August 31, 2040 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome', window );">Non capital loss carryforwards available to offset future taxable income</a></td>
<td class="nump">$ 81,205<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of non-capital loss carryforwards available to offset future taxable income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_NonCapitalLossCarryforwardsAvailableOffsetFutureTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ExpirationPeriodAxis=ogi_ExpirationPeriodYearFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132039967208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Disclosure of detailed information about unrecognized deductible temporary differences and unused tax losses for no deferred tax asset recognized (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences</a></td>
<td class="nump">$ 17,348<span></span>
</td>
<td class="nump">$ 12,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Tax losses</a></td>
<td class="nump">102,183<span></span>
</td>
<td class="nump">3,809<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised', window );">Temporary differences for which deferred tax liabilities have not been recognised</a></td>
<td class="nump">$ 119,531<span></span>
</td>
<td class="nump">$ 15,819<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary differences for which deferred tax assets have not been recognised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_TemporaryDifferencesForWhichDeferredTaxAssetsHaveNotBeenRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132035906824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LICENSING AGREEMENT (Narrative) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 04, 2016 </div>
<div>CAD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($) </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>CAD ($) </div>
<div>Share</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LicensingAndEndorsementAgreementLineItems', window );"><strong>Licensing And Endorsement Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share option issued | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,125,000<span></span>
</td>
<td class="nump">3,589,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TypeOfArrangementsAxis=ogi_LicensingAndEndorsementAgreementMember', window );">Licensing And Endorsement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LicensingAndEndorsementAgreementLineItems', window );"><strong>Licensing And Endorsement Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share option issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike price of stock option granted | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AmortizedToShareBasedCompensation', window );">Amortized to share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CashPaymentAndStockOptionsFeeCurrent', window );">Current portion of cash payment and stock options fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent', window );">Prepaid expense and long-term portion fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_TypeOfArrangementsAxis=ogi_LicensingAndEndorsementAgreementMember', window );">Licensing And Endorsement Agreement [Member] | Swear Net Inc. (the Trailer Park Boys "TPB") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LicensingAndEndorsementAgreementLineItems', window );"><strong>Licensing And Endorsement Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Paid in cash for services</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share option issued</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike price of stock option granted | $ / shares</a></td>
<td class="nump">$ 1.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AmortizedToShareBasedCompensation', window );">Amortized to share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_AmortizedToSellingAndMarketingExpenses', window );">Amortized to selling and marketing expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CashPaymentAndStockOptionsFeeCurrent', window );">Current portion of cash payment and stock options fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CashPaymentAndStockOptionFeeNoncurrent', window );">Long-term portion of cash payment and stock options fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to suppliers for goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 14<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_14_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToSuppliersForGoodsAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AmortizedToSellingAndMarketingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized To Selling And Marketing Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AmortizedToSellingAndMarketingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_AmortizedToShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of amortized to share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_AmortizedToShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CashPaymentAndStockOptionFeeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of long-term portion of cash payment and stock options fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CashPaymentAndStockOptionFeeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CashPaymentAndStockOptionsFeeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of cash payment and stock options fee, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CashPaymentAndStockOptionsFeeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LicensingAndEndorsementAgreementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents licensing and endorsement agreement line item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LicensingAndEndorsementAgreementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of prepaid expense and the long-term portion of the fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PrepaidExpenseAndLongTermPortionOfFeeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_TypeOfArrangementsAxis=ogi_LicensingAndEndorsementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_TypeOfArrangementsAxis=ogi_LicensingAndEndorsementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=ogi_SwearNetLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=ogi_SwearNetLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040427144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOVERNMENT SUBSIDIES (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2020 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GovernmentSubsidiesAbstract', window );"><strong>Government Subsidies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy', window );">Percentage of employee wages covered under CEWS</a></td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IncomeFromGovernmentSubsidies', window );">Government subsidies</a></td>
<td class="nump">$ 7,883<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_GovernmentSubsidiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_GovernmentSubsidiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IncomeFromGovernmentSubsidies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of income from government subsidies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IncomeFromGovernmentSubsidies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of employee wages covered under Canada Emergency Wage Subsidy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PercentageOfEmployeeWagesCoveredUnderCanadaEmergencyWageSubsidy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040318632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATIONS OF TRAUMA HEALING CENTERS (Narrative) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 16, 2018 </div>
<div>CAD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember', window );">Trauma Healing Centers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_OperationsOfTraumaHealingCentersLineItems', window );"><strong>Operations Of Trauma Healing Centers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ProportionOfOwnershipInterestInSubsidiarySold', window );">Proportion of ownership interest in subsidiary sold</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Fair value of consideration received</a></td>
<td class="nump">$ 1,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInstrumentsHeld', window );">Equity instruments held</a></td>
<td class="nump">$ 864,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_VivoCannabisIncMember', window );">Vivo Cannabis Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_OperationsOfTraumaHealingCentersLineItems', window );"><strong>Operations Of Trauma Healing Centers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_EquityInstrumentsHeldSharePrice', window );">Equity instruments held, share price | $ / shares</a></td>
<td class="nump">$ 1.32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of instruments held by the entity that provide evidence of a residual interest in the assets of another entity after deducting all of its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_EquityInstrumentsHeldSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents per share price of equity instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_EquityInstrumentsHeldSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_OperationsOfTraumaHealingCentersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operations Of Trauma Healing Centers [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_OperationsOfTraumaHealingCentersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ProportionOfOwnershipInterestInSubsidiarySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents proportion of ownership interest in subsidiary sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ProportionOfOwnershipInterestInSubsidiarySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_VivoCannabisIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_VivoCannabisIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132040299448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of derecognized assets and liabilities (Details) - Trauma Healing Centers [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 16, 2018 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_OperationsOfTraumaHealingCentersLineItems', window );"><strong>Operations Of Trauma Healing Centers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DerecognizedAssetsAndLiabilitiesCash', window );">Cash</a></td>
<td class="nump">$ 96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DerecognizedAssetsAndLiabilitiesGoodwill', window );">Goodwill</a></td>
<td class="nump">880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed', window );">Net assets disposed</a></td>
<td class="nump">1,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Fair value of consideration received</a></td>
<td class="nump">1,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain/(loss) on disposal</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gain on the disposal of investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DerecognizedAssetsAndLiabilitiesAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DerecognizedAssetsAndLiabilitiesCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derecognized assets and liabilities Cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DerecognizedAssetsAndLiabilitiesCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DerecognizedAssetsAndLiabilitiesGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derecognized assets and liabilities Goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DerecognizedAssetsAndLiabilitiesGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derecognized assets and liabilities net assets disposed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DerecognizedAssetsAndLiabilitiesNetAssetsDisposed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derecognized assets and liabilities Other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DerecognizedAssetsAndLiabilitiesOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derecognized Assets And Liabilities Property, Plant And Equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DerecognizedAssetsAndLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derecognized assets and liabilities Trade and other payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_DerecognizedAssetsAndLiabilitiesTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_OperationsOfTraumaHealingCentersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operations Of Trauma Healing Centers [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_OperationsOfTraumaHealingCentersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132036547272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of detailed information about Operating income (loss) of THCI and loss from remeasurement of assets and liabilities classified as held for sale (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 16, 2018</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,795<span></span>
</td>
<td class="nump">$ 80,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,004<span></span>
</td>
<td class="nump">42,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,996<span></span>
</td>
<td class="nump">18,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,528<span></span>
</td>
<td class="nump">14,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,020<span></span>
</td>
<td class="nump">42,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Investment income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income (loss) from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (146,628)<span></span>
</td>
<td class="num">(5,875)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (38)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember', window );">Trauma Healing Centers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Sales</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_GrossMarginFromDiscontinuedOperations', window );">Gross margin from discontinued operations</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total expenses</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Investment income (expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income (loss) from operations</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_LossOnRemeasurementToFairValueLessCostsToSell', window );">Loss on remeasurement to fair value less costs to sell</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Loss from discontinued operations</a></td>
<td class="num">$ (38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in economic benefits during the accounting period in the form of inflows or enhancements of assets or decreases of liabilities that result in an increase in equity, other than those relating to contributions from equity participants.
Effective 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_GrossMarginFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross margin from discontinued operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_GrossMarginFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_LossOnRemeasurementToFairValueLessCostsToSell">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss on remeasurement to fair value less costs to sell.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_LossOnRemeasurementToFairValueLessCostsToSell</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132103955352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of Cash flows generated by THCI for reporting periods (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 16, 2018</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_OperationsOfTraumaHealingCentersLineItems', window );"><strong>Operations Of Trauma Healing Centers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">Operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember', window );">Trauma Healing Centers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_OperationsOfTraumaHealingCentersLineItems', window );"><strong>Operations Of Trauma Healing Centers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">Operating activities</a></td>
<td class="num">$ (35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations', window );">Investing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations', window );">Cash used by discounted operations</a></td>
<td class="num">$ (35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents from discontinued operations. [Refer: Cash and cash equivalents; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_OperationsOfTraumaHealingCentersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operations Of Trauma Healing Centers [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_OperationsOfTraumaHealingCentersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ogi_TraumaHealingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140132035458216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Narrative) (Details) - CAD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2020</div></th>
<th class="th"><div>Nov. 27, 2020</div></th>
<th class="th"><div>Oct. 23, 2020</div></th>
<th class="th"><div>May 28, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Sep. 12, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from equity issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayments of non-current borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">$ 12,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CreditFacilitiesAxis=ogi_RevolvingCreditFacilitiesMember', window );">Revolving Credit Facilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommittedBorrowingFacilities', window );">Committed borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Term Loan [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommittedBorrowingFacilities', window );">Committed borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities', window );">Cash collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Term Loan [Member] | Amendment and Restatement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_CommittedBorrowingFacilities', window );">Committed borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayments of non-current borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_QuarterlyRepayments', window );">Quarterly repayments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ReductionInRevolverCommitment', window );">Reduction in Revolver commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_MinimumUnrestrictedCashBalanceRequirement', window );">Minimum unrestricted cash balance requirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member', window );">Bank of Montreal [Member] | Revolving Credit Facilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">Undrawn borrowing facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember', window );">Hyasynth Biologicals Inc. ("Hyasynth") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesReceivableFaceValue', window );">Convertible debentures, face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ogi_EventsAfterReportingPeriodMember', window );">Events After Reporting Period [Member] | Hyasynth Biologicals Inc. ("Hyasynth") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotesAndDebenturesIssued', window );">Advanced additional convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_ConvertibleDebenturesReceivableFaceValue', window );">Convertible debentures, face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_PotentialProportionOfOwnershipInterestInAssociate', window );">Potential proportion of ownership interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ogi_EventsAfterReportingPeriodMember', window );">Events After Reporting Period [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_IssuanceOfEquityFinancingShares', window );">Units sold</a></td>
<td class="nump">37,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_UnitsIssuedInPeriodPricePerUnit', window );">Units issued in period, price per unit</a></td>
<td class="nump">$ 1.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from equity issued</a></td>
<td class="nump">$ 69,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ogi_WeightedAverageExercisePriceOfWarrantsGranted', window );">Weighted average exercise price of warrants granted</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest and other costs that an entity incurs in connection with the borrowing of funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Contingent liabilities [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 14<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_14_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndDebenturesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of notes and debentures issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndDebenturesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UndrawnBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UndrawnBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CommittedBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of committed borrowing facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CommittedBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ConvertibleDebenturesReceivableFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of convertible deventures receivable face value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ConvertibleDebenturesReceivableFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_IssuanceOfEquityFinancingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>issuance of equity financing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_IssuanceOfEquityFinancingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_MinimumUnrestrictedCashBalanceRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum unrestricted cash balance requirement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_MinimumUnrestrictedCashBalanceRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_PotentialProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The potential proportion of ownership interest in an associate attributable to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_PotentialProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_QuarterlyRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of quarterly repayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_QuarterlyRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_ReductionInRevolverCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Revolver commitment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_ReductionInRevolverCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_UnitsIssuedInPeriodPricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Units issued in period, price per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_UnitsIssuedInPeriodPricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_WeightedAverageExercisePriceOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_WeightedAverageExercisePriceOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ogi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilitiesAxis=ogi_RevolvingCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilitiesAxis=ogi_RevolvingCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=ogi_BankOfMontrealBmoSeniorSecuredTermLoanTermLoanMaturingMay312022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilitiesAxis=ogi_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilitiesAxis=ogi_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilityAmendmentAxis=ogi_SecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilityAmendmentAxis=ogi_SecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ogi_CreditFacilityAmendmentAxis=ogi_AmendmentAndRestatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ogi_CreditFacilityAmendmentAxis=ogi_AmendmentAndRestatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_HyasynthBiologicalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ogi_EventsAfterReportingPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ogi_EventsAfterReportingPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ogi_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>141
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M!@ZL?H/5/PNK4LJ<Q0644F$FUFR)'"O=1N<6?'&>D4&#-7"J['AFF8XI6R_
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M?_I.CP,*:G\ISZKF%SRUV$CUF.XKR?.CL6KGK&B?Y/D8B!,#Z%L,T-$ O=<
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M)=7XY,JPOJ_]H4IB5E0@HQMEZ'V.U)!%>P7:-B0OFUO$1RXESYO7'25K*FJ
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MTOA-/VYR9TAC#Y5:J:SC(2Y!+9_.8TPN6DF-==N<B6SVA)-"/VBPF6YVP#Z
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MS-[2[T#)X$ !YNI3"^$!WY")[Q(B!/\(11:8!G3A*D'Y]\X#M'0.5H;WDFB
MFH-1KF'?@/L]_,/*!P,<XZ@G2$&W9OL#'X %*PP>;DUY?3ZA*V,%AOF [HSX
M!GG.C %)]<CG@V0A5<FRDL6#O0!=O3W));?XC&(!SUAPYB"F72<"N]'59[T,
M\A#%CED.P^JFV3*51#I;:+[UQH.1@?'A!EX46(P[$' @C@01[VK!YO-VZ1NP
M%S307+V=^!5E#L= @[CFY0(?6-QM98+TPJ;!PAV*[. \&9,;U'O@X(SY6 Y2
M<+6TE<[<8A1&MC;G4G<#+ >K,H,[ZJ&MT7?3BF%YI^ON%FE*#,212(?S8<!A
MM&COD6EH L'0]*95=7?7(BW37/GXD $<;5^8<)OME"@L>Z0D8/ P_C)6A;!O
MP"RZ9Z4=NATB95M8@&R[1W8K6KI9L$+BAY.-,/<0Y.->M>26-B3"N5F*0DAC
MF":((ZCTAN/KA^R),PUM=]]E;/D2>\+"''\NI#K:"'%AT=SKAHW,?])P%'O!
MSJIM]8TE8PPSU/.HSMMQ!%7J'8CPE( %@A^T(F!$WCMPU*[?SM2F">*?MN[P
MU=)T( \A!/Y30I<*;N-Y(JVE^V #PU+'8K"5+>;])F/3.WLS]+0TC*7P0;P7
M5R<F5QP^A+HL@LQ\D!GZUAKT<FA%4-_AQK7$9" M-"IP!I>H>PX;:2R@LR7W
M#9J,0G&S'84_< ,DFLB#^1>PJ)"T?#.9 V3*=%4-ZX$EN] HT@"8USH:C]W>
M7+W.[[$^9SX^I##5P#SR%*,=3#<M<0K-7"5"ER9/-M093[$$R]$,N1.H068M
M[#TI%_O]CQ0+-PT'&1"^+(9&-2#N[%0T.9CZA7HYV(9V^.*IVAH-\?4O$I@D
M/IV?R25D\@!V)KL6GOJ;@70!]3'\\//@0/HP_T(N 7'XV:>Q?@5>FQ4H%'+0
M=;>BKY$*#"1"^$M$6PHK17MJZT%3@!? A,V#FYP%ISI$CHN%<:8%?M^8_LZ8
MT; 4@85HDLV <UO2A#5FC\&4,[O9>H5X)NB9'P7QP7Z%^)/,#3HZ^B[6&4,V
MUATTR!('XL@@,ZT'FAV;5YH<XVMPRR =XDBJ1N,\8-F4OM40<Y-@P!P@ +L.
M@=?@H[8"06MDB6<C"/_;=!;5Z++E6_[J=X0P2M9B8H*UZ5==8 QZ>50@-C &
M\X)D]G#3F8GU'X-':;>+?'USR'0,>BC'-AVS-C"?^#%M]4K?IIWM"Z&?)=^B
M.?_'N!48 [OD#0R+/,01O3I>ZS\Z1SZB:U$F3\J%X=96%05 RP8RQ5M(S'Z!
M2.#.@FN,'QS>[DFD*0@82!5 .MIN;2L0NM8L;)_D>N&Z-9B&$$3A]#? '6)C
M3!G;KL]R"HPSL@ '0R-926'PYXDHZ_.LDRS_CH&;L&<?#' 4A>YM!UQZ?'Q+
MR2AQ#]CB(7_;!'G*GNXEIR8AKE'YD5?PH,@W00,X"/IQQ6->I<=AL*9KEZ>X
M?;7$&KT&#X,B+0)K[Q$[ ,Z<(F:'4?1V%SD0HY[EXGW?8) P]2!_92-3)@<2
M%RP155 UJ5Q;)S;3CJ$&E[$6*W%N!,#2D:]3 7, VV5!2?*9,V\6S'^0]'Y+
M^(D;UB);0!?MK<&@A*6"@\>?$^T43M,>41BSDZOCE"\;B/Y.KRLPR<93L$\)
M=%>;ABUX.=P'F /N08FA'8!\$,7Y^.C#]2=_Q"KSWC@"E-'*EC>]YYOVT9*6
M3YLDJ<?.#LS5FWL,3%F5%\:RB\$GDM>4IVKA81IA-WO*3,]B<&*E&1(G3PZ:
MQ\@1ADE@M/))UQKS,PQE4)$Y1;(0#L%M@19VRJ@A5?0?:!9]LL6[#XWBAUUY
MH@2 Q(#<%.LQAK7!H2"JCO!XF@_&233]C!K8=]7G*"'$'O8R;=>>FO6FZ;9&
M;&B2;#].IB<RG92?>>-N;4745(94VMQ79M.SLQH]C3$WF+J;?!]AY8Q(5AIG
MWX$OIPG849FPNCD(&2.*O+E@=RB6C*NE^#U??M!-<V]<9;U$IU&I8I:B/6.*
ME<,(AW+>598"Q8@BY$JY'<J8F_M[DBE9"GH53 ]W!IZK>X8=,D04[&1'/LNC
MU0T?Z2%2,4R2R2 Q:S/=(_329[ Y: +P%54YQ#JE(X4,70R;$,K.?UY@[VD0
MBS;&>-B3.HE /C?P$-)TX_S*;BC:A[MQ]PPFNBCPK;HX^PL$("W#-A !0L@H
M4!IK *8SG>,54K#5(X((/!G6&\ZQ0 ;@F@>'B7BW<>8+R1"$(]# TAC7$[4Q
M#%1WP&>4:(I0)KGZ;R[DBB,T3R9T_[:1B=E9#@3.X-A;3!75;4=.R6%^DH/5
MF*63E13QI\B2XE+]V:"X@SA6N4;-#\CBA/1$VU](3Y2U?9ELEJ=2+H]JCXJC
MJYC<2C)4  0I\,R@@ARTD9W[[__Z]N+\^??!#XE12:$[6>"0;R#5DL=DWCJM
M,S& ]XN"2'*.5""Y^OG#]2PD%7QCG'Z-H1I:3O1;*;"?6@72F:/5E.E5>< _
M5M#?H^#O3@QA+%8Y4IC"X;5/;F[$J=$*4"D@)D5(+Q*;^U3M U%> TME$M/&
M1$V&C^K!JH8I(VYQ%<"'&HQA-U?OT&G?@7&>%?I' 1*[=\;E^VQ',UPHNLRI
M+2T"M(-;U&S)O")X.2UJLQ1K"/*A#+"UXMPF5]],F'T)FT:;$A4BI,KH6$T=
M]"DFKM$O6I)UL61VM![P(AB'[X3:N[\4\/W>=$*J9 ?PDAFE>NUV/C4' E6.
MA7E/<C1&]7=#]ASMXK#Q,B>*8!3$=$%:*8U->89GL]Y!OG4(NPDA/4R<XI4R
M^V3_6G>T8[Q! ;:DNC.&DRS\@1VS$"!1\+Y8G*ZU^PPI/M4&P*R )PS"Q)ZK
MX'1.=RFX/%<W])NA3\$8>L%A#-K+34" @:"K%W N/A,S&>): $0"72RM^_A1
MP@@!0,E7P-;)E^ !["@!!P07@)681>R_ F>\-.1HPIQ3?@:8PECVK6DF)8Y,
M,<5OI5!0--C#Q/T4LB*Y.:03?U"DW15KP0S: \48O!*&2AD*VQHR=*FJ]AK2
MN*9C.(/NJ+.D)@?1NQ;3?Q3=]  /#G8#MRGJ!,29"!!NV20" ^JAHO0AJS+V
MIEJU6)! R6* ?(UNGGY8P$C(HMDA%(-&OM%T6X@T@JEBK)8B5KQ$D>6P6&#K
M18LRZ+O!51S1!KM9K M^1RYCHH(UN8B[[?(51F<TK3[$QQ*D6\(BG,3ENEYC
M<:=WHQ3JP3*@.!$I)>S6&$;7\RV_1^#CC78M&&D?[@!;(![J)3"_ JG?=YTP
MG:82<PL9#,%#:/"Q^C":=P39XS;#TF@@A&+1L0N>?D>=3J8^A8C5Z27(]["^
MX>H&W>[1.@ +6II*0#T2,+)B(,FV&9"B+Z6<+'QH%&"0?P86OQ>-)'\IF$>G
MEK0[Y#))JJ@H!?/ASRF6S9?W(+U<]I,Q9&A8[!VX3TU65G*]F4*$@_$-_%"N
M(L6QO2,%W$IR'8(M@@ 6IQ4E'O@$7XCM-AC3QRZ1!M= -Y*)JLU-3]IS@WAU
M&L*RZ:7+U")Q"E]/8>D&E-Y*\P)N=Z!3L.Z=Q8XG0^2WMZ>C.RE(R;E,.13E
MP=2$$5M=:).7;>=BG),QB^SB/:%^'Q"[&J)>DOD/O\4X4^J,!!8BJ:$L1[H6
MOG2V$5R2JR%2LRX@E)UL,V3:/O9?9.A%[%FA+CV42=XH2R YX>,<0:!CDTH6
MY(!4W"UH! HP=X6U95?F<9VQKP6\/H(+O;Y/<4-.[49O/=<6X!&[T0UK"3S&
MS]=#[%ZA,6!13<,@68>.8:6;!2_0NIH =6LR.O)J,\<#:$:*S Y9LDN7(2@N
M=%6A;"#*FBVPV 3AJKGOR<!3.QH)[PK,#OB<X$Q$$8J8&*(!V"S=<%B/?K>#
M@-.1;CF#T<J,[I%9R4YS"P1F90$Q9-&HK:?P ",0+)9I*G_@)H8-AZ' <[0B
M:)*< WGK3O92>L9BRY"8,"HFS-4O[%W0_0K('*0KSU.CG-9#[-0"<0&GI1 >
MS1-QW E/7"/#"'$*$.J08Y00D=#@A;93IAD7F-MEZ/K(-H4_<K$Q$SY$5],W
MCEE(_REV@CV14((D0M^+2-P8=#@>%TO[%[4M!!XT)295]4X.^5?"4-8V9&"(
MJ5)E>JL$#HS%YZS1@+#TD-N$U=2&?'XJ&%(TC+FV- Y [$>T+,/^2'&%&ZT(
MQ"L+0]0V >+J6DIA;SOD]?<1Y^/(,S(LAH2ZN4.%W6# PD%X:4]HH1+ IQ\A
MB6E(E8"-(6XE[L7@.U<]@4OA6J/M6A0K4%)FC7U0D;QRD6[.TVQGEMIA?TL/
M4=="8$V(!-H,O%ZB):<>CP&\&)O]&3,O]AY163O8C; _(>T5NM 34-,4HULD
M<$BV!+&C*(NO!PGCXIP@I>F.F$+"90R 0UN?,Y12YGT"2-A:?S;JCZ%>%MVD
ME":#3/8I?YW 4T 8S2UEZS!MH^\D4Y=4*Q6,"_(I@ _:LB#,?]C F L;^VX@
M=8$$4(O4DLV "=@>A3@MSEWL .LBF46?]PR)\%F(,O)A'\3&YMG61)#Z&$4(
MG=Y)8%?9=_-U,;'TG4'X0^Z=\<9R<WE7<7Z0<ZP8W>!Q@[EZ)3?C]="^%LQ\
M)A!!8 +=^.4DV >X@2Z61 4Q#:FYA'>X"Y1@FE;C+#/*38#-L%EB'N,5[0,.
M@:A6E)@25BO7,,E@,4S_ 4Y+/<B+'4KSAM6.J</&BL&/8_#QT]2)8=%6T4.A
M#S"_)<)%T8['=HA#!'=.P#C,CY,L3 /)L0P1E'X'2Y;M)L,G4L)!2Q"0SJE,
M1**$F#6P!4M\J7G$%]TCHQX1;E28MD*A6WT2P0TM)QVLU&\Z]F/(OQMR-#FZ
M6U%'3K)&A127["KF1SXDUY<%9A0]8Y(M(TVO>D(M"TSPH2BO#.]&ND=A'7;F
M1YQ%4UMQ'U T=BB'J1M:SGIPW=)!Q!&QQ%41)Z&&[S\9>\D65*9U!/UA-3#$
MBPRK61],@JC[7CN0VXQ,Z#1A><BFD@6RN]P*%2N?(,5^[YJ=&8NSR+!0Q5T/
M4@N9$-345W)@9Q,,EQDT0N1V;09F)02QM[L2)A$9/8*2&U8X)1T95!2XQ"5P
M/R$IU$_"+;&A 3'GQ.XF%P@Z$?<"S\],,WD4=4I1JLA;D\IC>:C4>%W$_.$,
M#D6)>[#M5HJ)6A+OUEBRECJ=86J1G05?0F'J>SI;LT,_&9-N?'8&I=;65E/?
M])?J+;94Q22,T[(HNQAD>F-X5P@W_![7,^.3+*7H%JU]>[BZE"8F"!4A4GP)
MMI';%!GY&W_?VZ4Z*@C,*/;IG42H*=*66:D*N]BF$Q41J'&IR15Y$7I9+>HS
MQI(Z&8*([9.)IL;B#JPO]0;7L?G59DVM >[4!*?B5'6=Y"XT0+,]"'2A/#32
M#L+-RZ'^D30X(XF4\N'II::F;D8,+B!LV7)99&:O1EW>D@^@VO-3[/],J-.^
M[7;FN3,CX'L'NN/"N^&FCGOLQL.S?QUJ!YZ6D 9B1*<N4W_GTG7#)A3MC91G
ML9UM\E$JR301%TI]M;&7.9PNZ<EZL++HU$,8G@QI&/)<8O1$'B-9?J46,'KT
M3U4#3J!!.T3M8@,?/8B/1<@^AA)-UH-$);YR[AE9!<KO8H=BENIR\R,5M[(S
M'=2FFB@ET1)3%/%(YJTA(<<:J^=N5.E.'/7[?<^U0!N9A4 4&4^%MJ!!D> S
M)H35-)JR1YE"[GN(Y$5&<MY5J\=B<(!.J6P$&<D:+.VADH#/,)>BJ7^?:.Z=
MAK92'B$CF9YYF(*OK$IP<_Z^P9)HDII1URM8_)8R:'$?8,TG?QS%A0$4<H)
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M3%GYS1?R'LPLXV!@'8@U#Q);/4BL]/P'6LJ*$(5#=.Q*^LG/+R02XN+ COP
M48L'B:J_F*B@9L7[X6)5:-38^[!T W7+@]2=/SU$V0P]%K\="9W_* :;D6FA
MMQ-*31E[O5@)TGN F/KQKZ7MR#-EZHL:W1[/*\;<L9Z>2Q<1=#E&>E/!]*/A
M-&*6YG%8E5I(Q@\!>U<'V?OT"Q2\/(VLLQVE"'X4X2*+)B67;Z0LB:4XO6TA
MRC#W#QS;!VA^6.'_0S0_E%!DQX;H7"GO!&A!FZWNFZ>SL[,S]>GZ-5?((1T<
ME[HLQWO@B2J@B-.!O 4U!4_IQ7EQK]=6L(N:7XYMZE0$D[2.NY6+:$_BP^E(
M@N^?\$643(S#\A?J0TGZ:9@7F!$<[;L1X2GQ\7O(^T8]GIT]^4[]!C9G/:P#
M3!@1=-[C6-LNG9LZ?G)^KDXXH4V_,OX*.X"'I05<RKS0J-4R%"AJZGK$^;*#
MW>A1> UP_=G3I\"$QIJ VW.K27JGM8C7\=/'WZJ3B5OE.@O7J1QTYP3F^/DS
M>.07AR^EF-BJJ7VZF#U[_AUWI4AR?OSDZ7<*7SU)V6?"U;]PP&]@R M($! E
MR=^T#G$M?*Y,JN$GH2YP#L_Q.N6;\74* DU(UH%HQ7P\9,2BK8MG(N30=KY9
M-'AYGDS>R)2F%1>&:28B,;$P2'0^?H$]I#9K]U0O0\L1V*)W5=\A/X 9W^YB
M*T=['SV>FNKD2*I<Z1KX,&<76X&&R\'2&WC)#%(]APZDRYM1L,N):[MT/$\Z
M/6/-+0NI\SY5D$W,HFXFWIRWIVU5+H:$*&NW'"TGO*,@WBQQUL+!+?B''G;H
MH[S).,FM,1U:.GDE7SR%M]-3N\/$XBP;+69J'9X/T+@Q1()\S< 3*=!;1S7F
MEALR1F]-^0*LY>*L3,:LSU^Z@VHHK;NK_(AS\38Q7RQRYU5R#W?(,)"07D>8
M&C#*]Y",9!5-^ OU2KKH4N/+KZ6C"$=<8/UO(6X)7T=[$P8L)%T0N$!EZF+.
M ?0DOLEA)^$M&CVK1 J&4.'K5-_75!??IUCS0,0V)RZ^_F8B9<CI&G>>[B.H
M?"-A\;J0/?A.['Y(0AC?5AC?&2-BD^,R#KN&1:"SUNNQQFIY,WD!XC7;'& <
M2_\708T7C__?Q7\^];<_'F5_=65MW)+^M@P.!DSC/\ 2?U7AS]=<\E]M2;?S
MW[[Y3;LEXA*-6<"C9_/G3X\8CPQ?^FY#?\/EINO[;DT?5Y!4&(<WP/5%!PN7
M+SA!_*,^/_T?4$L#!!0    ( (%H?E'S1<<"HP,   8(   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;)55;4_C.!#^*Z/<[AU(I7EI80M7*D'I+5T)
MBMK"?CC=!S>9-!:.'6R'PK^_L5.R905(?&D]SCS/,S,>CX<;I>]-@6CAJ132
MG :%M=5)&)JTP)*9KJI0TI=<Z9)9,O4Z-)5&EGE0*<(DBH["DG$9C(9^[T:/
MAJJV@DN\T6#JLF3Z^1R%VIP&<?"R,>?KPKJ-<#2LV!H7:&^K&TU6V+)DO$1I
MN)*@,3\-SN*3\[[S]PYW'#=F9PTNDY52]\Z89J=!Y )"@:EU#(S^'G&,0C@B
M"N-ARQFTD@ZXNWYA_\?G3KFLF,&Q$C]Y9HO38!! ACFKA9VKS25N\SET?*D2
MQO_"IO'M'060UL:J<@NF"$HNFW_VM*W##F 0O0-(MH#$Q]T(^2@OF&6CH58;
MT,Z;V-S"I^K1%!R7[E 65M-73C@[6ES.YDM83N97,+V^FRR65Y/KY6(86N)V
M'F&ZY3EO>))W>.($KI2TA8&)S#![31!24&UDR4MDY\F'C&?UN@N]N -)E$0?
M\/7:3'N>K_=>IH72%I:H2YC*1S266LO"V<I83:WQ@4"_%>A[@?ZG2@G_+O')
MPKE0Z?U_;]7U8])^%][A718(8U563#[_9<"X[ ZLRXZWV1E:IZ*F\P!+WKD2
M= >Y7 -=!RHO=5=;8& R>[T7'Y_ Q60QGD]OEM/9-6E3"*0.7^'L]OLM+5KL
M*SL^AN_3,1Q0E]I:.[4%5A;+%6J(C[:(J'M\^!6^0!QUHBBBQ9]_#)(X^?M]
M:-+_)/0"TZWHX189=^.C3R&3WB>1/VJ)$'_SJ-A%VMM!O6 F#S6WSV P)9#E
MZ$X)[J9W,Q@S*=F*&VK0M MQ,H#>P*D=1AUG?/'F3,(LM>I7.>-!QQ_OMAG
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M<,]_@L^(1\"QQ6?D^-_ONP&/0B+8EZ/_M^=G%94T:SZJW,7'VRESHU=AZ""
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M-<XR2;PYUF\?#'JKY\UO?/I)I H\RKE,(\M@/S5%67F!OF#F?LF1DOV;VRG
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MA1;T=B-%=.QEMA(EWK_+MKLH?1!Q(:)45.!C&Y<8G%;;N<QIU"+;;J$IGEW
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M[XS[?&=9R1XNM=_1Q1^:ZMD],WNV9>@9$%/"[J0[U=_G_H/IO)%]1;S=(MY
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MA9B',MOQ+T"@4BBS+7_<R A1GP;@_2J# ^@'6J#^29 W_PU02P,$%     @
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M^K#<7%-6W57,39G'=1*V( /H\O'U-%W%3O-^G:<>>&CAG[)/]:[+OU'U_0F
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MVFX.>HVJ6RP?G"[\QR#<VTYG_N=,"C1%/H#]B4:,]0,;6'T=//L;4$L#!!0
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MK^YNQ>65F-[>7L\NIW?GMZ\/*HBG10>Q%W7F1$7/B HC\<'DU<J*\SQ1R;J
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MO"GJRT!0Z#+\R^^U'CH79H-'+B3UA81Q!T:,\KWT\OS,FJVP=!K4:,"B\FV
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M(WHI$7CM?;Z% NH\T %#$U:$B54IEK #)1M*%LK"9@)9YJB&6)8G,Q.)#_5
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M=@RC":*;[-O<O&KZ&R +GS#-SC2:)J\$/&J6B&$T&$U_X IHPR2:(@M@-!J
M!T7J<!A-IQRR@TDT'4QIQ$FDN7975Z@C9BNYEY0+@UI/=:MMEKKGJ8O-N +5
MY6Y?&3HAV]$J"AA3*.MW./JL>)! /YD26;V$P8M-Q<E<AE>_38[!H9_#(3MP
M4'J0!PKM:_=\6)4X(CGJ@H]3XP-7I(8;P)#/D- ^A>]_SA%7W8:S+@&'@2\V
ME765A*O6T4#UAKV*K] 7A.M\':)INX9:X03((B)^+E)XYHIZ/J2P,EU3T!VV
MN2ZDQ:,-PJ':VFLL5>@?('(\/IZ$QH/!"15FCHK38Z]3_<X[8J'LBE]+2=^(
MGO"DV*ZV#[+S\ ZY/QY><Z%45$7D8+7$U<'I=-R#.OF%-$R\V?"KY,)X;PH>
MKA7JF*4#V%\:J*V>$(/VF?K\#U!+ P04    " "!:'Y1SW-IU!@$  "X"
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M?B"6C.W(HZ_UCTJ _:M9_^UT*DKP6!-Q>]ZIAXK"V>JH(W0\I5ET![ EZ;K
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MRR''!E@O+ +8#7B#_4?8XE]02P,$%     @ @6A^429-.JTX"0  DA8  !D
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M&2!8VYK_U?>"B.2%%V=[7KB0%P@1CW@C@O*M[O1//[3-G6KQ:5@-?Z"CTML
MG*V1*M=="]]:>*_[Z?KJ_8>KGZ_>7'[XHB[?O/GX]<.7JP_OU:>/OUR]N7IW
MK8X_-94MK'$G/SSJ8#]\ZU$A:[_FM2_VK'U^H7YMZF[EU+NZ-&6^P", -$![
MX:%]?3&YXF6_G*O'YS-U<79Q-K'>XW#ZQ[3>XSWKO;6NJ!K7MT9]7*AKNZSM
MPA:Z[M1E431]W=EZJ3P&U-\O;US7 A_]8V+K)V'K)[3UDSU;O]%NI?Z^P;6W
MJC/WG;JIFN*/?XRA>7HE>Z)H,?J?=4JKA:UU75A=*>T<2':WTAU^LS8:SUHJ
M^%6OF[:S?\(O1>.ZF;I;V6*E]&;3-O<6N!W.N]"V5;>ZZHW2=:EL751]"9\7
ML-%I4Y^N\%/\KS2;QMG.J96I2F#@;N5! /39VG6VZU$&W7P"<4\#XIY.'O=Z
M!8"?=J9=P]*WQG6@(V#K!Z)R>FT+N-RS_I>546^:]4;76\ 8:*72M$ZY\8=M
M#3@W"I6F:A9JV>L6F,J8,GE*%08(@.R&N.X:=8-HE@<0<:2P;+>=X][.9!MH
MX-C]U)QGT.K*-6JEG3+_[&$YY4S1M[9#CB;&P+4*W;:6ETJHWJW:IE^N%/#$
MPG:J:14(RR01GP4B/IM$]&O;5,T2SBXL^F#Z32]KD8"[:_^VLI4AB@A._NK4
MS<Y3B ?D72&>*\#T(?6N+J_5DW-UN6QM ;H>4#ZC!TK;@FD1T9!?$/L.7QI?
MOC3(*@!TJ7I'-*Y9Y#3(GK-K6^D660&7+_3&=KJR?VHR7P60S+16*S&MN"F!
M=J&N@#'JK@$".J2\=5%4$S@1-(3, 1LZ@GH)1$,@4-IAY0H^=>H.#"3^V\"K
M[?!@KD<=X11(<\4<A.NX?K.I\)?>,5BXJU\<#E<88!J 4I:J]$W3MPP/2 CM
M<6O+'@$ 'F^JV]U5<)M_PA/(OR!]70N&4E8FE8<L+H<N9^DQ0#7!II9Q"*=?
MZ[I?@&2!!."R1)JYNH2'_P5R!A*AY!"RM_0Y0-*W()ES];4&5XD?2.1J"=Z2
M>X2R!$@#N/"4H#/W[@.P-"V<#)\EU@#] ])2 MT ^QW\PUH!%CC&54\0@F;-
M:AM^ !2LT)&Z-?GW\Q%9&6H6V _@3H"O$.>,&.!4AWB>! NAB@:)# 708DJ)
M/ ]*Y/FDM"=\_U#U,;V@O3U)A2G[&3D5CF'!U0+):1J1H8TN_M!+SZ)!$I@+
MX*2ZJK:,.,(FVUI^],:!0H;UX0'&,VC7.Y YP!?)!CY5@_5F#M(WH,)HH;GZ
M,/(IB@&N@<9CS10 TK $VL)X@0(^ EJT*$5]ZTB_W: J J+.F+3Y(AFA<[O2
MFEOTD<DNI5AJ;H +0-'-X(FRKTMTI^C$<+S3=7.+,$4$XDJD5M)EP+C6:!L1
M::B50?=UIE9E<U<C+.-8^7)()P_(YS?<)I02'<+6._(\O(R?#*73TPV01<^L
M=(LFFD#99DHI(?= E0;E._.*43RJJ+;,/<1@2*N:3/B&I"K5E($):0U3>78$
M+;/AZ.>0BFM-1>3NF@0M#U%QS,SAXXRK@]H2JQHLD*Y8[_TG=5E&"[:?=:UO
M+-D'V*&<!W'>#GWA7.Z A<<8S /\;RBV%T&QO9C40Y]:<#W:;CM3F\I+3Z3\
M U7=]!:@Z:9WF?XVUV](: B=_A1?M(#'&!D!H;G992W(HL&\NA4^9*8DC=BU
M]J;O"/_H'..+^"R20$R5.$J  983YA!@;/JM-N@=H*I#I00/KL7)!I:F58%\
M>$3=<91":P&<-;D]H&Z0<V^V [<1'M!+(O_\ 2C*Q"'E.,8 Z5M=%/VZ9_'+
MQ)[$%/:U+:W'[L)<O4V?L2Y%/KZD,$3%5,0IDAPS%I8PA;JX$,F(FT=%WQI'
M/A@S^PRQXZ%!9"WL/6D ]I>^4'!35>R<@=NWZ"M5@4RRY=-D!<M7ZG5O*Z+P
MQ5.U-1H"IO?BT$4\G9_)5XCD'I1A\IU_ZV\&HE-4&OZ#G_L6N _C=L02 (<_
MN[C6+X!KLP*I1PRVS:THE0 %.F ^GB&@+;GC(N*E=2#.@ M PN8@D1.G7GN/
M>[$PK:D!WS>FNS-FL"QYKMX+9UW5MEN2A#5F';R]872SBO5^H)<S-XC*O)+U
M?COI1+3&]+N8$'1U67;0:HC_C"L#S]0.8&[9!M#F&)> [P#<(=:NJ#3N ^I7
MZ5L-L0HQ!NP!#+!KM?@,+D@K +1&E#C6U/"_36-1C"YK?N2O;H<) V<M1C98
MFV[5>,2@*X("Q K&8#P5=3,2G9%8_MX[Y':[2,\WAPC1H!EMV?!@& XZ'G^,
MI%[IVTC9+F/Z632 FO-&Z.\#8H!*SL"RB$-<T:GCM?Z]:<F0-37RY$E^,"1M
M49"7MJRV4\;D93 F+R<U_7MP=NXL6/\'VHWIU6XAP XKAA]:!-^1B)'GU)-H
M K?6S=H6( 2U6=@NRMFB;=:@JKSGB>BX 6H164-.HFZZ)#9$YRSQ"M&?%,QF
M!F@>@;(N36N0)=I1N"/Z];,!"J,0?&B :H^/;RFI0-0$,CF(PS>>OY.W.TG:
MD%"5J(RF:'=^%M.S9Y/X%G&EQ!K"@+[30REY8.E;/-?8^E. )WGE\^G@+.(&
M,%4U]?(49:44[[/38,Y1?WQ;^N? IDRK;]MZZK07\;07!Y*2P+&G6![ D'#[
M32G) TO;>\Q)CBR?QF+B6R0YOJZKT*$>>Y%_95N7Q_;B0R\Q6ZE*TOQU&:6+
M!!4-21Z7L"U);1$87'*YE,]E@@FUH*O3G1.GRGLA7N%V6\H:M_U:5 K 12)M
MT(%G9<"!UL\1=@H]233)Y=])M>&6KRN(E$ZO"_ ,C*/ F/)?36DJ=B3RY3[#
M'O ,*@JB@/I:HQ8[/OI\_=4=L>;^9%JJC:&QSQ_ZQ _M@R4>GX@D8?H.!>;J
MW3T&<6Q1%L:RIX-O1.=-WBH%AW&%W4Q#8@$7?2O. E?WR*$$A<L9:?36P7:F
MFZXUYC+0HT;]S>D$"UXY/.9A8=\0%6,1W!BTSBZZ!+LO#=S877ZB8)G8@+PE
M5M\8 GJ_!@N$6.B+^\$Z$::?4;-U(("!0P@][.S437UJUINJV1HQY9&SW3 7
M-I(5B+D,9]I;6Q TA2&-8^X+L^G89QJ\C?$I6+B;E(YP<J[#%!IWWRG:C .P
M(S+^='-@,JY4,'%!+5)($TY+L6YZ?"^;YMZTA742) 6A"A&]=ERK*%ITM"D_
MM$K2!<&Q]7F%5 \ER$W=3N(I.0HZ$YA*V5EXTJC&JM_YXX.)PZ14 W:@(=_K
MX2I[>OU[3B..;W$9?Z2#D1K I!<I329_HA^H<N.2RB1(*] >U8T/"W*?LX?
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M*7C\K5Z"#/;K&Z[VTN,.-1B0J::MI'Y 0D":%J3-5CU"]%#(R0KY7BZN)\[
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MHF"IJCI7[]D^HP,C90[/76D6(O!IV8=67V 7,/L*$_1IF@4IX0AKI+;!TP-
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MU 05.M_4M=E G()A MWV>_XR\[Z)?4KP#J1%*P9?=;XT1=1^_9!P 4L79VE
MO):VKJ4&M;/O*U[C_!G8PU^X!0TDY7\UK-!N\8EG;*:N+J]?4VN-WQ7>X.>]
M1H/@NM(%?GT)WSZ7;^7&S@"CQ=Y8O*K)Q8PN<HG)HL)X94'P:+5_C&RK'T7;
MTX'@"_T5GXA;TTD<2+<U%,)BZOC.5+<87N(USJ%MC0Q9%JX;2D63FKD+<8P'
MR(: L!P Q\;]M%F0.\+KA.PZ)YQ<= #PF=&M2>WR69+&CYV%FIO*+D-O+06C
M_(YW;MG<!U+<Z90C"64IX[B<<_#K!8Y$>][PC.N5%>7Z/=?F%XM-,GYLQ0>J
M<[(=7(XXHQ1OD.4&1YHHE^&4A5W21 N5J[A.RXVZF-9'_%.NAAQ_! PW$N;-
M!S>3[(DG&9'C^.CSQZ]X$X94O1?JNR>S)\^>1(/%!GDZ*CLF?_OER6Q 0TE[
MX)*/7PZ79&\M?927.7]\(BGDO">2DG0VF2W%E2^><O4JXH$B=1QFHDQ.BP-C
MP<*2_&(XOTLD.A#YVEDIT,^@P:>7_1+'7OWMY0,.8-8#9 I+(^_%B446N=P$
M#]A]-GJU"/7-(OS M;&$R<'/B+)3.Q/S=TU?E>*]<Y]LYXNAG/6.LRZH/1CS
MHD[\%S))(<-EBQ['O.+M?+!><T-^K9:+P'PUB]^6JZC9BD<$96,V(=@U]:UM
MFSI&Y'[\1_GQGRP@DK'G$3PT'OLCN$9>0_H\G3\_^TN>%C)5Z,'QVBK:)C\J
MS4F8TG)]2'2">#C>=#2UKYNBYF(U_4H=ZY-]$^OPTOS-8\2_"G_RP*+2X?8Q
MO!N@:T0%<)HBN.XZ3)B2$F_I5[HASRO5P?TRODDCR2Q[[\AU1M/QJ?&'.YS\
MF3AG01OY2WVH4C1RW_;Y\^_5\<WT85_  \?6GAPZ<TK(R#^C["_=URQG!ILL
MPB630VG+!L>];FFH.:=%'R"W+'":8OHTYV= W$-'87P&OR#S3^E[A?E[X#C;
MD#%.K'LHQFV#U!0KC;0 8P:>:8$PE@=AO#D(8XO%5\D[(RD?/Q^DQ3S;"73<
M)69:=.$]_V"8S?<JR27I293$Q0  UAP$MC@(K,SS>%CRVANY0S24*K,BYQ?B
M"7%!8X=_ *C%0:#*!P/EQ2R[J3?4WP;=\8>Y&Z!;3D)W_G0*LAE:++X"$HW_
MP >;D6JA>Z*EN0 ;)ED(XF6'#/WPTUQWI-$]-1<.'@_3W"'>+<?WTID'G:\1
M[Y@9?]7/:B>A*;M5L=MI^!*@=S6)WJ</$/#\'@F=4)0\^(&'BR@:Y5Q^D*(D
MYN)X3T[@86XD.;8'8#XL\/\AF \%%,E(($W=,R5 "NKD=-\]G9V=G:FOUV^Y
M%P'"P6%YSK*_!Y:H (@X'$C[N*/S%&\'#K1>6\FWE/R78TP9"W<2UG'+?^;M
MB7\X[DGP\R.VB(*)H5O^2GW.03_U^P(RO*'].  \!CYN#WC?J<>SLR<OU:^@
M<];]VJ<V0]:?:1RZ"'+CIHZ?G)^K$PYHXZ><,P8*X%42DA!+K-"@7]D754IJ
M'<;]DFLOT*+P&>#[9T^? A(J:WRM@7N.XE]B$?8Z?OKXA3H9>52^9^8ZE6M
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MP/>+!@XNO^ &X:]?_O1_4$L#!!0    ( (%H?E&[\ZL*G ,  !H(   9
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M@/OK'?L/F[O.)2021SS]16.5])R. S&N29&J.=_>8I5/V_!%/)7V%[:5K^=
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MSMR:$8G2!IC]M1#ZZ-@"]="-_P%02P,$%     @ @6A^49$I40W-!   #PP
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MD>,.7#RK$U*K2*7$ED 7C-]3KH5\A+I"NPW!)&%LG;V/=J/0..BD?\F'24"
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M6 W4HB.U3702<=WNSR$.QQ %47 "+QZDQ@XO_@[>%==9)76K$&1!<@WC%>;
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MIQF1#5[0'+]LN<B(0E;L+%D(2I+2*$LMU[9;5D98;@QZI6PI!CU^4"G+Z5*
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M+J0 A:NQ%W<OIWUK[PQ^%KC5!W>PE2REW%CA-AM[@4T(.:;&(C ZGO$*.;=
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MHNUHI5B>,+A'1E$;&&-J4&GX:[C61E$_?3^Q?JM:O^76;_W_^C*F?C*,"XR
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M7E3:ORCLAY_8#T*XEL(D&KZ+&./7"CQRIO(HW'AT$=9J'.:+)K2"8PC]T/\
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MK7[PMJ:,;E%&]TP4=/?6%WOZYP4%6510B3K"0*\HL/??&"#MY@STB\'ZEV
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M'SWMY0;H$H0)T.]7G*NG&W/^+/[?,/H74$L#!!0    ( (%H?E'XFD4^A (
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M=,Y5"!F*JF-7$\57ING-N8(6:H9+^,@1H0/@?<:YVDUT'VT^F]$_4$L#!!0
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MRPW!(>':0-U?,28/ _V \JQJ\@-02P,$%     @ @6A^49V]MRA! P  < D
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MPR5V9J"L .[G4IKUQ!KH>KWI;U!+ P04    " "!:'Y1@>/P.OX%   T(P
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MD9GB9'[UJ$UM6OO$*%33;5%-HU#MB/*CFBI4TY>A>IM:GBE\LUW"-U/X9F^
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M:-/RN.'.M+$H[0-F/Q5"OTZL0-L8+[X"4$L#!!0    ( (%H?E&;,_)5H08
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MV#NK\V2PLDQ7'T#KXRO\7268;]B5I\XV20Q6-F4 71^';F>2^(9-?>M&I _
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MT8S$S4;QRDZ5:Z[TC&J7._T9080QT-<WG*OGC0G0?9C,OP%02P,$%     @
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M;6<_.3#\5=NKYO>Z?N^HYK?3G[R1\4_L_">O(P!D5P$ ^U'8VR/$8!4 3J(
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MF= +U/LIYW)]HP/4Y\Z#_P%02P,$%     @ @6A^46Z.T&B1 P  LPT  !D
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MCAN6V.9!60/<7TIIMA-+T/TXTG]02P,$%     @ @6A^4?CG,;,9 P  SP@
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M9N@2C:E:,*%229!80DPTIHS$B/(L:VSTYY 2B!$((&(4SRFCFA*%SL=66ET
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MX1I>740: =A?"J%W$V.@>,?U?P-02P,$%     @ @6A^43\="K<M P  ) T
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M_[U5_B!YG/VR9L6EY&'V<D.)3X5: )\_<O"J>% _UBE_]7;^%U!+ P04
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M'>!+I5]O'97M&Z_<8NC6_&1T"LESFG]@#<-DQ=_Y/([Y+%!DC#D8<?(^FGU
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M9X*-/A5Z ZYO.5?'@390_^LP^P]02P,$%     @ @6A^47T<K1H" P  <PD
M !D   !X;"]W;W)K<VAE971S+W-H965T.30N>&ULS5;+;N(P%/T5*^JBE:;-
M"P)4@)1"F4'34@2TLQC-PB0.6$UBQG:@_?NY=M),2@-BT44WB1W?<W+NP[[N
M[AA_%FM")'I)XE3TC+64FVO3%,&:)%A<L0U)825B/,$2IGQEB@TG.-2@)#8=
MR_+,!-/4Z'?UMRGO=UDF8YJ2*4<B2Q+,7V](S'8]PS;>/LSH:BW5![/?W> 5
MF1/YN)ERF)DE2T@3D@K*4L1)U#-\^WI@:X"V>*)D)RICI%Q9,O:L)N.P9UA*
M$8E)(!4%AM>6#$@<*R;0\;<@-<I_*F!U_,8^TLZ#,TLLR(#%OV@HUSVC;:"0
M1#B+Y8SM?I#"H:;B"U@L]!/M"EO+0$$F)$L*,"A(:)J_\4L1B K ;AP . 7
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M9/*\P^<3R3:Z22Z9A):KAVNX%1&N#& ]8DR^353?+>]9_7]02P,$%     @
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M0T@[0AKB;AV%**\$B=G$F@:L1[.:7X14 YN#D]I?R@-9/I7,H]G]XFEQ^[B
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MTF#S<D.;&U#6 /=S*<UI8@.T?UB6OP!02P,$%     @ @6A^4:;:4KB9 P
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M;GD"R5L %R6H=?"W.@S]LXB#8G%% N\C\9M^\PBAT;O=O>LS=(+Z6 *+%YS
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M>R0W9,UUDDM=*B R0SD,XSFDA(LJ89SP&\P&O,%$BH3GO-I$8RX260 Q[(7
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M5E636[4P<N^&GXTT.$JYQQU.NZ"L ;[/I#2GA3V@GI_G_P%02P,$%     @
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M^;=8.>H$&Q7';AG_P* ;01\:6[P-_4:#<?<GTV\$%KL5MBW]I^*)@_ <KT9
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M>V#.%N$F41_YTY^LG!#-_44\D<5?\%3:>CT0;:3B:3E8(TCC;/L__%XNQ-X
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M0#\'],\!3@O R0$FU586BLG#G"HZ'@E^0D);@S?]8))IT!!^F.A]?U("WH:
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M5+TC0._8;78#](ZJ=P3H'57O"- [JMX1H'=4O2- [ZAZ1X#>2?5. +V3ZIT
M>B?5.P'T3JIW NB=5.\$T#MU?U8"]$ZJ=P+HG53O!- [J=X)H'=2O1- [ZQZ
M9X#>6?7. +VSZIT!>F?5.P/TSJIW!NB=5>\,T#MWATT >F?5.P/TSJIW!NB=
M5>\,T+NHW@6@=U&]"T#OHGH7@-Y%]2X O8OJ70!Z%]6[ /0NJG<!Z%VZPX(
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M'/?_.'YYQGW5#J_YR7)G_N8G4$L! A0#%     @ @6A^40=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "!:'Y14Y?V4>T    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "!:'Y1F5R<(Q &  "<)P  $P
M    @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (%H?E&S
M6E;N6P,  &@+   8              " @0P(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "!:'Y1H>$ ,*(%  "4%@  &
M    @(&="P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
M@6A^4<*>#0W+!@  E1L  !@              ("!=1$  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( (%H?E&0L5MQ]@4  !(9   8
M          " @788  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " "!:'Y1F@2K-4X"  "=!   &               @(&B'@  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ @6A^4>KXYJ!!"   QB$
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M965T,3 N>&UL4$L! A0#%     @ @6A^4?-%QP*C P  !@@  !D
M     ("!8UH  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (%H?E%[^&CJE@D  *X8   9              "
M@>=T  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ @6A^
M46:=H5W?!@  *1$  !D              ("!M'X  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " "!:'Y1&=5^C+8.  "%*   &0
M        @('*A0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( (%H?E'J$&0X Q4  !Y$   9              " @;>4  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ @6A^40#2M5Y<!P  *10
M !D              ("!\:D  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " "!:'Y1:J0MO<@.  "O)P  &0              @(&$L0
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( (%H?E%7UJ'L
MH00  /$*   9              " @8/   !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ @6A^40*H/+E7!   1PD  !D
M ("!6\4  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "!
M:'Y1!9E^E;8(  "R%@  &0              @('IR0  >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( (%H?E'/<VG4& 0  +@(   9
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M970R.2YX;6Q02P$"% ,4    " "!:'Y13]%X^F0'   Z$P  &0
M    @(%LZP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M (%H?E'S<420=00  /D*   9              " @0?S  !X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ @6A^4<=E[H)B P  [@8  !D
M             ("!L_<  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " "!:'Y1 >1U?DD&  #'#0  &0              @(%,^P  >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( (%H?E%AMF^YZ 8
M )@/   9              " @<P! 0!X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ @6A^44Z/-)/N(0  "7,  !D              ("!
MZP@! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "!:'Y1
MN_.K"IP#   :"   &0              @($0*P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( (%H?E%UANW0R (  #H&   9
M      " @>,N 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ @6A^40+[ 5.G @  @ 4  !D              ("!XC$! 'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " "!:'Y1D2E1#<T$   /#
M&0              @(' - $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( (%H?E%3('P^LP,  $0(   9              " @<0Y 0!X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ @6A^47(/%_R_
M!0  &P\  !D              ("!KCT! 'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    " "!:'Y1,<[:%&H#  #X"   &0
M@(&D0P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( (%H
M?E'FB5I<AP,  -D'   9              " @45' 0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ @6A^406B2 A@!@  /!,  !D
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M=#0X+GAM;%!+ 0(4 Q0    ( (%H?E$(=O5RZ (   $&   9
M  " @>=? 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
M@6A^45X$$D47 P  0 8  !D              ("!!F,! 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    " "!:'Y1:/*4R<<&  ":%   &0
M            @(%49@$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    ( (%H?E%8Q,T\(00   ,*   9              " @5)M 0!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ @6A^401\XG3B P
MU L  !D              ("!JG$! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    " "!:'Y184YT'3L#   %#@  &0              @('#
M=0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( (%H?E'#
M0C84R ,  -0*   9              " @35Y 0!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @ @6A^40?VIL^C P  >Q   !D
M     ("!-'T! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (%H?E&_,9TZE@0  +<2   9              "
M@9:, 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ @6A^
M49V]MRA! P  < D  !D              ("!8Y$! 'AL+W=O<FMS:&5E=',O
M<VAE970V,BYX;6Q02P$"% ,4    " "!:'Y1Y7-F>0$#  #Z!P  &0
M        @(';E $ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0
M   ( (%H?E%MTN)W=P,  /<)   9              " @1.8 0!X;"]W;W)K
M<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ @6A^48'C\#K^!0  -",
M !D              ("!P9L! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q0
M2P$"% ,4    " "!:'Y1@\X$ZE4#  "Z"0  &0              @('VH0$
M>&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( (%H?E$//!FJ
M+0P  $19   9              " @8*E 0!X;"]W;W)K<VAE971S+W-H965T
M-C<N>&UL4$L! A0#%     @ @6A^45!].7_W @  K0<  !D
M ("!YK$! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "!
M:'Y1 -UH.GP#   D"P  &0              @($4M0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( (%H?E&;,_)5H08  +LI   9
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M970W-"YX;6Q02P$"% ,4    " "!:'Y1AL<HAPD,  !V00  &0
M    @($'T0$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (
M (%H?E%]A!1,F0(  &\&   9              " @4?= 0!X;"]W;W)K<VAE
M971S+W-H965T-S8N>&UL4$L! A0#%     @ @6A^4< 6LN&5 P  I P  !D
M             ("!%^ ! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"
M% ,4    " "!:'Y1SCTA)G8$  "#%@  &0              @('CXP$ >&PO
M=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( (%H?E%NCM!HD0,
M +,-   9              " @9#H 0!X;"]W;W)K<VAE971S+W-H965T-SDN
M>&UL4$L! A0#%     @ @6A^442[@-<# P  [@<  !D              ("!
M6.P! 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    " "!:'Y1
MX.4QU*("  !$!@  &0              @(&2[P$ >&PO=V]R:W-H965T<R]S
M:&5E=#@Q+GAM;%!+ 0(4 Q0    ( (%H?E'XYS&S&0,  ,\(   9
M      " @6OR 0!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%
M  @ @6A^40L>(6". @  - <  !D              ("!N_4! 'AL+W=O<FMS
M:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " "!:'Y1PLVI%$8#   P"0
M&0              @(& ^ $ >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+
M 0(4 Q0    ( (%H?E$TC38@=P(   8&   9              " @?W[ 0!X
M;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ @6A^4<H8!(TN
M P  TPD  !D              ("!J_X! 'AL+W=O<FMS:&5E=',O<VAE970X
M-BYX;6Q02P$"% ,4    " "!:'Y1/QT*MRT#   D#0  &0
M@($0 @( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( (%H
M?E&QKU-VEP@   $G   9              " @70% @!X;"]W;W)K<VAE971S
M+W-H965T.#@N>&UL4$L! A0#%     @ @6A^4>GW*S0E!@  K1\  !D
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M=#DS+GAM;%!+ 0(4 Q0    ( (%H?E%]'*T: @,  ',)   9
M  " @5<D @!X;"]W;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%     @
M@6A^454#U).%!   9A8  !D              ("!D"<" 'AL+W=O<FMS:&5E
M=',O<VAE970Y-2YX;6Q02P$"% ,4    " "!:'Y1+$EO)U0"   $!0  &0
M            @(%,+ ( >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4
M Q0    ( (%H?E&[:>5XU ,  .,.   9              " @=<N @!X;"]W
M;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @ @6A^47.-B]Y< P
MO @  !D              ("!XC(" 'AL+W=O<FMS:&5E=',O<VAE970Y."YX
M;6Q02P$"% ,4    " "!:'Y1IMI2N)D#   X"@  &0              @(%U
M-@( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( (%H?E%-
M[MF3&P,  $T(   :              " @44Z @!X;"]W;W)K<VAE971S+W-H
M965T,3 P+GAM;%!+ 0(4 Q0    ( (%H?E%6)D:0\0,  $L+   :
M      " @9@] @!X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0
M   ( (%H?E&)R%@""P0  +X2   :              " @<%! @!X;"]W;W)K
M<VAE971S+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( (%H?E&.-@UK<@8  .8F
M   :              " @01& @!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM
M;%!+ 0(4 Q0    ( (%H?E'?>MT4"P,   @-   :              " @:Y,
M @!X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4 Q0    ( (%H?E&X
MSZUWN0(  (\&   :              " @?%/ @!X;"]W;W)K<VAE971S+W-H
M965T,3 U+GAM;%!+ 0(4 Q0    ( (%H?E&4$/5-% 0  "0/   :
M      " @>)2 @!X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0
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M965T,3$P+GAM;%!+ 0(4 Q0    ( (%H?E%DO)U$T0(  ,8'   :
M      " @3YE @!X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0
M   ( (%H?E'<;19,(P8  $P<   :              " @4=H @!X;"]W;W)K
M<VAE971S+W-H965T,3$R+GAM;%!+ 0(4 Q0    ( (%H?E&^?4M?:0(  #X-
M   -              "  :)N @!X;"]S='EL97,N>&UL4$L! A0#%     @
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H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !X '@ #"$  +U_ @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>404</ContextCount>
  <ElementCount>565</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>111</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/ConsolidatedStatementsOfFinancialPosition</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/ConsolidatedStatementsOfLossIncomeAndComprehensiveLossIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/ConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - NATURE OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/NatureOfOperations</Role>
      <ShortName>NATURE OF OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - BASIS OF PREPARATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/BasisOfPreparation</Role>
      <ShortName>BASIS OF PREPARATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - SHORT TERM INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/ShortTermInvestments</Role>
      <ShortName>SHORT TERM INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - ACCOUNTS RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/AccountsReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - LOAN RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/LoanReceivable</Role>
      <ShortName>LOAN RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - BIOLOGICAL ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/BiologicalAssets</Role>
      <ShortName>BIOLOGICAL ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/PropertyPlantAndEquipment</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/IntangibleAssets</Role>
      <ShortName>INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - LONG-TERM DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/LongTermDebt</Role>
      <ShortName>LONG-TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - SHARE CAPITAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/ShareCapital</Role>
      <ShortName>SHARE CAPITAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - OTHER LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OTHERLIABILITIES</Role>
      <ShortName>OTHER LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - INVESTMENTS IN ASSOCIATES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/InvestmentsInAssociates</Role>
      <ShortName>INVESTMENTS IN ASSOCIATES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - CAPITAL MANAGEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/CapitalManagement</Role>
      <ShortName>CAPITAL MANAGEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/FairValueOfFinancialInstrumentsAndFinancialRiskFactors</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/Revenue</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - COST OF SALES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/COSTOFSALES</Role>
      <ShortName>COST OF SALES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/Contingencies</Role>
      <ShortName>CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - OPERATING SEGMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SegmentedInformation</Role>
      <ShortName>OPERATING SEGMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/GeneralAndAdministrativeExpensesByNatureExcludingDiscontinuedOperations</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - LICENSING AGREEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/LicensingAndEndorsementAgreement</Role>
      <ShortName>LICENSING AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - GOVERNMENT SUBSIDIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/GOVERNMENTSUBSIDIES</Role>
      <ShortName>GOVERNMENT SUBSIDIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OperationsOfTraumaHealingCenters</Role>
      <ShortName>OPERATIONS OF TRAUMA HEALING CENTERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0035 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/SignificantAccountingPolicies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0038 - Disclosure - SHORT TERM INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SHORTTERMINVESTMENTSTables</Role>
      <ShortName>SHORT TERM INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/ShortTermInvestments</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0039 - Disclosure - ACCOUNTS RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/ACCOUNTSRECEIVABLETables</Role>
      <ShortName>ACCOUNTS RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/AccountsReceivable</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0040 - Disclosure - BIOLOGICAL ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/BIOLOGICALASSETSTables</Role>
      <ShortName>BIOLOGICAL ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/BiologicalAssets</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0041 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/Inventories</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0042 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/PropertyPlantAndEquipment</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0043 - Disclosure - INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/INTANGIBLEASSETSTables</Role>
      <ShortName>INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/IntangibleAssets</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0044 - Disclosure - Long-term debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/LONGTERMDEBTTables</Role>
      <ShortName>Long-term debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0045 - Disclosure - SHARE CAPITAL (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SHARECAPITALTables</Role>
      <ShortName>SHARE CAPITAL (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/ShareCapital</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0046 - Disclosure - OTHER LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OTHERLIABILITIESTables</Role>
      <ShortName>OTHER LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/OTHERLIABILITIES</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0047 - Disclosure - INVESTMENTS IN ASSOCIATES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/INVESTMENTSINASSOCIATESTables</Role>
      <ShortName>INVESTMENTS IN ASSOCIATES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/InvestmentsInAssociates</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0048 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSTables</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/RelatedPartyTransactions</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0049 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSTables</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/FairValueOfFinancialInstrumentsAndFinancialRiskFactors</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0050 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/Revenue</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0051 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/GENERALANDADMINISTRATIVEEXPENSESBYNATUREexcludingdiscontinuedoperationsTables</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/GeneralAndAdministrativeExpensesByNatureExcludingDiscontinuedOperations</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0052 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/IncomeTaxes</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0053 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSTables</Role>
      <ShortName>OPERATIONS OF TRAUMA HEALING CENTERS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/OperationsOfTraumaHealingCenters</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0054 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetail</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0055 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about estimated useful lives of property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about estimated useful lives of property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0056 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES  - Disclosure of detailed information about reconciliation of operating leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOperatingLeasesDetail</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES  - Disclosure of detailed information about reconciliation of operating leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0057 - Disclosure - SHORT TERM INVESTMENTS - Disclosure of detailed information about short term investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutShortTermInvestmentsDetails</Role>
      <ShortName>SHORT TERM INVESTMENTS - Disclosure of detailed information about short term investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0058 - Disclosure - ACCOUNTS RECEIVABLE (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/AccountsReceivableNarrativeDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/ACCOUNTSRECEIVABLETables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0059 - Disclosure - ACCOUNTS RECEIVABLE - Disclosure of detailed information about accounts receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAccountsReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE - Disclosure of detailed information about accounts receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0060 - Disclosure - LOAN RECEIVABLE (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/LoanReceivableNarrativeDetails</Role>
      <ShortName>LOAN RECEIVABLE (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/LoanReceivable</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0061 - Disclosure - BIOLOGICAL ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/BiologicalAssetsNarrativeDetails</Role>
      <ShortName>BIOLOGICAL ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/BIOLOGICALASSETSTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0062 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about changes in carrying value of biological assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInCarryingValueOfBiologicalAssetsDetails</Role>
      <ShortName>BIOLOGICAL ASSETS - Disclosure of detailed information about changes in carrying value of biological assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0063 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about unobservable inputs and their impact on fair value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnobservableInputsAndTheirImpactOnFairValueDetails</Role>
      <ShortName>BIOLOGICAL ASSETS - Disclosure of detailed information about unobservable inputs and their impact on fair value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0064 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about fair value adjustment to biological assets and inventory sold (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutFairValueAdjustmentToBiologicalAssetsAndInventorySoldDetails</Role>
      <ShortName>BIOLOGICAL ASSETS - Disclosure of detailed information about fair value adjustment to biological assets and inventory sold (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0065 - Disclosure - INVENTORIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/InventoriesNarrativeDetails</Role>
      <ShortName>INVENTORIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/INVENTORIESTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0066 - Disclosure - INVENTORIES - Disclosure of detailed information about inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutInventoriesDetails</Role>
      <ShortName>INVENTORIES - Disclosure of detailed information about inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0067 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0068 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Disclosure of detailed information about property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT - Disclosure of detailed information about property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0069 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Disclosure of detailed information about additions of property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAdditionsOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT - Disclosure of detailed information about additions of property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0070 - Disclosure - INTANGIBLE ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>INTANGIBLE ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/INTANGIBLEASSETSTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0071 - Disclosure - INTANGIBLE ASSETS - Disclosure of detailed information about intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutIntangibleAssetsDetails</Role>
      <ShortName>INTANGIBLE ASSETS - Disclosure of detailed information about intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0072 - Disclosure - LONG-TERM DEBT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>LONG-TERM DEBT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/LongTermDebt</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0073 - Disclosure - LONG-TERM DEBT - Disclosure of long term debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfLongTermDebtDetails</Role>
      <ShortName>LONG-TERM DEBT - Disclosure of long term debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0074 - Disclosure - LONG-TERM DEBT - Disclosure of long term debt (Parentheticals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfLongTermDebtParentheticalsDetails</Role>
      <ShortName>LONG-TERM DEBT - Disclosure of long term debt (Parentheticals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0075 - Disclosure - LONG-TERM DEBT - Disclosure of principal repayments required on long-term debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfPrincipalRepaymentsRequiredOnLongTermDebtDetails</Role>
      <ShortName>LONG-TERM DEBT - Disclosure of principal repayments required on long-term debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0076 - Disclosure - SHARE CAPITAL (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SHARECAPITALDetails8</Role>
      <ShortName>SHARE CAPITAL (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/SHARECAPITALTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0077 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about warrants, valuation assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutWarrantsValuationAssumptionsDetails</Role>
      <ShortName>SHARE CAPITAL - Disclosure of detailed information about warrants, valuation assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0078 - Disclosure - SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails</Role>
      <ShortName>SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0079 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about outstanding stock options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingStockOptionsDetails</Role>
      <ShortName>SHARE CAPITAL - Disclosure of detailed information about outstanding stock options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0080 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about options, valuation assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsDetails</Role>
      <ShortName>SHARE CAPITAL - Disclosure of detailed information about options, valuation assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0081 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about outstanding RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOutstandingRsusDetails</Role>
      <ShortName>SHARE CAPITAL - Disclosure of detailed information about outstanding RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0082 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about outstanding PSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SHARECAPITALPerformanceShareUnits</Role>
      <ShortName>SHARE CAPITAL - Disclosure of detailed information about outstanding PSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0083 - Disclosure - SHARE CAPITAL - Disclosure of detailed information about Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutLossPerShareDetails</Role>
      <ShortName>SHARE CAPITAL - Disclosure of detailed information about Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0084 - Disclosure - SHARE CAPITAL - Disclosure of anti-dilutive securities excluded from computation of diluted earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedEarningsPerShareDetails</Role>
      <ShortName>SHARE CAPITAL - Disclosure of anti-dilutive securities excluded from computation of diluted earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0085 - Disclosure - OTHER LIABILITIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OTHERLIABILITIESDetailTextuals</Role>
      <ShortName>OTHER LIABILITIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/OTHERLIABILITIESTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0086 - Disclosure - OTHER LIABILITIES - Disclosure of detailed information about carrying value of other liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OTHERLIABILITIESDetails</Role>
      <ShortName>OTHER LIABILITIES - Disclosure of detailed information about carrying value of other liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0087 - Disclosure - OTHER LIABILITIES - Disclosure of detailed information about lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OTHERLIABILITIESDetails1</Role>
      <ShortName>OTHER LIABILITIES - Disclosure of detailed information about lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0088 - Disclosure - OTHER LIABILITIES - Disclosure of detailed information about undiscounted contractual payments relating to current and future lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OTHERLIABILITIESDetails2</Role>
      <ShortName>OTHER LIABILITIES - Disclosure of detailed information about undiscounted contractual payments relating to current and future lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0089 - Disclosure - INVESTMENTS IN ASSOCIATES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/InvestmentsInAssociatesNarrativeDetails</Role>
      <ShortName>INVESTMENTS IN ASSOCIATES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/INVESTMENTSINASSOCIATESTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0090 - Disclosure - INVESTMENTS IN ASSOCIATES - Disclosure of detailed information about carrying value of investments in associates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutCarryingValueOfInvestmentsInAssociatesDetails</Role>
      <ShortName>INVESTMENTS IN ASSOCIATES - Disclosure of detailed information about carrying value of investments in associates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0091 - Disclosure - RELATED PARTY TRANSACTIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSDetails1</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/RELATEDPARTYTRANSACTIONSTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0092 - Disclosure - RELATED PARTY TRANSACTIONS - Disclosure of detailed information about management and board compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutManagementAndBoardCompensationDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS - Disclosure of detailed information about management and board compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0093 - Disclosure - CAPITAL MANAGEMENT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/CAPITALMANAGEMENTDetails</Role>
      <ShortName>CAPITAL MANAGEMENT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/CapitalManagement</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0094 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSDetails2</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/FAIRVALUEOFFINANCIALINSTRUMENTSANDFINANCIALRISKFACTORSTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0095 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Disclosure of detailed information about aging of trade receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutAgingOfTradeReceivablesDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Disclosure of detailed information about aging of trade receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0096 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Disclosure of detailed information about contractual maturities relating to their undiscounted cash flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutContractualMaturitiesRelatingToTheirUndiscountedCashFlowsDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Disclosure of detailed information about contractual maturities relating to their undiscounted cash flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0097 - Disclosure - REVENUE (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/RevenueNarrativeDetails</Role>
      <ShortName>REVENUE (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/REVENUETables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0098 - Disclosure - REVENUE - Disclosure of detailed information about revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRevenuesDetails</Role>
      <ShortName>REVENUE - Disclosure of detailed information about revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0099 - Disclosure - COST OF SALES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/COSTOFSALESDetailTextuals</Role>
      <ShortName>COST OF SALES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/COSTOFSALES</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0100 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) - Disclosure of detailed information about general and administrative expenses by nature (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpensesByNatureDetails</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES BY NATURE (EXCLUDING DISCONTINUED OPERATIONS) - Disclosure of detailed information about general and administrative expenses by nature (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/GENERALANDADMINISTRATIVEEXPENSESBYNATUREexcludingdiscontinuedoperationsTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0101 - Disclosure - INCOME TAXES - Disclosure of detailed information about components of deferred income tax expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutComponentsOfDeferredIncomeTaxExpenseDetails</Role>
      <ShortName>INCOME TAXES - Disclosure of detailed information about components of deferred income tax expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0102 - Disclosure - INCOME TAXES - Disclosure of detailed information about reconciliation of income tax expense at the statutory rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseAtTheStatutoryRateDetails</Role>
      <ShortName>INCOME TAXES - Disclosure of detailed information about reconciliation of income tax expense at the statutory rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0103 - Disclosure - INCOME TAXES - Disclosure of detailed information about recognized deferred tax assets and liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES - Disclosure of detailed information about recognized deferred tax assets and liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0104 - Disclosure - INCOME TAXES - Disclosure of detailed information about changes in temporary differences (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutChangesInTemporaryDifferencesDetails</Role>
      <ShortName>INCOME TAXES - Disclosure of detailed information about changes in temporary differences (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0105 - Disclosure - INCOME TAXES - Disclosure of detailed information about non-capital loss carryforwards available to offset future taxable income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutNonCapitalLossCarryforwardsAvailableToOffsetFutureTaxableIncomeDetails</Role>
      <ShortName>INCOME TAXES - Disclosure of detailed information about non-capital loss carryforwards available to offset future taxable income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0106 - Disclosure - INCOME TAXES - Disclosure of detailed information about unrecognized deductible temporary differences and unused tax losses for no deferred tax asset recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesAndUnusedTaxLossesForNoDeferredTaxAssetRecognizedDetails</Role>
      <ShortName>INCOME TAXES - Disclosure of detailed information about unrecognized deductible temporary differences and unused tax losses for no deferred tax asset recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0107 - Disclosure - LICENSING AGREEMENT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/LicensingAndEndorsementAgreementNarrativeDetails</Role>
      <ShortName>LICENSING AGREEMENT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/LicensingAndEndorsementAgreement</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>0108 - Disclosure - GOVERNMENT SUBSIDIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/GOVERNMENTSUBSIDIESDetailTextuals</Role>
      <ShortName>GOVERNMENT SUBSIDIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/GOVERNMENTSUBSIDIES</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>0109 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSDetails4</Role>
      <ShortName>OPERATIONS OF TRAUMA HEALING CENTERS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/OPERATIONSOFTRAUMAHEALINGCENTERSTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>0110 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of derecognized assets and liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDerecognizedAssetsAndLiabilitiesDetails</Role>
      <ShortName>OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of derecognized assets and liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>0111 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of detailed information about Operating income (loss) of THCI and loss from remeasurement of assets and liabilities classified as held for sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfDetailedInformationAboutOperatingIncomeLossOfThcAndLossFromRemeasurementOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails</Role>
      <ShortName>OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of detailed information about Operating income (loss) of THCI and loss from remeasurement of assets and liabilities classified as held for sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>0112 - Disclosure - OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of Cash flows generated by THCI for reporting periods (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/DisclosureOfCashFlowsGeneratedByThcForReportingPeriodsDetails</Role>
      <ShortName>OPERATIONS OF TRAUMA HEALING CENTERS - Disclosure of Cash flows generated by THCI for reporting periods (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="ogi-20200831.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>0113 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.organigram.ca/role/SubsequentEventsNarrativeDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.organigram.ca/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>112</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ogi-20200831.xml</File>
    <File>ogi-20200831.xsd</File>
    <File>ogi-20200831_cal.xml</File>
    <File>ogi-20200831_def.xml</File>
    <File>ogi-20200831_lab.xml</File>
    <File>ogi-20200831_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>146
<FILENAME>0001062993-20-005949-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062993-20-005949-xbrl.zip
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M/]' .FQ3>N,N7ZRPB^FN(N<=&=Y7%'RVEE: S$M"=D6HGZ29?\FUPQP&1G5
M62P<H,@<6[R^"O!RE#6[,1S#-!Y6*]<+UDYXH-$K<F:;JYEKQ*2^!>UCNV31
M*EH-2"Z^/J-50.C)LQW=><O:+9-[P "_,3QO@Q70TEV#XMEM%;U%*P_A5B+
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MRGS W<>/N:.]8T-.N0 O"KK><KU ;8$HY(3VC2,Y90.:0G4AZQH[SNUG-L*
M8M4!DD2=0M8^-WI!OT.E :!HY*Z#^!QN9=,!DH0;=8N'MREVC>YG\RR;)3Z/
M&YC)>G+K:+R?7Q)T29CF%PIH0MN9APOQ0!L7%U64%3JQW4E.=,H'/;WHY%4,
M<!S59:(K'.NFLWIRUN45%(@\U5NY:YP[MU][>E[E+'S+9_#>>D=<7A8@<,[
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M$ARI\62"(TQ%*CF_:P0M84BO9K>EUJ<!E^8DL;AP@^"@/GIE'@)111R+>"%
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MX4KNKVQ^J] 3]U 1H561XKHD \VKLL9FMSZ6?<*39+V$T)_FFXV<#',CB0E
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M7^3I@[<H0$!/!4 CLHZHKTDF$"Y"Y\4!/KJ^P"N*N2[YC(7]"@N9"8F$+3V
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MJ)WI[)O-7.1'>"[]'>@+2E:IZ$&YK,7:BUO<<5Z1=Q@<,,1F*1K=8JL@&X.
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M*\]@?^.3)'"01(0U\0=UE9@I'<0$ .8KGAK8X6@MH"HGG4BUQA_UV+'Z6K0
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MTUDR$PY93))\3B)3'DYWUG-L@IFA]]+IFX-"["9LW\:H7%:'L!.RQ[ SV@+
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MZ\[5.IVOUEAGD0WWAL+J ]_N0ZZ%YHR=TKR#H;#J!ORT!:E@<(H":.8<I^>
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M+TO,E/#4IHIZBVCQQT>A&IL5MPTW^L5N-G2G$QNVDYFP*)\,D]ES;_%9<B/
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M/A 0=!MA+Z/YA6>M"%-\H&;CB06/D'X3I@^) D=#QTLF#XLZP*.=_Z3"^7)
MOLJ+\'*#(V=4-1JA-Y&>H\I:*)$TT0XKN*;PU7@,I+D8N!0S#XH&G,,4OB7F
M9- ],JY%[BFU%$^NJ9R09*:\3+("$WX>07<[R1M";BKC&(MLI+ 6J$_J!#]?
M!QI8TWS5J:HC9JEN/0&&>QP!#@#!Z&%S0(&J/_+O$8H?RPBI^IG ,A=E1UE)
M\E:2I _;EA(A,0P-S &++01(MH.8D9HHMPUNB>.CF^MOT()<U/./G'^T*JU.
M2SLQR$FS.$?@& -\9R>5W#X2J7GPR.99_I'DX34OI<?4FR<B/3^+?H@9L+[1
MY R>W&A3Z9ZF R8-02<,S#:,H1>+\KJ@#(7,HMF-@A/"\$VF3%:V=^'?]J?W
MT'^MB7<T:KE=:/=$&?8$B&#.T$*T@PS6?:9(]61='SFQ7S'DI?:*($HI\!"7
MWKK$FB+>!;:N,],$]"F:!IZ(NA J:2J+M:FJ0S<U "U*W"_4JOQ! .6+[C"C
M*?1ID77S^+QH@/$(-Q23%^64=#<Y*(3W1!,HTT]!I;^P\-'G-J/.T9$='QS9
M\2$3YQ0]$ OH$$GJ%] :]CNL3_NT6_O%;IZR;!YE4P0*FDA:3OIX*'M74EZD
MYU-1I+!/A'=/FK%1*(NGP8HBD['@-%@&XKYLN=$?W&I,?JPV1/S*QPRV=]5Z
M\[0MQUE.GCAV3S1=YO2 Y<M\>MX$J45L(YK9#1AAHT&3X#02!B2E^ZE E*NZ
MZ>$1(,:/$#11)KD0I9[(+Y+ .4;!B?3E)BESD6$1MXJ@NB074NX?ODC$;-"H
ME:5Z0V[<(-/BX>JUP8%=,H/EX0(>'JS(PSU^Y;'OGRQC95.K:65:: L(X&\R
M.A@@XD@M/&-Z9+KI2F,W0ARL&!P#V>.F9=(#8]+ABDQ:KW&9O(Q#2?HI'U F
M]H6_.U"$QS6Z'Z'CQ?#DJ(+J9V49#A]<D)Q\\)RT0\MZA\9ZWNJL-UC*>C$
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MGQ!GK@G_M2IG@)<B:_$'!4'T!*^:AM& K\LC2!W^@,DTY:+ )2H275S.?<.
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MSZ=?;J73+^?2Q?_[=OEUB_NLAY-7;93K>L#;C<MJQN7[6;-/_$$.3(KZ4OK
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M*9-4Y0W]0'+IF<DH2-^6HAPU,! ?WTC7W%&=1/V3;PD)+P>%XW;+;;>?"8:
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MMTGD.>#KKO:"Y)LK>54Q9%M=45I9!*$+G;P>CJFES2Z\GFGE#KH>A@%P V[
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M 8X=CF.V(MMVP>N@03*0;*L!6OR:>!,D \DJ'*!CRQT=[A(DJ]22R5;'!L?
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M"+#59O>Z$?6W,.V4_+$A:SJNF@%G8"T@^<W6PI$MM:&W*8 S%7%&E1U%!V?
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M&+:UE@F*2>G^INWGVR MO'3JDW@8CJ+=J:JSK$S:\LZ%1LBF&9D$/WZN+U_
MV$!YU3A#(.5R[E3'6 H:36OISIMF"*OF(;_A\#HT]E*"WC&63B.(+2X$[Y,#
MN8JSH6"=X)(46EF,.]U4EJR;X]B+53KW!#+VU\]OI>OP@'M#?93:2:;.N^PU
M[4Y;<0+74.S%VM7UDTLSM]M3$F31NX;H4-,VW6O.'8^EE\YVJ::U='*E-D)J
M[.Y[@J*S/)6JZM;2/F0!9"42GGO8A4_2,>YXY+:4JYI+50H@G5=/6?,SJ)JU
M?&>8;5I+)4X+P+MFHCNS(&</;GC/6G)$=<?Z*/1R0SV(79"N@]!J4E-E27+\
MXO.7IT.;+CDQXN]=Q<B#@5:*4:C0?$<I:N33"BV9UUZ*8L;NNXK3T#=4-6RZ
M. \],;[;40K;T)7EW:2:9FQY89K 8A0;>$?MZ,Z2YE0!/'D/?GJW%T3)*&97
M_7.6NG[ O,NP'\6#?.C=:$2](&Q[?I C<]4_]3R?OTINH[4-7/P8TH_<-(J?
M-DIF)1"::6L=S72.?OL_0?HA=;L!D[I1[+'XUR-R]CT6!$/7XU'G]'TR='N3
M]TGZ%+!?CQY]+WUX3Y[EYP_YET]Z41"XPX2]G[SXT*?NG23^_QA];IC.?"Z*
MW_]5R?X<_9_[]$/6CV[D/4W?Q--7WJ3![X2&WW.#$S?P[\/WW2A-H\&'O!N6
M^58Q+//G_&GN8/CAKZJE9 ]XEWK+S^*@C9_3(TA9_.&EIZMO%4W7+!JHV_OS
MGJ@0>I-!.%;7Z'D5-:NM;_'#XX.?LA,N%_8^C!YC=SA%DGX83EJ<E\#ZC_3=
M@1\\O;_U!RR1OK!'Z3H:N*&<O9<3%OO]E=\=]ZF?_<D^<?KM]V\WMY*NRA(G
M7 8%_\;DVR^\V1VQ(H"5+37JP[Z:>H&7KN4:KK&_GJQ$?D,GA**JVA& JCE@
M+XOHW8QMK-A*%N0>T_IFWRVED94HE??\RA]?,=)>WZ,_U2%=WO,+/[XTNE=K
M;::!6P'#L97P9ZQ+P/KI!MY6.]B?RAZD-C>^F&=W!QV@H\FJO<DA%%"!UPEQ
M9XU;:*Y48[1Y*+/:W4@^[F^ JJ[(:D<]!"'W:J/WQLUR0Y17VJZR];H]9F0O
MHBHUZ!%,P?84!$DQRZ;]I#22+C]=WTBJ)7WF$VF"A$=[5_EJ<3_69&WC5$OE
M=J;:,;ZI?'AMLFL53[UDX_FA*:I19"*E7B85,0MB%J%T&S'+:VS5%Y9*O6Q)
M3_)#R>WU^)IB(@W=IVQ=S T]_L-X1,%,X+M=/Z (A\T%.,-13 ^@V$:*^KPG
MW?@=?_!PO'XG2WRY+LV>Q"9K> 6LXGCQ+ ?JO3K\(251X'O2>!UMNX6"LK5P
MITX)&$;9NE6B:.+[[K$B2_SOFTV+ 1LEPQ^F:98L:89)_YC*&U'#KG5PI+S.
MP]"-B?^O1&,O=*S*O.]!1_87VAUKJFQHMMA*HI-^:&KVCV!*@J@342>B3D2=
M7\<Q(X6,4K6!HDZ&UHM&/):M,%*L%JTBZSN[H2!::&K;,KFU,F'82VSZVN!H
MIG_[#A:KTQ.QUT'WH2=[7"A5'-FV#,$593D^W<*=O9O;(/LNV[;+W_WR;D^;
MC:<;FZ??N\XG06XCOL:C6OD*SQ9[DC=NU=:4CJJ;YHJMVEI>RF1S-Z:]S?=K
M7X:GXZF=K_G,#C\ZFL_K?'Z>UID^:>*?7SJ14&R@IMDQ[C25<JCE"Z#L\2W+
ME79[W\ 4K+2S#CSGSEB^;?$D W2/V'UR_?B?;C!BGUF2G$5)>AOEEW6Q*@ZB
M_4%JFT;A&5F)4?*5=](XRPZ^W P)H[[?V_H,A&8:IN%TE@\^Z^/;=U\>W.*A
MDNG1C<]1LEGQ#SQRDQRVMG0,3K=M8['XV_RXGA6&QA>[O73D!L'36308^"DQ
MY],H):O+81(? 4/K+-=I517SV:AN'./R37Y3OW,9IJ1W/M>T[%16@8,J5M>Q
M[*ZCG?35CG.BJLP]<?L*.S'ZMJH[5J]O]^S\V,IPQ;;K_XR2U.\_E;YU?(L@
M9?DXB*J\E2Z_W)Y^^?WRX^<+Z?3FYN+V9D-@,O=F.'GE^=\77\[%"T5/\&Q[
M;&?E29_-)WBFS:P,@LPL4<C_>9ZD6[F;/@\K5X=>6S_\52<>7FQQFWE,0;NU
M?!)C^YY6JT\WW[Y^_?SOF>6ST]^O+R[^N/AR6R"6WQ&RV=1S%\3J(]OZ]+1:
M%GZ^/+OX<G,!&H*&AZ3AV=4?7[_=7ES/\/#FZM/MOTZO+T!#T'!?-+R]NCW]
MO'_"E1M(S2T([1:2[AB!5FPS*#DK(*O*HVHT@ ;0 !IHO8'^Z 9NV&.R=#JZ
M'R7II.R LYN#S9:97ERB6W'P^C  %%F=W#*4>.$,^V'&NN,)B-<(^#6#?E5D
M"VJ!6J 6J 5J@5IMHU9;@M)=RM94I72E3;\)IP2J;.I%CFDWS[ V5\8U,W00
M-40-43?&<K<E;KEF/;Z#CN]_RS8S\W,TO6@P'*6,AAWUTT<W9M+QEZO;"^FT
MR!G6I9W<NYY>K%B/=N^?.,I6LETMX^!IA<87S *SP*RZ,\LQBE1G!*% J.83
MJBU!Z9H5WB)UA%^68Y'3B0V;]BX!$'%TO:SLLI0SK'OS'V!QLUA<:7 -,H/,
M=0^_P&%P>)^(:+)N-X?%XF01[5Q@*7?46- "WL ;>(N$MS@>IMJX8.9>7LG-
M+N/]7[:(6D*H &+"$ !OX V\1<:[+8X.1^[*F!.IR6P'=F."6J 6J 5J@5J@
M5OVHU9:@]!0S+OL%_%C7!*)_M6,MXZ@#&-4PRPI10]00-?Q$(3_1EK ,)PH;
M?)@"Y[[ +# +S*H3LXXURZP;HT0)6L!@$>0%!B/LQIE)<=8M&G6XH9QL?;]'
M&T0Q+M"9=NH,3FB"S(TA<R71)3P E*;92M.QA2").)#4,2=KY_*?>!OI@3?P
M!M[ &WL@]W)9(4@(I0?>P!MXUPGOMCBU"I>R6C3=4I.)E+I<" %.U8=3V&L.
M:E4TUG+*68)18%39Q241?>(FQ_JQ'ZZZ-:)6.U77"X*$#YW+:4(=_8.,JY"Q
M48M\O2WARN5@Z/KQ@(7I^$SE1Y0NV,L&(%76%5T@1:AVN" 5HF'X48@:HH:K
M:. ^T&H1.?>3892X00D4P+';VIIHE"0 L\ L,*MVIWE;4BD !!9!7B PPNE"
M^P,U,2Y^;M@FBD8=VM2T^IW9Q&E]<+C\571P&!P^Y)8W!;>"@\6U9[%A68UA
ML3C)0SN7H,0[;@:\@3?P!M[-\S#5Q@6X%;QFQ 3>P!MX V\X.M1IP#'52M=E
MF[;D"@;7A\'8<0UJ564<RRFA#>L("A^.PJ44M&X:A=L2RY=\F3IV3.Y1<]4.
M;@?#GM\:,QC'(<"LJJ(:!=O)81OKS&"]@HMF6L+@M@3O.!"QOW2^45L8C^MX
M(D(4ZP*E::?25)JM8!,[R+Q7#V!8\ #P %":5RF-U3&$((DXD-0Q*<-^N;;L
M= #>P!MXMP5O<3Q,M3[W"TNE;A3]*7UW@Q$389*X4?/Z!UC9$[Q[$"_$"_%"
MO! O0I,-VPE+/Q&$&;4FSZBILH&Z5F!QS5F,E4&0N3%D-NWF%+<"A]O)84U6
M[/JMU"%YP"Y&:#G"+I"YA61&?6=PN/8<ELT&A5U@<5M9;-OE'QX4('EXEW8C
M[^GYG4N=F;P;3D8Q<.-[/SQ)H^%[ N3#^.UX$/PG,\/\#X7K?O]I50>&Y3VX
MXB!RX2,YRG]UK*[1\_*TY(UTE3ZP6#J1SJ+!<)32RYNHGSZZ\:;-%W-O-D(B
M% !*]B?[Q/DH]L-[B3"@_V+&I $]Y2&16.@Q3_H2?6>#+F&B*_FBCYQ]DD/E
MAD^2QPBO@1_2)],'-Y6\$3TERC[BA[V8N0E_=K:318KZDI\F4F^"<C)&6:8?
M2\E#- H\J4OZPWJ!FR1^WZ>']N-H( WC:$AZ]"1+P\ -4\D-/8G]=^0/L_O1
MJ3D_3-WPWN?:1]]D:?+VF:_/4IVT)SVXB?3@)VD4<]4,GJA5%O+^!B,^9#_,
M^G\4<5H<23TW9?=1_"0]^ND#_>[EWHP!X .-6>"F_G=&#?AA0G*G(?7X-S(X
M9KMX2\TMK*T13/2.(/O),=2L#7=- =KL0YIECMOCHHR60:9!?V?Y0,L F/Y/
M<NE)R2A(WY:B)C4P%1_?2)=$>S_FL+3"-ER%TC_<<.02^U5GE?X3$"S.=(98
M0D]R[\F"9*SAVD)?4C7I[VPPY"1*6&]$1$Q&PR&I!+'V@?_B.-.UF^R',RIQ
M.GG0T9NWTM=1G(S<G(K\X_FGGS\SWR<_X9\CEC-2/F*I9OXL>7[2(S=+&I4K
M]Y!4G_XE!?G3#Z+[V!WP#GDQ5XFL6_T@>J3?/KCQ=Y:D$_-&CQZ.XAX9D(GJ
M3$?X-M-B;@WYDU;UDG\[^\XY=2VSJ:J=8>KP_C[_T,HFR/1,"V?'Q<T6?Q\-
M,[7/QAB2_,EZ]J,X0]_S?/X[-Y#Z-/:3)^;&?)!^Y$FC(7TG\7^,S?O?I#"B
MR(2]E2Z?OR<OM4<ZSD/ DZA_TO=CLD@QZX\2>OX8Q_XHY3(E \)EFXV2"Y:^
M0W8S#-VN[_E1(!V??3Q_,P9V@EH.V*0Q4BM/^HE2#$7A(WLFSC 8T;!C-TS<
M7C9N;AB3S.CI"K?5O2@,6?ZKC'-DI.>^($N/#W[O@</$1T2\X)&;EUFP<,FR
MY<]P";_03YDT2FB\@13X?98SX-$/ NZEQA:8GM/-R##&@YH<$3K?HV T8*LI
M]4R@#%]N>_FC<D/._08)D_5<PGKRR?'CDK?2R[YZ8895EL@NN/>Y5+KT2.J1
MF_F";"3/$#]21_INCS^9ANV&/9^&0,SWD@=_./%HKA10L,K[V*-&H@&-Q&.#
MS#'Q_R3J:7C/O3ZU&O])0))<<E8E^2>>'88\T_:#2Q'VLV\D?4G()V>P\M:(
MO)F3F_/H-VSHTH_)L<X1]F\ST&6 3_!+<N?GL2P@88L-SO2,#R_)Q408A1+[
M,21JT3=(2J3&Y#0C3AGIC(#U?/I U@X?'A&<GG'/_7/672+W*)$7GYU1A'>2
MRX0^1T^F'@8!(^B2.7GYF:-AWAI+LLC::<C1HW@M=K-?#+C!F["?RY@,F3_(
MX@?Z.''XI] /9*G[--8)+G^N$5,7Q_L6WV<T_BF[[%XBVBR0K)CS?^?YWQ=?
M__+.[\?)":E;\/Z<S'40)612KOJ7T[&>9J''Q0\>I+@4O3W]]A=)^F7UM\Y9
MZOK$H\N0X!YD0CGM1J/TA:=QQG)'?,WZOQZ=W7%GIW04-8WX.!5'5X\DW_OU
MZ-./;AS<\9^IJF:HIFFHNJ9K1[]E^6(&?9X;_GJD4/3(@F#([6MX/WU/F/0F
M[R?K/7DV21XX<(<)>S]Y\6'>;4_2:47Y^</S5Q:<=M:/V5QPUV6E+4\9[/]<
MPU:;_P3M%JEERDXX%=C[,'J,W:$H,R0WW[Y^_?QO_L%N_"Y+D7^_OKCXX^++
M;1F32:^#+//C9.W)&NV$6'UD6Y^>5LO"SY=G%U]N+D!#T/"0-#R[^N/KM]N+
MZQD>WEQ]NOW7Z?4%: @:[HN&MU>WIY_W3[AR ZFV['0ZBY)-TX.K9%5Y5(T&
MT  :0 .M-]!KKK@J8XM6B[:%U&3#!RX( K5 +5 +U *U0*WZ4:LM0>GI>!-&
M(E 4>L@*9-6BK<JF7L89M/H;UN;*N&:&#J*&J"'JQECNML0MU]/MY+WI?O3E
M[>?'7ZYN+Z13W%-5K]-2E1["1C$^, O, K-*9I9CJ" 4" 5"M3@H7;/"BY*E
M* ^PG^Q2C/( 8'$[68S:62!S8\A<1?@%#H/#^T1$DW6[.2P6)XMHYP*+>)=S
M 6_@#;R!=_,\3+5QP>F:HEXEA H@)@P!\ ;>P%MDO-OBZ'#DKHPYD9K,=F W
M)J@%:H%:H!:H!6K5CUIM"4I/,>.R7\"/]3*NWBB+_M6.M8RC#F!4PRPK1 U1
M0]3P$X7\1%O",IPH;/!A"IS[ K/ +#"K3LPZUBRS;HP2)6@!@T60%QB,L!MG
M)L59MVC4X89RLO7]'FT0Q;A 9]JI,SBA"3(WALR51)?P %":9BM-QQ:").)
M4L><K)W+?^)MI ?>P!MX V_L@=S+984@(90>> -OX%TGO-OBU"I<RFK1=$M-
M)E+J<B$$.%4?3F&O.:A5T5C+*6<)1H%191>71/2)FQSKQWZXZM:(6NU472\(
M$CYT+J<)=?0/,JY"QD8M\O6VA"N7@Z'KQP,6IN,SE1]1NF O&X!465=T@12A
MVN&"5(B&X4<A:H@:KJ*!^T"K1>3<3X91X@8E4 #';FMKHE&2 ,P"L\"LVIWF
M;4FE !!8!'F!P BG"^T/U,2X^+EAFR@:=6A3T^IW9A.G]<'A\E?1P6%P^)!;
MWA3<"@X6UY[%AF4UAL7B) _M7((2[[@9\ ;>P!MX-\_#5!L7X%;PFA$3> -O
MX V\X>A0IP''5"M=EVW:DBL87!\&8\<UJ%65<2RGA#:L(RA\. J74M"Z:11N
M2RQ?\F7JV#&Y1\U5.[@=#'M^:\Q@'(< LZJ*:A1L)X=MK#.#]0HNFFD)@]L2
MO.- Q/[2^49M83RNXXD(4:P+E*:=2E-IMH)-["#S7CV 8<$#P - :5ZE-%;'
M$((DXD!2QZ0,^^7:LM,!> -OX-T6O,7Q,-7ZW"\LE;I1]*?TW0U&3(1)XD;-
MZQ]@94_P[D&\$"_$"_%"O A--FPG+/U$$&;4FCRCILH&ZEJ!Q35G,58&0>;&
MD-FTFU/<"AQN)X<U6;'KMU*'Y &[&*'E"+M YA:2&?6=P>':<U@V&Q1V@<5M
M9;%MEW]X4(#DX5W:C;RGYW<N=8:_^^6=WX^3D_XH"-Z?^TDOB))1S*[ZYRQU
M_8!YEV$_B@=9B8#3;C1*+\/4#>]]^O9IDK TN?@Q#-S03:/XZ;>_2-(OST\[
M]3R??RVY2A]8?/O@AK</-)C[AX^CQ ]9DIQ%@ZX?9H].%A\[_<[O4>0]^D$@
M]4A8!/(UZ_]Z=):_OOOT[XL[1;V[8<,["@2=6T6YR__>7MWIZAWE%/SGG>>?
MG[EQ_.2']Z<#0C6=*=IYSH8QZ_GY.+.R"$G^.O2>+]NF-[_'$75\_BD__.1N
MQ<__8(,NB^\X(!R/L\"ED257_8U#S1X8W?LWH^$P>#J]CQGCK>?/.Y(\ZN?
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M!^P5U3NKM9(%N<>TOMEW2VED)4KE/;_RQU>,M-?WZ$]U2)?W_,*/+X'N!S)
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MXV5:1W-0*T\-H@,8%0P=;N%AR58F@6\,5;9M0^*+8IQU_XO=#I1E,OX&*%,
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MC1.46M![3&MFD1 <6#;H:6==ZHV'6$J"NA!S,$%J]@W-*0;1,%<98:HVISC
M4,IXROA 7C&E*FF\,.7#SYE:MJTP]5&FR@0F>B^;::05*P8> I:E?T-TO>3@
M=*1/BXN:9DTP+Z"9]?#O^6&1C(L4$1?UQU0PRI0#L9TLWJH3P9T"ZV#K6:"5
MGE>95JNS"HRL'@UG6O*&0S![ "_;=AE.:@_21\Q[5?8@WIZK2/?$%YO8HYC/
M(X,3Z?0*\W; 28U6:<]3VN>9$XJ598P%TS#@ ";\ ."MH9ZP7-6V'(C*%%$'
M+8SL+-DV]?=9U)B&:3.958PP@]S*Y+%%(3V$A;>B%EVDXZCOQ7&E;-FF\!Y3
M-FS[_<* <YE\D44LX:M462>V8(_Y?.!GM,%^,W*KN59J//;T/L_8'\ D[RND
MRVDK=*8LV=) 7T$07K7,,ZV,9JH6F:8IM _$9QE6H[K$EE6;\*UV>$\QV3$I
M1DQFEIY8F, (P>S3A!A!QF/A,A:KJNMGB>2(PFAI,260CX([H%,+LP? RZW"
M6D5A@;XJ9A]P^1_B,^9['\"<[RO"TQF(2?K52#>T9-OD,9T,6N43A%(G[V?;
MJ#*YYL79H!G8M2B^4@!$A,/ NX<H/-UZ!QX2EG2#"L(N\.GCD=ATK\!%_OL5
M_)YMQ.=9W+0X(^;[_##/'Z4;7_B^G<(8B]'ZE\)-N>HIW<$K((K[>>^S[#%;
M$\]2R_EV0I88]EF_:/R-QXKPY0O7@ED=R207,HT9-MR?BAGXPUCZ)&$_6W,Q
M8Q=4@"9+C^$SA:'+J#5Q%G+@7I L!@4?=CR&4>-CVXV,QRK7-VU@NHF]H9--
M"WP_03P> C@PSECBM2UQN9W!5)/IXK3DVS!XT9IX<R'J!O2//AS )"ZND4E1
M*TRR^.E\;'W<_<2,?3I_7N E'DS@[*]\LK)?ZYR"KHU^9H6W2GX,.J#RLVIW
M1KGN=<ZYFXN/"2R=:+:%I_T*YBJAI[C)!47A.7)'[0MJOJ A_<0>]L_SBR]_
MW)Y_DKI_GE]WOYR7A7E3'+/Z2;*+ 5YP3%WY#+\]>-M6IOO[CV\?SZ_K37(%
M6>N2LW,\=SZ )B?T_'_/K\\N;LZEJ^N+LYK2N][$;DJJFT3E8[H:>#J3_1*<
MGKU O;%=,7,//M4R.]V<WD\WX3@%#Z Q:"S94AS9$AT#O2X4JKD2%$M W"00
M@K-A]W7.U Y1=C%=^R',7W@BHQ5=339L1S:4G?!"*[JKJ=N.(3B6^;6(;E:>
MT KOK^_R2H!-LD.3(UY^MWRK#A9OY'?4UZL.SM I][&([1?I,]] 6E<U+!&2
M-:HZF@H%-ZM:'%LF=LW@ID;TM]\*9S.LL .%= B\979TL@N^VF]%5I5?V("K
M=VA^CBW;FB839Z-N3AND-#I4O:-JK]<K:?,+69I)3C?@M*)[,**K==2:]OD8
M1;?-+TR"@'030IM=>+W*@+QJ9=!F%S:C6(BLX#Y2HZ9J:?,+^Z*2#H&[S(ZZ
M$[[:;U56D5]8#2I@0:D?CK'8<;OZ;/Z+=\9RCJRHMNPH-3,4530US'@;G[V=
M*Z ]90>]H]2LA=D2)ZS?"78/ZJRK>J"]YK+^Z:)][,^0UNSGG6BKR_-=MN-Q
MQAI\F$_3A.PD"H,'P705?IB5@./?G[WMK0"E$O_%NP)6V0JPM-?'QZ5I>N$M
M*\T6?]QFU$DC_FU&J;8NI6EO\;W01^QAEU>W%Y??;Z3+'[<WM]WOGRZ^?YDC
MBWN&9LLW.^>;M(R\^_&KH(9<A.:".&F_E4R3"%[S+M(#*<M%+RMWQR-7^TU)
MDY/^SZP%9C?MD7&=-2)[;;._0 \<MC/2),M<L2.H7Y=1;A*__\$CE;'7P.4D
M1FK17'FM!*Z.W%Z"1WY\Q2,^*@_(:A%=DC]3/X"E:IIPI=;3B-NS_NO-;#O.
MPQIGZ_]GJ7"EHRF\#Z,NJ, ^9.^O29B(K.N*;#B""MD6HFPAPFK!J>8?S3)E
MTQ;4J;;J:9YZ K7$^[!VM%8]S2E]515=!L):B.;L9&W!J59/IJ'BSH=6/2VG
MGD M,?6D=\R6O>:H)\5T9-L0E*RT$&7JJ74MYZ@GE5BR(2IY:M73//4$:LE$
M]61US-8YG\->MFW*AJB]4@M1NBVR(]CWWX*3JR<([H1[1MLUIW74%Z@MF^6F
M2$==6G^UN?U"\DJU9%.T,;*%L*[^:_EO]8IUW9&=NMRWIG8\E.6FECMJ[&=H
M(=Q8;JL%+]_")>N6)A.RO/=VN-L;%ASE7AY&\[!G#\//E^DN@>+^@4?W:?8@
MN?0LU8B5++*#O?GJ91*F+F)V=&OIB.?)09L^5HN$ PE$AI\5T)%N0SSO*:XX
M&P</(X@><.R3DT@*)XZ.HK _[O$#E8<C/WRAV3#985+L7G;AO1?ZX0-NJY'<
M.*9)G)[T^D2#)(Q>Y*D3#"H.,,#S7=]8LN6(C\4CNFP[^OO) :EO("I1Q>?:
M$456-//][.&IQ5/29XY6$1T]FVWOR YKZ=<Y<)"3H<F6KHF'ILFV;K]G[XLG
M)PXBGOGAMH!O821NDA[SG;!1\<-PV0%>47X.;7]RL"U_(M X?9AM=EYI\C+"
M:?)?BIR6/(<<HXC24T8;/\B&<5PVQ.QY>!1N$&!Q4GYV+H5Y]O/#=3W@$1"(
M],4=Z2*0^A0?Z.5'K6<GI0^J.7-F[M)13!\W.X[3,U<_^F[O[].;WF/HPW"R
M>06QPA<.PS[UV8EB,6HQ+W[DY\K.FVSQF8CX62IKT@JUNFB7U885D6 OE'BG
M$SOZ+:N4!O$=#YLY=N18-_/LI><-A"'XOYUH)P+^2O<VW(.4/$0@>OW3\AEJ
MVR1I$[9V9D/<@/W#KNC^^/+CYG;./NW5$G\<U+T.Q.JP@&NZNJN_)A80M0)<
M-70_9-BNO?AO<  HQ7,X*1Z8#G8@J;])9D6=0]6!,7"/;+.6TM&-MZ<2Z9C&
MVUWHE'W&9J*RI'E[D]=79?U!'_XY,O0@]E. L]2.KM;DK"-45><0Y_0P',A"
MW,H3"UM=M?!A1@>+HDWX+_/LCT%=->T4':4F8?-N9KFA5I?P- 8\I2\]A3Y$
MDKZ7O+0:994<O?H6-(I]'*Y/JTOJ+"SH;T\MTCHD4M][\OHTZ$LO'O4%+2U;
M[5%3XGY"8*[O)!_3*I"#F/0CU")I*]QQ1*7K-O.R:O62PIR/CM5Z'Z]%>5@=
M[2U.N;*\ U*WKF%!%0''"X&:.VV[7NS[,X]KV,(T+N$.V;+J/:Z>9LNQI9*"
M1R].PHBMYT\BHZP18K;ZBDM_(7P1L85;-_"RXH#B1;TPB,$_BF)^481P\\5V
M.I72\8)TF3&BHXC&P'!\89(O(K-7XYHR>_[LPGRV$-Y+UXOOIYHU\K=%7OSW
M*<MU8XH;ESWYFG,82 ^X;AT,*5^0/G,#M^]*]V'0C[.2BTF%!2YC2_3?;/6;
M+TS3V<Q48;4ZK2J8*/GLW0!L;\S7M_-A%##'9T8>#7JTO Y=W;5Q;JG-5KCM
M_-]CY!,O0(7A/5%66K$$!9DRVM'PNS'.W\P*]W3%P:,[83O ^U'"51.8-/R;
ME3)(X\ #UGUW<GWS(SYYSX0$)G. G4>Q:_3T15?\(E#7:?4&N$.6E,)XD<-X
M!3"R)^%#"U<C?<*+.>/Q4A%67<26]F'\\  IC"1X+],'65U&D0]A+OZFV6T%
M1L6ZCUXOC/J,#B89MS?_*T5C++E(I9[)Z%21"KL.0$(A09%!BF7)[>.\PD.Q
MQ #'%83!:?IBO"L;0P&XK/P$%$K?X_(O&-'%Y^L;25U&:EY3D]O9$91[QTX7
MAZ35&JP/+HR3:^0AJ,LAT\^ _W195;'$#5E54!3R*BI$LN'/Z4B_K?,G=O&V
M)CV][S^^?3R_+K/.KA#;ZS,(1)O\1$ M:DH_VS2]+A/-?:[A3#^83<$&EDMU
M0U;K'I.VJ!G\<D#L!V\L=63>,7,"'KIE:H+- Z^%$Y8\@6V1^MP4KZSUWBWQ
MTCMBJ[B58O-(5C-;D_3,/6YI/[AWS7-\CUJSZ:JLF34/JS]&S=;:N*SYC G>
MCM& VW>HG+"DC3MF7GA'#%U6-JL67ID-RH^M_*7A0RM?M2]E*K)F"UH.M*[4
M=EVIQHXLW XW+_OB;3ECCB83J^;9OFM1M):-/MS]W&W&?E'&?K*L.[VIE:U/
M\O6AF"8)'K_,5I!6V-%,9$43;[;694/7WF?[B_'B?"EI9M,U6_KBZTKI>A%?
M)V);F_EBD>_CZFU$>^%#P IS\6R](-OF/-GE/+VY.:/UFBTN\8%X,;_:+5P3
M!BFAN.PT#($0-H"X@V=2+X!!1@P,2[PY79-URWC/5@?O*0UF"*C<XYR2)5BN
MVKNUJU8V=[J:=K7B:MK^<4R[OM>N[[7K>VWN<S-UPZ\E[=4F0//E7E4F=9,)
MQ\@)[2)?DPE4V5!JYD_;Q%2;F-KOQ!11\5">FO4/;6*J#7YWFIBZ6C$QI2F&
M,"4S.\#3F/9.O9^GCUZ_3X,/GW_>1_X=/H8052?$L!2'.!H;>>#Y4T*S=G*K
M5/"< X-@^-[?U/<>0YZC<GN/'N4Y ;F1I-C5=%*L .W BW&W 2)\*D2X9EY,
MM=1FID GIEDQ!6UNK54O4^WJWCUY[Z5S-\)M.;'T[FL8Q^^1\SE'',"L[RO&
M!14^@=>?AK>X2RN@">[X"8<TN\Q-DLB['_-,7Q*B7 Y!(MF=CZ'/=H/Q;?-L
M'YIP!UHP'M[#VT"'%>^>3HK.6(E6U(^4#3]Y_AAY(V6OE-DFS#BSH>Z%,U?>
M:W8T\L%Q15Y$5IU^2,I^\7B8F<N5.)&UXP4S[?;YWB2PJM,7LWV+S^'8[_/>
MS\R2%9_@#:11F. 6+M:<MX\DXVZNZ<<\NGU^JQ?'X[*?U$K D4H V\$*?D_0
M\WR/^S>+V97SS*3W]F@<C<*8LDV._52D:*;A<VF2LXVM<YX,L:(7N-%+_@K6
MB#E=P,I$,1TDN&9>3_@>$%LW3M?'ZB]N[1_K;GOS6MT5K=(B6 .+6^E#;<?*
M'K4X65)N)+ P+3._47'CKS3U.>_\%4*GA)X"-_90BI\C=[2!50VQ"EBYB?'Z
MH*C6*I@T/35L%-MZ607K\0;)VQN%::PRC!URX\)^RAOCQF+OZB:7:<IJKDEX
M_[G(9N?VM,IX;F;=;T''H#47!)F2+2W1+VQ2U%PZW%)ET[1EFY@-K!9:6X9/
M],)&IJ4>'Q2["*W+!T8]/IAI7-3@BK$B.ZHF:ZK@4*0-\4$=^/9/3UU6]5AN
ME<TBZ+ H5I&)W<1FG%;5'*JJ,?#<7-D6'>_:*IJB0^1&K Z[U30[KX=KE<VA
M*AM=MC1;UNPF-@,?L[*Y%G9L:U7/"ETX54M6K28:K+1:YU"UCFF#JZNUD=1\
ME*[$'2#KH=9TR>[:DK76@':MM-:HBERRR/>0E-H6>&PYI;<>C^U8*2[ODV^!
MT0Y3<];/E5<O::\R!0T4DS>L9Y<=T<X5K65C-QK9J=N>:+T2],/5MIMAM774
M[=*LMNN4OD%D0R>RLEJ#OLVPVI+ZMMT&<;RE6\5"O]1^8<5@\C)B&P!BVAM'
M7I*?G]!C=8*E<D":+@>7JQ@+I9"\!FLP9L<-W(^3M/*0PE]!R IU_7&_4*P5
M#D?C)"_6RFQHN:9W\HI[VG/!YF*96#\$-Z58U@CW1)35XK_KT_3C>_:B>8-^
MYP*=IUG)XWMVGL.Q58;MW^".OA%#6ZNV%]5!;:W:%EFOK55K:]4:A?<F"7M_
M5Y^VW>8K-U])HMD01-<]VJ'-6.Y'"'U@&4LBV[HE&W7/S3BJ=.5^Y&M>4VIP
M+9W6)@;;Q.!6U%J;%ESOQ-K"Z++/__C%&T3QZ6#L^Q\^>7'/#^-Q1"\'%VP[
MZYD[\A+7/_^)QT:Z21B]_/X?DO2/R2W?6>[L<G##5G[X37@@())T30>_G9RQ
M=A**K9$3J4][WM#UX]].+KY_/I&\_F\GTQTG%,<@JD,4YX2MQK,'\#6ED]^)
MHQN$*"8ICECT^J5'R#_?=>.[R\&=1NZZXX<[#$MN%>6._WM[*?R^'D6JHA'=
M%%%DF,0Q-=VJ15'XX.4_GK$MR',Q)PZ!_R0A0U]5G3M\!;[A]F5$X_3YK$G'
ME?N"K4VZ6/#YP#N?=G]Z\1V\\!/M47SC[7-X^QB.8S?H?_<"FE :=)-O[$1(
M?MCE510^1.[P&[NZ"(LB H7 +"NV@0"603'Q&EO[QR_S"5X%$T!"RS$Q8$97
MP:0[BCR_ ,CM,_SZLBX<FF*80A[1%<U0+7M#<)@Y'*9B[PT<JDELT]($<%B*
MKH..V 0:Q%&<' U[CYA#-57#M$4J426*C;+=.!RI1CP#8Q0.[Q1R]]]C'!&Q
MIE0BT07?W[@^0PN3% R5;O_)B\%PW-#HR>O1N/L0408:!^#NS$WH0QAY>-<U
M90TCKMP(EU[8[6=N$+CW7@QCBL=^XF;W+09.)Q8!%2NT)2HH'V7SL%WVDC)L
MJE;^OH8E07K  NJZ@!ZD9I_(V0D75.-F@]ZW1=I5W21NG_\Z1]!NZ C!L1=Z
M$Z@_2KBA3ED 7::G%D (3UH31?!DA)Z93NJB.'%SLB*B+J\A8E=>8:LVUJEL
M3YT9M<)ZVXH!"J6 S%GWT]T(IH:-Z^1WK:,Y11]O+O%K ;5[#Z<2(X"(F-48
MJ1V5; VC';L]%1BI)@0$ACH/(T/?#D:[=X:J,+(4HIG:/(RT)?F(Z2V:P$AZ
ME/;CSU$X9"KK<G"9-M7A>FQ?M=*I5@$5: !%LZ:A E]!M>V"]U.#\'51VC4K
M50)D02RA:+, Z> VJLL#-&&YR^211I\I[09]M(->''MA<)ZV!CTX)@(?6G5F
M,2)$X:Y3/:K7 VAO^0>"+X.4^,>QC&6A04:[I@_8HPL</;CR )4-,165E/AD
M(DC3]-4G>W]GG^BFK9<HGD?PA"7@=0/*^,#U\>>#50\JL32U) *F,R,"%?2N
MC,K^<H7J**H]"XCI6%L%1#A46S.L.]W4S))+H)D;'-Z*X7 %"2:Y$T@=4K4$
M!2B>:,EQ]]_E@$_U9S#H0<\+'D1^3$J#\@UI. 5Y.BUGPVS1]W7Y<68,M>)R
MQ2&FJBF.2A13%:;2==4V+)6KHP7TKH9+ROD9ZQ$0@EP6OP/RK,<ZW'O^Q"@=
M)#2ZIJ,PPN^N6$_T3!JKKYA)<]QX#X$W\'IND%P$V%^=@7@1=.,X['EN,DEW
M_ CZ-'J./'ADO$2B T(,,.&6 %#-TJR)ZUP7T!^XKY0G02X"3A(+0. C_K1O
MC)8%7J9*M#MM?EK#2*%80.)J4!PP;XF#5^ LPS"=.0$^Z=A&?40GNBZ-2OC<
M-L-0>(Y"&"#YV7,9Z5/+PBEZS?%>KN<9\^DV1&(E38]?SJCZ*?)W!LTUC6GT
M!.\Z>T2R+X(_\6R-RP$NSZ<?T_9=$ =D_74V#*%MV:78#;];""#RX$SJ)#O6
MBO'AY2"C(#WW;%_5V(RU)*A0]#EY2+V3Z?>ER&\"M"-4>+9N**8U-Z.Y%MK%
MBI5/-'$]'_4E:^R DM:]#\=)=B_*(/\6N'W();%0V%+#I^9R==\G.GQU.B".
M?4H(=4_=@4)/]8%%--OL#:R>=?+[9#L/KV!BBY0]ZOLC;$@?/.1_8RE^]O=T
MS5-Y6\[DAS#Z<.^[O;]GZX1X;=$'=YR$)Q(K@OKM1%?>5FW;R=\X6Q.%^^Y4
MPY"E[#_O3_"H(."6WTZ2<+)G8%*HE9:7.414:5]^W.;/6KOVXK^E041Q"QPP
M+?"V%.'Q/F]7W6# *;3L>@1NH'*N8\X=^U3I;8,S.UM M^1,-P\$1G*L693O
M#=ANS4S"I7=XY$(\]Y2]_9[AN4U07M\$NT$PAH'AP5)/(1Y@X*,3=[ 2;.JM
M",_,,#]T*.A++Q[U^X<[M77[R]2H(^;^4(.>S<1;HG$O\MCOEP.TCY_!/%ZD
MUO$:C.,B]W1>FK&4$ 6'&] @IF)I2M'A'HW1\U,Z"C%34I<<EIB>C*6^@E%8
M[&C/HX1444)LN+1 R5]@;3!H-P1TS!W.? K^S%7=1N9#50U;%<R'J8OF8^&@
M<EJR*S^E(MV-(>1 \01W?AU"1)$<N-J&KIBF;I0)X40L,9I2@5?V.SS#BQJJ
M[EI4KV@H&C%U8MO%C$>6:-,M75.G*ZQFQB@H4@O8U@A0*I_H/= -X,0WH2^F
MAO! _;_=X%1 3?G[Q9EI6]%5BYB:4Z0G'PFN((M*,"O&G%.7Y<!$5\XIQ5N'
M/"7/IVCJ'6:>JE?\%H^NO'Z25Q9\#*,H?,8V66>^&\<0E4,P'.<9CFXO 4YF
M'4F:IK"\EI7.GVV8AF&4U_X-I;3ZOQ(EDS6'M$G)I[1#R>TCV.^'1Q&.^6,:
M@6$#N;R*9!PR#U;GB5;(M<F:P@I %(S)@$:@"V[=GY?!YK&K)E1WE-*2,'Z7
MDUE_I+LB;JN,H2DE(8.OUD&K4@.=A7&R00W"R+%(66G@=SE!\T>W32*V.LV6
M45IYAZ^:107&&ST JX3Y;U\]]Y['S9N==5-Q2LOR^%U-^N8,?(;TF/FE$P<A
ML[K,66K<5YLLAVKZG:'/6;PS.KI:I'3N.'.:0,/3&(_@_>H-O02NATCO!9SM
M\9#.I,1O(Q<SQVE&O%AAOV#;QF=Z7][/J%J"[R>6^^/+=W=(^=X+D5<V;]U8
M-^ZL68U6!,KJ*&G$U 3Q,RY56N:!?DAI%0D>$L1NC\GM1?!//'_]2QCVX\LH
MVUMQ37O4>\*HH?\]3/X'DT^#E\]A=,U/..<Q-D39M$+_',J.J8KR)9U8JJV5
MRST-;7;%<&LPS]O->YFE.OA:4?\BF+=PN%306;T-1@.--K4W,>5JVW)47:G<
MRKO<6#=%=0,*L1H97;&)"!F5F)9MZIN!9OZZX0K/K[4?HL;:)]$UXFC.O&*/
MN3M>FJ%D^V@U:'-+B!J@..<4))&.HVX'T3F9F$O08C[ON+DMT5-42W,TA0A*
MUBSX1<W,[<(1+UG%D*.V09K%O*"HMD)4L\$Z#@$M,[)3S,AS)-'WG_/P>);'
MEJXUF"::**9BVG9:7?":SKA>H54B[VNSA:<UT]GQ=;Z@R16X?YY??/GC]OR3
MU/WS_+K[Y7SIE<25.6:5GF=-M;!KEN.;>=M6IOO[CV\?SZ_7ZHVW+CD[QW/G
M VBT).!_SZ_/+F[.I:OKB[.:TKO>Q&Y*JIM$Y:/KLR.J3B7PDL9QDO7,K=FG
M;[;P8U&SNJ;U?EIGXFRB#ZXE6XHC6WK-L\.7@4(U5X)B"8B;!.)-DZ9NLW.F
M=DC-QG_-3M=^"'-:;]"*KB8;ME._"60KNGLP9U;'$#1J?RVBFZ<'6N%]I\K$
MM&3;K'G$Z&KLT.2(ER\(;]7!XEIU1WV]ZN ,G7+?IWWI%^ES& VH5]NN+Q&2
M-:HZF@H%-ZM:'%LF=<]+KQ'][;?"V0PK[$ A'0)OF1V=[(*O]EN15>47-N#J
M'9J?8\NVILG$V:B;TP8IC0Y5[Z@USQL]1F%N\PM9FDDFJB$K;7[A@$17ZZ@U
M[?,QBFZ;7Y@$ ;;ER*J^4=EMLPO[S0/D52N#-KNP&<5"9,50\/_;_$*;7V@^
MOR Z5KG-+PCS"ZM!)3C^;3OZ;/Z+=\9RCJRHMNPH-3,4530US'@;G[V=*Z ]
M90>]H]2LA=D2)RQY:&+5481K%EM7[*6Y'"=QX@;]K&%K>F.MHP&K2MAK-TA(
MZ[EU35,MXVZJLX5"5$TEYM1>T6SC'':FQ2X=M:G9 .V-'(O(:=>(6:+=5$Q#
M503;JVRXW!%N(MH [<L<6IG28A1HX7L4= W^QW+*M&"'<-#:VZ8E[_IXC?M9
M<,/SE !!I%'QO+RM9/'Z_X]&X57H!0ENXF1_W8:7 65??0['T3G*:OVVRT2U
M 11+OR.&XUBJ,GTZ9+;!1]<5^/FP@2N"A&WX;\/;YP*2*^#F*(J9XT8,P0X\
ME;'H8>,VA1('#B%DW]UX/S][3W19V(B=PZ8)V$U53,<V#EQ.BQC!O[?A#7VB
M0?X-_K$L;*J3PZ8+N(W8MFD0^[!AFT*)R213;YGP C.N!)U.<NA,H8)3+5,1
M[B*N!UW]+8^%YZVXQ7,]KTB\L2_WB8"#E#N5S-GMB;7$J^WV7(KT/0)X.==K
M#L#H>)D&&%M=G7.4&BZF'BG 0O]N'F B[TYU')/,W8%J'CM\TSJ7*=+LFX\L
M5KP<L%_FM LQ5?5.T>;(N=+1CE7.Z^!X&X[J@0AL.:?3.B$=U=H^C*)&#VF9
MPI[TK> 6QR&SD2C1%=UV!.TL-,-V#+&-7IK*S:"U8F\3KNG4DJ;3  ]#L42-
M/=39H^[V'XFZYR5GE_T_^O+-#5S^]"L:Q6$04!^\RR#QDI?+".ZAHA8[I2:?
M>  %)CATP[!$R1UGMJ?BGF&YH@PN:E?4-+XV<*PA$%O3WG->+;602H]5-Z<@
M5G31]R\CT-FE0U*^@BH/8FRY&?3/@WX8Q>S'V7Y2'\=P#8WCLW!X[P7N)":Z
M>:9N])TFK#L7[==I(\6:#&.K%I48Y=,@T\:A^SP+(HT!L6$%PO!+/9#KH&:H
MJFEIY5:0FT2MOA=0Z^E;; =4:;<-0]<M?5[[.6/>:>Q-0+!MD%?J4%5E[L$^
M&?KL$9;3Y[ZMVKCJD #<EI\@;F]N:[;NZ.:<65 [NGUDL[!G'D;ES!B.H\[I
M;ZEW+&.[,R.R!GGAV#[%61HIZ6N5Z(ZC"!QBU;&)+<PBKT#FI@!;*]32R[I7
MA:\M0:A%<$',6.@"K(9&?0:M^?QMNP$BME(- SBH6DIQ/]AJ4KH$"-L'>@U7
M0,".IDZTV5/=IT%45\S-K0YBL32$Y<5F5WHJUTK6[\"GVA"\J^IN.O"5.NLM
M;L:W2@>^I8LM^;B ?PIO&65/XR<2GB;AZ,/D@,+LX?A-Z7$-G,.4UR*-FBTK
MS2C5UJ4T/;5J/5*;K!V[O+J]N/Q^(UW^N+VY[7[_=/']2[F4;%_1;/EFYWR3
M=F_K?OPJ:-TF0G-!>?)^*YDF$60F#$^QS(S8LG)W/'*UWY0T.>F9GR2ECI)T
M38<NV/G@X;7-_@(]<-C.2),LPWW;UV64F\3O?\8NR_=(A>"@17/E+8IP=>3V
MDK'K2WC$9?71RRVB2_)GZ@>P'1)-N%+K:<3M6?_U9K8=YV&-L_7_LQUH6-\F
MG4IO2$<7-#X[9.^O29B(K.N*;#B"QE0M1-G^/ZL%IYI_-,N435O0'JI53_/4
M$Z@E!]63VM%:]32GXY2JZ#(0UD(TIX%T"TZU>C(-%1L.MNII.?4$:HFI)[UC
MMNPU1STIIB/;AJ!31 M1IIY:UW*.>E*))1NB3B.M>IJGGD MF:B>K([9.N=S
MV,NV3=D0G6K40I1V(^X(VNVWX.3J"8([8:OF=LUI'?4%:LMFN2G</;@L_[6Y
M_4+R2K5D4]2/N(6PKOYK^6_U1G&Z(SMUN6]-[7@HRTTM=]1H(]A"N+'<5@M>
MWCE5UBU-)F1Y[VV=KH(KEX[/K^G/"[D*%1)8(%'YY.4VHVV_=5NM7FW:R>]7
M^E_V-Z)^FK,=8"5L#A_N91J^U>KP9@/:UE_FMQ;J-7K$U6H*IS&DB?)-U5O&
M7J>U7*U><LC7]E]JJT4::$A7JP.=Q@ _&K4]AVHC-U:ZO27U*=J?6:CM6W*7
MZ<[]@%5:N IV]1+-,DU;V(IT): .#O0-MW^=VJV986X:JBUN__HZ,-]PZU@1
MFZO8,TO8.O9U0+[9MK.&B,M5RZSH$/XZ(-]"RUH!ISO8OF%A8X)]0KT^Z06O
MP1%PG*E;&B$-<QS,ZH?/KA?]Z?IC]#>F.H,LM=<_[S/%VT-JMFZ7>DM9NL8Z
M2\U]Z[+C"M=O]C ]=AVFI-1,#.E98NS%W,\GFKB>C[T'!F$T9'OMN_?A.+E)
MPM[?_'Y\&/\ACL?#BL;3M1Q0536YQCK&I@%[F>$'PC"+^-L),%%Y+3S=0WWO
M]OY^B,)QT$\1^T_;O-=[_:TO6C292IU]6$K9@/W#KNC^^/+CYG;.,4RK%1AP
M4/=ZP:<."[BFJ[OZ:V(!T4G?JRX1'C)LUU[\MS2 \$#RD#=HG$B@3^MOQE]1
MYU!U8 S<(VL*H71TX^VI1#JF\787.F6?L9FH+&E&>ZT#DH"S^H,^_'-DZ)&.
MJ@!GJ1U=K<E91ZBJSG^.: ^=;A\W7H<#*>3N::NK5GB8T<'-ER;\EVU@/P9U
MU;13=)2:A,V[V3&6F?9CUB5N$(QAJOX//CZ%/D22OI>\M!IEE5H@]2UH%/LX
M7)]6E]0I8-+?GEJD=4BDOO?D]6G0EUX\Z@M.K&^U1TV)^PF!N;Z3?$RK0 YB
MTH]0BZ0=@<<1E:[;S,NJNR04YGQTK-;[>"W*P^IH;W'*E>4=D'KUTPVMGLVV
M\:9Q+_+83Y<#S+Y^CBB]2'.OJ  $!R,L67*WS'F$NGCMCEB&9CO%TPE'8WXH
MH:+H4Z<\K$+/CB&9=[1@%1ZVHCI39]/G>!!S__!8<27Z;H+5BFQC$^(8MA"F
MZ8[Y1P+32JRD6JJABS!2=763&/$KL9YSNSJFJM@$H-!,37,*4/Q%W>CD=Z-3
MS2MSB=@)]?-X8 [INF5.G4+,23=W3/K&-<<<1/",B?UCALTJB6HX',4@FBI@
MD&ISLS(<62;CSSP%NET-(3Z>!3 @R!,"56E5*\I:M.P4C#I'&Y>04#4R5>.<
M(6%7L\,ND-BX_J@$2%-516153?W( %J)?;#>482.11I%)[OG4YH1[<97-,+0
MT7U8R>S6HLW0#%M 6Y&P)<?5)%4-5(564 X0J;8F"$K6I9Q%OD56F.2HMA^A
MEDZ-S8@GQ')$&E&QT^+8Y4C8 >7S)+F2;%6S%#'9UL[(WKC6KT3#L(@I#,LM
M[8#16(4QB()UX0W+@[B' *_V[P;]>>?>85.!Y)%&Y_\>@^FX".(D&K,3I-<_
MCLY0-,N&:3_&RO)L^(!HXO5</TV_\J2L*#W<2).-O7E;DQGB[S^^?3R_+F>'
M=X78@@Y#6T+EHPO2UZ/2J00::!PG64&TH FA""CA*#.A0&8O(.7305*7B>8^
MUW"F'\RF8 -EEKHAJZ)^4<L.6#67!6(_>"-5_2TGV)8CFYJ@N=%KX83,E-?D
MA47J<U.\LM9[M\1+[XBM8JNGS2-9S6Q-TB,X[&K?N+?*Q@DV_;PZS::KLF8*
MFNJ^%LW6VKBL.;X)WH[1@-MWJ)RPI(T[9EYX1PQ=5C:K%EZ9#3I#"^3[M/]+
MFFII?:D&^-149,T6M$1N7:GMNE*B+?2+YP"X4^J'8\S2;9>;EWWQMIPQ1Y.)
M1;8 Y5HV>IU^LXWEBBLZY(CO*_0/6J973IJY[\9WEX-"CKXJ=U_X/E_2>1DA
M-?->F7<QNJ8P7@\7YU@)Z8_ 2^)ROE^IR($3^,=T!/V@=$,5-R9:$ZJM3\!2
MBR>U@5\7=5.Q!>V@(*R"J.I 42\WYMHB&\.;#4T J*.1Z>*$ P*T0H\XB]EX
ME0FXHA&K2 <SS:Y?:@94@]7>V>49.%0=LAXWKPFFINO*5-U\WJ7/-*=+M7:!
M:![Q7D9_@M3B7H:EF7KI9>TM:69-=133$B!OJ[HE; +:"$;;PW]>;<GV]+6F
M:C;1!3 ;NK*, 3QZF-=5)(9N6J)VGX:A[ G,>5[C +G8, V1UV$J&I91-8Q
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M*X.'<?\O$ &)^3X@;]YP/,Q& $\E,)<PG]E[8, 4W'$^B!"4%5'8TVM[('O
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M5B,K"D?A>,8S/)UQW]A@?5WB*+:EE,)98D[8H"X&.P)M:XK%(8YJERV3=BA
M[4#).+KJ&"4'RG8.!+(:-.+L6^ .EXRQJJY.Y-19=OO&%.NJ' T\.8O8CL"M
MKDW[+I#:DI[1%%4U3:L<6EEZSE![B]'650PPD^I85LD7WG.@ZO&!ID,HU!P?
M3/HW? WCJ<L7ITT.0*^H!DB.40Z+4JQJ4K\;M+;FP\"_JJ//0N08$V]OGW&J
M1:*J.)J^>Q*W7+E2AB.M0; 58EDE]^3PD%B>]TW'4N\$[J=6C'$/"('5367&
M"IH)&F#/6*%JZNQ&IVZ2-OSB>D&,-]#X,CC_V7MT@P?ZR1L,*&Z,Q"]O)ULC
MKVDOA.F):?\BN(K"@9=<1GCOX=I(5;<LLQ3NGZJS*R^-P+2_T&_-X+)UH5(Z
MZI08KPOO'>0>=%6W'9$W^%I KX>2H6GEI-:I9ATF?^[*ZS(=6[M32W+NZ*\9
MQE5<-MN\(R6A/7V]&*[M]#D$HJ'Y:]B'"VA5=8)Z5UX!W* LHC=::+5U.;@J
M-MIB/;4O!X4L</Q/+WG<V\"1E[3HQ+"(5O84R23]M ;)^PK;VE5@NJJ"#A.5
MAQXI8NN6A0%@IF54K0;L.V#U*"2.OGE)^CY&R"\'[(ZXV_OWV(MH?V_W?EQ\
M_YP7Z*O.G:U-(<1Z$\8GO^/7'"(Q>3GU9^%PZ+$QW8:?J.\]T2A;Y7=]H#OV
M^I3+\F70[3UZ](GBQ9>#+Q%H\6_L0,N/+JCW;YX/Q(7!W/I!(4+;0JZ2SRR#
MJ$I1DLY_7 .$EI'SV090VMX,S*\=FP;#)JA73'U78'QVO>A/UQ^#Z"+G>.!9
M! EGW8-C*ULS-*+-(FGJDU7\.=0>!2+@"*EW3CF- U\MA<$5C7KPK?L %UV%
M"7ST7+^TT^C,'8UHGW'697!&HP3\5!BNVP?7Y(;VQA&P*(VOZ<.8NZ9Q-^CC
M*R.P#V-XWKWO/? ?#F,'&W&*.FMJ]^@N0"LHM(!MN;[WZ2=Z#^^%D<$3>M1[
MPCW3G]T>91,^;R>'>@I@KK;/;0U7E&^CU$RB..;\$K^Z-#8)"E'%.2SA]QO?
MG,"Q,@ JQRXE'G:!%5>]BJKESOAW,$C]?X'8@E(Y?T+ZNP/@^FO*W,3@ 23$
M"_MYY%<T5046![>R/^[Q6!9DH&"V.$S;]_UU!?P5S2ZMU5K&X:%>?<7.T%5-
MP-$IY4&:0#=F@<KDCD\T[D7>B'43W2^;(Q)V73-L7)3Y_?:1<4&& &":$21A
M:_3B3VXB)7!U.,IZJ>-?CZ$/+B+^Y@8O4N(-V76N-(J\'CM%[0WI$$,:P34L
MH)&E,)*\( DE709W7;95$UXR',(3><"#]W"".M($Z>QUA>$-W1?IGDJ#$&QC
M7[I_2>^"A[,K*7(C?$I'_13Z8QC;,\7&*G"]"P\&>SH99\* $ X$WR&!U44T
M8C"D"?C)4M]]B24OEAXB"A,1X9L"Z8T*Q,I2/+[_%^W!BT-  J):;S@>9B.
MIQ)%P3,#LO? @*G;>^2#"&,*O[.G=XK\.8?=YHO]Y/8K1NJ.+;4Z<7O,.S*;
MY[X#/KEC'N/)[\@W<R1TAJZF0-BE958FV_6UN]F$=1$:?9[J6@J8VS!Q_9F\
MPI/K^:CY?HRP6#>7P/U2:N(L"O"4#EH%E(H@D9+^,@>Z^FAL%-5=MXTH(@J<
MB&6%4UL ,T#Y#\WB.77UU3CJ/4(\\T\WBH"V'S" ^5F]+2JR*;:S[A * 43X
MM2!Y-X^P'(H9P,"5JKKW$"75NK,M$6+P+0=L5?*G\1,A?6Q*#[B/6!4RFOY2
M@'0]1.:B>_Z31CTOILSP9!.VMQBJ102)-L?>DHXV!T$AU3E.W]R?Z/X54SC=
M((!@].R^?^GYV;-VKL]*C:AXZM/ (ORIS07%1E3+$"A, 7;!?:;]:_>97_Q/
M""=H[/KTFQO]39-J9VW/^ <K-040.48Y?U>#8L%ZPN<P$EK8F;1\=8*#+9EY
M@:I_ P0?Y^:;=YF;,HJ.AUI*1JG3@?NFT)ELZGV V7J 2YM_U^TS7/?R.1Q'
M^STC9H5><%3+44MYJ^G-T]M#;S)C]Y[O)2^W8:9W?HQNPU0?\?6.(/3ZEU'A
MC_05DW?NI5,^T3:&?D>F;#U7-R0%O0$ A*H:&Y^&XR#A"@R] I'N@@GF.;_+
MP2T-_J)N).;L?8%S-@EN*9JJV:+%&*6LRU>&I- UX G/#/CB/5&@1"@:KS4U
M;BJ*IFOE/BA3-J &?A-FSE;.5NZGBLAGI2_'-0?"VFC%5FUBZH:P?:N9^3;+
MHKI_\['#A8L*W#6#.(8I6A->$W=Q'^O, +A1\E)H7UVC](M7F][;9L]QE=,!
M<>Q30JA[Z@X4>JH/+*+!3P.K9YW\C@VU"[VU"Q]'64_P(2LHR7J *Z/D5WQ]
MVNR;3>?@92L'+\S<VX-)C#[\IVW>Z[T^NX(8'>GZ_&OW]OR3=-6]OOW_V?O2
MYL:-).WO^RL0'7:,.@*4<0-LCQU!2^H>O=LM]4KJV?5^44!D4<*8!#@ V&KM
MKW\S"P )$N"%LT"6=]:F2!Q5>5=5YI-_"@]W@YO[P<7#]>W-_0XX])4_9INH
M$'HS]D@0A7?TBO\D;P+<"8X0M0!/> +/=<F$GAM%!QG1=X'P8G\'E:)'+/8<
M?O(A0!%L=R2 B,XPRRB*6>@Y"TJ?"U>+PLCQR1!UD5Z*LNA[DPG]&[[^3K,9
MDI,;5(7P+;EG\A:=,B5_G0MXS/77I@''SX H=8:'6-'XB3"EVAJL_?RW0" _
MDD.@U.-"8D_I0/_P;'^$-UW2MWM^$+U^I7-PO"^"YAX/HT+X8@I/GA#W&5L*
MPV/B8RS7\\%2P+5S/Z"'1]XLSLB"QU8B9QW0MC/GO?!E2>HEE8? $P)417J<
MA-)]Q)-($(LW&E@3=P32L]YN"LF#MEK,B"W2BAXX#B=SO!-_'X-.>:^H5=-5
M"C]E*/RA$(GS&BIL]@6T%X,0-8.@)V)#,IG,[-$(1KCX&UN')G_'I(K;1P#%
M)O8L(!^2#[^NLBCIC2%)/_^ZO&6-R'0<Z0X1![0VI8\W]',)'/7>_4VVMO$X
MA\!&,6"X]O"O9Q^6&Z->5D/*OD3Y.2WRN, A_L8WMM3 =8-VC.D_](K!MT_?
M[A\6FG"(N!Y*L6H(5HYKN6.HYU4+*=QGTK9A:[96UTCVI/R.03 EJG*_9E'=
M1)[J&RWF6L!ZB7UO3VP?8\$X3 SF$QHUC@D)*B9EGAI$W8LR!";*6!_;K+::
M.D##XE94+4Y0$?NZ6JO]WH.'59IJ?%U=5GG#5$;C$?QSQ.+8W 0545>*=#PK
M+8[I*7;=9N,9>>\I/OC>>Q&71]92;96+V?/=6ENRUS-K]M?4BW2,+$.$&NQS
M^;[416UX0R*ZCWUH5$2;L\FZ*.LZBR)Z1#:;)HFM[Z)6:KP/[7!Z+-%XV3ZO
M;+D+732E(N%Z*2K4[B\*=:2MQF'4IQ9LKPJ:4(OF*&"*AFDPJ18'^JA#NR?C
MY[T.?C\LR+PZBLX=7:7.$B[G?G+TB6<V^4<VHF#VXY*PT!O^%9?8!<+9RG5R
M7^@)AJ7CA>^%5^(3X1GSC_$@Q]M\NDE+\Q;U;B1.5DX5Z"GGFI7WJI^T<U-_
M3W?5["233QC;CB]\I\6CM+A/-/M:[LWPBVJ\/Q>NX=TQI(0HC/:CAB++8M^2
MA;O[;_E$@,]]K?]>W)\*KPX]5]T\D[ZDY,Y#!7(K,(_TR=NF<5N6V)<EX>N&
M8:]+2R\@PY[SH_?BC$;$_;!>O(HEV8JA4S%RG<F*M8CY[P3!O.S$Y;Z<._%#
M1VO)BJD;^:,]WV'W]CJ</1KSL'*R[;P74FE%JUD"$>\6R455$+%3)]R;]"R=
MK>'32FVXRO6PKIAF/>$)MS<E^?IL:N\%SQ6<,,@O?(:;D]0N3,*(2X#M0!A%
M&5.$YF;<>*!)L@86Z,49OF A\!-!TP;#07\]BF]8]B80P.&2:&KDWW.: #.D
MR:/TZ)V$+]ZHI)8<"T?A,I=@;M!WXLZC%)^?]'SC?*B-4E6I+YD;+"H(Q2S*
MP,1- &I5!Q>?$@Z_V,AB0J]98I--8+@Q<!D,>>Q[T[B0W*7["-&W\*L+&CR!
M4<(7-&=0B+8^/7<M1V/EX5&!.,Y_521A5,5$)2\Z2\-![I$3N"6+\-H=8[(2
M#G[PY,W#_R1ORZ2=KXE#*I1?.*)(#D7S"WE."<\IX3DE/*>$YY3PG!*>4\+R
M(3[/*2GU.IY3PG-*3O=\DN>4=,K^\IP2GE/"M$WF.27UTYCGE'3Y\)SGE/"<
MDHZM"GA.R5'DE&PZM3CX#&+M/"/_^HN40[I_\?PP)/[T:CJ;>&^$_$%<,HY/
M$P]OE(,P)W*_;^H9*"6EKZO2:KNN$J.K:YY>A8T9%[3(P?U2Y%9I 8:9+BR_
MVF]QB%*&UYF&!(H9]^8N-:JJYU4+;S-@[#I$V2W,O20+,[!$B!QU\#1*CKH6
M!F7ZD)G@8XK-; 4$+M4=)NKH%26Y?8J2MZXCEOZ18ND T3472X(]N[9=P)N>
M/=RZ7SG"=F)HGN2R_ G<CJ\HCLBM_Y5&8MOZX2A2_Q$;C*Q32S;[RZ9FE4R^
M3E(6E*#''62NAKR*)F>L!9*\)O+F#SKO';?A"_&O:!;/M1N$_ISF=%0LR0]O
M,Z1NQM*E'K: F[HCF&F$6#+WF$!*,7W7L*L:50RPA-E.4=*R4U0CI&Z3L47U
M:F^F;^%X([II98,89'H+'%YZI;LH8^RC[TT3_+-JN-)(NRI3-I6^:AK93L6J
MN=ZW-V>F6Q*S;FDW$@<&_M6;.$,4!!?1/H<$&_]^]'S**<=]OK!G3F@72]&B
M$'#R*4' &>?"Q>#K]</@L_!E<#/X=/7EZN;AD*2+SN;H/J2R-8=QE\@@RJB-
M) AS)^D/H('>.,YCC'\3D_Q7D%KB@U"*PL1SGWNX4L,LW%#$S-CY=$XME^"A
M>:!;PCYY@>@28=>B]%XQAI##/G=P(::-@@P'J93<E8Q=3+1<A\I:R=-<9&?B
MD)=)FS,OH-4+F-'[DR9KHME7-V06&Z)N8:W U>H$<2AT @[-^1S35DGV%)-_
M@V7",$WV1D"\N',0CM>/6FXG#9>"#2><";27<!97CHBT=(+V6L)BA/="G(*[
MFOK_&N'7!W$9P;DPV(ON.!W$V_,Q^W5E7F//)R"LPG#N8__PMVA7,^HV*#QC
MKW'*L@EM.+Z<>28+MJ)T5^8SH]-Z%)U_K&H1>L,AS4FG13@4T12O6&8/C^?N
M"(B:]&I(Y"9^J(CDHUM]^ ->2Q\/T@)LH2(=9S?1]\1"AE>,[2%%9(R0"[.(
MAL+(@Z&Z7B@ G^#%3O B_'MN8P1A4V!$T,JY[^((D[D,?0<TW(F::2T/>T3A
M:1X*X"A1VD"B**9CW,$+A!K"EH!D$1C3N(N>$ !90+A@@I16(W".$V^6:#+>
M^30/P$8$P9'*40H;T2??'?*Z*D9I8+_9S/=HLS%D/OS[V<.T-I G)]+-)V0!
MVJRX<QI^'=\C"L\(LQP;IDG$Z "1L-<8)**%\(D-,1\*)14BX,LB@]X%Y_!B
M9X_VMD_R&>V/\.*]KA0+C,@8.2LLA&HY[52QV8RB^=:?-%\BTEHV?8A^6NF^
M?$@7:%.1S4?P1>"*U@-)\%[@O!8Q>MZ;#AC&2H^"_-7, ?M/=-B*I>9LK463
MV3WL?)ZDEAH?$Z>>6F@4"';34;LER9*F6BK\N"6\[7BD:YX+'P?7=\(_!Y^_
M70FW'X6/US>#FXMKB'RO;^X?[KYAY'LO#&XN4[_<7=__)]QV\7![5RT@<G<(
MY[P7/JY$7,NHTEE*X$DL&5)T<(+()M,"9.IF7KWY!%W/LI@/O3J93&CA*IC.
M$.W[S';H#S2H'&/346'BV#%TM!/Y,XQU("H=V\$+VJLG$KZBQYG2;@SP!#S5
M=&88]$:A3:J*$.X%WQ&US<YG%)92+R/HE0= 3))_2XRU"TXI  <:X)%4M-)9
MQKB!<!9=%8'PXDAI+!<L>G:_%Y-BP2 F$5Z ZR:8<_J+Q54S^XT^@\:-PZ&/
M5<()L9S<)5<,L1TU;4]6;&D36Q9NN@.2.868!7Q&S&RZ9(VVTOZ/+B%!]CYC
M;"G@H@\E4ETMXQL1[ ."(AJM0/$[QYW-X6%Q7#[>\B[O"5>+"Z[AY<%BWVG9
MHW:?!Z(VT$"?KM(0%ST:D$VC8VP<^Q15J$;@ST$Q8.=U$X29 !\4^=Q(S)#C
MCF $'WJR<M[76;--EOFD#\>I!(4?X-&5['S3MZ9GA<9VY 00/+Q]<-P)!*&]
MIXDW_"M.DK#.-3,>?%9OM@MD+&,)IY%I_YY[N":G)I,V#*8(^"2V%@%=4SDX
M+,S9B"PF#8E3*K]LA1QAY8-LXV,P,DTZ.Z<E"+=$=DD"%XOFQ4*)Q4*,-VAH
MV^EU\8CAW5]IJZRES:(2L&9JQO'.T,+++ERJ*!"'OB*_I\*OU$I5*"'&N:9G
M1,1,?<FXB&SG9YQ:>RY9:W/<)# E9$1-FXZYF^)V_/UFIA_I!LE#9N]S6SQ6
M=;05[:#\@!5O2#N+P#B&MN^_T58F\3;P:)YLWL&OJ6'!RA1,<A1KKLX@-U*D
M0!1)3+++:] V(SC'\830/B3Q+OEB<(MWP;<!246XD8?)&]5J7)F>>2#\),NZ
MJ%K]U:AI;$-PL[B?WN6!D(8P.MH&)@I=<$R4E,(8^$!K,1=H'Q"?DI,1W!A>
M8DN@CCP%G@.780Q+6B>V(<<@1(P<$>0;0EG$.\'9$P.Z'YA:=*5?-/+I[N#3
M6T[;D6$8M:Q9!K'I#?X%P@T(*'9&0^8F"['IHO%C-,CH:3"CY0\1%!(\!+A'
MQ=U[2JE>'$HO[O.C$W%J %"67N/[1W$OOVCQ";1$3<FCP KYUU9(@S ?VF0Y
MIC=Z_K.8)@V[4C.!F!P^4WVAXX UL6']O)A%,D@J\KE7*]+/Y\+U>.VM<:>D
MC>^%D 'W:U%0?-R<B_\ 7LK2S]$4EB\Z6!ZCY7WRCO0K\ TI$P%2]).J+L:_
M,MMM@]1WC'$3P^*1+49# YSHLY@<Q8$83" 6R@X4PM="-J=F>V+3/<J9_4P>
M5>W=+[M'QKP-O%S?QZ?,!BFC>NLN-X0B&8\=:K+U0\U>$"W948W42K#(.K'[
MB-N/"Y?M.\%?Z&OQ^.XD=AS3VWL.=4,T$P#,Y'=P6-X\H"3!=;'OS9]?HG//
MO#T\,;U3<J2;8-AAC5X5^A# X3<7/ADY(:51-+'%+["L</#\GJ)=C0C-CXBQ
MZIYL]Z]@\S8G^9%L<Z:_!B\?9X2L['BF@D#4\!&)<P=6@O @20))LN'23XY!
M&^F]*[>L'" F)]DOB/D59;1,,$3P:9R;C.F-GE-/87#/U!G12(CJU!,>0MJT
M+Z'G@F.@A'C%I7;JW'5YK$J]]$+.X/H RV:$*/;P9U&B'DXJ6E_X.']T0(MQ
MXBD[[F&'Z?W!D"95T(6=Z[D]L).T#L8=DH@(7GR^GB("T#?QWYDF@\EYN1#,
M<=LPVK#/K']2\P/?B@3#38*GD"9Z/,]MFL(7QV#Q!4MRVKA7&K,)575J@VN=
M3R,]Q6-\3"%:RF")-=OJ-QO%)5F/[$P#RL1X:ZN<?A^A3W-3A Q<_^AEX3!9
M-2(#ZH"W8?O!<H >?U/!6]=+&L^6W91NIMM@+N+;=I X=I#ALDA7C6#%'?C:
M7(2IT\**.XQB10A6-==@#$V]:HM<EL:*JT)43PLKK@)1/2+T.*EG2,+(?N-0
M<44FR1KVA"R+0/:*9\FQXHY,'IN;(,BCJ5EMR.,1 0\9<D]6"AMIC@]7-W_,
M\F@_'!R.@\/59X1UA44!/2(+_<G''<W,+A$/J8\DI.X7 :[B(34/J>N1Q[Y4
M!(Z6&^PE$3^3(/@@?/6][PXM+L7#*(25"\?SR>)TA@?;#)KC,YGY:+M> KRO
M</H\NN]^='^F&$4V6!H-[UG1B,J\$SL0MFQ'^L>%[(Q+ 8M#.W-HYT[H1:-+
M$D,MO\?406QG_+P?=@+K*:C8W9=>M<R=_.S\>^Z,*#H49K7UXGS2Q049'F]_
MPVH)^F3UX7&A/?V\J/Y,\AY?G<F$YA,^$2&!#IH2$J[EP7I/$\QXI,4;41[@
M&]Q!8:!&:S7P*Q!&:T-Y>HN1::(TR2SV3!JOQL=T4#])#MQ44Y&\]<4>"3\I
MFFA(4GX7<U/4=?U]DD!($P!?/?\O6F42OY'VP=9D45;RH;UD71$UV<0VX',?
M4RE7AS"UWX1Q],.BP""NK<6WQ-FM"VRT..$X*K5*('IH2=:1)@:NI6+',A4E
M8],2&YKQ1QD"[_7M83BG- F3JK8(;@@3@9,2.3!'RX*=92U/$TF#7<P?W#,_
MI^H$J:9R!CN7*7@1EUAFA/+)_V6_)PQHG<LAXMXH@5OD[2F+U=)\%I>L"[2F
M']&:<NEBZM5M2Q=N\%/ B>*R)0MOQ/9/4:[\YZ<S6=5$0;8D#"SU]SFC2!:C
M\NP'4P,RI&1 ;<N@C"&@2J6(FR>V7MVV:*@H&CH7#09?W;9H?/%\4M)S,2)8
MU6<*E,M:J2?#AC^5/[733\7@2E$,B*LT'?ZE2^\+A'9EW[6,VABG%G_JT3VU
MN">J-U88[(G95L"U;SU>['[:P;;I]5E+*C!%S>IX?C$7&2XR7&2XR-0L,A"/
M[GYA-L3LHOQ@/+R'!+4SV064L*P5V5=@2:2X%6IR?B<L..5>QQEY/,NZSRNP
MTVTOWHY++A&U6S&Z'N=P'JI6*Z AG(<59H1+>L=96&JY4>[=3(?_LJ2*AM%*
M"3)7T*IXV'64L!/G'P_ B]/N.FG&,K/?]NEJ67D),5LE_D<FVAT!UN*"4EI0
M3-%4=J'!<@DY90G11,-B$ONL&I9@^"^) O[O_78QJ7DI4WJ 3*]W5%'2S..5
M(FYG>,C"!84+2OW+NKK10;I_F%MJ_JP)NZPJHED!]BS#>#E<+#LHEIHD&M)1
MPSAQL>R>6*JJ:%: ),^P5#:T7.V0G!['^EB6#-&4RJ^0&19=;E"[9U"+'7%R
MD>0BV8WE?UNR61(N\7#HQ'B^+*,G(FK<!CPXUT/8-_O)^TX$VR>((0A_>^[*
M]:,Y$4:T)6_<YM@GP8P,0^=[J@%SNN;O2-'WKBE97)PY4(BVIUYMR?O%<X<A
M_'0!TCFGG=)MER+XSR;P817JT G2-)Y@M^SIU EC,+]4(V3XZ2>9@C)2X,4(
MYA >3=R1 WP\6FJ?.4[<2_T &$]ZQ0(#] L%@\QMO9X+Z3FV'5_X;D] WCU?
M&,^1O"E,1&2 G=O:/@(!'4_FR,R0(+"G/8\Z@ ]?;)=B>;HQ-J4P\YTA<$U(
MC8ZV>$A+!PC#+&H.[XV+03&NVRFTJ1]4@V$SM<J[11Z,CP1EC(5.>G#!*GBK
M$T2MUR-%=C+3P+[G!TKU>IOT V^?S?U@CJWM8Y30[[;OT))M.J:HL_N(!$/?
M>:*-W(4;\ J"+)\+ T'^.9X^?O]$W.$+DF"- !'M''?H$SN@A!^1^/.J@5S<
M1NT7_/Q$C9NLYR/.ZI+T7I@1GR+&%#-SNQS]WW]QQG[0&\\GDP^73C"<> %(
MS.WX(\C1/U&,X&,B+=<+80FN?J!)MT//?_O]/P3A[ZF'4$+.T$7<C@>^C[3#
M6SYZ/H(*.O"G&U[$V+84#SAU43!P1]?NB$Q=9PRA$OTU"$@8^0K0VSLR_NW=
MQ2,22.I+<NBA/$B6*K\3G-%O[S[^>/(GC_B=+"N&I,E]79,DX]WOF[!_P<L\
M16[[C:K&\,4AWRD^+/P(>@V\\MRXHSQ\I@Z)RO43$0SK9UKTCY<F&+*12.5=
MK4@_GPO7X[6W.E%0L?&]B4R-TD(U0K&1I9^C*2Q?E-;]Z$7#!<6%X 7CFV&:
M\,*K-Y^,\N46WK#F@U5U,?Z5V6X;I+YCC*GQY8UL,1IX;O(2,15]3=[$G('*
MROF*5-<BD&M2_\6&]\^G5VCX0'\>O N?0'ARA_9N7703@879P9@GP6_O>FHL
MOJ:BRX^&IIG&.V'N.O$]@\MWO_?[I@HQD)2>V9:7%AU>]/EQ$#S>CA]5^1&4
MABK;@R0]1O][N,W]?O-T9%6U\/?5^1BZ:ND'SL=[=E9LU"4);5 58!"$#].(
M.4_>/!R OW^^'3]@Q[^[9<._E,W:UYP83R-MJ/2EWECN6SU9)G;/'DNDIXU-
M6;6,X=@<FN]^W[Q8Z@RL<Y7-5?9%)EOK&M$4Q/.R34/GT.<&WSY]NW]8N+!#
M H+R%"M"L*JY!F-HZE5;Y-(V;,W6FAM)+N5W#((I495W)0(W(:H1P:K/GFFA
M0:+4,PIW'*^H@P_;^](5-.AIMG%5UPN^> _;NN6QT891IM9*A?<1]; UY)ZL
M%#;2O%-MW?RI()F'V51PWCBV^XUCY0I2<VON&]MQ"_W)][ +"6X2"?YREXB'
MU$<24O<[#C3$0^JC"JG[4BN8+$=DL+%KU ?AJ^]]=VA2">8,8(I5.)Y/$'F;
MPG'S8)M!<WPF,Q]MUTN ]Q5.GT?WW8_NSQ2CR 9+H^$]*QI1F7>J.YW[6"+]
M<E1@S??@4L ZZEJ#IAU"?7K!]HJC";UH=$EBJ&R6?Q^X9CFTSN'OOU272+3(
M2UJ_)MI=RD_]>H0;4I<.?C@!?O6_Q/<>O'OG1_AV:;\%7\CTB?BY>55 #TQQ
M5+)I5;(,RD;3JC8.ZI A%TX'>UR?7X')R=G)F9I5W>1V\8,.]M8E#Q[^ZQ7,
MZ]Y#SZ3OF4PPI?)YFAD6Z4H-#-HV"+F?IP1]@P%Z;Q]VCGCWJ0'=9]B+79"/
MGG\9[X&LWU&(F$IF5$O)W>>E)498+9T7F>!27[8D1=<5M:_TUV<'Z[!BTUO_
MX8:$A] [G:>N*8IF:+HJ63F";&TV'/#*_8=3$W'CX9N28LI9T9$APMAK^/_M
M^7^!J[V(J[L.R9A69?T1K(XF9VV1!J-;DF_U'7N]NN)L:#K4OMPWM!RS"1/8
M-=0=(<LW-\G+)Z,+.WCYB 4_%\L:NR^+LL=BF="Z+#T=?R;TGIF&5:=Z-I7]
MW+F<YPO;]]] *#*+D[T;;@^FJ!,[5CJ59:"VF"/=I5>W+E9+NUA<LM#*"M3,
M<NEBZM5M2Q<>56)-KEM<MF1:]'F*<H4X2;*JB0+$[5@]H+_/&46!+NB-#&C9
M*KUM&92Q\%2E4L3-$UNO;ELT5!0-G8L&@Z]N6S2^>#XIZ;D8$:SJ<Y[*Y=_5
MDRO(G\J?VNFG9E$Q"X1V9=^UC-H8IQ9_ZM$]E=5&;(,XHQ8;L='-6\2ZL8=#
M?TY&:;"[ J[]R%$QNP1Z*9NB9G6\4H*+#!<9+C)<9%CN.-TM^6$:T;XD3C-+
M(L6M4(< OKLL.+R_=M.,9'59]]ESGWLA\:?"B#SMRHK@<GE@3KTN*D;7XQS.
M0]5J!?Z(\[#"VA9)[S@+:^X*W=GP7Y94T3!: 5/@"MIJ]R?./U;XQP/PXK1;
M-/:8V6\48KX  7D3<%9%NR,0@5Q02@N**9K*+EQK+B&G+"&::%A,HCA6PY*&
M.@8W,$"FUSNJ*&GEV_<R*T7<SO"0A0L*%Y3ZEW6\G?-A#.YX.V=9542S A1M
MAI&_N%AV4"PU232DHP:DXV+9/;%45=&LH"<&PU+9T'*U0W)Z'.MC63)$4RJ_
M0F98=+E![9Y!+7;$R462BV0WEO]MR6;=P*^%4-36VFTG1[Q?X\JY(L" 4E\V
M%%56%-/,0MNMM,U>>UNAL3SB#7A]/+VW!!PT-?,%-?9 !M4RZ):FJ2"\93,#
M3[Z\\<+/-CSFX<5V;UWR)[']/0:OZ^N#UPQ+:7SPZR,?N*/T?!Y>?$*_WX<?
M1@;Y4I4TL[TI+0>_-JN/SO>=DUK7$16"3BV# MO6U K-0%=,-8,*>< ,_K#=
MO_[P?-][==SG(->&%;5"IFS(?4TU^QD1 L*;^KI>[#&2RL9>N=7**+ZL28:D
M,C?%DO8M:PQ4TV1WEE4:0E/-L%@R8/G(_N1+F<QD^E86)5?I .,/F:*Z/5HZ
M?'8KQH0B\EYXTZD3TN2]HJ#/IM37):5O];.@SP:-IM-CWCJ"!3SP!1#JF5R[
M?Q!W^#*U_;\2EW$'9,P.- OTNQRRDHOS#'Y*,OMR.K2;01@-!#Z7Y"BXWCZ&
M-<+^TY[,R2"\<X*_#H)\UG3I4<_K?:"O$R[UAGW?73'F,XXU"SNN9UB\>:3I
M]<H=^4[<.2F$WVP9P[ZM%L5OGB6K0&#JL^,FJT#$6TZMZ_XU#T)G_%9^I;K_
M0GC3Y^36+":8;)T+=U?_O+KY=K5C%;SG'[--1 J]&8,40FQX/Q(DVD,Q?"$"
MV!/X]4UP I#BL>.2D6 'PC-MAA!?*PJO+\[P!2]QX0G>6, ;AC ?;TI\(;&C
M@0@W/*&VBQ0Q)K 1Z-\G8-[=@'[CDZ'W'2:"5TP0*)7\&#H!$4+[!PG.*^0"
M6V3?()C1W@F],];N8,$5BJ,G$'<$[ ![ W,05!D12!6)4A*U7;!]@L2WGY]]
M\@QTIYP;>Q/T9!\J%O"\797--F,;$OQNVD=: S;5\^G&3(_>\L$!0^K8D\RO
M$3F37_?!BE=G/Y*-RB6\_(<T?NM.L/AM.UZ6KE:/31N/%X?>%&)\_$K=W/+.
M@^ L6U.U-";\MT_?[A\6VE2-FI2GLJ(7(7+5O%8,U(R&7K9!EFW#UFRMN5'H
M5I%A=$*\Y5U5"LV)M[&%R-6G_14QQ 5$M<*JP@U&ML*F\OD&IL(7&+72^K">
MP44TOKHW;)#VFCNRIZ2]'>LT&,TG86\. 3T$^CZAT9D]@<6#!\&^C6DG\=KC
M[ +6L"/'=G?U C[,).V4JO)GTO43<==9=84DH3:G@G/J^HEBJF)?W87,41UE
MJ*ULLLJ;&HRU%U9F2W=/9%?OV>.2>FL_J6^?*)8N2G*#4I\CA"?HQ?Y[X:Y"
M3_CL0' ;D)'PU?=&\R'Q@XXYL2K"TDZX"%D794OC+J(!%U%%^-T) VQ*Q1?0
MW/H6(OFE VN'$$WO#-8/Q V%*1GA:+G=9=3N2J*I\="<V]TJ94H6Y?ZN^DUN
M>BNF.DW8<)-=F[.G>>"XM)NE)R2?N<EEP>2JHF(VJ!W<XAZ_Q>WS;8:&*7X;
MOA _"6HK)7XI&)4ZS&ZI 77'+"O:+N#AYOA8B]'>,*#=![\%C7D#@GR8L2\G
MR)UQ!KI:/"VF<D'FW@(_?TKG8[(<A+=#'GYHFKLSHXJJM0L>@2\4^*GI<2UE
M3%'?"9O)ES,54_TJE<G/3/# 5S/%&7HF&Z)>\29LPRN:=@A7[1XI7W.=QIKK
M3#9%6:TV?Z'A=5=WU:W+CC=5TU>C\!R*_W2:"\=R-.M.;& 9HMFO<[/S4(BI
M^G<[ER-JR/76HW'MVVNF-*XSX8$EB9J\"U:P28VK9=5[**S;ML]K%?D?%A1>
M'0<KM>-WZ8J9)-7-"829[\ $X"7"T)O"'YB+[(WA:^^[XPX=N/@92^I=! 01
M@'H.B4KM)S!K++BA*'=^((0O=B@$9#(1AK;KVD\.?@6\>G[!>G,'3R*#&1F&
MSG=:4Q[ZSM,<1R-,O1&9! @!0&" 04XUCQ.LCFUY1?#BS"*LE- 3/'K@N7C[
MD.(.4"@ F,AD/G+<9V&2I%O/DG1KD9;$C^<^O1N^'I(@P$N7" - 3"^>!($O
M$UR"G8 "K+!^D\ZOW[J$VEU ]T9/PY\_N AC.(F^>25HR#YH,;I _H/2^ .7
M<Q]IFB /Y ,/B"MX$2_V""6(D"7!A;.5.^2^T!/"5V]YP?M(#!T7]-09S>T)
MB+5/9B!Z6$$Z EGS"5[B"K+T,XI2ZH5_B\ G8J$K#A:Q0Q[2R"S;\5<6Z#L[
M8"4'3]X\3  >HOL/@6]9 >*1=-E0#,7, K9P; 6.K<!6\3G'5N#8"AQ;H0GQ
MYM@*'%N!8RL<]_DJQU9@;N_I2#9S.;9"K5+?_MXASQ+*VU#EV HM4)UC*W32
M17!LA<9<Q,E4G'%L!8ZMP.TNQU;@=K=AF>+8"BU0G6,K=,3D<FP%;G$YMD+'
MK2W'5CBVC&..K<#K?(["&7!L!>:\!<=68.;XJ#/^B&,K\%/3$SPUY=@*;5"=
M8RL<V6J&8RL4)!S'5N!KKB+JQK$5.+9"@?ES; 5V(FB.K= .Z3BVPJFN63FV
M0DL:UQJVPM]_*5[/O"B'CE:K#[A8A5\QPS?8H]9Y1(;.U)X$O[WKJ7'ELZEK
MZJ-L0N3V3IB[3GSWX/+=[[(!JR<@8S3>G!?N/YCH\^/'/Z\>)?GQGLQP=-:#
M)#U&_WNX?53EQ\'\F8YZ\7WN@!>EVE)?EF13-713-JW,X'%&.P>_K$)?)_T7
M^U^>?[&HN2]81JXJBJ8I[W[O7N5_ND)_.VW6")F6:^0[S!M>_MFQGYR)$SJ)
M,-N'5.<;3Y8Q[-MZ;RSWK9XL$[MGCR72T\; 9?AI; ZSM?J;44H2BP$F*VT!
M=H)1Y!NZ*NQHM@A>D<Z%B]N;A^N;3U<W%]=7]X<8RRSF1CSQT)NQ-^L40L9#
M2@%\,O2>77AY($SPZ&B8"-/P+0)F"4 > PI< G\^460&O) @>@IQ!1B!_4PH
M8LL0WHFP*IX+5[T)!&8,XDRH^.,MY\)_XQWX9_+;*'KI!)%>7IWPQ7$%6_!M
M>/^JFN(H_5$ /VX>I/!D4] 65W#"0'B"5RR'$"OAR@S.A>NQX&+^,+JO^00,
MACT%IQ0F(Z%:3@>#L# V/#(,B9^>%TP81Q>AP40W1^.>.J/>S'/@6?&;%X^9
MPQC/A4$ YF.A[O#DH8=,_<OU7MWMDW2"F!@P5<H >TGS)5TI+YY@'/:(G L/
M*8K#1'Q:8.F05W@$S)#8PQ>T7YZ/KQ-&>#L"TH29NX8O.(OXO>0'0NS0\2^?
M&4W.%<!\X8PB$H[@!_J,L>]-UXSA8L!3&[D<S"=H6 4D[&CDQ"F&)'(F@H=Y
M,!.8+:'7".-Y" 90L(=#I#P.?@9:X(T. E0IAYS3I-K&[@WLM[ZJ':\V>!5[
MBNQ$.1V1,7@^B&0B*DWLUV#NT#_P[7_X<S=X=89_49U^\BG[04I!W,;."*0-
M5 \^0U"'\B:N7A'Z]C"DOP<S!SZ_44E97A+Z0+#T/?#(^="QP0F-YN&;2"]W
MR3,0EZ;L.\'"<5))BF0UF=<3 </PG021!8FG@5FFA*HH")D KA&_>Z'@3PZJ
M[F0B0'CN07@9@!&*:$$? ".G;[CQ$CU_L=%.H X-A_X<R.>@ 9M$.AGA,-&I
MXF88&JME:#IV7#M"K I@X"3"A4)ZTELFMC,]%XY3"&]=X8OM W-5&AR9P-)H
MPD@\()9+*)DI@^ G,%PS#\TR7!,$O8@'"UZ>(;G>7>#M[]Y3,1YC@![=C+_=
MST$ZIB@1<Y_:TAOONRW<#[W0L9.[\2>X.R#D+QK]><M@+!I;0(&^A-D<ADU=
M1%(I@F!D_YJ# XOL%+X?'QG,G_Z%M269R"T"\L+H#>Z>H D7+LF03)_ ^@,M
M#"K=_\]VYRCO2!S41Y@FVK87^SL5)EB"N# $5"0PKY-8=!+_A.9P"%H8"-,W
MB.^>YJ'M.I-(R1R09/O_T%:^OCC  +2YK@=SG*%W@&>B_&%1_=-;#O98K%D1
MIT#-0:+0Z0:@7[Z-0&IS=.DPCIA%"QPS$;4%Z$J=7/!!.'/>IS08A@HB*J*-
M)Q./ J1%S@-G@C>?.2O7@]#-Q_ *:LKHKZN/2Z&UB<B?OTB8!DC#.[Z_S[5)
M>,G9RF\)\^ 1=$J#89C833>8@^7 8LTPEM=!\@PJ=EC5"4_XY'D0="Q^<H*%
ME*%4CMX$)PIGT)/#]2ND$C"&> ZB-\*\P"3%<5($>3?&*"4Q/+&Q20Q?8DF"
M>!Q4;J9@<\(%2T-X,OE!IA#E@[!A=(8K,XIX9T\A(HN0\X#S*'#P@" ,CM4D
M+04;-1C\(%WV 4_!6$3**1N)L0)"1Y)-%G8+B0WJ3#"RL4?H]XCP0NP)F" T
M_N3?<W2*0:0BL8N-(Q5@S3Q(EIR155@RB$9Y=ACQ']4600=12%;7GP%58KB9
M.*C$^&5BG](AXHB :(%RV)$^K(Z3C,<@Q@6&>+P"D8A!)!CV)/!2UA>I VR%
M%0)E/L2KN,5%M04FD5"+ C02BN5(*1JYDN6W1TJ].,R<H,C^O[E+4',L,28.
MR"451Q \O H\*P@U_0L\%!E'.Q^QOSX7(%A(W"$^ G<>Q.7O8$\#&G6!Y.(.
M%%W?/,-*B8KXROOHHZ*X0UM]3FPP:=A@HRJ!YZ-<A77"=UJ:#_X1M"2*S%;F
M$+N(B*VQVWNB,*+@PYY!4D ^')C%Y[4GH96APZ3J&@>7RY\B8L"S;H>A1ZV/
M'N\C)1<O)HN78Z3B@^:?+Z-+G.Q@YH/C5Z7TIE4Z^%E$1(/HS?X<*4#C&"J[
M(/;HXR$"IWN>M% V"8J 8+ DH['^\HX%F.DR3GI:FJ+E[AAX$QKKP)IK,HHL
M#GUB>AF=:YW2$QPL+908,V!*334(%'TNVD0(\^FB%B-^*I+47D=Q=N+DJ/[F
M&\/8-V>U=H7.D80;:3*G:!>)E8OLG21BLTFXMG#G;RD!WQS;TGIE>VU\"Q^F
MIX>X:SPH6!!SP/HJYN/6%QZE&4LO))UX:YG&I! ^X[X.F:*&)T8 -TV?<Y:@
MT;X(B?0V\B480E#Q"N9@!(8DVIQ!_Q''Y3.Z\X-K'EAE!F2"=Z36H1?1\O!Z
M<3\N#U#6OX.F)@(_1"!D#$LPM(-E%&[.+$W6F&"LOM2"Z,7)<X+ &SHT5%S(
M6N(%XX7RZK*&O@N>DSP@6?_ ,+Z#Z8ZPC*<T7(4ID!\0/M%-P8A22\HEB,;1
M(CS:OD)(Y1C2& 45#!"A4XRW;N;N!&\(2!BBIN&*GH:[U'OD+-076U^1<B]5
MY8!E>KS*6X_ W@BN9D+B3Q<A0G9;+7$9$$Y'"TUX*2K>"TI8RH^DE?@XU2LQ
MG?+"=.ZW#["H&QXFB[#9<A&6NTF0LRVPL&#_-0>I !'^ WS9"[YY,'G")4^\
M-Y#\E>PP)*NWQ1(I]O+)*CA!C,A!]DX!>Z>D)\UG5(:5%PHCCT2RM?2-P*%(
MJQ>Q!WJT9!R1;"5O?/%><5S1#L)?.%Q<I<0[KI06,<YY:J\JC!>8#_^XH-IZ
M\<?EPA$F#_[;8@D9:?""-\G2/QIT'"RM1B8/:YJS8A]79Y^VDWL@F.?K01XB
M_B98ZUWG8%N.T*Y=W*Y^L'\4/#8;2T\2D\=FFS[7=)RF@E^[N;C]<B4\#/XG
MYS1M^^UK1_]%$AB:/J!K@+ZK,0V>=]"-/PC)?9_03?[HJ 6/W<'2O%&/18]*
M(L=.W6V\H83'XD'^N3@U%RCD%<'1U^'*FJ4VVCG/3?9G,8(#@H]2]%X<3"%'
MT$MYDXGW&GRHF(";NH+D?XS \Z.DG=_>2>_ CD\F,SQ-<Y\7?\.+ALG?JVD^
M6_'P46<R>/B]+.7H.,H@XQOZN:09^L_[IL0=".5]+BFJ8OS<-$"^LOF-!^&'
MMZ8<'8#'+T#BRL'Q?VX.E'ZS)#<-CY]+^0+@^,P)-T/@^)M)7%O!X*&6N*"T
M5HC/E$NE"HN)ZWY\S92N$+8HEQ05HN,7?7QEXMZ.?;KUG6<GVB>A03DFB_J!
M'6T:$(A)?9I/XXPA(*5'DY6:I+W$JGS)3OUD;+#H7?FYBGJ<^DERIIJB959;
MD+-#@[L@*<VA%68)4JFU+U_7<X)JV3Y)9+'?)/S*H7)RI&[VXB7*R7;I5HZ?
MI#W3#QURKN5CN$ZX+DV1V=*02E<4[#B%1L2I?9.K6(R)TTD9W+F[*#L:=7-)
M<R)65S'%JM%*N>$]:<,KBZK68+,4;GKI,[_Z#I8(T.HXP1[A\2M-AJJ4$:40
MF.HRPZ4&U14S?:88# &PG>*FSR:"A;[MPLV8J'$@T1H1\+I<50-:QX KZYC.
MG8"?>_!"6C>UR- YB[.@WMXGR3HU\NQ06*'3/4TI1[?.N&59$C6SVHV&<FA,
MW9"U.EUSBF)-^^;ZS$/[OK![YJ%]FJFBH52[%*[?.-0 U+;^F=%\X0%-J':'
MSL19E(_FI0)'51Q8;S2G503T/"E,2IF"]1*F%8 1(;=@R0F2$C.LL9UXK\4S
MM!<YQ3R-F*<1,Y=IR=.(>1HQ3R-N1[@92R/.!'"-Y!4?]M8*,H$/>F'S[VN:
M6X=M,E; K1I?>*K9RU$IK7"&&);O(\C'& H :Z>]&?'C"N88+B9=OEB74:2+
MF0HLR#&LK2NV<>V0Y$S6#%@]5]N,^!"!890NU>Z<'4:0 E:TC%ZVOW_#G%ZV
M3Y(SO?+Z@M):V3Y56FX]Q$)4<+_8#TOMF>'6&.LNO_%%0SO\4?KGTL]LZ6UA
M+K#MJQI?UW"!:F/QU9AL=6>'@YN!SFQO=$#!VC%K#Q"VP/ 0RRV,VF>LGO3Q
M<(:)<.9,4T1=J38_CV\/<%O+=,AU)HNF5&UG8+[X/@:G=>.YO1%!Q$\'DSK.
M7/@;UM^8X?%><$(R97[C_43<EB(:6K7-.WGX?=(N015-C;$HZ 06"9>+.F;L
M&?B*P.4)6"LB3,38Y\D.*#>^;!C?JA$FN.D]:=-;-<($-[R[:?X'<<G8"2.X
MYD6\FPLPD73=BE$HN UFP@;7@#?!S?!)F^'J\2:X(=Y-]2O:@XL"EB91+M:[
M1(TQ_S7WG6#DT&8C//AEQ/"*DFRPI2;<[G;9[D;S_*%(LG:0*''S6P'Q;]'.
MUDKU2E!'*K>\96%'6+3,9XI9[YE.2=P1%FE6[SEG>:R?HNZG)JTKZ9ZJU[KV
MW=>96N^BH7*E:Y]D_* UJ7W*!QY"^+W< O\&!:TH! F+1K[F\HO2&"0LTJP.
M1*)*)8Y1NIU&0%&==6C?&W7/.K1/L^H!B>JW#0T $G4 G.AN":>^Z%.*48@=
M!"3NVSY9]D2FF$-.$"[:R=.^I8[[7+QSZ0Y@(8XF=*)H0H6V#G<HR"[%:0AE
MJ+ EY/A#!\C^<>$/,:@.5>$2-:X.["(6E9/XPGO@A<6[SC>V\,+&.59X_[0P
MQ^I\8Y<.S9JPIY=Y ;6/2)^A[SS-H] V]*J*I$LN3+N8\L!QTKJ43W#".&E-
MF!LLUAK:,P<;&2"&6HGZ@')[-8T>##1!V>);@G7:Y IWO)L@HB$:9AT+:)Y"
M5L>..E>KCA!1ED13*@YGV+!>G;![_DSL@*0WTUOB&4_ :UL29%%2V]+86G/V
MJLM+XQEQ[6;$-;+=7$6B-V/:<&+^+6>'BXW@@]4-J_99EOYL=BET/-(E&<-5
M/7SY<N+F/?WYGH0];SR.*S,[Z*_YVJ4*,3AKTV<P4G#4!)V+YPW70V*^(#O^
M!=E9J\Z8D<*F[BOWD08@-R3,25%F0EC;+HXZZL,:9LJI3G)/K.HJK HKC4ZM
MR(EK^;$$6D>IY;Q)"F^2<KJ[JJ?;)*7Q3.IT/2*+Z=3<W'!SP\T-]^=<P;B"
M,:-@;/GSSY[[W N)/ZTT::0-)\T673N44<TN$<_Z1G&<H_H$LF-4;.L DUD7
MQA9[.F0IV"7BF2;VK>)MMQJV%>S2D9^'%B#:'PZP]1E'WOD@ZL33<,_D;A9&
MLD5%'G"TO69F2QZZ%,:S2T7NF@L0[=K]3MS0\]LK\N1.N;3YT$75,!ED7\?H
MR-TR=\NKP:XN*E)GXEUV"<D]<P&BW:$^];QQ;XY8#!21@2^>N^VG95'J%V]
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M*FQHBV#; B8[\-%X!/_PU_#7\-?PUS#PFJZER;/>N35-\W8HQ%PGM5TD*1@
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M8RP][9$O-4N\^M3VGQVW%WJS#YC1%/\9.W7\)N7V_S4/0F?\MIX%M2TN$:+
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MF<@MEO43'?($@O;!:.J '0[Q*=])W*>KN)U5#["S69UO\K!GCWM_S;,:&\S
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MV/)9^$Z ,W E9D+X(Z LB6S5D/BAC5KON=&#$WV=DI!VBH7GY,EG%* DM[Q
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MG=(T=V%HO)H%[PQ@#PM"A%47LS.!7X%HVDU2(UW-K-AR\ ,7E"Y<@6?+VN@
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M-^L%\'U5 /=+-/"MW_X\NK_EYLW\B@<_[G%?'412UOO(IAL/UO#B8B/]JA?
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M2HH\GDVC[!3'X4SS:-.O7)^[SOYK@-(JP ^*NC[2C9MA%SF/*5@6U!'VH'H
MO8 5UP^K NYD&J8X#(&JUM7?ZTX5-!!ZF4J1R7)U^&'&=INQ14G4SDH5D%Y*
MB@=Q2E*J3CL?OC JW+0;!-=%<.7G%EN)4=U%+U3Y?F0WH59>A1RDW"SE^\"C
MCK>W_279VP>>F+)$XS' K[>:NYU'T.N %#AKT(%]^OE1D'T?_BD0P'"\7[EC
M.^A$TR7;A$,_RM=LLQ:]#.7LN_)%VV$'/8?-^QFY"-J.YQ?BUS",=WON%W:V
M?]L,IA>Z(G&N*/0.=O!S@LN?^8%'TI*C,^A,L\[,X]TC"<;4_4R\S38B[OB)
M!/:&3%](X'@A@47;P21N_I;/HD%G3AE,KS.*ZE(ZG:$<$1[@>$Y0&=D"EQ%)
MD,$-P1')WB'B,V*#UIRZTBSB* 37%"_3K2+F?&E2F"/'T>N*_BVI+NL+R]$8
MA8C'H"-GT!'!PK-L1BW&TNK*C_)3S4?KBOCLL!6]YJ*R#..3%I-B?[UB*!Z.
M/L,BLEP]#*K0PK&X)P%G(W4(MQ4>@ !%,1\UF%ZP4M3N+(*]'P1[TAR_96$(
MTN12[#S!59WU2B %!8]6 OSV: ^V)O_ZH +-*C"FD7?E^3&Z]2OBQ '@3T+Q
MA EQKP.VF[#=/A;< *$C*'&G=D!AHC4KR7F'UZN1?(]9JT;@JGH7;H+;*,R0
M&Y$$N]$:T!LY.7Y<^02&(Y*@R+4M'+2M?24RP26+O$2QG:I, XQ>[E+H45&9
M; A='2<FK7R:!-.B9%R7RP+2#0$6;6'R^9[]Z/EBZ@ZR[2+;]UKAOF^0KA0X
M/$FZ_ +V(,NC9?E!*\L/#;*4'Y8[198QY;6;8GS<;H0UG +;P85\5#CH09;A
M*2 ;P;Z+QW\\/+B.\0&U01E.? >[/BN^#;!>5:1XGJ;>Y+#KGN5J8/GB7HT8
MNU\,[#2L5BE^4F3,U2G%23M^L0Z#QT-Z"9J#?G4K;EJV !JA]-*7HG.Z J?#
MFG".-2%_R7U,W4MF!R[ZT82&'*3S6M!N.+T62*$\C19T6 1V&6K<0GA$Y+A3
MGF(WJ%'-(\\B[G$WGH]O^-.7):VH;=4+60K5I=&5?*!ABK]60>.RJ7_B&'HY
M2[&T4XL:#SIQEILS&S"'^#.@+LFKKW2W_1K&T>N&%&\[43>Z7*!!O!$F0LP+
MI7P& _ 4!R-WT>_P!7/N<B\3%]UBO)3#0\&GG]CA]MIGST?X'*=^2:^94L#Q
M]]/,8IACEY%6"G2(@A/EX C0-UHC@8/^UC@PY(G0N*8(55VC7DNDP&56"W[8
MI,Y34Y1+I?OJ4.VH%Z/B60TAQDXE0<47!W'7^!"+E;6X7HUOU<=V]<UZT4DQ
M1!P(5V@^U# /SS,/;P@E@>V#1S]V=T!5& FF3E_0=R;AY6&.&U7W#(^N ^N4
MX?T[*79X_L<:.JP(&T$;CS78)>I&)"%O]'@844[@H)VG&)V[/:,8R468-0D"
MA''8CECV2Z))1]B7[0?5:Z7BBG#A"8I.AF&*D@ 42 $@8C6*[)=4KP9E.EL9
M\W55YN,(7(L5,"G&XEI+.^JN6L=_0J]H^K=.3BIOKM Q.T(W9!2F>(Y@;1LT
M[T3-VU#O/\1-UQM0B:S^W&U^A'V4PG4:6:]GBF=DC]<S@5>^FJ&*%<K8#2?W
MYZT):Q'80P([.%QY:^ XH<XQY[UM1M/KD!05/GI3S N_1BDV(S='9]":X[5F
MSNC$WGN1[6,V-#_E!X!G.W##\1/TP'"IQ1;K-4S7:YYO ^N*J-V*VT5GO3K3
M]_2:IZC+>)SF448O'('NR,=L<:>(\,A.,<: '>,XITE)D< ZW54'#3VA&'%0
MV-O<V(FP>(YJ68*-[H$BMJ RJ%TDO&;!G%4WQ.)6V5%[?P=<])JM*%!YG&;'
MM+0SIZ34++"X3<><'+YY^YR@$8P),T2QKQ=W_4'SU=6-/ =,;(]NL.(<=5D0
MBH2*34#X/VHJ'G7MI=<F*;9].YM,YRN,CHQOEM/A@+ZE,&\6GZ;+.3\@>KA<
MS:YJ[BTT@^G%)<6P\P%'V8B#O$Y__3+AVK?MWK_,H/72D\+8[5[ '*39S8C(
MMYZ.?G6[CEH9OY>BTZUD+&_;A?US<)3/7\0@><=/N!1HG2W6UM9!@<._\9KA
M$G93&T?!376Q5BG$Q ?)>&L/U>4C\5TP[U;V$2]>_2[8Z+56BEX?J;6UQF9&
M8^8.H07YW]C+^CB9">5&]XK?H0R*Y/*[E^HIX&0T \1H"U1SBS2TA[>ZVDR/
M+%M&'-!%Q+T\@-Z!YBP)N  HKGL2>,RM7S2[#Z%71"FZ?90B3O(TF4V*%Y["
M<55##0E2Y/ Z+F(WJ$M-68?X,23_CH'&*;YG4'-3J!%*+W3Y/C^8LM-_/J!5
MBSD:_W_63\;_>[1#LB3KT0O_)0*87]Z$WF[ODS?);]N K']YPS;>Q8=W'[ V
MPOM_ :5_>=GY*02.7A+SRV/@HZS? OPW0LQ5YB3?38>P T<:Y?D;/L;[GW[Z
MZ2V'>IL4*(>%^6V*^YNW9Z()A-"5IK+<C*/(MQ^[4@1=B&\D,:#L78FIS(]S
MD_37M_9^CW8(_@E_4,J$>O._B2],"VKOX!MC;E <+'8?!\X6!GG86VQ,*3CD
M$^@(]@9EGKL("G_P'%3BW@>,Q\T8%0LA,.5?YQE-,)[&NY^!0@=PG45DAXO$
M&["H0IXZ^LN;M>V'*!;@KO>SV,DLWL^- UN,$\+2''E1C'_=!"S>__)&@'LP
MWIL1]7P>OO[E313$"?.JW)$>9!TG"!1HUL (2L1'X3>T<Q6D\,^_.B5;CSPE
M-G0AM3CG>R*(.[!BPXA1<D>P$F&1SF-'2.3)*(K493O;HU^/#?^.O9"OC&&"
MKL5P_P5Z/!K#!B6,=6BN?1FCR))SC%94DAVP+;*#P^^B\<E0C[:/=:A^>>,$
MQ/4B-=_R%T/RRZ_%NZ\%IC2#&D.Q2QZ;",[D.KM>KMY_?XO7[574UL#UB52+
M<:P+CK6"3A50+XA,7Q1<T+$K2AZ"@G)922M="UB3UK0,73QENR(PC4% ,YK^
M=TZ2?(89O<<"XIZ;)I_".I0>R0%$L"D+_)RC]DI#D& \Z[1]C$'>@&AY7(IF
M62'9DYIB(X1M'7K!OT+/)2F::CZ>/*PQC-1N%FJ27X&+?W@.6FR.Y^1(+0[%
MB:L^WJIB4[M^QO!"-RUC/WI !PE7'AS=]C]OP3_"2&=R"T9>P-OW,6HA?T)N
MW'B X#@$M7U"!^\1 ]F/ !4'Y?6Y!?#)\O4H%@J-7E75.1WWHMR11%_VNRFD
MZ#3UR0OQ_602/&%]]BPO05;/!D"3='(#R&W LIVPW<[C2PLLP$IU V.IZ"+6
M^X7A9R_:>M1Z!KC#-8N#.UBKMT7=_CT_:HIBZ>9(RH_"_J:L('R#CTJ@$_(/
M<LCKE !H"+I$? 6'3QZQ#UN(@MCB0PX)C3/*?[P$\]9-EITQOM(A2-;S[HCA
M^L0X\3P&&E4[0)73E6XYQ%5PI@&^%!;CC5\OPN?[S.&C66Q)0EB1"2PUB23Q
M/9#DH1;N R6+SE5R*;U ^$FCF+(":13!WV_M)&@;WH/$=O;-[G$K;6QZ,).V
M-?BWF]1P H%%H+/*G5H/9B)!UX0H\.>_]F'%V>'9]'^2>V.Z&=<$: RQNGV]
M1,0L#&.P>,*20U<+80Q]C<)$ZV%%?%\D[M[9P1>"GGD:+I*(;83O&>F9%5"L
M$Z>FN@:T'P3':(!/=WN?'0CY#)9B.-[O?8]@.A9L"K9K3W<DV!#J'+ 5$R<\
M]U!BQ+%#&,,@_637D?= 77(.-C6.8PRO-,I$(\^57D(8OWC%Q4(#\\K'KF[T
ML^OM\"H"X_M]NPU:B>\5-QJ:J$JA3+(WE(C6/E91?:6BB>(. YGD3. L=! (
M=JV-1_%F>X%29>MIR0Y'6OYJY //MYZ9M65Q:%-71$K&D=B \;PZ.MP'#%/D
M)#.Y>U>35#G",WG/$8OF8H_ID3$5RPE?/L<.LR_CT*,D#*_($_$9/[E/*+IE
M-A4%VNAF1?81)_#]AW<?OI78]-H?,HFIXLW*Q([CSV?.*$QC'B_!V7L#%!58
MTPZ\.-==XG@[V_]JTT5@_)M'?!?PXWD=+2ALA#^5Q',*\5)LU:LM(=%M$N"0
MMBPMD$$:>6G3+XLU1GWQ\/!R!SX&]5C ]QPPODG )UCZWW2BW=F';W".?:A.
MYC,-9Q2#0B_$$#K9VT%R1:.:[*:#,2?9K7+0*8E.W6R2*'9LPCV):]OA&942
M"74 9A&1JG\C,7I DXAB0<">T0+%BQ8S&A$P.*.RH:>#,<;<RY&<KM?$0?.[
MB9H:0 -) @.".M[>]M.#ET(8#9&&W?:?L1U$)2T\JO=IQ+^.9BZQH($H"-PD
MTEI0@^EJK:]Z>!,I_(W805';5%3),"63,<'K*Q(313YQQ]2]MYTO8/&Z"\\O
MTJ%L-O\(3(FXM)/I@$S:Q6+_RS4+=C'/D2@+2&[J@7"J2$N"J0,P2"CIP2GF
M*\8^,JQ*13V$463PBE$UB9SJ5E,T3!.^3Q#G!S6!34.;9QGQP[CD.D=TD(\I
MN_7J06@^(:CP")+D(VI S'$1T>*9,!^7@\#VB\B7?S=%,W42";>IH4K=5<2<
M+R+QY)J0.:/)DY%E"MO ]YCR$$B9M*:[!-T3JIFX=:::?*I6@^9=<F<DO34)
M$N%7)JD+OT"G8EF/[$I5>IN41YX:;^6]XB>,6:!U&U5"_B6ASG9G!U^*;D\H
MLZD.SAS_*,6T6'_04E0=E&EK[F&,1#437ERBXF?[@! +'HE[[;V &?M$@BVQ
MW1+=3:#](3B?FS@1)S$_&I)HK8'J(9E)N.(S"[ZL&<RX>E)ER#Z0>_9<_@_?
M5B\.O.8W3+$,=$O_V<G_YOO79W'^C5ZQV&)7Q/> _/1J=,6KK; !L A#D?C!
M,_QR+JAX>\;!>\/4B ?.'K!&FO@KBWDFYT&>S*MV??K$@G9$]Y=,BJ8DKTHV
M?>'X2$&N>A"3HESI]6('LW=D-TS=;) ?EEV/YFET==$Z+50_]"VM4Y.5ZU,H
M7"V,81J7H.D?LH5 O!)0N370 M08@U$O/-@!0Y[WJ;0T1"JTXB):]Y[&\$-G
M0#<0)>[9\4LB77A1[E9:HKYN.FT1\QS=*Q(Z@;>7%JHFT'9K[U<DC&<]R@G2
MK8!+P1K^VU<FKJQCJJM-37"]F9%U) BO'2N"I6UIX/'0E@O:(7K*H# -SO%=
MBOGW(KIH;R2=;]_/H%BE$O-L"O-IVT1G%?K$R7W&#"LEOEE^C2CTR)]S28XT
MRYDYQ_4V7+8-V4A=^AA.*;B:HHY0 W4%N'YX"#()"A>A'L@L'T'&,R],VE:"
MRAZFR++C;F.QR/;3>A3"U,V>6GO88RY&NMHV,*7+0,89T15:4*3YU?G\*>!+
MLF;MK;4.PQACJ^A6@F+NN73?5-WZR@&=HVZ:5C&M7MBI:S=I'2M= \BK<-1+
MI IDO&!RA+7RD<%,$E/,$RK!D,DB*:I2=0U@/=A81':0J)JX", ^W;/0]ODG
MZAZ?*9)_3&_SN8)+/E_CDW,]7.ISJM6MQNP#W<A*ZCNA)RYR-O5T*L#[1'A8
M(\FP1S)TN'%>N),^]P!30FBK"^W']C=H;4Y+,%][%+@%^U_%H*MK[\.ZD[TB
MFT7#Y!,X/90Y!W$%/!=4965G E+2UMBG%[,U(X<OHH"WQ1#'L/! L!<0)_(/
M,RHFWIBZBVA+ O0Y K)%2^PI>25;R:?S#&P,,S5N3--;CO)[)46&=>_;AP5#
M3Q6>^K;G@8#N/]4WC+G/,'A[RO,>_:=^3A*#7)CCQ0/3([KVGQ]BS2MZ*NT9
MHNK;?XZTN&EPPA#]YX\5V"Y)=\ODCD4'I:GI;@I?M!MLEE6P6"<[(A8M8K[G
M'# I%DN887&1K&D*B.SP5@70^_?8W>!@X?1E#]^R(Q:4O,GSCUUR2B+R$EV"
M=_KEJP6D2R2FU:Y4]KL6S"0#OH H%BEU(KQBM":+=5KV.:D(7D-<0Y\BI5^[
M()02[T\,36OTK[K1J^EGSDEH"7.8@&OBH8.%![:*FN\U%+?H9RC% DW43''B
MU8K<IDX&96*5\%YZX9?K@)1.Y=NI=*N>!HDXNP%W2:)G0FAJO-$D210=YO)M
MP0Y=C'&2-;9-4G!4)&+(3U^$_.V+!4V/>Q>!ZU$@0S06N7+:. :=$U=)P7+W
M@8?K]$D<Z3B,P0Q)YW-W'C3W-(ILC(=9[!Y&)%A@Q$5[L^:AK5; )@7%LY?6
M,^NZ$,NZ!1N31P>+!+;L8) ]6D!Y IIWP#KZ/-T]!!H4GMB,EHXDU7[).0<U
MS2$ITB9>[@6;=+&NOG/:S)BVG8UF0 @K%AY!JWRR)D S9\$5F"">CR\R\<T9
M!QT_LC@:;P#!Q9I'(O))W2SG4\8S6/1U9"4%?D/5"G@\L]J/VD.69??(;@@E
M_";CY<'Z.)F!([@D6/8;8SH<O^,9>.PW^LC.]'U72U'#8X9/$8/W(7:A+NOU
M*WZNATQN"M@>S<Y. _>0<=DS@,77=ZMO[0+),PIF,5*Y8KY[-#=/_UH/62R6
M.!]+.+D[CWJ((/>PDC>ACN9FIX%[R+A4"TZ9OW5C]) =<T:3ZH3X</@)/-$.
MU$/&9"6OP700-?+ '/MW#.Z]NZ"WC&ZP0'M6=.)HMIWPF1XR%9.,*&9Q)W<D
MTEHNH<5J3X:/9NW)'^L_@_>\,@7=<-_[^+G=?M1>LHS'YA(ZCF&.W+^';%AM
MP4'"Q08W-V%%':\PC8/UD4%Y?=3LEA?8EO%.G.5U9%#38#UDT -EC_C0,P[%
MWW%"H]O:$B^8[?: ZH)FEOK1BG7L-WK)SE"\G*2^,'T\!UL/VT>FA60=^R)O
MQ++I!JD3#N#Q#&LW9 ^9E9["J5:@H]G5>M!^,4R<4^+#]<3;;+'(GGB];OI"
M L<+"2],$>8GFZV9UGW@?C&N:H6+BP.6_9($%(Y1M$YC]II=95.;G,XKS8#]
M8M0JLJ.DUF=RM\?VLS+OU"U=5L&(Q&(]I1&/KM[A2P8 7;!-TZLN=R3:,E<T
MD.,VV=\=KWZ)[8&Z22T;\<86/Z\I5.<3ST(>&UT_<G2#63@#BC"C)*\9W,B7
MABX&$WL+6QU,#+K!D QU61"*UU(V 2&M0D&=!C"9$<RF78Z4=?!&DQF&^)[Y
MDMS!=@0_B753><=,716@!6?.^@F#F3G'M8U@KG%2CK99;1JZF$QL2ZNYFG[*
MDRV;^7*VT0UF82YTGJ 3[^R/Q,:G(B8$<[8;DIW:]S8S ZH)_T8=Z32 R6J
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M-1;936/,?K$%](1+,HH\KNZ%U!9!,/['.?>ZUR!LE(Y-G6<?;(%I*D&J1,?
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M$LIX#5,US4XW-Z*\U;+HXQT,^3SS!N)KY8;>$/:HF2Y8FT!:HQR^@[FT=^Y
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MNK+1C*<J V12:^YBV0['[)*(>E/N7RGXT4PN&#DNY[R):[\:_49(G',P1II
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MC6):F[O"7V^'$\BZY$OGPHY'BITG_/H:!*F;*0G%,:5'^AI# N-<V+CX[KS
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M%EBJAX3.0X9JU6LY8KXU2KX =/+46ZE=/6FVH.KJ,JWK$P:6HP;U(L8UJ\W
MVK#FY)><7[)J-MUC5U8N!^!YU=K:?@='F["^3NMF@\F1)J9:.-U[Y7? ;N)]
M.D4,"0KQ'"E?%NKUP#ZH:JY8\&V1:Z8KB.K]O ]^]TH!P?4]UF/ZH&(07,=C
M%4;5!8G@NAVK\JLH=P37]UAO)4LK(8'M+ER3:66!)+ -A:MO9\VJ2V";"=><
M<E4U)K#M@RO/^&'A)[A-@.L?8J*R4'![_E:>6$75*;B]?2MSK%O+"FXK7_NL
M']3'@MNVMS+S6H6WX';KK7FJM5I$"V[O7DOVJ4DE+;B=?&T:Z^8UM. V]+5K
M$-BKD06W"7!=#XA!P2RX'8!MN(&*A;54?7V/C%/-FETYU]W1.#7*@>5<=T?9
M-*XMELN@&SJG1NVQG.-N:)O:1<UROKNA']:NBI;+HQLJHJ+P6LYM-Q0_[8IN
M.=_=4-_T*\5MXUF=8-Q"I;A<(AU2[2K6F\M%T1U]SZQ^72Z [JA^ZMIX.=/=
MT/5J%]?+Y=$=35"_8%_.?'?40<TZ@#GGW5#\E!X=O1J N52ZHR#:JAR8BZ8;
M.F2M^H';M*&.R<)BM<!<1MU0-%NI!9C+K!L:J?WB?[F NJ&QFE4$S)GOCN8J
M+3F8\]L=S=16H<)<--W16VO6.<PET@U]UD:5Q%PD F7V;Q^W$F&D_$A^M_NK
M'2GAUP@'[K:HXXZ<7EY>N)A0X/$Z)7^9HH^)E 9,T]Z<:X.@%X9DZC&.PGNN
M4O%* 5<X8OIH^#.,HJY77LAK+#*#B5WDWCSP9MZ4B5/ 1#Y]&7GE!9BKX73
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MX9S;Z+97:ONGS\6XS^@&3=,B-2:N@Q)PYQQ,U[RM5R";D['J>B@'X76X&IJ
M;9Y%$A U$?X>**]UUA"1B76SIQ\\(\_G$_^X(L&6$A/Z];$ZYS:ZW0I26@KI
MOX5J)U)&-'$XY_9ZWNXG*!4R#S1(+85SSFU<_CL3F*D;FQ20Y#F-B=HI@^>U
MINJ36S;,9B+YFY\)*8LU;I[_"#BH@Y+7_;+$U';S9'EK)=+4VJU5T3D7-B[Y
MWGQ.,;OY<)G8<KF*+& M8.?"QH4J7+&UCTL+F)T+&XWIRPC92>!1-%G6AG<N
M;-RP8YXU,R'9@(^K">D% 5.F^D_NT/,%1"J@>!4W:]T<BZIC<9!L<-&ZU@7G
MU=?LZME)D1%WC%[2D?Y8$&8Y(1^GW39D2HLA%EY/S<(2P%/"DZ;8AN@MN2=E
MHX GNND@> Q%U*H!>0$TN[+-O#U<QYR0&T+Q%'$O1*IY,GN "2:8>BOD9WE-
MY5J'Q@38&HH71:LOA,%RQ4Q&/DQB2<X$L2P!7YK0O)29A?G*#+RLJ.?NZ%<Q
M$V?VIZ*017-2$1TO3V;34\-60*G^NN<W$7N.PS^\:.$%YY_NF,VZ4#ML; _(
MJY995#;L$YJV);HA,95*J$4*>,$S"R)+W\*47IAI4#0@GCNDA7]DM:ES@D6R
ML(":5SR#N%$NOK2\4;(!>3FT9JZM]%+G>F?9?<[X2,. P]D$!W]B1'7\:95Q
M\QIH%A:W^\S3 []YSYC=)*7S(%J[:DA>J\SBA50C'E()#Z\VUDQNJ**3=/64
MP(RRPX<;E9+J.MAQNJ(@1'(5I.\!;D@MHEB70_#]G,4$[[*HS@\\NGZRYM-X
M) TS+.]:[:Q"R(VA]9D0B4&=< AUCVM0?KC957F,G6)6E1X)MD]#)6X5>9=O
MV"=:?9(WOX_?YR%OEK,)N96X(2?Z CEL%PWM-)#27'+$UT@(A:SM-;T"P'<K
MLF825TE,?1]2$>?#@FUOU("CQ"1?%FPWI";DHDZL!=LLR>[AT4Q*+MC&2U:%
MIT@"!MN(R:H0:J85@VW:9%5(;Y%S#+8IE.4#3#^Q&6R[J 9N.'$J--R&4LTO
MC)*D:[B]IIH7AUD.-]P>50U(RB!)'&X#J\;D(LQ(A]O/JCGK4I7V#K?7E569
MU$VDA]O,RKZ8*J;GPVUQ955$^L\ X/:V:GQK57A1 +>O5>/2$CY;@-OFRJI,
M-%Y)P&V#9542)F\QX/;(:LP[H?G4 VX?+;O;1NM9"=R&6HTM$YL/4N!VY[(J
M/H-W+W#[=ME=4#5>T\!MY=50?*:)%SAP.X0U8T^T\T@';O\QNU*U]-P';M<R
MX#NY^$0(;J.SQE602F^-X'9#L[M']9XUP6V-UHR^8?)F2M5!K8VZ\N/KV][D
M^FK4&T_^G(Q[]P^]_F0PO'_8U),_ UA0OI"*%E[BZ 7C[!@;(<K#V/E<9=0I
MRZ?KHX193EY)OUDU>3UT< J#MU<_&PS+BE1V*:^J-'@;U1'L5ZJV4E;7>E5O
MP^(+Q[D@@-6J[C/2YH2R<V@XVSV7E-M<#FI:#;VUV=PEU7Q&R^#A,/L_>'W'
M-G[:E8FIU"$) NP/9RD30\K(9G_0X-H$$1SVVYAK8#MXP@8--V%%02L_]5[6
M1>*<@='9I+1J3+4&O#&W@FI9!SW"Y UDQ !V""IKT26G2 (!J*Q]&RL"V.;?
M22K8[58H[^XI%41EK,85]9N3C'Y'5"W.^#A2F34PGG%; 'GUK4*FOY@<07]'
MD3YO S>@+@#9PB]TX!Y&"TS3YWF%WVX8T]I%NLCL] DHU]O*)DI*3*7ET,K8
M=GH)E!%5>LMM:)J0<N8,-D85]':Z%&0K,6\:_KKB6:]#KM]B24%4)9R=C@/R
MHW,[>/IK-=F5\1GW &CN)!KC9QS$^(:29>;QEAXV)=\#:A)0H.X!^6P2OA'B
MA@7K:EUTD^HRJH&JV%3@S<JI&7G$]P(B-9W*'2^FIB\'D52U?=6 JZOI\R"2
M@MJ+#;56AP;EAQ%&E7.\4\RJ?.YO6&[,6IVB&DO[".L4U3_UE*Y[R#7HU,1K
MK@6!)_](=K^(>A'SA@Y]R)6)FET![_)$, D 0"Y;9L2'4"G4"PU /2ATR3_4
M%>21A^[QJXAK@%:-6EOI1U6GS8ZM72L \H[DU%#0XRAJO]61H-78R5%4A+.[
M+TU"*D=1(:[N8FHM\G(4)>.:V)I5HS='45ZNKL"T D5'44.NKB1JQ9Z.HA:<
MG9-<$*\ZBMIOUB6@&<A2E81KXXW++5O'S$0)YKQH<> 2&B9'7O*ZB_]PSU=X
MY#WCS:,7HS<OI=%AU8BWDA<J1O"FSU$J42MZ/*(-:R5WG]N.PYE&AJCXXX;H
MN-KQ\"@I23^W0HM*^M($23U@4#(#ELEX&3/QX3#LD^63%VP*IZK2ED5 CF%[
MPM82TLL(-D]+%V,Q9;QTA3V\8$3O,3L9EQY_T"Q;^*7?OE_Q ]M46567"7F(
M5RO?8X8)HS]1--A!]8#I,SNWY%M,#P6@=P'@4J+!Y,?O&",EC"ASG'40.&<V
M4@+'9(W\:+T1Y[:>@. 4$GWNG%GI7[SDK]!YXPZR=8^PS;]B5WZR^T5)H"HX
MY\Q*K^#",-CW4R4DK:W 6ZZ\\N'$'56U@)TS*_U^4;C(-DB01I@VZ^<&XWY,
MJ3BS6 ?4^/%!^>,8BE?(<S><L\%N23"?8+H<9:4(E,2:H+"3XR\4#QOHG@33
M:K+= 2YFZ;>026EJN96X8G3-J<[D2!HQ?2@OH9T'+O513JT.9[G=""NFK2+6
M?)$#[BMK;19!)^S4V)1:=B[D3#T9V2)634Q=6)NW(@^'"UUD4\/;PFU--= 4
ME)I*2A4CNZL2J&5? \L7L28477L;6 :(!=U=9M #2^BPP*V6HP!8YH5EMN6^
M!V!)%!9XUW5H $N:L,"YJ7<$6%)$DW-_X'!1I$.T$? ?CJ['O:2,Y?!F,NX]
MWO6^7_=N!_??^M?WD^MQ5MSR4_U _W"U:3@9)BD6\3)YH<>DW,<\0T1:BM((
MWDJ@7S6:+-"O!0NG/F+:%S1.UWM2SS?Y-W:W?*B+Q>GA@,-T.8T:P4(9H)T$
M@)(5(XW1B@&LT/.[]TRR]Z6#8"HEI?1;.(4?FYGT2D%A07!"6A'Y(7X*/==#
M=/U ?%%U#",<CF%THM%#:-N2>(1XE7K>/591@T<(Y8"K.53L5ZD?BLX:7-HH
M'720%?X=^V[:IHL;H(+UI( "E!E02JD\X%T&48SHMQ0),U%M2A1.77VC4Y$P
M;:9%WA=]E05<@*P2$R(Y*!0:J$YX%=DE 2:9GM0=-D4Z&.C7KDVO8\ 1AIJ'
MOZF^URT)Z*F"  ,(5G@6J(H XP4U%[F&$@HP;&!ECH4ZJB)@T(;SD!\N^%\Q
MH^KZF9-6ZW50.^U?[IF$W'_&81*"2(CNS=A<C'%RB ;SM$V5S!=I!2_,WCAZ
M3)@UR#' "<<[J$>TTBNJCP8RZQK^,1&0I?XX(LDI6N3(P;HJ<F!O5-IK. 7U
M59+5_D(V$O6_KU&X#J+%I4=\]N\I\I6.?1F(%9H>F>Y!7ZBGC'8<?@BV/4V7
M&TM=$DK)"SM[PLOU/5IB]5O.$@! SN-]\C1FK!S$3@^72Q3\&,YX9UG*3(;+
M)7G @4?H YXRI<KEZ12W! 79?^]0%%-&R!U:7YPQ7.?2'60%=R>GSEXDK\\D
MZ44W:,J[,XN[K8D^M?-R;!^S]"%Y^<=V",G7DC2,O?.1G8''^)GXS]SBWN-.
MT:!)"F7IM9R%R6EHO:Y[3,%RD_PES66["V&GTXE@ 'TY[</8(8L=DR1P<]3R
MU_-EW]HA8ROPP.5E/9FFH"1'"F.G[XK]20.F]]P3;FX$[K9UMTY(7P!4;%]1
M0^9E#<53[S?WJC#!XJ3(F4C\FN#.N97WMZ;=OT5I+L9=Q,]MO,3E\\9KQ UG
MJ5_VQ@O8/]E5D;K@!<0JH)QSPVP5@07E19MU-0A21T?B'&<_\C\)S2DIE'-N
M>%@U6.R"DBG&;IC4%&,$RX2N >5<V#CO].K!B=N)&>-P+FRXU/IDN?0BABY7
MA+>ZA?"8$(,X%V!2_,9XM7ELE;B>-\G66WU?NEA4P,Z%C7H3_X@19<>3O]X.
M)Y!YR9?.A1V]V(V3PG.#(%5V,4WG5U H10GC7(#QOCT&+D4O@=[*U@%S+FQ<
M?'=>X"WCY6- \R+L_*' )?+YS3#&[&*@LN9[VO#.!9BDSLT]AWQV"^,H'/G8
MG;-S+NP3GY=!I(FGZ]9#3QM)#VF:!S)/'EGDOY;.FZ4QG LP&:/Y$NR3D+NY
MDV-(KF"6@S@7V\O[S;JCF0=&A:'PZF'%SF0^6A&&2+Y&X4K 29%F?.A+ WRR
MH(SD738U Z202Q(T/,N@JXXT>@QHAULAUR;19T(D!G4D%NHQH$'YX6F@B/!V
MBM?2&#+H_.CFE_/[/>]$D6G(?="$-.LR";_MEX3BPQUM+:8-6>.Q->GO;:O+
MHNRMY\IK53\44JMF;!NWA[6Q%;0>,G:8#W#D#&FD%0#40>PLQW=_Y!QF2+3^
M8,7\Y"DA6IO-;<X%\&U;2O(AF\)<CFZPI\P-.8:CR<)Z!?I0M''?NBQ%Y7W(
MPC07!MBCT@:E4BG7!M@CU ;%HY'= ^QQ:H/"T,@G E;ILO&C59J"!*ST98,K
MPSC-"5AMS$:O'7EN%; :F8WO&)T\K*-H)6IE=0BRP%3M0CLD 67J62Z+;JNH
MNMEJN3BZKYL:I<7E<NFV4MI(<EPNNV[KL#HY=;DHWK#T2I'IM-H*5[B3%O;)
M!#R1.+IF8ECR=M./(68LW7K/;(9GW(AC-NYZQ'8(]_9PHV65>$# %FT1DGQK
M7*=%C0IF:18AW6;56.1HX)3$Z/N(G5BRU:HN2:V% @[+0C(UWC,K8.$P>1E[
MOLM5>)U'VKO?PF%B.)LQF]5D?DHAX-3%YKU(8G9-FK D@'$,7\@TQ]3O>.%-
M?:W:&[N?.H8O;)I\/_&:>*#9CK[QHDASWPBAX%3(N<4HQ OBNX/EBI+GM-V?
M!FL2.#A58)H\R(&]AK["*XJYRY^IG'<X6G!GKX !N8JBCP=0P^TK'$ZIMTKC
M(9F./<-516"&K-B(^\T>]VAITT(+RT@Q[?@3'C7_(BEJZ[F 7^SH\R )LB@T
M8%AY&D:4"UT4!QIR!YD4Z<Y@LQ)J\"I6JL%F&]3@]D#M!ILS4(-)F38.-BV@
M!K]R%;WUV+]1$X+&;Z&CRBZKJ=R9J?3O0B+F&K[BV(<2:7A8$!KQA/W"X[0J
MX832RAE% LH&D@4!C."M-(Y4C29K'*D%:Z6F=AEV2;$_T>>-T2(M&"<&L$+/
MMQ@E24A\F6?X^SPKE+^_C-C]$(A+C!K!MT+MY(74HC:'-W575Z.6P=:3;@&#
MJ2^Z$L4W)*:U"-XB,'4\5Z/7>ZXGX"T"*X6_TYS9Y*%FDFLP"$P:CFI"FSJ'
M&S^G[%5NW7D.GF9BC\5E$P5? W*J;EJ#\RXW$9,5?ZC+V]_D9,N#4@K@EIVF
MIMK'GNIHHA)TQCUJQ/2AO"2:"CC_IXI>/>YRS0>6[T]-[B%[)II3][DM:E[
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MA-\;Y[V72X^IL;%?0"[?"J+/B\GI'3W_@-UE?Q#Z8Q",*&&W;RB_NG8_=<[
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MPE8JF=_QPIOZF(\5WK#+_D^,*)^1;.#_C@-\]E7)JBD:.+EJ]K9CI;2-\I[
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M,0M#N(5/+HL) E0YDQ+WF[^WQU\L4<[\#;ET0R_1XJW5:_[>'@\P"*(7=-]
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ML('+@:].0=V*_Q9J=^ONWJ/&O9/JN1':P*<)FPE>DT^+R)&MRPY .^X.Q1T
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M1;$T>P F([:*/X*ZD-I]YK_JICSAX\KH-2H8BG*/T?FZ4-H'<!FQ,>R^AKT
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M!Z*8%=7N@-:,/9,/=T=R8\],O? $4YL.X#=CY^3CUNL+2/-HZ!,"#LS82_G
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MT W*'#"AUXB7HX5\EJ,PI<<@MYCV!UK7/(TBVNZ6I.O(8W\@!I;]$X,$R9_
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MA&W)1TF2C-:Q5LCG)ND!F$Q8$39"7E968>8:+0&#"4O"*%=5\<HU04DZDGZ
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M>T +FKL #P6?TA;O1:5?85<W0&?",GS)7.H)$*\*!QGB.RH:'D:2SKV'.@%
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MN)TE$FJ= )M#E]T>/HUY@.!, X?FK<E4,Q<$6&_3ZNME25MIE5WL+;6CE(S
MVR6CT,YA>Q;6@<"%30>P AD"=-J)LH.T%%Q8-N$6>=R=4(]&0KI<LG'D,?U
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M(SC\'9Z*4KOOQ-@K[<9*8%6FN'H-B2D/$H\CL%]77LJ#)'+LO)1!Z _RUB&
M7B](Q14P91>%%_1;F>L".(>H!=#>UFTK.\:G@@$3Y N$_TU?/D5Y]("A\#=,
M#$6>TTQ5/FCR9"_G;/2ER/. *3-Q%_J(A4V36;ZSDTW ?.=T>T,A5:$%/9'V
MDA30I4H4T71*'GBO\,17[6Z-)&JZ/CGP3R-0D_:PGDG3-5%]:P4X]$3M2X(#
M4#E&-/&*,< KL<%R(MI /.TDIQ&RO29(&ZJW=Y\;6-8%^<HF8]5,QEJ.T9>>
M7T%"BJLTNH=D%#8O</R0J"^]!7\9!VR"_2D'["QI:<U?%N4MS>ESE(DKMUOV
M:Y%']]G+Q;<UA4O?1?&!RGN/Y,.FOB[J:9&CZ^<&XI;G]UF*=:R&)S#(4#3J
MP  GO)*/1MWIE6H\Z!T6BY;W5)T%$W*_J3%_1ZP/BQ1R7"=?8L>3<#>^9'?H
M]"PZE#>\I.F2R#XQ/)2J"[F$L'ZQ-$RK9Z*Z]K20CB=*T^)Y=1(\GAR.:4QS
MK"B5)Q=Y4C!3$G<2ME'P_[#%KJK&Z&>H-2>J?0 QK7TL7KD&RF6*7:PWJ;$;
M*78S;P%T[FP:%PJ7J;SR'VW7QZ4M1(P-#*P=-5G!39'-4'"9']_&0P][3N&1
M+DKF)VS2C;V])\]OC.55$>5--A#W)9$UT[* ^%S^.A@PS@>,NODXC(6M-7XW
M5=D2OB>U, S<2>CC ;YON%4S#'MR#OQ8&W0(*3JNBOQA0<L53X@P/"0Z8^W?
MUHR KXI^1@;,B(&0,!BI2&;A.03:.'#C46%+Q/YW9C'R#T59%L]L(_H4U9L2
M$WNR]40<:>;+FS+-XW0=9;/\FGZK%\\T>Z*?V$'E<4#:V 9?";V'O)DOH#EG
MA.U_6(1NN<DA<NL?FY2G,)6Y,O$^KZ*Q&)=\V559.DN:L*T2EX[[%_)89 E$
MG]9DF7Z#<(*2=0>]ICE^LB[36"3G2#!,9(4<L_[3'%_?<L8@:UM!SHX7&I5,
M-[(,98,_PS5$U?K FYX<,&EVK5*$R1EI:)^1ACI<M"KZ6#D1I,:[(+P/S[IX
M@'#,AWS,\LIVJG<XZ:]'8?_*1GN9/KEF"GT]BKI,E_7C[TU3U6P=74.!,@'2
MKT8QE2Q,"ODS7*#]@M/J+21S3Y;86'Y_RLB8^IUJ(TS72-K(2+\N;019F+3Q
M)]#&GU^C-BZ8GM!H67><E5ZE3B([O^\]4INV<72SZ>!5::@F%V.QDE&Y&E-+
M2_K[LV#KQ[1,?I_:"=,UEF(RVJ],)T$:)G5\#]OF3Z]RVWPN?G?JR'HJ\M^G
M/K+9&DD;GXO7I8M,$B9-? >:^-ZW)E;5/+]E*A!5&ZX)BT)Y_<$-%/J,+XH[
MFF4=SQ)513 OF$8#.-/<^C*XR>)>X^R'BI'R .(AC)J!RYB8P[.1SNBBT'U!
M\<H."<$/0,J+D_4P9LVO!OO,JC<4;U;KN\U*NE_=1&FR*!8BW6Z:O5RQ/\R7
MRR]%^96);L FPNB^K3:KQM-JS2AABK>&.%NBT^1ML5R29T[_]-@>QKX1W(P$
M830:]SR@ B#6Z! @Q-;D)1&D?"W#P_@UXGNOF?6%[T_1MW2U64VQ1![7YG.:
MI4Q4DR1)><V):9%7*3-&NF-HMX+"&IBO.'D2*_H@B(3W0"+5!?@)-GV<'.;#
MI6!"NJ!"&C* <D&(-)1(BY3GF>>AIO,E#+K@OO;59%,_%B7X<5X6Y>"@$2F&
M7 6QQDA;Q@=&BCH^U/-\&N$$AQQ%+C9XB.!>9H!RVC).L*&.#LQA1G4<13JF
M9?.XJ/&L5#<J$^!\.<GS#5L][I-YFMVP/A]AS"ZKJ%P[F[2"Z-:)Y,CTPSDI
MTHRL)45?>M+/JDT7FM:@#Q/!VSTS!1AOBH1?K/=S:,.SV^P%A%>,B$PF>3+?
MU.A/Q0ZC/#CK3MU='&>#:(M&7(?@54G3LXPLU.Y-7L?^,9Y(W?6)]XO>N%K/
M,IJPZ3N K:?WX#FZ6-V5>"2D>EL#TAR8O-Q 8CYK6I+=DRR$^,A@MB42: >T
MG5[[C,P8589_2?BGHZ8<<=EKC.,V8E*,6XA;G3+UJ=B)*PP*6]=%?<L'NBA:
MP6WNUR>K?800!AB[N1^ 4@Q3%&3@D-D.@ P)P]WL_E[ _3DO57;(:50]?H@R
MR*!RV[P F:T@P>I&:TYBUI[M$$A ?T/RA%P'UFR@U9L3:$\$ 7([+FON8'7@
MT(93;Y/GA,\BC^LBGT:K]::Z@7/&SU-TZK];TSA=IK$EJJ)5R8\9+RN>3XTM
MO8(JX63)6X*4R<]3\@;# $@EJ)^^?K KPT;,MME23&%[(@F,&N+0;P,[\F=$
MK/.T^8X_<>72E/=\.K^^6]Q^GBYF\VLRNR8WM_/IQ=V=]\B4:UK?E$5,:5)=
MEL4*3R[SY;QD!X>H?+%4!)AIRA?=L^,&5'E!.F3)"(D$4Y"'1]#R52; B4.3
MXD'J,]F20%.1!0V2WTB>/)8,<.++I'# 5\=<5:.QXX1%T*UU6D<9/,5.V0GT
MA6'L.2J32M77FR^73.&X);>(OO$"7W&Q&N"UEA?YVYCW0S)X\XWUGK0Z>LR>
M*[ [:?75O$,H6L1Z/#V2#Y*/$>*X[G)1X/-WBZA6K9&3E<:^($PX94^K\6'2
M,"H&D\8Q@.%3?S9ER;Z"M"II_L#^"]>!_G?2=JFW6#475T-^'T$=^>H$.&]+
MFL;B'G'TU\[^-=R-LX[Z%98Y\@9!P_,;OPUU>5CJ>F(3]YH)=R.$+]>T3(O3
M/RU9V#.BK^-!E3?Q@[AN#HQ+HG5&_*,,:KC4*5MZFVHO=T76"S8=:(J$7@0&
MJBIY1%<76WT@:WAI&I([?Q6B^CGJ UWG[/C&GO:TXUA 0M4DT-]F^I.0@J?U
M/7U(\QR^9W1&7/LXZ8L\<9E4DP1, -6^.X.$0@T/X[%P5T=EO2\3)DRVF#!,
MAZ^UPC1^T_U#LTKH#ZYCEOD8HDRX#TFW!3$HK'\TB?&R<L""SHTAZ;\@E4Z4
M17JF[+=(T/2VOO=S:U_GN?4J"<A)Y#6MB*3A><7OY]&^\ENG,1J1Q\&PW1>C
M52! '(2ZL/ U"$SAP$:NNBH7ZKR\I?AR. !#RIIH4IMB1E1.Y[B0^@OG,<?<
MU4ZV@8U%$\S4=W^4G\G3GM_MU<:'!7-:!2TMB^\<DO_RQE[/?C:F++:#$72>
MEP$;*S\;6/E-IESOV%^T/,$OG6G8>6PC6TGBNA@G0.*?M"Q^.XX4?@E$V_9;
M(->=&ZL1E/CYR0L['+(\KCMW7O';'Z^B=8#+X;IOVVTO@>NQ]MT]%CT^=&-Q
M:@&@T66]UPK'QVU:U;YL:T#(VMQC[-@V&]W"";%\2S_'=A-[6V$"M!BV&;(;
MW@';"]N,F-:#W[NUL"T#T]KR6FP%497'=4T)N A4%V>.:X?X/!!%DX,WK1.R
M4E00>)JO\>DT?T!?8%&*I+-(N;5R3B%)"7?@HB%V<C!ULV6\JE<CYW[;VO=>
M]I_NT1OOZ+OE3J(*WE$FFX=-59.?WIV1]S^^^XMGK+%QS9>+,MJLHE]IQ#Y\
MF+*&3"97UO3_36O0>]Z>" )$4!@]I;X#YAS8LV#0+WO'F,7N&@)N+/K)S^_&
MU?X3Y[?,!E;T^Y 6&?M''&7[YO#G*;/N%1U?J?QM[!BG",?=- @DL;^-#>-"
MO_CUXI9\F,VOYA]GT\D5F=S=72S\.U,C'^=T24MF5R^B;X?!*Q&$P+N0 \P/
MOKH8Z@:8; &.HA)BO)%/@'7Q8408\A$:GF2=RI0>!U190\\[M'9Y<\27UM!O
M$$P_1X$CS0U>VM&'0TI#D8"='S -0="I0..Z-@W!2G:BL3OCYI8^T7Q#]UV2
M2M[<#VC:8^\&C/@N"+"TQ]P-E/($8W8!B<QIX5 C4EM<U%6<*M'G:7'I&+X)
M*RHGR4EJ0CK@I6/LQN+DR1/&!RNYYPFI-NMU4>IS$ B6H-SPC'V9/X!O,#?G
M$/3N86"23\B;HBCY.LCULF5!&R\KW323%C<V](N[;GY,"%3\P-ZP,R?>$*=G
MV0(]2&ZC9YYHZ\LC(U)%&?T4E5\A'#.->^,0R_3A$7--JM>DS1K^N96 2];)
M34@9/:N_/LL.R0I[Y,FV3X_6@2(Q@K>=8(WS>@N\BB1KBA+AI C2\H7G@1P;
MX=U.N.8ZNR'@_CRM8E@W.>N?UT5NXIHI^PV^X<R7"XIIP'L?3]KYJQ+1C13.
MAG74(15<(R+Q9@1MW_V(F=(]+-U'D5._BDC:4E> >H>2X(; N\"K6,JSR/M*
MOW,<"?6KU%#XM,#C-26]24(H"/;#?Z=9\5!&*_9+F=+D5[I:7V;%<X>ILYN6
M04D%$CT_BOH,P#OY*BBC[( V>63$R1*I!Z%'_3(8H#=<-=B/1)+#GY%QH$@X
MR8"4I)_] 4KA..\AJ<!M5--%P18#&D=5/8,7)%K5DSQ1U2:DR6@.,=QS]RE9
MMYCW7W0,MBCVC&>BM2K.H9* =44J!J%#!PMQ@(I!7U@>0DI.=H>I/INR)LK2
M[XI:#4@)#Y;? !T]&O)"T.*+U3HK7BC]POY530LV2+;AYPDMIU$>)='%BI8/
M-(]?X/>[S7V5)B]VA961_YKDJ.B#/$,G3!;8"]E -X3W0U1'!'HBHBNONKF/
M:/K54%)%/J$F"Q?&YWYA>'DO.50@_7JU/SH"6'_V$8G)B76(2"Z^W(6P<MP4
M-?O/-,KFSSE#T6.ZELON-%JO:8*9DN?YE"U[49JC/-(H;W(KW]*'3<9=4=@Z
M#9E2RBBN-XR>NUM?>YU9RQ&10@ZI69MC')3(GPPYA/BXB!R8GGFY;(:&:WK<
M#,ZKG^#)Q=^_G*EA$#6.QI[@(Q&IP.=,UMLRUY*(:^-!.T0;T=@>C@-U_B22
M[U\W3XUV_VL.L]TF<5QN:"(%?DMCFCYUNO 95XI*]P)6 BL5)1!7Q)]9/"JX
ME5>[6J+!+AHWNM@T]ZY"5M[LP$=C.A*\&2;/PX3A50X#"P:[8_8$R].I]KW(
M$,$30GCUB;$QT0$UQ00/NN$9']Y\=W/WN?INW!2P3DM&!E$-L_R\?$GSASL
MCF5./NVX/*RQ/82=)$@!?GOPL!ITLF&<%3[H64[X]P0;>'_;[N3!J.A&P?O'
MD]QJIX\0<#3+9ZMUE);0#-):GF_HHI _Z3<2 ]ZYU68>(QT00:HZX8DNDPU>
M.S0?M&XD3H_.?85B!*_BGS<!&#?T>-I31A&NK9H/6C=:OO"]KQ2,\#\8!=Y
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MZ$Y(?@ME$U=UC"CM8X,1:B8T+Y!N\^"9V-UW53V0SFXK09FU/<@;'_S_T/S
MMJ?9ASV8UKWG_DL!;M1WMBEBM[W%TZ[D/07_]VJ>GEZS:<T;?(7[6-M2?<V#
ML\._'QY].@B,9(1^\R%T=]D;5%4W+F7FA/8_MM4!-$-/OWC1N&9])=OCIUYF
MEP#"'@S?EMC2S89VLPG:S6UNG9V\V:G.=<CB5+WZCL5=J;XF57RC44<>V,C
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M;TC:C#C/\N_IK318%$2380_#\1:!Q@J9Q+FS,SN0YL,WSB);6;A4?=A888O
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M];&BLL.9)\Q#H[['5VU&KBNF]10.<8^AM&V^^CCW1'>JF[TO-+@>TC0:7*\
MM9832.>>R)"["3[#FD"!SZQTH6=T]T1]R@_BVWU=C5%M?#N>F,F@+?!I%^OG
MGF#.PK.HEMY";T+V+D<T;,FE*S6>:#XRLP-[C2KD5FJ49CKW1%C:>"&AGM]3
M"WYP<.L7TK1@.2Y9,HXG3K6F+**^USIN4A[SPG7$PNZ@'@9C!T]D9DO9I/A
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M=ZZAV0L/BWG3B6]Y/?<H-ELVTQJ7)^8=D:.P1'G'9CJ-._&MC^M*0>VA[S*
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M5%A7\<DX=(>XZ[6FPK\VL%%A8AO8T#GY3\YT>:0V>-S!TNH6Z-QK  ,ZQQK
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M(<3B[.X0HK$T3* X2UH4OCMXX'J@])B9ANG'X;L4<=25>4G%K@Z$9'J:_M'
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MHZ;H<VGO$I+!%QDH'=E!O&,^">D/Q8'08V=>IW9[+!];H=_=[)C7L3,Y4%_
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MN)7&"U3X ELXQV,1IQ'!0V=XVM\(C7&-(T'C6>-(T-AE3^V;=>(-AVS'H3/
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M/T]?TP^=WCP+'\+O"^'5F[]02P,$%     @ @6A^48/7X!3VA@  WC\) !0
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MA1. 4^96T@0"HG%.0.8QQ]\$D?Q13D!B[MO7)F=L0RZYS/YZR)PW0;CNV">
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MS,.N\#YD#\.-,>]Y6IYVWZE>2?X2-71NC'GY=,DRFYHMSZY)%+^90;0Q >N
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M)DM0@[ F6_H25L>SKAW;TF14T!N4;U&'R\MA$.<!MA_Y!GXK<UG5?$VJ.@?
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M5HATLRG/<54(5+>A3J2</=+HJ5$MB[>S2!X]-9P'L7M6%;AI%DN-^#^KJMS
MH-I$Q*%%M7"@MVZ]<$6KA-'S0,N/=02KGF.$E>0\Z!:K(M2OJ(/)Y SA^ 'M
MG9+02XMXJ%HP" R>_.C.=V,MKHQ>G0C1^EO37(5(@SM4''H*QNG;>MZ%P:WU
M.7HC5:'-X'<<06NI60@0/I7XW/ILN>THJD3_6EF]LC:&E:.1K2QL";@E-<.;
MH8U!]@&J'C8-9Q.R4T*41%R_%XY1!@/WL0&+TZXM3E[*F:\,-7Q4-YC^([ .
M[0K1X5;9D1J_+3C!Y^]'R*P*(EC4.ICIR-K]6C_J'<R*9"G_ !8L;ZD#9+/\
M0YWX>C"9US[> 28H__U(P2#LA&YD?WW!V'9XU3,& 'I,&J1E (2R8NZ!'->K
M@%8BH*GG,LAQK*_&,6A_ZFG!1&D6K//5XQ(JNNN*2, 4(24K%"67!T;]' ]6
MQ6U7WU"__1U.*736LK:#_GC0Z]ZW)IW[\83\_ZG3GXP'#^W6^,M#;_!M/&0
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M5>X2:K4'<?,9H^F:WL'D0 LWUM%W(*/OWR/DPD;=!"UY!Y[SM3D)J=KKB+[
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M2X*U1\]E.DWJG,73DM?J$\3K]'@&=.#M)%B:,0+C!'=^3%&<AK>0&Q=1EK"
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MM%[^W!S)JV"1!Y+KI//-\;O*&(IYAG/$KD)%_2S'.9A7\\F1,D66>#G'SK:
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M1.@+0SV!S1FD7UIYQ!!T^ICRIJ%WCU[(M DQ<3>.UQ*K+J^1-EWE1Q43#IK
M1B32W0"I:H]*J>0\(I9_C'=J%9O3XB4 '@$$"L(/NX%$GYMSR3RO -U^:'V0
M^M.GZT:+.PUFJ;HL2P@7SIFBC'=;2UHYMQ"/""LUE>ZK;I@>(*:X(W^EO^+R
MWL)6SJTQV=O)0D\1\F)64(=,6 2Z0BOG%B31NU(QI2P<@;,$6GTXMR"O.\N
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MGHG:.S?&A)<6CH20JL)WSLWOYY+B^1)=J4;I2/:R(OJ(1QM/,7$LO5D!@Y!
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MK:N1K7_HC72S@SG[ 'I<,!\PDUYR$'2;T?36CW6T=C_KJ8W?0;!C@TS!)X!
M1L.BGGHXG$]0M+Q'+X9%,:DXJ=[A*$UBIN_TJ=ZEF6Z@\OGKN84J]F>.H]YN
M8G>;OKM$4G>NL@;FDJ-2X*FT"8A#YYT;?A_,GG"8$"8IN%OB,0I]'(W1E&P6
MCUX8/4Q8_NS/)S=91[1XM;OY<$/ZNA4Z@(+T#1-1EU#W?W_:=D/7<P>K%6&S
MUR%S]&_-43C=M*;8W0HT]^@5!7B5/2ST0BU.;XQ6"9L8G>-'(?T-CPH2T_<5
M+?QI@.A8\0/AU?Y$;D179#OP?Z]#=/.[E%3=;LQQ.-6[&GO:+F@:?>JZ(98N
MZ'W&G&15G\-Y&\<)+VBT_&-SW"%W("G>C^:X,FZKWU*!'H<I_T6$P*4B2?+F
MCC'%%#1)*R'ELUF2A1;+J*2[56>Z++.J5 2!ARF'M;,,-!Z5JJC8ZNG!I_/8
ML0.*^;0S[%L'R>;96$LM CH@5V"@+0W\!GXQJO/BMKF.U$#B>+]R)0<[[TLP
M[#A"RW6O2?%2DHC>@3T4",Y2*<RRE!=%F\>00;U A)%Q X.37%PM(%<+R-4"
M<K6 7"T@5PN(B5>M41:04]Q1W9"P22A.1H0?5+RCBDU C#J[KNFV2KT$_\V0
MY%T\W ;F6$AV<TS/2+)1A'?[><$"<B&<^=5L<#4;7,T&Y\;E:C:XF@TL ?EJ
M-KB:#8P"5E/U?< I6_;P@%I<A"R]I5=AHWNO($8T$3MY#H7WD-SY4W_E!B.T
M<C?T-8U'Z%]KGTQ_$%XC ,#UWZ7"^A;GO/MLH['<[MME*:Q5-^R3=9^\H> 5
M4<9SP?/6K-\QB"I1?QJ,*WG#8&1E_8&H_RJ.3GHLTP;5[%%7*0A(T0->\U2;
MU3MT-'.W0=)#N&%8>DB'CF8^-M =1Q@E=Y9P%=!UNS5']]K'Z>.;9IH07O/[
MGQ9TFQ?"LHC+AH!<^'9J(LX+\^X!NC+>3<&;O8=7=45# &?O<X,N/^\<WY1?
M> ?5F\]U010XE_KI#JQ&6< P@24Z2'#B!F=V^.-A],V-(I=LHJ]NL$Y_&L?K
M)2.TDBM@>>1E82+C!5GAMKOR$[I="Y/AJBXT>P#15-RC>!KYJ]2?=N3'WQ_(
MFUM4R6YQ>Z3_WRW+412I7C<@6HB]03L_5FA*W77]&8&NPJR%'8#H&4J'^XH#
MLJJ!GVQJS)G;"8@V83O*O?_J>^1PMN(ABJ;T!,\5MX=&#^>K-JI__$H>L@H'
MP2;I#!Y#V;&T*/MP<^")[@>KI"L0"/5N*\L")OIKZB30"KUOR)\O"(DM,B]"
M>.<'P<"/$6'!IS19/4-V\)[XIP:UG0SSP6RP3N+$#3WJ[U* 5ZS^%+<UQ^5?
MM)_VMU.!E&[(?O'BQL@;IF)@BQ[ .4O53\<2@M/0F.:4?]RN?I&4[&H2DZ&T
MI[1[-<>C77WEE0@#W&G*X^E:SDZ[R[840N\SQ7YUS7 F[#1%T@#WFL:(!MG^
M2G;% XYFR(>_U13[-2=B0GWM%4D#W&T:(YJ3N:I)WNNS*43:Q'L52IE>FG"I
MP[7;5I( $+SFN'HP99*%J-<1"BRJ>'66?:PC,UAES6]X_ZH+&]!5"2;O<R/K
M"216F?0;WLKJDDQ]<[]!"9+.LHOU!)TMWK]?=[&F]+1%[H\F*G!<-'8-"E=;
MT#_;4O:$YQ%4W'<)GGZ_&K/ ([EXQL016KI^R%)&AFSZ:S=(#?R<RT ONQ?L
ML.:8T$;TK,;4K%^TQ9+7B#-]:9*P*AU>+AP*2<:J=0GBS;8WY/]#$1YB/TR8
M#SS]UP0/0L1^1+VV.W1?"Y-15>T.GI;B0'T_1!,\>2O,1I,4]=Y ?/;VQMX;
M*1V<3H/];.S_H.[>ZH0H=P;DPU<8NC@.^6^"Q^@5A?E/Z#_4Z5#N#"02<&_H
MO9'8RK-MO=TB!&%-6K0Z-,<$V<C;U]/.\@8_]/LP$QE#9-UUT[4)51K '*N:
M0*-(^<9F'"/D/=MA(6N4GX<RKIW?''$JP'C+5%&"L"S+3U44H%"U-6U?=1SV
MD:TI$-D4H7$"<+5$-(OB-TX K8[0:)'1_03(ZHBQ5IG83X"MKE@-%C!OTLX]
M#W_6N'QNY?W=/&I5C:)_7&474+R!-!+O( ?0><Y!90U(8]R/42;L%)CWF]/B
M-#IUQA@=\D5 MNH*?1MF@56S,IMH.E8V"%<SC399-R5)\#+;/$JULXZ^-X>8
M"5ZI4W+XL3FAN'NWG#\/_9D_=</D.<0O,8I>TU=K18[U,W-_?7#]B-[;A Z7
M-J+OUF!&+G"45#"]00UHD$U3EDBEQ#]>#%>%#@V%(YTD9;)J@2#LQIQX4$E&
MDUH0*'5G3O2G*#.)+@Z:?>E:J>49L#(O:G(5J1]G_4X*YF([C*'5&$;+#$,
M@ AM;Q:;*=5LCW9;%'F::QG'_$[!*&&Z;2YQ!'RA-,2GV[P"D#!QEZ6:/&"G
M+\!9P9?)(>] N7YRS%4%'RN="$Z-O+ZH!>9A\/Y@KR0B-N9Q8)2U:,? C.+U
MU4($J/"EM0OB5NBU,8&7[:V,$(Z%4L]&5*EW@Q3\9%#)C.6ABJJ=F$.V<*H*
MI@Z%]B#!>B/"[Q(1AUR$+ SZ.?0%TQ,W, ?\.L='W_Q2>03S<GP.D@6*.O]:
M$XZP&Y)U7J>E5U2S"*@%0M4;PSS0BE24TJ:BD-?MS!SCE'A=\YP_@^@KN3E
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M?R(W&H1(Z#,C;-/8K"9O6'M6>1L01[W2$<CW^F@56H&XZ96-\8#7D?;$=HU
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M-]\__L;$8!?F_>=_4$L! A0#%     @ @6A^4>/35;\9+0( )2<F !
M         ( !     &]G:2TR,#(P,#@S,2YX;6Q02P$"% ,4    " "!:'Y1
MH:35P[,U  #"=@( $               @ %'+0( ;V=I+3(P,C P.#,Q+GAS
M9%!+ 0(4 Q0    ( (%H?E&,3(+4'!(  &;]   4              "  2AC
M @!O9VDM,C R,# X,S%?8V%L+GAM;%!+ 0(4 Q0    ( (%H?E']D8#Z4E
M '-2!0 4              "  79U @!O9VDM,C R,# X,S%?9&5F+GAM;%!+
M 0(4 Q0    ( (%H?E$CQ/8:H%P! )]O$@ 4              "  ?K% @!O
M9VDM,C R,# X,S%?;&%B+GAM;%!+ 0(4 Q0    ( (%H?E&#U^ 4]H8  -X_
M"0 4              "  <PB! !O9VDM,C R,# X,S%?<')E+GAM;%!+!08
1    !@ & (0!  #TJ00    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
